PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Younan, ND; Nadal, RC; Davies, P; Brown, DR; Viles, JH				Younan, Nadine D.; Nadal, Rebecca C.; Davies, Paul; Brown, David R.; Viles, John H.			Methionine Oxidation Perturbs the Structural Core of the Prion Protein and Suggests a Generic Misfolding Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE CHANGES; COPPER-CATALYZED OXIDATION; SULFOXIDE REDUCTASES; SPONGIFORM ENCEPHALOPATHIES; ANTIOXIDANT DEFENSE; DOMAIN PRP(121-231); HYDROGEN-PEROXIDE; HYDROXYL RADICALS; CELLULAR-RESPONSE; TERMINAL DOMAIN	Oxidative stress and misfolding of the prion protein (PrPC) are fundamental to prion diseases. We have therefore probed the effect of oxidation on the structure and stability of PrPC. Urea unfolding studies indicate that H2O2 oxidation reduces the thermodynamic stability of PrPC by as much as 9 kJ/mol.H-1-N-15 NMR studies indicate methionine oxidation perturbs key hydrophobic residues on one face of helix-C as follows: Met-205, Val-209, and Met-212 together with residues Val-160 and Tyr-156. These hydrophobic residues pack together and form the structured core of the protein, stabilizing its ternary structure. Copper-catalyzed oxidation of PrPC causes a more significant alteration of the structure, generating a monomeric molten globule species that retains its native helical content. Further copper-catalyzed oxidation promotes extended beta-strand structures that lack a cooperative fold. This transition from the helical molten globule to beta-conformation has striking similarities to a misfolding intermediate generated at low pH. PrP may therefore share a generic misfolding pathway to amyloid fibers, irrespective of the conditions promoting misfolding. Our observations support the hypothesis that oxidation of PrP destabilizes the native fold of PrPC, facilitating the transition to PrPSc. This study gives a structural and thermodynamic explanation for the high levels of oxidized methionine in scrapie isolates.	[Younan, Nadine D.; Nadal, Rebecca C.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Davies, Paul; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; University of Bath	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Davies, Paul/0000-0001-8022-2719; Nadal, Rebecca/0000-0002-5526-3508	Wellcome Trust [093241/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BBD0050271]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/D005027/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Project Grant 093241/Z/10/Z, Biotechnology and Biological Sciences Research Council Project Grant BBD0050271, and Biotechnology and Biological Sciences Research Council Quota studentships.	Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Binger KJ, 2010, BIOCHEMISTRY-US, V49, P2981, DOI 10.1021/bi902203m; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Crowhurst KA, 2002, J MOL BIOL, V322, P163, DOI 10.1016/S0022-2836(02)00741-6; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fernaeus S, 2005, NEUROSCI LETT, V389, P133, DOI 10.1016/j.neulet.2005.07.032; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JI, 2001, ANN NY ACAD SCI, V928, P182, DOI 10.1111/j.1749-6632.2001.tb05648.x; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Lee DW, 1999, FREE RADICAL RES, V30, P499, DOI 10.1080/10715769900300541; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liu L, 2011, J AM CHEM SOC, V133, P12229, DOI 10.1021/ja2045259; Martin SF, 2007, FREE RADICAL BIO MED, V42, P1723, DOI 10.1016/j.freeradbiomed.2007.03.005; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nadal RC, 2009, BIOCHEMISTRY-US, V48, P8929, DOI 10.1021/bi9011397; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Pamplona R, 2008, FREE RADICAL BIO MED, V45, P1159, DOI 10.1016/j.freeradbiomed.2008.07.009; Petropoulos I, 2005, BBA-PROTEINS PROTEOM, V1703, P261, DOI 10.1016/j.bbapap.2004.08.018; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Requena JR, 2004, ARCH BIOCHEM BIOPHYS, V432, P188, DOI 10.1016/j.abb.2004.09.012; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Schenck HL, 1996, J AM CHEM SOC, V118, P12487, DOI 10.1021/ja962026p; Shiraishi N, 2005, BIOCHEM J, V387, P247, DOI 10.1042/BJ20041561; Sideri TC, 2011, J BIOL CHEM, V286, P38924, DOI 10.1074/jbc.M111.272419; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Viles J. H., 2012, COORDINAT C IN PRESS; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong BS, 2000, BIOCHEM BIOPH RES CO, V275, P249, DOI 10.1006/bbrc.2000.3158; Wong BS, 1999, BIOCHEM BIOPH RES CO, V259, P352, DOI 10.1006/bbrc.1999.0802; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Younan ND, 2011, J MOL BIOL, V410, P369, DOI 10.1016/j.jmb.2011.05.013; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025	84	36	37	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28263	28275		10.1074/jbc.M112.354779	http://dx.doi.org/10.1074/jbc.M112.354779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22654104	Green Published, hybrid			2022-12-25	WOS:000308074600005
J	Goncharova, V; Serobyan, N; Iizuka, S; Schraufstatter, I; de Ridder, A; Povaliy, T; Wacker, V; Itano, N; Kimata, K; Orlovskaja, IA; Yamaguchi, Y; Khaldoyanidi, S				Goncharova, Valentina; Serobyan, Naira; Iizuka, Shinji; Schraufstatter, Ingrid; de Ridder, Audrey; Povaliy, Tatiana; Wacker, Valentina; Itano, Naoki; Kimata, Koji; Orlovskaja, Irina A.; Yamaguchi, Yu; Khaldoyanidi, Sophia			Hyaluronan Expressed by the Hematopoietic Microenvironment Is Required for Bone Marrow Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; STEM-CELLS; GROWTH-FACTOR; STEM/PROGENITOR CELLS; EXTRACELLULAR-MATRIX; CHEMOKINE FAMILY; LUNG INJURY; IN-VITRO; ACID; PROLIFERATION	The contribution of hyaluronan (HA) to the regulatory network of the hematopoietic microenvironment was studied using knock-out mice of three hyaluronan synthase genes (Has1, Has2, and Has3). The number of hematopoietic progenitors was decreased in bone marrow and increased in extramedullary sites of Prx1-Cre;Has2(flox/flox); Has1(-/-); Has3(-/-) triple knock-out (tKO) mice as compared with wild type (WT) and Has1(-/-); Has3(-/-) double knock-out (dKO) mice. In line with this observation, decreased hematopoietic activity was observed in long term bone marrow cultures (LTBMC) from tKO mice, whereas the formation of the adherent layer and generation of hematopoietic cells in WT and dKO cultures was not different. 4-Methylumbelliferone (4MU) was used to pharmacologically inhibit the production of HA in LTBMC. Treatment with 4MU inhibited HA synthesis, decreased expression of HAS2 and HAS3, and eliminated hematopoiesis in LTBMC, and this effect was alleviated by the addition of exogenous HA. Exogenous HA also augmented the cell motility in LTBMC, which correlated with the HA-stimulated production of chemokines and growth factors. Conditioned media from HA-induced LTBMC enhanced the chemotaxis of hematopoietic stem/progenitor cells (HSPC) in response to SDF-1. Exposure of endothelial cells to 4MU decreased their ability to support HSPC rolling and adhesion. In addition, migration of transplanted HSPC into the marrow of 4MU-pretreated mice was lower than in untreated mice. Collectively, the results suggest that HA depletion reduces the ability of the microenvironment to support HSPC, and confirm a role for HA as a necessary regulatory element in the structure of the hematopoietic microenvironment.	[Goncharova, Valentina; Schraufstatter, Ingrid; de Ridder, Audrey; Povaliy, Tatiana; Wacker, Valentina; Khaldoyanidi, Sophia] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Serobyan, Naira] La Jolla Inst Mol Med, San Diego, CA 92121 USA; [Iizuka, Shinji; Yamaguchi, Yu] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [de Ridder, Audrey] Univ Namur, B-5000 Namur, Belgium; [Itano, Naoki] Kyoto Sangyo Univ, Kyoto 6038555, Japan; [Kimata, Koji] Aichi Med Univ, Nagakute, Aichi 4801095, Japan; [Orlovskaja, Irina A.] Inst Clin Immunol, Novosibirsk 630099, Russia	Torrey Pines Institute for Molecular Studies, California; Sanford Burnham Prebys Medical Discovery Institute; University of Namur; Kyoto Sangyo University; Aichi Medical University; Russian Academy of Medical Sciences	Khaldoyanidi, S (corresponding author), 3550 Gen Atom Ct, San Diego, CA 92121 USA.	skhaldoyanidi@tpims.org			National Institutes of Health Grants [R41CA126004, R43AI082759, R21NS062428]; University of California TRDRP Grant [16RT-0134]; NATIONAL CANCER INSTITUTE [R41CA126004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI082759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062428] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California TRDRP Grant(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R41CA126004, R43AI082759, and R21NS062428 and University of California TRDRP Grant 16RT-0134 (to S. K. K.).	Andreutti D, 1999, J SUBMICR CYTOL PATH, V31, P173; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; Broxmeyer HE, 1996, ANN HEMATOL, V73, P1, DOI 10.1007/s002770050192; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Chang H, 2000, EXP HEMATOL, V28, P743, DOI 10.1016/S0301-472X(00)00184-3; Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fukuda S, 2007, BLOOD, V110, P860, DOI 10.1182/blood-2006-06-031401; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HAMANN KJ, 1995, J IMMUNOL, V154, P4073; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Imai K, 1999, BLOOD, V93, P149, DOI 10.1182/blood.V93.1.149.401a02_149_156; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Khaldoyanidi S, 1999, BLOOD, V94, P940, DOI 10.1182/blood.V94.3.940.415k27_940_949; Khaldoyanidi S, 2002, BLOOD, V99, P3955, DOI 10.1182/blood.V99.11.3955; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Liesveld JL, 2001, J HEMATOTH STEM CELL, V10, P643, DOI 10.1089/152581601753193850; Liu LQ, 2003, ONCOL RES, V13, P359; LU L, 1993, EXP HEMATOL, V21, P1442; Matrosova VY, 2004, STEM CELLS, V22, P544, DOI 10.1634/stemcells.22-4-544; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; MATSUMOTO T, 1994, BONE, V15, P97, DOI 10.1016/8756-3282(94)90898-2; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Moll J, 1998, J CLIN INVEST, V102, P1024, DOI 10.1172/JCI2494; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; NOORDEGRAAF EM, 1981, EXP HEMATOL, V9, P326; Oertli B, 1998, J IMMUNOL, V161, P3431; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; Pilarski LM, 1999, BLOOD, V93, P2918; PYE DA, 1994, BBA-MOL CELL RES, V1220, P266, DOI 10.1016/0167-4889(94)90148-1; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; REHAKOVA M, 1994, INT J BIOL MACROMOL, V16, P121, DOI 10.1016/0141-8130(94)90037-X; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Schraufstatter IU, 2012, FRONT BIOSCI, V17, P2271; Shin DY, 2007, J CHROMATOGR A, V1160, P270, DOI 10.1016/j.chroma.2007.05.047; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 2002, GLYCOCONJUGATE J, V19, P341, DOI 10.1023/A:1025321105691; Srinivas A, 2007, TISSUE ENG, V13, P447, DOI 10.1089/ten.2006.0196; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sudhoff T, 2002, J HEMATOTH STEM CELL, V11, P147, DOI 10.1089/152581602753448612; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; VERFAILLIE CM, 1993, BLOOD, V82, P2045; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; WEGROWSKI J, 1992, INT J RADIAT BIOL, V61, P685, DOI 10.1080/09553009214551501; Weidt Corinna, 2007, Curr Stem Cell Res Ther, V2, P89, DOI 10.2174/157488807779317008; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Xu Y. X., 1999, Hematology, V4, P345; YODER MC, 1995, EXP HEMATOL, V23, P961; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079	71	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25419	25433		10.1074/jbc.M112.376699	http://dx.doi.org/10.1074/jbc.M112.376699			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654110	Green Published, hybrid			2022-12-25	WOS:000306651700049
J	Lim, JC; Gruschus, JM; Kim, G; Berlett, BS; Tjandra, N; Levine, RL				Lim, Jung Chae; Gruschus, James M.; Kim, Geumsoo; Berlett, Barbara S.; Tjandra, Nico; Levine, Rodney L.			A Low pK(a) Cysteine at the Active Site of Mouse Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; ANTIOXIDANT DEFENSE; CATALYTIC MECHANISM; OXIDATIVE STRESS; PROTEIN; ENZYME; MSRA; ACID	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. Recently it has also been shown to catalyze the reverse reaction, oxidizing methionine residues to methionine sulfoxide. A cysteine at the active site of the enzyme is essential for both reductase and oxidase activities. This cysteine has been reported to have a pK(a) of 9.5 in the absence of substrate, decreasing to 5.7 upon binding of substrate. Using three independent methods, we show that the pK(a) of the active site cysteine of mouse methionine sulfoxide reductase is 7.2 even in the absence of substrate. The primary mechanism by which the pK(a) is lowered is hydrogen bonding of the active site Cys-72 to protonated Glu-115. The low pK(a) renders the active site cysteine susceptible to oxidation to sulfenic acid by micromolar concentrations of hydrogen peroxide. This characteristic supports a role for methionine sulfoxide reductase in redox signaling.	[Lim, Jung Chae; Kim, Geumsoo; Berlett, Barbara S.; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011		Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL000225] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health.	Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barton J.P., 1973, J CHEM SOC P2, V1, P1547; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brot N, 2006, J BIOL CHEM, V281, P32668, DOI 10.1074/jbc.M604971200; DONOVAN JW, 1964, BIOCHEMISTRY-US, V3, P67, DOI 10.1021/bi00889a012; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Onufriev A, 2001, BIOCHEMISTRY-US, V40, P3413, DOI 10.1021/bi002740q; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2006, J MOL BIOL, V358, P443, DOI 10.1016/j.jmb.2006.02.025; Regino CAS, 2007, INORG CHIM ACTA, V360, P3971, DOI 10.1016/j.ica.2007.05.020; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	38	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25596	25601		10.1074/jbc.M112.369116	http://dx.doi.org/10.1074/jbc.M112.369116			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661719	Green Published, hybrid			2022-12-25	WOS:000306651700067
J	Lefebure, T; Richards, VP; Lang, P; Pavinski-Bitar, P; Stanhope, MJ				Lefebure, Tristan; Richards, Vince P.; Lang, Ping; Pavinski-Bitar, Paulina; Stanhope, Michael J.			Gene Repertoire Evolution of Streptococcus pyogenes Inferred from Phylogenomic Analysis with Streptococcus canis and Streptococcus dysgalactiae	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; LANTIBIOTIC SALIVARICIN-A; COMPLETE GENOME SEQUENCE; POSITIVE SELECTION; M3 STRAIN; VIRULENCE; INFECTIONS; GROWTH; CLONE; IDENTIFICATION	Streptococcus pyogenes, is an important human pathogen classified within the pyogenic group of streptococci, exclusively adapted to the human host. Our goal was to employ a comparative evolutionary approach to better understand the genomic events concomitant with S. pyogenes human adaptation. As part of ascertaining these events, we sequenced the genome of one of the potential sister species, the agricultural pathogen S. canis, and combined it in a comparative genomics reconciliation analysis with two other closely related species, Streptococcus dysgalactiae and Streptococcus equi, to determine the genes that were gained and lost during S. pyogenes evolution. Genome wide phylogenetic analyses involving 15 Streptococcus species provided convincing support for a clade of S. equi, S. pyogenes, S. dysgalactiae, and S. canis and suggested that the most likely S. pyogenes sister species was S. dysgalactiae. The reconciliation analysis identified 113 genes that were gained on the lineage leading to S. pyogenes. Almost half (46%) of these gained genes were phage associated and 14 showed significant matches to experimentally verified bacteria virulence factors. Subsequent to the origin of S. pyogenes, over half of the phage associated genes were involved in 90 different LGT events, mostly involving different strains of S. pyogenes, but with a high proportion involving the horse specific pathogen S. equi subsp. equi, with the directionality almost exclusively (86%) in the S. pyogenes to S. equi direction. Streptococcus agalactiae appears to have played an important role in the evolution of S. pyogenes with a high proportion of LGTs originating from this species. Overall the analysis suggests that S. pyogenes adaptation to the human host was achieved in part by (i) the integration of new virulence factors (e. g. speB, and the sal locus) and (ii) the construction of new regulation networks (e. g. rgg, and to some extent speB).	[Lefebure, Tristan; Richards, Vince P.; Lang, Ping; Pavinski-Bitar, Paulina; Stanhope, Michael J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Lefebure, T (corresponding author), Univ Lyon 1, Ctr Natl Rech Sci, F-69622 Villeurbanne, France.	mjs297@cornell.edu	Lefebure, Tristan/A-6489-2009; Richards, Vince/AAO-4261-2020; Richards, Vincent/AAV-1816-2021	Lefebure, Tristan/0000-0003-3923-8166; Richards, Vincent/0000-0002-9309-6595	National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health [AI073368-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073368] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health, under Grant No. AI073368-01A2 awarded to M.J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; DeWinter LM, 1999, CAN J VET RES, V63, P90; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Eyre DW, 2010, EUR J CLIN MICROBIOL, V29, P1459, DOI 10.1007/s10096-010-1037-5; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Galperine T, 2007, J INFECTION, V55, P23, DOI 10.1016/j.jinf.2006.12.013; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; HUDSON RR, 1992, GENETICS, V131, P509; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Jensen A, 2012, J CLIN MICROBIOL, V50, P113, DOI 10.1128/JCM.05900-11; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Khalil S, 2011, BIOCHEMISTRY-US, V50, P533, DOI 10.1021/bi101558v; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Lam MM, 2007, J CLIN MICROBIOL, V45, P2327, DOI 10.1128/JCM.01765-06; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCormick JK, 2006, TOXINS SUPERANTIGENS, P47; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Muller-Alouf H, 2001, TOXICON, V39, P1691, DOI 10.1016/S0041-0101(01)00156-8; Murase T, 2003, VET REC, V153, P471, DOI 10.1136/vr.153.15.471; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Richards VP, 2011, INFECT GENET EVOL, V11, P1263, DOI 10.1016/j.meegid.2011.04.019; ROLSTON KVI, 1986, ARCH INTERN MED, V146, P857, DOI 10.1001/archinte.146.5.857; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Simpson WJ, 1995, DEV BIOL STAND, V85, P639; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Suzuki H, 2011, GENOME BIOL EVOL, V3, P168, DOI 10.1093/gbe/evr006; Sykes JE, 2006, JAVMA-J AM VET MED A, V228, P1723, DOI 10.2460/javma.228.11.1723; TALKINGTON DF, 1993, INFECT IMMUN, V61, P3369, DOI 10.1128/IAI.61.8.3369-3374.1993; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053; Tikofsky LL, 2005, J DAIRY SCI, V88, P2707, DOI 10.3168/jds.S0022-0302(05)72949-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Webb K, 2008, MICROBIOL-SGM, V154, P3016, DOI 10.1099/mic.0.2008/018911-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wozniak DJ, 2003, J BACTERIOL, V185, P7297, DOI 10.1128/JB.185.24.7297-7300.2003; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37607	10.1371/journal.pone.0037607	http://dx.doi.org/10.1371/journal.pone.0037607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666370	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400035
J	Miyamoto, R; Kikuchi, Y				Miyamoto, Reiko; Kikuchi, Yoshiaki			Gender Differences of Brain Activity in the Conflicts Based on Implicit Self-Esteem	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBRAL-BLOOD-FLOW; RESPONSE CONFLICT; NEURAL BASIS; PERSONALITY; KNOWLEDGE; PREDICTS; WOMEN; ADOLESCENCE; NEUROTICISM	There are gender differences in global and domain-specific self-esteem and the incidence of some psychiatric disorders related to self-esteem, suggesting that there are gender differences in the neural basis underlying one's own self-esteem. We investigated gender differences in the brain activity while subjects (14 males and 12 females) performed an implicit self-esteem task, using fMRI. While ventromedial prefrontal cortex (vmPFC) was significantly activated in females, medial and dorsomedial PFC (dmPFC) were activated in males in the incongruent condition (self = negative) compared with the congruent condition (self = positive). Additionally, scores on the explicit self-esteem test were negatively correlated with vmPFC activity in females and positively correlated with dmPFC activity in males. Furthermore, the functional relationships among the regions found by direct gender comparisons were discussed based on the somatic-marker model. These showed that, compared to males, females more firmly store even the incongruent associations as part of their schematic self-knowledge, and such associations automatically activate the neural networks for emotional response and control, in which vmPFC plays a central role. This may explain female cognitive/behavioral traits; females have more tendency to ruminate more often than males, which sometimes results in a prolonged negative affect.	[Miyamoto, Reiko] Tokyo Metropolitan Univ, Fac Hlth Sci, Div Occupat Therapy, Tokyo 158, Japan; [Kikuchi, Yoshiaki] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Frontier Hlth Sci, Tokyo 158, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University	Miyamoto, R (corresponding author), Tokyo Metropolitan Univ, Fac Hlth Sci, Div Occupat Therapy, Tokyo 158, Japan.	ykikuchi@hs.tmu.ac.jp		Miyamoto, Reiko/0000-0002-6058-7435; Kikuichi, Yoshiaki/0000-0002-8770-139X	Ministry of Education, Science, Sports and Culture [20700433]; Grants-in-Aid for Scientific Research [22700543] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grants-in-Aid for Young Scientists (B), (#20700433, 2008-2009 to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin MW, 2004, SELF IDENTITY, V3, P81, DOI 10.1080/13576500342000068; Bargh JA., 1994, HDB SOCIAL COGNITION; Baumeister RF, 1998, HDB SOCIAL PSYCHOL, P680; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; Berman ME, 1997, CLIN PSYCHOL REV, V17, P651, DOI 10.1016/S0272-7358(97)00039-1; Bolognini M, 1996, J ADOLESCENCE, V19, P233, DOI 10.1006/jado.1996.0022; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; BUTLER LD, 1994, SEX ROLES, V30, P331, DOI 10.1007/BF01420597; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Courtney Elizabeth A, 2008, Eat Behav, V9, P408, DOI 10.1016/j.eatbeh.2008.06.001; Damasio A., 1995, NEUROSCIENTIST, V1, P19, DOI [10.1177/107385849500100104, DOI 10.1177/107385849500100104]; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; EBMEIER KP, 1994, PERS INDIV DIFFER, V17, P587, DOI 10.1016/0191-8869(94)90131-7; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Gentile B, 2009, REV GEN PSYCHOL, V13, P34, DOI 10.1037/a0013689; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Gyurak A, 2012, SOC COGN AFFECT NEUR, V7, P322, DOI 10.1093/scan/nsr014; HAYNES NM, 1990, J SOC PSYCHOL, V130, P199, DOI 10.1080/00224545.1990.9924570; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Hunter MD, 2003, NEUROIMAGE, V20, P1264, DOI 10.1016/S1053-8119(03)00374-4; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Kernis MH, 2000, PERS SOC PSYCHOL B, V26, P1297, DOI 10.1177/0146167200262010; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; KLEIN SB, 1992, J PERS SOC PSYCHOL, V63, P739, DOI 10.1037/0022-3514.63.5.739; Klein SB, 1996, J EXP PSYCHOL GEN, V125, P250, DOI 10.1037/0096-3445.125.3.250; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Koch EJ, 2002, SELF IDENTITY, V1, P271, DOI 10.1080/152988602760124883; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; LEARY MR, 1995, J SOC CLIN PSYCHOL, V14, P297, DOI 10.1521/jscp.1995.14.3.297; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2004, J PERS SOC PSYCHOL, V87, P421, DOI 10.1037/0022-3514.87.4.421; Lin Y, 2005, PERS SOC PSYCHOL B, V31, P198, DOI 10.1177/0146167204271325; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Major B., 1999, SEXISM STEREOTYPES M, P223, DOI [DOI 10.1037/10277-009, 10.1037/10277-009]; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; McClure EB, 2004, BIOL PSYCHIAT, V55, P1047, DOI 10.1016/j.biopsych.2004.02.013; McGlashan R, 1988, Dimens Crit Care Nurs, V7, P28, DOI 10.1097/00003465-198801000-00005; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Nolen-Hoeksema S, 2001, PSYCHOL WOMEN QUART, V25, P37, DOI 10.1111/1471-6402.00005; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; NUTTIN JM, 1987, EUR J SOC PSYCHOL, V17, P381, DOI 10.1002/ejsp.2420170402; NUTTIN JM, 1985, EUR J SOC PSYCHOL, V15, P353, DOI 10.1002/ejsp.2420150309; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Pahl S, 2005, EXP PSYCHOL, V52, P303, DOI 10.1027/1618-3169.52.4.303; Ponsoda V, 2008, J INDIVID DIFFER, V29, P217, DOI 10.1027/1614-0001.29.4.217; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; ROVIARO S, 1984, J BEHAV MED, V7, P61, DOI 10.1007/BF00845347; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stringer Suzanne J., 2003, J INSTRUCTIONAL PSYC, V30, P69; Suslow T, 2010, NEUROSCIENCE, V167, P111, DOI 10.1016/j.neuroscience.2010.01.038; THAYER RE, 1994, J PERS SOC PSYCHOL, V67, P910, DOI 10.1037/0022-3514.67.5.910; Twenge JM, 2001, PERS SOC PSYCHOL REV, V5, P321, DOI 10.1207/S15327957PSPR0504_3; Verdejo-Garcia A, 2006, CURR NEUROPHARMACOL, V4, P17, DOI 10.2174/157015906775203057; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2	80	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37901	10.1371/journal.pone.0037901	http://dx.doi.org/10.1371/journal.pone.0037901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666409	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400057
J	Theodoro, RC; Teixeira, MD; Felipe, MSS; Paduan, KD; Ribolla, PM; San-Blas, G; Bagagli, E				Theodoro, Raquel Cordeiro; Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli; dos Santos Paduan, Karina; Ribolla, Paulo Martins; San-Blas, Gioconda; Bagagli, Eduardo			Genus Paracoccidioides: Species Recognition and Biogeographic Aspects	PLOS ONE			English	Article							ARMADILLOS DASYPUS-NOVEMCINCTUS; PHYLOGENETIC ANALYSIS; LOBOS-DISEASE; PATHOGENIC FUNGUS; ANDEAN TECTONICS; BRASILIENSIS; SPECIATION; HOST; DNA; DIFFERENTIATION	Background: Paracoccidioidomycosis is a systemic mycosis caused by Paracoccidioides brasiliensis (species S1, PS2, PS3), and Paracoccidioides lutzii. This work aimed to differentiate species within the genus Paracoccidioides, without applying multilocus sequencing, as well as to obtain knowledge of the possible speciation processes. Methodology/Principal Findings: Single nucleotide polymorphism analysis on GP43, ARF and PRP8 intein genes successfully distinguished isolates into four different species. Morphological evaluation indicated that elongated conidia were observed exclusively in P. lutzii isolates, while all other species (S1, PS2 and PS3) were indistinguishable. To evaluate the biogeographic events that led to the current geographic distribution of Paracoccidioides species and their sister species, Nested Clade and Likelihood Analysis of Geographic Range Evolution (LAGRANGE) analyses were applied. The radiation of Paracoccidioides started in northwest South America, around 11-32 million years ago, as calculated on the basis of ARF substitution rate, in the BEAST program. Vicariance was responsible for the divergence among S1, PS2 and P. lutzii and a recent dispersal generated the PS3 species, restricted to Colombia. Taking into account the ancestral areas revealed by the LAGRANGE analysis and the major geographic distribution of L. loboi in the Amazon basin, a region strongly affected by the Andes uplift and marine incursions in the Cenozoic era, we also speculate about the effect of these geological events on the vicariance between Paracoccidioides and L. loboi. Conclusions/Significance: The use of at least 3 SNPs, but not morphological criteria, as markers allows us to distinguish among the four cryptic species of the genus Paracoccidioides. The work also presents a biogeographic study speculating on how these species might have diverged in South America, thus contributing to elucidating evolutionary aspects of the genus Paracoccidioides.	[Theodoro, Raquel Cordeiro; dos Santos Paduan, Karina; Ribolla, Paulo Martins; Bagagli, Eduardo] Univ Estadual Paulista, Sao Paulo, Brazil; [Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli] Univ Brasilia UNB, Brasilia, DF, Brazil; [San-Blas, Gioconda] Ctr Microbiol & Cell Biol, Venezuelan Inst Sci Res, Caracas, Venezuela	Universidade Estadual Paulista; Universidade de Brasilia; Venezuelan Institute Science Research	Theodoro, RC (corresponding author), Univ Estadual Paulista, Campus Botucatu UNESP, Sao Paulo, Brazil.	bagagli@ibb.unesp.br	Bagagli, Eduardo/C-8036-2012; Felipe, Maria Sueli/L-6260-2016; Ribolla, Paulo EM/B-9122-2012; Ribolla, Paulo/AAH-3354-2020; Theodoro, Raquel C/C-2130-2017; PADUAN, KARINA S/F-4876-2015; de Melo Teixeira, Marcus/AAP-9530-2021	Bagagli, Eduardo/0000-0002-8003-4109; Felipe, Maria Sueli/0000-0003-4347-6853; Ribolla, Paulo EM/0000-0001-8735-6090; Theodoro, Raquel C/0000-0001-5016-1046; de Melo Teixeira, Marcus/0000-0003-1763-3464	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo);  [2007/01306-5];  [2010/08839-1];  [2010/08829-6]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; ; 	The authors' funding agency is FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [http://www.fapesp.br/]. The grant numbers of the authors' projects are 2007/01306-5, 2010/08839-1 and 2010/08829-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagagli E, 1998, AM J TROP MED HYG, V58, P505, DOI 10.4269/ajtmh.1998.58.505; Bagagli E, 2003, MED MYCOL, V41, P217, DOI 10.1080/13693780310001597368; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batista J, 2010, MYCOSES, V53, P176, DOI 10.1111/j.1439-0507.2008.01687.x; Burns RA, 2000, J CLIN MICROBIOL, V38, P1283, DOI 10.1128/JCM.38.3.1283-1285.2000; Calcagno AM, 1998, J CLIN MICROBIOL, V36, P1733, DOI 10.1128/JCM.36.6.1733-1736.1998; Carrero LL, 2008, FUNGAL GENET BIOL, V45, P605, DOI 10.1016/j.fgb.2008.02.002; Carvalho KC, 2005, MICROBES INFECT, V7, P55, DOI 10.1016/j.micinf.2004.09.008; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cisalpino PS, 1996, J BIOL CHEM, V271, P4553, DOI 10.1074/jbc.271.8.4553; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corredor German G., 1999, Revista Iberoamericana de Micologia, V16, P216; Corredor GG, 2005, MED MYCOL, V43, P275, DOI 10.1080/13693780412331271090; COWAN DF, 1993, J WILDLIFE DIS, V29, P488, DOI 10.7589/0090-3558-29.3.488; Coyne JA, 2004, SPECIATION, V37; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FARIAS MR, 2005, REV INST MED TROP SP, V47, P64; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Hahn RC, 2003, J CLIN MICROBIOL, V41, P2849, DOI 10.1128/JCM.41.7.2849-2854.2003; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Hebeler-Barbosa F, 2003, J CLIN MICROBIOL, V41, P5735, DOI 10.1128/JCM.41.12.5735-5737.2003; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Keely S.P., 2005, PNEUMOCYSTIS PNEUMON, V3rd ed., P39; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KWONCHUN.KJ, 1973, MYCOLOGIA, V65, P109, DOI 10.2307/3757791; Lundberg J.G., 1998, PHYLOGENY CLASSIFICA, V603, P14; Matute DR, 2006, J CLIN MICROBIOL, V44, P2153, DOI 10.1128/JCM.02540-05; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; McCullough MJ, 2000, CLIN INFECT DIS, V30, P328, DOI 10.1086/313649; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; MIGAKI G, 1971, J AM VET MED ASSOC, V159, P578; Morais FV, 2000, J CLIN MICROBIOL, V38, P3960, DOI 10.1128/JCM.38.11.3960-3966.2000; NAIFF RD, 1986, REV I MED TROP, V28, P19, DOI 10.1590/S0036-46651986000100005; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Puccia R, 2008, MYCOPATHOLOGIA, V165, P275, DOI 10.1007/s11046-007-9055-2; PURTILO DT, 1975, ANAT REC, V181, P725, DOI 10.1002/ar.1091810405; Ramos-e-Silva M, 2009, ACTAS DERMO-SIFILOGR, V100, P92, DOI 10.1016/S0001-7310(09)73173-4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ricci G, 2004, MED MYCOL, V42, P379, DOI 10.1080/1369378032000141417; Richini-Pereira VB, 2009, MEM I OSWALDO CRUZ, V104, P636, DOI 10.1590/S0074-02762009000400018; Salgado-Salazar C, 2010, CLADISTICS, V26, P613, DOI 10.1111/j.1096-0031.2010.00307.x; Sheff KW, 2010, MED MYCOL, V48, P466, DOI 10.3109/13693780903218990; Silva-Vergara ML, 2000, MED MYCOL, V38, P193, DOI 10.1080/714030937; SYMMERS WS, 1983, B SOC PATHOL EXOT, V76, P777; Taborda PR, 1999, J CLIN MICROBIOL, V37, P2031, DOI 10.1128/JCM.37.6.2031-2033.1999; Takayama A, 2010, MED MYCOL, V48, P64, DOI 10.3109/13693780902718065; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Tercarioli GR, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-92; Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003; Theodoro RC, 2008, MYCOPATHOLOGIA, V165, P355, DOI 10.1007/s11046-008-9091-6; Torres I, 2010, FUNGAL GENET BIOL, V47, P373, DOI 10.1016/j.fgb.2009.11.005; ULRICH M, 1976, CLIN EXP IMMUNOL, V25, P170; Untereiner WA, 2004, MYCOLOGIA, V96, P812, DOI 10.2307/3762114; Vilela R, 2009, MYCOL RES, V113, P851, DOI 10.1016/j.mycres.2009.04.007; Vries G. A. de, 1973, Aquatic Mammals, V1, P1; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P1; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35	69	100	100	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37694	10.1371/journal.pone.0037694	http://dx.doi.org/10.1371/journal.pone.0037694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666382	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400041
J	Van Gulck, E; Bracke, L; Heyndrickx, L; Coppens, S; Atkinson, D; Merlin, C; Pasternak, A; Florence, E; Vanham, G				Van Gulck, Ellen; Bracke, Lotte; Heyndrickx, Leo; Coppens, Sandra; Atkinson, Derek; Merlin, Celine; Pasternak, Alexander; Florence, Eric; Vanham, Guido			Immune and Viral Correlates of "Secondary Viral Control" after Treatment Interruption in Chronically HIV-1 Infected Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; NEUTRALIZING ANTIBODY; ELITE CONTROLLERS; PROLIFERATIVE RESPONSES; ANTIRETROVIRAL THERAPY; HIV NEUTRALIZATION; PLASMA VIREMIA; INFECTION; REPLICATION	Upon interruption of antiretroviral therapy, HIV-infected patients usually show viral load rebound to pre-treatment levels. Four patients, hereafter referred to as secondary controllers (SC), were identified who initiated therapy during chronic infection and, after stopping treatment, could control virus replication at undetectable levels for more than six months. In the present study we set out to unravel possible viral and immune parameters or mechanisms of this phenomenon by comparing secondary controllers with elite controllers and non-controllers, including patients under HAART. As candidate correlates of protection, virus growth kinetics, levels of intracellular viral markers, several aspects of HIV-specific CD4+ and CD8+ T cell function and HIV neutralizing antibodies were investigated. As expected all intracellular viral markers were lower in aviremic as compared to viremic subjects, but in addition both elite and secondary controllers had lower levels of viral unspliced RNA in PBMC as compared to patients on HAART. Ex vivo cultivation of the virus from CD4+ T cells of SC consistently failed in one patient and showed delayed kinetics in the three others. Formal in vitro replication studies of these three viruses showed low to absent growth in two cases and a virus with normal fitness in the third case. T cell responses toward HIV peptides, evaluated in IFN-gamma ELISPOT, revealed no significant differences in breadth, magnitude or avidity between SC and all other patient groups. Neither was there a difference in polyfunctionality of CD4+ or CD8+ T cells, as evaluated with intracellular cytokine staining. However, secondary and elite controllers showed higher proliferative responses to Gag and Pol peptides. SC also showed the highest level of autologous neutralizing antibodies. These data suggest that higher T cell proliferative responses and lower replication kinetics might be instrumental in secondary viral control in the absence of treatment.	[Van Gulck, Ellen; Bracke, Lotte; Heyndrickx, Leo; Coppens, Sandra; Atkinson, Derek; Merlin, Celine; Vanham, Guido] Antwerp ITMA, Inst Trop Med, Dept Biomed Sci, Virol Unit,Microbiol Grp, Antwerp, Belgium; [Pasternak, Alexander] Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Lab Expt Virol, Amsterdam, Netherlands; [Florence, Eric] ITMA, Dept Clin Sci, HIV STD Unit, Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Amsterdam; Institute of Tropical Medicine (ITM); University of Antwerp	Van Gulck, E (corresponding author), Antwerp ITMA, Inst Trop Med, Dept Biomed Sci, Virol Unit,Microbiol Grp, Antwerp, Belgium.	evangulck@hotmail.com	Pasternak, Alexander/P-2067-2017	Pasternak, Alexander/0000-0002-4097-4251; Florence, Eric/0000-0002-7004-9120; Atkinson, Derek/0000-0001-6097-3670	Fund for Scientific Research Flanders (FWO) [G.0.370.08.N.10]; IAP (Inter-University Attraction Poles of the Belgian government) [P6/41]; EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP) [LSHP-CT-2004-503487]	Fund for Scientific Research Flanders (FWO)(FWO); IAP (Inter-University Attraction Poles of the Belgian government); EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP)	This work was supported by grants from the Fund for Scientific Research Flanders (FWO) (G.0.370.08.N.10) and IAP (Inter-University Attraction Poles, P6/41 of the Belgian government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Viruses (DU174, 92UG024) and TriMab were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP Contract Number LSHP-CT-2004-503487).	Addo MM, 2002, DNA CELL BIOL, V21, P671, DOI 10.1089/104454902760330219; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Bedimo R, 2006, AIDS RES HUM RETROV, V22, P40, DOI 10.1089/aid.2006.22.40; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Binley JM, 2000, J INFECT DIS, V181, P1249, DOI 10.1086/315379; Blankson JN, 2010, DISCOV MED, V9, P261; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Bunce M., 1995, TISSUE ANTIGENS, V46, P355; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Gray CM, 2009, J VIROL, V83, P470, DOI 10.1128/JVI.01678-08; Guerrero MLF, 2005, CLIN INFECT DIS, V41, P390, DOI 10.1086/431487; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lieberman J, 2004, AIDS, V18, P1489, DOI 10.1097/01.aids.0000131320.75396.4d; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Pasternak AO, 2010, AIDS, V24, P1641, DOI 10.1097/QAD.0b013e32833b3171; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Ponsaerts P, 2002, LEUKEMIA, V16, P1324, DOI 10.1038/sj.leu.2402511; Resino S, 2003, CLIN EXP IMMUNOL, V131, P130, DOI 10.1046/j.1365-2249.2003.02034.x; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rowland-Jones S, 1997, ADV IMMUNOL, V65, P277, DOI 10.1016/S0065-2776(08)60745-2; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Scarlatti G, 1996, IMMUNOL LETT, V51, P23, DOI 10.1016/0165-2478(96)02550-3; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skiest DJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1351, DOI 10.1097/00126334-200411010-00003; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Valentine LE, 2008, J VIROL, V82, P575, DOI 10.1128/JVI.00275-07; Van Gulck E, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-6; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yang OO, 2003, TRENDS IMMUNOL, V24, P67, DOI 10.1016/S1471-4906(02)00034-0; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	62	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37792	10.1371/journal.pone.0037792	http://dx.doi.org/10.1371/journal.pone.0037792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666392	Green Published, gold			2022-12-25	WOS:000305353400049
J	van Woudenbergh, GJ; Kuijsten, A; Drogan, D; Van Der A, DL; Romaguera, D; Ardanaz, E; Amiano, P; Barricarte, A; Beulens, JWJ; Boeing, H; Bueno-De-Mesquita, HB; Dahm, CC; Chirlaque, MD; Clavel, FC; Crowe, FL; Eomois, PP; Fagher-Azzi, G; Franks, PW; Halkjaer, J; Khaw, KT; Masala, G; Mattiello, A; Nilsson, P; Overvad, K; Quiros, JR; Rolandsson, O; Romieu, I; Sacerdote, C; Sanchez, MJ; Schulze, MB; Slimani, N; Sluijs, I; Spijkerman, AMW; Tagliabue, G; Teucher, B; Tjonneland, A; Tumino, R; Forouhi, NG; Sharp, S; Langenberg, C; Feskens, EJM; Riboli, E; Wareham, NJ				van Woudenbergh, Geertruida J.; Kuijsten, Anneleen; Drogan, Dagmar; van der A, Daphne L.; Romaguera, Dora; Ardanaz, Eva; Amiano, Pilar; Barricarte, Aurelio; Beulens, Joline W. J.; Boeing, Heiner; Bueno-de-Mesquita, H. Bas; Dahm, Christina C.; Chirlaque, M-Doleres; Clavel, Fran-coise; Crowe, Francesca L.; Eomois, Piia-Piret; Fagher-azzi, Guy; Franks, Paul W.; Halkjaer, Jytte; Khaw, Kay T.; Masala, Giovanna; Mattiello, Amalia; Nilsson, Peter; Overvad, Kim; Quiros, J. Ramon; Rolandsson, Olov; Romieu, Isabelle; Sacerdote, Carlotta; Sanchez, Maria-Jose; Schulze, Matthias B.; Slimani, Nadia; Sluijs, Ivonne; Spijkerman, Annemieke M. W.; Tagliabue, Giovanna; Teucher, Birgit; Tjonneland, Anne; Tumino, Rosario; Forouhi, Nita G.; Sharp, Stephen; Langenberg, Claudia; Feskens, Edith J. M.; Riboli, Elio; Wareham, Nicholas J.		InterAct Consortium	Tea Consumption and Incidence of Type 2 Diabetes in Europe: The EPIC-InterAct Case-Cohort Study	PLOS ONE			English	Article							BLACK TEA; GREEN TEA; OOLONG TEA; COFFEE; RISK; PLASMA; CANCER; MILK; POLYPHENOLS; ABSORPTION	Background: In previous meta-analyses, tea consumption has been associated with lower incidence of type 2 diabetes. It is unclear, however, if tea is associated inversely over the entire range of intake. Therefore, we investigated the association between tea consumption and incidence of type 2 diabetes in a European population. Methodology/Principal Findings: The EPIC-InterAct case-cohort study was conducted in 26 centers in 8 European countries and consists of a total of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,835 individuals from a total cohort of 340,234 participants with 3.99 million person-years of follow-up. Country-specific Hazard Ratios (HR) for incidence of type 2 diabetes were obtained after adjustment for lifestyle and dietary factors using a Cox regression adapted for a case-cohort design. Subsequently, country-specific HR were combined using a random effects meta-analysis. Tea consumption was studied as categorical variable (0, >0-<1, 1-<4, >= 4 cups/day). The dose-response of the association was further explored by restricted cubic spline regression. Country specific medians of tea consumption ranged from 0 cups/day in Spain to 4 cups/day in United Kingdom. Tea consumption was associated inversely with incidence of type 2 diabetes; the HR was 0.84 [95% CI 0.71, 1.00] when participants who drank >= 4 cups of tea per day were compared with non-drinkers (p(linear) (trend) = 0.04). Incidence of type 2 diabetes already tended to be lower with tea consumption of 1-<4 cups/day (HR = 0.93 [95% CI 0.81, 1.05]). Spline regression did not suggest a non-linear association (p(non-linearity) = 0.20). Conclusions/Significance: A linear inverse association was observed between tea consumption and incidence of type 2 diabetes. People who drink at least 4 cups of tea per day may have a 16% lower risk of developing type 2 diabetes than non-tea drinkers.	[van Woudenbergh, Geertruida J.; Kuijsten, Anneleen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Drogan, Dagmar; Boeing, Heiner; Schulze, Matthias B.] German Inst Human Nutr, Potsdam, Germany; [van der A, Daphne L.; Bueno-de-Mesquita, H. Bas; Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Romaguera, Dora; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ardanaz, Eva; Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Amiano, Pilar] Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Beulens, Joline W. J.; Sluijs, Ivonne] Univ Med Ctr, Utrecht, Netherlands; [Dahm, Christina C.; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Aarhus, Denmark; [Chirlaque, M-Doleres] Murcia Reg Hlth Author, Murcia, Spain; [Clavel, Fran-coise; Fagher-azzi, Guy] INSERM, F-75654 Paris 13, France; [Crowe, Francesca L.] Univ Oxford, Oxford, England; [Eomois, Piia-Piret; Teucher, Birgit] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Franks, Paul W.] Lund Univ, Malmo, Sweden; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Khaw, Kay T.] Univ Cambridge, Cambridge, England; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Florence, Italy; [Mattiello, Amalia] Univ Naples Federico II, Naples, Italy; [Quiros, J. Ramon] Asturias Hlth & Hlth Care Council, Oviedo, Spain; [Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Romieu, Isabelle] Int Agcy Res Canc, F-69372 Lyon, France; [Sacerdote, Carlotta] Ctr Canc Prevent, Turin, Italy; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Tagliabue, Giovanna] Fdn IRCCS Ist Nazl Tumori, Canc Registry & Environm Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Canc Registry & Histopathol Unit, Ragusa, Italy; [Forouhi, Nita G.; Sharp, Stephen; Langenberg, Claudia; Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England	Wageningen University & Research; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Netherlands National Institute for Public Health & the Environment; Imperial College London; Public Health Institute of Navarra; Utrecht University; Utrecht University Medical Center; Aarhus University; Murcia Regional Health Council; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Danish Cancer Society; University of Cambridge; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Naples Federico II; Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Escuela Andaluza de Salud Publica; Fondazione IRCCS Istituto Nazionale Tumori Milan	van Woudenbergh, GJ (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.		Teucher, Birgit/J-6380-2015; Khaw, Kay-Tee/AAZ-3209-2021; Tagliabue, Giovanna/D-4194-2017; Mattiello, Amalia AM/K-5112-2016; Langenberg, Claudia/ABG-9067-2021; Feskens, Edith/ABI-1446-2020; Romaguera, Dora/ABE-7004-2020; Kuijsten, Anneleen/R-8073-2017; Masala, Giovanna/AAC-5474-2022; Sánchez, Maria-José/D-1087-2011; Schulze, Matthias B/AAH-6906-2021; Fagherazzi, Guy/P-3534-2017; Fagherazzi, Guy/ABB-2555-2020; Romaguera, Dora/AAB-2852-2020; Dahm, Christina C/G-9787-2014; Franks, Paul/AAA-3300-2020; Clavel-Chapelon, Francoise/G-6733-2014	Tagliabue, Giovanna/0000-0001-8165-5524; Mattiello, Amalia AM/0000-0003-3676-7353; Langenberg, Claudia/0000-0002-5017-7344; Feskens, Edith/0000-0001-5819-2488; Romaguera, Dora/0000-0002-5762-8558; Kuijsten, Anneleen/0000-0001-8120-7027; Masala, Giovanna/0000-0002-5758-9069; Sánchez, Maria-José/0000-0003-4817-0757; Schulze, Matthias B/0000-0002-0830-5277; Fagherazzi, Guy/0000-0001-5033-5966; Fagherazzi, Guy/0000-0001-5033-5966; Dahm, Christina C/0000-0003-0481-2893; Forouhi, Nita/0000-0002-5041-248X; tumino, rosario/0000-0003-2666-414X; Beulens, Joline/0000-0002-4181-0937; Overvad, Kim/0000-0001-6429-7921; Crowe, Francesca/0000-0003-4026-1726; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Franks, Paul/0000-0002-0520-7604; Sacerdote, Carlotta/0000-0002-8008-5096; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097	European Union of the European Community [LSHM-CT-2006-037197]; DLvdA; AMWS; HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); EA and AB: Health Research Fund (FIS); Regional Government of Andalucia; Regional Government of Basque Country; Regional Government of Murcia; Regional Government of Navarra; ISCIII RETIC (Spain) [RD06/0020]; NL Agency [IGE05012]; Board of the UMC Utrecht; AM: Compagnia di San Paolo; MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government [6236]; CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council; Novo Nordisk; Swedish Diabetes Association; Swedish Heart-Lung Foundation; JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa; AVIS-Ragusa; Sicilian Regional Government; KTK: Medical Research Council UK; Cancer Research UK; MRC [MC_UP_A100_1003] Funding Source: UKRI	European Union of the European Community; DLvdA; AMWS; HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); EA and AB: Health Research Fund (FIS); Regional Government of Andalucia(Junta de Andalucia); Regional Government of Basque Country(Basque Government); Regional Government of Murcia; Regional Government of Navarra; ISCIII RETIC (Spain)(Instituto de Salud Carlos III); NL Agency; Board of the UMC Utrecht; AM: Compagnia di San Paolo(Compagnia di San Paolo); MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government(Fundacion Seneca); CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council; Novo Nordisk(Novo Nordisk); Swedish Diabetes Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa; AVIS-Ragusa; Sicilian Regional Government(Regione Sicilia); KTK: Medical Research Council UK; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The EPIC-InterAct project was funded by the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Program 6 of the European Community). In addition, EPIC-InterAct investigators acknowledge funding from the following agencies:-DLvdA, AMWS, and HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); EA and AB: Health Research Fund (FIS), Regional Governments of Andalucia, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020) (Spain); JWJB and IS: Verification of diabetes cases was additionally funded by NL Agency grant IGE05012 and an Incentive Grant from the Board of the UMC Utrecht; AM: Compagnia di San Paolo; MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government (No 6236), and CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council, Novo Nordisk, Swedish Diabetes Association, Swedish Heart-Lung Foundation; JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian Regional Government; KTK: Medical Research Council UK, Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a; Boggs DA, 2010, AM J CLIN NUTR, V92, P960, DOI 10.3945/ajcn.2010.29598; Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-3; Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806; Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollman PCH, 2001, FREE RADICAL RES, V34, P297, DOI 10.1080/10715760100300261; Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Huyen VTT, 2010, HORM METAB RES, V42, P353, DOI 10.1055/s-0030-1248298; Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kyle JAM, 2007, J AGR FOOD CHEM, V55, P4889, DOI 10.1021/jf070351y; Lakenbrink C, 2000, J AGR FOOD CHEM, V48, P2848, DOI 10.1021/jf9908042; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P309, DOI 10.1080/096374800426902; Leenen R, 2000, EUR J CLIN NUTR, V54, P87, DOI 10.1038/sj.ejcn.1600900; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Manikandan R, 2009, MICROSC RES TECHNIQ, V72, P723, DOI 10.1002/jemt.20721; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741; Serafini M, 1996, EUR J CLIN NUTR, V50, P28; Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x; University FaAOWHOUN, 1985, WHO TECHN REP SER, V724; van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3; van het Hof KH, 1999, P SOC EXP BIOL MED, V220, P203, DOI 10.1046/j.1525-1373.1999.d01-34.x; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	33	38	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36910	10.1371/journal.pone.0036910	http://dx.doi.org/10.1371/journal.pone.0036910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666334	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400016
J	Yeung, TY; Seeberger, KL; Kin, T; Adesida, A; Jomha, N; Shapiro, AMJ; Korbutt, GS				Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Adesida, Adetola; Jomha, Nadr; Shapiro, A. M. James; Korbutt, Gregory S.			Human Mesenchymal Stem Cells Protect Human Islets from Pro-Inflammatory Cytokines	PLOS ONE			English	Article							THERAPY POSITION STATEMENT; STROMAL CELLS; BONE-MARROW; INTERNATIONAL-SOCIETY; TRANSPLANTED ISLETS; EDMONTON PROTOCOL; IN-VITRO; SURVIVAL; TERM; MASS	Transplantation of human islets is an attractive alternative to daily insulin injections for patients with type 1 diabetes. However, the majority of islet recipients lose graft function within five years. Inflammation is a primary contributor to graft loss, and inhibiting pro-inflammatory cytokine activity can reverse inflammation mediated dysfunction of islet grafts. As mesenchymal stem cells (MSCs) possess numerous immunoregulatory properties, we hypothesized that MSCs could protect human islets from pro-inflammatory cytokines. Five hundred human islets were co-cultured with 0.5 or 1.0x10(6) human MSCs derived from bone marrow or pancreas for 24 hours followed by 48 hour exposure to interferon-gamma, tumor necrosis factor-alpha and interleukin 1 beta. Controls include islets cultured alone (+/- cytokines) and with human dermal fibroblasts (+/- cytokines). For all conditions, glucose stimulated insulin secretion (GSIS), total islet cellular insulin content, islet beta cell apoptosis, and potential cytoprotective factors secreted in the culture media were determined. Cytokine exposure disrupted human islet GSIS based on stimulation index and percentage insulin secretion. Conversely, culture with 1.0x10(6) bMSCs preserved GSIS from cytokine treated islets. Protective effects were not observed with fibroblasts, indicating that preservation of human islet GSIS after exposure to pro-inflammatory cytokines is MSC dependent. Islet beta cell apoptosis was observed in the presence of cytokines; however, culture of bMSCs with islets prevented beta cell apoptosis after cytokine treatment. Hepatocyte growth factor (HGF) as well as matrix metalloproteinases 2 and 9 were also identified as putative secreted cytoprotective factors; however, other secreted factors likely play a role in protection. This study, therefore, demonstrates that MSCs may be beneficial for islet engraftment by promoting cell survival and reduced inflammation.	[Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Adesida, Adetola; Jomha, Nadr; Shapiro, A. M. James; Korbutt, Gregory S.] Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Dept Surg, Edmonton, AB, Canada; [Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Shapiro, A. M. James; Korbutt, Gregory S.] Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Alberta Diabet Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Yeung, TY (corresponding author), Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Dept Surg, Edmonton, AB, Canada.	korbutt@ualberta.ca	Yeung, Telford/GLV-4480-2022; Adesida, Adetola B/H-3549-2011; Kin, Tatsuya/A-3776-2012	Adesida, Adetola B/0000-0003-1798-6251; Kin, Tatsuya/0000-0002-5179-6067	Juvenile Diabetes Research Foundation [4-2008-812]; Alberta Diabetes Foundation/Institute Translational Grant; Canadian Institutes for Health Research MD/PhD studentship; Alberta Innovates Health Solutions Studentship	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Alberta Diabetes Foundation/Institute Translational Grant; Canadian Institutes for Health Research MD/PhD studentship(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions Studentship	This study is supported by the Juvenile Diabetes Research Foundation (Grant # 4-2008-812) and [an Alberta Diabetes Foundation/Institute Translational Grant]. TYY is a recipient of a Canadian Institutes for Health Research MD/PhD studentship and Alberta Innovates Health Solutions Studentship. The funders had no role in study design, data collection and analysis, decision to publish or publication of manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Gysemans C, 2003, DIABETOLOGIA, V46, P1115, DOI 10.1007/s00125-003-1154-0; Harb G, 2007, XENOTRANSPLANTATION, V14, P580, DOI 10.1111/j.1399-3089.2007.00427.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Itakura S, 2007, AM J TRANSPLANT, V7, P336, DOI 10.1111/j.1600-6143.2006.01643.x; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; KAUFMAN DB, 1994, DIABETES, V43, P778, DOI 10.2337/diabetes.43.6.778; Khan WS, 2010, J ORTHOP RES, V28, P834, DOI 10.1002/jor.21043; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Luo LG, 2007, BIOCHEM BIOPH RES CO, V361, P859, DOI 10.1016/j.bbrc.2007.07.105; MANDRUPPOULSEN T, 1990, CURR TOP MICROBIOL, V164, P169; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; RABINOVITCH A, 1993, DIABETES REV, V1, P215; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Seeberger KL, 2006, LAB INVEST, V86, P141, DOI 10.1038/labinvest.3700377; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454	38	85	91	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38189	10.1371/journal.pone.0038189	http://dx.doi.org/10.1371/journal.pone.0038189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666480	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400098
J	Liao, GJW; Chan, KCA; Jiang, PY; Sun, H; Leung, TY; Chiu, RWK; Lo, YMD				Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Leung, Tak Y.; Chiu, Rossa W. K.; Lo, Y. M. Dennis			Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA	PLOS ONE			English	Article							FORMALDEHYDE; ENRICHMENT; BLOOD; SERUM; PROPORTION; ANEUPLOIDY	Background: Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses. Methodology/Principal Findings: DNA was extracted from plasma samples collected from fourteen pregnant women carrying singleton fetuses. Hybridization-based targeted sequencing was used to enrich 2 906 single nucleotide polymorphism loci on chr7, chr13, chr18 and chr21. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of both the mother and fetus for each case were genotyped by single nucleotide polymorphism microarray analysis. For the targeted regions, the mean sequencing depth of the enriched samples was 225-fold higher than that of the non-enriched samples. From the targeted sequencing data, the ratio between fetus-specific and shared alleles increased by approximately 2-fold on chr21 in the paternally-derived trisomy 21 case. In comparison, the ratio is decreased by approximately 11% on chr21 in the maternally-derived trisomy 21 cases but with much overlap with the ratio of the euploid cases. Computer simulation revealed the relationship between the fetal DNA proportion, the number of informative alleles and the depth of sequencing. Conclusions/Significance: Targeted massively parallel sequencing of single nucleotide polymorphism loci in maternal plasma DNA is a potential approach for trisomy 21 detection. However, the method appears to be less robust than approaches using non-polymorphism-based counting of sequence tags in plasma.	[Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Leung, Tak Y.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Liao, GJW (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	JIANG, Peiyong/AAZ-9898-2020; Lo, Yuk Ming Dennis/D-4468-2011; Chan, K.C. Allen/M-2930-2013; sun, hao/GRS-7732-2022; Sun, Hao/J-9964-2013; Sun, Hao/T-5576-2019	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, K.C. Allen/0000-0003-1780-1691; Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme [AoE/M-04/06]; Sequenom; Endowed Chair from the Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme; Sequenom; Endowed Chair from the Li Ka Shing Foundation	The study was supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and an additional sponsored research agreement with Sequenom. YMDL was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; Benachi A, 2005, CLIN CHEM, V51, P242; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chinnapapagari SKR, 2005, CLIN CHEM, V51, P652, DOI 10.1373/clinchem.2004.042119; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chiu RWK, 2011, BRIT MED J, V342, P9; Chung GTY, 2005, CLIN CHEM, V51, P655, DOI 10.1373/clinchem.2004.042168; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851	19	43	74	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38154	10.1371/journal.pone.0038154	http://dx.doi.org/10.1371/journal.pone.0038154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666469	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600065
J	Luzardo, OP; Henriquez-Hernandez, LA; Valeron, PF; Lara, PC; Almeida-Gonzalez, M; Losada, A; Zumbado, M; Serra-Majem, L; Alvarez-Leon, EE; Boada, LD				Luzardo, Octavio P.; Alberto Henriquez-Hernandez, Luis; Valeron, Pilar F.; Lara, Pedro C.; Almeida-Gonzalez, Maira; Losada, Antonio; Zumbado, Manuel; Serra-Majem, Lluis; Elisa Alvarez-Leon, Eva; Boada, Luis D.			The Relationship between Dioxin-Like Polychlorobiphenyls and IGF-I Serum Levels in Healthy Adults: Evidence from a Cross-Sectional Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; POLYCHLORINATED-BIPHENYLS PCBS; HUDSON RIVER COMMUNITIES; BINDING PROTEIN-3; ESTROGENIC ACTIVITY; POPULATION SAMPLE; OLDER RESIDENTS; CANARY-ISLANDS; BREAST-CANCER; EXPOSURE	Objective: Insulin-like growth factor I (IGF-I) and dioxin-like polychlorobiphenyls (DL-PCBs) have been associated with the pathogenesis of several diseases like cancer, diabetes and growth disorders. Because it has been suggested that organohalogenated contaminants could influence IGF-I levels in adults, the potential relationship between DL-PCBs and IGF-I serum levels was studied in 456 healthy adults from a representative sample of the general population of the Canary Islands (Spain). Design: Free circulating serum levels of IGF-I and IGFBP-3 were measured through an ELISA methodology, while the serum levels of the 12 DL-PCBs congeners (IUPAC numbers # 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, and 189) were measured by gas chromatography/mass spectrometry (GC-MS). Results: DL-PCBs 156 and 167, Total DL-PCBs body burden (Sigma PCBs: sum over the 12 measured DL-PCBs), and Total toxic burden (in terms of toxic equivalence to dioxins: Sigma TEQs) showed a trend of inverse association with IGF-I serum levels in the whole studied population. After adjusting for potential confounders, including gender, body mass index (BMI), age, and IGF-binding protein-3 (IGFBP-3), younger (18-45 years) women with lower BMI (<27 kg/m(2)) and detectable levels of DL-PCB-156 showed significantly lower IGF-I levels than those in the same age and BMI subgroup with non-detectable levels of DL-PCB-156 (p<0.001). Similarly, Sigma PCBs and Sigma TEQs showed a tendency to an inverse association with IGF-I levels in the same group of women (p = 0.017 and p = 0.019 respectively). Conclusions: These findings suggest that DL-PCBs could be involved in the regulation of the IGF-system in a way possibly influenced by gender, age and BMI. Although these results should be interpreted with caution, such circumstances could contribute to explain the development of diseases associated to the IGF system.	[Luzardo, Octavio P.; Almeida-Gonzalez, Maira; Zumbado, Manuel; Boada, Luis D.] Univ Las Palmas Gran Canaria, Dept Clin Sci, Toxicol Unit, Las Palmas Gran Canaria, Spain; [Luzardo, Octavio P.; Alberto Henriquez-Hernandez, Luis; Valeron, Pilar F.; Lara, Pedro C.; Almeida-Gonzalez, Maira; Zumbado, Manuel; Serra-Majem, Lluis; Elisa Alvarez-Leon, Eva; Boada, Luis D.] Inst Canario Invest Canc, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Valeron, Pilar F.] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol Phisiol Genet & Immunol, Las Palmas Gran Canaria, Spain; [Losada, Antonio] Hosp Univ Gran Canaria Dr Negrin, Dept Lab Tests, Las Palmas Gran Canaria, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Prevent Med & Publ Hlth Unit, Las Palmas Gran Canaria, Spain; [Elisa Alvarez-Leon, Eva] Complejo Hosp Materno Insular Gran Canari, Prevent Med Serv, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Hosp Univ Gran Canaria Dr Negrin, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Luzardo, OP (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Toxicol Unit, Las Palmas Gran Canaria, Spain.	ldominguez@dcc.ulpgc.es	Serra-Majem, Lluis/I-6708-2019; Luzardo, Octavio P./H-3045-2019; Valeron, Pilar/AAJ-6771-2021; Dominguez-Boada, Luis/L-5577-2015; Zumbado, Manuel/B-4495-2010; Zumbado, Manuel/AAN-8373-2020; Henriquez-Hernandez, Luis Alberto/H-8981-2019	Serra-Majem, Lluis/0000-0002-9658-9061; Luzardo, Octavio P./0000-0002-4153-3028; Valeron, Pilar/0000-0001-5865-7003; Dominguez-Boada, Luis/0000-0002-0195-4565; Zumbado, Manuel/0000-0002-1534-7758; Henriquez-Hernandez, Luis Alberto/0000-0003-3237-0316; Almeida Gonzalez, Maira/0000-0003-2410-4659	Fundacion Canaria de Investigacion en Salud (FUNCIS) [21/99]; Spanish Government (Proyecto FIS, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) [PI060601]	Fundacion Canaria de Investigacion en Salud (FUNCIS); Spanish Government (Proyecto FIS, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo)	This work was funded with the grant No. 21/99 from the Fundacion Canaria de Investigacion en Salud (FUNCIS) and a grant from the Spanish Government (Proyecto FIS, PI060601, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency EFS, 2010, EFSA J, V8, P1385; Andersson PL, 1999, ARCH ENVIRON CON TOX, V37, P145, DOI 10.1007/s002449900499; Baibas N, 2003, EUR J CANCER PREV, V12, P229, DOI 10.1097/00008469-200306000-00010; Binoux M, 1995, DIABETES METAB, V21, P330; Boada LD, 2007, GROWTH HORM IGF RES, V17, P506, DOI 10.1016/j.ghir.2007.05.004; Brabant G, 2007, PITUITARY, V10, P129, DOI 10.1007/s11102-007-0035-9; Brian JV, 2005, ENVIRON HEALTH PERSP, V113, P721, DOI 10.1289/ehp.7598; Burns JS, 2011, PEDIATRICS, V127, pE59, DOI 10.1542/peds.2009-3556; Cerna M, 2008, CHEMOSPHERE, V72, P1124, DOI 10.1016/j.chemosphere.2008.04.019; Cocchi D, 2009, TOXICOL APPL PHARM, V237, P127, DOI 10.1016/j.taap.2009.03.008; Croutch CR, 2005, TOXICOL SCI, V85, P560, DOI 10.1093/toxsci/kfi106; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; Decastro BR, 2006, ENVIRON SCI TECHNOL, V40, P2819, DOI 10.1021/es051667u; Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103; Donato F, 2008, ENVIRON RES, V108, P380, DOI 10.1016/j.envres.2008.08.003; Dunger DB, 2003, HORM RES, V60, P131, DOI 10.1159/000074514; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Fitzgerald EF, 2008, ENVIRON HEALTH PERSP, V116, P209, DOI 10.1289/ehp.10432; Fitzgerald EF, 2007, ENVIRON RES, V104, P352, DOI 10.1016/j.envres.2007.01.010; Gomez JM, 2003, CLIN ENDOCRINOL, V58, P213, DOI 10.1046/j.1365-2265.2003.01698.x; Gonzalez CA, 2010, EUR J CANCER, V46, P2555, DOI 10.1016/j.ejca.2010.07.025; Hall K., 1999, Journal of Endocrinological Investigation, V22, P48; Henderson KD, 2006, CANCER EPIDEM BIOMAR, V15, P2298, DOI 10.1158/1055-9965.EPI-06-0344; Henriquez-Hernandez LA, 2011, ENVIRON RES, V111, P10, DOI 10.1016/j.envres.2010.11.005; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; (IARC) IAfRoC, 1987, IARC MON, V1-42, P367; Kaklamani VG, 1999, J CLIN ONCOL, V17, P813, DOI 10.1200/JCO.1999.17.3.813; Kanbur-Oksuz N, 2004, TURKISH J PEDIATR, V46, P315; Kang JH, 2008, CHEMOSPHERE, V73, P1625, DOI 10.1016/j.chemosphere.2008.07.087; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; Koppen G, 2002, CHEMOSPHERE, V48, P811, DOI 10.1016/S0045-6535(02)00111-X; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Leijs MM, 2008, CHEMOSPHERE, V73, P176, DOI 10.1016/j.chemosphere.2008.05.056; LEWITT MS, 1994, DIABETES RES CLIN PR, V23, P3, DOI 10.1016/0168-8227(94)90121-X; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P44, DOI 10.1097/00001648-200001000-00010; Luzardo OP, 2012, CHEMOSPHERE; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P62; Pelletier C, 2002, TOXICOL SCI, V67, P46, DOI 10.1093/toxsci/67.1.46; Philibert A, 2009, INT J ENV RES PUB HE, V6, P3179, DOI 10.3390/ijerph6123179; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2005, CANCER EPIDEM BIOMAR, V14, P48; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P276, DOI 10.1080/10937400701875923; Scarth JP, 2006, XENOBIOTICA, V36, P119, DOI 10.1080/00498250600621627; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P699, DOI 10.1530/eje.1.02131; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Succurro E, 2010, EUR J ENDOCRINOL, V163, P75, DOI 10.1530/EJE-10-0113; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tekle M, 2010, ENVIRON INT, V36, P188, DOI 10.1016/j.envint.2009.11.003; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; Yang FX, 2008, ENVIRON TOXICOL CHEM, V27, P220, DOI 10.1897/07-108.1; Zubero MB, 2009, CHEMOSPHERE, V76, P784, DOI 10.1016/j.chemosphere.2009.04.061; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022; Zumbado M, 2010, GROWTH HORM IGF RES, V20, P63, DOI 10.1016/j.ghir.2009.07.003	60	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38213	10.1371/journal.pone.0038213	http://dx.doi.org/10.1371/journal.pone.0038213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666488	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600073
J	McHugh, D; O'Connor, T; Bremer, J; Aguzzi, A				McHugh, Donal; O'Connor, Tracy; Bremer, Juliane; Aguzzi, Adriano			ZyFISH: A Simple, Rapid and Reliable Zygosity Assay for Transgenic Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PRP KNOCKOUT MICE; PRION PROTEIN; QUANTITATIVE PCR; EGF RECEPTOR; LACKING; SUSCEPTIBILITY; TOXICITY; SCRAPIE; ANIMALS	Microinjection of DNA constructs into fertilized mouse oocytes typically results in random transgene integration at a single genomic locus. The resulting transgenic founders can be used to establish hemizygous transgenic mouse lines. However, practical and experimental reasons often require that such lines be bred to homozygosity. Transgene zygosity can be determined by progeny testing assays which are expensive and time-consuming, by quantitative Southern blotting which is labor-intensive, or by quantitative PCR (qPCR) which requires transgene-specific design. Here, we describe a zygosity assessment procedure based on fluorescent in situ hybridization (zyFISH). The zyFISH protocol entails the detection of transgenic loci by FISH and the concomitant assignment of homozygosity using a concise and unbiased scoring system. The method requires small volumes of blood, is scalable to at least 40 determinations per assay, and produces results entirely consistent with the progeny testing assay. This combination of reliability, simplicity and cost-effectiveness makes zyFISH a method of choice for transgenic mouse zygosity determinations.	[McHugh, Donal; O'Connor, Tracy; Bremer, Juliane; Aguzzi, Adriano] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	McHugh, D (corresponding author), Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, Schmelzbergstr, Zurich, Switzerland.	adriano.aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Bremer, Juliane/AAH-9487-2020	Aguzzi, Adriano/0000-0002-0344-6708	ERC Advanced Investigator award [250356]; University of Zurich; Dr. Max Husmann Foundation Zurich; Swiss National Science Foundation [3100A0-111917]; Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair"; Novartis Research Foundation; European Union programs Prion Research Projects Community (PRIORITY) [222887]; Seventh Framework Programs [24098, 278611]	ERC Advanced Investigator award; University of Zurich; Dr. Max Husmann Foundation Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair"; Novartis Research Foundation; European Union programs Prion Research Projects Community (PRIORITY); Seventh Framework Programs	Adriano Aguzzi is supported by ERC Advanced Investigator award #250356. Tracy O'Connor and Juliane Bremer are supported by funding from the University of Zurich. Donal McHugh is supported by a scholarship from the Dr. Max Husmann Foundation Zurich. This work was funded by the Swiss National Science Foundation (3100A0-111917), the Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair", by an unrestricted grant of the Novartis Research Foundation to Adriano Aguzzi, and by the European Union programs Prion Research Projects Community (PRIORITY; 222887) and the Seventh Framework Programs (24098), and (278611; NeuriNox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation or the manuscript.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Buerki K, 2011, PRICE LIST RATES LAB; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; DINCHUK JE, 1994, BIOTECHNIQUES, V17, P954; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Knoll JH, 2005, CURRENT PROTOCOLS HU, P431; Kulnane LS, 2002, MAMM GENOME, V13, P223, DOI 10.1007/s00335-001-2128-5; NISHINO H, 1995, BIOTECHNIQUES, V19, P587; Paris D, 1996, TRANSGENIC RES, V5, P397, DOI 10.1007/BF01980204; Schneider MR, 2005, ANAL BIOCHEM, V344, P1, DOI 10.1016/j.ab.2005.03.035; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SWIGER RR, 1995, BIOTECHNIQUES, V18, P952; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; Tesson L, 2010, METHODS MOL BIOL, V597, P277, DOI 10.1007/978-1-60327-389-3_19; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2	24	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37881	10.1371/journal.pone.0037881	http://dx.doi.org/10.1371/journal.pone.0037881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666404	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305349600036
J	Yaniv, Y; Spurgeon, HA; Lyashkov, AE; Yang, DM; Ziman, BD; Maltsev, VA; Lakatta, EG				Yaniv, Yael; Spurgeon, Harold A.; Lyashkov, Alexey E.; Yang, Dongmei; Ziman, Bruce D.; Maltsev, Victor A.; Lakatta, Edward G.			Crosstalk between Mitochondrial and Sarcoplasmic Reticulum Ca2+ Cycling Modulates Cardiac Pacemaker Cell Automaticity	PLOS ONE			English	Article							SPONTANEOUS BEATING RATE; RYANODINE RECEPTOR; MYOCYTES; RABBIT; INHIBITION; CGP-37157; EXCHANGE; CHANNELS; OSCILLATIONS; CONTRACTION	Background: Mitochondria dynamically buffer cytosolic Ca2+ in cardiac ventricular cells and this affects the Ca2+ load of the sarcoplasmic reticulum (SR). In sinoatrial-node cells (SANC) the SR generates periodic local, subsarcolemmal Ca2+ releases (LCRs) that depend upon the SR load and are involved in SANC automaticity: LCRs activate an inward Na+-Ca2+ exchange current to accelerate the diastolic depolarization, prompting the ensemble of surface membrane ion channels to generate the next action potential (AP). Objective: To determine if mitochondrial Ca2+ (Ca-m(2+)), cytosolic Ca2+ (Ca-c(2+))-SR-Ca2+ crosstalk occurs in single rabbit SANC, and how this may relate to SANC normal automaticity. Results: Inhibition of mitochondrial Ca2+ influx into (Ru360) or Ca2+ efflux from (CGP-37157) decreased [Ca2+](m) to 80 +/- 8% control or increased [Ca2+](m) to 119 +/- 7% control, respectively. Concurrent with inhibition of mitochondrial Ca2+ influx or efflux, the SR Ca2+ load, and LCR size, duration, amplitude and period (imaged via confocal linescan) significantly increased or decreased, respectively. Changes in total ensemble LCR Ca2+ signal were highly correlated with the change in the SR Ca2+ load (r(2) = 0.97). Changes in the spontaneous AP cycle length (Ru360, 111 +/- 1% control; CGP-37157, 89 +/- 2% control) in response to changes in [Ca2+](m) were predicted by concurrent changes in LCR period (r(2) = 0.84). Conclusion: A change in SANC Ca-m(2+) flux translates into a change in the AP firing rate by effecting changes in Ca (2+)(c) and SR Ca2+ loading, which affects the characteristics of spontaneous SR Ca2+ release.	[Yaniv, Yael; Spurgeon, Harold A.; Lyashkov, Alexey E.; Yang, Dongmei; Ziman, Bruce D.; Maltsev, Victor A.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yaniv, Y (corresponding author), NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	LakattaE@mail.nih.gov	Yaniv, Yael/B-3311-2015; Lakatta, Edward G/AAL-1447-2020; Maltsev, Victor/AAY-9460-2020	Yaniv, Yael/0000-0002-5183-6284; Maltsev, Victor/0000-0002-3832-791X; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000599] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2011, J CELL MOL MED, V15, P2478, DOI 10.1111/j.1582-4934.2010.01249.x; Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Chikando AC, 2011, J MOL CELL CARDIOL, V51, P627, DOI 10.1016/j.yjmcc.2011.08.003; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Dorn GW, 2010, CIRC RES, V107, P689, DOI 10.1161/CIRCRESAHA.110.225714; Gao Z, 2010, J MOL CELL CARDIOL, V49, P33, DOI 10.1016/j.yjmcc.2010.03.019; Griffiths EJ, 1997, CELL CALCIUM, V21, P321, DOI 10.1016/S0143-4160(97)90120-2; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hashiatni H, 2010, BRIT J PHARMACOL, V161, P680, DOI 10.1111/j.1476-5381.2010.00902.x; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Liu T, 2010, J MOL CELL CARDIOL, V49, P728, DOI 10.1016/j.yjmcc.2010.06.012; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Maltsev VA, 2011, AM J PHYSIOL-HEART C, V300, pH2323, DOI 10.1152/ajpheart.00110.2011; Maltsev VA, 2010, AM J PHYSIOL-HEART C, V298, pH2010, DOI 10.1152/ajpheart.00783.2009; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; Neumann JT, 2011, MOL PHARMACOL, V79, P141, DOI 10.1124/mol.110.067165; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; SPURGEON HA, 1990, AM J PHYSIOL, V258, pH574, DOI 10.1152/ajpheart.1990.258.2.H574; Thu LT, 2006, EUR J PHARMACOL, V552, P15, DOI 10.1016/j.ejphar.2006.09.013; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P740, DOI 10.1016/j.yjmcc.2011.07.018	33	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37582	10.1371/journal.pone.0037582	http://dx.doi.org/10.1371/journal.pone.0037582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666369	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600023
J	Bian, T; Gibbs, JD; Orvell, C; Imani, F				Bian, Tao; Gibbs, John D.; Orvell, Claes; Imani, Farhad			Respiratory Syncytial Virus Matrix Protein Induces Lung Epithelial Cell Cycle Arrest through a p53 Dependent Pathway	PLOS ONE			English	Article							INFECTION; REPLICATION; EXPRESSION; ASSOCIATION; INCREASES; APOPTOSIS; CHILDREN; INFANTS; IMPACT; RISK	Respiratory syncytial virus (RSV) is the major cause of viral respiratory infections in children. Our previous study showed that the RSV infection induced lung epithelial cell cycle arrest, which enhanced virus replication. To address the mechanism of RSV-induced cell cycle arrest, we examined the contribution of RSV-matrix (RSV-M) protein. In this report, we show that in both the A549 cell line and primary human bronchial epithelial (PHBE) cells, transfection with RSV-M protein caused the cells to proliferate at a slower rate than in control cells. The cell cycle analysis showed that RSV-M protein induced G1 phase arrest in A549 cells, and G1 and G2/M phase arrest in PHBE cells. Interestingly, RSV-M expression induced p53 and p21 accumulation and decreased phosphorylation of retinoblastoma protein (Rb). Further, induction of cell cycle arrest by RSV-M was not observed in a p53-deficient epithelial cell line (H1299). However, cell cycle arrest was restored after transfection of p53 cDNA into H1299 cells. Taken together, these results indicate that RSV-M protein regulates lung epithelial cell cycle through a p53-dependent pathway, which enhances RSV replication.	[Bian, Tao] Natl Inst Environm Human Sci, Lab Resp Biol, Durham, NC USA; [Gibbs, John D.] Global Vaccines Inc, Durham, NC USA; [Orvell, Claes] Karolinska Inst, Huddinge Univ Hosp, Dept Clin Virol, Stockholm, Sweden; [Imani, Farhad] ViraSource Labs, Durham, NC USA	Karolinska Institutet	Bian, T (corresponding author), Natl Inst Environm Human Sci, Lab Resp Biol, Durham, NC USA.	fimani@virasource.com	Bian, Tao/I-7604-2013		National Institute of Health (NIH)	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was fully funded by Intramural National Institute of Health (NIH) funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Casavant NC, 2006, J VIROL, V80, P8390, DOI 10.1128/JVI.00505-06; Centers for Disease Control and Prevention, 2008, RESP SYNC VIR INF, P18; Chulu JL, 2010, J VIROL; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; De Beeck AO, 2001, J VIROL, V75, P11071, DOI 10.1128/JVI.75.22.11071-11078.2001; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emmett Stevan R., 2004, V296, P197; Genini D, 2001, FASEB J, V15, P5; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hayon IL, 2002, CELL CYCLE, V1, P111, DOI 10.4161/cc.1.2.109; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Hwang ES, 2009, J VIROL, V83, P12388, DOI 10.1128/JVI.00304-09; Kash JC, 2011, MBIO, V2, DOI 10.1128/mBio.00172-11; Klein MI, 2006, J INFECT DIS, V193, P1544, DOI 10.1086/503806; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005; Orba Y, 2010, J BIOL CHEM, V285, P1544, DOI 10.1074/jbc.M109.064311; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2008, J GEN VIROL, V89, P1106, DOI 10.1099/vir.0.83262-0; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Park GB, 2009, IMMUNOLOGY, V128, P360, DOI 10.1111/j.1365-2567.2009.03111.x; Pavelic SK, 2009, J CANCER RES CLIN, V135, P1747, DOI 10.1007/s00432-009-0621-5; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Restle A, 2005, ONCOGENE, V24, P4380, DOI 10.1038/sj.onc.1208639; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Royds JA, 2006, ONCOGENE, V25, P1509, DOI 10.1038/sj.onc.1209185; Sarfraz S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-133; Sato Y, 2010, CELL CYCLE, V9, P807, DOI 10.4161/cc.9.4.10675; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Subbramanian RA, 1998, J MOL BIOL, V278, P13, DOI 10.1006/jmbi.1998.1685; Vilcek J, 2003, NAT IMMUNOL, V4, P825, DOI 10.1038/ni0903-825; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027	46	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38052	10.1371/journal.pone.0038052	http://dx.doi.org/10.1371/journal.pone.0038052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662266	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300158
J	Hu, SS; Wang, BB; Qi, YH; Lin, H				Hu, Shanshan; Wang, Binbin; Qi, Yanhua; Lin, Hui			The Arg233Lys AQP0 Mutation Disturbs Aquaporin0-Calmodulin Interaction Causing Polymorphic Congenital Cataract	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; NUCLEAR CATARACT; MIP; GENE	Calmodulin (CaM) directly interacts with the aquaporin 0 (AQP0) C-terminus in a calcium dependent manner to regulate the water permeability of AQP0. We previously identified a missense mutation (p.R233K) in the putative CaM binding domain of AQP0 C-terminus in a congenital cataract family. This study was aimed at exploring the potential pathogenesis of this mutation causative of cataract and mainly identifying how it influenced the binding of AQP0 to CaM. Wild type and R233K mutant AQP0 with EGFP-tag were transfected separately into Hela cells to determine the expression and subcellular localizations. The co-immunoprecipitation (CoIP) assay was used to detect the interaction between AQP0 and CaM. AQP0 C-terminus peptides were synthesized with and without R233K, and the binding abilities of these peptides to CaM were assessed using a fluorescence binding assay. Localizations of wild type and R233K mutant AQP0 were determined from EGFP fluorescence, and the chimeric proteins were both localized abundantly in the plasma membrane. Protein expression levels of the culture cells showed no significant difference between them. The results from CoIP assay implied that R233K mutant presented more weakly in association with CaM than wild type AQP0. The AQP0 C-terminal mutant peptide was found to have 2.5-fold lower binding affinity to CaM than wild type peptide. These results suggested that R233K mutation did not affect the expression, location and trafficking of the protein but did influence the interaction between AQP0 and CaM. The binding affinity of AQP0 C-terminus to CaM was significantly reduced. Due to lack of the modulation of the Ca2+-calmodulin complex, the water permeability of AQP0 was subsequently augmented, which might lead to the development of this cataract.	[Hu, Shanshan; Qi, Yanhua; Lin, Hui] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China; [Wang, Binbin] Natl Res Inst Family Planning, Ctr Genet, Beijing, Peoples R China	Harbin Medical University; National Research Institute for Family Planning - China	Qi, YH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China.	qyh64@hotmail.com; LL266@yahoo.com		Wang, Binbin/0000-0002-1597-5930	National Natural Science Foundation of China [30801274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 30801274] (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2005, BIOL CELL, V97, P355, DOI 10.1042/BC20050027; ALCALA J, 1975, EXP EYE RES, V21, P581, DOI 10.1016/0014-4835(75)90040-8; ARNESON ML, 1995, EUR J BIOCHEM, V234, P670, DOI 10.1111/j.1432-1033.1995.670_b.x; Babu YS, 1998, J MOL BIOL, V1, P191; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Golestaneh N, 2008, MOL VIS, V14, P1006; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gu F, 2007, MOL VIS, V13, P1651; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; Jiang J, 2009, MOL VIS, V15, P38; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; KUSHMERICK C, 1995, EXP EYE RES, V61, P351, DOI 10.1016/S0014-4835(05)80129-0; Lin H, 2007, MOL VIS, V13, P1822; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; MAUCH L, 1990, J BIOL CHEM, V265, P12761; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Nemeth-Cahalan KL, 2007, J GEN PHYSIOL, V5, P4574; OH BH, 1993, J BIOL CHEM, V268, P11348; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Varadaraj K, 1999, J MEMBRANE BIOL, V170, P191, DOI 10.1007/s002329900549; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Wang KJ, 2011, MOL VIS, V17, P70; Wang W, 2010, MOL VIS, V16, P534; Xiao Xueshan, 2011, Mol Vis, V17, P2049; Yang GX, 2011, MOL VIS, V17, P1320; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313	35	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37637	10.1371/journal.pone.0037637	http://dx.doi.org/10.1371/journal.pone.0037637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662182	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300072
J	Johansson, M; Roberts, A; Chen, D; Li, YY; Delahaye-Sourdeix, M; Aswani, N; Greenwood, MA; Benhamou, S; Lagiou, P; Holcatova, I; Richiardi, L; Kjaerheim, K; Agudo, A; Castellsague, X; Macfarlane, TV; Barzan, L; Canova, C; Thakker, NS; Conway, DI; Znaor, A; Healy, CM; Ahrens, W; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Fabianova, E; Mates, IN; Bencko, V; Foretova, L; Janout, V; Curado, MP; Koifman, S; Menezes, A; Wunsch, V; Eluf-Neto, J; Boffetta, P; Franceschi, S; Herrero, R; Garrote, LF; Talamini, R; Boccia, S; Galan, P; Vatten, L; Thomson, P; Zelenika, D; Lathrop, M; Byrnes, G; Cunningham, H; Brennan, P; Wakefield, J; Mckay, JD				Johansson, Mattias; Roberts, Angus; Chen, Dan; Li, Yaoyong; Delahaye-Sourdeix, Manon; Aswani, Niraj; Greenwood, Mark A.; Benhamou, Simone; Lagiou, Pagona; Holcatova, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V.; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S.; Conway, David I.; Znaor, Ariana; Healy, Claire M.; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Boffetta, Paolo; Franceschi, Silvia; Herrero, Rolando; Fernandez Garrote, Leticia; Talamini, Renato; Boccia, Stefania; Galan, Pilar; Vatten, Lars; Thomson, Peter; Zelenika, Diana; Lathrop, Mark; Byrnes, Graham; Cunningham, Hamish; Brennan, Paul; Wakefield, Jon; Mckay, James D.			Using Prior Information from the Medical Literature in GWAS of Oral Cancer Identifies Novel Susceptibility Variant on Chromosome 4-the AdAPT Method	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; POOLED ANALYSIS; 15Q25; LOCUS; DISEASES; EUROPE; GENES; RISK	Background: Genome-wide association studies (GWAS) require large sample sizes to obtain adequate statistical power, but it may be possible to increase the power by incorporating complementary data. In this study we investigated the feasibility of automatically retrieving information from the medical literature and leveraging this information in GWAS. Methods: We developed a method that searches through PubMed abstracts for pre-assigned keywords and key concepts, and uses this information to assign prior probabilities of association for each single nucleotide polymorphism (SNP) with the phenotype of interest - the Adjusting Association Priors with Text (AdAPT) method. Association results from a GWAS can subsequently be ranked in the context of these priors using the Bayes False Discovery Probability (BFDP) framework. We initially tested AdAPT by comparing rankings of known susceptibility alleles in a previous lung cancer GWAS, and subsequently applied it in a two-phase GWAS of oral cancer. Results: Known lung cancer susceptibility SNPs were consistently ranked higher by AdAPT BFDPs than by p-values. In the oral cancer GWAS, we sought to replicate the top five SNPs as ranked by AdAPT BFDPs, of which rs991316, located in the ADH gene region of 4q23, displayed a statistically significant association with oral cancer risk in the replication phase (per-rare-allele log additive p-value [p(trend)] = 2.5 x 10(-3)). The combined OR for having one additional rare allele was 0.83 (95% CI: 0.76-0.90), and this association was independent of previously identified susceptibility SNPs that are associated with overall UADT cancer in this gene region. We also investigated if rs991316 was associated with other cancers of the upper aerodigestive tract (UADT), but no additional association signal was found. Conclusion: This study highlights the potential utility of systematically incorporating prior knowledge from the medical literature in genome-wide analyses using the AdAPT methodology. AdAPT is available online (url: http://services.gate.ac.uk/lld/gwas/service/config).	[Johansson, Mattias; Chen, Dan; Delahaye-Sourdeix, Manon; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; Mckay, James D.] Int Agcy Res Canc IARC, Sect Infect, Lyon, France; [Roberts, Angus; Aswani, Niraj; Greenwood, Mark A.; Cunningham, Hamish] Univ Sheffield, Dept Comp Sci, GATE Team, Sheffield S10 2TN, S Yorkshire, England; [Li, Yaoyong] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England; [Benhamou, Simone] INSERM, U946, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, CNRS, UMR8200, Villejuif, France; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Holcatova, Ivana; Bencko, Vladimir] Charles Univ Prague, Inst Hyg & Epidemiol, Fac Med 1, Prague, Czech Republic; [Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Agudo, Antonio; Castellsague, Xavier] IDIBELL, Inst Catala Oncol ICO, Lhospitalet De Llobregat, Catalonia, Spain; [Castellsague, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Barzan, Luigi] Gen Hosp Pordenone, Pordenone, Italy; [Canova, Cristina] Univ Padua, Dept Mol Med, Padua, Italy; [Canova, Cristina] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth Resp Epidemiol & Publ, Natl Heart & Lung Inst, London, England; [Thakker, Nalin S.] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Znaor, Ariana] Croatian Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Healy, Claire M.] Trinity Coll Dublin, Sch Dent Sci, Dublin, Ireland; [Ahrens, Wolfgang] Inst Epidemiol & Prevent Res BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Inst Stat, D-28359 Bremen, Germany; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Mates, Ioan Nicolae] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Curado, Maria Paula; Boffetta, Paolo] Int Prevent Res Inst IPRI, Ecully, France; [Curado, Maria Paula] Hosp Araujo Jorge ACCG, Goiania, Go, Brazil; [Koifman, Sergio] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Menezes, Ana] Univ Fed Pelotas, Pelotas, Brazil; [Wuensch-Filho, Victor; Eluf-Neto, Jose] Univ Sao Paulo, Sao Paulo, Brazil; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Herrero, Rolando] Inst Invest Epidemiol, San Jose, Costa Rica; [Fernandez Garrote, Leticia] Inst Oncol & Radiobiol, Havana, Cuba; [Talamini, Renato] IRCSS, Natl Canc Inst, Aviano, Italy; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Inst Hyg, Rome, Italy; [Boccia, Stefania] IRCCS San Raffaele Pisana, Rome, Italy; [Galan, Pilar] Univ Paris 13, INSERM, U557, UMR Inserm,INRA,CNAM, Paris, France; [Galan, Pilar] CRNH IdF, Bobigny, France; [Vatten, Lars] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Thomson, Peter] Newcastle Univ, Sch Dent, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Zelenika, Diana; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Lathrop, Mark] Fondat Jean Dausset CEPH, Paris, France; [Wakefield, Jon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Stat, Seattle, WA 98195 USA	World Health Organization; International Agency for Research on Cancer (IARC); University of Sheffield; Paterson Institute for Cancer Research; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Athens Medical School; National & Kapodistrian University of Athens; Charles University Prague; University of Turin; University of Oslo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Aberdeen; University of Padua; Imperial College London; University of Manchester; University of Glasgow; Trinity College Dublin; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Carol Davila University of Medicine & Pharmacy; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Fundacao Oswaldo Cruz; Universidade Federal de Pelotas; Universidade de Sao Paulo; Icahn School of Medicine at Mount Sinai; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS San Raffaele Pisana; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris 13; Norwegian University of Science & Technology (NTNU); Newcastle University - UK; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Johansson, M (corresponding author), Int Agcy Res Canc IARC, Sect Infect, Lyon, France.	johanssonm@iarc.fr; mckay@iarc.fr	Menezes, Ana MB/G-7266-2012; franceschi, silvia/M-2452-2014; Johansson, Mattias/ABF-3365-2020; Boccia, Stefania/AAB-9533-2022; Curado, Maria Paula/M-6200-2013; Boffetta, Paolo/AAI-7767-2021; Vatten, Lars/AAF-9380-2022; Holcatova, Ivana/C-8327-2017; Healy, Claire M/AGL-9755-2022; Boccia, Stefania/AFN-1666-2022; Agudo, Antonio/J-1805-2016; Filho, Victor Wunsch/C-4475-2012; Bencko, Vladimir/H-8598-2017; Pique, Xavier Castellsagué/N-5795-2014; Mates, Ioan Nicolae/E-9255-2017; Benhamou, Simone/K-6554-2015; Benhamou, Simone/ABD-2590-2020; Znaor, A/H-6718-2019; Janout, Vladimir/M-5133-2014; Szeszenia-Dabrowska, Neonila/F-7190-2010; Vatten, Lars/AFK-2073-2022; Zaridze, David/K-5605-2013; Eluf-Neto, Jose/B-2522-2009; Lissowska, Jolanta/AAH-3252-2020; richiardi, lorenzo/J-3480-2018; Thomson, Peter/L-7719-2016; Ahrens, Wolfgang/A-2740-2012	Menezes, Ana MB/0000-0002-2996-9427; franceschi, silvia/0000-0003-4181-8071; Boccia, Stefania/0000-0002-1864-749X; Curado, Maria Paula/0000-0001-8172-2483; Boffetta, Paolo/0000-0002-3811-2791; Holcatova, Ivana/0000-0002-1366-0337; Healy, Claire M/0000-0003-0583-6360; Boccia, Stefania/0000-0002-1864-749X; Agudo, Antonio/0000-0001-9900-5677; Bencko, Vladimir/0000-0003-1935-2228; Pique, Xavier Castellsagué/0000-0002-0802-3595; Eluf-Neto, Jose/0000-0001-7504-2115; Lissowska, Jolanta/0000-0003-2695-5799; Healy, Claire M/0000-0001-7940-4611; richiardi, lorenzo/0000-0003-0316-9402; CANOVA, CRISTINA/0000-0001-7027-7935; Roberts, Angus/0000-0002-4570-9801; Johansson, Mattias/0000-0002-3116-5081; Thomson, Peter/0000-0002-2007-7975; Cunningham, Hamish/0000-0001-5901-5483; Conway, David/0000-0001-7762-4063; Kjaerheim, Kristina/0000-0003-0691-3735; Ahrens, Wolfgang/0000-0003-3777-570X; Macfarlane, Tatiana/0000-0002-9392-0812; Foretova, Lenka/0000-0003-0494-2620; Ioan Nicoale, Mates/0000-0001-7210-0615; BENHAMOU, Simone/0000-0001-5853-8047; Byrnes, Graham/0000-0003-3893-7539	EU; United States National Cancer Institute [R01 CA092039 05]; National Institute of Dental and Craniofacial Research [1R03DE020116]; INCa (Institut National du Cancer, France);  [FP7-215535]; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020116] Funding Source: NIH RePORTER	EU(European Commission); United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); INCa (Institut National du Cancer, France); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by EU-FP7 grant [LarKC, url: http://www.larkc.eu][FP7-215535]. Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the United States National Cancer Institute (R01 CA092039 05) and the National Institute of Dental and Craniofacial Research (1R03DE020116). Support for the central Europe and ARCAGE genome-wide studies was provided by INCa (Institut National du Cancer, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 2009, UMLS REF MAN; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen D, 2011, CANCER EPIDEM BIOMAR, V20, P658, DOI 10.1158/1055-9965.EPI-10-1008; Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007; Cunningham H, 2011, INFORM EXTRACTION SE, P307; Cunningham H., 2011, TEXT PROCESSING GATE; Falush D, 2003, GENETICS, V164, P1567; Garavello W, 2008, INT J CANCER, V122, P1827, DOI 10.1002/ijc.23199; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Scelo G, 2004, CANCER CAUSE CONTROL, V15, P445, DOI 10.1023/B:CACO.0000036444.11655.be; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	31	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36888	10.1371/journal.pone.0036888	http://dx.doi.org/10.1371/journal.pone.0036888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662130	Green Published, gold, Green Accepted			2022-12-25	WOS:000305342300021
J	Khodadad, CLM; Foster, JS				Khodadad, Christina L. M.; Foster, Jamie S.			Metagenomic and Metabolic Profiling of Nonlithifying and Lithifying Stromatolitic Mats of Highborne Cay, The Bahamas	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; MODERN MARINE STROMATOLITES; LITHIFIED MICRITIC LAMINAE; MICROBIAL MATS; BIOCHEMICAL-CHARACTERIZATION; RAST SERVER; DIVERSITY; COMMUNITY; LITHIFICATION; CYANOBACTERIA	Background: Stromatolites are laminated carbonate build-ups formed by the metabolic activity of microbial mats and represent one of the oldest known ecosystems on Earth. In this study, we examined a living stromatolite located within the Exuma Sound, The Bahamas and profiled the metagenome and metabolic potential underlying these complex microbial communities. Methodology/Principal Findings: The metagenomes of the two dominant stromatolitic mat types, a nonlithifying (Type 1) and lithifying (Type 3) microbial mat, were partially sequenced and compared. This deep-sequencing approach was complemented by profiling the substrate utilization patterns of the mats using metabolic microarrays. Taxonomic assessment of the protein-encoding genes confirmed previous SSU rRNA analyses that bacteria dominate the metagenome of both mat types. Eukaryotes comprised less than 13% of the metagenomes and were rich in sequences associated with nematodes and heterotrophic protists. Comparative genomic analyses of the functional genes revealed extensive similarities in most of the subsystems between the nonlithifying and lithifying mat types. The one exception was an increase in the relative abundance of certain genes associated with carbohydrate metabolism in the lithifying Type 3 mats. Specifically, genes associated with the degradation of carbohydrates commonly found in exopolymeric substances, such as hexoses, deoxy-and acidic sugars were found. The genetic differences in carbohydrate metabolisms between the two mat types were confirmed using metabolic microarrays. Lithifying mats had a significant increase in diversity and utilization of carbon, nitrogen, phosphorus and sulfur substrates. Conclusion/Significance: The two stromatolitic mat types retained similar microbial communities, functional diversity and many genetic components within their metagenomes. However, there were major differences detected in the activity and genetic pathways of organic carbon utilization. These differences provide a strong link between the metagenome and the physiology of the mats, as well as new insights into the biological processes associated with carbonate precipitation in modern marine stromatolites.	[Khodadad, Christina L. M.; Foster, Jamie S.] Univ Florida, Dept Microbiol & Cell Sci, Space Life Sci Lab, Kennedy Space Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Khodadad, CLM (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Space Life Sci Lab, Kennedy Space Ctr, Gainesville, FL 32611 USA.	jfoster@ufl.edu		Foster, Jamie/0000-0001-8603-4006	National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element [NNX09AO57G]; NASA Florida Space Grant Consortium	National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element(National Aeronautics & Space Administration (NASA)); NASA Florida Space Grant Consortium	This work was supported by the National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element (NNX09AO57G) (http://astrobiology.nasa.gov/) and the NASA Florida Space Grant Consortium (http://www.floridaspacegrant.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, EARLY LIFE EARTH; Apple JK, 2011, APPL ENVIRON MICROB, V77, P3074, DOI 10.1128/AEM.02241-10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Bianchi TS, 2007, BIOCH ESTUARIES; Bowlin EM, 2011, SEDIMENT GEOL, DOI [10.1016/j.sedgeo.2011.1008.1002, DOI 10.1016/J.SEDGEO.2011.1008.1002]; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Burns BP, 2004, ENVIRON MICROBIOL, V6, P1096, DOI 10.1111/j.1462-2920.2004.00651.x; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; De Philippis R, 1998, APPL ENVIRON MICROB, V64, P1130; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Foster JS, 2011, CELL ORIG LIFE EXTRE, V18, P385; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Green SJ, 2008, ISME J, V2, P457, DOI 10.1038/ismej.2008.6; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; GUDE H, 1985, MICROBIAL ECOL, V11, P193, DOI 10.1007/BF02010599; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hewson I, 2010, ENVIRON MICROBIOL, V12, P1940, DOI 10.1111/j.1462-2920.2010.02198.x; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawaguchi T, 2000, PREP BIOCHEM BIOTECH, V30, P321, DOI 10.1080/10826060008544971; Kawaguchi T, 2002, PREP BIOCHEM BIOTECH, V32, P51, DOI 10.1081/PB-120013161; Macintyre IG, 2000, SEDIMENTOLOGY, V47, P915, DOI 10.1046/j.1365-3091.2000.00327.x; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Moreno AM, 2010, APPL ENVIRON MICROB, V76, P2203, DOI 10.1128/AEM.02777-09; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Paerl HW, 2001, ENVIRON MICROBIOL, V3, P123, DOI 10.1046/j.1462-2920.2001.00168.x; Perkins RG, 2007, MAR ECOL PROG SER, V349, P23, DOI 10.3354/meps07087; Pinckney JL, 1997, FACIES, V36, P204; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Steppe TF, 2001, MICROB ECOL, V41, P36; Stolz John F., 2009, Atoll Research Bulletin, P1; Varin T, 2010, LIMNOL OCEANOGR, V55, P1901, DOI 10.4319/lo.2010.55.5.1901; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 1999, APPL ENVIRON MICROB, V65, P3272; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Visscher PT, 2002, ACS SYM SER, V220, P265	59	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38229	10.1371/journal.pone.0038229	http://dx.doi.org/10.1371/journal.pone.0038229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662280	gold, Green Published			2022-12-25	WOS:000305342300172
J	Qi, RF; Zhang, LJ; Xu, Q; Zhong, JH; Wu, SY; Zhang, ZQ; Liao, W; Ni, L; Zhang, ZJ; Chen, HF; Zhong, Y; Jiao, Q; Wu, XJ; Fan, XX; Liu, YJ; Lu, GM				Qi, Rongfeng; Zhang, Long Jiang; Xu, Qiang; Zhong, Jianhui; Wu, Shengyong; Zhang, Zhiqiang; Liao, Wei; Ni, Ling; Zhang, Zongjun; Chen, Huafu; Zhong, Yuan; Jiao, Qing; Wu, Xingjiang; Fan, Xinxin; Liu, Yijun; Lu, Guangming			Selective Impairments of Resting-State Networks in Minimal Hepatic Encephalopathy	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; BRAIN METABOLISM; NEURAL MECHANISM; WORKING PARTY; DEFAULT-MODE; CIRRHOSIS; ABNORMALITIES; DIAGNOSIS	Background: Minimal hepatic encephalopathy (MHE) is a neuro-cognitive dysfunction characterized by impairment in attention, vigilance and integrative functions, while the sensorimotor function was often unaffected. Little is known, so far, about the exact neuro-pathophysiological mechanisms of aberrant cognition function in this disease. Methodology/Principal Findings: To investigate how the brain function is changed in MHE, we applied a resting-state fMRI approach with independent component analysis (ICA) to assess the differences of resting-state networks (RSNs) between MHE patients and healthy controls. Fourteen MHE patients and 14 age-and sex-matched healthy subjects underwent resting-state fMRI scans. ICA was used to identify six RSNs [dorsal attention network (DAN), default mode network (DMN), visual network (VN), auditory network (AN), sensorimotor network (SMN), self-referential network (SRN)] in each subject. Group maps of each RSN were compared between the MHE and healthy control groups. Pearson correlation analysis was performed between the RSNs functional connectivity (FC) and venous blood ammonia levels, and neuropsychological tests scores for all patients. Compared with the healthy controls, MHE patients showed significantly decreased FC in DAN, both decreased and increased FC in DMN, AN and VN. No significant differences were found in SRN and SMN between two groups. A relationship between FC and blood ammonia levels/neuropsychological tests scores were found in specific regions of RSNs, including middle and medial frontal gyrus, inferior parietal lobule, as well as anterior and posterior cingulate cortex/precuneus. Conclusions/Significance: MHE patients have selective impairments of RSNs intrinsic functional connectivity, with aberrant functional connectivity in DAN, DMN, VN, AN, and spared SMN and SRN. Our fMRI study might supply a novel way to understand the neuropathophysiological mechanism of cognition function changes in MHE.	[Qi, Rongfeng; Zhang, Long Jiang; Zhang, Zhiqiang; Ni, Ling; Zhang, Zongjun; Zhong, Yuan; Jiao, Qing; Lu, Guangming] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Xu, Qiang; Liao, Wei; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Dalian, Sichuan Provinc, Peoples R China; [Zhong, Jianhui] Univ Rochester, Sch Med & Dent, Dept Imaging Sci, Rochester, NY USA; [Wu, Shengyong] Med Imaging Inst Tianjin, Tianjin, Peoples R China; [Wu, Xingjiang; Fan, Xinxin] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA	Nanjing University; University of Electronic Science & Technology of China; University of Rochester; Nanjing University; State University System of Florida; University of Florida	Qi, RF (corresponding author), Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020; Wu, Shawn/J-8611-2014	Wu, Shawn/0000-0003-3432-9819; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 61125304, 30971019]; Natural Scientific Foundation of Jiangsu Province [BK2007572]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu Province	This work was supported by the grants from the Natural Scientific Foundation of China [grant no. 30700194 for LJZ grant no. 61125304 for HC, grant no. 30971019 for QJ] and the Natural Scientific Foundation of Jiangsu Province [grant no. BK2007572 for LJZ]. The funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen HJ, 2011, EUR J RADIOL; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordoba J, 2008, SEMIN LIVER DIS, V28, P70, DOI 10.1055/s-2008-1040322; Dhiman RK, 2010, J GASTROEN HEPATOL, V25, P1029, DOI 10.1111/j.1440-1746.2010.06318.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MOORE JW, 1989, J HEPATOL, V9, P319, DOI 10.1016/0168-8278(89)90140-2; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; SCHOMERUS H, 1993, Z GASTROENTEROL, V31, P231; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang L, 2011, HUM BRAIN MAPP; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	37	54	56	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37400	10.1371/journal.pone.0037400	http://dx.doi.org/10.1371/journal.pone.0037400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662152	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300041
J	Eppinger, B; Nystrom, LE; Cohen, JD				Eppinger, Ben; Nystrom, Leigh E.; Cohen, Jonathan D.			Reduced Sensitivity to Immediate Reward during Decision-Making in Older than Younger Adults	PLOS ONE			English	Article							DELAYED REWARDS; NEURAL MECHANISMS; AGE-DIFFERENCES; LIFE-SPAN; MAGNITUDE; CHOICE	We examined whether older adults differ from younger adults in the degree to which they favor immediate over delayed rewards during decision-making. To examine the neural correlates of age-related differences in delay discounting we acquired functional MR images while participants made decisions between smaller but sooner and larger but later monetary rewards. The behavioral results show age-related reductions in delay discounting. Less impulsive decision-making in older adults was associated with lower ventral striatal activations to immediate reward. Furthermore, older adults showed an overall higher percentage of delayed choices and reduced activity in the dorsal striatum than younger adults. This points to a reduced reward sensitivity of the dorsal striatum in older adults. Taken together, our findings indicate that less impulsive decision-making in older adults is due to a reduced sensitivity of striatal areas to reward. These age-related changes in reward sensitivity may result from transformations in dopaminergic neuromodulation with age.	[Eppinger, Ben; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Eppinger, Ben; Cohen, Jonathan D.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Demog Aging, Princeton, NJ 08544 USA; [Eppinger, Ben] Max Planck Inst Human Dev & Educ, Berlin, Germany	Princeton University; Princeton University; Max Planck Society	Eppinger, B (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eppinger@mpib-berlin.mpg	Eppinger, Ben/N-1865-2016	Eppinger, Ben/0000-0003-3639-2459	National Institute on Aging [AG02436, P30AG024361]; Center for Health and Wellbeing at Princeton University; NATIONAL INSTITUTE ON AGING [P30AG024361] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Health and Wellbeing at Princeton University(Princeton University); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging grants AG02436 and P30AG024361 (http://www.nia.nih.gov/GrantsAndTraining/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jessica Hughes, Paul Kruger, Peter Foster and Laura deSouza for assistance with data acquisition. We are also grateful for the support of the Center for Health and Wellbeing at Princeton University through which the grant was administered.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baddeley AD, 1992, SPEED CAPACITY LANGU; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Brown SBRE, 2009, COGN AFFECT BEHAV NE, V9, P365, DOI 10.3758/CABN.9.4.365; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Harris KC, 2009, J NEUROSCI, V29, P6078, DOI 10.1523/JNEUROSCI.0412-09.2009; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Manton KG, 2007, P NATL ACAD SCI USA, V104, P10802, DOI 10.1073/pnas.0704185104; Marco-Pallares J, 2010, BRAIN RES, V1320, P123, DOI 10.1016/j.brainres.2010.01.025; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mell T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.034.2009; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Raven J. C., 1998, RAVEN MANUAL; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Vaupel JW, 2006, SCIENCE, V312, P1911, DOI 10.1126/science.1127487; Wechsler W, 1982, HANDANWEISUNG ZUM HA	47	79	82	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36953	10.1371/journal.pone.0036953	http://dx.doi.org/10.1371/journal.pone.0036953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UB	22655032	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900007
J	Bishop, DVM; Hardiman, MJ; Barry, JG				Bishop, D. V. M.; Hardiman, Mervyn J.; Barry, Johanna G.			Auditory Deficit as a Consequence Rather than Endophenotype of Specific Language Impairment: Electrophysiological Evidence	PLOS ONE			English	Article							MISMATCH NEGATIVITY; T-COMPLEX; EVOKED-POTENTIALS; LEARNING-PROBLEMS; SYSTEM ACTIVITY; CHILDREN; MATURATION; RESPONSES; BRAIN; SPEECH	Background: Are developmental language disorders caused by poor auditory discrimination? This is a popular theory, but behavioural evidence has been inconclusive. Here we studied children with specific language impairment, measuring the brain's electrophysiological response to sounds in a passive paradigm. We focused on the T-complex, an event-related peak that has different origins and developmental course from the well-known vertex response. Methods: We analysed auditory event-related potentials to tones and syllables from 16 children and 16 adolescents with specific language impairment who were compared with 32 typically-developing controls, matched for gender, IQ and age. Results: We replicated prior findings of significant reduction in Ta amplitude for both children and adolescents with specific language impairment, which was particularly marked for syllables. The topography of the T-complex to syllables indicated a less focal response in those with language impairments. To distinguish causal models, we considered correlations between size of the Ta response and measures of language and literacy in parents as well as children. The best-fitting model was one in which auditory deficit was a consequence rather than a cause of difficulties in phonological processing. Conclusions: The T-complex to syllables has abnormal size and topography in children with specific language impairment, but this is more likely to be a consequence rather than a cause of difficulties in phonological processing.	[Bishop, D. V. M.; Hardiman, Mervyn J.; Barry, Johanna G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Barry, Johanna/0000-0002-3733-8721; Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [053335]; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Wellcome Trust Programme Grant 053335 (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Bishop D.V., 2004, EXPRESSION RECEPTION; Bishop D.V., 2003, CHILDRENS COMMUNICAT, V2nd; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; Bishop D.V.M., 2005, TEST RECEPTION GRAMM; Bishop D. V. M, 2003, TEST RECEPTION GRAMM; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; Bishop DVM, 2006, Q J EXP PSYCHOL, V59, P1153, DOI 10.1080/17470210500489372; Bishop DVM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018993; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bishop DVM, 2010, J NEUROSCI, V30, P15578, DOI 10.1523/JNEUROSCI.2217-10.2010; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Bishop DVM, 2004, DEVELOPMENTAL SCI, V7, pF11, DOI 10.1111/j.1467-7687.2004.00356.x; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; CACACE AT, 1988, HEARING RES, V34, P225, DOI 10.1016/0378-5955(88)90002-0; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; de Guibert C, 2011, BRAIN, V134, P3044, DOI 10.1093/brain/awr141; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; Fox AM, 2011, DEV SCI; Gomes H, 2001, DEV BRAIN RES, V129, P147, DOI 10.1016/S0165-3806(01)00196-1; Korkman M., 2007, NEPSY 2, V2nd; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; MASON SM, 1984, ELECTROEN CLIN NEURO, V59, P297, DOI 10.1016/0168-5597(84)90047-9; McArthur G, 2009, DEVELOPMENTAL SCI, V12, P768, DOI 10.1111/j.1467-7687.2008.00804.x; Miller CA, 2011, LANG SPEECH HEAR SER, V42, P309, DOI 10.1044/0161-1461(2011/10-0040); Norbury C. E, 2008, RUTTERS CHILD ADOLES, P782, DOI DOI 10.1002/9781444300895.CH47; Pang EW, 2000, CLIN NEUROPHYSIOL, V111, P388, DOI 10.1016/S1388-2457(99)00259-X; Parviainen T, 2011, HUM BRAIN MAPP, V32, P2193, DOI 10.1002/hbm.21181; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; ROBINSON RJ, 1991, DEV MED CHILD NEUROL, V33, P943; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; TonnquistUhlen I, 1996, ACTA OTO-LARYNGOL, V116, P680, DOI 10.3109/00016489609137907; Torgesen J.K., 1999, TOWRE TEST WORD READ; Weber-Fox C, 2010, BRAIN LANG, V115, P162, DOI 10.1016/j.bandl.2010.09.001; Wechsler D., 1999, WECHSLER ABBREVIATED; Whitehouse AJO, 2008, BRAIN, V131, P3193, DOI 10.1093/brain/awn266; WOLPAW JR, 1977, ELECTROEN CLIN NEURO, V43, P99, DOI 10.1016/0013-4694(77)90200-0; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Wright BA, 2004, P NATL ACAD SCI USA, V101, P9942, DOI 10.1073/pnas.0401825101; Wright S, 1978, APPL PATH ANAL ECOLO; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008	46	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35851	10.1371/journal.pone.0035851	http://dx.doi.org/10.1371/journal.pone.0035851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22662112	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100012
J	Kawabata, KC; Ehata, S; Komuro, A; Takeuchi, K; Miyazono, K				Kawabata, K. C.; Ehata, S.; Komuro, A.; Takeuchi, K.; Miyazono, K.			TGF-beta-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20	ONCOGENE			English	Article						B-cell lymphoma; apoptosis; TGF-beta; MS4A1/CD20; rituximab	BURKITT-LYMPHOMA; RITUXIMAB; INVOLVEMENT; RESISTANCE; EXPRESSION; ANTIBODIES; THERAPY; PROTEIN; LINES; NHL	Transforming growth factor-beta (TGF-beta) exhibits growth inhibitory effects on various types of tumor cells, including B-cell lymphoma cells. In the present study, the role of TGF-beta in the survival of Epstein-Barr virus-negative B-cell lymphoma Ramos cells was investigated. As TGF-beta-induced apoptosis of Ramos cells in vitro and in vivo, we attempted to identify novel target gene(s) responsible for their survival. Oligonucleotide microarray analysis and chromatin immunoprecipitation revealed that Smad proteins directly regulated the transcription of membrane-spanning 4-domains, subfamily A, member 1 (MS4A1), also known as CD20, in Ramos cells upon TGF-beta stimulation. In addition, immunohistochemical analysis using clinical samples from B-cell lymphoma patients showed an inverse correlation between the expression of MS4A1/CD20 and phosphorylation of Smad3. Although knockdown of MS4A1/CD20 in Ramos cells resulted in an increase of apoptotic cells, Ramos cells stably expressing MS4A1/CD20 were resistant to TGF-beta-induced apoptosis. This suggests that MS4A1/CD20 is responsible for TGF-beta-induced apoptosis of B-cell lymphoma cells. Moreover, downregulation of MS4A1/CD20 by TGF-beta attenuated the effects of the monoclonal anti-MS4A1/CD20 antibody, rituximab, on Ramos cells. Our findings suggest that the sensitivity of B-cell lymphoma cells to rituximab may be affected by TGF-beta signaling. Oncogene (2013) 32, 2096-2106; doi:10.1038/onc.2012.219; published online 4 June 2012	[Kawabata, K. C.; Ehata, S.; Komuro, A.; Miyazono, K.] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan; [Takeuchi, K.] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan	University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	; Takeuchi, Kengo/C-3614-2008	Ehata, Shogo/0000-0002-6740-9391; Takeuchi, Kengo/0000-0002-1599-5800	KAKENHI; Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling; Grants-in-Aid for Scientific Research [22112002] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D Koinuma (the University of Tokyo) and Y Morishita (the University of Tokyo) for technical assistance and H Miyoshi (RIKEN) for the lentiviral vectors. This work was supported by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' (to KM) Grant-in-Aid for Young Scientists (to SE)) and the Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This work was also supported by Japan Society for the Promotion of Science (JSPS) Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling'.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ANDERSON KC, 1984, BLOOD, V63, P1424, DOI 10.1182/blood.V63.6.1424.1424; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Daniel D, 2007, BLOOD, V110, P4037, DOI 10.1182/blood-2007-02-076075; Daniels I, 2008, BRIT J HAEMATOL, V142, P394, DOI 10.1111/j.1365-2141.2008.07193.x; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Fujita M, 2000, PATHOL INT, V50, P696, DOI 10.1046/j.1440-1827.2000.01108.x; Gopal AK, 2004, BLOOD, V103, P3516, DOI 10.1182/blood-2003-08-2795; Goyama S, 2009, CANCER SCI, V100, P990, DOI 10.1111/j.1349-7006.2009.01152.x; Guikema JEJ, 2006, GENE CHROMOSOME CANC, V45, P808, DOI 10.1002/gcc.20345; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Mancao C, 2005, BLOOD, V106, P4339, DOI 10.1182/blood-2005-06-2341; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; MYEROFF LL, 1995, CANCER RES, V55, P5545; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Saltzman A, 1998, EXP CELL RES, V242, P244, DOI 10.1006/excr.1998.4096; Shan DM, 2000, CANCER IMMUNOL IMMUN, V48, P673, DOI 10.1007/s002620050016; SHIRAMIZU B, 1991, BLOOD, V77, P1516; Spender LC, 2009, J BIOL CHEM, V284, P1435, DOI 10.1074/jbc.M808080200; Stolz C, 2009, LEUKEMIA LYMPHOMA, V50, P873, DOI 10.1080/10428190902878471; Sugimoto T, 2009, BIOCHEM BIOPH RES CO, V390, P48, DOI 10.1016/j.bbrc.2009.09.059; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Uchiyama S, 2010, CANCER SCI, V101, P201, DOI 10.1111/j.1349-7006.2009.01392.x; van Meerten T, 2009, NETH J MED, V67, P251; Vega MI, 2009, CLIN CANCER RES, V15, P6582, DOI 10.1158/1078-0432.CCR-09-1234; Witzig TE, 2005, J CLIN ONCOL, V23, P1103, DOI 10.1200/JCO.2005.12.052; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197	42	20	23	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2096	2106		10.1038/onc.2012.219	http://dx.doi.org/10.1038/onc.2012.219			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22665052				2022-12-25	WOS:000317919900011
J	Wu, QX; Song, R; Ortogero, N; Zheng, HL; Evanoff, R; Small, CL; Griswold, MD; Namekawa, SH; Royo, H; Turner, JM; Yan, W				Wu, Qiuxia; Song, Rui; Ortogero, Nicole; Zheng, Huili; Evanoff, Ryan; Small, Chris L.; Griswold, Michael D.; Namekawa, Satoshi H.; Royo, Helene; Turner, James M.; Yan, Wei			The RNase III Enzyme DROSHA Is Essential for MicroRNA Production and Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-CHROMOSOME INACTIVATION; MALE GERM-CELLS; GENE-EXPRESSION; MIRNA BIOGENESIS; BINDING PROTEINS; CONDITIONAL LOSS; CRE RECOMBINASE; DICER; DIFFERENTIATION; CYCLE	DROSHA is a nuclear RNase III enzyme responsible for cleaving primary microRNAs (miRNAs) into precursor miRNAs and thus is essential for the biogenesis of canonical miRNAs. DICER is a cytoplasmic RNase III enzyme that not only cleaves precursor miRNAs to produce mature miRNAs but also dissects naturally formed/synthetic double-stranded RNAs to generate small interfering RNAs (siRNAs). To investigate the role of canonical miRNA and/or endogenous siRNA production in spermatogenesis, we generated Drosha or Dicer conditional knock-out (cKO) mouse lines by inactivating Drosha or Dicer exclusively in spermatogenic cells in postnatal testes using the Cre-loxp strategy. Both Drosha and Dicer cKO males were infertile due to disrupted spermatogenesis characterized by depletion of spermatocytes and spermatids leading to oligoteratozoospermia or azoospermia. The developmental course of spermatogenic disruptions was similar at morphological levels between Drosha and Dicer cKO males, but Drosha cKO testes appeared to be more severe in spermatogenic disruptions than Dicer cKO testes. Microarray analyses revealed transcriptomic differences between Drosha- and Dicer-null pachytene spermatocytes or round spermatids. Although levels of sex-linked mRNAs were mildly elevated, meiotic sex chromosome inactivation appeared to have occurred normally. Our data demonstrate that unlike DICER, which is required for the biogenesis of several small RNA species, DROSHA is essential mainly for the canonical miRNA production, and DROSHA-mediated miRNA production is essential for normal spermatogenesis and male fertility.	[Wu, Qiuxia; Song, Rui; Ortogero, Nicole; Zheng, Huili; Yan, Wei] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA; [Evanoff, Ryan; Small, Chris L.; Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Namekawa, Satoshi H.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Reprod Sci, Cincinnati, OH 45229 USA; [Namekawa, Satoshi H.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Royo, Helene; Turner, James M.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Washington State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; MRC National Institute for Medical Research	Yan, W (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Sch Med, CMMBldg,Rm 202,1664 N Virginia St,MS0575, Reno, NV 89557 USA.	wyan@unr.edu	Yan, Wei/AAH-7943-2019		National Institutes of Health Grants [HD050281, HD060858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098605] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD050281 and HD060858 (to W.Y.).	Aoki Koji, 2008, V468, P307, DOI 10.1007/978-1-59745-249-6_24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648; Georgi SA, 2011, DEV NEUROBIOL, V71, P1153, DOI 10.1002/dneu.20899; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Ho JJD, 2008, J AM SOC NEPHROL, V19, P2043, DOI 10.1681/ASN.2008090986; Hogarth CA, 2011, BIOL REPROD, V84, P34, DOI 10.1095/biolreprod.110.086215; Huang CCJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-66; Huang TC, 2012, J PROTEOME RES, V11, P2193, DOI 10.1021/pr2009884; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Meng D. M., 2011, ACTA DIABET IN PRESS; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Namekawa SH, 2007, P NATL ACAD SCI USA, V104, P9730, DOI 10.1073/pnas.0700323104; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Paronetto MP, 2010, INT J ANDROL, V33, P2, DOI 10.1111/j.1365-2605.2009.00959.x; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang Xin, 2009, Methods Mol Biol, V561, P265, DOI 10.1007/978-1-60327-019-9_17; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yu Yiling, 2009, V493, P87, DOI 10.1007/978-1-59745-523-7_6; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	87	136	148	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25173	25190		10.1074/jbc.M112.362053	http://dx.doi.org/10.1074/jbc.M112.362053			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665486	hybrid, Green Published			2022-12-25	WOS:000306651700028
J	Sestak, K; Feely, S; Fey, B; Dufour, J; Hargitt, E; Alvarez, X; Pahar, B; Gregoricus, N; Vinje, J; Farkas, T				Sestak, Karol; Feely, Stephanie; Fey, Brittney; Dufour, Jason; Hargitt, Edwin; Alvarez, Xavier; Pahar, Bapi; Gregoricus, Nicole; Vinje, Jan; Farkas, Tibor			Experimental Inoculation of Juvenile Rhesus Macaques with Primate Enteric Caliciviruses	PLOS ONE			English	Article							INFECTIOUS NONBACTERIAL GASTROENTERITIS; EPIDEMIC VIRAL GASTROENTERITIS; NORWALK VIRUS-INFECTION; IMMUNE-RESPONSES; HUMAN NOROVIRUS; NONHUMAN-PRIMATES; SECRETING CELLS; UNITED-STATES; HAWAII AGENT; IN-VITRO	Background: Tissue culture-adapted Tulane virus (TV), a GI.1 rhesus enteric calicivirus (ReCV), and a mixture of GII.2 and GII.4 human norovirus (NoV)-containing stool sample were used to intrastomacheally inoculate juvenile rhesus macaques (Macaca mulatta) in order to evaluate infection caused by these viruses. Methodology & Findings: Two of the three TV-inoculated macaques developed diarrhea, fever, virus-shedding in stools, inflammation of duodenum and 16-fold increase of TV-neutralizing (VN) serum antibodies but no vomiting or viremia. No VN-antibody responses could be detected against a GI.2 ReCV strain FT285, suggesting that TV and FT285 represent different ReCV serotypes. Both NoV-inoculated macaques remained asymptomatic but with demonstrable virus shedding in one animal. Examination of duodenum biopsies of the TV-inoculated macaques showed lymphocytic infiltration of the lamina propria and villous blunting. TV antigen-positive (TV+) cells were detected in the lamina propria. In most of the TV+ cells TV co-localized perinuclearly with calnexin - an endoplasmic reticulum protein. A few CD20+TV+ double-positive B cells were also identified in duodenum. To corroborate the authenticity of CD20+TV+ B cells, in vitro cultures of peripheral blood mononuclear cells (PBMCs) from healthy macaques were inoculated with TV. Multicolor flow cytometry confirmed the presence of TV antigen-containing B cells of predominantly CD20+HLA-DR+ phenotype. A 2-log increase of viral RNA by 6 days post inoculation (p<0.05) suggested active TV replication in cultured lymphocytes. Conclusions/Significance: Taken together, our results show that ReCVs represent an alternative cell culture and animal model to study enteric calicivirus replication, pathogenesis and immunity.	[Sestak, Karol; Feely, Stephanie; Dufour, Jason; Alvarez, Xavier; Pahar, Bapi] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Sestak, Karol; Dufour, Jason; Alvarez, Xavier; Pahar, Bapi] Tulane Univ, Sch Med, Covington, LA USA; [Fey, Brittney; Hargitt, Edwin; Farkas, Tibor] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Farkas, Tibor] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Gregoricus, Nicole; Vinje, Jan] Ctr Dis Control & Prevent, Atlanta, GA USA	Tulane University; Tulane University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA	Sestak, K (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	ksestak@tulane.edu; tibor.farkas@cchmc.org	Pahar, Bapi/AFM-3129-2022; Vinje, Jan/ABE-6336-2020	Pahar, Bapi/0000-0003-1949-973X; Vinje, Jan/0000-0002-1530-3675; Sestak, Karol/0000-0003-3951-2719	National Institutes of Health [R21RR024871, P51RR000164, U24RR018111, P01HD013021]; Infectious Disease Scholar Fund of CCHMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, U24RR018111, R21RR024871] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Disease Scholar Fund of CCHMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health R21RR024871, P51RR000164 and U24RR018111 to KS, and P01HD013021 and the Infectious Disease Scholar Fund of CCHMC to TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barron EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021435; Bjorck P, 1998, J IMMUNOL, V161, P5795; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Cannon JL, 2009, J VIROL, V83, P5363, DOI 10.1128/JVI.02518-08; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Farkas T, 2010, J GEN VIROL, V91, P734, DOI 10.1099/vir.0.015263-0; Gerondopoulos A, 2010, J GEN VIROL, V91, P1428, DOI 10.1099/vir.0.016717-0; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Jiang BM, 2004, J MED PRIMATOL, V33, P30, DOI 10.1111/j.1600-0684.2003.00051.x; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; LoBue AD, 2010, J VIROL, V84, P8530, DOI 10.1128/JVI.00727-10; Lobue AD, 2009, J VIROL, V83, P3212, DOI 10.1128/JVI.01650-08; Mazumdar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010228; MOLICA S, 1994, HAEMATOLOGICA, V79, P452; Otto PH, 2011, J VIROL, V85, P12013, DOI 10.1128/JVI.05342-11; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Perry JW, 2010, J VIROL, V84, P6163, DOI 10.1128/JVI.00331-10; POSTIGO AA, 1991, J EXP MED, V174, P1313, DOI 10.1084/jem.174.6.1313; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Rockx BHG, 2005, J MED VIROL, V75, P313, DOI 10.1002/jmv.20273; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; SCHREIBER DS, 1974, J INFECT DIS, V129, P705, DOI 10.1093/infdis/129.6.705; Sestak K, 2004, J VIROL, V78, P10258, DOI 10.1128/JVI.78.19.10258-10264.2004; Sestak K, 2003, INFECT IMMUN, V71, P4079, DOI 10.1128/IAI.71.7.4079-4086.2003; SMITH AW, 1985, J WILDLIFE DIS, V21, P426, DOI 10.7589/0090-3558-21.4.426; Souza M, 2008, J VIROL, V82, P1777, DOI 10.1128/JVI.01347-07; Subekti DS, 2002, J MED VIROL, V66, P400, DOI 10.1002/jmv.2159; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Taube S, 2009, J VIROL, V83, P4092, DOI 10.1128/JVI.02245-08; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wang YH, 2007, J MED PRIMATOL, V36, P101, DOI 10.1111/j.1600-0684.2006.00167.x; Wei C, 2008, J VIROL, V82, P11429, DOI 10.1128/JVI.00696-08; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; WYATT RG, 1978, J MED VIROL, V2, P89, DOI 10.1002/jmv.1890020203; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; Yang SY, 2010, J MICROBIOL IMMUNOL, V43, P506, DOI 10.1016/S1684-1182(10)60078-3; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	58	36	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37973	10.1371/journal.pone.0037973	http://dx.doi.org/10.1371/journal.pone.0037973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666426	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400064
J	Ma, WH; Zhang, Z; Peng, CH; Wang, XP; Li, F; Lin, YJ				Ma, Weihua; Zhang, Zan; Peng, Chuanhua; Wang, Xiaoping; Li, Fei; Lin, Yongjun			Exploring the Midgut Transcriptome and Brush Border Membrane Vesicle Proteome of the Rice Stem Borer, Chilo suppressalis (Walker)	PLOS ONE			English	Article							THURINGIENSIS CRY1AB TOXIN; BACILLUS-THURINGIENSIS; HELICOVERPA-ARMIGERA; AMINOPEPTIDASE-N; MANDUCA-SEXTA; BINDING-PROTEINS; LARVAL MIDGUT; ALKALINE-PHOSPHATASE; HELIOTHIS-VIRESCENS; PLUTELLA-XYLOSTELLA	The rice stem borer, Chilo suppressalis (Walker) (Lepidoptera: Pyralidae), is one of the most detrimental pests affecting rice crops. The use of Bacillus thuringiensis (Bt) toxins has been explored as a means to control this pest, but the potential for C. suppressalis to develop resistance to Bt toxins makes this approach problematic. Few C. suppressalis gene sequences are known, which makes in-depth study of gene function difficult. Herein, we sequenced the midgut transcriptome of the rice stem borer. In total, 37,040 contigs were obtained, with a mean size of 497 bp. As expected, the transcripts of C. suppressalis shared high similarity with arthropod genes. Gene ontology and KEGG analysis were used to classify the gene functions in C. suppressalis. Using the midgut transcriptome data, we conducted a proteome analysis to identify proteins expressed abundantly in the brush border membrane vesicles (BBMV). Of the 100 top abundant proteins that were excised and subjected to mass spectrometry analysis, 74 share high similarity with known proteins. Among these proteins, Western blot analysis showed that Aminopeptidase N and EH domain-containing protein have the binding activities with Bt-toxin Cry1Ac. These data provide invaluable information about the gene sequences of C. suppressalis and the proteins that bind with Cry1Ac.	[Ma, Weihua; Lin, Yongjun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Ma, Weihua; Wang, Xiaoping] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhang, Zan] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Peng, Chuanhua] Hubei Plant Protect Stn, Wuhan, Peoples R China; [Ma, Weihua; Lin, Yongjun] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Zhang, Zan; Li, Fei] Minist Agr, Key Lab Monitoring & Management Plant Dis & Pests, Nanjing, Jiangsu, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Nanjing Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Ma, WH (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	lifei@njau.edu.cn; yongjunlin@mail.hzau.edu.cn	Li, Fei/B-3687-2012	Li, Fei/0000-0002-8410-5250; MA, WEIHUA/0000-0001-9521-2038	National Special Transgenic Project from the Chinese Ministry of Agriculture [2008ZX08001-001, 2009ZX08011-007B, 2011ZX08012-004]	National Special Transgenic Project from the Chinese Ministry of Agriculture	This work was surpported by the National Special Transgenic Project from the Chinese Ministry of Agriculture (grant No. 2008ZX08001-001; 2009ZX08011-007B; 2011ZX08012-004, http://www.agri.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2008, INSECT BIOCHEM MOLEC, V38, P125, DOI 10.1016/j.ibmb.2007.09.014; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Cheng XA, 2010, PEST MANAG SCI, V66, P762, DOI 10.1002/ps.1939; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Ekobu M, 2010, J ECON ENTOMOL, V103, P1493, DOI 10.1603/EC09432; Federici B.A., 2010, OPEN TOXINOL J, V3, P83, DOI [10.2174/1875414701003010083, DOI 10.2174/1875414701003010083]; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liao CY, 2005, CURR MICROBIOL, V51, P367, DOI 10.1007/s00284-005-0051-9; Liu CX, 2010, J INSECT PHYSIOL, V56, P718, DOI 10.1016/j.jinsphys.2009.12.012; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Liu JS, 2010, J PROTEOME RES, V9, P2117, DOI 10.1021/pr900826f; Luo K, 1997, APPL ENVIRON MICROB, V63, P1024, DOI 10.1128/AEM.63.3.1024-1027.1997; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P727, DOI 10.1271/bbb.62.727; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P467, DOI 10.1016/j.ibmb.2009.05.001; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Wang GR, 2005, SCI CHINA SER C, V48, P346, DOI 10.1360/03yc0273; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yao HP, 2009, BIOSCIENCE REP, V29, P363, DOI 10.1042/BSR20080144; Yu HK, 2010, INSECT SCI, V17, P393, DOI 10.1111/j.1744-7917.2010.01333.x; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	41	29	35	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38151	10.1371/journal.pone.0038151	http://dx.doi.org/10.1371/journal.pone.0038151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666467	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600064
J	Maher, BH; Lea, RA; Benton, M; Cox, HC; Bellis, C; Carless, M; Dyer, TD; Curran, J; Charlesworth, JC; Buring, JE; Kurth, T; Chasman, DI; Ridker, PM; Schurks, M; Blangero, J; Griffiths, LR				Maher, Bridget H.; Lea, Rod A.; Benton, Miles; Cox, Hannah C.; Bellis, Claire; Carless, Melanie; Dyer, Thomas D.; Curran, Joanne; Charlesworth, Jac C.; Buring, Julie E.; Kurth, Tobias; Chasman, Daniel I.; Ridker, Paul M.; Schuerks, Markus; Blangero, John; Griffiths, Lyn R.			An X Chromosome Association Scan of the Norfolk Island Genetic Isolate Provides Evidence for a Novel Migraine Susceptibility Locus at Xq12	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; HEPHAESTIN; EXPRESSION	Migraine is a common and debilitating neurovascular disorder with a complex envirogenomic aetiology. Numerous studies have demonstrated a preponderance of women affected with migraine and previous pedigree linkage studies in our laboratory have identified susceptibility loci on chromosome Xq24-Xq28. In this study we have used the genetic isolate of Norfolk Island to further analyse the X chromosome for migraine susceptibility loci. An association approach was employed to analyse 14,124 SNPs spanning the entire X chromosome. Genotype data from 288 individuals comprising a large core-pedigree, of which 76 were affected with migraine, were analysed. Although no SNP reached chromosome-wide significance (empirical alpha = 1 x 10(-5)) ranking by P-value revealed two primary clusters of SNPs in the top 25. A 10 SNP cluster represents a novel migraine susceptibility locus at Xq12 whilst a 11 SNP cluster represents a previously identified migraine susceptibility locus at Xq27. The strongest association at Xq12 was seen for rs599958 (OR = 1.75, P = 8.92 x 10(-4)), whilst at Xq27 the strongest association was for rs6525667 (OR = 1.53, P = 1.65 x 10(-4)). Further analysis of SNPs at these loci was performed in 5,122 migraineurs from the Women's Genome Health Study and provided additional evidence for association at the novel Xq12 locus (P<0.05). Overall, this study provides evidence for a novel migraine susceptibility locus on Xq12. The strongest effect SNP (rs102834, joint P = 1.63 x 10(-5)) is located within the 5'UTR of the HEPH gene, which is involved in iron homeostasis in the brain and may represent a novel pathway for involvement in migraine pathogenesis.	[Maher, Bridget H.; Lea, Rod A.; Benton, Miles; Cox, Hannah C.; Bellis, Claire; Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia; [Bellis, Claire; Carless, Melanie; Dyer, Thomas D.; Curran, Joanne; Charlesworth, Jac C.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Charlesworth, Jac C.] Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Buring, Julie E.; Kurth, Tobias; Chasman, Daniel I.; Ridker, Paul M.; Schuerks, Markus] Harvard Univ, Sch Med, Dept Med, Div Prevent Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Kurth, Tobias; Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Kurth, Tobias] INSERM, Unit Neuroepidemiol 708, Paris, France	Griffith University; Menzies Health Institute Queensland; Texas Biomedical Research Institute; University of Tasmania; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Maher, BH (corresponding author), Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia.	l.griffths@griffth.edu.au	Belllis, Claire/GYA-5547-2022; Blangero, John/ABA-7175-2021; Kurth, Tobias/A-9243-2012; Charlesworth, Jac/J-7661-2014	Belllis, Claire/0000-0001-5073-9610; Kurth, Tobias/0000-0001-7169-2620; Charlesworth, Jac/0000-0001-6201-3518; Carless, Melanie/0000-0001-8350-2302; Benton, Miles/0000-0003-3442-965X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lea, Rodney/0000-0002-1148-5862; Griffiths, Lyn/0000-0002-6774-5475; Curran, Joanne/0000-0002-6898-155X; Maher, Bridget/0000-0002-9735-0845	Australian National Health and Medical Research Council grant [G47268]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a Australian National Health and Medical Research Council grant (no. G47268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellis C, 2005, HUM HERED, V60, P211, DOI 10.1159/000090545; Bellis C, 2008, HUM GENET, V124, P543, DOI 10.1007/s00439-008-0580-y; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Cox HC, 2012, GENE, V494, P119, DOI 10.1016/j.gene.2011.11.056; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Hoare M., 1999, NORFOLK ISLAND REVIS, V5th ed.; Hudson DM, 2010, AM J PHYSIOL-GASTR L, V298, pG425, DOI 10.1152/ajpgi.00453.2009; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Macgregor S, 2010, EUR J HUM GENET, V18, P67, DOI 10.1038/ejhg.2009.111; Maher BH, 2012, NEUROGENETICS; McEvoy BP, 2010, HEREDITY, V105, P229, DOI 10.1038/hdy.2009.175; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Svensson DA, 2003, HEADACHE, V43, P235, DOI 10.1046/j.1526-4610.2003.03047.x; Wieser T, 2010, HEADACHE, V50, P955, DOI 10.1111/j.1526-4610.2010.01673.x	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37903	10.1371/journal.pone.0037903	http://dx.doi.org/10.1371/journal.pone.0037903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666411	gold, Green Published			2022-12-25	WOS:000305349600040
J	Burgio, G; Baylac, M; Heyer, E; Montagutelli, X				Burgio, Gaetan; Baylac, Michel; Heyer, Evelyne; Montagutelli, Xavier			Nasal Bone Shape Is under Complex Epistatic Genetic Control in Mouse Interspecific Recombinant Congenic Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ELLIPTIC FOURIER-ANALYSIS; MICE; INTEGRATION; TOOL; ARCHITECTURE; EVOLUTION	Background: Genetic determinism of cranial morphology in the mouse is still largely unknown, despite the localization of putative QTLs and the identification of genes associated with Mendelian skull malformations. To approach the dissection of this multigenic control, we have used a set of interspecific recombinant congenic strains (IRCS) produced between C57BL/6 and mice of the distant species Mus spretus (SEG/Pas). Each strain has inherited 1.3% of its genome from SEG/Pas under the form of few, small-sized, chromosomal segments. Results: The shape of the nasal bone was studied using outline analysis combined with Fourier descriptors, and differential features were identified between IRCS BcG-66H and C57BL/6. An F2 cross between BcG-66H and C57BL/6 revealed that, out of the three SEG/Pas-derived chromosomal regions present in BcG-66H, two were involved. Segments on chromosomes 1 (similar to 32 Mb) and 18 (similar to 13 Mb) showed additive effect on nasal bone shape. The three chromosomal regions present in BcG-66H were isolated in congenic strains to study their individual effect. Epistatic interactions were assessed in bicongenic strains. Conclusions: Our results show that, besides a strong individual effect, the QTL on chromosome 1 interacts with genes on chromosomes 13 and 18. This study demonstrates that nasal bone shape is under complex genetic control but can be efficiently dissected in the mouse using appropriate genetic tools and shape descriptors.	[Burgio, Gaetan; Montagutelli, Xavier] Inst Pasteur, CNRS, Unite Genet Fonct Souris, URA 2578, Paris, France; [Burgio, Gaetan; Heyer, Evelyne] Univ Paris 07, CNRS, Museum Natl Hist Nat, Unite Ecoanthropol,UMR 7206, Paris, France; [Burgio, Gaetan] Univ Tasmania, Dept Genet, Menzies Res Inst, Hobart, Tas, Australia; [Baylac, Michel] Museum Natl Hist Nat, UMR 5202, F-75231 Paris, France; [Baylac, Michel] Museum Natl Hist Nat, CNRS, IFR 101, F-75231 Paris, France; [Baylac, Michel] Museum Natl Hist Nat, Entomol Lab, UMR 5202, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University of Tasmania; Menzies Institute for Medical Research; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Burgio, G (corresponding author), Inst Pasteur, CNRS, Unite Genet Fonct Souris, URA 2578, Paris, France.	grburgio@utas.edu.au	Burgio, Gaetan/B-6722-2015; Heyer, Evelyne/K-9184-2013	Burgio, Gaetan/0000-0002-7434-926X; Heyer, Evelyne/0000-0002-0266-3196				Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Burgio G, 2009, EVOLUTION, V63, P2668, DOI 10.1111/j.1558-5646.2009.00737.x; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Dohmoto A, 2002, J DENT RES, V81, P501, DOI 10.1177/154405910208100714; Dryden IL, 1998, STAT SHAPE ANAL, Vxvii; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Kawakami M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-73; Kelsey JL., 1996, METHODS OBSERVATIONA; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2001, GENETICS, V157, P785; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; Laissue P, 2009, INT J DEV BIOL, V53, P623, DOI 10.1387/ijdb.082613pl; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Leamy LJ, 1999, AM NAT, V153, P201, DOI 10.1086/303165; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; Monti L, 2001, BIOL J LINN SOC, V72, P391, DOI [10.1006/bijl.2000.0506, 10.1111/j.1095-8312.2001.tb01325.x]; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1997, J IMMUNOL, V158, P6019; Rao CR, 1998, P NATL ACAD SCI USA, V95, P4121, DOI 10.1073/pnas.95.8.4121; Rogner UC, 2001, GENOMICS, V74, P163, DOI 10.1006/geno.2001.6508; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Sherwood RJ, 2008, GENETICS, V180, P619, DOI 10.1534/genetics.108.090407; Willmore KE, 2006, J ANAT, V208, P361, DOI 10.1111/j.1469-7580.2006.00527.x; Wolf JB, 2005, GENETICS, V171, P683, DOI 10.1534/genetics.104.038885	31	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37721	10.1371/journal.pone.0037721	http://dx.doi.org/10.1371/journal.pone.0037721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662199	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300089
J	de Borst, MH; Nauta, FL; Vogt, L; Laverman, GD; Gansevoort, RT; Navis, G				de Borst, Martin H.; Nauta, Ferdau L.; Vogt, Liffert; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan			Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIETARY-SODIUM RESTRICTION; CONVERTING ENZYME-INHIBITION; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM PROGNOSIS; NEPHROTIC SYNDROME; INJURY MOLECULE-1; PROTEINURIA; GLOMERULONEPHRITIS; NEPHROPATHY	Under specific conditions non-steroidal anti-inflammatory drugs (NSAIDs) may be used to lower therapy-resistant proteinuria. The potentially beneficial anti-proteinuric, tubulo-protective, and anti-inflammatory effects of NSAIDs may be offset by an increased risk of (renal) side effects. We investigated the effect of indomethacin on urinary markers of glomerular and tubular damage and renal inflammation. We performed a post-hoc analysis of a prospective open-label crossover study in chronic kidney disease patients (n = 12) with mild renal function impairment and stable residual proteinuria of 4.7 +/- 4.1 g/d. After a wash-out period of six wks without any RAAS blocking agents or other therapy to lower proteinuria (untreated proteinuria (UP)), patients subsequently received indomethacin 75 mg BID for 4 wks (NSAID). Healthy subjects (n = 10) screened for kidney donation served as controls. Urine and plasma levels of total IgG, IgG4, KIM-1, beta-2-microglobulin, H-FABP, MCP-1 and NGAL were determined using ELISA. Following NSAID treatment, 24 h -urinary excretion of glomerular and proximal tubular damage markers was reduced in comparison with the period without anti-proteinuric treatment (total IgG: UP 131[38-513] vs NSAID 38[17-218] mg/24 h, p<0.01; IgG4: 50[16-68] vs 10[1-38] mg/24 h, p<0.001; beta-2-microglobulin: 200[55-404] vs 50[28-110] ug/24 h, p = 0.03; KIM-1: 9[5-14] vs 5[2-9] ug/24 h, p = 0.01). Fractional excretions of these damage markers were also reduced by NSAID. The distal tubular marker H-FABP showed a trend to reduction following NSAID treatment. Surprisingly, NSAID treatment did not reduce urinary excretion of the inflammation markers MCP-1 and NGAL, but did reduce plasma MCP-1 levels, resulting in an increased fractional MCP-1 excretion. In conclusion, the anti-proteinuric effect of indomethacin is associated with reduced urinary excretion of glomerular and tubular damage markers, but not with reduced excretion of renal inflammation markers. Future studies should address whether the short term glomerulo- and tubulo-protective effects as observed outweigh the possible side-effects of NSAID treatment on the long term.	[de Borst, Martin H.; Nauta, Ferdau L.; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands; [de Borst, Martin H.; Nauta, Ferdau L.; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan] Univ Groningen, Groningen, Netherlands; [Vogt, Liffert] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	de Borst, MH (corresponding author), Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands.	m.h.de.borst@umcg.nl	Vogt, Liffert/C-3168-2018	Vogt, Liffert/0000-0002-4585-7505; De Borst, Martin/0000-0002-4127-8733	Merck Company [MSGP 9661]; personal development grants from the Dutch Kidney foundation [KJPB.08.07]; University Medical Center Groningen (Mandema stipend)	Merck Company(Merck & Company); personal development grants from the Dutch Kidney foundation; University Medical Center Groningen (Mandema stipend)	The original study that served as the source of the current post-hoc analysis was supported by Merck & Company (grant MSGP 9661). Dr. De Borst is supported by personal development grants from the Dutch Kidney foundation (KJPB.08.07; http://www.nierstichting.nl) and the University Medical Center Groningen (Mandema stipend). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berden AE, 2012, J AM SOC NEPHROL, V23, P313, DOI 10.1681/ASN.2011040330; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Cheng HF, 2002, KIDNEY INT, V62, P929, DOI 10.1046/j.1523-1755.2002.00520.x; Cheng HF, 2011, J AM SOC NEPHROL, V22, P1240, DOI 10.1681/ASN.2010111149; de Borst MH, 2007, AM J PHYSIOL-RENAL, V292, pF313, DOI 10.1152/ajprenal.00180.2006; DONKER AJM, 1978, NEPHRON, V22, P374, DOI 10.1159/000181478; GANSEVOORT RT, 1992, NEPHROL DIAL TRANSPL, V7, P91; GUASCH A, 1993, J CLIN INVEST, V92, P2274, DOI 10.1172/JCI116831; HEEG JE, 1991, CLIN SCI, V81, P367, DOI 10.1042/cs0810367; HEEG JE, 1990, AM J NEPHROL, V10, P94, DOI 10.1159/000168201; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; John R, 2009, J CLIN PATHOL, V62, P505, DOI 10.1136/jcp.2008.058271; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; Kramer AB, 2009, AM J PHYSIOL-RENAL, V296, pF1136, DOI 10.1152/ajprenal.00541.2007; Krikken JA, 2009, CURR OPIN NEPHROL HY, V18, P531, DOI 10.1097/MNH.0b013e3283312fc8; LAGRUE G, 1988, International Urology and Nephrology, V20, P669, DOI 10.1007/BF02549501; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Pisoni R, 2002, KIDNEY INT, V62, P1010, DOI 10.1046/j.1523-1755.2002.00535.x; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Sauvant C, 2010, AM J NEPHROL, V32, P57, DOI 10.1159/000313452; Schneider R, 2009, AM J PHYSIOL-RENAL, V297, pF1614, DOI 10.1152/ajprenal.00268.2009; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Vogt L, 2010, NETH J MED, V68, P400; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Vogt L, 2009, NEPHROL DIAL TRANSPL, V24, P1182, DOI 10.1093/ndt/gfn644; VRIESENDORP R, 1986, AM J MED, V81, P84, DOI 10.1016/0002-9343(86)90910-1; VRIESENDORP R, 1985, AM J NEPHROL, V5, P236, DOI 10.1159/000166941; VRIESENDORP R, 1986, CLIN NEPHROL, V25, P105; Waanders F, 2009, AM J KIDNEY DIS, V53, P16, DOI 10.1053/j.ajkd.2008.07.021; WEHRMANN M, 1989, CLIN NEPHROL, V31, P67; WEHRMANN M, 1990, CLIN NEPHROL, V33, P115; Whelton A, 2006, KIDNEY INT, V70, P1495, DOI 10.1038/sj.ki.5001766; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37957	10.1371/journal.pone.0037957	http://dx.doi.org/10.1371/journal.pone.0037957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662255	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300146
J	Luby, MD; Hsu, CT; Shuster, SA; Gallardo, CM; Mistlberger, RE; King, OD; Steele, AD				Luby, Matthew D.; Hsu, Cynthia T.; Shuster, Scott A.; Gallardo, Christian M.; Mistlberger, Ralph E.; King, Oliver D.; Steele, Andrew D.			Food Anticipatory Activity Behavior of Mice across a Wide Range of Circadian and Non-Circadian Intervals	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; SUPRACHIASMATIC LESIONS; FEEDING SCHEDULES; DAILY MEAL; RATS; RHYTHMS; TIME; CLOCK; ENTRAINMENT; EXPRESSION	When rodents are fed in a limited amount during the daytime, they rapidly redistribute some of their nocturnal activity to the time preceding the delivery of food. In rats, anticipation of a daily meal has been interpreted as a circadian rhythm controlled by a food-entrained oscillator (FEO) with circadian limits to entrainment. Lesion experiments place this FEO outside of the light-entrainable circadian pacemaker in the suprachiasmatic nucleus. Mice also anticipate a fixed daily meal, but circadian limits to entrainment and anticipation of more than 2 daily meals, have not been assessed. We used a video-based behavior recognition system to quantify food anticipatory activity in mice receiving 2, 3, or 6 daily meals at intervals of 12, 8, or 4-hours (h). Individual mice were able to anticipate as many as 4 of 6 daily meals, and anticipation persisted during meal omission tests. On the 6 meal schedule, pre-prandial activity and body temperature were poorly correlated, suggesting independent regulation. Mice showed a limited ability to anticipate an 18 h feeding schedule. Finally, mice showed concurrent circadian and sub-hourly anticipation when provided with 6 small meals, at 30 minute intervals, at a fixed time of day. These results indicate that mice can anticipate feeding opportunities at a fixed time of day across a wide range of intervals not previously associated with anticipatory behavior in studies of rats. The methods described here can be exploited to determine the extent to which timing of different intervals in mice relies on common or distinct neural and molecular mechanisms.	[Luby, Matthew D.; Hsu, Cynthia T.; Shuster, Scott A.; Gallardo, Christian M.; Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA USA	California Institute of Technology; Simon Fraser University; Boston Biomedical Research Institute	Luby, MD (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Ellison Medical Foundation; Klarman Family Foundation; Broad Fellows in Brain Circuitry Program at Caltech	Ellison Medical Foundation(Lawrence Ellison Foundation); Klarman Family Foundation; Broad Fellows in Brain Circuitry Program at Caltech	These studies were funded by grants to ADS from the Ellison Medical Foundation, the Klarman Family Foundation Program in Eating Disorders, and the Broad Fellows in Brain Circuitry Program at Caltech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2002, J BIOL RHYTHM, V17, P330, DOI 10.1177/074873002129002636; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; BIEBACH H, 1991, J BIOL RHYTHM, V6, P353, DOI 10.1177/074873049100600406; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; BOULOS Z, 1990, PHYSIOL BEHAV, V48, P523, DOI 10.1016/0031-9384(90)90294-E; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cordes S, 2008, BRAIN RES, V1227, P120, DOI 10.1016/j.brainres.2008.06.043; Crystal JD, 2006, BEHAV PROCESS, V72, P149, DOI 10.1016/j.beproc.2006.01.010; Crystal JD, 2001, J EXP PSYCHOL ANIM B, V27, P68, DOI 10.1037/0097-7403.27.1.68; Crystal JD, 2009, EUR J NEUROSCI, V30, P1756, DOI 10.1111/j.1460-9568.2009.06968.x; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gitler AD, 2007, J NEUROSCI, V27, P2433, DOI 10.1523/JNEUROSCI.0094-07.2007; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Gunapala KM, 2010, PRION, V4, P302, DOI 10.4161/pri.4.4.13721; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Hsu CL, 2010, PLOS ONE, V5; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Sanabria F, 2007, BEHAV PROCESS, V74, P126, DOI 10.1016/j.beproc.2006.10.012; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; STEPHAN FK, 1981, NEUROSCIENCE, V6, P2625, DOI 10.1016/0306-4522(81)90108-1; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2011, J MOL NEUROSCI; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37992	10.1371/journal.pone.0037992	http://dx.doi.org/10.1371/journal.pone.0037992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662260	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305342300152
J	Versluis, B; Dremmen, MHG; Nelemans, PJ; Wildberger, JE; Schurink, GW; Leiner, T; Backes, WH				Versluis, Bas; Dremmen, Marjolein H. G.; Nelemans, Patty J.; Wildberger, Joachim E.; Schurink, Geert-Willem; Leiner, Tim; Backes, Walter H.			Dynamic Contrast-Enhanced MRI Assessment of Hyperemic Fractional Microvascular Blood Plasma Volume in Peripheral Arterial Disease: Initial Findings	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; MUSCLE PERFUSION; ENDOTHELIAL DYSFUNCTION; LOWER-EXTREMITY; VASCULAR-MEDICINE; SKELETAL-MUSCLE; REPRODUCIBILITY; PERMEABILITY; INFLAMMATION; METAANALYSIS	Objectives: The aim of the current study was to describe a method that assesses the hyperemic microvascular blood plasma volume of the calf musculature. The reversibly albumin binding contrast agent gadofosveset was used in dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) to assess the microvascular status in patients with peripheral arterial disease (PAD) and healthy controls. In addition, the reproducibility of this method in healthy controls was determined. Materials and Methods: Ten PAD patients with intermittent claudication and 10 healthy control subjects were included. Patients underwent contrast-enhanced MR angiography of the peripheral arteries, followed by one DCE MRI examination of the musculature of the calf. Healthy control subjects were examined twice on different days to determine normative values and the interreader and interscan reproducibility of the technique. The MRI protocol comprised dynamic imaging of contrast agent wash-in under reactive hyperemia conditions of the calf musculature. Using pharmacokinetic modeling the hyperemic fractional microvascular blood plasma volume (V-p, unit: %) of the anterior tibial, gastrocnemius and soleus muscles was calculated. Results: V-p was significantly lower for all muscle groups in PAD patients (4.3 +/- 1.6%, 5.0 +/- 3.3% and 6.1 +/- 3.6% for anterior tibial, gastrocnemius and soleus muscles, respectively) compared to healthy control subjects (9.1 +/- 2.0%, 8.9 +/- 1.9% and 9.3 +/- 2.1%). Differences in V-p between muscle groups were not significant. The coefficient of variation of V-p varied from 10-14% and 11-16% at interscan and interreader level, respectively. Conclusions: Using DCE MRI after contrast-enhanced MR angiography with gadofosveset enables reproducible assessment of hyperemic fractional microvascular blood plasma volume of the calf musculature. V-p was lower in PAD patients than in healthy controls, which reflects a promising functional (hemodynamic) biomarker for the microvascular impairment of macrovascular lesions.	[Versluis, Bas; Dremmen, Marjolein H. G.; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Schurink, Geert-Willem] Maastricht Univ Med Ctr, Dept Surg, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Versluis, B (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	w.backes@maastrichtuniversity.nl		Backes, Walter H/0000-0001-7905-0681; Wildberger, Joachim/0000-0002-4810-6854				Aslam F, 2009, SOUTH MED J, V102, P1141, DOI 10.1097/SMJ.0b013e3181bb9ab8; Begelman Susan M, 2006, Cleve Clin J Med, V73 Suppl 4, pS22; Bland JM, 1996, BRIT MED J, V313, P744; Caravan P, 2002, J AM CHEM SOC, V124, P3152, DOI 10.1021/ja017168k; Caravan P, 2007, INORG CHEM, V46, P6632, DOI 10.1021/ic700686k; Chao CYL, 2009, DIABETES-METAB RES, V25, P604, DOI 10.1002/dmrr.1004; Creager M A, 1997, Vasc Med, V2, P231; de Lussanet QG, 2007, NMR BIOMED, V20, P717, DOI 10.1002/nbm.1133; de Vries M, 2005, INVEST RADIOL, V40, P495, DOI 10.1097/01.rli.0000163004.65460.8b; de Vries M, 2005, J MAGN RESON IMAGING, V21, P37, DOI 10.1002/jmri.20240; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; Gerhard-Herman M, 2006, VASC MED, V11, P183, DOI 10.1177/1358863x06070516; Grover-Paez F, 2009, DIABETES RES CLIN PR, V84, P1, DOI 10.1016/j.diabres.2008.12.013; Haacke EM, 2007, MAGN RESON MED, V58, P463, DOI 10.1002/mrm.21358; Haacke M, 1999, MAGNETIC RESONANCE I, P654; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Isbell DC, 2007, J MAGN RESON IMAGING, V25, P1013, DOI 10.1002/jmri.20899; Jansen JFA, 2007, INVEST RADIOL, V42, P327, DOI 10.1097/01.rli.0000262757.10271.e5; Kershaw LE, 2006, MAGN RESON MED, V56, P986, DOI 10.1002/mrm.21040; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Ledermann HP, 2006, CIRCULATION, V113, P2929, DOI 10.1161/CIRCULATIONAHA.105.605717; Leiner T, 2005, RADIOLOGY, V235, P699, DOI 10.1148/radiol.2352040089; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; McDermott MM, 2004, J VASC SURG, V39, P523, DOI 10.1016/j.jvs.2003.08.038; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Press WH, 1992, NUMERICAL RECIPES C, Vxxvi, P994; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Ribeiro Fernando, 2009, Rev Port Cardiol, V28, P1121; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Thompson RB, 2005, MAGNET RESON MED, V54, P289, DOI 10.1002/mrm.20535; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1994, MAGN RESON IMAGING, V12, P81, DOI 10.1016/0730-725X(94)92355-8; Versluis B, 2011, INVEST RADIOL, V46, P11, DOI 10.1097/RLI.0b013e3181f2bfb8; Vita JA, 2010, CAN J CARDIOL, V26, p45A, DOI 10.1016/S0828-282X(10)71062-X; Weber MA, 2007, EUR RADIOL, V17, P2663, DOI 10.1007/s00330-007-0641-y; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Ziegler MA, 2010, MICROCIRCULATION, V17, P3, DOI 10.1111/j.1549-8719.2010.00008.x	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37756	10.1371/journal.pone.0037756	http://dx.doi.org/10.1371/journal.pone.0037756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662212	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300102
J	Fang, YJ; Wu, H; Zhang, TW; Yang, M; Yin, YX; Pan, LL; Yu, XG; Zhang, XW; Hu, SNA; Al-Mssallem, IS; Yu, J				Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun			A Complete Sequence and Transcriptomic Analyses of Date Palm (Phoenix dactylifera L.) Mitochondrial Genome	PLOS ONE			English	Article							TRANSFER-RNA GENES; PLANT MITOCHONDRIAL; PHYLOGENETIC ANALYSIS; DYNAMIC EVOLUTION; LAND PLANTS; CHLOROPLAST; PROTEIN; MAIZE; DNA; ARABIDOPSIS	Based on next-generation sequencing data, we assembled the mitochondrial (mt) genome of date palm (Phoenix dactylifera L.) into a circular molecule of 715,001 bp in length. The mt genome of P. dactylifera encodes 38 proteins, 30 tRNAs, and 3 ribosomal RNAs, which constitute a gene content of 6.5% (46,770 bp) over the full length. The rest, 93.5% of the genome sequence, is comprised of cp (chloroplast)-derived (10.3% with respect to the whole genome length) and non-coding sequences. In the non-coding regions, there are 0.33% tandem and 2.3% long repeats. Our transcriptomic data from eight tissues (root, seed, bud, fruit, green leaf, yellow leaf, female flower, and male flower) showed higher gene expression levels in male flower, root, bud, and female flower, as compared to four other tissues. We identified 120 potential SNPs among three date palm cultivars (Khalas, Fahal, and Sukry), and successfully found seven SNPs in the coding sequences. A phylogenetic analysis, based on 22 conserved genes of 15 representative plant mitochondria, showed that P. dactylifera positions at the root of all sequenced monocot mt genomes. In addition, consistent with previous discoveries, there are three co-transcribed gene clusters-18S-5S rRNA, rps3-rpl16 and nad3-rps12-in P. dactylifera, which are highly conserved among all known mitochondrial genomes of angiosperms.	[Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] KACST, JCGR, Riyadh, Saudi Arabia; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] Chinese Acad Sci, Riyadh, Saudi Arabia; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Hu, Songnian; Yu, Jun] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] Chinese Acad Sci, BIG, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Dept Biotechnol, Coll Agr & Food Sci, Al Hufuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Zhejiang University; Chinese Academy of Sciences; King Faisal University	Fang, YJ (corresponding author), KACST, JCGR, Riyadh, Saudi Arabia.	zhangxw@big.ac.cn; husn@big.ac.cn; imssallem@kacst.edu.sa; junyu@big.ac.cn	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111; , Meng/0000-0002-2672-3069	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [428-29]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	The project is supported by a project grant from King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [428-29]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Binder S, 1996, PLANT MOL BIOL, V32, P303, DOI 10.1007/BF00039387; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Cummings MP, 2003, CURR GENET, V43, P131, DOI 10.1007/s00294-003-0378-3; FINNEGAN PM, 1990, PLANT CELL, V2, P71, DOI 10.1105/tpc.2.1.71; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grosskopf D, 1996, CURR GENET, V29, P556, DOI 10.1007/BF02426960; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He SC, 1996, P NATL ACAD SCI USA, V93, P11763, DOI 10.1073/pnas.93.21.11763; Hedtke B, 2002, PLANT J, V30, P625, DOI 10.1046/j.1365-313X.2002.01318.x; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; HUANG J, 1994, PLANT CELL, V6, P439, DOI 10.1105/tpc.6.3.439; HUH T Y, 1982, Plant Molecular Biology, V1, P245, DOI 10.1007/BF00021035; IS A-M, 1996, ARABIAN GLOBAL ENCY, V7, P182; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Kalantidis K, 2002, SEX PLANT REPROD, V14, P299, DOI 10.1007/s00497-001-0114-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Lilly JW, 2001, GENETICS, V159, P317; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; PRING D, 1993, PLANT MOL BIOL, V21, P1163, DOI 10.1007/BF00023611; Sghaier-Hammami B, 2009, PROTEOMICS, V9, P2543, DOI 10.1002/pmic.200800523; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; STERN DB, 1984, P NATL ACAD SCI-BIOL, V81, P1946, DOI 10.1073/pnas.81.7.1946; THOMSON MC, 1994, NUCLEIC ACIDS RES, V22, P5745, DOI 10.1093/nar/22.25.5745; Tian XJ, 2007, J MOL EVOL, V64, P299, DOI 10.1007/s00239-005-0200-6; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WINKLER M, 1991, CURR GENET, V20, P495, DOI 10.1007/BF00334778; WINTZ H, 1991, CURR GENET, V19, P61, DOI 10.1007/BF00362089; WISSINGER B, 1992, TRENDS GENET, V8, P322, DOI 10.1016/0168-9525(92)90265-6; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762	69	70	74	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37164	10.1371/journal.pone.0037164	http://dx.doi.org/10.1371/journal.pone.0037164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655034	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338900009
J	Molenda, O; Reid, A; Lortie, CJ				Molenda, Olivia; Reid, Anya; Lortie, Christopher J.			The Alpine Cushion Plant Silene acaulis as Foundation Species: A Bug's-Eye View to Facilitation and Microclimate	PLOS ONE			English	Article							POSITIVE INTERACTIONS; COMMUNITIES; PATTERNS; VEGETATION; SOIL; CONSEQUENCES; ECOSYSTEMS; RESPONSES; RICHNESS; INCREASE	Alpine ecosystems are important globally with high levels of endemic and rare species. Given that they will be highly impacted by climate change, understanding biotic factors that maintain diversity is critical. Silene acaulis is a common alpine nurse plant shown to positively influence the diversity and abundance of organisms-predominantly other plant species. The hypothesis that cushion or nurse plants in general are important to multiple trophic levels has been proposed but rarely tested. Alpine arthropod diversity is also largely understudied worldwide, and the plant-arthropod interactions reported are mostly negative, that is, herbivory. Plant and arthropod diversity and abundance were sampled on S. acaulis and at paired adjacent microsites with other non-cushion forming vegetation present on Whistler Mountain, B. C., Canada to examine the relative trophic effects of cushion plants. Plant species richness and abundance but not Simpson's diversity index was higher on cushion microsites relative to other vegetation. Arthropod richness, abundance, and diversity were all higher on cushion microsites relative to other vegetated sites. On a microclimatic scale, S. acaulis ameliorated stressful conditions for plants and invertebrates living inside it, but the highest levels of arthropod diversity were observed on cushions with tall plant growth. Hence, alpine cushion plants can be foundation species not only for other plant species but other trophic levels, and these impacts are expressed through both direct and indirect effects associated with altered environmental conditions and localized productivity. Whilst this case study tests a limited subset of the membership of alpine animal communities, it clearly demonstrates that cushion-forming plant species are an important consideration in understanding resilience to global changes for many organisms in addition to other plants.	[Molenda, Olivia] Univ Toronto, Toronto, ON, Canada; [Reid, Anya; Lortie, Christopher J.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Molenda, O (corresponding author), Univ Toronto, Toronto, ON, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014	lortie, christopher j/0000-0002-4291-7023; Molenda, Olivia/0000-0002-9487-0861	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to CJL and a Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant to CJL. AR was funded by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2007, J APPL ENTOMOL, V131, P493, DOI 10.1111/j.1439-0418.2007.01197.x; [Anonymous], 1996, BOUNDARY LAYER CLIMA; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Antonsson H, 2009, PLANT ECOL DIVERS, V2, P17, DOI 10.1080/17550870902926504; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Badano EI, 2006, J BIOGEOGR, V33, P304, DOI 10.1111/j.1365-2699.2005.01384.x; Badano EI, 2009, PERSPECT PLANT ECOL, V11, P191, DOI 10.1016/j.ppees.2009.03.002; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; Brooker R.W., 2008, J ECOL, V96, P8; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 2009, J ECOL, V97, P1117, DOI 10.1111/j.1365-2745.2009.01580.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Colwell R.K., 2010, ESTIMATES STAT ESTIM; Coulson SI, 2003, ECOGRAPHY, V26, P801, DOI 10.1111/j.0906-7590.2003.03646.x; Crain CM, 2006, BIOSCIENCE, V56, P211; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DAYTON PK, 1972, P C CONS PROBL ANT L; DETHIER M, 1984, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V57, P317; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Finch OD, 2010, BIODIVERS CONSERV, V19, P1341, DOI 10.1007/s10531-009-9765-5; Gobbi M, 2006, GLOBAL CHANGE BIOL, V12, P1985, DOI 10.1111/j.1365-2486.2006.01236.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hughes BB, 2010, J EXP MAR BIOL ECOL, V393, P90, DOI 10.1016/j.jembe.2010.07.003; Badano EI, 2010, ACTA OECOL, V36, P46, DOI 10.1016/j.actao.2009.09.008; Kaplan JO, 2006, CLIMATIC CHANGE, V79, P213, DOI 10.1007/s10584-006-9113-7; Kleier C, 2009, PLANT BIOLOGY, V11, P351, DOI 10.1111/j.1438-8677.2008.00115.x; KORNER C, 1979, OECOLOG PLANTAR, V14, P109; Krebs C.J., 1999, ECOLOGICAL METHODOLO, P410; Larcher W, 2010, FLORA, V205, P3, DOI 10.1016/j.flora.2008.12.005; Manly B.F.J., 2017, MULTIVARIATE STAT ME; MATTHEY W, 1981, B ECOL, V12, P339; Molina-Montenegro MA, 2006, ARCT ANTARCT ALP RES, V38, P224, DOI 10.1657/1523-0430(2006)38[224:CPAMSF]2.0.CO;2; Molina-Montenegro MA, 2009, ECOL RES, V24, P31, DOI 10.1007/s11284-008-0477-1; Mysterud A, 2010, BASIC APPL ECOL, V11, P320, DOI 10.1016/j.baae.2010.02.009; Offenberg J, 2006, FUNCT ECOL, V20, P52, DOI 10.1111/j.1365-2435.2005.01059.x; Oke T. R., 2005, BOUNDARY LAYER CLIMA; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; PAN HL, 1987, BOUND-LAY METEOROL, V38, P185, DOI 10.1007/BF00121563; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Prevey JS, 2010, ECOL APPL, V20, P1890, DOI 10.1890/09-0750.1; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Quiroz CL, 2009, REV CHIL HIST NAT, V82, P171; Ren H, 2008, PROG NAT SCI-MATER, V18, P137, DOI 10.1016/j.pnsc.2007.07.008; Sapir Y, 2009, ARTHROPOD-PLANT INTE, V3, P115, DOI 10.1007/s11829-009-9062-y; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Sokal RR, 2003, BIOMETRY; Streinzer M, 2010, ARTHROPOD-PLANT INTE, V4, P141, DOI 10.1007/s11829-010-9093-4; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Xu J, 2010, PLANT BIOLOGY, V12, P780, DOI 10.1111/j.1438-8677.2009.00271.x; Yang Y, 2010, J VEG SCI, V21, P1048, DOI 10.1111/j.1654-1103.2010.01215.x; Zuur Alain F., 2009, P1	62	47	49	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37223	10.1371/journal.pone.0037223	http://dx.doi.org/10.1371/journal.pone.0037223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655035	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900010
J	Cai, YM; Zhou, Q; Yu, CX; Wang, XM; Hu, SN; Yu, J; Yu, XM				Cai, Yimei; Zhou, Qing; Yu, Caixia; Wang, Xumin; Hu, Songnian; Yu, Jun; Yu, Xiaomin			Transposable-Element Associated Small RNAs in Bombyx mori Genome	PLOS ONE			English	Article							ENDOGENOUS SIRNAS; MOBILE ELEMENTS; HUMAN MICRORNAS; SILKWORM; DEFENSE; PATHWAY; PIWI; TRANSCRIPTS; EVOLUTION; SEQUENCE	Small RNAs are a group of regulatory RNA molecules that control gene expression at transcriptional or post-transcriptional levels among eukaryotes. The silkworm, Bombyx mori L., genome harbors abundant repetitive sequences derived from families of retrotransposons and transposons, which together constitute almost half of the genome space and provide ample resource for biogenesis of the three major small RNA families. We systematically discovered transposable-element (TE)-associated small RNAs in B. mori genome based on a deep RNA-sequencing strategy and the effort yielded 182, 788 and 4,990 TE-associated small RNAs in the miRNA, siRNA and piRNA species, respectively. Our analysis suggested that the three small RNA species preferentially associate with different TEs to create sequence and functional diversity, and we also show evidence that a Bombyx non-LTR retrotransposon, bm1645, alone contributes to the generation of TE-associated small RNAs in a very significant way. The fact that bm1645-associated small RNAs partially overlap with each other implies a possibility that this element may be modulated by different mechanisms to generate different products with diverse functions. Taken together, these discoveries expand the small RNA pool in B. mori genome and lead to new knowledge on the diversity and functional significance of TE-associated small RNAs.	[Cai, Yimei; Zhou, Qing; Yu, Caixia; Wang, Xumin; Hu, Songnian; Yu, Jun; Yu, Xiaomin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yu, Xiaomin] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cai, YM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn; yuxm@big.ac.cn	wang, xumin/HII-8627-2022; Yu, Xiaomin/I-6407-2016; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [31000578]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences and the National Natural Science Foundation of China (31000578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai YM, 2010, FUNCT INTEGR GENOMIC, V10, P405, DOI 10.1007/s10142-010-0162-7; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fujii Yoichi R, 2010, Open Virol J, V4, P63, DOI 10.2174/1874357901004010063; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Hedges DJ, 2005, BIOESSAYS, V27, P785, DOI 10.1002/bies.20268; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nilsen TW, 2008, NAT STRUCT MOL BIOL, V15, P546, DOI 10.1038/nsmb0608-546; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang X, 1992, J S CHINA AGR U, V2, P95; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36599	10.1371/journal.pone.0036599	http://dx.doi.org/10.1371/journal.pone.0036599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22662121	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500019
J	Hyodo, T; Ito, S; Hasegawa, H; Asano, E; Maeda, M; Urano, T; Takahashi, M; Hamaguchi, M; Senga, T				Hyodo, Toshinori; Ito, Satoko; Hasegawa, Hitoki; Asano, Eri; Maeda, Masao; Urano, Takeshi; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			Misshapen-like kinase 1 (MINK1) Is a Novel Component of Striatin-interacting Phosphatase and Kinase (STRIPAK) and Is Required for the Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20 KINASE; PROTEIN PHOSPHATASES; DENDRITIC SPINES; EPITHELIAL-CELLS; MITOTIC EXIT; FAMILY; PHOSPHORYLATION; DROSOPHILA; 2A; ABSCISSION	Cytokinesis is initiated by constriction of the cleavage furrow and terminated by abscission of the intercellular bridge that connects two separating daughter cells. The complicated processes of cytokinesis are coordinated by phosphorylation and dephosphorylation mediated by protein kinases and phosphatases. Mammalian Misshapen-like kinase 1 (MINK1) is a member of the germinal center kinases and is known to regulate cytoskeletal organization and oncogene-induced cell senescence. To search for novel regulators of cytokinesis, we performed a screen using a library of siRNAs and found that MINK1 was essential for cytokinesis. Time-lapse analysis revealed that MINK1-depleted cells were able to initiate furrowing but that abscission was disrupted. STRN4 (Zinedin) is a regulatory subunit of protein phosphatase 2A (PP2A) and was recently shown to be a component of a novel protein complex called striatin-interacting phosphatase and kinase (STRIPAK). Mass spectrometry analysis showed that MINK1 was a component of STRIPAK and that MINK1 directly interacted with STRN4. Similar to MINK1 depletion, STRN4-knockdown induced multinucleated cells and inhibited the completion of abscission. In addition, STRN4 reduced MINK1 activity in the presence of catalytic and structural subunits of PP2A. Our study identifies a novel regulatory network of protein kinases and phosphatases that regulate the completion of abscission.	[Hyodo, Toshinori; Ito, Satoko; Hasegawa, Hitoki; Asano, Eri; Maeda, Masao; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Takahashi, Masahide] Nagoya Univ, Dept Pathol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Matsue, Shimane 6938501, Japan	Nagoya University; Nagoya University; Shimane University	Senga, T (corresponding author), 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp	MAEDA, Masao/P-2709-2015; TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020	Takahashi, Masahide/0000-0002-2803-2683; Hyodo, Toshinori/0000-0003-3046-5338; Maeda, Masao/0000-0001-5936-5790	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22570182] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Cobreros-Reguera L, 2010, EMBO REP, V11, P943, DOI 10.1038/embor.2010.156; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daulat AM, 2012, MOL CELL BIOL, V32, P173, DOI 10.1128/MCB.06320-11; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Ruan WJ, 2002, NEURON, V36, P831, DOI 10.1016/S0896-6273(02)01027-9; Salaun P, 2008, ADV EXP MED BIOL, V617, P41; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	43	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25019	25029		10.1074/jbc.M112.372342	http://dx.doi.org/10.1074/jbc.M112.372342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665485	Green Published, hybrid			2022-12-25	WOS:000306651700015
J	Ritie, L; Spenle, C; Lacroute, J; Bolcato-Bellemin, AL; Lefebvre, O; Bole-Feysot, C; Jost, B; Klein, A; Arnold, C; Kedinger, M; Bagnard, D; Orend, G; Simon-Assmann, P				Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Bolcato-Bellemin, Anne-Laure; Lefebvre, Olivier; Bole-Feysot, Christine; Jost, Bernard; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia			Abnormal Wnt and PI3Kinase Signaling in the Malformed Intestine of lama5 Deficient Mice	PLOS ONE			English	Article							LAMININ ALPHA-5 CHAIN; BASEMENT-MEMBRANE; STEM-CELLS; HAIR MORPHOGENESIS; NUCLEAR PROTEINS; EPITHELIAL-CELLS; GENE-EXPRESSION; SELF-RENEWAL; ISOFORMS; DISEASE	Laminins are major constituents of basement membranes and are essential for tissue homeostasis. Laminin-511 is highly expressed in the intestine and its absence causes severe malformation of the intestine and embryonic lethality. To understand the mechanistic role of laminin-511 in tissue homeostasis, we used RNA profiling of embryonic intestinal tissue of lama5 knockout mice and identified a lama5 specific gene expression signature. By combining cell culture experiments with mediated knockdown approaches, we provide a mechanistic link between laminin alpha 5 gene deficiency and the physiological phenotype. We show that laminin alpha 5 plays a crucial role in both epithelial and mesenchymal cell behavior by inhibiting Wnt and activating PI3K signaling. We conclude that conflicting signals are elicited in the absence of lama5, which alter cell adhesion, migration as well as epithelial and muscle differentiation. Conversely, adhesion to laminin-511 may serve as a potent regulator of known interconnected PI3K/Akt and Wnt signaling pathways. Thus deregulated adhesion to laminin-511 may be instrumental in diseases such as human pathologies of the gut where laminin-511 is abnormally expressed as it is shown here.	[Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Lefebvre, Olivier; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia] INSERM, U682, Strasbourg, France; [Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Lefebvre, Olivier; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, Strasbourg, France; [Bolcato-Bellemin, Anne-Laure] Polyplus Transfect, Illkirch Graffenstaden, France; [Bole-Feysot, Christine; Jost, Bernard] IGBMC, Microarray & Sequencing Platform, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ritie, L (corresponding author), Labs SVM, Schirmeck, France.	Patricia.Simon-Assmann@inserm.u-strasbg.fr	Lefebvre, Olivier/I-2388-2016; Spenle, Caroline/P-6284-2016; Bagnard, Dominique/I-6535-2013; Orend, Gertraud/E-8446-2015; Spenlé, Caroline/Z-6177-2019; Lefebvre, Olivier/S-6436-2019	Lefebvre, Olivier/0000-0001-9130-9174; Spenle, Caroline/0000-0002-6353-3109; Orend, Gertraud/0000-0003-2522-1195; Spenlé, Caroline/0000-0002-6353-3109; Lefebvre, Olivier/0000-0001-9130-9174; Bagnard, Dominique/0000-0002-5261-902X	Inserm; Association pour la Recherche sur le Cancer (ARC) [7983]; Institut National du Cancer; Hautepierre Hospital, Strasbourg; Association pour la Recherche sur le Cancer; Ligue contre le Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Hautepierre Hospital, Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer(Ligue nationale contre le cancer)	This work has been supported by Inserm, by the Association pour la Recherche sur le Cancer (ARC # 7983: equipment to GO), the Institut National du Cancer (PSA, GO), Oncosuisse (GO), and the Hautepierre Hospital, Strasbourg (GO). LR and CS were recipients of fellowships from Association pour la Recherche sur le Cancer (LR) and the Ligue contre le Cancer (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2005, HUM PATHOL, V36, P1055, DOI 10.1016/j.humpath.2005.07.013; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chia J, 2007, AM J PATHOL, V170, P2135, DOI 10.2353/ajpath.2007.060709; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gerhart J, 2001, J CELL BIOL, V155, P381, DOI 10.1083/jcb.200105139; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GOULET O, 1995, J PEDIATR-US, V127, P212, DOI 10.1016/S0022-3476(95)70297-0; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Grille SJ, 2003, CANCER RES, V63, P2172; Gu J, 2002, BIOCHEM BIOPH RES CO, V296, P73, DOI 10.1016/S0006-291X(02)00831-8; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Kim BM, 2007, GASTROENTEROLOGY, V133, P529, DOI 10.1053/j.gastro.2007.04.072; Korhonen M, 2000, J HISTOCHEM CYTOCHEM, V48, P1011, DOI 10.1177/002215540004800714; Kusuma N, 2012, INT J CANCER, V130, P555, DOI 10.1002/ijc.26018; Lefebvre O, 1999, DEV BIOL, V210, P135, DOI 10.1006/dbio.1999.9270; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Olsen J, 2000, BIOCHEM J, V347, P407, DOI 10.1042/0264-6021:3470407; Park YK, 2005, GENESIS, V41, P1, DOI 10.1002/gene.20088; Patey N, 1997, GASTROENTEROLOGY, V113, P833, DOI 10.1016/S0016-5085(97)70178-1; Pouliot N, 2001, EXP CELL RES, V266, P1, DOI 10.1006/excr.2001.5197; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Simon-Assmann P, 2010, PROG MOL BIOL TRANSL, V96, P175, DOI 10.1016/S1877-1173(10)96008-0; Simon-Assmann Patricia, 2009, V522, P309, DOI 10.1007/978-1-59745-413-1_20; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; Slavotinek AM, 2009, CLIN GENET, V75, P429, DOI 10.1111/j.1399-0004.2009.01182.x; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025; Turck N, 2004, PROTEOMICS, V4, P93, DOI 10.1002/pmic.200300480; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Verzi Michael P, 2008, Organogenesis, V4, P87	54	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37710	10.1371/journal.pone.0037710	http://dx.doi.org/10.1371/journal.pone.0037710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666383	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400042
J	Yu, K; Zhang, T				Yu, Ke; Zhang, Tong			Metagenomic and Metatranscriptomic Analysis of Microbial Community Structure and Gene Expression of Activated Sludge	PLOS ONE			English	Article							WATER TREATMENT-PLANT; AMMONIA-OXIDIZING ARCHAEA; NITRIFICATION REACTOR; BACTERIAL COMMUNITY; QUANTIFICATION; MICROORGANISMS; DIVERSITY; PROTEINS	The present study applied both metagenomic and metatranscriptomic approaches to characterize microbial structure and gene expression of an activated sludge community from a municipal wastewater treatment plant in Hong Kong. DNA and cDNA were sequenced by Illumina Hi-seq2000 at a depth of 2.4 Gbp. Taxonomic analysis by MG-RAST showed bacteria were dominant in both DNA and cDNA datasets. The taxonomic profile obtained by BLAST against SILVA SSUref database and annotation by MEGAN showed that activated sludge was dominated by Proteobacteria, Actinobacteria, Bacteroidetes, Firmicutes and Verrucomicrobia phyla in both DNA and cDNA datasets. Global gene expression annotation based on KEGG metabolism pathway displayed slight disagreement between the DNA and cDNA datasets. Further gene expression annotation focusing on nitrogen removal revealed that denitrification-related genes sequences dominated in both DNA and cDNA datasets, while nitrifying genes were also expressed in relative high levels. Specially, ammonia monooxygenase and hydroxylamine oxidase demonstrated the high cDNA/DNA ratios in the present study, indicating strong nitrification activity. Enzyme subunits gene sequences annotation discovered that subunits of ammonia monooxygenase (amoA, amoB, amoC) and hydroxylamine oxygenase had higher expression levels compared with subunits of the other enzymes genes. Taxonomic profiles of selected enzymes (ammonia monooxygenase and hydroxylamine oxygenase) showed that ammonia-oxidizing bacteria present mainly belonged to Nitrosomonas and Nitrosospira species and no ammonia-oxidizing Archaea sequences were detected in both DNA and cDNA datasets.	[Yu, Ke; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yu, K (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008	Zhang, Tong/0000-0003-1148-4322	Hong Kong Research Grants Council [7198/10E]; Hong Kong UGC Special Equipment Grant [SEG HKU09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong UGC Special Equipment Grant	The authors wish to thank the Hong Kong Research Grants Council for the financial support of this study (7198/10E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Beijing Genomics Institute (Shenzhen) for sequencing and Mr. Zhiwei Fang for his help in metadata analysis. This research is conducted using the HKU Computer Centre research computing facilities that are supported in part by the Hong Kong UGC Special Equipment Grant (SEG HKU09).	Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gittel A, 2008, ENVIRON MICROBIOL, V10, P2645, DOI 10.1111/j.1462-2920.2008.01686.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Tavormina PL, 2011, ENV MICROBIOL REP, V3, P91, DOI 10.1111/j.1758-2229.2010.00192.x; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wilmes P, 2008, ISME J, V2, P853, DOI 10.1038/ismej.2008.38; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2006, APPL MICROBIOL BIOT, V70, P281, DOI 10.1007/s00253-006-0333-6; Zhang T, 2011, ISME J; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m	29	202	223	10	303	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38183	10.1371/journal.pone.0038183	http://dx.doi.org/10.1371/journal.pone.0038183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666477	Green Published, gold			2022-12-25	WOS:000305353400095
J	Blume, C; Felix, A; Shushakova, N; Gueler, F; Falk, CS; Haller, H; Schrader, J				Blume, Cornelia; Felix, Agnieszka; Shushakova, Nelli; Gueler, Faikah; Falk, Christine Susanne; Haller, Hermann; Schrader, Juergen			Autoimmunity in CD73/Ecto-5 '-Nucleotidase Deficient Mice Induces Renal Injury	PLOS ONE			English	Article							RECEPTOR ACTIVATION; ADENOSINE RECEPTORS; THERAPEUTIC TARGETS; ECTO-5'-NUCLEOTIDASE; INFLAMMATION; GENERATION; PROTECTS; PATHWAY; IL-18; CD73	Extracellular adenosine formed by 5'-ectonucleotidase (CD73) is involved in tubulo-glomerular feedback in the kidney but is also known to be an important immune modulator. Since CD73(-/-) mutant mice exhibit a vascular proinflammatory phenotype, we asked whether long term lack of CD73 causes inflammation related kidney pathologies. CD73(-/-) mice (13 weeks old) showed significantly increased low molecule proteinuria compared to C57BL6 wild type controls (4.8 >= 0.52 vs. 2.9 +/- 0.54 mg/24 h, p<0.03). Total proteinuria increased to 5.97 +/- 0.78 vs. 2.55 +/- 0.35 mg/24 h at 30 weeks (p<0.01) whereas creatinine clearance decreased (0.161 +/- 0.02 vs. 0.224 +/- 0.02 ml/min). We observed autoimmune inflammation in CD73(-/-) mice with glomerulitis and peritubular capillaritis, showing glomerular deposition of IgG and C3 and enhanced presence of CD11b, CD8, CD25 as well as GR-1-positive cells in the interstitium. Vascular inflammation was associated with enhanced serum levels of the cytokines IL-18 and TNF-alpha as well as VEGF and the chemokine MIP-2 (CXCL-2) in CD73(-/-) mice, whereas chemokines and cytokines in the kidney tissue were unaltered or reduced. In CD73(-/-) mice glomeruli, we found a reduced number of podocytes and endothelial fenestrations, increased capillaries per glomeruli, endotheliosis and enhanced tubular fibrosis. Our results show that adult CD73(-/-) mice exhibit spontaneous proteinuria and renal functional deterioration even without exogenous stress factors. Wehave identified an autoimmune inflammatory phenotype comprising the glomerular endothelium, leading to glomeruli inflammation and injury and to a cellular infiltrate of the renal interstitium. Thus, long term lack of CD73 reduced renal function and is associated with autoimmune inflammation.	[Blume, Cornelia; Felix, Agnieszka; Shushakova, Nelli; Gueler, Faikah; Haller, Hermann] Hannover Med Sch, Div Nephrol, Dept Med, D-3000 Hannover, Germany; [Falk, Christine Susanne] Hannover Med Sch, Inst Transplant Immunol, D-3000 Hannover, Germany; [Schrader, Juergen] Heinrich Heine Univ Duesseldorf, Inst Cardiovasc Physiol, Dusseldorf, Germany	Hannover Medical School; Hannover Medical School; Heinrich Heine University Dusseldorf	Blume, C (corresponding author), Hannover Med Sch, Div Nephrol, Dept Med, D-3000 Hannover, Germany.	Blume.cornelia@mh-hannover.de	Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318; Blume, Cornelia/0000-0001-7487-4884	Heinrich Heine University Duesseldorf [Sonderforschungsbereich 612, B6, Z2]; Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB); HGF Alliance Immunotherapy;  [TRR77];  [A3]	Heinrich Heine University Duesseldorf; Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB); HGF Alliance Immunotherapy; ; 	This study was supported by Sonderforschungsbereich 612, subprojects B6 and Z2 of the Heinrich Heine University Duesseldorf (JS) for development and raising of the knock out mice as well as by the Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB) and TRR77 (project A3, CSF) and HGF Alliance Immunotherapy (CSF) and IFB (Integrated Research and Treatment Center Transplantation)(CSF) for protein bioplex assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bell TD, 2010, AM J PHYSIOL-RENAL, V299, pF1158, DOI 10.1152/ajprenal.00202.2010; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hashimoto S, 2006, AM J PHYSIOL-RENAL, V290, pF888, DOI 10.1152/ajprenal.00381.2005; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF282, DOI 10.1152/ajprenal.00113.2005; Jackson EK, 2006, ANNU REV PHYSIOL, V66, P571; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; LEHIR M, 1993, AM J PHYSIOL, V264, pF377, DOI 10.1152/ajprenal.1993.264.3.F377; Linnemann C, 2009, IMMUNOLOGY, V128, pe728, DOI 10.1111/j.1365-2567.2009.03075.x; Nakav S, 2010, NEPHROL DIAL TRANSPL, V25, P931, DOI 10.1093/ndt/gfp542; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Ozuyaman B, 2006, PFLUG ARCH EUR J PHY, V452, P324, DOI 10.1007/s00424-006-0045-x; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Thompson LF, 2008, NUCLEOS NUCLEOT NUCL, V27, P755, DOI 10.1080/15257770802145678; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zernecke A, 2005, CIRCULATION, V112, pU370; Zhang H, 2008, AM J PHYSIOL-RENAL, V301, P171; Zhang L, 2011, LUPUS, V20, P667, DOI 10.1177/0961203310393262; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	38	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37100	10.1371/journal.pone.0037100	http://dx.doi.org/10.1371/journal.pone.0037100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666342	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600010
J	Thulborn, T				Thulborn, Tony			Impact of Sauropod Dinosaurs on Lagoonal Substrates in the Broome Sandstone (Lower Cretaceous), Western Australia	PLOS ONE			English	Article							FOSSIL VERTEBRATE TRACKS; PRESERVATION; UNDERTRACKS; MECHANICS	Existing knowledge of the tracks left by sauropod dinosaurs (loosely 'brontosaurs') is essentially two-dimensional, derived mainly from footprints exposed on bedding planes, but examples in the Broome Sandstone (Early Cretaceous) of Western Australia provide a complementary three-dimensional picture showing the extent to which walking sauropods could deform the ground beneath their feet. The patterns of deformation created by sauropods traversing thinly-stratified lagoonal deposits of the Broome Sandstone are unprecedented in their extent and structural complexity. The stacks of transmitted reliefs (underprints or ghost prints) beneath individual footfalls are nested into a hierarchy of deeper and more inclusive basins and troughs which eventually attain the size of minor tectonic features. Ultimately the sauropod track-makers deformed the substrate to such an extent that they remodelled the topography of the landscape they inhabited. Such patterns of substrate deformation are revealed by investigating fragmentary and eroded footprints, not by the conventional search for pristine footprints on intact bedding planes. For that reason it is not known whether similar patterns of substrate deformation might occur at sauropod track-sites elsewhere in the world.				paswamp@mailbox.uq.edu.au						Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ALLEN JRL, 1989, J GEOL SOC LONDON, V146, P600, DOI 10.1144/gsjgs.146.4.0600; [Anonymous], 2009, GEOLOGY JAMES PRICE; Avanzini Marco, 1998, Ichnos, V6, P129; Brunnschweiler RO, 1957, REP AUST BUREAU MINE, V13, P1; COLBERT E H, 1967, Journal of the Royal Society of Western Australia, V50, P21; DETTMANN ME, 1992, CRETACEOUS RES, V13, P207, DOI 10.1016/0195-6671(92)90001-7; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Farlow J.O., 1989, P371; Farlow James O., 1992, Zubia, V10, P89; Fornos JJ, 2002, PALAEOGEOGR PALAEOCL, V180, P277, DOI 10.1016/S0031-0182(01)00431-X; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; GILL ED, 1972, SEARCH, V3, P444; Glauert L., 1952, West Australian Naturalist, V3, P82; Gorter JD, 1981, B AUST BUREAU MINERA, V210, P37; Henderson R.A., 2000, Memoir of the Association of Australasian Palaeontologists, V23, P355; Hill D, 1966, JURASSIC FOSSILS QUE; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Hunt A, 1995, REV GEOCIENC MUS NAC, V10, P261; Jackson S, 2002, PALAEONTOLOGICAL ASS, V51, P81; Karajas J, 1984, CANNING BASIN W AUST, P169; Klein N., 2011, BIOL SAUROPOD DINOSA; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin G., 2004, Ichnos, V11, P261, DOI 10.1080/10420940490428805; Long JA, 1992, REC N TERRITORY MUS, V9, P262; Long John A., 1998, Records of the Western Australian Museum, V19, P121; Long John A., 1992, Beagle, V9, P21; MARTY D., 2008, GEOFOCUS, V21, P1; McLoughlin S, 2001, ANCIENT FLORAS W AUS; McLoughlin Stephen, 1996, P61; MCWHAE JRH, 1958, J GEOLOGICAL SOC AUS, V4, P1; Middleton MF, 1990, MEMOIR GEOL SURV W A, V3, P425; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Milan J, 2004, LETHAIA, V37, P285, DOI 10.1080/00241160410002036; Milan J, 2003, 1 M EUR ASS VERT PAL, P15; Molnar R., 1982, P169; MOLNAR R E, 1982, Memoirs of the Queensland Museum, V20, P613; Molnar Ralph E., 1991, P605; Pittman J.G., 1989, P313; Playford PE, 1975, MEM GEOL SURV W AUST, V2, P221; Ride W. D. L., 1999, INT CODE ZOOLOGICAL; Rogers KAC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P1; Rose PJ, 2007, PALAEONTOL ELECTRON, V10; Siversson M, 2010, 60103995 AECOM AUSTR; Siversson M, 2010, REPORT MACROFO UNPUB; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn R.A., 1989, DINOSAUR TRACKS TRAC, P39; THULBORN RA, 1982, PALAEOGEOGR PALAEOCL, V38, P227, DOI 10.1016/0031-0182(82)90005-0; Thulborn RA, 1995, REV GEOCIENC MUS NAC, V10, P85; Thulborn T., 1990, DINOSAUR TRACKS; Thulborn T, 2009, MEGALOSAUROPUS BROOM; Towner R. R., 1983, BUREAU MINERAL RESOU, V215, P1; Veevers J. J., 1961, BUREAU MINERAL RESOU, V60, P1; Weishampel D.B., 1990, P63; White M. E., 1961, BUREAU MINERAL RESOU, V60, P291; YEATES AN, 1984, CANNING BASIN, P23; Zammit M, 2012, AUSTR AGE DINOSAURS, V9, P22	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36208	10.1371/journal.pone.0036208	http://dx.doi.org/10.1371/journal.pone.0036208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662116	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300010
J	Xu, F; Xie, L; Li, X; Li, Q; Wang, T; Ji, YJ; Kong, F; Zhan, QL; Cheng, K; Fang, L; Xie, P				Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Zhan, Qunlin; Cheng, Ke; Fang, Liang; Xie, Peng			Construction and Validation of a Systematic Ethogram of Macaca fascicularis in a Free Enclosure	PLOS ONE			English	Article							ANIMAL-WELFARE; BEHAVIOR; MONKEYS; ISSUES; FILES	Behavioral studies in non-human primates have become ideal models for further investigations into advanced cognitive function in humans. To date, there is no systematic ethogram of the cynomolgus monkey (Macaca fascicularis) in a free enclosure. In a field observation of 6012 subjects, 107 distinct behaviors of M. fascicularis were preliminarily described. 83 of these behaviors were then independently validated through a randomized cohort and classified into 12 behavioral categories. 53 of these behaviors were then selected to accurately reflect the daily mundane activity of the species in a free enclosure. These findings systematically document the behavior of M. fascicularis in a free enclosure for use in further investigations.	[Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Fang, Liang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Fang, Liang; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp Chongqing, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xu, F (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Li, Qi/ABE-4182-2021	Li, Qi/0000-0002-9144-148X	National Basic Research Program of China (the 973 Program) [2009CB918300]; National Natural Science Foundation of China [30900456]; Natural Science Foundation Project of Chongqing (CSTC) [2010BB5185, 2011BA5012]	National Basic Research Program of China (the 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This work was supported by the National Basic Research Program of China (the 973 Program; Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 30900456) and the Natural Science Foundation Project of Chongqing (CSTC, 2010BB5185 and 2011BA5012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1984, J UROLOGY, V131, P571, DOI 10.1016/S0022-5347(17)50506-6; Allen C., 1995, PERSP ETHOL, P1; ALMOND R, 1969, J NERV MENT DIS, V149, P398, DOI 10.1097/00005053-196911000-00003; Bakeman R, 2000, BEHAV RES METH INS C, V32, P207, DOI 10.3758/BF03200803; Beauchamp TL, 1994, PRINCIPLES BIOMEDICA, p[12, 327]; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Cappenter S, 2000, MONITOR PSYCHOL, V31, P22; Dawkins MS, 1990, BEHAV BRAIN SCI, V13, P54; Duncan I. J. H., 1997, Animal welfare., P19; Duncan Ian J. H., 1993, Journal of Agricultural and Environmental Ethics, V6, P8; HUNTINGFORD FA, 1984, ANIM BEHAV, V32, P210, DOI 10.1016/S0003-3472(84)80339-5; Jiang Zhigang, 2000, Acta Theriologica Sinica, V20, P1; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Lehner PN, HANDBBOK ETHOLOGICAL, P1; Martin PBP, MEASURE BEHAV INTRO, P1; MEARS CE, 1975, P NATL ACAD SCI USA, V72, P1878, DOI 10.1073/pnas.72.5.1878; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; Regan T, 1983, CASE ANIMAL RIGHTS, P20; Rollin BE, 1992, ANIMAL RIGHTS HUMAN, P21; SKINNER SW, 1979, APPL ANIM ETHOL, V5, P241, DOI 10.1016/0304-3762(79)90059-2; Stafleu FR, 1996, ANIM WELFARE, V5, P225; TANNENBAUM J, 1991, J AM VET MED ASSOC, V198, P1360; THORPE WH, 1969, NATURE, V224, P18, DOI 10.1038/224018a0; William T, 1971, ARCH GEN PSYCHIAT, V26, P1313; WOODGUSH DG, 1973, BRIT VET J, V129, P167, DOI 10.1016/S0007-1935(17)36541-7; Yamada Kazunori, 2010, Japanese Journal of Animal Psychology, V59, P199, DOI 10.2502/janip.59.2.2; Zhang J, 2010, CURR ZOOL, V56, P222, DOI 10.1093/czoolo/56.2.222	27	16	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37486	10.1371/journal.pone.0037486	http://dx.doi.org/10.1371/journal.pone.0037486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662158	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300048
J	Cheuk, BLY; Chan, YC; Cheng, SWK				Cheuk, Bernice L. Y.; Chan, Y. C.; Cheng, Stephen W. K.			Changes in Inflammatory Response after Endovascular Treatment for Type B Aortic Dissection	PLOS ONE			English	Article							STENT-GRAFT PLACEMENT; NECROSIS-FACTOR-ALPHA; ANEURYSM REPAIR; RENAL-FUNCTION; IMPACT; STRATEGIES; SURGERY; INJURY; TRIAL	This present study aims to investigate the changes in the inflammatory markers after elective endovascular treatment of Type B aortic dissection with aneurysm, as related to different anatomical features of the dissection flap in the paravisceral perfusion. Consecutive patients with type B aortic dissections with elective endovascular stent graft repair were recruited and categorized into different groups. Serial plasma levels of cytokines (Interleukin-1 beta, -6, -8, -10, TNF-alpha), chemokines (MCP-1), and serum creatinine were monitored at pre-, peri-and post-operative stages. The length of stent graft employed in each surgery was retrieved and correlated with the change of all studied biochemical parameters. A control group of aortic dissected patients with conventional medication management was recruited for comparing the baseline biochemical parameters. In total, 22 endovascular treated and 16 aortic dissected patients with surveillance were recruited. The endovascular treated patients had comparable baseline levels as the non-surgical patients. There was no immediate or thirty day-mortality, and none of the surgical patients developed post-operative mesenteric ischaemia or clinically significant renal impairment. All surgical patients had detectable pro-inflammatory mediators, but none of the them showed any statistical significant surge in the peri-operative period except IL-1 beta and IL-6. Similar results were obtained when categorized into different groups. IL-1 beta and IL-6 showed maximal levels within hours of the endovascular procedure (range, 3.93 to 27.3 higher than baseline; p = 0.001), but returned to baseline 1 day post-operatively. The change of IL-1 beta and IL-6 at the stent graft deployment was statistically greater in longer stent graft (p>0.05). No significant changes were observed in the serum creatinine levels. In conclusion, elective endovascular repair of type B aortic dissection associated with insignificant changes in inflammatory mediators and creatinine. All levels fell toward basal levels post-operatively suggesting that thoracic endovascular aortic repair is rather less aggressive with insignificant inflammatory modulation.	[Cheuk, Bernice L. Y.; Chan, Y. C.; Cheng, Stephen W. K.] Univ Hong Kong, Med Ctr, Dept Surg, Div Vasc Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheuk, BLY (corresponding author), Univ Hong Kong, Med Ctr, Dept Surg, Div Vasc Surg, Hong Kong, Hong Kong, Peoples R China.	bernice@hku.hk			University of Hong Kong [201007176013, 10401294.41462.21700.323.01]	University of Hong Kong(University of Hong Kong)	This work was supported by Small Project Funding, The University of Hong Kong (Fund Code: 201007176013; Account code: 10401294.41462.21700.323.01) to BLYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho PS, 2007, SCAND J SURG, V96, P229, DOI 10.1177/145749690709600308; Akowuah Enoch, 2007, Interact Cardiovasc Thorac Surg, V6, P741; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Alric P, 2003, J ENDOVASC THER, V10, P397, DOI 10.1583/1545-1550(2003)010<0397:LRFFEA>2.0.CO;2; Alsac JM, 2005, J VASC SURG, V41, P926, DOI 10.1016/j.jvs.2005.02.024; Arnaoutoglou E, 2011, INTERACT CARDIOV TH, V12, P609, DOI 10.1510/icvts.2010.256784; Benvenuti Luiz Alberto, 2005, Clinics, V60, P355, DOI 10.1590/S1807-59322005000500002; Birch PC, 1999, EUR J VASC ENDOVASC, V17, P185, DOI 10.1053/ejvs.1998.0672; Carpenter JP, 2001, CARDIOVASC SURG, V9, P559, DOI 10.1016/S0967-2109(01)00085-0; Chan YC, 2011, EUR J VASC ENDOVASC, V42, P464, DOI 10.1016/j.ejvs.2011.05.022; Chan Yiu Che, 2008, Asian Cardiovasc Thorac Ann, V16, P272; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Dake MD, 2006, SEMIN VASC SURG, V19, P40, DOI 10.1053/j.semvascsurg.2005.11.007; De La Motte L, 2011, J CARDIOVASC SURG, V52, P73; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Eggebrecht H, 2008, J ENDOVASC THER, V15, P135, DOI 10.1583/07-2284.1; Gerasimidis T, 2005, ANGIOLOGY, V56, P743, DOI 10.1177/000331970505600612; GOLDBLUM SE, 1987, J APPL PHYSIOL, V62, P122, DOI 10.1152/jappl.1987.62.1.122; Gomes WJ, 2006, ANN THORAC SURG, V81, P1918, DOI 10.1016/j.athoracsur.2005.10.014; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Karthikesalingam A, 2011, VASC ENDOVASC SURG, V44, P165; Lin Yan-jun, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P108; Melissano G, 2008, J THORAC CARDIOV SUR, V136, P1012, DOI 10.1016/j.jtcvs.2008.06.021; Nienaber CA, 2010, J THORAC CARDIOV SUR, V140, pS101, DOI 10.1016/j.jtcvs.2010.07.026; Oberhuber A, 2011, J VASC SURG, V54, P1303, DOI 10.1016/j.jvs.2011.05.020; Shu C, 2011, EUR J VASC ENDOVASC, V42, P448, DOI 10.1016/j.ejvs.2011.05.013; Swartbol P, 1996, EUR J VASC ENDOVASC, V12, P18, DOI 10.1016/S1078-5884(96)80270-X; Sweeney KJ, 2002, EUR J VASC ENDOVASC, V23, P303, DOI 10.1053/ejvs.2001.1585; Ting ACW, 2009, ASIAN J SURG, V32, P39, DOI 10.1016/S1015-9584(09)60007-5; Tsai TT, 2007, NEW ENGL J MED, V357, P349, DOI 10.1056/NEJMoa063232; van Keulen JW, 2009, EUR J VASC ENDOVASC, V38, P586, DOI 10.1016/j.ejvs.2009.06.018; Veenhof AAFA, 2012, ANN SURG, V255, P216, DOI 10.1097/SLA.0b013e31824336e2; Welorn MB, 2000, CRIT CARE MED, V28, P3356; Wen D, 2012, CLIN CHIM ACTA, V413, P198, DOI 10.1016/j.cca.2011.09.029; Xenos ES, 2009, EUR J CARDIO-THORAC, V35, P282, DOI 10.1016/j.ejcts.2008.10.042; Zipfel B, 2011, J ENDOVASC THER, V18, P131, DOI 10.1583/10-3233MR.1	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37389	10.1371/journal.pone.0037389	http://dx.doi.org/10.1371/journal.pone.0037389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655044	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900019
J	Haj, FG; Sabet, O; Kinkhabwala, A; Wimmer-Kleikamp, S; Roukos, V; Han, HM; Grabenbauer, M; Bierbaum, M; Antony, C; Neel, BG; Bastiaens, PI				Haj, Fawaz G.; Sabet, Ola; Kinkhabwala, Ali; Wimmer-Kleikamp, Sabine; Roukos, Vassilis; Han, Hong-Mei; Grabenbauer, Markus; Bierbaum, Martin; Antony, Claude; Neel, Benjamin G.; Bastiaens, Philippe I.			Regulation of Signaling at Regions of Cell-Cell Contact by Endoplasmic Reticulum-Bound Protein-Tyrosine Phosphatase 1B	PLOS ONE			English	Article							PLASMA-MEMBRANE; FLUORESCENCE RECOVERY; INSULIN-RECEPTOR; PHOTOBLEACHING RECOVERY; SPATIAL REGULATION; H-RAS; K-RAS; BINDING; PTP1B; DYNAMICS	Protein-tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed PTP that is anchored to the endoplasmic reticulum (ER). PTP1B dephosphorylates activated receptor tyrosine kinases after endocytosis, as they transit past the ER. However, PTP1B also can access some plasma membrane (PM)-bound substrates at points of cell-cell contact. To explore how PTP1B interacts with such substrates, we utilized quantitative cellular imaging approaches and mathematical modeling of protein mobility. We find that the ER network comes in close proximity to the PM at apparently specialized regions of cell-cell contact, enabling PTP1B to engage substrate(s) at these sites. Studies using PTP1B mutants show that the ER anchor plays an important role in restricting its interactions with PM substrates mainly to regions of cell-cell contact. In addition, treatment with PTP1B inhibitor leads to increased tyrosine phosphorylation of EphA2, a PTP1B substrate, specifically at regions of cell-cell contact. Collectively, our results identify PM-proximal sub-regions of the ER as important sites of cellular signaling regulation by PTP1B.	[Haj, Fawaz G.; Neel, Benjamin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Sabet, Ola; Kinkhabwala, Ali; Wimmer-Kleikamp, Sabine; Roukos, Vassilis; Han, Hong-Mei; Grabenbauer, Markus; Bierbaum, Martin; Bastiaens, Philippe I.] Max Planck Inst Mol Physiol, Dept System Cell Biol, D-44139 Dortmund, Germany; [Antony, Claude] European Mol Biol Labs, Heidelberg, Germany; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst,Campbel Family Canc Res Inst, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Davis; Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Haj, FG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	fghaj@ucdavis.edu; bneel@uhnresreach.ca; philippe.bastiaens@mpi-dortmund.mpg.de	Roukos, Vassilis/AAC-4827-2020; Han, Hong-Mei/I-6916-2015; antony, claude/K-5342-2013; Roukos, Vassilis/K-6248-2012	Roukos, Vassilis/0000-0002-5065-3937	EMBO; Juvenile Diabetes Research Foundation [1-2009-337]; American Diabetes Association [7-06-JF-28, R37 CA49152]; Ontario Ministry of Health; Princess Margaret Hospital Foundation; National Health and Medical Research Council of Australia [384352]; Sydney Medical School; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by an EMBO short-term fellowship, a Research Grant from the Juvenile Diabetes Research Foundation (1-2009-337) and a Junior Faculty Award from the American Diabetes Association (7-06-JF-28) to F. G. H., and R37 CA49152 to B.G.N. B.G.N. is a Canada Research Chair, Tier 1, and work in his laboratory is partially supported by funds from the Ontario Ministry of Health and The Princess Margaret Hospital Foundation. S. W. K was supported by a CJ Martin Fellowship (384352) of the National Health and Medical Research Council of Australia, and an Early Career Award of the Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bouchet-Marquis C, 2008, J MICROSC-OXFORD, V230, P308, DOI 10.1111/j.1365-2818.2008.01988.x; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cromlish WA, 2006, BIOCHEM PHARMACOL, V72, P1279, DOI 10.1016/j.bcp.2006.07.038; Dadke S, 2000, J BIOL CHEM, V275, P23642, DOI 10.1074/jbc.M001063200; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; Lavieu G, 2010, P NATL ACAD SCI USA, V107, P6876, DOI 10.1073/pnas.1002536107; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mertins P, 2008, MOL CELL PROTEOMICS; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sprague BL, 2006, BIOPHYS J, V91, P1169, DOI 10.1529/biophysj.105.073676; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stuible M, 2010, J BIOL CHEM, V285, P23899, DOI 10.1074/jbc.M110.115295; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; TERASAKI M, 1994, CELL MOTIL CYTOSKEL, V29, P291, DOI 10.1002/cm.970290402; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	61	43	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36633	10.1371/journal.pone.0036633	http://dx.doi.org/10.1371/journal.pone.0036633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655028	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900002
J	Finger, JN; Lich, JD; Dare, LC; Cook, MN; Brown, KK; Duraiswami, C; Bertin, JJ; Gough, PJ				Finger, Joshua N.; Lich, John D.; Dare, Lauren C.; Cook, Michael N.; Brown, Kristin K.; Duraiswami, Chaya; Bertin, John J.; Gough, Peter J.			Autolytic Proteolysis within the Function to Find Domain (FIIND) Is Required for NLRP1 Inflammasome Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRAX LETHAL TOXIN; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; PROTEIN ASC; FAMILY; PYRIN; GENE; ACTIVATION; APOPTOSIS; CASPASE-1	Nucleotide-binding domain leucine-rich repeat proteins (NLRs) play a key role in immunity and disease through their ability to modulate inflammation in response to pathogen-derived and endogenous danger signals. Here, we identify the requirements for activation of NLRP1, an NLR protein associated with a number of human pathologies, including vitiligo, rheumatoid arthritis, and Crohn disease. We demonstrate that NLRP1 activity is dependent upon ASC, which associates with the C-terminal CARD domain of NLRP1. In addition, we show that NLRP1 activity is dependent upon autolytic cleavage at Ser(1213) within the FIIND. Importantly, this post translational event is dependent upon the highly conserved distal residue His(1186). A disease-associated single nucleotide polymorphism near His(1186) and a naturally occurring mRNA splice variant lacking exon 14 differentially affect this autolytic processing and subsequent NLRP1 activity. These results describe key molecular pathways that regulate NLRP1 activity and offer insight on how small sequence variations in NLR genes may influence human disease pathogenesis.	[Finger, Joshua N.; Lich, John D.; Dare, Lauren C.; Cook, Michael N.; Bertin, John J.; Gough, Peter J.] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA; [Brown, Kristin K.; Duraiswami, Chaya] GlaxoSmithKline, Computat Chem, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Gough, PJ (corresponding author), GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	peter.j.gough@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was supported by GlaxoSmithKline.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Davenport EA, 2009, METHODS MOL BIOL, V552, P199, DOI 10.1007/978-1-60327-317-6_14; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Hedrich CM, 2008, SCAND J RHEUMATOL, V37, P385, DOI 10.1080/03009740801978889; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Jin Y, 2010, J INVEST DERMATOL, V130, P774, DOI 10.1038/jid.2009.273; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sui JD, 2012, ARTHRITIS RHEUM-US, V64, P647, DOI 10.1002/art.33370; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Verma D., 2012, PIGMENT CEL IN PRESS; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Zurawek M, 2010, HUM IMMUNOL, V71, P530, DOI 10.1016/j.humimm.2010.02.004	33	152	160	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25030	25037		10.1074/jbc.M112.378323	http://dx.doi.org/10.1074/jbc.M112.378323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665479	Green Published, hybrid			2022-12-25	WOS:000306651700016
J	Grassmann, F; Fritsche, LG; Keilhauer, CN; Heid, IM; Weber, BHF				Grassmann, Felix; Fritsche, Lars G.; Keilhauer, Claudia N.; Heid, Iris M.; Weber, Bernhard H. F.			Modelling the Genetic Risk in Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; PREVALENCE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; MACULOPATHY; CLASSIFICATION; METAANALYSIS; RANIBIZUMAB; EXPRESSION	Late-stage age-related macular degeneration (AMD) is a common sight-threatening disease of the central retina affecting approximately 1 in 30 Caucasians. Besides age and smoking, genetic variants from several gene loci have reproducibly been associated with this condition and likely explain a large proportion of disease. Here, we developed a genetic risk score (GRS) for AMD based on 13 risk variants from eight gene loci. The model exhibited good discriminative accuracy, area-under-curve (AUC) of the receiver-operating characteristic of 0.820, which was confirmed in a cross-validation approach. Noteworthy, younger AMD patients aged below 75 had a significantly higher mean GRS (1.87, 95% CI: 1.69-2.05) than patients aged 75 and above (1.45, 95% CI: 1.36-1.54). Based on five equally sized GRS intervals, we present a risk classification with a relative AMD risk of 64.0 (95% CI: 14.11-1131.96) for individuals in the highest category (GRS 3.44-5.18, 0.5% of the general population) compared to subjects with the most common genetic background (GRS -0.05-1.70, 40.2% of general population). The highest GRS category identifies AMD patients with a sensitivity of 7.9% and a specificity of 99.9% when compared to the four lower categories. Modeling a general population around 85 years of age, 87.4% of individuals in the highest GRS category would be expected to develop AMD by that age. In contrast, only 2.2% of individuals in the two lowest GRS categories which represent almost 50% of the general population are expected to manifest AMD. Our findings underscore the large proportion of AMD cases explained by genetics particularly for younger AMD patients. The five-category risk classification could be useful for therapeutic stratification or for diagnostic testing purposes once preventive treatment is available.	[Grassmann, Felix; Fritsche, Lars G.; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Keilhauer, Claudia N.] Univ Eye Hosp Wurzburg, Wurzburg, Germany; [Heid, Iris M.] Univ Hosp Regensburg, Inst Epidemiol & Prevent Med, Regensburg, Germany; [Heid, Iris M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany	University of Regensburg; University of Wurzburg; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Grassmann, F (corresponding author), Univ Regensburg, Inst Human Genet, Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Grassmann, Felix/0000-0003-1390-7528; Weber, Bernhard H.F./0000-0002-8808-7723	Deutsche Forschungsgemeinschaft [WE 1259/19-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft WE 1259/19-2. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chongsuvivatwong V., 2010, EPICALC EPIDEMIOLOGI; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Fritsche LG, 2009, HUM MUTAT, V30, P1048, DOI 10.1002/humu.20957; Gibson J, 2010, BRIT J OPHTHALMOL, V94, P1382, DOI 10.1136/bjo.2010.182568; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hu B, 2006, STAT SINICA, V16, P847; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Liu QZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008250; Lumley T, 2009, RMETA METAANALYSIS R; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; McFadden D, 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Spencer KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017784; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; [No title captured]	50	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37979	10.1371/journal.pone.0037979	http://dx.doi.org/10.1371/journal.pone.0037979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666427	Green Published, gold			2022-12-25	WOS:000305353400065
J	Lu, L; Yan, WH; Xue, WY; Shao, D; Xing, YZ				Lu, Li; Yan, Wenhao; Xue, Weiya; Shao, Di; Xing, Yongzhong			Evolution and Association Analysis of Ghd7 in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FLOWERING-TIME; GENE-EXPRESSION; ARABIDOPSIS; SOFTWARE; DOMESTICATION; DIVERSITY; HD1; POPULATION	Plant height, heading date, and yield are the main targets for rice genetic improvement. Ghd7 is a pleiotropic gene that controls the aforementioned traits simultaneously. In this study, a rice germplasm collection of 104 accessions (Oryza sativa) and 3 wild rice varieties (O. rufipogon) was used to analyze the evolution and association of Ghd7 with plant height, heading date, and yield. Among the 104 accessions, 76 single nucleotide polymorphisms (SNPs) and six insertions and deletions were found within a 3932-bp DNA fragment of Ghd7. A higher pairwise pi and theta in the promoter indicated a highly diversified promoter of Ghd7. Sixteen haplotypes and 8 types of Ghd7 protein were detected. SNP changes between haplotypes indicated that Ghd7 evolved from two distinct ancestral gene pools, and independent domestication processes were detected in indica and japonica varietals respectively. In addition to the previously reported premature stop mutation in the first exon of Ghd7, which caused phenotypic changes of multiple traits, we found another functional C/T mutation (SNP S_555) by structure-based association analysis. SNP S_555 is located in the promoter and was related to plant height probably by altering gene expression. Moreover, another seven SNP mutations in complete linkage were found to be associated with the number of spikelets per panicle, regardless of the photoperiod. These associations provide the potential for flexibility of Ghd7 application in rice breeding programs.	[Lu, Li] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lu, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yzxing@mail.hzau.edu.cn		Xing, Yongzhong/0000-0003-1376-1514; Lu, Li/0000-0003-0490-7163	National Science Foundation of China [30830064]; 863 program on platform establishment for rice resources, genomics and bioinformatics [2012AA10A304]; National Special Program for Research of Transgenic Plant of China [2008ZX08009-103B]; National Key Program on the Development of Basic Research of China [2007CB109001]; Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation [2009YB006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program on platform establishment for rice resources, genomics and bioinformatics; National Special Program for Research of Transgenic Plant of China; National Key Program on the Development of Basic Research of China; Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation	The work was supported by National Science Foundation of China (30830064); 863 program on platform establishment for rice resources, genomics and bioinformatics (2012AA10A304); National Special Program for Research of Transgenic Plant of China (2008ZX08009-103B); National Key Program on the Development of Basic Research of China (2007CB109001); and Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation (2009YB006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chen YS, 2010, TRENDS PLANT SCI, V15, P454, DOI 10.1016/j.tplants.2010.05.004; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pritchard JK, 2000, GENETICS, V155, P945; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu L, 2010, PLANT CELL REP, V29, P1061, DOI 10.1007/s00299-010-0892-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	41	68	74	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e34021	10.1371/journal.pone.0034021	http://dx.doi.org/10.1371/journal.pone.0034021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666315	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400004
J	Rogers, SW; Gahring, LC				Rogers, Scott W.; Gahring, Lorise C.			Nicotinic Receptor Alpha7 Expression during Tooth Morphogenesis Reveals Functional Pleiotropy	PLOS ONE			English	Article							DEVELOPING RAT MOLARS; 1ST MOLAR; ACETYLCHOLINE-RECEPTORS; DENTAL DEVELOPMENT; GENETIC-BASIS; NGF RECEPTOR; NERVE-FIBERS; ENAMEL KNOT; CELLS; MOUSE	The expression of nicotinic acetylcholine receptor (nAChR) subtype, alpha7, was investigated in the developing teeth of mice that were modified through homologous recombination to express a bi-cistronic IRES-driven tau-enhanced green fluorescent protein (GFP); alpha7GFP) or IRES-Cre (alpha7Cre). The expression of alpha7GFP was detected first in cells of the condensing mesenchyme at embryonic (E) day E13.5 where it intensifies through E14.5. This expression ends abruptly at E15.5, but was again observed in ameloblasts of incisors at E16.5 or molar ameloblasts by E17.5-E18.5. This expression remains detectable until molar enamel deposition is completed or throughout life as in the constantly erupting mouse incisors. The expression of alpha7GFP also identifies all stages of innervation of the tooth organ. Ablation of the alpha7-cell lineage using a conditional alpha7Cre x ROSA26-LoxP(diphtheria toxin A) strategy substantially reduced the mesenchyme and this corresponded with excessive epithelium overgrowth consistent with an instructive role by these cells during ectoderm patterning. However, alpha7knock-out (KO) mice exhibited normal tooth size and shape indicating that under normal conditions alpha7 expression is dispensable to this process. The function of ameloblasts in alpha7KO mice is altered relative to controls. High resolution micro-computed tomography analysis of adult mandibular incisors revealed enamel volume of the alpha7KO was significantly reduced and the organization of enamel rods was altered relative to controls. These results demonstrate distinct and varied spatiotemporal expression of alpha7 during tooth development, and they suggest that dysfunction of this receptor would have diverse impacts upon the adult organ.	[Rogers, Scott W.; Gahring, Lorise C.] Vet Adm, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Gahring, Lorise C.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Vet Adm, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.	Scott.Rogers@hsc.utah.edu			National Institutes of Health [DA025057, AG017517, AG029838]; NATIONAL INSTITUTE ON AGING [R01AG017517, R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA025057, AG017517 and AG029838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arredondo J, 2003, LIFE SCI, V72, P2063, DOI 10.1016/S0024-3205(03)00084-5; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Atluri P, 2001, DEV BIOL, V240, P143, DOI 10.1006/dbio.2001.0453; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; BYERS MR, 1990, DEVELOPMENT, V109, P461; Chowdhury IG, 2000, ANAT RECORD, V258, P397; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; FRIED K, 1982, J NEUROL SCI, V53, P169, DOI 10.1016/0022-510X(82)90003-X; Fried K, 2000, CRIT REV ORAL BIOL M, V11, P318, DOI 10.1177/10454411000110030301; FRISTAD I, 1994, ARCH ORAL BIOL, V39, P633, DOI 10.1016/0003-9969(94)90089-2; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2003, J NEUROCHEM, V87, P1125, DOI 10.1046/j.1471-4159.2003.02074.x; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Jussila M, 2012, COLD SPRING HARB PER; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; KHAN MA, 1981, J BIOL BUCCALE, V9, P335; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Leamy LJ, 2005, HEREDITY, V94, P316, DOI 10.1038/sj.hdy.6800637; Li Q, 2011, CELL PHYSIOL BIOCHEM, V27, P605, DOI 10.1159/000329982; Li Y, 2008, J BIOL CHEM, V283, P15056, DOI 10.1074/jbc.M707992200; Loes S, 2002, ANAT EMBRYOL, V205, P187, DOI 10.1007/s00429-002-0247-8; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; Luukko K, 2005, DEV DYNAM, V234, P482, DOI 10.1002/dvdy.20586; Luukko K, 2008, ANN ANAT, V190, P178, DOI 10.1016/j.aanat.2007.10.003; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; MITSIADIS TA, 1992, DIFFERENTIATION, V49, P47, DOI 10.1111/j.1432-0436.1992.tb00768.x; Moe K, 2008, ARCH ORAL BIOL, V53, P865, DOI 10.1016/j.archoralbio.2008.03.004; MOHAMED SS, 1983, J ANAT, V136, P735; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; Picciotto MR, 2001, PHARMACOL THERAPEUT, V92, P89, DOI 10.1016/S0163-7258(01)00161-9; Rajchgot H, 2009, SCHIZOPHR RES, V110, P194, DOI 10.1016/j.schres.2009.02.014; ROBINSON RM, 1984, CALCIFIED TISSUE INT, V36, P31, DOI 10.1007/BF02405291; Rogers SW, 2012, AM J MED GE IN PRESS; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; SAAD AY, 1991, ACTA ANAT, V140, P269; Shore R C, 1995, Connect Tissue Res, V33, P151, DOI 10.3109/03008209509016995; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Thesleff I, 2003, QUINTESSENCE INT, V34, P613; Thesleff I, 2001, Adv Dent Res, V15, P14; Thesleff I, 1997, COLD SPRING HARB SYM, V62, P257; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; TSUZUKI H, 1991, ARCH ORAL BIOL, V36, P139, DOI 10.1016/0003-9969(91)90076-7; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tucker AS, 1999, J DENT RES, V78, P826, DOI 10.1177/00220345990780040201; Tulin S, 2010, BIRTH DEFECTS RES C, V90, P214, DOI 10.1002/bdrc.20182; Workman MS, 2002, GENETICS, V160, P1573; Xu MQ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-19; Xu W, 1999, J NEUROSCI, V19, P9298; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	59	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36467	10.1371/journal.pone.0036467	http://dx.doi.org/10.1371/journal.pone.0036467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666322	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400009
J	Wee, CY; Yap, PT; Denny, K; Browndyke, JN; Potter, GG; Welsh-Bohmer, KA; Wang, LH; Shen, DG				Wee, Chong-Yaw; Yap, Pew-Thian; Denny, Kevin; Browndyke, Jeffrey N.; Potter, Guy G.; Welsh-Bohmer, Kathleen A.; Wang, Lihong; Shen, Dinggang			Resting-State Multi-Spectrum Functional Connectivity Networks for Identification of MCI Patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; SEMANTIC MEMORY IMPAIRMENT; ALZHEIMERS-DISEASE; SMALL-WORLD; CEREBRAL-CORTEX; LOW-FREQUENCY; BRAIN; FMRI; PATTERNS	In this paper, a high-dimensional pattern classification framework, based on functional associations between brain regions during resting-state, is proposed to accurately identify MCI individuals from subjects who experience normal aging. The proposed technique employs multi-spectrum networks to characterize the complex yet subtle blood oxygenation level dependent (BOLD) signal changes caused by pathological attacks. The utilization of multi-spectrum networks in identifying MCI individuals is motivated by the inherent frequency-specific properties of BOLD spectrum. It is believed that frequency specific information extracted from different spectra may delineate the complex yet subtle variations of BOLD signals more effectively. In the proposed technique, regional mean time series of each region-of-interest (ROI) is band-pass filtered (0.025 <= f <= 0.100 Hz) before it is decomposed into five frequency sub-bands. Five connectivity networks are constructed, one from each frequency sub-band. Clustering coefficient of each ROI in relation to the other ROIs are extracted as features for classification. Classification accuracy was evaluated via leave-one-out cross-validation to ensure generalization of performance. The classification accuracy obtained by this approach is 86.5%, which is an increase of at least 18.9% from the conventional full-spectrum methods. A cross-validation estimation of the generalization performance shows an area of 0.863 under the receiver operating characteristic (ROC) curve, indicating good diagnostic power. It was also found that, based on the selected features, portions of the prefrontal cortex, orbitofrontal cortex, temporal lobe, and parietal lobe regions provided the most discriminant information for classification, in line with results reported in previous studies. Analysis on individual frequency sub-bands demonstrated that different sub-bands contribute differently to classification, providing extra evidence regarding frequency-specific distribution of BOLD signals. Our MCI classification framework, which allows accurate early detection of functional brain abnormalities, makes an important positive contribution to the treatment management of potential AD patients.	[Wee, Chong-Yaw; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, BRIC, IDEA Lab, Chapel Hill, NC 27515 USA; [Wee, Chong-Yaw; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Denny, Kevin; Browndyke, Jeffrey N.; Wang, Lihong] Duke Univ, Med Ctr, BIAC, Durham, NC USA; [Browndyke, Jeffrey N.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Browndyke, Jeffrey N.; Potter, Guy G.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Browndyke, Jeffrey N.] Duke Univ, Duke Inst Brain Sci, Durham, NC USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Duke University	Wee, CY (corresponding author), Univ N Carolina, BRIC, IDEA Lab, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020; Shen, Dinggang/ABF-6812-2020; Yap, Pew-Thian/G-3292-2012; Browndyke, Jeffrey/AAE-7292-2021	Shen, Dinggang/0000-0002-7934-5698; Browndyke, Jeffrey/0000-0002-8573-7073	United States National Institutes of Health [EB006733, EB008374, EB009634, MH088520, K23-AG028982]; National Alliance for Research in Schizophrenia and Depression Young Investigator Award from The Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB008374, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088520, K23MH087741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028982] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research in Schizophrenia and Depression Young Investigator Award from The Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by United States National Institutes of Health grants EB006733, EB008374, EB009634, MH088520, K23-AG028982, as well as a National Alliance for Research in Schizophrenia and Depression Young Investigator Award (LW) from The Brain and Behavior Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Bain LJ, 2008, ALZHEIMERS DEMENT, V4, P443, DOI 10.1016/j.jalz.2008.08.006; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879; Eckerstrom C, 2008, J NEUROL SCI, V272, P48, DOI 10.1016/j.jns.2008.04.024; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, BIOL PSYCHIAT, V63, P118, DOI 10.1016/j.biopsych.2007.03.015; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Machulda MM, 2009, J INT NEUROPSYCH SOC, V15, P372, DOI 10.1017/S1355617709090523; Machulda MM, 2003, NEUROLOGY, V61, P500, DOI 10.1212/01.WNL.0000079052.01016.78; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pihlajamiki M, 2008, FUTUR NEUROL, V3, P409, DOI 10.2217/14796708.3.4.409; Rakotomamonjy A., 2003, Journal of Machine Learning Research, V3, P1357, DOI 10.1162/153244303322753706; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Saykin AJ, 1999, J INT NEUROPSYCH SOC, V5, P377, DOI 10.1017/S135561779955501X; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Thompson PM, 2007, BRIT J RADIOL, V80, pS78, DOI 10.1259/BJR/20005470; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Zahn R, 2004, PSYCHIAT RES-NEUROIM, V132, P159, DOI 10.1016/j.psychresns.2004.07.006; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	73	97	107	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37828	10.1371/journal.pone.0037828	http://dx.doi.org/10.1371/journal.pone.0037828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666397	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400051
J	Turvey, ST; Risley, CL; Barrett, LA; Hao, YJ; Ding, W				Turvey, Samuel T.; Risley, Claire L.; Barrett, Leigh A.; Hao Yujiang; Ding, Wang			River Dolphins Can Act as Population Trend Indicators in Degraded Freshwater Systems	PLOS ONE			English	Article							YANGTZE FINLESS PORPOISE; TOP PREDATORS; EXTINCTION RISK; LIFE-HISTORY; SPECIES RICHNESS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; CHINA; FISHERIES	Conservation attention on charismatic large vertebrates such as dolphins is often supported by the suggestion that these species represent surrogates for wider biodiversity, or act as indicators of ecosystem health. However, their capacity to act as indicators of patterns or trends in regional biodiversity has rarely been tested. An extensive new dataset of >300 last-sighting records for the Yangtze River dolphin or baiji and two formerly economically important fishes, the Yangtze paddlefish and Reeves' shad, all of which are probably now extinct in the Yangtze, was collected during an interview survey of fishing communities across the middle-lower Yangtze drainage. Untransformed last-sighting date frequency distributions for these species show similar decline curves over time, and the linear gradients of transformed last-sighting date series are not significantly different from each other, demonstrating that these species experienced correlated population declines in both timing and rate of decline. Whereas species may be expected to respond differently at the population level even in highly degraded ecosystems, highly vulnerable (e.g. migratory) species can therefore display very similar responses to extrinsic threats, even if they represent otherwise very different taxonomic, biological and ecological groupings. Monitoring the status of river dolphins or other megafauna therefore has the potential to provide wider information on the status of other threatened components of sympatric freshwater biotas, and so represents a potentially important monitoring tool for conservation management. We also show that interview surveys can provide robust quantitative data on relative population dynamics of different species.	[Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Risley, Claire L.] Univ Liverpool, Neston, Cheshire, England; [Barrett, Leigh A.] Freshwater Dolphin CIC, Madrid, Spain; [Hao Yujiang; Ding, Wang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China	Zoological Society of London; University of Liverpool; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Turvey, ST (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	samuel.turvey@ioz.ac.uk			Marine Mammal Commission; Ocean Park Conservation Foundation Hong Kong; People's Trust for Endangered Species; Zoological Society of London's (ZSL's) EDGE of Existence programme; Natural Environment Research Council (NERC) Postdoctoral Fellowship; Royal Society University Research Fellowship	Marine Mammal Commission; Ocean Park Conservation Foundation Hong Kong; People's Trust for Endangered Species; Zoological Society of London's (ZSL's) EDGE of Existence programme; Natural Environment Research Council (NERC) Postdoctoral Fellowship; Royal Society University Research Fellowship(Royal Society of London)	Funding was provided by the Marine Mammal Commission, Ocean Park Conservation Foundation Hong Kong, People's Trust for Endangered Species, Zoological Society of London's (ZSL's) EDGE of Existence programme, a Natural Environment Research Council (NERC) Postdoctoral Fellowship, and a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Bilton DT, 2006, FRESHWATER BIOL, V51, P578, DOI 10.1111/j.1365-2427.2006.01505.x; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Cabeza M, 2008, J APPL ECOL, V45, P976, DOI 10.1111/j.1365-2664.2007.01364.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Chen DQ, 2009, ENVIRON BIOL FISH, V85, P337, DOI 10.1007/s10641-009-9517-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Dudgeon D, 2000, HYDROBIOLOGIA, V418, P1, DOI 10.1023/A:1003998519910; Dudgeon D, 2010, AQUAT CONSERV, V20, P127, DOI 10.1002/aqc.1098; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Entwistle A, 2000, PRIORITIES CONSERVAT; Fang J, 2006, FRONT ECOL ENVIRON, V4, P369, DOI 10.1890/1540-9295(2006)004[0369:BCITLO]2.0.CO;2; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Huang H, 1982, FRESHWATER FISHES CH, V1; Ichthyological Department of the Institute of Hydrobiology, 1976, FISH YANGTZ RIV; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; IUCN, 2019, IUCN RED LIST THREAT; Jager HI, 2008, HYDROBIOLOGIA, V602, P15, DOI 10.1007/s10750-008-9287-2; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Kelkar N, 2010, CONSERV BIOL, V24, P1130, DOI 10.1111/j.1523-1739.2010.01467.x; Liao Fu-chu, 2002, Acta Hydrobiologica Sinica, V26, P623; Lindenmayer DB, 2000, CONSERV BIOL, V14, P941, DOI 10.1046/j.1523-1739.2000.98533.x; Linnell JDC, 2000, BIODIVERS CONSERV, V9, P857, DOI 10.1023/A:1008969104618; LIU CH, 1988, COPEIA, P482, DOI 10.2307/1445891; Liu Shao-ping, 2002, Acta Hydrobiologica Sinica, V26, P679; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Owen-Smith N., 1988, MEGAHERBIVORES INFLU; Ping C., 1931, Contributions from the Biological Laboratory of the Science Society of China Nanking, V7, P173; Pratt Antwerp E., 1892, SNOWS TIBET CHINA; Qiu Shunlin, 1998, Freshwater Fisheries, V28, P18; QIU SL, 1989, ACTA ZOOL SINICA, V35, P300; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Read BE, 1939, COMMON FOOD FISHES S; Reeves Randall R., 2000, Occasional Papers of the IUCN Species Survival Commission, V23, P67; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Sergio F, 2008, J APPL ECOL, V45, P992, DOI 10.1111/j.1365-2664.2008.01484.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Wang H, 1997, SHAD J, V2, P4; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Xie P, 2003, SCIENCE, V302, P1149; Zhang X, 2003, AQUAT CONSERV, V13, P51, DOI 10.1002/aqc.547; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zheng JS, 2005, BIOCHEM GENET, V43, P307, DOI 10.1007/s10528-005-5222-7; Zhong YG, 1997, CAN J FISH AQUAT SCI, V54, P224, DOI 10.1139/cjfas-54-1-224; ZHOU K, 1977, Acta Zoologica Sinica, V23, P72; ZHOU K, 2002, ENCY MARINE MAMMALS, P58; Zhou K., 1991, BAIJI YANGTZE RIVER	60	26	26	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37902	10.1371/journal.pone.0037902	http://dx.doi.org/10.1371/journal.pone.0037902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666410	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600039
J	Esselens, C; Sannerud, R; Gallardo, R; Baert, V; Kaden, D; Serneels, L; De Strooper, B; Rousseau, F; Multhaup, G; Schymkowitz, J; Langedijk, JPM; Annaert, W				Esselens, Cary; Sannerud, Ragna; Gallardo, Rodrigo; Baert, Veerle; Kaden, Daniela; Serneels, Lutgarde; De Strooper, Bart; Rousseau, Frederic; Multhaup, Gerd; Schymkowitz, Joost; Langedijk, Johannes P. M.; Annaert, Wim			Peptides based on the presenilin-APP binding domain inhibit APP processing and A beta production through interfering with the APP transmembrane domain	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid precursor protein; Notch-sparing; viral translocation peptide	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE INHIBITORS; CELL-PENETRATING PEPTIDES; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; HIPPOCAMPAL-NEURONS; IN-VITRO; DELIVERY; MUTATIONS	Presenilins (PSENs) form the catalytic component of the gamma-secretase complex, responsible for intramembrane proteolysis of amyloid precursor protein (APP) and Notch, among many other membrane proteins. Previously, we identified a PSEN1-binding domain in APP, encompassing half of the transmembrane domain following the amyloid beta (A beta) sequence. Based on this, we designed peptides mimicking this interaction domain with the aim to selectively block APP processing and A beta generation through interfering with enzyme-substrate binding. We identified a peptide sequence that, when fused to a virally derived translocation peptide, significantly lowered A beta production (IC50: 317 nM) in cell-free and cell-based assays using APP-carboxy terminal fragment as a direct gamma-secretase substrate. Being derived from the APP sequence, this inhibitory peptide did not affect Notch Delta E gamma-cleavage, illustrating specificity and potential therapeutic value. In cell-based assays, the peptide strongly suppressed APP shedding, demonstrating that it exerts the inhibitory effect already upstream of gamma-secretase, most likely through steric hindrance.-Esselens, C., Sannerud, R., Gallardo, R., Baert, V., Kaden, D., Serneels, L., De Strooper, B., Rousseau, F., Multhaup, G., Schymkowitz, J., Langedijk, J. P. M., Annaert, W. Peptides based on the presenilin-APP binding domain inhibit APP processing and A beta production through interfering with the APP transmembrane domain. FASEB J. 26, 3765-3778 (2012). www.fasebj.org	[Serneels, Lutgarde; De Strooper, Bart] Katholieke Univ Leuven, Lab Res Neurodegenerat Dis, Ctr Human Genet, Louvain, Belgium; [Gallardo, Rodrigo; Rousseau, Frederic; Schymkowitz, Joost] Katholieke Univ Leuven, Dept Mol Med, Louvain, Belgium; [Esselens, Cary; Sannerud, Ragna; Baert, Veerle; Serneels, Lutgarde; De Strooper, Bart; Annaert, Wim] Katholieke Univ Leuven VIB, Ctr Biol Dis, Louvain, Belgium; [Gallardo, Rodrigo; Rousseau, Frederic; Schymkowitz, Joost] VIB Switch Lab, Louvain, Belgium; [Kaden, Daniela; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Langedijk, Johannes P. M.] Pepscan Therapeut, Lelystad, Netherlands; [Esselens, Cary; Sannerud, Ragna; Baert, Veerle; Annaert, Wim] Katholieke Univ Leuven, Lab Membrane Trafficking, Louvain, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Free University of Berlin; McGill University; KU Leuven	Annaert, W (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Lab Membrane Trafficking, O& N4,Rm 7-159, B-3000 Louvain, Belgium.	wim.annaert@cme.vib-kuleuven.be	Rousseau, Frederic/J-9044-2016; Sannerud, Ragna/AAA-6497-2021; Schymkowitz, Joost/AAV-3680-2021; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; De Strooper, Bart/0000-0001-5455-5819; Sannerud, Ragna/0000-0002-6694-3154; Schymkowitz, Joost/0000-0003-2020-0168; Esselens, Cary/0000-0001-8876-634X; Gallardo, Rodrigo/0000-0003-1584-3564; Serneels, Lutgarde/0000-0002-5463-4231	Vlaams Instituut voor Biotechnologie (VIB); Katholieke Universiteit Leuven (KU Leuven-Methusalem); Fonds voor Wetenschappelijk Onderzoek [FWO G.0663.09, G.0.754.10.N]; Stichting Alzheimer Onderzoek (SAO-FRMA/cycle); federal government IAP P7; Alzheimer Association [IIRG-08-91535]; federal government (Belspo)	Vlaams Instituut voor Biotechnologie (VIB); Katholieke Universiteit Leuven (KU Leuven-Methusalem); Fonds voor Wetenschappelijk Onderzoek(FWO); Stichting Alzheimer Onderzoek (SAO-FRMA/cycle); federal government IAP P7; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); federal government (Belspo)	The work presented here was supported by the Vlaams Instituut voor Biotechnologie (VIB); Katholieke Universiteit Leuven (KU Leuven-Methusalem to B. D. S.); Fonds voor Wetenschappelijk Onderzoek (FWO G.0663.09 and G.0.754.10.N); Stichting Alzheimer Onderzoek (SAO-FRMA/cycle 2010); federal government IAP P7 (2012-2017); and Alzheimer Association (IIRG-08-91535). C. E. is holder of a return fellowship from the federal government (Belspo). The authors thank S. Munck for help with PiMP analysis.	Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200; Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Annaert W, 2010, CELL, V141, P1112, DOI 10.1016/j.cell.2010.06.009; Aubele DL, 2011, BIOORG MED CHEM LETT, V21, P5791, DOI 10.1016/j.bmcl.2011.08.008; Auffret A, 2010, REV NEUROSCIENCE, V21, P239; Bakshi P, 2004, J MED CHEM, V47, P6485, DOI 10.1021/jm049566e; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bihel F, 2004, J MED CHEM, V47, P3931, DOI 10.1021/jm049788c; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Chen L, 2007, BIOCHEM SOC T, V35, P821, DOI 10.1042/BST0350821; Churcher I, 2003, BIOORG MED CHEM LETT, V13, P179, DOI 10.1016/S0960-894X(02)00909-5; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Dietz Gunnar P. H., 2007, V399, P181, DOI 10.1007/978-1-59745-504-6_13; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; FIELDS C G, 1991, Peptide Research, V4, P95; GREENBERG R, 1976, PHARMACOL BIOCHEM BE, V5, P151, DOI 10.1016/0091-3057(76)90345-2; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Huber O, 1999, J CELL SCI, V112, P4415; Kilic U, 2004, ACTA NEUROPATHOL, V108, P65, DOI 10.1007/s00401-004-0867-6; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Langedijk JPM, 2004, MOL DIVERS, V8, P101, DOI 10.1023/B:MODI.0000025653.26130.ce; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lichtenthaler SF, 2002, P NATL ACAD SCI USA, V99, P1365, DOI 10.1073/pnas.032395699; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Munck S, 2012, J CELL SCI, V125, P2257, DOI 10.1242/jcs.098939; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Panza F, 2010, CNS NEUROSCI THER, V16, P272, DOI 10.1111/j.1755-5949.2010.00164.x; PEREZ F, 1992, J CELL SCI, V102, P717; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rait A, 2000, BIOCONJUGATE CHEM, V11, P153, DOI 10.1021/bc990106n; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rao KS, 2008, BIOMATERIALS, V29, P4429, DOI 10.1016/j.biomaterials.2008.08.004; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Samson K, 2010, ANN NEUROL, V68, pA11, DOI 10.1002/ana.22249; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Schulz J. G., 2003, J BIOL CHEM, V26, P26; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Song BW, 2002, J PHARMACOL EXP THER, V301, P605, DOI 10.1124/jpet.301.2.605; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vaslin A, 2011, J NEUROCHEM, V119, P1243, DOI 10.1111/j.1471-4159.2011.07535.x; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	68	10	10	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3765	3778		10.1096/fj.11-201368	http://dx.doi.org/10.1096/fj.11-201368			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22661005				2022-12-25	WOS:000308391600017
J	Hanaoka, M; Takai, N; Hosokawa, N; Fujiwara, M; Akimoto, Y; Kobori, N; Iwasaki, H; Kondo, T; Tanaka, K				Hanaoka, Mitsumasa; Takai, Naoki; Hosokawa, Norimune; Fujiwara, Masayuki; Akimoto, Yuki; Kobori, Nami; Iwasaki, Hideo; Kondo, Takao; Tanaka, Kan			RpaB, Another Response Regulator Operating Circadian Clock-dependent Transcriptional Regulation in Synechococcus elongatus PCC 7942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAIC PHOSPHORYLATION; GENE-EXPRESSION; HIGH-LIGHT; ACETYL PHOSPHATE; PROTEIN; FEEDBACK; RHYTHMS; SASA; OSCILLATION; UPSTREAM	The circadian clock of cyanobacteria is composed of KaiA, KaiB, and KaiC proteins, and the SasA-RpaA two-component system has been implicated in the regulation of one of the output pathways of the clock. In this study, we show that another response regulator that is essential for viability, the RpaA paralog, RpaB, plays a central role in the transcriptional oscillation of clock-regulated genes. In vivo and in vitro analyses revealed that RpaB and not RpaA could specifically bind to the kaiBC promoter, possibly repressing transcription during subjective night. This suggested that binding may be terminated by RpaA to activate gene transcription during subjective day. Moreover, we found that rpoD6 and sigF2, which encode group-2 and group-3 sigma factors forRNApolymerase, respectively, were also targets of the RpaAB system, suggesting that a specific group of sigma factors can propagate genome-wide transcriptional oscillation. Our findings thus reveal a novel mechanism for a circadian output pathway that is mediated by two paralogous response regulators.	[Hanaoka, Mitsumasa; Akimoto, Yuki; Kobori, Nami; Tanaka, Kan] Chiba Univ, Div Appl Biol Chem, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Fujiwara, Masayuki] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Matsudo, Chiba 2718510, Japan; [Hanaoka, Mitsumasa; Akimoto, Yuki; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Mol Genet Lab, Bunkyo Ku, Tokyo 1130032, Japan; [Hanaoka, Mitsumasa; Takai, Naoki; Kondo, Takao; Tanaka, Kan] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Takai, Naoki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hosokawa, Norimune; Iwasaki, Hideo] Waseda Univ, Dept Elect Engn & Biol Sci, Tokyo, Japan; [Hosokawa, Norimune; Iwasaki, Hideo] Waseda Univ, Ctr Adv Biomed Sci TWIns, Tokyo, Japan; [Iwasaki, Hideo] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Shinjuku Ku, Tokyo 1628480, Japan; [Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Div Bioresources, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Chiba University; Chiba University; University of Tokyo; Japan Science & Technology Agency (JST); Nagoya University; Waseda University; Waseda University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Hanaoka, M (corresponding author), Chiba Univ, Div Appl Biol Chem, Grad Sch Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.	mhanaoka@faculty.chiba-u.jp	Tanaka, Kan/E-3724-2015; Hanaoka, Mitsumasa/M-9904-2015	Tanaka, Kan/0000-0001-7560-7884; Iwasaki, Hideo/0000-0002-3754-4955	Special Coordination Fund for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16GS0304]; Japan Society for the Promotion of Science [21370015, 21770034, 20370072, 22657043, 21010517]; COE (Center of Excellence) StartUp Program of Chiba University; Waseda University [2010A-503]; Asahi Glass Foundation; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Grants-in-Aid for Scientific Research [24117505, 23770039] Funding Source: KAKEN	Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); COE (Center of Excellence) StartUp Program of Chiba University; Waseda University; Asahi Glass Foundation; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Special Coordination Fund for Promoting Science and Technology (to M. H.) and Grant-in-aid 16GS0304 for Creative Scientific Research (to K. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by Grants-in-aid from the Japan Society for the Promotion of Science 21370015 (to K. T.), 21770034 (to M. H.), 20370072, 22657043, and 21010517 (to H. I.), by the COE (Center of Excellence) StartUp Program of Chiba University (to K. T.), by Waseda University Grant 2010A-503 for Special Research Projects (to H. I.), by the Asahi Glass Foundation (to H. I.), and by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" (to M. H. and K. T.).	Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Golden SS, 2003, CURR OPIN MICROBIOL, V6, P535, DOI 10.1016/j.mib.2003.10.012; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kutsuna S, 2005, MOL MICROBIOL, V57, P1474, DOI 10.1111/j.1365-2958.2005.04781.x; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishimura H, 2002, MICROBIOL-SGM, V148, P2903, DOI 10.1099/00221287-148-9-2903; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Seki A, 2007, J BIOL CHEM, V282, P36887, DOI 10.1074/jbc.M707582200; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	45	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26321	26327		10.1074/jbc.M111.338251	http://dx.doi.org/10.1074/jbc.M111.338251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665493	hybrid, Green Published			2022-12-25	WOS:000306916300058
J	Qian, H; Le Blanc, K; Sigvardsson, M				Qian, Hong; Le Blanc, Katarina; Sigvardsson, Mikael			Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL CELLS; DIFFERENTIATION; FIBRONECTIN; TRAFFICKING; MIGRATION; ADHESION; MARKERS	Despite significant progress in our understanding of mesenchymal stem cell (MSC) biology during recent years, much of the information is based on experiments using in vitro culture-selected stromal progenitor cells. Therefore, the natural cellular identity of MSCs remains poorly defined. Numerous studies have reported that CD44 expression is one of the characteristics of MSCs in both humans and mice; however, we here have prospectively isolated bone marrow stromal cell subsets from both human and mouse bone marrow by flow cytometry and characterized them by gene expression analysis and function assays. Our data provide functional and molecular evidence suggesting that primary mesenchymal stem and progenitor cells of bone marrow reside in the CD44(-) cell fraction in both mice and humans. The finding that these CD44(-) cells acquire CD44 expression after in vitro culture provides an explanation for the previous misconceptions concerning CD44 expression on MSCs. In addition, the other previous reported MSC markers, including CD73, CD146, CD271, and CD106/VCAM1, are also differentially expressed on those two cell types. Our microarray data revealed a distinct gene expression profile of the freshly isolated CD44(-) cells and the cultured MSCs generated from these cells. Thus, we conclude that bone marrow MSCs physiologically lack expression of CD44, highlighting the natural phenotype of MSCs and opening new possibilities to prospectively isolate MSCs from the bone marrow.	[Qian, Hong] Karolinska Univ, Huddinge Hosp, HERM, Ctr Hematol & Regenerat Med,Dept Med, S-14186 Stockholm, Sweden; [Qian, Hong; Sigvardsson, Mikael] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Linkoping University	Qian, H (corresponding author), Karolinska Univ, Huddinge Hosp, HERM, Ctr Hematol & Regenerat Med,Dept Med, Novum Floor 4,Halsovagen 7, S-14186 Stockholm, Sweden.	hong.qian@ki.se	Qian, Hong/D-5588-2014; Le Blanc, Katarina/L-4631-2019	Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Foundation; Faculty of Medicine at Linkoping University	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Faculty of Medicine at Linkoping University	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Childhood Cancer Foundation, and the Faculty of Medicine at Linkoping University.	Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Battula V. L., 2010, ASH ANN M, V116, P3845; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dai LJ, 2011, CANCER LETT, V305, P8, DOI 10.1016/j.canlet.2011.02.012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eslaminejad MB, 2007, DEV GROWTH DIFFER, V49, P351, DOI 10.1111/j.1440-169x.2007.00932.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gee K, 2004, ARCH IMMUNOL THER EX, V52, P13; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Lin HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-56; Lu FZ, 2005, J LAB CLIN MED, V146, P271, DOI 10.1016/j.lab.2005.07.003; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; Mareddy S, 2010, TISSUE ENG PT A, V16, P749, DOI [10.1089/ten.tea.2009.0307, 10.1089/ten.TEA.2009.0307]; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Poulsom R, 2007, KIDNEY INT, V72, P389, DOI 10.1038/sj.ki.5002398; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Sogo Y, 2007, BIOMED MATER, V2, P116, DOI 10.1088/1748-6041/2/2/009; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Tanabe S, 2008, J BIOCHEM, V144, P399, DOI 10.1093/jb/mvn082; Thankamony SP, 2011, P NATL ACAD SCI USA, V108, P2258, DOI 10.1073/pnas.1018064108; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	51	103	108	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25795	25807		10.1074/jbc.M112.339622	http://dx.doi.org/10.1074/jbc.M112.339622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654106	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000306916300010
J	Zhang, XJ; Gao, XZ; Yao, W; Cote, RH				Zhang, Xiu-Jun; Gao, Xiong-Zhuo; Yao, Wei; Cote, Rick H.			Functional Mapping of Interacting Regions of the Photoreceptor Phosphodiesterase (PDE6) gamma-Subunit with PDE6 Catalytic Dimer, Transducin, and Regulator of G-protein Signaling9-1 (RGS9-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; CGMP BINDING-SITES; ROD OUTER SEGMENTS; ALPHA-SUBUNIT; RETINITIS-PIGMENTOSA; TERMINAL REGION; GAF DOMAINS; GTPASE; ENZYME; AFFINITY	The cGMP phosphodiesterase (PDE6) involved in visual transduction in photoreceptor cells contains two inhibitory gamma-subunits (P gamma) which bind to the catalytic core (P alpha beta) to inhibit catalysis and stimulate cGMP binding to the GAF domains of P alpha beta. During visual excitation, interaction of activated transducin with P gamma relieves inhibition. P gamma also participates in a complex with RGS9-1 and other proteins to accelerate the GTPase activity of activated transducin. We studied the structural determinants for these important functions of P gamma. First, we identified two important sites in the middle region of P gamma (amino acids 27-38 and 52-54) that significantly stabilize the overall binding affinity of P gamma with P alpha beta. The ability of P gamma to stimulate noncatalytic cGMP binding to the GAF domains of PDE6 has been localized to amino acids 27-30 of P gamma. Transducin activation of PDE6 catalysis critically depends on the presence of Ile54 in the glycine-rich region of P gamma in order to relieve inhibition of catalysis. The central glycine-rich region of P gamma is also required for transducin to increase cGMP exchange at the GAF domains. Finally, Thr-65 and/or Val-66 of P gamma are critical residues for P gamma to stimulate GTPase activity of transducin in a complex with RGS9-1. We propose that the glycine-rich region of P gamma is a primary docking site for PDE6-interacting proteins involved in the activation/inactivation pathways of visual transduction. This functional mapping of P gamma with its binding partners demonstrates the remarkable versatility of this multifunctional protein and its central role in regulating the activation and lifetime of visual transduction.	[Zhang, Xiu-Jun; Gao, Xiong-Zhuo; Yao, Wei; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2479.	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARSHAVSKY VY, 1994, J BIOL CHEM, V269, P19882; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DETERRE P, 1986, Proteins Structure Function and Genetics, V1, P188, DOI 10.1002/prot.340010210; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2011, J BIOL CHEM, V286, P15260, DOI 10.1074/jbc.M110.210567; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Matte SL, 2012, J BIOL CHEM, V287, P20111, DOI 10.1074/jbc.M112.354647; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Pentia Dana C., 2005, V307, P125; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel Theodore G., 2005, V307, P289; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406; Zhang ZM, 2010, BIOCHEMISTRY-US, V49, P3862, DOI 10.1021/bi100354a	57	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26312	26320		10.1074/jbc.M112.377333	http://dx.doi.org/10.1074/jbc.M112.377333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665478	Green Published, hybrid			2022-12-25	WOS:000306916300057
J	Kaul, V; Van Kaer, L; Das, G; Das, J				Kaul, Vandana; Van Kaer, Luc; Das, Gobardhan; Das, Jyoti			Prostanoid Receptor 2 Signaling Protects T Helper 2 Cells from BALB/c Mice against Activation-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LEISHMANIA-MAJOR; AUTOIMMUNE-DISEASE; RESPONSES; TH1; DIFFERENTIATION; ANTIGEN; POLARIZATION; PHARMACOLOGY; INFLAMMATION	T helper 2 (Th2) cells play a central role in the progression of many diseases such as allergic airway inflammation, autoimmune diseases, and infections caused by intracellular pathogens. Consequently, animals such as BALB/c mice, which exhibit a propensity for generating Th2 responses, are susceptible to allergic airway inflammation, type-II autoimmune diseases, and various infections induced by intracellular pathogens, namely, Leishmania. In contrast, C3H/OuJ mice have a tendency for generating T helper 1 (Th1) responses and show resistance to these diseases. Here, we show that prostaglandin endoperoxide E-2 selectively inhibits activation-induced cell death of Th2 cells by signaling through its receptor E-prostanoid receptor 2 (EP2). Consequently, Th2 cells derived from BALB/c mice expressed very high levels of EP2. On the other hand, Th2 cells derived from C3H/OuJ mice expressed very low levels of EP2, which failed to support the survival of Th2 cells. Furthermore, we found that this effect of EP2 on Th2 cells from BALB/c mice was executed by a granzyme B-mediated mechanism. EP2 belongs to a group of G-protein-coupled receptors that are amenable to therapeutic targeting. Our findings therefore identify EP2 as a promising target for small molecule-directed immunomodulation.	[Das, Jyoti] Natl Inst Malaria Res, Div Immunol, New Delhi 110077, India; [Kaul, Vandana; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Van Kaer, Luc] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, J (corresponding author), Natl Inst Malaria Res, Div Immunol, Sect 8, New Delhi 110077, India.	jyoti@mrcindia.org	kaul, vandana/C-9788-2018; Van Kaer, Luc/H-1033-2015	kaul, vandana/0000-0002-1841-5584; Van Kaer, Luc/0000-0001-5275-2309	Wellcome Trust International senior fellowship; Ramaligaswami fellowship(Government of India); Department of Biotechnology, Government of India	Wellcome Trust International senior fellowship(Wellcome Trust); Ramaligaswami fellowship(Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a Wellcome Trust International senior fellowship, a Ramaligaswami fellowship(Government of India), and a grant from the Department of Biotechnology, Government of India.	Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; Biedermann T, 2004, J INVEST DERM SYMP P, V9, P5, DOI 10.1111/j.1087-0024.2004.00829.x; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; GOETZL EJ, 1995, J IMMUNOL, V154, P1041; GORCZYNSKI RM, 1982, DEV COMP IMMUNOL, V6, P199, DOI 10.1016/S0145-305X(82)80003-7; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Launois P, 1999, MICROBES INFECT, V1, P59, DOI 10.1016/S1286-4579(99)80015-X; Mazzarella G, 2000, ALLERGY, V55, P6, DOI 10.1034/j.1398-9995.2000.00511.x; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; SCOTT P, 1991, J IMMUNOL, V147, P3149; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Wangoo A, 2001, J IMMUNOL, V166, P3432, DOI 10.4049/jimmunol.166.5.3432; Wilson RJ, 2004, EUR J PHARMACOL, V501, P49, DOI 10.1016/j.ejphar.2004.08.025	27	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25434	25439		10.1074/jbc.C111.324707	http://dx.doi.org/10.1074/jbc.C111.324707			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654101	hybrid, Green Published			2022-12-25	WOS:000306651700050
J	Francescone, R; Scully, S; Bentley, B; Yan, W; Taylor, SL; Oh, D; Moral, L; Shao, R				Francescone, Ralph; Scully, Steve; Bentley, Brooke; Yan, Wei; Taylor, Sherry L.; Oh, Dennis; Moral, Luis; Shao, Rong			Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEVACIZUMAB PLUS IRINOTECAN; VASCULAR CHANNEL FORMATION; RECEPTOR TYROSINE KINASE; STEM-LIKE CELLS; THERAPEUTIC IMPLICATIONS; RECURRENT GLIOBLASTOMA; ENDOTHELIAL-CELLS; MALIGNANT GLIOMAS; BREAST-CANCER; LUNG-CANCER	Glioblastoma (GBM) is extremely aggressive and essentially incurable. Its malignancy is characterized by vigorous microvascular proliferations. Recent evidence has shown that tumor cells display the ability to drive blood-perfused vasculogenic mimicry (VM), an alternative microvascular circulation independent of endothelial cell angiogenesis. However, molecular mechanisms underlying this vascular pathogenesis are poorly understood. Here, we found that vascular channels of VM in GBM were composed of mural-like tumor cells that strongly express VEGF receptor 2 (Flk-1). To explore a potential role of Flk-1 in the vasculogenesis, we investigated two glioblastoma cell lines U87 and GSDC, both of which express Flk-1 and exhibit a vascular phenotype on Matrigel. Treatment of both cell lines with either Flk-1 gene knockdown or Flk-1 kinase inhibitor SU1498 abrogated Flk-1 activity and impaired vascular function. Furthermore, inhibition of Flk-1 activity suppressed intracellular signaling cascades, including focal adhesion kinase and mitogen-activated protein kinase ERK1/2. In contrast, blockade of VEGF activity by the neutralizing antibody Bevacizumab failed to recapitulate the impact of SU1498, suggesting that Flk-1-mediated VM is independent of VEGF. Xenotransplantation of SCID/Beige mice with U87 cells and GSDCs gave rise to tumors harboring robust mural cell-associated vascular channels. Flk-1 shRNA restrained VM in tumors and subsequently inhibited tumor development. Collectively, all the data demonstrate a central role of Flk-1 in the formation of VM in GBM. This study has shed light on molecular mechanisms mediating tumor aggressiveness and also provided a therapeutic target for patient treatment.	[Francescone, Ralph; Scully, Steve; Shao, Rong] Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA; [Bentley, Brooke; Yan, Wei; Shao, Rong] Pioneer Valley Life Sci Inst, Springfield, MA 01199 USA; [Taylor, Sherry L.; Oh, Dennis] Tufts Univ, Dept Neurosurg, Baystate Med Ctr, Springfield, MA 01199 USA; [Moral, Luis] Tufts Univ, Dept Pathol, Baystate Med Ctr, Springfield, MA 01199 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA.	rong.shao@bhs.org		Francescone, Ralph/0000-0002-3149-6825	National Institutes of Health from NCI [R01 CA120659]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA120659 from NCI (to R. S.).	Basu GD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1626; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Chen YS, 2012, MED ONCOL, V29, P324, DOI 10.1007/s12032-010-9765-z; di Tomaso E, 2005, CANCER RES, V65, P5740, DOI 10.1158/0008-5472.CAN-04-4552; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Francescone R.A., 2011, JOVE-J VIS EXP, V55, P3040; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kozin SV, 2001, CANCER RES, V61, P39; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu C, 2002, CANCER RES, V62, P5470; Liu XM, 2011, J NEURO-ONCOL, V105, P173, DOI 10.1007/s11060-011-0578-5; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Manegold C, 2008, EXPERT REV ANTICANC, V8, P689, DOI 10.1586/14737140.8.5.689; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nghiemphu PL, 2009, NEUROLOGY, V72, P1217, DOI 10.1212/01.wnl.0000345668.03039.90; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Ping YF, 2011, STEM CELLS, V29, P888, DOI 10.1002/stem.650; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sood AK, 2002, CANCER BIOL THER, V1, P661, DOI 10.4161/cbt.316; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Timke C, 2008, CLIN CANCER RES, V14, P2210, DOI 10.1158/1078-0432.CCR-07-1893; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005	61	107	109	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24821	24831		10.1074/jbc.M111.334540	http://dx.doi.org/10.1074/jbc.M111.334540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654102	Green Published, hybrid			2022-12-25	WOS:000306651100075
J	Kanamarlapudi, V; Owens, SE; Lartey, J; Bernal, AL				Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Lartey, Jon; Bernal, Andres Lopez			ADP-Ribosylation Factor 6 Expression and Activation Are Reduced in Myometrium in Complicated Pregnancies	PLOS ONE			English	Article							LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPASE-D; SMOOTH-MUSCLE; NUCLEOTIDE EXCHANGE; MYOSIN PHOSPHATASE; RAT MYOMETRIUM; GROWTH-FACTOR; ARF6; MEMBRANE	Background: ARF6 (ADP-ribosylation factor 6) small GTP binding protein plays critical roles in actin cytoskeleton rearrangements and membrane trafficking, including internalisation of G protein coupled receptors (GPCR). ARF6 operates by cycling between GDP-bound (inactive) and GTP-bound (active) forms and is a potential regulator of GPCR-mediated uterine activity during pregnancy and labour. ARF6 contains very low intrinsic GTP binding activity and depends on GEFs (guanine nucleotide exchange factors) such as CYTH3 (cytohesin 3) to bind GTP. ARF6 and CYTH3 were originally cloned from human placenta, but there is no information on their expression in other reproductive tissues. Methods: The expression of ARF6, ARF1, and CYTH1-4 was investigated by measuring mRNA (using RT-PCR) and protein levels (using immunoblotting) in samples of myometrium obtained from non-pregnant women, and women with normal pregnancies, before or after the spontaneous onset of labour. We also analysed myometrial samples from women with spontaneous preterm labour and from women with complicated pregnancies requiring emergency preterm delivery. The GST)-effector pull down assay was used to study the presence of active ARF6 and ARF1 in all myometrial extracts. Results: ARF6, ARF1 and CYTH3 but not CYTH1, CYTH2 and CYTH4 were expressed in all samples and the levels did not change with pregnancy or labour. However, ARF6 and CYTH3 but not ARF1 levels were significantly reduced in complicated pregnancies. The alterations in the expression of ARF6 and its GEF in human myometrium indicate a potential involvement of this signalling system in modulating the response of myometrial smooth muscle in complicated pregnancies. The levels of ARF6-GTP or ARF1-GTP did not change with pregnancy or labour but ARF6-GTP levels were significantly decreased in women with severe complications of pregnancy. Conclusions: We have demonstrated a functional ARF6 system in human myometrium and a correlation between ARF6 level and activity in uterine and abnormal pregnancy.	[Kanamarlapudi, Venkateswarlu; Owens, Sian E.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Lartey, Jon; Bernal, Andres Lopez] Univ Bristol, Sch Clin Sci, Div Obstet & Gynaecol, Bristol, Avon, England	Swansea University; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk; A.LopezBernal@bristol.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483; Owens, Sian-Eleri/0000-0003-1806-5235	Wellbeing of Women Research Training Fellowship; MRC [G0401232] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL2-Lartey] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; National Institute for Health Research [CL-2012-01-501] Funding Source: researchfish	Wellbeing of Women Research Training Fellowship(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JL was supported by a Wellbeing of Women Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal AL, 2007, SEMIN CELL DEV BIOL, V18, P340, DOI 10.1016/j.semcdb.2007.05.002; Bernal AL, 2003, BJOG-INT J OBSTET GY, V110, P39, DOI 10.1016/S1470-0328(03)00023-5; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BREUILLER M, 1990, J CLIN ENDOCR METAB, V70, P1299, DOI 10.1210/jcem-70-5-1299; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; CREASY RK, 1991, NEW ENGL J MED, V325, P727, DOI 10.1056/NEJM199109053251009; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; HA KS, 1994, BIOCHEM J, V303, P55, DOI 10.1042/bj3030055; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hiroyama M, 2005, J CELL BIOCHEM, V95, P149, DOI 10.1002/jcb.20351; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; IKEBE M, 1987, J BIOL CHEM, V262, P9569; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kanamarlapudi V, 2012, J BIOL CHEM, VM112; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Lartey J, 2007, BIOL REPROD, V76, P971, DOI 10.1095/biolreprod.106.058982; Lartey J, 2006, BIOL REPROD, V75, P452, DOI 10.1095/biolreprod.105.049130; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Le Stunff H, 2000, BIOCHEM J, V352, P491, DOI 10.1042/0264-6021:3520491; Lee YN, 2000, BIOCHEMISTRY-US, V39, P4863, DOI 10.1021/bi992272o; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Miko E, 2009, J REPROD IMMUNOL, V80, P100, DOI 10.1016/j.jri.2009.01.003; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Morrison JJ, 1997, BRIT J OBSTET GYNAEC, V104, P1341, DOI 10.1111/j.1471-0528.1997.tb11002.x; Mukherjee S, 2001, J BIOL CHEM, V276, P6524, DOI 10.1074/jbc.C000725200; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nonaka Y, 2002, TISSUE ANTIGENS, V60, P319, DOI 10.1034/j.1399-0039.2002.600406.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strakova Z, 1997, AM J PHYSIOL-ENDOC M, V272, pE870, DOI 10.1152/ajpendo.1997.272.5.E870; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Yuan W, BMC RES NOTES, V3, P119; Yuan Wei, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS10, DOI 10.1186/1471-2393-7-S1-S10	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37954	10.1371/journal.pone.0037954	http://dx.doi.org/10.1371/journal.pone.0037954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666423	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400062
J	Ma, WB; McKeller, MR; Rangel, R; Ortiz-Quintero, B; Blackburn, MR; Martinez-Valdez, H				Ma, Wenbin; McKeller, Morgan R.; Rangel, Roberto; Ortiz-Quintero, Blanca; Blackburn, Michael R.; Martinez-Valdez, Hector			Spare PRELI Gene Loci: Failsafe Chromosome Insurance?	PLOS ONE			English	Article							LEA PROTEINS; CELL-DEATH; B-CELL; MITOCHONDRIAL PROTEIN; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; MESSENGER-RNA; REAL-TIME; T-CELL; APOPTOSIS	Background: LEA (late embryogenesis abundant) proteins encode conserved N-terminal mitochondrial signal domains and C-terminal (A/TAEKAK) motif repeats, long-presumed to confer cell resistance to stress and death cues. This prompted the hypothesis that LEA proteins are central to mitochondria mechanisms that connect bioenergetics with cell responses to stress and death signaling. In support of this hypothesis, recent studies have demonstrated that mammalian LEA protein PRELI can act as a biochemical hub, which upholds mitochondria energy metabolism, while concomitantly promoting B cell resistance to stress and induced death. Hence, it is important to define in vivo the physiological relevance of PRELI expression. Methods and Findings: Given the ubiquitous PRELI expression during mouse development, embryo lethality could be anticipated. Thus, conditional gene targeting was engineered by insertion of flanking loxP (flox)/Cre recognition sites on PRELI chromosome 13 (Chr 13) locus to abort its expression in a tissue-specific manner. After obtaining mouse lines with homozygous PRELI floxed alleles (PRELIf/f), the animals were crossed with CD19-driven Cre-recombinase transgenic mice to investigate whether PRELI inactivation could affect B-lymphocyte physiology and survival. Mice with homozygous B cell-specific PRELI deletion (CD19-Cre/Chr13 PRELI-/-) bred normally and did not show any signs of morbidity. Histopathology and flow cytometry analyses revealed that cell lineage identity, morphology, and viability were indistinguishable between wild type CD19-Cre/Chr13 PRELI+/+ and CD19-Cre/Chr13 PRELI-/- deficient mice. Furthermore, B cell PRELI gene expression seemed unaffected by Chr13 PRELI gene targeting. However, identification of additional PRELI loci in mouse Chr1 and Chr5 provided an explanation for the paradox between LEA-dependent cytoprotection and the seemingly futile consequences of Chr 13 PRELI gene inactivation. Importantly, PRELI expression from spare gene loci appeared ample to surmount Chr 13 PRELI gene deficiency. Conclusions: These findings suggest that PRELI is a vital LEA B cell protein with failsafe genetics.	[Ma, Wenbin; McKeller, Morgan R.; Rangel, Roberto; Ortiz-Quintero, Blanca; Martinez-Valdez, Hector] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Blackburn, Michael R.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Ma, WB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	hmartine@mdanderson.org	Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957; Blackburn, Michael/0000-0002-1394-9966; ortiz, blanca/0000-0001-6298-0073; Ma, Wenbin/0000-0001-8774-7593	Leukemia and Lymphoma Society [6161-03]; National Institutes of Health (NIH) [AI056125-01, AI065796-01, T32 CA009598-15, CA-16672]; Odyssey Program; Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056125, R01AI065796] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Odyssey Program; Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present work was supported by the grants 6161-03 from the Leukemia and Lymphoma Society and AI056125-01 and AI065796-01 from the National Institutes of Health (NIH). MRM was supported by the training grant T32 CA009598-15 from NIH. WM was supported by the Odyssey Program and the Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center. MD Anderson's Genetically Engineered Mouse and DNA Analysis Core Facilities are partially supported by NIH CA-16672 (GEMF/DAF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chaudhari AA, 2007, ONCOL REP, V18, P71; CURRY J, 1993, PLANT MOL BIOL, V21, P907, DOI 10.1007/BF00027121; Dee CT, 2005, DEV GENES EVOL, V215, P248, DOI 10.1007/s00427-005-0470-4; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ESPELUND M, 1995, PLANT CELL ENVIRON, V18, P943, DOI 10.1111/j.1365-3040.1995.tb00605.x; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; FINKELSTEIN RR, 1993, MOL GEN GENET, V238, P401, DOI 10.1007/BF00291999; Fox EJ, 2004, BIOCHEM J, V378, P817, DOI 10.1042/BJ20031504; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Goh CH, 2003, PLANT J, V36, P240, DOI 10.1046/j.1365-313X.2003.01872.x; Gottlieb E, 2006, CELL, V126, P27, DOI 10.1016/j.cell.2006.06.030; Guzman-Rojas L, 2002, IMMUNOLOGY, V107, P167, DOI 10.1046/j.1365-2567.2002.01494.x; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Hall BM, 2011, J BIOL CHEM, V286, P39141, DOI 10.1074/jbc.M111.259853; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Liu SS, 2010, ANN NY ACAD SCI, V1201, P84, DOI 10.1111/j.1749-6632.2010.05632.x; Ma WB, 2011, CELL RES, V21, P1564, DOI 10.1038/cr.2011.84; MARTIN D, 1991, J EXP MED, V173, P639, DOI 10.1084/jem.173.3.639; McKeller MR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.19; Mocellin S, 2003, TRENDS MOL MED, V9, P189, DOI 10.1016/S1471-4914(03)00047-9; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Nicholls DG, 2010, ESSAYS BIOCHEM, V47, P25, DOI [10.1042/BSE0470025, 10.1042/bse0470025]; Niu S, 1996, GENE, V175, P187, DOI 10.1016/0378-1119(96)00146-1; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Singh S, 2005, J BIOMED BIOTECHNOL, P232, DOI 10.1155/JBB.2005.232; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37949	10.1371/journal.pone.0037949	http://dx.doi.org/10.1371/journal.pone.0037949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666421	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400060
J	Ortega, FJ; Moreno-Navarrete, JM; Mayas, D; Garcia-Santos, E; Gomez-Serrano, M; Rodriguez-Hermosa, JI; Ruiz, B; Ricart, W; Tinahones, FJ; Fruhbeck, G; Peral, B; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Mayas, Dolores; Garcia-Santos, Eva; Gomez-Serrano, Maria; Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu; Ricart, Wifredo; Tinahones, Francisco J.; Fruehbeck, Gema; Peral, Belen; Fernandez-Real, Jose M.			Breast Cancer 1 (BrCa1) May Be behind Decreased Lipogenesis in Adipose Tissue from Obese Subjects	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; INSULIN-RESISTANCE; EXPRESSION PATTERNS; GENE-EXPRESSION; CELLS; DIFFERENTIATION; ADIPOGENESIS; MICE; PROLIFERATION; MORPHOGENESIS	Context: Expression and activity of the main lipogenic enzymes is paradoxically decreased in obesity, but the mechanisms behind these findings are poorly known. Breast Cancer 1 (BrCa1) interacts with acetyl-CoA carboxylase (ACC) reducing the rate of fatty acid biosynthesis. In this study, we aimed to evaluate BrCa1 in human adipose tissue according to obesity and insulin resistance, and in vitro cultured adipocytes. Research Design and Methods: BrCa1 gene expression, total and phosphorylated (P-) BrCa1, and ACC were analyzed in adipose tissue samples obtained from a total sample of 133 subjects. BrCa1 expression was also evaluated during in vitro differentiation of human adipocytes and 3T3-L1 cells. Results: BrCa1 gene expression was significantly up-regulated in both omental (OM; 1.36-fold, p = 0.002) and subcutaneous (SC; 1.49-fold, p = 0.001) adipose tissue from obese subjects. In parallel with increased BrCa1 mRNA, P-ACC was also up-regulated in SC (p = 0.007) as well as in OM (p = 0.010) fat from obese subjects. Consistent with its role limiting fatty acid biosynthesis, both BrCa1 mRNA (3.5-fold, p<0.0001) and protein (1.2-fold, p = 0.001) were increased in pre-adipocytes, and decreased during in vitro adipogenesis, while P-ACC decreased during differentiation of human adipocytes (p = 0.005) allowing lipid biosynthesis. Interestingly, BrCa1 gene expression in mature adipocytes was restored by inflammatory stimuli (macrophage conditioned medium), whereas lipogenic genes significantly decreased. Conclusions: The specular findings of BrCa1 and lipogenic enzymes in adipose tissue and adipocytes reported here suggest that BrCa1 might help to control fatty acid biosynthesis in adipocytes and adipose tissue from obese subjects.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Ricart, Wifredo; Fernandez-Real, Jose M.] CIBER Fisiopatol Obesidad & Nutr, Inst Invest Biomed Girona, Serv Diabet Endocrinol & Nutr, Girona, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Salud Carlos III, Girona, Spain; [Mayas, Dolores; Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria Malaga, CIBER Fisiopatol Obesidad & Nutr, Serv Endocrinol & Nutr, Malaga, Spain; [Mayas, Dolores; Tinahones, Francisco J.] Inst Salud Carlos III, Malaga, Spain; [Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrinol Physiopathol & Nervous Syst, Madrid, Spain; [Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu] Inst Invest Biomed Girona, Dept Surg, Girona, Spain; [Fruehbeck, Gema] Univ Navarra Clin, CIBER Fisiopatol Obesidad & Nutr, Inst Salud Carlos III, Dept Endocrinol, Navarra, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra	Ortega, FJ (corresponding author), CIBER Fisiopatol Obesidad & Nutr, Inst Invest Biomed Girona, Serv Diabet Endocrinol & Nutr, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Fernández-Real, Jose Manuel/AGH-3599-2022; Peral, Belén/F-4562-2015; Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021; Tinahones, Francisco José/AAB-2882-2020; Ortega, Francisco José J/F-3883-2016; Gómez-Serrano, María/AAZ-3953-2021	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Peral, Belén/0000-0003-4984-4020; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Gómez-Serrano, María/0000-0002-9669-091X; Ricart, Wifredo/0000-0002-3452-9098; Tinahones, Francisco J/0000-0001-6871-4403	Ministerio de Educacion y Ciencia [SAF2008-02073, SAF2009-10461]; Fundacion Mutua Madrilena; Instituto de Salud Carlos III [ISCIIIRETIC RD06, CIBERObN]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (SAF2008-02073 and SAF2009-10461), the Fundacion Mutua Madrilena, and the Instituto de Salud Carlos III (ISCIIIRETIC RD06, CIBERObN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bernard-Gallon DJ, 2001, INT J ONCOL, V18, P271; Blackshear PE, 1998, ONCOGENE, V16, P61, DOI 10.1038/sj.onc.1201506; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; Fernandez-Real JM, 1998, DIABETES, V47, P1757, DOI 10.2337/diabetes.47.11.1757; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; Mayas MD, 2009, AM J HYPERTENS, V22, P1258, DOI 10.1038/ajh.2009.178; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; MIETTINEN TA, 1981, INT J OBESITY, V5, P613; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Mobbs CV, 2002, NAT MED, V8, P335, DOI 10.1038/nm0402-335; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Moreno-Navarrete JM, 2009, INT J OBESITY, V33, P991, DOI 10.1038/ijo.2009.143; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ortega FJ, 2009, INT J OBES LOND; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Ray H, 2009, BIOCHEM BIOPH RES CO, V378, P615, DOI 10.1016/j.bbrc.2008.11.090; Ray H, 2006, J MOL BIOL, V359, P973, DOI 10.1016/j.jmb.2006.04.010; RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Smith J, 2006, CLIN SCI, V110, P1; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e33233	10.1371/journal.pone.0033233	http://dx.doi.org/10.1371/journal.pone.0033233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666314	Green Published, gold			2022-12-25	WOS:000305353400003
J	Rulker, T; Voss, L; Thullier, P; O' Brien, LM; Pelat, T; Perkins, SD; Langermann, C; Schirrmann, T; Dubel, S; Marschall, HJ; Hust, M; Hulseweh, B				Ruelker, Torsten; Voss, Luzie; Thullier, Philippe; O' Brien, Lyn M.; Pelat, Thibaut; Perkins, Stuart D.; Langermann, Claudia; Schirrmann, Thomas; Duebel, Stefan; Marschall, Hans-Juergen; Hust, Michael; Huelseweh, Birgit			Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo	PLOS ONE			English	Article							VENEZUELAN EQUINE ENCEPHALITIS; ENCEPHALOMYELITIS VIRUS-INFECTION; MONOCLONAL-ANTIBODY; PROTECTS MICE; GERMLINE HUMANIZATION; AIRBORNE CHALLENGE; PASSIVE PROTECTION; 24 H; VACCINE; DISEASE	Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus genus and several species of this family are pathogenic to humans. The viruses are classified as potential agents of biological warfare and terrorism and sensitive detection as well as effective prophylaxis and antiviral therapies are required. In this work, we describe the isolation of the anti-VEEV single chain Fragment variable (scFv), ToR67-3B4, from a non-human primate (NHP) antibody gene library. We report its recloning into the bivalent scFv-Fc format and further immunological and biochemical characterisation. The scFv-Fc ToR67-3B4 recognised viable as well as formalin and beta-propionolactone (beta-Pl) inactivated virus particles and could be applied for immunoblot analysis of VEEV proteins and immuno-histochemistry of VEEV infected cells. It detected specifically the viral E1 envelope protein of VEEV but did not react with reduced viral glycoprotein preparations suggesting that recognition depends upon conformational epitopes. The recombinant antibody was able to detect multiple VEEV subtypes and displayed only marginal cross-reactivity to other Alphavirus species except for EEEV. In addition, the scFv-Fc fusion described here might be of therapeutic use since it successfully inactivated VEEV in a murine disease model. When the recombinant antibody was administered 6 hours post challenge, 80% to 100% of mice survived lethal VEEV IA/B or IE infection. Forty to sixty percent of mice survived when scFv-Fc ToR67-3B4 was applied 6 hours post challenge with VEEV subtypes II and former IIIA. In combination with E2-neutralising antibodies the NHP antibody isolated here could significantly improve passive protection as well as generic therapy of VEE.	[Ruelker, Torsten; Schirrmann, Thomas; Duebel, Stefan; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-38106 Braunschweig, Germany; [Voss, Luzie; Langermann, Claudia; Marschall, Hans-Juergen; Huelseweh, Birgit] ABC Schutz, WIS, Munster, Germany; [Thullier, Philippe; Pelat, Thibaut] CRSSA IRBA, La Tronche, France; [O' Brien, Lyn M.; Perkins, Stuart D.] Dept Biomed Sci, Def Sci & Technol Lab, Salisbury, Wilts, England	Braunschweig University of Technology; Defence Science & Technology Laboratory	Rulker, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-38106 Braunschweig, Germany.	birgithuelseweh@bwb.org		Dubel, Stefan/0000-0001-8811-7390; Hust, Michael/0000-0003-3418-6045; Pelat, thibaut/0000-0003-4312-1032				ALEVIZATOS AC, 1967, AM J TROP MED HYG, V16, P762, DOI 10.4269/ajtmh.1967.16.762; [Anonymous], GUID CAR US LAB AN; Bennett AM, 2000, VACCINE, V19, P337, DOI 10.1016/S0264-410X(00)00123-7; BERGE TO, 1961, J IMMUNOL, V87, P509; CASAMASSIMA AC, 1987, TERATOLOGY, V36, P287, DOI 10.1002/tera.1420360303; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Dai X, 2008, TR2008050 DRDC SUFF; DEMUCHAMACIAS J, 1965, AM J TROP MED HYG, V14, P475, DOI 10.4269/ajtmh.1965.14.475; DIETZ WH, 1979, AM J TROP MED HYG, V28, P329, DOI 10.4269/ajtmh.1979.28.329; Duggan JM, 2001, VIRAL IMMUNOL, V14, P263, DOI 10.1089/088282401753266774; EDDY GA, 1972, INFECT IMMUN, V5, P160, DOI 10.1128/IAI.5.2.160-163.1972; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Goodchild SA, 2011, ANTIVIR RES, V90, P1, DOI 10.1016/j.antiviral.2011.01.010; GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743; GREISERWILKE IM, 1991, J CLIN MICROBIOL, V29, P131, DOI 10.1128/JCM.29.1.131-137.1991; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; HENDERSON DW, 1952, J HYG-CAMBRIDGE, V50, P53, DOI 10.1017/S0022172400019422; Hu WG, 2010, VACCINE, V28, P5558, DOI 10.1016/j.vaccine.2010.06.038; Hu WG, 2004, J IMMUNOL METHODS, V289, P27, DOI 10.1016/j.jim.2004.03.007; Hu WG, 2002, HYBRIDOMA HYBRIDOM, V21, P415, DOI 10.1089/153685902321043945; Huelseweh B, 2006, PROTEOMICS, V6, P2972, DOI 10.1002/pmic.200500721; Hunt AR, 2006, J GEN VIROL, V87, P2467, DOI 10.1099/vir.0.81925-0; Hunt AR, 2011, VIROLOGY, V414, P146, DOI 10.1016/j.virol.2011.03.016; Hunt AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000739; HUST M, 2007, HDB THERAPEUTIC ANTI, P45; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; JENSEN MH, 1981, ACTA VET SCAND, V22, P85; Johnson K M, 1974, Adv Vet Sci Comp Med, V18, P79; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kirsch M, 2005, J IMMUNOL METHODS, V301, P173, DOI 10.1016/j.jim.2005.04.017; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Kubes V, 1939, SCIENCE, V90, P20, DOI 10.1126/science.90.2323.20; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luers AJ, 2005, COMP FUNCT GENOM, V6, P217, DOI 10.1002/cfg.478; Marschall HJ, 1995, EC1055 DEF R D GER 1; Marschall HJ, 1996, EC1178EC1179 DEF R 1; Martin SS, 2010, VACCINE, V28, P3143, DOI 10.1016/j.vaccine.2010.02.056; MATHEWS JH, 1985, J VIROL, V55, P594, DOI 10.1128/JVI.55.3.594-600.1985; May K. R., 1973, Journal of Aerosol Science, V4, P235, DOI 10.1016/0021-8502(73)90006-2; McCurdy K, 2011, VIROLOGY, V415, P20, DOI 10.1016/j.virol.2011.03.030; McKinney R. W., 1972, Venezuelan encephalitis-proceedings of the workshop-symposium on Venezuelan encephalitis virus., P369; MCKINNEY RW, 1963, AM J TROP MED HYG, V12, P597, DOI 10.4269/ajtmh.1963.12.597; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Murphy KM, 2009, JANEWAYS IMMUNOLOGY; O'Brien LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-206; Parker MD, 2010, J VIROL, V84, P12683, DOI 10.1128/JVI.01345-10; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Phillpotts RJ, 2006, VIRUS RES, V120, P107, DOI 10.1016/j.virusres.2006.02.003; Phillpotts RJ, 1999, VACCINE, V17, P982, DOI 10.1016/S0264-410X(98)00315-6; Phillpotts RJ, 2002, VACCINE, V20, P1497, DOI 10.1016/S0264-410X(01)00505-9; Pittman PR, 1996, VACCINE, V14, P337, DOI 10.1016/0264-410X(95)00168-Z; Powers AM, 1997, J VIROL, V71, P6697, DOI 10.1128/JVI.71.9.6697-6705.1997; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Pratt WD, 2003, VACCINE, V21, P3854, DOI 10.1016/S0264-410X(03)00328-1; RAYFIELD EJ, 1976, DIABETES, V25, P623, DOI 10.2337/diabetes.25.7.623; Reed DS, 2004, J INFECT DIS, V189, P1013, DOI 10.1086/382281; ROEHRIG JT, 1982, VIROLOGY, V118, P269, DOI 10.1016/0042-6822(82)90346-4; Roehrig JT, 1997, J CLIN MICROBIOL, V35, P1887, DOI 10.1128/JCM.35.7.1887-1890.1997; ROEHRIG JT, 1985, VIROLOGY, V142, P347, DOI 10.1016/0042-6822(85)90343-5; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Sagripanti JL, 2011, APPL ENVIRON MICROB, V77, P7289, DOI 10.1128/AEM.05553-11; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Schirrmann T, 2010, METHODS MOL BIOL, V651, P177, DOI 10.1007/978-1-60761-786-0_11; SCHMALJOHN AL, 1982, NATURE, V297, P70, DOI 10.1038/297070a0; SMITH JF, 1997, TXB MILITARY MED MED, P561; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; SUDIA WD, 1975, AM J EPIDEMIOL, V101, P17, DOI 10.1093/oxfordjournals.aje.a112068; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Wright AJ, 1998, ARCH VIROL, V143, P1155, DOI 10.1007/s007050050363; WUST CJ, 1987, P SOC EXP BIOL MED, V184, P56; WUST CJ, 1989, VIRUS RES, V13, P101, DOI 10.1016/0168-1702(89)90009-9	80	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37242	10.1371/journal.pone.0037242	http://dx.doi.org/10.1371/journal.pone.0037242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666347	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400023
J	Salari, N; Buchel, C; Rose, M				Salari, Neda; Buechel, Christian; Rose, Michael			Functional Dissociation of Ongoing Oscillatory Brain States	PLOS ONE			English	Article							RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; ALPHA-RHYTHM; COGNITIVE PERFORMANCE; NEURAL ACTIVITY; EEG; SYNCHRONIZATION; PRESTIMULUS; CORTEX; FLUCTUATIONS; NEUROFEEDBACK	The state of a neural assembly preceding an incoming stimulus is assumed to modulate the processing of subsequently presented stimuli. The nature of this state can differ with respect to the frequency of ongoing oscillatory activity. Oscillatory brain activity of specific frequency range such as alpha (8-12 Hz) and gamma (above 30 Hz) band oscillations are hypothesized to play a functional role in cognitive processing. Therefore, a selective modulation of this prestimulus activity could clarify the functional role of these prestimulus fluctuations. For this purpose, we adopted a novel non-invasive brain-computer-interface (BCI) strategy to selectively increase alpha or gamma band activity in the occipital cortex combined with an adaptive presentation of visual stimuli within specific brain states. During training, oscillatory brain activity was estimated online and fed back to the participants to enable a deliberate modulation of alpha or gamma band oscillations. Results revealed that volunteers selectively increased alpha and gamma frequency oscillations with a high level of specificity regarding frequency range and localization. At testing, alpha or gamma band activity was classified online and at defined levels of activity, visual objects embedded in noise were presented instantly and had to be detected by the volunteer. In experiment I, the effect of two levels of prestimulus gamma band activity on visual processing was examined. During phases of increased gamma band activity significantly more visual objects were detected. In experiment II, the effect was compared against increased levels of alpha band activity. An improvement of visual processing was only observed for enhanced gamma band activity. Both experiments demonstrate the specific functional role of prestimulus gamma band oscillations for perceptual processing. We propose that the BCI method permits the selective modulation of oscillatory activity and the direct assessment of behavioral consequences to test for functional dissociations of different oscillatory brain states.	[Salari, Neda; Buechel, Christian; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Salari, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	n.salari@uke.uni-hamburg.de			Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Becker R, 2011, J NEUROSCI, V31, P11016, DOI 10.1523/JNEUROSCI.0210-11.2011; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; BOYLAN C, 1989, INVEST OPHTH VIS SCI, V30, P2521; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cannon R, 2007, INT J NEUROSCI, V117, P337, DOI 10.1080/00207450500514003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Congedo M, 2004, IEEE T NEUR SYS REH, V12, P387, DOI 10.1109/TNSRE.2004.840492; de Munck JC, 2007, NEUROIMAGE, V35, P1142, DOI 10.1016/j.neuroimage.2007.01.022; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Ebrahimi T, 2003, IEEE SIGNAL PROC MAG, V20, P14, DOI 10.1109/MSP.2003.1166626; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Keizer AW, 2010, NEUROIMAGE, V49, P3404, DOI 10.1016/j.neuroimage.2009.11.023; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krishnaveni V, 2006, J NEURAL ENG, V3, P338, DOI 10.1088/1741-2560/3/4/011; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rose M, 2005, CEREB CORTEX, V15, P1290, DOI 10.1093/cercor/bhi012; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Siegel M, 2003, J NEUROSCI, V23, P4251; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Super H, 2003, J NEUROSCI, V23, P3407; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; WELFORD BP, 1962, TECHNOMETRICS, V4, P419, DOI 10.2307/1266577; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	64	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38090	10.1371/journal.pone.0038090	http://dx.doi.org/10.1371/journal.pone.0038090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666454	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400080
J	Soland, MA; Bego, MG; Colletti, E; Porada, CD; Zanjani, ED; Jeor, SS; Almeida-Porada, G				Soland, Melisa A.; Bego, Mariana G.; Colletti, Evan; Porada, Christopher D.; Zanjani, Esmail D.; Jeor, Stephen St.; Almeida-Porada, Graca			Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins	PLOS ONE			English	Article							MARROW STROMAL CELLS; SUPPRESS T-LYMPHOCYTE; COMPLEX CLASS-I; DOWN-REGULATION; IMMUNE-RESPONSE; HLA EXPRESSION; IFN-GAMMA; NK CELLS; TRANSPLANTATION; PROLIFERATION	Background: Mesenchymal stem cells (MSC) are promising candidates for cell therapy, as they migrate to areas of injury, differentiate into a broad range of specialized cells, and have immunomodulatory properties. However, MSC are not invisible to the recipient's immune system, and upon in vivo administration, allogeneic MSC are able to trigger immune responses, resulting in rejection of the transplanted cells, precluding their full therapeutic potential. Human cytomegalovirus (HCMV) has developed several strategies to evade cytotoxic T lymphocyte (CTL) and Natural Killer (NK) cell recognition. Our goal is to exploit HCMV immunological evasion strategies to reduce MSC immunogenicity. Methodology/Principal Findings: We genetically engineered human MSC to express HCMV proteins known to downregulate HLA-I expression, and investigated whether modified MSC were protected from CTL and NK attack. Flow cytometric analysis showed that amongst the US proteins tested, US6 and US11 efficiently reduced MSC HLA-I expression, and mixed lymphocyte reaction demonstrated a corresponding decrease in human and sheep mononuclear cell proliferation. NK killing assays showed that the decrease in HLA-I expression did not result in increased NK cytotoxicity, and that at certain NK: MSC ratios, US11 conferred protection from NK cytotoxic effects. Transplantation of MSC-US6 or MSC-US11 into pre-immune fetal sheep resulted in increased liver engraftment when compared to control MSC, as demonstrated by qPCR and immunofluorescence analyses. Conclusions and Significance: These data demonstrate that engineering MSC to express US6 and US11 can be used as a means of decreasing recognition of MSC by the immune system, allowing higher levels of engraftment in an allogeneic transplantation setting. Since one of the major factors responsible for the failure of allogeneic-donor MSC to engraft is the mismatch of HLA-I molecules between the donor and the recipient, MSC-US6 and MSC-US11 could constitute an off-the-shelf product to overcome donor-recipient HLA-I mismatch.	[Soland, Melisa A.; Colletti, Evan; Porada, Christopher D.; Zanjani, Esmail D.; Almeida-Porada, Graca] Univ Nevada, Dept Anim Biotechnol, Reno, NV 89557 USA; [Bego, Mariana G.] IRCM, Lab Human Retrovirol, Montreal, PQ, Canada; [Jeor, Stephen St.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Nevada System of Higher Education (NSHE); University of Nevada Reno	Soland, MA (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	galmeida@wakehealth.edu		soland, Melisa/0000-0001-8217-9734; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	National Institutes of Health (Bethesda, MD, USA) [HL73737, HL97623]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097623, R01HL073737] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (Bethesda, MD, USA) grants HL73737 and HL97623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lin AF, 2007, CELL MOL IMMUNOL, V4, P91; Bacigalupo A, 2007, BRIT J HAEMATOL, V137, P87, DOI 10.1111/j.1365-2141.2007.06533.x; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Barel MT, 2003, J IMMUNOL, V171, P6757, DOI 10.4049/jimmunol.171.12.6757; BILGRAMI S, 1994, BRIT J HAEMATOL, V87, P357, DOI 10.1111/j.1365-2141.1994.tb04922.x; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; BRUTKIEWICZ RR, 1995, J VIROL, V69, P3967, DOI 10.1128/JVI.69.7.3967-3971.1995; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Colletti EJ, 2009, STEM CELL RES, V2, P125, DOI 10.1016/j.scr.2008.08.002; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; de Jong MD, 1998, ANTIVIR RES, V39, P141, DOI 10.1016/S0166-3542(98)00044-8; de la Garza-Rodea AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014493; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fletcher JM, 1998, J IMMUNOL, V161, P2365; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Gotherstrom C, 2010, CYTOTHERAPY, V0, P1; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Jones DRE, 1999, MOL MED TODAY, V5, P288, DOI 10.1016/S1357-4310(99)01473-2; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kim JY, 2005, INT J BIOCHEM CELL B, V37, P69, DOI 10.1016/j.biocel.2004.04.024; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee EM, 2005, BIOCHEM BIOPH RES CO, V326, P825, DOI 10.1016/j.bbrc.2004.11.106; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Li A, 2006, GENE THER, V13, P1178, DOI 10.1038/sj.gt.3302741; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; Petersdorf EW, 1997, BLOOD, V89, P1818, DOI 10.1182/blood.V89.5.1818.1818_1818_1823; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; ROLSTAD B, 1984, EUR J IMMUNOL, V14, P793, DOI 10.1002/eji.1830140906; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rouas-Freiss N, 2003, AM J TRANSPLANT, V3, P11, DOI 10.1034/j.1600-6143.2003.30103.x; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang H, 2011, J IMMUNOTHER, V34, P187, DOI 10.1097/CJI.0b013e31820d2a21	63	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36163	10.1371/journal.pone.0036163	http://dx.doi.org/10.1371/journal.pone.0036163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666319	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400006
J	Webb, JM; Jacobus, LM; Funk, DH; Zhou, X; Kondratieff, B; Geraci, CJ; DeWalt, RE; Baird, DJ; Richard, B; Phillips, I; Hebert, PDN				Webb, Jeffrey M.; Jacobus, Luke M.; Funk, David H.; Zhou, Xin; Kondratieff, Boris; Geraci, Christy J.; DeWalt, R. Edward; Baird, Donald J.; Richard, Barton; Phillips, Iain; Hebert, Paul D. N.			A DNA Barcode Library for North American Ephemeroptera: Progress and Prospects	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; TRICHOPTERA; PLECOPTERA; PHYLOGENY; SPECIMEN; LEVEL	DNA barcoding of aquatic macroinvertebrates holds much promise as a tool for taxonomic research and for providing the reliable identifications needed for water quality assessment programs. A prerequisite for identification using barcodes is a reliable reference library. We gathered 4165 sequences from the barcode region of the mitochondrial cytochrome c oxidase subunit I gene representing 264 nominal and 90 provisional species of mayflies (Insecta: Ephemeroptera) from Canada, Mexico, and the United States. No species shared barcode sequences and all can be identified with barcodes with the possible exception of some Caenis. Minimum interspecific distances ranged from 0.3-24.7% (mean: 12.5%), while the average intraspecific divergence was 1.97%. The latter value was inflated by the presence of very high divergences in some taxa. In fact, nearly 20% of the species included two or three haplotype clusters showing greater than 5.0% sequence divergence and some values are as high as 26.7%. Many of the species with high divergences are polyphyletic and likely represent species complexes. Indeed, many of these polyphyletic species have numerous synonyms and individuals in some barcode clusters show morphological attributes characteristic of the synonymized species. In light of our findings, it is imperative that type or topotype specimens be sequenced to correctly associate barcode clusters with morphological species concepts and to determine the status of currently synonymized species.	[Webb, Jeffrey M.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Jacobus, Luke M.] Indiana Univ Purdue Univ Columbus, Div Sci, Columbus, IN USA; [Funk, David H.] Stroud Water Res Ctr, Avondale, PA USA; [Zhou, Xin] BGI, Shenzhen, Guangdong, Peoples R China; [Kondratieff, Boris] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Geraci, Christy J.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [DeWalt, R. Edward] Univ Illinois, Prairie Res Inst, Champaign, IL 61820 USA; [Baird, Donald J.] Univ New Brunswick, Dept Biol, Canadian Rivers Inst, Environm Canada, Fredericton, NB E3B 6E1, Canada; [Richard, Barton] Florida A&M Univ, Lab Aquat Entomol, Tallahassee, FL 32307 USA; [Phillips, Iain] Saskatchewan Watershed Author, Saskatoon, SK, Canada	University of Guelph; Indiana University System; Indiana University-Purdue University Indianapolis; Beijing Genomics Institute (BGI); Colorado State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Illinois System; University of Illinois Urbana-Champaign; Environment & Climate Change Canada; University of New Brunswick; State University System of Florida; Florida A&M University	Webb, JM (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	jmw975@yahoo.com	Baird, Donald/A-5267-2009; Zhou, Xin/AAI-9326-2021; Zhou, Xin/D-4025-2009; Phillips, Iain/L-3116-2019; Hebert, Paul DN/C-4161-2013	Zhou, Xin/0000-0002-1407-7952; Zhou, Xin/0000-0002-1407-7952; Hebert, Paul DN/0000-0002-3081-6700; Phillips, Iain/0000-0003-0955-3771	Government of Canada through Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]; Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program	This project was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03), and Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LC, 2009, J N AM BENTHOL SOC, V28, P584, DOI 10.1899/08-150.1; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P122, DOI 10.1899/10-154.1; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Cao Y, 2011, J N AM BENTHOL SOC, V30, P680, DOI 10.1899/10-067.1; DeWaard Jeremy R., 2008, V410, P275; DeWalt RE, 2011, J N AM BENTHOL SOC, V30, P174, DOI 10.1899/10-021.1; Favret C, 2011, P ENTOMOL SOC WASH, V113, P119, DOI 10.4289/0013-8797.113.2.119; Feio MJ, 2006, CAN J FISH AQUAT SCI, V63, P367, DOI [10.1139/f05-221, 10.1139/F05-221]; Funk DH, 2008, J N AM BENTHOL SOC, V27, P647, DOI 10.1899/08-026.1; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2011, SPIXIANA, V34, P47; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacobus LM, 2004, J NEW YORK ENTOMOL S, V112, P127, DOI 10.1664/0028-7199(2004)112[0127:RCTTGD]2.0.CO;2; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Lenat DR, 2001, J N AM BENTHOL SOC, V20, P287, DOI 10.2307/1468323; Lenat DR, 1996, B N AM BENTHOLOGICAL, V13, P305, DOI DOI 10.2307/1467463; Mynott JH, 2011, INVERTEBR SYST, V25, P11, DOI 10.1071/IS10025; Ogden TH, 2009, SYST ENTOMOL, V34, P616, DOI 10.1111/j.1365-3113.2009.00488.x; Ogden TH, 2005, MOL PHYLOGENET EVOL, V37, P625, DOI 10.1016/j.ympev.2005.08.008; Pfrender ME, 2010, Q REV BIOL, V85, P319, DOI 10.1086/655118; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Rosenberg David M., 1993, P1; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Webb JM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.6301; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhou X, 2007, J N AM BENTHOL SOC, V26, P719, DOI 10.1899/06-089.1; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	38	89	95	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38063	10.1371/journal.pone.0038063	http://dx.doi.org/10.1371/journal.pone.0038063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666447	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400074
J	Weis, S; Jesinghaus, M; Kovacs, P; Schleinitz, D; Schober, R; Ruffert, C; Herms, M; Wittenburg, H; Stumvoll, M; Bluher, M; Grutzmann, R; Schulz, HU; Keim, V; Mossner, J; Bugert, P; Witt, H; Drenth, JPH; Krohn, K; Rosendahl, J				Weis, Sebastian; Jesinghaus, Moritz; Kovacs, Peter; Schleinitz, Dorit; Schober, Robert; Ruffert, Claudia; Herms, Max; Wittenburg, Henning; Stumvoll, Michael; Blueher, Matthias; Gruetzmann, Robert; Schulz, Hans-Ulrich; Keim, Volker; Moessner, Joachim; Bugert, Peter; Witt, Heiko; Drenth, Joost P. H.; Krohn, Knut; Rosendahl, Jonas			Genetic Analyses of Heme Oxygenase 1 (HMOX1) in Different Forms of Pancreatitis	PLOS ONE			English	Article							CYSTIC-FIBROSIS GENE; MICROSATELLITE POLYMORPHISM; PROMOTER VARIANT; MUTATIONS; DISEASE; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; INHIBITOR; INDUCTION	Background: Heme oxygenase 1 (HMOX1) is the rate limiting enzyme in heme degradation and a key regulator of inflammatory processes. In animal models the course of pancreatitis was ameliorated by up-regulation of HMOX1 expression. Additionally, carbon monoxide released during heme breakdown inhibited proliferation of pancreatic stellate cells and might thereby prevent the development of chronic pancreatitis (CP). Transcription of HMOX1 in humans is influenced by a GT-repeat located in the promoter. As such, HMOX1 variants might be of importance in the pathogenesis of pancreatitis. Methods: The GT-repeat and SNP rs2071746 were investigated with fluorescence labelled primers and by melting curve analysis in 285 patients with acute pancreatitis, 208 patients with alcoholic CP, 207 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and in 289 controls, respectively. GT-repeat analysis was extended to a total of 446 alcoholic CP patients. In addition, we performed DNA sequencing in 145 patients with alcoholic CP, 138 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and 151 controls. Exon 3 screening was extended to additional patients and controls. Results: S- and L-alleles of the GT-repeat, genotypes and alleles of SNP rs2071746 and non-synonymous variants detected by sequencing were found with similar frequencies in all groups. Conclusions: Although functional data implicate a potential influence of HMOX1 variants on the pathogenesis of pancreatitis, we did not find any association. As rare non-synonymous HMOX1 variants were found in patients and controls, it is rather unlikely that they will have functional consequences essential for pancreatitis development.	[Weis, Sebastian; Jesinghaus, Moritz; Schober, Robert; Ruffert, Claudia; Herms, Max; Wittenburg, Henning; Keim, Volker; Moessner, Joachim; Rosendahl, Jonas] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany; [Kovacs, Peter; Schleinitz, Dorit; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol, Leipzig, Germany; [Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Gruetzmann, Robert] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, D-01062 Dresden, Germany; [Schulz, Hans-Ulrich] Univ Magdeburg, Dept Surg, D-39106 Magdeburg, Germany; [Bugert, Peter] Univ Heidelberg, German Red Cross Blood Serv Baden Wurttemberg Hes, Med Fac Mannheim, Inst Transfus Med & Immunol, D-6800 Mannheim, Germany; [Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum Ernahrungsmed EKFZ, Dept Pediat, Munich, Germany; [Witt, Heiko] Tech Univ Munich, ZIEL, Munich, Germany; [Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Krohn, Knut] Univ Leipzig, Core Unit DNA Technol, Interdisciplinary Ctr Clin Res Leipzig, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Radboud University Nijmegen; Leipzig University	Weis, S (corresponding author), Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany.	jonas.rosendahl@medizin.uni-leipzig.de	Drenth, J.P.H./H-8025-2014; Stumvoll, Michael/ABE-1121-2021; Schober, Robert/ABC-9480-2020; Drenth, Joost/V-7436-2019; Weis, Sebastian/P-9016-2014	Stumvoll, Michael/0000-0001-6225-8240; Weis, Sebastian/0000-0003-3201-2375; Kovacs, Peter/0000-0002-0290-5423	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1, Wi 2036/2-2, Wi 2036/2-3]; Colora Stiftung gGmbH; Else Kroner-Fresenius-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH; Else Kroner-Fresenius-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1 (to JR) and Wi 2036/2-2 & Wi 2036/2-3 (to HW), by a grant of the Colora Stiftung gGmbH (to JR) and the Else Kroner-Fresenius-Foundation (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Becker T, 2007, TRANSPLANTATION, V84, P1644, DOI 10.1097/01.tp.0000290233.81395.81; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Chen P, 2010, CYTOKINE, V49, P15, DOI 10.1016/j.cyto.2009.09.013; Chen YH, 2004, EUR HEART J, V25, P39, DOI 10.1016/j.ehj.2003.10.009; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Derikx MHM, 2010, BEST PRACT RES CL GA, V24, P251, DOI 10.1016/j.bpg.2010.02.001; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; MAINES MD, 1986, J BIOL CHEM, V261, P411; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; O'Reilly DA, 2008, EUR J GASTROEN HEPAT, V20, P726, DOI 10.1097/MEG.0b013e3282f5728c; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Ono K, 2003, J HYPERTENS, V21, P1497, DOI 10.1097/00004872-200308000-00013; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sato H, 1997, FEBS LETT, V405, P219, DOI 10.1016/S0014-5793(97)00191-9; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Von Dobschuetz E, 2008, PANCREAS, V36, P377, DOI 10.1097/MPA.0b013e31815ceb0e; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37981	10.1371/journal.pone.0037981	http://dx.doi.org/10.1371/journal.pone.0037981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666428	Green Published, gold			2022-12-25	WOS:000305353400066
J	Zhang, HG; Liu, LB; Yu, D; Kandimalla, ER; Sun, HB; Agrawal, S; Guha, C				Zhang, Huagang; Liu, Laibin; Yu, Dong; Kandimalla, Ekambar R.; Sun, Hui Bin; Agrawal, Sudhir; Guha, Chandan			An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy	PLOS ONE			English	Article							KILLER DENDRITIC CELLS; 2ND-GENERATION IMMUNOMODULATORY OLIGONUCLEOTIDES; TOLL-LIKE RECEPTOR-9; PRODUCE IFN-GAMMA; IMMUNE-RESPONSES; CPG OLIGODEOXYNUCLEOTIDES; CANCER; IMMUNOTHERAPY; RECOGNITION; MOTIF	Purpose: Recent studies have shown that a new generation of synthetic agonist of Toll-like receptor (TLR) 9 consisting a 3'-3'-attached structure and a dCp7-deaza-dG dinucultodie shows more potent immunostimulatory effects in both mouse and human than conventional CpG oligonucleotides. Radiation therapy (RT) provides a source of tumor antigens that are released from dying, irradiated, tumor cells without causing systemic immunosuppression. We, therefore, examined effect of combining RT with a designer synthetic agonist of TLR9 on anti-tumoral immunity, primary tumor growth retardation and metastases in a murine model of lung cancer. Methods: Grouped C57BL/6 and congenic B cell deficient mice (B-/-) bearing footpad 3LL tumors were treated with PBS, TLR9 agonist, control oligonucelotide, RT or the combination of RT and TLR9 agonist. Immune phenotype of splenocytes and serum IFN-gamma and IL-10 levels were analyzed by FACS and ELISA, 24 h after treatment. Tumor growth, lung metastases and survival rate were monitored and tumor specific antibodies in serum and deposition in tumor tissue were measured by ELISA and immunofluorescence. Results: TLR9 agonist expanded and activated B cells and plasmacytoid dendritic cells in wild-type mice and natural killer DCs (NKDCs) in B cell-deficient (B-/-) mice bearing ectopic Lewis lung adenocarcinoma (3LL). Combined RT with TLR9 agonist treatment inhibited 3LL tumor growth in both wild type and B-/- mice. A strong tumor-specific humoral immune response (titer: 1/3200) with deposition of mouse IgG auto-antibodies in tumor tissue were found in wildtype mice, whereas the number of tumor infiltrating NKDCs increased in B-/- mice following RT+ TLR9 agonist therapy. Furthermore, mice receiving combination therapy had fewer lung metastases and a higher survival than single treatment cohorts. Conclusions: Combination therapy with TLR9 agonist and RT induces systemic anti-tumoral humoral response, augments tumoral infiltration of NKDCs, reduces pulmonary metastases and improves survival in a murine model of 3LL cancer.	[Zhang, Huagang; Liu, Laibin; Sun, Hui Bin; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Zhang, Huagang; Liu, Laibin; Sun, Hui Bin; Guha, Chandan] Montefiore Med Ctr, Bronx, NY 10467 USA; [Sun, Hui Bin] Albert Einstein Coll Med, Dept Orthoped, Bronx, NY 10467 USA; [Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir] Idera Pharmaceut Inc, Cambridge, MA USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zhang, HG (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net		Agrawal, Sudhir/0000-0003-4275-2510	National Institutes of Health (NIH) [R01DK064670, R01EB009040, RC2 AI087612, U19AI091175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175, RC2AI087612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064670] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (NIH) grants R01DK064670, R01EB009040, RC2 AI087612 and U19AI091175 to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aurisicchio L, 2009, CLIN CANCER RES, V15, P1575, DOI 10.1158/1078-0432.CCR-08-2628; Cerkovnik P, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-45; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chamoto K, 2009, CANCER SCI, V100, P934, DOI 10.1111/j.1349-7006.2009.01114.x; Chaudhry U, 2006, J AM COLL SURGEONS, V203, pS79, DOI 10.1016/j.jamcollsurg.2006.05.208; Chaudhry UI, 2006, CANCER RES, V66, P10497, DOI 10.1158/0008-5472.CAN-06-1908; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Damiano V, 2007, P NATL ACAD SCI USA, V104, P12468, DOI 10.1073/pnas.0705226104; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Friedman EJ, 2002, CURR PHARM DESIGN, V8, P1765, DOI 10.2174/1381612023394089; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Kandimalla ER, 2005, P NATL ACAD SCI USA, V102, P6925, DOI 10.1073/pnas.0501729102; Kandimalla ER, 2003, P NATL ACAD SCI USA, V100, P14303, DOI 10.1073/pnas.2335947100; Kandimalla ER, 2003, NUCLEIC ACIDS RES, V31, P2393, DOI 10.1093/nar/gkg343; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LICHTER AS, 1995, NEW ENGL J MED, V332, P371, DOI 10.1056/NEJM199502093320607; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Mason KA, 2005, CLIN CANCER RES, V11, P361; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029357; Stevenson FK, 2010, J CLIN ONCOL, V28, P4295, DOI 10.1200/JCO.2010.30.4212; Sutherland Robert M, 2006, Int J Radiat Oncol Biol Phys, V64, P3, DOI 10.1016/j.ijrobp.2005.08.036; Wang DQ, 2005, VACCINE, V23, P2614, DOI 10.1016/j.vaccine.2004.11.028; Wang DQ, 2004, INT J ONCOL, V24, P901; Wang H, 2006, MOL CANCER THER, V5, P1585, DOI 10.1158/1535-7163.MCT-06-0094; Yu D, 2002, NUCLEIC ACIDS RES, V30, P4460, DOI 10.1093/nar/gkf582	39	137	141	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38111	10.1371/journal.pone.0038111	http://dx.doi.org/10.1371/journal.pone.0038111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666458	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400083
J	Aljubran, SA; Cox, R; Parthasarathy, PT; Ramanathan, GK; Rajanbabu, V; Bao, H; Mohapatra, SM; Lockey, R; Kolliputi, N				Aljubran, Salman A.; Cox, Ruan, Jr.; Parthasarathy, Prasanna Tamarapu; Ramanathan, Gurukumar Kollongod; Rajanbabu, Venugopal; Huynh Bao; Mohapatra, Shyam M.; Lockey, Richard; Kolliputi, Narasaiah			Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							OPERATION EVEREST-II; GROUP PROTEIN EZH2; POLYCOMB PROTEIN; HYPERTENSION; CANCER; CALPONIN; OVEREXPRESSION; APOPTOSIS; ALTITUDE; HYPOXIA	Introduction: Pulmonary Arterial Hypertension (PAH) is a progressively devastating disease characterized by excessive proliferation of the Pulmonary Arterial Smooth Muscle Cells (PASMCs). Studies suggest that PAH and cancers share an apoptosis-resistant state featuring excessive cell proliferation. The proliferation of cancer cells is mediated by increased expression of Enhancer of Zeste Homolog 2 (EZH2), a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes. However, the role of EZH2 in PAH has not been studied. In this study, it is hypothesized that EZH2 could play a role in the proliferation of PASMCs. Methods: In the present study, the expression patterns of EZH2 were investigated in normal and hypertensive mouse PASMCs. The effects of EZH2 overexpression on the proliferation of human PASMCs were tested. PASMCs were transfected with EZH2 or GFP using nucleofector system. After transfection, the cells were incubated for 48 hours at 37 degrees C. Proliferation and cell cycle analysis were performed using flow cytometry. Apoptosis of PASMCs was determined using annexin V staining and cell migration was tested by wound healing assay. Results: EZH2 protein expression in mouse PASMCs were correlated with an increase in right ventricular systolic pressure and Right Ventricular Hypertrophy (RVH). The overexpression of EZH2 in human PASMCs enhances proliferation, migration, and decrease in the rate of apoptosis when compared to GFP-transfected cells. In the G2/M phase of the EZH2 transfected cells, there was a 3.5 fold increase in proliferation, while there was a significant decrease in the rate of apoptosis of PASMCs, when compared to control. Conclusion: These findings suggest that EZH2 plays a role in the migration and proliferation of PASMCs, which is a major hallmark in PAH. It also suggests that EZH2 could play a role in the development of PAH and can serve as a potential target for new therapies for PAH.	[Aljubran, Salman A.; Cox, Ruan, Jr.; Parthasarathy, Prasanna Tamarapu; Ramanathan, Gurukumar Kollongod; Rajanbabu, Venugopal; Huynh Bao; Lockey, Richard; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Div Allergy & Immunol, Tampa, FL 33620 USA; [Mohapatra, Shyam M.] Univ S Florida, Morsani Coll Med, Nanomed Res Ctr, Tampa, FL USA; [Mohapatra, Shyam M.] Univ S Florida, Morsani Coll Med, Div Translat Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Aljubran, SA (corresponding author), Univ S Florida, Morsani Coll Med, Div Allergy & Immunol, Tampa, FL 33620 USA.	nkollipu@health.usf.edu	Kolliputi, Narasaiah/I-6050-2012; Rajanbabu, Venugopal/AAE-5576-2020	Kolliputi, Narasaiah/0000-0002-2654-1900; Rajanbabu, Venugopal/0000-0001-8761-3333	American Heart Association National Scientist Development Grant [09SDG2260957]; National Institutes of Health [R01 HL105932]; Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the American Heart Association National Scientist Development Grant 09SDG2260957 and National Institutes of Health R01 HL105932 to NK and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Archer SL, 2006, CURR OPIN CARDIOL, V21, P385; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; ARIASSTELLA J, 1963, CIRCULATION, V28, P915, DOI 10.1161/01.CIR.28.5.915; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Dromparis P, 2010, J MOL MED, V88, P1003, DOI 10.1007/s00109-010-0670-x; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Durak H, 2010, BRATISL MED J, V111, P432; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Gladwin MT, 2010, AM J RESP CRIT CARE, V181, P1020, DOI 10.1164/rccm.201002-0235UP; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P5476, DOI 10.1002/cncr.26179; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Jiang Z, 1997, FEBS LETT, V413, P441, DOI 10.1016/S0014-5793(97)00944-7; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kolliputi N, 2009, AM J RESP CELL MOL, V40, P314, DOI 10.1165/rcmb.2007-0287OC; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Sakao S, 2011, INT J CARDIOL, V147, P4, DOI 10.1016/j.ijcard.2010.07.003; Sklepkiewicz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018883; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sutendra G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002194; Tonini T, 2008, J CELL PHYSIOL, V214, P295, DOI 10.1002/jcp.21241; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Xu XF, 2011, HYPERTENS RES, V34, P981, DOI 10.1038/hr.2011.79; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5	38	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37712	10.1371/journal.pone.0037712	http://dx.doi.org/10.1371/journal.pone.0037712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662197	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300087
J	Byun, K; Bayarsaikhan, E; Kim, D; Kim, CY; Mook-Jung, I; Paek, SH; Kim, SU; Yamamoto, T; Won, MH; Song, BJ; Park, YM; Lee, B				Byun, Kyunghee; Bayarsaikhan, Enkhjaigal; Kim, Daesik; Kim, Chae Young; Mook-Jung, Inhee; Paek, Sun Ha; Kim, Seung U.; Yamamoto, Tadashi; Won, Moo-Ho; Song, Byoung-Joon; Park, Young Mok; Lee, Bonghee			Induction of Neuronal Death by Microglial AGE-Albumin: Implications for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ADVANCED GLYCATION ENDPRODUCTS; CEREBROSPINAL-FLUID; PROGRESSION FACTOR; PROTEIN; ACTIVATION; APOPTOSIS; SYSTEM; IMMUNE; CELLS	Advanced glycation end products (AGEs) have long been considered as potent molecules promoting neuronal cell death and contributing to neurodegenerative disorders such as Alzheimer's disease (AD). In this study, we demonstrate that AGE-albumin, the most abundant AGE product in human AD brains, is synthesized in activated microglial cells and secreted into the extracellular space. The rate of AGE-albumin synthesis in human microglial cells is markedly increased by amyloid-beta exposure and oxidative stress. Exogenous AGE-albumin upregulates the receptor protein for AGE (RAGE) and augments calcium influx, leading to apoptosis of human primary neurons. In animal experiments, soluble RAGE (sRAGE), pyridoxamine or ALT-711 prevented A beta-induced neuronal death in rat brains. Collectively, these results provide evidence for a new mechanism by which microglial cells promote death of neuronal cells through synthesis and secretion of AGE-albumin, thereby likely contributing to neurodegenerative diseases such as AD.	[Byun, Kyunghee; Bayarsaikhan, Enkhjaigal; Kim, Daesik; Lee, Bonghee] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea; [Byun, Kyunghee; Lee, Bonghee] Gachon Univ Med & Sci, Dept Anat & Cell Biol, Inchon, South Korea; [Kim, Chae Young; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Yamamoto, Tadashi] Niigata Univ, Inst Nephrol, Grad Sch Med & Dent Sci, Niigata, Japan; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, South Korea; [Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Park, Young Mok] Korea Basic Sci Inst, Mass Spectrometer Res Ctr, Chungcheong Bukdo, South Korea	Gachon University; Gachon University; Seoul National University (SNU); Seoul National University (SNU); University of British Columbia; Niigata University; Kangwon National University; Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Korea Basic Science Institute (KBSI)	Byun, K (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea.	ympark@kbsi.re.kr; bhlee@gachon.ac.kr	Paek, Sun Ha/J-2760-2012; Mook, Inhee/J-2754-2012; Kim, Chaeyoung/GPW-6531-2022		National Research Foundation grant; Korean Government [SC-2110, 20110003677, 2010-0002054]; KBSI (Korea Basic Science Institute) grant [G30124]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	National Research Foundation grant(National Research Foundation of Korea); Korean Government(Korean Government); KBSI (Korea Basic Science Institute) grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Research Foundation grant funded by the Korean Government (No. SC-2110, 20110003677 and 2010-0002054) and the KBSI (Korea Basic Science Institute) grant (G30124; Y.M.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; [Anonymous], 2002, CELL CALCIUM, V40, P553; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eikelenboom P, 2000, ALZ DIS ASSOC DIS, V14, pS54, DOI 10.1097/00002093-200000001-00009; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Gsell W, 1996, J NEURAL TRANSM-SUPP, P73; Gsell W, 1997, J NEURAL TRANSM-SUPP, P145; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Ko HW, 1998, J NEUROCHEM, V71, P1390; Ko HW, 1998, KO HW PARK KY KIM H; Krautwald M, 2011, REJUV RES, V14, P383, DOI 10.1089/rej.2010.1143; LeBlanc A, 1995, J NEUROSCI, V15, P7837; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; LUBERNAROD J, 1988, NEUROSCI LETT, V94, P17, DOI 10.1016/0304-3940(88)90263-7; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1; Munch G, 1998, J NEURAL TRANSM, V105, P439, DOI 10.1007/s007020050069; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rahmadi A, 2011, CLIN CHEM LAB MED, V49, P385, DOI 10.1515/CCLM.2011.079; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHUMACHER U, 1994, ACTA NEUROPATHOL, V87, P422; Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takeuchi M, 2007, MED HYPOTHESES, V69, P1358, DOI 10.1016/j.mehy.2006.12.017; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030	34	59	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37917	10.1371/journal.pone.0037917	http://dx.doi.org/10.1371/journal.pone.0037917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662249	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300140
J	Furger, E; Fedosov, SN; Lildballe, DL; Waibel, R; Schibli, R; Nexo, E; Fischer, E				Furger, Evelyne; Fedosov, Sergey N.; Lildballe, Dorte Launholt; Waibel, Robert; Schibli, Roger; Nexo, Ebba; Fischer, Eliane			Comparison of Recombinant Human Haptocorrin Expressed in Human Embryonic Kidney Cells and Native Haptocorrin	PLOS ONE			English	Article							HUMAN INTRINSIC-FACTOR; VITAMIN-B12 BINDING-PROTEINS; COBALAMIN-BINDING; HEPATOCELLULAR-CARCINOMA; AFFINITY-CHROMATOGRAPHY; TRANSCOBALAMIN-I; HUMAN-PLASMA; ANALOGS; PURIFICATION; RECOGNITION	Haptocorrin (HC) is a circulating corrinoid binding protein with unclear function. In contrast to transcobalamin, the other transport protein in blood, HC is heavily glycosylated and binds a variety of cobalamin (Cbl) analogues. HC is present not only in blood but also in various secretions like milk, tears and saliva. No recombinant form of HC has been described so far. We report the expression of recombinant human HC (rhHC) in human embryonic kidney cells. We purified the protein with a yield of 6 mg (90 nmol) per litre of cell culture supernatant. The isolated rhHC behaved as native HC concerning its spectral properties and ability to recognize both Cbl and its baseless analogue cobinamide. Similar to native HC isolated from blood, rhHC bound to the asialoglycoprotein receptor only after removal of terminal sialic acid residues by treatment with neuraminidase. Interestingly, rhHC, that compared to native HC contains four excessive amino acids ( ... LVPR) at the C-terminus, showed subtle changes in the binding kinetics of Cbl, cobinamide and the fluorescent Cbl conjugate CBC. The recombinant protein has properties very similar to native HC and although showing slightly different ligand binding kinetics, rhHC is valuable for further biochemical and structural studies.	[Furger, Evelyne; Waibel, Robert; Schibli, Roger; Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, Villigen, Switzerland; [Fedosov, Sergey N.] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Lildballe, Dorte Launholt; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Aarhus University; Aarhus University	Furger, E (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci, Villigen, Switzerland.	eliane.fischer@psi.ch	Fedosov, Sergey N./J-2340-2019; Fischer, Eliane/M-2590-2013	Fedosov, Sergey N./0000-0002-7016-2959; Fischer, Eliane/0000-0002-3399-3737; Schibli, Roger/0000-0002-1537-3833; Nexo, Ebba/0000-0001-9406-9081	PSI Forschungskommission; Danish Medical Research Council; Lundbeck Foundation	PSI Forschungskommission; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the PSI Forschungskommission, The Danish Medical Research Council, and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGER RL, 1975, J CLIN INVEST, V56, P1262, DOI 10.1172/JCI108202; BURGER RL, 1975, J BIOL CHEM, V250, P7707; BURGER RL, 1974, J BIOL CHEM, V249, P7220; Clardy SM, 2011, EXPERT OPIN DRUG DEL, V8, P127, DOI 10.1517/17425247.2011.539200; Fedosov SN, 2007, J ORGANOMET CHEM, V692, P1234, DOI 10.1016/j.jorganchem.2006.08.081; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2006, FEBS J, V273, P4742, DOI 10.1111/j.1742-4658.2006.05478.x; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Fedosov SN, 2005, BIOCHEMISTRY-US, V44, P3604, DOI 10.1021/bi047936v; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; Fedosov SN, 2003, EUR J BIOCHEM, V270, P3362, DOI 10.1046/j.1432-1033.2003.03716.x; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; GORDON M, 1992, BIOCHIM BIOPHYS ACTA, V1132, P276, DOI 10.1016/0167-4781(92)90161-R; Grunberg J, 2003, BIOTECHNIQUES, V34, P968, DOI 10.2144/03345st02; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Henning Stefanie, 2009, V492, P181, DOI 10.1007/978-1-59745-493-3_10; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Lildballe DL, 2011, EJSO-EUR J SURG ONC, V37, P72, DOI 10.1016/j.ejso.2010.11.001; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Morkbak AL, 2005, CLIN CHIM ACTA, V356, P184, DOI 10.1016/j.cccn.2005.01.013; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1976, BIOCHIM BIOPHYS ACTA, V446, P143, DOI 10.1016/0005-2795(76)90106-9; NEXO E, 1975, SCAND J HAEMATOL, V14, P320; NEXO E, 1978, SCAND J HAEMATOL, V20, P221; NEXO E, 1975, SCAND J CLIN LAB INV, V35, P683, DOI 10.3109/00365517509095798; Nexo E., 1998, VITAMIN B12 B12 PROT; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; QUADROS EV, 1993, BLOOD, V81, P1239; Sandig V., 2005, PRODUCTION RECOMBINA, P233; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394; YANG SY, 1982, BLOOD, V59, P747	40	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37421	10.1371/journal.pone.0037421	http://dx.doi.org/10.1371/journal.pone.0037421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662153	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300042
J	Villar, VH; Vogler, O; Martinez-Serra, J; Ramos, R; Calabuig-Farinas, S; Gutierrez, A; Barcelo, F; Martin-Broto, J; Alemany, R				Hugo Villar, Victor; Voegler, Oliver; Martinez-Serra, Jordi; Ramos, Rafael; Calabuig-Farinas, Silvia; Gutierrez, Antonio; Barcelo, Francisca; Martin-Broto, Javier; Alemany, Regina			Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE INHIBITORS; DOSE DOXORUBICIN; CANCER-THERAPY; CELL-LINES; BCR-ABL; PHASE-I; IMATINIB; SUNITINIB	The therapeutic effect of doxorubicin (DXR) in the treatment of soft tissue sarcomas (STS) is limited by its toxicity and the development of multidrug resistance (MDR), the latter mainly induced by high expression of efflux pumps (e. g., P-glycoprotein [P-gp]). Therefore, the search for alternative therapies, which sensitize these tumors to chemotherapy while maintaining a low toxicity profile, is a rational approach. We assessed efficacy and molecular mechanisms involved in the antiproliferative effects of the tyrosine kinase inhibitors, nilotinib and imatinib, as single agents or in combination with DXR, in human synovial sarcoma SW982 and leiomyosarcoma SK-UT-1 cells. As single compound nilotinib (1-10 mu M) was more potent than imatinib inhibiting the growth of SK-UT-1 and SW982 cells by 33.5-59.6%, respectively. Importantly, only nilotinib synergized the antitumoral effect of DXR (0.05-0.5 mu M) by at least 2-fold, which clearly surpassed the mere sum of effects according to isobolographic analysis. Moreover, nilotinib in combination with DXR had a sustained effect on cell number (-70.3+/-5.8%) even 12 days after withdrawal of drugs compared to DXR alone. On the molecular level, only nilotinib fully blocked FBS-induced ERK1 and p38 MAPK activation, hence, reducing basal and DXR-induced up-regulation of P-gp levels. Moreover, efflux activity of the MDR-related proteins P-gp and MRP-1 was inhibited, altogether resulting in intracellular DXR retention. In high-risk STS tumors 53.8% and 15.4% were positive for P-gp and MRP-1 expression, respectively, with high incidence of P-gp in synovial sarcoma (72.7%). In summary, nilotinib exhibits antiproliferative effects on cellular models of STS and sensitizes them to DXR by reverting DXR-induced P-gp-mediated MDR and inhibiting MRP-1 activity, leading to a synergistic effect with potential for clinical treatment.	[Hugo Villar, Victor; Voegler, Oliver; Martinez-Serra, Jordi; Ramos, Rafael; Calabuig-Farinas, Silvia; Gutierrez, Antonio; Barcelo, Francisca; Martin-Broto, Javier; Alemany, Regina] Univ Balearic Isl, Clin & Translat Res Grp, Dept Biol, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain; [Martinez-Serra, Jordi; Gutierrez, Antonio] Univ Hosp Son Espases, Dept Hematol, Palma De Mallorca, Spain; [Ramos, Rafael] Univ Hosp Son Espases, Dept Pathol, Palma De Mallorca, Spain; [Calabuig-Farinas, Silvia; Martin-Broto, Javier] Univ Hosp Son Espases, Dept Oncol, Palma De Mallorca, Spain	Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases	Villar, VH (corresponding author), Univ Balearic Isl, Clin & Translat Res Grp, Dept Biol, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain.	regina.alemany@uib.es	VILLAR, VICTOR H./AAD-2404-2020; Fariñas, Silvia Calabuig/D-8196-2018; IBIS, BIOMARCADORES/P-3515-2015; Alemany, Regina/A-2314-2011; Martinez-Serra, Jordi/C-2535-2009; Martín-Broto, Javier/AAI-2313-2019; Villar, Victor H./GQA-6295-2022; Barceló, Francisca/K-5288-2014; Vögler, Oliver/D-7658-2011; Villar, Victor H./GQR-0553-2022; Gutiérrez, Antonio/AAL-9381-2021	Villar, Victor H./0000-0003-2837-5018; Barceló, Francisca/0000-0002-9158-099X; Villar, Victor H./0000-0003-2837-5018; Martin-Broto, Javier/0000-0001-7350-6916; Alemany, Regina/0000-0003-2180-1213; Calabuig, Silvia/0000-0001-7749-174X	"Jose Ma Buesa del grupo GEIS"; "Asociacion Espanola contra el Cancer (Junta de Baleares)"; Spanish Ministry of Health [EC10-150]; "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)"	"Jose Ma Buesa del grupo GEIS"; "Asociacion Espanola contra el Cancer (Junta de Baleares)"; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)"	Research was supported by grants "Jose Ma Buesa del grupo GEIS" and the "Asociacion Espanola contra el Cancer (Junta de Baleares)" and by Grand EC10-150 awarded by the Spanish Ministry of Health in 2010 (Independent Clinical Research Call). V. H. V. is supported by a PhD fellowship from the "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; DeAngelo DJ, 2010, LEUKEMIA LYMPHOMA, V51, P363, DOI 10.3109/10428190903518295; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Gonzalez I, 2004, CLIN CANCER RES, V10, P751, DOI 10.1158/1078-0432.CCR-0778-03; Gooskens SLM, 2010, PEDIATR BLOOD CANCER, V55, P369, DOI 10.1002/pbc.22494; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gramza AW, 2009, CLIN CANCER RES, V15, P7510, DOI 10.1158/1078-0432.CCR-09-0190; Gronchi A, 2010, J CLIN ONCOL, V28, p15s; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Hamada A, 2003, J PHARMACOL EXP THER, V307, P824, DOI 10.1124/jpet.103.055574; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Moreno BH, 2010, CLIN TRANSL ONCOL, V12, P468, DOI 10.1007/s12094-010-0539-z; Le Cesne A, 2000, J CLIN ONCOL, V18, P2676, DOI 10.1200/JCO.2000.18.14.2676; Lu MS, 2008, J HUAZHONG U SCI-MED, V28, P451, DOI 10.1007/s11596-008-0417-x; Lubieniecka JM, 2005, J SURG ONCOL, V92, P267, DOI 10.1002/jso.20409; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Maurel J, 2010, CANCER-AM CANCER SOC, V116, P3692, DOI 10.1002/cncr.25111; Mealey KL, 1998, CANCER LETT, V126, P187, DOI 10.1016/S0304-3835(98)00004-4; Milano A, 2006, CRIT REV ONCOL HEMAT, V59, P74, DOI 10.1016/j.critrevonc.2005.12.002; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Nichols GL, 2003, CANCER INVEST, V21, P758, DOI 10.1081/CNV-120023774; O'Connor R, 2007, ANTICANCER RES, V27, P1267; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Peng CL, 2009, CANCER BIOL THER, V8, P1729, DOI 10.4161/cbt.8.18.9208; Potti A, 2004, ANTICANCER RES, V24, P333; Prenen H, 2006, PHARMACOLOGY, V77, P11, DOI 10.1159/000091943; Quintas-Cardama A, 2008, FUTURE ONCOL, V4, P611, DOI 10.2217/14796694.4.5.611; Reichardt P, 2008, CURR ONCOL REP, V10, P344, DOI 10.1007/s11912-008-0053-4; SCHOENFELD DA, 1982, CANCER, V50, P2757, DOI 10.1002/1097-0142(19821215)50:12<2757::AID-CNCR2820501211>3.0.CO;2-J; Serra JM, 2008, MOL PHARMACOL, V73, P1679, DOI 10.1124/mol.107.043372; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Swords R, 2009, DRUG DES DEV THER, V3, P89; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687	44	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37735	10.1371/journal.pone.0037735	http://dx.doi.org/10.1371/journal.pone.0037735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662203	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300093
J	Lohmann, M; Walenda, G; Hemeda, H; Joussen, S; Drescher, W; Jockenhoevel, S; Hutschenreuter, G; Zenke, M; Wagner, W				Lohmann, Michael; Walenda, Gudrun; Hemeda, Hatim; Joussen, Sylvia; Drescher, Wolf; Jockenhoevel, Stefan; Hutschenreuter, Gabriele; Zenke, Martin; Wagner, Wolfgang			Donor Age of Human Platelet Lysate Affects Proliferation and Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							FETAL BOVINE SERUM; FIBROBLAST-GROWTH-FACTOR; STROMAL CELLS; RICH PLASMA; DNA-METHYLATION; OSTEOGENIC DIFFERENTIATION; INTERNATIONAL-SOCIETY; ANIMAL SERUM; CALF SERUM; LIFE-SPAN	The regenerative potential declines upon aging. This might be due to cell-intrinsic changes in stem and progenitor cells or to influences by the microenvironment. Mesenchymal stem cells (MSC) raise high hopes in regenerative medicine. They are usually culture expanded in media with fetal calf serum (FCS) or other serum supplements such as human platelet lysate (HPL). In this study, we have analyzed the impact of HPL-donor age on culture expansion. 31 single donor derived HPLs (25 to 57 years old) were simultaneously compared for culture of MSC. Proliferation of MSC did not reveal a clear association with platelet counts of HPL donors or growth factors concentrations (PDGF-AB, TGF-beta 1, bFGF, or IGF-1), but it was significantly higher with HPLs from younger donors (<35 years) as compared to older donors (>45 years). Furthermore, HPLs from older donors increased activity of senescence-associated beta-galactosidase (SA-beta gal). HPL-donor age did not affect the fibroblastoid colony-forming unit (CFU-f) frequency, immunophenotype or induction of adipogenic differentiation, whereas osteogenic differentiation was significantly lower with HPLs from older donors. Concentrations of various growth factors (PDGF-AB, TGF-beta 1, bFGF, IGF-1) or hormones (estradiol, parathormone, leptin, 1,25 vitamin D3) were not associated with HPL-donor age or MSC growth. Taken together, our data support the notion that aging is associated with systemic feedback mechanisms acting on stem and progenitor cells, and this is also relevant for serum supplements in cell culture: HPLs derived from younger donors facilitate enhanced expansion and more pronounced osteogenic differentiation.	[Lohmann, Michael; Walenda, Gudrun; Hemeda, Hatim; Joussen, Sylvia; Zenke, Martin; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Dept Stem Cell Biol & Cellular Engn, Helmholtz Inst Biomed Engn, Aachen, Germany; [Drescher, Wolf] Rhein Westfal TH Aachen, Dept Orthoped, Sch Med, D-52062 Aachen, Germany; [Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Dept Appl Med Engn, Helmholtz Inst Biomed Engn, D-52062 Aachen, Germany; [Hutschenreuter, Gabriele] Rhein Westfal TH Aachen, Sch Med, Inst Transfus Med, D-52062 Aachen, Germany; [Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Inst Biomed Engn Cell Biol, D-52062 Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Lohmann, M (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Stem Cell Biol & Cellular Engn, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de		Jockenhoevel, Stefan/0000-0003-0584-9444; Wagner, Wolfgang/0000-0002-1971-3217	German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES); Else-Kroner Fresenius Stiftung; state North Rhine Westphalia within BioNRW2 (StemCellFactory); state North Rhine Westphalia within Stem Cell Network NRW	German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES)(Federal Ministry of Education & Research (BMBF)); Else-Kroner Fresenius Stiftung; state North Rhine Westphalia within BioNRW2 (StemCellFactory); state North Rhine Westphalia within Stem Cell Network NRW	This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES), by the Else-Kroner Fresenius Stiftung, and by the state North Rhine Westphalia within BioNRW2 (StemCellFactory) and the Stem Cell Network NRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Auer D, 2008, ANTICANCER RES, V28, P2213; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carrel A, 1921, J EXP MED, V34, P599, DOI 10.1084/jem.34.6.599; Chieregato K, 2011, CYTOTHERAPY, V13, P933, DOI 10.3109/14653249.2011.583232; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; DOUMIT ME, 1993, J CELL PHYSIOL, V157, P326, DOI 10.1002/jcp.1041570216; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; George T, 2010, EXP GERONTOL, V45, P875, DOI 10.1016/j.exger.2010.07.006; Goedecke A, 2011, J TISSUE ENG REGEN M, V5, P648, DOI 10.1002/term.359; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang Q, 2009, CHINESE MED J-PEKING, V122, P83, DOI 10.3760/cma.j.issn.0366-6999.2009.01.015; HWANG DL, 1992, EXP CELL RES, V200, P358, DOI 10.1016/0014-4827(92)90183-9; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; KONDO H, 1988, EXP CELL RES, V178, P287, DOI 10.1016/0014-4827(88)90399-0; Kumar A, 2010, TISSUE ENG PT A, V16, P983, DOI [10.1089/ten.tea.2009.0230, 10.1089/ten.TEA.2009.0230]; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lucchini G, 2010, BIOL BLOOD MARROW TR, V16, P1293, DOI 10.1016/j.bbmt.2010.03.017; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ogino Y, 2006, ORAL SURG ORAL MED O, V101, P724, DOI 10.1016/j.tripleo.2005.08.016; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Parker RC, 1931, SCIENCE, V74, P181, DOI 10.1126/science.74.1911.181; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schallmoser Katharina, 2009, J Vis Exp, DOI 10.3791/1523; Schallmoser K, 2009, BIO-MED MATER ENG, V19, P271, DOI 10.3233/BME-2009-0591; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; von Bonin M, 2009, BONE MARROW TRANSPL, V43, P245, DOI 10.1038/bmt.2008.316; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0; Wirz S, 2011, TISSUE ENG PT A, V17, P1891, DOI [10.1089/ten.tea.2010.0610, 10.1089/ten.TEA.2010.0610]; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	61	106	113	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37839	10.1371/journal.pone.0037839	http://dx.doi.org/10.1371/journal.pone.0037839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662236	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300126
J	Lu, CC; Yang, JS; Chiang, JH; Hour, MJ; Lin, KL; Lin, JJ; Huang, WW; Tsuzuki, M; Lee, TH; Chung, JG				Lu, Chi-Cheng; Yang, Jai-Sing; Chiang, Jo-Hua; Hour, Mann-Jen; Lin, Kuei-Li; Lin, Jen-Jyh; Huang, Wen-Wen; Tsuzuki, Minoru; Lee, Tsung-Han; Chung, Jing-Gung			Novel Quinazolinone MJ-29 Triggers Endoplasmic Reticulum Stress and Intrinsic Apoptosis in Murine Leukemia WEHI-3 Cells and Inhibits Leukemic Mice	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VIVO; TUBULIN POLYMERIZATION; ANTITUMOR-ACTIVITY; IMMUNE-RESPONSE; BINDING AGENTS; BALB/C MICE; DEATH; CANCER	The present study was to explore the biological responses of the newly compound, MJ-29 in murine myelomonocytic leukemia WEHI-3 cells in vitro and in vivo fates. We focused on the in vitro effects of MJ-29 on ER stress and mitochondria-dependent apoptotic death in WEHI-3 cells, and to hypothesize that MJ-29 might fully impair the orthotopic leukemic mice. Our results indicated that a concentration-dependent decrease of cell viability was shown in MJ-29-treated cells. DNA content was examined utilizing flow cytometry, whereas apoptotic populations were determined using annexin V/PI, DAPI staining and TUNEL assay. Increasing vital factors of mitochondrial dysfunction by MJ-29 were further investigated. Thus, MJ-29-provaked apoptosis of WEHI-3 cells is mediated through the intrinsic pathway. Importantly, intracellular Ca2+ release and ER stress-associated signaling also contributed to MJ-29-triggered cell apoptosis. We found that MJ-29 stimulated the protein levels of calpain 1, CHOP and p-eIF2 alpha pathways in WEHI-3 cells. In in vivo experiments, intraperitoneal administration of MJ-29 significantly improved the total survival rate, enhanced body weight and attenuated enlarged spleen and liver tissues in leukemic mice. The infiltration of immature myeloblastic cells into splenic red pulp was reduced in MJ-29-treated leukemic mice. Moreover, MJ-29 increased the differentiations of T and B cells but decreased that of macrophages and monocytes. Additionally, MJ-29-stimulated immune responses might be involved in anti-leukemic activity in vivo. Based on these observations, MJ-29 suppresses WEHI-3 cells in vitro and in vivo, and it is proposed that this potent and selective agent could be a new chemotherapeutic candidate for anti-leukemia in the future.	[Lu, Chi-Cheng; Chiang, Jo-Hua; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Jai-Sing] China Med Univ, Dept Pharmacol, Taichung, Taiwan; [Hour, Mann-Jen] China Med Univ, Sch Pharm, Taichung, Taiwan; [Lin, Kuei-Li] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Jen-Jyh] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Lin, Jen-Jyh] China Med Univ Hosp, Div Cardiol, Taichung, Taiwan; [Huang, Wen-Wen; Lee, Tsung-Han; Chung, Jing-Gung] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Tsuzuki, Minoru] Nihon Pharmaceut Univ, Dept Biochem, Saitama, Japan; [Tsuzuki, Minoru] China Med Univ, Tsuzuki Inst Tradit Med, Taichung, Taiwan; [Chung, Jing-Gung] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Chi Mei Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Lu, CC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@dragon.nchu.edu.tw; jgchung@mail.cmu.edu.tw	huang, wen/GXW-0661-2022; Chiang, Jo-Hua/E-4411-2016; Yang, Jai Sing/M-1162-2015; Lu, Chi-Cheng/N-7770-2013; Huang, WW/GXH-0977-2022	Yang, Jai Sing/0000-0001-7302-8248; Lu, Chi-Cheng/0000-0003-3149-0914; Lee, Tsung-Han/0000-0002-3542-4335	National Science Council, Republic of China (Taiwan) [NSC 95-2320-B-039-049-MY2]; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence	The authors thank the grant-in-aid (NSC 95-2320-B-039-049-MY2) from the National Science Council, Republic of China ( Taiwan) and the grant support by the Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astashkin E I, 2004, Dokl Biol Sci, V399, P500, DOI 10.1007/s10630-005-0023-z; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Ceruti S, 2003, MOL PHARMACOL, V63, P1437, DOI 10.1124/mol.63.6.1437; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; Chen JC, 2000, CYTOBIOS, V102, P95; Chiang JH, 2011, CHEM RES TOXICOL, V24, P20, DOI 10.1021/tx100248s; Choi AY, 2011, EUR J PHARMACOL, V668, P115, DOI 10.1016/j.ejphar.2011.06.047; Chung JG, 2007, PROTEOMICS, V7, P3305, DOI 10.1002/pmic.200700200; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Funk RK, 2008, BLOOD, V112, P1434, DOI 10.1182/blood-2008-01-132084; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; He Q, 2001, LEUKEMIA RES, V25, P455, DOI 10.1016/S0145-2126(00)00153-3; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Hour MJ, 2007, J CHIN CHEM SOC-TAIP, V54, P785, DOI 10.1002/jccs.200700113; Hour MJ, 2000, J MED CHEM, V43, P4479, DOI 10.1021/jm000151c; Itzykson R, 2009, LEUKEMIA, V23, P673, DOI 10.1038/leu.2008.362; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelloff GJ, 2000, J NUTR, V130, p467S, DOI 10.1093/jn/130.2.467S; LANDRIGAN PJ, 1995, NEW ENGL J MED, V333, P1286; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee SJ, 2007, BIOCHEM BIOPH RES CO, V357, P620, DOI 10.1016/j.bbrc.2007.03.191; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Lin JP, 2011, ENV TOXICOL; Lin SY, 2010, NUTR CANCER, V62, P593, DOI 10.1080/01635580903532341; Lin SS, 2000, NEUROCHEM RES, V25, P1503, DOI 10.1023/A:1007632326953; Liu T, 2002, LEUKEMIA, V16, P223, DOI 10.1038/sj.leu.2402360; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Moretta L, 2007, SURG ONCOL, V16, pS3, DOI 10.1016/j.suronc.2007.10.043; Morris PG, 2008, CLIN CANCER RES, V14, P7167, DOI 10.1158/1078-0432.CCR-08-0169; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ripamonti M, 1996, INVEST NEW DRUG, V14, P139; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sitaresmi MN, 2009, J PEDIATR ONCOL NURS, V26, P198, DOI 10.1177/1043454209340315; Stahnke K, 2003, LEUKEMIA, V17, P2130, DOI 10.1038/sj.leu.2403144; Tsou MF, 2009, LEUKEMIA RES, V33, P1505, DOI 10.1016/j.leukres.2009.01.030; Weisberg E, 2004, LEUKEMIA, V18, P1951, DOI 10.1038/sj.leu.2403519; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu PP, 2011, ONCOL REP, V25, P551, DOI 10.3892/or.2010.1080; Yang JS, 2010, J PHARMACOL EXP THER, V334, P477, DOI 10.1124/jpet.109.165415; Yang JS, 2006, ANTICANCER RES, V26, P219; Yang JS, 2004, ANTICANCER RES, V24, P1769; Yu FS, 2011, J DENT RES, V90, P168, DOI 10.1177/0022034510384619; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	58	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36831	10.1371/journal.pone.0036831	http://dx.doi.org/10.1371/journal.pone.0036831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662126	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300017
J	Meeran, SM; Patel, SN; Li, YY; Shukla, S; Tollefsbol, TO				Meeran, Syed M.; Patel, Shweta N.; Li, Yuanyuan; Shukla, Samriddhi; Tollefsbol, Trygve O.			Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HISTONE DEACETYLASE INHIBITOR; TUMOR-SUPPRESSOR GENES; DNA METHYLTRANSFERASE; TEA POLYPHENOL; METHYLATION; APOPTOSIS; GROWTH; SULFORAPHANE; MECHANISMS	Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tamoxifen therapy is successful for some patients, it does not provide adequate benefit for those who have estrogen receptor (ER)-negative cancers. Therefore, we approached novel treatment strategies by combining two potential bioactive dietary supplements for the reactivation of ER alpha expression for effective treatment of ER alpha-negative breast cancer with tamoxifen. Bioactive dietary supplements such as green tea polyphenols (GTPs) and sulforaphane (SFN) inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), respectively, which are of central importance to cancer prevention. In the present study, we have observed that treatment of ER alpha-negative breast cancer cells with GTPs and SFN alone or in combination leads to the reactivation of ER alpha expression. The combination of 20 mu g/mL GTPs and 5 mu M SFN was found to be the optimal dose of ER alpha-reactivation at 3 days in MDA-MB-231 cells. The reactivation of ER alpha expression was consistently correlated with ER alpha promoter hypomethylation and hyperacetylation. Chromatin immunoprecipitation (ChIP) analysis of the ER alpha promoter revealed that GTPs and SFN altered the binding of ER alpha-transcriptional co-repressor complex thereby contributing to ER alpha-activation. In addition, treatment with tamoxifen in combination with GTPs and SFN significantly increased both cell death and inhibition of cellular proliferation in MDA-MB-231 cells in comparison to treatment with tamoxifen alone. Collectively, our findings suggest that a novel combination of bioactive-HDAC inhibitors with bioactive-demethylating agents is a promising strategy for the effective treatment of hormonal refractory breast cancer with available anti-estrogens.	[Meeran, Syed M.; Shukla, Samriddhi] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Meeran, Syed M.; Patel, Shweta N.; Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Meeran, SM (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	s.musthapa@cdri.res.in	Shukla, Samriddhi/AAF-1876-2021; Meeran, Syed Musthapa/AAG-2157-2020	Shukla, Samriddhi/0000-0002-3771-4184; Meeran, Syed Musthapa/0000-0003-3859-146X; Tollefsbol, Trygve/0000-0002-0284-1511	National Cancer Institute, National Institutes of Health [R01 CA129415]; American Institute for Cancer Research; Ministry of Health and Family Welfare, Government of India, India; CSIR, Government of India; NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; Ministry of Health and Family Welfare, Government of India, India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to TOT from the National Cancer Institute, National Institutes of Health (R01 CA129415) and the American Institute for Cancer Research. Part of the work was also supported by the Ministry of Health and Family Welfare, Government of India, India (SMM). Junior Research Fellowship grant from CSIR, Government of India, is also acknowledged (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Fang MZ, 2003, CANCER RES, V63, P7563; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Issa JPJ, 1996, CANCER RES, V56, P973; Jang ER, 2004, ONCOGENE, V23, P1724, DOI 10.1038/sj.onc.1207315; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Landis-Piwowar KR, 2008, J CELL BIOCHEM, V105, P514, DOI 10.1002/jcb.21853; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Li YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-274; Lin Jen-Kun, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P1; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Meeran SM, 2006, MOL CANCER THER, V5, P825, DOI 10.1158/1535-7163.MCT-06-0003; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Meeran SM, 2011, CANCER PREV RES, V4, P1243, DOI 10.1158/1940-6207.CAPR-11-0009; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Rossi C, 2008, EUR J CANCER, V44, P2696, DOI 10.1016/j.ejca.2008.08.021; Saxena Neeraj K, 2010, Mol Cell Pharmacol, V2, P191; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Yang XW, 2001, CANCER RES, V61, P7025; Zhou Q, 2007, CANCER BIOL THER, V6, P64, DOI 10.4161/cbt.6.1.3549	36	83	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37748	10.1371/journal.pone.0037748	http://dx.doi.org/10.1371/journal.pone.0037748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662208	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300098
J	Wiemann, P; Albermann, S; Niehaus, EM; Studt, L; von Bargen, KW; Brock, NL; Humpf, HU; Dickschat, JS; Tudzynski, B				Wiemann, Philipp; Albermann, Sabine; Niehaus, Eva-Maria; Studt, Lena; von Bargen, Katharina W.; Brock, Nelson L.; Humpf, Hans-Ulrich; Dickschat, Jeroen S.; Tudzynski, Bettina			The Sfp-Type 4 '-Phosphopantetheinyl Transferase Ppt1 of Fusarium fujikuroi Controls Development, Secondary Metabolism and Pathogenicity	PLOS ONE			English	Article							GIBBERELLA-FUJIKUROI; SIDEROPHORE BIOSYNTHESIS; TRANSCRIPTION FACTOR; OXIDATIVE-STRESS; SYNTHETASE GENE; USTILAGO-MAYDIS; IRON STORAGE; ACID; MONILIFORMIN; SYNTHASE	The heterothallic ascomycete Fusarium fujikuroi is a notorious rice pathogen causing super-elongation of plants due to the production of terpene-derived gibberellic acids (GAs) that function as natural plant hormones. Additionally, F. fujikuroi is able to produce a variety of polyketide- and non-ribosomal peptide-derived metabolites such as bikaverins, fusarubins and fusarins as well as metabolites from yet unidentified biosynthetic pathways, e. g. moniliformin. The key enzymes needed for their production belong to the family of polyketide synthases (PKSs) and non-ribosomal peptide synthases (NRPSs) that are generally known to be post-translationally modified by a Sfp-type 4'-phosphopantetheinyl transferase (PPTase). In this study we provide evidence that the F. fujikuroi Sfp-type PPTase FfPpt1 is essentially involved in lysine biosynthesis and production of bikaverins, fusarubins and fusarins, but not moniliformin as shown by analytical methods. Concomitantly, targeted Ffppt1 deletion mutants reveal an enhancement of terpene-derived metabolites like GAs and volatile substances such as alpha-acorenol. Pathogenicity assays on rice roots using fluorescent labeled wild-type and Ffppt1 mutant strains indicate that lysine biosynthesis and iron acquisition but not PKS and NRPS metabolism is essential for establishment of primary infections of F. fujikuroi. Additionally, FfPpt1 is involved in conidiation and sexual mating recognition possibly by activating PKS- and/or NRPS-derived metabolites that could act as diffusible signals. Furthermore, the effect on iron acquisition of Ffppt1 mutants led us to identify a previously uncharacterized putative third reductive iron uptake system (FfFtr3/FfFet3) that is closely related to the FtrA/FetC system of A. fumigatus. Functional characterization provides evidence that both proteins are involved in iron acquisition and are liable to transcriptional repression of the homolog of the Aspergillus GATA-type transcription factor SreA under iron-replete conditions. Targeted deletion of the first Fusarium homolog of this GATA-type transcription factor-encoding gene, Ffsre1, strongly indicates its involvement in regulation of iron homeostasis and oxidative stress resistance.	[Wiemann, Philipp; Albermann, Sabine; Niehaus, Eva-Maria; Studt, Lena; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, Munster, Germany; [Studt, Lena; von Bargen, Katharina W.; Humpf, Hans-Ulrich] Univ Munster, Inst Lebensmittelchem, D-4400 Munster, Germany; [Brock, Nelson L.; Dickschat, Jeroen S.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany	University of Munster; University of Munster; Braunschweig University of Technology	Wiemann, P (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, Hindenburgpl 55, Munster, Germany.	tudzynsb@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020; Studt, Lena/AAE-3991-2021	Wiemann, Philipp/0000-0002-7983-2218; Humpf, Hans-Ulrich/0000-0003-3296-3058; Studt-Reinhold, Lena/0000-0002-8738-2106	Allianz Industrie Forschung [IGF16001N]; Deutsche Forschungsgemeinschaft [TU 101/16-1, HU 730/9-1, GRK1409, DI1536/1-2]; Fonds der Chemischen Industrie	Allianz Industrie Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The project was supported by the "Allianz Industrie Forschung'' (IGF16001N); by the "Deutsche Forschungsgemeinschaft'' (TU 101/16-1; HU 730/9-1; GRK1409 and DI1536/1-2) as well as the "Fonds der Chemischen Industrie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE J, 1993, FUNGAL GENET NEWSL A, V40, P68; Allen G, 2011, FUNGAL GENET BIOL, V48, P456, DOI 10.1016/j.fgb.2010.12.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An ZQ, 1997, P NATL ACAD SCI USA, V94, P5882, DOI 10.1073/pnas.94.11.5882; Apsimon John W., 1994, P3; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AVALOS J, 1986, PHYTOCHEMISTRY, V25, P1837, DOI 10.1016/S0031-9422(00)81158-9; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; BARRERO AF, 1991, PHYTOCHEMISTRY, V30, P2259, DOI 10.1016/0031-9422(91)83625-U; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Carreto JI, 2011, MAR DRUGS, V9, P387, DOI 10.3390/md9030387; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Choquer M, 2007, FEBS LETT, V581, P489, DOI 10.1016/j.febslet.2007.01.011; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Crawford JM, 2008, CHEMBIOCHEM, V9, P1559, DOI 10.1002/cbic.200700659; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dyer RB, 2005, J AGR FOOD CHEM, V53, P9281, DOI 10.1021/jf051441a; Ehmann DE, 1999, BIOCHEMISTRY-US, V38, P6171, DOI 10.1021/bi9829940; Eichhorn H, 2006, PLANT CELL, V18, P3332, DOI 10.1105/tpc.106.043588; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; FAVREBONVIN J, 1976, CAN J CHEM, V54, P1105, DOI 10.1139/v76-158; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fotso J, 2002, APPL ENVIRON MICROB, V68, P5195, DOI 10.1128/AEM.68.10.5195-5197.2002; GAUMANN E, 1957, PHYTOPATHOLOGY, V47, P342; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Greenshields DL, 2007, MOL PLANT PATHOL, V8, P411, DOI [10.1111/j.1364-3703.2007.00401.x, 10.1111/J.1364-3703.2007.00401.X]; Haas H, 1997, GENE, V184, P33, DOI 10.1016/S0378-1119(96)00570-7; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Han Yoo Jeong, 1993, Korean Journal of Genetics, V15, P1; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Hubner Florian, 2012, Mycotoxin Res, V28, P37, DOI 10.1007/s12550-011-0114-7; Hwang LH, 2012, EUKARYOT CELL, V11, P16, DOI 10.1128/EC.05274-11; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Keszenman-Pereyra D, 2003, CURR GENET, V43, P186, DOI 10.1007/s00294-003-0382-7; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Kim HK, 2008, FUNGAL GENET BIOL, V45, P1188, DOI 10.1016/j.fgb.2008.05.008; KJAER D, 1971, J CHEM SOC C, P2792, DOI 10.1039/j39710002792; Kleigrewe K, 2011, J AGR FOOD CHEM, V59, P10470, DOI 10.1021/jf2026814; KLITTICH CJR, 1988, GENETICS, V118, P417; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Lev S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Marquez-Fernandez O, 2007, EUKARYOT CELL, V6, P710, DOI 10.1128/EC.00362-06; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Mikkelsen L, 2003, FEMS MICROBIOL LETT, V223, P135, DOI 10.1016/S0378-1097(03)00355-0; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Neville C, 2005, CHEMBIOCHEM, V6, P679, DOI 10.1002/cbic.200400147; Oberegger H, 2003, CURR GENET, V44, P211, DOI 10.1007/s00294-003-0434-z; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Park YS, 2007, BIOCHEM J, V408, P97, DOI 10.1042/BJ20070450; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Proctor RH, 2004, MYCOL RES, V108, P815, DOI 10.1017/S0953756204000577; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V6; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Schwerdt G, 2009, J APPL TOXICOL, V29, P174, DOI 10.1002/jat.1398; Seefelder W, 2003, TOXICOL APPL PHARM, V192, P146, DOI 10.1016/S0041-008X(03)00262-X; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Sondergaard TE, 2011, TOXICOL LETT, V205, P116, DOI 10.1016/j.toxlet.2011.05.1029; Sorensen JL, 2007, J AGR FOOD CHEM, V55, P9764, DOI 10.1021/jf0715875; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Stuible HP, 1998, J BIOL CHEM, V273, P22334, DOI 10.1074/jbc.273.35.22334; Teichert S, 2004, MOL MICROBIOL, V53, P1661, DOI 10.1111/j.1365-2958.2004.04243.x; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; TRIONE EJ, 1966, NATURE, V212, P163, DOI 10.1038/212163a0; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Tudzynski B, 1998, CURR GENET, V34, P234, DOI 10.1007/s002940050392; Velazquez-Robledo R, 2011, MOL PLANT MICROBE IN, V24, P1459, DOI 10.1094/MPMI-02-11-0045; VOISARD C, 1993, MOL CELL BIOL, V13, P7091, DOI 10.1128/MCB.13.11.7091; von Bargen KW, 2012, J AGR FOOD CHEM, V60, P3586, DOI 10.1021/jf300323d; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Yabuta T., 1935, AGR HORTIC, V10, P17; Zhan JX, 2007, J NAT PROD, V70, P227, DOI 10.1021/np060394t; Zhao Deyu, 1993, Biomedical and Environmental Sciences, V6, P37	104	50	54	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37519	10.1371/journal.pone.0037519	http://dx.doi.org/10.1371/journal.pone.0037519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662164	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300054
J	Blinowska, KJ; Kwaskiewicz, K; Jedrzejczak, WW; Skarzynski, H				Blinowska, Katarzyna J.; Kwaskiewicz, Konrad; Jedrzejczak, W. Wiktor; Skarzynski, Henryk			Musical Ratios in Sounds from the Human Cochlea	PLOS ONE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; OUTER HAIR-CELLS; RESONANT MODES; BASILAR-MEMBRANE; HIGH-RESOLUTION; SYNCHRONIZATION; MICROSTRUCTURE; DISSONANCE; CONSONANCE; AMPLIFIER	The physiological roots of music perception are a matter of long-lasting debate. Recently light on this problem has been shed by the study of otoacoustic emissions (OAEs), which are weak sounds generated by the inner ear following acoustic stimulation and, sometimes, even spontaneously. In the present study, a high-resolution time-frequency method called matching pursuit was applied to the OAEs recorded from the ears of 45 normal volunteers so that the component frequencies, amplitudes, latencies, and time-spans could be accurately determined. The method allowed us to find that, for each ear, the OAEs consisted of characteristic frequency patterns that we call resonant modes. Here we demonstrate that, on average, the frequency ratios of the resonant modes from all the cochleas studied possessed small integer ratios. The ratios are the same as those found by Pythagoras as being most musically pleasant and which form the basis of the Just tuning system. The statistical significance of the results was verified against a random distribution of ratios. As an explanatory model, there are attractive features in a recent theory that represents the cochlea as a surface acoustic wave resonator; in this situation the spacing between the rows of hearing receptors can create resonant cavities of defined lengths. By adjusting the geometry and the lengths of the resonant cavities, it is possible to generate the preferred frequency ratios we have found here. We conclude that musical perception might be related to specific geometrical and physiological properties of the cochlea.	[Blinowska, Katarzyna J.; Kwaskiewicz, Konrad] Univ Warsaw, Dept Biomed Phys, Fac Phys, Warsaw, Poland; [Jedrzejczak, W. Wiktor; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Jedrzejczak, W. Wiktor; Skarzynski, Henryk] World Hearing Ctr, Kajetany, Poland	University of Warsaw; Institute of Physiology & Hearing Pathology; Institute of Physiology & Hearing Pathology	Blinowska, KJ (corresponding author), Univ Warsaw, Dept Biomed Phys, Fac Phys, Warsaw, Poland.	w.jedrzejczak@ifps.org.pl	Jedrzejczak, W. Wiktor/L-2529-2015	Jedrzejczak, W. Wiktor/0000-0001-8404-0672; Blinowska, Katarzyna/0000-0001-6429-4421; Skarzynski, Henryk/0000-0001-7141-9851	Ministry of Science and High Education	Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	The research was supported by statutory grant from Ministry of Science and High Education to Faculty of Physics Warsaw University and to Institute of Physiology and Pathology of Hearing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SCI MUSIC NATURE WEB; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bell A, 2004, J ACOUST SOC AM, V116, P1016, DOI 10.1121/1.1766053; Bell A, 2002, P INT C MUS PERC COG; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Blinowska K. J., 1994, Intelligent Engineering Systems Through Artificial Neural Networks. Vol.4, P535; Blinowska KJ, 2007, PHYSIOL MEAS, V28, P1293, DOI 10.1088/0967-3334/28/10/013; Blinowska KJ, 2005, BIOL CYBERN, V93, P366, DOI 10.1007/s00422-005-0012-l; Blinowska KJ, 2001, ACTA NEUROBIOL EXP, V61, P157; Braun M, 1997, HEARING RES, V114, P197, DOI 10.1016/S0378-5955(97)00160-3; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Carterette EC, 1999, PSYCHOL MUSIC, P725; Chernick M. R., 2007, BOOTSTRAP METHODS GU, V2nd; Durka PJ, 2001, MED BIOL ENG COMPUT, V39, P315, DOI 10.1007/BF02345286; ELBERLING C, 1985, ACTA OTO-LARYNGOL, P77; Jedrzejczak WW, 2008, HEARING RES, V235, P80, DOI 10.1016/j.heares.2007.10.005; Jedrzejczak WW, 2007, HEARING RES, V231, P54, DOI 10.1016/j.heares.2007.05.009; Jedrzejczak WW, 2009, J ACOUST SOC AM, V126, P3137, DOI 10.1121/1.3243294; Jedrzejczak WW, 2008, J ACOUST SOC AM, V124, P3720, DOI 10.1121/1.2999556; Jedrzejczak WW, 2006, J ACOUST SOC AM, V119, P2226, DOI 10.1121/1.2178718; Jedrzejczak WW, 2004, J ACOUST SOC AM, V115, P2148, DOI 10.1121/1.1690077; Kemp David T., 2008, V30, P1; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; LONSBURYMARTIN BL, 1988, HEARING RES, V33, P69, DOI 10.1016/0378-5955(88)90021-4; Lots IS, 2008, J R SOC INTERFACE, V5, P1429, DOI 10.1098/rsif.2008.0143; Malinowska U, 2006, IEEE ENG MED BIOL, V25, P26, DOI 10.1109/MEMB.2006.1657784; Malinowska U, 2009, NEUROINFORMATICS, V7, P245, DOI 10.1007/s12021-009-9059-9; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; Nobili R, 2003, JARO-J ASSOC RES OTO, V4, P478, DOI 10.1007/s10162-002-3055-1; Notaro G, 2007, J ACOUST SOC AM, V122, P3576, DOI 10.1121/1.2799924; Pinsky MA, INTRO FOURIER ANAL W; PRIEVE BA, 1995, EAR HEARING, V16, P521, DOI 10.1097/00003446-199510000-00009; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Sisto R, 1999, J ACOUST SOC AM, V106, P1893, DOI 10.1121/1.427938; Talmadge CL, 2000, J ACOUST SOC AM, V108, P2911, DOI 10.1121/1.1321012; WABLE J, 1994, HEARING RES, V80, P141, DOI 10.1016/0378-5955(94)90105-8; Zatorre RJ, 2001, ANN N Y ACAD SCI, V930; ZWEIG G, 1995, J ACOUST SOC AM, V98, P2018, DOI 10.1121/1.413320; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	42	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37988	10.1371/journal.pone.0037988	http://dx.doi.org/10.1371/journal.pone.0037988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655092	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900069
J	Kiss, K; Brozik, A; Kucsma, N; Toth, A; Gera, M; Berry, L; Vallentin, A; Vial, H; Vidal, M; Szakacs, G				Kiss, Katalin; Brozik, Anna; Kucsma, Nora; Toth, Alexandra; Gera, Melinda; Berry, Laurence; Vallentin, Alice; Vial, Henri; Vidal, Michel; Szakacs, Gergely			Shifting the Paradigm: The Putative Mitochondrial Protein ABCB6 Resides in the Lysosomes of Cells and in the Plasma Membrane of Erythrocytes	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; IRON HOMEOSTASIS; RETICULOCYTE MATURATION; INNER MEMBRANE; HEME-SYNTHESIS; BLOOD-CELLS; K562 CELLS; DIFFERENTIATION; SYSTEM	ABCB6, a member of the adenosine triphosphate-binding cassette (ABC) transporter family, has been proposed to be responsible for the mitochondrial uptake of porphyrins. Here we show that ABCB6 is a glycoprotein present in the membrane of mature erythrocytes and in exosomes released from reticulocytes during the final steps of erythroid maturation. Consistent with its presence in exosomes, endogenous ABCB6 is localized to the endo/lysosomal compartment, and is absent from the mitochondria of cells. Knock-down studies demonstrate that ABCB6 function is not required for de novo heme biosynthesis in differentiating K562 cells, excluding this ABC transporter as a key regulator of porphyrin synthesis. We confirm the mitochondrial localization of ABCB7, ABCB8 and ABCB10, suggesting that only three ABC transporters should be classified as mitochondrial proteins. Taken together, our results challenge the current paradigm linking the expression and function of ABCB6 to mitochondria.	[Kiss, Katalin; Brozik, Anna; Kucsma, Nora; Toth, Alexandra; Gera, Melinda; Szakacs, Gergely] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Berry, Laurence; Vallentin, Alice; Vial, Henri; Vidal, Michel] Univ Montpellier 2, CNRS, Unite Mixte Rech Dynam Interact Membranaires Norm, Montpellier, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kiss, K (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	szakacs@biomembrane.hu	Szakacs, Gergely/A-2580-2009	Szakacs, Gergely/0000-0002-9311-7827; Vidal, Michel/0000-0002-5451-5603; Berry, laurence/0000-0002-8150-7860	National Institutes of Health [R01 AR055225]; ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy"); Lendulet Program of the Hungarian Academy of Sciences; CNRS; University Montpellier II; ANR (Agence Nationale de la Recherche) [ANR-09-BLAN-0292-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy")(French National Research Agency (ANR)); Lendulet Program of the Hungarian Academy of Sciences; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Montpellier II; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (R01 AR055225), ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy"), and the Lendulet Program of the Hungarian Academy of Sciences (GS). AV and MV were supported by the CNRS, the University Montpellier II and a grant from ANR (Agence Nationale de la Recherche) (ANR-09-BLAN-0292-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Annereau JP, 2004, MOL PHARMACOL, V66, P1397, DOI 10.1124/mol.104.005009; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Blanc L, 2005, BLOOD CELL MOL DIS, V35, P21, DOI 10.1016/j.bcmd.2005.04.008; Blanc L, CURR OPIN HEMATOL, V17, P177; Blanc L, 2009, BLOOD, V114, P3928, DOI 10.1182/blood-2009-06-230086; Brozik A, 2006, ANN NY ACAD SCI, V1090, P344, DOI 10.1196/annals.1378.038; Chandra NC, 1998, J BIOL CHEM, V273, P19715, DOI 10.1074/jbc.273.31.19715; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; D'Alessandro A, J PROTEOME RES, V9, P144; DEAN A, 1981, SCIENCE, V212, P459, DOI 10.1126/science.6163216; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LUFTIG RB, 1977, J VIROL, V23, P799, DOI 10.1128/JVI.23.3.799-810.1977; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marzac C, 2011, HAEMATOL-HEMATOL J, V96, P1293, DOI 10.3324/haematol.2010.031823; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Polireddy K, 2011, MOL ONCOL; Ponka P, 1997, BLOOD, V89, P1; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schueck ND, 2001, MITOCHONDRION, V1, P51, DOI 10.1016/S1567-7249(01)00004-6; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Steck T L, 1974, Methods Enzymol, V31, P172; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Tang L, 2011, BRIT J HAEMATOLOGY; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Turk D, 2009, IDRUGS, V12, P246; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	64	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37378	10.1371/journal.pone.0037378	http://dx.doi.org/10.1371/journal.pone.0037378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655043	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900018
J	Starcevich, SJ; Howell, PJ; Jacobs, SE; Sankovich, PM				Starcevich, Steven J.; Howell, Philip J.; Jacobs, Steven E.; Sankovich, Paul M.			Seasonal Movement and Distribution of Fluvial Adult Bull Trout in Selected Watersheds in the Mid-Columbia River and Snake River Basins	PLOS ONE			English	Article							SALVELINUS-CONFLUENTUS; LIFE-HISTORY; MIGRATION PATTERNS; HABITAT USE; POPULATION; CONSERVATION; DRAINAGE; ECOLOGY; IDAHO; CHARR	From 1997 to 2004, we used radio telemetry to investigate movement and distribution patterns of 206 adult fluvial bull trout (mean, 449 mm FL) from watersheds representing a wide range of habitat conditions in northeastern Oregon and southwestern Washington, a region for which there was little previous information about this species. Migrations between spawning and wintering locations were longest for fish from the Imnaha River (median, 89 km) and three Grande Ronde River tributaries, the Wenaha (56 km) and Lostine (41 km) rivers and Lookingglass Creek (47 km). Shorter migrations were observed in the John Day (8 km), Walla Walla (20 km) and Umatilla river (22 km) systems, where relatively extensive human alterations of the riverscape have been reported. From November through May, fish displayed station-keeping behavior within a narrow range (basin medians, 0.5-6.2 km). Prespawning migrations began after snowmelt-driven peak discharge and coincided with declining flows. Most postspawning migrations began by late September. Migration rates of individuals ranged from 0.1 to 10.7 km/day. Adults migrated to spawning grounds in consecutive years and displayed strong fidelity to previous spawning areas and winter locations. In the Grande Ronde River basin, most fish displayed an unusual fluvial pattern: After exiting the spawning tributary and entering a main stem river, individuals moved upstream to wintering habitat, often a substantial distance (maximum, 49 km). Our work provides additional evidence of a strong migratory capacity in fluvial bull trout, but the short migrations we observed suggest adult fluvial migration may be restricted in basins with substantial anthropogenic habitat alteration. More research into bull trout ecology in large river habitats is needed to improve our understanding of how adults establish migration patterns, what factors influence adult spatial distribution in winter, and how managers can protect and enhance fluvial populations.	[Starcevich, Steven J.; Jacobs, Steven E.] Oregon Dept Fish & Wildlife, Native Fish Invest Project, Corvallis, OR USA; [Howell, Philip J.] US Forest Serv, USDA, La Grande, OR USA; [Sankovich, Paul M.] US Fish & Wildlife Serv, Columbia River Fisheries Program Off, La Grande, OR USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service	Starcevich, SJ (corresponding author), Oregon Dept Fish & Wildlife, Native Fish Invest Project, Corvallis, OR USA.	steve.starcevich@oregonstate.edu			Bonneville Power Administration [94B134342, 4101]; USDA Forest Service; Idaho Power Company	Bonneville Power Administration; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Idaho Power Company	Bonneville Power Administration Contract Numbers 94B134342, 4101 (http://www.bpa.gov/corporate/). USDA Forest Service (http://www.fs.fed.us/pnw/about/labs.shtml). No contract number is available. Idaho Power Company (http://www.idahopower.com/). No contract number is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr MA, 2004, ECOL FRESHW FISH, V13, P294, DOI 10.1111/j.1600-0633.2004.00071.x; Baxter C.V., 2002, THESIS OREGON STATE; BJORNN TED C, 1964, TRANS AMER FISH SOC, V93, P70, DOI 10.1577/1548-8659(1964)93[70:MOPAWT]2.0.CO;2; Brenkman SJ, 2005, N AM J FISH MANAGE, V25, P1073, DOI 10.1577/M04-132.1; Brown Richard S., 1999, North American Journal of Fisheries Management, V19, P867, DOI 10.1577/1548-8675(1999)019&lt;0867:ETCTRF&gt;2.0.CO;2; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Downs CC, 2006, N AM J FISH MANAGE, V26, P190, DOI 10.1577/M04-180.1; Dunham J, 2008, FISHERIES, V33, P537, DOI 10.1577/1548-8446-33.11.537; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; DuPont J, 2007, N AM J FISH MANAGE, V27, P1268, DOI 10.1577/M06-137.1; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fitch L, 1997, FRIENDS BULL TROUT C, P427; FRALEY JJ, 1989, NORTHWEST SCI, V63, P133; Gross M.R., 1987, AM FISHERIES SOC S, V1, P14; Herman S. J., 1997, FRIENDS B TROUT C P, P217; Hogen DM, 2006, ECOL FRESHW FISH, V15, P376, DOI 10.1111/j.1600-0633.2006.00148.x; Jakober MJ, 1998, T AM FISH SOC, V127, P223, DOI 10.1577/1548-8659(1998)127<0223:ROSIOF>2.0.CO;2; Johnston F. D., 2005, THESIS U CALGARY ALB; MCCART P, 1997, FRIENDS B TROUT C P, P191; MCLEOD CL, 1997, FRIENDS BULL TROUT C, P413; Mogen JT, 2005, T AM FISH SOC, V134, P841, DOI 10.1577/T04-143.1; Moore TL, 2006, MIGRATORY PATTERNS S; Nelson ML, 2002, ENVIRON BIOL FISH, V64, P321, DOI 10.1023/A:1016062708588; Northcote T. G., 1997, North American Journal of Fisheries Management, V17, P1029, DOI 10.1577/1548-8675(1997)017<1029:PISAMI>2.3.CO;2; Power G, 2002, ENVIRON BIOL FISH, V64, P17, DOI 10.1023/A:1016066519418; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Riehle M., 1997, FRIENDS B TROUT C P, P137; Rieman B.E., 1993, INT302 US FOR SERV I; Rieman BE, 2001, N AM J FISH MANAGE, V21, P756, DOI 10.1577/1548-8675(2001)021&lt;0756:EPSAGC&gt;2.0.CO;2; RIEMAN BE, 1995, T AM FISH SOC, V124, P285, DOI 10.1577/1548-8659(1995)124<0285:OOBTIN>2.3.CO;2; ROSS MJ, 1982, PROG FISH CULT, V44, P41, DOI 10.1577/1548-8659(1982)44[41:STFSIR]2.0.CO;2; Schill D, 1994, SEASONAL MOVEMENT SP; Schoby GP, 2011, T AM FISH SOC, V140, P636, DOI 10.1080/00028487.2011.585578; Sokal R. R., 2012, BIOMETRY; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Spruell P, 1999, ECOL FRESHW FISH, V8, P114, DOI 10.1111/j.1600-0633.1999.tb00063.x; Starcevich SJ, 2010, CONSERVING WILD TROU, P258; Swanberg TR, 1997, T AM FISH SOC, V126, P735, DOI 10.1577/1548-8659(1997)126<0735:MOAHUB>2.3.CO;2; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; USFWS [U.S. Fish and Wildlife Service], 2002, B TROUT SALV CONFL; Watry CB, 2008, ECOL FRESHW FISH, V17, P231, DOI 10.1111/j.1600-0633.2007.00274.x; White G.C., 1990, ANAL WILDLIFE RADIO; Whiteley AR, 2004, MOL ECOL, V13, P3675, DOI 10.1111/j.1365-294X.2004.02365.x; WINTER JD, 1996, FISHERIES TECHNIQUES; WISSMAR RC, 1994, NORTHWEST SCI, V68, P1	46	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37257	10.1371/journal.pone.0037257	http://dx.doi.org/10.1371/journal.pone.0037257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655037	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900012
J	Mihlan, S; Reiss, C; Thalheimer, P; Herterich, S; Gaetzner, S; Kremerskothen, J; Pavenstadt, HJ; Lewandrowski, U; Sickmann, A; Butt, E				Mihlan, S.; Reiss, C.; Thalheimer, P.; Herterich, S.; Gaetzner, S.; Kremerskothen, J.; Pavenstaedt, H. J.; Lewandrowski, U.; Sickmann, A.; Butt, E.			Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions	ONCOGENE			English	Article						LASP-1; nucleo-cytoplasmatic shuttling; phosphatase 2B; ZO-2; LPP	BINDING-PROTEINS; CELL-MIGRATION; OVARIAN-CANCER; ACTIN-BINDING; LIM; DOMAIN; TRANSCRIPTION; LOCALIZATION; ZO-2; CAMP	LASP-1 is a multidomain protein predominantly localized at focal contacts, where it regulates cytoskeleton dynamics and cell migration. However, in different tumor entities, a nuclear LASP-1 accumulation is observed, thought to have an important role in cancer progression. Until now, the molecular mechanisms that control LASP-1 nuclear import were not elucidated. Here, we identified a novel LASP-1-binding partner, zona occludens protein 2 (ZO-2), and established its role in the signal transduction pathway of LASP-1 nucleo-cytoplasmatic shuttling. Phosphorylation of LASP-1 by PKA at serine 146 induces translocation of the LASP-1/ZO-2 complex from the cytoplasm to the nucleus. Interaction occurs within the carboxyterminal proline-rich motif of ZO-2 and the SH3 domain in LASP-1. In situ proximity ligation assay confirmed the direct binding between LASP-1 and ZO-2 and visualized the shuttling. Nuclear export is mediated by Crm-1 and a newly identified nuclear export signal in LASP-1. Finally, dephosphorylation of LASP-1 by phosphatase PP2B is suggested to relocalize the protein back to focal contacts. In summary, we define a new pathway for LASP-1 in tumor progression. Oncogene (2013) 32, 2107-2113; doi:10.1038/onc.2012.216; published online 4 June 2012	[Mihlan, S.; Reiss, C.; Thalheimer, P.; Herterich, S.; Gaetzner, S.; Butt, E.] Univ Clin Wuerzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; [Kremerskothen, J.; Pavenstaedt, H. J.] Univ Hosp Muenster, Div Mol Nephrol, Dept Internal Med D, Munster, Germany; [Lewandrowski, U.; Sickmann, A.] Leibniz Inst Analyt Wissensch ISAS eV, Dept Bioanalyt, Dortmund, Germany; [Sickmann, A.] Ruhr Univ Bochum, Med Proteome Ctr, Bochum, Germany	University of Wurzburg; University of Munster; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Ruhr University Bochum	Butt, E (corresponding author), Univ Clin Wuerzburg, Inst Clin Biochem & Pathobiochem, Grombuehlstr 12, D-97080 Wurzburg, Germany.	butt@klin-biochem.uni-wuerzburg.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265	DFG [BU 740/6-2, RE 3183/1-1, SFB 688 A2]; Innovative Medizinische Forschung, University Hospital Munster [KR110904]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	DFG(German Research Foundation (DFG)); Innovative Medizinische Forschung, University Hospital Munster; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	We thank Dr Viacheslav Nikolaev for his help with confocal microscopy. This work was supported by grants from the DFG (BU 740/6-2 to EB, RE 3183/1-1 to CR, SFB 688 A2 to SG) the Innovative Medizinische Forschung, University Hospital Munster (KR110904 to JK) and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (UL and AS).	Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Betanzos A, 2004, EXP CELL RES, V292, P51, DOI 10.1016/j.yexcr.2003.08.007; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Call GS, 1942, BIOCHEM BIOPH RES CO, V404, P780; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 2008, AM J PHYSIOL-GASTR L, V288, pG376; CHIYOMARU T, 2010, UROL ONCOL; Dimova I, 2009, TUMORI, V95, P357; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Hammarstrom A, 1996, BIOCHEMISTRY-US, V35, P12723, DOI 10.1021/bi961149j; Huerta M, 2007, MOL BIOL CELL, V18, P4826, DOI 10.1091/mbc.E07-02-0109; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; LEREA KM, 1991, BIOCHEMISTRY-US, V30, P6819, DOI 10.1021/bi00242a003; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Oka T, 2002, BIOCHEM J, V432, P461; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Traenka J, 2009, THROMB HAEMOSTASIS, V102, P520, DOI 10.1160/TH09-03-0143; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Zhang H, 2009, PHYSIOL GENOMICS, V38, P372, DOI 10.1152/physiolgenomics.00048.2009; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	34	46	49	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2107	2113		10.1038/onc.2012.216	http://dx.doi.org/10.1038/onc.2012.216			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22665060				2022-12-25	WOS:000317919900012
J	Kuroda, I; Inukai, T; Zhang, X; Kikuchi, J; Furukawa, Y; Nemoto, A; Akahane, K; Hirose, K; Honna-Oshiro, H; Goi, K; Kagami, K; Yagita, H; Tauchi, T; Maeda, Y; Sugita, K				Kuroda, I.; Inukai, T.; Zhang, X.; Kikuchi, J.; Furukawa, Y.; Nemoto, A.; Akahane, K.; Hirose, K.; Honna-Oshiro, H.; Goi, K.; Kagami, K.; Yagita, H.; Tauchi, T.; Maeda, Y.; Sugita, K.			BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia	ONCOGENE			English	Article						Philadelphia chromosome-positive leukemia; tumor necrosis factor-related apoptosis-inducing ligand; BCR-ABL	ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; IMATINIB; INHIBITOR; SURVEILLANCE; METASTASIS; MECHANISMS; INITIATION	Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT. Ph(+) leukemia cells frequently express death-inducing receptors (DR4 and DR5) for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which is one of the cytotoxic ligands expressed on cytotoxic T cells and natural killer cells mediating the GVL effect. Here we demonstrate that imatinib specifically downregulated DR4 and DR5 expression in cell lines and clinical samples of Ph(+) leukemia. Second-generation tyrosine kinase inhibitors (dasatinib and nilotinib) and short hairpin RNA against bcr-abl also downregulated DR4 and DR5 expression in Ph(+) leukemia cells, and transfection of bcr-abl into a Ph(-) leukemia cell line induced DR4 and DR5 expression, which was abrogated by imatinib treatment. Accordingly, Ph(+) leukemia cells that had been pretreated with imatinib showed resistance to the pro-apoptotic activity of recombinant human soluble TRAIL. These observations demonstrate that BCR-ABL is critically involved in the leukemia-specific expression of DR4 and DR5 and in the susceptibility of Ph(+) leukemia to TRAIL-mediated anti-leukemic activity, providing new insight into the mechanisms of the tumor-specific cytotoxic activities of TRAIL. Oncogene (2013) 32, 1670-1681; doi:10.1038/onc.2012.186; published online 4 June 2012	[Kuroda, I.; Inukai, T.; Zhang, X.; Nemoto, A.; Akahane, K.; Hirose, K.; Honna-Oshiro, H.; Goi, K.; Kagami, K.; Sugita, K.] Univ Yamanashi, Dept Pediat, Sch Med, Chuo, Yamanashi 4093898, Japan; [Kikuchi, J.; Furukawa, Y.] Jichi Med Sch, Ctr Mol Med, Simotsuke, Tochigi, Japan; [Yagita, H.] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Tauchi, T.] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1608402, Japan; [Maeda, Y.] Kinki Univ, Sch Med, Div Hematol, Dept Internal Med, Osaka 589, Japan	University of Yamanashi; Juntendo University; Tokyo Medical University; Kindai University (Kinki University)	Inukai, T (corresponding author), Univ Yamanashi, Dept Pediat, Sch Med, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	tinukai@yamanashi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	Ministry of Education, Science and Culture, Japan	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank technological supports by Masako Abe. This work was supported in part by research grants from the Ministry of Education, Science and Culture, Japan.	Akahane K, 2010, EXP HEMATOL, V38, P885, DOI 10.1016/j.exphem.2010.06.014; Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Carpenter PA, 2007, BLOOD, V109, P2791, DOI 10.1182/blood-2006-04-019836; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fielding AK, 2010, BLOOD, V116, P3409, DOI 10.1182/blood-2010-01-242750; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hess G, 2005, J CLIN ONCOL, V23, P7583, DOI 10.1200/JCO.2005.01.3110; Hirase C, 2009, LEUKEMIA RES, V33, P450, DOI 10.1016/j.leukres.2008.07.023; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; INUKAI T, 1993, BRIT J HAEMATOL, V85, P823; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Jabbour E, 2011, BLOOD, V117, P1822, DOI 10.1182/blood-2010-07-293977; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Nimmanapalli R, 2001, CLIN CANCER RES, V7, P350; Olavarria E, 2007, BLOOD, V110, P4614, DOI 10.1182/blood-2007-04-082990; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; PRETI HA, 1994, AM J MED, V97, P60, DOI 10.1016/0002-9343(94)90049-3; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Savani BN, 2005, BONE MARROW TRANSPL, V36, P1009, DOI 10.1038/sj.bmt.1705167; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tiribelli M, 2009, LEUKEMIA RES, V33, P174, DOI 10.1016/j.leukres.2008.03.031; Uckun FM, 1998, CANCER-AM CANCER SOC, V83, P2030, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2030::AID-CNCR21>3.0.CO;2-Q; Uno K, 2003, BLOOD, V101, P3658, DOI 10.1182/blood-2002-06-1770; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Yoshimitsu M, 2008, INT J HEMATOL, V88, P331, DOI 10.1007/s12185-008-0150-z; Zhang XC, 2011, LEUKEMIA RES, V35, P940, DOI 10.1016/j.leukres.2011.03.016	41	6	8	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1670	1681		10.1038/onc.2012.186	http://dx.doi.org/10.1038/onc.2012.186			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22665066				2022-12-25	WOS:000316855800007
J	Stobbe, MD; Houten, SM; van Kampen, AHC; Wanders, RJA; Moerland, PD				Stobbe, Miranda D.; Houten, Sander M.; van Kampen, Antoine H. C.; Wanders, Ronald J. A.; Moerland, Perry D.			Improving the description of metabolic networks: the TCA cycle as example	FASEB JOURNAL			English	Article						pathway database; community effort; curation	ALPHA-KETOGLUTARATE DEHYDROGENASE; SUCCINYL-COA SYNTHETASES; CITRIC-ACID CYCLE; ISOCITRATE DEHYDROGENASE; REDUCTIVE CARBOXYLATION; COMMUNITY APPROACH; RAT-LIVER; RECONSTRUCTION; MITOCHONDRIAL; DATABASES	To collect the ever-increasing yet scattered knowledge on metabolism, multiple pathway databases like the Kyoto Encyclopedia of Genes and Genomes have been created. A complete and accurate description of the metabolic network for human and other organisms is essential to foster new biological discoveries. Previous research has shown, however, that the level of agreement among pathway databases is surprisingly low. We investigated whether the lack of consensus among databases can be explained by an inaccurate representation of the knowledge described in scientific literature. As an example, we focus on the well-known tricarboxylic acid (TCA) cycle and evaluated the description of this pathway as found in a comprehensive selection of 10 human metabolic pathway databases. Remarkably, none of the descriptions given by these databases is entirely correct. Moreover, consensus exists on only 3 reactions. Mistakes in pathway databases might lead to the propagation of incorrect knowledge, misinterpretation of high-throughput molecular data, and poorly designed follow-up experiments. We provide an improved description of the TCA cycle via the community-curated database WikiPathways. We review various initiatives that aim to improve the description of the human metabolic network and discuss the importance of the active involvement of biological experts in these.-Stobbe, M. D., Houten, S. M., van Kampen, A. H. C., Wanders, R. J. A., Moerland, P. D. Improving the description of metabolic networks: the TCA cycle as example. FASEB J. 26, 3625-3636 (2012). www.fasebj.org	[Stobbe, Miranda D.; van Kampen, Antoine H. C.; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1100 DE Amsterdam, Netherlands; [Houten, Sander M.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Stobbe, Miranda D.; van Kampen, Antoine H. C.; Moerland, Perry D.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam	Moerland, PD (corresponding author), Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, POB 22700, NL-1100 DE Amsterdam, Netherlands.	p.d.moerland@amc.uva.nl	Houten, Sander/Y-3599-2019; Moerland, Perry/AAG-1425-2020	Houten, Sander/0000-0002-6167-9147; Moerland, Perry/0000-0002-2357-3659	BioRange program of The Netherlands Bioinformatics Centre (NBIC) [SP1.2.4]; Besluit Subsidies Investeringen Kennisinfrastructuur (BSIK) through The Netherlands Genomics Initiative (NGI) and within the research program of the Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research [016.086.336]	BioRange program of The Netherlands Bioinformatics Centre (NBIC); Besluit Subsidies Investeringen Kennisinfrastructuur (BSIK) through The Netherlands Genomics Initiative (NGI) and within the research program of the Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was performed within the BioRange program (project SP1.2.4) of The Netherlands Bioinformatics Centre (NBIC; http://www.nbic.nl), supported by a Besluit Subsidies Investeringen Kennisinfrastructuur (BSIK) grant through The Netherlands Genomics Initiative (NGI) and within the research program of the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. S.M.H. was supported by the Netherlands Organization for Scientific Research (VIDI grant 016.086.336).	Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Aral B, 1997, AM J HUM GENET, V61, P1318, DOI 10.1086/301653; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berg JM, 2012, BIOCHEMISTRY; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; Bunik VI, 2008, PROTEINS, V71, P874, DOI 10.1002/prot.21766; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chindelevitch L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r6; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; FERNANDEZ CA, 1995, J BIOL CHEM, V270, P10037, DOI 10.1074/jbc.270.17.10037; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; GREKSAK M, 1982, EUR J BIOCHEM, V122, P423, DOI 10.1111/j.1432-1033.1982.tb05897.x; Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; HOEK JB, 1988, BIOCHEM J, V254, P1; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karp PD, 2011, ARCH TOXICOL, V85, P1015, DOI 10.1007/s00204-011-0705-2; Kitano H, 2011, NAT CHEM BIOL, V7, P323, DOI 10.1038/nchembio.574; KREBS H. A., 1937, Enzymologia, V4, P148; KREBS HA, 1952, BIOCHEM J, V52, P527, DOI 10.1042/bj0520527; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; LAWSON AM, 1976, CLIN CHEM, V22, P1283; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; LIU TC, 1993, P NATL ACAD SCI USA, V90, P5186, DOI 10.1073/pnas.90.11.5186; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; McCartney RG, 1998, J BIOL CHEM, V273, P24158, DOI 10.1074/jbc.273.37.24158; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Mo ML, 2009, TRENDS BIOTECHNOL, V27, P37, DOI 10.1016/j.tibtech.2008.09.007; Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; PLAUT GWE, 1954, J BIOL CHEM, V207, P305; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Radrich K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-114; RAMAKRISHNA M, 1966, BIOCHEM BIOPH RES CO, V25, P378, DOI 10.1016/0006-291X(66)90215-4; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Romero P, 2005, GENOME BIOL, V6; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Sheu KFR, 1999, ANN NY ACAD SCI, V893, P61; SIEBERT G, 1957, J BIOL CHEM, V226, P977; Stobbe MD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-165; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Zelezniak A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000729	63	18	19	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3625	3636		10.1096/fj.11-203091	http://dx.doi.org/10.1096/fj.11-203091			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22661004				2022-12-25	WOS:000308391600005
J	Sana, TG; Hachani, A; Bucior, I; Soscia, C; Garvis, S; Termine, E; Engel, J; Filloux, A; Bleves, S				Sana, Thibault G.; Hachani, Abderrahman; Bucior, Iwona; Soscia, Chantal; Garvis, Steve; Termine, Elise; Engel, Joanne; Filloux, Alain; Bleves, Sophie			The Second Type VI Secretion System of Pseudomonas aeruginosa Strain PAO1 Is Regulated by Quorum Sensing and Fur and Modulates Internalization in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC UPTAKE REGULATOR; IRON STARVATION RESPONSE; GRAM-NEGATIVE BACTERIA; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; GENES; VIRULENCE; EXPRESSION; IDENTIFICATION; PROTEIN	The genome of Pseudomonas aeruginosa PAO1 contains three type VI secretion systems (T6SSs) called H1-, H2-, and H3-T6SS. The H1-T6SS secretes three identified toxins that target other bacteria, providing a fitness advantage for P. aeruginosa, and likely contributes to bacterial pathogenesis in chronic infections. However, no specific substrates or defined roles have been described for the two other systems. Here, we demonstrate that the expression of H2-T6SS genes of strain PAO1 is up-regulated during the transition from exponential to stationary phase growth and regulated by the Las and Rhl quorum sensing systems. In addition, we identify two putative Fur boxes in the promoter region and find that H2-T6SS transcription is negatively regulated by iron. We also show that the H2-T6SS system enhances bacterial uptake into HeLa cells (75% decrease in internalization with a H2-T6SS mutant) and into lung epithelial cells through a phosphatidylinositol 3-kinase-dependent pathway that induces Akt activation in the host cell (50% decrease in Akt phosphorylation). Finally, we show that H2-T6SS plays a role in P. aeruginosa virulence in the worm model. Thus, in contrast to H1-T6SS, H2-T6SS modulates interaction with eukaryotic host cells. Together, T6SS can carry out different functions that may be important in establishing chronic P. aeruginosa infections in the human host.	[Sana, Thibault G.; Hachani, Abderrahman; Soscia, Chantal; Garvis, Steve; Termine, Elise; Filloux, Alain; Bleves, Sophie] Aix Marseille Univ, F-13402 Marseille 20, France; [Sana, Thibault G.; Hachani, Abderrahman; Soscia, Chantal; Garvis, Steve; Termine, Elise; Filloux, Alain; Bleves, Sophie] CNRS, Lab Ingn Syst Macromol, UMR7255, F-13402 Marseille 20, France; [Bucior, Iwona; Engel, Joanne] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Engel, Joanne] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bleves, S (corresponding author), Aix Marseille Univ, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	bleves@imm.cnrs.fr	Hachani, Abderrahman/H-1801-2013; Bleves, SOPHIE/HII-4948-2022; Sana, Thibault G/B-1599-2013; Hachani, Abderrahman/AAV-3320-2020	Hachani, Abderrahman/0000-0001-8032-2154; Sana, Thibault/0000-0003-0723-6924; garvis, steve/0000-0002-0547-0672	EuroPathoGenomics REX Grant [LSHB-CT-2005512061-EPG]; "Pathomics" ERA-net PATHO Grant [ANR-08-PATH-004-01]; Royal Society Wellcome Trust Grant [WT097939]; National Institutes of Health [P01 AI053194, R01 AI065902]; Ph.D. fellowship from the French Research Ministry; post-doctoral fellowship from the French Research Minister; EuroPathoGenomics network of excellence; Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc.; MRC [G0800171] Funding Source: UKRI; Medical Research Council [G0800171] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065902, P01AI053194] Funding Source: NIH RePORTER	EuroPathoGenomics REX Grant; "Pathomics" ERA-net PATHO Grant; Royal Society Wellcome Trust Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ph.D. fellowship from the French Research Ministry; post-doctoral fellowship from the French Research Minister; EuroPathoGenomics network of excellence; Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by EuroPathoGenomics REX Grant LSHB-CT-2005512061-EPG), "Pathomics" ERA-net PATHO Grant ANR-08-PATH-004-01. This work was also supported by funds from the Royal Society Wellcome Trust Grant WT097939 (to A. F.), National Institutes of Health Grants P01 AI053194 and R01 AI065902 (to J. E.), a Ph.D. fellowship from the French Research Ministry (to T. G. S.), a post-doctoral fellowship from the French Research Minister and from EuroPathoGenomics network of excellence (to A. H.), and a Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc. (to I. B.).	Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; CHI E, 1991, INFECT IMMUN, V59, P822, DOI 10.1128/IAI.59.3.822-828.1991; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Engel J., 2007, PSEUDOMONAS AERUGINO, P343; Engel J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00114; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	77	117	122	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27095	27105		10.1074/jbc.M112.376368	http://dx.doi.org/10.1074/jbc.M112.376368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665491	Green Published, hybrid			2022-12-25	WOS:000307386000062
J	Bohm, C; Katari, VS; Brecht, M; Goringer, HU				Boehm, Cordula; Katari, Venkata Subbaraju; Brecht, Michael; Goeringer, H. Ulrich			Trypanosoma brucei 20 S Editosomes Have One RNA Substrate-binding Site and Execute RNA Unwinding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; GUIDE RNA; EDITING COMPLEX; MESSENGER-RNA; DIRECTED ENDONUCLEASE; FOLDING LANDSCAPE; PROTEIN; MITOCHONDRIA; MOLECULES; GENE	Editing of mitochondrial pre-mRNAs in African trypanosomes generates full-length transcripts by the site-specific insertion and deletion of uridylate nucleotides. The reaction is catalyzed by a 0.8 MDa multienzyme complex, the editosome. Although the binding of substrate pre-edited mRNAs and cognate guide RNAs (gRNAs) represents the first step in the reaction cycle, the biochemical and biophysical details of the editosome/RNA interaction are not understood. Here we show that editosomes bind full-length substrate mRNAs with nanomolar affinity in a nonselective fashion. The complexes do not discriminate-neither kinetically nor thermodynamically-between different mitochondrial pre-mRNAs or between edited and unedited versions of the same transcript. They also bind gRNAs and gRNA/pre-mRNA hybrid RNAs with similar affinities and association rate constants. Gold labeling of editosome-bound RNA in combination with transmission electron microscopy identified a single RNA-binding site per editosome. However, atomic force microscopy of individual pre-mRNA-editosome complexes revealed that multiple editosomes can interact with one pre-mRNA. Lastly, we demonstrate a so far unknown activity of the editing machinery: editosome-bound RNA becomes unfolded by a chaperone-type RNA unwinding activity.	[Boehm, Cordula; Katari, Venkata Subbaraju; Brecht, Michael; Goeringer, H. Ulrich] Tech Univ Darmstadt, Dept Mol Genet, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Goringer, HU (corresponding author), Tech Univ Darmstadt, Dept Mol Genet, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	goringer@hrzpub.tu-darmstadt.de			German Research Council [DFG-SFB902]; International Research Scholar Grant of the Howard Hughes Medical Institute	German Research Council(German Research Foundation (DFG)); International Research Scholar Grant of the Howard Hughes Medical Institute	This work was supported by German Research Council Grant DFG-SFB902 and an International Research Scholar Grant of the Howard Hughes Medical Institute (to H. U. G.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2001, J BIOL CHEM, V276, P21280, DOI 10.1074/jbc.M100297200; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2011, J BIOL CHEM, V286, P19320, DOI 10.1074/jbc.M111.228965; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; Frech GC, 1996, MOL CELL BIOL, V16, P4584; Goringer HU, 2011, WIRES RNA, V2, P395, DOI 10.1002/wrna.67; Goeringer H. Ulrich, 2008, V20, P165; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Hansma HG, 1996, NUCLEIC ACIDS RES, V24, P713, DOI 10.1093/nar/24.4.713; Hauser R, 1996, J CELL SCI, V109, P517; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Kala S, 2010, RNA, V16, P1951, DOI 10.1261/rna.2124610; Kuznetsov YG, 2010, NUCLEIC ACIDS RES, V38, P8284, DOI 10.1093/nar/gkq662; Kwon SH, 2007, BIOCHEM BIOPH RES CO, V361, P681, DOI 10.1016/j.bbrc.2007.07.084; Minh PNL, 2009, NUCLEIC ACIDS RES, V37, P1463, DOI 10.1093/nar/gkn1078; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Matsuura T, 2006, BIOSCI BIOTECH BIOCH, V70, P300, DOI 10.1271/bbb.70.300; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Mikamo-Satoh E, 2009, ANAL BIOCHEM, V394, P275, DOI 10.1016/j.ab.2009.07.033; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Moreno-Herrero F, 2003, ULTRAMICROSCOPY, V96, P167, DOI 10.1016/S0304-3991(03)00004-4; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Piller KJ, 1997, RNA, V3, P279; Pusnik M, 2012, EUKARYOT CELL, V11, P79, DOI 10.1128/EC.05213-11; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Santos S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023821; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751	63	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26268	26277		10.1074/jbc.M112.365916	http://dx.doi.org/10.1074/jbc.M112.365916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661715	Green Published, hybrid			2022-12-25	WOS:000306916300053
J	Hamaia, SW; Pugh, N; Raynal, N; Nemoz, B; Stone, R; Gullberg, D; Bihan, D; Farndale, RW				Hamaia, Samir W.; Pugh, Nicholas; Raynal, Nicolas; Nemoz, Benjamin; Stone, Rachael; Gullberg, Donald; Bihan, Dominique; Farndale, Richard W.			Mapping of Potent and Specific Binding Motifs, GLOGEN and GVOGEA, for Integrin alpha 1 beta 1 Using Collagen Toolkits II and III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; RECOGNITION SITE; CELL-ADHESION; A-DOMAIN; IN-VIVO; EXPRESSION; RECEPTOR; ALPHA(1)BETA(1); IV; BETA-1-INTEGRINS	Integrins are well characterized cell surface receptors for extracellular matrix proteins. Mapping integrin-binding sites within the fibrillar collagens identified GFOGER as a high affinity site recognized by alpha 2 beta 1, but with lower affinity for alpha 1 beta 1. Here, to identify specific ligands for alpha 1 beta 1, we examined binding of the recombinant human alpha 1 I domain, the rat pheochromocytoma cell line (PC12), and the rat glioma Rugli cell line to our collagen Toolkit II and III peptides using solid-phase and real-time label-free adhesion assays. We observed Mg2+-dependent binding of the alpha 1 I domain to the peptides in the following rank order: III-7 (GLOGEN), II-28 (GFOGER), II-7 and II-8 (GLOGER), II-18 (GAOGER), III-4 (GROGER). PC12 cells showed a similar profile. Using antibody blockade, we confirmed that binding of PC12 cells to peptide III-7 was mediated by integrin alpha 1 beta 1. We also identified a new alpha 1 beta 1-binding activity within peptide II-27. The sequence GVOGEA bound weakly to PC12 cells and strongly to activated Rugli cells or to an activated alpha 1 I domain, but not to the alpha 2 I domain or to C2C12 cells expressing alpha 2 beta 1 or alpha 11 beta 1. Thus, GVOGEA is specific for alpha 1 beta 1. Although recognized by both alpha 2 beta 1 and alpha 11 beta 1, GLOGEN is a better ligand for alpha 1 beta 1 compared with GFOGER. Finally, using biosensor assays, we show that although GLOGEN is able to compete for the alpha 1 I domain from collagen IV (IC50 similar to 3 mu M), GFOGER is much less potent (IC50 similar to 90 mu M), as shown previously. These data confirm the selectivity of GFOGER for alpha 2 beta 1 and establish GLOGEN as a high affinity site for alpha 1 beta 1.	[Hamaia, Samir W.; Pugh, Nicholas; Raynal, Nicolas; Nemoz, Benjamin; Stone, Rachael; Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Gullberg, Donald] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway	University of Cambridge; University of Bergen	Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	rwf10@cam.ac.uk	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437; Nemoz, Benjamin/0000-0002-3843-9380; Pugh, Nicholas/0000-0002-6916-4199	Wellcome Trust; Medical Research Council; SRU Biosystems (Woburn, NJ); Medical Research Council [G0500707, G0400701] Funding Source: researchfish; MRC [G0400701, G0500707] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SRU Biosystems (Woburn, NJ); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust, the Medical Research Council, and SRU Biosystems (Woburn, NJ).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Castillo-Briceno P, 2011, MOL IMMUNOL, V48, P826, DOI 10.1016/j.molimm.2010.12.004; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Deschaseaux F, 2003, BRIT J HAEMATOL, V122, P506, DOI 10.1046/j.1365-2141.2003.04469.x; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FITZSIMMONS CM, 1986, THROMB HAEMOSTASIS, V56, P95; Gailit J, 1996, J CELL PHYSIOL, V169, P281, DOI 10.1002/(SICI)1097-4652(199611)169:2<281::AID-JCP7>3.0.CO;2-K; Gilhar A, 1997, MELANOMA RES, V7, P486, DOI 10.1097/00008390-199712000-00007; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; HEINO J, 1989, J BIOL CHEM, V264, P21806; Hemler M E, 1995, Curr Opin Hematol, V2, P61; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarvis GE, 2012, J THROMB HAEMOST, V10, P268, DOI 10.1111/j.1538-7836.2011.04567.x; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Koukoulis GK, 1997, HUM PATHOL, V28, P1018, DOI 10.1016/S0046-8177(97)90054-X; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; MECHTERSHEIMER G, 1994, AM J PATHOL, V144, P1172; MENDRICK DL, 1995, LAB INVEST, V72, P367; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Pirila L, 1996, J RHEUMATOL, V23, P1691; Racine-Samson L, 1997, J BIOL CHEM, V272, P30911, DOI 10.1074/jbc.272.49.30911; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; SCHADENDORF D, 1993, J PATHOL, V170, P429, DOI 10.1002/path.1711700405; Schadendorf D, 1996, BRIT J CANCER, V74, P194, DOI 10.1038/bjc.1996.337; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Stewart HJS, 1997, J NEUROBIOL, V33, P914, DOI 10.1002/(SICI)1097-4695(199712)33:7<914::AID-NEU4>3.0.CO;2-B; Szulgit G, 2002, J INVEST DERMATOL, V118, P409, DOI 10.1046/j.0022-202x.2001.01680.x; TAWIL NJ, 1990, BIOCHEMISTRY-US, V29, P6540, DOI 10.1021/bi00479a028; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; ZHANG ZY, 1993, J BIOL CHEM, V268, P5557	54	45	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26019	26028		10.1074/jbc.M112.353144	http://dx.doi.org/10.1074/jbc.M112.353144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654115	Green Published, hybrid			2022-12-25	WOS:000306916300029
J	Xu, JK; Chen, HJ; Li, XD; Huang, ZL; Xu, H; Yang, HL; Hu, J				Xu, Jian-kun; Chen, Hong-jiang; Li, Xue-dong; Huang, Zhong-lian; Xu, Huan; Yang, Hai-long; Hu, Jun			Optimal Intensity Shock Wave Promotes the Adhesion and Migration of Rat Osteoblasts via Integrin beta 1-mediated Expression of Phosphorylated Focal Adhesion Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TYROSINE PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; LONG-BONE FRACTURES; FLUID SHEAR-STRESS; MECHANICAL STIMULATION; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS; SEGMENTAL DEFECT; GENE-EXPRESSION; BETA-CATENIN	To search for factors promoting bone fracture repair, we investigated the effects of extracorporeal shock wave (ESW) on the adhesion, spreading, and migration of osteoblasts and its specific underlying cellular mechanisms. After a single period of stimulation by 10 kV (500 impulses) of shock wave (SW), the adhesion rate was increased as compared with the vehicle control. The data from both wound healing and transwell tests confirmed an acceleration in the migration of osteoblasts by SW treatment. RT-PCR, flow cytometry, and Western blotting showed that SW rapidly increased the surface expression of alpha 5 and beta 1 subunit integrins, indicating that integrin beta 1 acted as an early signal for ESW-induced osteoblast adhesion and migration. It has also been found that a significant elevation occurred in the expression of phosphorylated beta-catenin and focal adhesion kinase (FAK) at the site of tyrosine 397 in response to SW stimulation after the increasing expression of the integrin beta 1 molecule. When siRNAs of integrin alpha 5 and beta 1 subunit were added, the level of FAK phosphorylation elevated by SW declined. Interestingly, the adhesion and migration of osteoblasts were decreased when these siRNA reagents as well as the ERK1/2 signaling pathway inhibitors, U0126 and PD98059, were present. Further studies demonstrated that U0126 could inhibit the downstream integrin-dependent signaling pathways, such as the FAK signaling pathway, whereas it had no influence on the synthesis of integrin beta 1 molecule. In conclusion, these data suggest that ESW promotes the adhesion and migration of osteoblasts via integrin beta 1-mediated expression of phosphorylated FAK at the Tyr-397 site; in addition, ERK1/2 are also important for osteoblast adhesion, spreading, migration, and integrin expression.	[Xu, Jian-kun; Chen, Hong-jiang; Li, Xue-dong; Huang, Zhong-lian; Xu, Huan; Yang, Hai-long; Hu, Jun] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, Shantou 515041, Guangdong, Peoples R China	Shantou University	Hu, J (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	hjzkm@yahoo.cn	yang, hailong/GXH-9625-2022					Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Beutler S, 1999, UNFALLCHIRURG, V102, P839, DOI 10.1007/s001130050492; Birnbaum K, 2002, ARCH ORTHOP TRAUM SU, V122, P324, DOI 10.1007/s00402-001-0365-4; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Cacchio A, 2009, J BONE JOINT SURG AM, V91A, P2589, DOI 10.2106/JBJS.H.00841; Chaturvedi LS, 2007, AM J PHYSIOL-CELL PH, V292, pC1701, DOI 10.1152/ajpcell.00529.2006; Chen YJ, 2004, J ORTHOP RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005; Chen YJ, 2003, FEBS LETT, V554, P154, DOI 10.1016/S0014-5793(03)01157-8; Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6; CLOVER J, 1992, J CELL SCI, V103, P267; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; GRONOWICZ GA, 1995, ENDOCRINOLOGY, V136, P598, DOI 10.1210/en.136.2.598; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hu J, 2006, PROG BIOCHEM BIOPHYS, V33, P452; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikeda K, 1999, J TRAUMA, V47, P946, DOI 10.1097/00005373-199911000-00024; ILLC D, 1995, NATURE, V377, P539; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI 10.1359/JBMR.080302; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; McClure S., 2003, Clinical Techniques in Equine Practice, V2, P348, DOI 10.1053/j.ctep.2004.04.008; Moretti B, 2009, ULTRASOUND MED BIOL, V35, P1042, DOI 10.1016/j.ultrasmedbio.2008.12.002; Moursi AM, 1997, J CELL SCI, V110, P2187; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Rompe JD, 2001, CLIN ORTHOP RELAT R, P102, DOI 10.1097/00003086-200106000-00014; RUBIN CT, 1995, J BONE MINER RES, V10, P488; Schaden W, 2001, CLIN ORTHOP RELAT R, P90; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1; SEIDL M, 1994, ULTRASONICS, V32, P397, DOI 10.1016/0041-624X(94)90111-2; Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6; Sieg DJ, 1999, J CELL SCI, V112, P2677; STEINBACH P, 1992, ULTRASOUND MED BIOL, V18, P691, DOI 10.1016/0301-5629(92)90120-Y; Tang CH, 2003, J BONE MINER RES, V18, P502, DOI 10.1359/jbmr.2003.18.3.502; Tarone G, 2000, INT J DEV BIOL, V44, P725; TUCKWELL DS, 1993, CRIT REV ONCOL HEMAT, V15, P149, DOI 10.1016/1040-8428(93)90053-7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Uslu M M, 1999, Bull Hosp Jt Dis, V58, P114; Wang C. J., 2012, AM J SPORTS IN PRESS; Wang CJ, 2001, CLIN ORTHOP RELAT R, P112; Wang CJ, 2001, CLIN ORTHOP RELAT R, P95; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Wang FS, 2001, BIOCHEM BIOPH RES CO, V287, P648, DOI 10.1006/bbrc.2001.5654; Wang LP, 2006, BIOMATERIALS, V27, P3716, DOI 10.1016/j.biomaterials.2006.02.022; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058	67	44	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26200	26212		10.1074/jbc.M112.349811	http://dx.doi.org/10.1074/jbc.M112.349811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654119	Green Published, hybrid			2022-12-25	WOS:000306916300047
J	Zhang, J; Li, HF; Zhou, TW; Zhou, JC; Herrup, K				Zhang, Jie; Li, Huifang; Zhou, Tingwen; Zhou, Jiechao; Herrup, Karl			Cdk5 Levels Oscillate during the Neuronal Cell Cycle Cdh1 UBIQUITINATION TRIGGERS PROTEOSOME-DEPENDENT DEGRADATION DURING S-PHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; ALZHEIMERS-DISEASE BRAIN; S-PHASE ENTRY; DEPENDENT KINASE-5; NUCLEAR-LOCALIZATION; POSTMITOTIC NEURONS; REGULATORY SUBUNIT; DEATH; PROTEIN; P35	When cell cycle re-activation occurs in post-mitotic neurons it places them at increased risk for death. The cell cycle/cell death association has been reported in many neurodegenerative diseases including Alzheimer disease (AD), yet the mechanisms by which a normal neuron suppresses the cycle remain largely unknown. Recently, our laboratory has shown that Cdk5 (cyclin-dependent kinase 5) is a key player in this protective function. When a neuron is under stress, Cdk5 is transported to the cytoplasm; this eliminates its cell cycle suppression activity and the neuron re-enters S-phase. In the current study we show that a similar principle applies during a normal cell cycle. When a neuronal cell enters S phase, Cdk5 is transported to the cytoplasm where it is ubiquitinated by the E3 ligase APC-Cdh1. Ubiquitinated Cdk5 is then rapidly degraded by the proteasome. The ubiquitination site of Cdk5 appears to be in the p35 binding area; in the presence of high levels of p35, the ubiquitination of Cdk5 was blocked, and the degradation in S phase was attenuated. The data suggest an unsuspected role for Cdk5 during the progression of a normal cell cycle and offer new pharmaceutical targets for regulating neuronal cell cycling and cell death.	[Zhang, Jie; Li, Huifang; Zhou, Tingwen; Zhou, Jiechao] Xiamen Univ, Inst Neurosci, Xiamen 361005, Fujian, Peoples R China; [Zhang, Jie; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Xiamen University; Rutgers State University New Brunswick	Zhang, J (corresponding author), Xiamen Univ, Inst Neurosci, SiMing NanLu 422, Xiamen 361005, Fujian, Peoples R China.	jiezhang@xmu.edu.cn; herrup@biology.rutgers.edu	Zhang, Jie/A-5426-2010; Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	National Institutes of Health [NS20591]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS20591 and Rutgers University.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Busser J, 1998, J NEUROSCI, V18, P2801; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fischer A, 2003, NEUROSIGNALS, V12, P200, DOI 10.1159/000074621; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gao CY, 1997, DEV GENET, V20, P267; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; HOSOI T, 1995, J BIOCHEM, V117, P741, DOI 10.1093/oxfordjournals.jbchem.a124771; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Huynh MA, 2009, J NEUROSCI, V29, P4322, DOI 10.1523/JNEUROSCI.5329-08.2009; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Veeranna, 1995, J NEUROCHEM, V64, P2681; Vincent I, 1997, J NEUROSCI, V17, P3588; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328; Zhang J, 2010, J BIOL CHEM, V285, P14052, DOI 10.1074/jbc.M109.068262; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494	45	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25985	25994		10.1074/jbc.M112.343152	http://dx.doi.org/10.1074/jbc.M112.343152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654103	Green Published, hybrid			2022-12-25	WOS:000306916300026
J	Busse, S; von Grumbkow, P; Hummel, S; Shah, DN; Shah, RDT; Li, JK; Zhang, XP; Yoshizawa, K; Wedmann, S; Hornschemeyer, T				Buesse, Sebastian; von Grumbkow, Philipp; Hummel, Susanne; Shah, Deep Narayan; Shah, Ram Devi Tachamo; Li, Jingke; Zhang, Xueping; Yoshizawa, Kazunori; Wedmann, Sonja; Hoernschemeyer, Thomas			Phylogeographic Analysis Elucidates the Influence of the Ice Ages on the Disjunct Distribution of Relict Dragonflies in Asia	PLOS ONE			English	Article							EPIOPHLEBIA-LAIDLAWI TILLYARD; PHYLOGENETIC ANALYSIS; DNA-SEQUENCES; ODONATA; INFERENCE; ALIGNMENT; MRBAYES; 28S	Unusual biogeographic patterns of closely related groups reflect events in the past, and molecular analyses can help to elucidate these events. While ample research on the origin of disjunct distributions of different organism groups in the Western Paleartic has been conducted, such studies are rare for Eastern Palearctic organisms. In this paper we present a phylogeographic analysis of the disjunct distribution pattern of the extant species of the strongly cool-adapted Epiophlebia dragonflies from Asia. We investigated sequences of the usually more conserved 18 S rDNA and 28 S rDNA genes and the more variable sequences of ITS1, ITS2 and CO2 of all three currently recognised Epiophlebia species and of a sample of other odonatan species. In all genes investigated the degrees of similarity between species of Epiophlebia are very high and resemble those otherwise found between different populations of the same species in Odonata. This indicates that substantial gene transfer between these populations occurred in the comparatively recent past. Our analyses imply a wide distribution of the ancestor of extant Epiophlebia in Southeast Asia during the last ice age, when suitable habitats were more common. During the following warming phase, its range contracted, resulting in the current disjunct distribution. Given the strong sensitivity of these species to climatic parameters, the current trend to increasing global temperatures will further reduce acceptable habitats and seriously threaten the existences of these last representatives of an ancient group of Odonata.	[Buesse, Sebastian; Hoernschemeyer, Thomas] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Morphol Systemat & Evolutionary Biol, Gottingen, Germany; [von Grumbkow, Philipp; Hummel, Susanne] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Hist Anthropol & Human Ecol, Gottingen, Germany; [Shah, Deep Narayan] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Shah, Deep Narayan] Nat Hist Museums, Gelnhausen, Germany; [Shah, Ram Devi Tachamo] Hindu Kush Himalayan Benthol Soc, Kathmandu, Nepal; [Zhang, Xueping] Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China; [Yoshizawa, Kazunori] Hokkaido Univ Sapporo, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Wedmann, Sonja] Senckenberg Res Inst, Messel, Germany; [Wedmann, Sonja] Nat Hist Museums, Res Stn Messel Pit, Messel, Germany	University of Gottingen; University of Gottingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Harbin Normal University; Hokkaido University; Senckenberg Gesellschaft fur Naturforschung (SGN)	Busse, S (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Morphol Systemat & Evolutionary Biol, Gottingen, Germany.	thoerns@gwdg.de	Yoshizawa, Kazunori/A-4268-2012; Hörnschemeyer, Thomas/AAU-9813-2020; Tachamo, Ram Devi/AAA-8590-2019; Yoshizawa, Kazunori/Q-9390-2019	Hörnschemeyer, Thomas/0000-0002-4924-5389; Tachamo, Ram Devi/0000-0002-1061-2903; Yoshizawa, Kazunori/0000-0001-6170-4296; Wedmann, Sonja/0000-0002-9778-4125	DFG (Deutsche Forschungsgemeinschaft) [HO2306/6-1]; DFG Heisenberg grant [HO2306/7-1]; National Science Foundation of China [41071033]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG Heisenberg grant(German Research Foundation (DFG)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was partly financed through the DFG (Deutsche Forschungsgemeinschaft) grant HO2306/6-1. TH was directly supported through the DFG Heisenberg grant HO2306/7-1. JL and XZ were supported by a grant from the National Science Foundation of China (No. 41071033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina A, 1954, MORPHOLOGICAL STUDY; Asahina A, 1963, TOMBO, V6, P18; ASAHINA SYOZIRO, 1961, INTERNATL REV GESAMTEN HYDROBIOL, V46, P441, DOI 10.1002/iroh.19610460310; Bernard R, 2011, J ZOOL SYST EVOL RES, V49, P292, DOI 10.1111/j.1439-0469.2011.00630.x; Brockhaus T, 2009, ODONATOLOGICA, V38, P203; Bybee SM, 2008, CLADISTICS, V24, P477, DOI 10.1111/j.1096-0031.2007.00191.x; Carle Frank Louis, 2008, Arthropod Systematics & Phylogeny, V66, P37; Carpenter FM, 1992, TREATISE INVERTEBR R, V4, P59; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Davies A, 1992, FLYING KIMMINSIA, V3, P10; Dumont HJ, 2010, SYST ENTOMOL, V35, P6, DOI 10.1111/j.1365-3113.2009.00489.x; Fleck G, 2008, J ZOOL SYST EVOL RES, V46, P310, DOI 10.1111/j.1439-0469.2008.00474.x; Fleck G, 2003, ANN SOC ENTOMOL FR, V39, P55, DOI 10.1080/00379271.2003.10697363; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Friedrich M, 1997, MOL BIOL EVOL, V14, P644, DOI 10.1093/oxfordjournals.molbev.a025804; FURUKAWA HARUO, 1934, ANNOT ZOOL JAPONENSES, V14, P451; Grimaldi David, 2005, pi; Habel JC, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P1, DOI 10.1007/978-3-540-92160-8; Hasegawa E, 2006, ENTOMOL SCI, V9, P55, DOI 10.1111/j.1479-8298.2006.00154.x; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Hovmoller R, 2002, CLADISTICS, V18, P313, DOI [10.1006/clad.2002.0199, 10.1111/j.1096-0031.2002.tb00153.x]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hummel S, 2003, ANCIENT DNA TYPING M; Ikeda H, 1998, B U MUSEUM U TOKYO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Li JK, 2012, SYST ENTOMOL, V37, P408, DOI 10.1111/j.1365-3113.2011.00610.x; Li ZX, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045404; Lohmann H, 1996, ENTOMOL ZEITSCHR, V106, P209; Lomolino MV, 2006, BIOGEOGRAPHY; Millien-Parra V, 1999, J BIOGEOGR, V26, P959, DOI 10.1046/j.1365-2699.1999.00346.x; Nel A., 1993, NUMERO HORS SERIE, V3, P1; Nesemann H, 2011, ODONATOLOGICA, V40, P191; Nylander J, 2004, MR MODELTEST V2 PROG; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Segota T, 1973, EISZEITALTER GEGENWA, V23, P107; Selys Longchamps E.D., 1889, COMPTES RENDUS SOC E, V3, P153; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tabaru N., 1984, Tombo (Tokyo), V27, P27; Tamariz J, 2006, J FORENSIC SCI, V51, P790, DOI 10.1111/j.1556-4029.2006.00172.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillyard R. J., 1921, Records of the Indian Museum, V22, P93; TUSHINGHAM AM, 1993, QUATERNARY RES, V39, P125, DOI 10.1006/qres.1993.1015; Xylander WER, 2003, LEHRB SPEZIELLE, P167	48	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38132	10.1371/journal.pone.0038132	http://dx.doi.org/10.1371/journal.pone.0038132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666462	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400087
J	Zuo, NM; Fang, JL; Lv, XY; Zhou, Y; Hong, Y; Li, T; Tong, HB; Wang, XL; Wang, WD; Jiang, TZ				Zuo, Nianming; Fang, Jiliang; Lv, Xueyu; Zhou, Yuan; Hong, Yang; Li, Tao; Tong, Haibing; Wang, Xiaoling; Wang, Weidong; Jiang, Tianzi			White Matter Abnormalities in Major Depression: A Tract-Based Spatial Statistics and Rumination Study	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; DIFFUSION-TENSOR; ELECTROCONVULSIVE-THERAPY; FUNCTIONAL NEUROANATOMY; BIPOLAR DISORDER; RTMS TREATMENT; CIRCUITS; ADULTS; BRAIN	Increasing evidence indicates that major depressive disorder (MDD) is usually accompanied by altered white matter in the prefrontal cortex, the parietal lobe and the limbic system. As a behavioral abnormity of MDD, rumination has been believed to be a substantial indicator of the mental state of the depressive state. So far, however, no report that we are aware of has evaluated the relationship between white matter alterations and the ruminative state. In this study, we first explored the altered white matter using a tract-based spatial statistics (TBSS) method based on diffusion tensor imaging of 19 healthy and 16 depressive subjects. We then investigated correlations between the altered white matter microstructure in the identified altered regions and the severity of ruminations measured by the ruminative response scale. Our results demonstrated altered white matter microstructure in circuits connecting the prefrontal lobe, the parietal lobe and the limbic system (p<0.005, uncorrected), findings which support previous research. More importantly, the result also indicated that a greater alteration in the white matter is associated with a more ruminative state (p<0.05, Bonferroni corrected). The detected abnormalities in the white matter should be interpreted cautiously because of the small sample size in this study. This finding supports the psychometric significance of white matter deficits in MDD.	[Zuo, Nianming; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Fang, Jiliang; Hong, Yang; Tong, Haibing; Wang, Xiaoling] China Acad Chinese Med Sci, Guang An Men Hosp, Dept Radiol, Lab Funct Brain Imaging, Beijing, Peoples R China; [Lv, Xueyu; Li, Tao; Wang, Weidong] China Acad Chinese Med Sci, Guang An Men Hosp, Dept Psychol, Beijing, Peoples R China; [Zhou, Yuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; University of Queensland	Zuo, NM (corresponding author), Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China.	prof_wwd@126.com; jiangtz@nlpr.ia.ac.cn	Zhou, Yuan/AAI-6570-2021; Zhou, Yuan/N-5569-2017; Fang, Jiliang/AAE-5400-2020; Jiang, Tianzi/I-4256-2012	Zhou, Yuan/0000-0001-6378-1711; Zhou, Yuan/0000-0001-6378-1711; Jiang, Tianzi/0000-0001-9531-291X	Natural Science Foundation of China [81000634, 30772845, 30870668, 60831004]; National Institutes of Health/National Center for Complementary and Alternative Medicine, USA [F05 AT003022-01-04]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F05AT003022] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health/National Center for Complementary and Alternative Medicine, USA; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was partially supported by the Natural Science Foundation of China, Grant Nos. 81000634, 30772845, 30870668, 60831004, and National Institutes of Health/National Center for Complementary and Alternative Medicine (F05 AT003022-01-04), USA. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Bagby RM, 2004, COGNITIVE THER RES, V28, P527, DOI 10.1023/B:COTR.0000045562.17228.29; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bech P, 2002, ACTA PSYCHIAT SCAND, V106, P252, DOI 10.1034/j.1600-0447.2002.01404.x; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Brunoni AR, 2010, ARQ NEURO-PSIQUIAT, V68, P433, DOI 10.1590/S0004-282X2010000300021; Cardoso EF, 2008, INT J NEUROPSYCHOPH, V11, P173, DOI 10.1017/S1461145707007961; Chan S, 2009, ARCH SUICIDE RES, V13, P123, DOI 10.1080/13811110902835015; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Colloby SJ, 2011, J AFFECT DISORDERS, V135, P216, DOI 10.1016/j.jad.2011.07.025; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Dannlowski U, 2009, INT J NEUROPSYCHOPH, V12, P11, DOI 10.1017/S1461145708008973; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Farrow TFD, 2005, BIOL PSYCHIAT, V58, P713, DOI 10.1016/j.biopsych.2005.04.033; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hooley JM, 2009, PSYCHIAT RES-NEUROIM, V171, P106, DOI 10.1016/j.pscychresns.2008.04.001; Huang H, 2011, NEUROPSYCHOPHARMACOL, V36, P684, DOI 10.1038/npp.2010.199; Jhanwar Venu Gopal, 2011, Indian J Psychol Med, V33, P92, DOI 10.4103/0253-7176.85406; Joormann J., 2005, COGNITIVE LIMITATION, P275, DOI [DOI 10.1017/CB09780511720413.012, 10.1017/CBO9780511720413.012]; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Ladouceur CD, 2012, DEV COGN NEUROS-NETH, V2, P36, DOI 10.1016/j.dcn.2011.06.002; Li LJ, 2007, BRAIN RES, V1168, P124, DOI 10.1016/j.brainres.2007.06.094; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marchand WR, 2012, PROG NEURO-PSYCHOPH, V36, P290, DOI 10.1016/j.pnpbp.2011.10.016; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; McLaughlin KA, 2011, BEHAV RES THER, V49, P186, DOI 10.1016/j.brat.2010.12.006; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Nofzinger EA, 2004, ARCH GEN PSYCHIAT, V61, P695, DOI 10.1001/archpsyc.61.7.695; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Oudega ML, 2011, J CLIN PSYCHIAT, V72, P104, DOI 10.4088/JCP.08m04989blu; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Purves D, 2004, NEUROSCIENCE, P773; Reetz K, 2008, BIOL PSYCHIAT, V64, P241, DOI 10.1016/j.biopsych.2007.12.010; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schneider B, 2011, PROG NEUROBIOL, V95, P703, DOI 10.1016/j.pneurobio.2011.08.001; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson RJ, 2010, BEHAV RES THER, V48, P459, DOI 10.1016/j.brat.2010.01.007; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Wall CA, 2011, J CLIN PSYCHIAT, V72, P1263, DOI 10.4088/JCP.11m07003; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; [杨娟 YANG Juan], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P27; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	72	53	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37561	10.1371/journal.pone.0037561	http://dx.doi.org/10.1371/journal.pone.0037561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666366	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400033
J	Brink, DL; Gilbert, M; Xie, XJ; Petley-Ragan, L; Auld, VJ				Brink, Deidre L.; Gilbert, Mary; Xie, Xiaojun; Petley-Ragan, Lindsay; Auld, Vanessa J.			Glial Processes at the Drosophila Larval Neuromuscular Junction Match Synaptic Growth	PLOS ONE			English	Article							BLOOD-NERVE BARRIER; SEPTATE JUNCTION; PERIPHERAL GLIA; IN-VIVO; ELECTRICAL-ACTIVITY; FASCICLIN-II; SYSTEM; CELLS; PLASTICITY; AXONS	Glia are integral participants in synaptic physiology, remodeling and maturation from blowflies to humans, yet how glial structure is coordinated with synaptic growth is unknown. To investigate the dynamics of glial development at the Drosophila larval neuromuscular junction (NMJ), we developed a live imaging system to establish the relationship between glia, neuronal boutons, and the muscle subsynaptic reticulum. Using this system we observed processes from two classes of peripheral glia present at the NMJ. Processes from the subperineurial glia formed a blood-nerve barrier around the axon proximal to the first bouton. Processes from the perineurial glial extended beyond the end of the blood-nerve barrier into the NMJ where they contacted synapses and extended across non-synaptic muscle. Growth of the glial processes was coordinated with NMJ growth and synaptic activity. Increasing synaptic size through elevated temperature or the highwire mutation increased the extent of glial processes at the NMJ and conversely blocking synaptic activity and size decreased the presence and size of glial processes. We found that elevated temperature was required during embryogenesis in order to increase glial expansion at the nmj. Therefore, in our live imaging system, glial processes at the NMJ are likely indirectly regulated by synaptic changes to ensure the coordinated growth of all components of the tripartite larval NMJ.	[Brink, Deidre L.; Gilbert, Mary; Xie, Xiaojun; Petley-Ragan, Lindsay; Auld, Vanessa J.] Univ British Columbia, Inst Life Sci, Dept Zool Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Brink, DL (corresponding author), Univ British Columbia, Inst Life Sci, Dept Zool Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada.	auld@zoology.ubc.ca		Petley-Ragan, Lindsay/0000-0001-5316-7267; Auld, Vanessa/0000-0003-3976-9186	Canadian Institute of Health Research [MOP-82862]; Natural Sciences and Engineering Research Council [RGPIN 227814-06]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Canadian Institute of Health Research (MOP-82862) and Natural Sciences and Engineering Research Council RGPIN 227814-06 http://www.nserc-crsng.gc.ca/Index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brink Dee, 2009, J Vis Exp, DOI 10.3791/1154; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Danjo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017131; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Georgiou J, 1999, J NEUROSCI, V19, P3836; GORCZYCA MG, 1991, J NEUROBIOL, V22, P391, DOI 10.1002/neu.480220407; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Huang YM, 2002, J NEUROSCI, V22, P1698, DOI 10.1523/JNEUROSCI.22-05-01698.2002; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Keller LC, 2011, NEURON, V72, P760, DOI 10.1016/j.neuron.2011.09.031; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; Lavery W, 2007, J NEUROSCI, V27, P279, DOI 10.1523/JNEUROSCI.3370-06.2007; Lnenicka GA, 2003, J NEUROBIOL, V54, P337, DOI 10.1002/neu.10133; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Rival T, 2006, J NEUROBIOL, V66, P1061, DOI 10.1002/neu.20270; ROBITAILLE R, 1995, J NEUROSCI, V15, P7121; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xie XJ, 2011, DEVELOPMENT, V138, P3813, DOI 10.1242/dev.064816; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	62	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37876	10.1371/journal.pone.0037876	http://dx.doi.org/10.1371/journal.pone.0037876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666403	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600035
J	Marta-Almeida, M; Reboreda, R; Rocha, C; Dubert, J; Nolasco, R; Cordeiro, N; Luna, T; Rocha, A; Silva, JDLE; Queiroga, H; Peliz, A; Ruiz-Villarreal, M				Marta-Almeida, Martinho; Reboreda, Rosa; Rocha, Carlos; Dubert, Jesus; Nolasco, Rita; Cordeiro, Nuno; Luna, Tiago; Rocha, Alfredo; Lencart e Silva, Joao D.; Queiroga, Henrique; Peliz, Alvaro; Ruiz-Villarreal, Manuel			Towards Operational Modeling and Forecasting of the Iberian Shelves Ecosystem	PLOS ONE			English	Article							CONTINENTAL-SHELF; NORTHWEST IBERIA; OCEAN MODEL; CRAB LARVAE; SYSTEM; COASTAL; CLIMATOLOGY; DISPERSAL; BOUNDARY; DYNAMICS	There is a growing interest on physical and biogeochemical oceanic hindcasts and forecasts from a wide range of users and businesses. In this contribution we present an operational biogeochemical forecast system for the Portuguese and Galician oceanographic regions, where atmospheric, hydrodynamic and biogeochemical variables are integrated. The ocean model ROMS, with a horizontal resolution of 3 km, is forced by the atmospheric model WRF and includes a Nutrients-Phytoplankton-Zooplankton-Detritus biogeochemical module (NPZD). In addition to oceanographic variables, the system predicts the concentration of nitrate, phytoplankton, zooplankton and detritus (mmol N m(-3)). Model results are compared against radar currents and remote sensed SST and chlorophyll. Quantitative skill assessment during a summer upwelling period shows that our modelling system adequately represents the surface circulation over the shelf including the observed spatial variability and trends of temperature and chlorophyll concentration. Additionally, the skill assessment also shows some deficiencies like the overestimation of upwelling circulation and consequently, of the duration and intensity of the phytoplankton blooms. These and other departures from the observations are discussed, their origins identified and future improvements suggested. The forecast system is the first of its kind in the region and provides free online distribution of model input and output, as well as comparisons of model results with satellite imagery for qualitative operational assessment of model skill.	[Marta-Almeida, Martinho; Reboreda, Rosa; Rocha, Carlos; Dubert, Jesus; Nolasco, Rita; Cordeiro, Nuno; Rocha, Alfredo; Lencart e Silva, Joao D.] Univ Aveiro, CESAM Dep Fis, P-3800 Aveiro, Portugal; [Luna, Tiago] Univ Aveiro, Inst Ambiente & Desenvolvimento, P-3800 Aveiro, Portugal; [Queiroga, Henrique] Univ Aveiro, CESAM Dep Biol, P-3800 Aveiro, Portugal; [Peliz, Alvaro] Univ Lisbon, Ctr Oceanog, P-1699 Lisbon, Portugal; [Ruiz-Villarreal, Manuel] Ctr Oceanog A Coruna, Inst Espanol Oceanog, Galicia, Spain	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Lisboa; Spanish Institute of Oceanography	Marta-Almeida, M (corresponding author), Univ Aveiro, CESAM Dep Fis, P-3800 Aveiro, Portugal.	mma@ua.pt	Reboreda, Rosa/AAT-5876-2021; Marta-Almeida, Martinho/C-1715-2008; Rocha, Alfredo/E-1201-2011; Dubert, Jesus/B-7517-2008; Nolasco, Rita TS/D-1809-2019; Queiroga, Henrique/C-5134-2008; Ruiz-Villarreal, Manuel/F-3389-2010; Lencart e Silva, João D./B-3513-2011; Ramírez, Sergio/J-8073-2014; Dubert, Jesus/B-2803-2009; Peliz, Alvaro/C-8154-2009; Cordeiro, Nuno/D-5185-2019	Marta-Almeida, Martinho/0000-0001-8214-3096; Rocha, Alfredo/0000-0003-4940-6522; Queiroga, Henrique/0000-0002-2338-0013; Ruiz-Villarreal, Manuel/0000-0003-0169-0958; Lencart e Silva, João D./0000-0001-8237-6981; Dubert, Jesus/0000-0002-3338-6777; Peliz, Alvaro/0000-0003-1649-5151; Cordeiro, Nuno/0000-0001-8239-4020; nolasco, maria rita/0000-0003-1942-8800	project RAIA; Programa Operativo de Cooperacion Transfronteriza Espasimilar toa-Portugal, POCTEP [0313-RAIA-1-E]; FCT [SFRH/BD/33388/2008]	project RAIA; Programa Operativo de Cooperacion Transfronteriza Espasimilar toa-Portugal, POCTEP; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors CR and NC are supported by project RAIA funded by Programa Operativo de Cooperacion Transfronteriza Espa similar to a-Portugal, POCTEP 2007-2013 (0313-RAIA-1-E). R.Reboreda is supported by the FCT grant SFRH/BD/33388/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JI, 2007, J MARINE SYST, V68, P381, DOI 10.1016/j.jmarsys.2007.01.005; Barth A, 2008, CONT SHELF RES, V28, P561, DOI 10.1016/j.csr.2007.11.004; Berx B, 2011, OCEANOGRAPHY, V24, P166, DOI 10.5670/oceanog.2011.14; Borja A, 2005, CONT SHELF RES, V25, P1768, DOI 10.1016/j.csr.2005.05.004; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Brachet G, 2004, SPACE POLICY, V20, P7, DOI 10.1016/j.spacepol.2003.11.002; Capet XJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020123; Cornillon P, 2009, OCEANOGRAPHY, V22, P116, DOI 10.5670/oceanog.2009.43; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; Dufois F, 2012, OCEAN MODEL, V47, P113, DOI 10.1016/j.ocemod.2012.01.007; FASHAM MJR, 1990, J MAR RES, V48, P591, DOI 10.1357/002224090784984678; Ferreira APGF, 2007, SENSIBILIDADE PARAME; Ferreira J.G., 2003, TRANSITIONAL COASTAL; Garcia H. E., 2006, WORLD OCEAN ATLAS 20; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; Gruber N, 2006, DEEP-SEA RES PT I, V53, P1483, DOI 10.1016/j.dsr.2006.06.005; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Jolliff JK, 2009, J MARINE SYST, V76, P64, DOI 10.1016/j.jmarsys.2008.05.014; Kone V, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002427; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Lazzari P, 2010, OCEAN SCI, V6, P25, DOI 10.5194/os-6-25-2010; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Marta-Almeida M, 2006, MAR ECOL PROG SER, V307, P1, DOI 10.3354/meps307001; Marta-Almeida M, 2011, J OPER OCEANOGR, V4, P3, DOI 10.1080/1755876X.2011.11020123; Marta-Almeida M, 2008, CAN J FISH AQUAT SCI, V65, P2253, DOI 10.1139/F08-138; Marta-Almeida M, 2011, ENVIRON MODELL SOFTW, V26, P680, DOI 10.1016/j.envsoft.2010.11.015; National Oceanic and Atmospheric Administration, 2003, GFS ATM MOD; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Otero P, 2008, J MARINE SYST, V72, P238, DOI 10.1016/j.jmarsys.2007.05.016; Otero P, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004740; Otero P, 2009, ICES J MAR SCI, V66, P1853, DOI 10.1093/icesjms/fsp156; Otero P., 2011, OCEANS 2011, DOI [10.1109/Oceans-Spain.2011.6003564, DOI 10.1109/OCEANS-SPAIN.2011.6003564]; Otero P, 2010, SCI MAR, V74, P247, DOI 10.3989/scimar.2010.74n2247; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Peliz A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004159; Peliz A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004771; Penven P, 2006, OCEAN MODEL, V12, P157, DOI 10.1016/j.ocemod.2005.05.002; Pinardi N., 2002, OCEAN FORECASTING CO; Ruiz-Villarreal M, 2006, EUROPEAN OPERATIONAL, P342; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Siddorn JR, 2007, J MARINE SYST, V65, P417, DOI 10.1016/j.jmarsys.2006.01.018; Signell RP, 2008, J MARINE SYST, V69, P154, DOI 10.1016/j.jmarsys.2007.02.013; Silva PA, 2007, J COASTAL RES, V29, P1622; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Sotillo MG, 2008, MAR POLLUT BULL, V56, P686, DOI 10.1016/j.marpolbul.2007.12.021; Teruzzi A, 2011, MERCATOR OCEAN NEWSL, V40; WOOSTER WS, 1976, J MAR RES, V34, P131; Zhang X, 2012, J OPER OCEANOGR, V5, P19, DOI 10.1080/1755876X.2012.11020129	49	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37343	10.1371/journal.pone.0037343	http://dx.doi.org/10.1371/journal.pone.0037343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666349	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600013
J	Rasila, TS; Vihinen, M; Paulin, L; Haapa-Paananen, S; Savilahti, H				Rasila, Tiina S.; Vihinen, Mauno; Paulin, Lars; Haapa-Paananen, Saija; Savilahti, Harri			Flexibility in MuA Transposase Family Protein Structures: Functional Mapping with Scanning Mutagenesis and Sequence Alignment of Protein Homologues	PLOS ONE			English	Article							IN-VITRO TRANSPOSITION; DNA-BINDING DOMAIN; PHAGE-MU; BACTERIOPHAGE-MU; STRAND TRANSFER; MOLECULAR-BIOLOGY; RIBONUCLEASE-H; STRATEGY; EFFICIENT; RECOMBINATION	MuA transposase protein is a member of the retroviral integrase superfamily (RISF). It catalyzes DNA cleavage and joining reactions via an initial assembly and subsequent structural transitions of a protein-DNA complex, known as the Mu transpososome, ultimately attaching transposon DNA to non-specific target DNA. The transpososome functions as a molecular DNA-modifying machine and has been used in a wide variety of molecular biology and genetics/genomics applications. To analyze structure-function relationships in MuA action, a comprehensive pentapeptide insertion mutagenesis was carried out for the protein. A total of 233 unique insertion variants were generated, and their activity was analyzed using a quantitative in vivo DNA transposition assay. The results were then correlated with the known MuA structures, and the data were evaluated with regard to the protein domain function and transpososome development. To complement the analysis with an evolutionary component, a protein sequence alignment was produced for 44 members of MuA family transposases. Altogether, the results pinpointed those regions, in which insertions can be tolerated, and those where insertions are harmful. Most insertions within the subdomains I gamma, II alpha, II beta, and III alpha completely destroyed the transposase function, yet insertions into certain loop/linker regions of these subdomains increased the protein activity. Subdomains I alpha and III beta were largely insertion-tolerant. The comprehensive structure-function data set will be useful for designing MuA transposase variants with improved properties for biotechnology/genomics applications, and is informative with regard to the function of RISF proteins in general.	[Rasila, Tiina S.; Paulin, Lars; Haapa-Paananen, Saija; Savilahti, Harri] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Vihinen, Mauno] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Vihinen, Mauno] BioMediTech, Tampere, Finland; [Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Savilahti, Harri] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Helsinki; Tampere University; Lund University; University of Turku	Rasila, TS (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland.	harri.savilahti@utu.fi	Vihinen, Mauno/A-8452-2012	Vihinen, Mauno/0000-0002-9614-7976; Savilahti, Harri/0000-0002-6246-2572	Academy of Finland; Finnish National Technology Agency (TEKES); Biocenter Finland; Medical Reseach Fund of Tampere University Hospital; Sigrid Juselius Foundation; Finnish Cultural Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish National Technology Agency (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Biocenter Finland; Medical Reseach Fund of Tampere University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation	This study has been funded by the Academy of Finland, Finnish National Technology Agency (TEKES), Biocenter Finland, Medical Reseach Fund of Tampere University Hospital, Sigrid Juselius Foundation, Finnish Cultural Foundation, and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhverdyan VZ, 2011, APPL MICROBIOL BIOT, V91, P857, DOI 10.1007/s00253-011-3416-y; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6654, DOI 10.1073/pnas.91.14.6654; BAKER TA, 1991, CELL, V65, P1003, DOI 10.1016/0092-8674(91)90552-A; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeke JD, 2002, MOBILE DNA, P24; Brady T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr140; Chaconas George, 2002, P384; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; CLUBB RT, 1994, STRUCTURE, V2, P1041, DOI 10.1016/S0969-2126(94)00107-3; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; Craig NL, 2002, MOBILE DNA 2; CRAIGIE R, 1987, CELL, V51, P493, DOI 10.1016/0092-8674(87)90645-3; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7703, DOI 10.1074/jbc.M110342200; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7694, DOI 10.1074/jbc.M110341200; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gronholm M, 2006, ONCOGENE, V25, P4389, DOI 10.1038/sj.onc.1209475; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Haapa S, 1999, GENOME RES, V9, P308; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; HARSHEY RM, 1986, J GENET, V65, P159, DOI 10.1007/BF02931149; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; HOWE MM, 1975, SCIENCE, V190, P624, DOI 10.1126/science.1103291; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim YC, 2009, J MOL MICROB BIOTECH, V17, P30, DOI 10.1159/000178019; Krementsova E, 1998, J BIOL CHEM, V273, P31358, DOI 10.1074/jbc.273.47.31358; Krupovic M, 2006, J VIROL, V80, P9270, DOI 10.1128/JVI.00536-06; Lamberg A, 2002, APPL ENVIRON MICROB, V68, P705, DOI 10.1128/AEM.68.2.705-712.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; LEUNG PC, 1991, J MOL BIOL, V219, P189, DOI 10.1016/0022-2836(91)90561-J; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; Nesmelova IV, 2010, ADV DRUG DELIVER REV, V62, P1187, DOI 10.1016/j.addr.2010.06.006; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Orsini L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm070; Paatero AO, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn801; Pajunen M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm563; Pajunen MI, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-24; Pajunen MI, 2005, MICROBIOL-SGM, V151, P1209, DOI 10.1099/mic.0.27807-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petyuk V, 2004, J BIOL CHEM, V279, P37040, DOI 10.1074/jbc.M406042200; Poussu E, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni102; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saariaho AH, 2005, VIROLOGY, V331, P6, DOI 10.1016/j.virol.2004.09.041; Saarlaho AH, 2006, NUCLEIC ACIDS RES, V34, P3139, DOI 10.1093/nar/gkl405; Sambrook J, 2001, MOL CLONING LAB MANU; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Vilen H, 2003, J VIROL, V77, P123, DOI 10.1128/JVI.77.1.123-134.2003; von Nandelstadh P, 2005, EXP CELL RES, V310, P131, DOI 10.1016/j.yexcr.2005.06.027; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; WU ZG, 1995, EMBO J, V14, P3835, DOI 10.1002/j.1460-2075.1995.tb00053.x; WU ZG, 1992, J BIOL CHEM, V267, P9552; Yang JY, 1996, CELL, V85, P447, DOI 10.1016/S0092-8674(00)81122-8; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	84	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37922	10.1371/journal.pone.0037922	http://dx.doi.org/10.1371/journal.pone.0037922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666413	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600042
J	Zhang, Y; Wang, MY; He, J; Wang, JC; Yang, YJ; Jin, L; Chen, ZY; Ma, XJ; Sun, MH; Xia, KQ; Hong, XN; Wei, QY; Zhou, XY				Zhang, Yan; Wang, Meng-Yun; He, Jing; Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li; Chen, Zhi-Yu; Ma, Xue-Jun; Sun, Meng-Hong; Xia, Kai-Qin; Hong, Xiao-Nan; Wei, Qing-Yi; Zhou, Xiao-Yan			Tumor Necrosis Factor-alpha Induced Protein 8 Polymorphism and Risk of Non-Hodgkin's Lymphoma in a Chinese Population: A Case-Control Study	PLOS ONE			English	Article							COMMON GENETIC-VARIANTS; DEATH EFFECTOR DOMAIN; BODY-MASS INDEX; FACTOR TNF; SCC-S2; SUSCEPTIBILITY; IDENTIFICATION; INFLAMMATION; FREQUENCIES; METASTASIS	Background: Non-Hodgkin's lymphoma (NHL) has been reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the susceptibility to NHL. To evaluate the role of such genetic variations in risk of NHL, we conducted a case-control study of 514 NHL patients and 557 cancer-free controls in a Chinese population. Method: We used the Taqman assay to genotype six potentially functional single nucleotide polymorphisms (SNPs) in six previously reported inflammation and immune-related genes (TNF rs1799964T>C, LTA rs1800683G>A, IL-10 rs1800872T>G, LEP rs2167270G>A, LEPR rs1327118C>G, TNFAIP8 rs1045241C>T). Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CI). Results: We observed a significantly increased risk of NHL associated with the TNFAIP8 rs1045241C>T polymorphism (adjusted OR = 3.03; 95% CI = 1.68-5.45 for TT vs. CC and adjusted OR = 2.03; 95% CI = 1.53-2.69 for CT/TT vs. CC). The risk associated with the T allele was more evident in subgroups of 40-60 year-old, non-smokers or light-smokers (less than 25 pack-years), and subjects with normal weight or overweight. Risk for both B and T cell non-Hodgkin's lymphoma was elevated for CT/TT genotypes (adjusted OR = 1.95, 95% CI = 1.41-2.70 for B cell NHL and adjusted OR = 2.22, 95% CI = 1.49-3.30 for T cell NHL), particularly for DLBCL (adjusted OR = 2.01, 95% CI = 1.41-2.85) and FL (adjusted OR = 2.53, 95% CI = 1.17-5.45). These risks were not observed for variant genotypes of other five SNPs compared with their common homozygous genotypes. Conclusions: The polymorphism of TNFAIP8 rs1045241C>T may contribute to NHL susceptibility in a Chinese population. Further large-scale and well-designed studies are needed to confirm these results.	[Zhang, Yan; Chen, Zhi-Yu; Hong, Xiao-Nan] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Zhang, Yan; Wang, Meng-Yun; He, Jing; Chen, Zhi-Yu; Ma, Xue-Jun; Sun, Meng-Hong; Xia, Kai-Qin; Hong, Xiao-Nan; Zhou, Xiao-Yan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Meng-Yun; He, Jing; Xia, Kai-Qin; Wei, Qing-Yi; Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Ma, Xue-Jun] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Sun, Meng-Hong; Xia, Kai-Qin; Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, Y (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	xnhong@126.com; xyzhou100@yahoo.com	Zhang, Yong/H-1774-2012; Zhang, Yiming/HGB-7344-2022; Jin, Li/C-1468-2009; Zhang, Yufeng/GZL-1973-2022; Wang, Jiucun/J-8744-2012; He, Jing/M-5774-2015; Jin, Li/M-5063-2019	Zhang, Yong/0000-0002-5831-637X; Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; He, Jing/0000-0002-1954-2892; 	National Natural Science Foundation of China [30870985, 30973391]; Ministry of Health [201002007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health	This study was supported by the funding from National Natural Science Foundation of China (30870985, 30973391) and the Ministry of Health (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; Chen Y, 2010, BLOOD, V117, P585; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Dong QZ, 2010, CANCER SCI, V101, P1562, DOI 10.1111/j.1349-7006.2010.01557.x; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Hadisaputri YE, 2011, ANN SURG ONCOLOGY; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Larsson SC, 2007, INT J CANCER, V121, P1564, DOI 10.1002/ijc.22762; Li AN, 2010, MOL GENET GENOMICS, V284, P185, DOI 10.1007/s00438-010-0558-z; Li X, 2011, ANN ONCOL, V22, P141; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Lou Y, 2011, MOL IMMUNOLOGY; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang SS, 2007, CANCER RES, V67, P5042, DOI 10.1158/0008-5472.CAN-06-4752; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Willett EV, 2005, BRIT J CANCER, V93, P811, DOI 10.1038/sj.bjc.6602762; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; Xiao H, 2011, ANN HEMATOL, V90, P725, DOI 10.1007/s00277-010-1079-x; You ZB, 2001, J BIOL CHEM, V276, P26398, DOI 10.1074/jbc.M102464200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	36	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37846	10.1371/journal.pone.0037846	http://dx.doi.org/10.1371/journal.pone.0037846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666399	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600033
J	Ferrandiz, N; Caraballo, JM; Garcia-Gutierrez, L; Devgan, V; Rodriguez-Paredes, M; Lafita, MC; Bretones, G; Quintanilla, A; Munoz-Alonso, MJ; Blanco, R; Reyes, JC; Agell, N; Delgado, MD; Dotto, GP; Leon, J				Ferrandiz, Nuria; Caraballo, Juan M.; Garcia-Gutierrez, Lucia; Devgan, Vikram; Rodriguez-Paredes, Manuel; Carmen Lafita, M.; Bretones, Gabriel; Quintanilla, Andrea; Jose Munoz-Alonso, M.; Blanco, Rosa; Reyes, Jose C.; Agell, Neus; Dolores Delgado, M.; Dotto, G. Paolo; Leon, Javier			p21 as a Transcriptional Co-Repressor of S-Phase and Mitotic Control Genes	PLOS ONE			English	Article							CELL-CYCLE INHIBITION; PROMOTER ELEMENTS; DNA-REPLICATION; P21(WAF1/CIP1); DIFFERENTIATION; P21(CIP1/WAF1); EXPRESSION; CDK; INDUCTION; CHROMATIN	It has been previously described that p21 functions not only as a CDK inhibitor but also as a transcriptional co-repressor in some systems. To investigate the roles of p21 in transcriptional control, we studied the gene expression changes in two human cell systems. Using a human leukemia cell line (K562) with inducible p21 expression and human primary keratinocytes with adenoviral-mediated p21 expression, we carried out microarray-based gene expression profiling. We found that p21 rapidly and strongly repressed the mRNA levels of a number of genes involved in cell cycle and mitosis. One of the most strongly down-regulated genes was CCNE2 (cyclin E2 gene). Mutational analysis in K562 cells showed that the N-terminal region of p21 is required for repression of gene expression of CCNE2 and other genes. Chromatin immunoprecipitation assays indicated that p21 was bound to human CCNE2 and other p21-repressed genes gene in the vicinity of the transcription start site. Moreover, p21 repressed human CCNE2 promoter-luciferase constructs in K562 cells. Bioinformatic analysis revealed that the CDE motif is present in most of the promoters of the p21-regulated genes. Altogether, the results suggest that p21 exerts a repressive effect on a relevant number of genes controlling S phase and mitosis. Thus, p21 activity as inhibitor of cell cycle progression would be mediated not only by the inhibition of CDKs but also by the transcriptional down-regulation of key genes.	[Ferrandiz, Nuria; Caraballo, Juan M.; Garcia-Gutierrez, Lucia; Carmen Lafita, M.; Bretones, Gabriel; Quintanilla, Andrea; Jose Munoz-Alonso, M.; Blanco, Rosa; Dolores Delgado, M.; Leon, Javier] Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol,Inst Biomed & Biotecnol Cantabria I, E-39005 Santander, Spain; [Devgan, Vikram; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Rodriguez-Paredes, Manuel; Reyes, Jose C.] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, E-41080 Seville, Spain; [Jose Munoz-Alonso, M.] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Agell, Neus] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Harvard University; Massachusetts General Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Lausanne	Ferrandiz, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Fac Med, Hammersmith Hosp Campus, London, England.	leonj@unican.es	Ferrandiz-Diaz, Nuria/V-4071-2017; Leon, Javier/K-4615-2014; Rodríguez Paredes, Manuel/B-1480-2019; Agell, Neus/E-9640-2016; Gutierrez, Lucia Garcia/ABH-3682-2020; Rodríguez, Manuel/N-2708-2019; Bretones, Gabriel/AAB-4637-2021; Reyes, Jose C/K-3699-2014; Delgado, M. Dolores/K-9056-2014	Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; Rodríguez Paredes, Manuel/0000-0001-5471-4277; Agell, Neus/0000-0002-1205-6074; Gutierrez, Lucia Garcia/0000-0003-4396-4814; Bretones, Gabriel/0000-0002-1521-5544; Reyes, Jose C/0000-0002-8042-5142; Leon, Javier/0000-0001-5803-0112; Delgado, M. Dolores/0000-0003-4682-4040; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X	Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF08-01581, ISCIII-RETIC RD06/0020/0017]; MICINN [BFU2008-00238, CSD2006-00049]; Junta de Andalucia [P06-CVI-4844]; postdoctoral fellowship of the University of Cantabria;  [FIS 08/0829]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); postdoctoral fellowship of the University of Cantabria; 	This study was supported by grants SAF08-01581 and ISCIII-RETIC RD06/0020/0017 from the Spanish Ministerio de Ciencia e Innovacion (MICINN) to JL; FIS 08/0829 to MDD; BFU2008-00238 and CSD2006-00049 from MICINN, and P06-CVI-4844 from Junta de Andalucia to JCR. NF was the recipient of a postdoctoral fellowship of the University of Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Delgado MD, 2000, ONCOGENE, V19, P783, DOI 10.1038/sj.onc.1203384; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Efeyan A, 2007, ONCOGENE, V26, P1645, DOI 10.1038/sj.onc.1209972; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Gartel AL, 2002, MOL CANCER THER, V1, P639; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1993, CELL, V75, P805; Iglesias-Ara A, 2010, ONCOGENE, V29, P5579, DOI 10.1038/onc.2010.296; Janicke RU, 2007, CELL CYCLE, V6, P407; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Maclaren A, 2003, ONCOGENE, V22, P2383, DOI 10.1038/sj.onc.1206329; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Munoz-Alonso MJ, 2003, MOL B INT U, P236; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pippa R, 2012, ONCOGENE IN PRESS; Poole JC, 2004, CELL CYCLE, V3, P931; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; van Betteraey-Nikoleit M, 2003, EUR J BIOCHEM, V270, P3880, DOI 10.1046/j.1432-1033.2003.03769.x; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Zhu HM, 2002, CELL CYCLE, V1, P59, DOI 10.4161/cc.1.1.101	48	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37759	10.1371/journal.pone.0037759	http://dx.doi.org/10.1371/journal.pone.0037759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662213	Green Published, gold			2022-12-25	WOS:000305342300103
J	Hosseini-Tabatabaei, A; Jalili, RB; Li, YY; Kilani, RT; Rezakhanlou, AM; Ghahary, A				Hosseini-Tabatabaei, Azadeh; Jalili, Reza Baradar; Li, Yunyuan; Kilani, Ruhangiz T.; Rezakhanlou, Alireza Moeen; Ghahary, Aziz			Mechanism Underlying Defective Interferon Gamma-Induced IDO Expression in Non-obese Diabetic Mouse Fibroblasts	PLOS ONE			English	Article							INDOLEAMINE 2,3 DIOXYGENASE; TUMOR-INDUCED TOLERANCE; CLASS-I ANTIGEN; GENE-EXPRESSION; IFN-GAMMA; MHC CLASS; T-CELLS; 2,3-DIOXYGENASE EXPRESSION; TRYPTOPHAN CATABOLISM; PANCREATIC-ISLETS	Indoleamine 2,3-dioxygenase (IDO) can locally suppress T cell-mediated immune responses. It has been shown that defective self-tolerance in early prediabetic female non-obese diabetic (NOD) mice can be attributed to the impaired interferon-gamma (IFN-gamma)-induced IDO expression in dendritic cells of these animals. As IFN-gamma can induce IDO in both dendritic cells and fibroblasts, we asked the question of whether there exists a similar defect in IFN-gamma-induced IDO expression in NOD mice dermal fibroblasts. To this end, we examined the effect of IFN-gamma on expression of IDO and its enzymatic activity in NOD dermal fibroblasts. The results showed that fibroblasts from either prediabetic (8 wks of age) female or male, and diabetic female or male (12 and 24 wks of age respectively) NOD mice failed to express IDO in response to IFN-gamma treatment. To find underlying mechanisms, we scrutinized the IFN-gamma signaling pathway and investigated expression of other IFN-gamma-modulated factors including major histocompatibility complex class I (MHC-I) and type I collagen (COL-I). The findings revealed a defect of signal transducer and activator of transcription 1 (STAT1) phosphorylation in NOD cells relative to that of controls. Furthermore, we found an increase in MHC-I and suppression of COL-I expression in fibroblasts from both NOD and control mice following IFN-gamma treatment; indicating that the impaired response to IFN-gamma in NOD fibroblasts is specific to IDO gene. Finally, we showed that an IFN-gamma-independent IDO expression pathway i.e. lipopolysaccharide (LPS)-mediated-c-Jun kinase is operative in NOD mice fibroblast. In conclusion, the findings of this study for the first time indicate that IFN-gamma fails to induce IDO expression in NOD dermal fibroblasts; this may partially be due to defective STAT1 phosphorylation in IFN-gamma-induced-IDO signaling pathway.	[Hosseini-Tabatabaei, Azadeh; Jalili, Reza Baradar; Li, Yunyuan; Kilani, Ruhangiz T.; Rezakhanlou, Alireza Moeen; Ghahary, Aziz] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Hosseini-Tabatabaei, A (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@interchange.ubc.ca			Canadian Institute of Health Research (CIHR); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC)(Canadian Institutes of Health Research (CIHR))	The Canadian Institute of Health Research (CIHR) supported this study through a grant held by A. Ghahary. A. Hosseini-Tabatabaei holds the Vanier Canada Graduate Scholarship (Vanier CGS) and was also supported by a scholarship from CIHR/Skin Research Training Centre (CIHR/SRTC). The URLs for the CIHR and Vanier CGS websites are: http://www.cihr-irsc.gc.ca/and http://www.vanier.gc.ca/respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; CHON SY, 1995, J INTERF CYTOK RES, V15, P517, DOI 10.1089/jir.1995.15.517; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Forouzandeh F, 2008, WOUND REPAIR REGEN, V16, P379, DOI 10.1111/j.1524-475X.2008.00377.x; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Ghosh AK, 2006, J CELL PHYSIOL, V207, P251, DOI 10.1002/jcp.20559; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Jalili RB, 2007, IRAN J ALLERGY ASTHM, V6, P167; Jalili RB, 2007, J CELL PHYSIOL, V213, P137, DOI 10.1002/jcp.21100; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Jalili RB, 2009, AM J PATHOL, V174, P196, DOI 10.2353/ajpath.2009.080539; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; Li YY, 2004, J INVEST DERMATOL, V122, P953, DOI 10.1111/j.0022-202X.2004.22409.x; Li YY, 2004, HUM IMMUNOL, V65, P114, DOI 10.1016/j.humimm.2003.11.004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Puccetti P, 2007, EUR J IMMUNOL, V37, P876, DOI 10.1002/eji.200737184; Sarkhosh K, 2004, J CELL PHYSIOL, V201, P146, DOI 10.1002/jcp.20043; Sarkhosh K, 2003, WOUND REPAIR REGEN, V11, P337, DOI 10.1046/j.1524-475X.2003.11505.x; Sarkhosh K, 2003, J CELL BIOCHEM, V90, P206, DOI 10.1002/jcb.10593; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; Tan PH, 2009, EXPERT OPIN THER TAR, V13, P987, DOI 10.1517/14728220903018940; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; Wang YX, 2010, BRAIN BEHAV IMMUN, V24, P201, DOI 10.1016/j.bbi.2009.06.152; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37747	10.1371/journal.pone.0037747	http://dx.doi.org/10.1371/journal.pone.0037747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662207	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300097
J	Long, QZ; Du, YF; Ding, XY; Li, X; Song, WB; Yang, Y; Zhang, P; Zhou, JP; Liu, XG				Long, Qing-Zhi; Du, Yue-Feng; Ding, Xiao-Ying; Li, Xiang; Song, Wen-Bin; Yang, Yong; Zhang, Peng; Zhou, Jian-Ping; Liu, Xiao-Gang			Replication and Fine Mapping for Association of the C2orf43, FOXP4, GPRC6A and RFX6 Genes with Prostate Cancer in the Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; SCAN; HEMOCHROMATOSIS; LOCI	Background: Prostate cancer represents the leading cause of male death across the world. A recent genome-wide association study (GWAS) identified five novel susceptibility loci for prostate cancer in the Japanese population. This study is to replicate and fine map the potential association of these five loci with prostate cancer in the Chinese Han population. Methods: In Phase I of the study, we tested the five single nucleotide polymorphisms (SNPs) which showed the strongest association evidence in the original GWAS in Japanese. The study sample consists of 1,169 Chinese Hans, comprising 483 patients and 686 healthy controls. Then in phase II, flanking SNPs of the successfully replicated SNPs in Phase I were genotyped and tested for association with prostate cancer to fine map those significant association signals. Results: We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60 x 10(-5)), rs12653946 (P = 1.33 x 10(-6)), rs1983891 (FOXP4, P = 6.22 x 10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42 x 10(-5)) with prostate cancer. The most significant odds ratio (OR) was recorded as 1.41 (95% confidence interval 1.18-1.68) for rs12653946. Rs9600079 did not show significant association (P = 8.07 x 10(-2)) with prostate cancer in this study. The Phase II study refined these association signals, and identified several SNPs showing more significant association with prostate cancer than the very SNPs tested in Phase I. Conclusions: Our results provide further support for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in Eastern Asian populations. This study also characterized the novel loci reported in the original GWAS with more details. Further work is still required to determine the functional variations and finally clarify the underlying biological mechanisms.	[Long, Qing-Zhi; Du, Yue-Feng; Li, Xiang; Song, Wen-Bin] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Ding, Xiao-Ying] Xi An Jiao Tong Univ, Dept Anesthesia, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Yang, Yong] Xi An Jiao Tong Univ, Affiliated Xian Ninth Hosp, Sch Med, Dept Urol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Peng] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Zhou, Jian-Ping] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 3, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Liu, Xiao-Gang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Long, QZ (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China.	qingzhilong@yahoo.cn			National Science Foundation of China [30900800, 30901500]; Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University	This work was supported by the following: National Science Foundation of China (grant number: 30900800, 30901500; URL: http://www.nsfc.gov.cn); Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; the Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Christensen GB, 2010, PROSTATE, V70, P735, DOI 10.1002/pros.21106; Cropp CD, 2011, INT J CANC; Gillanders EM, 2004, JNCI-J NATL CANCER I, V96, P1240, DOI 10.1093/jnci/djh228; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Martinovici D, 2010, EUR J MED GENET, V53, P25, DOI 10.1016/j.ejmg.2009.10.004; Peng YM, 2008, J BONE MINER RES, V23, P247, DOI 10.1359/JBMR.071017; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Slager SL, 2006, PROSTATE, V66, P173, DOI 10.1002/pros.20332; Syrjakoski K, 2006, INT J CANCER, V118, P518, DOI 10.1002/ijc.21331; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Witte JS, 2003, PROSTATE, V57, P298, DOI 10.1002/pros.10304; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	17	31	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37866	10.1371/journal.pone.0037866	http://dx.doi.org/10.1371/journal.pone.0037866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662242	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300132
J	Takahashi, J; Waki, S; Matsumoto, R; Odake, J; Miyaji, T; Tottori, J; Iwanaga, T; Iwahashi, H				Takahashi, Junko; Waki, Shiori; Matsumoto, Rena; Odake, Junji; Miyaji, Takayuki; Tottori, Junichi; Iwanaga, Takehiro; Iwahashi, Hitoshi			Oligonucleotide Microarray Analysis of Dietary-Induced Hyperlipidemia Gene Expression Profiles in Miniature Pigs	PLOS ONE			English	Article							METABOLIC SYNDROME; INDUCED ATHEROSCLEROSIS; MESSENGER-RNA; ANIMAL-MODELS; GENOME; SWINE; TOXICOGENOMICS; REVEALS; PROGRAM; DISEASE	Background: Hyperlipidemia animal models have been established, but complete gene expression profiles of the transition from normal lipid levels have not been obtained. Miniature pigs are useful model animals for gene expression studies on dietary-induced hyperlipidemia because they have a similar anatomy and digestive physiology to humans, and blood samples can be obtained from them repeatedly. Methodology: Two typical dietary treatments were used for dietary-induced hyperlipidemia models, by using specific pathogen-free (SPF) Clawn miniature pigs. One was a high-fat and high-cholesterol diet (HFCD) and the other was a high-fat, high-cholesterol, and high-sucrose diet (HFCSD). Microarray analyses were conducted from whole blood samples during the dietary period and from white blood cells at the end of the dietary period to evaluate the transition of expression profiles of the two dietary models. Principal Findings: Variations in whole blood gene expression intensity within the HFCD or the HFCSD group were in the same range as the controls provide with normal diet at all periods. This indicates uniformity of dietary-induced hyperlipidemia for our dietary protocols. Gene ontology-(GO) based functional analyses revealed that characteristics of the common changes between HFCD and HFCSD were involved in inflammatory responses and reproduction. The correlation coefficient between whole blood and white blood cell expression profiles at 27 weeks with the HFCSD diet was significantly lower than that of the control and HFCD diet groups. This may be due to the effects of RNA originating from the tissues and/or organs. Conclusions: No statistically significant differences in fasting plasma lipids and glucose levels between the HFCD and HFCSD groups were observed. However, blood RNA analyses revealed different characteristics corresponding to the dietary protocols. In this study, whole blood RNA analyses proved to be a useful tool to evaluate transitions in dietary-induced hyperlipidemia gene expression profiles in miniature pigs.	[Takahashi, Junko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Waki, Shiori; Matsumoto, Rena; Odake, Junji; Miyaji, Takayuki; Iwahashi, Hitoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Waki, Shiori; Iwahashi, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Tottori, Junichi; Iwanaga, Takehiro] Japan Farm Co Ltd, Kagoshima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Takahashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	junko-takahashi@aist.go.jp	Iwahashi, Hitoshi/S-1360-2019; Takahashi, Junko/AAN-1019-2020; Takahashi, Junko/L-6921-2018	Takahashi, Junko/0000-0002-1941-0136	Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan	Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan	This work was partially supported by a Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deSmet BJGL, 1997, RADIOLOGY, V203, P484, DOI 10.1148/radiology.203.2.9114109; Hayashi Y, 2010, BIOL PHARM BULL, V33, P1033, DOI 10.1248/bpb.33.1033; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KOBARI Y, 1991, LAB ANIM, V25, P110, DOI 10.1258/002367791781082478; Kopreski MS, 1999, CLIN CANCER RES, V5, P1961; KROTKIEWSKI M, 1994, PRESSE MED, V23, P1393; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Lo KW, 1999, CLIN CHEM, V45, P1292; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Orbe J, 2001, CARDIOVASC RES, V49, P484, DOI 10.1016/S0008-6363(00)00260-1; Oron-Herman M, 2008, AM J HYPERTENS, V21, P1018, DOI 10.1038/ajh.2008.218; Pennie W, 2004, ENVIRON HEALTH PERSP, V112, P417, DOI 10.1289/ehp.6674; Poon LLM, 2000, CLIN CHEM, V46, P1832; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Roberts CK, 2002, ATHEROSCLEROSIS, V161, P133, DOI 10.1016/S0021-9150(01)00622-0; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Takahashi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019761; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Williams-Devane CR, 2009, TOXICOL SCI, V109, P358, DOI 10.1093/toxsci/kfp061; Yin W, 2004, J ENDOCRINOL, V180, P399, DOI 10.1677/joe.0.1800399; Zhang C, 2006, J LIPID RES, V47, P2055, DOI 10.1194/jlr.M600226-JLR200	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37581	10.1371/journal.pone.0037581	http://dx.doi.org/10.1371/journal.pone.0037581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662175	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300065
J	Vermeulen, JF; van de Ven, RAH; Ercan, C; van der Groep, P; van der Wall, E; Bult, P; Christgen, M; Lehmann, U; Daniel, J; van Diest, PJ; Derksen, PWB				Vermeulen, Jeroen F.; van de Ven, Robert A. H.; Ercan, Cigdem; van der Groep, Petra; van der Wall, Elsken; Bult, Peter; Christgen, Matthias; Lehmann, Ulrich; Daniel, Juliet; van Diest, Paul J.; Derksen, Patrick W. B.			Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; LOBULAR CARCINOMA; TUMOR MICROENVIRONMENT; ANOIKIS RESISTANCE; POOR-PROGNOSIS; PARTNER KAISO; DELTA-CATENIN; P120 CATENIN	Kaiso is a BTB/POZ transcription factor that is ubiquitously expressed in multiple cell types and functions as a transcriptional repressor and activator. Little is known about Kaiso expression and localization in breast cancer. Here, we have related pathological features and molecular subtypes to Kaiso expression in 477 cases of human invasive breast cancer. Nuclear Kaiso was predominantly found in invasive ductal carcinoma (IDC) (p = 0.007), while cytoplasmic Kaiso expression was linked to invasive lobular carcinoma (ILC) (p = 0.006). Although cytoplasmic Kaiso did not correlate to clinicopathological features, we found a significant correlation between nuclear Kaiso, high histological grade (p = 0.023), ER alpha negativity (p = 0.001), and the HER2-driven and basal/triple-negative breast cancers (p = 0.018). Interestingly, nuclear Kaiso was also abundant in BRCA1-associated breast cancer (p < 0.001) and invasive breast cancer overexpressing EGFR (p = 0.019). We observed a correlation between nuclear Kaiso and membrane-localized E-cadherin and p120-catenin (p120) (p < 0.01). In contrast, cytoplasmic p120 strongly correlated with loss of E-cadherin and low nuclear Kaiso (p = 0.005). We could confirm these findings in human ILC cells and cell lines derived from conditional mouse models of ILC. Moreover, we present functional data that substantiate a mechanism whereby E-cadherin controls p120-mediated relief of Kaiso-dependent gene repression. In conclusion, our data indicate that nuclear Kaiso is common in clinically aggressive ductal breast cancer, while cytoplasmic Kaiso and a p120-mediated relief of Kaiso-dependent transcriptional repression characterize ILC.	[Vermeulen, Jeroen F.; van de Ven, Robert A. H.; Ercan, Cigdem; van der Groep, Petra; van Diest, Paul J.; Derksen, Patrick W. B.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Groep, Petra; van der Wall, Elsken] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Christgen, Matthias] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany; [Daniel, Juliet] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Hannover Medical School; McMaster University	Vermeulen, JF (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.w.b.derksen@umcutrecht.nl	Derksen, Patrick/C-6643-2008; Bult, Peter/L-4236-2015	Derksen, Patrick/0000-0003-0732-7762; Bult, Peter/0000-0001-6427-9889	UMC Utrecht Cancer Center; Netherlands Organization for Scientific Research [NWO-VIDI 917.96.318]; Dutch Cancer Society [KWF-UU 2011-5230]; Pink Ribbon; AEGON Inc.	UMC Utrecht Cancer Center; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Pink Ribbon; AEGON Inc.	This work was supported by the UMC Utrecht Cancer Center, grants from The Netherlands Organization for Scientific Research (NWO-VIDI 917.96.318), the Dutch Cancer Society (KWF-UU 2011-5230), Pink Ribbon, and an unrestricted educational research grant from AEGON Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dai SD, 2011, CANCER SCI, V102, P95, DOI 10.1111/j.1349-7006.2010.01766.x; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Gonzalez-Angulo AM, 2006, CLIN BREAST CANCER, V7, P396, DOI 10.3816/CBC.2006.n.056; Iioka H, 2009, FEBS LETT, V583, P627, DOI 10.1016/j.febslet.2009.01.012; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Korkola JE, 2003, CANCER RES, V63, P7167; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; Packeisen J, 2003, J CLIN PATHOL-MOL PA, V56, P198, DOI 10.1136/mp.56.4.198; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Qureshi HS, 2006, AM J CLIN PATHOL, V125, P377, DOI 10.1309/WMX7DRWTFVQP2LOT; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Ruzov A, 2009, DEVELOPMENT, V136, P729, DOI 10.1242/dev.025569; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Schonborn I, 1997, INT J ONCOL, V11, P1327; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Singh R, 2009, EXP CELL RES, V315, P2899, DOI 10.1016/j.yexcr.2009.07.002; Siziopikou KP, 2007, BREAST, V16, P104, DOI 10.1016/j.breast.2006.09.003; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Takahashi K, 1997, ONCOGENE, V15, P71, DOI 10.1038/sj.onc.1201160; van de Wetering M, 2001, CANCER RES, V61, P278; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van der Groep P, 2004, JNCI-J NATL CANCER I, V96, P712, DOI 10.1093/jnci/djh114; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	61	41	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37864	10.1371/journal.pone.0037864	http://dx.doi.org/10.1371/journal.pone.0037864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662240	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300130
J	Schillinger, C; Petrich, A; Lux, R; Riep, B; Kikhney, J; Friedmann, A; Wolinsky, LE; Gobel, UB; Daims, H; Moter, A				Schillinger, Claudia; Petrich, Annett; Lux, Renate; Riep, Birgit; Kikhney, Judith; Friedmann, Anton; Wolinsky, Lawrence E.; Goebel, Ulf B.; Daims, Holger; Moter, Annette			Co-Localized or Randomly Distributed? Pair Cross Correlation of In Vivo Grown Subgingival Biofilm Bacteria Quantified by Digital Image Analysis	PLOS ONE			English	Article							HUMAN PERIODONTAL POCKETS; DENTAL PLAQUE; ORAL BACTERIA; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; ACTINOMYCES-VISCOSUS; SPATIAL-DISTRIBUTION; MICROBIAL COMPLEXES; COAGGREGATION; HEALTH	The polymicrobial nature of periodontal diseases is reflected by the diversity of phylotypes detected in subgingival plaque and the finding that consortia of suspected pathogens rather than single species are associated with disease development. A number of these microorganisms have been demonstrated in vitro to interact and enhance biofilm integration, survival or even pathogenic features. To examine the in vivo relevance of these proposed interactions, we extended the spatial arrangement analysis tool of the software daime (digital image analysis in microbial ecology). This modification enabled the quantitative analysis of microbial co-localization in images of subgingival biofilm species, where the biomass was confined to fractions of the whole-image area, a situation common for medical samples. Selected representatives of the disease-associated red and orange complexes that were previously suggested to interact with each other in vitro (Tannerella forsythia with Fusobacterium nucleatum and Porphyromonas gingivalis with Prevotella intermedia) were chosen for analysis and labeled with specific fluorescent probes via fluorescence in situ hybridization. Pair cross-correlation analysis of in vivo grown biofilms revealed tight clustering of F. nucleatum/periodonticum and T. forsythia at short distances (up to 6 mu m) with a pronounced peak at 1.5 mu m. While these results confirmed previous in vitro observations for F. nucleatum and T. forsythia, random spatial distribution was detected between P. gingivalis and P. intermedia in the in vivo samples. In conclusion, we successfully employed spatial arrangement analysis on the single cell level in clinically relevant medical samples and demonstrated the utility of this approach for the in vivo validation of in vitro observations by analyzing statistically relevant numbers of different patients. More importantly, the culture-independent nature of this approach enables similar quantitative analyses for "as-yet-uncultured'' phylotypes which cannot be characterized in vitro.	[Schillinger, Claudia; Petrich, Annett; Kikhney, Judith; Goebel, Ulf B.; Moter, Annette] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany; [Lux, Renate] Univ Calif Los Angeles, UCLA Sch Dent, Los Angeles, CA USA; [Riep, Birgit] Charite, Abt Parodontol & Synopt Zahnmed, D-13353 Berlin, Germany; [Friedmann, Anton] Univ Witten, Fac Hlth, Sch Dent, Witten, Germany; [Wolinsky, Lawrence E.] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Daims, Holger] Univ Vienna, Ctr Ecol, Dept Microbial Ecol, Vienna, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Vienna	Schillinger, C (corresponding author), Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany.	daims@microbial-ecology.net; annette.moter@charite.de	Daims, Holger/I-8410-2012	Daims, Holger/0000-0002-4195-0913; Valeeva, Aygul V./0000-0002-9968-9586; Kikhney, Judith/0000-0002-4849-7947; Petrich, Annett/0000-0002-2372-826X; Moter, Annette/0000-0003-1318-5780	National Institutes of Health [1R03DE018424-01A1]; Austrian Science Fund (FWF) [I44-B06]; European Science Foundation (ESF) [ERAS-CT-2003-980409]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Science Foundation (ESF)(European Science Foundation (ESF)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funded by National Institutes of Health grant 1R03DE018424-01A1 to RL and AM. In addition, this research was partly funded by Austrian Science Fund (FWF) grant I44-B06 and the European Science Foundation (ESF) under the EUROCORES Programme EuroDIVERSITY, COMIX project (contract no. ERAS-CT-2003-980409 of the European Commission, DG Research, FP6) to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2010, PERIODONTOL 2000, V53, P70, DOI 10.1111/j.1600-0757.2010.00357.x; Augspurger C, 2010, FEMS MICROBIOL ECOL, V72, P47, DOI 10.1111/j.1574-6941.2009.00830.x; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 2011, METHOD ENZYMOL, V496, P185, DOI 10.1016/B978-0-12-386489-5.00008-7; Dewhirst FE, 2010, J BACTERIOL; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Drescher J, 2010, EUR J ORAL SCI, V118, P466, DOI 10.1111/j.1600-0722.2010.00765.x; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Honma K, 2009, MICROBIOL-SGM, V155, P1912, DOI 10.1099/mic.0.027920-0; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; Kamaguchi A, 2003, MICROBIOL-SGM, V149, P1257, DOI 10.1099/mic.0.25997-0; Kara D, 2007, FEMS MICROBIOL LETT, V271, P90, DOI 10.1111/j.1574-6968.2007.00701.x; Kirschbaum M, 2010, ANAEROBE; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; KOLENBRANDER PE, 1988, ANNU REV MICROBIOL, V42, P627, DOI 10.1146/annurev.mi.42.100188.003211; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; KOLENBRANDER PE, 1985, INFECT IMMUN, V48, P741, DOI 10.1128/IAI.48.3.741-746.1985; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; LISTGARTEN MA, 1973, ARCH ORAL BIOL, V18, P651, DOI 10.1016/0003-9969(73)90105-2; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Listgarten MA, 1999, DENT PLAQUE REVISITE, P187; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nagaoka S, 2008, FEMS MICROBIOL LETT, V281, P183, DOI 10.1111/j.1574-6968.2008.01092.x; Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; Palmer Jr R. J., 2010, COMPEND CONTIN ED DE, V31, P108; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P138; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P124; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P110; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palmer Robert J Jr, 2010, Compend Contin Educ Dent, V31, P104; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Reed MG, 1999, J MICROSC-OXFORD, V195, P96, DOI 10.1046/j.1365-2818.1999.00592.x; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Seymour RA, 2010, DENT UPDATE, V37, P210; Seymour Robin A, 2010, Dent Update, V37, P206; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; SOCRANSKY SS, 1988, J CLIN PERIODONTOL, V15, P440, DOI 10.1111/j.1600-051X.1988.tb01598.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Suzuki N, 2004, J CLIN MICROBIOL, V42, P2255, DOI 10.1128/JCM.42.5.2255-2257.2004; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Wade WG, 2010, J DENT, V38, pS21, DOI 10.1016/S0300-5712(10)70007-5; Wagner M, 2009, ANNU REV MICROBIOL, V63, P411, DOI 10.1146/annurev.micro.091208.073233; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wimmer G, 2008, J CLIN PERIODONTOL, V35, P380, DOI 10.1111/j.1600-051X.2008.01284.x; Yamada M, 2005, FEMS MICROBIOL LETT, V250, P271, DOI 10.1016/j.femsle.2005.07.019; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	62	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37583	10.1371/journal.pone.0037583	http://dx.doi.org/10.1371/journal.pone.0037583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655057	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900033
J	Vahling-Armstrong, CM; Zhou, HS; Benyon, L; Morgan, JK; Duan, YP				Vahling-Armstrong, Cheryl M.; Zhou, Huasong; Benyon, Lesley; Morgan, J. Kent; Duan, Yongping			Two Plant Bacteria, S. meliloti and Ca. Liberibacter asiaticus, Share Functional znuABC Homologues That Encode for a High Affinity Zinc Uptake System	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; ESCHERICHIA-COLI; TRANSPORT PROTEIN; BINDING PROTEIN; SEQUENCE; GENE; VIRULENCE; ZUR; IDENTIFICATION; CONSTRUCTION	The Znu system, encoded for by znuABC, can be found in multiple genera of bacteria and has been shown to be responsible for the import of zinc under low zinc conditions. Although this high-affinity uptake system is known to be important for both growth and/or pathogenesis in bacteria, it has not been functionally characterized in a plant-associated bacterium. A single homologue of this system has been identified in the plant endosymbiont, Sinorhizobium meliloti, while two homologous systems were found in the destructive citrus pathogen, Candidatus Liberibacter asiaticus. To understand the role of these protein homologues, a complementation assay was devised allowing the individual genes that comprise the system to be assayed independently for their ability to reinstate a partially-inactivated Znu system. Results from the assays have demonstrated that although all of the genes from S. meliloti were able to restore activity, only one of the two Ca. Liberibacter asiaticus encoded gene clusters contained genes that were able to functionally complement the system. Additional analysis of the gene clusters reveals that distinct modes of regulation may also exist between the Ca. Liberibacter asiaticus and S. meliloti import systems despite the intracellular-plant niche common to both of these bacteria.	[Vahling-Armstrong, Cheryl M.; Zhou, Huasong; Benyon, Lesley; Morgan, J. Kent; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Vahling-Armstrong, CM (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA.	yongping.duan@ars.usda.gov	Benyon, Lesley/GXV-7974-2022		US Department of Agriculture (USDA); Citrus Research and Development Foundation (CRDF) [162]; Florida Citrus Advanced Technology Program [162]	US Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation (CRDF); Florida Citrus Advanced Technology Program	US Department of Agriculture (USDA), and Citrus Research and Development Foundation (CRDF) grant #162. Funding for this work was provided by the Florida Citrus Advanced Technology Program award 162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Beard SJ, 2000, FEMS MICROBIOL LETT, V184, P231, DOI 10.1016/S0378-1097(00)00055-0; Bove JM, 2006, J PLANT PATHOL, V88, P7; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Choudhury R, 2001, CURR SCI INDIA, V81, P768; Dalet K, 1999, FEMS MICROBIOL LETT, V174, P111, DOI 10.1016/S0378-1097(99)00128-7; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Garrido ME, 2003, FEMS MICROBIOL LETT, V221, P31, DOI 10.1016/S0378-1097(03)00131-9; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gottwald T.R., 2007, PLANT HLTH PROG, V8, P31, DOI [10.1094/PHP-2007-0906-01-RV, DOI 10.1094/PHP-2007-0906-01-RV]; Grass G, 2002, J BACTERIOL, V184, P864, DOI 10.1128/JB.184.3.864-866.2002; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; House BL, 2004, APPL ENVIRON MICROB, V70, P2806, DOI 10.1128/AEM.70.5.2806-2815.2004; Humann JL, 2008, APPL ENVIRON MICROB, V74, P6756, DOI 10.1128/AEM.01468-08; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Sabri M, 2009, INFECT IMMUN, V77, P1155, DOI 10.1128/IAI.01082-08; Schroeder BK, 2005, APPL ENVIRON MICROB, V71, P5858, DOI 10.1128/AEM.71.10.5858-5864.2005; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; Yang XH, 2006, INFECT IMMUN, V74, P3874, DOI 10.1128/IAI.01957-05; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zekri M, 2009, MICRONUTRIENT DEFICI	43	30	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37340	10.1371/journal.pone.0037340	http://dx.doi.org/10.1371/journal.pone.0037340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655039	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900014
J	Xu, SL; Poidevin, M; Han, EJ; Bi, JZ; Jin, P				Xu, Shunliang; Poidevin, Mickael; Han, Enji; Bi, Jianzhong; Jin, Peng			Circadian Rhythm-Dependent Alterations of Gene Expression in Drosophila Brain Lacking Fragile X Mental Retardation Protein	PLOS ONE			English	Article							CGG REPEAT; FMR-1 GENE; INSTABILITY; RNA; INTERACTS; MUTATION; HOMOLOG; OUTPUT; LEVEL; DFMR1	Fragile X syndrome is caused by the loss of the FMR1 gene product, fragile X mental retardation protein (FMRP). The loss of FMRP leads to altered circadian rhythm behaviors in both mouse and Drosophila; however, the molecular mechanism behind this phenomenon remains elusive. Here we performed a series of gene expression analyses, including of both mRNAs and microRNAs (miRNAs), and identified a number of mRNAs and miRNAs (miRNA-1 and miRNA-281) with circadian rhythm-dependent altered expression in dfmr1 mutant flies. Identification of these RNAs lays the foundation for future investigations of the molecular pathway(s) underlying the altered circadian rhythms associated with loss of dFmr1.	[Xu, Shunliang; Bi, Jianzhong] Shandong Univ, Dept Neurol, Hosp 2, Jinan 250100, Shandong, Peoples R China; [Han, Enji] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Xu, Shunliang; Poidevin, Mickael; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Shandong University; Shandong University; Emory University	Xu, SL (corresponding author), Shandong Univ, Dept Neurol, Hosp 2, Jinan 250100, Shandong, Peoples R China.	sl_hsu@yahoo.com	Xu, Shunliang/AAO-7265-2021	Xu, Shunliang/0000-0001-6516-723X	NIH [R01 MH076090]; Shandong Provincial Natural Science Foundation, China [ZR2011LH021]; Independent Innovation Foundation of Shandong University, IIFSDU [2010JC016]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University, IIFSDU; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant R01 MH076090 to P.J. S. X. is supported by Shandong Provincial Natural Science Foundation, China (ZR2011LH021) and Independent Innovation Foundation of Shandong University, IIFSDU (2010JC016). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Francke F, 2006, J BIOL CHEM, V281, P32496, DOI 10.1074/jbc.M602889200; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gao FB, 2002, NEURON, V34, P859, DOI 10.1016/S0896-6273(02)00740-7; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Inoue SB, 2002, CURR BIOL, V12, P1331, DOI 10.1016/S0960-9822(02)01036-9; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Sherman S. L., 2001, METABOLIC MOL BASES, V1, P1257; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; WOHRLE D, 1992, AM J HUM GENET, V51, P299; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37937	10.1371/journal.pone.0037937	http://dx.doi.org/10.1371/journal.pone.0037937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655085	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900062
J	Xu, ZK; Waeckerlin, R; Urbanowski, MD; van Marle, G; Hobman, TC				Xu, Zaikun; Waeckerlin, Regula; Urbanowski, Matt D.; van Marle, Guido; Hobman, Tom C.			West Nile Virus Infection Causes Endocytosis of a Specific Subset of Tight Junction Membrane Proteins	PLOS ONE			English	Article							CELLS; EXPRESSION; TRANSPORT; TRAFFICKING; INHIBITOR; MECHANISM; DYNAMIN; ENTRY; PCR	West Nile virus (WNV) is a blood-borne pathogen that causes systemic infections and serious neurological disease in human and animals. The most common route of infection is mosquito bites and therefore, the virus must cross a number of polarized cell layers to gain access to organ tissue and the central nervous system. Resistance to trans-cellular movement of macromolecules between epithelial and endothelial cells is mediated by tight junction complexes. While a number of recent studies have documented that WNV infection negatively impacts the barrier function of tight junctions, the intracellular mechanism by which this occurs is poorly understood. In the present study, we report that endocytosis of a subset of tight junction membrane proteins including claudin-1 and JAM-1 occurs in WNV infected epithelial and endothelial cells. This process, which ultimately results in lysosomal degradation of the proteins, is dependent on the GTPase dynamin and microtubule-based transport. Finally, infection of polarized cells with the related flavivirus, Dengue virus-2, did not result in significant loss of tight junction membrane proteins. These results suggest that neurotropic flaviviruses such as WNV modulate the host cell environment differently than hemorrhagic flaviviruses and thus may have implications for understanding the molecular basis for neuroinvasion.	[Xu, Zaikun; Urbanowski, Matt D.; Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Dept Cell Biol, Edmonton, AB, Canada; [Waeckerlin, Regula] Univ Calgary, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 1N4, Canada; [van Marle, Guido] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta; University of Calgary; University of Calgary; University of Alberta	Xu, ZK (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Cell Biol, Edmonton, AB, Canada.	tom.hobman@ualberta.ca		van Marle, Guido/0000-0002-5148-6229	Alberta Innovates Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR); Tier 1 Canada Research Chair; CIHR; AIHS	Alberta Innovates Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS	ZX is the recipient of a Graduate Studentship from Alberta Innovates Health Solutions (AIHS) and MDU holds a Doctoral Scholarship from the Canadian Institutes of Health Research (CIHR). TCH holds a Scientist award from AIHS and a Tier 1 Canada Research Chair. This work is supported by a research grant from the CIHR to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Grone A, 2002, VIRAL IMMUNOL, V15, P493, DOI 10.1089/088282402760312368; HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08; Michikawa H, 2008, CELL TISSUE RES, V334, P255, DOI 10.1007/s00441-008-0689-2; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; SCHEEL J, 1990, J CELL SCI, V96, P711; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sips GJ, 2011, REV MED VIROL; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Wahl-Jensen VM, 2005, J VIROL, V79, P10442, DOI 10.1128/JVI.79.16.10442-10450.2005; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232	38	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37886	10.1371/journal.pone.0037886	http://dx.doi.org/10.1371/journal.pone.0037886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655077	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900054
J	Scarpassa, VM; Alencar, RB				Scarpassa, Vera Margarete; Alencar, Ronildo Baiatone			Lutzomyia umbratilis, the Main Vector of Leishmania guyanensis, Represents a Novel Species Complex?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; PHLEBOTOMINE SANDFLIES; TRIATOMA-BRASILIENSIS; POPULATION-STRUCTURE; GENETIC-DIVERGENCE; DIPTERA; PSYCHODIDAE; PHYLOGEOGRAPHY; LONGIPALPIS; BRAZIL	Background: Lutzomyia umbratilis is an important Leishmania guyanensis vector in South America. Previous studies have suggested differences in the vector competence between L. umbratilis populations situated on opposite banks of the Amazonas and Negro Rivers in the central Amazonian Brazil region, likely indicating a species complex. However, few studies have been performed on these populations and the taxonomic status of L. umbratilis remains unclear. Methodology/Principal Findings: Phylogeographic structure was estimated for six L. umbratilis samples from the central Amazonian region in Brazil by analyzing mtDNA using 1181 bp of the COI gene to assess whether the populations on opposite banks of these rivers consist of incipient or distinct species. The genetic diversity was fairly high and the results revealed two distinct clades (=lineages) with 1% sequence divergence. Clade I consisted of four samples from the left bank of the Amazonas and Negro Rivers, whereas clade II comprised two samples from the right bank of Negro River. No haplotypes were shared between samples of two clades. Samples within clades exhibited low to moderate genetic differentiation (F-ST = 20.0390-0.1841), whereas samples between clades exhibited very high differentiation (F-ST = 0.7100-0.8497) and fixed differences. These lineages have diverged approximately 0.22 Mya in the middle Pleistocene. Demographic expansion was detected for the lineages I and II approximately 30,448 and 15,859 years ago, respectively, in the late Pleistocene. Conclusions/Significance: The two genetic lineages may represent an advanced speciation stage suggestive of incipient or distinct species within L. umbratilis. These findings suggest that the Amazonas and Negro Rivers may be acting as effective barriers, thus preventing gene flow between populations on opposite sides. Such findings have important implications for epidemiological studies, especially those related to vector competence and anthropophily, and for vector control strategies. In addition, L. umbratilis represents an interesting example in speciation studies.	[Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Alencar, Ronildo Baiatone] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Entomol, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Scarpassa, VM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	vera@inpa.gov.br	Scarpassa, Vera M./H-4125-2013	Scarpassa, Vera/0000-0003-1607-9246	National Council of Scientific and Technological Development [409058/2006-8, 575482/2008-7]; Foundation of Research Support of the State of Amazonas, Brazil; CNPq; FAPEAM	National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation of Research Support of the State of Amazonas, Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM	This study was funded by National Council of Scientific and Technological Development grants, process numbers 409058/2006-8 to Toby Vicent Barrett and 575482/2008-7 to VMS, and by the Foundation of Research Support of the State of Amazonas to VMS, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are especially grateful for Sara A. Bickersmith (Wadsworth Center, Albany, NY, USA) who kindly and generously helped in the Bayesian inference statistical analyses and for Juliana de Souza Araujo (UFAM, Manaus) who kindly helped to prepare the figures. RBA was a doctoral student of the Graduate Program in Entomology at INPA, and received a fellowship from CNPq (from February 2008 to July 2010) and FAPEAM (from August 2010 to January 2012).	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; ARIAS J R, 1977, Acta Amazonica, V7, P507; ARIAS J R, 1981, Memorias do Instituto Oswaldo Cruz, V76, P279, DOI 10.1590/S0074-02761981000300005; ARIAS J R, 1978, Acta Amazonica, V8, P387; Arrivillaga JC, 2002, INFECT GENET EVOL, V2, P83, DOI 10.1016/S1567-1348(02)00087-4; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise John C., 1994, pi; Azevedo ACR, 2002, J MED ENTOMOL, V39, P587, DOI 10.1603/0022-2585-39.4.587; Azevedo ACR, 2008, MEM I OSWALDO CRUZ, V103, P760, DOI 10.1590/S0074-02762008000800003; Balbino VQ, 2001, MEM I OSWALDO CRUZ, V96, P315, DOI 10.1590/S0074-02762001000300005; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa J, 1997, MEM I OSWALDO CRUZ, V92, P459, DOI 10.1590/S0074-02761997000400002; Coutinho-Abreu IV, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-16; Coyne JA, 2004, SPECIATION; CRANDALL KA, 1993, GENETICS, V134, P959; Guerra Jorge Augusto de Oliveira, 2003, Rev. Soc. Bras. Med. Trop., V36, P587, DOI 10.1590/S0037-86822003000500008; DYE C, 1991, ANIM BEHAV, V42, P183, DOI 10.1016/S0003-3472(05)80549-4; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Excoffier L., 2006, ARLEQUIN VERSION 3 1; FELICIANGELI MD, 1985, T ROY SOC TROP MED H, V79, P878, DOI 10.1016/0035-9203(85)90150-6; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fu YX, 1997, GENETICS, V147, P915; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GENTILE B, 1981, T ROY SOC TROP MED H, V75, P612, DOI 10.1016/0035-9203(81)90223-6; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; He LP, 2007, MOL PHYLOGENET EVOL, V43, P24, DOI 10.1016/j.ympev.2006.08.010; Herbert PDN, 2004, PLOS BIOL, V2, P312; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Justiniano S. C. B., 2004, Braz. J. Biol., V64, P227, DOI 10.1590/S1519-69842004000200007; Justiniano S. C. B., 2004, THESIS I NACL PESQUI; LAINSON R, 1981, T ROY SOC TROP MED H, V75, P530, DOI 10.1016/0035-9203(81)90192-9; LAINSON R, 1976, T ROY SOC TROP MED H, V70, P171, DOI 10.1016/0035-9203(76)90202-9; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P239, DOI 10.1016/0035-9203(79)90225-6; Le Pont F, 1980, CAHIERS ORSTOM EMP, V18, P359; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E., 1942, P1; Mazzoni CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-141; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; Monteiro FA, 2004, MOL PHYLOGENET EVOL, V32, P46, DOI 10.1016/j.ympev.2003.12.011; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; MORRISON AC, 1993, J MED ENTOMOL, V30, P427, DOI 10.1093/jmedent/30.2.427; Nei M, 1987, MOL EVOLUTIONARY GEN; Nery LCD, 2004, MEM I OSWALDO CRUZ, V99, P571, DOI 10.1590/S0074-02762004000600006; PAJOT FX, 1982, T ROY SOC TROP MED H, V76, P112, DOI 10.1016/0035-9203(82)90033-5; Pinheiro Francimeire Gomes, 2008, Acta Amaz., V38, P165, DOI 10.1590/S0044-59672008000100019; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL JR, 1986, P NATL ACAD SCI USA, V83, P9090, DOI 10.1073/pnas.83.23.9090; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rona LDP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-91; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J, 2001, LAB MANUAL; Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scarpassa VM, 1999, AM J TROP MED HYG, V60, P1010, DOI 10.4269/ajtmh.1999.60.1010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Gil LHS, 2009, MEM I OSWALDO CRUZ, V104, P955, DOI 10.1590/S0074-02762009000700002; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valenta DT, 1999, ANN TROP MED PARASIT, V93, P389, DOI 10.1080/00034989958384; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; WRIGHT S, 1978, P580; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x	72	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37341	10.1371/journal.pone.0037341	http://dx.doi.org/10.1371/journal.pone.0037341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22662146	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500103
J	Shi, G; DiRenzo, D; Qu, C; Barney, D; Miley, D; Konieczny, SF				Shi, G.; DiRenzo, D.; Qu, C.; Barney, D.; Miley, D.; Konieczny, S. F.			Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia	ONCOGENE			English	Article						Mist1; pancreatic cancer; lineage tracing; signaling pathways; 3D tissue culture	TRANSCRIPTION FACTOR MIST1; PANCREATIC INTRAEPITHELIAL NEOPLASIA; K-RAS ONCOGENE; CANCER; MICE; INDUCTION; ADENOCARCINOMA; PROGRESSION; TRANSDIFFERENTIATION; TRANSFORMATION	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers owing to a number of characteristics including difficulty in establishing early diagnosis and the absence of effective therapeutic regimens. A large number of genetic alterations have been ascribed to PDAC with mutations in the KRAS2 proto-oncogene thought to be an early event in the progression of disease. Recent lineage-tracing studies have shown that acinar cells expressing mutant Kras(G12D) are induced to transdifferentiate, generating duct-like cells through a process known as acinar-ductal metaplasia (ADM). ADM lesions then convert to precancerous pancreatic intraepithelial neoplasia (PanIN) that progresses to PDAC over time. Thus, understanding the earliest events involved in ADM/PanIN formation would provide much needed information on the molecular pathways that are instrumental in initiating this disease. As studying the transition of acinar cells to metaplastic ductal cells in vivo is complicated by analysis of the entire organ, an in vitro three dimensional (3D) culture system was used to model ADM outside the animal. Kras(G12D)-expressing acinar cells rapidly underwent ADM in 3D culture, forming ductal cysts that silenced acinar genes and activated duct genes, characteristics associated with in vivo ADM/PanIN lesions. Analysis of downstream KRAS signaling events established a critical importance for the Raf/MEK/ERK pathway in ADM induction. In addition, forced expression of the acinar-restricted transcription factor Mist1, which is critical to acinar cell organization, significantly attenuated Kras(G12D)-induced ADM/PanIN formation. These results suggest that maintaining MIST1 activity in Kras(G12D)-expressing acinar cells can partially mitigate the transformation activity of oncogenic KRAS. Future therapeutics that target both the MAPK pathway and Mist1 transcriptional networks may show promising efficacy in combating this deadly disease. Oncogene (2013) 32, 1950-1958; doi:10.1038/onc.2012.210; published online 4 June 2012	[Konieczny, S. F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Konieczny, S. F.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Konieczny, SF (corresponding author), Purdue Univ, Dept Biol Sci, Hansen Life Sci Res Bldg,201 South Univ St, W Lafayette, IN 47907 USA.	sfk@purdue.edu	Shi, Guanglu/G-1641-2013	Shi, Guanglu/0000-0001-5562-111X	NIH [CA124586, DK55489]; CTSI Predoctoral Fellowship; Phi Beta Psi Sorority for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA124586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI Predoctoral Fellowship; Phi Beta Psi Sorority for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Judy Hallett of the Purdue Center for Cancer Research Transgenic Mouse Core Facility for generating the transgenic mouse strains used in this study and David Hess and Anju Karki for critical reading of the manuscript. This work was supported by grants to SFK (NIH CA124586, NIH DK55489 and the Phi Beta Psi Sorority for Cancer Research) and to DD (CTSI Predoctoral Fellowship).	ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Brembeck FH, 2003, CANCER RES, V63, P2005; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ray KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016786; Rovira M, 2008, GASTROENTEROLOGY, V135, P1301, DOI 10.1053/j.gastro.2008.06.049; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176; Zhu LQ, 2004, MOL CELL BIOL, V24, P2673, DOI 10.1128/MCB.24.7.2673-2681.2004	47	96	97	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1950	1958		10.1038/onc.2012.210	http://dx.doi.org/10.1038/onc.2012.210			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22665051	Green Accepted			2022-12-25	WOS:000317599900009
J	Lopez-Lago, MA; Posner, S; Thodima, VJ; Molina, AM; Motzer, RJ; Chaganti, RSK				Lopez-Lago, M. A.; Posner, S.; Thodima, V. J.; Molina, A. M.; Motzer, R. J.; Chaganti, R. S. K.			Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression	ONCOGENE			English	Article						kidney cancer; metastasis; neutrophil	COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; NUDE-MICE; CANCER METASTASIS; MELANOMA-CELLS; BREAST-CANCER; INTERLEUKIN-8; GROWTH; IL-8; INFILTRATION	The mechanism by which renal cell carcinoma (RCC) colonizes the lung microenvironment during metastasis remains largely unknown. To investigate this process, we grafted human RCC cells with varying lung metastatic potential in mice. Gene expression profiling of the mouse lung stromal compartment revealed a signature enriched for neutrophil-specific functions that was induced preferentially by poorly metastatic cells. Analysis of the gene expression signatures of tumor cell lines showed an inverse correlation between metastatic activity and the levels of a number of chemokines, including CXCL5 and IL8. Enforced depletion of CXCL5 and IL8 in these cell lines enabled us to establish a functional link between lung neutrophil infiltration, secretion of chemokines by cancer cells and metastatic activity. We further show that human neutrophils display a higher cytotoxic activity against poorly metastatic cells compared with highly metastatic cells. Together, these results support a model in which neutrophils recruited to the lung by tumor-secreted chemokines build an antimetastatic barrier with loss of neutrophil chemokines in tumor cells acting as a critical rate-limiting step during lung metastatic seeding. Oncogene (2013) 32, 1752-1760; doi: 10.1038/onc.2012.201; published online 4 June 2012	[Lopez-Lago, M. A.; Posner, S.; Thodima, V. J.; Chaganti, R. S. K.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Molina, A. M.; Motzer, R. J.; Chaganti, R. S. K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chaganti, RSK (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	chagantr@mskcc.org		Motzer, Robert/0000-0001-6925-2327	National Cancer Institute [CA-121327]; V-Foundation; Syms kidney cancer award; NATIONAL CANCER INSTITUTE [R01CA121327] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V-Foundation; Syms kidney cancer award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research grants from the National Cancer Institute (CA-121327), the V-Foundation and a Syms kidney cancer award. We thank Marco Seandel and Eric Pamer for critical reading of the manuscript. The MSKCC Genomics Core Facility provided expert assistance in performing the gene expression profiling assays. R Chaganti is a Board member and a paid consultant of Cancer Genetics Inc., Rutherford, NJ, USA.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bellocq A, 1998, AM J PATHOL, V152, P83; Bissig H, 1999, AM J PATHOL, V155, P267, DOI 10.1016/S0002-9440(10)65120-6; Buonocore S, 2008, J LEUKOCYTE BIOL, V84, P713, DOI 10.1189/jlb.0108075; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; EBERT T, 1990, CANCER RES, V50, P5531; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finak G, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1608; Foekens JA, 2003, CANCER RES, V63, P337; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gorbachev AV, 2007, J IMMUNOL, V178, P2278, DOI 10.4049/jimmunol.178.4.2278; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jiang F, 2000, CANCER RES, V60, P6503; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kondo T, 2004, J UROLOGY, V171, P2171, DOI 10.1097/01.ju.0000127726.25609.87; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lee LF, 2000, J IMMUNOL, V164, P2769, DOI 10.4049/jimmunol.164.5.2769; Linehan WM, 2003, J UROLOGY, V170, P2163, DOI 10.1097/01.ju.0000096060.92397.ed; Lopez-Lago MA, 2010, CANC RES; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Monti P, 2003, CANCER RES, V63, P7451; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; MURPHY GP, 1973, JNCI-J NATL CANCER I, V50, P1013, DOI 10.1093/jnci/50.4.1013; NAITO S, 1989, CLIN EXP METASTAS, V7, P381, DOI 10.1007/BF01753659; NAITO S, 1986, CANCER RES, V46, P4109; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; PAGET S, 1989, CANCER METAST REV, V8, P98; SCHADENDORF D, 1993, J IMMUNOL, V151, P2667; Schaider H, 2003, INT J CANCER, V103, P335, DOI 10.1002/ijc.10775; SINGH RK, 1994, CANCER RES, V54, P3242; Speetjens FM, 2008, CLIN CANCER RES, V14, P2276, DOI 10.1158/1078-0432.CCR-07-4045; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Tan XJ, 2008, INT J CANCER, V123, P1080, DOI 10.1002/ijc.23637; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986	50	98	105	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2013	32	14					1752	1760		10.1038/onc.2012.201	http://dx.doi.org/10.1038/onc.2012.201			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22665059	Green Accepted			2022-12-25	WOS:000317043900002
J	Ijiri, T; Ashihara, T; Umetani, N; Igarashi, T; Haraguchi, R; Yokota, H; Nakazawa, K				Ijiri, Takashi; Ashihara, Takashi; Umetani, Nobuyuki; Igarashi, Takeo; Haraguchi, Ryo; Yokota, Hideo; Nakazawa, Kazuo			A Kinematic Approach for Efficient and Robust Simulation of the Cardiac Beating Motion	PLOS ONE			English	Article							FIBER ORIENTATION	Computer simulation techniques for cardiac beating motions potentially have many applications and a broad audience. However, most existing methods require enormous computational costs and often show unstable behavior for extreme parameter sets, which interrupts smooth simulation study and make it difficult to apply them to interactive applications. To address this issue, we present an efficient and robust framework for simulating the cardiac beating motion. The global cardiac motion is generated by the accumulation of local myocardial fiber contractions. We compute such local-to-global deformations using a kinematic approach; we divide a heart mesh model into overlapping local regions, contract them independently according to fiber orientation, and compute a global shape that satisfies contracted shapes of all local regions as much as possible. A comparison between our method and a physics-based method showed that our method can generate motion very close to that of a physics-based simulation. Our kinematic method has high controllability; the simulated ventricle-wall-contraction speed can be easily adjusted to that of a real heart by controlling local contraction timing. We demonstrate that our method achieves a highly realistic beating motion of a whole heart in real time on a consumer-level computer. Our method provides an important step to bridge a gap between cardiac simulations and interactive applications.	[Ijiri, Takashi; Yokota, Hideo] RIKEN, Biores Infrastruct Construct Team, Wako, Saitama, Japan; [Ashihara, Takashi] Shiga Univ Med Sci, Heart Rhythm Ctr, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Umetani, Nobuyuki; Igarashi, Takeo] Univ Tokyo, Dept Comp Sci, Tokyo, Japan; [Haraguchi, Ryo; Nakazawa, Kazuo] Natl Cerebral & Cardiovasc Ctr, Res Inst, Lab Biomed Sci & Informat Management, Suita, Osaka, Japan	RIKEN; Shiga University of Medical Science; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Ijiri, T (corresponding author), RIKEN, Biores Infrastruct Construct Team, Wako, Saitama, Japan.	takashi.ijiri@riken.jp	Haraguchi, Ryo/AAS-6426-2021		JSPS;  [22700115];  [21790717];  [21500420];  [22136011]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported in part by Grant-in-Aid for Young Scientists (B) (22700115; 21790717), Grant-in-Aid for Scientific Research (C) (21500420), Grant-in-Aid for Scientific Research on Innovative Areas (22136011), and JSPS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2004, P ANN INT IEEE EMBS, V26, P3658; Ashihara T, 1999, J ELECTROCARDIOL, V32, P129, DOI 10.1016/S0022-0736(99)90062-6; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P402; DEMER LL, 1983, J PHYSIOL-LONDON, V339, P615, DOI 10.1113/jphysiol.1983.sp014738; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Herman Irving P, 2007, BIOL MED PHYS BIOMED; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Ijiri T, 2009, COMPUT GRAPH FORUM, V28, P1821, DOI 10.1111/j.1467-8659.2009.01559.x; Liao SH, 2011, COMPUT ANIMAT VIRT W, V22, P269, DOI 10.1002/cav.393; Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021; Liu F, 2001, JSME INT J C-MECH SY, V44, P125; Matsuoka S, 2003, JPN J PHYSIOL, V53, P105, DOI 10.2170/jjphysiol.53.105; Muller M, 2005, ACM T GRAPHIC, V24, P471, DOI 10.1145/1073204.1073216; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; OHAYON J, 1988, BIOPHYS J, V54, P1077, DOI 10.1016/S0006-3495(88)83044-3; Rivers AR, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239533; Rungjiratananon W, 2010, COMPUT GRAPH FORUM, V29, P2438, DOI [10.1111/j.1467-8659.2010.01755.x, 10.1111/J.1467-8659.2010.01755.x]; Ruprecht D, 1998, MATH VISUALIZATION, P61; Si H, 2006, PROCEEDINGS OF THE 15TH INTERNATIONAL MESHING ROUNDTABLE, P509, DOI 10.1007/978-3-540-34958-7_29; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Takamatsu K, 2009, ACM SIGGRAPH ASIA 20; Takayama K, 2008, J PHYSIOL SCI, V58, P487, DOI 10.2170/physiolsci.RP008108; Teran J., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P68; TRAILL TA, 1978, BRIT HEART J, V40, P162; Watanabe H, 2002, JSME INT J C-MECH SY, V45, P1003, DOI 10.1299/jsmec.45.1003; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhukov L, 2003, IEEE VISUALIZATION 2003, PROCEEDINGS, P597, DOI 10.1109/VISUAL.2003.1250425	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36706	10.1371/journal.pone.0036706	http://dx.doi.org/10.1371/journal.pone.0036706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666327	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400013
J	Poon, R; Hong, HL; Wei, X; Pan, J; Alman, BA				Poon, Raymond; Hong, Helen; Wei, Xin; Pan, James; Alman, Benjamin A.			A High Throughput Screen Identifies Nefopam as Targeting Cell Proliferation in beta-Catenin Driven Neoplastic and Reactive Fibroproliferative Disorders	PLOS ONE			English	Article							FIBROMATOSIS DESMOID TUMOR; DEPENDENT TRANSCRIPTIONAL ACTIVATION; HYPERPLASTIC CUTANEOUS WOUNDS; AGGRESSIVE FIBROMATOSIS; PULMONARY-FIBROSIS; SIGNALING PATHWAY; MOUSE MODEL; IN-VITRO; DISEASE; EXPRESSION	Fibroproliferative disorders include neoplastic and reactive processes (e. g. desmoid tumor and hypertrophic scars). They are characterized by activation of beta-catenin signaling, and effective pharmacologic approaches are lacking. Here we undertook a high throughput screen using human desmoid tumor cell cultures to identify agents that would inhibit cell viability in tumor cells but not normal fibroblasts. Agents were then tested in additional cell cultures for an effect on cell proliferation, apoptosis, and beta-catenin protein level. Ultimately they were tested in Apc1638N mice, which develop desmoid tumors, as well as in wild type mice subjected to full thickness skin wounds. The screen identified Neofopam, as an agent that inhibited cell numbers to 42% of baseline in cell cultures from beta-catenin driven fibroproliferative disorders. Nefopam decreased cell proliferation and beta-catenin protein level to 50% of baseline in these same cell cultures. The half maximal effective concentration in-vitro was 0.5 uM and there was a plateau in the effect after 48 hours of treatment. Nefopam caused a 45% decline in tumor number, 33% decline in tumor volume, and a 40% decline in scar size when tested in mice. There was also a 50% decline in beta-catenin level in-vivo. Nefopam targets beta-catenin protein level in mesenchymal cells in-vitro and in-vivo, and may be an effective therapy for neoplastic and reactive processes driven by beta-catenin mediated signaling.	[Poon, Raymond; Hong, Helen; Alman, Benjamin A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wei, Xin] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Pan, James] Univ Toronto, Donnelly Ctr Cellular & Mol Res, Toronto, ON, Canada; [Pan, James] Univ Toronto, Banting & Best Inst Med Res, Toronto, ON, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Div Orthopaed, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Poon, R (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	benjamin.alman@sickkids.ca			Canadian Institutes of Health Research (CIHR) [RFN 15136]; Canadian Cancer Society Research Institute; Desmoid Tumor Research Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Desmoid Tumor Research Foundation	This work was funded by grants from the Canadian Institutes of Health Research (CIHR) RFN 15136, the Canadian Cancer Society Research Institute, and the Desmoid Tumor Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alman BA, 1997, AM J PATHOL, V151, P329; ALMAN BA, 1992, J PEDIATR ORTHOPED, V12, P1; Aymard G, 2002, J PHARMACEUT BIOMED, V30, P1013, DOI 10.1016/S0731-7085(02)00443-0; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; CASE MT, 1975, TOXICOL APPL PHARM, V33, P46, DOI 10.1016/0041-008X(75)90242-2; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Couture J, 2000, CLIN GENET, V57, P205, DOI 10.1034/j.1399-0004.2000.570306.x; ESPOSITO E, 1986, EUR J PHARMACOL, V128, P157, DOI 10.1016/0014-2999(86)90762-4; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Girard P, 2004, EUR J PHARMACOL, V503, P63, DOI 10.1016/j.ejphar.2004.09.030; HEEL RC, 1980, DRUGS, V19, P249, DOI 10.2165/00003495-198019040-00001; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Henriksson E, 2006, IN VITRO CELL DEV-AN, V42, P320; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Juarez-Rojop IE, 2006, PAIN, V122, P118, DOI 10.1016/j.pain.2006.01.018; Kim TH, 2011, TOHOKU J EXP MED, V223, P45, DOI 10.1620/tjem.223.45; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Li C, 1998, AM J PATHOL, V153, P709, DOI 10.1016/S0002-9440(10)65614-3; MARAZZITI D, 1991, DRUG EXP CLIN RES, V17, P259; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; PILLANS PI, 1995, NEW ZEAL MED J, V108, P382; Poon R, 2001, ONCOGENE, V20, P451, DOI 10.1038/sj.onc.1204107; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tejpar S, 2001, BRIT J CANCER, V85, P98, DOI 10.1054/bjoc.2001.1857; TISCHLER AS, 1986, J ENDOCRINOL, V110, P309, DOI 10.1677/joe.0.1100309; TOBIN WE, 1972, J CLIN PHARMACOL N D, V12, P230; Varallo VM, 2003, ONCOGENE, V22, P3680, DOI 10.1038/sj.onc.1206415; Verleye M, 2004, BRAIN RES, V1013, P249, DOI 10.1016/j.brainres.2004.04.035; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; WANG RIH, 1979, J CLIN PHARMACOL, V19, P395, DOI 10.1002/j.1552-4604.1979.tb02498.x; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Yang JC, 1998, J CLIN ONCOL, V16, P197, DOI 10.1200/JCO.1998.16.1.197; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11	51	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37940	10.1371/journal.pone.0037940	http://dx.doi.org/10.1371/journal.pone.0037940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666417	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400059
J	Hou, WG; Ai, WB; Bai, XG; Dong, HL; Li, Z; Zhang, YQ; Xiong, LZ				Hou, Wu-Gang; Ai, Wen-Bo; Bai, Xiao-Guang; Dong, Hai-Long; Li, Zhen; Zhang, Yuan-Qiang; Xiong, Li-Ze			Genetic Variation in the EGFR Gene and the Risk of Glioma in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN CANCER; LUNG-CANCER; POLYMORPHISM; SUSCEPTIBILITY; LOCI	Previous studies have shown that regulation of the epidermal growth factor gene (EGFR) pathway plays a role in glioma progression. Certain genotypes of the EGFR gene may be related to increased glioblastoma risk, indicating that germ line EGFR polymorphisms may have implications in carcinogenesis. To examine whether and how variants in the EGFR gene contribute to glioma susceptibility, we evaluated nine tagging single-nucleotide polymorphisms (tSNPs) of the EGFR gene in a case-control study from Xi'an city of China (301 cases, 302 controls). EGFR SNP associations analyses were performed using SPSS 16.0 statistical packages, PLINK software, Haploview software package (version 4.2) and SHEsis software platform. We identified two susceptibility tSNPs in the EGFR gene that were potentially associated with an increased risk of glioma (rs730437, p = 0.016; OR: 1.32; 95% CI: 1.05-1.66 and rs1468727, p = 0.008; OR: 1.31; 95% CI: 1.04-1.65). However, after a strict Bonferroni correction analysis was applied, the significance level of the association between EGFR tSNPs and risk of glioma was attenuated. We observed a protective effect of haplotype "AATT'' of the EGFR gene, which was associated with a 29% reduction in the risk of developing glioma, while haplotype "CGTC'' increased the risk of developing glioma by 36%. Our results, combined with previous studies, suggested an association between the EGFR gene and glioma development.	[Hou, Wu-Gang; Bai, Xiao-Guang; Dong, Hai-Long; Xiong, Li-Ze] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Ai, Wen-Bo] Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Serv, Xian 710032, Peoples R China; [Li, Zhen; Zhang, Yuan-Qiang] Fourth Mil Med Univ, Dept Histol & Embryol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Hou, WG (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	mzkxlz@126.com		Dong, Hailong/0000-0001-8984-9067	Natural Science Foundation of China [81000563]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (2010: No. 81000563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC C, 1964, Cesk Zdrav, V12, P613; Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender D, 2007, AM J HUMAN GENETICS, P81; Bethke L, 2008, HUM MOL GENET, V17, P800, DOI 10.1093/hmg/ddm351; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kharrat N, 2007, INT J BIOL MARKER, V22, P258, DOI 10.1177/172460080702200404; Koechl Silvano, 2005, V297, P13; Liu YH, 2010, CURR OPIN GENET DEV, V20, P239, DOI 10.1016/j.gde.2010.02.001; Ohgaki H, 2006, J NEUROPATH EXP NEUR, V65, P1111, DOI 10.1097/01.jnen.0000248544.28423.48; Perez CA, 2010, J UROLOGY, V183, P2062, DOI 10.1016/j.juro.2009.12.098; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Upadhyay R, 2008, ONCOL RES, V17, P167, DOI 10.3727/096504008785114147; Weiss WA, 2003, CANCER RES, V63, P1589; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Zhao Li, 2010, Chinese Journal of Pathology, V39, P476, DOI 10.3760/cma.j.issn.0529-5807.2010.07.010	26	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37531	10.1371/journal.pone.0037531	http://dx.doi.org/10.1371/journal.pone.0037531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662167	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300057
J	Liborio, AB; Santos, JPL; Minete, NFA; Diogenes, CD; Soares, AP; Queiroz, AL; Barreto, DMS				Liborio, Alexandre Braga; Lima Santos, Joao Paulo; Arraes Minete, Natalia Feitosa; Diogenes, Cecilia de Alencar; Soares, Ariane Pontes; Queiroz, Anaiara Lucena; Silva Barreto, Dulce Maria			Proteinuria Is Associated with Quality of Life and Depression in Adults with Primary Glomerulopathy and Preserved Renal Function	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NEPHROTIC SYNDROME; INFLAMMATION; ANXIETY; CKD	Background: There is no information about HRQoL, depression and associated factors in adult with nephrotic syndrome-associated glomerulopathy. Methodology/Principal Findings: Patients with primary glomerulopathy where compared with age and sex-matched hemodialysis patients and healthy subjects. Laboratory data, medical history, comorbid conditions were collected to evaluate factors associated with HRQoL (SF-36) and Depression (Hamilton Depression Rating Scale - HAMD). Glomerulopathy patients had low HRQoL in all eight SF-36 domains and two composite scores (physical and mental) in comparison with healthy subjects. HAMD score also was elevated and there was high depression prevalence. Overall, these data were comparable between glomerulopathy and hemodialysis patients. Using multiple regression analysis, factors associated with low HRQoL physical composite score were: last 24 h-urine protein excretion (-0.183, 95% CI -0.223 to -0.710 for each gram of proteinuria, p = 0.01) and cyclosporine use (-15.315, 95% CI -25.913 to 22.717, p = 0.03). Low HRQoL mental composite score was associated with last 24 h-urine protein excretion (-0.157, 95% CI -0.278 to -0.310 for each gram of proteinuria, p = 0.03) and HMAD score was independently associated with age (0.155, 95% CI 0.318 to 0.988 for each year, p = 0.04), female sex (4.788, 95% CI 1.005 to 8.620, 0 = 0.03), disease duration (0.074, 95% CI 0.021 to 0.128 for each month, p = 0.01) and last 24 h-urine protein excretion (0.050, 95% CI 0.018 to 0.085 for each gram of proteinuria, p = 0.02). Conclusions/Significance: Nephrotic-syndrome associated glomerulopathy patients have low HRQoL and high prevalence of depression symptoms, comparable with those of hemodialysis patients. Last 24 h-protein excretion rate is independently associated with physical and mental HRQoL domains in addition to depression.	[Liborio, Alexandre Braga] Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil; [Lima Santos, Joao Paulo; Arraes Minete, Natalia Feitosa; Diogenes, Cecilia de Alencar; Soares, Ariane Pontes] Univ Fortaleza, UNIFOR, Med Course, Fortaleza, Ceara, Brazil; [Liborio, Alexandre Braga; Queiroz, Anaiara Lucena; Silva Barreto, Dulce Maria] Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Fortaleza	Liborio, AB (corresponding author), Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil.	alexandreliborio@yahoo.com.br		Lima Santos, Joao Paulo/0000-0003-0676-8515				Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Almawi W, 2008, J ENDOCRINOL INVEST, V31, P1020, DOI 10.1007/BF03345642; [Anonymous], DIAGN STAT MENT DIS; Cameron JI, 2000, AM J KIDNEY DIS, V35, P629, DOI 10.1016/S0272-6386(00)70009-6; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P1332, DOI 10.2215/CJN.03951106; Dogra GK, 2002, NEPHROL DIAL TRANSPL, V17, P2220, DOI 10.1093/ndt/17.12.2220; Faller H, 2009, J CARD FAIL, V15, P286, DOI 10.1016/j.cardfail.2008.10.022; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Fleck MPD, 2004, J NERV MENT DIS, V192, P103, DOI 10.1097/01.nmd.0000110281.35970.33; Gipson DS, 2011, KIDNEY INT, V79, P678, DOI 10.1038/ki.2010.485; GOKAL R, 1993, KIDNEY INT, V43, pS23; Kalender B, 2006, NEPHRON CLIN PRACT, V102, pC115, DOI 10.1159/000089669; Kennedy SH, 2001, J PSYCHIATR NEUROSCI, V26, pS23; Kimmel PL, 2006, CLIN J AM SOC NEPHRO, V1, P349, DOI 10.2215/CJN.00890306; Malafronte P, 2006, NEPHROL DIAL TRANSPL, V21, P3098, DOI 10.1093/ndt/gfl237; Mazairac AH, 2010, J REN NUTR; Miettola J, 2008, QUAL LIFE RES, V17, P1055, DOI 10.1007/s11136-008-9386-6; Omachi TA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.036; Painter PL, 2003, KIDNEY INT, V63, P2309, DOI 10.1046/j.1523-1755.2003.00038.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Ruth EM, 2004, J PEDIATR-US, V145, P778, DOI 10.1016/j.jpeds.2004.08.022; Saveanu RV, 2011, HEART FAIL CLIN, V7, P75, DOI 10.1016/j.hfc.2010.08.010; Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292; Snow V, 2000, ANN INTERN MED, V132, P738, DOI 10.7326/0003-4819-132-9-200005020-00010; Taner E, 2007, INT J DERMATOL, V46, P1118, DOI 10.1111/j.1365-4632.2007.03247.x; Aguiar CCT, 2008, ARQ BRAS ENDOCRINOL, V52, P931, DOI 10.1590/S0004-27302008000600004; Unutzer J, 2007, NEW ENGL J MED, V357, P2269, DOI 10.1056/NEJMcp073754; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Zhu WL, 2011, J NEUROCHEM, V117, P1075, DOI 10.1111/j.1471-4159.2011.07285.x	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37763	10.1371/journal.pone.0037763	http://dx.doi.org/10.1371/journal.pone.0037763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662214	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300104
J	Rigothier, C; Auguste, P; Welsh, GI; Lepreux, S; Deminiere, C; Mathieson, PW; Saleem, MA; Ripoche, J; Combe, C				Rigothier, Claire; Auguste, Patrick; Welsh, Gavin I.; Lepreux, Sebastien; Deminiere, Colette; Mathieson, Peter W.; Saleem, Moin A.; Ripoche, Jean; Combe, Christian			IQGAP1 Interacts with Components of the Slit Diaphragm Complex in Podocytes and Is Involved in Podocyte Migration and Permeability In Vitro	PLOS ONE			English	Article							CONGENITAL NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; GLOMERULAR PROTEIN; MAJOR SIALOPROTEIN; ADHERENS JUNCTION; BINDING PROTEIN; MICE LACKING; NEPHRIN; CELL; CDC42	IQGAP1 is a scaffold protein that interacts with proteins of the cytoskeleton and the intercellular adhesion complex. In podocytes, IQGAP1 is associated with nephrin in the glomerular slit diaphragm (SD) complex, but its role remains ill-defined. In this work, we investigated the interaction of IQGAP1 with the cytoskeleton and SD proteins in podocytes in culture, and its role in podocyte migration and permeability. Expression, localization, and interactions between IQGAP1 and SD or cytoskeletal proteins were determined in cultured human podocytes by Western blot (WB), immunocytolocalization (IC), immunoprecipitation (IP), and In situ Proximity Ligation assay (IsPL). Involvement of IQGAP1 in migration and permeability was also assessed. IQGAP1 expression in normal kidney biopsies was studied by immunohistochemistry. IQGAP1 expression by podocytes increased during their in vitro differentiation. IC, IP, and IsPL experiments showed colocalizations and/or interactions between IQGAP1 and SD proteins (nephrin, MAGI-1, CD2AP, NCK 1/2, podocin), podocalyxin, and cytoskeletal proteins (alpha-actinin-4). IQGAP1 silencing decreased podocyte migration and increased the permeability of a podocyte layer. Immunohistochemistry on normal human kidney confirmed IQGAP1 expression in podocytes and distal tubular epithelial cells and also showed an expression in glomerular parietal epithelial cells. In summary, our results suggest that IQGAP1, through its interaction with components of SD and cytoskeletal proteins, is involved in podocyte barrier properties.	[Rigothier, Claire; Ripoche, Jean; Combe, Christian] Univ Bordeaux Segalen, INSERM, U1026, Bordeaux, France; [Rigothier, Claire; Welsh, Gavin I.; Mathieson, Peter W.; Saleem, Moin A.] Univ Bristol, Southmead Hosp, Acad & Childrens Renal Unit, Bristol, Avon, England; [Rigothier, Claire; Combe, Christian] Ctr Hosp Univ, Serv Nephrol, Bordeaux, France; [Auguste, Patrick] Univ Bordeaux 1, F-33405 Talence, France; [Lepreux, Sebastien; Deminiere, Colette] Ctr Hosp Univ, Serv Anat Pathol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Southmead Hospital; University of Bristol; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Rigothier, C (corresponding author), Univ Bordeaux Segalen, INSERM, U1026, Bordeaux, France.	claire.rigothier@etud.u-bordeaux2.fr	Auguste, Patrick/J-9901-2014; Combe, Christian/N-3726-2015; HERAULT, EMILIE/M-3701-2014	Combe, Christian/0000-0002-0360-573X; Saleem, Moin/0000-0002-9808-4518; Welsh, Gavin Iain/0000-0002-2148-6658; Auguste, Patrick/0000-0003-1485-0295	ERA-EDTA (European Renal Association - European Dialysis and Transplant Association); Societe de Nephrologie; Centre Hospitalier Universitaire de Bordeaux; MRC [G0800200] Funding Source: UKRI; Medical Research Council [G0800200] Funding Source: researchfish	ERA-EDTA (European Renal Association - European Dialysis and Transplant Association); Societe de Nephrologie; Centre Hospitalier Universitaire de Bordeaux; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C. Rigothier has been supported by a long-term fellowship from the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) and by grants from the Societe de Nephrologie and the Centre Hospitalier Universitaire de Bordeaux. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Coward RJM, 2005, J AM SOC NEPHROL, V16, P629, DOI 10.1681/ASN.2004030172; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Garcia AN, 2010, AM J RESP CRIT CARE, V181; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; KERJASCHKI D, 1986, J CLIN INVEST, V78, P1142, DOI 10.1172/JCI112694; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lai LW, 2008, J HISTOCHEM CYTOCHEM, V56, P659, DOI 10.1369/jhc.2008.950113; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Nakhaei-Nejad M, 2010, EUR J IMMUNOL, V40, P204, DOI 10.1002/eji.200839214; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	44	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37695	10.1371/journal.pone.0037695	http://dx.doi.org/10.1371/journal.pone.0037695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662192	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300082
J	Stautz, D; Wewer, UM; Kveiborg, M				Stautz, Dorte; Wewer, Ulla M.; Kveiborg, Marie			Functional Analysis of a Breast Cancer-Associated Mutation in the Intracellular Domain of the Metalloprotease ADAM12	PLOS ONE			English	Article							MELTRIN-ALPHA; TUMOR; DISINTEGRIN; EXPRESSION; TARGET	A recently identified breast cancer-associated mutation in the metalloprotease ADAM12 alters a potential dileucine trafficking signal, which could affect protein processing and cellular localization. ADAM12 belongs to the group of A Disintegrin And Metalloproteases (ADAMs), which are typically membrane-associated proteins involved in ectodomain shedding, cell-adhesion, and signaling. ADAM12 as well as several members of the ADAM family are over-expressed in various cancers, correlating with disease stage. Three breast cancer-associated somatic mutations were previously identified in ADAM12, and two of these, one in the metalloprotease domain and another in the disintegrin domain, were investigated and found to result in protein misfolding, retention in the secretory pathway, and failure of zymogen maturation. The third mutation, p.L792F in the ADAM12 cytoplasmic tail, was not investigated, but is potentially significant given its location within a di-leucine motif, which is recognized as a potential cellular trafficking signal. The present study was motivated both by the potential relevance of this documented mutation to cancer, as well as for determining the role of the di-leucine motif in ADAM12 trafficking. Expression of ADAM12 p. L792F in mammalian cells demonstrated quantitatively similar expression levels and zymogen maturation as wild-type (WT) ADAM12, as well as comparable cellular localizations. A cell surface biotinylation assay demonstrated that cell surface levels of ADAM12 WT and ADAM12 p. L792F were similar and that internalization of the mutant occurred at the same rate and extent as for ADAM12 WT. Moreover, functional analysis revealed no differences in cell proliferation or ectodomain shedding of epidermal growth factor (EGF), a known ADAM12 substrate between WT and mutant ADAM12. These data suggest that the ADAM12 p. L792F mutation is unlikely to be a driver (cancer causing)-mutation in breast cancer.	[Stautz, Dorte] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Stautz, D (corresponding author), Univ Copenhagen, Dept Biomed Sci, Ole Maaloes Vej, Copenhagen, Denmark.	marie.kveiborg@bric.ku.dk	Kveiborg, Marie/AAM-3019-2020	Kveiborg, Marie/0000-0002-1293-1019	Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Arvid Nilssons Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilssons Foundation	Funding provided by The Lundbeck Foundation: http://www.lundbeckfonden.dk, The Danish Cancer Society: http://www.cancer.dk, The Novo Nordisk Foundation: http://www.novonordiskfonden.dk and Arvid Nilssons Foundation: http://www.arvidnilsson.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2011, MOL CANCER RES, V9, P1449, DOI 10.1158/1541-7786.MCR-11-0100; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Jacobsen J, 2009, CURR PHARM DESIGN, V15, P2300, DOI 10.2174/138161209788682389; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Murphy G, 2010, INT J EXP PATHOL, V91, P303, DOI 10.1111/j.1365-2613.2010.00736.x; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tian BL, 2002, J CLIN PATHOL-MOL PA, V55, P394, DOI 10.1136/mp.55.6.394; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37628	10.1371/journal.pone.0037628	http://dx.doi.org/10.1371/journal.pone.0037628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662180	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300070
J	Liu, Q; Zhou, H; Cui, J; Cao, ZW; Xu, Y				Liu, Qi; Zhou, Han; Cui, Juan; Cao, Zhiwei; Xu, Ying			Reconsideration of In-Silico siRNA Design Based on Feature Selection: A Cross-Platform Data Integration Perspective	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; RANK AGGREGATION; MONTE-CARLO; INTERFERENCE; PREDICTION; EFFICIENT; MODEL	RNA interference via exogenous short interference RNAs (siRNA) is increasingly more widely employed as a tool in gene function studies, drug target discovery and disease treatment. Currently there is a strong need for rational siRNA design to achieve more reliable and specific gene silencing; and to keep up with the increasing needs for a wider range of applications. While progress has been made in the ability to design siRNAs with specific targets, we are clearly at an infancy stage towards achieving rational design of siRNAs with high efficacy. Among the many obstacles to overcome, lack of general understanding of what sequence features of siRNAs may affect their silencing efficacy and of large-scale homogeneous data needed to carry out such association analyses represents two challenges. To address these issues, we investigated a feature-selection based in-silico siRNA design from a novel cross-platform data integration perspective. An integration analysis of 4,482 siRNAs from ten meta-datasets was conducted for ranking siRNA features, according to their possible importance to the silencing efficacy of siRNAs across heterogeneous data sources. Our ranking analysis revealed for the first time the most relevant features based on cross-platform experiments, which compares favorably with the traditional in-silico siRNA feature screening based on the small samples of individual platform data. We believe that our feature ranking analysis can offer more creditable suggestions to help improving the design of siRNA with specific silencing targets. Data and scripts are available at http://csbl.bmb.uga.edu/publications/materials/qiliu/siRNA.html.	[Liu, Qi; Zhou, Han; Cao, Zhiwei] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Cui, Juan; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Cui, Juan; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Tongji University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Liu, Q (corresponding author), Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; xyn@bmb.uga.edu			Project White Magnolia Funding, Shanghai [2010B127]; Shanghai Pujiang Talents Funding [11PJ1407400]; Tongji Excellent Young Scientist Funding [2000219052]; National Natural Science Foundation of China [30976611, 31100956, 61173117]; Young Teachers for the Doctoral Program of Ministry of Education, China [20110072120048]	Project White Magnolia Funding, Shanghai; Shanghai Pujiang Talents Funding; Tongji Excellent Young Scientist Funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers for the Doctoral Program of Ministry of Education, China	1. Project White Magnolia Funding, Shanghai (Grant No. 2010B127) http://www.stcsm.gov.cn/structure/index.htm, 2. Shanghai Pujiang Talents Funding (Grant No. 11PJ1407400) http://www.stcsm.gov.cn/structure/index.htm, 3. Tongji Excellent Young Scientist Funding (Grant No. 2000219052) http://www.tongji.edu.cn/, 4. National Natural Science Foundation of China (Grant No. 30976611, Grant No. 31100956 and Grant No. 61173117)http://www.nsfc.gov.cn/Portal0/default152.htm, 5. Young Teachers for the Doctoral Program of Ministry of Education, China (Grant No. 20110072120048) http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chalk AM, 2004, BIOCHEM BIOPH RES CO, V319, P264, DOI 10.1016/j.bbrc.2004.04.181; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gomase VS, 2008, CURR DRUG METAB, V9, P241, DOI 10.2174/138920008783884777; Gong WM, 2008, BIOINFORMATICS, V24, P2405, DOI 10.1093/bioinformatics/btn442; Gong WM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-516; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; JI S., 2009, P 26 ANN INT C MACH, P457; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2003, J KOREAN MED SCI, V18, P309, DOI 10.3346/jkms.2003.18.3.309; Klingelhoefer JW, 2009, BIOINFORMATICS, V25, P1594, DOI 10.1093/bioinformatics/btp284; Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x; Liu J, SLEP SPARSE LEARNING; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-181; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Naito Y, 2006, NUCLEIC ACIDS RES, V34, pW448, DOI 10.1093/nar/gkl214; Peek AS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-182; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Ren YL, 2006, BIOINFORMATICS, V22, P1027, DOI 10.1093/bioinformatics/btl026; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2006, NUCLEIC ACIDS RES, V34, P5660, DOI 10.1093/nar/gkl715; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang LQ, 2004, BIOINFORMATICS, V20, P1818, DOI 10.1093/bioinformatics/bth164; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	39	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37879	10.1371/journal.pone.0037879	http://dx.doi.org/10.1371/journal.pone.0037879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655076	Green Published, gold			2022-12-25	WOS:000305338900053
J	Zhou, MT; Chen, BC; Sun, HW; Jin, YP; Yang, FJ; Zhang, X; Andersson, R; Zhang, QY				Zhou, Meng Tao; Chen, Bi Cheng; Sun, Hong Wei; Jin, Yue Peng; Yang, Fa Jing; Zhang, Xing; Andersson, Roland; Zhang, Qi Yu			Continuous Regional Arterial Infusion with Fluorouracil and Octreotide Attenuates Severe Acute Pancreatitis in a Canine Model	PLOS ONE			English	Article							ACUTE NECROTIZING PANCREATITIS; ACUTE LUNG INJURY; PROTEASE INHIBITOR; EARLY PHASE; RATS; 5-FLUOROURACIL; BAICALIN; ISCHEMIA; MECHANISMS; 5-FU	Aim: To investigate the therapeutic effects of fluorouracil (5-Fu) and octreotide (Oct) continuous regional arterial infusion (CRAI,) alone or in combination, was administered in a canine model of severe acute pancreatitis (SAP). Materials and Methods: The animals were divided into five groups; group A (Sham), group B (SAP), group C (SAP and 5-Fu), group D (SAP and Oct), and group E (SAP and 5-Fu + Oct). Levels of amylase, alpha-tumor necrosis factor (TNF-alpha), blood urea nitrogen (BUN), creatinine, thromboxane B2 and 6-keto-prostaglandin F1 alpha were measured both before and after the induction of SAP. Pathologic examination of the pancreas and kidneys was performed after termination of the study. Results: Pathologic changes noted in the pancreas in SAP significantly improved following CRAI with either single or combined administration of 5-Fu and Oct, where combination therapy demonstrated the lowest injury score. All treatment groups had significantly lower levels of serum TNF-alpha and amylase activity (P<0.05), though only groups D and E had a lower BUN level as compared to group B. The plasma thromboxane B-2 level increased in SAP, but the ratio of thromboxane B-2/6-keto-prostaglandin F-1 alpha decreased in the treatment groups, with the combination therapy (group E) demonstrating the lowest ratio as compared to the other 3 experimental groups (P<0.05). Conclusions: The findings in the present study demonstrate an attenuation of SAP in a canine model following CRAI administration with 5-Fu or Oct, alone or in combination.	[Zhou, Meng Tao; Chen, Bi Cheng; Zhang, Xing] Wenzhou Med Coll, Affiliated Hosp 1, Zhejiang Prov Top Key Discipline Surg, Wenzhou Key Lab Surg,Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Andersson, Roland] Lund Univ, Dept Surg, Lund, Sweden; [Andersson, Roland] Skane Univ Hosp, Lund, Sweden	Wenzhou Medical University; Lund University; Lund University; Skane University Hospital	Zhou, MT (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Zhejiang Prov Top Key Discipline Surg, Wenzhou Key Lab Surg,Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zhangqiyu0577@hotmail.com		Zhou, Mengtao/0000-0002-2455-250X	grants of Zhejiang Provincial Top Key Discipline in Surgery; Natural Science Foundation of Zhejiang Province [Z2100853]; National Natural Science Foundation of China [81070732]	grants of Zhejiang Provincial Top Key Discipline in Surgery; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by grants of Zhejiang Provincial Top Key Discipline in Surgery, the Natural Science Foundation of Zhejiang Province (Grant No. Z2100853) and the National Natural Science Foundation of China (Grant No. 81070732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Andersson B, 2006, PANCREATOLOGY, V6, P536, DOI 10.1159/000096977; Bai Y, 2007, PANCREAS, V35, P232, DOI 10.1097/MPA.0b013e3180654d20; Barreto SG, 2010, HPB, V12, P403, DOI 10.1111/j.1477-2574.2010.00191.x; BIELECKI K, 1994, PANCREAS, V9, P518, DOI 10.1097/00006676-199407000-00016; CASTELLANOS J, 1975, J SURG RES, V18, P305, DOI 10.1016/0022-4804(75)90156-0; Chen BQZNLC, 2006, CHIN J CURR ADV GEN, V9, P215; Chen XL, 2009, WORLD J GASTROENTERO, V15, P2032, DOI 10.3748/wjg.15.2032; Coelho AMD, 2003, PANCREAS, V26, P230, DOI 10.1097/00006676-200304000-00004; Gu F, 1995, Zhonghua Wai Ke Za Zhi, V33, P339; Guler O, 2009, SURG TODAY, V39, P876, DOI 10.1007/s00595-009-3972-2; Gultekin FA, 2007, WORLD J GASTROENTERO, V13, P2932, DOI 10.3748/wjg.v13.i21.2932; Hayashi J, 1996, PANCREAS, V13, P184, DOI 10.1097/00006676-199608000-00010; Hukkanen RR, 2009, TOXICOL PATHOL, V37, P799, DOI 10.1177/0192623309343778; Imaizumi H, 2004, PANCREAS, V28, P369, DOI 10.1097/00006676-200405000-00003; Inoue K, 2003, PANCREAS, V26, P218, DOI 10.1097/00006676-200304000-00002; JOHNSON RM, 1973, AM J SURG, V125, P211, DOI 10.1016/0002-9610(73)90030-5; Kakugawa Y, 1990, Nihon Shokakibyo Gakkai Zasshi, V87, P1444; Kinami Y, 1976, Gastroenterol Jpn, V11, P123; Laptev VV, 1981, 5 FLUOROURACIL TREAT, P67; MANN SK, 1979, ARCH PATHOL LAB MED, V103, P79; Mikami Y, 2005, PANCREAS, V30, P248, DOI 10.1097/01.mpa.0000153328.54569.28; Mironov VI, 1985, CUMULATION 5 FLUOROU, P168; Omata F, 2010, J GASTROENTEROL, V45, P885, DOI 10.1007/s00535-010-0234-4; Paran H, 2000, DIGEST DIS SCI, V45, P2247, DOI 10.1023/A:1026679106463; SAARIO IA, 1983, AM J SURG, V145, P349, DOI 10.1016/0002-9610(83)90198-8; Satoh Hirohiko, 2004, J Med Invest, V51, P186, DOI 10.2152/jmi.51.186; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Takeda K, 2005, PANCREAS, V30, P40; Takeda K, 2001, J Hepatobiliary Pancreat Surg, V8, P216, DOI 10.1007/s005340170019; Tian H, 2009, INFLAMMATION, V32, P191, DOI 10.1007/s10753-009-9120-8; VANOOIJEN B, 1988, SCAND J GASTROENTERO, V23, P188, DOI 10.3109/00365528809103966; Woeste G, 2008, TRANSPLANTATION, V86, P961, DOI 10.1097/TP.0b013e318186b783; ZC ZS, 1991, CHINESE J PRACTICA Z, VZ1, P466; Zhang XP, 2007, J PANCREAS, V8, P400; Zhang XP, 2008, DIGEST DIS SCI, V53, P581, DOI 10.1007/s10620-007-9868-3; Zhang XP, 2007, WORLD J GASTROENTERO, V13, P5079, DOI 10.3748/wjg.v13.i38.5079; Zhang XP, 2008, WORLD J GASTROENTERO, V14, P6551, DOI 10.3748/wjg.14.6551; Zhao Yupei HY, 2001, CHINESE J EXPT SURG, V18, P54; Zhou MT, 2010, WORLD J GASTROENTERO, V16, P2094, DOI 10.3748/wjg.v16.i17.2094; Zhou MT, 2011, SCAND J GASTROENTERO, V46, P211, DOI 10.3109/00365521.2010.525715	42	11	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37347	10.1371/journal.pone.0037347	http://dx.doi.org/10.1371/journal.pone.0037347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655040	Green Published, gold			2022-12-25	WOS:000305338900015
J	Mojzita, D; Herold, S; Metz, B; Seiboth, B; Richard, P				Mojzita, Dominik; Herold, Silvia; Metz, Benjamin; Seiboth, Bernhard; Richard, Peter			L-xylo-3-Hexulose Reductase Is the Missing Link in the Oxidoreductive Pathway for D-Galactose Catabolism in Filamentous Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINITOL 4-DEHYDROGENASE; L-ARABINOSE CATABOLISM; L-XYLULOSE REDUCTASE; ASPERGILLUS-NIGER; HYPOCREA-JECORINA; CELLULASE INDUCTION; METABOLISM; NIDULANS; DEHYDROGENASE; LACTOSE	In addition to the well established Leloir pathway for the catabolism of D-galactose in fungi, the oxidoreductive pathway has been recently identified. In this oxidoreductive pathway, D-galactose is converted via a series of NADPH-dependent reductions and NAD(+)-dependent oxidations into D-fructose. The pathway intermediates include galactitol, L-xylo-3-hexulose, and D-sorbitol. This study identified the missing link in the pathway, the L-xylo-3-hexulose reductase that catalyzes the conversion of L-xylo-3-hexulose to D-sorbitol. In Trichoderma reesei (Hypocrea jecorina) and Aspergillus niger, we identified the genes lxr4 and xhrA, respectively, that encode the L-xylo-3-hexulose reductases. The deletion of these genes resulted in no growth on galactitol and in reduced growth on D-galactose. The LXR4 was heterologously expressed, and the purified protein showed high specificity for L-xylo-3-hexulose with a K-m = 2.0 +/- 0.5 mM and a V-max = 5.5 +/- 1.0 units/mg. We also confirmed that the product of the LXR4 reaction is D-sorbitol.	[Mojzita, Dominik; Richard, Peter] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland; [Herold, Silvia; Metz, Benjamin; Seiboth, Bernhard] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, A-1040 Vienna, Austria	VTT Technical Research Center Finland; Technische Universitat Wien	Richard, P (corresponding author), VTT Tech Res Ctr Finland, Tietotie 2,POB 1000, Espoo 02044, VTT, Finland.	Peter.Richard@vtt.fi	Richard, Peter/A-4229-2009	Richard, Peter/0000-0003-0922-6092; Mojzita, Dominik/0000-0001-6078-4503; Herold, Silvia/0000-0001-7109-4997	Academy of Finland; Finnish Centre of Excellence in White Biotechnology-Green Chemistry and Sustainable Energy [118573, 131869]; Austrian Science Foundation [P19421]; Vienna University of Technology	Academy of Finland(Academy of Finland); Finnish Centre of Excellence in White Biotechnology-Green Chemistry and Sustainable Energy; Austrian Science Foundation(Austrian Science Fund (FWF)); Vienna University of Technology	This work was supported by the Academy of Finland in the following research programs: Finnish Centre of Excellence in White Biotechnology-Green Chemistry (Grant 118573) and Sustainable Energy (Grant 131869). The work was further supported by a from of the Austrian Science Foundation (Grant P19421) (to B.S.).; A member of the Applied Bioscience Technologies (AB-Tec) Ph. D. program financed by the Vienna University of Technology.	BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; Christensen U, 2011, APPL ENVIRON MICROB, V77, P7084, DOI 10.1128/AEM.05290-11; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Vries RP, 2008, ASPERGILLUS IN THE GENOMIC ERA, P87; DELEY J, 1957, J BIOL CHEM, V227, P745; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; Fekete E, 2004, ARCH MICROBIOL, V181, P35, DOI 10.1007/s00203-003-0622-8; Fekete E, 2008, ACTA MICROBIOL IMM H, V55, P119, DOI 10.1556/AMicr.55.2008.2.4; Fekete E, 2012, FEMS MICROBIOL LETT, V329, P198, DOI 10.1111/j.1574-6968.2012.02524.x; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Metz B, 2009, FEBS LETT, V583, P1309, DOI 10.1016/j.febslet.2009.03.027; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Mojzita D, 2010, J BIOL CHEM, V285, P23622, DOI 10.1074/jbc.M110.113399; Pail M, 2004, EUR J BIOCHEM, V271, P1864, DOI 10.1111/j.1432-1033.2004.04088.x; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Richard P, 2002, BIOCHEMISTRY-US, V41, P6432, DOI 10.1021/bi025529i; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; ROBERTS CF, 1970, BIOCHIM BIOPHYS ACTA, V201, P267, DOI 10.1016/0304-4165(70)90301-6; Seiboth B, 2004, MOL MICROBIOL, V51, P1015, DOI 10.1046/j.1365-2958.2003.03901.x; Seiboth B, 2003, EUKARYOT CELL, V2, P867, DOI 10.1128/EC.2.5.867-875.2003; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Seiboth Bernhard, 2007, Fungal Biology Reviews, V21, P42, DOI 10.1016/j.fbr.2007.02.006; Seiboth B, 2011, APPL MICROBIOL BIOT, V89, P1665, DOI 10.1007/s00253-010-3071-8	28	21	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26010	26018		10.1074/jbc.M112.372755	http://dx.doi.org/10.1074/jbc.M112.372755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654107	Green Published, hybrid			2022-12-25	WOS:000306916300028
J	Bagley, DC; Paradkar, PN; Kaplan, J; Ward, DM				Bagley, Dustin C.; Paradkar, Prasad N.; Kaplan, Jerry; Ward, Diane M.			Mon1a Protein Acts in Trafficking through the Secretory Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; EARLY ENDOSOMES; COPII; COMPLEX; TRANSPORT; PATHWAY; FUSION; IDENTIFICATION	Mon1a was originally identified as a modifier gene of vesicular traffic, as a mutant Mon1a allele resulted in increased localization of cell surface proteins, whereas reduced levels of Mon1a showed decreased secretory activity. Here we show that Mon1a affects different steps in the secretory pathway including endoplasmic reticulum-to-Golgi traffic. siRNA-dependent reduction of Mon1a levels resulted in a delay in the reformation of the Golgi apparatus after Brefeldin A treatment. Endoglycosidase H treatment of ts045VSVG-GFP confirmed that knockdown of Mon1a delayed endoplasmic reticulum-to-Golgi trafficking. Reductions in Mon1a also resulted in delayed trafficking from Golgi to the plasma membrane. Immunoprecipitation and mass spectrometry analysis showed that Mon1a associates with dynein intermediate chain. Reductions in Mon1a or dynein altered steady state Golgi morphology. Reductions in Mon1a delayed formation of ERGIC-53-positive vesicles, whereas reductions in dynein did not affect vesicle formation. These data provide strong evidence for a role for Mon1a in anterograde trafficking through the secretory apparatus.	[Bagley, Dustin C.; Paradkar, Prasad N.; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu	Paradkar, Prasad/ABA-5851-2020	Paradkar, Prasad/0000-0002-6553-2214	National Institutes of Health Grant [HL26922]; National Institutes of Health Training Grant [T32DK00715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026922, R37HL026922] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL26922 (to D. M. W.).; Supported by National Institutes of Health Training Grant T32DK00715.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Durchfort N, 2012, TRAFFIC, V13, P108, DOI 10.1111/j.1600-0854.2011.01300.x; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hamasaki M, 2003, CELL STRUCT FUNCT, V28, P49; Hauri HP, 2000, J CELL SCI, V113, P587; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107; Hoffman-Sommer M, 2009, EUR J CELL BIOL, V88, P639, DOI 10.1016/j.ejcb.2009.07.003; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Iyadurai SJP, 2008, J CELL SCI, V121, P2643, DOI 10.1242/jcs.027144; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kucharczyk R, 2009, FEMS YEAST RES, V9, P565, DOI 10.1111/j.1567-1364.2009.00515.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; PEROU CM, 1993, J CELL SCI, V106, P99; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Raiborg C, 2001, J CELL SCI, V114, P2255; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	34	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25577	25588		10.1074/jbc.M112.354043	http://dx.doi.org/10.1074/jbc.M112.354043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665492	Green Published, hybrid			2022-12-25	WOS:000306651700065
J	Downer, EJ; Clifford, E; Amu, S; Fallon, PG; Moynagh, PN				Downer, Eric J.; Clifford, Eileen; Amu, Sylvie; Fallon, Padraic G.; Moynagh, Paul N.			The Synthetic Cannabinoid R(+)WIN55,212-2 Augments Interferon-beta Expression via Peroxisome Proliferator-activated Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; RAT MICROGLIAL CELLS; SMOOTH-MUSCLE-CELLS; PPAR-ALPHA; SIGNALING PATHWAY; TNF-ALPHA; ANTIINFLAMMATORY ACTIONS; INFLAMMATORY RESPONSES	We have demonstrated that R(+)WIN55,212-2, a synthetic cannabinoid that possesses cannabimimetic properties, acts as a novel regulator of Toll-like receptor 3 (TLR3) signaling to interferon (IFN) regulatory factor 3 (IRF3) activation and IFN-beta expression, and this is critical for manifesting its protective effects in a murine multiple sclerosis model. Here we investigated the role of peroxisome proliferator-activated receptor-alpha (PPAR alpha) in mediating the effects of R(+)WIN55,212-2 on this pathway. Data herein demonstrate that the TLR3 agonist poly(I:C) promotes IFN-beta expression and R(+)WIN55,212-2 enhances TLR3-induced IFN-beta expression in a stereoselective manner via PPAR alpha. R(+)WIN55,212-2 promotes increased transactivation and expression of PPAR alpha. Using the PPAR alpha antagonist GW6471, we demonstrate that R(+)WIN55,212-2 acts via PPAR alpha to activate JNK, activator protein-1, and positive regulatory domain IV to transcriptionally regulate the IFN-beta promoter. Furthermore, GW6471 ameliorated the protective effects of R(+) WIN55,212-2 during the initial phase of experimental autoimmune encephalomyelitis. Overall, these findings define PPAR alpha as an important mediator in manifesting the effects of R(+) WIN55,212-2 on the signaling cascade regulating IFN-beta expression. The study adds to our molecular appreciation of potential therapeutic effects of R(+)WIN55,212-2 in multiple sclerosis.	[Downer, Eric J.; Clifford, Eileen; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland; [Amu, Sylvie; Fallon, Padraic G.] Trinity Coll Dublin, St Jamess Hosp, Inst Mol Med, Dublin 8, Ireland	Maynooth University; Trinity College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland.	Paul.Moynagh@nuim.ie	Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293; Amu, Sylvie/0000-0001-9593-7952; Moynagh, Paul/0000-0002-4139-3061; Downer, Eric/0000-0002-6012-2291	Science Foundation Ireland; IRCSET postdoctoral fellowship	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET postdoctoral fellowship(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland (to P.N.M.) and an IRCSET postdoctoral fellowship (to E.J.D.).	Alvarado M, 2008, BIOORGAN MED CHEM, V16, P10098, DOI 10.1016/j.bmc.2008.10.023; Alvaro-Bartolome M, 2010, BRIT J PHARMACOL, V160, P643, DOI 10.1111/j.1476-5381.2010.00710.x; Atzei P, 2010, J BIOL CHEM, V285, P36804, DOI 10.1074/jbc.M110.139113; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Bosier B, 2009, BIOCHEM PHARMACOL, V77, P216, DOI 10.1016/j.bcp.2008.10.010; Carroll C. B., 2012, NEUROPATHOL IN PRESS; Cheng SM, 2010, EUR J PHARM SCI, V40, P316, DOI 10.1016/j.ejps.2010.04.003; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; De Morrow S, 2008, AM J PHYSIOL-GASTR L, V294, pG506, DOI 10.1152/ajpgi.00304.2007; Deplanque D, 2003, J NEUROSCI, V23, P6264; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Downer EJ, 2011, J BIOL CHEM, V286, P10316, DOI 10.1074/jbc.M110.188599; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Eichele K, 2009, PHARM RES-DORDR, V26, P346, DOI 10.1007/s11095-008-9748-3; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Froger N, 2009, J NEUROCHEM, V111, P1383, DOI 10.1111/j.1471-4159.2009.06407.x; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Germain N, 2002, INT IMMUNOPHARMACOL, V2, P537, DOI 10.1016/S1567-5769(01)00200-4; Giuliano M, 2009, BIOCHIMIE, V91, P457, DOI 10.1016/j.biochi.2008.11.003; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Graber JJ, 2010, CLIN NEUROL NEUROSUR, V112, P583, DOI 10.1016/j.clineuro.2010.05.002; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Hasseldam H, 2011, INT J NEUROSCI, V121, P510, DOI 10.3109/00207454.2011.582237; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Herzberg U, 1997, NEUROSCI LETT, V221, P157, DOI 10.1016/S0304-3940(96)13308-5; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Ji YY, 2010, CELL PHYSIOL BIOCHEM, V25, P631, DOI 10.1159/000315082; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Lee JW, 2007, GASTROENTEROLOGY, V133, P108, DOI 10.1053/j.gastro.2007.03.113; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu JL, 2003, MOL PHARMACOL, V63, P983, DOI 10.1124/mol.63.5.983; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Luca T, 2009, EUR J PHARMACOL, V616, P16, DOI 10.1016/j.ejphar.2009.06.004; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marchalant Y, 2007, NEUROSCIENCE, V144, P1516, DOI 10.1016/j.neuroscience.2006.11.016; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Miralles F, 1998, MOL CELL BIOL, V18, P4537, DOI 10.1128/MCB.18.8.4537; Mohapatra SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-10; Molina-Holgado F, 2002, J NEUROSCI RES, V67, P829, DOI 10.1002/jnr.10165; Moranta D, 2007, J NEUROSCI RES, V85, P656, DOI 10.1002/jnr.21140; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; O'Sullivan SE, 2009, EUR J PHARMACOL, V612, P61, DOI 10.1016/j.ejphar.2009.03.010; O'Sullivan SE, 2006, J PHARMACOL EXP THER, V317, P428, DOI 10.1124/jpet.105.095828; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; PACHECO M, 1991, J PHARMACOL EXP THER, V257, P170; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park JM, 2011, J CELL BIOCHEM, V112, P1192, DOI 10.1002/jcb.23041; Pellerito O, 2010, MOL PHARMACOL, V77, P854, DOI 10.1124/mol.109.062257; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Racke MK, 2008, PPAR RES, V2008, DOI 10.1155/2008/638356; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Ryoo S, 2004, BIOCHEM BIOPH RES CO, V318, P329, DOI 10.1016/j.bbrc.2004.04.031; Sagar DR, 2008, BRIT J PHARMACOL, V155, P1297, DOI 10.1038/bjp.2008.335; Sanchez AJ, 2006, BIOCHEM PHARMACOL, V72, P1697, DOI 10.1016/j.bcp.2006.08.018; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Smeets PJH, 2008, J BIOL CHEM, V283, P29109, DOI 10.1074/jbc.M802143200; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Sun Y, 2006, BIOCHEM SOC T, V34, P1095, DOI 10.1042/BST0341095; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Yang H, 2010, EXP EYE RES, V91, P462, DOI 10.1016/j.exer.2010.06.022; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	87	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25440	25453		10.1074/jbc.M112.371757	http://dx.doi.org/10.1074/jbc.M112.371757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654113	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000306651700051
J	Noborn, F; Ancsin, JB; Ubhayasekera, W; Kisilevsk, R; Li, JP				Noborn, Fredrik; Ancsin, John B.; Ubhayasekera, Wimal; Kisilevsk, Robert; Li, Jin-Ping			Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-A AMYLOIDOSIS; PLASMON RESONANCE; APOLIPOPROTEIN-E; BINDING; FIBRILS; ANTITHROMBIN; MICE; GLYCOSAMINOGLYCANS; FIBRILLIZATION; ELECTROSTATICS	Inflammation-related (AA) amyloidosis is a severe clinical disorder characterized by the systemic deposition of the acute-phase reactant serum amyloid A (SAA). SAA is normally associated with the high-density lipoprotein (HDL) fraction in plasma, but under yet unclear circumstances, the apolipoprotein is converted into amyloid fibrils. AA amyloid and heparan sulfate (HS) display an intimate relationship in situ, suggesting a role for HS in the pathogenic process. This study reports that HS dissociates SAA from HDLs isolated from inflamed mouse plasma. Application of surface plasmon resonance spectroscopy and molecular modeling suggests that HS simultaneously binds to two apolipoproteins of HDL, SAA and ApoA-I, and thereby induce SAA dissociation. The activity requires a minimum chain length of 12-14 sugar units, proposing an explanation to previous findings that short HS fragments preclude AA amyloidosis. The results address the initial events in the pathogenesis of AA amyloidosis.	[Noborn, Fredrik; Ancsin, John B.; Ubhayasekera, Wimal; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Kisilevsk, Robert] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Uppsala University; McMaster University; Queens University - Canada	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.	jin-ping.li@imbim.uu.se			European Commission (EURAMY European Rare Amyloidosis Network); Swedish Research Council [K2009-67X-21128-01-3]; Mizutani Foundation for Glycoscience; Swedish Cancerfonden [090717]; Polysackaridforskning Foundation (Uppsala, Sweden)	European Commission (EURAMY European Rare Amyloidosis Network)(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Mizutani Foundation for Glycoscience; Swedish Cancerfonden; Polysackaridforskning Foundation (Uppsala, Sweden)	The study was supported by grants from the European Commission (EURAMY European Rare Amyloidosis Network), the Swedish Research Council (K2009-67X-21128-01-3), the Mizutani Foundation for Glycoscience, the Swedish Cancerfonden (090717), and the Polysackaridforskning Foundation (Uppsala, Sweden).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; AXELRAD MA, 1982, LAB INVEST, V47, P139; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOOK GER, 1982, J BIOL CHEM, V257, P9211; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karplus K, 2001, PROTEINS, P86, DOI 10.1002/prot.10021; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Krimbou L, 1997, J LIPID RES, V38, P35; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Salamon Z, 2000, BIOPHYS J, V79, P2463, DOI 10.1016/S0006-3495(00)76489-7; SNOW AD, 1987, LAB INVEST, V57, P687; Staatz W D, 2001, Methods Mol Biol, V171, P41; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026	43	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25669	25677		10.1074/jbc.M112.363895	http://dx.doi.org/10.1074/jbc.M112.363895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654109	hybrid, Green Published			2022-12-25	WOS:000306651700074
J	Bouchard, C; Blair, SN; Church, TS; Earnest, CP; Hagberg, JM; Hakkinen, K; Jenkins, NT; Karavirta, L; Kraus, WE; Leon, AS; Rao, DC; Sarzynski, MA; Skinner, JS; Slentz, CA; Rankinen, T				Bouchard, Claude; Blair, Steven N.; Church, Timothy S.; Earnest, Conrad P.; Hagberg, James M.; Hakkinen, Keijo; Jenkins, Nathan T.; Karavirta, Laura; Kraus, William E.; Leon, Arthur S.; Rao, D. C.; Sarzynski, Mark A.; Skinner, James S.; Slentz, Cris A.; Rankinen, Tuomo			Adverse Metabolic Response to Regular Exercise: Is It a Rare or Common Occurrence?	PLOS ONE			English	Article							RISK REDUCTION INTERVENTION; SUDDEN CARDIAC DEATH; HERITAGE FAMILY; SUBMAXIMAL EXERCISE; PHYSICAL-ACTIVITY; DEFINED EXERCISE; REPRODUCIBILITY; DESIGN; HERITABILITY; AGGREGATION	Background: Individuals differ in the response to regular exercise. Whether there are people who experience adverse changes in cardiovascular and diabetes risk factors has never been addressed. Methodology/Principal Findings: An adverse response is defined as an exercise-induced change that worsens a risk factor beyond measurement error and expected day-to-day variation. Sixty subjects were measured three times over a period of three weeks, and variation in resting systolic blood pressure (SBP) and in fasting plasma HDL-cholesterol (HDL-C), triglycerides (TG), and insulin (FI) was quantified. The technical error (TE) defined as the within-subject standard deviation derived from these measurements was computed. An adverse response for a given risk factor was defined as a change that was at least two TEs away from no change but in an adverse direction. Thus an adverse response was recorded if an increase reached 10 mm Hg or more for SBP, 0.42 mmol/L or more for TG, or 24 pmol/L or more for FI or if a decrease reached 0.12 mmol/L or more for HDL-C. Completers from six exercise studies were used in the present analysis: Whites (N = 473) and Blacks (N = 250) from the HERITAGE Family Study; Whites and Blacks from DREW (N = 326), from INFLAME (N = 70), and from STRRIDE (N = 303); and Whites from a University of Maryland cohort (N = 160) and from a University of Jyvaskyla study (N = 105), for a total of 1,687 men and women. Using the above definitions, 126 subjects (8.4%) had an adverse change in FI. Numbers of adverse responders reached 12.2% for SBP, 10.4% for TG, and 13.3% for HDL-C. About 7% of participants experienced adverse responses in two or more risk factors. Conclusions/Significance: Adverse responses to regular exercise in cardiovascular and diabetes risk factors occur. Identifying the predictors of such unwarranted responses and how to prevent them will provide the foundation for personalized exercise prescription.	[Bouchard, Claude; Sarzynski, Mark A.; Rankinen, Tuomo] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Blair, Steven N.] Univ S Carolina, Dept Exercise Sci & Epidemiol Biostat, Columbia, SC 29208 USA; [Church, Timothy S.; Earnest, Conrad P.] Pennington Biomed Res Ctr, Prevent Med Lab, Baton Rouge, LA USA; [Hagberg, James M.; Jenkins, Nathan T.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Hakkinen, Keijo; Karavirta, Laura] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Kraus, William E.; Slentz, Cris A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Leon, Arthur S.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN USA; [Rao, D. C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Skinner, James S.] Indiana Univ, Bloomington, IN USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University System of Maryland; University of Maryland College Park; University of Jyvaskyla; Duke University; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Indiana University System; Indiana University Bloomington	Bouchard, C (corresponding author), Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA.	claude.bouchard@pbrc.edu	Bouchard, Claude/A-7637-2009; Rankinen, Tuomo/N-1984-2017; Earnest, Conrad P./M-6849-2017; Bouchard, Claude/AAE-2035-2019; Sarzynski, Mark/A-9798-2014	Bouchard, Claude/0000-0002-0048-491X; Earnest, Conrad P./0000-0002-6546-1268; Karavirta, Laura/0000-0003-1372-2304; Kraus, William E/0000-0003-1930-9684	National Institutes of Health (NIH) [HL-45670, HL-47323, HL-47317, HL-47327, HL-47321, HL-66262, HL-57354, AG-17474, AG-15389, T32 AG00068, T32 AR048523]; John W. Barton, Sr. Chair in Genetics and Nutrition; John S. McIlhenny Chair in Health Wisdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045670, R01HL057354, R01HL047321, R01HL047317, R01HL047327, R01HL047323, R01HL066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR048523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015389, R01AG017474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John W. Barton, Sr. Chair in Genetics and Nutrition; John S. McIlhenny Chair in Health Wisdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Studies used for this report were supported by multiple grants from the National Institutes of Health (NIH): HL-45670, HL-47323, HL-47317, HL-47327, HL-47321, HL-66262, HL-57354, AG-17474, and AG-15389. C. Bouchard is partially supported by the John W. Barton, Sr. Chair in Genetics and Nutrition. T. Church is partially supported by the John S. McIlhenny Chair in Health Wisdom. N.T. Jenkins was supported by NIH T32 AG00068 and NIH T32 AR048523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2005, DIABETOLOGIA, V48, P1142, DOI 10.1007/s00125-005-1769-4; Bateman LA, 2011, AM J CARDIOL, V108, P838, DOI 10.1016/j.amjcard.2011.04.037; BOUCHARD C, 1995, MED SCI SPORT EXER, V27, P721; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Despres JP, 1999, CLIN BIOCHEM, V32, P157, DOI 10.1016/S0009-9120(98)00106-4; Gagnon J, 1996, ANN EPIDEMIOL, V6, P520, DOI 10.1016/S1047-2797(96)00068-3; Hong YL, 2000, MED SCI SPORT EXER, V32, P1438, DOI 10.1097/00005768-200008000-00012; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; Katzmarzyk Peter T., 2000, Ethnicity and Disease, V10, P138; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Kraus WE, 2001, MED SCI SPORT EXER, V33, P1774, DOI 10.1097/00005768-200110000-00025; Leon AS, 2002, INT J SPORTS MED, V23, P1, DOI 10.1055/s-2002-19270; Malina R.M., 1973, DHEW PUBLICATION, P73; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rankinen T, 2002, MED SCI SPORT EXER, V34, P1219, DOI 10.1097/00005768-200208000-00001; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Rice T, 2002, MED SCI SPORT EXER, V34, P972, DOI 10.1097/00005768-200206000-00011; Rice T, 2002, CIRCULATION, V105, P1904, DOI 10.1161/01.CIR.0000014969.85364.9F; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Skinner JS, 1999, MED SCI SPORT EXER, V31, P1623, DOI 10.1097/00005768-199911000-00020; Thompson AM, 2008, CONTEMP CLIN TRIALS, V29, P418, DOI 10.1016/j.cct.2007.09.009; THOMPSON PD, 1984, NEW ENGL J MED, V311, P914, DOI 10.1056/NEJM198410043111410; THOMPSON PD, 1993, MED SCI SPORT EXER, V25, P981; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; U.S.A Department of Health and Human Services, 2008, 2008 ACT GUID AM; Wilmore JH, 1998, MED SCI SPORT EXER, V30, P259, DOI 10.1097/00005768-199802000-00014; Wilmore JH, 1997, INT J OBESITY, V21, P297, DOI 10.1038/sj.ijo.0800404; Wilund KR, 2002, METABOLISM, V51, P1053, DOI 10.1053/meta.2002.33356	33	257	262	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37887	10.1371/journal.pone.0037887	http://dx.doi.org/10.1371/journal.pone.0037887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666405	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400055
J	Edri-Brami, M; Rosental, B; Hayoun, D; Welt, M; Rosen, H; Wirguin, I; Nefussy, B; Drory, VE; Porgador, A; Lichtenstein, RG				Edri-Brami, Meital; Rosental, Benyamin; Hayoun, Dana; Welt, Michael; Rosen, Hila; Wirguin, Itzhak; Nefussy, Beatrice; Drory, Vivian E.; Porgador, Angel; Lichtenstein, Rachel G.			Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells	PLOS ONE			English	Article							SPINAL-CORD; ANTIINFLAMMATORY ACTIVITY; GLYCOSYLATION PATTERN; DISEASE PROGRESSION; EFFECTOR FUNCTIONS; IMMUNE-RESPONSES; MOTOR CORTEX; ALS PATIENTS; MOUSE MODEL; NK CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by degeneration of upper and lower motor neurons. To date, glycosylation patterns of glycoproteins in fluids of ALS patients have not been described. Moreover, the aberrant glycosylation related to the pathogenesis of other neurodegenerative diseases encouraged us to explore the glycome of ALS patient sera. We found high levels of sialylated glycans and low levels of core fucosylated glycans in serum-derived N-glycans of patients with ALS, compared to healthy volunteer sera. Based on these results, we analyzed the IgG Fc N-297 -glycans, as IgG are major serum glycoproteins affected by sialylation or core fucosylation and are found in the motor cortex of ALS patients. The analyses revealed a distinct glycan, A2BG2, in IgG derived from ALS patient sera (ALS-IgG). This glycan increases the affinity of IgG to CD16 on effector cells, consequently enhancing Antibody-Dependent Cellular Cytotoxicity (ADCC). Therefore, we explore whether the Fc-N-297-glycans of IgG may be involved in ALS disease. Immunostaining of brain and spinal cord tissues revealed over-expression of CD16 and co-localization of intact ALS-IgG with CD16 and in brain with activated microglia of G93A-SOD1 mice. Intact ALS-IgG enhanced effector cell activation and ADCC reaction in comparison to sugar-depleted or control IgG. ALS-IgG were localized in the synapse between brain microglia and neurons of G93A-SOD1 mice, manifesting a promising in vivo ADCC reaction. Therefore, glycans of ALS-IgG may serve as a biomarker for the disease and may be involved in neuronal damage.	[Edri-Brami, Meital; Hayoun, Dana; Rosen, Hila; Lichtenstein, Rachel G.] Ben Gurion Univ Negev, Fac Engn, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Rosental, Benyamin; Welt, Michael; Porgador, Angel] Ben Gurion Univ Negev, Canc Res Ctr, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Rosental, Benyamin; Welt, Michael; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; [Wirguin, Itzhak] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurol, Beer Sheva, Israel; [Nefussy, Beatrice; Drory, Vivian E.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Nefussy, Beatrice; Drory, Vivian E.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Edri-Brami, M (corresponding author), Ben Gurion Univ Negev, Fac Engn, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel.	ruha@bgu.ac.il	Rosental, Benyamin/X-5400-2019	Rosental, Benyamin/0000-0002-3974-3296; Porgador, Angel/0000-0003-1540-4449; Lichtenstein, Rachel/0000-0002-2225-1068	European Union [FP6 lifesciheal-7-037661]; IsrALS organization [IsrALS2083]	European Union(European Commission); IsrALS organization	This work was supported by the European Union's Sixth Research Framework Programme (FP6 lifesciheal-7-037661) and by the IsrALS organization (IsrALS2083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P601, DOI 10.1016/j.cbpa.2009.08.015; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Appel SH, 1996, CLIN NEUROSCI, V3, P368; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Avidan A, 2009, GLYCOCONJUGATE J, V26, P1181, DOI 10.1007/s10719-009-9238-9; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Brettschneider J, 2008, NEUROCHEM RES, V33, P2358, DOI 10.1007/s11064-008-9742-5; Brettschneider J, 2010, NEUROSCI LETT, V468, P23, DOI 10.1016/j.neulet.2009.10.053; Cohen M, 2010, J IMMUNOL, V185, P5869, DOI 10.4049/jimmunol.1001635; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; Couratier P, 1998, J NEUROL SCI, V154, P137, DOI 10.1016/S0022-510X(97)00219-0; Demestre M, 2005, J NEUROCHEM, V94, P268, DOI 10.1111/j.1471-4159.2005.03184.x; DONNENFELD H, 1984, J NEUROIMMUNOL, V6, P51, DOI 10.1016/0165-5728(84)90042-0; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAWASHIMA I, 1990, J BIOCHEM-TOKYO, V108, P109, DOI 10.1093/oxfordjournals.jbchem.a123148; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Polymenidou M, 2008, NATURE, V454, P284, DOI 10.1038/454284a; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Routier FH, 1997, GLYCOCONJUGATE J, V14, P201, DOI 10.1023/A:1018589704981; RUDD PM, 1991, MOL IMMUNOL, V28, P1369, DOI 10.1016/0161-5890(91)90039-M; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; Schuster M, 2005, CANCER RES, V65, P7934, DOI 10.1158/0008-5472.CAN-04-4212; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Sengun IS, 2003, J NEUROIMMUNOL, V142, P137, DOI 10.1016/S0165-5728(03)00263-7; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Silveyra MX, 2006, J NEUROCHEM, V96, P97, DOI 10.1111/j.1471-4159.2005.03514.x; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Tzur Y, 2008, J PROTEOME RES, V7, P1188, DOI 10.1021/pr070392+; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5	51	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e35772	10.1371/journal.pone.0035772	http://dx.doi.org/10.1371/journal.pone.0035772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666317	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400005
J	Zhou, P; Liu, L; Tong, HC; Dong, XZ				Zhou, Peng; Liu, Lei; Tong, Huichun; Dong, Xiuzhu			Role of Operon aao(So)-mutT in Antioxidant Defense in Streptococcus oligofermentans	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; OXIDATIVE STRESS; LACTOCOCCUS-LACTIS; SP-NOV.; AMINOACETONE; SUPEROXIDE; OXIDASE; MUTANS; ACID; H2O2	Previously, we have found that an insertional inactivation of aao(So), a gene encoding L-amino acid oxidase (LAAO), causes marked repression of the growth of Streptococcus oligofermentans. Here, we found that aao(So) and mutT, a homolog of pyrophosphohydrolase gene of Escherichia coli, constituted an operon. Deletion of either gene did not impair the growth of S. oligofermentans, but double deletion of both aao(So) and mutT was lethal. Quantitative PCR showed that the transcript abundance of mutT was reduced for 13-fold in the aao(So) insertional mutant, indicating that gene polarity derived from the inactivation of aao(So) attenuated the expression of mutT. Enzymatic assays were conducted to determine the biochemical functions of LAAO and MutT of S. oligofermentans. The results indicated that LAAO functioned as an aminoacetone oxidase [47.75 nmol H2O2 (min.mg protein)(-1)]; and MutT showed the pyrophosphohydrolase activity, which removed mutagens such as 8-oxo-dGTP. Like paraquat, aao(So) mutations increased the expression of SOD, and addition of aminoacetone (final concentration, 5 mM) decreased the mutant's growth by 11%, indicating that the aao(So) mutants are under ROS stress. HPLC did reveal elevated levels of cytoplasmic aminoacetone in both the deletion and insertional gene mutants of aao(So). Electron spin resonance spectroscopy showed increased hydroxyl radicals in both types of aao(So) mutant. This demonstrated that inactivation of aao(So) caused the elevation of the prooxidant aminoacetone, resulting the cellular ROS stress. Our study indicates that the presence of both LAAO and MutT can prevent endogenous metabolites-generated ROS and mutagens. In this way, we were able to determine the role of the aao(So)-mutT operon in antioxidant defense in S. oligofermentans.	[Zhou, Peng; Liu, Lei; Tong, Huichun; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhou, P (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	Tonghuichun@im.ac.cn; dongxz@im.ac.cn	zhou, peng/S-9353-2019	Zhou, Peng/0000-0002-0221-5967; Zhou, Peng/0000-0001-8619-1124	China National Science Foundation [30870042]	China National Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China National Science Foundation under grant 30870042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Barre O, 2007, J BACTERIOL, V189, P5947, DOI 10.1128/JB.00576-07; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bialkowski K, 1998, NUCLEIC ACIDS RES, V26, P3194, DOI 10.1093/nar/26.13.3194; Buffoni F, 2000, MOL GENET METAB, V71, P559, DOI 10.1006/mgme.2000.3098; CLAPP PA, 1994, FREE RADICAL RES, V21, P147, DOI 10.3109/10715769409056566; Deng YL, 1999, ANAL BIOCHEM, V270, P97, DOI 10.1006/abio.1999.4058; Dong XZ, 2000, INT J SYST EVOL MICR, V50, P119, DOI 10.1099/00207713-50-1-119; Dutra F, 2001, CHEM RES TOXICOL, V14, P1323, DOI 10.1021/tx015526r; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Hiraku Y, 1999, ARCH BIOCHEM BIOPHYS, V365, P62, DOI 10.1006/abbi.1999.1161; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; Kazachkov M, 2005, J CHROMATOGR B, V824, P116, DOI 10.1016/j.jchromb.2005.07.006; Liu L, 2012, APPL ENV MI IN PRESS; Magnani D, 2008, J BACTERIOL, V190, P536, DOI 10.1128/JB.01481-07; Mao SY, 2009, ANAL BIOCHEM, V384, P20, DOI 10.1016/j.ab.2008.09.029; MARCUS JP, 1993, BIOCHIM BIOPHYS ACTA, V1164, P299, DOI 10.1016/0167-4838(93)90262-P; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Nie Z, 2006, MAGN RESON CHEM, V44, P38, DOI 10.1002/mrc.1730; Pericone CD, 2002, J BACTERIOL, V184, P4392, DOI 10.1128/JB.184.16.4392-4399.2002; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Scardovi V, 1986, BERGEYS MANUAL SYSTE; Scorei R, 2005, BIOL TRACE ELEM RES, V107, P127, DOI 10.1385/BTER:107:2:127; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Spolarics Z, 1997, AM J PHYSIOL-GASTR L, V273, pG1304, DOI 10.1152/ajpgi.1997.273.6.G1304; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tong HC, 2006, FEMS MICROBIOL LETT, V264, P213, DOI 10.1111/j.1574-6968.2006.00453.x; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Zhu Baoli, 2009, Weishengwu Xuebao, V49, P1341	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38133	10.1371/journal.pone.0038133	http://dx.doi.org/10.1371/journal.pone.0038133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666463	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400088
J	Calabrese, F; Guidotti, G; Molteni, R; Racagni, G; Mancini, M; Riva, MA				Calabrese, Francesca; Guidotti, Gianluigi; Molteni, Raffaella; Racagni, Giorgio; Mancini, Michele; Riva, Marco Andrea			Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; SYNAPTIC PLASTICITY; TYROSINE PHOSPHORYLATION; GLUTAMATERGIC SYSTEM; NR2B SUBUNIT; DEPRESSION; ALTERS; ANTIDEPRESSANTS; TRAFFICKING; RELEASE	It is now well established that the glutamatergic system contributes to the pathophysiology of depression. Exposure to stress, a major precipitating factor for depression, enhances glutamate release that can contribute to structural abnormalities observed in the brain of depressed subjects. On the other hand, it has been demonstrated that NMDA antagonists, like ketamine, exert an antidepressant effect at preclinical and clinical levels. On these bases, the purpose of our study was to investigate whether chronic mild stress is associated with specific alterations of the NMDA receptor complex, in adult rats, and to establish whether concomitant antidepressant treatment could normalize such deficits. We found that chronic stress increases the expression of the obligatory GluN1 subunit, as well as of the accessory subunits GluN2A and GluN2B at transcriptional and translational levels, particularly in the ventral hippocampus. Concomitant treatment with the antidepressant duloxetine was able to normalize the increase of glutamatergic receptor subunit expression, and correct the changes in receptor phosphorylation produced by stress exposure. Our data suggest that prolonged stress, a condition that has etiologic relevance for depression, may enhance glutamate activity through post-synaptic mechanisms, by regulating NMDA receptors, and that antidepressants may in part normalize such changes. Our results provide support to the notion that antidepressants may exert their activity in the long-term also via modulation of the glutamatergic synapse.	[Calabrese, Francesca; Guidotti, Gianluigi; Molteni, Raffaella; Racagni, Giorgio; Riva, Marco Andrea] Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Neuropharmacol, Milan, Italy; [Mancini, Michele] Eli Lilly Italia SpA, Dept Med, Sesto Fiorentino, Italy; [Racagni, Giorgio; Riva, Marco Andrea] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy	University of Milan; Eli Lilly; University of Milan	Calabrese, F (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Neuropharmacol, Milan, Italy.	M.Riva@unimi.it	Calabrese, Francesca/K-8899-2016; Racagni, Giorgio A./B-5826-2011; Riva, Marco Andrea/N-7418-2017; Molteni, Raffaella/Q-5011-2017	Riva, Marco Andrea/0000-0002-1699-5060; Calabrese, Francesca/0000-0001-7946-2424; Molteni, Raffaella/0000-0002-5481-7572	Ministry of Health [Ricerca Finalizzata RF 2007 conv/42]; Regione Lombardia	Ministry of Health; Regione Lombardia(Regione Lombardia)	This publication was made possible by grants to M. A. Riva from the Ministry of Health (Ricerca Finalizzata RF 2007 conv/42), from Regione Lombardia (Accordo Quadro 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bobula B, 2003, NEUROSCIENCE, V120, P765, DOI 10.1016/S0306-4522(03)00380-4; Bobula B, 2008, PHARMACOL REP, V60, P865; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Bymaster FP, 2005, CURR PHARM DESIGN, V11, P1475, DOI 10.2174/1381612053764805; Calabrese F, 2011, PHARMACOL THERAPEUT, V132, P39, DOI 10.1016/j.pharmthera.2011.05.007; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fontella FU, 2004, NEUROCHEM RES, V29, P1703, DOI 10.1023/B:NERE.0000035805.46592.6c; Fumagalli F, 2010, INT J NEUROPSYCHOPH, V13, P1255, DOI 10.1017/S1461145710000544; Fumagalli F, 2009, J NEUROCHEM, V109, P1733, DOI 10.1111/j.1471-4159.2009.06088.x; Garcia LSB, 2009, PROG NEURO-PSYCHOPH, V33, P450, DOI 10.1016/j.pnpbp.2009.01.004; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Musazzi L, 2011, NEUROCHEM INT, V59, P138, DOI 10.1016/j.neuint.2011.05.002; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; NOWAK G, 1993, J PHARMACOL EXP THER, V265, P1380; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rosenzweig-Lipson S, 2007, PHARMACOL THERAPEUT, V113, P134, DOI 10.1016/j.pharmthera.2006.07.002; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Taniguchi S, 2009, EMBO J, V28, P3717, DOI 10.1038/emboj.2009.300; Tata DA, 2008, SYNAPSE, V62, P325, DOI 10.1002/syn.20497; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Uher R, 2008, MOL PSYCHIATR, V13, P1070, DOI 10.1038/mp.2008.92; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	42	77	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37916	10.1371/journal.pone.0037916	http://dx.doi.org/10.1371/journal.pone.0037916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666412	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600041
J	Huang, M; Volgushev, M; Wolf, F				Huang, Min; Volgushev, Maxim; Wolf, Fred			A Small Fraction of Strongly Cooperative Sodium Channels Boosts Neuronal Encoding of High Frequencies	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; DYNAMICAL RESPONSE PROPERTIES; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; NEUROBLASTOMA-CELLS; RYANODINE RECEPTORS; CORTICAL-NEURONS; POPULATION; AXON; BACKPROPAGATION	Generation of action potentials (APs) is a crucial step in neuronal information processing. Existing biophysical models for AP generation almost universally assume that individual voltage-gated sodium channels operate statistically independently, and their avalanche-like opening that underlies AP generation is coordinated only through the transmembrane potential. However, biological ion channels of various types can exhibit strongly cooperative gating when clustered. Cooperative gating of sodium channels has been suggested to explain rapid onset dynamics and large threshold variability of APs in cortical neurons. It remains however unknown whether these characteristic properties of cortical APs can be reproduced if only a fraction of channels express cooperativity, and whether the presence of cooperative channels has an impact on encoding properties of neuronal populations. To address these questions we have constructed a conductance-based neuron model in which we continuously varied the size of a fraction p of sodium channels expressing cooperativity and the strength of coupling between cooperative channels l. We show that starting at a critical value of the coupling strength lambda*, the activation curve of sodium channels develops a discontinuity at which opening of all coupled channels becomes an all-or-none event, leading to very rapid AP onsets. Models with a small fraction, 5-15%, of strongly cooperative channels generate APs with the most rapid onset dynamics. In this regime APs are triggered by simultaneous opening of the cooperative channel fraction and exhibit a pronounced biphasic waveform often observed in cortical neurons. We further show that presence of a small fraction of cooperative Na+ channels significantly improves the ability of neuronal populations to phase-lock their firing to high frequency input fluctuation. We conclude that presence of a small fraction of strongly coupled sodium channels can explain characteristic features of cortical APs and has a functional impact of enhancing the spike encoding of rapidly varying signals.	[Huang, Min; Wolf, Fred] GAUSS, Max Planck Inst Dynam & Self Org, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Huang, Min; Wolf, Fred] GAUSS, Fac Phys, Gottingen, Germany; [Huang, Min] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Volgushev, Maxim] Univ Connecticut, Dept Psychol, Storrs, CT USA	Max Planck Society; Beijing Normal University; University of Connecticut	Huang, M (corresponding author), GAUSS, Max Planck Inst Dynam & Self Org, Bernstein Ctr Computat Neurosci, Gottingen, Germany.	maxim.volgushev@uconn.edu; fred-wl@nld.ds.mpg.de	Wolf, Fred/D-5771-2011; Volgushev, Maxim/AAO-6793-2020	Wolf, Fred/0000-0002-7068-3762; Volgushev, Maxim/0000-0002-8080-1136	Federal Ministry of Education and Research, Germany [01GQ1005B, 01GQ07113, 01GQ07112]; German-Israeli Foundation for Scientific Research and Development [I-906-17.1/2006]; German Research Foundation [SFB889]; Volkswagenstiftung Stiftung [ZN2632]; Max Planck Society; University of Connecticut; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); German Research Foundation(German Research Foundation (DFG)); Volkswagenstiftung Stiftung; Max Planck Society(Max Planck Society); University of Connecticut; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Federal Ministry of Education and Research, Germany (www.bmbf.de, http://www.bmbf.de, grants #01GQ1005B, #01GQ07113, #01GQ07112) and German-Israeli Foundation for Scientific Research and Development (www.gif.org.il, http://www.gif.org.il, grant #I-906-17.1/2006) to MV, FW; German Research Foundation (www.dfg.de, http://www.dfg.de, SFB889), Volkswagenstiftung Stiftung (http://www.volkswagenstiftung.de, #ZN2632) and the Max Planck Society (www.mpg.de, http://www.mpg.de) to FW; and start-up funds from the University of Connecticut to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Boucsein C, 2009, J NEUROSCI, V29, P1006, DOI 10.1523/JNEUROSCI.3424-08.2009; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; ECCLES JC, 1958, J PHYSIOL-LONDON, V143, P11, DOI 10.1113/jphysiol.1958.sp006041; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; IWASA K, 1986, BIOPHYS J, V50, P531, DOI 10.1016/S0006-3495(86)83491-9; Keleshian AM, 2000, BIOPHYS J, V78, P1, DOI 10.1016/S0006-3495(00)76568-4; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P767, DOI 10.1085/jgp.59.6.767; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; POST JA, 1985, BIOCHIM BIOPHYS ACTA, V845, P119, DOI 10.1016/0167-4889(85)90062-X; Schindler H, 1984, Prog Clin Biol Res, V164, P291; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Tchumatchenko T, 2011, J NEUROSCI, V31, P12171, DOI 10.1523/JNEUROSCI.2182-11.2011; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Wang XJ, 1996, J NEUROSCI, V16, P6402; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	45	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37629	10.1371/journal.pone.0037629	http://dx.doi.org/10.1371/journal.pone.0037629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666374	Green Published, gold			2022-12-25	WOS:000305349600025
J	Ramakrishna, S; Suresh, B; Bae, SM; Ahn, WS; Lim, KH; Baek, KH				Ramakrishna, Suresh; Suresh, Bharathi; Bae, Su-Mi; Ahn, Woong-Shick; Lim, Key-Hwan; Baek, Kwang-Hyun			Hyaluronan Binding Motifs of USP17 and SDS3 Exhibit Anti-Tumor Activity	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CELL-SURFACE CD44; MAMMARY-CARCINOMA CELLS; DEUBIQUITINATING ENZYMES; INTRACELLULAR HYALURONAN; RECEPTOR RHAMM; LINK PROTEIN; LOCALIZATION; ACID; IDENTIFICATION	Background: We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells. Furthermore, USP17 and SDS3 mutually interact with each other to block cell proliferation in HeLa cells but the mechanism for this inhibition in cell proliferation is not known. We wished to investigate whether the HABMs of USP17 were responsible for tumor suppression activity. Methodology/ Principal Findings: Similarly to USP17, we have identified that SDS3 also has three consecutive HABMs and shows direct binding with hyaluronan (HA) using cetylpyridinium chloride (CPC) assay. Additionally, HA oligosaccharides (618 sugar units) competitively block binding of endogenous HA polymer to HA binding proteins. Thus, administration of HA oligosaccharides antagonizes the interaction between HA and USP17 or SDS3. Interestingly, HABMs deleted USP17 showed lesser interaction with SDS3 but retain its deubiquitinating activity towards SDS3. The deletion of HABMs of USP17 could not alter its functional regulation on SDS3-associated HDAC activity. Furthermore, to explore whether HABMs in USP17 and SDS3 are responsible for the inhibition of cell proliferation, we investigated the effect of USP17 and SDS3-lacking HABMs on cell proliferation by soft agar, apoptosis, cell migration and cell proliferation assays. Conclusions: Our results have demonstrated that these HABMs in USP17 and its substrate SDS3 are mainly involved in the inhibition of anchorage-independent tumor growth.	[Ramakrishna, Suresh; Suresh, Bharathi; Lim, Key-Hwan; Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea; [Bae, Su-Mi; Ahn, Woong-Shick] Catholic Univ, Korea Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea	Pochon Cha University; Catholic University of Korea	Ramakrishna, S (corresponding author), CHA Univ, CHA Gen Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Korea Research Foundation Grant; Korean Government [KRF-2008-313-C00718]	Korea Research Foundation Grant(National Research Foundation of Korea); Korean Government(Korean Government)	The Korea Research Foundation Grant funded by the Korean Government (KRF-2008-313-C00718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599; Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Assmann V, 1998, J CELL SCI, V111, P1685; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; David G, 2006, ONCOGENE, V25, P7354, DOI 10.1038/sj.onc.1209734; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; EGGLI PS, 1995, J HISTOCHEM CYTOCHEM, V43, P689, DOI 10.1177/43.7.7608523; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Gao F, 2004, CHINESE MED J-PEKING, V117, P1072; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hofmann M, 1998, J CELL SCI, V111, P1673; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lesley J, 2000, J BIOL CHEM, V275, P26967; Liu NF, 2001, CANCER RES, V61, P1022; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Peterson RM, 2000, AM J PATHOL, V156, P2159, DOI 10.1016/S0002-9440(10)65086-9; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; RIPELLINO JA, 1988, J CELL BIOL, V106, P845, DOI 10.1083/jcb.106.3.845; RIPELLINO JA, 1989, J CELL BIOL, V108, P1899, DOI 10.1083/jcb.108.5.1899; Shin JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-292; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2008, CURR PHARM BIOTECHNO, V9, P249, DOI 10.2174/138920108785161569; Xu XM, 2003, CANCER RES, V63, P5685; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37772	10.1371/journal.pone.0037772	http://dx.doi.org/10.1371/journal.pone.0037772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662218	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300108
J	Sargsyan, O				Sargsyan, Ori			Analytical Framework for Identifying and Differentiating Recent Hitchhiking and Severe Bottleneck Effects from Multi-Locus DNA Sequence Data	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECENT COMMON ANCESTRY; HUMAN Y-CHROMOSOMES; MITOCHONDRIAL-DNA; SEGREGATING SITES; STATISTICAL PROPERTIES; NONCODING REGION; EVOLUTION; NUMBER; HUMANS	Hitchhiking and severe bottleneck effects have impact on the dynamics of genetic diversity of a population by inducing homogenization at a single locus and at the genome-wide scale, respectively. As a result, identification and differentiation of the signatures of such events from DNA sequence data at a single locus is challenging. This paper develops an analytical framework for identifying and differentiating recent homogenization events at multiple neutral loci in low recombination regions. The dynamics of genetic diversity at a locus after a recent homogenization event is modeled according to the infinite-sites mutation model and the Wright-Fisher model of reproduction with constant population size. In this setting, I derive analytical expressions for the distribution, mean, and variance of the number of polymorphic sites in a random sample of DNA sequences from a locus affected by a recent homogenization event. Based on this framework, three likelihood-ratio based tests are presented for identifying and differentiating recent homogenization events at multiple loci. Lastly, I apply the framework to two data sets. First, I consider human DNA sequences from four non-coding loci on different chromosomes for inferring evolutionary history of modern human populations. The results suggest, in particular, that recent homogenization events at the loci are identifiable when the effective human population size is 50000 or greater in contrast to 10000, and the estimates of the recent homogenization events are agree with the "Out of Africa" hypothesis. Second, I use HIV DNA sequences from HIV-1-infected patients to infer the times of HIV seroconversions. The estimates are contrasted with other estimates derived as the mid-time point between the last HIV-negative and first HIV-positive screening tests. The results show that significant discrepancies can exist between the estimates.	Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Sargsyan, O (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA.	sargsyan@lanl.gov			United States Department of Energy through the LANL/LDRD Program; National Institute of Health [5R01AI08752002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	United States Department of Energy through the LANL/LDRD Program; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Energy through the LANL/LDRD Program and by the National Institute of Health [grant number 5R01AI08752002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIYOSHI K, 1992, LANCET, V340, P1257, DOI 10.1016/0140-6736(92)92953-D; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1996, SCIENCE, V274, P1554, DOI 10.1126/science.274.5292.1554; Buneman P., 1971, MATH ARCHAEOLOGICAL, P387; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Drake JW, 1998, GENETICS, V148, P1667; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2000, GENETICS, V155, P981; GRIFFITHS RC, 1981, J APPL PROBAB, V18, P42, DOI 10.2307/3213165; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; HUDSON RR, 1985, GENETICS, V111, P147; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Nachman MW, 2000, GENETICS, V156, P297; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perlitz M, 1997, J MATH BIOL, V36, P1, DOI 10.1007/s002850050087; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sherry ST, 1997, GENETICS, V147, P1977; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber J, 2001, BRIT MED BULL, V58, P61, DOI 10.1093/bmb/58.1.61; Wolfram Research Inc, 2007, MATH VERS 6 0; Yang ZH, 1996, GENETICS, V144, P1941; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	53	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37588	10.1371/journal.pone.0037588	http://dx.doi.org/10.1371/journal.pone.0037588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662176	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300066
J	Wang, L; Jia, Y; Tang, RJ; Xu, Z; Cao, YB; Jia, XM; Jiang, YY				Wang, Lin; Jia, Yu; Tang, Ren-Jie; Xu, Zheng; Cao, Yong-Bing; Jia, Xin-Ming; Jiang, Yuan-Ying			Proteomic Analysis of Rta2p-Dependent Raft-Association of Detergent-Resistant Membranes in Candida albicans	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; SPHINGOLIPID METABOLISM; ANTIFUNGAL AGENTS; ATPASE PMA1P; TRANSPORT; DOMAINS	In Candida albicans, lipid rafts (also called detergent-resistant membranes, DRMs) are involved in many cellular processes and contain many important proteins. In our previous study, we demonstrated that Rta2p was required for calcineurin-mediated azole resistance and sphingoid long-chain base release in C. albicans. Here, we found that Rta2p was co-localized with raft-constituted ergosterol on the plasma membrane of C. albicans. Furthermore, this membrane expression pattern was totally disturbed by inhibitors of either ergosterol or sphingolipid synthesis. Biochemical fractionation of DRMs together with immunoblot uncovered that Rta2p, along with well-known DRM-associated proteins (Pma1p and Gas1p homologue), was associated with DRMs and their associations were blocked by inhibitors of either ergosterol or sphingolipid synthesis. Finally, we used the proteomic analysis together with immunoblot and identified that Rta2p was required for the association of 10 proteins with DRMs. These 5 proteins (Pma1p, Gas1p homologue, Erg11p, Pmt2p and Ali1p) have been reported to be DRM-associated and also that Erg11p is a well-known target of azoles in C. albicans. In conclusion, our results showed that Rta2p was predominantly localized in lipid rafts and was required for the association of certain membrane proteins with lipid rafts in C. albicans.	[Wang, Lin; Jia, Yu; Tang, Ren-Jie; Xu, Zheng; Cao, Yong-Bing; Jiang, Yuan-Ying] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Wang, Lin; Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China	Naval Medical University; Tongji University	Jia, XM (corresponding author), Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China.	jiaxm@tongji.edu.cn; jiangyy@smmu.edu.cn	jiang, anyi/GPT-0379-2022		National Science Foundation of China [30900055, 30825041, 90913008]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (30900055, 30825041 and 90913008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; Cabezon V, 2009, PROTEOMICS, V9, P4770, DOI 10.1002/pmic.200800988; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dupre S, 2003, TRAFFIC, V4, P83, DOI 10.1034/j.1600-0854.2003.40204.x; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Ferreira C, 2008, BBA-BIOMEMBRANES, V1778, P2648, DOI 10.1016/j.bbamem.2008.08.011; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hearn JD, 2003, J BIOL CHEM, V278, P3679, DOI 10.1074/jbc.M209170200; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; Insenser M, 2006, PROTEOMICS, V6, pS74, DOI 10.1002/pmic.200500465; Jia X, 2009, CELL MOL LIFE SCI, V66, P122, DOI 10.1007/s00018-008-8409-3; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Meroni V, 2006, CLIN MICROBIOL INFEC, V12, P679; Mishra N. N., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P367, DOI 10.1556/AMicr.54.2007.4.4; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Pasrija R, 2005, BIOCHEM SOC T, V33, P1219, DOI 10.1042/BST20051219; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Prasad T, 2005, ANTIMICROB AGENTS CH, V49, P3442, DOI 10.1128/AAC.49.8.3442-3452.2005; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Shukla S, 2007, BIOCHEMISTRY-US, V46, P12081, DOI 10.1021/bi700453e; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Sutterlin C, 1997, J CELL SCI, V110, P2703; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200	58	7	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37768	10.1371/journal.pone.0037768	http://dx.doi.org/10.1371/journal.pone.0037768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662216	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300106
J	Zakharova, L; Nural-Guvener, H; Gaballa, MA				Zakharova, Liudmila; Nural-Guvener, Hikmet; Gaballa, Mohamed A.			Cardiac Explant-Derived Cells Are Regulated by Notch-Modulated Mesenchymal Transition	PLOS ONE			English	Article							STEM-CELLS; EPICARDIAL CELLS; PROGENITOR CELLS; SIGNALING PATHWAY; IN-VITRO; TGF-BETA; HEART; DIFFERENTIATION; ACTIVATION; EXPRESSION	Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the molecular mechanisms regulating the generation of cardiac progenitor cells is not fully understood. We hypothesized that cardiac progenitor cells are generated from cardiac explant via a process similar to epithelial to mesenchymal transition (EMT). Methods/Findings: Explant-derived cells were generated from partially digested atrial tissue. After 21 days in culture, c-Kit+ cells were isolated from cell outgrowth. The majority of explant-originated c-Kit+ cells expressed the epicardial marker Wt1. Cardiac cell outgrowth exhibits a temporal up-regulation of EMT-markers. Notch stimulation augmented, while Notch inhibition suppressed, mesenchymal transition in both c-Kit+ and c-Kit-cells. In c-Kit+ cells, Notch stimulation reduced, while Notch inhibition up-regulated pluripotency marker expressions such as Nanog and Sox2. Notch induction was associated with degradation of beta-catenin in c-Kit-cells. In contrast, Notch inhibition resulted in b-catenin accumulation, acquisition of epitheloid morphology, and up-regulation of Wnt target genes in c-Kit-cells. Conclusion: Our study suggests that Notch-mediated reversible EMT process is a mechanism that regulates explant-derived c-Kit+ and c-Kit-cells.	[Zakharova, Liudmila; Nural-Guvener, Hikmet; Gaballa, Mohamed A.] Banner Sun Hlth Res Inst, Cardiovasc Res Ctr, Sun City, AZ USA; [Gaballa, Mohamed A.] Univ Arizona, Tucson, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; University of Arizona	Zakharova, L (corresponding author), Banner Sun Hlth Res Inst, Cardiovasc Res Ctr, Sun City, AZ USA.	mohamed.gaballa@bannerhealth.com			National Institute of Aging; National Institutes of Health [NIH RO1 AG027263]; Banner Sun Health Research Institute, Sun City, Arizona; NATIONAL INSTITUTE ON AGING [R01AG027263] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banner Sun Health Research Institute, Sun City, Arizona; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Aging, National Institutes of Health (NIH RO1 AG027263) and funds from Banner Sun Health Research Institute, Sun City, Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Castaldo C, 2008, STEM CELLS, V26, P1723, DOI 10.1634/stemcells.2007-0732; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Compton LA, 2006, DEV DYNAM, V235, P82, DOI 10.1002/dvdy.20629; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Gittenberger-de Groot AC, 2010, J CELL MOL MED, V14, P1056, DOI 10.1111/j.1582-4934.2010.01077.x; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37800	10.1371/journal.pone.0037800	http://dx.doi.org/10.1371/journal.pone.0037800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662227	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300117
J	Albuquerque, P; Caridade, CMR; Rodrigues, AS; Marcal, ARS; Cruz, J; Cruz, L; Santos, CL; Mendes, MV; Tavares, F				Albuquerque, Pedro; Caridade, Cristina M. R.; Rodrigues, Arlete S.; Marcal, Andre R. S.; Cruz, Joana; Cruz, Leonor; Santos, Catarina L.; Mendes, Marta V.; Tavares, Fernando			Evolutionary and Experimental Assessment of Novel Markers for Detection of Xanthomonas euvesicatoria in Plant Samples	PLOS ONE			English	Article							CAMPESTRIS PV.-VESICATORIA; BACTERIAL SPOT DISEASE; PHYTOPATHOGENIC XANTHOMONAS; PATHOGENIC BACTERIA; BIOLOGICAL-CONTROL; DNA-SEQUENCES; TOMATO; PEPPER; IDENTIFICATION; STRAINS	Background: Bacterial spot-causing xanthomonads (BSX) are quarantine phytopathogenic bacteria responsible for heavy losses in tomato and pepper production. Despite the research on improved plant spraying methods and resistant cultivars, the use of healthy plant material is still considered as the most effective bacterial spot control measure. Therefore, rapid and efficient detection methods are crucial for an early detection of these phytopathogens. Methodology: In this work, we selected and validated novel DNA markers for reliable detection of the BSX Xanthomonas euvesicatoria (Xeu). Xeu-specific DNA regions were selected using two online applications, CUPID and Insignia. Furthermore, to facilitate the selection of putative DNA markers, a customized C program was designed to retrieve the regions outputted by both databases. The in silico validation was further extended in order to provide an insight on the origin of these Xeu-specific regions by assessing chromosomal location, GC content, codon usage and synteny analyses. Primer-pairs were designed for amplification of those regions and the PCR validation assays showed that most primers allowed for positive amplification with different Xeu strains. The obtained amplicons were labeled and used as probes in dot blot assays, which allowed testing the probes against a collection of 12 non-BSX Xanthomonas and 23 other phytopathogenic bacteria. These assays confirmed the specificity of the selected DNA markers. Finally, we designed and tested a duplex PCR assay and an inverted dot blot platform for culture-independent detection of Xeu in infected plants. Significance: This study details a selection strategy able to provide a large number of Xeu-specific DNA markers. As demonstrated, the selected markers can detect Xeu in infected plants both by PCR and by hybridization-based assays coupled with automatic data analysis. Furthermore, this work is a contribution to implement more efficient DNA-based methods of bacterial diagnostics.	[Albuquerque, Pedro; Santos, Catarina L.; Mendes, Marta V.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Albuquerque, Pedro; Tavares, Fernando] Univ Porto, Dept Biol, FCUP Fac Ciencias, P-4100 Oporto, Portugal; [Caridade, Cristina M. R.; Marcal, Andre R. S.] Univ Porto, Fac Ciencias, CICGE, P-4100 Oporto, Portugal; [Caridade, Cristina M. R.] ISEC, Coimbra, Portugal; [Rodrigues, Arlete S.; Marcal, Andre R. S.] Univ Porto, Fac Ciencias, CMUP, P-4100 Oporto, Portugal; [Cruz, Joana; Cruz, Leonor] INRB, Unidade Invest Proteccao Plantas, Lisbon, Portugal; [Tavares, Fernando] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Albuquerque, P (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	psilva@ibmc.up.pt	MARCAL, ANDRE R. S./F-6230-2013; Cruz, Leonor/AAH-1033-2021; Cruz, Joana/T-4472-2018; Tavares, Fernando/C-3375-2013; Cruz, Leonor/B-7847-2016; Mendes, Marta Vaz/A-8541-2008; Marcal, Andre/L-9850-2019; Albuquerque, Pedro/C-6180-2008; Caridade, Cristina Maria Ribeiro/AAI-5026-2021; Caridade, Cristina M.R./ABF-7942-2020	MARCAL, ANDRE R. S./0000-0002-8501-0974; Cruz, Joana/0000-0002-3390-0801; Tavares, Fernando/0000-0001-9913-1155; Cruz, Leonor/0000-0002-0053-5422; Mendes, Marta Vaz/0000-0002-6105-522X; Marcal, Andre/0000-0002-8501-0974; Albuquerque, Pedro/0000-0001-5916-557X; Caridade, Cristina Maria Ribeiro/0000-0003-3667-5328; Caridade, Cristina M.R./0000-0003-3667-5328; Rodrigues, Arlete/0000-0002-6966-1486; Lopes dos Santos, Catarina/0000-0002-4273-1077	FCT (Fundacao para a Ciencia e Tecnologia) [PTDC/AGR-PRO/111857/2009, POCTI/AGG/39216/2001, SFRH/BD/37249/2007, SFRH/BD/32150/2006, SFRH/BPD/62978/2009]; POPH(QREN); MCTES	FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); POPH(QREN); MCTES	This work was supported by the FCT (Fundacao para a Ciencia e Tecnologia) grants PTDC/AGR-PRO/111857/2009 and POCTI/AGG/39216/2001. Pedro Albuquerque, Cristina Caridade and Catarina L. Santos were supported by the FCT fellowships, SFRH/BD/37249/2007, SFRH/BD/32150/2006 and SFRH/BPD/62978/2009, respectively. Marta V. Mendes was supported by the "Ciencia 2007'' FCT program, sponsored by the POPH(QREN) program subsidized by the European Social Fund and by the MCTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-You N, 2009, INT J SYST EVOL MICR, V59, P306, DOI 10.1099/ijs.0.65453-0; Albuquerque P, 2011, APPL ENVIRON MICROB, V77, P5619, DOI 10.1128/AEM.05189-11; Albuquerque P, 2009, SCI TOTAL ENVIRON, V407, P3641, DOI 10.1016/j.scitotenv.2008.10.054; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; CABI/EPPO, 1997, QUARANTINE PESTS EUR; Call DR, 2003, J MICROBIOL METH, V53, P235, DOI 10.1016/S0167-7012(03)00027-7; Canteros BI, 1995, PHYTOPATHOLOGY, V85, P1482, DOI 10.1094/Phyto-85-1482; Caridade CMR, 2010, IEEE ENG MED BIO, P6122, DOI 10.1109/IEMBS.2010.5627805; Cortez D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r65; Cuppels DA, 2006, PLANT DIS, V90, P451, DOI 10.1094/PD-90-0451; Drummond A., 2011, GENEIOUS V5 5; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; GARDE S, 1991, APPL ENVIRON MICROB, V57, P2435, DOI 10.1128/AEM.57.8.2435-2439.1991; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; GITAITIS R, 1992, PLANT DIS, V76, P651, DOI 10.1094/PD-76-0651; Hert AP, 2009, APPL ENVIRON MICROB, V75, P3323, DOI 10.1128/AEM.02399-08; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; JONES JB, 1993, PHYTOPATHOLOGY, V83, P551, DOI 10.1094/Phyto-83-551; Kuflu KM, 1997, APPL ENVIRON MICROB, V63, P4462, DOI 10.1128/AEM.63.11.4462-4470.1997; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lanna R, 2010, PESQUI AGROPECU BRAS, V45, P1381, DOI 10.1590/S0100-204X2010001200007; LAZO GR, 1987, PHYTOPATHOLOGY, V77, P448, DOI 10.1094/Phyto-77-448; LAZO GR, 1987, INT J SYST BACTERIOL, V37, P214, DOI 10.1099/00207713-37-3-214; LEITE RP, 1994, APPL ENVIRON MICROB, V60, P1068, DOI 10.1128/AEM.60.4.1068-1077.1994; LEITE RP, 1995, PLANT DIS, V79, P917, DOI 10.1094/PD-79-0917; Lopez MM, 2009, CURR ISSUES MOL BIOL, V11, P13; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; LOUWS FJ, 1995, PHYTOPATHOLOGY, V85, P528, DOI 10.1094/Phyto-85-528; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Louws FJ, 2001, PLANT DIS, V85, P481, DOI 10.1094/PDIS.2001.85.5.481; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Marcal ARS, 2009, IEEE ENG MED BIO, P6710, DOI 10.1109/IEMBS.2009.5333807; Mazumder R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-279; Moretti C, 2009, LETT APPL MICROBIOL, V49, P466, DOI 10.1111/j.1472-765X.2009.02690.x; Moss WP, 2007, BIOL CONTROL, V41, P199, DOI 10.1016/j.biocontrol.2007.01.008; Obradovic A, 2004, EUR J PLANT PATHOL, V110, P285, DOI 10.1023/B:EJPP.0000019797.27952.1d; Palacio-Bielsa A, 2009, J PLANT PATHOL, V91, P249; Park DS, 2009, MICROBIOL RES, V164, P36, DOI 10.1016/j.micres.2006.11.005; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Roberts PD, 2008, CROP PROT, V27, P1519, DOI 10.1016/j.cropro.2008.06.007; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Sahin F, 1998, PLANT DIS, V82, P794, DOI 10.1094/PDIS.1998.82.7.794; Sambrook J, 2001, MOL CLONING LAB MANU; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; STALL RE, 1994, INT J SYST BACTERIOL, V44, P47, DOI 10.1099/00207713-44-1-47; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Vallejos CE, 2010, THEOR APPL GENET, V121, P37, DOI 10.1007/s00122-010-1289-6; van Doorn J, 2001, APPL ENVIRON MICROB, V67, P598, DOI 10.1128/AEM.67.2.598-607.2001; VAUTERIN L, 1990, INT J SYST BACTERIOL, V40, P312, DOI 10.1099/00207713-40-3-312; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; WELLS JM, 1981, APPL ENVIRON MICROB, V42, P357, DOI 10.1128/AEM.42.2.357-363.1981; Wen AM, 2009, CROP PROT, V28, P859, DOI 10.1016/j.cropro.2009.04.013; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004	67	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37836	10.1371/journal.pone.0037836	http://dx.doi.org/10.1371/journal.pone.0037836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655073	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900050
J	Grafe, TU; Preininger, D; Sztatecsny, M; Kasah, R; Dehling, JM; Proksch, S; Hodl, W				Grafe, T. Ulmar; Preininger, Doris; Sztatecsny, Marc; Kasah, Rosli; Dehling, J. Maximilian; Proksch, Sebastian; Hoedl, Walter			Multimodal Communication in a Noisy Environment: A Case Study of the Bornean Rock Frog Staurois parvus	PLOS ONE			English	Article							ANIMAL COMMUNICATION; ANTHROPOGENIC NOISE; COURTSHIP DISPLAYS; AUDITORY MASKING; HIGHER PITCH; CALL; BEHAVIOR; ANURA; EVOLUTION; SIGNALS	High background noise is an impediment to signal detection and perception. We report the use of multiple solutions to improve signal perception in the acoustic and visual modality by the Bornean rock frog, Staurois parvus. We discovered that vocal communication was not impaired by continuous abiotic background noise characterised by fast-flowing water. Males modified amplitude, pitch, repetition rate and duration of notes within their advertisement call. The difference in sound pressure between advertisement calls and background noise at the call dominant frequency of 5578 Hz was 8 dB, a difference sufficient for receiver detection. In addition, males used several visual signals to communicate with conspecifics with foot flagging and foot flashing being the most common and conspicuous visual displays, followed by arm waving, upright posture, crouching, and an open-mouth display. We used acoustic playback experiments to test the efficacy-based alerting signal hypothesis of multimodal communication. In support of the alerting hypothesis, we found that acoustic signals and foot flagging are functionally linked with advertisement calling preceding foot flagging. We conclude that S. parvus has solved the problem of continuous broadband low-frequency noise by both modifying its advertisement call in multiple ways and by using numerous visual signals. This is the first example of a frog using multiple acoustic and visual solutions to communicate in an environment characterised by continuous noise.	[Grafe, T. Ulmar; Kasah, Rosli] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei; [Preininger, Doris; Sztatecsny, Marc; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria; [Dehling, J. Maximilian; Proksch, Sebastian] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Theodor Boveri Inst, Biozentrum, Wurzburg, Germany	University Brunei Darussalam; University of Vienna; University of Wurzburg	Grafe, TU (corresponding author), Univ Brunei Darussalam, Dept Biol, Gadong, Brunei.	grafe@biozentrum.uni-wuerzburg.de		Kasah, Rosli/0000-0002-9634-3723; Preininger, Doris/0000-0001-6842-1133	Austrian Science Fund (FWF) [P22069-B17]; German Academic Exchange Programme (DAAD); Universiti Brunei Darussalam [RG 58]; Austrian Science Fund (FWF) [P 22069] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Academic Exchange Programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Universiti Brunei Darussalam; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the Austrian Science Fund (FWF): P22069-B17 (www.fwf.ac.at/en/index.asp), the German Academic Exchange Programme (DAAD) (www.daad.org/) and a research grant from the Universiti Brunei Darussalam (RG 58) (http://www.ubd.edu.bn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2004, HERPETOLOGICA, V60, P420, DOI 10.1655/02-51; Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Arifin U, 2011, ZOOTAXA, P39; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Boeckle M, 2009, HERPETOLOGICA, V65, P154, DOI 10.1655/07-071R1.1; Boersma P., 2010, PRAAT DOING PHONETIC; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BRENOWITZ EA, 1982, J COMP PHYSIOL, V147, P511, DOI 10.1007/BF00612017; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Brumm H, 2006, CURR BIOL, V16, pR1003, DOI 10.1016/j.cub.2006.10.043; Diaz M, 2011, BEHAV ECOL, V22, P332, DOI 10.1093/beheco/arq210; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe TU, 1996, BEHAV ECOL SOCIOBIOL, V38, P149, DOI 10.1007/s002650050227; Grafe TU, 2003, ANIM BEHAV, V66, P127, DOI 10.1006/anbe.2003.2173; GREER BJ, 1980, HERPETOLOGICA, V36, P318; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Haddad CFB, 1999, HERPETOLOGICA, V55, P324; HARDING K A, 1982, Proceedings of the Biological Society of Washington, V95, P621; Hartmann MT, 2004, AMPHIBIA-REPTILIA, V25, P395, DOI 10.1163/1568538042788933; Hebets EA, 1999, ANIM BEHAV, V57, P865, DOI 10.1006/anbe.1998.1048; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hirschmann W, 2006, HERPETOLOGICA, V62, P18, DOI 10.1655/04-06.1; HODL W, 1977, OECOLOGIA, V28, P351, DOI 10.1007/BF00345990; Hodl W, 1997, FOOT FLAGGING DISPLA; Hoedl Walter, 2001, P121; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Kaiser K, 2009, BEHAVIOUR, V146, P1053, DOI 10.1163/156853909X404457; Malkmus R., 2002, AMPHIBIANS REPTILES; Martin P., 1994, MEASURING BEHAV INTR, V3rd; Matsui M, 2007, ZOOL SCI, V24, P101, DOI 10.2108/zsj.24.101; Mclennan DA, 2003, BIOL J LINN SOC, V80, P555, DOI 10.1111/j.1095-8312.2003.00254.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NARINS PM, 1982, J COMP PHYSIOL, V147, P439, DOI 10.1007/BF00612008; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parris KM, 2009, ECOL SOC, V14; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2011, ETHOLOGY, V117, P1147, DOI 10.1111/j.1439-0310.2011.01973.x; Preininger D, 2009, HERPETOLOGICA, V65, P166, DOI 10.1655/08-037R.1; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Schwartz JJ, 1998, ANIM BEHAV, V56, P55, DOI 10.1006/anbe.1998.0737; Schwartz JJ, 2002, BEHAV ECOL SOCIOBIOL, V53, P9, DOI 10.1007/s00265-002-0542-7; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Sukumaran Jeet, 2006, Herpetological Review, V37, P288; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Velez A, 2011, ANIM BEHAV, V82, P1319, DOI 10.1016/j.anbehav.2011.09.015; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wilgers DJ, 2011, CURR ZOOL, V57, P175, DOI 10.1093/czoolo/57.2.175; Wollerman L, 2002, ANIM BEHAV, V63, P15, DOI 10.1006/anbe.2001.1885; ZELICK RD, 1983, J COMP PHYSIOL, V153, P403, DOI 10.1007/BF00612594	63	88	91	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37965	10.1371/journal.pone.0037965	http://dx.doi.org/10.1371/journal.pone.0037965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655089	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338900066
J	Klinger, C; Patel, Y; Postma, HWC				Klinger, Colin; Patel, Yogeshwari; Postma, Henk W. Ch.			Carbon Nanotube Solar Cells	PLOS ONE			English	Article							CHARGE-TRANSFER SENSITIZERS; COUNTER ELECTRODE; BLACK DYE; HIGH-EFFICIENCY; TIO2 FILMS; SINGLE; CONVERSION; TRANSPARENT; IMPROVEMENT	We present proof-of-concept all-carbon solar cells. They are made of a photoactive side of predominantly semiconducting nanotubes for photoconversion and a counter electrode made of a natural mixture of carbon nanotubes or graphite, connected by a liquid electrolyte through a redox reaction. The cells do not require rare source materials such as In or Pt, nor high-grade semiconductor processing equipment, do not rely on dye for photoconversion and therefore do not bleach, and are easy to fabricate using a spray-paint technique. We observe that cells with a lower concentration of carbon nanotubes on the active semiconducting electrode perform better than cells with a higher concentration of nanotubes. This effect is contrary to the expectation that a larger number of nanotubes would lead to more photoconversion and therefore more power generation. We attribute this to the presence of metallic nanotubes that provide a short for photo-excited electrons, bypassing the load. We demonstrate optimization strategies that improve cell efficiency by orders of magnitude. Once it is possible to make semiconducting-only carbon nanotube films, that may provide the greatest efficiency improvement.	[Klinger, Colin; Patel, Yogeshwari; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	California State University System; California State University Northridge	Klinger, C (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Funde, Adinath M./D-8169-2012; Postma, Henk W.Ch./A-8770-2014	Postma, Henk/0000-0003-4349-9406				Aiga F, 2003, J MOL STRUCT, V658, P25, DOI 10.1016/S0022-2860(03)00408-3; Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; Boschloo G, 2002, J PHOTOCH PHOTOBIO A, V148, P11, DOI 10.1016/S1010-6030(02)00072-2; Gao FF, 2008, CHEM COMMUN, P2635, DOI 10.1039/b802909a; Goldemberg J., 2004, WORLD ENERGY ASSESSM; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Han LY, 2006, CR CHIM, V9, P645, DOI 10.1016/j.crci.2005.02.046; Hu L, 2004, NANO LETT, V4, P2513, DOI 10.1021/nl048435y; Hwang S, 2007, ELECTRON LETT, V43, P1455, DOI 10.1049/el:20072867; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Kang M, 2010, ELECTRON LETT, V46, P1509, DOI 10.1049/el.2010.2606; Kohle O, 1996, INORG CHEM, V35, P4779, DOI 10.1021/ic9515665; Koo BK, 2006, J ELECTROCERAM, V17, P79, DOI 10.1007/s10832-006-9941-x; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Li C, 2007, J MATER CHEM, V17; Li C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2827189; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Mickelson ET, 1998, CHEM PHYS LETT, V296, P188, DOI 10.1016/S0009-2614(98)01026-4; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Nazeeruddin MK, 1997, CHEM COMMUN, P1705, DOI 10.1039/a703277c; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Postma HWC, 2000, PHYS REV B, V62, P10653, DOI 10.1103/PhysRevB.62.R10653; Ramasamy E, 2008, ELECTROCHEM COMMUN, V10, P1087, DOI 10.1016/j.elecom.2008.05.013; Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734; Saito Y, 2002, SYNTHETIC MET, V131, P185, DOI 10.1016/S0379-6779(02)00198-4; Shi D, 2008, J PHYS CHEM C, V112, P17046, DOI 10.1021/jp808018h; Tang YB, 2010, ACS NANO, V4, P3482, DOI 10.1021/nn100449w; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Trancik JE, 2008, NANO LETT, V8, P982, DOI 10.1021/nl071945i; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; VOGEL R, 1994, J PHYS CHEM-US, V98, P3183, DOI 10.1021/j100063a022; Wang ZS, 2005, LANGMUIR, V21, P4272, DOI 10.1021/la050134w; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Zhou YX, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187945	41	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37806	10.1371/journal.pone.0037806	http://dx.doi.org/10.1371/journal.pone.0037806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655070	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900046
J	Moore, FE; Reyon, D; Sander, JD; Martinez, SA; Blackburn, JS; Khayter, C; Ramirez, CL; Joung, JK; Langenau, DM				Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.			Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs)	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; POOL ENGINEERING OPEN; MICROINJECTION; KNOCKOUT	Zinc Finger Nucleases (ZFNs) made by Context-Dependent Assembly (CoDA) and Transcription Activator-Like Effector Nucleases (TALENs) provide robust and user-friendly technologies for efficiently inactivating genes in zebrafish. These designer nucleases bind to and cleave DNA at particular target sites, inducing error-prone repair that can result in insertion or deletion mutations. Here, we assess the relative efficiencies of these technologies for inducing somatic DNA mutations in mosaic zebrafish. We find that TALENs exhibited a higher success rate for obtaining active nucleases capable of inducing mutations than compared with CoDA ZFNs. For example, all six TALENs tested induced DNA mutations at genomic target sites while only a subset of CoDA ZFNs exhibited detectable rates of mutagenesis. TALENs also exhibited higher mutation rates than CoDA ZFNs that had not been pre-screened using a bacterial two-hybrid assay, with DNA mutation rates ranging from 20%-76.8% compared to 1.1%-3.3%. Furthermore, the broader targeting range of TALENs enabled us to induce mutations at the methionine translation start site, sequences that were not targetable using the CoDA ZFN platform. TALENs exhibited similar toxicity to CoDA ZFNs, with >50% of injected animals surviving to 3 days of life. Taken together, our results suggest that TALEN technology provides a robust alternative to CoDA ZFNs for inducing targeted gene-inactivation in zebrafish, making it a preferred technology for creating targeted knockout mutants in zebrafish.	[Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Moore, Finola E.; Martinez, Sarah A.; Blackburn, Jessica S.; Langenau, David M.] Harvard Stem Cell Inst, Boston, MA USA; [Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Reyon, Deepak; Sander, Jeffry D.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Moore, FE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA.	dlangenau@partners.org	Langenau, David/GXI-0197-2022; Reyon, Deepak/HCH-3183-2022	Langenau, David/0000-0001-6664-8318; Martinez Roth, Sarah/0000-0001-9528-7152; Blackburn, Jessica/0000-0001-9464-3784; Ramirez, Cherie/0000-0002-0397-6872	Alex's Lemonade Stand Foundation; American Cancer Society; Harvard Stem Cell Institute; NIH [K01 AR055619, RO1 CA154923, R21 CA156056, DP1 OD006862, R01 GM088040, T32 CA009216]; Jim and Ann Orr MGH Research Scholar Award; National Science Foundation [DBI-0923827]; NATIONAL CANCER INSTITUTE [T32CA009216, R21CA156056, R01CA154923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	D.M.L. is supported by NIH grants K01 AR055619, RO1 CA154923, and R21 CA156056, the Alex's Lemonade Stand Foundation, the American Cancer Society, and the Harvard Stem Cell Institute. J.K.J. is supported by an NIH Director's Pioneer Award (DP1 OD006862), NIH R01 GM088040, and the Jim and Ann Orr MGH Research Scholar Award. J.D.S. is supported by NIH T32 CA009216. D. R. is supported by National Science Foundation award DBI-0923827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Reyon D, 2012, NATURE BIOTECHNOLOGY; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Westerfield M, 1993, ZEBRAFISH BOOK; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xu QL, 1999, METH MOL B, V127, P125, DOI 10.1385/1-59259-678-9:125; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779	32	125	164	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37877	10.1371/journal.pone.0037877	http://dx.doi.org/10.1371/journal.pone.0037877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655075	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900052
J	Vaca-Paniagua, F; Alvarez-Gomez, RM; Fragoso-Ontiveros, V; Vidal-Millan, S; Herrera, LA; Cantu, D; Bargallo-Rocha, E; Mohar, A; Lopez-Camarillo, C; Perez-Plasencia, C				Vaca-Paniagua, Felipe; Maria Alvarez-Gomez, Rosa; Fragoso-Ontiveros, Veronica; Vidal-Millan, Silvia; Alonso Herrera, Luis; Cantu, David; Bargallo-Rocha, Enrique; Mohar, Alejandro; Lopez-Camarillo, Cesar; Perez-Plasencia, Carlos			Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer	PLOS ONE			English	Article							GENOMIC REARRANGEMENTS; HEREDITARY BREAST; HIGH-RISK; GENES; VARIANTS; POPULATION; FAMILIES; CARRIERS; IDENTIFICATION; PREVALENCE	Hereditary breast cancer comprises 10% of all breast cancers. The most prevalent genes causing this pathology are BRCA1 and BRCA2 (breast cancer early onset 1 and 2), which also predispose to other cancers. Despite the outstanding relevance of genetic screening of BRCA deleterious variants in patients with a history of familial cancer, this practice is not common in Latin American public institutions. In this work we assessed mutations in the entire exonic and splice-site regions of BRCA in 39 patients with breast and ovarian cancer and with familial history of breast cancer or with clinical features suggestive for BRCA mutations by massive parallel pyrosequencing. First we evaluated the method with controls and found 41-485 reads per sequence in BRCA pathogenic mutations. Negative controls did not show deleterious variants, confirming the suitability of the approach. In patients diagnosed with cancer we found 4 novel deleterious mutations (c.2805_2808delAGAT and c.3124_3133delAGCAATATTA in BRCA1; c.2639_2640delTG and c.5114_5117delTAAA in BRCA2). The prevalence of BRCA mutations in these patients was 10.2%. Moreover, we discovered 16 variants with unknown clinical significance (11 in exons and 5 in introns); 4 were predicted as possibly pathogenic by in silico analyses, and 3 have not been described previously. This study illustrates how massive pyrosequencing technology can be applied to screen for BRCA mutations in the whole exonic and splice regions in patients with suspected BRCA-related cancers. This is the first effort to analyse the mutational status of BRCA genes on a Mexican-mestizo population by means of pyrosequencing.	[Vaca-Paniagua, Felipe; Fragoso-Ontiveros, Veronica; Perez-Plasencia, Carlos] Inst Nacl Cancerol, Lab Genom, Tlalpan, Mexico; [Vaca-Paniagua, Felipe; Maria Alvarez-Gomez, Rosa; Fragoso-Ontiveros, Veronica; Perez-Plasencia, Carlos] Inst Nacl Cancerol, Unidad Genom & Secuenciac Mas UGESEM, Tlalpan, Mexico; [Vidal-Millan, Silvia] Inst Nacl Cancerol, Clin Genet, Tlalpan, Mexico; [Alonso Herrera, Luis; Mohar, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Tlalpan, Mexico; [Cantu, David; Bargallo-Rocha, Enrique] Inst Nacl Cancerol, Dept Med Oncol, Tlalpan, Mexico; [Lopez-Camarillo, Cesar] UACM, Benito Juarez, Mexico; [Perez-Plasencia, Carlos] UNAM, Unidad Biomed, FES IZTACALA, Tlalnepantla, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Vaca-Paniagua, F (corresponding author), Inst Nacl Cancerol, Lab Genom, Tlalpan, Mexico.	carlos.pplas@gmail.com	Lopez-Camarillo, Cesar/I-1946-2019; Perez-Plasencia, Carlos/P-2372-2019; Herrera, Luis/GOV-3311-2022; Cantu-de Leon, David/P-7930-2017	Lopez-Camarillo, Cesar/0000-0002-9417-2609; Perez-Plasencia, Carlos/0000-0002-8593-8211; Vaca Paniagua, Felipe/0000-0002-2200-9706; Cantu-de Leon, David/0000-0002-0229-7931	National Cancer Instite of Mexico;  [SALUD-2010-01-141907]	National Cancer Instite of Mexico; 	This work was supported by federal funds SALUD-2010-01-141907 (http://www.conacyt.mx/) and by National Cancer Instite of Mexico funds (www.incan.edu.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Clark AS, 2011, J MAMMARY GLAND BIOL, V16, P17, DOI 10.1007/s10911-011-9200-x; De Leeneer K, 2011, HUM MUTAT, V32, P335, DOI 10.1002/humu.21428; De Leeneer K, 2009, J MOL DIAGN, V11, P415, DOI 10.2353/jmoldx.2009.090032; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Diez Gilbert O, 1996, MED CLIN-BARCELONA, V107, P623; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EASTON DF, 1995, AM J HUM GENET, V56, P265; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Evans DGR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012104; Ewald IP, 2009, GENET MOL BIOL, V32, P437, DOI 10.1590/S1415-47572009005000049; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Gerhardus A, 2007, EUR J HUM GENET, V15, P619, DOI 10.1038/sj.ejhg.5201806; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Espeleta GAG, 2012, CLIN GENET, V82, P484, DOI 10.1111/j.1399-0004.2011.01774.x; Hofmann Wera, 2003, Hum Mutat, V22, P103, DOI 10.1002/humu.9154; Kwon JS, 2010, J CLIN ONCOL, V28, P675, DOI 10.1200/JCO.2008.21.4684; Lecarpentier J, 2011, BREAST CANCER RES TR, V130, P927, DOI 10.1007/s10549-011-1655-3; Liede A, 2002, AM J HUM GENET, V71, P595, DOI 10.1086/342506; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lynch HT, 2005, CANCER GENET CYTOGEN, V158, P119, DOI 10.1016/j.cancergencyto.2004.01.032; Manoukian S, 2011, BREAST CANCER RES TR, V130, P207, DOI 10.1007/s10549-011-1548-5; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Milne RL, 2010, BREAST CANCER RES TR, V119, P221, DOI 10.1007/s10549-009-0394-1; Moller P, 2007, EUR J CANCER, V43, P1713, DOI 10.1016/j.ejca.2007.04.023; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Musolino A, 2007, BREAST, V16, P280, DOI 10.1016/j.breast.2006.12.003; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nkondjock A, 2006, BREAST CANCER RES TR, V98, P285, DOI 10.1007/s10549-006-9161-8; Paradiso A, 2011, ANN ONCOL, V22, pi31, DOI 10.1093/annonc/mdq663; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414; Ruiz-Flores P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9084; Salazar R, 2006, CANCER LETT, V233, P172, DOI 10.1016/j.canlet.2005.03.006; Saxena S, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-75; Simard J, 2007, J MED GENET, V44, P107, DOI 10.1136/jmg.2006.044388; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Tischkowitz M, 2008, EUR J HUM GENET, V16, P820, DOI 10.1038/ejhg.2008.13; Trainer AH, 2010, NAT REV CLIN ONCOL, V7, P708, DOI 10.1038/nrclinonc.2010.175; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vidal-Millan S, 2009, EUR J GYNAECOL ONCOL, V30, P527; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Wang G, 2011, GENET MED, V13, P1045, DOI 10.1097/GIM.0b013e31822a8113; Zhang LY, 2009, J MOL DIAGN, V11, P176, DOI 10.2353/jmoldx.2009.080137	53	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37432	10.1371/journal.pone.0037432	http://dx.doi.org/10.1371/journal.pone.0037432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655046	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900021
J	Chen, Z; Guo, L; Hadas, J; Gutowski, S; Sprang, SR; Sternweis, PC				Chen, Zhe; Guo, Liang; Hadas, Jana; Gutowski, Stephen; Sprang, Stephen R.; Sternweis, Paul C.			Activation of p115-RhoGEF Requires Direct Association of G alpha(13) and the Dbl Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RGRGS DOMAIN; RHO-GTPASES; STRUCTURAL DETERMINANTS; P115 RHOGEF; PDZ-RHOGEF; PROTEIN; COMPLEX; BINDING; MECHANISM	RGS-containing RhoGEFs (RGS-RhoGEFs) represent a direct link between the G(12) class of heterotrimeric G proteins and the monomeric GTPases. In addition to the canonical Dbl homology (DH) and pleckstrin homology domains that carry out the guanine nucleotide exchange factor (GEF) activity toward RhoA, these RhoGEFs also possess RGS homology (RH) domains that interact with activated alpha subunits of G(12) and G(13). Although the GEF activity of p115-RhoGEF (p115), an RGS-RhoGEF, can be stimulated by G alpha(13), the exact mechanism of the stimulation has remained unclear. Using combined studies with small angle x-ray scattering, biochemistry, and mutagenesis, we identify an additional binding site for activated G alpha(13) in the DH domain of p115. Small angle x-ray scattering reveals that the helical domain of G alpha(13) docks onto the DH domain, opposite to the surface of DH that binds RhoA. Mutation of a single tryptophan residue in the alpha 3b helix of DH reduces binding to activated G alpha(13) and ablates the stimulation of p115 by G alpha(13). Complementary mutations at the predicted DH-binding site in the alpha B-alpha C loop of the helical domain of G alpha(13) also affect stimulation of p115 by G alpha(13). Although the GAP activity of p115 is not required for stimulation by G alpha(13), two hydrophobic motifs in RH outside of the consensus RGS box are critical for this process. Therefore, the binding of G alpha(13) to the RH domain facilitates direct association of G alpha(13) to the DH domain to regulate its exchange activity. This study provides new insight into the mechanism of regulation of the RGS-RhoGEF and broadens our understanding of G protein signaling.	[Chen, Zhe] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hadas, Jana; Gutowski, Stephen; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Guo, Liang] Argonne Natl Lab, Adv Photon Source, BioCAT, Argonne, IL 60439 USA; [Sprang, Stephen R.] Univ Montana, Div Biol Sci, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Argonne National Laboratory; University of Montana System; University of Montana	Chen, Z (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Zhe.Chen@UTsouthwestern.edu; Paul.Sternweis@UTsouthwestern.edu		Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954, DK46371, RR-08630]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31954 (to P. C. S.) and DK46371 (to S. R. S.). This work was also supported in part by U.S. Department of Energy, Basic Energy Sciences, Office of Science Contract W-31-109-ENG-38; National Institutes of Health Grant RR-08630; and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bielnicki JA, 2011, J BIOL CHEM, V286, P35163, DOI 10.1074/jbc.M111.270918; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	35	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25490	25500		10.1074/jbc.M111.333716	http://dx.doi.org/10.1074/jbc.M111.333716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661716	Green Published, hybrid			2022-12-25	WOS:000306651700055
J	Bai, YH; Shi, Q; Wen, DH; Li, ZX; Jefferson, WA; Feng, CP; Tang, XY				Bai, Yaohui; Shi, Qing; Wen, Donghui; Li, Zongxun; Jefferson, William A.; Feng, Chuanping; Tang, Xiaoyan			Bacterial Communities in the Sediments of Dianchi Lake, a Partitioned Eutrophic Waterbody in China	PLOS ONE			English	Article							ORGANIC-CARBON; ARCHAEAL ASSEMBLAGES; SPATIAL-DISTRIBUTION; SEASONAL-CHANGES; DIVERSITY; TAIHU; PHOSPHORUS; SEQUENCES; ABUNDANCE; SIZE	Bacteria play an important role in the decomposition and cycling of a variety of compounds in freshwater aquatic environments, particularly nutrient-rich eutrophic lakes. A unique Chinese eutrophic lake - Dianchi - was selected for study because it has two separate and distinct basins, Caohai with higher organic carbon levels and Waihai with lower organic carbon levels. Sediment bacterial communities were studied in the two basins using samples collected in each season from June 2010 to March 2011. Barcoded pyrosequencing based on the 16 S rRNA gene found that certain common phyla, Proteobacteria, Bacteroidetes, Firmicutes and Chloroflexi, were dominant in the sediments from both basins. However, from the class to genus level, the dominant bacterial groups found in the sediments were distinct between the two basins. Correlation analysis revealed that, among the environmental parameters examined, total organic carbon (TOC) accounted for the greatest proportion of variability in bacterial community. Interestingly, study results suggest that increasing allochthonous organic carbon could enhance bacterial diversity and biomass in the sediment. In addition, analysis of function genes (amoA and nosZ) demonstrated that ammonia-oxidizing bacteria (AOB) were dominant in sediments, with 99% belonging to Nitrosomonas. Denitrifying bacteria were comparatively diverse and were associated with some cultivatable bacteria.	[Bai, Yaohui; Jefferson, William A.] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Bai, Yaohui; Wen, Donghui; Tang, Xiaoyan] Peking Univ, Coll Environm Sci & Engn, Key Lab Water & Sediment Sci, Minist Educ, Beijing 100871, Peoples R China; [Shi, Qing; Feng, Chuanping] China Univ Geosci, Sch Water Resource & Environm Sci, Beijing, Peoples R China; [Li, Zongxun] Kunming Inst Environm Sci, Kunming, Yunnan Province, Peoples R China; [Jefferson, William A.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Peking University; China University of Geosciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, YH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	yhbai@rcees.ac.cn		Feng, Chuanping/0000-0002-9700-4416	General Project [51008003]; National Natural Science Foundation of China; Postdoctoral Science Foundation of China [201104016]	General Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by a General Project (No. 51008003) granted by the National Natural Science Foundation of China and a special financial grant (201104016) from the Postdoctoral Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1988, HYDROBIOLOGIA, V159, P159; Ansari AA, EUTROPHICATION CAUSE; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen GY, 2009, RES MICROBIOL, V160, P173, DOI 10.1016/j.resmic.2009.01.003; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gao L, 2005, ENVIRON GEOL, V48, P835, DOI 10.1007/s00254-005-0005-3; GAUDETTE HE, 1974, J SEDIMENT PETROL, V44, P249; Gong ZJ, 2009, LIMNOLOGY, V10, P247, DOI 10.1007/s10201-009-0282-8; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hempel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-58; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Hu J, 2009, ENVIRON GEOL, V58, P833, DOI 10.1007/s00254-008-1559-7; Hubert CRJ, 2012, ENVIRON MICROBIOL, V14, P387, DOI 10.1111/j.1462-2920.2011.02521.x; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li RY, 2007, PEDOSPHERE, V17, P265, DOI 10.1016/S1002-0160(07)60033-2; Liu YM, 2006, ENVIRON TOXICOL, V21, P289, DOI 10.1002/tox.20182; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Luo J, 2004, FUNGAL DIVERS, V16, P93; [吕明姬 Lv Mingji], 2011, [环境科学学报, Acta Scientiae Circumstantiae], V31, P299; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moss JA, 2006, APPL ENVIRON MICROB, V72, P5679, DOI 10.1128/AEM.02773-05; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Scala DJ, 1999, APPL ENVIRON MICROB, V65, P1681; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Shao KQ, 2011, CAN J MICROBIOL, V57, P263, DOI [10.1139/W11-003, 10.1139/w11-003]; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; State Environmental Protection Administration of China, 1989, MON AN METH WAT WAST; Steven B, 2011, AQUAT MICROB ECOL, V64, P41, DOI 10.3354/ame01507; Su Tao, 2011, ENV SCI SURVEY, V30, P33, DOI DOI 10.3969/j.issn.1673-9655.2011.05.010; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang XM, 2009, MICROB ECOL, V58, P307, DOI 10.1007/s00248-008-9482-8; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen DH, 2012, ANN MICROBIOL, V62, P715, DOI 10.1007/s13213-011-0311-9; Wu X, 2007, FEMS MICROBIOL ECOL, V61, P85, DOI 10.1111/j.1574-6941.2007.00326.x; Wu YC, 2010, ENV MICROBIOL REP, V2, P569, DOI 10.1111/j.1758-2229.2010.00146.x; Xiong YQ, 2010, J PALEOLIMNOL, V44, P217, DOI 10.1007/s10933-009-9398-4; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x; Zeng J, 2008, CAN J MICROBIOL, V54, P1053, DOI 10.1139/W08-098; Zhou C, 2011, GEOMICROBIOL J, V28, P660, DOI 10.1080/01490451.2010.511438	65	126	143	5	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37796	10.1371/journal.pone.0037796	http://dx.doi.org/10.1371/journal.pone.0037796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666393	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400050
J	Lai, SL; Cheah, SC; Wong, PF; Noor, SM; Mustafa, MR				Lai, Siew-Li; Cheah, Shiau-Chuen; Wong, Pooi-Fong; Noor, Suzita Mohd; Mustafa, Mohd Rais			In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin A	PLOS ONE			English	Article							KAEMPFERIA-PANDURATA; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; CANCER; INHIBITOR; INDUCTION; APOPTOSIS; MIGRATION; METALLOPROTEINASES; ACTIVATION	Background: Targeting angiogenesis has emerged as an attractive and promising strategy in anti-cancer therapeutic development. The present study investigates the anti-angiogenic potential of Panduratin A (PA), a natural chalcone isolated from Boesenbergia rotunda by using both in vitro and in vivo assays. Methodology/Principal Findings: PA exerted selective cytotoxicity on human umbilical vein endothelial cells (HUVECs) with IC50 value of 6.91 +/- 0.85 mu M when compared to human normal fibroblast and normal liver epithelial cells. Assessment of the growth kinetics by cell impedance-based Real-Time Cell Analyzer showed that PA induced both cytotoxic and cytostatic effects on HUVECs, depending on the concentration used. Results also showed that PA suppressed VEGF-induced survival and proliferation of HUVECs. Furthermore, endothelial cell migration, invasion, and morphogenesis or tube formation demonstrated significant time-and dose-dependent inhibition by PA. PA also suppressed matrix metalloproteinase-2 (MMP-2) secretion and attenuated its activation to intermediate and active MMP-2. In addition, PA suppressed F-actin stress fiber formation to prevent migration of the endothelial cells. More importantly, anti-angiogenic potential of PA was also evidenced in two in vivo models. PA inhibited neo-vessels formation in murine Matrigel plugs, and angiogenesis in zebrafish embryos. Conclusions/Significance: Taken together, our study demonstrated the distinctive anti-angiogenic properties of PA, both in vitro and in vivo. This report thus reveals another biological activity of PA in addition to its reported anti-inflammatory and anti-cancer activities, suggestive of PA's potential for development as an anti-angiogenic agent for cancer therapy.	[Lai, Siew-Li; Cheah, Shiau-Chuen; Wong, Pooi-Fong; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia; [Noor, Suzita Mohd] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Lai, SL (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia.	rais@um.edu.my	Mustafa, Mohamed R/B-1647-2009; Cheah, Shiau-Chuen/H-7564-2013; NOOR, SUZITA M/B-9883-2010; WONG, POOI-FONG PF/B-5234-2010	Mustafa, Mohamed R/0000-0002-7864-5189; Cheah, Shiau-Chuen/0000-0002-9247-7265; NOOR, SUZITA M/0000-0001-5344-8165; WONG, POOI-FONG PF/0000-0002-6705-2521	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) [E000002-20001]; Fundamental Research Grant Scheme (FRGS) [FP039/2010A]	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG); Fundamental Research Grant Scheme (FRGS)	This work was funded by Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) E000002-20001 (URL: http://hir.um.edu.my/) and partially supported by Fundamental Research Grant Scheme (FRGS) FP039/2010A (URL: http://jpt.mohe.gov.my/menupenyelidik.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Cheah SC, 2011, MOLECULES, V16, P2583, DOI 10.3390/molecules16032583; Childs S, 2002, DEVELOPMENT, V129, P973; COOMBER BL, 1990, ARTERIOSCLEROSIS, V10, P215, DOI 10.1161/01.ATV.10.2.215; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fong TAT, 1999, CANCER RES, V59, P99; Ghosh RN, 2007, METH MOL B, V356, P63; Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Imai K, 1996, CANCER RES, V56, P2707; Jeong SJ, 2011, PHYTOTHER RES, V25, P1, DOI 10.1002/ptr.3224; Kargozaran H, 2007, CLIN EXP METASTAS, V24, P495, DOI 10.1007/s10585-007-9086-6; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Malinda KM, 2003, METH MOLEC MED, V78, P329; Mojzis J, 2008, PHARMACOL RES, V57, P259, DOI 10.1016/j.phrs.2008.02.005; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; MOORE GL, 1981, BIOCHEM MED METAB B, V26, P167, DOI 10.1016/0006-2944(81)90043-0; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Pang XF, 2009, CANCER RES, V69, P518, DOI 10.1158/0008-5472.CAN-08-2531; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Rodriguez Luis G., 2004, V294, P23; Rukayadi Y, 2009, ANTIMICROB AGENTS CH, V53, P4529, DOI 10.1128/AAC.00624-09; Samant RS, 2011, ONCOTARGET, V2, P122; Shindo K, 2006, BIOSCI BIOTECH BIOCH, V70, P2281, DOI 10.1271/bbb.60086; Sohn JH, 2005, BIOL PHARM BULL, V28, P1083, DOI 10.1248/bpb.28.1083; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vucenik I, 2004, CARCINOGENESIS, V25, P2115, DOI 10.1093/carcin/bgh232; Xiao H, 2006, EJC SUPPL, V4, P195, DOI 10.1016/S1359-6349(06)70651-6; Yun JM, 2003, PLANTA MED, V69, P1102, DOI 10.1055/s-2003-45190; Yun JM, 2006, CARCINOGENESIS, V27, P1454, DOI 10.1093/carcin/bgi348; Zoellner H, 1996, J CELL SCI, V109, P2571	40	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38103	10.1371/journal.pone.0038103	http://dx.doi.org/10.1371/journal.pone.0038103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666456	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305353400081
J	Ruzicka, F; Jech, R; Novakova, L; Urgosik, D; Vymazal, J; Ruzicka, E				Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Urgosik, Dusan; Vymazal, Josef; Ruzicka, Evzen			Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; BODY-WEIGHT; BASAL GANGLIA; NUCLEUS STIMULATION; ENERGY-INTAKE; FOOD-INTAKE; REWARD; LOCALIZATION; MECHANISMS; ELECTRODES	The aim of our study was to assess changes in body-weight in relation to active electrode contact position in the subthalamic nucleus. Regular body weight measurements were done in 20 patients with advanced Parkinson's disease within a period of 18 months after implantation. T1-weighted (1.5T) magnetic resonance images were used to determine electrode position in the subthalamic nucleus and the Unified Parkinson's disease rating scale (UPDRS-III) was used for motor assessment. The distance of the contacts from the wall of the third ventricle in the mediolateral direction inversely correlated with weight gain (r = -0.55, p<0.01) and with neurostimulation-related motor condition expressed as the contralateral hemi-body UPDRS-III (r = -0.42, p<0.01). Patients with at least one contact within 9.3 mm of the wall experienced significantly greater weight gain (9.4+/-(SD) 4.4 kg, N = 11) than those with both contacts located laterally (3.9+/-2.7 kg, N = 9) (p<0.001). The position of the active contact is critical not only for motor outcome but is also associated with weight gain, suggesting a regional effect of subthalamic stimulation on adjacent structures involved in the central regulation of energy balance, food intake or reward.	[Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Urgosik, Dusan] Na Homolce Hosp, Dept Stereotact & Radiat Neurosurg, Prague, Czech Republic; [Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Na Homolce Hospital; Na Homolce Hospital	Ruzicka, F (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Urgošík, Dušan/AAA-9551-2021; Jech, Robert/HHY-7342-2022; Růžička, Evžen/F-9299-2017	Jech, Robert/0000-0002-9732-8947; Růžička, Evžen/0000-0002-4893-9661; Ruzicka, Filip/0000-0003-2743-2703	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA NT12282-5/2011]; Czech Ministry of Education [MSM 0021620849, PRVOUK-P26/LF1/4]; Medtronic Czechia	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Medtronic Czechia(Medtronic)	This work was supported by the Czech Science Foundation: grant project 309/09/1145, Czech Ministry of Health: IGA NT12282-5/2011 and by the Czech Ministry of Education: research project MSM 0021620849 and PRVOUK-P26/LF1/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R. Jech, D. Urgosik and Evzen Ruzicka received consulting fees from Medtronic Czechia. R. Jech received a travel grant from Medtronic Czechia to attend the XVIII World Congress of Parkinson's disease and Related Disorders in 2009. The authors declare no other potential conflicts of interest with respect to the authorship and/or publication of this article. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Bannier S, 2009, J NEUROL NEUROSUR PS, V80, P484, DOI 10.1136/jnnp.2008.158576; Barichella M, 2003, MOVEMENT DISORD, V18, P1337, DOI 10.1002/mds.10543; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Daniluk S, 2010, ACTA NEUROCHIR, V152, P201, DOI 10.1007/s00701-009-0514-z; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; Delikanaki-Skaribas E, 2009, MOVEMENT DISORD, V24, P667, DOI 10.1002/mds.22372; Gironell A, 2002, NEUROLOGIA, V17, P310; Godinho F, 2006, J NEUROL, V253, P1347, DOI 10.1007/s00415-006-0222-z; GROENEWEGEN HJ, 1993, NEUROSCIENCE, V57, P113, DOI 10.1016/0306-4522(93)90115-V; GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408; Haegelen C, 2009, MED HYPOTHESES, V72, P421, DOI 10.1016/j.mehy.2008.07.065; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Hamel W, 2003, J NEUROL NEUROSUR PS, V74, P1036, DOI 10.1136/jnnp.74.8.1036; Herzog J, 2004, MOVEMENT DISORD, V19, P1050, DOI 10.1002/mds.20056; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Holmberg B, 2005, MOVEMENT DISORD, V20, P976, DOI 10.1002/mds.20492; Jakes RW, 2004, INT J EPIDEMIOL, V33, P1382, DOI 10.1093/ije/dyh181; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Jech R, 2006, CLIN NEUROPHYSIOL, V117, P1017, DOI 10.1016/j.clinph.2006.01.009; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Lardeux S, 2009, J NEUROPHYSIOL, V102, P2526, DOI 10.1152/jn.91009.2008; Lee EM, 2011, BRAIN BEHAV, V1, P12, DOI 10.1002/brb3.9; Ludwig J, 2007, J NEUROL NEUROSUR PS, V78, P742, DOI 10.1136/jnnp.2006.103739; Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959; Macia F, 2004, MOVEMENT DISORD, V19, P206, DOI 10.1002/mds.10630; Maks CB, 2009, J NEUROL NEUROSUR PS, V80, P659, DOI 10.1136/jnnp.2007.126219; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Montaurier C, 2007, BRAIN, V130, P1808, DOI 10.1093/brain/awm113; Morel A, 2007, ATLAS HUMAN THALAMUS; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Novakova L, 2007, NEUROENDOCRINOL LETT, V28, P21; Novakova L, 2011, NEUROENDOCRINOL LETT, V32, P437; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Perlemoine C, 2005, BRIT J NUTR, V93, P191, DOI 10.1079/BJN20041297; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Priori A, 2001, NEUROL SCI, V22, P85, DOI 10.1007/s100720170059; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Rieu I, 2011, J NEUROL SCI, V310, P267, DOI 10.1016/j.jns.2011.06.055; Rouaud T, 2010, P NATL ACAD SCI USA, V107, P1196, DOI 10.1073/pnas.0908189107; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Sauleau P, 2009, MOVEMENT DISORD, V24, P2149, DOI 10.1002/mds.22765; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Serranova T, 2011, MOVEMENT DISORD, V26, P2260, DOI 10.1002/mds.23880; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Turner MS, 2001, J NEUROSCI, V21, P2820, DOI 10.1523/JNEUROSCI.21-08-02820.2001; Walker HC, 2009, PARKINSONISM RELAT D, V15, P709, DOI 10.1016/j.parkreldis.2009.01.009; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Winter C, 2008, EXP BRAIN RES, V185, P497, DOI 10.1007/s00221-007-1171-1; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Zhu XL, 2002, ACTA NEUROCHIR, V144, P959, DOI 10.1007/s00701-002-0982-x	58	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38020	10.1371/journal.pone.0038020	http://dx.doi.org/10.1371/journal.pone.0038020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666437	Green Submitted, gold, Green Published			2022-12-25	WOS:000305353400069
J	Elmabsout, AA; Kumawat, A; Saenz-Mendez, P; Krivospitskaya, O; Savenstrand, H; Olofsson, PS; Eriksson, LA; Strid, A; Valen, G; Torma, H; Sirsjo, A				Elmabsout, Ali Ateia; Kumawat, Ashok; Saenz-Mendez, Patricia; Krivospitskaya, Olesya; Savenstrand, Helena; Olofsson, Peder S.; Eriksson, Leif A.; Strid, Ake; Valen, Guro; Torma, Hans; Sirsjo, Allan			Cloning and Functional Studies of a Splice Variant of CYP26B1 Expressed in Vascular Cells	PLOS ONE			English	Article							TRANS-RETINOIC ACID; SMOOTH-MUSCLE-CELLS; HUMAN CYTOCHROME-P450; METABOLIZING ENZYME; IDENTIFICATION; RESISTANCE; LIVER; P450S	Background: All-trans retinoic acid (atRA) plays an essential role in the regulation of gene expression, cell growth and differentiation and is also important for normal cardiovascular development but may in turn be involved in cardiovascular diseases, i.e. atherosclerosis and restenosis. The cellular atRA levels are under strict control involving several cytochromes P450 isoforms (CYPs). CYP26 may be the most important regulator of atRA catabolism in vascular cells. The present study describes the molecular cloning, characterization and function of atRA-induced expression of a spliced variant of the CYP26B1 gene. Methodology/Principal Findings: The coding region of the spliced CYP26B1 lacking exon 2 was amplified from cDNA synthesized from atRA-treated human aortic smooth muscle cells and sequenced. Both the spliced variant and full length CYP26B1 was found to be expressed in cultured human endothelial and smooth muscle cells, and in normal and atherosclerotic vessel. atRA induced both variants of CYP26B1 in cultured vascular cells. Furthermore, the levels of spliced mRNA transcript were 4.5 times higher in the atherosclerotic lesion compared to normal arteries and the expression in the lesions was increased 20-fold upon atRA treatment. The spliced CYP26B1 still has the capability to degrade atRA, but at an initial rate one-third that of the corresponding full length enzyme. Transfection of COS-1 and THP-1 cells with the CYP26B1 spliced variant indicated either an increase or a decrease in the catabolism of atRA, probably depending on the expression of other atRA catabolizing enzymes in the cells. Conclusions/Significance: Vascular cells express the spliced variant of CYP26B1 lacking exon 2 and it is also increased in atherosclerotic lesions. The spliced variant displays a slower and reduced degradation of atRA as compared to the full-length enzyme. Further studies are needed, however, to clarify the substrate specificity and role of the CYP26B1 splice variant in health and disease.	[Elmabsout, Ali Ateia; Kumawat, Ashok; Krivospitskaya, Olesya; Sirsjo, Allan] Univ Orebro, Sch Hlth Sci, Dept Clin Med, Orebro, Sweden; [Saenz-Mendez, Patricia] UdelaR, Computat Chem & Biol Grp, Fac Quim, Montevideo, Uruguay; [Savenstrand, Helena; Strid, Ake] Univ Orebro, Orebro Life Sci Ctr, Dept Sci & Technol, Orebro, Sweden; [Olofsson, Peder S.] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden; [Olofsson, Peder S.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA; [Eriksson, Leif A.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Valen, Guro] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Valen, Guro] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Torma, Hans] Uppsala Univ, Dept Med Sci Dermatol & Venereol, Uppsala, Sweden	Orebro University; Universidad de la Republica, Uruguay; Orebro University; Karolinska Institutet; Northwell Health; University of Gothenburg; University of Oslo; University of Oslo; Uppsala University	Elmabsout, AA (corresponding author), Univ Orebro, Sch Hlth Sci, Dept Clin Med, Orebro, Sweden.	allan.sirsjo@.oru.se	Strid, Åke/J-9068-2019; Saenz-Méndez, Patricia/G-3678-2011; Törmä, Hans/F-8152-2011; Eriksson, Leif A/D-1226-2012	Strid, Åke/0000-0003-3315-8835; Saenz-Méndez, Patricia/0000-0002-6711-4972; Törmä, Hans/0000-0002-3617-8551; Eriksson, Leif A/0000-0001-5654-3109; Kumawat, Ashok Kumar/0000-0002-2244-9816	Swedish Science Research Council (VR); Orebro University	Swedish Science Research Council (VR)(Swedish Research Council); Orebro University	The Swedish Science Research Council (VR) and Orebro University financially supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Colbert Melissa C, 2002, Cardiovasc Toxicol, V2, P25, DOI 10.1385/CT:2:1:25; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Kizaki M, 1996, BLOOD, V87, P725, DOI 10.1182/blood.V87.2.725.bloodjournal872725; Krivospitskaya O, 2012, MOL MED IN PRESS; Lorie EP, 2009, BRIT J DERMATOL, V160, P26, DOI 10.1111/j.1365-2133.2008.08895.x; Lorie EP, 2009, BBA-MOL CELL BIOL L, V1791, P220, DOI 10.1016/j.bbalip.2008.12.004; Maden M, 2001, INT REV CYTOL, V209, P1; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Ocaya P, 2007, ARTERIOSCL THROM VAS, V27, P1542, DOI 10.1161/ATVBAHA.106.138602; Ocaya PA, 2011, J VASC RES, V48, P23, DOI 10.1159/000317397; Olofsson PS, 2009, J MOL MED-JMM, V87, P337, DOI 10.1007/s00109-008-0412-5; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Streb Jeffrey W., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P31, DOI 10.2174/1568006033337393; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Wagsater D, 2006, J VASC RES, V43, P377, DOI 10.1159/000094258; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yamamoto Y, 2000, FASEB J, V14, P2119, DOI 10.1096/fj.00-0061com; Zolfaghari R, 2007, AM J PHYSIOL-GASTR L, V292, pG1029, DOI 10.1152/ajpgi.00494.2006	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e36839	10.1371/journal.pone.0036839	http://dx.doi.org/10.1371/journal.pone.0036839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666329	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600006
J	Ingrassia, R; Lanzillotta, A; Sarnico, I; Benarese, M; Blasi, F; Borgese, L; Bilo, F; Depero, L; Chiarugi, A; Spano, PF; Pizzi, M				Ingrassia, Rosaria; Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Blasi, Francesco; Borgese, Laura; Bilo, Fabjola; Depero, Laura; Chiarugi, Alberto; Spano, Pier Franco; Pizzi, Marina			1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-kappa B/RelA Acetylation at Lys310	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; PARKINSONS-DISEASE; IRON CHELATORS; SUBSTANTIA-NIGRA; B ACTIVATION; BELGRADE RAT; ISOFORMS; LOCALIZATION; DEFEROXAMINE; NEUROPROTECTION	The molecular mechanisms responsible for increasing iron and neurodegeneration in brain ischemia are an interesting area of research which could open new therapeutic approaches. Previous evidence has shown that activation of nuclear factor kappa B (NF-kappa B) through RelA acetylation on Lys310 is the prerequisite for p50/RelA-mediated apoptosis in cellular and animal models of brain ischemia. We hypothesized that the increase of iron through a NF-kappa B-regulated 1B isoform of the divalent metal transporter-1 (1B/DMT1) might contribute to post-ischemic neuronal damage. Both in mice subjected to transient middle cerebral artery occlusion (MCAO) and in neuronally differentiated SK-N-SH cells exposed to oxygen-glucose-deprivation (OGD), 1A/DMT1 was only barely expressed while the 1B/DMT1 without iron-response-element (-IRE) protein and mRNA were early up-regulated. Either OGD or over-expression of 1B/(-)IRE DMT1 isoform significantly increased iron uptake, as detected by total reflection X-ray fluorescence, and iron-dependent cell death. Iron chelation by deferoxamine treatment or (2) IRE DMT1 RNA silencing displayed significant neuroprotection against OGD which concomitantly decreased intracellular iron levels. We found evidence that 1B/(-)IRE DMT1 was a target gene for RelA activation and acetylation on Lys310 residue during ischemia. Chromatin immunoprecipitation analysis of the 1B/DMT1 promoter showed there was increased interaction with RelA and acetylation of H3 histone during OGD exposure of cortical neurons. Over-expression of wild-type RelA increased 1B/DMT1 promoter-luciferase activity, the (2) IRE DMT1 protein, as well as neuronal death. Expression of the acetylation-resistant RelA-K310R construct, which carried a mutation from lysine 310 to arginine, but not the acetyl-mimic mutant RelA-K310Q, down-regulated the 1B/DMT1 promoter, consequently offering neuroprotection. Our data showed that 1B/(-)IRE DMT1 expression and intracellular iron influx are early downstream responses to NF-kappa B/RelA activation and acetylation during brain ischemia and contribute to the pathogenesis of stroke-induced neuronal damage.	[Ingrassia, Rosaria] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Spano, Pier Franco; Pizzi, Marina] Univ Brescia, Sch Med, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Blasi, Francesco; Chiarugi, Alberto] Univ Florence, Dept Pharmacol, Florence, Italy; [Borgese, Laura; Bilo, Fabjola; Depero, Laura] Univ Brescia, Sch Engn, Chem Technol Lab, Brescia, Italy; [Spano, Pier Franco; Pizzi, Marina] IRCCS S Camillo Hosp, Venice, Italy; [Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Spano, Pier Franco; Pizzi, Marina] Univ Brescia, Sch Med, Natl Inst Neurosci Italy, Brescia, Italy	University of Brescia; University of Brescia; University of Florence; University of Brescia; IRCCS Ospedale San Camillo; University of Brescia	Ingrassia, R (corresponding author), Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy.	ingrassi@med.unibs.it	Spano, Pier Franco A/E-7621-2010; Borgese, Laura/ABF-9537-2021; Ingrassia, Rosaria/AAC-3140-2021; Blasi, Francesco/G-1055-2015; Pizzi, Marina/K-2064-2016; SPANO, PIERFRANCO/J-9944-2016; Depero, Laura Eleonora/A-3176-2009	Borgese, Laura/0000-0003-3486-2656; Blasi, Francesco/0000-0002-6616-8418; Bilo, Fabjola/0000-0001-7362-3258; Pizzi, Marina/0000-0002-4857-5204; SPANO, PIERFRANCO/0000-0002-9906-0964; Depero, Laura Eleonora/0000-0001-7818-3212	Progetti di Ricerca di Interesse Nazionale-PRIN [PROT. 20089BARSR_003]; Network Enabled Drug Design Project- NEDD, Regione Lombardia, Italy [CUP H81J09002660007]	Progetti di Ricerca di Interesse Nazionale-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Network Enabled Drug Design Project- NEDD, Regione Lombardia, Italy	The study was partially supported by Progetti di Ricerca di Interesse Nazionale-PRIN 2008 (Grant number: PROT. 20089BARSR_003) and by Network Enabled Drug Design Project- NEDD (CUP H81J09002660007), Regione Lombardia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Burdo JR, 1999, NEUROSCIENCE, V93, P1189, DOI 10.1016/S0306-4522(99)00207-9; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chew KCM, 2011, J BIOL CHEM, V286, P33380, DOI 10.1074/jbc.M111.268409; Connor JR, 2009, BBA-GEN SUBJECTS, V1790, DOI 10.1016/j.bbagen.2009.05.004; CRENON I, 1993, ONCOGENE, V8, P867; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Faraco G, 2010, STROKE, V41, P181, DOI 10.1161/STROKEAHA.109.567826; Faucheux BA, 1997, BRAIN RES, V749, P170, DOI 10.1016/S0006-8993(96)01412-6; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haile DJ, 1999, AM J MED SCI, V318, P230, DOI 10.1097/00000441-199910000-00003; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; HILL JM, 1985, P NATL ACAD SCI USA, V82, P4553, DOI 10.1073/pnas.82.13.4553; Hirsch EC, 2009, PARKINSONISM RELAT D, V15, pS209, DOI 10.1016/S1353-8020(09)70816-8; Huang E, 2004, NEUROSCIENCE, V128, P487, DOI 10.1016/j.neuroscience.2004.06.055; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jiang H, 2006, NEUROCHEM INT, V49, P605, DOI 10.1016/j.neuint.2006.04.015; Kuo HC, 2004, J NEUROSCI RES, V76, P497, DOI 10.1002/jnr.20112; Kupershmidt L, 2011, NEUROSCIENCE, V189, P345, DOI 10.1016/j.neuroscience.2011.03.040; Lanzillotta A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.76; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Lis A, 2005, BIOCHEM PHARMACOL, V69, P1647, DOI 10.1016/j.bcp.2005.03.023; Lis A, 2004, MOL BRAIN RES, V122, P62, DOI 10.1016/j.molbrainres.2003.11.023; Mandel S, 2007, PROG NEUROBIOL, V82, P348, DOI 10.1016/j.pneurobio.2007.06.001; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Paradkar PN, 2006, J NEUROCHEM, V96, P1768, DOI 10.1111/j.1471-4159.2006.03702.x; Paramar PN, 2006, BIOCHEM J, V394, P173, DOI 10.1042/BJ20051296; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Qian ZM, 2011, J CELL PHYSIOL, V226, P1596, DOI 10.1002/jcp.22485; Roth JA, 2000, J NEUROSCI, V20, P7595; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Snyder AM, 2009, BBA-GEN SUBJECTS, V1790, P606, DOI 10.1016/j.bbagen.2008.08.005; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; Wang D, 2010, IUBMB LIFE, V62, P629, DOI 10.1002/iub.363; Wang XS, 2003, NEUROSCIENCE, V120, P21, DOI 10.1016/S0306-4522(03)00293-8; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Xu HM, 2010, J CELL BIOCHEM, V111, P1537, DOI 10.1002/jcb.22885; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang L, 2011, CELL PHYSIOL BIOCHEM, V27, P23, DOI 10.1159/000325202; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Youdim MBH, 1999, ANN NY ACAD SCI, V890, P7, DOI 10.1111/j.1749-6632.1999.tb07977.x; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhu L, 2008, J CELL MOL MED, V12, P569, DOI 10.1111/j.1582-4934.2007.00145.x	63	33	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38019	10.1371/journal.pone.0038019	http://dx.doi.org/10.1371/journal.pone.0038019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666436	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600054
J	Schmidt, J; Riechers, A; Stoll, R; Amann, T; Fink, F; Spruss, T; Gronwald, W; Konig, B; Hellerbrand, C; Bosserhoff, AK				Schmidt, Jennifer; Riechers, Alexander; Stoll, Raphael; Amann, Thomas; Fink, Florian; Spruss, Thilo; Gronwald, Wolfram; Koenig, Burkhard; Hellerbrand, Claus; Bosserhoff, Anja Katrin			Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CELLS; EXPRESSION; MIGRATION; TRANSITION; SECRETION; INVASION; SPECTRA; FAMILY	Melanoma is the most aggressive form of skin cancer, with fast progression and early dissemination mediated by the melanoma inhibitory activity (MIA) protein. Here, we discovered that dimerization of MIA is required for functional activity through mutagenesis of MIA which showed the correlation between dimerization and functional activity. We subsequently identified the dodecapeptide AR71, which prevents MIA dimerization and thereby acts as a MIA inhibitor. Two-dimensional nuclear magnetic resonance (NMR) spectroscopy demonstrated the binding of AR71 to the MIA dimerization domain, in agreement with in vitro and in vivo data revealing reduced cell migration, reduced formation of metastases and increased immune response after AR71 treatment. We believe AR71 is a lead structure for MIA inhibitors. More generally, inhibiting MIA dimerization is a novel therapeutic concept in melanoma therapy.	[Schmidt, Jennifer; Bosserhoff, Anja Katrin] Univ Regensburg, Inst Pathol, Regensburg, Germany; [Riechers, Alexander; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-8400 Regensburg, Germany; [Stoll, Raphael] Ruhr Univ Bochum, Biomol NMR, Fac Chem & Biochem, Bochum, Germany; [Amann, Thomas; Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany; [Fink, Florian; Gronwald, Wolfram] Univ Regensburg, Inst Funct Gen, Regensburg, Germany; [Spruss, Thilo] Univ Regensburg, Inst Pharm, D-8400 Regensburg, Germany	University of Regensburg; University of Regensburg; Ruhr University Bochum; University of Regensburg; University of Regensburg; University of Regensburg	Schmidt, J (corresponding author), Univ Regensburg, Inst Pathol, Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022; Koenig, Burkhard/O-8172-2019; Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Bosserhoff, Anja/0000-0001-8147-394X	German Research Foundation; German Cancer Aid (Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung; FCI; Proteincenter (NRW Center of Excellence); RUBiospek	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); FCI(Fonds der Chemischen Industrie); Proteincenter (NRW Center of Excellence); RUBiospek	This work was supported by the German Research Foundation and the German Cancer Aid (Deutsche Krebshilfe) to AKB. Furthermore, RS gratefully recognizes generous support from the Bundesministerium fur Bildung und Forschung, FCI, Proteincenter (NRW Center of Excellence), and RUBiospek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; BLESCH A, 1994, CANCER RES, V54, P5695; Bosserhoff AK, 1996, J BIOL CHEM, V271, P490, DOI 10.1074/jbc.271.1.490; Bosserhoff AK, 2003, LAB INVEST, V83, P1583, DOI 10.1097/01.LAB.0000097191.12477.5D; Bosserhoff AK, 2002, HISTOL HISTOPATHOL, V17, P289, DOI 10.14670/HH-17.289; Bosserhoff AK, 2001, MELANOMA RES, V11, P417, DOI 10.1097/00008390-200108000-00013; Carrascal MT, 2003, CANCER RES, V63, P491; DAVIS DG, 1985, J AM CHEM SOC, V107, P7197, DOI 10.1021/ja00310a085; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Guba M, 2000, BRIT J CANCER, V83, P1216, DOI 10.1054/bjoc.2000.1424; Jachimczak P, 2005, INT J CANCER, V113, P88, DOI 10.1002/ijc.20549; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lougheed JC, 2001, P NATL ACAD SCI USA, V98, P5515, DOI 10.1073/pnas.091601698; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Moser M, 2002, MOL CELL BIOL, V22, P1438, DOI 10.1128/MCB.22.5.1438-1445.2002; Riechers A, 2009, BIOTECHNIQUES, V47, P837, DOI 10.2144/000113223; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schmidt J, 2009, INT J CANCER, V125, P1587, DOI 10.1002/ijc.24508; Schwarten M, 2007, BIOMOL NMR ASSIGM, V1, P105, DOI 10.1007/s12104-007-9030-3; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Stahlecker J, 2000, ANTICANCER RES, V20, P5041; Stoll R, 2008, CURR PROTEIN PEPT SC, V9, P221, DOI 10.2174/138920308784534014; Stoll R, 2001, EMBO J, V20, P340, DOI 10.1093/emboj/20.3.340; Stoll R, 2006, BIOL CHEM, V387, P1601, DOI 10.1515/BC.2006.199; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	29	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37941	10.1371/journal.pone.0037941	http://dx.doi.org/10.1371/journal.pone.0037941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666418	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600045
J	Aggarwal, A; Monsivais, P; Drewnowski, A				Aggarwal, Anju; Monsivais, Pablo; Drewnowski, Adam			Nutrient Intakes Linked to Better Health Outcomes Are Associated with Higher Diet Costs in the US	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-ENERGY-DENSITY; VITAMIN-E CONSUMPTION; SOCIOECONOMIC POSITION; MONETARY COSTS; FATTY-ACIDS; WEIGHT-GAIN; RISK; CANCER; WOMEN	Purpose: Degrees of nutrient intake and food groups have been linked to differential chronic disease risk. However, intakes of specific nutrients may also be associated with differential diet costs and unobserved differences in socioeconomic status (SES). The present study examined degrees of nutrient intake, for every key nutrient in the diet, in relation to diet cost and SES. Methods: Socio-demographic data for a stratified random sample of adult respondents in the Seattle Obesity Study were obtained through telephone survey. Dietary intakes were assessed using food frequency questionnaire (FFQ) (n = 1,266). Following standard procedures, nutrient intakes were energy-adjusted using the residual method and converted into quintiles. Diet cost for each respondent was estimated using Seattle supermarket retail prices for 384 FFQ component foods. Results: Higher intakes of dietary fiber, vitamins A, C, D, E, and B12, beta carotene, folate, iron, calcium, potassium, and magnesium were associated with higher diet costs. The cost gradient was most pronounced for vitamin C, beta carotene, potassium, and magnesium. Higher intakes of saturated fats, trans fats and added sugars were associated with lower diet costs. Lower cost lower quality diets were more likely to be consumed by lower SES. Conclusion: Nutrients commonly associated with a lower risk of chronic disease were associated with higher diet costs. By contrast, nutrients associated with higher disease risk were associated with lower diet costs. The cost variable may help somewhat explain why lower income groups fail to comply with dietary guidelines and have highest rates of diet related chronic disease.	[Aggarwal, Anju; Monsivais, Pablo; Drewnowski, Adam] Univ Washington, Sch Publ Hlth, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA; [Aggarwal, Anju] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Monsivais, Pablo] Cambridge Inst Publ Hlth, United Kingdom Clin Res Collaborat Ctr Diet & Act, Cambridge, England	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge	Aggarwal, A (corresponding author), Univ Washington, Sch Publ Hlth, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA.	anjuagg@uw.edu	Drewnowski, Adam/HCI-4117-2022	Monsivais, Pablo/0000-0002-7088-6674	National Institutes of Health [NIDDK R01DK076608]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institutes of Health Grant no. NIDDK R01DK076608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Bazzano LA, 2001, STROKE, V32, P1473, DOI 10.1161/01.STR.32.7.1473; Bray GA, 2004, AM J CLIN NUTR, V79, P537; BURKITT DP, 1972, LANCET, V1, P1408; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Carlson A., 2008, DEV CNPP PRICES DATA; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P713; Cui X, 2010, INT J CANC; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555; Drewnowski A, 2001, NUTR REV, V59, P370; Drewnowski A, 2010, AM J CLIN NUTR; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Fletcher RH, 2002, JAMA-J AM MED ASSOC, V287, P3127, DOI 10.1001/jama.287.23.3127; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Holcomb G, 2004, USDA COOKING YIELD D; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Jenkins DJA, 2000, BRIT J NUTR, V83, pS157; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1; KROMHOUT D, 1982, LANCET, V2, P518; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; MCCARRON DA, 1990, MED HYPOTHESES, V31, P265, DOI 10.1016/0306-9877(90)90017-9; Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009; Monsivais P, 2012, J EPIDEMIOL COMMUN H, V66, P530, DOI 10.1136/jech.2010.122333; Monsivais P, 2011, HEALTH AFFAIR, V30, P1471, DOI 10.1377/hlthaff.2010.1273; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Murakami K, 2009, ENVIRON HEALTH INSIG, V3, P27; Neuhouser ML, 1999, CANCER EPIDEM BIOMAR, V8, P721; Ng K, 2009, BRIT J CANCER, V101, P916, DOI 10.1038/sj.bjc.6605262; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sources of Calcium among the US Population 2005-06, SOURC CALC US POP 20; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; Townsend MS, 2009, AM J CLIN NUTR, V89, P1220, DOI 10.3945/ajcn.2008.26916; TROWELL H, 1978, AM J CLIN NUTR, V31, pS53, DOI 10.1093/ajcn/31.10.S53; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; US Department of Agriculture, 2005, AD NUTR CAL NEEDS DI; US Department of Agriculture, 2010, TOT DIET COMB NUTR C; Waterlander WE, 2010, PUBLIC HEALTH NUTR, V13, P1599, DOI 10.1017/S1368980009992989; White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Yang H, 1999, Sheng Li Ke Xue Jin Zhan, V30, P123	66	82	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37533	10.1371/journal.pone.0037533	http://dx.doi.org/10.1371/journal.pone.0037533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662168	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300058
J	Jeelani, G; Sato, D; Husain, A; Escueta-de Cadiz, A; Sugimoto, M; Soga, T; Suematsu, M; Nozaki, T				Jeelani, Ghulam; Sato, Dan; Husain, Afzal; Escueta-de Cadiz, Aleyla; Sugimoto, Masahiro; Soga, Tomoyoshi; Suematsu, Makoto; Nozaki, Tomoyoshi			Metabolic Profiling of the Protozoan Parasite Entamoeba invadens Revealed Activation of Unpredicted Pathway during Encystation	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; L-CYSTEINE DEPRIVATION; ESCHERICHIA-COLI; GIARDIA-LAMBLIA; HISTOLYTICA; DIFFERENTIATION; IDENTIFICATION; POLYAMINE; CHITIN; GROWTH	Encystation, which is cellular differentiation from the motile, proliferative, labile trophozoite form to the dormant, resistant cyst form, is a crucial process found in parasitic and free-living protozoa such as Entamoeba, Giardia, Acanthamoeba, and Balamuthia. Since encystation is an essential process to deal with the adverse external environmental changes during the life cycle, and often integral to the transmission of the diseases, biochemical understanding of the process potentially provides useful measures against the infections caused by this group of protozoa. In this study, we investigated metabolic and transcriptomic changes that occur during encystation in Entamoeba invadens, the reptilian sibling of mammal-infecting E. histolytica, using capillary electrophoresis-tandem mass spectrometry-based metabolite profiling and DNA microarray-based expression profiling. As the encystation progressed, the levels of majority of metabolites involved in glycolysis and nucleotides drastically decreased, indicating energy generation is ceased. Furthermore, the flux of glycolysis was redirected toward chitin wall biosynthesis. We found remarkable temporal increases in biogenic amines such as isoamylamine, isobutylamine, and cadaverine, during the early period of encystation, when the trophozoites form large multicellular aggregates (precyst). We also found remarkable induction of c-aminobutyric acid (GABA) during encystation. This study has unveiled for the first time the dynamics of the transcriptional and metabolic regulatory networks during encystation, and should help in better understanding of the process in pathogenic eukaryotes, and further development of measures controlling infections they cause.	[Jeelani, Ghulam; Husain, Afzal; Escueta-de Cadiz, Aleyla; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Jeelani, Ghulam; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo, Japan; [Sato, Dan; Sugimoto, Masahiro; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Husain, Afzal; Escueta-de Cadiz, Aleyla] Gunma Univ, Grad Sch Med, Dept Parasitol, Maebashi, Gunma 371, Japan; [Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); Keio University; Keio University; Gunma University; University of Tsukuba	Jeelani, G (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Soga, Tomoyoshi/B-8105-2014; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Sugimoto, Masahiro/0000-0003-3316-2543; HUSAIN, AFZAL/0000-0002-6627-5520	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18GS0314, 18050006, 18073001, 20390119, 23390099]; MEXT [23117001]; Ministry of Health, Labour and Welfare of Japan [H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014]; Japan Health Sciences Foundation [KAA1551, KHA1101]; Global Center of Excellence Program for Human Metabolomic System Biology of MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Global Center of Excellence Program for Human Metabolomic System Biology of MEXT	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (18GS0314, 18050006, 18073001, 20390119, 23390099), a Grant-in-Aid for Innovative Scientific Research from MEXT (23117001), a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan (H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014), and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (KAA1551, KHA1101) to TN. GJ and TN were supported in part by the Global Center of Excellence Program for Human Metabolomic System Biology of MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; ARROYOBEGOVICH A, 1982, J PARASITOL, V68, P253, DOI 10.2307/3281183; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; BADETDENISOT MA, 1993, B SOC CHIM FR, V130, P249; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barron-Gonzalez MP, 2008, EXP PARASITOL, V118, P600, DOI 10.1016/j.exppara.2007.11.002; BAUZA T, 1995, B OIV, V767, P42; BLANKENSHIP J, 1984, P SOC EXP BIOL MED, V177, P180, DOI 10.3181/00379727-177-41930; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Boudonck KJ, 2009, BIOANALYSIS, V1, P1645, DOI 10.4155/BIO.09.142; BRUCKNER DA, 1992, CLIN MICROBIOL REV, V5, P356, DOI 10.1128/CMR.5.4.356-369.1992; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CHAGLA AH, 1974, J GEN MICROBIOL, V85, P139, DOI 10.1099/00221287-85-1-139; CHAPMAN A, 1985, FEBS LETT, V191, P287, DOI 10.1016/0014-5793(85)80026-0; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chavez-Munguia B, 2005, J EUKARYOT MICROBIOL, V52, P153, DOI 10.1111/j.1550-7408.2005.04-3273.x; Chavez-Munguia B, 2007, PARASITOL RES, V100, P1169, DOI 10.1007/s00436-006-0447-x; EDWARDS MR, 1989, MOL BIOCHEM PARASIT, V37, P19, DOI 10.1016/0166-6851(89)90098-4; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Husain A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-275; Husain A, 2010, J BIOL CHEM, V285, P39160, DOI 10.1074/jbc.M110.167304; JAKOBY WB, 1959, J BIOL CHEM, V234, P2145; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kimball E, 2006, ANAL BIOCHEM, V358, P273, DOI 10.1016/j.ab.2006.07.038; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lonvaud-Funel A, 2001, FEMS MICROBIOL LETT, V199, P9, DOI 10.1016/S0378-1097(01)00157-4; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MCCONNACHIE EW, 1955, PARASITOLOGY, V45, P452, DOI 10.1017/S0031182000027803; MCLAUGHLIN J, 1985, J PROTOZOOL, V32, P221; MEEROVITCH E, 1961, J PARASITOL, V47, P791, DOI 10.2307/3275473; Morales-Vallarta M, 1997, Arch Med Res, V28 Spec No, P150; Muller M., 1991, P80; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Park MH, 1997, BIOL SIGNAL, V6, P115; Ramputh AL, 1996, PLANT PHYSIOL, V111, P1349, DOI 10.1104/pp.111.4.1349; REEVES RE, 1984, ADV PARASIT, V23, P105, DOI 10.1016/S0065-308X(08)60286-9; RHODES D, 1986, PLANT PHYSIOL, V82, P890, DOI 10.1104/pp.82.4.890; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Schnackenberg LK, 2006, PHARMACOGENOMICS, V7, P1077, DOI 10.2217/14622416.7.7.1077; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SHUKLA O P, 1990, Biological Memoirs, V16, P6; Siddiqui R, 2010, EXP PARASITOL, V126, P22, DOI 10.1016/j.exppara.2009.09.013; Siddiqui R, 2009, PARASITOL RES, V104, P1439, DOI 10.1007/s00436-009-1346-8; SJOERDSMA A, 1984, CLIN PHARMACOL THER, V35, P287, DOI 10.1038/clpt.1984.33; SLOCUM RD, 1984, ARCH BIOCHEM BIOPHYS, V235, P283, DOI 10.1016/0003-9861(84)90201-7; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; SPINDLER KD, 1990, PARASITOL RES, V76, P283, DOI 10.1007/BF00928180; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P177, DOI 10.1002/app.1987.070330115; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; VERMA AK, 1974, BIOCHEM PHARMACOL, V23, P57, DOI 10.1016/0006-2952(74)90313-X; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; WALLACE W, 1984, PLANT PHYSIOL, V75, P170, DOI 10.1104/pp.75.1.170; WARD HD, 1985, INFECT IMMUN, V49, P629, DOI 10.1128/IAI.49.3.629-634.1985; Ximenez C, 2009, INFECT GENET EVOL, V9, P1023, DOI 10.1016/j.meegid.2009.06.008; Zhou JX, 1998, DIABETES, V47, P1836, DOI 10.2337/diabetes.47.12.1836; ZHU CM, 1989, MOL CELL BIOCHEM, V90, P145, DOI 10.1007/BF00221214; ZUO X, 1995, FEMS MICROBIOL LETT, V130, P253	74	48	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37740	10.1371/journal.pone.0037740	http://dx.doi.org/10.1371/journal.pone.0037740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662204	Green Published, gold			2022-12-25	WOS:000305342300094
J	Ma, Y; Han, SH				Ma, Yina; Han, Shihui			Is the Self Always Better than a Friend? Self-Face Recognition in Christians and Atheists	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; ADVANTAGE; AWARENESS; COGNITION; CULTURE; OTHERS	Early behavioral studies found that human adults responded faster to their own faces than faces of familiar others or strangers, a finding referred to as self-face advantage. Recent research suggests that the self-face advantage is mediated by implicit positive association with the self and is influenced by sociocultural experience. The current study investigated whether and how Christian belief and practice affect the processing of self-face in a Chinese population. Christian and Atheist participants were recruited for an implicit association test (IAT) in Experiment 1 and a face-owner identification task in Experiment 2. Experiment 1 found that atheists responded faster to self-face when it shared the same response key with positive compared to negative trait adjectives. This IAT effect, however, was significantly reduced in Christians. Experiment 2 found that atheists responded faster to self-face compared to a friend's face, but this self-face advantage was significantly reduced in Christians. Hierarchical regression analyses further showed that the IAT effect positively predicted self-face advantage in atheists but not in Christians. Our findings suggest that Christian belief and practice may weaken implicit positive association with the self and thus decrease the advantage of the self over a friend during face recognition in the believers.	[Ma, Yina; Han, Shihui] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Peking University	Ma, Y (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	shan@pku.edu.cn	Ma, Yina/AAI-4307-2020; Ma, Yina/H-6203-2017	Ma, Yina/0000-0002-5457-0354	National Natural Science Foundation of China [91024032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Project 91024032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], 2011, BLUE BOOK RELIG ANN; Burns C, 2003, BUDDHIST CHRISTIAN S, V23, P87; Ching Julia, 1984, BUDDHIST CHRISTIAN S, V4, P31, DOI DOI 10.2307/1389935; Chiu C-Y., 2006, SOCIAL PSYCHOL CULTU; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Heine SJ, 2001, J PERS, V69, P881, DOI 10.1111/1467-6494.696168; Hoekema AA, 1975, CHRISTIAN LOOKS HIMS; Johnson MK, 2010, SOC PSYCHOL PERS SCI, V1, P119, DOI 10.1177/1948550609357246; Keenan J. P., 2003, FACE MIRROR SEARCH O; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Koole SL, 2010, PERS SOC PSYCHOL REV, V14, P95, DOI 10.1177/1088868309351109; Liew SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016901; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Ma YN, 2009, J EXP SOC PSYCHOL, V45, P1048, DOI 10.1016/j.jesp.2009.05.008; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Ng SH, 2010, ASIAN J SOC PSYCHOL, V13, P83, DOI 10.1111/j.1467-839X.2010.01303.x; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Sui J, 2007, PSYCHOL SCI, V18, P861, DOI 10.1111/j.1467-9280.2007.01992.x; Sui J, 2009, SOC NEUROSCI, V4, P402, DOI 10.1080/17470910802674825; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016	26	9	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37824	10.1371/journal.pone.0037824	http://dx.doi.org/10.1371/journal.pone.0037824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662231	Green Published, gold			2022-12-25	WOS:000305342300121
J	Maude, RJ; Socheat, D; Nguon, C; Saroth, P; Dara, P; Li, GQ; Song, JP; Yeung, S; Dondorp, AM; Day, NP; White, NJ; White, LJ				Maude, Richard J.; Socheat, Duong; Nguon, Chea; Saroth, Preap; Dara, Prak; Li, Guoqiao; Song, Jianping; Yeung, Shunmay; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.			Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance	PLOS ONE			English	Article							871G-GREATER-THAN-A; POPULATION; VARIANT; AREA	Background: Malaria elimination requires a variety of approaches individually optimized for different transmission settings. A recent field study in an area of low seasonal transmission in South West Cambodia demonstrated dramatic reductions in malaria parasite prevalence following both mass drug administration (MDA) and high treatment coverage of symptomatic patients with artemisinin-piperaquine plus primaquine. This study employed multiple combined strategies and it was unclear what contribution each made to the reductions in malaria. Method and Findings: A mathematical model fitted to the trial results was used to assess the effects of the various components of these interventions, design optimal elimination strategies, and explore their interactions with artemisinin resistance, which has recently been discovered in Western Cambodia. The modelling indicated that most of the initial reduction of P. falciparum malaria resulted from MDA with artemisinin-piperaquine. The subsequent continued decline and near elimination resulted mainly from high coverage with artemisinin-piperaquine treatment. Both these strategies were more effective with the addition of primaquine. MDA with artemisinin combination therapy (ACT) increased the proportion of artemisinin resistant infections, although much less than treatment of symptomatic cases with ACT, and this increase was slowed by adding primaquine. Artemisinin resistance reduced the effectiveness of interventions using ACT when the prevalence of resistance was very high. The main results were robust to assumptions about primaquine action, and immunity. Conclusions: The key messages of these modelling results for policy makers were: high coverage with ACT treatment can produce a long-term reduction in malaria whereas the impact of MDA is generally only short-term; primaquine enhances the effect of ACT in eliminating malaria and reduces the increase in proportion of artemisinin resistant infections; parasite prevalence is a better surveillance measure for elimination programmes than numbers of symptomatic cases; combinations of interventions are most effective and sustained efforts are crucial for successful elimination.	[Maude, Richard J.; Yeung, Shunmay; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Maude, Richard J.; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Maude, Richard J.] Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5ST, W Midlands, England; [Socheat, Duong; Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Saroth, Preap] Kampot Prov Hlth Dept, Kampot, Cambodia; [Dara, Prak] Kampong Speu Prov Hlth Dept, Kampong Speu, Cambodia; [Li, Guoqiao; Song, Jianping] Guangzhou Univ Chinese Med, Res Ctr Qinghao Artemisia Annual L, Guangzhou, Guangdong, Peoples R China; [Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Heart of England NHS Foundation Trust; University of Birmingham; National Center Parasitology, Entomology & Malaria Control; Guangzhou University of Chinese Medicine; University of London; London School of Hygiene & Tropical Medicine	Maude, RJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	richardmaude@gmail.com	White, Lisa/AAC-9396-2020; White, Nick/AAC-6527-2019; Maude, Richard James/AAV-3567-2020; White, Nicholas J/I-4629-2012	White, Lisa/0000-0002-6523-185X; White, Nick/0000-0002-1897-1978; Maude, Richard James/0000-0002-5355-0562; Yeung, Shunmay/0000-0002-0997-0850	Wellcome Trust of Great Britain [077166/Z/05/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	This study was funded by the Wellcome Trust of Great Britain (www.wellcome.ac.uk, grant number 077166/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006627; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Li G, 2010, J GUANGZHOU U TRADIT, V1, P90; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Maude RJ, 2010, INT HEALTH, V2, P239, DOI 10.1016/j.inhe.2010.09.005; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; National Center for Parasitology Entomology and Malaria Control Kingdom of Cambodia Ministry of Health Cambodia, 2011, STRAT PLAN EL MAL CA; National Center for Parasitology Entomology and Malaria Control Ministry of Health Cambodia, 2004, ANN PROGR REP NAT CT; National Institute of Statistics Ministry of Planning Cambodia, 2008, GEN POP CENS CAMB 20; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Pagnoni F, 1997, T ROY SOC TROP MED H, V91, P512, DOI 10.1016/S0035-9203(97)90006-7; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Song J, 2006, J GUANGZHOU U TRADIT, V23, P89; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; WHO, 2010, GUID TREATM MAL, V2nd; *WHO MEK MAL PROGR, 2008, DEV STRAT EL PLASM F	24	67	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37166	10.1371/journal.pone.0037166	http://dx.doi.org/10.1371/journal.pone.0037166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662135	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300026
J	Morales-Espinosa, R; Soberon-Chavez, G; Delgado-Sapien, G; Sandner-Miranda, L; Mendez, JL; Gonzalez-Valencia, G; Cravioto, A				Morales-Espinosa, Rosario; Soberon-Chavez, Gloria; Delgado-Sapien, Gabriela; Sandner-Miranda, Luisa; Mendez, Jose L.; Gonzalez-Valencia, Gerardo; Cravioto, Alejandro			Genetic and Phenotypic Characterization of a Pseudomonas aeruginosa Population with High Frequency of Genomic Islands	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PATHOGENICITY ISLANDS; VIRULENCE GENES; ANTIBIOTIC-RESISTANCE; STRAIN PA14; DIVERSITY; CLONE; SEQUENCE; IDENTIFICATION; ENVIRONMENT	Various genomic islands, PAPI-1, PAPI-2, PAGI-1, PAGI-2, PAGI-3, and PAGI-4, and the element pKLC102 have been characterized in different P. aeruginosa strains from diverse habitats and geographical locations. Chromosomal DNA macroarray of 100 P. aeruginosa strains isolated from 85 unrelated patients hospitalized in an intensive care unit was created to assess the occurrence of these genomic islands (GEIs). The macroarray was then hybridized with labeled probes derived from each genomic island. In addition, PFGE patterns with SpeI, frequency of virulence genes, and antimicrobial resistance patterns of the strains were studied. Our results showed that almost all P. aeruginosa strains presented up to eight virulence genes. By SpeI macrorestriction fragment analysis we were able to identify 49 restriction patterns; 35 patterns correspond to single strains and the remaining 14 to strains subgroup (a-n). Most of the strains showed variation in number or composition of GEIs and a specific antimicrobial pattern indicating that each strain was an unrelated isolate. In terms of the number of genomic islands per strain, 7 GEIs were found in 34% of the strains, 6 in 18%, 5 in 12%, 4 in 14%, 3 in 10%, 2 in 7%, and 1 in 4%; only one isolate did not present any GEI. The genomic islands PAPI-1 and PAPI-2 and the element pKLC102 were the most frequently detected. The analysis of the location of each GEI in the chromosome of two strains show that the islands PAGI-3, PAPI-1, PAPI-2 and pKLC102 are present in the insertion site previously reported, but that PAGI-2 and PAGI-4 are inserted in another chromosome place in a site not characterized yet. In conclusion our data show that P. aeruginosa strains exhibited an epidemic population structure with horizontal transfer of DNA resulting in a high frequency of GEIs.	[Morales-Espinosa, Rosario; Delgado-Sapien, Gabriela; Sandner-Miranda, Luisa; Mendez, Jose L.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Soberon-Chavez, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico; [Gonzalez-Valencia, Gerardo] Inst Mexicano Seguro Social, Ctr Med Nacl, Unit Med Invest Infect & Parasitol Dis, Mexico City, DF, Mexico; [Cravioto, Alejandro] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social; International Centre for Diarrhoeal Disease Research (ICDDR)	Morales-Espinosa, R (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	marosari@servidor.unam.mx		Delgado, Gabriela/0000-0003-4577-4440; Soberon-Chavez, Gloria/0000-0002-0282-3882; Morales-Espinosa, Rosario/0000-0003-2110-4397	CONACYT [100343]; DGAPA from Universidad Nacional Autonoma de Mexico [N206808]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA from Universidad Nacional Autonoma de Mexico	This research was funded by CONACYT grant number 100343 and DGAPA grant number N206808 from Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 2005, M100S15 CLSINCCLS; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; Arruda EAG, 1999, INFECT CONT HOSP EP, V20, P620, DOI 10.1086/501683; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Battle SE, 2009, FEMS MICROBIOL LETT, V290, P70, DOI 10.1111/j.1574-6968.2008.01406.x; Brewer C, 1996, CHEST, V109, P1019; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; Finnan S, 2004, J CLIN MICROBIOL, V42, P5783, DOI 10.1128/JCM.42.12.5783-5792.2004; Gaballa A, 1998, MOL MICROBIOL, V30, P547, DOI 10.1046/j.1365-2958.1998.01085.x; GALLOWAY DR, 1991, MOL MICROBIOL, V5, P2315, DOI 10.1111/j.1365-2958.1991.tb02076.x; Gilligan Peter H., 1995, P509; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GRIFFITH SJ, 1989, J INFECT DIS, V160, P1030, DOI 10.1093/infdis/160.6.1030; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; KAPER JB, 1999, PATHOGENICITY ISLAND; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Liang XY, 2001, J BACTERIOL, V183, P843, DOI 10.1128/JB.183.3.843-853.2001; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Qiu XY, 2006, P NATL ACAD SCI USA, V103, P19830, DOI 10.1073/pnas.0606810104; REGELMANN WE, 1995, PEDIATR PULM, V19, P1, DOI 10.1002/ppul.1950190102; Romling U, 1997, J MOL BIOL, V271, P386, DOI 10.1006/jmbi.1997.1186; ROMLING U, 1995, MOL MICROBIOL, V17, P323, DOI 10.1111/j.1365-2958.1995.mmi_17020323.x; Rumbaugh KP, 1999, J SURG RES, V82, P95, DOI 10.1006/jsre.1998.5523; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Shen K, 2002, INFECT IMMUN, V74, P5272; Smith JM, 1993, P NATL ACAD SCI USA, V10, P3484; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tummler B, 2006, PSEUDOMONAS, V4, P5; WICK MJ, 1990, ANNU REV MICROBIOL, V44, P335, DOI 10.1146/annurev.mi.44.100190.002003; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wolska K, 2009, POL J MICROBIOL, V58, P255; Woods DE, 2004, TRENDS MICROBIOL, V12, P437, DOI 10.1016/j.tim.2004.08.003; Wuerdemann D, 2007, FEMS MICROBIOL LETT, V275, P244, DOI 10.1111/j.1574-6968.2007.00891.x	55	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37459	10.1371/journal.pone.0037459	http://dx.doi.org/10.1371/journal.pone.0037459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662157	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300047
J	Sato, N; Ochi, D; Minami, H; Yokawa, K				Sato, Noriyosi; Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro			Evaluation of the Effectiveness of Light Streamer Tori-Lines and Characteristics of Bait Attacks by Seabirds in the Western North Pacific	PLOS ONE			English	Article							LONGLINE FISHERY; MITIGATION MEASURES; CATCH RATES; BY-CATCH	To improve the effectiveness of tori-lines it is necessary to evaluate the ability of tori-lines to mitigate seabird bycatch and determine what kind of seabird species gather during line settings, attack the bait and are incidentally caught. We conducted two experiments in the western North Pacific and examined the effectiveness for seabird mitigation of light streamer tori-lines which have no long streamers but many light (short) streamers and are mainly used in the North Pacific area. Firstly, the effectiveness of two different types of tori-line (light streamer (1 m) and long streamer (up to 7 m) tori-line) and of two different colors (yellow and red) of light streamers for seabird bycatch avoidance was evaluated using 567 sets based on data from 20 offshore surface commercial longliners. No significant difference in the bycatch number between the different tori-line types and streamer colors was found. Secondly, we investigated the characteristics of the seabird bycatch in the North Pacific and the effectiveness of three different types of streamers (light, hybrid and modified light types) by detailed observations of seabird attacks using a chartered longline vessel. Although the appearance rate of albatrosses and shearwaters were 40.9% and 27.7%, Laysan albatross was the main seabird species that followed the vessel but shearwaters seldom followed the vessel and did not aggregate during line setting. In all attacks on bait observed during line settings, 81% and 7% were by albatrosses and shearwaters, respectively. In the number of primary attacks by Laysan albatrosses which attacked most aggressively of all seabirds, there were no significant differences among the tori-line types. No individuals of shearwater were caught. The results of both experiments indicated that light streamer tori-lines were as effective as tori-lines with long streamers for mitigating seabird bycatch in the North Pacific.	[Sato, Noriyosi; Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro] Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka, Japan; [Sato, Noriyosi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan	Japan Fisheries Research & Education Agency (FRA); Nagasaki University	Sato, N (corresponding author), Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka, Japan.	norico3000@gmail.com	Ochi, Daisuke/B-4329-2016	Ochi, Daisuke/0000-0002-6614-8193; Sato, Noriyosi/0000-0001-5023-5375				[Anonymous], 2010, R LANG ENV STAT COMP; Ashford J.R., 1995, CCAMLR Science, V2, P111; Barnes KN, 1997, BIOL CONSERV, V82, P227, DOI 10.1016/S0006-3207(97)00020-7; Bates D. M., 2007, LME4 LINEAR MIXED EF; Boggs CH, 2001, UASGCP REP, V2001, P79; Brooke M, 2004, ALBATROSSES PETRELS; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Hosono Takashi, 2008, Bulletin of Fisheries Research Agency, P1; IUCN, 2010, RED LIST THREAT SPEC; Japan WCPFC report, 2008, 4 REG SESS SCI COMM; Japan WCPFC report, 2009, 5 REG SESS SCI COMM; Klaer N, 1998, EMU, V98, P305, DOI 10.1071/MU98042; Lokkeborg S, 1998, ICES J MAR SCI, V55, P145, DOI 10.1006/jmsc.1997.9997; Melvin E.F., 2010, 3 M SEAB BYC WORK GR; Murray Talbot E., 1993, Bird Conservation International, V3, P181; Shealer David A., 2002, P137; Shiode D, 2001, CCSBTERS011160; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WCPFC, 2007, 4 REG SESS SCI COMM; Yokota K, 2008, 4 REG SESS SCI COMM; Yokota K, 2007, 3 REG SESS SCI COMM; Yokota K, 2011, FISHERIES SCI, V77, P479, DOI 10.1007/s12562-011-0357-4	23	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37546	10.1371/journal.pone.0037546	http://dx.doi.org/10.1371/journal.pone.0037546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662169	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300059
J	Wang, JM; Wu, ZQ; Jin, Q				Wang, Jianmin; Wu, Zhiqiang; Jin, Qi			COPI Is Required for Enterovirus 71 Replication	PLOS ONE			English	Article							FUNCTIONAL GENOMIC SCREEN; MOUTH-DISEASE; BREFELDIN-A; SECRETORY PATHWAY; MOLECULAR EPIDEMIOLOGY; ENDOPLASMIC-RETICULUM; POLIOVIRUS INFECTION; WESTERN-AUSTRALIA; BINDING PROTEIN; RNA VIRUSES	Enterovirus 71 (EV71), a member of the Picornaviridae family, is found in Asian countries where it causes a wide range of human diseases. No effective therapy is available for the treatment of these infections. Picornaviruses undergo RNA replication in association with membranes of infected cells. COPI and COPII have been shown to be involved in the formation of picornavirus-induced vesicles. Replication of several picornaviruses, including poliovirus and Echovirus 11 (EV11), is dependent on COPI or COPII. Here, we report that COPI, but not COPII, is required for EV71 replication. Replication of EV71 was inhibited by brefeldin A and golgicide A, inhibitors of COPI activity. Furthermore, we found EV71 2C protein interacted with COPI subunits by co-immunoprecipitation and GST pull-down assay, indicating that COPI coatomer might be directed to the viral replication complex through viral 2C protein. Additionally, because the pathway is conserved among different species of enteroviruses, it may represent a novel target for antiviral therapies.	[Wang, Jianmin] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JM (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Basic Research Program [2011CB504902, 2005CB522905]; Ministry of Science and Technology of China	National Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The work was supported by the National Basic Research Program (Grant No. 2011CB504902 and No. 2005CB522905) (http://www.973.gov.cn/AreaAppl.aspx) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Barco A, 1998, J VIROL, V72, P3560, DOI 10.1128/JVI.72.5.3560-3570.1998; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1994, ARCH VIROL, P147; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2006, PLOS PATHOG, V2, P900, DOI 10.1371/journal.ppat.0020102; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Craig ME, 1999, J PAEDIATR CHILD H, V35, P107, DOI 10.1046/j.1440-1754.1999.t01-1-00348.x; Crotty S, 2004, J VIROL, V78, P3378, DOI 10.1128/JVI.78.7.3378-3386.2004; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; DeLisle RC, 1996, EUR J CELL BIOL, V71, P62; DOEDENS J, 1994, ARCH VIROL, P159; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gazina EV, 2002, J VIROL, V76, P11113, DOI 10.1128/JVI.76.21.11113-11122.2002; IRURZUN A, 1992, VIROLOGY, V191, P166, DOI 10.1016/0042-6822(92)90178-R; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Orcl L, 1991, CELL, V64, P1183; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; van der Linden L, 2010, J VIROL, V84, P7535, DOI 10.1128/JVI.02684-09; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	58	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38035	10.1371/journal.pone.0038035	http://dx.doi.org/10.1371/journal.pone.0038035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662263	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300155
J	Pecsi, I; Hirmondo, R; Brown, AC; Lopata, A; Parish, T; Vertessy, BG; Toth, J				Pecsi, Ildiko; Hirmondo, Rita; Brown, Amanda C.; Lopata, Anna; Parish, Tanya; Vertessy, Beata G.; Toth, Judit			The dUTPase Enzyme Is Essential in Mycobacterium smegmatis	PLOS ONE			English	Article							BIFUNCTIONAL DCTP DEAMINASE; PHOSPHATE ESTER HYDROLYSIS; ACTIVE-SITE; CATALYTIC MECHANISM; ESCHERICHIA-COLI; METHANOCALDOCOCCUS-JANNASCHII; QUANTITATIVE-DETERMINATION; SACCHAROMYCES-CEREVISIAE; THYMIDYLATE METABOLISM; STRUCTURAL BASIS	Thymidine biosynthesis is essential in all cells. Inhibitors of the enzymes involved in this pathway (e. g. methotrexate) are thus frequently used as cytostatics. Due to its pivotal role in mycobacterial thymidylate synthesis dUTPase, which hydrolyzes dUTP into the dTTP precursor dUMP, has been suggested as a target for new antitubercular agents. All mycobacterial genomes encode dUTPase with a mycobacteria-specific surface loop absent in the human dUTPase. Using Mycobacterium smegmatis as a fast growing model for Mycobacterium tuberculosis, we demonstrate that dUTPase knock-out results in lethality that can be reverted by complementation with wild-type dUTPase. Interestingly, a mutant dUTPase gene lacking the genus-specific loop was unable to complement the knock-out phenotype. We also show that deletion of the mycobacteria-specific loop has no major effect on dUTPase enzymatic properties in vitro and thus a yet to be identified loop-specific function seems to be essential within the bacterial cell context. In addition, here we demonstrated that Mycobacterium tuberculosis dUTPase is fully functional in Mycobacterium smegmatis as it rescues the lethal knock-out phenotype. Our results indicate the potential of dUTPase as a target for antitubercular drugs and identify a genus-specific surface loop on the enzyme as a selective target.	[Pecsi, Ildiko; Hirmondo, Rita; Lopata, Anna; Vertessy, Beata G.; Toth, Judit] Hungarian Acad Sci, Inst Enzymol, RCNS, Budapest, Hungary; [Pecsi, Ildiko; Brown, Amanda C.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of London; Queen Mary University London; Budapest University of Technology & Economics	Pecsi, I (corresponding author), Hungarian Acad Sci, Inst Enzymol, RCNS, Budapest, Hungary.	vertessy@enzim.hu; tothj@enzim.hu	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982	US National Institutes of Health [1R01TW008130]; Howard Hughes Medical Institutes [55000342]; Hungarian Scientific Research Funds [PD72008, CK-78646, K68229, K72973, NI68466]; National Office for Research and Technology, Hungary [JAP_TSZ_071128_TB_INTER]; EU [SPINE2c LSHG-CT-2006-031220, TEACH-SG LSSG-CT-2007-037198]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; EMBO Short Term Fellowship; Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary; Gedeon Richter Plc; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Office for Research and Technology, Hungary(National Office for Research and Technology); EU(European Commission); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary; Gedeon Richter Plc; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the US National Institutes of Health [grant number 1R01TW008130];, the Howard Hughes Medical Institutes [grant number 55000342]; the Hungarian Scientific Research Funds [grant numbers PD72008, CK-78646, K68229, K72973, NI68466]; the National Office for Research and Technology, Hungary [grant number JAP_TSZ_071128_TB_INTER] and the EU FP6 [grant numbers SPINE2c LSHG-CT-2006-031220, TEACH-SG LSSG-CT-2007-037198]. JT is the recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. IP is the recipient of an EMBO Short Term Fellowship and the Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that the first author received funding from a commercial source (Gedeon Richter Plc). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Chakroborty A, DRUG RESISTANT TUBER; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Furlow Bryant, 2010, Radiol Technol, V82, P33; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Goude R, 2008, J VIS EXP; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Helt SS, 2008, J MOL BIOL, V376, P554, DOI 10.1016/j.jmb.2007.11.099; Horvath A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq815; Huffman JL, 2003, J MOL BIOL, V331, P885, DOI 10.1016/S0022-2836(03)00789-7; Jagielski Tomasz, 2010, Wiad Lek, V63, P230; Jarmula A, 2010, MINI-REV MED CHEM, V10, P1211, DOI 10.2174/13895575110091211; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Johansson E, 2005, J BIOL CHEM, V280, P3051, DOI 10.1074/jbc.M409534200; Johansson E, 2003, J BIOL CHEM, V278, P27916, DOI 10.1074/jbc.M304361200; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Merenyi G, 2011, NUCLEOS NUCLEOT NUCL, V30, P369, DOI 10.1080/15257770.2011.582849; Mustafa AS, 2002, CLIN EXP IMMUNOL, V130, P37, DOI 10.1046/j.1365-2249.2002.01937.x; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Nyman PO, 2001, CURR PROTEIN PEPT SC, V2, P277, DOI 10.2174/1389203013381071; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Roberts G, 2003, FEMS MICROBIOL LETT, V221, P131, DOI 10.1016/S0378-1097(03)00177-0; Sampathkumar P, 2006, J MOL BIOL, V360, P1, DOI 10.1016/j.jmb.2006.04.061; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Silhavy T. J., 1984, EXPT GENE FUSIONS; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Wilson PM, 2009, NUCLEIC ACIDS RES, V37, P78, DOI 10.1093/nar/gkn910; World Health Organization, 2010, GLOB TUB CONTR	61	41	42	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37461	10.1371/journal.pone.0037461	http://dx.doi.org/10.1371/journal.pone.0037461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655049	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305338900024
J	Jia, Y; Song, W; Zhang, F; Yan, J; Yang, Q				Jia, Y.; Song, W.; Zhang, F.; Yan, J.; Yang, Q.			Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway	ONCOGENE			English	Article						Brca1; PKB/Akt; Chk1; Rad51; HR	CYCLE CHECKPOINT; BRCA1; CANCER; BREAST; ACTIVATION; RAD51; CHK1	Brca1 deficiency leads to the development of breast cancer. We previously found that Brca1 deficiency activates the Akt oncogenic pathway. Reduced expression of Brca1 was highly correlated with increased activated Akt in human breast cancer samples. Furthermore, activation of Akt1 was involved in Brca1-deficiency-mediated tumorigenesis in mice. Defective homologous recombination (HR) is thought to be a major contributor to tumorigenesis in Brca1 deficiency. Here, we show that Akt1 promotes chromosome instability in Brca1-deficent cells. DNA breaks in Brca1-deficent cells are aberrantly joined into complex chromosome rearrangements by a process dependent on Akt1. Depletion of Akt1 increases HR in Brca1-mutant cells, which is rescued by expression of wild-type, but not mutant Akt1 with deletion of Brca1-binding domain. Mechanistically, activated Akt1 in Brca1-deficient cells impairs Chk1 nuclear localization and subsequently disrupts interaction of Chk1 and Rad51 leading to HR defects. Our results indicate that Brca1 deficiency might activate Akt1 contributing to tumorigenesis through regulation of the Chk1-Rad51 signaling. Oncogene (2013) 32, 1943-1949; doi:10.1038/onc.2012.211; published online 4 June 2012	[Jia, Y.; Song, W.; Zhang, F.; Yan, J.; Yang, Q.] Washington Univ, Sch Med, Dept Radiat Oncol, Div Canc Biol, St Louis, MO 63108 USA; [Jia, Y.] Harbin Med Univ, Affiliated Hosp 3, Colorectal Canc Surg Dept, Harbin, Peoples R China; [Yan, J.] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA	Washington University (WUSTL); Harbin Medical University; University of Washington; University of Washington Seattle	Yang, Q (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, Div Canc Biol, 4511 Forest Pk, St Louis, MO 63108 USA.	qyang@wustl.edu			Susan G. Komen Foundation; Siteman Cancer Center Award; NIH [CA129440]; NATIONAL CANCER INSTITUTE [R01CA129440] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Siteman Cancer Center Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Chuxia Deng for providing the Brca1<SUP>WT</SUP> and Brca1<SUP>Delta 11/Delta 11</SUP> MEFs. We thank Buck Rogers and Xiaowei Wang for proof reading. This work is supported in part by grants from the Susan G. Komen Foundation (QY), Siteman Cancer Center Award (QY) and NIH CA129440 (QY).	Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Deng CX, 2002, ENVIRON MOL MUTAGEN, V39, P171, DOI 10.1002/em.10069; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yang O, 2004, ONCOGENE, V23, P3749, DOI 10.1038/sj.onc.1207462; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867	25	30	30	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1943	1949		10.1038/onc.2012.211	http://dx.doi.org/10.1038/onc.2012.211			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22665067	Green Accepted			2022-12-25	WOS:000317599900008
J	Das, CM; Taylor, P; Gireud, M; Singh, A; Lee, D; Fuller, G; Ji, L; Fangusaro, J; Rajaram, V; Goldman, S; Eberhart, C; Gopalakrishnan, V				Das, C. M.; Taylor, P.; Gireud, M.; Singh, A.; Lee, D.; Fuller, G.; Ji, L.; Fangusaro, J.; Rajaram, V.; Goldman, S.; Eberhart, C.; Gopalakrishnan, V.			The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation	ONCOGENE			English	Article						REST; proliferation; p27; USP37; deubiquitylase	CDK INHIBITOR P27; RESTRICTIVE SILENCER FACTOR; SCF-BETA-TRCP; NEURONAL DIFFERENTIATION; N-MYC; ONCOGENIC TRANSFORMATION; REGULATES PROTEOLYSIS; SUBTYPE SPECIFICATION; NEURAL DEVELOPMENT; TUMOR SUPPRESSORS	The RE1 silencing transcription factor (REST) is a repressor of neuronal differentiation and its elevated expression in neural cells blocks neuronal differentiation. In this study, we demonstrate a role for REST in the control of proliferation of medulloblastoma cells. REST expression decreased the levels of cyclin-dependent kinase (CDK)NIB/p27, a CDK inhibitor and a brake of cell proliferation in these cells. The reciprocal relationship between REST and p27 was validated in human tumor samples. REST knockdown in medulloblastoma cells derepessed a novel REST target gene encoding the deubiquitylase ubiquitin (Ub)-specific peptidase 37 (USP37). Ectopically expressed wild-type USP37 formed a complex with p27, promoted its deubiquitination and stabilization and blocked cell proliferation. Knockdown of REST and USP37 prevented p27 stabilization and blocked the diminution in proliferative potential that normally accompanied REST loss. Unexpectedly, wild-type USP37 expression also induced the expression of REST-target neuronal differentiation genes even though REST levels were unaffected. In contrast, a mutant of USP37 carrying a site-directed change in a conserved cysteine failed to rescue REST-mediated p27 destabilization, maintenance of cell proliferation and blockade to neuronal differentiation. Consistent with these findings, a significant correlation between USP37 and p27 was observed in patient tumors. Collectively, these findings provide a novel connection between REST and the proteasomal machinery in the control of p27 and cell proliferation in medulloblastoma cells. Oncogene (2013) 32, 1691-1701; doi:10.1038/onc.2012.182; published online 4 June 2012	[Das, C. M.; Taylor, P.; Gireud, M.; Singh, A.; Lee, D.; Gopalakrishnan, V.] Univ Texas MD Anderson Canc Ctr, Dept Pediat & Mol & Cellular Oncol, Houston, TX 77030 USA; [Fuller, G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Ji, L.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Fangusaro, J.; Goldman, S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Rajaram, V.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Eberhart, C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gopalakrishnan, V.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gopalakrishnan, V.] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Gopalakrishnan, V.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Gopalakrishnan, V.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Gopalakrishnan, V.] Univ Texas Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Gopalakrishnan, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat & Mol & Cellular Oncol, Unit 853, 1515 Holcombe Blvd, Houston, TX 77030 USA.	vgopalak@mdanderson.org	Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392; Gireud-Goss, Monica/0000-0001-5172-2351; Fuller, Gregory/0000-0001-9447-2647	American Cancer Center [RSG-09-273-01-DDC]; National Institutes of Neurological Disorders and Stroke [1R03NS077021]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS077021, R01NS079715] Funding Source: NIH RePORTER	American Cancer Center; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Cancer Center (RSG-09-273-01-DDC) and the National Institutes of Neurological Disorders and Stroke (1R03NS077021) to VG.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Aguilera DG, 2009, J NEURO-ONCOL, V93, P303, DOI 10.1007/s11060-008-9788-x; Ayrault O, 2009, MOL CANCER RES, V7, P33, DOI 10.1158/1541-7786.MCR-08-0369; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bhatia B, 2010, CELL CYCLE, V9, P4307, DOI 10.4161/cc.9.21.13441; Bhatia B, 2010, CELL CYCLE, V9, P456, DOI 10.4161/cc.9.3.10532; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chang L, 2011, MOL CANC RES; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; Das CM, 2010, EUR J CANCER, V46, P2771, DOI 10.1016/j.ejca.2010.05.010; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuller GN, 2005, MOL CANCER THER, V4, P343; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Gopalakrishnan V, 2009, FUTUR NEUROL, V4, P317, DOI 10.2217/FNL.09.1; Goto T, 2004, DEV NEUROSCI-BASEL, V26, P208, DOI 10.1159/000082138; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hayes SD, 2010, NAT CELL BIOL, V12, P311, DOI 10.1038/ncb2043; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kaldis P, 2007, CELL, V128, P241, DOI 10.1016/j.cell.2007.01.006; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koff A, 2006, CANCER CELL, V9, P75, DOI 10.1016/j.ccr.2006.01.020; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lu Z, 2010, CELL CYCLE, V9, P2400; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Masuda K, 2010, ONCOGENE, V29, P1798, DOI 10.1038/onc.2009.469; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Peschiaroli A, 2010, ONCOGENE, V29, P1384, DOI 10.1038/onc.2009.430; Ravanpay AC, 2010, MOL CELL NEUROSCI, V44, P178, DOI 10.1016/j.mcn.2010.03.006; Reed SI, 2002, CELL CYCLE, V1, P389, DOI 10.4161/cc.1.6.261; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Singh A, 2011, CANCER-AM CANCER SOC, V117, P5189, DOI 10.1002/cncr.26145; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Todi S.V., 2011, TRENDS NEUROSCI; Tomasoni R, 2011, J CELL SCI, V124, P3174, DOI 10.1242/jcs.087551; Ungermannova D, 2005, J BIOL CHEM, V280, P30301, DOI 10.1074/jbc.M411103200; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	72	29	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 28	2013	32	13					1691	1701		10.1038/onc.2012.182	http://dx.doi.org/10.1038/onc.2012.182			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22665064	Green Accepted			2022-12-25	WOS:000316855800009
J	Ramakrishnan, G; Sen, B; Johnson, R				Ramakrishnan, Girija; Sen, Bhaswati; Johnson, Richard			Paralogous Outer Membrane Proteins Mediate Uptake of Different Forms of Iron and Synergistically Govern Virulence in Francisella tularensis tularensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; MACROPHAGES; SIDEROPHORE; TULAREMIA; GROWTH; IDENTIFICATION; ACQUISITION; MODULATION; BACTERIA; ESCAPE	Francisella tularensis subsp. tularensis is a highly infectious bacterium causing acute disease in mammalian hosts. Mechanisms for the acquisition of iron within the iron-limiting host environment are likely to be critical for survival of this intracellular pathogen. FslE (FTT0025) and FupA (FTT0918) are paralogous proteins that are predicted to form beta-barrels in the outer membrane of virulent strain Schu S4 and are unique to Francisella species. Previous studies have implicated both FupA, initially identified as a virulence factor and FslE, encoded by the siderophore biosynthetic operon, in iron acquisition. Using single and double mutants, we demonstrated that these paralogs function in concert to promote growth under iron limitation. We used a Fe-55 transport assay to demonstrate that FslE is involved in siderophore-mediated ferric iron uptake, whereas FupA facilitates high affinity ferrous iron uptake. Optimal replication within J774A.1 macrophage-like cells required at least one of these uptake systems to be functional. In a mouse model of tularemia, the Delta fupA mutant was attenuated, but the Delta fslE Delta fupA mutant was significantly more attenuated, implying that the two systems of iron acquisition function synergistically to promote virulence. These studies highlight the importance of specific iron acquisition functions, particularly that of ferrous iron, for virulence of F. tularensis in the mammalian host.	[Ramakrishnan, Girija; Sen, Bhaswati; Johnson, Richard] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22901 USA	University of Virginia	Ramakrishnan, G (corresponding author), Univ Virginia, Dept Med, Div Infect Dis, POB 801340, Charlottesville, VA 22908 USA.	girija@virginia.edu			National Institutes of Health Grant [AI067823]; University of Virginia School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067823] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067823 (to G.R.). This work was also supported by intramural funding from the University of Virginia School of Medicine.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; ABEL K, 1963, J BACTERIOL, V85, P1039, DOI 10.1128/JB.85.5.1039-1044.1963; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANTHONY LSD, 1988, INFECT IMMUN, V56, P2089, DOI 10.1128/IAI.56.8.2089-2093.1988; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Asare R, 2010, ENVIRON MICROBIOL, V12, P2559, DOI 10.1111/j.1462-2920.2010.02229.x; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bagos PG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-29; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chatfield CH, 2012, MICROBIOL-SGM, V158, P721, DOI 10.1099/mic.0.055533-0; Chatfield CH, 2011, J BACTERIOL, V193, P1563, DOI 10.1128/JB.01111-10; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Conlan J Wayne, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1914s93; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dhungana S, 2007, APPL ENVIRON MICROB, V73, P3428, DOI 10.1128/AEM.02586-06; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SHENKER M, 1995, SOIL SCI SOC AM J, V59, P1612, DOI 10.2136/sssaj1995.03615995005900060015x; Siddaramappa S, 2011, APPL ENVIRON MICROB, V77, P5110, DOI 10.1128/AEM.00337-11; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104	51	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25191	25202		10.1074/jbc.M112.371856	http://dx.doi.org/10.1074/jbc.M112.371856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661710	hybrid, Green Published			2022-12-25	WOS:000306651700029
J	Sun, R; Eriksson, S; Wang, LY				Sun, Ren; Eriksson, Staffan; Wang, Liya			Oxidative Stress Induced S-glutathionylation and Proteolytic Degradation of Mitochondrial Thymidine Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA DEPLETION MYOPATHY; PROTEIN GLUTATHIONYLATION; MUTATIONS; MECHANISM; DYSFUNCTION; CANCER; DAMAGE	Protein glutathionylation in response to oxidative stress can affect both the stability and activity of target proteins. Mitochondrial thymidine kinase 2 (TK2) is a key enzyme in mitochondrial DNA precursor synthesis. Using an antibody specific for glutathione (GSH), S-glutathionylated TK2 was detected after the addition of glutathione disulfide (GSSG) but not GSH. This was reversed by the addition of dithiothreitol, suggesting that S-glutathionylation of TK2 is reversible. Site-directed mutagenesis of the cysteine residues and subsequent analysis of mutant enzymes demonstrated that Cys-189 and Cys-264 were specifically glutathionylated by GSSG. These cysteine residues do not appear to be part of the active site, as demonstrated by kinetic studies of the mutant enzymes. Treatment of isolated rat mitochondria with hydrogen peroxide resulted in S-glutathionylation of added recombinant TK2. Treatment of intact cells with hydrogen peroxide led to reduction of mitochondrial TK2 activity and protein levels, as well as S-glutathionylation of TK2. Furthermore, the addition of S-glutathionylated recombinant TK2 to mitochondria isolated from hydrogen peroxide-treated cells led to degradation of the S-glutathionylated TK2, which was not observed with unmodified TK2. S-Glutathionylation on Cys-189 was responsible for the observed selective degradation of TK2 in mitochondria. These results strongly suggest that oxidative damage-induced S-glutathionylation and degradation of TK2 have significant impact on mitochondrial DNA precursor synthesis.	[Sun, Ren; Eriksson, Staffan; Wang, Liya] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Wang, LY (corresponding author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Box 575, SE-75123 Uppsala, Sweden.	liya.wang@slu.se			Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas)	This work was supported by a grant from the Swedish Research Council and in part by a grant from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning.	Anathy V, 2012, ANTIOXID REDOX SIGN, V16, P496, DOI 10.1089/ars.2011.4281; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bulteau AL, 2012, BBA-MOL BASIS DIS, V1822, P212, DOI 10.1016/j.bbadis.2011.11.003; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; Graham JM, 1999, CURRENT PROTOCOLS CE, P331; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kline ER, 2009, CARDIOVASC TOXICOL, V9, P1, DOI 10.1007/s12012-008-9029-8; Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Sun R, 2010, NUCLEOS NUCLEOT NUCL, V29, P382, DOI 10.1080/15257771003741018; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438; Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Yusuf MA, 2010, FREE RADICAL BIO MED, V49, P908, DOI 10.1016/j.freeradbiomed.2010.06.020	35	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24304	24312		10.1074/jbc.M112.381996	http://dx.doi.org/10.1074/jbc.M112.381996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661713	Green Published, hybrid			2022-12-25	WOS:000306651100024
J	Bombari, D; Mora, B; Schaefer, SC; Mast, FW; Lehr, HA				Bombari, Dario; Mora, Braulio; Schaefer, Stephan C.; Mast, Fred W.; Lehr, Hans-Anton			What Was I Thinking? Eye-Tracking Experiments Underscore the Bias that Architecture Exerts on Nuclear Grading in Prostate Cancer	PLOS ONE			English	Article							ERROR; MEDICINE; SEE	We previously reported that nuclear grade assignment of prostate carcinomas is subject to a cognitive bias induced by the tumor architecture. Here, we asked whether this bias is mediated by the non-conscious selection of nuclei that "match the expectation" induced by the inadvertent glance at the tumor architecture. 20 pathologists were asked to grade nuclei in high power fields of 20 prostate carcinomas displayed on a computer screen. Unknown to the pathologists, each carcinoma was shown twice, once before a background of a low grade, tubule-rich carcinoma and once before the background of a high grade, solid carcinoma. Eye tracking allowed to identify which nuclei the pathologists fixated during the 8 second projection period. For all 20 pathologists, nuclear grade assignment was significantly biased by tumor architecture. Pathologists tended to fixate on bigger, darker, and more irregular nuclei when those were projected before kigh grade, solid carcinomas than before low grade, tubule-rich carcinomas (and vice versa). However, the morphometric differences of the selected nuclei accounted for only 11% of the architecture-induced bias, suggesting that it can only to a small part be explained by the unconscious fixation on nuclei that "match the expectation". In conclusion, selection of "matching nuclei" represents an unconscious effort to vindicate the gravitation of nuclear grades towards the tumor architecture.	[Bombari, Dario; Mast, Fred W.] Univ Bern, Inst Psychol, Bern, Switzerland; [Mora, Braulio; Schaefer, Stephan C.; Lehr, Hans-Anton] CHU Vaudois, Univ Inst Pathol, Lausanne, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bombari, D (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.	hansanton.lehr@yahoo.de	Mast, Fred/B-5058-2013	Mast, Fred/0000-0002-0665-4457	Swiss National Science Foundation [32000-120417]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a grant from the Swiss National Science Foundation (No32000-120417 "cognition bias in cancer grading"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Charlin BD, 2000, ACAD MED, V75, P182, DOI 10.1097/00001888-200002000-00020; CHIMOWITZ MI, 1990, ANN NEUROL, V28, P78, DOI 10.1002/ana.410280114; Croskerry P, 2000, ACAD EMERG MED, V7, P1223, DOI 10.1111/j.1553-2712.2000.tb00467.x; Day L, 2010, AM J CRIT CARE, V19, P296, DOI 10.4037/ajcc2010839; Elston EW, 1993, HISTOPATHOLOGY, V19, P403; Fandel TM, 2008, J PATHOL, V216, P193, DOI 10.1002/path.2395; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graber M, 2002, ACAD MED, V77, P981, DOI 10.1097/00001888-200210000-00009; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Hamilton PW, 2009, J PATHOL, V218, P285, DOI 10.1002/path.2527; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lehner PE, 2008, IEEE T SYST MAN CY A, V38, P584, DOI 10.1109/TSMCA.2008.918634; McLendon RE, 2006, ARCH PATHOL LAB MED, V130, P613; Meissner CA, 2002, LAW HUMAN BEHAV, V26, P469, DOI 10.1023/A:1020278620751; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pines JM, 2006, ACAD EMERG MED, V13, P90, DOI 10.1197/j.aem.2005.07.028; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Regehr G, 1996, ACAD MED, V71, P988, DOI 10.1097/00001888-199609000-00015; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Tolkott MA, 1989, IEEE T SYST MAN CYB, V189, P606; Tversky A, 1974, HEURISTIC BIASES SCI, V186, P1124; Vickrey BG, 2010, ANN NEUROL, V67, P425, DOI 10.1002/ana.21907; Wiegmann DA, 2010, CHEST, V137, P250, DOI 10.1378/chest.09-1176	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38023	10.1371/journal.pone.0038023	http://dx.doi.org/10.1371/journal.pone.0038023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666438	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400070
J	Kroener, S; Mulholland, PJ; New, NN; Gass, JT; Becker, HC; Chandler, JL				Kroener, Sven; Mulholland, Patrick J.; New, Natasha N.; Gass, Justin T.; Becker, Howard C.; Chandler, L. Judson			Chronic Alcohol Exposure Alters Behavioral and Synaptic Plasticity of the Rodent Prefrontal Cortex	PLOS ONE			English	Article							CHRONIC ETHANOL EXPOSURE; NMDA RECEPTOR SUBUNIT; D-ASPARTATE RECEPTORS; LONG-TERM POTENTIATION; CALCIUM SPIKES; MESSENGER-RNA; UP-REGULATION; WITHDRAWAL; EXPRESSION; DRINKING	In the present study, we used a mouse model of chronic intermittent ethanol (CIE) exposure to examine how CIE alters the plasticity of the medial prefrontal cortex (mPFC). In acute slices obtained either immediately or 1-week after the last episode of alcohol exposure, voltage-clamp recording of excitatory post-synaptic currents (EPSCs) in mPFC layer V pyramidal neurons revealed that CIE exposure resulted in an increase in the NMDA/AMPA current ratio. This increase appeared to result from a selective increase in the NMDA component of the EPSC. Consistent with this, Western blot analysis of the postsynaptic density fraction showed that while there was no change in expression of the AMPA GluR1 subunit, NMDA NR1 and NRB subunits were significantly increased in CIE exposed mice when examined immediately after the last episode of alcohol exposure. Unexpectedly, this increase in NR1 and NR2B was no longer observed after 1-week of withdrawal in spite of a persistent increase in synaptic NMDA currents. Analysis of spines on the basal dendrites of layer V neurons revealed that while the total density of spines was not altered, there was a selective increase in the density of mushroom-type spines following CIE exposure. Examination of NMDA-receptor mediated spike-timing-dependent plasticity (STDP) showed that CIE exposure was associated with altered expression of long-term potentiation (LTP). Lastly, behavioral studies using an attentional set-shifting task that depends upon the mPFC for optimal performance revealed deficits in cognitive flexibility in CIE exposed mice when tested up to 1-week after the last episode of alcohol exposure. Taken together, these observations are consistent with those in human alcoholics showing protracted deficits in executive function, and suggest these deficits may be associated with alterations in synaptic plasticity in the mPFC.	[Kroener, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Mulholland, Patrick J.; New, Natasha N.; Gass, Justin T.; Becker, Howard C.; Chandler, L. Judson] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Becker, Howard C.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	University of Texas System; University of Texas Dallas; Medical University of South Carolina; Medical University of South Carolina	Kroener, S (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	kroener@utdallas.edu	Mulholland, Patrick J/L-9353-2017; Chandler, Lawrence/N-8569-2017; Kroener, Sven/F-4561-2012	Chandler, Lawrence/0000-0002-1468-7320; Kroener, Sven/0000-0003-1728-8111	National Institutes of Health [AA017527, AA010983, AA019967, AA010761, AA007474, AA017922, AA013641, AA019362]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (Grants AA017527, AA010983, AA019967, AA010761, AA007474, AA017922, AA013641, and AA019362; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bonci A, 1999, J NEUROSCI, V19, P3723; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Carlson VCC, 2011, NEUROPSYCHOPHARMACOL, V36, P2513, DOI 10.1038/npp.2011.140; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Carpenter-Hyland EP, 2006, EUR J NEUROSCI, V24, P3496, DOI 10.1111/j.1460-9568.2006.05247.x; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; Dalton GL, 2011, PSYCHOPHARMACOLOGY, V216, P525, DOI 10.1007/s00213-011-2246-z; Dias R, 1997, J NEUROSCI, V17, P9285; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Follesa P, 1996, J BIOL CHEM, V271, P13297, DOI 10.1074/jbc.271.23.13297; Fujii S, 2008, BRAIN RES, V1211, P13, DOI 10.1016/j.brainres.2008.02.052; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Ghods-Sharifi S, 2008, NEUROBIOL LEARN MEM, V89, P567, DOI 10.1016/j.nlm.2007.10.007; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Griffin WC, 2009, PSYCHOPHARMACOLOGY, V201, P569, DOI 10.1007/s00213-008-1324-3; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hardy PA, 1999, BRAIN RES, V819, P33, DOI 10.1016/S0006-8993(98)01340-7; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Hendricson AW, 2004, J NEUROPHYSIOL, V91, P2568, DOI 10.1152/jn.00997.2003; Jeanes ZM, 2011, J PHARMACOL EXP THER, V336, P155, DOI 10.1124/jpet.110.171009; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Krystal JH, 2011, NEUROPSYCHOPHARMACOL, V36, P701, DOI 10.1038/npp.2010.203; Kumari M, 2000, PROG DRUG RES, V54, P152; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; Lopez MF, 2011, ALCOHOL CLIN EXP RES, V35, P953, DOI 10.1111/j.1530-0277.2010.01426.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; Mulholland PJ, 2011, BIOL PSYCHIAT, V69, P625, DOI 10.1016/j.biopsych.2010.09.025; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Narita M, 2000, EUR J PHARMACOL, V401, P191, DOI 10.1016/S0014-2999(00)00428-3; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; Qiang M, 2007, MOL PHARMACOL, V72, P95, DOI 10.1124/mol.106.033043; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Sanderson JL, 2009, NEUROPHARMACOLOGY, V56, P541, DOI 10.1016/j.neuropharm.2008.10.012; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Snell LD, 1996, MOL BRAIN RES, V40, P71; Stramiello M, 2010, SYNAPSE, V64, P644, DOI 10.1002/syn.20764; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Veatch LM, 2002, BRAIN RES, V946, P272, DOI 10.1016/S0006-8993(02)02895-0; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Weitlauf C, 2008, ALCOHOL CLIN EXP RES, V32, P690, DOI 10.1111/j.1530-0277.2008.00625.x; Xia JX, 2006, ALCOHOL CLIN EXP RES, V30, P819, DOI 10.1111/j.1530-0277.2006.00095.x; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhou FC, 2007, BRAIN RES, V1134, P148, DOI 10.1016/j.brainres.2006.11.046	65	148	148	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37541	10.1371/journal.pone.0037541	http://dx.doi.org/10.1371/journal.pone.0037541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666364	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400031
J	Long, Y; Li, LC; Li, Q; He, XZ; Cui, ZB				Long, Yong; Li, Linchun; Li, Qing; He, Xiaozhen; Cui, Zongbin			Transcriptomic Characterization of Temperature Stress Responses in Larval Zebrafish	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; GENE-EXPRESSION; HEAT-STRESS; GILLICHTHYS-MIRABILIS; THERMAL-ACCLIMATION; COLD; FISH; MICROARRAY; HYPOTHALAMUS; ADAPTATION	Temperature influences nearly all biochemical, physiological and life history activities of fish, but the molecular mechanisms underlying the temperature acclimation remains largely unknown. Previous studies have identified many temperature-regulated genes in adult tissues; however, the transcriptional responses of fish larvae to temperature stress are not well understood. In this study, we characterized the transcriptional responses in larval zebrafish exposed to cold or heat stress using microarray analysis. In comparison with genes expressed in the control at 28 degrees C, a total of 2680 genes were found to be affected in 96 hpf larvae exposed to cold (16 degrees C) or heat (34 degrees C) for 2 and 48 h and most of these genes were expressed in a temperature-specific and temporally regulated manner. Bioinformatic analysis identified multiple temperature-regulated biological processes and pathways. Biological processes overrepresented among the earliest genes induced by temperature stress include regulation of transcription, nucleosome assembly, chromatin organization and protein folding. However, processes such as RNA processing, cellular metal ion homeostasis and protein transport and were enriched in genes up-regulated under cold exposure for 48 h. Pathways such as mTOR signalling, p53 signalling and circadian rhythm were enriched among cold-induced genes, while adipocytokine signalling, protein export and arginine and praline metabolism were enriched among heat-induced genes. Although most of these biological processes and pathways were specifically regulated by cold or heat, common responses to both cold and heat stresses were also found. Thus, these findings provide new interesting clues for elucidation of mechanisms underlying the temperature acclimation in fish.	[Long, Yong; Li, Qing; He, Xiaozhen; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Li, Linchun] Xiamen Ocean Vocat Coll, Dept Biotechnol, Xiamen, Fujian, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Long, Y (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn			National Natural Science Foundation of China [31101892]; National High-tech RD (863) Program [2007AA10Z164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD (863) Program(National High Technology Research and Development Program of China)	This work was funded by grants from the National Natural Science Foundation of China (#31101892 to Y. Long) and the National High-tech R&D (863) Program (#2007AA10Z164 to Z. Cui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bachtell RK, 2003, BRAIN RES, V960, P157, DOI 10.1016/S0006-8993(02)03807-6; Beitinger TL, 2000, ENVIRON BIOL FISH, V58, P237, DOI 10.1023/A:1007676325825; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Buckley BA, 2006, J EXP BIOL, V209, P2660, DOI 10.1242/jeb.02292; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cortemeglia C, 2005, T AM FISH SOC, V134, P1431, DOI 10.1577/T04-197.1; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; diIorio PJ, 1996, CELL STRESS CHAPERON, V1, P139; Donaldson MR, 2008, J FISH BIOL, V73, P1491, DOI 10.1111/j.1095-8649.2008.02061.x; Driedzic WR, 1996, J EXP ZOOL, V275, P186, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<186::AID-JEZ10>3.3.CO;2-T; FADER SC, 1994, J THERM BIOL, V19, P335, DOI 10.1016/0306-4565(94)90070-1; Fang H, 2009, MOL CELL TOXICOL, V5, P40; GERLACH GF, 1990, AM J PHYSIOL, V259, pR237, DOI 10.1152/ajpregu.1990.259.2.R237; GOLDSPINK G, 1995, J THERM BIOL, V20, P167, DOI 10.1016/0306-4565(94)00045-K; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; HOCHACHKA PW, 1970, J BIOL CHEM, V245, P6567; Johnston IA, 1996, ANIMALS TEMPERATURE, Vxvi, P419; JOHNSTON PV, 1964, COMP BIOCHEM PHYSIOL, V11, P303, DOI 10.1016/0010-406X(64)90111-2; JOYCE MP, 1992, NEUROSCIENCE, V49, P163, DOI 10.1016/0306-4522(92)90084-F; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Kassahn KS, 2007, MOL ECOL, V16, P1749, DOI 10.1111/j.1365-294X.2006.03178.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Logan CA, 2011, AM J PHYSIOL-REG I, V300, pR1373, DOI 10.1152/ajpregu.00689.2010; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; McKitrick DJ, 2000, BRAIN RES BULL, V53, P307, DOI 10.1016/S0361-9230(00)00346-4; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pan J, 2008, BIOPHYS J, V94, P117, DOI 10.1529/biophysj.107.115691; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Podrabsky JE, 2004, J EXP BIOL, V207, P2237, DOI 10.1242/jeb.01016; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schilling TF, 1996, DEVELOPMENT, V123, P329; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIMON SA, 1995, BIOPHYS J, V69, P1473, DOI 10.1016/S0006-3495(95)80017-2; SOMERO GN, 1971, AM ZOOL, V11, P157; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; St-Pierre J, 1998, J EXP BIOL, V201, P2961; TEMPLETON M, 1961, J HISTOCHEM CYTOCHEM, V9, P670, DOI 10.1177/9.6.670; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; THORNHILL JA, 1994, CAN J PHYSIOL PHARM, V72, P89, DOI 10.1139/y94-014; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; UEDA MJ, 1976, J CELL BIOL, V71, P670, DOI 10.1083/jcb.71.2.670; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Weidenhammer EM, 1996, NUCLEIC ACIDS RES, V24, P1164, DOI 10.1093/nar/24.6.1164; Xu Joshua, 2010, Hum Genomics, V4, P428; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	63	121	134	10	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37209	10.1371/journal.pone.0037209	http://dx.doi.org/10.1371/journal.pone.0037209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666345	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400021
J	Toukam, DK; Tenbusch, M; Stang, A; Temchura, V; Bonsmann, MSG; Grewe, B; Koch, S; Meyerhans, A; Nchinda, G; Kaptue, L; Uberla, K				Toukam, Donatien Kamdem; Tenbusch, Matthias; Stang, Alexander; Temchura, Vladimir; Bonsmann, Michael Storcksdieck genannt; Grewe, Bastian; Koch, Stefanie; Meyerhans, Andreas; Nchinda, Godwin; Kaptue, Lazare; Ueberla, Klaus			Targeting Antibody Responses to the Membrane Proximal External Region of the Envelope Glycoprotein of Human Immunodeficiency Virus	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; HIV-1 GP41; ECTODOMAIN REGION; TYPE-1; EPITOPE; 4E10; 2F5; NEUTRALIZATION; PROTEIN; CONFORMATION	Although human immunodeficiency type 1 (HIV-1) infection induces strong antibody responses to the viral envelope glycoprotein (Env) only a few of these antibodies possess the capacity to neutralize a broad range of strains. The induction of such antibodies represents an important goal in the development of a preventive vaccine against the infection. Among the broadly neutralizing monoclonal antibodies discovered so far, three (2F5, Z13 and 4E10) target the short and hidden membrane proximal external region (MPER) of the gp41 transmembrane protein. Antibody responses to MPER are rarely observed in HIV-infected individuals or after immunization with Env immunogens. To initiate antibody responses to MPER in its membrane-embedded native conformation, we generated expression plasmids encoding the membrane-anchored ectodomain of gp41 with N-terminal deletions of various sizes. Following transfection of these plasmids, the MPER domains are displayed on the cell surface and incorporated into HIV virus like particles (VLP). Transfected cells displaying MPER mutants bound as efficiently to both 2F5 and 4E10 as cells transfected with a plasmid encoding full-length Env. Mice immunized with VLPs containing the MPER mutants produced MPER-specific antibodies, the levels of which could be increased by the trimerization of the displayed proteins as well as by a DNA prime-VLP boost immunization strategy. Although 2F5 competed for binding to MPER with antibodies in sera of some of the immunized mice, neutralizing activity could not be detected. Whether this is due to inefficient binding of the induced antibodies to MPER in the context of wild type Env or whether the overall MPER-specific antibody response induced by the MPER display mutants is too low to reveal neutralizing activity, remains to be determined.	[Toukam, Donatien Kamdem; Tenbusch, Matthias; Stang, Alexander; Temchura, Vladimir; Bonsmann, Michael Storcksdieck genannt; Grewe, Bastian; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Koch, Stefanie] Fraunhofer Inst Biomed Engn, Sulzbach, Germany; [Meyerhans, Andreas] Univ Pompeu Fabra, ICREA Infect Biol Lab, Dept Expt & Hlth Sci, Barcelona, Spain; [Nchinda, Godwin] Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Immunol Lab, Yaounde, Cameroon; [Kaptue, Lazare] Univ Montagnes, Inst Super Sci Sante, Bangante, Cameroon	Ruhr University Bochum; Fraunhofer Gesellschaft; ICREA; Pompeu Fabra University	Toukam, DK (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Univ Str 150, Bochum, Germany.	Klaus.ueberla@rub.de	Meyerhans, Andreas/D-3382-2014; Meyerhans, Andreas/S-2559-2019	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317	European Commission FP6 program (DEC-VAC) [LSHP-CT-2005-018685]; EUROPRISE network of excellence; German Research Foundation [TRR60/1]; Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant) [OPP38580_01]; ICREA Funding Source: Custom	European Commission FP6 program (DEC-VAC); EUROPRISE network of excellence; German Research Foundation(German Research Foundation (DFG)); Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant); ICREA(ICREA)	This work was supported by grants from the European Commission FP6 program (DEC-VAC, LSHP-CT-2005-018685; EUROPRISE network of excellence), the German Research Foundation (TRR60/1) and the Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant # OPP38580_01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2009, PNAS, P2; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CLOSA MONTERO C., 2005, CURRENT PROTOCOLS IM, P17; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Harbury B, 1994, NATURE, V371, P80; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Leapman RD, 2002, ANALYSIS, V76, P7863, DOI [10.1128/JVI.76.15.7863, DOI 10.1128/JVI.76.15.7863]; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Quinnan GV, 1999, AIDS RES HUM RETROV, V15, P561, DOI 10.1089/088922299311088; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tenbusch M, 2010, VACCINE, V28, P3273, DOI 10.1016/j.vaccine.2010.02.090; Wagner R, 2000, HUM GENE THER, V11, P2403, DOI 10.1089/104303400750038507; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	32	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38068	10.1371/journal.pone.0038068	http://dx.doi.org/10.1371/journal.pone.0038068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666448	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400075
J	Welzel, F; Kaehler, C; Isau, M; Hallen, L; Lehrach, H; Krobitsch, S				Welzel, Franziska; Kaehler, Christian; Isau, Melanie; Hallen, Linda; Lehrach, Hans; Krobitsch, Sylvia			FOX-2 Dependent Splicing of Ataxin-2 Transcript Is Affected by Ataxin-1 Overexpression	PLOS ONE			English	Article							RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIA; POLYGLUTAMINE EXPANSION; STRESS GRANULES; GENE-EXPRESSION; CELL-TYPE; DISEASE; TYPE-1; SCA1; IDENTIFICATION	Alternative splicing is a fundamental posttranscriptional mechanism for controlling gene expression, and splicing defects have been linked to various human disorders. The splicing factor FOX-2 is part of a main protein interaction hub in a network related to human inherited ataxias, however, its impact remains to be elucidated. Here, we focused on the reported interaction between FOX-2 and ataxin-1, the disease-causing protein in spinocerebellar ataxia type 1. In this line, we further evaluated this interaction by yeast-2-hybrid analyses and co-immunoprecipitation experiments in mammalian cells. Interestingly, we discovered that FOX-2 localization and splicing activity is affected in the presence of nuclear ataxin-1 inclusions. Moreover, we observed that FOX-2 directly interacts with ataxin-2, a protein modulating spinocerebellar ataxia type 1 pathogenesis. Finally, we provide evidence that splicing of pre-mRNA of ataxin-2 depends on FOX-2 activity, since reduction of FOX-2 levels led to increased skipping of exon 18 in ataxin-2 transcripts. Most striking, we observed that ataxin-1 overexpression has an effect on this splicing event as well. Thus, our results demonstrate that FOX-2 is involved in splicing of ataxin-2 transcripts and that this splicing event is altered by overexpression of ataxin-1.	[Welzel, Franziska; Kaehler, Christian; Hallen, Linda; Krobitsch, Sylvia] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Isau, Melanie; Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Gen, D-14195 Berlin, Germany; [Welzel, Franziska; Kaehler, Christian; Isau, Melanie] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany	Max Planck Society; Max Planck Society; Free University of Berlin	Welzel, F (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	krobitsc@molgen.mpg.de	Kaehler, Christian/A-2912-2015		Max Planck Society; Ataxia UK [PSMOGE 727]	Max Planck Society(Max Planck Society); Ataxia UK	This work was supported by the Max Planck Society and Ataxia UK (PSMOGE 727; www.ataxia.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Branco J, 2008, HUM MOL GENET, V17, P376, DOI 10.1093/hmg/ddm315; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Einum DD, 2003, ARCH NEUROL-CHICAGO, V60, P97, DOI 10.1001/archneur.60.1.97; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Gottschalk A, 1998, RNA, V4, P374; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hallen L, 2011, HUM MOL GENET, V20, P104, DOI 10.1093/hmg/ddq436; Hamshere ML, 2009, BRIT J PSYCHIAT, V195, P23, DOI 10.1192/bjp.bp.108.061424; Harris GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013695; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jiang W, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-72; Kang S, 2009, MOL CELLS, V27, P621, DOI 10.1007/s10059-009-0095-y; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lale S, 2011, FETAL PEDIAT PATHOL; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Neuwald AF, 1998, J MOL MED, V76, P3, DOI 10.1007/s109-1998-8098-0; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Papin C, 2008, FEBS J, V275, P490, DOI 10.1111/j.1742-4658.2007.06216.x; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Rich T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001014; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Truant R, 2006, CAN J NEUROL SCI, V33, P278, DOI 10.1017/S031716710000514X; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	66	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37985	10.1371/journal.pone.0037985	http://dx.doi.org/10.1371/journal.pone.0037985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666429	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400067
J	Dieppois, G; Ducret, V; Caille, O; Perron, K				Dieppois, Guennaelle; Ducret, Verena; Caille, Olivier; Perron, Karl			The Transcriptional Regulator CzcR Modulates Antibiotic Resistance and Quorum Sensing in Pseudomonas aeruginosa	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; BASIC-AMINO-ACIDS; OUTER-MEMBRANE; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; VIRULENCE FACTORS; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; POLYMYXIN-B; SYSTEMS	The opportunistic pathogen Pseudomonas aeruginosa responds to zinc, cadmium and cobalt by way of the CzcRS two-component system. In presence of these metals the regulatory protein CzcR induces the expression of the CzcCBA efflux pump, expelling and thereby inducing resistance to Zn, Cd and Co. Importantly, CzcR co-regulates carbapenem antibiotic resistance by repressing the expression of the OprD porin, the route of entry for these antibiotics. This unexpected co-regulation led us to address the role of CzcR in other cellular processes unrelated to the metal response. We found that CzcR affected the expression of numerous genes directly involved in the virulence of P. aeruginosa even in the absence of the inducible metals. Notably the full expression of quorum sensing 3-oxo-C12-HSL and C4-HSL autoinducer molecules is impaired in the absence of CzcR. In agreement with this, the virulence of the czcRS deletion mutant is affected in a C. elegans animal killing assay. Additionally, chromosome immunoprecipitation experiments allowed us to localize CzcR on the promoter of several regulated genes, suggesting a direct control of target genes such as oprD, phzA1 and lasI. All together our data identify CzcR as a novel regulator involved in the control of several key genes for P. aeruginosa virulence processes.	[Dieppois, Guennaelle; Ducret, Verena; Caille, Olivier; Perron, Karl] Univ Geneva, Microbiol Unit, Dept Bot & Plant Biol, Geneva, Switzerland	University of Geneva	Dieppois, G (corresponding author), EPFL SV GHI UPLEM, Lausanne, Switzerland.	karl.perron@unige.ch	Perron, Karl/AAC-3128-2022	Perron, Karl/0000-0002-3259-4638	Swiss National Science Fondation [31003A_124931]; Novartis foundation; Ernst et Lucie Schmidheiny foundation	Swiss National Science Fondation(Swiss National Science Foundation (SNSF)); Novartis foundation(Novartis); Ernst et Lucie Schmidheiny foundation	This work was supported by funding from the Swiss National Science Fondation (Grant 31003A_124931 to KP), the Novartis foundation and the Ernst et Lucie Schmidheiny foundation (to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Alteri CJ, 2011, MOL MICROBIOL; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BRENNER S, 1974, GENETICS, V77, P71; Brocker M, 2011, J BACTERIOL, V193, P1237, DOI 10.1128/JB.01032-10; Caille O, 2007, J BACTERIOL, V189, P4561, DOI 10.1128/JB.00095-07; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Conejo MC, 2003, ANTIMICROB AGENTS CH, V47, P2313, DOI 10.1128/AAC.47.7.2313-2315.2003; De Kievit T, 1999, J BACTERIOL, V181, P2175, DOI 10.1128/JB.181.7.2175-2184.1999; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GUAN CD, 1983, J BACTERIOL, V156, P710, DOI 10.1128/JB.156.2.710-717.1983; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P397, DOI 10.1128/AAC.43.2.397; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Miller J.H., 1972, EXPT MOL GENETICS; Moss JE, 2000, CELL MICROBIOL, V2, P443, DOI 10.1046/j.1462-5822.2000.00065.x; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Perron K, 2004, J BIOL CHEM, V279, P8761, DOI 10.1074/jbc.M312080200; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; REITZER LJ, 1983, P NATL ACAD SCI-BIOL, V80, P5554, DOI 10.1073/pnas.80.18.5554; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Rosenfeld M, 2003, CURR OPIN PULM MED, V9, P492, DOI 10.1097/00063198-200311000-00008; Sambrook J., MOL CLONING LAB MANU; SCARLATO V, 1990, P NATL ACAD SCI USA, V87, P6753, DOI 10.1073/pnas.87.17.6753; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; SIEGMUND I, 1991, BIOTECHNOL TECH, V5, P265, DOI 10.1007/BF02438660; Silflow CD, 2001, J CELL BIOL, V153, P63, DOI 10.1083/jcb.153.1.63; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TRIAS J, 1990, J BIOL CHEM, V265, P15680; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Van Delden C, 1998, INFECT IMMUN, V66, P4499; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Verhamme DT, 2002, MICROBIOL-SGM, V148, P69, DOI 10.1099/00221287-148-1-69; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zakikhany K, 2010, MOL MICROBIOL, V77, P771, DOI 10.1111/j.1365-2958.2010.07247.x	68	74	78	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38148	10.1371/journal.pone.0038148	http://dx.doi.org/10.1371/journal.pone.0038148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666466	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600063
J	Liu, YQ; Hu, XY; Lu, T; Cheng, YN; Young, CYF; Yuan, HQ; Lou, HX				Liu, Yong-Qing; Hu, Xiao-Yan; Lu, Tao; Cheng, Yan-Na; Young, Charles Y. F.; Yuan, Hui-Qing; Lou, Hong-Xiang			Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-kappa B Signaling in Prostate Cancer Cells in Vitro and in Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; URSOLIC ACID; ACETYL-11-KETO-BETA-BOSWELLIC ACID; P65 PHOSPHORYLATION; ANDROGEN RECEPTOR; DOWN-REGULATION; ALPHA KINASE; INHIBITION; ACTIVATION; APOPTOSIS	Previously, we reported that retigeric acid B (RB), a natural pentacyclic triterpenic acid isolated from lichen, inhibited cell growth and induced apoptosis in androgen-independent prostate cancer (PCa) cells. However, the mechanism of action of RB remains unclear. In this study, we found that using PC3 and DU145 cells as models, RB inhibited phosphorylation levels of I kappa B alpha and p65 subunit of NF-kappa B in a time- and dosage-dependent manner. Detailed study revealed that RB blocked the nuclear translocation of p65 and its DNA binding activity, which correlated with suppression of NF-kappa B-regulated proteins including Bcl-2, Bcl-x(L), cyclin D1 and survivin. NF-kappa B reporter assay suggested that RB was able to inhibit both constitutive activated-NF-kappa B and LPS (lipopolysaccharide)-induced activation of NF-kappa B. Overexpression of RelA/p65 rescued RB-induced cell death, while knockdown of RelA/p65 significantly promoted RB-mediated inhibitory effect on cell proliferation, suggesting the crucial involvement of NF-kappa B pathway in this event. We further analyzed antitumor activity of RB in in vivo study. In C57BL/6 mice carrying RM-1 homografts, RB inhibited tumor growth and triggered apoptosis mainly through suppressing NF-kappa B activity in tumor tissues. Additionally, DNA microarray data revealed global changes in the gene expression associated with cell proliferation, apoptosis, invasion and metastasis in response to RB treatment. Therefore, our findings suggested that RB exerted its anti-tumor effect by targeting the NF-kappa B pathway in PCa cells, and this could be a general mechanism for the anti-tumor effect of RB in other types of cancers as well.	[Liu, Yong-Qing; Hu, Xiao-Yan; Yuan, Hui-Qing] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China; [Liu, Yong-Qing; Lou, Hong-Xiang] Shandong Univ, Sch Pharmaceut Sci, Dept Nat Product Chem, Jinan 250100, Peoples R China; [Lu, Tao] Indiana Univ, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Sch Med, Indianapolis, IN 46202 USA; [Cheng, Yan-Na] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250100, Peoples R China; [Young, Charles Y. F.] Mayo Clin, Mayo Clin Coll Med, Dept Urol, Rochester, MN USA	Shandong University; Shandong University; Indiana University System; Indiana University-Purdue University Indianapolis; Shandong University; Mayo Clinic	Liu, YQ (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China.	lyuanhq@sdu.edu.cn; louhongxiang@sdu.edu.cn			National Natural Science Foundation of China [30973551, 30925038]; Shandong Scientific Technology Program [2008GG10002042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Scientific Technology Program	This work was supported by the National Natural Science Foundation of China (30973551, 30925038), and Shandong Scientific Technology Program (2008GG10002042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Gasparian AV, 2002, J CELL SCI, V115, P141; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Huang CY, 2011, TOXICOL IN VITRO, V25, P1274, DOI 10.1016/j.tiv.2011.04.014; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim DK, 2009, CANCER RES, V69, P923, DOI 10.1158/0008-5472.CAN-08-2115; Kunnumakkara AB, 2009, MOL CANCER RES, V7, P118, DOI 10.1158/1541-7786.MCR-08-0154; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Liu H, 2010, CHEM-BIOL INTERACT, V188, P598, DOI 10.1016/j.cbi.2010.07.024; Mauro C, 2009, METHODS MOL BIOL, V512, P169, DOI 10.1007/978-1-60327-530-9_10; Park B, 2011, INT J CANCER, V129, P23, DOI 10.1002/ijc.25966; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Shishodia S, 2003, CANCER RES, V63, P4375; Sriprasad S, 2009, SURG ONCOL, V18, P185, DOI 10.1016/j.suronc.2009.07.001; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Takada Y, 2006, J IMMUNOL, V176, P3127, DOI 10.4049/jimmunol.176.5.3127; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Viji V, 2010, BRIT J PHARMACOL, V162, P1291; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Yuan HQ, 2008, BIOCHEM PHARMACOL, V75, P2112, DOI 10.1016/j.bcp.2008.03.005; Yuan Huiqing, 2010, Mol Cell Biochem, V339, P253, DOI 10.1007/s11010-010-0388-7; Zhang AL, 2006, CANCER LETT, V233, P185, DOI 10.1016/j.canlet.2005.03.051	29	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38000	10.1371/journal.pone.0038000	http://dx.doi.org/10.1371/journal.pone.0038000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666431	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600050
J	Steinberg, G				Steinberg, Gero			Cytoplasmic Fungal Lipases Release Fungicides from Ultra-Deformable Vesicular Drug Carriers	PLOS ONE			English	Article							TDT 067 TERBINAFINE; ENDOPLASMIC-RETICULUM; CELL-WALL; PATHOGENIC DEVELOPMENT; USTILAGO-MAYDIS; ENDOCYTOSIS; TRANSFERSOMES; ACTIN; DYNAMICS; MOTILITY	The Transfersome (R) is a lipid vesicle that contains membrane softeners, such as Tween 80, to make it ultra-deformable. This feature makes the Transfersome (R) an efficient carrier for delivery of therapeutic drugs across the skin barrier. It was reported that TDT 067 (a topical formulation of 15 mg/ml terbinafine in Transfersome (R) vesicles) has a much more potent antifungal activity in vitro compared with conventional terbinafine, which is a water-insoluble fungicide. Here we use ultra-structural studies and live imaging in a model fungus to describe the underlying mode of action. We show that terbinafine causes local collapse of the fungal endoplasmic reticulum, which was more efficient when terbinafine was delivered in Transfersome (R) vesicles (TFVs). When applied in liquid culture, fluorescently labeled TFVs rapidly entered the fungal cells (T-1/2 similar to 2 min). Entry was F-actin-and ATP-independent, indicating that it is a passive process. Ultra-structural studies showed that passage through the cell wall involves significant deformation of the vesicles, and depends on a high concentration of the surfactant Tween 80 in their membrane. Surprisingly, the TFVs collapsed into lipid droplets after entry into the cell and the terbinafine was released from their interior. With time, the lipid bodies were metabolized in an ATP-dependent fashion, suggesting that cytosolic lipases attack and degrade intruding TFVs. Indeed, the specific monoacylglycerol lipase inhibitor URB602 prevented Transfersome (R) degradation and neutralized the cytotoxic effect of Transfersome (R)-delivered terbinafine. These data suggest that (a) Transfersomes deliver the lipophilic fungicide Terbinafine to the fungal cell wall, (b) the membrane softener Tween 80 allows the passage of the Transfersomes into the fungal cell, and (c) fungal lipases digest the invading Transfersome (R) vesicles thereby releasing their cytotoxic content. As this mode of action of Transfersomes is independent of the drug cargo, these results demonstrate the potential of Transfersomes in the treatment of all fungal diseases.	Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Steinberg, G (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	G.Steinberg@exeter.ac.uk			Celtic Pharma Development Services Bermuda Ltd., New York, USA; Celtic Pharma	Celtic Pharma Development Services Bermuda Ltd., New York, USA; Celtic Pharma	This work was supported by Celtic Pharma Development Services Bermuda Ltd., New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by Celtic Pharma. This did not influence the outcome or judgment of the data. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials.	Adamikova L, 2004, MOL BIOL CELL, V15, P1969, DOI 10.1091/mbc.E03-09-0675; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Benson Heather A E, 2006, Expert Opin Drug Deliv, V3, P727, DOI 10.1517/17425247.3.6.727; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Cevc G, 1998, BBA-BIOMEMBRANES, V1368, P201, DOI 10.1016/S0005-2736(97)00177-6; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Cevc G, 2001, BBA-BIOMEMBRANES, V1514, P191, DOI 10.1016/S0005-2736(01)00369-8; CEVC G, 1995, J CONTROL RELEASE, V36, P3, DOI 10.1016/0168-3659(95)00056-E; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Copland MJ, 2005, IMMUNOL CELL BIOL, V83, P97, DOI 10.1111/j.1440-1711.2005.01315.x; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Foster KW, 2004, J AM ACAD DERMATOL, V50, P748, DOI 10.1016/S0190-9622(03)02117-0; Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; Ghannoum M, 2012, ANTIMICROBI IN PRESS; Ghannoum M, 2011, J CLIN MICROBIOL, V49, P1716, DOI 10.1128/JCM.00083-11; Ghannoum M, 2011, J AM ACAD DERMATOL, V64, pAB93; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gupta PN, 2005, J PHARM PHARMACOL, V57, P295, DOI 10.1211/0022357055515; Haneke E, 1999, J EUR ACAD DERMATOL, V12, pS2, DOI 10.1016/S0926-9959(99)00052-5; HAY RJ, 1993, J AM ACAD DERMATOL, V29, pS50, DOI 10.1016/S0190-9622(08)81838-5; HIROSE S, 1974, J BIOCHEM-TOKYO, V76, P213, DOI 10.1093/oxfordjournals.jbchem.a130549; Hofer C, 2004, CYTOKINE, V25, P141, DOI 10.1016/j.cyto.2003.10.010; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jain S, 2003, DRUG DEV IND PHARM, V29, P1013, DOI 10.1081/DDC-120025458; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Katz HI, 1999, BRIT J DERMATOL, V141, P26; King AR, 2007, CHEM BIOL, V14, P1357, DOI 10.1016/j.chembiol.2007.10.017; Kulkarni PR, 2011, INT J PHARM SCI RES, V2, P735, DOI 10.13040/IJPSR.0975-8232.2(4).735-41; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; LYTLE CD, 1995, APPL ENVIRON MICROB, V61, P643, DOI 10.1128/AEM.61.2.643-649.1995; Mahlert M, 2009, J CELL SCI, V122, P2402, DOI 10.1242/jcs.039354; Pereira RD, 1996, APPL BIOCHEM BIOTECH, V59, P135, DOI 10.1007/BF02787815; PETRANYI G, 1984, SCIENCE, V224, P1239, DOI 10.1126/science.6547247; PLANAS ME, 1992, ANESTH ANALG, V75, P615; Plou FJ, 1998, BIOTECHNOL TECH, V12, P183, DOI 10.1023/A:1008809105270; Read ND, 2003, FUNGAL GENET BIOL, V39, P199, DOI 10.1016/S1087-1845(03)00045-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts DT, 1997, DERMATOLOGY, V194, P37, DOI 10.1159/000246183; ROBERTS DT, 1994, J AM ACAD DERMATOL, V31, pS78, DOI 10.1016/S0190-9622(08)81274-1; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; RYDER NS, 1985, ANTIMICROB AGENTS CH, V27, P252, DOI 10.1128/AAC.27.2.252; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Steinberg G, 1998, J CELL SCI, V111, P2235; Steinberg Gero, 2011, Fungal Biology Reviews, V25, P14, DOI 10.1016/j.fbr.2011.01.008; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Treichel H, 2010, FOOD BIOPROCESS TECH, V3, P182, DOI 10.1007/s11947-009-0202-2; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Zhang Y.Q., 2010, VIRULENCE, V1, P1	81	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38181	10.1371/journal.pone.0038181	http://dx.doi.org/10.1371/journal.pone.0038181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666476	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349600069
J	Wang, YJ; Wang, YT; Jung, TP				Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping			Translation of EEG Spatial Filters from Resting to Motor Imagery Using Independent Component Analysis	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SINGLE-TRIAL EEG; SYNCHRONIZATION; CLASSIFICATION; ALGORITHMS; DYNAMICS	Electroencephalogram (EEG)-based brain-computer interfaces (BCIs) often use spatial filters to improve signal-to-noise ratio of task-related EEG activities. To obtain robust spatial filters, large amounts of labeled data, which are often expensive and labor-intensive to obtain, need to be collected in a training procedure before online BCI control. Several studies have recently developed zero-training methods using a session-to-session scenario in order to alleviate this problem. To our knowledge, a state-to-state translation, which applies spatial filters derived from one state to another, has never been reported. This study proposes a state-to-state, zero-training method to construct spatial filters for extracting EEG changes induced by motor imagery. Independent component analysis (ICA) was separately applied to the multi-channel EEG in the resting and the motor imagery states to obtain motor-related spatial filters. The resultant spatial filters were then applied to single-trial EEG to differentiate left- and right-hand imagery movements. On a motor imagery dataset collected from nine subjects, comparable classification accuracies were obtained by using ICA-based spatial filters derived from the two states (motor imagery: 87.0%, resting: 85.9%), which were both significantly higher than the accuracy achieved by using monopolar scalp EEG data (80.4%). The proposed method considerably increases the practicality of BCI systems in real-world environments because it is less sensitive to electrode misalignment across different sessions or days and does not require annotated pilot data to derive spatial filters.	[Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, San Diego, CA 92103 USA; [Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, San Diego, CA 92103 USA.	yijun@sccn.ucsd.edu	Wang, Yijun/GXW-1763-2022; Wang, Yijun/F-3547-2012		Abraxis Bioscience Inc.; US Army Research Laboratory [W911NF-10-2-0022]; Army Research Office [W911NF-09-1-0510]; Office of Naval Research [N00014-08-1215]; DARPA [USDI D11PC20183]	Abraxis Bioscience Inc.; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; Office of Naval Research(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a gift fund from Abraxis Bioscience Inc. Research was also sponsored in part by the US Army Research Laboratory (W911NF-10-2-0022), Army Research Office (W911NF-09-1-0510), Office of Naval Research (N00014-08-1215), and DARPA (USDI D11PC20183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Congedo M, 2010, INT J PSYCHOPHYSIOL, V78, P89, DOI 10.1016/j.ijpsycho.2010.06.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duda R.O., 2000, PATTERN CLASSIFICATI; Gouy-Pailler C, 2010, IEEE T BIO-MED ENG, V57, P469, DOI 10.1109/TBME.2009.2032162; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Huang RS, 2008, NEUROIMAGE, V39, P1896, DOI 10.1016/j.neuroimage.2007.10.036; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vidaurre C, 2007, IEEE T BIO-MED ENG, V54, P550, DOI 10.1109/TBME.2006.888836; Vigario R, 2000, IEEE T BIO-MED ENG, V47, P589, DOI 10.1109/10.841330; Wang YJ, 2007, P ANN INT IEEE EMBS, P5059, DOI 10.1109/IEMBS.2007.4353477; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Zhang Dan, 2007, Comput Intell Neurosci, P39714, DOI 10.1155/2007/39714	36	40	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37665	10.1371/journal.pone.0037665	http://dx.doi.org/10.1371/journal.pone.0037665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666377	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600026
J	Wu, XM; Li, YQ; Wan, XL; Kayira, TM; Cao, RJ; Ju, XD; Zhu, XJ; Zhao, G				Wu, Xinmin; Li, Yunqian; Wan, Xilin; Kayira, Tabitha Mlowoka; Cao, Rangjuan; Ju, Xingda; Zhu, Xiaojuan; Zhao, Gang			Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis	PLOS ONE			English	Article							DCC GENE-PRODUCT; REPULSIVE GUIDANCE; DEPENDENCE RECEPTORS; NEURONAL DIFFERENTIATION; NETRIN-1 RECEPTOR; MULTIPLE ROLES; CELL-DEATH; EXPRESSION; CANCER; SURVIVAL	Background: Dependence receptors have been proved to act as tumor suppressors in tumorigenesis. Neogenin, a DCC homologue, well known for its fundamental role in axon guidance and cellular differentiation, is also a dependence receptor functioning to control apoptosis. However, loss of neogenin has been reported in several kinds of cancers, but its role in glioma remains to be further investigated. Methodology/Principal Findings: Western blot analysis showed that neogenin level was lower in glioma tissues than in their matching surrounding non-neoplastic tissues (n = 13, p<0.01). By immunohistochemical analysis of 69 primary and 16 paired initial and recurrent glioma sections, we found that the loss of neogenin did not only correlate negatively with glioma malignancy (n = 69, p<0.01), but also glioma recurrence (n = 16, p<0.05). Kaplan-Meier plot and Cox proportional hazards modelling showed that over-expressive neogenin could prolong the tumor latency (n = 69, p<0.001, 1187.6 +/- 162.6 days versus 687.4 +/- 254.2 days) and restrain high-grade glioma development (n = 69, p<0.01, HR: 0.264, 95% CI: 0.102 to 0.687). By Methylation specific polymerase chain reaction (MSP), we reported that neogenin promoter was methylated in 31.0% (9/29) gliomas, but absent in 3 kinds of glioma cell lines. Interestingly, the prevalence of methylation in high-grade gliomas was higher than low-grade gliomas and non-neoplastic brain tissues (n = 33, p, 0.05) and overall methylation rate increased as glioma malignancy advanced. Furthermore, when cells were over-expressed by neogenin, the apoptotic rate in SHG-44 was increased to 39.7% compared with 8.1% in the blank control (p<0.01) and 9.3% in the negative control (p<0.01). Conclusions/Significance: These observations recapitulated the proposed role of neogenin as a tumor suppressor in gliomas and we suggest its down-regulation owing to promoter methylation is a selective advantage for glioma genesis, progression and recurrence. Furthermore, the induction of apoptosis in SHG-44 cells after overexpression of neogenin, indicated that neogenin could be a novel target for glioma therapy.	[Wu, Xinmin; Wan, Xilin; Kayira, Tabitha Mlowoka; Cao, Rangjuan; Ju, Xingda; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wu, Xinmin; Li, Yunqian; Zhao, Gang] Jilin Univ, First Hosp, Dept Neurosurg, Changchun 130023, Peoples R China	Northeast Normal University - China; Jilin University	Wu, XM (corresponding author), NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China.	zhuxj720@nenu.edu.cn; zhaogang20052000@yahoo.com.cn		Zhu, Xiao-Juan/0000-0001-8386-8064	Program for New Century Excellent Talents in University [NCET-07-0173, 111496019]; National Natural Science Foundation of China [30670689, 30871302, 31171042]; National Natural Science Foundation of Jilin Province, China [200805130]; Scientific Research Foundation from Northeast Normal University [09ZDQD04, 10JCXK002]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jilin Province, China; Scientific Research Foundation from Northeast Normal University	This work was supported by the Program for New Century Excellent Talents in University (NCET-07-0173; 111496019), the National Natural Science Foundation of China (30670689; 30871302; 31171042), the National Natural Science Foundation of Jilin Province, China (200805130), and the Scientific Research Foundation from Northeast Normal University (09ZDQD04, 10JCXK002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2005, CELL DEATH DIFFER, V12, P1057, DOI 10.1038/sj.cdd.4401601; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Berrar D, 2005, J COMPUT BIOL, V12, P534, DOI 10.1089/cmb.2005.12.534; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Delloye-Bourgeois C, 2009, J EXP MED, V206, P833, DOI 10.1084/jem.20082299; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Grady WM, 2007, GASTROENTEROLOGY, V133, P2045, DOI 10.1053/j.gastro.2007.10.034; Graf D, 2007, ARCH BIOCHEM BIOPHYS, V462, P162, DOI 10.1016/j.abb.2007.03.029; Hanninen MM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-36; HEDRICK L, 1994, GENE DEV, V8, P1174, DOI 10.1101/gad.8.10.1174; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hibi K, 2010, ANTICANCER RES, V30, P107; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lee HK, 2008, KOREAN J PHYSIOL PHA, V12, P225, DOI 10.4196/kjpp.2008.12.5.225; Lee JE, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-85-154; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2005, BRIT J CANCER, V93, P1, DOI 10.1038/sj.bjc.6602656; Mehlen P, 2004, CELL MOL LIFE SCI, V61, P1854, DOI 10.1007/s00018-004-3467-7; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nakatani K, 1998, J NEURO-ONCOL, V40, P237, DOI 10.1023/A:1006114328134; Nighat PK, 2011, J CANC RES EXPT ONCO, V3; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Papanastasiou AD, 2011, ONCOTARGET, V2, P363; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Paunu N, 2002, INT J CANCER, V97, P819, DOI 10.1002/ijc.10107; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Shibata D, 1996, NEW ENGL J MED, V335, P1727, DOI 10.1056/NEJM199612053352303; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Tran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026858; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Yang F, 2011, J STRUCT BIOL, V174, P239, DOI 10.1016/j.jsb.2010.10.005	57	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38074	10.1371/journal.pone.0038074	http://dx.doi.org/10.1371/journal.pone.0038074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666451	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600061
J	Zhang, BY; Green, JV; Murthy, SK; Radisic, M				Zhang, Boyang; Green, James V.; Murthy, Shashi K.; Radisic, Milica			Label-Free Enrichment of Functional Cardiomyocytes Using Microfluidic Deterministic Lateral Flow Displacement	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ENGINEERED HEART-TISSUE; ELECTRICAL-STIMULATION; CARDIAC MYOCYTES; TRANSPLANTATION; SURVIVAL; SIZE; PHENOTYPE; IMPROVES; SYSTEMS	Progress in cardiac cell replacement therapies and tissue engineering critically depends on our ability to isolate functional cardiomyocytes (CMs) from heterogeneous cell mixtures. Label-free enrichment of cardiomyocytes is desirable for future clinical application of cell based products. Taking advantage of the physical properties of CMs, a microfluidic system was designed to separate CMs from neonatal rat heart tissue digest based on size using the principles of deterministic lateral displacement (DLD). For the first time, we demonstrate enrichment of functional CMs up to 91 +/- 2.4% directly from the digested heart tissue without any pre-treatment or labeling. Enriched cardiomyocytes remained viable after sorting and formed contractile cardiac patches in 3-dimensional culture. The broad significance of this work lies in demonstrating functional cell enrichment from the primary tissue digest leading directly to the creation of the engineered tissue.	[Zhang, Boyang; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Green, James V.; Murthy, Shashi K.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Zhang, Boyang; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; Northeastern University; University of Toronto	Zhang, BY (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	smurthy@coe.neu.edu; m.radisic@utoronto.ca			National Institutes of Health [R01-EB009327]; Natural Sciences and Engineering Research Council Discovery Accelerator Supplement [RGPAS 396125-10]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council Discovery Accelerator Supplement; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Institutes of Health RO1 (R01-EB009327) and Natural Sciences and Engineering Research Council Discovery Accelerator Supplement (RGPAS 396125-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AC N, 1980, CYTOBIOS, V20; Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001; Au HTH, 2009, LAB CHIP, V9, P564, DOI 10.1039/b810034a; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Brown MA, 2008, BIOTECHNOL PROGR, V24, P907, DOI 10.1002/btpr.11; Cooper R, 2007, LAB CHIP; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Dengler J, 2010, BIOTECHNOL BIOENG; Dengler J, 2007, FUTUR CARDIOL, V3, P425, DOI 10.2217/14796678.3.4.425; Dubois NC, 2011, NAT BIOTECHNOL; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Green JV, 2009, ANAL CHEM, V81, P9178, DOI 10.1021/ac9018395; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Huwer H, 2003, CELL TRANSPLANT, V12, P757, DOI 10.3727/000000003108747361; Inglis DW, 2008, J IMMUNOL METHODS, V329, P151, DOI 10.1016/j.jim.2007.10.004; Inglis DW, 2006, LAB CHIP, V6, P655, DOI 10.1039/b515371a; Iyer RK, 2009, J TISSUE ENG REGEN M, V3, P196, DOI 10.1002/term.153; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219; Li RK, 1996, ANN THORAC SURG, V62, P654; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Murthy SK, 2006, BIOMED MICRODEVICES, V8, P231, DOI 10.1007/s10544-006-8169-5; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Perin EC, 2011, PHASE 2 DOSE ESCALAT; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; RADISIC M, 2007, J BIOMED MAT RES A; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	44	31	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37619	10.1371/journal.pone.0037619	http://dx.doi.org/10.1371/journal.pone.0037619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666372	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600024
J	Deng, ZF; Yan, HJ; Hu, JJ; Zhang, SW; Peng, P; Liu, QZ; Guo, DY				Deng, Zhongfan; Yan, Huijuan; Hu, Jiajie; Zhang, Shengwei; Peng, Peng; Liu, Qingzhen; Guo, Deyin			Hepatitis C Virus Sensitizes Host Cells to TRAIL-Induced Apoptosis by Up-Regulating DR4 and DR5 via a MEK1-Dependent Pathway	PLOS ONE			English	Article							DEATH RECEPTOR-4; SP1 PHOSPHORYLATION; ACTIVATION; REPLICATION; INFECTION; LIGAND; IDENTIFICATION; INTERFERON; STABILITY; KINASE	Background: Hepatitis C virus (HCV) is the leading cause of liver fibrosis, cirrhosis and hepatocellular carcinoma. It is believed that continuous liver cell apoptosis contributes to HCV pathogenesis. Recent studies have shown that HCV infection can sensitize host cells to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis, but the mechanism by which HCV regulates the TRAIL pathway remains unclear. Methods and Results: Using a sub-genomic replicon and full length virus, JFH-1, we demonstrate that HCV can sensitize host cells to TRAIL-induced apoptosis by up-regulating two TRAIL receptors, death receptor 4 (DR4) and death receptor 5 (DR5). Furthermore, the HCV replicon enhanced transcription of DR5 via Sp1, and the HCV-mediated up-regulation of DR4 and DR5 required MEK1 activity. HCV infection also stimulated the activity of MEK1, and the inhibition of MEK1 activity or the knockdown of MEK1 increased the replication of HCV. Conclusions: Our studies demonstrate that HCV replication sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1 dependent pathway. These findings may help to further understand the pathogenesis of HCV infection and provide a therapeutic target.	[Deng, Zhongfan] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Deng, ZF (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	qzhliu@whu.edu.cn; dguo@whu.edu.cn	Guo, Deyin/A-9498-2011	Guo, Deyin/0000-0002-8297-0814	China "973" program [2009CB522506, 2010CB911800]; China Natural Science Foundation [30921001]	China "973" program(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by China "973" program (grant no. 2009CB522506 and 2010CB911800) and the China Natural Science Foundation (grant # 30921001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bild AH, 2002, ONCOGENE, V21, P6649, DOI 10.1038/sj.onc.1205819; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROTT BK, 1993, CELL GROWTH DIFFER, V4, P921; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Janssen HLA, 2003, J HEPATOL, V39, P414, DOI 10.1016/S0168-8278(03)00265-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kotelkin A, 2003, J VIROL, V77, P9156, DOI 10.1128/JVI.77.17.9156-9172.2003; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu XH, 2008, BIOCHEM BIOPH RES CO, V373, P643, DOI 10.1016/j.bbrc.2008.06.087; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Murata T, 2005, VIROLOGY, V340, P105, DOI 10.1016/j.virol.2005.06.015; Ndjomou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007498; Saitou Y, 2005, HUM PATHOL, V36, P1066, DOI 10.1016/j.humpath.2005.07.019; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SA, 2009, J MOL BIOL, V387, P1106, DOI 10.1016/j.jmb.2009.02.040; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; YAN MH, 1994, NATURE, V372, P798; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026; Yano Y, 2003, INT J MOL MED, V11, P499; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	49	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37700	10.1371/journal.pone.0037700	http://dx.doi.org/10.1371/journal.pone.0037700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662193	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300083
J	Miro-Moran, A; Jardin, I; Ortega-Ferrusola, C; Salido, GM; Pena, FJ; Tapia, JA; Aparicio, IM				Miro-Moran, Alvaro; Jardin, Isaac; Ortega-Ferrusola, Cristina; Salido, Gines M.; Pena, Fernando J.; Tapia, Jose A.; Aparicio, Ines M.			Identification and Function of Exchange Proteins Activated Directly by Cyclic AMP (Epac) in Mammalian Spermatozoa	PLOS ONE			English	Article							INTACT BOAR SPERMATOZOA; ACROSOMAL EXOCYTOSIS; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; SPERM MOTILITY; CELL-ADHESION; CAMP; CAPACITATION; RAP1; BICARBONATE	The role of cAMP in spermatic functions was classically thought to be mediated exclusively through the activation of Protein Kinase A (PKA). However, it has recently been shown that cAMP also exerts its effects through a PKA-independent pathway activating a family of proteins known as Epac proteins. Therefore, many of the spermatic functions thought to be regulated by cAMP through the activation of PKA are again under study. We aimed to identify and to investigate the role of Epac proteins in spermatozoa using a specific permeable analog (8-Br-2'-O-Me-cAMP). Also, we aimed to study its relationship with E-cadherin, an adhesion protein involved in fertility. Our results demonstrate the presence and sub-cellular distribution of Epac 1 and Epac 2 in mammalian spermatozoa. Capacitation and the acrosome reaction induced a change in the localization of Epac proteins in sperm. Moreover, incubation with 8-Br-2'-O-Me-cAMP prompted an increase in Rap1 activation, in the scrambling of plasma membrane phospholipids (necessary for the capacitation process), the acrosome reaction, motility, and calcium mobilization, when spermatozoa were incubated in acrosome reaction conditions. Finally, the activation of Epac proteins induced a change in the distribution of E-cadherin. Therefore, the increase in the acrosome reaction, together with the increase in calcium (which is known to be essential for fertilization) and the Epac nteraction with E-cadherin, might indicate that Epac proteins have an important role in gamete recognition and fertilization.	[Miro-Moran, Alvaro; Jardin, Isaac; Salido, Gines M.; Tapia, Jose A.; Aparicio, Ines M.] Univ Extremadura, Cell Physiol Res Grp, Caceres, Spain; [Ortega-Ferrusola, Cristina; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Spermatol, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Miro-Moran, A (corresponding author), Univ Extremadura, Cell Physiol Res Grp, Caceres, Spain.	imad@unex.es	Salido, Gines M/A-4292-2009; Ortega-Ferrusola, Cristina/AGI-8478-2022; Aparicio, Ines Maria/L-5775-2014; Peña, Fernando J/D-8450-2012; Aparicio, Ines/AAH-2781-2021; Jardin, Isaac/E-8310-2016; Tapia, Jose A./C-5181-2008	Salido, Gines M/0000-0002-8687-2445; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Aparicio, Ines/0000-0003-0023-853X; Jardin, Isaac/0000-0003-4575-8264; Tapia, Jose A./0000-0002-3614-6867	University of Extremadura (Proyecto Accion VII); Junta de Extremadura-FEDER [GR10010]; Ministerio de Ciencia e Innovacion-FEDER [BFU2011-30261, AGL 2010-20758]; Ministerio Ciencia e Innovacion [BES-2008-002106]; Consejeria de Economia, Comercio e Innovacion (JUEX) [REI09013]	University of Extremadura (Proyecto Accion VII); Junta de Extremadura-FEDER(European Commission); Ministerio de Ciencia e Innovacion-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Comercio e Innovacion (JUEX)	This work was supported by University of Extremadura (Proyecto Accion VII), Junta de Extremadura-FEDER (GR10010) and by Ministerio de Ciencia e Innovacion-FEDER, grants BFU2011-30261 and AGL 2010-20758). Dr. Miro-Moran was supported by a predoctoral fellowship from the Ministerio Ciencia e Innovacion (BES-2008-002106). Dr. Aparicio was supported by Consejeria de Economia, Comercio e Innovacion (JUEX, REI09013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivatiadou E, 2007, MOL BIOL CELL, V18, P1530, DOI 10.1091/mbc.E06-10-0902; Aivatiadou E, 2009, MOL REPROD DEV, V76, P407, DOI 10.1002/mrd.20963; Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Angst BD, 2001, J CELL SCI, V114, P625; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragado MJ, 2010, J CELL BIOCHEM, V109, P65, DOI 10.1002/jcb.22393; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bravo MM, 2005, MOL REPROD DEV, V71, P88, DOI 10.1002/mrd.20286; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Breitbart H, 2002, J REPROD IMMUNOL, V53, P151, DOI 10.1016/S0165-0378(01)00085-7; Carr D W, 2007, Soc Reprod Fertil Suppl, V63, P135; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; DZHURA I, 2010, J PHYSL; Espino J, 2010, FERTIL STERIL, V94, P1915, DOI 10.1016/j.fertnstert.2009.12.082; Fazeli A, 1997, BIOL REPROD, V56, P430, DOI 10.1095/biolreprod56.2.430; Flesch FM, 2001, J CELL SCI, V114, P3543; FRASER LR, 1992, J REPROD FERTIL, V96, P363, DOI 10.1530/jrf.0.0960363; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gadella BM, 2004, ANIM REPROD SCI, V82-3, P307, DOI 10.1016/j.anireprosci.2004.04.030; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gonzalez-Fernandez L, 2009, BIOL REPROD, V80, P1239, DOI 10.1095/biolreprod.108.073486; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harkema W, 1998, BIOL REPROD, V58, P421, DOI 10.1095/biolreprod58.2.421; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; HONG CY, 1985, BRIT J CLIN PHARMACO, V19, P45, DOI 10.1111/j.1365-2125.1985.tb02611.x; Kinukawa M, 2006, FEBS LETT, V580, P1515, DOI 10.1016/j.febslet.2006.01.078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Luconi M, 2011, FRONT BIOSCI-LANDMRK, V16, P1315, DOI 10.2741/3791; Marin-Briggiler CI, 2008, MOL HUM REPROD, V14, P561, DOI 10.1093/molehr/gan053; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rufas O, 2000, MOL HUM REPROD, V6, P163, DOI 10.1093/molehr/6.2.163; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Wuttke M S, 2001, JOP, V2, P154; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Zarintash RJ, 1996, BIOL REPROD, V55, P19, DOI 10.1095/biolreprod55.1.19	47	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37713	10.1371/journal.pone.0037713	http://dx.doi.org/10.1371/journal.pone.0037713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662198	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300088
J	Qiu, P				Qiu, Peng			Inferring Phenotypic Properties from Single-Cell Characteristics	PLOS ONE			English	Article							FLOW-CYTOMETRY DATA; AUTOMATED IDENTIFICATION; CANCER; EXPRESSION; CLASSIFICATION; LEUKEMIA; MODEL; DREAM	Flow cytometry provides multi-dimensional data at the single-cell level. Such data contain information about the cellular heterogeneity of bulk samples, making it possible to correlate single-cell features with phenotypic properties of bulk tissues. Predicting phenotypes from single-cell measurements is a difficult challenge that has not been extensively studied. The 6th Dialogue for Reverse Engineering Assessments and Methods (DREAM6) invited the research community to develop solutions to a computational challenge: classifying acute myeloid leukemia (AML) positive patients and healthy donors using flow cytometry data. DREAM6 provided flow cytometry data for 359 normal and AML samples, and the class labels for half of the samples. Researchers were asked to predict the class labels of the remaining half. This paper describes one solution that was constructed by combining three algorithms: spanning-tree progression analysis of density-normalized events (SPADE), earth mover's distance, and a nearest-neighbor classifier called Relief. This solution was among the topper-forming methods that achieved 100% prediction accuracy.	Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Qiu, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	pqiu@mdanderson.org			TCGA Genome Data Analysis Center [U24 CA143883 02 S1]; Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143883] Funding Source: NIH RePORTER	TCGA Genome Data Analysis Center; Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is partially supported by: (1) TCGA Genome Data Analysis Center grant U24 CA143883 02 S1; (2) the Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Finak Greg, 2009, Advances in Bioinformatics, V2009, P247646, DOI 10.1155/2009/247646; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; HAHNE F, 2009, BMC BIOINFORMATICS, V10; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; Nowakowski GS, 2007, MAYO CLIN PROC, V82, P449, DOI 10.4065/82.4.449; O'Neill MC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-13; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pettie S., 1999, J ACM, V49, P49; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Qiu P, 2005, BIOINFORMATICS, V21, P3114, DOI 10.1093/bioinformatics/bti483; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun YJ, 2007, BIOINFORMATICS, V23, P30, DOI 10.1093/bioinformatics/btl543; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Walther Guenther, 2009, Advances in Bioinformatics, V2009, P686759, DOI 10.1155/2009/686759; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	33	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37038	10.1371/journal.pone.0037038	http://dx.doi.org/10.1371/journal.pone.0037038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662133	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300024
J	Kazlauskas, E; Petrikaite, V; Michailoviene, V; Revuckiene, J; Matuliene, J; Grinius, L; Matulis, D				Kazlauskas, Egidijus; Petrikaite, Vilma; Michailoviene, Vilma; Revuckiene, Jurgita; Matuliene, Jurgita; Grinius, Leonas; Matulis, Daumantas			Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90	PLOS ONE			English	Article							SHOCK-PROTEIN 90; THERMAL SHIFT ASSAYS; 1-ANILINO-8-NAPHTHALENE SULFONATE; TITRATION CALORIMETRY; HIT IDENTIFICATION; RADICICOL BINDING; INHIBITORS; DOMAIN; ENERGETICS; CONSTANTS	The design of specific inhibitors against the Hsp90 chaperone and other enzyme relies on the detailed and correct understanding of both the thermodynamics of inhibitor binding and the structural features of the protein-inhibitor complex. Here we present a detailed thermodynamic study of binding of aryl-dihydroxyphenyl-thiadiazole inhibitor series to recombinant human Hsp90 alpha isozyme. The inhibitors are highly potent, with the intrinsic K-d approximately equal to 1 nM as determined by isothermal titration calorimetry (ITC) and thermal shift assay (TSA). Dissection of protonation contributions yielded the intrinsic thermodynamic parameters of binding, such as enthalpy, entropy, Gibbs free energy, and the heat capacity. The differences in binding thermodynamic parameters between the series of inhibitors revealed contributions of the functional groups, thus providing insight into molecular reasons for improved or diminished binding efficiency. The inhibitor binding to Hsp90 alpha primarily depended on a large favorable enthalpic contribution combined with the smaller favorable entropic contribution, thus suggesting that their binding was both enthalpically and entropically optimized. The enthalpy-entropy compensation phenomenon was highly evident when comparing the inhibitor binding enthalpies and entropies. This study illustrates how detailed thermodynamic analysis helps to understand energetic reasons for the binding efficiency and develop more potent inhibitors that could be applied for therapeutic use as Hsp90 inhibitors.	[Kazlauskas, Egidijus; Petrikaite, Vilma; Michailoviene, Vilma; Revuckiene, Jurgita; Matuliene, Jurgita; Grinius, Leonas; Matulis, Daumantas] Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania; [Petrikaite, Vilma] Lithuanian Univ Hlth Sci, Fac Pharm, Dept Drug Chem, Kaunas, Lithuania	Vilnius University; Lithuanian University of Health Sciences	Kazlauskas, E (corresponding author), Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	matulis@ibt.lt	Petrikaite, Vilma/D-3134-2017; Matulis, Daumantas/F-9367-2010; Petrikaite, Vilma/AAN-3351-2020	Matulis, Daumantas/0000-0002-6178-6276; Petrikaite, Vilma/0000-0002-4106-5535; Kazlauskas, Egidijus/0000-0001-8430-7349	Research Council of Lithuania [LIG-16/2010]; Lithuanian Science Council; European Union	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Lithuanian Science Council(Research Council of Lithuania (LMTLT)); European Union(European Commission)	This research was funded by a grant (No. LIG-16/2010) from the Research Council of Lithuania. Vilma Petrikaite thanks the Lithuanian Science Council for the fellowship obtained from the project "Postdoctoral Fellowship Implementation in Lithuania" funded by the European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SR, 1969, BIOCHEMISTRY-US, V8, P371, DOI 10.1021/bi00829a051; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Banz VM, 2009, BBA-MOL CELL RES, V1793, P1597, DOI 10.1016/j.bbamcr.2009.08.002; Barril X, 2006, BIOORG MED CHEM LETT, V16, P2543, DOI 10.1016/j.bmcl.2006.01.099; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Cikotiene I, 2009, BIOORG MED CHEM LETT, V19, P1089, DOI 10.1016/j.bmcl.2009.01.003; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cimmperman P, 2011, RSC BIOMOL SCI, P247; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Freire Ernesto, 2004, Drug Discov Today Technol, V1, P295, DOI 10.1016/j.ddtec.2004.11.016; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Huang KH, 2009, J MED CHEM, V52, P4288, DOI 10.1021/jm900230j; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kung PP, 2010, J MED CHEM, V53, P499, DOI 10.1021/jm901209q; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nilapwar S, 2009, J MOL BIOL, V392, P923, DOI 10.1016/j.jmb.2009.07.041; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Petrikaite V, 2011, APPLICATION OF THERMODYNAMICS TO BIOLOGICAL AND MATERIALS SCIENCE, P77; Petrikaite V, 2011, MEDICINA-LITHUANIA, V47, P413, DOI 10.3390/medicina47080062; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Sgobba M, 2009, CHEMMEDCHEM, V4, P1399, DOI 10.1002/cmdc.200900256; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2011, BIOORGAN MED CHEM, V19, P2603, DOI 10.1016/j.bmc.2011.03.013; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Todd MJ, 2003, GENET ENG NEWS, V23, P28; Toleikis Z, 2011, ANAL BIOCHEM, V413, P171, DOI 10.1016/j.ab.2011.02.019; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zubriene A, 2010, BIOPHYS CHEM, V152, P153, DOI 10.1016/j.bpc.2010.09.003; Zubriene A, 2009, INT J MOL SCI, V10, P2662, DOI 10.3390/ijms10062662; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36899	10.1371/journal.pone.0036899	http://dx.doi.org/10.1371/journal.pone.0036899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655030	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900005
J	Yao, YZ; Ren, D; Rider, DA; Cai, WZ				Yao, Yunzhi; Ren, Dong; Rider, David A.; Cai, Wanzhi			Phylogeny of the Infraorder Pentatomomorpha Based on Fossil and Extant Morphology, with Description of a New Fossil Family from China	PLOS ONE			English	Article							HEMIPTERA HETEROPTERA; YIXIAN FORMATION; INSECTA; GENUS	Background: An extinct new family of Pentatomomorpha, Venicoridae Yao, Ren & Cai fam. nov., with 2 new genera and 2 new species (Venicoris solaris Yao, Ren & Rider gen. & sp. nov. and Clavaticoris zhengi Yao, Ren & Cai gen. & sp. nov.) are described from the Early Cretaceous Yixian Formation in Northeast China. Methodology/Principal Findings: A cladistic analysis based on a combination of fossil and extant morphological characters clarified the phylogenetic status of the new family and has allowed the reconstruction of intersuperfamily and interfamily relationships within the Infraorder Pentatomomorpha. The fossil record and diversity of Pentatomomorpha during the Mesozoic is discussed. Conclusions/Significance: Pentatomomorpha is a monophyletic group; Aradoidea and the Trichophora are sister groups; these fossils belong to new family, treated as the sister group of remainder of Trichophora; Pentatomoidea is a monophyletic group; Piesmatidae should be separated as a superfamily, Piesmatoidea. Origin time of Pentatomomorpha should be tracked back to the Middle or Early Triassic.	[Yao, Yunzhi; Ren, Dong; Cai, Wanzhi] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Rider, David A.] N Dakota State Univ, Dept Entomol, Fargo, ND 58105 USA; [Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Yao, Yunzhi] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China	Capital Normal University; North Dakota State University Fargo; China Agricultural University; Chinese Academy of Sciences	Yao, YZ (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn; david.rider@ndsu.edu			National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [30800095, 31071964, 40872022]; Nature Science Foundation of Beijing [5082002]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [131021]; Beijing Municipal Education Commission of China [KM201210028016]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123114]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Beijing Municipal Education Commission of China(Beijing Municipal Commission of Education); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	This research is partly supported by grants from the National Basic Research Program of China (973 Program) (No. 2012CB821900); National Natural Science Foundation of China (Nos. 30800095, 31071964, 40872022); Nature Science Foundation of Beijing (No. 5082002); Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (No. 131021); The General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (No. KM201210028016); and the State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Migdisova E. E., 1962, OSNOVY PALEONTOLOGII, P208; Carver M., 1991, P429; Cassis G, 2010, CLADISTICS, V26, P262, DOI 10.1111/j.1096-0031.2009.00283.x; Chen W., 2005, J STRATIGRAPHY, V29, P582; DRAKE CARL J., 1958, ANN ENT SOC AMER, V51, P567; Franzosa EA, 2007, TREEROT VERSION 3; Giebel CG, 1856, FAUNA VORWELT MIT ST, V2; Goloboff P., 1999, NONA NO NAME VERSION; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Handlirsch A., 1939, ANN NATURHISTORISCHE, V49, P1; Heiss Ernst, 2001, Carolinea, V59, P99; Henry T. J., 1988, CATALOG HETEROPTERA; Henry TJ, 1997, ANN ENTOMOL SOC AM, V90, P275, DOI 10.1093/aesa/90.3.275; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; KORMILEV NA, 1986, J NAT HIST, V20, P279, DOI 10.1080/00222938600770231; Leston D., 1962, Proceedings of the Royal Entomological Society of London (A), V37, P135; Li HM, 2005, MOL PHYLOGENET EVOL, V37, P313, DOI 10.1016/j.ympev.2005.07.013; LI XZ, 1994, ZOOLOGICAL SOC CHINA, P1; Lin Q.-b., 1985, Acta Palaeontologica Sinica, V24, P300; Lin Q.-b., 1992, Acta Palaeontologica Sinica, V31, P313; Lin Q.B., 1986, EARLY MESOZOIC FOSSI, P54; Liu YS, 2007, CRETACEOUS RES, V28, P322, DOI 10.1016/j.cretres.2006.08.003; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Nixon K. C., 2002, WINCLADA VER 1 00 08; Pinto I. D., 1974, 28 C BRAS GEOL, V2, P289; Popov Y.A., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P166; Popov Y.A., 1986, INSECTS EARLY CRETAC, VVolume 28, P47; POPOV YA, 1977, SYST ENTOMOL, V2, P333, DOI 10.1111/j.1365-3113.1977.tb00382.x; Popov Yu.A., 1990, Trudy Paleontologicheskogo Instituta, V239, P20; Popov Yuri A., 1994, Genus (Wroclaw), V5, P307; Ren D., 1995, FAUNAE STRATIGRAPHY; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; SCHAEFER CW, 1993, EUR J ENTOMOL, V90, P105; Schuh R. T., 1995, CLASSIFICATION NATUR; Schuh R.T., 1979, SYST ZOOL, V28, P653, DOI DOI 10.2307/2412577; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1986, ANNU REV ENTOMOL, V31, P67, DOI 10.1146/annurev.en.31.010186.000435; SCOTESE C, 2009, PALEOMAP PROJECT; Shcherbakov DE, 2002, SUPERORDER CIMICIDEA, P143; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; Sweet Merrill H., 1996, P119; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; WOOTTON RJ, 1986, SYST ENTOMOL, V11, P389, DOI 10.1111/j.1365-3113.1986.tb00191.x; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Yao YZ, 2006, ANN ZOOL, V56, P753; Yao YZ, 2007, ZOOTAXA, P59, DOI 10.11646/zootaxa.1388.1.5; Yao Y, 2006, ZOOTAXA, P41; Yao YZ, 2006, ZOOTAXA, P1; Yao YZ, 2006, ZOOTAXA, P57; Yunzhi Y, 2008, ACTA GEOL SIN-ENGL, V82, P35; Zhang BL, 2006, ACTA GEOL SIN-ENGL, V80, P327; Zhang S.M., 1985, EC INSECT FAUNA CHIN; Zhou Zhonghe, 2006, P705	57	40	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37289	10.1371/journal.pone.0037289	http://dx.doi.org/10.1371/journal.pone.0037289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655038	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900013
J	Stehberg, J; Moraga-Amaro, R; Salazar, C; Becerra, A; Echeverria, C; Orellana, JA; Bultynck, G; Ponsaerts, R; Leybaert, L; Simon, F; Saez, JC; Retamal, MA				Stehberg, Jimmy; Moraga-Amaro, Rodrigo; Salazar, Christian; Becerra, Alvaro; Echeverria, Cesar; Orellana, Juan A.; Bultynck, Geert; Ponsaerts, Raf; Leybaert, Luc; Simon, Felipe; Saez, Juan C.; Retamal, Mauricio A.			Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala	FASEB JOURNAL			English	Article						astrocyte; amnesia; gliotransmitters; learning	GAP-JUNCTION HEMICHANNELS; LONG-TERM POTENTIATION; GLUTAMATE RELEASE; GLIAL-CELLS; ASTROCYTES; EXPRESSION; CHANNEL; NETWORKS; PANNEXIN; BLOCKERS	Recent in vitro evidence indicates that astrocytes can modulate synaptic plasticity by releasing neuroactive substances (gliotransmitters). However, whether gliotransmitter release from astrocytes is necessary for higher brain function in vivo, particularly for memory, as well as the contribution of connexin (Cx) hemichannels to gliotransmitter release, remain elusive. Here, we microinfused into the rat basolateral amygdala (BLA) TAT-Cx43L2, a peptide that selectively inhibits Cx43-hemichannel opening while maintaining synaptic transmission or interastrocyte gap junctional communication. In vivo blockade of Cx43 hemichannels during memory consolidation induced amnesia for auditory fear conditioning, as assessed 24 h after training, without affecting short-term memory, locomotion, or shock reactivity. The amnesic effect was transitory, specific for memory consolidation, and was confirmed after microinfusion of Gap27, another Cx43-hemichannel blocker. Learning capacity was recovered after coinfusion of TAT-Cx43L2 and a mixture of putative gliotransmitters (glutamate, glutamine, lactate, D-serine, glycine, and ATP). We propose that gliotransmitter release from astrocytes through Cx43 hemichannels is necessary for fear memory consolidation at the BLA. Thus, the present study is the first to demonstrate a physiological role for astroglial Cx43 hemichannels in brain function, making these channels a novel pharmacological target for the treatment of psychiatric disorders, including post-traumatic stress disorder.-Stehberg, J., Moraga-Amaro, R., Salazar, C., Becerra, A., Echeverria, C., Orellana, J. A., Bultynck, G., Ponsaerts, R., Leybaert, L., Simon, F., Saez, J. C., Retamal, M. A. Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. FASEB J. 26, 3649-3657 (2012). www.fasebj.org.	[Stehberg, Jimmy; Moraga-Amaro, Rodrigo; Salazar, Christian] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Neurobiol Lab, Santiago, Chile; [Becerra, Alvaro; Echeverria, Cesar; Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Fisiopatol Integrat, Santiago, Chile; [Stehberg, Jimmy] Univ Andres Bello, Ctr Invest Biomed, Santiago, Chile; [Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Bultynck, Geert; Ponsaerts, Raf] Katholieke Univ Leuven, Dept Cell & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium; [Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Saez, Juan C.] Ctr Interdiciplinario Neurociencias Valparaiso, Inst Milenio, Valparaiso, Chile; [Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Fac Med, Dept Fisiol, Santiago, Chile; [Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Pontificia Universidad Catolica de Chile; KU Leuven; Ghent University; Universidad del Desarrollo	Stehberg, J (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Neurobiol Lab, Santiago, Chile.	jstehberg@unab.cl	Orellana, Juan A./F-6148-2012; Echeverría, César/AAH-4994-2019; Leybaert, Luc/F-4079-2015	Echeverría, César/0000-0001-5431-7183; Leybaert, Luc/0000-0001-6452-6982; Orellana, Juan Andres/0000-0003-4076-207X; Bultynck, Geert/0000-0002-5968-4828; Retamal, Mauricio A./0000-0003-2562-6686; Simon, Felipe/0000-0002-2653-9798	Universidad Andres Bello [(UNAB) AR-05-09, UNAB AR-01-10, UNAB DI-02-11/N, UNAB DI-33-11/R]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1121078]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D07I1086]; FONDECYT [1120214, 1070591]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Research Council of the Katholieke Universiteit Leuven (Leuven, Belgium) [GOA/09/012]; Interuniversity Attraction Poles Program Belgian Science Policy [P6/28, P6/31, P7]; Research Foundation-Flanders (FWO) [G.0298.11]; FWO; Anillo [ACT71]	Universidad Andres Bello; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy; Research Council of the Katholieke Universiteit Leuven (Leuven, Belgium); Interuniversity Attraction Poles Program Belgian Science Policy(Belgian Federal Science Policy Office); Research Foundation-Flanders (FWO)(FWO); FWO(FWO); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	The authors thank Dr. Gabriel Leon, Juan Pablo Morales Montenegro, Juan Pablo Donoso Ramos, Mar a Viviana Moreno, Gabriela Andaur, Francia Quintana, Raul Galarce and Fernando Bustos for technical assistance. This work was partially supported by grants Universidad Andres Bello (UNAB) AR-05-09 (J.S.), UNAB AR-01-10 (J.S.), UNAB DI-02-11/N (J.S.), UNAB DI-33-11/R (F. S.), Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1121078 (F. S.), Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) D07I1086 (J.C.S.), FONDECYT 1120214 (M. A. R), FONDECYT 1070591, Millennium Institute on Immunology and Immunotherapy P09-016-F (F. S.), and Anillo ACT71 (J.C.S.), by the Research Council of the Katholieke Universiteit Leuven (Leuven, Belgium) via the Concerted Actions program GOA/09/012 (G. B.), and by the Interuniversity Attraction Poles Program Belgian Science Policy P6/28 (G. B.) and P6/31 and P7 (L. L.) and by the Research Foundation-Flanders (FWO) through research grant G.0298.11 (G. B. and L. L.) and the FWO-sponsored Cx/Panx research network.	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bonansco C, 2011, EUR J NEUROSCI, V33, P1483, DOI 10.1111/j.1460-9568.2011.07631.x; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Domingues AMD, 2010, NEUROCHEM INT, V57, P359, DOI 10.1016/j.neuint.2010.03.024; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Frisch C, 2003, EUR J NEUROSCI, V18, P2313, DOI 10.1046/j.1460-9568.2003.02971.x; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Genever PG, 2001, FASEB J, V15, P1586, DOI 10.1096/fj.00-0594fje; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; GUTNICK MJ, 1981, BRAIN RES, V213, P486, DOI 10.1016/0006-8993(81)90259-6; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Jiang S, 2011, BRAIN RES, V1392, P8, DOI 10.1016/j.brainres.2011.03.056; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ponsaerts R, 2012, BIOL CELL, V104, P367, DOI 10.1111/boc.201100079; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rudkouskaya A, 2008, J NEUROCHEM, V105, P2260, DOI 10.1111/j.1471-4159.2008.05312.x; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Welsh DK, 1996, BRAIN RES, V706, P30, DOI 10.1016/0006-8993(95)01172-2; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	46	162	170	1	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3649	3657		10.1096/fj.11-198416	http://dx.doi.org/10.1096/fj.11-198416			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22665389				2022-12-25	WOS:000308391600007
J	Chen, Y; Lu, H; Liu, Q; Huang, GC; Lim, CP; Zhang, LH; Hao, AJ; Cao, XM				Chen, Yong; Lu, Hao; Liu, Qian; Huang, Guochang; Lim, Cheh Peng; Zhang, Lianhui; Hao, Aijun; Cao, Xinmin			Function of GRIM-19, a Mitochondrial Respiratory Chain Complex I Protein, in Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; HYDROGEN-PEROXIDE; AUTOPHAGY; NLRX1; IDENTIFICATION; MACROPHAGES; RECEPTOR; PATHWAY; TARGETS	Mitochondria respiratory chain (RC), consisting of five multisubunit complexes, is crucial for cellular energy production, reactive oxygen species generation, and regulation of apoptosis. Recently, a few mitochondrial proteins have been reported to be essential for innate immunity, but the function of mitochondrial RC in innate immunity is largely unknown. By knock-out of GRIM-19, a newly identified subunit protein of mitochondrial complex I, in mice, we found that heterogeneous mice (GRIM-19(+/-)) are prone to spontaneous urinary tract infection, mostly by Staphylococcus saprophyticus. Macrophages derived from these mice have compromised mitochondrial complex I activity and increased reactive oxygen species level. Bacterial infection induces a rapid up-regulation of GRIM-19 and complex I activity in the wild-type macrophages, but both are reduced in the macrophages from GRIM-19(+/-) mice. These cells also have decreased intracellular killing ability against S. saprophyticus. The defects for this probably occur in the fusion of bacteria to lysosome, but not in the bacterial engulfment and macrophage migration. In addition, production of proinflammatory cytokines, such as interleukin (IL)-1, IL-12, IL-6, and interferon (IFN)-gamma, induced by both bacterial infection and lipopolysaccharide (LPS) and monodansylcadaverine treatment, is also decreased in the GRIM19(+/-) macrophages. Inhibition of mitochondrial RC activity by inhibitors shows a similar reduction on the cytokine production. Due to low cytokine production, the inflammatory response caused by in vivo bacterial challenge in the bladders of GRIM-19(+/-) mice is compromised. This study provides genetic evidence for a critical role of mitochondrial RC in innate immunity.	[Liu, Qian; Hao, Aijun; Cao, Xinmin] Shandong Univ, Dept Histol & Embryol, Jinan 250012, Peoples R China; [Chen, Yong; Lu, Hao; Huang, Guochang; Lim, Cheh Peng; Zhang, Lianhui; Cao, Xinmin] ASTAR, Inst Mol & Cell Biol, Biopolis, Singapore 138632, Singapore	Shandong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hao, AJ (corresponding author), Shandong Univ, Dept Histol & Embryol, 44 Wenhua Xi Rd, Jinan 250012, Peoples R China.	aijunhao@sdu.edu.cn; mcbcaoxm@gmail.com			Agency for Science, Technology and Research of Singapore; Natural Science Foundation of China [81071057]	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agency for Science, Technology and Research of Singapore and the Natural Science Foundation of China Grant 81071057.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cao XM, 2009, SEMIN CELL DEV BIOL, V20, P337, DOI 10.1016/j.semcdb.2008.12.014; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen Y, 2007, MOL CELL BIOL, V27, P6420, DOI 10.1128/MCB.01946-06; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Raz R, 2005, CLIN INFECT DIS, V40, P896, DOI 10.1086/428353; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975	34	37	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27227	27235		10.1074/jbc.M112.340315	http://dx.doi.org/10.1074/jbc.M112.340315			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665480	Green Published, hybrid			2022-12-25	WOS:000307386000074
J	Bardowell, SA; Duan, FP; Manor, D; Swanson, JE; Parker, RS				Bardowell, Sabrina A.; Duan, Faping; Manor, Danny; Swanson, Joy E.; Parker, Robert S.			Disruption of Mouse Cytochrome P450 4f14 (Cyp4f14 Gene) Causes Severe Perturbations in Vitamin E Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOCOPHEROL TRANSFER PROTEIN; ALPHA-TOCOPHEROL; OMEGA-HYDROXYLASE; GAMMA-TOCOPHEROL; COMMON VARIANTS; LEUKOTRIENE B-4; HEPG2 CELLS; FATTY-ACIDS; HUMAN URINE; TOCOTRIENOLS	Vitamin E is a family of naturally occurring and structurally related lipophilic antioxidants, one of which, alpha-tocopherol (alpha-TOH), selectively accumulates in vertebrate tissues. The omega-hydroxylase cytochrome P450-4F2 (CYP4F2) is the only human enzyme shown to metabolize vitamin E. Using cDNA cloning, cell culture expression, and activity assays, we identified Cyp4f14 as a functional murine ortholog of CYP4F2. We then investigated the effect of Cyp4f14 deletion on vitamin E metabolism and status in vivo. Cyp4f14-null mice exhibited substrate-specific reductions in liver microsomal vitamin E-omega-hydroxylase activity ranging from 93% (gamma-TOH) to 48% (gamma-tocotrienol). In vivo data obtained from metabolic cage studies showed whole-body reductions in metabolism of gamma-TOH of 90% and of 68% for delta- and alpha-TOH. This metabolic deficit in Cyp4f14(-/-) mice was partially offset by increased fecal excretion of nonmetabolized tocopherols and of novel omega-1- and omega-2-hydroxytocopherols. 12'-OH-gamma-TOH represented 41% of whole-body production of gamma-TOH metabolites in Cyp4f14(-/-) mice fed a soybean oil diet. Despite these counterbalancing mechanisms, Cyp4f14-null mice fed this diet for 6 weeks hyper-accumulated gamma-TOH (2-fold increase over wild-type litter-mates) in all tissues and appeared normal. We conclude that CYP4F14 is the major but not the only vitamin E-omega-hydroxylase in mice. Its disruption significantly impairs whole-body vitamin E metabolism and alters the widely conserved phenotype of preferential tissue deposition of alpha-TOH. This model animal and its derivatives will be valuable in determining the biological actions of specific tocopherols and tocotrienols in vivo.	[Bardowell, Sabrina A.; Swanson, Joy E.; Parker, Robert S.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14850 USA; [Duan, Faping] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA; [Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Cornell University; Cornell University; Case Western Reserve University; Case Western Reserve University	Parker, RS (corresponding author), Cornell Univ, Div Nutr Sci, 226 Savage Hall, Ithaca, NY 14850 USA.	rsp3@cornell.edu		Gardner, Sabrina/0000-0003-2566-3743	National Institutes of Health [DK067494, DK007158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494, T32DK007158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR007091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067494 (to D. M.) and DK007158 (to S. A. B.).	Bardowel SA, 2010, J NUTR, V140, P1901, DOI 10.3945/jn.110.128579; BIERI JG, 1973, J AM DIET ASSOC, V62, P147; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Christmas P, 2001, J BIOL CHEM, V276, P38166; Cooney RV, 2001, NUTR CANCER, V39, P66, DOI 10.1207/S15327914nc391_9; Dial Steve, 1995, P327; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Jiang Q, 2002, FREE RADICAL BIO MED, V33, P1534, DOI 10.1016/S0891-5849(02)01091-2; Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Mustacich DJ, 2009, J NUTR BIOCHEM, V20, P469, DOI 10.1016/j.jnutbio.2008.05.007; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Parker RS, 2000, BIOCHEM BIOPH RES CO, V277, P531, DOI 10.1006/bbrc.2000.3706; Parker RS, 2005, BIOCHEM BIOPH RES CO, V338, P1537, DOI 10.1016/j.bbrc.2005.10.124; Parker RS, 2000, BIOCHEM BIOPH RES CO, V269, P580, DOI 10.1006/bbrc.2000.2319; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; SCHONFELD A, 1993, NAHRUNG, V37, P498; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Swanson JE, 1999, J LIPID RES, V40, P665; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wechter WJ, 1996, P NATL ACAD SCI USA, V93, P6002, DOI 10.1073/pnas.93.12.6002; Yamane M, 2000, J BIOCHEM-TOKYO, V128, P827, DOI 10.1093/oxfordjournals.jbchem.a022821; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0; You CS, 2005, J NUTR, V135, P227, DOI 10.1093/jn/135.2.227; Zhao Y, 2010, J AGR FOOD CHEM, V58, P4844, DOI 10.1021/jf904464u	31	47	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26077	26086		10.1074/jbc.M112.373597	http://dx.doi.org/10.1074/jbc.M112.373597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665481	Green Published, hybrid			2022-12-25	WOS:000306916300035
J	Yu, PL; Zhang, ZH; Hao, BX; Zhao, YJ; Zhang, LH; Lee, HC; Zhang, LR; Yue, JB				Yu, Pei-Lin; Zhang, Zhe-Hao; Hao, Bai-Xia; Zhao, Yong-Juan; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren; Yue, Jianbo			A Novel Fluorescent Cell Membrane-permeable Caged Cyclic ADP-ribose Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE DIPHOSPHORIBOSE; RYANODINE RECEPTOR; CADPR; CA2+; ACTIVATION; CHANNEL; TRPM2; DISSOCIATION; MIMICS; NAADP	Cyclic adenosine diphosphate ribose is an endogenous Ca2+ mobilizer involved in diverse cellular processes. A cell membrane-permeable cyclic adenosine diphosphate ribose analogue, cyclic inosine diphosphoribose ether (cIDPRE), can induce Ca2+ increase in intact human Jurkat T-lymphocytes. Here we synthesized a coumarin-caged analogue of cIDPRE (Co-i-cIDPRE), aiming to have a precisely temporal and spatial control of bioactive cIDPRE release inside the cell using UV uncaging. We showed that Co-i-cIDPRE accumulated inside Jurkat cells quickly and efficiently. Uncaging of Co-i-cIDPRE evoked Ca2+ release from endoplasmic reticulum, with concomitant Ca2+ influx in Jurkat cells. Ca2+ release evoked by uncaged Co-i-cIDPRE was blocked by knockdown of ryanodine receptors (RyRs) 2 and 3 in Jurkat cells. The associated Ca2+ influx, on the other hand, was abolished by double knockdown of Stim1 and TRPM2 in Jurkat cells. Furthermore, Ca2+ release or influx evoked by uncaged Co-i-cIDPRE was recapitulated in HEK293 cells that overexpress RyRs or TRPM2, respectively, but not in wild-type cells lacking these channels. In summary, our results indicate that uncaging of Co-i-cIDPRE incites Ca2+ release from endoplasmic reticulum via RyRs and triggers Ca2+ influx via TRPM2.	[Yu, Pei-Lin; Zhang, Li-He; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China; [Yu, Pei-Lin; Zhang, Zhe-Hao; Hao, Bai-Xia; Zhao, Yong-Juan; Lee, Hon-Cheung; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Peking University; University of Hong Kong	Zhang, LR (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.	liangren@bjmu.edu.cn; jyue@hku.hk	Zhang, Liang/GWM-6088-2022; Yue, Jianbo/AAC-4588-2019; Zhao, Yongjuan/AAS-9919-2021; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447; Zhao, Yong Juan/0000-0003-4564-1912; Hao, Helen Baixia/0000-0002-5648-3705	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong [N_HKU 737/09]; NSFC [20910094, 90713005]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong; NSFC(National Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) Grants HKU 784710M, HKU 782709M, and HKU 785911M, a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (Grant N_HKU 737/09), NSFC Grant 20910094 and 90713005, and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	AARHUS R, 1995, J BIOL CHEM, V270, P7745, DOI 10.1074/jbc.270.13.7745; Dong M, 2010, ORG BIOMOL CHEM, V8, P4705, DOI 10.1039/c0ob00090f; Fukuoka M, 2000, J ORG CHEM, V65, P5238, DOI 10.1021/jo0000877; Furuta T, 1996, BIOCHEM BIOPH RES CO, V228, P193, DOI 10.1006/bbrc.1996.1638; Galione A, 2000, Sci STKE, V2000, ppe1; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2005, J BIOL CHEM, V280, P15952, DOI 10.1074/jbc.M414032200; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Higashida H, 2007, NEUROCHEM INT, V51, P192, DOI 10.1016/j.neuint.2007.06.023; Kirchberger T, 2006, BRIT J PHARMACOL, V149, P337, DOI 10.1038/sj.bjp.0706869; Kirchberger T, 2009, BIOCHEM J, V422, P139, DOI 10.1042/BJ20082308; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lagisetti C, 2007, J ORG CHEM, V72, P9886, DOI 10.1021/jo0711900; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; Li LJ, 2008, TETRAHEDRON LETT, V49, P4491, DOI 10.1016/j.tetlet.2008.05.076; Li LJ, 2010, ORG BIOMOL CHEM, V8, P1843, DOI 10.1039/b925295a; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Qi N, 2011, CHEM COMMUN, V47, P9462, DOI 10.1039/c1cc13062e; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shirato M, 1995, Nucleic Acids Symp Ser, P165; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Shuto Satoshi, 2007, Nucleic Acids Symp Ser (Oxf), P109; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Thomas JM, 2002, CURR BIOL, V12, P2018, DOI 10.1016/S0960-9822(02)01335-0; Thomas JM, 2001, BIOCHEM J, V359, P451, DOI 10.1042/0264-6021:3590451; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; WALSETH TF, 1993, J BIOL CHEM, V268, P26686; Wong L, 1999, BBA-GEN SUBJECTS, V1472, P555, DOI 10.1016/S0304-4165(99)00161-0; Wu HM, 2010, NEW J CHEM, V34, P956, DOI 10.1039/b9nj00595a; Xu JF, 2006, J MED CHEM, V49, P5501, DOI 10.1021/jm060320e; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang B, 2008, J ORG CHEM, V73, P1693, DOI 10.1021/jo071236p; Zhang B, 2008, J MED CHEM, V51, P1623, DOI 10.1021/jm7010386; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang X, 2009, CARDIOVASC RES, V84, P253, DOI 10.1093/cvr/cvp212	41	23	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24774	24783		10.1074/jbc.M111.329854	http://dx.doi.org/10.1074/jbc.M111.329854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661714	Green Published, hybrid			2022-12-25	WOS:000306651100070
J	Godefroit, P; Bolotsky, YL; Lauters, P				Godefroit, Pascal; Bolotsky, Yuri L.; Lauters, Pascaline			A New Saurolophine Dinosaur from the Latest Cretaceous of Far Eastern Russia	PLOS ONE			English	Article							LAMBEOSAURINE DINOSAUR; HADROSAURIDAE; ORIGIN	Background: Four main dinosaur sites have been investigated in latest Cretaceous deposits from the Amur/Heilongjiang Region: Jiayin and Wulaga in China (Yuliangze Formation), Blagoveschensk and Kundur in Russia (Udurchukan Formation). More than 90% of the bones discovered in these localities belong to hollow-crested lambeosaurine saurolophids, but flat-headed saurolophines are also represented: Kerberosaurus manakini at Blagoveschensk and Wulagasaurus dongi at Wulaga. Methodology/Principal Findings: Herein we describe a new saurolophine dinosaur, Kundurosaurus nagornyi gen. et sp. nov., from the Udurchukan Formation (Maastrichtian) of Kundur, represented by disarticulated cranial and postcranial material. This new taxon is diagnosed by four autapomorphies. Conclusions/Significance: A phylogenetic analysis of saurolophines indicates that Kundurosaurus nagornyi is nested within a rather robust clade including Edmontosaurus spp., Saurolophus spp., and Prosaurolophus maximus, possibly as a sister-taxon for Kerberosaurus manakini also from the Udurchukan Formation of Far Eastern Russia. The high diversity and mosaic distribution of Maastrichtian hadrosaurid faunas in the Amur-Heilongjiang region are the result of a complex palaeogeographical history and imply that many independent hadrosaurid lineages dispersed without any problem between western America and eastern Asia at the end of the Cretaceous.	[Godefroit, Pascal; Lauters, Pascaline] Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1040 Brussels, Belgium; [Bolotsky, Yuri L.] Russian Acad Sci, Inst Geol & Nat Management, Far Eastern Branch, Blagoveshchensk, Russia; [Lauters, Pascaline] Univ Libre Bruxelles, Sect Anthropol, Brussels, Belgium	Institute of Geology & Nature Management FEB RAS; Russian Academy of Sciences; Universite Libre de Bruxelles	Godefroit, P (corresponding author), Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1040 Brussels, Belgium.	Pascal.Godefroit@naturalsciences.be	Lauters, Pascaline/AAJ-8493-2020		Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program) [BL/36/C22 - R12]; Russian Foundation of Basic Research [07-05-00168]; Far Eastern Branch of Russian Academy of Sciences [06-III-A-06-477]; Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Far Eastern Branch of Russian Academy of Sciences(Russian Academy of Sciences); Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	Excavation, preparation, and study of the specimen were supported by grants from the Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program BL/36/C22 - R12), from the Russian Foundation of Basic Research (07-05-00168), and from the Far Eastern Branch of Russian Academy of Sciences (06-III-A-06-477). The excavations at Kundur were also supported, from a logistic point of view, by the gold-mining company Pakrovskiy Rudnik. PL's research was supported by a grant from the Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifanov VR, 2002, CRETACEOUS CONTINENT, P25; Averianov A. O., 2002, CRETACEOUS CONTINENT, P27; Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Brett-Surman M.K., 1989, REVISION HADROSAURID, P1; Brown B, 1914, B AM MUS NAT HIST, V33, P559; Brown B, 1913, B AM MUS NAT HIST, V32, P395; Danilov I. G., 2002, Russian Journal of Herpetology, V9, P155; Fiorillo AR, 2008, GEOL SOC AM SPEC PAP, V442, P313, DOI 10.1130/2008.442(15); Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit Pascal, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V71, P119; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit P, 2012, ACTA PALAEONTOL POL, V57, P527, DOI 10.4202/app.2011.0051; Godefroit P, 2009, NATURWISSENSCHAFTEN, V96, P495, DOI 10.1007/s00114-008-0499-0; Goloboff PA, TNT TREE ANAL USING; Hopson J.A., 1979, P39; HOPSON J A, 1975, Paleobiology, V1, P21; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; LAMBE LM, 1920, MEMOIRS CANADIAN GEO, V120, P1; Langston W., 1960, Fieldiana Geology Memoir, V3, P313; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Markevich V.S., 2001, FLORA DINOZAVRY GRAN, P79; MARYANSKA T, 1979, LETHAIA, V12, P265, DOI 10.1111/j.1502-3931.1979.tb01006.x; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; Nichols DJ, 2004, MESOZOIC SYSTEMS ROC, P503; NICHOLS DJ, 1993, GEOLOGICAL ASS CANAD, V39, P539; Nixon K. C., 2002, WINCLADA VER 1 00 08; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Parks W.A., 1919, T ROY SOC CAN SECT 3, V13, P51; Pinna G., 1979, MEM SOC ITAL SCI NAT, V22, P33; Prieto-Marquez A, 2005, J VERTEBR PALEONTOL, V25, P144, DOI 10.1671/0272-4634(2005)025[0144:NIOTCO]2.0.CO;2; Prieto-Marquez A., 2010, ZOOLOGICAL J LINNEAN, V159, P135; Prieto-Marquez Albert, 2007, P91; Riabinin A.N., 1930, MEMOIRES SOC PALEONT, V2, P1; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Rozhdestvensky AK, 1968, UPPER PALEOZOIC MESO, P97; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Tumanova TA, 2004, PALEONTOL J+, V38, P73; Van Itterbeeck J, 2005, GEOL MAG, V142, P735, DOI 10.1017/S0016756805001226; Wagner J.R., 2001, THESIS TEXAS TECH U; Wu W, 2010, GLOBAL GEOLOGY, V29, P1	47	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36849	10.1371/journal.pone.0036849	http://dx.doi.org/10.1371/journal.pone.0036849			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666331	gold, Green Published			2022-12-25	WOS:000305353400014
J	Lim, YM; Hayashi, S; Tsuda, L				Lim, Young-Mi; Hayashi, Shigeo; Tsuda, Leo			Ebi/AP-1 Suppresses Pro-Apoptotic Genes Expression and Permits Long-Term Survival of Drosophila Sensory Neurons	PLOS ONE			English	Article							OXIDATIVE STRESS; HEARING-LOSS; CELL-DEATH; TRANSCRIPTION FACTOR; COREPRESSOR COMPLEX; DEGENERATION; ACTIVATION; REPRESSION; ANGIOGENESIS; CHECKPOINT	Sensory organs are constantly exposed to physical and chemical stresses that collectively threaten the survival of sensory neurons. Failure to protect stressed neurons leads to age-related loss of neurons and sensory dysfunction in organs in which the supply of new sensory neurons is limited, such as the human auditory system. Transducin beta-like protein 1 (TBL1) is a candidate gene for ocular albinism with late-onset sensorineural deafness, a form of X-linked age-related hearing loss. TBL1 encodes an evolutionarily conserved F-box-like and WD40 repeats-containing subunit of the nuclear receptor co-repressor/silencing mediator for retinoid and thyroid hormone receptor and other transcriptional co-repressor complexes. Here we report that a Drosophila homologue of TBL1, Ebi, is required for maintenance of photoreceptor neurons. Loss of ebi function caused late-onset neuronal apoptosis in the retina and increased sensitivity to oxidative stress. Ebi formed a complex with activator protein 1 (AP-1) and was required for repression of Drosophila pro-apoptotic and anti-apoptotic genes expression. These results suggest that Ebi/AP-1 suppresses basal transcription levels of apoptotic genes and thereby protects sensory neurons from degeneration.	[Lim, Young-Mi; Tsuda, Leo] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan; [Hayashi, Shigeo] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo, Japan; [Hayashi, Shigeo] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan	National Center for Geriatrics & Gerontology; RIKEN; Kobe University	Lim, YM (corresponding author), Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan.	ltsuda@ncgg.go.jp	Hayashi, Shigeo/J-9628-2019; Hayashi, Shigeo/N-5128-2015	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290	Ministry of Education and Scientific Research for Priority Areas in Japan	Ministry of Education and Scientific Research for Priority Areas in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been funded by a Grant-in-Aid from the Ministry of Education and Scientific Research for Priority Areas in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Bassi MT, 1999, AM J HUM GENET, V64, P1604, DOI 10.1086/302408; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Guenther MG, 2000, GENE DEV, V14, P1048; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lambert C, 2003, APOPTOSIS, V8, P551, DOI 10.1023/A:1026113222478; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogita K, 2000, NEUROREPORT, V11, P859, DOI 10.1097/00001756-200003200-00040; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; PERKINS KK, 1988, EMBO J, V7, P4265, DOI 10.1002/j.1460-2075.1988.tb03324.x; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xiang L, 2011, AGING-US, V3, P1098, DOI 10.18632/aging.100396; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200; Zine A, 2004, CNS NEUROL DISORD-DR, V3, P325, DOI 10.2174/1568007043337166	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37028	10.1371/journal.pone.0037028	http://dx.doi.org/10.1371/journal.pone.0037028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666340	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400020
J	Arapitsas, P; Scholz, M; Vrhovsek, U; Di Blasi, S; Bartolini, AB; Masuero, D; Perenzoni, D; Rigo, A; Mattivi, F				Arapitsas, Panagiotis; Scholz, Matthias; Vrhovsek, Urska; Di Blasi, Stefano; Bartolini, Alessandra Biondi; Masuero, Domenico; Perenzoni, Daniele; Rigo, Adelio; Mattivi, Fulvio			A Metabolomic Approach to the Study of Wine Micro-Oxygenation	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FLIGHT MASS-SPECTROMETRY; SUPPORT VECTOR MACHINES; COLOR-RELATED PHENOLICS; OAK CHIP TREATMENTS; RED WINES; MALOLACTIC FERMENTATION; MULTIVARIATE-STATISTICS; VOLATILE COMPOSITION; VITIS-VINIFERA	Wine micro-oxygenation is a globally used treatment and its effects were studied here by analysing by untargeted LC-MS the wine metabolomic fingerprint. Eight different procedural variations, marked by the addition of oxygen (four levels) and iron (two levels) were applied to Sangiovese wine, before and after malolactic fermentation. Data analysis using supervised and unsupervised multivariate methods highlighted some known candidate biomarkers, together with a number of metabolites which had never previously been considered as possible biomarkers for wine micro-oxygenation. Various pigments and tannins were identified among the known candidate biomarkers. Additional new information was obtained suggesting a correlation between oxygen doses and metal contents and changes in the concentration of primary metabolites such as arginine, proline, tryptophan and raffinose, and secondary metabolites such as succinic acid and xanthine. Based on these findings, new hypotheses regarding the formation and reactivity of wine pigment during micro-oxygenation have been proposed. This experiment highlights the feasibility of using unbiased, untargeted metabolomic fingerprinting to improve our understanding of wine chemistry.	[Arapitsas, Panagiotis; Vrhovsek, Urska; Masuero, Domenico; Perenzoni, Daniele; Mattivi, Fulvio] Fdn Edmund Mach, Dept Food Qual & Nutr, Res & Innovat Ctr, San Michele All Adige, Italy; [Scholz, Matthias] Fdn Edmund Mach, Res & Innovat Ctr, Dept Computat Biol, San Michele All Adige, Italy; [Di Blasi, Stefano; Bartolini, Alessandra Biondi] Consorzio Tuscania, Florence, Italy; [Rigo, Adelio] Univ Padua, Dept Biol Chem, Padua, Italy	Fondazione Edmund Mach; Fondazione Edmund Mach; University of Padua	Arapitsas, P (corresponding author), Fdn Edmund Mach, Dept Food Qual & Nutr, Res & Innovat Ctr, San Michele All Adige, Italy.	fulvio.mattivi@fmach.it	Arapitsas, Panagiotis/N-5179-2019; Mattivi, Fulvio/B-7645-2011; Scholz, Matthias/B-3508-2018; Di Blasi, Stefano/AAT-2030-2021; Arapitsas, Panagiotis/B-7763-2011	Arapitsas, Panagiotis/0000-0002-9378-9287; Mattivi, Fulvio/0000-0003-4935-5876; Scholz, Matthias/0000-0003-1414-5924; Arapitsas, Panagiotis/0000-0002-9378-9287; Masuero, Domenico/0000-0003-0696-3206				Alcalde-Eon C, 2006, ANAL CHIM ACTA, V563, P238, DOI 10.1016/j.aca.2005.11.028; Atanasova V, 2002, ANAL CHIM ACTA, V458, P15, DOI 10.1016/S0003-2670(01)01617-8; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boccard J, 2010, CHEMOMETR INTELL LAB, V104, P20, DOI 10.1016/j.chemolab.2010.03.003; Bodan M, 2010, CROAT MED J, V51, P16; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boulton R. B., 1996, PRINCIPLES PRACTICES, DOI DOI 10.1007/978-1-4615-1781-8; Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4; Cano-Lopez M, 2008, J AGR FOOD CHEM, V56, P5932, DOI 10.1021/jf8006147; Cano-Lopez M, 2006, AM J ENOL VITICULT, V57, P325; Carpentieri A, 2007, ANAL BIOANAL CHEM, V389, P969, DOI 10.1007/s00216-007-1476-8; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Cejudo-Bastante MJ, 2011, LWT-FOOD SCI TECHNOL, V44, P866, DOI 10.1016/j.lwt.2010.10.015; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Danilewicz JC, 2003, AM J ENOL VITICULT, V54, P73; Danilewicz JC, 2010, AM J ENOL VITICULT, V61, P166; de Freitas V, 2011, ANAL BIOANAL CHEM, V401, P1463, DOI 10.1007/s00216-010-4479-9; Llaudy MD, 2006, J AGR FOOD CHEM, V54, P4246, DOI 10.1021/jf052842t; Dew TP, 2005, J AGR FOOD CHEM, V53, P6510, DOI 10.1021/jf050716j; Doco T, 2003, CARBOHYD POLYM, V53, P253, DOI 10.1016/S0144-8617(03)00072-9; Drinkine J, 2007, J AGR FOOD CHEM, V55, P6292, DOI 10.1021/jf070038w; Ducasse MA, 2010, CARBOHYD POLYM, V79, P747, DOI 10.1016/j.carbpol.2009.10.001; Ducasse MA, 2010, FOOD CHEM, V118, P369, DOI 10.1016/j.foodchem.2009.04.130; Durner D, 2010, AM J ENOL VITICULT, V61, P474, DOI 10.5344/ajev.2010.09122; Fulcrand H, 2008, PHYTOCHEMISTRY, V69, P3131, DOI 10.1016/j.phytochem.2008.03.016; Gomez-Plaza E, 2011, FOOD CHEM, V125, P1131, DOI 10.1016/j.foodchem.2010.10.034; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; Guadalupe Z, 2007, J AGR FOOD CHEM, V55, P10720, DOI 10.1021/jf0716782; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Guasch-Jane MR, 2006, J ARCHAEOL SCI, V33, P1075, DOI 10.1016/j.jas.2005.11.012; Hong YS, 2011, J AGR FOOD CHEM, V59, P7237, DOI 10.1021/jf200664t; Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P738, DOI 10.1016/j.foodchem.2010.07.064; Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P727, DOI 10.1016/j.foodchem.2010.06.067; Kontoudakis N, 2011, J AGR FOOD CHEM, V59, P1974, DOI 10.1021/jf103038g; Liebermeister W, 2002, BIOINFORMATICS, V18, P51, DOI 10.1093/bioinformatics/18.1.51; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; Martoglio AM, 2002, BIOINFORMATICS, V18, P1617, DOI 10.1093/bioinformatics/18.12.1617; Mattivi F, 1990, VITIS, P119; Mazerolles G, 2010, ANAL CHIM ACTA, V678, P195, DOI 10.1016/j.aca.2010.07.034; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; Nassiri-Asl M, 2009, PHYTOTHER RES, V23, P1197, DOI 10.1002/ptr.2761; PASTEUR L, 1873, ETUDES VIN; Perez-Magarino S, 2007, FOOD CHEM, V101, P881, DOI 10.1016/j.foodchem.2006.02.037; Ribereau-Gayon P, 2005, HDB ENOLOGY, V1, p[99, 51]; Ribereau-Gayon P, 2000, HDB ENOLOGY, V2, p[99, 129]; Scholz M, 2004, BIOINFORMATICS, V20, P2447, DOI 10.1093/bioinformatics/bth270; Schwarz M, 2003, J AGR FOOD CHEM, V51, P3682, DOI 10.1021/jf0340963; SINGLETON VL, 1987, AM J ENOL VITICULT, V38, P69; Skogerson K, 2009, J AGR FOOD CHEM, V57, P6899, DOI 10.1021/jf9019322; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Son HS, 2009, ANAL CHEM, V81, P1137, DOI 10.1021/ac802305c; Son HS, 2009, J AGR FOOD CHEM, V57, P4801, DOI 10.1021/jf9005017; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theodoridis G, 2012, METABOLOMICS, V8, P175, DOI 10.1007/s11306-011-0298-z; Vaclavik L, 2011, ANAL CHIM ACTA, V685, P45, DOI 10.1016/j.aca.2010.11.018; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; Vapnik V., 1998, STAT LEARNING THEORY; Villagra E, 2012, FOOD CHEM, V131, P692, DOI 10.1016/j.foodchem.2011.08.078; Waterhouse AL, 2006, AM J ENOL VITICULT, V57, P306; Yetukuri L, 2010, METABOLOMICS, V6, P18, DOI 10.1007/s11306-009-0179-x	64	70	72	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37783	10.1371/journal.pone.0037783	http://dx.doi.org/10.1371/journal.pone.0037783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662221	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300111
J	Flores, F; Hoogenboom, MO; Smith, LD; Cooper, TF; Abrego, D; Negri, AP				Flores, Florita; Hoogenboom, Mia O.; Smith, Luke D.; Cooper, Timothy F.; Abrego, David; Negri, Andrew P.			Chronic Exposure of Corals to Fine Sediments: Lethal and Sub-Lethal Impacts	PLOS ONE			English	Article							SHADE-ADAPTED COLONIES; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORALS; SUSPENDED SEDIMENTS; HERMATYPIC CORAL; REEF CORALS; LIGHT; TURBIDITY; RESPIRATION; EFFICIENCY	Understanding the sedimentation and turbidity thresholds for corals is critical in assessing the potential impacts of dredging projects in tropical marine systems. In this study, we exposed two species of coral sampled from offshore locations to six levels of total suspended solids (TSS) for 16 weeks in the laboratory, including a 4 week recovery period. Dose-response relationships were developed to quantify the lethal and sub-lethal thresholds of sedimentation and turbidity for the corals. The sediment treatments affected the horizontal foliaceous species (Montipora aequituberculata) more than the upright branching species (Acropora millepora). The lowest sediment treatments that caused full colony mortality were 30 mg l(-1) TSS (25 mg cm(-2) day(-1)) for M. aequituberculata and 100 mg l(-1) TSS (83 mg cm(-2) day(-1)) for A. millepora after 12 weeks. Coral mortality generally took longer than 4 weeks and was closely related to sediment accumulation on the surface of the corals. While measurements of damage to photosystem II in the symbionts and reductions in lipid content and growth indicated sub-lethal responses in surviving corals, the most reliable predictor of coral mortality in this experiment was long-term sediment accumulation on coral tissue.	[Flores, Florita; Abrego, David; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Smith, Luke D.] James Cook Univ, Australian Res Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cooper, Timothy F.; Abrego, David] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Nedlands, WA 6009, Australia	Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science; University of Western Australia	Flores, F (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Abrego, David/AAT-8120-2020; Flores, Florita/I-3033-2017; Hoogenboom, Mia O/D-3664-2012; Negri, Andrew P/G-9909-2017	Abrego, David/0000-0003-3311-2730; Flores, Florita/0000-0003-4637-1379; Hoogenboom, Mia O/0000-0003-3709-6344; Negri, Andrew P/0000-0003-1388-7395	Woodside Energy Ltd (as operator of the Browse LNG Development); Woodside Energy Ltd	Woodside Energy Ltd (as operator of the Browse LNG Development); Woodside Energy Ltd	This study was supported by funding from Woodside Energy Ltd (as operator of the Browse LNG Development) woodside.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Woodside Energy Ltd part funded this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 1999, LIMNOL OCEANOGR, V44, P1415, DOI 10.4319/lo.1999.44.6.1415; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Bayer E, 2008, ICES J MAR SCI, V65, P1402, DOI 10.1093/icesjms/fsn141; BROWN BE, 1990, MAR ECOL PROG SER, V65, P273, DOI 10.3354/meps065273; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cooper KM, 2008, J EXP MAR BIOL ECOL, V366, P82, DOI 10.1016/j.jembe.2008.07.011; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Cooper TF, 2009, ESTUAR COAST SHELF S, V83, P186, DOI 10.1016/j.ecss.2009.03.015; CRIPPS GC, 1992, MAR POLLUT BULL, V25, P266, DOI 10.1016/0025-326X(92)90681-U; DODGE RE, 1977, J MAR RES, V35, P715; DUBINSKY Z, 1984, PROC R SOC SER B-BIO, V222, P203, DOI 10.1098/rspb.1984.0059; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; ENTSCH B, 1983, LIMNOL OCEANOGR, V28, P465, DOI 10.4319/lo.1983.28.3.0465; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gilmour JP, 2002, MAR FRESHWATER RES, V53, P805, DOI 10.1071/MF01219; HARRIOTT VJ, 1993, ENVIRON MONIT ASSESS, V25, P131, DOI 10.1007/BF00549134; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Je CH, 2007, CHEMOSPHERE, V70, P187, DOI 10.1016/j.chemosphere.2007.06.033; JOHNSTONE RW, 1990, MAR ECOL PROG SER, V66, P273, DOI 10.3354/meps066273; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Larcombe P, 2001, SEDIMENTOLOGY, V48, P811, DOI 10.1046/j.1365-3091.2001.00396.x; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; McMahon K, 2011, MAR POLLUT BULL, V62, P270, DOI 10.1016/j.marpolbul.2010.11.001; MILLER RL, 1995, REMOTE SENS ENVIRON, V53, P177, DOI 10.1016/0034-4257(95)00081-B; Muscatine L., 1990, P75; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; PIANC, 2010, 1082010 PIANC UNEP; Pocock YP, 1972, INT J EARTH STUD, V61, P598; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; RICE SA, 1992, B MAR SCI, V51, P429; RIEGL B, 1995, MAR BIOL, V121, P517, DOI 10.1007/BF00349461; ROGERS CS, 1979, J EXP MAR BIOL ECOL, V41, P269, DOI 10.1016/0022-0981(79)90136-9; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Simpson CJ, 1988, ECOLOGY SCLERACTINIA; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Te F.T., 1997, P1899; TELESNICKI GJ, 1995, B MAR SCI, V57, P527; Thomas S, 2004, MAR GEOL, V207, P95, DOI 10.1016/j.margeo.2004.03.011; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Wesseling I, 1999, MAR ECOL PROG SER, V176, P11, DOI 10.3354/meps176011; WOLANSKI E, 1992, ESTUAR COAST SHELF S, V35, P473, DOI 10.1016/S0272-7714(05)80026-5; Wolanski E, 2008, ESTUAR COAST SHELF S, V77, P755, DOI 10.1016/j.ecss.2007.10.014; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	59	48	48	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37795	10.1371/journal.pone.0037795	http://dx.doi.org/10.1371/journal.pone.0037795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662225	gold, Green Accepted, Green Published			2022-12-25	WOS:000305342300115
J	Rao, ZC; He, WY; Liu, L; Zheng, SC; Huang, LH; Feng, QL				Rao, Zhongchen; He, Wenyin; Liu, Lin; Zheng, Sichun; Huang, Lihua; Feng, Qili			Identification, Expression and Target Gene Analyses of MicroRNAs in Spodoptera litura	PLOS ONE			English	Article							NERVOUS-SYSTEM; SERINE PROTEASES; DROSOPHILA; CELL; PROTEIN; DIFFERENTIATION; MECHANISM; GENOMICS; MIRBASE; MIR-34A	MicroRNAs (miRNAs) are small RNAs widely present in animals and plants and involved in post-transcriptional regulation of gene transcripts. In this study we identified and validated 58 miRNAs from an EST dataset of Spodoptera litura based on the computational and experimental analysis of sequence conservation and secondary structure of miRNA by comparing the miRNA sequences in the miRbase. RT-PCR was conducted to examine the expression of these miRNAs and stem-loop RTPCR assay was performed to examine expression of 11 mature miRNAs (out of the 58 putative miRNA) that showed significant changes in different tissues and stages of the insect development. One hundred twenty eight possible target genes against the 11 miRNAs were predicted by using computational methods. Binding of one miRNA (sli-miR-928b) with the three possible target mRNAs was confirmed by Southern blotting, implying its possible function in regulation of the target genes.	[Rao, Zhongchen; He, Wenyin; Liu, Lin; Zheng, Sichun; Huang, Lihua; Feng, Qili] S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University	Rao, ZC (corresponding author), S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	qlfeng@scnu.edu.cn			National Basic Research Program of China [2010CB126100]; Chinese National Natural Science Foundation [31071688]; National High-Tech R&D Program of China [2011AA10A204-3]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This research was supported partially by the National Basic Research Program of China (2010CB126100), Chinese National Natural Science Foundation (31071688), and National High-Tech R&D Program of China (2011AA10A204-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-454; Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5; Begemann G, 1997, DEVELOPMENT, V124, P4321; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Champagne MB, 2000, J MOL BIOL, V300, P759, DOI 10.1006/jmbi.2000.3802; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; del Alamo D, 2008, DEVELOPMENT, V135, P2895, DOI 10.1242/dev.022194; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; Giannakou ME, 2001, J EXP BIOL, V204, P3703; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Inbal A, 2004, DEV CELL, V7, P241, DOI 10.1016/j.devcel.2004.07.001; Ivanov AI, 2004, P NATL ACAD SCI USA, V101, P16216, DOI 10.1073/pnas.0407188101; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koizumi K, 2007, P NATL ACAD SCI USA, V104, P5626, DOI 10.1073/pnas.0611687104; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu SP, 2010, BMC GENOMICS, V11; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Neubueser D, 2010, MOL BIOL CELL, V21, P2869, DOI 10.1091/mbc.E10-04-0328; Oakley BR, 2000, TRENDS CELL BIOL, V10, P537, DOI 10.1016/S0962-8924(00)01857-2; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Ozdowski EF, 2009, GENETICS, V183, P1027, DOI 10.1534/genetics.109.107367; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Plasterk R, 2006, FEBS J, V273, P15; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Shah PK, 2008, GENE, V407, P199, DOI 10.1016/j.gene.2007.10.012; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Szafer-Glusman E, 2008, CURR BIOL, V18, P1426, DOI 10.1016/j.cub.2008.08.061; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37730	10.1371/journal.pone.0037730	http://dx.doi.org/10.1371/journal.pone.0037730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662202	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300092
J	Robinson, KM; Ingvarsson, PK; Jansson, S; Albrectsen, BR				Robinson, Kathryn M.; Ingvarsson, Par K.; Jansson, Stefan; Albrectsen, Benedicte R.			Genetic Variation in Functional Traits Influences Arthropod Community Composition in Aspen (Populus tremula L.)	PLOS ONE			English	Article							HOST-PLANT; PHYSIOLOGICAL TRAITS; PHENOTYPIC VARIATION; STRUCTURAL TRAITS; HERBIVORE ATTACK; LEAF TRAITS; RESISTANCE; DEFENSE; DIVERSITY; PERFORMANCE	We conducted a study of natural variation in functional leaf traits and herbivory in 116 clones of European aspen, Populus tremula L., the Swedish Aspen (SwAsp) collection, originating from ten degrees of latitude across Sweden and grown in a common garden. In surveys of phytophagous arthropods over two years, we found the aspen canopy supports nearly 100 morphospecies. We identified significant broad-sense heritability of plant functional traits, basic plant defence chemistry, and arthropod community traits. The majority of arthropods were specialists, those coevolved with P. tremula to tolerate and even utilize leaf defence compounds. Arthropod abundance and richness were more closely related to plant growth rates than general chemical defences and relationships were identified between the arthropod community and stem growth, leaf and petiole morphology, anthocyanins, and condensed tannins. Heritable genetic variation in plant traits in young aspen was found to structure arthropod community; however no single trait drives the preferences of arthropod folivores among young aspen genotypes. The influence of natural variation in plant traits on the arthropod community indicates the importance of maintaining genetic variation in wild trees as keystone species for biodiversity. It further suggests that aspen can be a resource for the study of mechanisms of natural resistance to herbivores.	[Robinson, Kathryn M.; Jansson, Stefan; Albrectsen, Benedicte R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University; Umea University	Robinson, KM (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	benedicte.albrectsen@plantphys.umu.se	Ingvarsson, Pär/G-2748-2010; Albrectsen, Benedicte/E-6963-2013; Jansson, Stefan/A-1119-2009; Robinson, Kathryn M/B-7807-2016	Jansson, Stefan/0000-0002-7906-6891; Robinson, Kathryn M/0000-0002-5249-604X; Ingvarsson, Par/0000-0001-9225-7521; Albrectsen, Benedicte Riber/0000-0002-9337-4540	Swedish Research Council; Kempe Foundation; 446 the Swedish Foundation for Strategic Research; Carl Tryggers Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; 446 the Swedish Foundation for Strategic Research; Carl Tryggers Foundation	The research was supported by the Swedish Research Council, the Kempe Foundation, 446 the Swedish Foundation for Strategic Research, and the Carl Tryggers Foundation. Funders provided salary for KMR and also funds to establish common gardens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Albrectsen BR, 2010, ECOGRAPHY, V33, P483, DOI 10.1111/j.1600-0587.2009.05982.x; Albrectsen BR, 2004, OIKOS, V105, P268, DOI 10.1111/j.0030-1299.2004.12892.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrew RL, 2007, OECOLOGIA, V153, P891, DOI 10.1007/s00442-007-0784-1; Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; AUERBACH M, 1992, OECOLOGIA, V89, P1, DOI 10.1007/BF00319008; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Barnes B. V., 1969, Silvae Genetica, V18, P130; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Campos RI, 2006, ECOGRAPHY, V29, P442, DOI 10.1111/j.2006.0906-7590.04520.x; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chang SX, 2003, FOREST ECOL MANAG, V181, P331, DOI 10.1016/S0378-1127(03)00004-5; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coulianos C.-C, 1991, GALLER FALTHANDBOK G; Crawford KM, 2007, ECOLOGY, V88, P2114, DOI 10.1890/06-1441.1; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Delaplanque A, INSECTS ASS PEUPLIER; Donaldson JR, 2007, ECOLOGY, V88, P729, DOI 10.1890/06-0064; Donaldson JR, 2006, J CHEM ECOL, V32, P1415, DOI 10.1007/s10886-006-9059-2; Dungey HS, 2000, EVOLUTION, V54, P1938, DOI 10.1111/j.0014-3820.2000.tb01238.x; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Frewen BE, 2000, GENETICS, V154, P837; Fukui A, 2001, POPUL ECOL, V43, P31, DOI 10.1007/PL00012013; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hedenas H, 2007, BIOL CONSERV, V135, P380, DOI 10.1016/j.biocon.2006.10.008; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Holeski LM, 2009, ECOLOGY, V90, P2969, DOI 10.1890/08-2378.1; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Kanaga MK, 2008, CAN J FOREST RES, V38, P1690, DOI 10.1139/X08-012; Kearsley MJC, 1998, ECOLOGY, V79, P178, DOI 10.1890/0012-9658(1998)079[0178:TDSOCA]2.0.CO;2; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Kleemann F, 2011, EUR J FOREST RES, V130, P707, DOI 10.1007/s10342-010-0460-6; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Lopez-de-Heredia U, 2004, SILVAE GENET, V53, P227, DOI 10.1515/sg-2004-0041; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Lynch Michael, 1998; Marques ESD, 2000, ENVIRON ENTOMOL, V29, P696, DOI 10.1603/0046-225X-29.4.696; Marron N, 2007, ENVIRON EXP BOT, V61, P103, DOI 10.1016/j.envexpbot.2007.04.002; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Myking T, 2011, FORESTRY, V84, P61, DOI 10.1093/forestry/cpq044; Nakamura M, 2010, OIKOS, V119, P1445, DOI 10.1111/j.1600-0706.2010.18255.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Osier TL, 2000, ECOL ENTOMOL, V25, P197, DOI 10.1046/j.1365-2311.2000.00245.x; Ossipova S, 2001, PHYTOCHEM ANALYSIS, V12, P128, DOI 10.1002/pca.568; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Peacock L, 2001, J CHEM ECOL, V27, P1943, DOI 10.1023/A:1012278417424; Peeters PJ, 2002, BIOL J LINN SOC, V77, P43, DOI 10.1046/j.1095-8312.2002.00091.x; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; R Development Core Team, 2006, R LANG ENV STAT COMP; Rae AM, 2004, CAN J FOREST RES, V34, P1488, DOI 10.1139/X04-033; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; ROWELLRAHIER M, 1984, OECOLOGIA, V62, P26, DOI 10.1007/BF00377368; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Santos JC, 2010, ACTA OECOL, V36, P617, DOI 10.1016/j.actao.2010.09.007; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Smith EA, 2011, TREE PHYSIOL, V31, P68, DOI 10.1093/treephys/tpq100; St Clair SB, 2010, FOREST SCI, V56, P222; Stevens MT, 2008, FUNCT ECOL, V22, P40, DOI 10.1111/j.1365-2435.2007.01356.x; Stiling P, 2000, ECOLOGY, V81, P281, DOI 10.1890/0012-9658(2000)081[0281:DAIEOP]2.0.CO;2; Strong D.R., 1984, INSECTS PLANTS COMMU; Suominen O, 2003, FOREST ECOL MANAG, V175, P403, DOI 10.1016/S0378-1127(02)00142-1; Suvanto LI, 2005, MOL ECOL, V14, P2851, DOI 10.1111/j.1365-294X.2005.02634.x; Tovar-Sanchez E, 2006, OIKOS, V112, P370, DOI 10.1111/j.0030-1299.2006.14029.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Valkama E, 2005, TREES-STRUCT FUNCT, V19, P191, DOI 10.1007/s00468-004-0380-5; Waltz AM, 1997, ECOLOGY, V78, P2133, DOI 10.1890/0012-9658(1997)078[2133:PDAACO]2.0.CO;2; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu R, 1997, AM J BOT, V84, P143, DOI 10.2307/2446076; WU R, 1994, THEOR APPL GENET, V89, P1046, DOI 10.1007/BF00224537; Yarnes CT, 2005, ENTOMOL EXP APPL, V114, P87, DOI 10.1111/j.1570-7458.2005.00226.x	97	57	57	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37679	10.1371/journal.pone.0037679	http://dx.doi.org/10.1371/journal.pone.0037679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662190	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300080
J	Ishikawa, Y; Hosogane, M; Okuyama, R; Aoyama, S; Onoyama, I; Nakayama, KI; Nakayama, K				Ishikawa, Y.; Hosogane, M.; Okuyama, R.; Aoyama, S.; Onoyama, I.; Nakayama, K. I.; Nakayama, K.			Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch	ONCOGENE			English	Article						ubiquitin ligase; Fbxw7; Notch; c-Myc; keratinocyte	F-BOX PROTEIN; TUMOR-SUPPRESSOR; STEM-CELLS; CYCLIN-E; GENE; DEGRADATION; CANCER; SEL-10; DETERMINANT; PROTEOLYSIS	The tumor suppressor Fbxw7 (also known as Sel-10, hCdc4, hAgo, or Fbw7) is an F-box protein that functions as the substrate-recognition subunit of an SCF ubiquitin ligase complex and targets a group of oncoproteins for degradation. We now show that Fbxw7 regulates the proliferation and differentiation of keratinocytes by mediating the degradation of c-Myc and Notch proteins. Fbxw7-deficient keratinocytes showed an increased proliferative capacity that was dependent on the accumulation of c-Myc but not on that of Notch. Fbxw7 deficiency also resulted in the premature differentiation of keratinocytes in a manner dependent on both c-Myc and Notch. Although Fbxw7-deficient keratinocytes proliferated excessively in vitro, loss of Fbxw7 did not predispose keratinocytes to the formation of squamous cell carcinoma in vivo induced by the expression of oncogenic Ras, possibly because the stem cell population of keratinocytes becomes exhausted as a result of enhanced Notch activity. Indeed, suppression of Notch signaling by additional ablation of RBP-J in Fbxw7-deficient keratinocytes conferred a more aggressive tumorigenic capacity. Collectively, these results indicate that Fbxw7 controls the proliferation and differentiation of keratinocytes, and that it exerts both inhibitory and stimulatory actions in skin carcinogenesis by counteracting the proliferation-promoting effect of c-Myc and the tumor-suppressive effect of Notch, respectively. Oncogene (2013) 32, 1921-1932; doi:10.1038/onc.2012.213; published online 4 June 2012	[Ishikawa, Y.; Hosogane, M.; Aoyama, S.; Nakayama, K.] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Cell Proliferat, Sendai, Miyagi 9808575, Japan; [Ishikawa, Y.; Hosogane, M.; Aoyama, S.; Onoyama, I.; Nakayama, K. I.; Nakayama, K.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Okuyama, R.] Shinshu Univ, Grad Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Onoyama, I.; Nakayama, K. I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan	Tohoku University; Japan Science & Technology Agency (JST); Shinshu University; Kyushu University	Nakayama, K (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Cell Proliferat,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	nakayak2@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global Center of Excellence Program of Japan; Grants-in-Aid for Scientific Research [23591615] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T Honjo for Rbpj<SUP>F/F</SUP> mice; IM de Alboran for c-Myc<SUP>F/F</SUP> mice; R Tsunematsu for the NICD1 plasmid; T Kitamura for pMX-puro and Plat-E cells; Y Gotoh for pMX-Cre-SV40-GFP; S Ikawa for the cDNA-encoding H-Ras<SUP>G12V</SUP>; E Ogawa and E Nishimura for technical advice; Y Ono, T Senga and N Yanagihara for technical assistance; and other laboratory members for discussion. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Global Center of Excellence Program of Japan.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Dotto GP, 2005, SCIENCE, V309, P890, DOI 10.1126/science.1117192; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Ishikawa Y, 2008, ONCOGENE; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Masuda K, 2010, ONCOGENE, V29, P1798, DOI 10.1038/onc.2009.469; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MORRIS RJ, 1988, CANCER RES, V48, P6285; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rounbehler RJ, 2001, ONCOGENE, V20, P5341, DOI 10.1038/sj.onc.1204691; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tan Y, 2008, CANC LETT; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yu L, 2009, J ONCOL, V2009, DOI 10.1155/2009/780874	49	21	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1921	1932		10.1038/onc.2012.213	http://dx.doi.org/10.1038/onc.2012.213			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22665065				2022-12-25	WOS:000317599900006
J	Raines, AN; Nagdas, S; Kerber, ML; Cheney, RE				Raines, Alexander N.; Nagdas, Sarbajeet; Kerber, Michael L.; Cheney, Richard E.			Headless Myo10 Is a Negative Regulator of Full-length Myo10 and Inhibits Axon Outgrowth in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-X; FILOPODIA FORMATION; CARGO RECOGNITION; PYRAMIDAL NEURONS; ACTIN-FILAMENTS; GENE-EXPRESSION; NERVOUS-SYSTEM; MOTOR-ACTIVITY; DOMAIN; GUIDANCE	Myo10 is an unconventional myosin that localizes to and induces filopodia, structures that are critical for growing axons. In addition to the similar to 240-kDa full-length Myo10, brain expresses a similar to 165 kDa isoform that lacks a functional motor domain and is known as headless Myo10. We and others have hypothesized that headless Myo10 acts as an endogenous dominant negative of full-length Myo10, but this hypothesis has not been tested, and the function of headless Myo10 remains unknown. We find that cortical neurons express both headless and full-length Myo10 and report the first isoform-specific localization of Myo10 in brain, which shows enrichment of headless Myo10 in regions of proliferating and migrating cells, including the embryonic ventricular zone and the postnatal rostral migratory stream. We also find that headless and full-length Myo10 are expressed in embryonic and neuronal stem cells. To directly test the function of headless and full-length Myo10, we used RNAi specific to each isoform in mouse cortical neuron cultures. Knockdown of full-length Myo10 reduces axon outgrowth, whereas knockdown of headless Myo10 increases axon outgrowth. To test whether headless Myo10 antagonizes full-length Myo10, we coexpressed both isoforms in COS-7 cells, which revealed that headless Myo10 suppresses the filopodia-inducing activity of full-length Myo10. Together, these results demonstrate that headless Myo10 can function as a negative regulator of full-length Myo10 and that the two isoforms of Myo10 have opposing roles in axon outgrowth.	[Nagdas, Sarbajeet; Kerber, Michael L.; Cheney, Richard E.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Raines, Alexander N.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Raines, Alexander N.; Cheney, Richard E.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cheney, RE (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, 111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	richard_cheney@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Cheney, Richard/0000-0001-6565-7888	National Institutes of Health [R01 DC03299]; Medical Science Training Program Grant [T32GM008719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Science Training Program Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DC03299 (to R. E. C.). This work was also supported by Medical Science Training Program Grant T32GM008719 (to A. N. R.).	Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dent E. W., 2011, COLD SPRING HARB PER, V3, P1; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Hutton S. R., 2008, CSH PROTOC, V11, P1029; Hwang YS, 2009, DEV DYNAM, V238, P2522, DOI 10.1002/dvdy.22077; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Y, 2012, J CELL SCI, V125, P751, DOI 10.1242/jcs.094946; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Nagy S, 2010, J BIOL CHEM, V285, P26608, DOI 10.1074/jbc.M110.104661; Nie SY, 2009, DEV BIOL, V335, P132, DOI 10.1016/j.ydbio.2009.08.018; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Polleux F, 2002, SCI STKE, V136, P19; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang JJ, 2009, CELL BIOL INT, V33, P578, DOI 10.1016/j.cellbi.2009.02.006; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Woolner S, 2012, DEV CELL, V22, P775, DOI 10.1016/j.devcel.2012.01.002; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhong HB, 2006, P NATL ACAD SCI USA, V103, P16800, DOI 10.1073/pnas.0603959103; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	57	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24873	24883		10.1074/jbc.M112.369173	http://dx.doi.org/10.1074/jbc.M112.369173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661706	hybrid, Green Published			2022-12-25	WOS:000306651700002
J	Agarwal, SK; Jothi, R				Agarwal, Sunita K.; Jothi, Raja			Genome-Wide Characterization of Menin-Dependent H3K4me3 Reveals a Specific Role for Menin in the Regulation of Genes Implicated in MEN1-Like Tumors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOCRINE-NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; PANCREATIC NEUROENDOCRINE TUMORS; SUPPRESSOR MENIN; EXPRESSED GENES; IN-VITRO; DIFFERENTIATION; MICE; LEUKEMIA	Inactivating mutations in the MEN1 gene predisposing to the multiple endocrine neoplasia type 1 (MEN1) syndrome can also cause sporadic pancreatic endocrine tumors. MEN1 encodes menin, a subunit of MLL1/MLL2-containing histone methyltransferase complexes that trimethylate histone H3 at lysine 4 (H3K4me3). The importance of menin-dependent H3K4me3 in normal and transformed pancreatic endocrine cells is unclear. To study the role of menin-dependent H3K4me3, we performed in vitro differentiation of wild-type as well as menin-null mouse embryonic stem cells (mESCs) into pancreatic islet-like endocrine cells (PILECs). Gene expression analysis and genome-wide H3K4me3 ChIP-Seq profiling in wild-type and menin-null mESCs and PILECs revealed menin-dependent H3K4me3 at the imprinted Dlk1-Meg3 locus in mESCs, and all four Hox loci in differentiated PILECs. Specific and significant loss of H3K4me3 and gene expression was observed for genes within the imprinted Dlk1-Meg3 locus in menin-null mESCs and the Hox loci in menin-null PILECs. Given that the reduced expression of genes within the DLK1-MEG3 locus and the HOX loci is associated with MEN1-like sporadic tumors, our data suggests a possible role for menin-dependent H3K4me3 at these genes in the initiation and progression of sporadic pancreatic endocrine tumors. Furthermore, our investigation also demonstrates that menin-null mESCs can be differentiated in vitro into islet-like endocrine cells, underscoring the utility of menin-null mESC-derived specialized cell types for genome-wide high-throughput studies.	[Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Jothi, Raja] Natl Inst Environm Hlth Sci, Syst Biol Sect, Biostat Branch, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Agarwal, SK (corresponding author), NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA.	SunitaA@mail.nih.gov; jothi@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Jothi, Raja/G-3780-2015	Agarwal, Sunita K/0000-0002-7557-3191; Jothi, Raja/0000-0002-4833-1090	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [1ZIADK075035-03]; National Institute of Environmental Health Sciences [1ZIAES102625-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (SKA; Project number: 1ZIADK075035-03), and the National Institute of Environmental Health Sciences (RJ; Project number: 1ZIAES102625-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2009, HORM RES, V71, P131, DOI 10.1159/000192450; Balasubramanian D, 2009, ADV EXP MED BIOL, V668, P105; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bingham EL, 2009, STEM CELLS DEV, V18, P1071, DOI 10.1089/scd.2008.0337; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; Dani C, 1997, J CELL SCI, V110, P1279; Fontaniere S, 2008, J ENDOCRINOL, V199, P287, DOI 10.1677/JOE-08-0289; Gordon FE, 2010, ENDOCRINOLOGY, V151, P2443, DOI 10.1210/en.2009-1151; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jensen RT, 2006, J GASTROINTEST SURG, V10, P324, DOI 10.1016/j.gassur.2005.08.022; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muntean AG, 2011, ANN REV PATHOLOGY; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Naujok O, 2011, MOL THER, V19, P1759, DOI 10.1038/mt.2011.165; Novotny E, 2009, MECH DEVELOP, V126, P517, DOI 10.1016/j.mod.2009.04.001; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shen HCJ, 2008, ENDOCR-RELAT CANCER, V15, P267, DOI 10.1677/ERC-07-0191; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Velculescu VE, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003001; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang HL, 2011, MOL MED REP, V4, P301, DOI 10.3892/mmr.2011.409; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	36	36	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37952	10.1371/journal.pone.0037952	http://dx.doi.org/10.1371/journal.pone.0037952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666422	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400061
J	Larsen, FW; Turner, WR; Brooks, TM				Larsen, Frank W.; Turner, Will R.; Brooks, Thomas M.			Conserving Critical Sites for Biodiversity Provides Disproportionate Benefits to People	PLOS ONE			English	Article							ECOSYSTEM SERVICES; CONSERVATION PRIORITIES; ECONOMIC-BENEFITS; DIVERSITY; POVERTY; WORLDS; AREAS; CARBON; COSTS; LAND	Protecting natural habitats in priority areas is essential to halt the loss of biodiversity. Yet whether these benefits for biodiversity also yield benefits for human well-being remains controversial. Here we assess the potential human well-being benefits of safeguarding a global network of sites identified as top priorities for the conservation of threatened species. Conserving these sites would yield benefits - in terms of a) climate change mitigation through avoidance of CO2 emissions from deforestation; b) freshwater services to downstream human populations; c) retention of option value; and d) benefits to maintenance of human cultural diversity - significantly exceeding those anticipated from randomly selected sites within the same countries and ecoregions. Results suggest that safeguarding sites important for biodiversity conservation provides substantial benefits to human well-being.	[Larsen, Frank W.; Turner, Will R.] Conservat Int, Sci & Knowledge Div, Arlington, VA 22202 USA; [Larsen, Frank W.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Brooks, Thomas M.] NatureServe, Arlington, VA USA; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr, Los Banos, Laguna, Philippines	Conservation International; University of Copenhagen; Nature Conservancy; University of Tasmania; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Larsen, FW (corresponding author), Conservat Int, Sci & Knowledge Div, Arlington, VA 22202 USA.	frankwugtlarsen@gmail.com	Larsen, Frank/C-5172-2009	Brooks, Thomas/0000-0001-8159-3116	Danish Council for Research (FNU); Gordon and Betty Moore Foundation; John D. and Catherine T. MacArthur Foundation	Danish Council for Research (FNU)(Danish Natural Science Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine T. MacArthur Foundation	FWL acknowledges a grant from the Danish Council for Research (FNU). All authors are grateful for funding from the Gordon and Betty Moore Foundation, and for partial support by an award from the John D. and Catherine T. MacArthur Foundation to NatureServe addressing "Dashboard assessments: proof-of-concept and baselines." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2010, EC EC BIOD MAINSTR E; [Anonymous], 2009, GROSS DOM PROD 2008; Armsworth PR, 2007, CONSERV BIOL, V21, P1383, DOI 10.1111/j.1523-1739.2007.00821.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A., 2008, EC BIODIVERSITY ECOS; *BIRDLIFE INT, 2008, STAT WORLDS BIRDS; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Campbell A, 2008, CARBON EMISSIONS FOR; CBD, 2010, DEC X 2 STRAT PLAN B; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P206; Chivian E, 2008, SUSTAINING LIFE HUMA; da Fonseca GAB, 2007, PLOS BIOL, V5, P1645, DOI 10.1371/journal.pbio.0050216; Dudley N., 2003, RUNNING PURE IMPORTA; EC-JRC (EUROPEAN COMMISSION JOINT RESEARCH CENTRE), 2006, GLOB LAND COV 2000 D; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2014, IUCN RED LIST THREAT; Iverson JB, EMYSYSTEM WORLD TURT; Jarvis A., 2008, EOS T AGU, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Langhammer P.F., 2007, IDENTIFICATION GAP A; Larsen FW, 2011, CONSERV LETT, V4, P355, DOI 10.1111/j.1755-263X.2011.00183.x; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; MAFFI L, 2001, NEW DIRECTIONS ANTHR, P24; Manne LL, 2003, EVOL ECOL RES, V5, P517; McKinsey & Company, 2009, PATHW LOW CARB EC VE; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Moore JL, 2002, P ROY SOC B-BIOL SCI, V269, P1645, DOI 10.1098/rspb.2002.2075; Mulligan M, 2005, FID FRP PROJECT ZF02; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; *OAK RIDG NAT LAB, 2006, LANDSCAN GLOB POP DA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paolillo J. C., 2006, EVALUATING LANGUAGE; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roe D, 2008, ORYX, V42, P491, DOI 10.1017/S0030605308002032; Ruesch A, 2008, NEW GLOBAL BIOMASS C; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; STRASSBURG B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI [DOI 10.1016/j.gloenvcha.2008.11.004, DOI 10.1016/J.GLOENVCHA.2008.11.004]; Stuart S. N., 2008, THREATENED AMPHIBIAN; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; Turner WR, 2012, BIOSCIENCE, V62, P85, DOI 10.1525/bio.2012.62.1.13; U.S.Geological Survey, 2000, HYDRO1K EL DER DAT; UNEP-WCMC, 2008, WORLD DAT PROT AR WD; UNFCCC, 2010, CANC AGR; United Nations Development Programme (UNDP), 2008, HUM DEV IND STAT UPD; United Nations Food and Agricultural Organization, 2005, GLOB FOR RES ASS 200; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671	66	28	28	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36971	10.1371/journal.pone.0036971	http://dx.doi.org/10.1371/journal.pone.0036971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666337	Green Published, gold			2022-12-25	WOS:000305353400019
J	de Voux, A; Spaulding, AC; Beckwith, C; Avery, A; Williams, C; Messina, LC; Ball, S; Altice, FL				de Voux, Alex; Spaulding, Anne C.; Beckwith, Curt; Avery, Ann; Williams, Chyvette; Messina, Lauren C.; Ball, Sarah; Altice, Frederick L.			Early Identification of HIV: Empirical Support for Jail-Based Screening	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; INFECTED PRISONERS; CARE; ADHERENCE; RELEASE; TRANSMISSION; ACCEPTANCE; PREVENTION; FACILITIES	Background: Although routine HIV testing is recommended for jails, little empirical data exist describing newly diagnosed individuals in this setting. Methods: Client-level data (CLD) are available on a subset of individuals served in EnhanceLink, for the nine of the 10 sites who enrolled newly diagnosed persons in the client level evaluation. In addition to information about time of diagnosis, we analyzed data on initial CD4 count, use of antiretroviral therapy (ART), and linkage to care post discharge. Baseline data from newly diagnosed persons were compared to data from persons whose diagnoses predated jail admission. Results: CLD were available for 58 newly diagnosed and 708 previously diagnosed individuals enrolled between 9/08 and 3/11. Those newly diagnosed had a significantly younger median age (34 years) when compared to those previously diagnosed (41 years). In the 30 days prior to incarceration, 11% of those newly diagnosed reported injection drug use and 29% reported unprotected anal intercourse. Median CD4 count at diagnosis was 432 cells/mL (range: 22-1,453 cells/mL). A minority (21%, N = 12) of new diagnoses started antiretroviral treatment (ART) before release; 74% have evidence of linkage to community services. Conclusion: Preliminary results from a cross-sectional analysis of this cohort suggest testing in jails finds individuals early on in disease progression. Most HIV+ detainees did not start ART in jail; therefore screening may not increase pharmacy costs for jails. Detainees newly diagnosed with HIV in jails can be effectively linked to community resources. Jail-based HIV testing should be a cornerstone of "test and treat" strategies.	[de Voux, Alex; Spaulding, Anne C.; Messina, Lauren C.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Beckwith, Curt] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Avery, Ann] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Williams, Chyvette] Univ Illinois, Sch Publ Hlth, Chicago, IL USA; [Ball, Sarah] ABT Associates Inc, Cambridge, MA 02138 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06510 USA; [Altice, Frederick L.] Yale Univ, Div Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA	Emory University; Rollins School Public Health; Brown University; Case Western Reserve University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; ABT Associates; Yale University; Yale University	de Voux, A (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	ASpauld@emory.edu			HRSA [H97HA08541, H97HA08543, H97HA085xx, H97HA08535, U90HA07632]; National Institutes on Drug Abuse for career development award [K24 DA017072]; National Institute on Drug Abuse grant [K23DA021095]; Lifespan/Tufts/Brown Center for AIDS Research grant [P30AI42853]; Emory Center for AIDS Research [P30AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, K23DA021095] Funding Source: NIH RePORTER	HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes on Drug Abuse for career development award; National Institute on Drug Abuse grant; Lifespan/Tufts/Brown Center for AIDS Research grant; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Authors are supported by the following HRSA grants: Dr. Altice: H97HA08541; Dr. Avery: H97HA08543; Dr. Williams: H97HA085xx; Dr. Beckwith: H97HA08535; and Dr. Spaulding: U90HA07632; Dr. Ball worked as a subcontractor under this grant. Frederick Altice was also supported by a National Institutes on Drug Abuse for career development award (K24 DA017072). Curt Beckwith was also supported by a National Institute on Drug Abuse grant (K23DA021095) and the Lifespan/Tufts/Brown Center for AIDS Research grant (P30AI42853). Alex de Voux, Lauren Messina and Anne Spaulding would like to acknowledge support from the Emory Center for AIDS Research (P30AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beckwith C. G., 2010, Morbidity and Mortality Weekly Report, V59, P742; Beckwith CG, 2010, IDSA C VANC; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; CDC, 2006, MMWR WEEKLY, P421; CDC, 2011, 16 CDC; Centers for Disease Control and Prevention (CDC), 2009, HIV TEST IMPL GUID C, P1; Chandler RK, 2011, SEEK TEST TREAT RETA; Chen NE, 2013, AIDS BEHAV, V17, P2654, DOI 10.1007/s10461-011-0080-2; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Draine J, 2011, AIDS CARE, V23, P366, DOI 10.1080/09540121.2010.507738; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goetz MB, 2011, JAIDS-J ACQ IMM DEF, V57, pE23, DOI 10.1097/QAI.0b013e31821a0600; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammett TM, NATL SURVEY INFECT D, P1; Huaman MA, 2011, INT J INFECT DIS, V15, pE764, DOI 10.1016/j.ijid.2011.06.007; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lyons MS, 2011, ANN EMERG MED S1, V58, p[S17, e11]; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Maruschak Laura M., 2006, MED PROBLEMS JAIL IN; Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Pai NP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007115; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rich Josiah D, 2011, Curr HIV/AIDS Rep, V8, P288, DOI 10.1007/s11904-011-0095-3; Spaulding AC, 2011, AJPH, pe1; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Strick Lara B., 2011, Morbidity and Mortality Weekly Report, V60, P811; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027; White House Office of AIDS Policy, 2010, NAT HIV AIDS STRAT U	47	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37603	10.1371/journal.pone.0037603	http://dx.doi.org/10.1371/journal.pone.0037603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662177	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300067
J	Varga, Z; Diebold, J; Dommann-Scherrer, C; Frick, H; Kaup, D; Noske, A; Obermann, E; Ohlschlegel, C; Padberg, B; Rakozy, C; Oliver, SS; Schobinger-Clement, S; Schreiber-Facklam, H; Singer, G; Tapia, C; Wagner, U; Mastropasqua, MG; Viale, G; Lehr, HA				Varga, Zsuzsanna; Diebold, Joachim; Dommann-Scherrer, Corina; Frick, Harald; Kaup, Daniela; Noske, Aurelia; Obermann, Ellen; Ohlschlegel, Christian; Padberg, Barbara; Rakozy, Christiane; Oliver, Sara Sancho; Schobinger-Clement, Sylviane; Schreiber-Facklam, Heide; Singer, Gad; Tapia, Coya; Wagner, Urs; Mastropasqua, Mauro G.; Viale, Giuseppe; Lehr, Hans-Anton			How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; MIB-1 LABELING INDEXES; IMAGE-ANALYSIS; PROLIFERATIVE ACTIVITY; INTEROBSERVER VARIABILITY; HISTOLOGICAL GRADE; PROGNOSTIC-FACTORS; PRIMARY THERAPY; CANCER; EXPRESSION	Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessment of tumor proliferation. The Swiss Working Group of Gyneco- and Breast Pathologists has surveyed inter-and intraobserver consistency of Ki-67-based proliferative fraction in breast carcinomas. Methods: Five pathologists evaluated MIB-1-labeling index (LI) in ten breast carcinomas (G1, G2, G3) by counting and eyeballing. In the same way, 15 pathologists all over Switzerland then assessed MIB-1-LI on three G2 carcinomas, in self-selected or pre-defined areas of the tumors, comparing centrally immunostained slides with slides immunostained in the different laboratoires. To study intra-observer variability, the same tumors were re-examined 4 months later. Results: The Kappa values for the first series of ten carcinomas of various degrees of differentiation showed good to very good agreement for MIB-1-LI (Kappa 0.56-0.72). However, we found very high inter-observer variabilities (Kappa 0.04-0.14) in the read-outs of the G2 carcinomas. It was not possible to explain the inconsistencies exclusively by any of the following factors: (i) pathologists' divergent definitions of what counts as a positive nucleus (ii) the mode of assessment (counting vs. eyeballing), (iii) immunostaining technique, and (iv) the selection of the tumor area in which to count. Despite intensive confrontation of all participating pathologists with the problem, inter-observer agreement did not improve when the same slides were reexamined 4 months later (Kappa 0.01-0.04) and intra-observer agreement was likewise poor (Kappa 0.00-0.35). Conclusion: Assessment of mid-range Ki-67-LI suffers from high inter-and intra-observer variability. Oncologists should be aware of this caveat when using Ki-67-LI as a basis for treatment decisions in moderately differentiated breast carcinomas.	[Varga, Zsuzsanna; Noske, Aurelia] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Diebold, Joachim] Cantonal Hosp Luzern, Inst Pathol, Luzern, Switzerland; [Dommann-Scherrer, Corina] Cantonal Hosp Winterthur, Inst Pathol, Winterthur, Switzerland; [Frick, Harald; Padberg, Barbara] Cantonal Hosp Graubunden, Inst Pathol, Chur, Switzerland; [Kaup, Daniela] Liestal Hosp, Cantonal Inst Pathol, Liestal, Switzerland; [Obermann, Ellen] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Ohlschlegel, Christian] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland; [Rakozy, Christiane] Pathol Inst Biopsy Diagnost, Zurich, Switzerland; [Oliver, Sara Sancho; Schobinger-Clement, Sylviane] Promed SA, Pathol, Med Lab, Marly, Switzerland; [Schreiber-Facklam, Heide] Municipal Hosp Konstanz, Inst Pathol, Constance, Germany; [Singer, Gad] Cantonal Hosp Baden, Inst Pathol, Baden, Switzerland; [Tapia, Coya] Univ Bern, Inselspital, Inst Pathol, CH-3010 Bern, Switzerland; [Wagner, Urs] Unilabs Mittelland, Pathol, Bern, Switzerland; [Mastropasqua, Mauro G.; Viale, Giuseppe] European Inst Oncol, Div Anat Pathol, Milan, Italy; [Mastropasqua, Mauro G.; Viale, Giuseppe] Univ Milan, Milan, Italy; [Lehr, Hans-Anton] CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland	University of Zurich; University Zurich Hospital; Lucerne Cantonal Hospital; Kantonsspital Graubunden; University of Basel; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; IRCCS European Institute of Oncology (IEO); University of Milan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	Hans-Anton.Lehr@chuv.ch	MASTROPASQUA, Mauro/AAK-8813-2020; Obermann, Ellen/E-2656-2013; Viale, Giuseppe/AAE-8921-2019; Singer, Gad/W-4511-2017	MASTROPASQUA, Mauro/0000-0002-8306-0839; Singer, Gad/0000-0001-8090-7267				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abramovich CM, 1999, ARCH PATHOL LAB MED, V123, P793; Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesterfeld S, 1998, J PATHOL, V185, P25, DOI 10.1002/(SICI)1096-9896(199805)185:1<25::AID-PATH40>3.0.CO;2-R; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fandel TM, 2008, J PATHOL, V216, P193, DOI 10.1002/path.2395; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Grzybicki DM, 2001, CANCER-AM CANCER SOC, V92, P2720, DOI 10.1002/1097-0142(20011115)92:10<2720::AID-CNCR1626>3.0.CO;2-Z; Hamilton PW, 2009, J PATHOL, V218, P285, DOI 10.1002/path.2527; Hasegawa T, 2002, PATHOL INT, V52, P433, DOI 10.1046/j.1440-1827.2002.01378.x; Klintman M, 2010, MODERN PATHOL, V23, P251, DOI 10.1038/modpathol.2009.167; Lehr HA, 1999, HUM PATHOL, V30, P1314, DOI 10.1016/S0046-8177(99)90062-X; Lehr HA, 1996, APPL IMMUNOHISTOCHEM, V4, P117; MAKKINKNOMBRADO SV, 1995, ANAL CELL PATHOL, V8, P227; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Menter DG, 2001, ANAL QUANT CYTOL, V23, P218; Molenaar W M, 2000, Ann Diagn Pathol, V4, P228, DOI 10.1053/adpa.2000.8126; Offersen BV, 2003, HISTOPATHOLOGY, V43, P573, DOI 10.1111/j.1365-2559.2003.01745.x; Ozcan A, 2007, ANAL QUANT CYTOL, V29, P159; PINDER SE, 1995, BRIT J CANCER, V71, P146, DOI 10.1038/bjc.1995.30; Rezanko T, 2008, ANAL QUANT CYTOL, V30, P47; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; van Sandick JW, 2000, J PATHOL, V190, P177; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Yamaguchi U, 2006, APPL IMMUNOHISTO M M, V14, P46, DOI 10.1097/01.pai.0000151023.88969.d7; Zhang R, 2010, CHINESE MED J-PEKING, V123, P1976, DOI 10.3760/cma.j.issn.0366-6999.2010.15.005	37	159	167	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37379	10.1371/journal.pone.0037379	http://dx.doi.org/10.1371/journal.pone.0037379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662150	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305342300039
J	Huang, WW; He, TT; Chai, CS; Yang, Y; Zheng, YH; Zhou, P; Qiao, XX; Zhang, B; Liu, ZZ; Wang, JR; Shi, CH; Lei, LP; Gao, K; Li, HW; Zhong, S; Yao, LB; Huang, ME; Lei, M				Huang, Weiwei; He, Tiantian; Chai, Chengsen; Yang, Yuan; Zheng, Yahong; Zhou, Pei; Qiao, Xiaoxia; Zhang, Bin; Liu, Zengzhen; Wang, Junru; Shi, Changhong; Lei, Liping; Gao, Kun; Li, Hewei; Zhong, Sue; Yao, Libo; Huang, Meng-Er; Lei, Ming			Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression	PLOS ONE			English	Article							ANDROGEN RECEPTOR; C-JUN; DEPENDENT TRANSCRIPTION; MOLECULAR-BIOLOGY; BREAST-CANCER; CROSS-TALK; KAPPA-B; PATHWAY; GROWTH; APOPTOSIS	Recently, traditional Chinese medicine and medicinal herbs have attracted more attentions worldwide for its anti-tumor efficacy. Celastrol and Triptolide, two active components extracted from the Chinese herb Tripterygium wilfordii Hook F (known as Lei Gong Teng or Thunder of God Vine), have shown anti-tumor effects. Celastrol was identified as a natural 26 s proteasome inhibitor which promotes cell apoptosis and inhibits tumor growth. The effect and mechanism of Triptolide on prostate cancer (PCa) is not well studied. Here we demonstrated that Triptolide, more potent than Celastrol, inhibited cell growth and induced cell death in LNCaP and PC-3 cell lines. Triptolide also significantly inhibited the xenografted PC-3 tumor growth in nude mice. Moreover, Triptolide induced PCa cell apoptosis through caspases activation and PARP cleavage. Unbalance between SUMOylation and deSUMOylation was reported to play an important role in PCa progression. SUMO-specific protease 1 (SENP1) was thought to be a potential marker and therapeutical target of PCa. Importantly, we observed that Triptolide down-regulated SENP1 expression in both mRNA and protein levels in dose-dependent and time-dependent manners, resulting in an enhanced cellular SUMOylation in PCa cells. Meanwhile, Triptolide decreased AR and c-Jun expression at similar manners, and suppressed AR and c-Jun transcription activity. Furthermore, knockdown or ectopic SENP1, c-Jun and AR expression in PCa cells inhibited the Triptolide anti-PCa effects. Taken together, our data suggest that Triptolide is a natural compound with potential therapeutic value for PCa. Its anti-tumor activity may be attributed to mechanisms involving down-regulation of SENP1 that restores SUMOylation and deSUMOyaltion balance and negative regulation of AR and c-Jun expression that inhibits the AR and c-Jun mediated transcription in PCa.	[Huang, Weiwei; He, Tiantian; Chai, Chengsen; Yang, Yuan; Zheng, Yahong; Zhou, Pei; Qiao, Xiaoxia; Zhang, Bin; Liu, Zengzhen; Wang, Junru; Lei, Ming] NW A&F Univ, Coll Life Sci, Key Lab Agr Mol Biol, Yangling, Shaanxi Provinc, Peoples R China; [He, Tiantian; Huang, Meng-Er] Univ Paris 11, Ctr Natl Rech Sci, Inst Curie, UMR3348, Orsay, France; [Shi, Changhong; Yao, Libo] Fourth Mil Med Univ, State Key Lab Tumor Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Lei, Liping; Zhong, Sue] Xian San Yao Biopharmaceut Corp, Xian, Shaanxi Provinc, Peoples R China; [Gao, Kun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Gansu Province, Peoples R China; [Li, Hewei] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China	Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Air Force Military Medical University; Lanzhou University; Beijing University of Chinese Medicine	Huang, WW (corresponding author), NW A&F Univ, Coll Life Sci, Key Lab Agr Mol Biol, Yangling, Shaanxi Provinc, Peoples R China.	leiming70@hotmail.com	wang, junru/E-8981-2015; zhong, sue/GRY-4030-2022; haung, weiwei/M-8866-2019; Wang, Junru/GPF-3569-2022	wang, junru/0000-0003-1967-5967; 	National Forestry Public Welfare Industry Research Project [201204603]; Program for New Century Excellent Talents in University [NCET-08-0467]; 100 Talents Program of Shaanxi Province of China	National Forestry Public Welfare Industry Research Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 100 Talents Program of Shaanxi Province of China	This study was funded by National Forestry Public Welfare Industry Research Project (201204603), Program for New Century Excellent Talents in University (NCET-08-0467) and 100 Talents Program of Shaanxi Province of China to Ming Lei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Annereau JP, 2006, P AM ASS CANC RES, V47, P1366; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Ghobrial IM, 2010, J CLIN ONCOL, V28, P1422, DOI 10.1200/JCO.2009.25.3237; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hobisch A, 1996, PROSTATE, V28, P129; Jang SY, 2011, CANCER LETT, V300, P57, DOI 10.1016/j.canlet.2010.09.006; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; Kim KI, 2006, MOL CELLS, V22, P247; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li W, 2011, PLANTA MED, V77, P27, DOI 10.1055/s-0030-1250076; Liu J, 2009, PHYTOMEDICINE, V16, P1006, DOI 10.1016/j.phymed.2009.03.021; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Pan JX, 2010, CANCER LETT, V292, P149, DOI 10.1016/j.canlet.2009.11.018; Petrie K, 2008, NAT CELL BIOL, V10, P507, DOI 10.1038/ncb0508-507; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson Paul G, 2003, Cancer Control, V10, P361; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Tan BJ, 2011, ONCOL REP, V26, P1315, DOI 10.3892/or.2011.1406; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wan CK, 2006, CANCER LETT, V241, P31, DOI 10.1016/j.canlet.2005.10.001; Xianxi WX, 2006, J MOL MED, V84, P405, DOI 10.1007/s00109-005-0022-4; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023993; Wang ZP, 2009, EXP MOL MED, V41, P717, DOI 10.3858/emm.2009.41.10.078; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Xu Y, 2010, J BIOL CHEM, V285, P36682, DOI 10.1074/jbc.M110.164236; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang SM, 2003, MOL CANCER THER, V2, P65; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu WB, 2009, MOL PHARMACOL, V75, P812, DOI 10.1124/mol.108.052605	60	35	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37693	10.1371/journal.pone.0037693	http://dx.doi.org/10.1371/journal.pone.0037693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666381	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400040
J	Hummelshoj, T; Ma, YJ; Munthe-Fog, L; Bjarnsholt, T; Moser, C; Skjoedt, MO; Romani, L; Fujita, T; Endo, Y; Garred, P				Hummelshoj, Tina; Ma, Ying Jie; Munthe-Fog, Lea; Bjarnsholt, Thomas; Moser, Claus; Skjoedt, Mikkel-Ole; Romani, Luigina; Fujita, Teizo; Endo, Yuichi; Garred, Peter			The Interaction Pattern of Murine Serum Ficolin-A with Microorganisms	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; MANNAN-BINDING LECTIN; H-FICOLIN; HAKATA ANTIGEN; PATHWAY; INFECTIONS; BACTERIA; MOUSE; ACID	The ficolins are soluble pattern recognition molecules in the lectin pathway of complement, but the spectrum and mode of interaction with pathogens are largely unknown. In this study, we investigated the binding properties of the murine serum ficolin-A towards a panel of different clinical relevant microorganisms (N = 45) and compared the binding profile with human serum ficolin-2 and ficolin-3. Ficolin-A was able to bind Gram-positive bacteria strains including E. faecalis, L. monocytogenes and some S. aureus strains, but not to the investigated S. agalactiae (Group B streptococcus) strains. Regarding Gram-negative bacteria ficolin-A was able to bind to some E. coli and P. aeruginosa strains, but not to the investigated Salmonella strains. Of particular interest ficolin-A bound strongly to the pathogenic E. coli, O157:H7 and O149 strains, but it did not bind to the non-pathogenic E. coli, ATCC 25922 strain. Additionally, ficolin-A was able to bind purified LPS from these pathogenic strains. Furthermore, ficolin-A bound to a clinical isolate of the fungus A. fumigatus. In general ficolin-2 showed similar selective binding spectrum towards pathogenic microorganisms as observed for ficolin-A indicating specific pathophysiological roles of these molecules in host defence. In contrast, ficolin-3 did not bind to any of the investigated microorganisms and the anti-microbial role of ficolin-3 still remains elusive.	[Hummelshoj, Tina; Ma, Ying Jie; Munthe-Fog, Lea; Skjoedt, Mikkel-Ole; Garred, Peter] Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2100 Copenhagen, Denmark; [Bjarnsholt, Thomas; Moser, Claus] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Bjarnsholt, Thomas] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Fujita, Teizo; Endo, Yuichi] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Perugia; Fukushima Medical University	Hummelshoj, T (corresponding author), Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Romani, Luigina/O-9987-2018; Jie, Ying/AAJ-4697-2021; Moser, Claus Ernst/N-5951-2017; Bjarnsholt, Thomas/ABD-6178-2021; Moser, Claus Ernst/GPK-5546-2022	Jie, Ying/0000-0003-4003-2579; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Garred, Peter/0000-0002-2876-8586; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Munthe-Fog, Lea/0000-0003-1345-176X; Romani, Luigina/0000-0002-1356-525X; Bjarnsholt, Thomas/0000-0002-8003-7414	Carlsberg Foundation; Novo Nordisk Research Foundation; Lundbeck Foundation; Research Foundation of the Capital Region of Denmark; Danish Agency for Science, Technology and Innovation; Grants-in-Aid for Scientific Research [22570144] Funding Source: KAKEN	Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Research Foundation of the Capital Region of Denmark; Danish Agency for Science, Technology and Innovation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from The Carlsberg Foundation, The Novo Nordisk Research Foundation, The Lundbeck Foundation, The Research Foundation of the Capital Region of Denmark and The Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIOLE VT, 1993, CLIN INFECT DIS, V17, pS481, DOI 10.1093/clinids/17.Supplement_2.S481; Aoyagi Y, 2008, INFECT IMMUN, V76, P179, DOI 10.1128/IAI.00837-07; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Heidema J, 2011, BMJ-BRIT MED J, V342, DOI [10.1136/bmj.d3884, DOI 10.1136/BMJ.D3884]; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Liu Y, 2005, MOL IMMUNOL, V42, P1265, DOI 10.1016/j.molimm.2004.11.019; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nahid AM, 2006, DEV COMP IMMUNOL, V30, P335, DOI 10.1016/j.dci.2005.04.002; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Tsujimura M, 2002, CLIN CHIM ACTA, V325, P139, DOI 10.1016/S0009-8981(02)00274-7; Wachsmuth I. Kaye, 1991, Acta Paediatrica Japonica, V33, P603; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Yang LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019647	40	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38196	10.1371/journal.pone.0038196	http://dx.doi.org/10.1371/journal.pone.0038196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666482	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400099
J	Yu, H; Chen, JX; Xu, X; Li, Y; Zhao, HH; Fang, YP; Li, XX; Zhou, W; Wang, W; Wang, YH				Yu, Hua; Chen, Jianxin; Xu, Xue; Li, Yan; Zhao, Huihui; Fang, Yupeng; Li, Xiuxiu; Zhou, Wei; Wang, Wei; Wang, Yonghua			A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data	PLOS ONE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; SUPPORT VECTOR MACHINE; SIMPLEX-VIRUS TYPE-1; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; PROTEIN INTERACTIONS; INTERACTION NETWORKS; INHIBITORY-ACTIVITY; THYMIDINE KINASE; GENE-EXPRESSION; RANDOM FOREST	In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest (RF) and Support Vector Machine (SVM). The performance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of prediction for drug-target interactions, with a concordance of 82.83%, a sensitivity of 81.33%, and a specificity of 93.62%, respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.	[Yu, Hua; Xu, Xue; Fang, Yupeng; Li, Xiuxiu; Zhou, Wei; Wang, Yonghua] NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Chen, Jianxin; Zhao, Huihui; Wang, Wei] Beijing Univ Chinese Med, Beijing, Peoples R China; [Li, Yan] Dalian Univ Technol, Dept Chem Engn & Mat Sci, Dalian, Peoples R China; [Wang, Yonghua] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Yonghua] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Beijing University of Chinese Medicine; Dalian University of Technology; Northwest A&F University - China; Northwest A&F University - China	Yu, H (corresponding author), NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.	wangwei@bucm.edu.cn; yh_wang@nwsuaf.edu.cn	Li, Yuan/GXV-1310-2022; , Paulin/U-9063-2019; Chen, Jianxin/G-5881-2015; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022	, Paulin/0000-0001-6045-3712; Chen, Jianxin/0000-0003-4067-5638; 	National Natural Science Foundation of China [31170796]; Youth Fund of Northwest A F University; National Basic Research Program of China (973 Program) [2011CB505106]; National Department Public Benefit Research Foundation [200807007]; International Science and Technology Cooperation of China [2008DFA30610]; National Science Foundation of China [30902020, 81173463, 81102730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Fund of Northwest A F University; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Department Public Benefit Research Foundation; International Science and Technology Cooperation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (Grant No. 31170796) and also the Youth Fund of Northwest A & F University. This work was partially supported by the National Basic Research Program of China (973 Program) under grant No. 2011CB505106, the National Department Public Benefit Research Foundation (200807007), the International Science and Technology Cooperation of China (2008DFA30610), and the National Science Foundation of China (30902020, 81173463 and 81102730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2007, NEOPLASIA, V9, P222, DOI 10.1593/neo.06673; Balakin KV, 2002, J CHEM INF COMP SCI, V42, P1332, DOI 10.1021/ci025538y; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561; Biezonski DK, 2010, J NEUROCHEM, V112, P951, DOI 10.1111/j.1471-4159.2009.06515.x; Bock JR, 2005, J CHEM INF MODEL, V45, P1402, DOI 10.1021/ci050006d; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRIDGES CC, 1966, PSYCHOL REP, V18, P851, DOI 10.2466/pr0.1966.18.3.851; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Datta S, 2003, BIOINFORMATICS, V19, P459, DOI 10.1093/bioinformatics/btg025; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donnelly LE, 2004, AM J PHYSIOL-LUNG C, V287, pL774, DOI 10.1152/ajplung.00110.2004; Doucet JP, 2007, CURR COMPUT-AID DRUG, V3, P263, DOI 10.2174/157340907782799372; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Frimurer TM, 2005, BIOORG MED CHEM LETT, V15, P3707, DOI 10.1016/j.bmcl.2005.05.102; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Hansen JP, 2002, J PHARMACOL EXP THER, V300, P1093, DOI 10.1124/jpet.300.3.1093; Hao M, 2011, INT J MOL SCI, V12, P1259, DOI 10.3390/ijms12021259; Hao M, 2010, INT J MOL SCI, V11, P3413, DOI 10.3390/ijms11093413; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacoby E, 2003, DRUG NEWS PERSPECT, V16, P93, DOI 10.1358/dnp.2003.16.2.829326; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; KAUFMAN HE, 1985, OPHTHALMOLOGY, V92, P533; KLABUNDE T, 2006, LIGAND DESIGN G PROT, P115; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Li Y, 2009, QSAR COMB SCI, V28, P396, DOI 10.1002/qsar.200810100; Li YY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002139; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; LYON RA, 1986, PSYCHOPHARMACOLOGY, V88, P525; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Mithoefer MC, 2011, J PSYCHOPHARMACOL, V25, P439, DOI 10.1177/0269881110378371; Nagamine M, 2000, J CLIN MICROBIOL, V38, P2750, DOI 10.1128/JCM.38.7.2750-2752.2000; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Satoh T, 2004, INT J RADIAT ONCOL, V59, P562, DOI 10.1016/j.ijrobp.2004.01.020; Schmitt BM, 2004, CHEMBIOCHEM, V5, P1384, DOI 10.1002/cbic.200400126; Selken J, 2007, PHARMACOL BIOCHEM BE, V86, P622, DOI 10.1016/j.pbb.2007.02.006; Shankaran H, 1999, EUR J PHARMACOL, V385, P103, DOI 10.1016/S0014-2999(99)00728-1; Sprague JE, 2003, J PHARMACOL EXP THER, V305, P159, DOI 10.1124/jpet.102.044982; Sun XL, 2008, MOL DIVERS, V12, P157, DOI 10.1007/s11030-008-9092-x; Suzuki M, 2006, ANTIVIR RES, V72, P157, DOI 10.1016/j.antiviral.2006.05.001; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; VANE JR, 1998, INFLAMM RES, V2, P78, DOI DOI 10.1007/S000110050284; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Waterbury LD, 2006, CURR MED RES OPIN, V22, P1133, DOI 10.1185/030079906X112471; Wild K, 1997, PROTEIN SCI, V6, P2097; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xia Z, 2009, LECT NOTES OPER RES, V11, P123; Yabuuchi H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.5; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2011, J CHEM INF MODEL, V51, P1183, DOI 10.1021/ci100476q; Zhao CY, 2006, TOXICOLOGY, V217, P105, DOI 10.1016/j.tox.2005.08.019; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	73	270	286	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37608	10.1371/journal.pone.0037608	http://dx.doi.org/10.1371/journal.pone.0037608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666371	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400036
J	Gutierrez-Ibanez, C; Iwaniuk, AN; Lisney, TJ; Faunes, M; Marin, GJ; Wylie, DR				Gutierrez-Ibanez, Cristian; Iwaniuk, Andrew N.; Lisney, Thomas J.; Faunes, Macarena; Marin, Gonzalo J.; Wylie, Douglas R.			Functional Implications of Species Differences in the Size and Morphology of the Isthmo Optic Nucleus (ION) in Birds	PLOS ONE			English	Article							CENTRIFUGAL VISUAL-SYSTEM; LOWER-FIELD MYOPIA; PHYLOGENETIC COMPARATIVE METHODS; SOMATIC SENSORY REPRESENTATION; LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; PIGEONS COLUMBA-LIVIA; AVIAN RETINA; LAMINAR ORGANIZATION; MOLECULAR PHYLOGENY	In birds, there is a retinofugal projection from the brain to the retina originating from the isthmo optic nucleus (ION) in the midbrain. Despite a large number of anatomical, physiological and histochemical studies, the function of this retinofugal system remains unclear. Several functions have been proposed including: gaze stabilization, pecking behavior, dark adaptation, shifting attention, and detection of aerial predators. This nucleus varies in size and organization among some species, but the relative size and morphology of the ION has not been systematically studied. Here, we present a comparison of the relative size and morphology of the ION in 81 species of birds, representing 17 different orders. Our results show that several orders of birds, besides those previously reported, have a large, well-organized ION, including: hummingbirds, woodpeckers, coots and allies, and kingfishers. At the other end of the spectrum, parrots, herons, waterfowl, owls and diurnal raptors have relatively small ION volumes. ION also appears to be absent or unrecognizable is several taxa, including one of the basal avian groups, the tinamous, which suggests that the ION may have evolved only in the more modern group of birds, Neognathae. Finally, we demonstrate that evolutionary changes in the relative size and the cytoarchitectonic organization of ION have occurred largely independent of phylogeny. The large relative size of the ION in orders with very different lifestyles and feeding behaviors suggest there is no clear association with pecking behavior or predator detection. Instead, our results suggest that the ION is more complex and enlarged in birds that have eyes that are emmetropic in some parts of the visual field and myopic in others. We therefore posit that the ION is involved in switching attention between two parts of the retina i.e. from an emmetropic to a myopic part of the retina.	[Gutierrez-Ibanez, Cristian; Wylie, Douglas R.] Univ Alberta, Univ Ctr Neurosci, Edmonton, AB, Canada; [Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Faunes, Macarena; Marin, Gonzalo J.] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Lisney, Thomas J.; Wylie, Douglas R.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Marin, Gonzalo J.] Univ Finis Terrae, Fac Med, Santiago, Chile	University of Alberta; University of Lethbridge; Universidad de Chile; University of Alberta; Universidad Finis Terrae	Gutierrez-Ibanez, C (corresponding author), Univ Alberta, Univ Ctr Neurosci, Edmonton, AB, Canada.	cagutier@ualberta.ca	Lisney, Thomas/AAA-3288-2021; Iwaniuk, Andrew/H-7255-2019	Lisney, Thomas/0000-0001-5149-3720; Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to ANI and DRW (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumann T, 2001, WILDLIFE RES, V28, P379, DOI 10.1071/WR99092; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cajal SR, 1888, REV TRIM HISTOL NORM, V2, P1; CATSICAS S, 1987, NATURE, V326, P186, DOI 10.1038/326186a0; CHMIELEWSKI CE, 1988, ANAT HISTOL EMBRYOL, V17, P319, DOI 10.1111/j.1439-0264.1988.tb00570.x; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; Clarke PGH, 1996, VISUAL NEUROSCI, V13, P1043, DOI 10.1017/S0952523800007690; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; CROSSLAND WJ, 1978, BRAIN RES, V145, P239, DOI 10.1016/0006-8993(78)90860-0; Davis KE, 2008, THESIS U GLASGOW UK; DEACON TW, 1990, INT J PRIMATOL, V11, P193, DOI 10.1007/BF02192869; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DESROCHERS BA, 1986, CAN J ZOOL, V64, P1400, DOI 10.1139/z86-208; Dogiel A.S., 1895, ANAT ENTWICKLUNGSGES, V44, P622, DOI [10.1007/BF02934032, DOI 10.1007/BF02934032]; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; EBINGER P, 1987, J HIRNFORSCH, V28, P291; EBINGER P, 1995, J BRAIN RES, V36, P219; EBINGER P, 1995, BRAIN BEHAV EVOLUT, V45, P286, DOI 10.1159/000113557; EDDLEMAN WR, 1985, WILSON BULL, V97, P463; FERGUSON JL, 1978, BRAIN BEHAV EVOLUT, V15, P294, DOI 10.1159/000123784; FEYERABEND B, 1994, NEUROSCI LETT, V182, P66, DOI 10.1016/0304-3940(94)90207-0; Finger TE, 1975, ACTA PHYSL SCAND S, V638, P59; FITZKE FW, 1985, J PHYSIOL-LONDON, V369, P33, DOI 10.1113/jphysiol.1985.sp015886; Galifret Y, 1971, Vision Res, VSuppl 3, P185; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gass C.L., 1981, P159; GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAHMANN U, 1992, VISUAL NEUROSCI, V9, P225, DOI 10.1017/S0952523800010634; HAYES BP, 1983, EXP BRAIN RES, V49, P189; Higgins PJ, 2002, HDB AUSTR NZ ANTARCT, V5; Hirschberger W, 1971, THESIS GOETHE U FRAN; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; HOLDEN AL, 1968, J PHYSIOL-LONDON, V197, P199, DOI 10.1113/jphysiol.1968.sp008555; HOLDEN AL, 1972, J PHYSIOL-LONDON, V223, P419, DOI 10.1113/jphysiol.1972.sp009856; Holyoak DT., 2001, NIGHTJARS THEIR ALLI; Howard CV, 2005, UNBIASED STEREOLOGY; HOWARD V, 1985, J MICROSC-OXFORD, V138, P203, DOI 10.1111/j.1365-2818.1985.tb02613.x; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Iwaniuk A., 2004, INT J COMP PSYCHOL, V17, P17; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; JAKSIC FM, 1985, ORNIS SCAND, V16, P165, DOI 10.2307/3676627; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; KAAS JH, 1978, J COMP NEUROL, V182, P517, DOI 10.1002/cne.901820308; Kahn DM, 2002, J COMP NEUROL, V447, P114, DOI 10.1002/cne.10206; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; KNIPLING RR, 1978, PHYSIOL BEHAV, V21, P813, DOI 10.1016/0031-9384(78)90022-7; Kolmer W, 1924, PFLUEGERS ARCH GESAM, V2, P266; KRUGER L, 1969, AM J ANAT, V125, P247, DOI 10.1002/aja.1001250302; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LINDSEY GD, 1994, J FIELD ORNITHOL, V65, P76; Lindstrom SH, 2009, VISUAL NEUROSCI, V26, P215, DOI 10.1017/S0952523809090063; Lindstrom SH, 2010, VISUAL NEUROSCI, V27, P103, DOI 10.1017/S0952523810000155; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison, 2019, MESQUITE MODULAR SYS; MARIN G, 1990, EXP BRAIN RES, V82, P263; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; MARTIN GR, 1994, BRAIN BEHAV EVOLUT, V44, P74, DOI 10.1159/000113571; Martin Graham R., 1993, P5; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Medina M, 2004, J COMP NEUROL, V468, P65, DOI 10.1002/cne.10959; MICELI D, 1995, VISUAL NEUROSCI, V12, P425, DOI 10.1017/S0952523800008336; Miceli D, 1999, BEHAV BRAIN RES, V98, P203, DOI 10.1016/S0166-4328(98)00085-0; Miceli D, 1997, VISUAL NEUROSCI, V14, P213, DOI 10.1017/S0952523800011354; Midford PE, 2008, PDAP MESQUITE TRANSL; MILES FA, 1972, BRAIN RES, V48, P93, DOI 10.1016/0006-8993(72)90172-2; MILES FA, 1972, BRAIN RES, V48, P115, DOI 10.1016/0006-8993(72)90173-4; Moore JM, 2011, P NATL ACAD SCI USA, V108, P16440, DOI 10.1073/pnas.1102077108; MORITA Y, 1985, J COMP NEUROL, V238, P187, DOI 10.1002/cne.902380206; MURPHY CJ, 1995, VISION RES, V35, P1153, DOI 10.1016/0042-6989(94)00240-M; NICKLA DL, 1994, VISUAL NEUROSCI, V11, P401, DOI 10.1017/S0952523800001747; OLEARY DDM, 1982, J COMP NEUROL, V212, P399, DOI 10.1002/cne.902120407; PEARLMAN AL, 1976, J COMP NEUROL, V166, P123, DOI 10.1002/cne.901660109; Pereira SL, 2007, SYST BIOL, V56, P656, DOI 10.1080/10635150701549672; PUBOLS BH, 1972, BRAIN BEHAV EVOLUT, V5, P342; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Ramon y Cajal S., 1889, ANAT ANZEIGER, V4, P111; Reperant J, 2007, BRAIN RES REV, V53, P161, DOI 10.1016/j.brainresrev.2006.08.004; Reperant J, 2006, BRAIN RES REV, V52, P1, DOI 10.1016/j.brainresrev.2005.11.008; REPERANT J, 1989, INT REV CYTOL, V118, P115, DOI 10.1016/S0074-7696(08)60874-8; ROGERS LJ, 1972, BRAIN RES, V48, P147, DOI 10.1016/0006-8993(72)90175-8; SANDERSON KJ, 1974, J COMP NEUROL, V153, P239, DOI 10.1002/cne.901530303; SCHAEFFEL F, 1994, J OPT SOC AM A, V11, P487, DOI 10.1364/JOSAA.11.000487; Scheaffer R.L., 1996, ELEMENTARY SURVEY SA; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; SHORTESS GK, 1975, BRAIN RES, V88, P525, DOI 10.1016/0006-8993(75)90665-4; SHORTESS GK, 1977, PHYSIOL BEHAV, V18, P409, DOI 10.1016/0031-9384(77)90252-9; SHOWERS MJC, 1968, J COMP NEUROL, V132, P589, DOI 10.1002/cne.901320407; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SOHAL GS, 1975, EXP NEUROL, V46, P521, DOI 10.1016/0014-4886(75)90123-5; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; TATE J, 1973, AUK, V90, P840, DOI 10.2307/4084364; UCHIYAMA H, 1989, VISUAL NEUROSCI, V3, P183, DOI 10.1017/S0952523800009950; Uchiyama H, 2005, VISUAL NEUROSCI, V22, P881, DOI 10.1017/S0952523805226160; Uchiyama H, 1998, VISUAL NEUROSCI, V15, P417; Uchiyama H, 1996, VISUAL NEUROSCI, V13, P1119, DOI 10.1017/S0952523800007768; Uchiyama H, 1999, NEUROCOMPUTING, V26-7, P565, DOI 10.1016/S0925-2312(99)00035-1; Uchiyama H, 2004, J COMP NEUROL, V476, P146, DOI 10.1002/cne.20225; UCHIYAMA H, 1994, VISION RES, V34, P2189, DOI 10.1016/0042-6989(94)90101-5; Verhaart W. J. C., 1971, J Hirnforsch, V13, P39; WARD R, 1991, NATO ADV SCI I A-LIF, V222, P61; WEIDNER C, 1989, Biological Structures and Morphogenesis, V2, P89; WEIDNER C, 1987, BRAIN RES, V436, P153, DOI 10.1016/0006-8993(87)91568-X; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WESTCOTT DA, 1988, AUST J ZOOL, V36, P335, DOI 10.1071/ZO9880335; Wilson M, 2011, VISUAL NEUROSCI, V28, P337, DOI 10.1017/S0952523811000022; Wink M, 2008, OWLS WORLD, P42; Wink Michael, 2004, P517; Witmer MC, 1996, AUK, V113, P414, DOI 10.2307/4088908; WOLFOBERHOLLENZER F, 1987, NEUROSCI LETT, V73, P16, DOI 10.1016/0304-3940(87)90023-1; WOODSON W, 1995, J COMP NEUROL, V362, P489, DOI 10.1002/cne.903620405; WOODSON W, 1991, J COMP NEUROL, V305, P470, DOI 10.1002/cne.903050310; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160	130	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37816	10.1371/journal.pone.0037816	http://dx.doi.org/10.1371/journal.pone.0037816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666395	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600031
J	Esteves, CL; Kelly, V; Begay, V; Man, TY; Morton, NM; Leutz, A; Seckl, JR; Chapman, KE				Esteves, Cristina L.; Kelly, Val; Begay, Valerie; Man, Tak Y.; Morton, Nicholas M.; Leutz, Achim; Seckl, Jonathan R.; Chapman, Karen E.			Regulation of Adipocyte 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD1) by CCAAT/Enhancer-Binding Protein (C/EBP) beta Isoforms, LIP and LAP	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL INHIBITORY PROTEIN; ADIPOSE-TISSUE; GENE-TRANSCRIPTION; METABOLIC SYNDROME; GLUCOSE-PRODUCTION; VISCERAL OBESITY; MICE; EXPRESSION; ALPHA	11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyses intracellular regeneration of active glucocorticoids, notably in liver and adipose tissue. 11 beta-HSD1 is increased selectively in adipose tissue in human obesity, a change implicated in the pathogenesis of metabolic syndrome. With high fat (HF)-feeding, adipose tissue 11 beta-HSD1 is down-regulated in mice, plausibly to counteract metabolic disease. Transcription of 11 beta-HSD1 is directly regulated by members of the CCAAT/enhancer binding protein (C/EBP) family. Here we show that while total C/EBP beta in adipose tissue is unaltered by HF diet, the ratio of the C/EBP beta isoforms liver-enriched inhibitor protein (LIP) and liver-enriched activator protein (LAP) (C/EBP beta-LIP:LAP) is increased in subcutaneous adipose. This may cause changes in 11 beta-HSD1 expression since genetically modified C/EBP beta((+/L)) mice, with increased C/EBP beta-LIP:LAP ratio, have decreased subcutaneous adipose 11 beta-HSD1 mRNA levels, whereas C/EBP beta(Delta uORF) mice, with decreased C/EBP beta-LIP:LAP ratio, show increased subcutaneous adipose 11 beta-HSD1. C/EBP beta-LIP:LAP ratio is regulated by endoplasmic reticulum (ER) stress and mTOR signalling, both of which are altered in obesity. In 3T3-L1 adipocytes, 11 beta-HSD1 mRNA levels were down-regulated following induction of ER stress by tunicamycin but were up-regulated following inhibition of mTOR by rapamycin. These data point to a central role for C/EBP beta and its processing to LIP and LAP in transcriptional regulation of 11 beta-HSD1 in adipose tissue. Down-regulation of 11 beta-HSD1 by increased C/EBP beta-LIP:LAP in adipocytes may be part of a nutrient-sensing mechanism counteracting nutritional stress generated by HF diet.	[Esteves, Cristina L.; Kelly, Val; Man, Tak Y.; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Morton, Nicholas M.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Mol Metab Grp, Edinburgh, Midlothian, Scotland; [Begay, Valerie; Leutz, Achim] Max Delbrueck Ctr Mol Med, Berlin, Germany	University of Edinburgh; University of Edinburgh; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Esteves, CL (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Seckl, Jonathan R/C-3555-2013; Esteves, Cristina/Y-5577-2019; Morton, NICHOLAS/ABF-3774-2020; Leutz, Achim/K-9643-2013	Leutz, Achim/0000-0001-8259-927X; Chapman, Karen/0000-0001-7777-6817	Wellcome Trust Programme Grant [WT083184]; Wellcome Trust Career Development Fellowship [079660/z/06/z]	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust Career Development Fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Programme Grant (grant number WT083184 to JRS and KEC). NMM was funded by a Wellcome Trust Career Development Fellowship (grant 079660/z/06/z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2007, ENDOCRINOLOGY, V148, P5268, DOI 10.1210/en.2007-0349; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Cucinotta M, 2008, J BIOL CHEM, V283, P29760, DOI 10.1074/jbc.M803145200; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Gout J, 2006, BIOCHIMIE, V88, P1115, DOI 10.1016/j.biochi.2006.05.020; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Man TY, 2011, AM J PHYSIOL-ENDOC M, V300, pE1076, DOI 10.1152/ajpendo.00531.2010; Masaki T, 2006, BIOCHEM J, V397, P345, DOI 10.1042/BJ20051863; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wethmar K, GENES DEV, V24, P15; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4	44	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37953	10.1371/journal.pone.0037953	http://dx.doi.org/10.1371/journal.pone.0037953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662254	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305342300145
J	Lee, CH; Lee, MC; Lin, HH; Shu, CC; Wang, JY; Lee, LN; Chao, KM				Lee, Chih-Hsin; Lee, Ming-Chia; Lin, Hsien-Ho; Shu, Chin-Chung; Wang, Jann-Yuan; Lee, Li-Na; Chao, Kun-Mao			Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							IMPAIRMENT; PREDICTORS; DIAGNOSIS; BURDEN; COPD	Objective: Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. It has been suggested as an important risk factor of chronic obstructive pulmonary disease (COPD), which is also a major cause of morbidity and mortality. This study investigated the impact of pulmonary TB and anti-TB treatment on the risk of developing COPD. Design, Setting, and Participants: This cohort study used the National Health Insurance Database of Taiwan, particularly the Longitudinal Health Insurance Database 2005 to obtain 3,176 pulmonary TB cases and 15,880 control subjects matched in age, sex, and timing of entering the database. Main Outcome Measures: Hazard ratios of potential risk factors of COPD, especially pulmonary TB and anti-TB treatment. Results: The mean age of pulmonary TB cases was 51.9 +/- 19.2. The interval between the initial study date and commencement of anti-TB treatment (delay in anti-TB treatment) was 75.8 +/- 65.4 days. Independent risk factors for developing COPD were age, male, low income, and history of pulmonary TB (hazard ratio 2.054 [1.768-2.387]), while diabetes mellitus was protective. The impact of TB persisted for six years after TB diagnosis and was significant in women and subjects aged >70 years. Among TB patients, delay in anti-TB treatment had a dose-response relationship with the risk of developing COPD. Conclusions: Some cases of COPD may be preventable by controlling the TB epidemic, early TB diagnosis, and prompt initiation of appropriate anti-TB treatment. Follow-up care and early intervention for COPD may be necessary for treated TB patients.	[Lee, Chih-Hsin; Chao, Kun-Mao] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Chih-Hsin] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, New Taipei, Taiwan; [Lee, Chih-Hsin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ming-Chia] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Pharm, New Taipei, Taiwan; [Lin, Hsien-Ho] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Shu, Chin-Chung; Wang, Jann-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CH (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	jywang@ntu.edu.tw	Lee, Ming-Chia/W-5350-2019; Lee, Ming-Chia/ABB-8800-2021; Lee, Chih-Hsin/D-2697-2014	Lee, Ming-Chia/0000-0002-6209-2313; SHU, CHIN-CHUNG/0000-0003-0311-5148; CHAO, KUN-MA0/0000-0003-2837-1279; WANG, JANN-YUAN/0000-0003-3406-366X; LIN, HSIEN-HO/0000-0002-7481-6016; LEE, LI-NA/0000-0002-7654-2450; Lee, Chih-Hsin/0000-0003-1492-3044	National Science Council, Taiwan [NSC 99-2314-B-002-088-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (grant NSC 99-2314-B-002-088-MY2; http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Blanc L, 2010, GLOBAL TUBERCULOSIS; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Grzybowski S, 1987, Tubercle, V68, P33; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Luh K-T, 2011, TAIWAN GUIDELINES TB; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pirkis JE, 1996, TUBERCLE LUNG DIS, V77, P401, DOI 10.1016/S0962-8479(96)90111-2; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Tan WC, 2003, RESPIROLOGY, V8, P192; Theakston F, 2008, WORLD HLTH STAT	29	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37978	10.1371/journal.pone.0037978	http://dx.doi.org/10.1371/journal.pone.0037978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662259	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300151
J	Liang, CY; Sun, LL; Yao, ZF; Liao, H; Tian, J				Liang, Cuiyue; Sun, Lili; Yao, Zhufang; Liao, Hong; Tian, Jiang			Comparative Analysis of PvPAP Gene Family and Their Functions in Response to Phosphorus Deficiency in Common Bean	PLOS ONE			English	Article							PURPLE ACID-PHOSPHATASE; ARABIDOPSIS-THALIANA; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; PHASEOLUS-VULGARIS; PHYTASE ACTIVITY; ACQUISITION; STARVATION; EFFICIENCY; IDENTIFICATION	Background: Purple acid phosphatases (PAPs) play a vital role in adaptive strategies of plants to phosphorus (P) deficiency. However, their functions in relation to P efficiency are fragmentary in common bean. Principal Findings: Five PvPAPs were isolated and sequenced in common bean. Phylogenetic analysis showed that PvPAPs could be classified into two groups, including a small group with low molecular mass, and a large group with high molecular mass. Among them, PvPAP3, PvPAP4 and PvPAP5 belong to the small group, while the other two belong to the large group. Transient expression of 35S:PvPAPs-GFP on onion epidermal cells verified the variations of subcellular localization among PvPAPs, suggesting functional diversities of PvPAPs in common bean. Quantitative PCR results showed that most PvPAPs were up-regulated by phosphate (Pi) starvation. Among them, the expression of the small group PvPAPs responded more to Pi starvation, especially in the roots of G19833, the P-efficient genotype. However, only overexpressing PvPAP1 and PvPAP3 could result in significantly increased utilization of extracellular dNTPs in the transgenic bean hairy roots. Furthermore, overexpressing PvPAP3 in Arabidopsis enhanced both plant growth and total P content when dNTPs were supplied as the sole external P source. Conclusions: The results suggest that PvPAPs in bean varied in protein structure, response to P deficiency and subcellular localization. Among them, both PvPAP1 and PvPAP3 might function as utilization of extracellular dNTPs.	[Liang, Cuiyue; Sun, Lili; Yao, Zhufang; Liao, Hong; Tian, Jiang] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China; [Liang, Cuiyue] Cornell Univ, Robert Holley Ctr Agr & Hlth, USDA, Agr Res Serv, Ithaca, NY USA; [Sun, Lili] Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Danzhou, Peoples R China	South China Agricultural University; Cornell University; United States Department of Agriculture (USDA); Chinese Academy of Tropical Agricultural Sciences	Liang, CY (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China.	jtian@scau.edu.cn			National Natural Science Foundation of China [31101593, 30890131]; National Key Basic Research Special Funds of China [2011CB100301]; Ph.D. Programs Foundation of Ministry of Education of China [20094404120022]; project of science and technology new star in Zhujiang Guangzhou city	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Special Funds of China(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); project of science and technology new star in Zhujiang Guangzhou city	This study was in part supported by National Natural Science Foundation of China (No. 31101593 and 30890131), National Key Basic Research Special Funds of China (2011CB100301), Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20094404120022) and the project of science and technology new star in Zhujiang Guangzhou city. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat DL, 2010, SOIL BIOL BIOCHEM, V42, P2231, DOI 10.1016/j.soilbio.2010.08.023; BECK JL, 1986, BIOCHIM BIOPHYS ACTA, V869, P61, DOI 10.1016/0167-4838(86)90310-9; Bozzo GG, 2002, EUR J BIOCHEM, V269, P6278, DOI 10.1046/j.1432-1033.2002.03347.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buenemann EK, 2008, SOIL BIOL BIOCHEM, V40, P1908, DOI 10.1016/j.soilbio.2008.03.017; Cashikar AG, 1997, PLANT PHYSIOL, V114, P907, DOI 10.1104/pp.114.3.907; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11&lt;1754::AID-ELPS1754&gt;3.0.CO;2-E; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Fan MS, 2003, FUNCT PLANT BIOL, V30, P493, DOI 10.1071/FP03046; George Timothy S., 2008, V7, P247; Graham MA, 2006, FUNCT PLANT BIOL, V33, P789, DOI 10.1071/FP06101; Hegeman CE, 2001, PLANT PHYSIOL, V126, P1598, DOI 10.1104/pp.126.4.1598; Hurley BA, 2010, PLANT PHYSIOL, V153, P1112, DOI 10.1104/pp.110.153270; Kaida R, 2008, PHYTOCHEMISTRY, V69, P2546, DOI 10.1016/j.phytochem.2008.07.008; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Li CC, 2012, ANN BOT-LONDON, V109, P275, DOI 10.1093/aob/mcr246; Li DP, 2002, J BIOL CHEM, V277, P27772, DOI 10.1074/jbc.M204183200; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Liang CY, 2010, PLANT PHYSIOL, V152, P854, DOI 10.1104/pp.109.147918; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Ligaba A, 2004, FUNCT PLANT BIOL, V31, P1075, DOI 10.1071/FP04091; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Olczak M, 1997, BBA-PROTEIN STRUCT M, V1341, P14, DOI 10.1016/S0167-4838(97)00055-1; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Schenk G, 1999, ARCH BIOCHEM BIOPHYS, V370, P183, DOI 10.1006/abbi.1999.1407; Schenk G, 2000, GENE, V250, P117, DOI 10.1016/S0378-1119(00)00186-4; Shen H, 2002, ENVIRON EXP BOT, V48, P1, DOI 10.1016/S0098-8472(02)00009-6; Tian J, 2007, PLANTA, V227, P151, DOI 10.1007/s00425-007-0603-2; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Veljanovski V, 2006, PLANT PHYSIOL, V142, P1282, DOI 10.1104/pp.106.087171; Wang XR, 2009, PLANT PHYSIOL, V151, P233, DOI 10.1104/pp.109.138891; Xiao K, 2006, PLANT SCI, V170, P191, DOI 10.1016/j.plantsci.2005.08.001; YAN XL, 1995, CROP SCI, V35, P1094, DOI 10.2135/cropsci1995.0011183X003500040029x; Yan XL, 2001, PLANT PHYSIOL, V125, P1901, DOI 10.1104/pp.125.4.1901; Yoneyama T, 2004, J BIOL CHEM, V279, P37477, DOI 10.1074/jbc.M405305200; Zhang SC, 2009, PLANT MOL BIOL, V69, P745, DOI 10.1007/s11103-009-9452-7; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zimmermann R, 2004, PLANT BIOLOGY, V6, P519, DOI 10.1055/s-2004-821091	44	23	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38106	10.1371/journal.pone.0038106	http://dx.doi.org/10.1371/journal.pone.0038106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662274	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300166
J	Verriere, V; Higgins, G; Al-Alawi, M; Costello, RW; McNally, P; Chiron, R; Harvey, BJ; Urbach, V				Verriere, Valia; Higgins, Gerard; Al-Alawi, Mazen; Costello, Richard W.; McNally, Paul; Chiron, Raphael; Harvey, Brian J.; Urbach, Valerie			Lipoxin A(4) Stimulates Calcium-Activated Chloride Currents and Increases Airway Surface Liquid Height in Normal and Cystic Fibrosis Airway Epithelia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN BRONCHIAL EPITHELIUM; ION-TRANSPORT; CA2+; CELLS; SECRETION; RESPONSES; VOLUME	Cystic Fibrosis (CF) is a genetic disease characterised by a deficit in epithelial Cl- secretion which in the lung leads to airway dehydration and a reduced Airway Surface Liquid (ASL) height. The endogenous lipoxin LXA(4) is a member of the newly identified eicosanoids playing a key role in ending the inflammatory process. Levels of LXA(4) are reported to be decreased in the airways of patients with CF. We have previously shown that in normal human bronchial epithelial cells, LXA(4) produced a rapid and transient increase in intracellular Ca2+. We have investigated, the effect of LXA(4) on Cl- secretion and the functional consequences on ASL generation in bronchial epithelial cells obtained from CF and non-CF patient biopsies and in bronchial epithelial cell lines. We found that LXA(4) stimulated a rapid intracellular Ca2+ increase in all of the different CF bronchial epithelial cells tested. In non-CF and CF bronchial epithelia, LXA(4) stimulated whole-cell Cl- currents which were inhibited by NPPB (calcium-activated Cl- channel inhibitor), BAPTA-AM (chelator of intracellular Ca2+) but not by CFTRinh-172 (CFTR inhibitor). We found, using confocal imaging, that LXA(4) increased the ASL height in non-CF and in CF airway bronchial epithelia. The LXA(4) effect on ASL height was sensitive to bumetanide, an inhibitor of transepithelial Cl- secretion. The LXA(4) stimulation of intracellular Ca2+, whole-cell Cl- currents, conductances and ASL height were inhibited by Boc-2, a specific antagonist of the ALX/FPR2 receptor. Our results provide, for the first time, evidence for a novel role of LXA(4) in the stimulation of intracellular Ca2+ signalling leading to Ca2+-activated Cl- secretion and enhanced ASL height in non-CF and CF bronchial epithelia.	[Verriere, Valia; Higgins, Gerard; Al-Alawi, Mazen; Harvey, Brian J.; Urbach, Valerie] Beaumont Hosp, Dept Mol Med, RCSI Educ & Res Ctr, Dublin 9, Ireland; [Chiron, Raphael] CRCM, Montpellier, France; [Al-Alawi, Mazen; Costello, Richard W.] Beaumont Hosp, Dept Resp Med, Dublin 9, Ireland; [Higgins, Gerard; McNally, Paul; Urbach, Valerie] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Universite de Montpellier; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Verriere, V (corresponding author), Beaumont Hosp, Dept Mol Med, RCSI Educ & Res Ctr, Dublin 9, Ireland.	valerie.urbach@ncrc.ie	Urbach, Valerie/C-3615-2012; McNally, Paul/I-3151-2013; McNally, Paul/AAL-4407-2021; Harvey, Brian J/A-5120-2010; Harvey, Brian/AAJ-4085-2020	Urbach, Valerie/0000-0001-7437-9365; McNally, Paul/0000-0001-7102-1712; McNally, Paul/0000-0001-7102-1712; Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Costello, Richard/0000-0003-1179-6692; Higgins, Gerard/0000-0001-6739-8138; Al-Alawi, Mazen/0000-0002-0926-3208	French National Institute of Health (INSERM); Centre Hospitalier Universitaire (CHU) of Montpellier; French Cystic Fibrosis Association (Vaincre La Mucoviscidose); Career Enhancement and Mobility Programme Marie Curie Fellowship; Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI); National Biophotonics and Imaging Platform, Ireland	French National Institute of Health (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre Hospitalier Universitaire (CHU) of Montpellier; French Cystic Fibrosis Association (Vaincre La Mucoviscidose); Career Enhancement and Mobility Programme Marie Curie Fellowship; Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI); National Biophotonics and Imaging Platform, Ireland	This work was funded by the French National Institute of Health (INSERM), the Centre Hospitalier Universitaire (CHU) of Montpellier, the French Cystic Fibrosis Association (Vaincre La Mucoviscidose), a Career Enhancement and Mobility Programme Marie Curie Fellowship, the Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI) Cycle 4 and the National Biophotonics and Imaging Platform, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Boat T.F., 1989, ACTA PAEDIATR SC   S, V363, P29; BOAT TF, 1989, ACTA PAEDIATR SCAND, P25; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bonnans C, 2003, J BIOL CHEM, V278, P10879, DOI 10.1074/jbc.M210294200; Bonnans C, 2007, BIOMED PHARMACOTHER, V61, P261, DOI 10.1016/j.biopha.2007.02.016; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Grumbach Y, 2009, AM J PHYSIOL-LUNG C, V296, pL101, DOI 10.1152/ajplung.00018.2008; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Scheckenbach KEL, 2011, AM J RESP CELL MOL, V44, P74, DOI 10.1165/rcmb.2009-0361OC; Serhan CN, 1999, CLIN CHEM LAB MED, V37, P299, DOI 10.1515/CCLM.1999.052; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	27	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37746	10.1371/journal.pone.0037746	http://dx.doi.org/10.1371/journal.pone.0037746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662206	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300096
J	Walker, J; Tabrizi, SN; Fairley, CK; Chen, MY; Bradshaw, CS; Twin, J; Taylor, N; Donovan, B; Kaldor, JM; McNamee, K; Urban, E; Walker, S; Currie, M; Birden, H; Bowden, F; Gunn, J; Pirotta, M; Gurrin, L; Harindra, V; Garland, SM; Hocking, JS				Walker, Jennifer; Tabrizi, Sepehr N.; Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Twin, Jimmy; Taylor, Nicole; Donovan, Basil; Kaldor, John M.; McNamee, Kathleen; Urban, Eve; Walker, Sandra; Currie, Marian; Birden, Hudson; Bowden, Francis; Gunn, Jane; Pirotta, Marie; Gurrin, Lyle; Harindra, Veerakathy; Garland, Suzanne M.; Hocking, Jane S.			Chlamydia trachomatis Incidence and Re-Infection among Young Women - Behavioural and Microbiological Characteristics	PLOS ONE			English	Article							INCLUSION-FORMING UNITS; ANTIMICROBIAL RESISTANCE; INFECTION; SEROVAR; DISEASE; LOAD	Background: This study aimed to estimate rates of chlamydia incidence and re-infection and to investigate the dynamics of chlamydia organism load in prevalent, incident and re-infections among young Australian women. Methods: 1,116 women aged 16 to 25 years were recruited from primary care clinics in Australia. Vaginal swabs were collected at 3 to 6 month intervals for chlamydia testing. Chlamydia organism load was measured by quantitative PCR. Results: There were 47 incident cases of chlamydia diagnosed and 1,056.34 person years of follow up with a rate of 4.4 per 100 person years (95% CI: 3.3, 5.9). Incident infection was associated with being aged 16 to 20 years [RR = 3.7 (95% CI: 1.9, 7.1)], being employed [RR = 2.4 (95% CI: 1.1, 4.9)] and having two or more new sex partners [RR = 5.5 (95% CI: 2.6, 11.7)]. Recent antibiotic use was associated with a reduced incidence [RR: 0.1 (95% CI: 0.0, 0.5)]. There were 14 re-infections with a rate of 22.3 per 100 person years (95% CI: 13.2, 37.6). The median time to re-infection was 4.6 months. Organism load was higher for prevalent than incident infections (p<0.01) and for prevalent than re-infections (p<0.01). Conclusions: Chlamydia is common among young women and a high proportion of women are re-infected within a short period of time, highlighting the need for effective partner treatment and repeat testing. The difference in organism load between prevalent and incident infections suggests prevalent infection may be more important for ongoing transmission of chlamydia.	[Walker, Jennifer] Univ Melbourne, CERSH Melbourne Med Sch, Melbourne, Vic 3010, Australia; [Walker, Jennifer; Garland, Suzanne M.; Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Tabrizi, Sepehr N.; Twin, Jimmy; Taylor, Nicole] Royal Womens Hosp, Dept Mol Microbiol, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Urban, Eve] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Walker, Sandra] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic 3010, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Donovan, Basil; Kaldor, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Donovan, Basil; Kaldor, John M.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNamee, Kathleen] Family Planning Victoria, Melbourne, Vic, Australia; [McNamee, Kathleen] Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Currie, Marian; Bowden, Francis] Australian Natl Univ, Canberra, ACT, Australia; [Birden, Hudson] Univ Sydney, Sydney Sch Publ Hlth, Sydney Inst Emerging Infect Dis & Biosecur, Lismore, NSW, Australia; [Birden, Hudson] Univ Ctr Rural Hlth, Lismore, NSW, Australia; [Gunn, Jane; Pirotta, Marie] Univ Melbourne, Dept Gen Practice, Primary Care Res Unit, Melbourne, Vic 3010, Australia; [Gurrin, Lyle] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Harindra, Veerakathy; Garland, Suzanne M.] St Marys Hosp, Portsmouth PO3 6AQ, Hants, England; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute; Monash University; Australian National University; University of Sydney; University of Melbourne; University of Melbourne; University of Melbourne	Walker, J (corresponding author), Univ Melbourne, CERSH Melbourne Med Sch, Melbourne, Vic 3010, Australia.	walker@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Kaldor, John M/D-4545-2011; Donovan, Basil J/K-1246-2012; Birden, Hudson H/Q-7151-2016	Hocking, Jane/0000-0001-9329-8501; Donovan, Basil J/0000-0001-8851-4126; Birden, Hudson H/0000-0001-5134-7408; McIntosh, Jennifer/0000-0002-6655-0940; Gunn, Jane/0000-0001-8836-7525; Christopher, Fairley/0000-0001-9081-1664; Gurrin, Lyle/0000-0001-7052-1969; bradshaw, catriona/0000-0002-6643-5678	Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program; National Health and Research Council in Australia [509144]	Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program; National Health and Research Council in Australia	Funding was provided by the Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program and by the National Health and Research Council (research grant number 509144) in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken IJ, 2007, SEX TRANSM DIS, V34, P739, DOI 10.1097/01.olq.0000261326.65503.f6; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#; Chen MY, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.030700; Cohen CR, 2005, J INFECT DIS, V192, P591, DOI 10.1086/432070; Cotter TW, 1996, RES IMMUNOL, V147, P587, DOI 10.1016/S0923-2494(97)85226-1; Eckert LO, 2000, J INFECT DIS, V182, P540, DOI 10.1086/315738; Geisler WM, 2004, J INFECT DIS, V190, P1723, DOI 10.1086/425077; Geisler WM, 2001, J INFECT DIS, V184, P1350, DOI 10.1086/323998; Ginige Samitha, 2006, Sex Health, V3, P221, DOI 10.1071/SH06013; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Guy R, 2012, SEX TRANSM DIS, V39, P136, DOI 10.1097/OLQ.0b013e31823ed4ec; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Handsfield HH, 2011, SEX TRANSM DIS, V38; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; Hocking Jane S, 2006, Sex Health, V3, P235, DOI 10.1071/SH06033; Horner P, 2006, SEX TRANSM INFECT, V82, P340, DOI 10.1136/sti.2005.019158; Horner PJ, 2012, SEX TRANSM INFECT, V88, P154, DOI 10.1136/sextrans-2011-050385; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Jones RB, 1995, PRINCIPLES PRACTICE, P1676; Jurstrand M, 2010, SEX TRANSM INFECT, V86, P56, DOI 10.1136/sti.2009.037572; LaMontagne DS, 2007, SEX TRANSM INF, V83; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Ness RB, 2008, SEX TRANSM DIS, V35, P129, DOI 10.1097/OLQ.0b013e3181557c25; Oh MK, 1996, J ADOLESCENT HEALTH, V18, P270, DOI 10.1016/1054-139X(95)00232-H; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V151, P645, DOI 10.1016/0002-9378(85)90156-5; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pol BVD, 2010, P 12 INT S HUM CHLAM, P393; Rogers SM, SEX TRANSM INF, V84, P23; Schachter J, 2008, SEXUALLY TRANSMITTED; Schiller JH, 2003, SEMIN ONCOL, V30, P49, DOI [10.1053/sonc.2003.50032, 10.1097/00007435-200301000-00011]; Sex Health Society of Victoria, 2008, NAT MAN GUID SEX TRA; Stata Corporation, 2009, STAT STAT SOFTW REL; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Stevens MP, 2004, J CLIN MICROBIOL, V42, P2501, DOI 10.1128/JCM.42.6.2501-2507.2004; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; van den Broek IVF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-39; Veldhuijzen IK, 2005, SEX TRANSM DIS, V32, P599, DOI 10.1097/01.olq.0000179887.01141.c3; Walker J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-156; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; Wang SA, 2005, J INFECT DIS, V191, P917, DOI 10.1086/428290; Xu FJ, 2000, AM J EPIDEMIOL, V152, P1164, DOI 10.1093/aje/152.12.1164	46	84	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37778	10.1371/journal.pone.0037778	http://dx.doi.org/10.1371/journal.pone.0037778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662220	Green Published, gold			2022-12-25	WOS:000305342300110
J	Zandevakili, P; Hu, M; Qin, ZH				Zandevakili, Pooya; Hu, Ming; Qin, Zhaohui			GPUmotif: An Ultra-Fast and Energy-Efficient Motif Analysis Program Using Graphics Processing Units	PLOS ONE			English	Article							FACTOR-BINDING SITES; CHIP-SEQ DATA; CHROMATIN-IMMUNOPRECIPITATION; STATISTICAL PHYLOGENETICS; SEQUENCE ALIGNMENT; GENOME; ALGORITHM; ASSOCIATION	Computational detection of TF binding patterns has become an indispensable tool in functional genomics research. With the rapid advance of new sequencing technologies, large amounts of protein-DNA interaction data have been produced. Analyzing this data can provide substantial insight into the mechanisms of transcriptional regulation. However, the massive amount of sequence data presents daunting challenges. In our previous work, we have developed a novel algorithm called Hybrid Motif Sampler (HMS) that enables more scalable and accurate motif analysis. Despite much improvement, HMS is still time-consuming due to the requirement to calculate matching probabilities position-by-position. Using the NVIDIA CUDA toolkit, we developed a graphics processing unit (GPU)-accelerated motif analysis program named GPUmotif. We proposed a "fragmentation'' technique to hide data transfer time between memories. Performance comparison studies showed that commonly-used model-based motif scan and de novo motif finding procedures such as HMS can be dramatically accelerated when running GPUmotif on NVIDIA graphics cards. As a result, energy consumption can also be greatly reduced when running motif analysis using GPUmotif. The GPUmotif program is freely available at http://sourceforge.net/projects/gpumotif/	[Zandevakili, Pooya] Univ Michigan, Dept Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Hu, Ming] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Qin, Zhaohui] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Qin, Zhaohui] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Qin, Zhaohui] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Harvard University; Emory University; Emory University; Emory University	Zandevakili, P (corresponding author), Microsoft Corp, Redmond, WA 98052 USA.	zhaohui.qin@emory.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; Hu, Ming/0000-0002-6062-8794	National Institutes of Health [R01HG005119]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work is supported by National Institutes of Health grant R01HG005119. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdahl G M, 1967, P APR 18 20 1967 SPR, V30, P483, DOI [DOI 10.1145/1465482.1465560, 10.1145/1465482]; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buckner J, 2010, BIOINFORMATICS, V26, P134, DOI 10.1093/bioinformatics/btp608; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Chikkagoudar Satish, 2011, BMC Res Notes, V4, P158, DOI 10.1186/1756-0500-4-158; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lei GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S14; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Shterev ID, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-329; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	26	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36865	10.1371/journal.pone.0036865	http://dx.doi.org/10.1371/journal.pone.0036865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662128	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300019
J	Zhang, BB; Lou, WY; Chen, WJ; Zong, MH				Zhang, Bo-Bo; Lou, Wen-Yong; Chen, Wen-Jing; Zong, Min-Hua			Efficient Asymmetric Reduction of 4-(Trimethylsilyl)-3-Butyn-2-One by Candida parapsilosis Cells in an Ionic Liquid-Containing System	PLOS ONE			English	Article							CCTCC M203011 CELLS; ALCOHOL-DEHYDROGENASE; KETONES; BIOCATALYSIS; SOLVENTS; ACID; BIOTRANSFORMATIONS; ENANTIOSELECTIVITY; CONVERSION; ADDITIVES	Hydrophilic ionic liquids (ILs) were employed as green solvents to construct an IL-containing co-solvent system for improving the asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one by immobilized Candida parapsilosis cells. Among 14 hydrophilic ILs examined, 1-(2'-hydroxyl)ethyl-3-methylimidazolium nitrate (C2OHMIM center dot NO3) was considered as the most suitable IL for the bioreduction with the fastest initial reaction rate, the highest yield and the highest product e. e., which may be due to the good biocompatibility with the cells. For a better understanding of the bioreduction performed in the C2OHMIM center dot NO3-containing co-solvent system, the effects of several crucial variables were systematically investigated. The optimal C2OHMIM center dot NO3 content, substrate concentration, buffer pH, co-substrate concentration and temperature were 10% (v/v), 3.0 mmol/L, 5.0, 98.1 mmol/L and 30 degrees C, respectively. Under the optimal conditions, the initial reaction rate, the maximum yield and the product e.e. were 17.3 mu mol/h g(cell), 95.2% and >99.9%, respectively, which are much better than the corresponding results previously reported. Moreover, the immobilized cells remained more than 83% of their initial activity even after being used repeatedly for 10 batches in the C2OHMIM center dot NO3-containing system, exhibiting excellent operational stability.	[Zhang, Bo-Bo; Lou, Wen-Yong; Chen, Wen-Jing] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Bo-Bo] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zong, Min-Hua] S China Univ Technol, Lab Appl Biocatalysis, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Jiangnan University; South China University of Technology	Zhang, BB (corresponding author), S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	wylou@scut.edu.cn; btmhzong@scut.edu.cn	Lou, Wen-Yong/AAL-8087-2020; Zhang, Bo-Bo/L-7234-2013	Lou, Wen-Yong/0000-0003-3474-3446; Zhang, Bo-Bo/0000-0003-1295-1703	National Program on Key Basic Research Project '973' [2010CB732201]; National Natural Science Foundation of China [21072065]; Fundamental Research Funds for the Central Universities - SCUT [2011ZG0018]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201504]; New Century Excellent Talents in University [NCET-10-0367]; Ph.D. Programs Foundation of the Ministry of Education of China [20090172110019]	National Program on Key Basic Research Project '973'(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities - SCUT(Fundamental Research Funds for the Central Universities); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This study was partially supported by the National Program on Key Basic Research Project '973' (Grant No. 2010CB732201), the National Natural Science Foundation of China (Grant No. 21072065), the Fundamental Research Funds for the Central Universities - SCUT (Grants No. 2011ZG0018), the Foundation for the Author of National Excellent Doctoral Dissertation of China (Grants No. 201504), the New Century Excellent Talents in University (Grant No. NCET-10-0367) and the Ph.D. Programs Foundation of the Ministry of Education of China (Grant No. 20090172110019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum S, 2012, ADV SYNTH CATAL, V354, P113, DOI 10.1002/adsc.201100391; Brautigam S, 2009, ENZYME MICROB TECH, V45, P310, DOI 10.1016/j.enzmictec.2009.06.015; Cornmell RJ, 2008, GREEN CHEM, V10, P836, DOI 10.1039/b807214k; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; de Gonzalo G, 2007, TETRAHEDRON-ASYMMETR, V18, P2541, DOI 10.1016/j.tetasy.2007.10.010; Dipeolu O, 2009, GREEN CHEM, V11, P397, DOI 10.1039/b812600c; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Itoh T, 2004, GREEN CHEM, V6, P437, DOI 10.1039/b405396f; Kohlmann C, 2011, J MOL CATAL B-ENZYM, V68, P147, DOI 10.1016/j.molcatb.2010.10.003; Kolasa T, 1996, TETRAHEDRON-ASYMMETR, V7, P729, DOI 10.1016/0957-4166(96)00068-7; Kratzer R, 2011, BIOTECHNOL BIOENG, V108, P797, DOI 10.1002/bit.23002; Kristensen JB, 2007, ENZYME MICROB TECH, V40, P888, DOI 10.1016/j.enzmictec.2006.07.014; Kulacki KJ, 2008, GREEN CHEM, V10, P104, DOI [10.1039/b709289j, 10.1039/B709289J]; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Liu ZQ, 2011, BIOTECHNOL PROGR, V27, P698, DOI 10.1002/btpr.603; Lou WY, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-90; Lou WY, 2009, J BIOTECHNOL, V143, P190, DOI 10.1016/j.jbiotec.2009.07.004; Lou WY, 2009, GREEN CHEM, V11, P1377, DOI 10.1039/b823502c; Luo F, 2011, J MOL CATAL B-ENZYM, V70, P101, DOI 10.1016/j.molcatb.2011.02.011; Matsuda T, 2009, TETRAHEDRON-ASYMMETR, V20, P513, DOI 10.1016/j.tetasy.2008.12.035; Moniruzzaman M, 2010, BIOCHEM ENG J, V48, P295, DOI 10.1016/j.bej.2009.10.002; Musa MM, 2008, ORG BIOMOL CHEM, V6, P887, DOI 10.1039/b717120j; Nakamura K, 2003, TETRAHEDRON-ASYMMETR, V14, P2659, DOI 10.1016/S0957-4166(03)00526-3; Ni Y, 2012, BIOTECHNOL IN PRESS, DOI [10.1016/j.biote-chadv.2011.10.007, DOI 10.1016/J.BIOTE-CHADV.2011.10.007]; NICANDER L, 1975, ACTA PHARMACOL TOX, V36, P40; Nie Y, 2004, ORG PROCESS RES DEV, V8, P246, DOI 10.1021/op0341519; Nie Y, 2007, APPL ENVIRON MICROB, V73, P3759, DOI 10.1128/AEM.02185-06; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Ranke J, 2007, CHEM REV, V107, P2183, DOI 10.1021/cr050942s; Schroer K, 2009, BIOTECHNOL BIOENG, V104, P251, DOI 10.1002/bit.22390; Schubert T, 2001, EUR J ORG CHEM, V2001, P4181; Shibata J, 2000, ANTICANCER RES, V20, P3169; Stolte S, 2007, GREEN CHEM, V9, P1170, DOI 10.1039/b711119c; Tacke R, 2000, ORGANOMETALLICS, V19, P3486, DOI 10.1021/om000169l; Weaver KD, 2010, GREEN CHEM, V12, P507, DOI 10.1039/b918726j; Wood N, 2011, GREEN CHEM, V13, P1843, DOI 10.1039/c0gc00579g; Xie Y, 2010, BIORESOURCE TECHNOL, V101, P1054, DOI 10.1016/j.biortech.2009.09.003; Zhang BB, 2008, J MOL CATAL B-ENZYM, V54, P122, DOI 10.1016/j.molcatb.2007.12.018; Zhao H, 2010, J CHEM TECHNOL BIOT, V85, P891, DOI 10.1002/jctb.2375; Zheng LY, 2006, J MOL CATAL B-ENZYM, V38, P17, DOI 10.1016/j.molcatb.2005.10.003; ZHU XD, 1995, EUR J PHARMACOL, V276, P93, DOI 10.1016/0014-2999(95)00014-C	41	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37641	10.1371/journal.pone.0037641	http://dx.doi.org/10.1371/journal.pone.0037641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662183	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300073
J	Amalfi, S; Velez, LM; Heber, MF; Vighi, S; Ferreira, SR; Orozco, AV; Pignataro, O; Motta, AB				Amalfi, Sabrina; Martin Velez, Leandro; Florencia Heber, Maria; Vighi, Susana; Rocio Ferreira, Silvana; Vega Orozco, Adriana; Pignataro, Omar; Motta, Alicia Beatriz			Prenatal Hyperandrogenization Induces Metabolic and Endocrine Alterations Which Depend on the Levels of Testosterone Exposure	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ACTIVATED-RECEPTOR-GAMMA; IMPAIRED GLUCOSE-TOLERANCE; LOW-BIRTH-WEIGHT; PRECOCIOUS PUBARCHE; NITRIC-OXIDE; ANDROGEN EXPOSURE; DIABETES-MELLITUS; CORPUS-LUTEUM; NEUROENDOCRINE CONSEQUENCES	Prenatal hyperandrogenism is able to induce polycystic ovary syndrome (PCOS) in rats. The aim of the present study was to establish if the levels of prenatal testosterone may determine the extent of metabolic and endocrine alterations during the adult life. Pregnant Sprague Dawley rats were prenatally injected with either 2 or 5 mg free testosterone (groups T2 and T5 respectively) from day 16 to day 19 day of gestation. Female offspring from T2 and T5 displayed different phenotype of PCOS during adult life. Offspring from T2 showed hyperandrogenism, ovarian cysts and ovulatory cycles whereas those from T5 displayed hyperandrogenism, ovarian cysts and anovulatory cycles. Both group showed increased circulating glucose levels after the intraperitoneal glucose tolerance test (IPGTT; an evaluation of insulin resistance). IPGTT was higher in T5 rats and directly correlated with body weight at prepubertal age. However, the decrease in the body weight at prepubertal age was compensated during adult life. Although both groups showed enhanced ovarian steroidogenesis, it appears that the molecular mechanisms involved were different. The higher dose of testosterone enhanced the expression of both the protein that regulates cholesterol availability (the steroidogenic acute regulatory protein (StAR)) and the protein expression of the transcriptional factor: peroxisome proliferator-activated receptor gamma (PPAR gamma). Prenatal hyperandrogenization induced an anti-oxidant response that prevented a possible pro-oxidant status. The higher dose of testosterone induced a pro-inflammatory state in ovarian tissue mediated by increased levels of prostaglandin E (PG) and the protein expression of cyclooxygenase 2 (COX2, the limiting enzyme of PGs synthesis). In summary, our data show that the levels of testosterone prenatally injected modulate the uterine environment and that this, in turn, would be responsible for the endocrine and metabolic abnormalities and the phenotype of PCOS during the adult life.	[Amalfi, Sabrina; Martin Velez, Leandro; Florencia Heber, Maria; Rocio Ferreira, Silvana; Motta, Alicia Beatriz] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Ctr Estudios Farmacol & Bot, Lab Fisiopatol Ovar, Buenos Aires, DF, Argentina; [Vighi, Susana] Hosp Clin Buenos Aires, Dept Patol, Buenos Aires, DF, Argentina; [Vega Orozco, Adriana] Inst Biol & Med Cuyo, Lab Invest Biomed, Buenos Aires, DF, Argentina; [Pignataro, Omar] Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Endocrinol Mol & Transducc Senales, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Amalfi, S (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Ctr Estudios Farmacol & Bot, Lab Fisiopatol Ovar, Buenos Aires, DF, Argentina.	aliciabmotta@yahoo.com.ar	Velez, Leandro Martin/V-8791-2019	Velez, Leandro Martin/0000-0001-8371-2633; Motta, Alicia/0000-0002-8478-728X; Heber, Maria Florencia/0000-0002-2392-3671	FONCyT-Argentina [BID 949/2006, BID 71/2010]	FONCyT-Argentina(FONCyT)	This work was supported by FONCyT-Argentina (BID 949/2006 and BID 71/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Andreu C, 1998, MOL REPROD DEV, V51, P287, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;287::AID-MRD8&gt;3.0.CO;2-L; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crawford MJ, 1995, DEV GENET, V17, P291, DOI 10.1002/dvg.1020170402; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Curti MLR, 2011, J OBES, V2011, DOI 10.1155/2011/497401; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Diamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x; Diamanti-Kandarakis E, 2008, J STEROID BIOCHEM, V109, P242, DOI 10.1016/j.jsbmb.2008.03.014; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1083, P54, DOI 10.1196/annals.1367.006; Diamanti-Kandarakis E, 2006, TRENDS MOL MED, V12, P324, DOI 10.1016/j.molmed.2006.05.006; Diamanti-Kandarakis E, 2009, EUR J ENDOCRINOL, V160, P847, DOI 10.1530/EJE-08-0510; Elia E, 2006, MOL HUM REPROD, V12, P475, DOI 10.1093/molehr/gal057; Faut M, 2011, FERTIL STERIL, V95, P333, DOI 10.1016/j.fertnstert.2010.07.1083; Foecking EM, 2008, HORM BEHAV, V53, P673, DOI 10.1016/j.yhbeh.2007.12.013; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Franks S, 2003, ENDOCRIN METAB CLIN, V32, P639, DOI 10.1016/S0889-8529(03)00044-6; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Froment P, 2003, BIOL REPROD, V69, P1665, DOI 10.1095/biolreprod.103.017244; Gonzalez E, 2000, BRAZ J MED BIOL RES, V33, P1335, DOI 10.1590/S0100-879X2000001100012; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang Z, 2008, BRIT J PHARMACOL, V155, P596, DOI 10.1038/bjp.2008.331; Husein MQ, 2003, REPROD DOMEST ANIM, V38, P228, DOI 10.1046/j.1439-0531.2003.00411.x; Ibabe A, 2002, HISTOCHEM CELL BIOL, V118, P231, DOI 10.1007/s00418-002-0434-y; Ibanez L, 1998, DIABETOLOGIA, V41, P1057, DOI 10.1007/s001250051030; Ibanez L, 1999, J CLIN ENDOCR METAB, V84, P2691, DOI 10.1210/jc.84.8.2691; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Ibanez L, 2004, J PEDIATR-US, V144, P23, DOI 10.1016/j.jpeds.2003.08.015; Ibanez L, 2001, J CLIN ENDOCR METAB, V86, P5788, DOI 10.1210/jc.86.12.5788; Ibanez L, 2001, CLIN ENDOCRINOL, V55, P667, DOI 10.1046/j.1365-2265.2001.01399.x; Ibanez L, 1999, CLIN ENDOCRINOL, V51, P395, DOI 10.1046/j.1365-2265.1999.00778.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Komar CM, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-41; LEE MT, 1991, ANAT REC, V231, P185, DOI 10.1002/ar.1092310206; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P789, DOI 10.1210/jc.2009-1849; Luchetti CG, 2004, J REPROD IMMUNOL, V64, P59, DOI 10.1016/j.jri.2004.04.002; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Elia EM, 2009, MOL HUM REPROD, V15, P421, DOI 10.1093/molehr/gap033; Medan MS, 2003, REPRODUCTION, V125, P751, DOI 10.1530/reprod/125.5.751; Mohan M, 2002, BIOL REPROD, V66, P692, DOI 10.1095/biolreprod66.3.692; Mondillo C, 2009, BIOL REPROD, V80, P144, DOI 10.1095/biolreprod.108.069484; Motta AB, 2001, REPRODUCTION, V121, P631, DOI 10.1530/rep.0.1210631; Motta AB, 2001, MOL HUM REPROD, V7, P43, DOI 10.1093/molehr/7.1.43; Motta AB, 1999, MOL HUM REPROD, V5, P1011, DOI 10.1093/molehr/5.11.1011; Mukherjee S, 2010, INDIAN J MED RES, V131, P743; Navarra P, 1996, PROSTAGLANDINS, V52, P187, DOI 10.1016/S0090-6980(96)00096-2; Neville KA, 2005, ARCH DIS CHILD, V90, P258, DOI 10.1136/adc.2004.053959; Nisenblat V, 2009, CURR OPIN ENDOCRINOL, V16, P224, DOI 10.1097/MED.0b013e32832afd4d; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Panidis D, 2011, HUM REPROD IN PRESS; Pustovrh MC, 2005, FREE RADICAL RES, V39, P1285, DOI 10.1080/10715760500188796; SADRKHANLOO R, 1987, ENDOCRINOLOGY, V120, P146, DOI 10.1210/endo-120-1-146; Sander VA, 2008, REPROD FERT DEVELOP, V20, P760, DOI 10.1071/RD08051; Sander VA, 2009, REPRODUCTION, V138, P571, DOI 10.1530/REP-08-0325; Stikkelbroeck NMML, 2003, OBSTET GYNECOL SURV, V58, P275; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Ward IL, 2003, HORM BEHAV, V43, P531, DOI 10.1016/S0018-506X(03)00061-8; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Wu XY, 2010, ENDOCR J, V57, P201, DOI 10.1507/endocrj.K09E-205	72	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37658	10.1371/journal.pone.0037658	http://dx.doi.org/10.1371/journal.pone.0037658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655062	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900038
J	Hazlerigg, CRE; Lorenzen, K; Thorbek, P; Wheeler, JR; Tyler, CR				Hazlerigg, Charles R. E.; Lorenzen, Kai; Thorbek, Pernille; Wheeler, James R.; Tyler, Charles R.			Density-Dependent Processes in the Life History of Fishes: Evidence from Laboratory Populations of Zebrafish Danio rerio	PLOS ONE			English	Article							ECOLOGICAL RISK; MORTALITY; GROWTH; MONOPOLIZATION; CONSEQUENCES; RECRUITMENT; MECHANISMS; PREDATION; SURVIVAL; FOOD	Population regulation is fundamental to the long-term persistence of populations and their responses to harvesting, habitat modification, and exposure to toxic chemicals. In fish and other organisms with complex life histories, regulation may involve density dependence in different life-stages and vital rates. We studied density dependence in body growth and mortality through the life-cycle of laboratory populations of zebrafish Danio rerio. When feed input was held constant at population-level (leading to resource limitation), body growth was strongly density-dependent in the late juvenile and adult phases of the life-cycle. Density dependence in mortality was strong during the early juvenile phase but declined thereafter and virtually ceased prior to maturation. Provision of feed in proportion to individual requirements (easing resource limitation) removed density dependence in growth and substantially reduced density dependence in mortality, thus indicating that 'bottom-up' effects act on growth as well as mortality, but most strongly on growth. Both growth and mortality played an important role in population regulation, with density-dependent growth having the greater impact on population biomass while mortality had the greatest impact on numbers. We demonstrate a clear ontogenic pattern of change in density-dependent processes within populations of a very small (maximum length 5 mm) fish, maintained in constant homogeneous laboratory conditions. The patterns are consistent with those distilled from studies on wild fish populations, indicating the presence of broad ontogenic patterns in density-dependent processes that are invariant to maximum body size and hold in homogeneous laboratory, as well as complex natural environments.	[Hazlerigg, Charles R. E.; Lorenzen, Kai] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Hazlerigg, Charles R. E.; Tyler, Charles R.] Univ Exeter, Ecotoxicol & Aquat Biol Res Grp, Exeter, Devon, England; [Hazlerigg, Charles R. E.; Lorenzen, Kai] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Thorbek, Pernille; Wheeler, James R.] Syngenta, Jealotts Hill Int Res Ctr, Environm Safety, Bracknell, Berks, England	Imperial College London; University of Exeter; State University System of Florida; University of Florida; Syngenta	Hazlerigg, CRE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England.	C.Hazlerigg07@imperial.ac.uk; klorenzen@ufl.edu	Lorenzen, Kai/A-3032-2015; Thorbek, Pernille/HGV-0078-2022	Lorenzen, Kai/0000-0002-9691-3693; Wheeler, James/0000-0002-9162-5035	University of Exeter; Syngenta, Ltd.; Biological and Biochemical Science Research Council	University of Exeter; Syngenta, Ltd.(Syngenta); Biological and Biochemical Science Research Council	The authors are grateful to the University of Exeter, Syngenta, Ltd. and the Biological and Biochemical Science Research Council for the funding of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Syngenta Ltd provided financial support for this work. Pernille Thorbek and James R. Wheeler are Syngenta employees (and were involved in the study design and preparation of the manuscript). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Beverton R.J.H., 1957, FISH INVEST LONDON S, V19; BUTLER JL, 1988, FISH B-NOAA, V86, P163; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Detrich HW, 2004, ZEBRAFISH; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Ferson S, 1996, WATER AIR SOIL POLL, V90, P71, DOI 10.1007/BF00619269; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1; Forbes VE, 2002, PHILOS T R SOC B, V357, P1299, DOI 10.1098/rstb.2002.1129; FORRESTER GE, 1995, OECOLOGIA, V103, P275, DOI 10.1007/BF00328615; GRANT JWA, 1992, ANIM BEHAV, V44, P101, DOI 10.1016/S0003-3472(05)80759-6; GULLAND JA, 1987, MAR ECOL PROG SER, V39, P197, DOI 10.3354/meps039197; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hilborn Ray, 1997, V28; Hixon M. A., 2002, CORAL REEF FISHES DY, P303; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hommen Udo, 2010, Integrated Environmental Assessment and Management, V6, P325, DOI 10.1002/ieam.69; ILES TC, 1991, NETH J SEA RES, V27, P217, DOI 10.1016/0077-7579(91)90026-W; Ish TL, 2003, THESIS U CALIFORNIA; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Lorenzen K, 2005, PHILOS T R SOC B, V360, P171, DOI 10.1098/rstb.2004.1570; Lorenzen K, BIOL REV IN PRESS; Lorenzen K, 2008, B MAR SCI, V83, P181; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Munch SB, 2005, ECOL LETT, V8, P691, DOI 10.1111/j.1461-0248.2005.00766.x; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Paull GC, 2008, AQUAT TOXICOL, V87, P115, DOI 10.1016/j.aquatox.2008.01.008; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rothschild B.J., 1986, DYNAMICS MARINE FISH; Sandin SA, 2005, AM NAT, V165, P107, DOI 10.1086/426674; Schultz ET, 1997, OECOLOGIA, V109, P516, DOI 10.1007/s004420050112; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Tyler JA, 1997, EARLY LIFE HIST RECR, P391; VANDERVEER HW, 1986, MAR ECOL PROG SER, V29, P223, DOI 10.3354/meps029223; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1	44	46	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37550	10.1371/journal.pone.0037550	http://dx.doi.org/10.1371/journal.pone.0037550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655056	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900032
J	Morfin, M; Fromentin, JM; Jadaud, A; Bez, N				Morfin, Marie; Fromentin, Jean-Marc; Jadaud, Angelique; Bez, Nicolas			Spatio-Temporal Patterns of Key Exploited Marine Species in the Northwestern Mediterranean Sea	PLOS ONE			English	Article							HAKE MERLUCCIUS-MERLUCCIUS; COD GADUS-MORHUA; NEPHROPS-NORVEGICUS L; EUROPEAN HAKE; DEMERSAL ASSEMBLAGES; POPULATION-STRUCTURE; CONTINENTAL-SHELF; SPATIAL STRUCTURE; NORTH-SEA; FISH	This study analyzes the temporal variability/stability of the spatial distributions of key exploited species in the Gulf of Lions (Northwestern Mediterranean Sea). To do so, we analyzed data from the MEDITS bottom-trawl scientific surveys from 1994 to 2010 at 66 fixed stations and selected 12 key exploited species. We proposed a geostatistical approach to handle zero-inflated and non-stationary distributions and to test for the temporal stability of the spatial structures. Empirical Orthogonal Functions and other descriptors were then applied to investigate the temporal persistence and the characteristics of the spatial patterns. The spatial structure of the distribution (i.e. the pattern of spatial autocorrelation) of the 12 key species studied remained highly stable over the time period sampled. The spatial distributions of all species obtained through kriging also appeared to be stable over time, while each species displayed a specific spatial distribution. Furthermore, adults were generally more densely concentrated than juveniles and occupied areas included in the distribution of juveniles. Despite the strong persistence of spatial distributions, we also observed that the area occupied by each species was correlated to its abundance: the more abundant the species, the larger the occupation area. Such a result tends to support MacCall's basin theory, according to which density-dependence responses would drive the expansion of those 12 key species in the Gulf of Lions. Further analyses showed that these species never saturated their habitats, suggesting that they are below their carrying capacity; an assumption in agreement with the overexploitation of several of these species. Finally, the stability of their spatial distributions over time and their potential ability to diffuse outside their main habitats give support to Marine Protected Areas as a potential pertinent management tool.	[Morfin, Marie; Fromentin, Jean-Marc; Jadaud, Angelique] IFREMER, UMR EME 212, Sete, France; [Bez, Nicolas] IRD, UMR EME 212, Sete, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Morfin, M (corresponding author), IFREMER, UMR EME 212, Sete, France.	marie.morfin@ifremer.fr		Fromentin, Jean-Marc/0000-0002-1496-4332	Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission); L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer); AMPED project through a grant from the French National Research Agency (ANR), Systerra Program [ANR-08-STRA-03]	Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission); L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer); AMPED project through a grant from the French National Research Agency (ANR), Systerra Program(French National Research Agency (ANR))	MEDITS trawl survey is funded by the Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission) and L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer). MM was supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Program, grant number ANR-08-STRA-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2005, FISH RES, V71, P295, DOI 10.1016/j.fishres.2004.08.036; Aldebert Y, 1997, VIE MILIEU, V47, P275; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Atkinson DB, 1997, CAN J FISH AQUAT SCI, V54, P132, DOI 10.1139/f96-158; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CADDY JF, 1995, OCEAN COAST MANAGE, V26, P1, DOI 10.1016/0964-5691(95)00015-T; Carlucci R, 2009, ESTUAR COAST SHELF S, V83, P529, DOI 10.1016/j.ecss.2009.04.034; Casini M, 2005, ICES J MAR SCI, V62, P671, DOI 10.1016/j.icesjms.2004.12.018; Chapman CJ, 1980, ECOLOGY JUVENILE ADU, V2, P143; Chiles J. P., 1999, GEOSTATISTICS MODELI; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Clark I, 1979, DOES GEOSTATISTICS W, P213; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; CRECCO V, 1990, CAN J FISH AQUAT SCI, V47, P385, DOI 10.1139/f90-040; Cressie N, 1993, WILEY SERIES PROBABI; Crowder LB, 2000, B MAR SCI, V66, P799; David M., 1977, GEOSTATISTICAL ORE R; FARINA AC, 1994, FISH RES, V19, P333, DOI 10.1016/0165-7836(94)90048-5; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; Fiorentino F, 2003, HYDROBIOLOGIA, V503, P223, DOI 10.1023/B:HYDR.0000008485.85468.ef; Freire J, 2000, MAR POLICY, V24, P375, DOI 10.1016/S0308-597X(00)00013-0; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gaertner JC, 1999, MAR BIOL, V135, P199, DOI 10.1007/s002270050617; Gaertner JC, 2000, J MAR BIOL ASSOC UK, V80, P777, DOI 10.1017/S0025315400002745; Gaertner JC, 2002, SCI MAR, V66, P221; Gaertner JC, 2007, MAR ECOL PROG SER, V341, P191, DOI 10.3354/meps341191; GFCM, 2008, 11 SESS SCI ADV COMM; GFCM, 2011, 13 SESS SCI ADV COMM; GFCM (General Fisheries Commission for the Mediterranean), 2010, 12 SESS SCI ADV COMM; GOOVAERTS P, 1994, MATH GEOL, V26, P389, DOI 10.1007/BF02089230; Isaaks E.H., 1989, APPL GEOSTATISTICS; Journel A. G., 1978, MINING GEOSTATISTICS; Korres G, 2000, J CLIMATE, V13, P732, DOI 10.1175/1520-0442(2000)013<0732:TORTLF>2.0.CO;2; Lantuejoul C, 2002, GEOSTATISTICAL SIMULATION, P1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; LLORIS D, 1995, SCI MAR, V59, P399; Lombarte A, 2000, MAR ECOL PROG SER, V206, P239, DOI 10.3354/meps206239; Lorenz E.N., 1956, EMPIRICAL ORTHOGONAL; MacCall A.D., 1990, DYNAMIC GEOGRAPHY MA; Manchuk JG, 2009, MATH GEOSCI, V41, P799, DOI 10.1007/s11004-008-9195-z; MARSHALL CT, 1994, CAN J FISH AQUAT SCI, V51, P808, DOI 10.1139/f94-079; Martin CS, 2010, MAR ECOL PROG SER, V417, P211, DOI 10.3354/meps08802; Matern B., 1986, SPATIAL VARIATION, V2nd ed., DOI [10.1007/978-1-4615-7892-5, DOI 10.1007/978-1-4615-7892-5]; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Maynou F, 2006, FISH OCEANOGR, V15, P390, DOI 10.1111/j.1365-2419.2005.00398.x; Maynou F, 2003, FISH RES, V60, P65, DOI 10.1016/S0165-7836(02)00062-0; Maynou FX, 1998, ICES J MAR SCI, V55, P102, DOI 10.1006/jmsc.1997.0236; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; Mittermeier RA., 2005, HOTSPOTS REVISITED E; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perdichizzi A, 2011, FISH RES, V109, P342, DOI 10.1016/j.fishres.2011.03.001; Petitgas P, 1997, ICES J MAR SCI, V54, P213, DOI 10.1006/jmsc.1996.0184; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; QUERO JC, 1997, POISSONS MER PECHES; R Core Team, 2021, R LANG ENV STAT COMP; Recasens L, 1998, J FISH BIOL, V53, P387, DOI 10.1111/j.1095-8649.1998.tb00988.x; Rivoirard J., 2008, GEOSTATISTICS ESTIMA; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 2003, ECOL APPL, V13, pS199; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; SARDA F, 1991, CRUSTACEANA, V60, P186, DOI 10.1163/156854091X00399; Sumaila UR, 2007, MAR ECOL PROG SER, V345, P305, DOI 10.3354/meps07065; SWAIN DP, 1994, CAN J FISH AQUAT SCI, V51, P1046, DOI 10.1139/f94-104; TULLY O, 1995, FISH RES, V21, P329, DOI 10.1016/0165-7836(94)00303-E; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Woillez M, 2007, ICES J MAR SCI, V64, P537, DOI 10.1093/icesjms/fsm025	72	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37907	10.1371/journal.pone.0037907	http://dx.doi.org/10.1371/journal.pone.0037907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655079	Green Published, gold			2022-12-25	WOS:000305338900056
J	Sprecher, BN; Gittings, ME; Ludwig, RA				Sprecher, Brittany N.; Gittings, Margo E.; Ludwig, Robert A.			Respiratory Membrane endo-Hydrogenase Activity in the Microaerophile Azorhizobium caulinodans Is Bidirectional	PLOS ONE			English	Article							SP STRAIN ORS571; PARACOCCUS-DENITRIFICANS; RHODOSPIRILLUM-RUBRUM; NITROGENASE ACTIVITY; ELECTRON-TRANSPORT; SESBANIA-ROSTRATA; N-2 FIXATION; COMPLEX-I; WILD-TYPE; RHIZOBIUM	Background: The microaerophilic bacterium Azorhizobium caulinodans, when fixing N-2 both in pure cultures held at 20 mu M dissolved O-2 tension and as endosymbiont of Sesbania rostrata legume nodules, employs a novel, respiratory-membrane endo-hydrogenase to oxidize and recycle endogenous H-2 produced by soluble Mo-dinitrogenase activity at the expense of O-2. Methods and Findings: From a bioinformatic analysis, this endo-hydrogenase is a core (6 subunit) version of (14 subunit) NADH:ubiquinone oxidoreductase (respiratory complex I). In pure A. caulinodans liquid cultures, when O-2 levels are lowered to <1 mu M dissolved O-2 tension (true microaerobic physiology), in vivo endo-hydrogenase activity reverses and continuously evolves H-2 at high rates. In essence, H-1 ions then supplement scarce O-2 as respiratory-membrane electron acceptor. Paradoxically, from thermodynamic considerations, such hydrogenic respiratory-membrane electron transfer need largely uncouple oxidative phosphorylation, required for growth of non-phototrophic aerobic bacteria, A. caulinodans included. Conclusions: A. caulinodans in vivo endo-hydrogenase catalytic activity is bidirectional. To our knowledge, this study is the first demonstration of hydrogenic respiratory-membrane electron transfer among aerobic (non-fermentative) bacteria. When compared with O-2 tolerant hydrogenases in other organisms, A. caulinodans in vivo endo-hydrogenase mediated H-2 production rates (50,000 pmol 10(9).cells(-1) min(-1)) are at least one-thousandfold higher. Conceivably, A. caulinodans respiratory-membrane hydrogenesis might initiate H-2 crossfeeding among spatially organized bacterial populations whose individual cells adopt distinct metabolic states in response to variant O-2 availability. Such organized, physiologically heterogeneous cell populations might benefit from augmented energy transduction and growth rates of the populations, considered as a whole.	[Sprecher, Brittany N.; Gittings, Margo E.; Ludwig, Robert A.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sprecher, BN (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	rludwig@ucsc.edu			California Institute for Quantitative Biosciences	California Institute for Quantitative Biosciences	This study was funded by the California Institute for Quantitative Biosciences (www.qb3.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GC, 1991, APPL ENVIRON MICROB, V57, P3220, DOI 10.1128/AEM.57.11.3220-3225.1991; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; BERGERSEN FJ, 1986, J GEN MICROBIOL, V132, P3325; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; BOOGERD FC, 1994, APPL ENVIRON MICROB, V60, P1859, DOI 10.1128/AEM.60.6.1859-1866.1994; BUCKMILLER LM, 1991, J BACTERIOL, V173, P2017, DOI 10.1128/jb.173.6.2017-2025.1991; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Ciccolella CO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012094; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DONALD RGK, 1985, J BACTERIOL, V162, P317, DOI 10.1128/JB.162.1.317-323.1985; DONALD RGK, 1986, J BACTERIOL, V165, P72, DOI 10.1128/jb.165.1.72-81.1986; DREYFUS BL, 1981, FEMS MICROBIOL LETT, V10, P313; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Kaminski PA, 1996, J BACTERIOL, V178, P5989, DOI 10.1128/jb.178.20.5989-5994.1996; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Kotlyar AB, 2002, EUR J BIOCHEM, V269, P4020, DOI 10.1046/j.1432-1033.2002.03091.x; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOROCH AI, 1995, J BACTERIOL, V177, P7210, DOI 10.1128/jb.177.24.7210-7221.1995; Ludwig RA, 2004, RES MICROBIOL, V155, P61, DOI 10.1016/j.resmic.2003.11.001; LUDWIG RA, 1986, J BACTERIOL, V165, P304, DOI 10.1128/jb.165.1.304-307.1986; MEINHARDT SW, 1987, J BIOL CHEM, V262, P9147; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Pauling DC, 2001, MICROBIOL-SGM, V147, P2233, DOI 10.1099/00221287-147-8-2233; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCOTT A, 1966, J BIOL CHEM, V241, P1060; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VINOGRADOV AD, 1993, J BIOENERG BIOMEMBR, V25, P367, DOI 10.1007/BF00762462; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; VREMAN HJ, 1988, CLIN CHEM, V34, P2562; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36744	10.1371/journal.pone.0036744	http://dx.doi.org/10.1371/journal.pone.0036744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22662125	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300033
J	Gallagher, SJ; Rambow, F; Kumasaka, M; Champeval, D; Bellacosa, A; Delmas, V; Larue, L				Gallagher, S. J.; Rambow, F.; Kumasaka, M.; Champeval, D.; Bellacosa, A.; Delmas, V.; Larue, L.			Beta-catenin inhibits melanocyte migration but induces melanoma metastasis	ONCOGENE			English	Article						Wnt; melanoblast; melanoma; MITF; CSK; mouse	SIGNALING PATHWAY; EXPRESSION; PROLIFERATION; ACTIVATION; CANCER; PROGRESSION; MUTATIONS; CADHERIN; TUMORS; CELLS	The canonical Wnt signalling pathway induces the beta-catenin/lymphoid enhancer factor transcription factors. It is activated in various cancers, most characteristically carcinomas, in which it promotes metastatic spread by increasing migration and/or invasion. The Wnt/beta-catenin signalling pathway is frequently activated in melanoma, but the presence of beta-catenin in the nucleus does not seem to be a sign of aggressiveness in these tumours. We found that, unlike its positive role in stimulating migration and invasion of carcinoma cells, beta-catenin signalling decreased the migration of melanocytes and melanoma cell lines. In vivo, beta-catenin signalling in melanoblasts reduced the migration of these cells, causing a white belly-spot phenotype. The inhibition by beta-catenin of migration was dependent on MITF-M, a key transcription factor of the melanocyte lineage, and CSK, an Src-inhibitor. Despite reducing migration, beta-catenin signalling promoted lung metastasis in the NRAS-driven melanoma murine model. Thus, beta-catenin may have conflicting roles in the metastatic spread of melanoma, repressing migration while promoting metastasis. These results highlight that metastasis formation requires a series of successful cellular processes, any one of which may not be optimally efficient. Oncogene (2013) 32, 2230-2238; doi:10.1038/onc.2012.229; published online 4 June 2012	[Gallagher, S. J.; Rambow, F.; Kumasaka, M.; Champeval, D.; Delmas, V.; Larue, L.] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Gallagher, S. J.; Rambow, F.; Kumasaka, M.; Champeval, D.; Delmas, V.; Larue, L.] CNRS, UMR3347, F-91405 Orsay, France; [Gallagher, S. J.; Rambow, F.; Kumasaka, M.; Champeval, D.; Delmas, V.; Larue, L.] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Bellacosa, A.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Bellacosa, A.] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Keystone Program, Philadelphia, PA 19111 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Fox Chase Cancer Center; Fox Chase Cancer Center	Larue, L (corresponding author), Inst Curie, Ctr Rech, Bat 110, F-91405 Orsay, France.	lionel.larue@curie.fr	Larue, Lionel/F-7355-2013; Larue, Lionel/I-6532-2016; Gallagher, Stuart J/E-6617-2011; Gallagher, Stuart/S-6718-2019	Gallagher, Stuart J/0000-0003-2651-9671; Gallagher, Stuart/0000-0003-2651-9671; rambow, florian/0000-0002-9727-8986; Delmas, veronique/0000-0001-7368-3664	LNCC; Curie; Ligue Nationale Contre le Cancer (Equipe labellisee); INCa; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA078412] Funding Source: NIH RePORTER	LNCC; Curie; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank D Bennett, M Herlyn and F Beermann for kindly providing materials. We thank staff from the animal colony and imaging facilities of Curie, including Y Bourgeois, F Cordelieres and H Harmange in particular. SG was supported by LNCC and Curie. This work was supported by the Ligue Nationale Contre le Cancer (Equipe labellisee) and INCa.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; BENNETT DC, 1989, DEVELOPMENT, V105, P379; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Gallagher SJ, 2011, PIGM CELL MELANOMA R, V24, P987, DOI 10.1111/j.1755-148X.2011.00907.x; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Larue L, 1996, DEVELOPMENT, V122, P3185; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Luciani F, 2011, DEVELOPMENT, V138, P3943, DOI 10.1242/dev.067447; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049	32	79	81	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2230	2238		10.1038/onc.2012.229	http://dx.doi.org/10.1038/onc.2012.229			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22665063	Green Accepted			2022-12-25	WOS:000318062800012
J	Gu, Z; Zhang, F; Wang, ZQ; Ma, W; Davis, RE; Wang, Z				Gu, Z.; Zhang, F.; Wang, Z-Q; Ma, W.; Davis, R. E.; Wang, Z.			The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer	ONCOGENE			English	Article						lung; lung cancer; p44/wdr77; proliferation; differentiation	RECEPTOR COFACTOR P44; RETINOBLASTOMA PROTEIN; PHENOTYPIC DIFFERENTIATION; MYOGENIC DIFFERENTIATION; POTENTIAL MEDIATOR; ANALYSIS REVEALS; CYCLE ARREST; EXPRESSION; P21; IDENTIFICATION	During lung development, cells proliferate for a defined length of time before they begin to differentiate. Factors that control this proliferative process and how this growth process is related to lung cancer are currently unknown. Here, we found that the WD40-containing protein (p44/wdr77) was expressed in growing epithelial cells at the early stages of lung development. In contrast, p44/wdr77 expression was diminished in fully differentiated epithelial cells in the adult lung. Loss of p44/wdr77 gene expression led to cell growth arrest and differentiation. Re-expression of p44/wdr77 caused terminally differentiated cells to re-enter the cell cycle. Our findings suggest that p44/wdr77 is essential and sufficient for proliferation of lung epithelial cells. P44/Wdr77 was re-expressed in lung cancer, and silencing p44/wdr77 expression strongly inhibited growth of lung adenocarcinoma cells in tissue culture and abolished growth of lung adenocarcinoma tumor xenografts in mice. The growth arrest induced by loss of p44/wdr77 expression was partially through the p21-Rb signaling. Our results suggest that p44/wdr77 controls cellular proliferation during lung development, and this growth process is reactivated during lung tumorigenesis. Oncogene (2013) 32, 1888-1900; doi:10.1038/onc.2012.207; published online 4 June 2012	[Gu, Z.; Zhang, F.; Wang, Z.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gu, Z.] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China; [Wang, Z-Q; Ma, W.; Davis, R. E.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University; University of Texas System; UTMD Anderson Cancer Center	Wang, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	zhenwang@mdanderson.org		Gu, Zhongping/0000-0002-7395-7888	National Institutes of Health through MD Anderson's Cancer Center [CA16672]; National Natural Science Foundation of China [81171922]; Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China [2008K27G01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Joe Munch in MD Anderson's Department of Scientific Publications for editing the manuscript and Shen Gao for performing the experiment as described in Supplementary Figure S1. This work was supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA16672, National Natural Science Foundation of China (81171922) and Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China (2008K27G01). No additional external funding for this study was received. The funding agency had no role in study design, data collection or analysis, decision to publish, or manuscript preparation.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen G, 1999, DNA CELL BIOL, V18, P305, DOI 10.1089/104454999315367; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Conlon I, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-36; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Gonzalo S, 2005, CELL CYCLE, V4, P752, DOI 10.4161/cc.4.6.1720; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HARPER JW, 1993, CELL, V75, P805; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Jakt LM, 2001, GENOME RES, V11, P112, DOI 10.1101/gr.148301; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Langley RR, 2003, CANCER RES, V63, P2971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2004, DEV BIOL, V273, P418, DOI 10.1016/j.ydbio.2004.05.035; Ma WC, 2010, CANCER EPIDEM BIOMAR, V19, P2445, DOI 10.1158/1055-9965.EPI-10-0565; Mal A, 2000, J CELL BIOL, V149, P281, DOI 10.1083/jcb.149.2.281; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; WANG J, 1995, CELL GROWTH DIFFER, V6, P1299; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	48	22	22	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1888	1900		10.1038/onc.2012.207	http://dx.doi.org/10.1038/onc.2012.207			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22665061	Green Accepted			2022-12-25	WOS:000317599900003
J	Kyrkou, A; Soufi, M; Bahtz, R; Ferguson, C; Bai, M; Parton, RG; Hoffmann, I; Zerial, M; Fotsis, T; Murphy, C				Kyrkou, A.; Soufi, M.; Bahtz, R.; Ferguson, C.; Bai, M.; Parton, R. G.; Hoffmann, I.; Zerial, M.; Fotsis, T.; Murphy, C.			RhoD participates in the regulation of cell-cycle progression and centrosome duplication	ONCOGENE			English	Article						RhoD; proliferation; centrosome cycle	CENTRIOLE DUPLICATION; ENDOSOME DYNAMICS; GTPASES; EXPRESSION; BINDING; PROTEIN; RAC1; NUCLEOPHOSMIN/B23; PHOSPHORYLATION; MICROTUBULES	We have previously identified a Rho protein, RhoD, which localizes to the plasma membrane and the early endocytic compartment. Here, we show that a GTPase-deficient mutant of RhoD, RhoDG26V, causes hyperplasia and perturbed differentiation of the epidermis, when targeted to the skin of transgenic mice. In vitro, gain-of-function and loss-of-function approaches revealed that RhoD is involved in the regulation of G1/S-phase progression and causes overduplication of centrosomes. Centriole overduplication assays in aphidicolin-arrested p53-deficient U2OS cells, in which the cell and the centrosome cycles are uncoupled, revealed that the effects of RhoD and its mutants on centrosome duplication and cell cycle are independent. Enhancement of G1/S-phase progression was mediated via Diaph1, a novel effector of RhoD, which we have identified using a two-hybrid screen. These results indicate that RhoD participates in the regulation of cell-cycle progression and centrosome duplication. Oncogene (2013) 32, 1831-1842; doi: 10.1038/onc.2012.195; published online 4 June 2012	[Kyrkou, A.; Soufi, M.; Fotsis, T.] Univ Ioannina, Sch Med, Lab Biol Chem, GR-45110 Ioannina, Greece; [Kyrkou, A.; Fotsis, T.; Murphy, C.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Ioannina 45110, Greece; [Bahtz, R.; Hoffmann, I.] German Canc Res Ctr, Heidelberg, Germany; [Ferguson, C.; Parton, R. G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ferguson, C.; Parton, R. G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Bai, M.] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece; [Zerial, M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Helmholtz Association; German Cancer Research Center (DKFZ); University of Queensland; University of Queensland; University of Ioannina; Max Planck Society	Murphy, C (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Univ Campus Ioannina, Ioannina 45110, Greece.	cmurphy@cc.uoi.gr	Murphy, Carol/ABE-4282-2021; Parton, Robert/C-5673-2009	Murphy, Carol/0000-0003-1353-8558; Parton, Robert/0000-0002-7494-5248	European Commission [HRPN-CT-2000-00081]; short-term EMBO fellowship; Biotechnology of the University of Ioannina; Ministry of Education and Religious Affairs of Greece; E.U.-European Social Fund; Greek Ministry of Development-GSRT; National Health and Medical Research Council of Australia	European Commission(European CommissionEuropean Commission Joint Research Centre); short-term EMBO fellowship; Biotechnology of the University of Ioannina; Ministry of Education and Religious Affairs of Greece; E.U.-European Social Fund(European Social Fund (ESF)European Commission); Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the confocal laser microscope facility of the University of Ioannina for the use of the Leica TCS-SP confocal microscope. We thank George Bartholomatos for FACS analysis; Zoi Lygerou, University of Patras, Greece for critical reading of the manuscript; George Keech for excellent animal husbandry; and Angelika Giner for expert technical assistance. This work was supported by a Research Training Network grant (to MZ and CM) of the European Commission (contract no: HRPN-CT-2000-00081). CM was supported by a short-term EMBO fellowship. MS was supported by the Postgraduate Master's Program of Biotechnology of the University of Ioannina funded by the Ministry of Education and Religious Affairs of Greece. AK was supported by the PENED 03E Delta 688 program, which was co-financed by E.U.-European Social Fund (75%) and the Greek Ministry of Development-GSRT (25%). RGP was supported by grants from the National Health and Medical Research Council of Australia.	BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kato T, 2001, J CELL SCI, V114, P775; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Krause A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009849; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Murphy C, 1996, NATURE, V384, P427, DOI 10.1038/384427a0; Murphy C, 2001, EUR J CELL BIOL, V80, P391, DOI 10.1078/0171-9335-00173; Nagasaki T, 1996, J CELL SCI, V109, P2461; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Panopoulou E, 2005, CANCER RES, V65, P1877, DOI 10.1158/0008-5472.CAN-04-2828; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Sflomos G, 2011, J CELL SCI, V124, P3209, DOI 10.1242/jcs.062307; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tsubakimoto K, 1999, ONCOGENE, V18, P2431, DOI 10.1038/sj.onc.1202604; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Wen YD, 2004, KENYON REV, V26, P1; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	47	14	15	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1831	1842		10.1038/onc.2012.195	http://dx.doi.org/10.1038/onc.2012.195			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22665057				2022-12-25	WOS:000317043900009
J	Phongsak, T; Sucharitakul, J; Thotsaporn, K; Oonanant, W; Yuvaniyama, J; Svasti, J; Ballou, DP; Chaiyen, P				Phongsak, Thanawat; Sucharitakul, Jeerus; Thotsaporn, Kittisak; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Ballou, David P.; Chaiyen, Pimchai			The C-terminal Domain of 4-Hydroxyphenylacetate 3-Hydroxylase from Acinetobacter baumannii Is an Autoinhibitory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; FLAVIN-REDUCTASE; CRYSTAL-STRUCTURE; OXYGENASE COMPONENT; DEPENDENT MONOOXYGENASE; ELECTRON-TRANSFER; SWISS-MODEL; MECHANISM; 3-MONOOXYGENASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase from Acinetobacter baumannii consists of a reductase component (C-1) and an oxygenase component (C-2). C-1 catalyzes the reduction of FMN by NADH to provide FMNH- as a substrate for C-2. The rate of reduction of flavin is enhanced similar to 20-fold by binding HPA. The N-terminal domain of C-1 is homologous to other flavin reductases, whereas the C-terminal domain (residues 192-315) is similar to MarR, a repressor protein involved in bacterial antibiotic resistance. In this study, three forms of truncated C-1 variants and single site mutation variants of residues Arg-21, Phe-216, Arg-217, Ile-246, and Arg-247 were constructed to investigate the role of the C-terminal domain in regulating C-1. In the absence of HPA, the C-1 variant in which residues 179-315 were removed (t178C(1)) was reduced by NADH and released FMNH- at the same rates as wild-type enzyme carries out these functions in the presence of HPA. In contrast, variants with residues 231-315 removed behaved similarly to the wild-type enzyme. Thus, residues 179-230 are involved in repressing the production of FMNH- in the absence of HPA. These results are consistent with the C-terminal domain in the wild-type enzyme being an autoinhibitory domain that upon binding the effector HPA undergoes conformational changes to allow faster flavin reduction and release. Most of the single site variants investigated had catalytic properties similar to those of the wild-type enzyme except for the F216A variant, which had a rate of reduction that was not stimulated by HPA. F216A could be involved with HPA binding or in the required conformational change for stimulation of flavin reduction by HPA.	[Phongsak, Thanawat; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Phongsak, Thanawat; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Sucharitakul, Jeerus; Thotsaporn, Kittisak] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Ballou, David P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Mahidol University; Mahidol University; Chulalongkorn University; University of Michigan System; University of Michigan	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	pimchai.cha@mahidol.ac.th	Svasti, Jisnuson/J-9262-2016; Chaiyen, Pimchai/R-5052-2019	Svasti, Jisnuson/0000-0002-2217-4517; Chaiyen, Pimchai/0000-0002-8533-1604; Yuvaniyama, Jirundon/0000-0002-6800-8944	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project	This work was supported in part by The Thailand Research Fund Grants BRG5480001 (to P. C.) and MRG5380240 (to J. S.) and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project.	Abdurachim K, 2006, J BACTERIOL, V188, P8153, DOI 10.1128/JB.00966-06; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P11795; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Chosrowjan H, 2009, J PHYS CHEM B, V113, P8439, DOI 10.1021/jp901136y; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; DUCH DS, 1971, ANAL BIOCHEM, V44, P42, DOI 10.1016/0003-2697(71)90343-5; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Feng CJ, 2009, DALTON T, P6692, DOI 10.1039/b902884f; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Low JC, 2003, PHOTOCHEM PHOTOBIOL, V77, P446, DOI 10.1562/0031-8655(2003)077<0446:ETEFIV>2.0.CO;2; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Oonanant W, 2012, ACTA CRYSTALLOGR F, V68, P720, DOI 10.1107/S1744309112016909; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; Tu SC, 2008, PHOTOCH PHOTOBIO SCI, V7, P183, DOI 10.1039/b713462b; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Zhang Y, 2011, ACTA CRYSTALLOGR F, V67, P1100, DOI 10.1107/S1744309111012541	47	20	22	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26213	26222		10.1074/jbc.M112.354472	http://dx.doi.org/10.1074/jbc.M112.354472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661720	hybrid, Green Published			2022-12-25	WOS:000306916300048
J	Cyphert, HA; Ge, XM; Kohan, AB; Salati, LM; Zhang, YQ; Hillgartner, FB				Cyphert, Holly A.; Ge, Xuemei; Kohan, Alison B.; Salati, Lisa M.; Zhang, Yanqiao; Hillgartner, F. Bradley			Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY RAT HEPATOCYTES; GLUCAGON-LIKE PEPTIDE-1; BILE-ACID; NUCLEAR RECEPTOR; PPAR-ALPHA; GENE-EXPRESSION; HIGH-FAT; ENERGY-EXPENDITURE; METABOLIC STATE; GLUCOSE	Previous studies have shown that starvation or consumption of a high fat, low carbohydrate (HF-LC) ketogenic diet induces hepatic fibroblast growth factor 21 (FGF21) gene expression in part by activating the peroxisome proliferator-activated receptor-alpha (PPAR alpha). Using primary hepatocyte cultures to screen for endogenous signals that mediate the nutritional regulation of FGF21 expression, we identified two sources of PPAR alpha activators (i.e. nonesterified unsaturated fatty acids and chylomicron remnants) that induced FGF21 gene expression. In addition, we discovered that natural (i.e. bile acids) and synthetic (i.e. GW4064) activators of the farnesoid X receptor (FXR) increased FGF21 gene expression and secretion. The effects of bile acids were additive with the effects of nonesterified unsaturated fatty acids in regulating FGF21 expression. FXR activation of FGF21 gene transcription was mediated by an FXR/retinoid X receptor binding site in the 5'-flanking region of the FGF21 gene. FGF19, a gut hormone whose expression and secretion is induced by intestinal bile acids, also increased hepatic FGF21 secretion. Deletion of FXR in mice suppressed the ability of an HF-LC ketogenic diet to induce hepatic FGF21 gene expression. The results of this study identify FXR as a new signaling pathway activating FGF21 expression and provide evidence that FXR activators work in combination with PPAR alpha activators to mediate the stimulatory effect of an HF-LC ketogenic diet on FGF21 expression. We propose that the enhanced enterohepatic flux of bile acids during HF-LC consumption leads to activation of hepatic FXR and FGF19 signaling activity and an increase in FGF21 gene expression and secretion.	[Cyphert, Holly A.; Kohan, Alison B.; Salati, Lisa M.; Hillgartner, F. Bradley] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Ge, Xuemei; Zhang, Yanqiao] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA	West Virginia University; Northeast Ohio Medical University (NEOMED)	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu		Kohan, Alison/0000-0003-3127-7283	American Diabetes Association [1-12-BS-75]; United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative [2010-65206-20618]; National Institutes of Health [R01-HL103227, R01-DK46897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046897, R15DK088733] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Basic Science Award 1-12-BS-75 (to F. B. H.) and United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Competitive Grant 2010-65206-20618 (to F. B. H.). This work was also supported, in whole or in part, by National Institutes of Health Grants R01-HL103227 (to Y. Z.) and R01-DK46897 (to L. M. S.).	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collier JJ, 2004, MOL ENDOCRINOL, V18, P1051, DOI 10.1210/me.2003-0357; Corring T, 1989, Nutr Res Rev, V2, P161, DOI 10.1079/NRR19890013; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; DUMASWALA R, 1994, AM J PHYSIOL-GASTR L, V267, pG836, DOI 10.1152/ajpgi.1994.267.5.G836; FLOREN CH, 1977, BIOCHEM BIOPH RES CO, V74, P520, DOI 10.1016/0006-291X(77)90335-7; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; HYLEMON PB, 1985, J BIOL CHEM, V260, P1015; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ichihara A, 1980, Ann N Y Acad Sci, V349, P77, DOI 10.1111/j.1749-6632.1980.tb29517.x; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; JUSTE C, 1983, J NUTR, V113, P1691, DOI 10.1093/jn/113.9.1691; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kohan AB, 2011, J NUTR, V141, P171, DOI 10.3945/jn.110.129106; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lu WJ, 2007, AM J PHYSIOL-GASTR L, V293, pG963, DOI 10.1152/ajpgi.00146.2007; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Miles JM, 2007, HORM METAB RES, V39, P726, DOI 10.1055/s-2007-990273; MOONEY RA, 1981, J BIOL CHEM, V256, P1724; Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2010, BIOCHEM BIOPH RES CO, V401, P313, DOI 10.1016/j.bbrc.2010.09.060; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stabile LP, 1998, J LIPID RES, V39, P1951; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; TSO P, 1995, AM J PHYSIOL-GASTR L, V268, pG568, DOI 10.1152/ajpgi.1995.268.4.G568; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	69	107	114	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25123	25138		10.1074/jbc.M112.375907	http://dx.doi.org/10.1074/jbc.M112.375907			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661717	Green Published, hybrid			2022-12-25	WOS:000306651700024
J	Davis, FM; Peters, AA; Grice, DM; Cabot, PJ; Parat, MO; Roberts-Thomson, SJ; Monteith, GR				Davis, Felicity M.; Peters, Amelia A.; Grice, Desma M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Non-Stimulated, Agonist-Stimulated and Store-Operated Ca2+ Influx in MDA-MB-468 Breast Cancer Cells and the Effect of EGF-Induced EMT on Calcium Entry	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOPLASMIC-RETICULUM; SMOOTH-MUSCLE; TRPC CHANNELS; ION CHANNELS; I-CRAC; STIM1; ACTIVATION; ORAI1; LOCALIZATION	In addition to their well-defined roles in replenishing depleted endoplasmic reticulum (ER) Ca2+ reserves, molecular components of the store-operated Ca2+ entry pathway regulate breast cancer metastasis. A process implicated in cancer metastasis that describes the conversion to a more invasive phenotype is epithelial-mesenchymal transition (EMT). In this study we show that EGF-induced EMT in MDA-MB-468 breast cancer cells is associated with a reduction in agonist-stimulated and store-operated Ca2+ influx, and that MDA-MB-468 cells prior to EMT induction have a high level of non-stimulated Ca2+ influx. The potential roles for specific Ca2+ channels in these pathways were assessed by siRNA-mediated silencing of ORAI1 and transient receptor potential canonical type 1 (TRPC1) channels in MDA-MB-468 breast cancer cells. Non-stimulated, agonist-stimulated and store-operated Ca2+ influx were significantly inhibited with ORAI1 silencing. TRPC1 knockdown attenuated non-stimulated Ca2+ influx in a manner dependent on Ca2+ influx via ORAI1. TRPC1 silencing was also associated with reduced ERK1/2 phosphorylation and changes in the rate of Ca2+ release from the ER associated with the inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (time to peak [Ca2+](CYT) = 188.7 +/- 34.6 s (TRPC1 siRNA) versus 124.0 +/- 9.5 s (non-targeting siRNA); P<0.05). These studies indicate that EMT in MDA-MB-468 breast cancer cells is associated with a pronounced remodeling of Ca2+ influx, which may be due to altered ORAI1 and/or TRPC1 channel function. Our findings also suggest that TRPC1 channels in MDA-MB-468 cells contribute to ORAI1-mediated Ca2+ influx in non-stimulated cells.	[Davis, Felicity M.; Peters, Amelia A.; Grice, Desma M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland	Davis, FM (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	gregm@uq.edu.au	Parat, Marie-Odile/G-4410-2010; Roberts-Thomson, Sarah J/B-4282-2011; Monteith, Gregory/B-1626-2008; Peters, Amelia/AAP-3886-2021; Cabot, Peter John/B-2424-2013; Grice, Desma M/A-7730-2011; Roberts-Thomson, Sarah/W-5676-2019; Davis, Felicity M/P-1387-2016; Peters, Amelia A/E-4254-2010	Parat, Marie-Odile/0000-0003-4895-7381; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Monteith, Gregory/0000-0002-4345-530X; Peters, Amelia/0000-0002-0700-7817; Cabot, Peter John/0000-0003-1778-3753; Roberts-Thomson, Sarah/0000-0001-8202-5786; Davis, Felicity M/0000-0001-9112-118X; 	National Health and Medical Research Council (NHMRC) [569645, 1022263, 511262]; Australian Postgraduate Award	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This research was partially supported by National Health and Medical Research Council (NHMRC) project grants (569645 & 1022263). FD was funded by an NHMRC Biomedical Postgraduate Scholarship (511262); www.nhmrc.gov.au. DG was supported by an Australian Postgraduate Award; http://www.innovation.gov.au. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Berbey C, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.N109.073221; Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Graham SJL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206946; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Tajeddine N, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.L109.073221; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	54	79	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36923	10.1371/journal.pone.0036923	http://dx.doi.org/10.1371/journal.pone.0036923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666335	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400017
J	Li, PN; Li, H; Wu, ML; Wang, SY; Kong, QY; Zhang, Z; Sun, Y; Liu, J; Lv, DC				Li, Pei-Nan; Li, Hong; Wu, Mo-Li; Wang, Shou-Yu; Kong, Qing-You; Zhang, Zhen; Sun, Yuan; Liu, Jia; Lv, De-Cheng			A Cost-Effective Transparency-Based Digital Imaging for Efficient and Accurate Wound Area Measurement	PLOS ONE			English	Article							TRACINGS; PLANIMETRY	Wound measurement is an objective and direct way to trace the course of wound healing and to evaluate therapeutic efficacy. Nevertheless, the accuracy and efficiency of the current measurement methods need to be improved. Taking the advantages of reliability of transparency tracing and the accuracy of computer-aided digital imaging, a transparency-based digital imaging approach is established, by which data from 340 wound tracing were collected from 6 experimental groups (8 rats/group) at 8 experimental time points (Day 1, 3, 5, 7, 10, 12, 14 and 16) and orderly archived onto a transparency model sheet. This sheet was scanned and its image was saved in JPG form. Since a set of standard area units from 1 mm(2) to 1 cm(2) was integrated into the sheet, the tracing areas in JPG image were measured directly, using the "Magnetic lasso tool" in Adobe Photoshop program. The pixel values/PVs of individual outlined regions were obtained and recorded in an average speed of 27 second/region. All PV data were saved in an excel form and their corresponding areas were calculated simultaneously by the formula of Y (PV of the outlined region)/X (PV of standard area unit) x Z (area of standard unit). It took a researcher less than 3 hours to finish area calculation of 340 regions. In contrast, over 3 hours were expended by three skillful researchers to accomplish the above work with traditional transparency-based method. Moreover, unlike the results obtained traditionally, little variation was found among the data calculated by different persons and the standard area units in different sizes and shapes. Given its accurate, reproductive and efficient properties, this transparency-based digital imaging approach would be of significant values in basic wound healing research and clinical practice.	[Li, Pei-Nan; Wang, Shou-Yu; Zhang, Zhen; Lv, De-Cheng] Dalian Med Univ, Clin Coll 1, Dept Orthoped Surg, Dalian, Peoples R China; [Li, Hong; Wu, Mo-Li; Kong, Qing-You; Sun, Yuan; Liu, Jia] Dalian Med Univ, Coll Med Sci, Dept Cell Biol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Li, PN (corresponding author), Dalian Med Univ, Clin Coll 1, Dept Orthoped Surg, Dalian, Peoples R China.	lvdecheng55@126.com			National Natural Science Foundation of China [30971038, 81071971]; Liaoning Education Department for the Creative Research Team [2007-7-26, 2008T028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Education Department for the Creative Research Team	This work was supported by the grants from National Natural Science Foundation of China (No. 30971038 and No. 81071971) and from Liaoning Education Department for the Creative Research Team (2007-7-26 and 2008T028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanger AA, 2011, N-S ARCH PHARMACOL, V384, P93, DOI 10.1007/s00210-011-0653-7; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOHANNON RW, 1983, PHYS THER, V63, P1622, DOI 10.1093/ptj/63.10.1622; Bowling FL, 2009, DIABETIC MED, V26, P93, DOI 10.1111/j.1464-5491.2008.02611.x; Chang Angela Christine, 2011, Eplasty, V11, pe18; Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gethin G, 2006, J CLIN NURS, V15, P422, DOI 10.1111/j.1365-2702.2006.01364.x; Gethin G, 2006, WOUNDS UK, V2, P1; Grey JE, 2006, BRIT MED J, V332, P285, DOI 10.1136/bmj.332.7536.285; GRIFFIN JW, 1993, PHYS THER, V73, P117, DOI 10.1093/ptj/73.2.117; Lagan KM, 2000, ARCH PHYS MED REHAB, V81, P1110, DOI 10.1053/apmr.2000.6281; Langemo Diane, 2008, Adv Skin Wound Care, V21, P42, DOI 10.1097/01.ASW.0000284967.69863.2f; Oduncu Hakan, 2004, Int J Low Extrem Wounds, V3, P151; Paul DR, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-26; Rajbhandari SM, 1999, DIABETIC MED, V16, P339, DOI 10.1046/j.1464-5491.1999.00053.x; Shaw J, 2007, DIABETES CARE, V30, P2641, DOI 10.2337/dc07-0122; Shrivastava R, 2011, DIABETES RES CLIN PR, V92, P92, DOI 10.1016/j.diabres.2010.12.021; St-Supery Veronique, 2011, Ann Plast Surg, V67, P193, DOI 10.1097/SAP.0b013e3181f3e0e8; Vitalo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005523; Wendelken ME, 2011, WOUNDS, V23, P267	21	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38069	10.1371/journal.pone.0038069	http://dx.doi.org/10.1371/journal.pone.0038069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666449	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400076
J	Liou, YJ; Chen, CH; Cheng, CY; Chen, SY; Chen, TJ; Yu, YWY; Nian, FS; Tsai, SJ; Hong, CJ				Liou, Ying-Jay; Chen, Chien-Hsiun; Cheng, Chih-Ya; Chen, Shiow-Yi; Chen, Tai-Jui; Yu, Younger W-Y; Nian, Fang-Shin; Tsai, Shih-Jen; Hong, Chen-Jee			Convergent Evidence from Mouse and Human Studies Suggests the Involvement of Zinc Finger Protein 326 Gene in Antidepressant Treatment Response	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; SEROTONIN REUPTAKE INHIBITORS; GENETICALLY SPECIFIC TYPES; QUANTITATIVE TRAIT LOCI; TAIL SUSPENSION TEST; REMISSION RATES; MICE; GENOME; DIFFERENTIATION	Objectives: The forced swim test (FST) is a commonly used model to predict antidepressant efficacy. Uncovering the genetic basis of the model may unravel the mechanism of antidepressant treatment. Methods: FVB/NJ (FVB) and C57BL/6J (B6) were first identified as the response and non-response strains to fluoxetine (a serotonin-specific reuptake inhibitor antidepressant) treatment in the mouse FST. Simple-interval (SIM) and composite-interval (CIM) mappings were applied to map the quantitative trait loci (QTLs) of the anti-immobility effect of fluoxetine in FST (FSTFLX) in 865 male B66FVB-F2 mice. The brain mRNA expressions of the gene with the maximum QTL-linkage signal for FSTFLX after the FST were compared between B6 and FVB mice and also compared between fluoxetine and saline treatment. The association of the variants in the human homologue of the mouse FSTFLX-QTL gene with major depressive disorder (MDD) and antidepressant response were investigated in 1080 human subjects (MDD/control = 582/498). Results: One linkage signal for FSTFLX-QTL was detected at an intronic SNP (rs6215396) of the mouse Zfp326 gene (maximal CIM-LOD = 9.36). The Zfp326 mRNA expression in the FVB thalamus was significantly down-regulated by fluoxetine in the FST, and the higher FVB-to-B6 Zfp326 mRNA expressions in the frontal cortex, striatum and hypothalamus diminished after fluoxetine treatment. Two coding-synonymous SNPs (rs2816881 and rs10922744) in the human homologue of Zfp326, ZNF326, were significantly associated with the 8-week antidepressant treatment response in the MDD patients (Bonferroni-corrected p = 0.004-0.028). Conclusions: The findings suggest the involvement of the Zfp326 and ZNF326 genes in antidepressant treatment response.	[Liou, Ying-Jay; Tsai, Shih-Jen; Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Liou, Ying-Jay; Tsai, Shih-Jen; Hong, Chen-Jee] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Nian, Fang-Shin; Hong, Chen-Jee] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Cheng, Chih-Ya] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chen, Shiow-Yi] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chen, Tai-Jui; Yu, Younger W-Y] Yus Psychiat Clin, Kaohsiung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan Ocean University	Liou, YJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	cjhong@vghtpe.gov.tw	Tsai, Shih-Jen/AAK-7944-2020; Chen, Chien Hsiun/Q-3826-2018	Tsai, Shih-Jen/0000-0002-9987-022X; 	National Science Council, Taiwan [NSC 95-2314-B-075-108-MY2, 96-2314-B-075-065-MY2, 97-3112-B-075-005, 98-3112-B-075-005, 99-3112-B-075-005]; Taipei Veterans General Hospital, Taiwan [V98C1-055, V99A-045, V99C1-041 VGHUST98-P1-02, VGHUST99-P1-01]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC 95-2314-B-075-108-MY2, 96-2314-B-075-065-MY2, 97-3112-B-075-005, 98-3112-B-075-005 and 99-3112-B-075-005) and from Taipei Veterans General Hospital, Taiwan (V98C1-055, V99A-045, V99C1-041 VGHUST98-P1-02 and VGHUST99-P1-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett DK, 1997, GENET EPIDEMIOL, V14, P749, DOI 10.1002/(SICI)1098-2272(1997)14:6<749::AID-GEPI31>3.3.CO;2-I; Bauer Michael, 2002, World J Biol Psychiatry, V3, P5, DOI 10.3109/15622970209150599; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cheng ATA, 2001, BRIT J PSYCHIAT, V178, P567, DOI 10.1192/bjp.178.6.567; Crowley JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2433, DOI 10.1038/sj.npp.1301065; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; Della Beffa Cristina, 2011, BMC Res Notes, V4, P443, DOI 10.1186/1756-0500-4-443; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Falconer D. S, 1996, INTRO QUANTITATIVE G; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Hong CJ, 2006, PHARMACOGENOMICS J, V6, P27, DOI 10.1038/sj.tpj.6500340; Kobayashi MS, 2004, J NEUROSCI RES, V76, P512, DOI 10.1002/jnr.20094; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leduc V, 2011, J NEUROSCI METH, V200, P14, DOI 10.1016/j.jneumeth.2011.05.026; Lee JY, 1998, DNA CELL BIOL, V17, P849, DOI 10.1089/dna.1998.17.849; Lee JY, 2000, DNA CELL BIOL, V19, P227, DOI 10.1089/104454900314492; Lerer B, 2002, INT J NEUROPSYCHOPH, V5, P255, DOI 10.1017/S1461145702002936; Liou YJ, 2009, PHARMACOGENET GENOM, V19, P735, DOI 10.1097/FPC.0b013e32832cbe61; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; OREILLY RL, 1994, BIOL PSYCHIAT, V36, P467, DOI 10.1016/0006-3223(94)90642-4; PARE CMB, 1971, J MED GENET, V8, P306, DOI 10.1136/jmg.8.3.306; PARE CMB, 1962, LANCET, V2, P1340; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Serretti A, 2008, PHARMACOGENOMICS J, V8, P90, DOI 10.1038/sj.tpj.6500477; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tecott LH, 2003, AM J PSYCHIAT, V160, P646, DOI 10.1176/appi.ajp.160.4.646; Tecott LH, 2001, ARCH GEN PSYCHIAT, V58, P995, DOI 10.1001/archpsyc.58.11.995; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Thase ME, 2003, J CLIN PSYCHIAT, V64, P3; Tomida S, 2009, NAT GENET; Tsai SJ, 2008, PHARMACOGENOMICS J, V8, P384, DOI 10.1038/sj.tpj.6500486; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Watters JW, 2003, TRENDS PHARMACOL SCI, V24, P55, DOI 10.1016/S0165-6147(02)00044-5; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yu YWY, 2002, MOL PSYCHIATR, V7, P1115, DOI 10.1038/sj.mp.4001141; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e32984	10.1371/journal.pone.0032984	http://dx.doi.org/10.1371/journal.pone.0032984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666313	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400002
J	Liu, XF; Bera, TK; Kahue, C; Escobar, T; Fei, ZL; Raciti, GA; Pastan, I				Liu, Xiu-Fen; Bera, Tapan K.; Kahue, Charissa; Escobar, Thelma; Fei, Zhaoliang; Raciti, Gregory A.; Pastan, Ira			ANKRD26 and Its Interacting Partners TRIO, GPS2, HMMR and DIPA Regulate Adipogenesis in 3T3-L1 Cells	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; TYROSINE PHOSPHATASE; ANKYRIN REPEAT; SUBUNIT GPS2; PROTEIN; KINASE; RHAMM; OBESITY; GENE; FIBROBLASTS	Partial inactivation of the Ankyrin repeat domain 26 (Ankrd26) gene causes obesity and diabetes in mice and increases spontaneous and induced adipogenesis in mouse embryonic fibroblasts. However, it is not yet known how the Ankrd26 protein carries out its biological functions. We identified by yeast two-hybrid and immunoprecipitation assays the triple functional domain protein (TRIO), the G protein pathway suppressor 2 (GPS2), the delta-interacting protein A (DIPA) and the hyaluronan-mediated motility receptor (HMMR) as ANKRD26 interacting partners. Adipogenesis of 3T3-L1 cells was increased by selective down-regulation of Ankrd26, Trio, Gps2, Hmmr and Dipa. Furthermore, GPS2 and DIPA, which are normally located in the nucleus, were translocated to the cytoplasm, when the C-terminus of ANKRD26 was introduced into these cells. These findings provide biochemical evidence that ANKRD26, TRIO, GPS2 and HMMR are novel and important regulators of adipogenisis and identify new targets for the modulation of adipogenesis.	[Liu, Xiu-Fen; Bera, Tapan K.; Kahue, Charissa; Escobar, Thelma; Fei, Zhaoliang; Raciti, Gregory A.; Pastan, Ira] NCI, Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, XF (corresponding author), NCI, Mol Biol Lab, Canc Res Ctr, NIH, Bldg 37, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019; fei, zhaoliang/ADK-2083-2022	pastan, ira/0000-0002-9223-0270; fei, zhaoliang/0000-0002-5400-8126; Escobar, Thelma/0000-0001-5352-3903; RACITI, GREGORYALEXANDER/0000-0003-2742-5634	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010298] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bezy O, 2005, J BIOL CHEM, V280, P11432, DOI 10.1074/jbc.M411741200; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Kim WK, 2009, J CELL SCI, V122, P4160, DOI 10.1242/jcs.053009; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.e02-07-0377; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Medley QG, 2003, J BIOL CHEM, V278, P13265, DOI 10.1074/jbc.M300277200; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Raciti GA, 2011, DIABETOLOGIA, V54, P2911, DOI 10.1007/s00125-011-2263-9; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; TURLEY EA, 1991, J CELL BIOL, V112, P1041, DOI 10.1083/jcb.112.5.1041; Walder K, 2003, CURR PHARM DESIGN, V9, P1357, DOI 10.2174/1381612033454739; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	32	24	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38130	10.1371/journal.pone.0038130	http://dx.doi.org/10.1371/journal.pone.0038130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666460	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400085
J	Yao, Z; Namkung, W; Ko, EA; Park, J; Tradtrantip, L; Verkman, AS				Yao, Zhen; Namkung, Wan; Ko, Eun A.; Park, Jinhong; Tradtrantip, Lukmanee; Verkman, A. S.			Fractionation of a Herbal Antidiarrheal Medicine Reveals Eugenol as an Inhibitor of Ca2+-Activated Cl- Channel TMEM16A	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; CHLORIDE SECRETION; MOLECULAR-BASIS; ESSENTIAL OIL; NEURONS; PHARMACOKINETICS; EXPRESSION; CURRENTS; PROTEIN; INJURY	The Ca2+-activated Cl- channel TMEM16A is involved in epithelial fluid secretion, smooth muscle contraction and neurosensory signaling. We identified a Thai herbal antidiarrheal formulation that inhibited TMEM16A Cl- conductance. C18-reversed-phase HPLC fractionation of the herbal formulation revealed >98% of TMEM16A inhibition activity in one out of approximately 20 distinct peaks. The purified, active compound was identified as eugenol (4-allyl-2-methoxyphenol), the major component of clove oil. Eugenol fully inhibited TMEM16A Cl- conductance with single-site IC50 similar to 150 mu M. Eugenol inhibition of TMEM16A in interstitial cells of Cajal produced strong inhibition of intestinal contraction in mouse ileal segments. TMEM16A Cl- channel inhibition adds to the list of eugenol molecular targets and may account for some of its biological activities.	[Yao, Zhen; Namkung, Wan; Ko, Eun A.; Tradtrantip, Lukmanee; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Yao, Zhen; Namkung, Wan; Ko, Eun A.; Tradtrantip, Lukmanee; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Namkung, Wan; Park, Jinhong] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Inchon, South Korea	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yonsei University	Yao, Z (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [DK72517, HL73856, DK35124, DK86125, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK72517, HL73856, DK35124, DK86125, EB00415, and EY13574 and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqareer A, 2006, J DENT, V34, P747, DOI 10.1016/j.jdent.2006.01.009; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BARTELS HA, 1947, AM J ORTHOD ORAL SUR, V33, P458; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Damiani CEN, 2004, J CARDIOVASC PHARM, V44, P688, DOI 10.1097/00005344-200412000-00011; Deans S. G., 1995, Flavour and Fragrance Journal, V10, P323, DOI 10.1002/ffj.2730100507; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; FISCHER IU, 1990, J CHROMATOGR-BIOMED, V525, P369, DOI 10.1016/S0378-4347(00)83413-1; Guenette SA, 2006, J VET PHARMACOL THER, V29, P265, DOI 10.1111/j.1365-2885.2006.00740.x; Guenette SA, 2007, EUR J PHARMACOL, V562, P60, DOI 10.1016/j.ejphar.2007.01.044; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kaur G, 2010, MOL CARCINOGEN, V49, P290, DOI 10.1002/mc.20601; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Li HY, 2007, J DENT RES, V86, P898, DOI 10.1177/154405910708600918; Lima FC, 2011, FUND CLIN PHARMACOL, V25, P690, DOI 10.1111/j.1472-8206.2010.00892.x; Lionnet L, 2010, PHYTOTHER RES, V24, P1645, DOI 10.1002/ptr.3174; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Magalhaes CB, 2010, J APPL PHYSIOL, V108, P845, DOI 10.1152/japplphysiol.00560.2009; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Pal D, 2010, J DERMATOL SCI, V59, P31, DOI 10.1016/j.jdermsci.2010.04.013; Park CK, 2009, PAIN, V144, P84, DOI 10.1016/j.pain.2009.03.016; Said MM, 2011, FUND CLIN PHARMACOL, V25, P708, DOI 10.1111/j.1472-8206.2010.00900.x; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; THOMPSON D, 1989, MOL PHARMACOL, V36, P809; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Yeon KY, 2011, PAIN, V152, P2108, DOI 10.1016/j.pain.2011.05.018	33	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38030	10.1371/journal.pone.0038030	http://dx.doi.org/10.1371/journal.pone.0038030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666439	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400071
J	Alves, L; Azevedo, A; Silva, S; Barros, H				Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique			Socioeconomic Inequalities in the Prevalence of Nine Established Cardiovascular Risk Factors in a Southern European Population	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; MULTILEVEL ANALYSIS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; HEALTH; POSITION; DISEASE; ASSOCIATION; DETERMINANTS	The evaluation of the gender-specific prevalence of cardiovascular risk factors across socioeconomic position (SEP) categories may unravel mechanisms involved in the development of coronary heart disease. Using a sample of 1704 community dwellers of a Portuguese urban center aged 40 years or older, assessed in 1999-2003, we quantified the age-standardized prevalence of nine established cardiovascular risk factors (diabetes mellitus, hypertension, hypercholesterolemia, smoking, sedentariness, abdominal obesity, poor diet, excessive alcohol intake and depression) across SEP and gender categories. Data on individual education and occupation were collected by questionnaire and used to characterize SEP. The prevalence of seven out of nine well-established risk factors was higher in men. Among women, the prevalence of most of the studied risk factors was higher in lower SEP groups. The main exception was smoking, which increased with education and occupation levels. Among men, socioeconomic gradients were less clear, but lower SEP was associated with a higher prevalence of diabetes, excessive alcohol intake and depression in a graded mode. The historical cultural beliefs and practices captured throughout the lifecourse frame the wide socioeconomic gradients discernible in our study conducted in an unequal European developed population. While men were more exposed to most risk factors, the clearer associations between SEP and risk factors among women support that their adoption of particular healthy behaviors is more dependent on material and symbolic conditions. To fully address the issue of health inequalities, interventions within the health systems should be complemented with population-based policies specifically designed to reduce socioeconomic gradients.	[Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique] Univ Porto ISPUP, Inst Publ Hlth, Oporto, Portugal; Santo Andre de Canidelo Hlth Family Unit, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto	Alves, L (corresponding author), Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lalves@med.up.pt	Silva, Susana/AAV-5517-2020; Alves, Luís Andrés Amorim/C-1618-2018; Azevedo, Ana/AAA-2287-2020; Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019; Silva, Susana/E-5828-2012	Silva, Susana/0000-0002-1335-8648; Alves, Luís Andrés Amorim/0000-0001-5855-2754; Azevedo, Ana/0000-0002-7368-9609; Barros, Henrique/0000-0003-4699-6571; Silva, Susana/0000-0002-1335-8648	Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology) [POCI/SAU-ESP/61160/2004]	Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology)	Funded by Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology) (POCI/SAU-ESP/61160/2004) http://www.fct.mctes.pt/projectos/pub/2004/painel_result/vglobal_projecto.asp?idProjecto=61160&idElemConcurso=34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Annandale E, 2000, GENDER INEQUALITIES, Vix, P214; [Anonymous], 1997, GUID CONTR MON TOB E; Barreto A., 2003, SOCIAL CHANGE PORTUG; Bartley M, 2004, HLTH INEQUALITY INTR, Vviii, P208; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berkman L, 2000, SOCIAL EPIDEMIOLOGY, Vxxii, P391; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bourdieu P., 1979, DISTINCTION CRITIQUE; BUCOLO G, 1973, CLIN CHEM, V19, P476; Camoes M, 2010, ANN HUM BIOL, V37, P186, DOI 10.3109/03014460903341836; CARVALHO M, 2011, PERSISTENCIA DESIGUA; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Courtenay W. H., 2002, International Journal of Men's Health, V1, P281, DOI 10.3149/jmh.0103.281; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; CRIQUI MH, 1980, PREV MED, V9, P525, DOI 10.1016/0091-7435(80)90047-X; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Davey Smith G, 2003, HLTH INEQUALITIES LI, Vlix, P548; Den Hond E, 2003, BLOOD PRESS MONIT, V8, P37, DOI 10.1097/00126097-200302000-00008; Dolan E, 2004, BLOOD PRESS MONIT, V9, P307, DOI 10.1097/00126097-200412000-00007; Fernandez E, 2001, PREV MED, V32, P218, DOI 10.1006/pmed.2000.0794; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraga Sílvia, 2005, Arq Med, V19, P207; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; Guerreiro M, 1995, REV PORTUGUESA NEURO, V1, P9; Hart C, 1997, SOC SCI MED, V45, P893, DOI 10.1016/S0277-9536(96)00431-5; Instituto do Emprego e Formacao Profissional, 1994, NAT CLASS OCC; JIN RL, 1995, CAN MED ASSOC J, V153, P529; Kimmel MS, 2006, MANHOOD AM CULTURAL, Vxi, P322; Krauss RM, 2000, CIRCULATION, V102, P2284; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopes C, 2000, THESIS U PORTO PORTO, P79; Lopes C, 2007, J AM DIET ASSOC, V107, P276, DOI 10.1016/j.jada.2006.11.008; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Loucks EB, 2007, ANN EPIDEMIOL, V17, P782, DOI 10.1016/j.annepidem.2007.05.003; Machado A, 2009, CONSUMO TABACO POPUL, V4, P5; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marmot MG, 2006, SOCIAL DETERMINANTS, Vx, P366; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Myint PK, 2006, GERONTOLOGY, V52, P51, DOI 10.1159/000089826; National Research Council (U.S.). Subcommittee on the Tenth Edition of the RDAs. National Institutes of Health (U.S.) National Research Council (U.S.). Committee on Dietary Allowances, 1989, REC DIET ALL, Vx, P284; Oakes JM, 2006, METHODS SOCIAL EPIDE, Vxxv, P478; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Pleck JH, 1981, MYTH MASCULINITY, Vix, P229; Ramos E, 2004, ANN EPIDEMIOL, V14, P437, DOI 10.1016/j.annepidem.2003.09.013; Regidor E, 2006, J EPIDEMIOL COMMUN H, V60, P74, DOI 10.1136/jech.2005.038331; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Santos AC, 2003, PUBLIC HEALTH, V117, P430, DOI 10.1016/S0033-3506(03)00139-2; SCHMAND B, 1995, J NEUROL NEUROSUR PS, V59, P170, DOI 10.1136/jnnp.59.2.170; Seale C, 2008, SOCIOLOGY, V42, P453, DOI 10.1177/0038038508088835; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Viinamaki H, 2004, NORD J PSYCHIAT, V58, P49, DOI 10.1080/08039480310000798; WARNICK GR, 1978, J LIPID RES, V19, P65; Wilkinson RG, 2010, SPIRIT LEVEL WHY GRE, Vxv, P330; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; WILSON MG, 1991, AM J PREV MED, V7, P280, DOI 10.1016/S0749-3797(18)30900-0; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wolin KY, 2008, J PHYS ACT HEALTH, V5, P229, DOI 10.1123/jpah.5.2.229; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	66	30	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37158	10.1371/journal.pone.0037158	http://dx.doi.org/10.1371/journal.pone.0037158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666343	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600011
J	Clegg, HV; Itahana, Y; Itahana, K; Ramalingam, S; Zhang, YP				Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping			Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction	PLOS ONE			English	Article							UBIQUITIN LIGASE; FINGER DOMAIN; IN-VITRO; MECHANISTIC INSIGHTS; ONCOPROTEIN MDM2; DNA-DAMAGE; ACETYLATION; ACTIVATION; DEGRADATION; PROTEIN	The p53 transcription factor and tumor suppressor is regulated primarily by the E3 ubiquitin ligase Mdm2, which ubiquitinates p53 to target it for proteasomal degradation. Aside from its ubiquitin ligase function, Mdm2 has been believed to be capable of suppressing p53's transcriptional activity by binding with and masking the transactivation domain of p53. The ability of Mdm2 to restrain p53 activity by binding alone, without ubiquitination, was challenged by a 2007 study using a knockin mouse harboring a single cysteine-to-alanine point mutation (C462A) in Mdm2's RING domain. Mouse embryonic fibroblasts with this mutation, which abrogates Mdm2's E3 ubiquitin ligase activity without affecting its ability to bind with p53, were unable to suppress p53 activity. In this study, we utilized the Mdm2(C462A) mouse model to characterize in further detail the role of Mdm2's RING domain in the control of p53. Here, we show in vivo that the Mdm2(C462A) protein not only fails to suppress p53, but compared to the complete absence of Mdm2, Mdm2(C462A) actually enhances p53 transcriptional activity toward p53 target genes p21/CDKN1A, MDM2, BAX, NOXA, and 14-3-3s. In addition, we found that Mdm2(C462A) facilitates the interaction between p53 and the acetyltransferase CBP/p300, and it fails to heterodimerize with its homolog and sister regulator of p53, Mdmx, suggesting that a fully intact RING domain is required for Mdm2's inhibition of the p300-p53 interaction and for its interaction with Mdmx. These findings help us to better understand the complex regulation of the Mdm2-p53 pathway and have important implications for chemotherapeutic agents targeting Mdm2, as they suggest that inhibition of Mdm2's E3 ubiquitin ligase activity may be sufficient for increasing p53 activity in vivo, without the need to block Mdm2-p53 binding.	[Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Itahana, Yoko; Itahana, Koji] Duke NUS Grad Med Sch Singapore, Canc & Stem Cell Biol Program, Singapore, Singapore	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National University of Singapore	Clegg, HV (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	ypzhang@med.unc.edu	Itahana, Koji/J-5505-2013	Itahana, Koji/0000-0002-7241-2894	National Institutes of Health; American Cancer Society [2R01-CA100302, 1R01-CA127770, 1RC2CA148487-01]; NATIONAL CANCER INSTITUTE [RC2CA148487, R01CA167637, R01CA127770, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health and the American Cancer Society (2R01-CA100302, 1R01-CA127770, and 1RC2CA148487-01, to Y.Z.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Liu L, 1999, MOL CELL BIOL, V19, P1202; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Sabbatini P, 2002, DNA CELL BIOL, V21, P519, DOI 10.1089/104454902320219077; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	26	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38212	10.1371/journal.pone.0038212	http://dx.doi.org/10.1371/journal.pone.0038212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666487	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600072
J	van Bergeijk, P; Heimiller, J; Uyetake, L; Su, TT				van Bergeijk, Petra; Heimiller, Joseph; Uyetake, Lyle; Su, Tin Tin			Genome-Wide Expression Analysis Identifies a Modulator of Ionizing Radiation-Induced p53-Independent Apoptosis in Drosophila melanogaster	PLOS ONE			English	Article							N-TERMINAL KINASE; DNA-DAMAGE; GENE-EXPRESSION; CELL-DEATH; COMPENSATORY PROLIFERATION; SIGNALING PATHWAYS; P53 RESPONSE; HOMOLOG; FAMILY; REPAIR	Tumor suppressor p53 plays a key role in DNA damage responses in metazoa, yet more than half of human tumors show p53 deficiencies. Therefore, understanding how therapeutic genotoxins such as ionizing radiation (IR) can elicit DNA damage responses in a p53-independent manner is of clinical importance. Drosophila has been a good model to study the effects of IR because DNA damage responses as well as underlying genes are conserved in this model, and because streamlined gene families make loss-of-function analyses feasible. Indeed, Drosophila is the only genetically tractable model for IR-induced, p53-independent apoptosis and for tissue regeneration and homeostasis after radiation damage. While these phenomenon occur only in the larvae, all genome-wide gene expression analyses after irradiation to date have been in embryos. We report here the first analysis of IR-induced, genome-wide gene expression changes in wild type and p53 mutant Drosophila larvae. Key data from microarrays were confirmed by quantitative RT-PCR. The results solidify the central role of p53 in IR-induced transcriptome changes, but also show that nearly all changes are made of both p53-dependent and p53-independent components. p53 is found to be necessary not just for the induction of but also for the repression of transcript levels for many genes in response to IR. Furthermore, Functional analysis of one of the top-changing genes, EF1a-100E, implicates it in repression of IR-induced p53-independent apoptosis. These and other results support the emerging notion that there is not a single dominant mechanism but that both positive and negative inputs collaborate to induce p53-independent apoptosis in response to IR in Drosophila larvae.	[van Bergeijk, Petra; Heimiller, Joseph; Uyetake, Lyle; Su, Tin Tin] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	van Bergeijk, P (corresponding author), Univ Utrecht, Div Cell Biol, Dept Biol, Fac Sci, Utrecht, Netherlands.	tin.su@colorado.edu		Heimiller, Joseph/0000-0002-7770-3746	National Institutes of Health [RO1GM87276, T32GM007135]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM087276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (RO1GM87276) to TTS. JH was supported by a pre-doctoral training grant from the National Institutes of Health (T32GM007135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZK, 2009, ARCH OTOLARYNGOL, V135, P662, DOI 10.1001/archoto.2009.79; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gladstone M, 2012, DIS MODELS MECH; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Peretz G, 2007, GENETICS, V177, P1691, DOI 10.1534/genetics.107.079517; Rashi-Elkeles S, 2011, MOL ONCOL, V5, P336, DOI 10.1016/j.molonc.2011.06.004; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sokolov M, 2006, RADIAT PROT DOSIM, V122, P195, DOI 10.1093/rpd/ncl423; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakatsuki M, 2008, INT J RADIAT ONCOL, V70, P1189, DOI 10.1016/j.ijrobp.2007.08.033; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Wells BS, 2011, DEV BIOL IN PRESS; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	46	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e36539	10.1371/journal.pone.0036539	http://dx.doi.org/10.1371/journal.pone.0036539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666323	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600005
J	Liu, J; Liu, HX; Sefah, K; Liu, B; Pu, Y; Van Simaeys, D; Tan, WH				Liu, Jun; Liu, Huixia; Sefah, Kwame; Liu, Bo; Pu, Ying; Van Simaeys, Dimitri; Tan, Weihong			Selection of Aptamers Specific for Adipose Tissue	PLOS ONE			English	Article							FATTY-ACID UPTAKE; 3T3-L1 ADIPOCYTES; BIOMARKER DISCOVERY; CARDIOVASCULAR-DISEASE; TRANSFERRIN RECEPTORS; MOLECULAR RECOGNITION; METABOLIC SYNDROME; CELL SELEX; INSULIN; DIFFERENTIATION	Background: Obesity has reached epidemic proportions, affecting more than one tenth of the world's population. As such, adipose tissue is being increasingly recognized as an important therapeutic target for obesity and related metabolic disorders. While many potential targets of adipose tissue have been established and drugs developed, very few of those drugs specifically target adipose tissue without affecting other tissue. This results from a limited knowledge of both cell-surface markers and physicochemical traits specific to adipocytes that might otherwise be exploited by circulating drugs. Methodology/Principal Findings: Here we report the use of cell-SELEX technology to select two aptamers that can specifically recognize mature adipocytes: adipo-1 and adipo-8. Adipo-8 shows high affinity for differentiated, mature 3T3-L1 adipocytes with a K-d value of 17.8 +/- 5.1 nM. The binding was sustained upon incubation at 37 degrees C and insulin stimulation, but was lost upon trypsin treatment. The binding ability was also verified on frozen tissue slides with low background fluorescence and isolated adipocytes. Conclusions/Significance: Aptamer adipo-8 selected from a random library appears to bind to mature differentiated adipocytes specifically. This aptamer holds great promise as a molecular recognition tool for adipocyte biomarker discovery or for targeted delivery of molecules to adipocytes.	[Liu, Jun; Liu, Huixia; Liu, Bo; Pu, Ying] Cent S Univ, Xiangya Hosp, Div Geriatr, Changsha, Hunan, Peoples R China; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Shands Canc Ctr, UF Genet Inst, Gainesville, FL 32611 USA; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Central South University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, J (corresponding author), Cent S Univ, Xiangya Hosp, Div Geriatr, Changsha, Hunan, Peoples R China.	lhx900@yahoo.com.cn; tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	National Key Scientific Program of China [2011CB911001, 2011CB911003]; Natural Science Foundation of Hunan Province, China [07JJ5108]; National Institutes of Health [GM066137, GM079359, CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066137, R01GM079359] Funding Source: NIH RePORTER	National Key Scientific Program of China; Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Key Scientific Program of China (2011CB911001, 2011CB911003) and by the Natural Science Foundation of Hunan Province (07JJ5108), China. This work is also supported by grants awarded by the National Institutes of Health (GM066137, GM079359 and CA133086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-45; Berezovski MV, 2008, J AM CHEM SOC, V130, P9137, DOI 10.1021/ja801951p; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergman RN, 2001, J INVEST MED, V49, P119, DOI 10.2310/6650.2001.34108; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Ching JK, 2010, AM J PHYSIOL-CELL PH, V299, pC1171, DOI 10.1152/ajpcell.00514.2009; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim YM, 2009, BIOMARK MED, V3, P193, DOI 10.2217/BMM.09.5; Klein J, 2006, TRENDS ENDOCRIN MET, V17, P26, DOI 10.1016/j.tem.2005.11.008; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kratchmarova I, 2002, MOL CELL PROTEOMICS, V1, P213, DOI 10.1074/mcp.M200006-MCP200; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li SH, 2009, J PATHOL, V218, P327, DOI 10.1002/path.2543; Liu J, 2011, ENDOCR J, V58, P199, DOI 10.1507/endocrj.K10E-318; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Ulrich H, 2009, CYTOM PART A, V75A, P727, DOI 10.1002/cyto.a.20766; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; ZHOU SL, 1992, J BIOL CHEM, V267, P14456	39	10	14	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37789	10.1371/journal.pone.0037789	http://dx.doi.org/10.1371/journal.pone.0037789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662223	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300113
J	Schulz, P; Neukermans, J; Van der Kelen, K; Muhlenbock, P; Van Breusegem, F; Noctor, G; Teige, M; Metzlaff, M; Hannah, MA				Schulz, Philipp; Neukermans, Jenny; Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank; Noctor, Graham; Teige, Markus; Metzlaff, Michael; Hannah, Matthew A.			Chemical PARP Inhibition Enhances Growth of Arabidopsis and Reduces Anthocyanin Accumulation and the Activation of Stress Protective Mechanisms	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; GENE-EXPRESSION; ADP-RIBOSYLATION; DROUGHT STRESS; REDOX STATE; CELL-DEATH; HIGH LIGHT; SECONDARY METABOLISM	Poly-ADP-ribose polymerase (PARP) post-translationally modifies proteins through the addition of ADP-ribose polymers, yet its role in modulating plant development and stress responses is only poorly understood. The experiments presented here address some of the gaps in our understanding of its role in stress tolerance and thereby provide new insights into tolerance mechanisms and growth. Using a combination of chemical and genetic approaches, this study characterized phenotypes associated with PARP inhibition at the physiological level. Molecular analyses including gene expression analysis, measurement of primary metabolites and redox metabolites were used to understand the underlying processes. The analysis revealed that PARP inhibition represses anthocyanin and ascorbate accumulation under stress conditions. The reduction in defense is correlated with enhanced biomass production. Even in unstressed conditions protective genes and molecules are repressed by PARP inhibition. The reduced anthocyanin production was shown to be based on the repression of transcription of key regulatory and biosynthesis genes. PARP is a key factor for understanding growth and stress responses of plants. PARP inhibition allows plants to reduce protection such as anthocyanin, ascorbate or Non-Photochemical-Quenching whilst maintaining high energy levels likely enabling the observed enhancement of biomass production under stress, opening interesting perspectives for increasing crop productivity.	[Schulz, Philipp; Metzlaff, Michael; Hannah, Matthew A.] Bayer CropSci NV, Ghent, Belgium; [Schulz, Philipp; Teige, Markus] Univ Vienna, Dept Biochem & Cell Biol, MFPL, Vienna, Austria; [Neukermans, Jenny; Noctor, Graham] Univ Paris 11, Inst Biol Plantes, Orsay, France; [Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Bayer AG; Bayer CropScience; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); UDICE-French Research Universities; Universite Paris Saclay; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Schulz, P (corresponding author), Bayer CropSci NV, Ghent, Belgium.	matthew.hannah@bayer.com	Van Breusegem, Frank/AAJ-2647-2020; Noctor, Graham/H-3157-2015; Teige, Markus/R-6443-2016; Van Breusegem, Frank/Y-2999-2019	Van Breusegem, Frank/0000-0002-3147-0860; Teige, Markus/0000-0001-7204-1379; Neukermans, Jenny/0000-0002-2618-7198; Van Der Kelen, Katrien/0000-0002-7686-8477; Hannah, Matthew/0000-0002-4889-490X	Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2009-235827]; EU [ITN-GA-2008-215174]; Multidisciplinary Research Partnership Ghent Bio-economy; Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix'')	Marie Curie Intra-European Fellowship for Career Development; EU(European Commission); Multidisciplinary Research Partnership Ghent Bio-economy; Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix'')	P.M. is the recipient of a Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2009-235827). The project was supported by the EU funded Marie-Curie ITN project on "Chloroplast signals'' (COSI) (ITN-GA-2008-215174), the Multidisciplinary Research Partnership Ghent Bio-economy and the Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Amor Y, 1998, FEBS LETT, V440, P1, DOI 10.1016/S0014-5793(98)01408-2; Arena C, 2011, PLANT PHYSIOL BIOCH, V49, P435, DOI 10.1016/j.plaphy.2011.02.004; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Babiychuk E, 2001, PLANT J, V28, P245, DOI 10.1046/j.1365-313X.2001.01143.x; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Berglund T, 1996, FEBS LETT, V380, P188, DOI 10.1016/0014-5793(96)00027-0; Briggs AG, 2011, TRENDS PLANT SCI, V16, P372, DOI 10.1016/j.tplants.2011.03.008; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHEN YM, 1994, EUR J BIOCHEM, V224, P135, DOI 10.1111/j.1432-1033.1994.tb20004.x; Chung HJ, 1999, PLANT PHYSIOL, V121, P429, DOI 10.1104/pp.121.2.429; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Block M, 2005, PLANT J, V41, P95, DOI 10.1111/j.1365-313X.2004.02277.x; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; Divi UK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-151; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge LF, 2008, PLANTA, V228, P191, DOI 10.1007/s00425-008-0729-x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDERER G, 1991, BIOCHEM J, V277, P607, DOI 10.1042/bj2770607; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hernandez I, 2010, PLANT SCI, V179, P297, DOI 10.1016/j.plantsci.2010.06.001; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Hughes NM, 2010, J EXP BOT, V61, P1699, DOI 10.1093/jxb/erq042; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; HWANG SY, 1991, PLANT PHYSIOL, V97, P593, DOI 10.1104/pp.97.2.593; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kornas A, 2010, ACTA BIOCHIM POL, V57, P143; Lamb RS, 2012, CELL MOL LIFE SCI, V69, P175, DOI 10.1007/s00018-011-0793-4; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; LEPINIEC L, 1995, FEBS LETT, V364, P103, DOI 10.1016/0014-5793(95)00335-7; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; McCourt P, 2010, NEW PHYTOL, V185, P15, DOI 10.1111/j.1469-8137.2009.03045.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Munne-Bosch S, 2003, PLANT PHYSIOL, V131, P1816, DOI 10.1104/pp.102.019265; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagata T, 2003, J AGR FOOD CHEM, V51, P2992, DOI 10.1021/jf026179+; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Noctor G, 2007, METABOLOMICS, V3, P161, DOI 10.1007/s11306-007-0057-3; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pellny TK, 2009, MOL PLANT, V2, P442, DOI 10.1093/mp/ssp008; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; RANKIN PW, 1989, J BIOL CHEM, V264, P4312; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Smyth GK, 2004, STAT APP GEN MOL BIO, V3; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Storozhenko S, 2001, J EXP BOT, V52, P1375, DOI 10.1093/jexbot/52.359.1375; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tian RH, 2000, FEBS LETT, V474, P11, DOI 10.1016/S0014-5793(00)01561-1; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Toth R, 2010, TRENDS PLANT SCI, V15, P81, DOI 10.1016/j.tplants.2009.11.005; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Vanderauwera S, 2007, P NATL ACAD SCI USA, V104, P15150, DOI 10.1073/pnas.0706668104; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	94	40	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37287	10.1371/journal.pone.0037287	http://dx.doi.org/10.1371/journal.pone.0037287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662141	Green Published, gold			2022-12-25	WOS:000305342300031
J	Wiysonge, CS; Uthman, OA; Ndumbe, PM; Hussey, GD				Wiysonge, Charles S.; Uthman, Olalekan A.; Ndumbe, Peter M.; Hussey, Gregory D.			Individual and Contextual Factors Associated with Low Childhood Immunisation Coverage in Sub-Saharan Africa: A Multilevel Analysis	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; VACCINATION; CHILDREN; COSTS; DETERMINANTS; STRATEGIES; NIGERIA; MEASLES; HEALTH	Background: In 2010, more than six million children in sub-Saharan Africa did not receive the full series of three doses of the diphtheria-tetanus-pertussis vaccine by one year of age. An evidence-based approach to addressing this burden of unimmunised children requires accurate knowledge of the underlying factors. We therefore developed and tested a model of childhood immunisation that includes individual, community and country-level characteristics. Method and Findings: We conducted multilevel logistic regression analysis of Demographic and Health Survey data for 27,094 children aged 12-23 months, nested within 8,546 communities from 24 countries in sub-Saharan Africa. According to the intra-country and intra-community correlation coefficient implied by the estimated intercept component variance, 21% and 32% of the variance in unimmunised children were attributable to country- and community-level factors respectively. Children born to mothers (OR 1.35, 95%CI 1.18 to 1.53) and fathers (OR 1.13, 95%CI 1.12 to 1.40) with no formal education were more likely to be unimmunised than those born to parents with secondary or higher education. Children from the poorest households were 36% more likely to be unimmunised than counterparts from the richest households. Maternal access to media significantly reduced the odds of children being unimmunised (OR 0.94, 95%CI 0.94 to 0.99). Mothers with health seeking behaviours were less likely to have unimmunised children (OR 0.56, 95%CI 0.54 to 0.58). However, children from urban areas (OR 1.12, 95% CI 1.01 to 1.23), communities with high illiteracy rates (OR 1.13, 95% CI 1.05 to 1.23), and countries with high fertility rates (OR 4.43, 95% CI 1.04 to 18.92) were more likely to be unimmunised. Conclusion: We found that individual and contextual factors were associated with childhood immunisation, suggesting that public health programmes designed to improve coverage of childhood immunisation should address people, and the communities and societies in which they live.	[Wiysonge, Charles S.; Hussey, Gregory D.] Univ Cape Town, Vaccines Africa Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Wiysonge, Charles S.; Hussey, Gregory D.] Univ Cape Town, Div Med Microbiol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Uthman, Olalekan A.] African Publ Hlth Fdn, Abuja, Nigeria; [Uthman, Olalekan A.] Keele Univ, Keele, Staffs, England; [Ndumbe, Peter M.] Univ Buea, Fac Hlth Sci, Buea, Cameroon	University of Cape Town; University of Cape Town; Keele University	Wiysonge, CS (corresponding author), Univ Cape Town, Vaccines Africa Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	charles.wiysonge@uct.ac.za	Wiysonge, Charles Shey U/A-3843-2008; Uthman, Olalekan/N-5584-2019	Wiysonge, Charles Shey U/0000-0002-1273-4779; Uthman, Olalekan/0000-0002-8567-3081				Antai D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-181; Antai D, 2009, J BIOSOC SCI, V41, P57, DOI 10.1017/S0021932008002861; Babalola S, 2009, MATERN CHILD HLTH J, V13, P550, DOI 10.1007/s10995-008-0386-5; Bale C, 2011, PEDIATR INFECT DIS J, V30, P689, DOI 10.1097/INF.0b013e31821786a4; Batt K, 2004, B WORLD HEALTH ORGAN, V82, P689; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Clements CJ, 2008, VACCINE, V26, P1926, DOI 10.1016/j.vaccine.2008.02.032; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Measure DHS, 2011, DEMOGRAPHIC HLTH SUR; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Oladokun R E, 2009, Afr J Med Med Sci, V38, P9; Osgood D.W., 2003, JUVENILE DELINQUENCY, P12; Oyo-Ita A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008145.pub2; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Rasbash J, 2011, USERS GUIDE MLWIN VE; Ryman TK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-134; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sanou A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S10; Sia D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-416; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Sullivan MC, 2010, J COMMUN HEALTH, V35, P53, DOI 10.1007/s10900-009-9192-2; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; WARNER BD, 1993, CRIMINOLOGY, V31, P493, DOI 10.1111/j.1745-9125.1993.tb01139.x; Waters HR, 2004, B WORLD HEALTH ORGAN, V82, P668; Wiysonge CS, 2007, TROP DOCT, V37, P125, DOI 10.1177/004947550703700233; Wiysonge CS, 2009, LANCET, V373, P1174, DOI 10.1016/S0140-6736(09)60685-1; Wiysonge CS, 2002, LANCET, V359, P713, DOI 10.1016/S0140-6736(02)07798-X; Wiysonge CS, 2006, LANCET, V367, P394, DOI 10.1016/S0140-6736(06)68133-6; World Bank, WORLD BANK DAT; World Health Organization, 2010, WHO VACC PREV DIS MO	36	125	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37905	10.1371/journal.pone.0037905	http://dx.doi.org/10.1371/journal.pone.0037905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662247	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300138
J	Zell, E; Balcetis, E				Zell, Ethan; Balcetis, Emily			The Influence of Social Comparison on Visual Representation of One's Face	PLOS ONE			English	Article							BODY-IMAGE; SELF; RECOGNITION; VIEWPOINT; ATTRACTIVENESS; ENHANCEMENT; ADAPTATION; AWARENESS; IDENTITY; MIRROR	Can the effects of social comparison extend beyond explicit evaluation to visual self-representation-a perceptual stimulus that is objectively verifiable, unambiguous, and frequently updated? We morphed images of participants' faces with attractive and unattractive references. With access to a mirror, participants selected the morphed image they perceived as depicting their face. Participants who engaged in upward comparison with relevant attractive targets selected a less attractive morph compared to participants exposed to control images (Study 1). After downward comparison with relevant unattractive targets compared to control images, participants selected a more attractive morph (Study 2). Biased representations were not the products of cognitive accessibility of beauty constructs; comparisons did not influence representations of strangers' faces (Study 3). We discuss implications for vision, social comparison, and body image.	[Zell, Ethan] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA; [Balcetis, Emily] NYU, Dept Psychol, New York, NY 10003 USA	University of North Carolina; University of North Carolina Greensboro; New York University	Zell, E (corresponding author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.	e_zell@uncg.edu						Anton S D, 2000, Eat Behav, V1, P153, DOI 10.1016/S1471-0153(00)00015-5; Borod J. C., 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; BROWN JD, 1992, J PERS SOC PSYCHOL, V62, P717, DOI 10.1037/0022-3514.62.5.717; Buckingham JT, 2002, J PERS SOC PSYCHOL, V83, P1117, DOI 10.1037//0022-3514.83.5.1117; Burke P H, 1992, Br J Orthod, V19, P273; CARTER LF, 1949, PSYCHOL REV, V56, P200, DOI 10.1037/h0060745; CASH TF, 1983, PERS SOC PSYCHOL B, V9, P351, DOI 10.1177/0146167283093004; Clerkin EM, 2008, COGNITION EMOTION, V22, P1327, DOI 10.1080/02699930701766099; Crerand CE, 2006, PLAST RECONSTR SURG, V118, p167E, DOI 10.1097/01.prs.0000242500.28431.24; DARLEY JM, 1983, J PERS SOC PSYCHOL, V44, P20, DOI 10.1037/0022-3514.44.1.20; DUNNING D, 1992, J PERS SOC PSYCHOL, V63, P341, DOI 10.1037/0022-3514.63.3.341; Dunning D., 2001, BLACKWELL HDB SOCIAL, P348, DOI DOI 10.1002/9780470998519.ch16; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; ERDELYI MH, 1974, PSYCHOL REV, V81, P1, DOI 10.1037/h0035852; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gebauer JE, 2008, J EXP SOC PSYCHOL, V44, P1346, DOI 10.1016/j.jesp.2008.03.016; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Gramzow RH, 2006, PERS SOC PSYCHOL B, V32, P1114, DOI 10.1177/0146167206288600; Gurari I, 2006, BASIC APPL SOC PSYCH, V28, P273, DOI 10.1207/s15324834basp2803_6; HERR PM, 1986, J PERS SOC PSYCHOL, V51, P1106, DOI 10.1037/0022-3514.51.6.1106; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Kawakami K, 2012, J PERS SOC PSYCHOL, V102, P562, DOI 10.1037/a0025970; Khurana B, 2000, J EXP PSYCHOL HUMAN, V26, P246, DOI 10.1037/0096-1523.26.1.246; Krizan Z, 2007, PSYCHOL BULL, V133, P95, DOI 10.1037/0033-2909.133.1.95; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Laurence S, VIS COG IN PRESS; Laurence S, 2011, PERCEPTION, V40, P450, DOI 10.1068/p6774; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Maltby J, 2005, BRIT J HEALTH PSYCH, V10, P17, DOI 10.1348/135910704X15257; Mendes WB, 2001, EUR J SOC PSYCHOL, V31, P477, DOI 10.1002/ejsp.80; Moskowitz GB, 1999, J PERS SOC PSYCHOL, V76, P911, DOI 10.1037/0022-3514.76.6.911; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; Mussweiler T., 2005, SELF SOCIAL JUDGMENT, P109; Or CCF, 2010, VISION RES, V50, P1581, DOI 10.1016/j.visres.2010.05.016; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Pham-Kanter G, 2009, SOC SCI MED, V69, P335, DOI 10.1016/j.socscimed.2009.05.017; Polivy J, 2002, ANNU REV PSYCHOL, V53, P187, DOI 10.1146/annurev.psych.53.100901.135103; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Pyszczynski T, 1987, PSYCHOL BULL, P122; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ryu JJ, 2006, VISION RES, V46, P4059, DOI 10.1016/j.visres.2006.07.018; Scherer LD, 2009, J PERS SOC PSYCHOL, V97, P383, DOI 10.1037/a0015844; Senik C, 2009, J ECON BEHAV ORGAN, V72, P408, DOI 10.1016/j.jebo.2009.04.019; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Silvia PJ, 2001, PERS SOC PSYCHOL REV, V5, P230, DOI 10.1207/S15327957PSPR0503_4; Stone A, 2004, PSYCHON B REV, V11, P469, DOI 10.3758/BF03196597; Stone A, 2003, CORTEX, V39, P31, DOI 10.1016/S0010-9452(08)70072-8; Stone A, 2001, COGN AFFECT BEHAV NE, V1, P183, DOI 10.3758/CABN.1.2.183; Summerville A, 2008, J EXP SOC PSYCHOL, V44, P664, DOI 10.1016/j.jesp.2007.04.002; Sweeney PD, 2005, J OCCUP ORGAN PSYCH, V78, P113, DOI 10.1348/096317904X23808; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; van den Berg P, 2007, BODY IMAGE, V4, P29, DOI 10.1016/j.bodyim.2006.12.004; Van Overwalle F, 2012, J EXP SOC PSYCHOL, V48, P13, DOI 10.1016/j.jesp.2011.06.016; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360	60	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36742	10.1371/journal.pone.0036742	http://dx.doi.org/10.1371/journal.pone.0036742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662124	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300015
J	Zhu, HS; Vadigepalli, R; Rafferty, R; Gonye, GE; Weaver, DR; Schwaber, JS				Zhu, Haisun; Vadigepalli, Rajanikanth; Rafferty, Rachel; Gonye, Gregory E.; Weaver, David R.; Schwaber, James S.			Integrative Gene Regulatory Network Analysis Reveals Light-Induced Regional Gene Expression Phase Shift Programs in the Mouse Suprachiasmatic Nucleus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GABP; PHOTIC REGULATION; CREB PHOSPHORYLATION; CIRCADIAN VARIATION; PERIOD HOMOLOGS; IDENTIFICATION; ORGANIZATION; CLOCK; CELLS; MODEL	We use the multigenic pattern of gene expression across suprachiasmatic nuclei (SCN) regions and time to understand the dynamics within the SCN in response to a circadian phase-resetting light pulse. Global gene expression studies of the SCN indicate that circadian functions like phase resetting are complex multigenic processes. While the molecular dynamics of phase resetting are not well understood, it is clear they involve a "functional gene expression program'', e. g., the coordinated behavior of functionally related genes in space and time. In the present study we selected a set of 89 of these functionally related genes in order to further understand this multigenic program. By use of high-throughput qPCR we studied 52 small samples taken by anatomically precise laser capture from within the core and shell SCN regions, and taken at time points with and without phase resetting light exposure. The results show striking regional differences in light response to be present in the mouse SCN. By using network-based analyses, we are able to establish a highly specific multigenic correlation between genes expressed in response to light at night and genes normally activated during the day. The light pulse triggers a complex and highly coordinated network of gene regulation. The largest differences marking neuroanatomical location are in transmitter receptors, and the largest time-dependent differences occur in clock-related genes. Nighttime phase resetting appears to recruit transcriptional regulatory processes normally active in the day. This program, or mechanism, causes the pattern of core region gene expression to transiently shift to become more like that of the shell region.	[Zhu, Haisun; Vadigepalli, Rajanikanth; Rafferty, Rachel; Gonye, Gregory E.; Schwaber, James S.] Thomas Jefferson Univ, Daniel Baugh Inst, Philadelphia, PA 19107 USA; [Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhu, HS (corresponding author), Thomas Jefferson Univ, Daniel Baugh Inst, Philadelphia, PA 19107 USA.	james.schwaber@jefferson.edu		Weaver, David/0000-0001-7941-6719; Vadigepalli, Rajanikanth/0000-0002-8405-1037; schwaber, james/0000-0003-0598-7345	National Institutes of Health [R01GM076495, R01GM083108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083108, R01GM076495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM076495 and R01GM083108. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2007, J BIOL RHYTHM, V22, P14, DOI 10.1177/0748730406296319; Araki R, 2006, BRAIN RES, V1098, P9, DOI 10.1016/j.brainres.2006.04.096; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; Bannert N, 1999, P NATL ACAD SCI USA, V96, P1541, DOI 10.1073/pnas.96.4.1541; Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Clarke C, 2011, J BIOTECHNOL, V155, P350, DOI 10.1016/j.jbiotec.2011.07.011; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding JM, 1997, J NEUROSCI, V17, P667; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; EARNEST DJ, 1990, EXP NEUROL, V109, P353, DOI 10.1016/S0014-4886(05)80027-5; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Kang HS, 2008, J MOL BIOL, V377, P636, DOI 10.1016/j.jmb.2008.01.054; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Porterfield VM, 2009, NEUROSCI LETT, V463, P70, DOI 10.1016/j.neulet.2009.07.066; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1992, MOL BRAIN RES, V14, P124, DOI 10.1016/0169-328X(92)90019-8; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tanaka M, 1997, NEUROREPORT, V8, P2187, DOI 10.1097/00001756-199707070-00020; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; UHL GR, 1986, SCIENCE, V232, P390, DOI 10.1126/science.3961487; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Welsh DK, 2007, J BIOL RHYTHM, V22, P26, DOI 10.1177/0748730406297067; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	61	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37833	10.1371/journal.pone.0037833	http://dx.doi.org/10.1371/journal.pone.0037833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662235	Green Published, gold			2022-12-25	WOS:000305342300125
J	Kubo, M; Li, TS; Kurazumi, H; Takemoto, Y; Ohshima, M; Yamamoto, Y; Nishimoto, A; Mikamo, A; Fujimoto, M; Nakai, A; Hamano, K				Kubo, Masayuki; Li, Tao-Sheng; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ohshima, Mako; Yamamoto, Yumi; Nishimoto, Arata; Mikamo, Akihito; Fujimoto, Mitsuaki; Nakai, Akira; Hamano, Kimikazu			Heat Shock Factor 1 Contributes to Ischemia-Induced Angiogenesis by Regulating the Mobilization and Recruitment of Bone Marrow Stem/Progenitor Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; TRANSCRIPTION FACTOR-1; ISCHEMIA/REPERFUSION INJURY; THERAPEUTIC ANGIOGENESIS; PROTEOTOXIC STRESS; HINDLIMB ISCHEMIA; STEM-CELLS; NEOVASCULARIZATION; POTENCY; DISEASE	Bone marrow (BM)-derived stem/progenitor cells play an important role in ischemia-induced angiogenesis in cardiovascular diseases. Heat shock factor 1 (HSF1) is known to be induced in response to hypoxia and ischemia. We examined whether HSF1 contributes to ischemia-induced angiogenesis through the mobilization and recruitment of BM-derived stem/progenitor cells using HSF1-knockout (KO) mice. After the induction of ischemia, blood flow and microvessel density in the ischemic hindlimb were significantly lower in the HSF1-KO mice than in the wild-type (WT) mice. The mobilization of BM-derived Sca-1- and c-kit-positive cells in peripheral blood after ischemia was significantly lower in the HSF1-KO mice than in the WT mice. BM stem/progenitor cells from HSF1-KO mice showed a significant decrease in their recruitment to ischemic tissue and in migration, adhesion, and survival when compared with WT mice. Blood flow recovery in the ischemic hindlimb significantly decreased in WT mice receiving BM reconstitution with donor cells from HSF1-KO mice. Conversely, blood flow recovery in the ischemic hindlimb significantly increased in HSF1-KO mice receiving BM reconstitution with donor cells from WT mice. These findings suggest that HSF1 contributes to ischemia-induced angiogenesis by regulating the mobilization and recruitment of BM-derived stem/progenitor cells.	[Kubo, Masayuki; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ohshima, Mako; Yamamoto, Yumi; Nishimoto, Arata; Mikamo, Akihito; Hamano, Kimikazu] Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Fujimoto, Mitsuaki; Nakai, Akira] Yamaguchi Univ, Dept Biochem & Mol Biol, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University; Nagasaki University; Yamaguchi University	Kubo, M (corresponding author), Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Ube, Yamaguchi 755, Japan.	litaoshe@nagasaki-u.ac.jp; kimikazu@yamaguchi-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Yamaguchi University Research Project on STRESS	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi University Research Project on STRESS	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Yamaguchi University Research Project on STRESS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e3; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kubo M, 2008, AM J PHYSIOL-HEART C, V294, pH590, DOI 10.1152/ajpheart.00856.2007; Kubo M, 2007, AM J PHYSIOL-HEART C, V292, pH2582, DOI 10.1152/ajpheart.00786.2006; Kubo M, 2012, CIRC J, V76, P986, DOI 10.1253/circj.CJ-11-0605; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakai A, 2009, BMB REP, V42, P631, DOI 10.5483/BMBRep.2009.42.10.631; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pfosser A, 2005, CARDIOVASC RES, V65, P728, DOI 10.1016/j.cardiores.2004.10.019; Qin S, 2008, CIRC J, V72, P2075, DOI 10.1253/circj.CJ-08-0392; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Tongers J, 2008, CARDIOVASC RES, V78, P294, DOI 10.1093/cvr/cvm107; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wu BJ, 2009, ARTERIOSCL THROM VAS, V29, P1537, DOI 10.1161/ATVBAHA.109.184713; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37934	10.1371/journal.pone.0037934	http://dx.doi.org/10.1371/journal.pone.0037934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655083	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900060
J	Merolla, F; Luise, C; Muller, MT; Pacelli, R; Fusco, A; Celetti, A				Merolla, Francesco; Luise, Chiara; Muller, Mark T.; Pacelli, Roberto; Fusco, Alfredo; Celetti, Angela			Loss of CCDC6, the First Identified RET Partner Gene, Affects pH2AX S139 Levels and Accelerates Mitotic Entry upon DNA Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FACTOR RECEPTOR-BETA; DEPHOSPHORYLATES GAMMA-H2AX; PROTEIN PHOSPHATASE-4; ATM ACTIVATION; THYROID-CANCER; COMPLEX; H4(D10S170); CHECKPOINTS; LEUKEMIA	CCDC6 was originally identified in chimeric genes caused by chromosomal translocation involving the RET proto-oncogene in some thryoid tumors mostly upon ionizing radiation exposure. Recognised as a pro-apoptotic phosphoprotein that negatively regulates CREB1-dependent transcription, CCDC6 is an ATM substrate that is responsive to genotoxic stress. Here we report that following genotoxic stress, loss or inactivation of CCDC6 in cancers that carry the CCDC6 fusion, accelerates the dephosphorylation of pH2AX S139, resulting in defective G2 arrest and premature mitotic entry. Moreover, we show that CCDC6 depleted cells appear to repair DNA damaged in a shorter time compared to controls, based on reporter assays in cells. High-troughput proteomic screening predicted the interaction between the CCDC6 gene product and the catalytic subunit of Serin-Threonin Protein Phosphatase 4 (PP4c) recently identified as the evolutionarily conserved pH2AX S139 phosphatase that is activated upon DNA Damage. We describe the interaction between CCDC6 and PP4c and we report the modulation of PP4c enzymatic activity in CCDC6 depleted cells. We discuss the functional significance of CCDC6-PP4c interactions and hypothesize that CCDC6 may act in the DNA Damage Response by negatively modulating PP4c activity. Overall, our data suggest that in primary tumours the loss of CCDC6 function could influence genome stability and thereby contribute to carcinogenesis.	[Merolla, Francesco; Luise, Chiara; Fusco, Alfredo; Celetti, Angela] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Merolla, Francesco; Luise, Chiara; Fusco, Alfredo] Univ Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Muller, Mark T.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Pacelli, Roberto] Univ Federico II, Dipartimento Sci Biomorfolog & Funzionali, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; State University System of Florida; University of Central Florida; University of Naples Federico II	Merolla, F (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy.	celetti@unina.it	Pacelli, Roberto/AFS-0333-2022; Celetti, Angela/AAY-7172-2020	Pacelli, Roberto/0000-0002-2048-7675; Fusco, Alfredo/0000-0003-3332-5197	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR) [20072JHN5W_003]; "Accademia Nazionale dei Lincei", Italy; UICC	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); "Accademia Nazionale dei Lincei", Italy; UICC	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) and from the Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR) (PRIN 20072JHN5W_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Professor VE Avvedimento for helpful discussions and encouragments and to Mario Berardone for artwork. Francesco Merolla is recipient of a Post-Doctoral Fellowship from "Accademia Nazionale dei Lincei", Italy. Angela Celetti kindly acknowledges UICC for the ICRETT Award in 2010.	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Dainiak N, 1997, STEM CELLS, V15, P1; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Deininger MWN, 1998, CANCER RES, V58, P421; DiBiase SJ, 1999, INT J RADIAT ONCOL, V45, P743, DOI 10.1016/S0360-3016(99)00229-1; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Freeman AK, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-27; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gandhi M, 2010, MOL CELL ENDOCRINOL, V321, P36, DOI 10.1016/j.mce.2009.09.013; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; GRIECO M, 1994, ONCOGENE, V9, P2531; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Jossart GH, 1996, CYTOGENET CELL GENET, V75, P254, DOI 10.1159/000134495; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kulkarni S, 2000, CANCER RES, V60, P3592; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nikiforov YE, 2007, ENDOCR PATHOL, V17, P307; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SPEIT G, 1995, MUTAGENESIS, V10, P555, DOI 10.1093/mutage/10.6.555; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tong Q, 1997, J BIOL CHEM, V272, P9043; Tsai IC, 2005, J CELL BIOCHEM, V94, P967, DOI 10.1002/jcb.20353; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	58	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36177	10.1371/journal.pone.0036177	http://dx.doi.org/10.1371/journal.pone.0036177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655027	Green Published, gold			2022-12-25	WOS:000305338900001
J	Lim, JC; Gruschus, JM; Ghesquiere, B; Kim, G; Piszczek, G; Tjandra, N; Levine, RL				Lim, Jung Chae; Gruschus, James M.; Ghesquiere, Bart; Kim, Geumsoo; Piszczek, Grzegorz; Tjandra, Nico; Levine, Rodney L.			Characterization and Solution Structure of Mouse Myristoylated Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. The cytosolic form of the enzyme is myristoylated, but it is not known to translocate to membranes, and the function of myristoylation is not established. We compared the biochemical and biophysical properties of myristoylated and nonmyristoylated mouse methionine sulfoxide reductase A. These were almost identical for both forms of the enzyme, except that the myristoylated form reduced methionine sulfoxide in protein much faster than the nonmyristoylated form. We determined the solution structure of the myristoylated protein and found that the myristoyl group lies in a relatively surface exposed "myristoyl nest." We propose that this structure functions to enhance protein-protein interaction.	[Lim, Jung Chae; Ghesquiere, Bart; Kim, Geumsoo; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Ghesquiere, Bart] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Piszczek, Grzegorz] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ghent University; Flanders Institute for Biotechnology (VIB)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Piszczek, Grzegorz/GYU-2029-2022; Ghesquiere, Bart/HGU-8736-2022; Levine, Rodney L/D-9885-2011	Ghesquiere, Bart/0000-0003-1547-1705; 	Intramural Research Program of the National Institutes of Health through the NHLBI; fellowship from the Fund for Scientific Research, Flanders; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIAHL001048, ZIAHL000225] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health through the NHLBI; fellowship from the Fund for Scientific Research, Flanders; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through the NHLBI. This work was also supported by a fellowship from the Fund for Scientific Research, Flanders (to B. G.).	Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Morgan CR, 2011, BIOCHEMISTRY-US, V50, P3394, DOI 10.1021/bi200197e; Pankhurst G, 2003, J LIPID RES, V44, P349, DOI 10.1194/jlr.M200256-JLR200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P3; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zhao H, 2011, AM J PHYSIOL-HEART C, V301, pH1513, DOI 10.1152/ajpheart.00441.2011; Zhao H, 2010, FREE RADICAL BIO MED, V49, P641, DOI 10.1016/j.freeradbiomed.2010.05.017; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	29	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25589	25595		10.1074/jbc.M112.368936	http://dx.doi.org/10.1074/jbc.M112.368936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661718	hybrid, Green Published			2022-12-25	WOS:000306651700066
J	Zhou, L; Wang, LJ; Lu, LN; Jiang, PY; Sun, H; Wang, HT				Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating			A Novel Target of MicroRNA-29, Ring1 and YY1-binding Protein (Rybp), Negatively Regulates Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; POLYCOMB; YY1; COMPLEXES; MUSCLE; DOMAIN; DIFFERENTIATION; COMPONENTS; MECHANISM	Skeletal muscle cell differentiation (myogenesis) is a process orchestrated by a complex network involving transcription factors, epigenetic regulators, and microRNAs. Previous studies identified miR-29 as a pro-myogenic factor that interacts with components of Polycomb repressive complex, YY1 and Ezh2. In a genome-wide survey of miR-29-mediated transcriptome changes in C2C12 myoblasts, many epigenetic factors were found to be down-regulated by miR-29. Among them, Rybp was shown to be a direct target of miR-29 through binding to its 3' UTR. Functional studies demonstrated that Rybp is down-regulated during myogenesis and acts as a negative regulator of skeletal myogenesis both in vitro during C2C12 differentiation and in vivo in injury-induced muscle regeneration. Furthermore, we found that Rybp and YY1 co-occupy several myogenic loci, including miR-29 itself, to silence their expression, thus forming a Rybp-miR-29 feedback loop. Rybp overexpression was found to enhance the enrichment of Ezh2 and trimethylation of H3K27 at target loci, suggesting it may facilitate the recruitment or stabilization of the Polycomb repressive complex. Collectively, our results identify Rybp as a novel regulator of myogenesis that co-acts with YY1 to silence miR-29 and other myogenic loci.	[Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Zhou, Liang; Wang, Lijun; Wang, Huating] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Lu, Leina; Jiang, Peiyong; Sun, Hao] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, H (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci 306G, Shatin, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk; huating.wang@cuhk.edu.hk	Zhou, Liang/P-4174-2015; Sun, Hao/T-5576-2019; Wang, Huating/C-6719-2014; Sun, Hao/J-9964-2013; JIANG, Peiyong/AAZ-9898-2020; sun, hao/GRS-7732-2022	Zhou, Liang/0000-0001-5973-7873; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China; Chinese University of Hong Kong (CUHK) [476309, 476310, 473211]; CUHK Grants [2041492, 2041662, 2041474]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); CUHK Grants	The work was supported by General Research Funds from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China, Chinese University of Hong Kong (CUHK) 476309 and 476310 (to H.W.) and 473211 (to H.S.), CUHK Grants 2041492 and 2041662 (to H.W.), and CUHK Grant 2041474 (to H.S.).	Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Enright AJ, 2004, GENOME BIOL, V5; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766	35	76	82	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25255	25265		10.1074/jbc.M112.357053	http://dx.doi.org/10.1074/jbc.M112.357053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661705	hybrid, Green Published			2022-12-25	WOS:000306651700034
J	Chami, L; Buggia-Prevot, V; Duplan, E; Delprete, D; Chami, M; Peyron, JF; Checler, F				Chami, Linda; Buggia-Prevot, Virginie; Duplan, Eric; Delprete, Dolores; Chami, Mounia; Peyron, Jean-Francois; Checler, Frederic			Nuclear Factor-kappa B Regulates beta APP and beta- and gamma-Secretases Differently at Physiological and Supraphysiological A beta Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PRESENILIN-1 EXPRESSION; CELL BIOLOGY; IN-VITRO; P53; INHIBITION; ACTIVATION; PROMOTER; DEATH	Anatomical lesions in Alzheimer disease-affected brains mainly consist of senile plaques, inflammation stigmata, and oxidative stress. The nuclear factor-kappa B (NF-kappa B) is a stress-activated transcription factor that is activated around senile plaques. We have assessed whether NF-kappa B could be differentially regulated at physiological or supraphysiological levels of amyloid beta (A beta) peptides. Under these experimental conditions, we delineated the putative NF-kappa B-dependent modulation of all cellular participants in A beta production, namely its precursor beta APP (beta-amyloid precursor protein) and the beta- and gamma-secretases, the two enzymatic machines involved in A beta genesis. Under physiological conditions, NF-kappa B lowers the transcriptional activity of the promoters of beta APP, beta-secretase (beta-site APP-cleaving enzyme 1, BACE1), and of the four protein components (Aph-1, Pen-2, nicastrin, presenilin-1, or presenilin-2) of the gamma-secretase in HEK293 cells. This was accompanied by a reduction of both protein levels and enzymatic activities, thereby ultimately yielding lower amounts of A beta and AICD (APP intracellular domain). In stably transfected Swedish beta APP-expressing HEK293 cells triggering supraphysiological concentrations of A beta peptides, NF-kappa B activates the transcription of beta APP, BACE1, and some of the gamma-secretase members and increases protein expression and enzymatic activities, resulting in enhanced A beta production. Our pharmacological approach using distinct NF-kappa B kinase modulators indicates that both NF-kappa B canonical and alternative pathways are involved in the control of A beta production. Overall, our data demonstrate that under physiological conditions, NF-kappa B triggers a repressive effect on A beta production that contributes to maintaining its homeostasis, while NF-kappa B participates in a degenerative cycle where A beta would feed its own production under pathological conditions.	[Chami, Linda; Buggia-Prevot, Virginie; Duplan, Eric; Delprete, Dolores; Chami, Mounia; Checler, Frederic] CNRS UNSA, Equipe Labellisee Fdn Rech Med & Excellence Lab D, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Peyron, Jean-Francois] INSERM, Ctr Mediterraneen Med Mol, UMR UNS U895, F-06204 Nice 3, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Checler, F (corresponding author), CNRS UNSA, Equipe Labellisee Fdn Rech Med & Excellence Lab D, Inst Pharmacol Mol & Cellulaire, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Peyron, Jean-Francois/M-5682-2016; Duplan, Eric/AAK-8224-2020; Chami, Mounia/S-6471-2019; Jean-Francois, Peyron/AAA-9496-2022; Checler, Frederic/C-1241-2009	Peyron, Jean-Francois/0000-0001-6113-916X; Duplan, Eric/0000-0002-1348-1507; Chami, Mounia/0000-0003-1498-7187; Jean-Francois, Peyron/0000-0001-6113-916X; Checler, Frederic/0000-0003-2098-1750; Gary-Chami, Linda/0000-0001-9607-2807	Fondation pour la Recherche Medicale (FRM); Conseil General des Alpes Maritimes; Ministere de l'enseignement superieur et de la Recherche; LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Ministere de l'enseignement superieur et de la Recherche; LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease)	This work was supported by the Fondation pour la Recherche Medicale (FRM), by the Conseil General des Alpes Maritimes, and by the Ministere de l'enseignement superieur et de la Recherche. This work has been developed and supported through the LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease).	Ait-Ghezala G, 2007, EUR J NEUROSCI, V25, P1685, DOI 10.1111/j.1460-9568.2007.05424.x; Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Arevalo MA, 2009, J NEUROCHEM, V111, P1425, DOI 10.1111/j.1471-4159.2009.06412.x; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Checler F, 2010, NEURODEGENER DIS, V7, P50, DOI 10.1159/000283483; Chen CH, 2011, INT J NEUROPSYCHOPH, V18, P1, DOI DOI 10.1017/S1461145711000149; Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151; Choi DY, 2012, NEUROCHEM INT, V60, P68, DOI 10.1016/j.neuint.2011.11.005; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Dunys J, 2009, J CELL SCI, V122, P4003, DOI 10.1242/jcs.051169; GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guglielmotto M., 2010, NEUROBIOL AGING, V33, P113; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Heber S, 2000, J NEUROSCI, V20, P7951; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785; Lee YJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-132; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Martin AG, 2010, CELL CYCLE, V9, P3131, DOI 10.4161/cc.9.16.12780; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pandey NR, 2009, NEUROSCIENCE, V164, P1744, DOI 10.1016/j.neuroscience.2009.09.062; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Paris D, 2011, BIOINFORMATION, V6, P229, DOI 10.6026/97320630006229; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Pastorcic M, 2000, J BIOL CHEM, V275, P34938, DOI 10.1074/jbc.M005411200; Pennypacker KR, 1998, MOL BRAIN RES, V56, P57, DOI 10.1016/S0169-328X(98)00028-X; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun X., 2012, J NEUROCHEM S1, P62; Sun X., 2012, J NEUROCHEM S1, P120; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tamagno E., 2011, NEUROTOX RE IN PRESS; Terai K, 1996, BRAIN RES, V735, P159; TERRY RD, 1980, ANNU REV NEUROSCI, V3, P77, DOI 10.1146/annurev.ne.03.030180.000453; Tomita S, 2000, J BIOL CHEM, V275, P13056, DOI 10.1074/jbc.C000019200; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; WU HY, 1994, J BIOL CHEM, V269, P20067	64	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24573	24584		10.1074/jbc.M111.333054	http://dx.doi.org/10.1074/jbc.M111.333054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654105	Green Published, hybrid			2022-12-25	WOS:000306651100050
J	Capsoni, S; Marinelli, S; Ceci, M; Vignone, D; Amato, G; Malerba, F; Paoletti, F; Meli, G; Viegi, A; Pavone, F; Cattaneo, A				Capsoni, Simona; Marinelli, Sara; Ceci, Marcello; Vignone, Domenico; Amato, Gianluca; Malerba, Francesca; Paoletti, Francesca; Meli, Giovanni; Viegi, Alessandro; Pavone, Flaminia; Cattaneo, Antonino			Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACTOR GENE-THERAPY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSGENIC MICE; CRYSTAL-STRUCTURE; SENSORY NEURONS; NGF; TRKA; RECEPTOR	Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease (AD) treatment but the clinical application is hindered by its potent pro-nociceptive activity. Thus, to reduce systemic exposure that would induce pain, in recent clinical studies NGF was administered through an invasive intracerebral gene-therapy approach. Our group demonstrated the feasibility of a non-invasive intranasal delivery of NGF in a mouse model of neurodegeneration. NGF therapeutic window could be further increased if its nociceptive effects could be avoided altogether. In this study we exploit forms of NGF, mutated at residue R100, inspired by the human genetic disease HSAN V (Hereditary Sensory Autonomic Neuropathy Type V), which would allow increasing the dose of NGF without triggering pain. We show that "painless" hNGF displays full neurotrophic and anti-amyloidogenic activities in neuronal cultures, and a reduced nociceptive activity in vivo. When administered intranasally to APPxPS1 mice (n = 8), hNGFP61S/R100E prevents the progress of neurodegeneration and of behavioral deficits. These results demonstrate the in vivo neuroprotective and anti-amyloidogenic properties of hNGFR100 mutants and provide a rational basis for the development of "painless" hNGF variants as a new generation of therapeutics for neurodegenerative diseases.	[Capsoni, Simona; Ceci, Marcello; Vignone, Domenico; Amato, Gianluca; Malerba, Francesca; Paoletti, Francesca; Meli, Giovanni; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Capsoni, Simona; Malerba, Francesca; Viegi, Alessandro; Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy; [Marinelli, Sara; Pavone, Flaminia] CNR, Inst Neurosci, Rome, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR)	Capsoni, S (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Cattaneo, Antonino/K-4471-2016; Marinelli, Sara/L-7738-2019; Cattaneo, Antonino/AAA-7252-2019	Cattaneo, Antonino/0000-0002-6975-8923; Marinelli, Sara/0000-0001-5393-4796; Pavone, Flaminia/0000-0001-5189-2748; Capsoni, Simona/0000-0003-2670-8237; Ceci, Marcello/0000-0002-5066-1590; Meli, Giovanni/0000-0002-4633-364X	Ministero Universita' e Ricerca [RBAP10L8TY]; Italian Institute of Technology (EBRI/IIT project)	Ministero Universita' e Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Institute of Technology (EBRI/IIT project)	The work was supported by: Ministero Universita' e Ricerca (Project RBAP10L8TY) and Italian Institute of Technology (EBRI/IIT project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Aguado F, 1998, ACTA NEUROPATHOL, V96, P495, DOI 10.1007/s004010050924; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Capsoni S, 2002, MOL CELL NEUROSCI, V21, P15, DOI 10.1006/mcne.2002.1163; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; Capsoni S, 2009, J ALZHEIMERS DIS, V16, P371, DOI 10.3233/JAD-2009-0953; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; CHEVALIER S, 1994, BLOOD, V83, P1479; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Delcroix JD, 2004, PROG BRAIN RES, V146, P3, DOI 10.1016/S0079-6123(03)46001-69; Doya H, 2005, BIOCHEM BIOPH RES CO, V335, P132, DOI 10.1016/j.bbrc.2005.07.055; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Heese K, 1998, J NEUROCHEM, V70, P699; Heikkinen T, 2004, EXP NEUROL, V187, P105, DOI 10.1016/j.expneurol.2004.01.015; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; JUNIER MP, 1994, MOL BRAIN RES, V24, P247, DOI 10.1016/0169-328X(94)90138-4; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Malerba F, 2011, EXPERT OPIN DRUG DEL, V8, P1277, DOI 10.1517/17425247.2011.588204; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Oderfeld-Nowak B, 2003, NEUROSCIENCE, V120, P31, DOI 10.1016/S0306-4522(03)00289-6; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; POLUHA W, 1995, ONCOGENE, V10, P185; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ruberti F, 2000, J NEUROSCI, V20, P2589; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wilson SG, 2003, J PHARMACOL EXP THER, V304, P547, DOI 10.1124/jpet.102.041889; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002	74	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37555	10.1371/journal.pone.0037555	http://dx.doi.org/10.1371/journal.pone.0037555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666365	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400032
J	Lostal, W; Bartoli, M; Roudaut, C; Bourg, N; Krahn, M; Pryadkina, M; Borel, P; Suel, L; Roche, JA; Stockholm, D; Bloch, RJ; Levy, N; Bashir, R; Richard, I				Lostal, William; Bartoli, Marc; Roudaut, Carinne; Bourg, Nathalie; Krahn, Martin; Pryadkina, Marina; Borel, Perrine; Suel, Laurence; Roche, Joseph A.; Stockholm, Daniel; Bloch, Robert J.; Levy, Nicolas; Bashir, Rumaisa; Richard, Isabelle			Lack of Correlation between Outcomes of Membrane Repair Assay and Correction of Dystrophic Changes in Experimental Therapeutic Strategy in Dysferlinopathy	PLOS ONE			English	Article							NULL SKELETAL-MUSCLE; MYOBLAST FUSION; T-TUBULE; RECOVERY; PROTEIN; GENE; DEFICIENCY; MYOFERLIN; INTERACTS; GROWTH	Mutations in the dysferlin gene are the cause of Limb-girdle Muscular Dystrophy type 2B and Miyoshi Myopathy. The dysferlin protein has been implicated in sarcolemmal resealing, leading to the idea that the pathophysiology of dysferlin deficiencies is due to a deficit in membrane repair. Here, we show using two different approaches that fullfiling membrane repair as asseyed by laser wounding assay is not sufficient for alleviating the dysferlin deficient pathology. First, we generated a transgenic mouse overexpressing myoferlin to test the hypothesis that myoferlin, which is homologous to dysferlin, can compensate for the absence of dysferlin. The myoferlin overexpressors show no skeletal muscle abnormalities, and crossing them with a dysferlin-deficient model rescues the membrane fusion defect present in dysferlin-deficient mice in vitro. However, myoferlin overexpression does not correct muscle histology in vivo. Second, we report that AAV-mediated transfer of a minidysferlin, previously shown to correct the membrane repair deficit in vitro, also fails to improve muscle histology. Furthermore, neither myoferlin nor the minidysferlin prevented myofiber degeneration following eccentric exercise. Our data suggest that the pathogenicity of dysferlin deficiency is not solely related to impairment in sarcolemmal repair and highlight the care needed in selecting assays to assess potential therapies for dysferlinopathies.	[Lostal, William; Roudaut, Carinne; Bourg, Nathalie; Pryadkina, Marina; Borel, Perrine; Suel, Laurence; Stockholm, Daniel; Richard, Isabelle] Genethon, CNRS, UMR8587, Evry, France; [Bartoli, Marc; Krahn, Martin; Levy, Nicolas] Univ Mediterranee, Hop Enfants Timone, AP HM, Dept Med Genet, Marseille, France; [Bartoli, Marc; Krahn, Martin; Levy, Nicolas] Univ Mediterranee, Inserm, UMR S 910, Fac Med Timone, Marseille, France; [Roche, Joseph A.; Bloch, Robert J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Bashir, Rumaisa] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 1TA, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University System of Maryland; University of Maryland Baltimore; Durham University	Lostal, W (corresponding author), Genethon, CNRS, UMR8587, Evry, France.	richard@genethon.fr	Richard, isabelle/J-8298-2013; Stockholm, Daniel/J-7912-2013; Bartoli, Marc/O-8893-2016; LEVY, Nicolas/J-1632-2014; Bartoli, Marc/Q-5979-2017; Lostal, William/Q-1079-2018	Bartoli, Marc/0000-0003-3339-9858; LEVY, Nicolas/0000-0001-5171-6365; Bartoli, Marc/0000-0003-3339-9858; Roche, Joseph/0000-0002-9497-6850; Lostal, William/0000-0003-1014-1950	AFM; jain Foundation; Jain Foundation Inc.	AFM(Association Francaise contre les Myopathies); jain Foundation; Jain Foundation Inc.	This work was supported by grants from the AFM (www.AFM-telethon.fr) and the jain Foundation (www.jain-foundation.org). WL was the recipient of the Jain Foundation Inc. fellowship. The funders had no role in study design, data collection and analysis or decision to publish. Regarding the preparation of the manuscript, one person of the foundation served as reader for english editing.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P889, DOI 10.1038/ejhg.2010.4; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Cacciottolo M, 2011, J BIOL CHEM; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Demonbreun AR, 2010, FASEB J; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Glover LE, 2010, ANN NEUROL, V67, P384, DOI 10.1002/ana.21926; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Humphrey GW, 2012, EXP CELL RES, V318, P127, DOI 10.1016/j.yexcr.2011.10.004; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Lovering RM, 2007, ARCH PHYS MED REHAB, V88, P617, DOI 10.1016/j.apmr.2007.02.010; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Millay DP, 2009, AM J PATHOL, V175, P1817, DOI 10.2353/ajpath.2009.090107; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Posey AD, 2011, CURR TOP DEV BIOL, V96, P203, DOI 10.1016/B978-0-12-385940-2.00008-5; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roche JA, 2008, NEUROREPORT, V19, P1579, DOI 10.1097/WNR.0b013e328311ca35; Roche JA, 2010, AM J PHYSIOL-CELL PH, V298, pC298, DOI 10.1152/ajpcell.00122.2009; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Wein N, 2010, NEUROMUSCULAR DISORD, V20, P57, DOI 10.1016/j.nmd.2009.08.004; Wenzel K, 2005, J IMMUNOL, V175, P6219, DOI 10.4049/jimmunol.175.9.6219	40	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38036	10.1371/journal.pone.0038036	http://dx.doi.org/10.1371/journal.pone.0038036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666441	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305349600057
J	Sama, DM; Abdul, HM; Furman, JL; Artiushin, IA; Szymkowski, DE; Scheff, SW; Norris, CM				Sama, Diana M.; Abdul, Hafiz Mohmmad; Furman, Jennifer L.; Artiushin, Irina A.; Szymkowski, David E.; Scheff, Stephen W.; Norris, Christopher M.			Inhibition of Soluble Tumor Necrosis Factor Ameliorates Synaptic Alterations and Ca2+ Dysregulation in Aged Rats	PLOS ONE			English	Article							LONG-TERM DEPRESSION; NF-KAPPA-B; SUBUNIT MESSENGER-RNA; CALCIUM-CHANNEL ACTIVITY; CYTOKINE UP-REGULATION; FACTOR-ALPHA; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TNF-ALPHA; AREA CA1	The role of tumor necrosis factor alpha (TNF) in neural function has been investigated extensively in several neurodegenerative conditions, but rarely in brain aging, where cognitive and physiologic changes are milder and more variable. Here, we show that protein levels for TNF receptor 1 (TNFR1) are significantly elevated in the hippocampus relative to TNF receptor 2 (TNFR2) in aged (22 months) but not young adult (6 months) Fischer 344 rats. To determine if altered TNF/TNFR1 interactions contribute to key brain aging biomarkers, aged rats received chronic (4-6 week) intracranial infusions of XPro1595: a soluble dominant negative TNF that preferentially inhibits TNFR1 signaling. Aged rats treated with XPro1595 showed improved Morris Water Maze performance, reduced microglial activation, reduced susceptibility to hippocampal long-term depression, increased protein levels for the GluR1 type glutamate receptor, and lower L-type voltage sensitive Ca2+ channel (VSCC) activity in hippocampal CA1 neurons. The results suggest that diverse functional changes associated with brain aging may arise, in part, from selective alterations in TNF signaling.	[Sama, Diana M.] Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA; [Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Scheff, Stephen W.; Norris, Christopher M.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Szymkowski, David E.] Xencor Inc, Monrovia, CA USA	University of Kentucky; University of Kentucky	Sama, DM (corresponding author), Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA.	cnorr2@uky.edu		Szymkowski, David/0000-0002-8934-7902	National Institutes of Health [AG027297, AG024190, AG000242]; KSCHIRT award; NATIONAL INSTITUTE ON AGING [T32AG000242, R01AG027297, K01AG024190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSCHIRT award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: AG027297, AG024190, AG000242, and a KSCHIRT award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2000, SYNAPSE, V35, P151; Aloe L, 1999, CYTOKINE, V11, P45, DOI 10.1006/cyto.1998.0397; BARNES CA, 1992, HIPPOCAMPUS, V2, P457, DOI 10.1002/hipo.450020413; Barnum CJ, 2011, EXP NEUROL, V229, P198, DOI 10.1016/j.expneurol.2011.02.016; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Billard JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009843; Blalock EM, 2001, EPILEPSY RES, V43, P211, DOI 10.1016/S0920-1211(00)00199-6; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Campbell LW, 1996, J NEUROSCI, V16, P6286; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Chen KC, 2000, P NATL ACAD SCI USA, V97, P4357, DOI 10.1073/pnas.070056097; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; DISTERHOFT JF, 1994, ANN NY ACAD SCI, V747, P382; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; Furman JL, 2010, NEUROSCI LETT, V469, P365, DOI 10.1016/j.neulet.2009.12.029; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Gant JC, 2011, J NEUROSCI, V31, P1693, DOI 10.1523/JNEUROSCI.4805-10.2011; Gavilan MP, 2007, J NEUROCHEM, V103, P984, DOI 10.1111/j.1471-4159.2007.04787.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Gray R, 1990, PREPARATIONS VERTEBR, P3; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Herman JP, 1998, NEUROBIOL AGING, V19, P581, DOI 10.1016/S0197-4580(98)00099-2; Hsu KS, 2002, HIPPOCAMPUS, V12, P787, DOI 10.1002/hipo.10032; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Jouvenceau A, 2006, J PHYSIOL-PARIS, V99, P154, DOI 10.1016/j.jphysparis.2005.12.009; Kantrow SP, 2000, FEBS LETT, V483, P119, DOI 10.1016/S0014-5793(00)02083-4; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; Kumar A, 2007, J NEUROPHYSIOL, V98, P2729, DOI 10.1152/jn.00514.2007; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Macdonald NJ, 2003, AGING CELL, V2, P245, DOI 10.1046/j.1474-9728.2003.00059.x; Macdonald NJ, 2000, J ANAT, V197, P543, DOI 10.1046/j.1469-7580.2000.19740543.x; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; McAlpine FE, 2008, J INFLAMM RES, V1, P29; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; MCMONAGLESTRUCKO K, 1993, PHARMACOL BIOCHEM BE, V44, P827, DOI 10.1016/0091-3057(93)90013-J; MOYER JR, 1994, HIPPOCAMPUS, V4, P11, DOI 10.1002/hipo.450040104; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 2010, NEUROBIOL AGING, V31, P328, DOI 10.1016/j.neurobiolaging.2008.03.026; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Norris CM, 1996, J NEUROSCI, V16, P5382; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; Paredes D, 2010, AGING DIS, V1, P191; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Sukhareva M, 2002, J NEUROPHYSIOL, V88, P1077, DOI 10.1152/jn.2002.88.3.1077; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387	95	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38170	10.1371/journal.pone.0038170	http://dx.doi.org/10.1371/journal.pone.0038170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666474	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600067
J	Henze, J; Muhlenberg, T; Simon, S; Grabellus, F; Rubin, B; Taeger, G; Schuler, M; Treckmann, J; Debiec-Rychter, M; Taguchi, T; Fletcher, JA; Bauer, S				Henze, Joern; Muehlenberg, Thomas; Simon, Susanne; Grabellus, Florian; Rubin, Brian; Taeger, Georg; Schuler, Martin; Treckmann, Juergen; Debiec-Rychter, Maria; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian			p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							GENE AMPLIFICATION; IMATINIB MESYLATE; IN-VIVO; C-KIT; APOPTOSIS; ACTIVATION; MUTATIONS; MDM2; HEAT-SHOCK-PROTEIN-90; INHIBITION	The KIT-inhibitor imatinib mesylate (IM) has greatly improved the treatment of metastatic gastrointestinal stromal tumors (GIST). IM exhibits strong antiproliferative effects but fails to induce sufficient levels of apoptosis resulting in low pathologic complete remission rates and a high rate of secondary progression in the metastatic setting. Upregulation of p53 by MDM2 inhibitors has been shown to induce apoptosis in p53 wildtype tumors. Analyzing a series of 62 mostly untreated, localized and metastatic GIST we detected a low rate (3%) of inactivating p53 mutations, thus providing a rationale for further exploration of p53-directed therapeutic strategies. To this end, we studied nutlin-3, an inhibitor of the p53 antagonist MDM2, and RITA, a putative p53 activator, in GIST cell lines. Nutlin-3 effectively induced p53 at therapeutically relevant levels, which resulted in moderate antiproliferative effects and cell cycle arrest in p53 wildtype GIST cell lines GIST430, GIST48 and GIST48B. P53 reactivation substantially improved the apoptotic response after effective KIT inhibition with sunitinib and 17-AAG in IM-resistant cell lines. The commonly used imatinib-sensitive cell lines GIST882 and GIST-T1 were shown to harbor defective p53 and therefore failed to respond to nutlin-3 treatment. RITA induced p53 in GIST48B, followed by antiproliferative effects and a strong induction of apoptosis. Surprisingly, GIST-T1 was also highly sensitive to RITA despite lacking functional p53. This suggested a more complex, p53-independent mechanism of action for the latter compound. No antagonistic effects from p53-activating drugs were seen with any drug combination. Our data provide first evidence that modulation of the MDM2/p53 pathway may be therapeutically useful to improve the apoptotic response of KIT-inhibitory drugs in the treatment of naive GIST, with p53 mutation status being a predictive factor of response.	[Henze, Joern; Muehlenberg, Thomas; Simon, Susanne; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Sch Med, Dept Med Oncol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Grabellus, Florian] Univ Duisburg Essen, Sch Med, Dept Pathol & Neuropathol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Taeger, Georg] Univ Duisburg Essen, Sch Med, Dept Trauma & Orthoped Surg, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Treckmann, Juergen] Univ Duisburg Essen, Sch Med, Dept Visceral & Transplant Surg, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Rubin, Brian] Cleveland Clin, Taussig Canc Ctr, Dept Mol Genet & Anat Pathol, Lerner Res Inst, Cleveland, OH 44106 USA; [Debiec-Rychter, Maria] Univ Leuven, Dept Human Genet, Louvain, Belgium; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Nankoku, Kochi, Japan; [Fletcher, Jonathan A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Cleveland Clinic Foundation; KU Leuven; Kochi University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Henze, J (corresponding author), Univ Duisburg Essen, Sch Med, Dept Med Oncol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany.	sebastian.bauer@uk-essen.de	Mühlenberg, Thomas/J-8423-2019; Bauer, Sebastian/HHR-9319-2022; Bauer, Sebastian/D-8120-2012	Mühlenberg, Thomas/0000-0002-2078-8857; Bauer, Sebastian/0000-0001-5949-8120	Max-Eder Fellowship from Deutsche Krebshilfe; Life Raft Group Research Initiative	Max-Eder Fellowship from Deutsche Krebshilfe; Life Raft Group Research Initiative	Grant support was received from Max-Eder Fellowship from the Deutsche Krebshilfe (SB) and Life Raft Group Research Initiative (SB, BR, JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Bauer S, 2005, INT J CANCER, V117, P316, DOI 10.1002/ijc.21164; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Choi Y, 2004, STEM CELLS, V22, P1070, DOI 10.1634/stemcells.22-6-1070; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 2001, J PATHOL, V193, P505, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E; Jackson SP, 2009, CANCER CELL, P171, DOI [10.1016/j.ccr.2009.01.019, DOI 10.1016/J.CCR.2009.01.019]; Karvinen J, 2002, J BIOMOL SCREEN, V7, P223, DOI 10.1177/108705710200700306; Kurosu T, 2010, APOPTOSIS, V15, P608, DOI 10.1007/s10495-010-0457-0; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohayon T, 2005, BRIT J CANCER, V92, P1144, DOI 10.1038/sj.bjc.6602451; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Romeo S, 2009, CLIN CANCER RES, V15, P4191, DOI 10.1158/1078-0432.CCR-08-3297; Rubin BP, 2001, CANCER RES, V61, P8118; Schneider-Stock R, 2005, CLIN CANCER RES, V11, P638; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Tornillo L, 2005, LAB INVEST, V85, P921, DOI 10.1038/labinvest.3700284; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211; Xia M, 2011, ONCOGENE, V30, P346, DOI 10.1038/onc.2010.413; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; Zhao CY, 2010, CELL CYCLE, V9, P1847, DOI 10.4161/cc.9.9.11545	38	42	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37776	10.1371/journal.pone.0037776	http://dx.doi.org/10.1371/journal.pone.0037776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662219	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300109
J	Maly, IV				Maly, Ivan V.			Efficiency of Organelle Capture by Microtubules as a Function of Centrosome Nucleation Capacity: General Theory and the Special Case of Polyspermia	PLOS ONE			English	Article							DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; TRANSITION FREQUENCIES; TUBULIN; PHOSPHORYLATION; ESTABLISHMENT; TRANSPORT; GROWTH; CYCLE; FERTILIZATION	Transport of organelles along microtubules is essential for the cell metabolism and morphogenesis. The presented analysis derives the probability that an organelle of a given size comes in contact with the microtubule aster. The question is asked how this measure of functionality of the microtubule aster is controlled by the centrosome. A quantitative model is developed to address this question. It is shown that for the given set of cellular parameters, such as size and total tubulin content, a centrosome nucleation capacity exists that maximizes the probability of the organelle capture. The developed general model is then applied to the capture of the female pronucleus by microtubules assembled on the sperm centrosome, following physiologically polyspermic fertilization. This application highlights an unintuitive reflection of nonlinearity of the nucleated polymerization of the cellular pool of tubulin. The prediction that the sperm centrosome should lower its nucleation capacity in the face of the competition from the other sperm is a stark illustration of the new optimality principle. Overall, the model calls attention to the capabilities of the centrosomal pathway of regulation of the transport-related functionality of the microtubule cytoskeleton. It establishes a quantitative and conceptual framework that can guide experiment design and interpretation.	Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maly, IV (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	ivanvmaly@gmail.com						Alieva I B, 1997, Membr Cell Biol, V11, P17; Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; [Anonymous], 1987, LINEAR AGGREGATION T; Borisy GG, 1999, FASEB J, V13, pS221, DOI 10.1096/fasebj.13.9002.S221; CARRE D, 1991, DEV BIOL, V147, P381, DOI 10.1016/0012-1606(91)90296-F; CARRE D, 1984, DEV BIOL, V105, P188, DOI 10.1016/0012-1606(84)90274-4; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; FREEMAN G, 1977, J EMBRYOL EXP MORPH, V42, P237; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gregoretti IV, 2006, J CELL SCI, V119, P4781, DOI 10.1242/jcs.03240; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HOULISTON E, 1993, DEVELOPMENT, V117, P75; Howell B, 1999, J CELL SCI, V112, P3713; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Komarova YA, 2002, J CELL SCI, V115, P3527; KURIYAMA R, 1981, J CELL BIOL, V91, P822, DOI 10.1083/jcb.91.3.822; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Lippincott-Schwartz Jennifer, 1993, Trends in Cell Biology, V3, P81, DOI 10.1016/0962-8924(93)90078-F; Maly IV, 2002, B MATH BIOL, V64, P213, DOI 10.1006/bulm.2001.0265; Maly IV, 2002, CELL BIOL INT, V26, P791, DOI 10.1016/S1065-6995(02)90946-7; Margolin G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041920; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1987, CELL BIOPHYS, V11, P35, DOI 10.1007/BF02797111; Mourao M, 2011, COMPUT BIOL CHEM, V35, P269, DOI 10.1016/j.compbiolchem.2011.06.002; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Oosawa F., 1975, THERMODYNAMICS POLYM; PFEFFER TA, 1976, J CELL BIOL, V69, P599, DOI 10.1083/jcb.69.3.599; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; ROUVIERE C, 1994, CELL MOTIL CYTOSKEL, V29, P301, DOI 10.1002/cm.970290403; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SCHATTEN G, 1982, INT REV CYTOL, V79, P59, DOI 10.1016/S0074-7696(08)61673-3; Smurova K. M., 2007, CELL TISSUE BIOL, V1, P225; SNYDER JA, 1975, J CELL BIOL, V67, P744, DOI 10.1083/jcb.67.3.744; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Vorob'ev I A, 2000, Ontogenez, V31, P420; Vorobjev I, 2008, CELL TISSUE BIOL, V2, P272; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	54	0	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37675	10.1371/journal.pone.0037675	http://dx.doi.org/10.1371/journal.pone.0037675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662187	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300077
J	Parachnowitsch, AL; Caruso, CM; Campbell, SA; Kessler, A				Parachnowitsch, Amy L.; Caruso, Christina M.; Campbell, Stuart A.; Kessler, Andre			Lobelia siphilitica Plants That Escape Herbivory in Time Also Have Reduced Latex Production	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FLOWERING PHENOLOGY; NATURAL-SELECTION; FLORAL TRAITS; BRASSICA-RAPA; WILD RADISH; RAPHANUS-RAPHANISTRUM; DEFENSE; RESISTANCE; FITNESS	Flowering phenology is an important determinant of a plant's reproductive success. Both assortative mating and niche construction can result in the evolution of correlations between phenology and other reproductive, functional, and life history traits. Correlations between phenology and herbivore defence traits are particularly likely because the timing of flowering can allow a plant to escape herbivory. To test whether herbivore escape and defence are correlated, we estimated phenotypic and genetic correlations between flowering phenology and latex production in greenhouse-grown Lobelia siphilitica L. (Lobeliaceae). Lobelia siphilitica plants that flower later escape herbivory by a specialist pre-dispersal seed predator, and thus should invest fewer resources in defence. Consistent with this prediction, we found that later flowering was phenotypically and genetically correlated with reduced latex production. To test whether herbivore escape and latex production were costly, we also measured four fitness correlates. Flowering phenology was negatively genetically correlated with three out of four fitness estimates, suggesting that herbivore escape can be costly. In contrast, we did not find evidence for costs of latex production. Generally, our results suggest that herbivore escape and defence traits will not evolve independently in L. siphilitica.	[Parachnowitsch, Amy L.; Campbell, Stuart A.; Kessler, Andre] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Caruso, Christina M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Campbell, Stuart A.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; University of Guelph; Cornell University	Parachnowitsch, AL (corresponding author), Uppsala Univ, Dept Plant Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden.	amyparachnowitsch@gmail.com	Kessler, Andre/C-7810-2014; Campbell, Stuart/B-1494-2012; Parachnowitsch, Amy L/H-8398-2019	Parachnowitsch, Amy L/0000-0001-9668-6593; Caruso, Christina/0000-0001-7069-9572; Kessler, Andre/0000-0002-1797-7518	Cornell University; USA National Science Foundation [NSF-DEB 0717139]; Natural Science and Engineering Research Council (NSERC) of Canada; NSERC Doctoral Fellowship	Cornell University; USA National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Fellowship	This study was funded by Cornell University and the USA National Science Foundation (NSF-DEB 0717139), as well as a Discovery grant from the Natural Science and Engineering Research Council (NSERC) of Canada to CMC and an NSERC Doctoral Fellowship to SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, EVOL ECOL RES, V7, P651; Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Agrawal AA, 2008, ENTOMOL EXP APPL, V128, P126, DOI 10.1111/j.1570-7458.2008.00690.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; AGREN J, 1993, AM NAT, V141, P338, DOI 10.1086/285477; Aizen MA, 2003, ECOLOGY, V84, P2613, DOI 10.1890/02-0521; ANDERSON DM, 1973, P ENTOMOL SOC WASH, V75, P133; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Beaudoin Yetter R, 1989, EXPRESSION MALE STER; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Bishop JG, 1998, ECOLOGY, V79, P534, DOI 10.1890/0012-9658(1998)079[0534:VIFPAI]2.0.CO;2; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Caruso CM, 2008, J EVOLUTION BIOL, V21, P1514, DOI 10.1111/j.1420-9101.2008.01610.x; Caruso CM, 2007, J EVOLUTION BIOL, V20, P1396, DOI 10.1111/j.1420-9101.2007.01361.x; Caruso CM, 2003, OECOLOGIA, V135, P524, DOI 10.1007/s00442-003-1199-2; CONNER J, 1993, EVOLUTION, V47, P704, DOI 10.1111/j.1558-5646.1993.tb02128.x; Conner JK, 2003, EVOLUTION, V57, P487, DOI 10.1111/j.0014-3820.2003.tb01540.x; Donohue K, 2003, INT J PLANT SCI, V164, pS79, DOI 10.1086/368397; Dudle DA, 2001, HEREDITY, V86, P265, DOI 10.1046/j.1365-2540.2001.00833.x; Dussourd DE, 2003, J CHEM ECOL, V29, P2023, DOI 10.1023/A:1025630301162; Ehrlen J, 2009, AM NAT, V173, P819, DOI 10.1086/598492; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; ENGLISHLOEB GM, 1992, OECOLOGIA, V89, P588, DOI 10.1007/BF00317168; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fornoni J, 2003, EVOL ECOL RES, V5, P1049; Franks SJ, 2008, J EVOLUTION BIOL, V21, P1321, DOI 10.1111/j.1420-9101.2008.01566.x; Franks SJ, 2008, AM NAT, V171, P678, DOI 10.1086/587078; Franks SJ, 2011, NEW PHYTOL, V190, P249, DOI 10.1111/j.1469-8137.2010.03603.x; Franks SJ, 2009, EVOL APPL, V2, P481, DOI 10.1111/j.1752-4571.2009.00073.x; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; JOHNSTON MO, 1992, EVOLUTION, V46, P688, DOI [10.2307/2409638, 10.1111/j.1558-5646.1992.tb02076.x]; Juenger T, 2005, EVOL ECOL, V19, P79, DOI 10.1007/s10682-004-8090-4; Kawagoe T, 2010, OECOLOGIA, V164, P713, DOI 10.1007/s00442-010-1709-y; Kesting JR, 2009, J NAT PROD, V72, P312, DOI 10.1021/np800743w; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kristensen TN, 2005, J EVOLUTION BIOL, V18, P763, DOI 10.1111/j.1420-9101.2005.00883.x; Lynch M., 1998, GENETICS ANAL QUANTI; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; McKey D, 1979, HERBIVORES THEIR INT, P55; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Oppel CB, 2009, J CHEM ECOL, V35, P625, DOI 10.1007/s10886-009-9643-3; Parachnowitsch AL, 2005, NATURAL SELECTION FL; Parachnowitsch AL, 2008, ECOLOGY, V89, P1802, DOI 10.1890/07-0555.1; Parachnowitsch AL, 2010, NEW PHYTOL, V188, P393, DOI 10.1111/j.1469-8137.2010.03410.x; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Rhoades D. F., 1979, HERBIVORES THEIR INT, P3; SCHMID B, 1995, CAN J BOT, V73, P1831, DOI 10.1139/b95-194; Sherrard ME, 2006, EVOLUTION, V60, P2478, DOI 10.1111/j.0014-3820.2006.tb01883.x; Sokal RR, 1995, BIOMETRY; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; Weis AE, 2005, J EVOLUTION BIOL, V18, P536, DOI 10.1111/j.1420-9101.2005.00891.x; Williams JL, 2001, AM J BOT, V88, P1577, DOI 10.2307/3558401	66	10	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37745	10.1371/journal.pone.0037745	http://dx.doi.org/10.1371/journal.pone.0037745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662205	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300095
J	Xu, Y; Li, Y; Pang, Y; Ling, M; Shen, L; Yang, XJ; Zhang, JP; Zhou, JW; Wang, XR; Liu, QZ				Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Yang, Xiaojun; Zhang, Jianping; Zhou, Jianwei; Wang, Xinru; Liu, Qizhan			EMT and Stem Cell-Like Properties Associated with HIF-2 alpha Are Involved in Arsenite-Induced Transformation of Human Bronchial Epithelial Cells	PLOS ONE			English	Article							LUNG-CANCER; MESENCHYMAL TRANSITION; MALIGNANT-TRANSFORMATION; TUMOR PROGRESSION; E-CADHERIN; KAPPA-B; EXPRESSION; HYPOXIA; GROWTH; OCT-4	Background: Arsenic is well-established as a human carcinogen, but the molecular mechanisms leading to arsenic-induced carcinogenesis are complex and elusive. It is not been determined if the epithelial-mesenchymal transition (EMT) and stem cell-like properties contribute in causing to carcinogen-induced malignant transformation and subsequent tumor formation. Methods: To investigate the molecular mechanisms underlying EMT and the emergence of cancer stem cell-like properties during neoplastic transformation of human bronchial epithelial (HBE) cells induced by chronic exposure to arsenite. HBE cells were continuously exposed to arsenite. Spheroid formation assays and analyses of side populations (SPs) were performed to confirm that arsenite induces the acquired EMT and cancer stem cell-like phenotype. Treated HBE cells were molecularly characterized by RT-PCR, Western blots, immunofluorescence, Southwestern assays, reporter assays, and chromatin immunoprecipitation. Results: With chronic exposure to arsenite, HBE cells undergo an EMT and then acquire a malignant cancer stem cell-like phenotype. Twist1 and Bmi1 are involved in arsenite-induced EMT. The process is directly regulated by HIF-2 alpha. The self-renewal genes, Oct4, Bmi1, and ALDH1, are necessary for arsenite-mediated maintenance of stem cells. Conclusions: EMT, regulated by HIF-2 alpha, and the development of a cancer stem cell-like phenotype are associated with arsenite-induced transformation of HBE cells.	[Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Liu, Qizhan] Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Zhou, Jianwei; Wang, Xinru; Liu, Qizhan] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiaojun; Zhang, Jianping] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China.	drqzliu@hotmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Natural Science Foundations of China [30872146, 81072327]; Research Fund for the Doctoral Program of Higher Education of China [20103234110005]; Key Program of Educational Commission of Jiangsu Province of China [11KJA330002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of Educational Commission of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundations of China (30872146 and 81072327), Research Fund for the Doctoral Program of Higher Education of China (20103234110005), and Key Program of Educational Commission of Jiangsu Province of China (11KJA330002), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P269; Jacquot C, 2002, ANTICANCER RES, V22, P2229; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patterson TJ, 2007, TOXICOL APPL PHARM, V221, P119, DOI 10.1016/j.taap.2007.02.003; Patterson TJ, 2005, TOXICOL APPL PHARM, V207, P69, DOI 10.1016/j.taap.2004.11.020; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; REDDEL RR, 1988, CANCER RES, V48, P1904; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shen SW, 2008, MOL CARCINOGEN, V47, P508, DOI 10.1002/mc.20406; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tokar EJ, 2011, ENV HLTH PERSPECT, V118, P108; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Waalkes MP, 2008, CANCER RES, V68, P8278, DOI 10.1158/0008-5472.CAN-08-2099; Wang Bo, 2010, Chin J Cancer, V29, P254; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Wang ZS, 2011, TOXICOL SCI, V121, P110, DOI 10.1093/toxsci/kfr029; Wen GY, 2008, MOL MED, V14, P2, DOI 10.2119/2007-00090.Wen; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	47	38	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37765	10.1371/journal.pone.0037765	http://dx.doi.org/10.1371/journal.pone.0037765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662215	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300105
J	Zhu, LH; Ye, JR; Negi, S; Xu, XL; Wang, ZL; Ji, JY				Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi			Pathogenicity of Aseptic Bursaphelenchus xylophilus	PLOS ONE			English	Article							PINE WILT DISEASE; WOOD; APHELENCHOIDIDAE; TOXIN	Pine wilt is a disease of pine (Pinus spp.) caused by the pine wood nematode (PWN), Bursaphelenchus xylophilus. However, the pathogenic mechanism of pine wilt disease (PWD) remains unclear. Although the PWN was thought to be the only pathogenic agent associated with this disease, a potential role for bacterial symbionts in the disease process was recently proposed. Studies have indicated that aseptic PWNs do not cause PWD in aseptic pine trees, while PWNs associated with bacteria cause wilting symptoms. To investigate the pathogenicity of the PWN and its associated bacteria, 3-month-old microcuttings derived from certain clones of Pinus densiflora Siebold & Zucc. produced in vitro were inoculated under aseptic conditions with aseptic PWNs, non-aseptic PWNs and bacteria isolated from the nematodes. Six-month-old aseptic P. densiflora microcuttings and 7-month-old P. massoniana seedlings were also inoculated under aseptic conditions with aseptic PWNs and non-aseptic PWNs. The results showed that the aseptic microcuttings and seedlings inoculated with aseptic PWNs or non-aseptic PWNs wilted, while those inoculated with bacterial isolates did not wilt. Nematodes were recovered from wilted microcuttings and seedlings inoculated with aseptic PWNs and non-aseptic PWNs, and the asepsis of nematodes recovered from aseptic PWN-inoculated microcuttings and seedlings was reconfirmed by culturing them in NB liquid medium at 30 degrees C for more than 7 days. Taken together, the results indicate that the asepsis of PWN did not cause the loss of pathogenicity.	[Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi] Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi] Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Zhu, LH (corresponding author), Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	njfuhlyjr@yahoo.cn	Negi, Sapna/HGA-5265-2022		National Basic Research and Development Program of China [2009CB119205]; National Nature Science Foundation of China [31000303]; National Forestry Public Program of China [201204501]	National Basic Research and Development Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Forestry Public Program of China	Work in the Professor Jian-ren Ye Laboratory was supported by the National Basic Research and Development Program of China (No. 2009CB119205), National Nature Science Foundation of China (No. 31000303) and National Forestry Public Program of China (201204501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLLA RI, 1982, J NEMATOL, V14, P377; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Chi ShuYou, 2006, Scientia Silvae Sinicae, V42, P71; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; *FOR AG, 2004, ANN REP TRENDS FOR F; Fukuda K., 1992, Journal of the Japanese Forestry Society, V74, P289; GRESSHOFF PM, 1972, PLANTA, V107, P161, DOI 10.1007/BF00387721; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Higgins D. F., 1999, Sustainability of pine forests in relation to pine wilt and decline. Proceedings of International Symposium, Tokyo, Japan, 27-28 October, 1998, P23; Huang RE, 2007, THESIS NANJING FORES; Iwahori H., 1985, Japanese Journal of Nematology, V15, P64; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Kawazu K., 1999, Scientific Reports of the Faculty of Agriculture, Okayama University, P1; Kawazu K., 1998, Scientific Reports of the Faculty of Agriculture, Okayama University, P1; Kawazu K, 1996, BIOSCI BIOTECH BIOCH, V60, P1410, DOI 10.1271/bbb.60.1410; Kawazu Kazuyoshi, 1997, Japanese Journal of Nematology, V27, P76; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; MAMIYA Y, 1975, T JPN FOR SOC, V86, P285; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nobuchi T., 1984, Bulletin of the Kyoto University Forests, P224; OKU H, 1979, NATURWISSENSCHAFTEN, V66, P210, DOI 10.1007/BF00366031; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Sambrook J, 2001, MOL CLONING LAB MANU; Shin SC, 2006, P INT S CURR STAT RE, P31; Tamura H., 1983, Japanese Journal of Nematology, V13, P1; Tamura H., 1973, Japanese Journal of Nematology., V3, P30; Tan Jiajin, 2004, Scientia Silvae Sinicae, V40, P110; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Tian Xueliang, 2010, Weishengwu Xuebao, V50, P909; Tzean S., 1985, P 6 ROC S ELECT MICR, P38; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang Bao-jun, 2002, Zhongguo Senlin Bingchong, V21, P27; Yang BJ, 2003, BURSAPHELENCHUS XYLO, P6; Yano S., 1913, SANRINKOUHOU, V4, P1; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhu LH, 2010, PLANT CELL TISS ORG, V102, P121, DOI 10.1007/s11240-010-9711-y; Zhu Lihua, 2011, Scientia Silvae Sinicae, V47, P92	43	30	38	8	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38095	10.1371/journal.pone.0038095	http://dx.doi.org/10.1371/journal.pone.0038095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662271	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300163
J	Na, HW; Shin, WS; Ludwig, A; Lee, ST				Na, Hye-Won; Shin, Won-Sik; Ludwig, Andreas; Lee, Seung-Taek			The Cytosolic Domain of Protein-tyrosine Kinase 7 (PTK7), Generated from Sequential Cleavage by a Disintegrin and Metalloprotease 17 (ADAM17) and gamma-Secretase, Enhances Cell Proliferation and Migration in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST MIGRATION; INTRACELLULAR DOMAIN; ENDOTHELIAL-CELLS; TISSUE INHIBITOR; BREAST-CANCER; OFF-TRACK; EXPRESSION; RECEPTOR; CARCINOMA; PROTEASES	Protein-tyrosine kinase 7 (PTK7) is a member of the defective receptor protein-tyrosine kinases and is known to function as a regulator of planar cell polarity during development. Its expression is up-regulated in some cancers including colon carcinomas. A 100-kDa fragment of PTK7 was detected in the culture media from colon cancer cells and HEK293 cells. The shed fragment was named sPTK7-Ig1-7 because its molecular mass was very similar to that of the entire extracellular domain of PTK7 that contains immunoglobulin-like loops 1 to 7 (Ig1-7). The shedding of sPTK7-Ig1-7 was enhanced by treatment with phorbol 12-myristate 13-acetate. In addition to the sPTK7-Ig1-7 found in the culture medium, two C-terminal fragments of PTK7 were detected in the cell lysates: PTK7-CTF1, which includes a transmembrane segment and a cytoplasmic domain, and PTK7-CTF2, which lacks most of the transmembrane segment from PTK7-CTF1. Analysis of PTK7 processing in the presence of various protease inhibitors or after knockdown of potential proteases suggests that shedding of PTK7 into sPTK7-Ig1-7 and PTK7-CTF1 is catalyzed by ADAM17, and further cleavage of PTK7-CTF1 into PTK7-CTF2 is mediated by the gamma-secretase complex. PTK7-CTF2 localizes to the nucleus and enhances proliferation, migration, and anchorage-independent colony formation. Our findings demonstrate a novel role for PTK7 in the tumorigenesis via generation of PTK7-CTF2 by sequential cleavage of ADAM17 and gamma-secretase.	[Na, Hye-Won; Shin, Won-Sik; Lee, Seung-Taek] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany	Yonsei University; RWTH Aachen University	Lee, ST (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	stlee@yonsei.ac.kr	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986; Shin, Won-Sik/0000-0001-9432-1320; Lee, Seung-Taek/0000-0001-7300-9784	Basic Research Program Grant [2009-0076146]; Studies on Ubiquitome Functions Grant [2005-2001143]; Mid-Career Researcher Program Grant of the National Research Foundation [2010-0026103]; Ministry of Education, Science, and Technology, Republic of Korea; National R&D Program for Cancer Control Grant, Ministry of Health and Welfare, Republic of Korea [1120110]	Basic Research Program Grant; Studies on Ubiquitome Functions Grant; Mid-Career Researcher Program Grant of the National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control Grant, Ministry of Health and Welfare, Republic of Korea	This work was supported by grants from the Basic Research Program Grant 2009-0076146, Studies on Ubiquitome Functions Grant 2005-2001143, and the Mid-Career Researcher Program Grant 2010-0026103 of the National Research Foundation, Ministry of Education, Science, and Technology, Republic of Korea and by the National R&D Program for Cancer Control Grant 1120110, Ministry of Health and Welfare, Republic of Korea (to S.-T. L.).	Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Karan D, 2003, INT J ONCOL, V23, P1365; Kim HI, 2005, J BIOL CHEM, V280, P28973, DOI 10.1074/jbc.M504568200; LEE ST, 1993, ONCOGENE, V8, P3403; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Park SK, 1996, J BIOCHEM, V119, P235; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wagner G, 2010, BIOCHEM BIOPH RES CO, V402, P402, DOI 10.1016/j.bbrc.2010.10.044; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wigler M, 1992, Biotechnology, V24, P444; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Xue H, 2010, J PROTEOME RES, V9, P545, DOI 10.1021/pr9008817; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	56	46	46	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25001	25009		10.1074/jbc.M112.348904	http://dx.doi.org/10.1074/jbc.M112.348904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665490	hybrid, Green Published			2022-12-25	WOS:000306651700013
J	Sutherland, C; Walsh, MP				Sutherland, Cindy; Walsh, Michael P.			Myosin Regulatory Light Chain Diphosphorylation Slows Relaxation of Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; OKADAIC ACID; PROTEIN PHOSPHATASE; BLACK SPONGE; SWINE MODEL; RHO-KINASE; PHOSPHORYLATION; CONTRACTION; CALCIUM; ACTIVATION	The principal signal to activate smooth muscle contraction is phosphorylation of the regulatory light chains of myosin (LC20) at Ser(19) by Ca2+/calmodulin-dependent myosin light chain kinase. Inhibition of myosin light chain phosphatase leads to Ca2+-independent phosphorylation at both Ser(19) and Thr(18) by integrin-linked kinase and/or zipper-interacting protein kinase. The functional effects of phosphorylation at Thr(18) on steady-state isometric force and relaxation rate were investigated in Triton-skinned rat caudal arterial smooth muscle strips. Sequential phosphorylation at Ser(19) and Thr(18) was achieved by treatment with adenosine 5'-O-(3-thiotriphosphate) in the presence of Ca2+, which induced stoichiometric thiophosphorylation at Ser(19), followed by microcystin (phosphatase inhibitor) in the absence of Ca2+, which induced phosphorylation at Thr(18). Phosphorylation at Thr(18) had no effect on steady-state force induced by Ser(19) thiophosphorylation. However, phosphorylation of Ser(19) or both Ser(19) and Thr(18) to comparable stoichiometries (0.5 mol of P-i/mol of LC20) and similar levels of isometric force revealed differences in the rates of dephosphorylation and relaxation following removal of the stimulus: t(1/2) values for dephosphorylation were 83.3 and 560 s, and for relaxation were 560 and 1293 s, for monophosphorylated (Ser(19)) and diphosphorylated LC20, respectively. We conclude that phosphorylation at Thr(18) decreases the rates of LC20 dephosphorylation and smooth muscle relaxation compared with LC20 phosphorylated exclusively at Ser(19). These effects of LC20 diphosphorylation, combined with increased Ser(19) phosphorylation (Ca2+-independent), may underlie the hypercontractility that is observed in response to certain physiological contractile stimuli, and under pathological conditions such as cerebral and coronary arterial vasospasm, intimal hyperplasia, and hypertension.	[Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary	Walsh, MP (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	walsh@ucalgary.ca			Canadian Institutes of Health Research [MOP-111262]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-111262 (to M.P.W.).	ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; BIALOJAN C, 1988, J PHYSIOL-LONDON, V398, P81, DOI 10.1113/jphysiol.1988.sp017030; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Craig M, 1996, BIOCHEM CELL BIOL, V74, P569, DOI 10.1139/o96-061; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; HARADA T, 1995, NEUROSURGERY, V36, P1178, DOI 10.1227/00006123-199506000-00018; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HIRANO K, 1989, BRIT J PHARMACOL, V98, P1261, DOI 10.1111/j.1476-5381.1989.tb12672.x; HORI M, 1991, FEBS LETT, V285, P145, DOI 10.1016/0014-5793(91)80745-O; IKEBE M, 1988, J BIOL CHEM, V263, P6432; IKEBE M, 1986, J BIOL CHEM, V261, P36; IKEBE M, 1985, J BIOL CHEM, V260, P27; ISHIHARA H, 1989, J PHARMACOL EXP THER, V250, P388; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Katsumata N, 1997, CIRCULATION, V96, P4357; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; MILLERHANCE WC, 1988, J BIOL CHEM, V263, P13979; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; NGAI PK, 1984, J BIOL CHEM, V259, P3656; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; OBARA K, 1989, PFLUG ARCH EUR J PHY, V414, P134, DOI 10.1007/BF00580954; Obara K, 2005, J VASC RES, V42, P67, DOI 10.1159/000083093; OZAKI H, 1987, J PHARMACOL EXP THER, V243, P1167; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; SETO M, 1991, EUR J PHARMACOL, V195, P267, DOI 10.1016/0014-2999(91)90545-2; SETO M, 1993, EXP MOL PATHOL, V58, P1, DOI 10.1006/exmp.1993.1001; SHERRY JMF, 1978, BIOCHEMISTRY-US, V17, P4411, DOI 10.1021/bi00614a009; SHIBATA S, 1982, J PHARMACOL EXP THER, V223, P135; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SUZUKI A, 1993, BRIT J PHARMACOL, V109, P703, DOI 10.1111/j.1476-5381.1993.tb13631.x; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Takeya K, 2011, FASEB J, V25; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; WALSH MP, 1991, BIOCHEM CELL BIOL, V69, P771, DOI 10.1139/o91-119; WALSH MP, 1983, FED PROC, V42, P45; WALSH MP, 1984, BIOCHEM J, V224, P117, DOI 10.1042/bj2240117; WALSH MP, 1982, J BIOL CHEM, V257, P5987; WALSH MP, 1985, BIOCHEMISTRY-US, V24, P3724, DOI 10.1021/bi00335a047; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wilson DP, 2002, J BIOL CHEM, V277, P2186, DOI 10.1074/jbc.M110056200	58	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24064	24076		10.1074/jbc.M112.371609	http://dx.doi.org/10.1074/jbc.M112.371609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661704	Green Published, hybrid			2022-12-25	WOS:000306651100001
J	Hewitt, KM; Gerba, CP; Maxwell, SL; Kelley, ST				Hewitt, Krissi M.; Gerba, Charles P.; Maxwell, Sheri L.; Kelley, Scott T.			Office Space Bacterial Abundance and Diversity in Three Metropolitan Areas	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL DIVERSITY; INDOOR ENVIRONMENT; DUST; AIR; BIOSPHERE; EVOLUTION; PATHOGENS; SEQUENCES; COMMUNITY	People in developed countries spend approximately 90% of their lives indoors, yet we know little about the source and diversity of microbes in built environments. In this study, we combined culture-based cell counting and multiplexed pyrosequencing of environmental ribosomal RNA (rRNA) gene sequences to investigate office space bacterial diversity in three metropolitan areas. Five surfaces common to all offices were sampled using sterile double-tipped swabs, one tip for culturing and one for DNA extraction, in 30 different offices per city (90 offices, 450 total samples). 16S rRNA gene sequences were PCR amplified using bar-coded "universal" bacterial primers from 54 of the surfaces (18 per city) and pooled for pyrosequencing. A three-factorial Analysis of Variance (ANOVA) found significant differences in viable bacterial abundance between offices inhabited by men or women, among the various surface types, and among cities. Multiplex pyrosequencing identified more than 500 bacterial genera from 20 different bacterial divisions. The most abundant of these genera tended to be common inhabitants of human skin, nasal, oral or intestinal cavities. Other commonly occurring genera appeared to have environmental origins (e. g., soils). There were no significant differences in the bacterial diversity between offices inhabited by men or women or among surfaces, but the bacterial community diversity of the Tucson samples was clearly distinguishable from that of New York and San Francisco, which were indistinguishable. Overall, our comprehensive molecular analysis of office building microbial diversity shows the potential of these methods for studying patterns and origins of indoor bacterial contamination. "[H]umans move through a sea of microbial life that is seldom perceived except in the context of potential disease and decay." - Feazel et al. (2009).	[Hewitt, Krissi M.; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gerba, Charles P.; Maxwell, Sheri L.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA	California State University System; San Diego State University; University of Arizona	Hewitt, KM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skelley@sciences.sdsu.edu			San Diego State University; Clorox Corporation; Alfred P. Sloan Foundation	San Diego State University; Clorox Corporation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was funded by grants from San Diego State University, the Clorox Corporation and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MOL ECOL, V4, P543, DOI 10.1111/j.1365-294X.1995.tb00255.x; Andersson AM, 1999, J APPL MICROBIOL, V86, P622, DOI 10.1046/j.1365-2672.1999.00706.x; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Benson CA, 2011, FEMS MICROBIOL ECOL, V76, P74, DOI 10.1111/j.1574-6941.2011.01047.x; BIRDSELL DC, 1967, J BACTERIOL, V93, P427, DOI 10.1128/JB.93.1.427-437.1967; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Caporaso J.G., 2010, NAT METHODS; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CUSTOVIC A, 1994, CLIN EXP ALLERGY, V24, P1164, DOI 10.1111/j.1365-2222.1994.tb03323.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; GOLDBERG I, 1976, BIOTECHNOL BIOENG, V18, P1657, DOI 10.1002/bit.260181202; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kampfer P, 1999, INT J SYST BACTERIOL, V49, P681, DOI 10.1099/00207713-49-2-681; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu LJS, 2000, J AIR WASTE MANAGE, V50, P1957, DOI 10.1080/10473289.2000.10464225; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Macher JM, 2001, INDOOR AIR, V11, P134, DOI 10.1034/j.1600-0668.2001.110208.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Osman S, 2008, ISME J, V2, P482, DOI 10.1038/ismej.2008.11; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PACE NR, 1985, ASM NEWS, V51, P4; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Tsai FC, 2005, INDOOR AIR, V15, P71, DOI 10.1111/j.1600-0668.2005.00346.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VEHKALAHTI MM, 1988, J DENT RES, V67, P911, DOI 10.1177/00220345880670060401; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	44	96	98	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37849	10.1371/journal.pone.0037849	http://dx.doi.org/10.1371/journal.pone.0037849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666400	gold, Green Published			2022-12-25	WOS:000305353400053
J	Chechko, N; Kellermann, T; Zvyagintsev, M; Augustin, M; Schneider, F; Habel, U				Chechko, Natalia; Kellermann, Thilo; Zvyagintsev, Michael; Augustin, Marc; Schneider, Frank; Habel, Ute			Brain Circuitries Involved in Semantic Interference by Demands of Emotional and Non-Emotional Distractors	PLOS ONE			English	Article							COUNTING STROOP; FRONTAL-CORTEX; TASK; ACTIVATION; AMYGDALA; SYSTEMS; FMRI	Background: Previous studies have indicated that the processes leading to the resolution of emotional and non-emotional interference conflicts are unrelated, involving separate networks. It is also known that conflict resolution itself suggests a considerable overlap of the networks. Our study is an attempt to examine how these findings may be related. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to study neural responses of 24 healthy subjects to emotional and non-emotional conflict paradigms involving the presentation of congruent and incongruent word-face pairs based on semantic incompatibility between targets and distractors. In the emotional task, the behavioral interference conflict was greater (compared to the non-emotional task) and was paralleled by involvement of the extrastriate visual and posterodorsal medial frontal cortices. In both tasks, we also observed a common network including the dorsal anterior cingulate, the supplemental motor area, the anterior insula and the inferior prefrontal cortex, indicating that these brain structures are markers of experienced conflict. However, the emotional task involved conflict-triggered networks to a considerably higher degree. Conclusions/Significance: Our findings indicate that responses to emotional and non-emotional distractors involve the same systems, which are capable of flexible adjustments based on conflict demands. The function of systems related to conflict resolution is likely to be adjusted on the basis of an evaluation process that primarily involves the extrastriate visual cortex, with target playing a significant role.	[Chechko, Natalia; Kellermann, Thilo; Zvyagintsev, Michael; Augustin, Marc; Schneider, Frank; Habel, Ute] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Kellermann, Thilo; Zvyagintsev, Michael; Schneider, Frank; Habel, Ute] Forschungszentrum Julich GmbH, JARA Translat Brain Med, Julich, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich	Chechko, N (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	nchechko@ukaachen.de	Kellermann, Thilo/B-1712-2012	Kellermann, Thilo/0000-0003-4081-5581; Schneider, Frank/0000-0003-1557-7956; Habel, Ute/0000-0003-0703-7722; Zvyagintsev, Mikhail/0000-0001-9521-042X				Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Murphy K, 2005, NEUROIMAGE, V27, P771, DOI 10.1016/j.neuroimage.2005.05.007; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schweizer TA, 2007, J COGNITIVE NEUROSCI, V19, P1974, DOI 10.1162/jocn.2007.19.12.1974; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Whalen PJ, 2006, NAT PROTOC, V1, P293, DOI 10.1038/nprot.2006.45; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wittchen H.-U., 1997, SKID STRUKTURIERTES	26	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38155	10.1371/journal.pone.0038155	http://dx.doi.org/10.1371/journal.pone.0038155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666470	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349600066
J	Firacative, C; Trilles, L; Meyer, W				Firacative, Carolina; Trilles, Luciana; Meyer, Wieland			MALDI-TOF MS Enables the Rapid Identification of the Major Molecular Types within the Cryptococcus neoformans/C. gattii Species Complex	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ANTIFUNGAL SUSCEPTIBILITY; VAR. NEOFORMANS; POLYMORPHIC DNA; STRAIN; SEROTYPE; AIDS; DIVERSITY; GRUBII	Background: The Cryptococcus neoformans/C. gattii species complex comprises two sibling species that are divided into eight major molecular types, C. neoformans VNI to VNIV and C. gattii VGI to VGIV. These genotypes differ in host range, epidemiology, virulence, antifungal susceptibility and geographic distribution. The currently used phenotypic and molecular identification methods for the species/molecular types are time consuming and expensive. As Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) offers an effective alternative for the rapid identification of microorganisms, the objective of this study was to examine its potential for the identification of C. neoformans and C. gattii strains at the intra-and inter-species level. Methodology: Protein extracts obtained via the formic acid extraction method of 164 C. neoformans/C. gattii isolates, including four inter-species hybrids, were studied. Results: The obtained mass spectra correctly identified 100% of all studied isolates, grouped each isolate according to the currently recognized species, C. neoformans and C. gattii, and detected potential hybrids. In addition, all isolates were clearly separated according to their major molecular type, generating greater spectral differences among the C. neoformans molecular types than the C. gattii molecular types, most likely reflecting a closer phylogenetic relationship between the latter. The number of colonies used and the incubation length did not affect the results. No spectra were obtained from intact yeast cells. An extended validated spectral library containing spectra of all eight major molecular types was established. Conclusions: MALDI-TOF MS is a rapid identification tool for the correct recognition of the two currently recognized human pathogenic Cryptococcus species and offers a simple method for the separation of the eight major molecular types and the detection of hybrid strains within this species complex in the clinical laboratory. The obtained mass spectra provide further evidence that the major molecular types warrant variety or even species status.	[Firacative, Carolina; Trilles, Luciana; Meyer, Wieland] Univ Sydney, Westmead Hosp, Sydney Med School Westmead, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,West, Sydney, NSW 2006, Australia; [Firacative, Carolina] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia; [Trilles, Luciana] Fundacao Oswaldo Cruz, Lab Micol, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	University of Sydney; Instituto Nacional de Salud (Colombia); Fundacao Oswaldo Cruz	Firacative, C (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med School Westmead, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,West, Sydney, NSW 2006, Australia.	w.meyer@usyd.edu.au	Meyer, Wieland/G-1204-2015; Firacative, Carolina/ABB-9942-2021	Meyer, Wieland/0000-0001-9933-8340; Firacative, Carolina/0000-0001-7547-5172	PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia	PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia	The authors express their thanks to Elizabeth Castaneda (Emeritus Professor, Instituto Nacional de Salud, Bogota, Colombia) for her useful comments on the manuscript, to Mr. Leith Fremlin (Bruker Daltonic, Australia) for the technical support and to Mojgan Aminnejad for providing the proteins extracts for the inter-species hybrid strains. The authors wish also to thank the following researchers from around the world for generously contributing strains for this study: A. Arechavala, I. Arthur, K. Bartlett, T. Boekhout, B. Calvo, S. Chen, A. Chindamporn, G. Davel, V. Davis, M. Diaz, F. Dromer, D. Ellis, P. Escandon, M. Fyfe, M. Ghannoum, J. Graybill, D. Howard, R. Igreja, E. Jacobsen, M. A. John, M. Krockenberger, S. Kidd, R. Lopez-Martinez, R. Malik, M. S. Matthews, T. Mitchell, M. Montagna, P. Ngamsklrungroj, A. Padhye, D. Parr, C. Perez, T. Pfeiffer, P. Rajendran, M. F. A. Razak, B. Samayoa, B. Speed, A. Sturm, S. Sukroongreung, J. Sykes, K. Tintelnot, J. M. Torres, M. Vainstein, N. Vasilyeva, A. Velegraki, and K. Weeks. Carolina Firacative was supported by a PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia.	Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 1996, J INFECT DIS, V173, P754, DOI 10.1093/infdis/173.3.754; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cogliati M, 2012, MYCOPATHOLOGIA, V173, P347, DOI 10.1007/s11046-011-9467-x; Sidrim JJC, 2010, CAN J MICROBIOL, V56, P445, DOI [10.1139/W10-030, 10.1139/w10-030]; Coulibaly O, 2011, MED MYCOL, V49, P621, DOI 10.3109/13693786.2011.555424; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; ESPINELINGROFF A, 1992, J CLIN MICROBIOL, V30, P3138, DOI 10.1128/JCM.30.12.3138-3145.1992; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Hanafy A, 2008, MED MYCOL, V46, P685, DOI 10.1080/13693780802027062; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; Hettick JM, 2011, ACS SYM SER, V1065, P35; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kluger EK, 2006, MED MYCOL, V44, P561, DOI 10.1080/13693780600582847; Kwon-Chung KJ, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P3; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lemmer K, 2004, MED MYCOL, V42, P135, DOI 10.1080/13693780310001624565; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; McTaggart L, 2011, J CLIN MICROBIOL, V49, P2522, DOI 10.1128/JCM.00502-11; McTaggart LR, 2011, J CLIN MICROBIOL, V49, P3050, DOI 10.1128/JCM.00651-11; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; MEYER W, 1995, ELECTROPHORESIS, V16, P1648, DOI 10.1002/elps.11501601273; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2003, PROBLEMS MED MYCOL N, VN3, P8; Meyer W, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P327; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Santos C, 2010, J APPL MICROBIOL, V108, P375, DOI 10.1111/j.1365-2672.2009.04448.x; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Trilles L, 2004, J CLIN MICROBIOL, V42, P4815, DOI 10.1128/JCM.42.10.4815-4817.2004; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; Viviani MA, 2001, MED MYCOL, V39, P383, DOI 10.1080/mmy.39.5.383.386	51	95	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37566	10.1371/journal.pone.0037566	http://dx.doi.org/10.1371/journal.pone.0037566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666368	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349600019
J	Sanchez-Martinez, S; Aloia, AL; Harvin, D; Mirro, J; Gorelick, RJ; Jern, P; Coffin, JM; Rein, A				Sanchez-Martinez, Silvia; Aloia, Amanda L.; Harvin, Demetria; Mirro, Jane; Gorelick, Robert J.; Jern, Patric; Coffin, John M.; Rein, Alan			Studies on the Restriction of Murine Leukemia Viruses by Mouse APOBEC3	PLOS ONE			English	Article							REPLICATION; GAG; INFECTION; GENE; PATHOGENESIS; REPLACEMENT; VIRIONS; ENCODES; PROTEIN	APOBEC3 proteins function to restrict the replication of retroviruses. One mechanism of this restriction is deamination of cytidines to uridines in (-) strand DNA, resulting in hypermutation of guanosines to adenosines in viral (+) strands. However, Moloney murine leukemia virus (MoMLV) is partially resistant to restriction by mouse APOBEC3 (mA3) and virtually completely resistant to mA3-induced hypermutation. In contrast, the sequences of MLV genomes that are in mouse DNA suggest that they were susceptible to mA3-induced deamination when they infected the mouse germline. We tested the possibility that sensitivity to mA3 restriction and to deamination resides in the viral gag gene. We generated a chimeric MLV in which the gag gene was from an endogenous MLV in the mouse germline, while the remainder of the viral genome was from MoMLV. This chimera was fully infectious but its response to mA3 was indistinguishable from that of MoMLV. Thus, the Gag protein does not seem to control the sensitivity of MLVs to mA3. We also found that MLVs inactivated by mA3 do not synthesize viral DNA upon infection; thus mA3 restriction of MLV occurs before or at reverse transcription. In contrast, HIV-1 restricted by mA3 and MLVs restricted by human APOBEC3G do synthesize DNA; these DNAs exhibit APOBEC3-induced hypermutation.	[Sanchez-Martinez, Silvia; Aloia, Amanda L.; Harvin, Demetria; Mirro, Jane; Rein, Alan] NCI, HIV Drug Resistance Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Gorelick, Robert J.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Uppsala University; Tufts University	Sanchez-Martinez, S (corresponding author), NCI, HIV Drug Resistance Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.	reina@mail.nih.gov	Jern, Patric/AAR-2133-2021	Jern, Patric/0000-0003-3393-5825	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Swedish Wenner-Gren foundations; Swedish research council FORMAS; American Cancer Society; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC010773] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Wenner-Gren foundations; Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); American Cancer Society(American Cancer Society); F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. P.J. was supported by the Swedish Wenner-Gren foundations and the Swedish research council FORMAS. J.M.C. was supported by a Research Professorship from the American Cancer Society, with support from the F.M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; EDWARDS SA, 1979, J VIROL, V30, P551, DOI 10.1128/JVI.30.2.551-563.1979; Elion EA, 2007, CURR PROTOC MOL BIOL, P17; Fu W, 2003, J VIROL, V77, P754, DOI 10.1128/JVI.77.1.754-761.2003; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Gorelick RJ, 1996, J VIROL, V70, P2593, DOI 10.1128/JVI.70.4.2593-2597.1996; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; Langlois MA, 2009, J VIROL, V83, P11550, DOI 10.1128/JVI.01430-09; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Low A, 2009, VIROLOGY, V385, P455, DOI 10.1016/j.virol.2008.11.051; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003; Okeoma CM, 2009, J VIROL, V83, P3029, DOI 10.1128/JVI.02536-08; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith DS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002284; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38190	10.1371/journal.pone.0038190	http://dx.doi.org/10.1371/journal.pone.0038190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666481	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349600070
J	Choi, KS; Lee, C; Maatouk, DM; Harfe, BD				Choi, Kyung-Suk; Lee, Chanmi; Maatouk, Danielle M.; Harfe, Brian D.			Bmp2, Bmp4 and Bmp7 Are Co-Required in the Mouse AER for Normal Digit Patterning but Not Limb Outgrowth	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; VERTEBRATE LIMB; BONE-FORMATION; BUD; FGF8; INITIATION; P63; MORPHOGENESIS; MAINTENANCE	Outgrowth and patterning of the vertebrate limb requires a functional apical ectodermal ridge (AER). The AER is a thickening of ectodermal tissue located at the distal end of the limb bud. Loss of this structure, either through genetic or physical manipulations results in truncation of the limb. A number of genes, including Bmps, are expressed in the AER. Previously, it was shown that removal of the BMP receptor Bmpr1a specifically from the AER resulted in complete loss of hindlimbs suggesting that Bmp signaling in the AER is required for limb outgrowth. In this report, we genetically removed the three known AER-expressed Bmp ligands, Bmp2, Bmp4 and Bmp7 from the AER of the limb bud using floxed conditional alleles and the Msx2-cre allele. Surprisingly, only defects in digit patterning and not limb outgrowth were observed. In triple mutants, the anterior and posterior AER was present but loss of the central region of the AER was observed. These data suggest that Bmp ligands expressed in the AER are not required for limb outgrowth but instead play an essential role in maintaining the AER and patterning vertebrate digits.	[Choi, Kyung-Suk; Lee, Chanmi; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Choi, Kyung-Suk; Lee, Chanmi; Harfe, Brian D.] Univ Florida, Genet Inst, Gainesville, FL USA; [Maatouk, Danielle M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University	Choi, KS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	bharfe@mgm.ufl.edu			Korea Science and Engineering Foundation [KRF-2005-215-C00105]; March of Dimes	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); March of Dimes(March of Dimes)	K.-S.C. was partially supported by the Korea Science and Engineering Foundation (KRF-2005-215-C00105). Funding was provided by the March of Dimes (http://www.marchofdimes.com/) to B. D. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Cheifetz S, 1999, CRIT REV ORAL BIOL M, V10, P182, DOI 10.1177/10454411990100020501; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dealy CN, 1998, DEV BIOL, V202, P43, DOI 10.1006/dbio.1998.8988; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Loomis CA, 1998, DEVELOPMENT, V125, P1137; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Maatouk DM, 2009, DEV BIOL, V327, P516, DOI 10.1016/j.ydbio.2009.01.004; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Tsuji K, 2010, J ORTHOP RES, V28, P384, DOI 10.1002/jor.20996; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37826	10.1371/journal.pone.0037826	http://dx.doi.org/10.1371/journal.pone.0037826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662233	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300123
J	Coppin, E; Berteaux-Lecellier, V; Bidard, F; Brun, S; Ruprich-Robert, G; Espagne, E; Ait-Benkhali, J; Goarin, A; Nesseir, A; Planamente, S; Debuchy, R; Silar, P				Coppin, Evelyne; Berteaux-Lecellier, Veronique; Bidard, Frederique; Brun, Sylvain; Ruprich-Robert, Gwenael; Espagne, Eric; Ait-Benkhali, Jinane; Goarin, Anne; Nesseir, Audrey; Planamente, Sara; Debuchy, Robert; Silar, Philippe			Systematic Deletion of Homeobox Genes in Podospora anserina Uncovers Their Roles in Shaping the Fruiting Body	PLOS ONE			English	Article							MATING-TYPE; CLP1 PROTEIN; MORPHOLOGY; PHEROMONE; SEQUENCES; CYTOLOGY; NUCLEAR; CYCLE	Higher fungi, which comprise ascomycetes and basidiomycetes, play major roles in the biosphere. Their evolutionary success may be due to the extended dikaryotic stage of their life cycle, which is the basis for their scientific name: the Dikarya. Dikaryosis is maintained by similar structures, the clamp in basidiomycetes and the crozier in ascomycetes. Homeodomain transcription factors are required for clamp formation in all basidiomycetes studied. We identified all the homeobox genes in the filamentous ascomycete fungus Podospora anserina and constructed deletion mutants for each of these genes and for a number of gene combinations. Croziers developed normally in these mutants, including those with up to six deleted homeogenes. However, some mutants had defects in maturation of the fruiting body, an effect that could be rescued by providing wild-type maternal hyphae. Analysis of mutants deficient in multiple homeogenes revealed interactions between the genes, suggesting that they operate as a complex network. Similar to their role in animals and plants, homeodomain transcription factors in ascomycetes are involved in shaping multicellular structures.	[Coppin, Evelyne; Berteaux-Lecellier, Veronique; Bidard, Frederique; Brun, Sylvain; Ruprich-Robert, Gwenael; Espagne, Eric; Ait-Benkhali, Jinane; Goarin, Anne; Nesseir, Audrey; Planamente, Sara; Debuchy, Robert; Silar, Philippe] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Coppin, Evelyne; Berteaux-Lecellier, Veronique; Brun, Sylvain; Ruprich-Robert, Gwenael; Goarin, Anne; Debuchy, Robert; Silar, Philippe] CNRS, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Brun, Sylvain; Goarin, Anne; Silar, Philippe] Univ Paris Diderot, UFR Sci Vivant, Paris, France; [Ruprich-Robert, Gwenael] Univ Paris 05, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Coppin, E (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France.	evelyne.coppin@igmors.u-psud.fr; philippe.silar@igmors.u-psud.fr	Debuchy, Robert/J-3040-2012; Espagne, Eric/AAF-9794-2019; BERTEAUX-LECELLIER, Veronique/P-6456-2019; Ruprich-Robert, Gwenaël/AAF-9000-2020; Berteaux-Lecellier, Veronique/O-4767-2018; Espagne, Eric/GMX-2417-2022; Planamente, Sara/ABB-4551-2020	Debuchy, Robert/0000-0003-1206-0361; BERTEAUX-LECELLIER, Veronique/0000-0003-2152-6231; Berteaux-Lecellier, Veronique/0000-0003-2152-6231; Planamente, Sara/0000-0003-2778-1356; Ruprich-Robert, Gwenael/0000-0003-3679-428X; Espagne, Eric/0000-0002-5813-498X; silar, philippe/0000-0003-0104-987X; Brun, Sylvain/0000-0002-6714-4012	French National Research Agency [ANR-05-BLAN-0385]	French National Research Agency(French National Research Agency (ANR))	This study was funded by the French National Research Agency (http://www.agence-nationale-recherche.fr/) grant number ANR-05-BLAN-0385, project SexDevMycol, coordinator R. Debuchy and by a donor who wishes to remain anonymous. The salary of FB was funded by the French National Research Agency grant number ANR-05-BLAN-0385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaise S, 2001, MOL MICROBIOL, V39, P54, DOI 10.1046/j.1365-2958.2001.02163.x; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Bauer R, 2009, MYCOL RES, V113, P960, DOI 10.1016/j.mycres.2009.05.003; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Bidard Frederique, 2010, BMC Res Notes, V3, P171, DOI 10.1186/1756-0500-3-171; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Buller AHR, 1958, RES FUNGI, V5, P1; BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179; Casselton L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P536; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2000, GENETICS, V155, P657; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; COPPIN E, 1993, MOL GEN GENET, V241, P409, DOI 10.1007/BF00284694; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Ekena JL, 2008, EUKARYOT CELL, V7, P49, DOI 10.1128/EC.00377-07; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Hansen PV, 2007, MYCOL RES, V111, P592, DOI 10.1016/j.mycres.2007.02.010; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Heimel K, 2010, PLANT CELL, V22, P2908, DOI 10.1105/tpc.110.076265; Inada K, 2001, GENETICS, V157, P133; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kirschner R, 2001, MYCOLOGIA, V93, P634, DOI 10.2307/3761818; KRAMER CL, 1960, MYCOLOGIA, V52, P295, DOI 10.2307/3756013; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Marcou D., 1961, ANN SCI NAT BOT BIOL, V12, P653; Martens P, 1932, B SOC MYCOL FR, V48, P259; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; OBERWINKLER F, 1990, MYCOLOGIA, V82, P671, DOI 10.2307/3760154; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; SHAFFER RL, 1975, MYCOLOGIA, V67, P1, DOI 10.2307/3758222; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; Silar P, 2011, FUNGAL BIOL-UK, V115, P793, DOI 10.1016/j.funbio.2011.06.005; SYROP M, 1976, CAN J BOT, V54, P293, DOI 10.1139/b76-027; THOMPSONCOFFE C, 1994, DEV BIOL, V165, P257, DOI 10.1006/dbio.1994.1251; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webster J., 2007, INTRO FUNGI, V3rd	51	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37488	10.1371/journal.pone.0037488	http://dx.doi.org/10.1371/journal.pone.0037488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662159	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300049
J	Farahat, WA; Wood, LB; Zervantonakis, IK; Schor, A; Ong, S; Neal, D; Kamm, RD; Asada, HH				Farahat, Waleed A.; Wood, Levi B.; Zervantonakis, Ioannis K.; Schor, Alisha; Ong, Sharon; Neal, Devin; Kamm, Roger D.; Asada, H. Harry			Ensemble Analysis of Angiogenic Growth in Three-Dimensional Microfluidic Cell Cultures	PLOS ONE			English	Article							ENDOTHELIAL-CELL; IN-VITRO; MATRIX; MIGRATION; PROLIFERATION; MORPHOGENESIS; PROTEOLYSIS; CHEMOTAXIS; PLATFORM; MODELS	We demonstrate ensemble three-dimensional cell cultures and quantitative analysis of angiogenic growth from uniform endothelial monolayers. Our approach combines two key elements: a micro-fluidic assay that enables parallelized angiogenic growth instances subject to common extracellular conditions, and an automated image acquisition and processing scheme enabling high-throughput, unbiased quantification of angiogenic growth. Because of the increased throughput of the assay in comparison to existing three-dimensional morphogenic assays, statistical properties of angiogenic growth can be reliably estimated. We used the assay to evaluate the combined effects of vascular endothelial growth factor (VEGF) and the signaling lipid sphingoshine-1-phosphate (S1P). Our results show the importance of S1P in amplifying the angiogenic response in the presence of VEGF gradients. Furthermore, the application of S1P with VEGF gradients resulted in angiogenic sprouts with higher aspect ratio than S1P with background levels of VEGF, despite reduced total migratory activity. This implies a synergistic effect between the growth factors in promoting angiogenic activity. Finally, the variance in the computed angiogenic metrics (as measured by ensemble standard deviation) was found to increase linearly with the ensemble mean. This finding is consistent with stochastic agent-based mathematical models of angiogenesis that represent angiogenic growth as a series of independent stochastic cell-level decisions.	[Farahat, Waleed A.; Wood, Levi B.; Zervantonakis, Ioannis K.; Schor, Alisha; Neal, Devin; Kamm, Roger D.; Asada, H. Harry] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kamm, Roger D.; Asada, H. Harry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ong, Sharon; Kamm, Roger D.; Asada, H. Harry] Singapore MIT Alliance Res & Technol SMART, BioSym Interdisciplinary Res Grp, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Farahat, WA (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	wfarahat@mit.edu	Zervantonakis, Ioannis/C-2890-2011; Kamm, Roger D/I-7630-2012; Zervantonakis, Ioannis/N-9717-2019; Zervantonakis, Ioannis/ADS-2519-2022	Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; /0000-0002-7232-304X; Ong, Lee Ling/0000-0002-4120-163X	National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program [0735997]; Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG)	National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program; Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG)(Singapore-MIT Alliance for Research & Technology Centre (SMART))	This work is funded by The National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program (grant #0735997) (http://www.nsf.gov./div/index.jsp?div = EFRI) and The Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG) (http://smart.mit.edu/research/biosym/biosym.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Baronikova S, 2004, PLANTA MED, V70, P887, DOI 10.1055/s-2004-832611; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bishop C.M., 2006, PATTERN RECOGNITION; Bonetta L, 2005, NAT METHODS, V2, P785, DOI 10.1038/nmeth1005-785; Bonvin C, 2010, BIOTECHNOL BIOENG, V105, P982, DOI 10.1002/bit.22608; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j; Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cosgrove BD, 2008, CELL MOL BIOENG, V1, P33, DOI 10.1007/s12195-008-0007-9; Czirok A, 1998, PHYS REV LETT, V84; Das A, 2010, PHILOS T R SOC A, V368, P2937, DOI 10.1098/rsta.2010.0085; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Elcin Y, 2002, TECHNOL HEALTH CARE, V10, P306; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher KE, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-69; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Hegedus B, 2000, J NEUROSURG, V92, P428, DOI 10.3171/jns.2000.92.3.0428; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Johnson PC, 2010, ADV TISSUE ENG; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Kothapalli C. R., 2011, LAB CHIP; KUNDU P.K., 2004, FLUID MECH-SOV RES; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Liu WW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002382; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Sudo R, 2009, FASEB J; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Wissner-Gross ZD, 2011, INTEGRATIVE BIOL; Wood LB, 2008, STOCHASTIC CONTROL F, P390; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952; Zervantonakis SCIK, 2010, INT J MICRONANO SCAL, V1, P27	52	84	87	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37333	10.1371/journal.pone.0037333	http://dx.doi.org/10.1371/journal.pone.0037333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662145	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300035
J	Garza, DR; Thompson, CC; Loureiro, ECB; Dutilh, BE; Inada, DT; Sousa, EC; Cardoso, JF; Nunes, MRT; de Lima, CPS; Silvestre, RVD; Nunes, KNB; Santos, ECO; Edwards, RA; Vicente, ACP; Morais, LLCD				Garza, Daniel Rios; Thompson, Cristiane C.; Brito Loureiro, Edvaldo Carlos; Dutilh, Bas E.; Inada, Davi Toshio; Sousa Junior, Edivaldo Costa; Cardoso, Jedson Ferreira; Nunes, Marcio Roberto T.; Silva de Lima, Clayton Pereira; Duarte Silvestre, Rodrigo Vellasco; Barbosa Nunes, Keley Nascimento; Santos, Elisabeth C. O.; Edwards, Robert A.; Vicente, Ana Carolina P.; Canto de Sa Morais, Lena Lillian			Genome-Wide Study of the Defective Sucrose Fermenter Strain of Vibrio cholerae from the Latin American Cholera Epidemic	PLOS ONE			English	Article							VARIANTS; SEQUENCE	The 7th cholera pandemic reached Latin America in 1991, spreading from Peru to virtually all Latin American countries. During the late epidemic period, a strain that failed to ferment sucrose dominated cholera outbreaks in the Northern Brazilian Amazon region. In order to understand the genomic characteristics and the determinants of this altered sucrose fermenting phenotype, the genome of the strain IEC224 was sequenced. This paper reports a broad genomic study of this strain, showing its correlation with the major epidemic lineage. The potentially mobile genomic regions are shown to possess GC content deviation, and harbor the main V. cholera virulence genes. A novel bioinformatic approach was applied in order to identify the putative functions of hypothetical proteins, and was compared with the automatic annotation by RAST. The genome of a large bacteriophage was found to be integrated to the IEC224's alanine aminopeptidase gene. The presence of this phage is shown to be a common characteristic of the El Tor strains from the Latin American epidemic, as well as its putative ancestor from Angola. The defective sucrose fermenting phenotype is shown to be due to a single nucleotide insertion in the V. cholerae sucrose-specific transportation gene. This frame-shift mutation truncated a membrane protein, altering its structural pore-like conformation. Further, the identification of a common bacteriophage reinforces both the monophyletic and African-Origin hypotheses for the main causative agent of the 1991 Latin America cholera epidemics.	[Garza, Daniel Rios; Canto de Sa Morais, Lena Lillian] Evandro Chagas Inst, Lab Environm Microbiol, Ananindeua, Para, Brazil; [Thompson, Cristiane C.; Vicente, Ana Carolina P.] Inst Oswaldo Cruz, Lab Mol Genet Microorganisms, BR-20001 Rio De Janeiro, Brazil; [Brito Loureiro, Edvaldo Carlos] Evandro Chagas Inst, Bacteriol Sect, Ananindeua, Para, Brazil; [Dutilh, Bas E.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Inada, Davi Toshio; Sousa Junior, Edivaldo Costa; Cardoso, Jedson Ferreira; Nunes, Marcio Roberto T.; Silva de Lima, Clayton Pereira; Duarte Silvestre, Rodrigo Vellasco; Barbosa Nunes, Keley Nascimento] Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Instituto Evandro Chagas; Fundacao Oswaldo Cruz; Instituto Evandro Chagas; Radboud University Nijmegen; Radboud University Nijmegen; California State University System; San Diego State University; California State University System; San Diego State University; Instituto Evandro Chagas; United States Department of Energy (DOE); Argonne National Laboratory	Garza, DR (corresponding author), Evandro Chagas Inst, Lab Environm Microbiol, Ananindeua, Para, Brazil.	lenasa@iec.pa.gov.br	Thompson, Cristiane C/I-5783-2016; Edwards, Robert/Q-1691-2019; Garza, Daniel/AAN-8016-2021; Garza, Daniel Rios/A-1716-2016; Garza, Daniel/AAF-6237-2019; Dutilh, Bas E./B-9719-2011; Teixera Nunes, Marcio Roberto/B-2238-2016	Edwards, Robert/0000-0001-8383-8949; Garza, Daniel/0000-0003-3865-2146; Garza, Daniel Rios/0000-0001-5956-6832; Dutilh, Bas E./0000-0003-2329-7890; Teixera Nunes, Marcio Roberto/0000-0001-9739-5499	Evandro Chagas Institute, SVS, Brazilian Ministry of Health; Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA	Evandro Chagas Institute, SVS, Brazilian Ministry of Health; Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Evandro Chagas Institute, SVS, Brazilian Ministry of Health (http://www.iec.pa.gov.br/); Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA (http://www.fapespa.pa.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1959, CHOLERA, P51; ANSARUZZAMAN M, 1995, J CLIN MICROBIOL, V33, P1339, DOI 10.1128/JCM.33.5.1339-1340.1995; Arakawa K, 2007, EVOL BIOINFORM, V3, P159; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; CAMERON DN, 1994, J CLIN MICROBIOL, V32, P1685, DOI 10.1128/JCM.32.7.1685-1690.1994; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASTILLO L, 1994, REV MED CHILE, V122, P986; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cho YJ, 2010, CURR OPIN MICROBIOL, V3, P1; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cuevas DA, ACSESS P; Drummond AJ AB, 2011, GENEIOUS V4 8; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King AM, 2012, 9 REPORT INT COMMITT, P770; Lam C, 2010, EMERG INFECT DIS, V16, P1130, DOI 10.3201/eid1607.100131; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mutreja A, 2011, NATURE, V000, P1; Natale DA, 2000, GENETICA, V108, P9, DOI 10.1023/A:1004031323748; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; POPOVIC T, 1993, J CLIN MICROBIOL, V31, P2474, DOI 10.1128/JCM.31.9.2474-2482.1993; Ramos F, 1997, LATIN AM MICROBIOL, V39, P141; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Tauxe Robert, 1994, P321; Timms AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-214; VUGIA DJ, 1994, AM J TROP MED HYG, V50, P566, DOI 10.4269/ajtmh.1994.50.566; WACHSMUTH IK, 1993, J INFECT DIS, V167, P621, DOI 10.1093/infdis/167.3.621; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wei SW, 2008, INT J FOOD MICROBIOL, V122, P148, DOI 10.1016/j.ijfoodmicro.2007.11.061; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37283	10.1371/journal.pone.0037283	http://dx.doi.org/10.1371/journal.pone.0037283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662140	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300030
J	Jelsone-Swain, LM; Smith, DV; Baylis, GC				Jelsone-Swain, Laura M.; Smith, David V.; Baylis, Gordon C.			The Effect of Stimulus Duration and Motor Response in Hemispatial Neglect during a Visual Search Task	PLOS ONE			English	Article							SPATIAL NEGLECT; UNILATERAL NEGLECT; EXTINCTION; ATTENTION; AWARENESS; OBJECTS; INFORMATION; HEMISPHERE; DEFICITS; ANATOMY	Patients with hemispatial neglect exhibit a myriad of profound deficits. A hallmark of this syndrome is the patients' absence of awareness of items located in their contralesional space. Many studies, however, have demonstrated that neglect patients exhibit some level of processing of these neglected items. It has been suggested that unconscious processing of neglected information may manifest as a fast denial. This theory of fast denial proposes that neglected stimuli are detected in the same way as non-neglected stimuli, but without overt awareness. We evaluated the fast denial theory by conducting two separate visual search task experiments, each differing by the duration of stimulus presentation. Specifically, in Experiment 1 each stimulus remained in the participants' visual field until a response was made. In Experiment 2 each stimulus was presented for only a brief duration. We further evaluated the fast denial theory by comparing verbal to motor task responses in each experiment. Overall, our results from both experiments and tasks showed no evidence for the presence of implicit knowledge of neglected stimuli. Instead, patients with neglect responded the same when they neglected stimuli as when they correctly reported stimulus absence. These findings thus cast doubt on the concept of the fast denial theory and its consequent implications for non-conscious processing. Importantly, our study demonstrated that the only behavior affected was during conscious detection of ipsilesional stimuli. Specifically, patients were slower to detect stimuli in Experiment 1 compared to Experiment 2, suggesting a duration effect occurred during conscious processing of information. Additionally, reaction time and accuracy were similar when reporting verbally versus motorically. These results provide new insights into the perceptual deficits associated with neglect and further support other work that falsifies the fast denial account of non-conscious processing in hemispatial visual neglect.	[Jelsone-Swain, Laura M.; Smith, David V.; Baylis, Gordon C.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jelsone-Swain, LM (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	lauraswa@med.umich.edu	Smith, David V./A-5487-2011	Smith, David V./0000-0001-5754-9633; BAYLIS, Gordon/0000-0002-4223-9074; Jelsone-Swain, Laura/0000-0002-9179-8884	National Institutes of Health [NS042047]; University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (GCB: NS042047) and by intramural funding from the University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Baylis GC, 2004, NEUROPSYCHOLOGIA, V42, P175, DOI 10.1016/j.neuropsychologia.2003.07.001; Baylis GC, 2001, VIS COGN, V8, P359, DOI 10.1080/13506280143000052; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; Berti A, 1999, NEUROPSYCHOLOGIA, V37, P333, DOI 10.1016/S0028-3932(98)00077-3; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bisiach E, 1985, ATTENTION PERFORM, P239; Broeren J, 2007, ACTA NEUROL SCAND, V116, P157, DOI 10.1111/j.1600-0404.2007.00821.x; Cappelletti M, 2006, NEUROPSYCHOLOGIA, V44, P1999, DOI 10.1016/j.neuropsychologia.2006.03.014; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Cubelli R, 2011, CORTEX, V47, P899, DOI 10.1016/j.cortex.2011.01.006; Danckert J, 2006, NEUROPSYCHOLOGIA, V44, P987, DOI 10.1016/j.neuropsychologia.2005.09.004; DIPELLEGRINO G, 1995, NEUROPSYCHOLOGIA, V33, P353, DOI 10.1016/0028-3932(94)00106-Y; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Eskes GA, 2006, RESTOR NEUROL NEUROS, V24, P385; Gore CL, 2001, BEHAV NEUROL, V13, P29; Kanne SM, 2002, COGN NEUROPSYCHOL, V19, P245, DOI 10.1080/02643290143000178; Karnath H. O., 2011, NEUROPSYCHOLOGIA; Karnath HO, 2011, BRAIN, V134, P903, DOI 10.1093/brain/awq355; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Ladavas E, 1997, NEUROPSYCHOLOGIA, V35, P257, DOI 10.1016/S0028-3932(96)00066-8; Laeng B, 2002, NEUROPSYCHOLOGIA, V40, P1622, DOI 10.1016/S0028-3932(01)00230-5; Maravita A, 1997, NEUROREPORT, V8, P1671, DOI 10.1097/00001756-199705060-00022; MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; MIJOVICPRELEC D, 1994, NEUROPSYCHOLOGIA, V32, P151, DOI 10.1016/0028-3932(94)90002-7; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; POSNER MI, 1984, J NEUROSCI, V4, P1863; Rafal R, 2006, BRAIN RES, V1080, P2, DOI 10.1016/j.brainres.2005.01.108; Rastelli F, 2008, EXP BRAIN RES, V187, P439, DOI 10.1007/s00221-008-1316-x; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Sackur J, 2008, CORTEX, V44, P673, DOI 10.1016/j.cortex.2007.02.003; Snow JC, 2011, CORTEX, P1; Suchan J, 2011, BRAIN, V134, P3059, DOI 10.1093/brain/awr120; VOLPE BT, 1979, NATURE, V282, P722, DOI 10.1038/282722a0; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2001, CORTEX, V37, P741, DOI 10.1016/S0010-9452(08)70629-4; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072	39	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37369	10.1371/journal.pone.0037369	http://dx.doi.org/10.1371/journal.pone.0037369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662149	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300038
J	Lundasen, T; Andersson, EM; Snaith, M; Lindmark, H; Lundberg, J; Ostlund-Lindqvist, AM; Angelin, B; Rudling, M				Lundasen, Thomas; Andersson, Eva-Marie; Snaith, Michael; Lindmark, Helena; Lundberg, Johanna; Ostlund-Lindqvist, Ann-Margret; Angelin, Bo; Rudling, Mats			Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LIVER-X-RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE ACTIVITY; INSULIN-RESISTANCE; ILEAL EXCLUSION; PPAR-ALPHA; CHOLESTYRAMINE; INDUCTION; EXPRESSION; ASSAY	Interruption of the enterohepatic circulation of bile acids increases cholesterol catabolism, thereby stimulating hepatic cholesterol synthesis from acetate. We hypothesized that such treatment should lower the hepatic acetate pool which may alter triglyceride and glucose metabolism. We explored this using mice deficient of the ileal sodium-dependent BA transporter (Slc10a2) and ob/ob mice treated with a specific inhibitor of Slc10a2. Plasma TG levels were reduced in Slc10a2-deficient mice, and when challenged with a sucrose-rich diet, they displayed a reduced response in hepatic TG production as observed from the mRNA levels of several key enzymes in fatty acid synthesis. This effect was paralleled by a diminished induction of mature sterol regulatory element-binding protein 1c (Srebp1c). Unexpectedly, the SR-diet induced intestinal fibroblast growth factor (FGF) 15 mRNA and normalized bile acid synthesis in Slc10a2-/- mice. Pharmacologic inhibition of Slc10a2 in diabetic ob/ob mice reduced serum glucose, insulin and TGs, as well as hepatic mRNA levels of Srebp1c and its target genes. These responses are contrary to those reported following treatment of mice with a bile acid binding resin. Moreover, when key metabolic signal transduction pathways in the liver were investigated, those of Mek1/2 - Erk1/2 and Akt were blunted after treatment of ob/ob mice with the Slc10a2 inhibitor. It is concluded that abrogation of Slc10a2 reduces hepatic Srebp1c activity and serum TGs, and in the diabetic ob/ob model it also reduces glucose and insulin levels. Hence, targeting of Slc10a2 may be a promising strategy to treat hypertriglyceridemia and diabetes.	[Lundasen, Thomas; Lundberg, Johanna; Angelin, Bo; Rudling, Mats] Karolinska Inst, Dept Endocrinol Metab & Diabet, Dept Med, Stockholm, Sweden; [Lundasen, Thomas; Lundberg, Johanna; Angelin, Bo; Rudling, Mats] Karolinska Univ Hosp Huddinge, Mol Nutr Unit, Ctr Biosci, Novum, Stockholm, Sweden; [Andersson, Eva-Marie; Lindmark, Helena; Ostlund-Lindqvist, Ann-Margret] AstraZeneca R&D, Biosci, Molndal, Sweden; [Lindmark, Helena] AstraZeneca R&D, Lead Generat, Molndal, Sweden; [Snaith, Michael] AstraZeneca R&D, Transgen & Comparat Genom, Molndal, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; AstraZeneca; AstraZeneca	Lundasen, T (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Florida Campus, Jupiter, FL USA.	mats.rudling@ki.se			Swedish Research Council; Swedish Foundation for Strategic Research; non-profit foundations of Gronberg; Female Old Servants; Swedish Diabetes; Swedish Heart-Lung Foundations; Stockholm City Council (ALF); Cardiovascular program, Karolinska Institute/Stockholm City Council; AstraZeneca; Albireo AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); non-profit foundations of Gronberg; Female Old Servants; Swedish Diabetes; Swedish Heart-Lung Foundations(Swedish Heart-Lung Foundation); Stockholm City Council (ALF); Cardiovascular program, Karolinska Institute/Stockholm City Council; AstraZeneca(AstraZeneca); Albireo AB	The work performed at Karolinska Institute was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, and the non-profit foundations of Gronberg, Female Old Servants, Swedish Diabetes, and Swedish Heart-Lung Foundations, the Stockholm City Council (ALF), and the Cardiovascular program, Karolinska Institute/Stockholm City Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BA and MR have for other studies received research grants from AstraZeneca and Albireo AB; BA has served as a board member of and is a shareholder in AstraZeneca PLC; EMA, HL, SS and A-MO-L are employees at AstraZeneca. MS and SS were previously employed by AstraZeneca; TL and JL have nothing to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AKERLUND JE, 1994, GUT, V35, P1116, DOI 10.1136/gut.35.8.1116; ANGELIN B, 1990, J INTERN MED, V227, P201, DOI 10.1111/j.1365-2796.1990.tb00143.x; ANGELIN B, 1987, P NATL ACAD SCI USA, V84, P5434, DOI 10.1073/pnas.84.15.5434; ANGELIN B, 1978, J LIPID RES, V19, P1017; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DOWLING R H, 1970, Journal of Clinical Investigation, V49, P232, DOI 10.1172/JCI106232; EINARSSON K, 1986, J LIPID RES, V27, P82; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Galman C, 2002, FASEB J, V16, P265, DOI 10.1096/fj.0341fje; Galman C, 2003, J LIPID RES, V44, P859, DOI 10.1194/jlr.D200043-JLR200; Galman C, 2002, ENDOCRINOLOGY, V143, P1809, DOI 10.1210/en.143.5.1809; Galman C, 2011, J INTERN MED; GRUNDY SM, 1971, J LAB CLIN MED, V78, P94; HASSAN AS, 1984, ATHEROSCLEROSIS, V51, P327, DOI 10.1016/0021-9150(84)90180-1; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Herrema H, 2010, HEPATOLOGY, V51, P806, DOI 10.1002/hep.23408; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; REIHNER E, 1990, J LIPID RES, V31, P2219; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; RUDLING M, 1992, J LIPID RES, V33, P493; RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; WHITE MF, 1994, J BIOL CHEM, V269, P1; WITZTUM JL, 1976, J LAB CLIN MED, V88, P1008	44	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37787	10.1371/journal.pone.0037787	http://dx.doi.org/10.1371/journal.pone.0037787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662222	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300112
J	Tivnan, A; Orr, WS; Gubala, V; Nooney, R; Williams, DE; McDonagh, C; Prenter, S; Harvey, H; Domingo-Fernandez, R; Bray, IM; Piskareva, O; Ng, CY; Lode, HN; Davidoff, AM; Stallings, RL				Tivnan, Amanda; Orr, Wayne Shannon; Gubala, Vladimir; Nooney, Robert; Williams, David E.; McDonagh, Colette; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Ng, Catherine Y.; Lode, Holger N.; Davidoff, Andrew M.; Stallings, Raymond L.			Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles	PLOS ONE			English	Article							IN-VIVO; CANCER-CELLS; DOWN-REGULATION; MYCN ONCOGENE; LUNG-CANCER; PHASE-I; N-MYC; EXPRESSION; THERAPY; SUPPRESSOR	Background: Neuroblastoma is one of the most challenging malignancies of childhood, being associated with the highest death rate in paediatric oncology, underlining the need for novel therapeutic approaches. Typically, patients with high risk disease undergo an initial remission in response to treatment, followed by disease recurrence that has become refractory to further treatment. Here, we demonstrate the first silica nanoparticle-based targeted delivery of a tumor suppressive, proapoptotic microRNA, miR-34a, to neuroblastoma tumors in a murine orthotopic xenograft model. These tumors express high levels of the cell surface antigen disialoganglioside GD2 (GD(2)), providing a target for tumor-specific delivery. Principal Findings: Nanoparticles encapsulating miR-34a and conjugated to a GD(2) antibody facilitated tumor-specific delivery following systemic administration into tumor bearing mice, resulted in significantly decreased tumor growth, increased apoptosis and a reduction in vascularisation. We further demonstrate a novel, multi-step molecular mechanism by which miR-34a leads to increased levels of the tissue inhibitor metallopeptidase 2 precursor (TIMP2) protein, accounting for the highly reduced vascularisation noted in miR-34a-treated tumors. Significance: These novel findings highlight the potential of anti-GD(2)-nanoparticle-mediated targeted delivery of miR-34a for both the treatment of GD(2)-expressing tumors, and as a basic discovery tool for elucidating biological effects of novel miRNAs on tumor growth.	[Tivnan, Amanda; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Tivnan, Amanda; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Orr, Wayne Shannon; Ng, Catherine Y.; Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Orr, Wayne Shannon; Davidoff, Andrew M.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Gubala, Vladimir; Nooney, Robert; Williams, David E.; McDonagh, Colette] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland; [Lode, Holger N.] Ernst Moritz Arndt Univ Greifswald, Dept Paediat & Paediat Haematol Oncol, Greifswald, Germany	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Dublin City University; Ernst Moritz Arndt Universitat Greifswald	Tivnan, A (corresponding author), Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Williams, David E/B-3222-2012	Williams, David E/0000-0003-4123-5626; Gubala, Vladimir/0000-0001-6301-3632; McDonagh, Colette/0000-0003-2786-8785; Lode, Holger/0000-0002-1201-208X; Harvey, Harry/0000-0001-9542-7530	Science Foundation Ireland [07/IN.1/B1776, 10/CE/B1821]; Children's Medical and Research Foundation; HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease [PHD/2007/11]; Assisi Foundation of Memphis; US Public Health Service [CA23099]; Cancer Center Support Grant from the National Cancer Institute [21766]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P01CA023099] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease; Assisi Foundation of Memphis; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cancer Center Support Grant from the National Cancer Institute; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Science Foundation Ireland Principal Investigator Award (07/IN.1/B1776) (RLS), the Children's Medical and Research Foundation (RLS), the HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease (PHD/2007/11) (HH), the Assisi Foundation of Memphis (AMD), the US Public Health Service Childhood Solid Tumor Program Project Grant No. CA23099 (AMD), the Cancer Center Support Grant No. 21766 from the National Cancer Institute (AMD), and by the American Lebanese Syrian Associated Charities (ALSAC) (AMD). This material is based upon research supported by the Science Foundation Ireland, under Grant No. 10/CE/B1821 (RN). Human/mouse chimeric antibody ch14.18/CHO was made available by a European effort through SIOPN (President Assoc. Prof. R. Ladenstein) funded by charities throughout Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Barbe C., 2004, ADV MATER, V16, P8; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136; Cheung NKV, 2000, CLIN CANCER RES, V6, P2653; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; Di Paolo D, 2011, MOL THER; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; FATTAL E, 1991, J MICROENCAPSUL, V8, P29, DOI 10.3109/02652049109021855; Finnie KS, 2009, J SOL-GEL SCI TECHN, V49, P12, DOI 10.1007/s10971-008-1847-4; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Foster-Waldl E, 2005, MOL IMMUNOL, V42, P319, DOI 10.1016/j.molimm.2004.07.011; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Gubala V, 2011, ANAL ADV ARTICLE; Gubala V, 2010, TALANTA, V81, P1833, DOI 10.1016/j.talanta.2010.03.048; Haber M, 1999, ONCOGENE, V18, P2777, DOI 10.1038/sj.onc.1202859; HANDGRETINGER R, 1995, EUR J CANCER, V31A, P261, DOI 10.1016/0959-8049(94)00413-Y; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hobley G, 2008, SYNLETT, P1510, DOI 10.1055/s-2007-1077795; Hom C, 2009, J MATER CHEM, V19, P6308, DOI 10.1039/b904197d; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kim M, 2011, LANCET ONCOL, V12, P319, DOI 10.1016/S1470-2045(11)70067-5; Kim VN, 2005, MOL CELLS, V19, P1; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; MUELLER BM, 1990, J IMMUNOL, V144, P1382; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Murray JL, 1996, J IMMUNOTHER, V19, P206, DOI 10.1097/00002371-199605000-00005; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Nooney RI, 2009, ANAL BIOANAL CHEM, V393, P1143, DOI 10.1007/s00216-008-2418-9; Pagnan G, 2000, J NATL CANCER I, V92, P253, DOI 10.1093/jnci/92.3.253; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Park SJ, 2008, LANGMUIR, V24, P12134, DOI 10.1021/la8028885; Patil YB, 2010, BIOMATERIALS, V31, P358, DOI 10.1016/j.biomaterials.2009.09.048; Patterson DM, 2011, ANGIOGENESIS ADV ONL; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Ritter G, 1991, Semin Cancer Biol, V2, P401; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Seo DW, 2011, PEPTIDES, V32, P1840, DOI 10.1016/j.peptides.2011.08.010; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Trang P, 2011, MOL THER; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Wallace M, 1997, AN H ANALG, V85, P2; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, CANC RES, V70, P5923; Williams RF, 2010, J PEDIATR SURG, V45, P1103, DOI 10.1016/j.jpedsurg.2010.02.073; WU ZL, 1986, CANCER RES, V46, P440; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yu AL, 1998, J CLIN ONCOL, V16, P2169, DOI 10.1200/JCO.1998.16.6.2169; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018; Zeytin HE, 2000, CANCER GENE THER, V7, P1426, DOI 10.1038/sj.cgt.7700240	74	176	187	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38129	10.1371/journal.pone.0038129	http://dx.doi.org/10.1371/journal.pone.0038129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662276	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305342300168
J	Veracx, A; Boutellis, A; Merhej, V; Diatta, G; Raoult, D				Veracx, Aurelie; Boutellis, Amina; Merhej, Vicky; Diatta, Georges; Raoult, Didier			Evidence for an African Cluster of Human Head and Body Lice with Variable Colors and Interbreeding of Lice between Continents	PLOS ONE			English	Article							PHTHIRAPTERA; PEDICULIDAE; EVOLUTION; LOUSE	Background: Human head lice and body lice have been classified based on phenotypic characteristics, including geographical source, ecotype (preferred egg laying site hair or clothes), shape and color. More recently, genotypic studies have been based on mitochondrial genes, nuclear genes and intergenic spacers. Mitochondrial genetic analysis reclassified lice into three genotypes (A, B and C). However, no previous study has attempted to correlate both genotypic and phenotypic data. Materials and Methods: Lice were collected in four African countries: Senegal, Burundi, Rwanda and Ethiopia and were photographed to compare their colors. The Multi-Spacer-Typing (MST) method was used to genotype lice belonging to the worldwide Clade A, allowing a comparison of phenotypic and genotypic data. Results: No congruence between louse color and genotype has been identified. Phylogenetic analysis of the spacer PM2, performed including lice from other sources, showed the existence of an African cluster of human lice. However, the analysis of other spacers suggested that lice from different areas are interbreeding. Conclusions: We identified two geotypes of Clade A head and body lice including one that is specifically African, that can be either black or grey and can live on the head or in clothing. We also hypothesized that lice from different areas are interbreeding.	[Veracx, Aurelie; Boutellis, Amina; Merhej, Vicky; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 198,IFR48,Fac Med, Marseille, France; [Diatta, Georges] URMITE, Inst Rech Dev, Hann, UMR 198, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Veracx, A (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 198,IFR48,Fac Med, Marseille, France.	Didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Merhej, Vicky/J-4733-2015	RAOULT, Didier/0000-0002-0633-5974; merhej, vicky/0000-0002-8688-6943				ALPATOV WW, 1955, B SOC NAT MOSCOW, V60, P79; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Bacot A., 1917, Parasitology Cambridge, V9, DOI 10.1017/S0031182000006065; Boutellis A, 2011, VECTOR BORN IN PRESS; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; BUSVINE JR, 1948, PARASITOLOGY, V39, P1, DOI 10.1017/S0031182000083505; BUSVINE JR, 1978, SYST ENTOMOL, V3, P1, DOI 10.1111/j.1365-3113.1978.tb00383.x; Buxton P. A, 1947, LOUSE ACCOUNT LICE W; De Geer C., 1778, MEMOIRES SERVIR HIST, P62; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler W., 1956, Dermatologische Wochenschrift Leipzig, V133, P657; EICHLER W, 1982, Angewandte Parasitologie, V23, P102; EWING H. E., 1926, PROC U S NATION MUS, V68, P1; Hans Zinsser, 1935, RATS LICE HIST; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Leo NP, 2005, PARASITOL RES, V98, P44, DOI 10.1007/s00436-005-0013-y; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Leo NP, 2002, INSECT MOL BIOL, V11, P651, DOI 10.1046/j.1365-2583.2002.00367.x; Leo NP, 2002, J MED ENTOMOL, V39, P662, DOI 10.1603/0022-2585-39.4.662; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Maunder J.W., 1983, Proceedings of the Royal Institution of Great Britain, V55, P1; Nuttall GH, 2012, PARASITOLOGY, V12, P136; Raoult D, 2008, J INFECT DIS, P197; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Shipley A.E., 1915, MINOR HORRORS WAR, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yong Z, 2003, C R BIOL, V326	27	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37804	10.1371/journal.pone.0037804	http://dx.doi.org/10.1371/journal.pone.0037804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662229	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300119
J	Ishima, T; Hashimoto, K				Ishima, Tamaki; Hashimoto, Kenji			Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors	PLOS ONE			English	Article							RAT-BRAIN; NEUROPSYCHIATRIC DISORDERS; THERAPEUTIC DRUGS; NMDA RECEPTORS; FLUVOXAMINE; ANTAGONIST; BINDING; AGONIST; CALCIUM; LIGAND	In addition to both the alpha 1 adrenergic receptor and N-methyl-D-aspartate (NMDA) receptor antagonists, ifenprodil binds to the sigma receptor subtypes 1 and 2. In this study, we examined the effects of ifenprodil on nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Ifenprodil significantly potentiated NGF-induced neurite outgrowth, in a concentration-dependent manner. In contrast, the alpha 1 adrenergic receptor antagonist, prazosin and the NMDA receptor NR2B antagonist, Ro 25-6981 did not alter NGF-induced neurite outgrowth. Potentiation of NGF-induced neurite outgrowth mediated by ifenprodil was significantly antagonized by co-administration of the selective sigma-1 receptor antagonist, NE-100, but not the sigma-2 receptor antagonist, SM-21. Similarly, ifenprodil enhanced NGF-induced neurite outgrowth was again significantly reduced by the inositol 1,4,5-triphosphate (IP3) receptor antagonists, xestospongin C and 2-aminoethoxydiphenyl borate (2-APB) treatment. Furthermore, BAPTA-AM, a chelator of intracellular Ca2+, blocked the effects of ifenprodil on NGF-induced neurite outgrowth, indicating the role of intracellular Ca2+ in the neurite outgrowth. These findings suggest that activation at sigma-1 receptors and subsequent interaction with IP3 receptors may mediate the pharmacological effects of ifenprodil on neurite outgrowth.	[Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University	Ishima, T (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Grants-in-Aid for Scientific Research [23791308] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chambers R A, 1999, Semin Clin Neuropsychiatry, V4, P274; Cortese BM, 2005, CNS SPECTRUMS, V10, P820, DOI 10.1017/S1092852900010427; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Ghelardini C, 2000, PHARMACOL BIOCHEM BE, V67, P659, DOI 10.1016/S0091-3057(00)00405-6; HASHIMOTO K, 1994, EUR J PHARM-MOLEC PH, V266, P67, DOI 10.1016/0922-4106(94)90211-9; HASHIMOTO K, 1995, EUR J PHARMACOL, V273, P307, DOI 10.1016/0014-2999(94)00763-W; HASHIMOTO K, 1993, EUR J PHARMACOL, V236, P159, DOI 10.1016/0014-2999(93)90241-9; Hashimoto K, 2012, INT J GERIA IN PRESS; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hashimoto K, 2009, CNS NEUROL DISORD-DR, V8, P470, DOI 10.2174/187152709789824633; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hayashi T, 2008, EXPERT OPIN THER TAR, V12, P45, DOI 10.1517/14728222.12.1.45; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hindmarch I, 2010, HUM PSYCHOPHARM CLIN, V25, P193, DOI 10.1002/hup.1106; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Itoh K, 2011, BRAIN RES, V1377, P32, DOI 10.1016/j.brainres.2010.12.075; Kishimoto A, 2012, BIOL PSYCHIAT, V71, pE7, DOI 10.1016/j.biopsych.2011.10.014; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Mutel V, 1998, J NEUROCHEM, V70, P2147; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Okuyama S., 1996, CNS DRUG REV, V2, P226, DOI 10.1111/j.1527-3458.1996.tb00299.x; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Takeshita M, 2011, CHEM RES TOXICOL, V24, P1845, DOI 10.1021/tx200160g; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Yoshida T, 2012, CURR PSYCHI IN PRESS	37	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37989	10.1371/journal.pone.0037989	http://dx.doi.org/10.1371/journal.pone.0037989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655093	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900070
J	Jayasinghe, SS; Pathirana, KD				Jayasinghe, Sudheera S.; Pathirana, Kithsiri D.			Autonomic Function following Acute Organophosphorus Poisoning: A Cohort Study	PLOS ONE			English	Article							NEUROPATHY	Autonomic dysfunction after chronic low level exposure to organophosphorus (OP) pesticides has been consistently reported in the literature, but not following a single acute overdose. In order to study autonomic function after an acute OP overdose, sixty-six overdose patients were compared to 70 matched controls. Assessment of autonomic function was done by heart rate response to standing, deep breathing (HR-DB) and Valsalva manoeuvre; blood pressure (BP) response to standing and sustained hand grip; amplitude and latency of sympathetic skin response (SSR); pupil size and post-void urine volume. The patients were assessed one and six weeks after the exposure. The number of patients who showed abnormal autonomic function compared to standard cut-off values did not show statistically significantly difference from that of controls by Chi-Square test. When compared to the controls at one week the only significant differences consistent with autonomic dysfunction were change of diastolic BP 3 min after standing, HR-DB, SSR-Amplitude, SSR-Latency, post-void urine volume and size of the pupil. At 6 weeks significant recovery of autonomic function was observed and only HR-DB was decreased to a minor degree, -5 beats/min [95%CI 2-8]. This study provides good evidence for the lack of long term autonomic dysfunction following acute exposure to OP pesticides.	[Jayasinghe, Sudheera S.] Univ Ruhuna, Dept Pharmacol, Fac Med, Karapitiya, Galle, Sri Lanka; [Jayasinghe, Sudheera S.] Univ Peradeniya, S Asian Clin Toxicol Res Collaborat, Dept Med, Fac Med, Peradeniya, Sri Lanka; [Jayasinghe, Sudheera S.; Pathirana, Kithsiri D.] Univ Ruhuna, Clin Neurosci Ctr, Dept Med, Fac Med, Karapitiya, Galle, Sri Lanka	University Ruhuna; University of Peradeniya; University Ruhuna	Jayasinghe, SS (corresponding author), Univ Ruhuna, Dept Pharmacol, Fac Med, Karapitiya, Galle, Sri Lanka.	sudheerasj@yahoo.com			South Asian Clinical Toxicology Research Collaboration; Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant [GR071669MA]	South Asian Clinical Toxicology Research Collaboration; Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant	This study was supported by the South Asian Clinical Toxicology Research Collaboration, which is funded by the Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant GR071669MA. The study sponsor had no role in study design, data collection, data analysis, data interpretation, decision to publish, or preparation of the manuscript.	AMINOFF MJ, 2005, ELECTRODIAGNOSIS CLI; Annual Health Bulletin, 2003, ANN HLTH B HLTH MIN, P21; Eddleston M, 2008, QJM-INT J MED, V101, P467, DOI 10.1093/qjmed/hcn026; Engel LS, 1998, ARCH ENVIRON HEALTH, V53, P7, DOI 10.1080/00039899809605684; EWING DJ, 1981, DIABETOLOGIA, V21, P18, DOI 10.1007/BF03216217; EWING DJ, 1982, BRIT MED J, V285, P916, DOI 10.1136/bmj.285.6346.916; EWING DJ, 1981, LANCET, V1, P224; Guidelines EBM, 2004, DETERMINE VOLUME RES; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; Jayarathnam J, 1982, B WORLD HEALTH ORGAN, V60, P615; Kelly Christopher E, 2004, Rev Urol, V6 Suppl 1, pS32; RUIJTEN MWMM, 1994, ARCH ENVIRON HEALTH, V49, P188, DOI 10.1080/00039896.1994.9940381; SENANAYAKE N, 1987, NEW ENGL J MED, V316, P761, DOI 10.1056/NEJM198703263161301; SENANAYAKE N, 1982, NEW ENGL J MED, V306, P155, DOI 10.1056/NEJM198201213060306; Singh S, 2000, NEUROL INDIA, V48, P308; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; Worek F, 1999, CLIN CHIM ACTA, V288, P73, DOI 10.1016/S0009-8981(99)00144-8	18	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37987	10.1371/journal.pone.0037987	http://dx.doi.org/10.1371/journal.pone.0037987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655091	gold, Green Published			2022-12-25	WOS:000305338900068
J	Rosjo, H; Stridsberg, M; Florholmen, G; Stenslokken, KO; Ottesen, AH; Sjaastad, I; Husberg, C; Dahl, MB; Oie, E; Louch, WE; Omland, T; Christensen, G				Rosjo, Helge; Stridsberg, Mats; Florholmen, Geir; Stenslokken, Kare-Olav; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir			Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties	PLOS ONE			English	Article							CHROMOGRANIN-A; PROGNOSTIC VALUE; SECRETONEURIN; NEUROPEPTIDE; PATHWAY; QUANTIFICATION; ASSOCIATION; EXPRESSION; CATESTATIN; PEPTIDE	Background: Several beneficial effects have been demonstrated for secretogranin II (SgII) in non-cardiac tissue. As cardiac production of chromogranin A and B, two related proteins, is increased in heart failure (HF), we hypothesized that SgII could play a role in cardiovascular pathophysiology. Methodology/Principal Findings: SgII production was characterized in a post-myocardial infarction heart failure (HF) mouse model, functional properties explored in experimental models, and circulating levels measured in mice and patients with stable HF of moderate severity. SgII mRNA levels were 10.5 fold upregulated in the left ventricle (LV) of animals with myocardial infarction and HF (p<0.001 vs. sham-operated animals). SgII protein levels were also increased in the LV, but not in other organs investigated. SgII was produced in several cell types in the myocardium and cardiomyocyte synthesis of SgII was potently induced by transforming growth factor-beta and norepinephrine stimulation in vitro. Processing of SgII to shorter peptides was enhanced in the failing myocardium due to increased levels of the proteases PC1/3 and PC2 and circulating SgII levels were increased in mice with HF. Examining a pathophysiological role of SgII in the initial phase of post-infarction HF, the SgII fragment secretoneurin reduced myocardial ischemia-reperfusion injury and cardiomyocyte apoptosis by 30% and rapidly increased cardiomyocyte Erk1/2 and Stat3 phosphorylation. SgII levels were also higher in patients with stable, chronic HF compared to age-and gender-matched control subjects: median 0.16 (Q1-3 0.14-0.18) vs. 0.12 (0.10-0.14) nmol/L, p<0.001. Conclusions: We demonstrate increased myocardial SgII production and processing in the LV in animals with myocardial infarction and HF, which could be beneficial as the SgII fragment secretoneurin protects from ischemia-reperfusion injury and cardiomyocyte apoptosis. Circulating SgII levels are also increased in patients with chronic, stable HF and may represent a new cardiac biomarker.	[Rosjo, Helge; Ottesen, Anett Hellebo; Dahl, Mai Britt; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Rosjo, Helge; Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway; [Rosjo, Helge; Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Inst Clin Med, Oslo, Norway; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Louch, William E.; Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Stenslokken, Kare-Olav] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Dahl, Mai Britt] Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; [Oie, Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Uppsala University; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Rosjo, H (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.	helge.rosjo@medisin.uio.no		Stenslokken, Kare-Olav/0000-0003-2962-4143	South-Eastern Norway Regional Health Authority, Akershus University Hospital; University of Oslo; Norwegian National Health Association; Anders Jahre Foundation for Promotion of Science; K.G. Jebsen Foundation; South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority, Akershus University Hospital; University of Oslo; Norwegian National Health Association; Anders Jahre Foundation for Promotion of Science; K.G. Jebsen Foundation; South-Eastern Norway Regional Health Authority	This work was supported by the South-Eastern Norway Regional Health Authority, Akershus University Hospital, the University of Oslo, the Norwegian National Health Association, the Anders Jahre Foundation for Promotion of Science, and the K.G. Jebsen Foundation. H. R. is recipient of a research fellowship from the South-Eastern Norway Regional Health Authority to study granin proteins in cardiovascular disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1996, BLOOD, V87, P674, DOI 10.1182/blood.V87.2.674.bloodjournal872674; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Berman Y, 2000, J NEUROCHEM, V75, P1763, DOI 10.1046/j.1471-4159.2000.0751763.x; Biswas N, 2010, CELL TISSUE RES, V342, P353, DOI 10.1007/s00441-010-1059-4; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Damas JK, 2000, CARDIOVASC RES, V45, P428, DOI 10.1016/S0008-6363(99)00262-X; DITTIE AS, 1995, BIOCHEM J, V310, P777, DOI 10.1042/bj3100777; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Estensen ME, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.008; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; Heidrich Felix M, 2011, Congest Heart Fail, V17, P314, DOI 10.1111/j.1751-7133.2011.00249.x; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; HOFLEHNER J, 1995, FEBS LETT, V360, P294, DOI 10.1016/0014-5793(95)00127-U; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jin HK, 2004, CIRCULATION, V109, P2240, DOI 10.1161/01.CIR.0000127951.13380.B4; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitner B, 1996, J NEUROCHEM, V66, P1312; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Mahata SK, 2002, ANN NY ACAD SCI, V971, P27, DOI 10.1111/j.1749-6632.2002.tb04429.x; Omland T, 2003, AM J MED, V114, P25, DOI 10.1016/S0002-9343(02)01425-0; Peinado JR, 2006, ENDOCRINOLOGY, V147, P1408, DOI 10.1210/en.2005-0975; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; REINISCH N, 1993, FEBS LETT, V334, P41, DOI 10.1016/0014-5793(93)81676-Q; Rosjo H, 2010, CIRC-HEART FAIL, V3, P503, DOI 10.1161/CIRCHEARTFAILURE.109.867747; Rosjo H, 2010, EUR J HEART FAIL, V12, P549, DOI 10.1093/eurjhf/hfq055; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schneitler C, 1998, J NEUROIMMUNOL, V86, P87, DOI 10.1016/S0165-5728(98)00012-5; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Stridsberg M, 2005, REGUL PEPTIDES, V125, P193, DOI 10.1016/j.regpep.2004.08.027; Stridsberg M, 2008, REGUL PEPTIDES, V148, P95, DOI 10.1016/j.regpep.2008.03.007; Yoo SH, 2012, CELL CALCIUM, V51, P342, DOI 10.1016/j.ceca.2011.12.008	42	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37401	10.1371/journal.pone.0037401	http://dx.doi.org/10.1371/journal.pone.0037401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655045	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900020
J	Mendlova, M; Desdevises, Y; Civanova, K; Pariselle, A; Simkova, A				Mendlova, Monika; Desdevises, Yves; Civanova, Kristina; Pariselle, Antoine; Simkova, Andrea			Monogeneans of West African Cichlid Fish: Evolution and Cophylogenetic Interactions	PLOS ONE			English	Article							CYTOCHROME-B GENE; ANCYROCEPHALIDAE GILL PARASITES; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; NUCLEOTIDE SUBSTITUTION; GYRODACTYLUS MONOGENEA; EXPLOSIVE SPECIATION; ENTEROGYRUS-PAPERNA; SYSTEMATIC REVISION; ADAPTIVE RADIATION	The goals of this paper were to investigate phylogenetic and evolutionary patterns of cichlid fish from West Africa and their Cichlidogyrus and Scutogyrus monogenean parasites, to uncover the presence of host-parasite cospeciation and to assess the level of morphological adaptation in parasites. This required the following steps, each one representing specific objectives of this paper: (1) to build phylogenetic trees for Cichlidogyrus and Scutogyrus species based on ribosomal DNA sequences, (2) to investigate phylogenetic relationships within West African cichlid fish based on the analysis of mitochondrial cytochrome b DNA sequences, (3) to investigate host-parasite cophylogenetic history to gain clues on parasite speciation process, and (4) to investigate the link between the morphology of the attachment apparatus and parasite phylogeny. Phylogenetic analyses supported the monophyletic origin of the Cichlidogyrus/Scutogyrus group, and suggested that Cichlidogyrus is polyphyletic and that Scutogyrus is monophyletic. The phylogeny of Cichlidae supported the separation of mouthbrooders and substrate-brooders and is consistent with the hypothesis that the mouthbrooding behavior of Oreochromis and Sarotherodon evolved from substrate-brooding behavior. The mapping of morphological characters of the haptor onto the parasite phylogenetic tree suggests that the attachment organ has evolved from a very simple form to a more complex one. The cophylogenetic analyses indicated a significant fit between trees using distance-based tests, but no significant cospeciation signal using tree-based tests, suggesting the presence of parasite duplications and host switches on related host species. This shed some light on the diversification process of Cichlidogyrus species parasitizing West African cichlids.	[Mendlova, Monika; Civanova, Kristina; Simkova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Desdevises, Yves] Univ Paris 06, UPMC, UMR 7232, Observ Oceanol,BIOM, Banyuls Sur Mer, France; [Desdevises, Yves] CNRS, UMR 7232, BIOM, Observ Oceanol, Banyuls Sur Mer, France; [Pariselle, Antoine] Univ Montpellier 2 CC065, Inst Sci Evolut, IRD CNRS UM2, Montpellier, France	Masaryk University Brno; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Mendlova, M (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	simkova@sci.muni.cz	Desdevises, Yves/AAH-2097-2019; Desdevises, Yves/H-5334-2019; Pariselle, Antoine/L-5776-2016; Simkova, Andrea/F-7636-2019; Desdevises, Yves/D-5528-2011; Civanova, Kristina/G-1182-2014	Desdevises, Yves/0000-0001-9774-0336; Pariselle, Antoine/0000-0002-1591-7423; Simkova, Andrea/0000-0002-5995-6766; Desdevises, Yves/0000-0001-9774-0336; Civanova, Kristina/0000-0001-5690-3637	Masaryk University, Brno, Czech Republic; Czech Science Foundation [P505/12/G112]	Masaryk University, Brno, Czech Republic(Czech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic)	The field studies in Africa and molecular analyses were funded by the research project of Masaryk University, Brno, Czech Republic. This study was supported by Czech Science Foundation No. P505/12/G112 (ECIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentz S, 2001, INT J PARASITOL, V31, P697, DOI 10.1016/S0020-7519(01)00179-5; Bilong Bilong Charles Felix, 1995, Journal of African Zoology, V109, P253; BILONG-BILONG C F, 1989, Revue de Zoologie Africaine, V103, P99; BilongBilong CF, 1996, SYST PARASITOL, V34, P37, DOI 10.1007/BF01531208; Boeger WA, 1997, INT J PARASITOL, V27, P1495, DOI 10.1016/S0020-7519(97)00140-9; BROOKS DR, 1979, SYST ZOOL, V28, P299, DOI 10.2307/2412584; Brooks DR, 1993, PARASCRIPT PARASITES; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Desdevises Y, 2002, EVOLUTION, V56, P2459, DOI 10.1111/j.0014-3820.2002.tb00171.x; Desdevises Y, 2000, INT J PARASITOL, V30, P741, DOI 10.1016/S0020-7519(00)00051-5; DOSSOU C, 1984, ANN SCI NAT ZOOL, V6, P101; DOSSOU C, 1982, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V44, P295; DOUELLOU L, 1993, SYST PARASITOL, V25, P159, DOI 10.1007/BF00007007; ERGENS R, 1981, FOLIA PARASIT, V28, P205; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; Huyse T, 2003, INT J PARASITOL, V33, P1679, DOI 10.1016/S0020-7519(03)00253-4; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Light JE, 2008, SYST BIOL, V57, P449, DOI 10.1080/10635150802169610; Lom J, 1970, AGENTS FISH DIS; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; MALMBERG G., 1957, Skrifter utgivna av Sodra Sveriges Fiskeriforening, P19; Martin AP, 1998, MOL PHYLOGENET EVOL, V9, P192, DOI 10.1006/mpev.1997.0461; Mayer WE, 1998, HEREDITY, V80, P702, DOI 10.1046/j.1365-2540.1998.00347.x; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Mendlova M, 2010, PARASITOL RES, V107, P1405, DOI 10.1007/s00436-010-2008-6; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Musilova Z, 2008, MOL PHYLOGENET EVOL, V46, P659, DOI 10.1016/j.ympev.2007.10.011; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; NOBLE ER, 1989, PARASITOLOGY BIOL AN; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Paperna I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA I, 1968, Bamidgeh, V20, P88; PAPERNA I, 1968, P HELM SOC WASH, V35, P200; Pariselle A, 1998, FOLIA PARASIT, V45, P275; PARISELLE A, 1994, SYST PARASITOL, V29, P229, DOI 10.1007/BF00009678; PARISELLE A, 1995, J HELMINTHOL SOC W, V62, P157; PARISELLE A, 1991, SYST PARASITOL, V20, P211, DOI 10.1007/BF00009785; Pariselle A, 2004, PARASITE, V11, P359, DOI 10.1051/parasite/2004114359; Pariselle A, 1997, SYST PARASITOL, V38, P221, DOI 10.1023/A:1005803202543; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulin R, 2002, INT J PARASITOL, V32, P245, DOI 10.1016/S0020-7519(01)00329-0; ROHDE K, 1991, OIKOS, V60, P91, DOI 10.2307/3544997; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Simkova A, 2006, PARASITOLOGY, V133, P43, DOI 10.1017/S0031182006009942; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Simkova A, 2003, SYST PARASITOL, V54, P1, DOI 10.1023/A:1022133608662; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; STIASSNY MLJ, 1987, J NAT HIST, V21, P1311, DOI 10.1080/00222938700770811; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; Streelman JT, 1998, MOL BIOL EVOL, V15, P798, DOI 10.1093/oxfordjournals.molbev.a025985; Sturmbauer C, 1998, J FISH BIOL, V53, P18; SULTMANN H, 1995, MOL BIOL EVOL, V12, P1033; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Wu XY, 2007, MOL PHYLOGENET EVOL, V44, P530, DOI 10.1016/j.ympev.2007.03.025; Yang JQ, 2006, HYDROBIOLOGIA, V553, P255, DOI 10.1007/s10750-005-1301-3; Zardoya R, 1996, P ROY SOC B-BIOL SCI, V263, P1589, DOI 10.1098/rspb.1996.0233; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	85	67	69	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37268	10.1371/journal.pone.0037268	http://dx.doi.org/10.1371/journal.pone.0037268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22662139	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500087
J	Li, Z; Hann, SR				Li, Z.; Hann, S. R.			Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription	ONCOGENE			English	Article						c-Myc; NPM/B23; nucleolus; rRNA	RIBOSOMAL DNA; PROTEIN; DEGRADATION; CELLS; STABILIZATION; ACCUMULATION; PROTEOLYSIS; ISOFORM; NETWORK; PATHWAY	The transcription factor c-Myc has a critical role in cell proliferation and growth. The control of ribosome biogenesis by c-Myc through the regulation of transcription mediated by all three RNA polymerases is essential for c-Myc-driven proliferation. Specifically, in the nucleolus, c-Myc has been shown to be recruited to ribosomal DNA and activate RNA polymerase (pol) I-mediated transcription of ribosomal RNA (rRNA) genes. In addition, c-Myc accumulates in nucleoli upon inhibition of the proteasome, suggesting nucleolar localization also has a role in c-Myc proteolysis. Nucleophosmin (NPM), a predominantly nucleolar protein, is also critical in ribosome biogenesis and, like c-Myc, is found overexpressed in many types of tumors. Previously, we demonstrated that NPM directly interacts with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Here, we show that NPM is necessary for the localization of c-Myc protein to nucleoli, whereas c-Myc nucleolar localization is independent of p53, Mdm2 and ARF. Conversely, high transient NPM expression enhances c-Myc nucleolar localization, leading to increased c-Myc proteolysis. In addition, NPM is necessary for the ability of c-Myc to induce rRNA synthesis in the nucleolus, and constitutive NPM overexpression stimulates c-Myc-mediated rRNA synthesis. Taken together, these results demonstrate an essential role for NPM in c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene (2013) 32, 1988-1994; doi:10.1038/onc.2012.227; published online 4 June 2012	[Li, Z.; Hann, S. R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Hann, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, MCN B-2317, Nashville, TN 37232 USA.	steve.hann@vanderbilt.edu			NCI [RO1 CA109586, CA125760]; NATIONAL CANCER INSTITUTE [R01CA109586, R01CA125760, R56CA109586] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C Pfarr for pCMV14-NPM-Flag vector, S McMahon for pSUPER retro vector, E Lee for the anti-HA (12CA5), W Tansey for pCGN-HA-Myc1-220 and pCGN-HA-Myc221-439 vectors, E Colombo and PG Pelicci for NPM<SUP>-/-</SUP> p53<SUP>-/-</SUP> MEFs, G Zambetti for ARF<SUP>-/-</SUP> p53<SUP>-/-</SUP> MEFs, E Ruley for p53<SUP>-/-</SUP> MEFs and J Sedivy for c-myc<SUP>-/-</SUP> cells. This work was supported by grants RO1 CA109586 and CA125760 from NCI to SRH.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Li J, 2007, CARCINOGENESIS, V28, P1163, DOI 10.1093/carcin/bgm025; Li ZL, 2009, CELL CYCLE, V8, P2703, DOI 10.4161/cc.8.17.9418; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sanders JA, 2005, BBA-MOL CELL RES, V1743, P141, DOI 10.1016/j.bbamcr.2004.09.009; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	34	39	39	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1988	1994		10.1038/onc.2012.227	http://dx.doi.org/10.1038/onc.2012.227			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22665062	Green Accepted			2022-12-25	WOS:000317599900013
J	May, D; Baastrup, J; Nientit, MR; Binder, A; Schunke, M; Baron, R; Cascorbi, I				May, Denisa; Baastrup, Jonas; Nientit, Maria Raphaela; Binder, Andreas; Schuenke, Michael; Baron, Ralf; Cascorbi, Ingolf			Differential Expression and Functionality of TRPA1 Protein Genetic Variants in Conditions of Thermal Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; COLD HYPERALGESIA; SENSORY NEURONS; CALCIUM-IONS; PAIN; ACTIVATION; SENSITIVITY; MECHANISMS; DIAGNOSIS	The role of genetic modifications of the TRPA1 receptor has been well documented in inflammatory and neuropathic pain. We recently reported that the E179K variant of TRPA1 appears to be crucial for the generation of paradoxical heat sensation in pain patients. Here, we describe the consequences of the single amino acid exchange at position 179 in the ankyrin repeat 4 of human TRPA1. TRPA1 wild type Lys-179 protein expressed in HEK cells exhibited intact biochemical properties, inclusive trafficking into the plasma membrane, formation of large protein complexes, and the ability to be activated by cold. Additionally, a strong increase of Lys-179 protein expression was observed in cold (4 degrees C) and heat (49 degrees C)-treated cells. In contrast, HEK cells expressing the variant Lys-179 TRPA1 failed to get activated by cold possibly due to the loss of ability to interact with other proteins or other TRPA1 monomers during oligomerization. In conclusion, the detailed understanding of TRPA1 genetic variants might provide a fruitful strategy for future development of pain treatments.	[May, Denisa; Baastrup, Jonas; Nientit, Maria Raphaela; Cascorbi, Ingolf] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany; [Binder, Andreas; Baron, Ralf] Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, D-24105 Kiel, Germany; [Schuenke, Michael] Univ Kiel, Inst Anat, D-24118 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Cascorbi, I (corresponding author), Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Arnold Heller Str 3, D-24105 Kiel, Germany.	cascorbi@pharmakologie.uni-kiel.de	Cascorbi, Ingolf/AAT-1927-2021	Cascorbi, Ingolf/0000-0002-2182-9534	Medical Faculty (University of Kiel)	Medical Faculty (University of Kiel)	This work was supported by a grant from the Medical Faculty (University of Kiel).	Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binder A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017387; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Donnerer J, 2011, TISSUE CELL, V43, P178, DOI 10.1016/j.tice.2011.02.002; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Ji G, 2008, NEUROSCIENCE, V154, P1054, DOI 10.1016/j.neuroscience.2008.04.039; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liu MG, 2011, BRAIN RES, V1382, P57, DOI 10.1016/j.brainres.2011.01.076; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Mizushima T, 2005, PAIN, V113, P51, DOI 10.1016/j.pain.2004.09.038; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Story GM, 2006, CURR NEUROPHARMACOL, V4, P183, DOI 10.2174/157015906778019482; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	31	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27087	27094		10.1074/jbc.M112.341776	http://dx.doi.org/10.1074/jbc.M112.341776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665484	hybrid, Green Published			2022-12-25	WOS:000307386000061
J	Bensing, BA; Yen, YT; Seepersaud, R; Sullam, PM				Bensing, Barbara A.; Yen, Yihfen T.; Seepersaud, Ravin; Sullam, Paul M.			A Specific Interaction between SecA2 and a Region of the Preprotein Adjacent to the Signal Peptide Occurs during Transport via the Accessory Sec System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-GSPB; STREPTOCOCCUS-PNEUMONIAE ADHESIN; SURFACE GLYCOPROTEIN GSPB; STAPHYLOCOCCUS-AUREUS; HUMAN PLATELETS; ATPASE SECA; GORDONII; EXPORT; GLYCOSYLATION; TRANSLOCATION	The accessory Sec systems of streptococci and staphylococci mediate the transport of a family of large, serine-rich glycoproteins to the bacterial cell surface. These systems are comprised of SecA2, SecY2, and three core accessory Sec proteins (Asp1-3). In Streptococcus gordonii, transport of the serine-rich glycoprotein GspB requires both a unique 90-residue N-terminal signal peptide and an adjacent 24-residue segment (the AST domain). We used in vivo site-specific photo-cross-linking to identify proteins that interact with the AST domain during transport. To facilitate this analysis, the entire accessory Sec system of S. gordonii was expressed in Escherichia coli. The determinants of GspB trafficking to the accessory Sec system in E. coli matched those in S. gordonii, establishing the validity of this approach. When the photo-cross-linker was placed within the AST domain, the preprotein was found to cross-link to SecA2. Importantly, no cross-linking to SecA was detected. Cross-linking of the N-terminal end of the AST domain to SecA2 occurred regardless of whether Asp1-3 were present. However, cross-linking to the C-terminal end was dependent on the Asps. The combined results indicate that full engagement of the AST domain by SecA2 is modulated by one or more of the Asps, and suggest that this process is important for initiating transport.	San Francisco VA Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Sullam, PM (corresponding author), VA Med Ctr, Div Infect Dis, 111W,4150 Clement St, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu			National Institutes of Health [RO1AI41513]; Dept. of Veterans Affairs; VA Merit Review program; Northern California Institute for Research and Education; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs(US Department of Veterans Affairs); VA Merit Review program(US Department of Veterans Affairs); Northern California Institute for Research and Education; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the National Institutes of Health Grant RO1AI41513 (to P. S.), the Dept. of Veterans Affairs, and the VA Merit Review program, the Northern California Institute for Research and Education, and by a Postdoctoral Fellowship Award from the American Heart Association (to Y. Y.).	Auclair SM, 2010, BIOCHEMISTRY-US, V49, P782, DOI 10.1021/bi901446r; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2007, J BACTERIOL, V189, P3846, DOI 10.1128/JB.00027-07; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Bensing BA, 2009, J BACTERIOL, V191, P3482, DOI 10.1128/JB.00365-09; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MACRINA FL, 1983, GENE, V25, P145; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takahashi Y, 1997, INFECT IMMUN, V65, P5042, DOI 10.1128/IAI.65.12.5042-5051.1997; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	42	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24438	24447		10.1074/jbc.M112.378059	http://dx.doi.org/10.1074/jbc.M112.378059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654116	Green Published, hybrid			2022-12-25	WOS:000306651100037
J	Lorca-Oro, C; Pujols, J; Garcia-Bocanegra, I; Mentaberre, G; Granados, JE; Solanes, D; Fandos, P; Galindo, I; Domingo, M; Lavin, S; Lopez-Olvera, JR				Lorca-Oro, Cristina; Pujols, Joan; Garcia-Bocanegra, Ignacio; Mentaberre, Gregorio; Enrique Granados, Jose; Solanes, David; Fandos, Paulino; Galindo, Ivan; Domingo, Mariano; Lavin, Santiago; Ramon Lopez-Olvera, Jorge			Protection of Spanish Ibex (Capra pyrenaica) against Bluetongue Virus Serotypes 1 and 8 in a Subclinical Experimental Infection	PLOS ONE			English	Article							WILD RUMINANTS; MEDITERRANEAN BASIN; EPIDEMIOLOGY; DISEASE; EUROPE; IDENTIFICATION; SURVEILLANCE; ORBIVIRUS; EFFICACY	Many wild ruminants such as Spanish ibex (Capra pyrenaica) are susceptible to Bluetongue virus (BTV) infection, which causes disease mainly in domestic sheep and cattle. Outbreaks involving either BTV serotypes 1 (BTV-1) and 8 (BTV-8) are currently challenging Europe. Inclusion of wildlife vaccination among BTV control measures should be considered in certain species. In the present study, four out of fifteen seronegative Spanish ibexes were immunized with a single dose of inactivated vaccine against BTV-1, four against BTV-8 and seven ibexes were non vaccinated controls. Seven ibexes (four vaccinated and three controls) were inoculated with each BTV serotype. Antibody and IFN-gamma responses were evaluated until 28 days after inoculation (dpi). The vaccinated ibexes showed significant (P<0.05) neutralizing antibody levels after vaccination compared to non vaccinated ibexes. The non vaccinated ibexes remained seronegative until challenge and showed neutralizing antibodies from 7 dpi. BTV RNA was detected in the blood of non vaccinated ibexes from 2 to the end of the study (28 dpi) and in target tissue samples obtained at necropsy (8 and 28 dpi). BTV-1 was successfully isolated on cell culture from blood and target tissues of non vaccinated ibexes. Clinical signs were unapparent and no gross lesions were found at necropsy. Our results show for the first time that Spanish ibex is susceptible and asymptomatic to BTV infection and also that a single dose of vaccine prevents viraemia against BTV-1 and BTV-8 replication.	[Lorca-Oro, Cristina; Pujols, Joan; Solanes, David; Galindo, Ivan; Domingo, Mariano] UAB IRTA, CReSA, Barcelona, Spain; [Pujols, Joan] IRTA, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Mentaberre, Gregorio; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] UAB, Dept Med & Cirurgia Anim, Servei Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Enrique Granados, Jose] Agencia Medio Ambiente & Agua, Granada, Spain; [Fandos, Paulino] Agencia Medio Ambiente & Agua, Seville, Spain; [Galindo, Ivan; Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; IRTA; Universidad de Cordoba; Autonomous University of Barcelona; Autonomous University of Barcelona	Lorca-Oro, C (corresponding author), UAB IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	cristina.lorca@cresa.uab.cat	Domingo, Mariano/A-1015-2009; Fandos, Paulino/M-7304-2015; Torres, José Enrique Granados/AAS-5629-2020; Pujols, Joan/AAV-6427-2020; Lavín, Santiago/L-5975-2014; Olvera, Jorge R López/H-8382-2015; Lorca-Oró, Cristina/ABE-7268-2021; Pujols, Joan/K-9693-2015; Bocanegra, Ignacio Garcia/G-1443-2016; Mentaberre, Gregorio A/H-4629-2015; Pujols, Joan/S-1141-2018; Mentaberre, Gregorio/AAB-5912-2020	Domingo, Mariano/0000-0002-9623-4826; Fandos, Paulino/0000-0002-9607-8931; Torres, José Enrique Granados/0000-0002-9787-9896; Pujols, Joan/0000-0002-6940-1529; Lavín, Santiago/0000-0001-5655-588X; Olvera, Jorge R López/0000-0002-2999-3451; Lorca-Oró, Cristina/0000-0001-5351-4169; Pujols, Joan/0000-0002-6940-1529; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Mentaberre, Gregorio A/0000-0001-9542-7514; Mentaberre, Gregorio/0000-0001-9542-7514	Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA) [FAU2008-00019-C03-01]	Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA))	This work was supported by the project FAU2008-00019-C03-01, from the Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2007, DIVERS DISTRIB, V13, P587, DOI 10.1111/j.1472-4642.2007.00374.x; Aguero M, 2002, VET MICROBIOL, V86, P337, DOI 10.1016/S0378-1135(02)00011-1; Backx A, 2007, VET REC, V161, P591, DOI 10.1136/vr.161.17.591; BARRATTBOYES SM, 1992, J GEN VIROL, V73, P1953, DOI 10.1099/0022-1317-73-8-1953; Barzilai E., 1972, Refuah Veterinarith, V29, P45; Bender LC, 2003, J WILDLIFE DIS, V39, P772, DOI 10.7589/0090-3558-39.4.772; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Clavijo A, 2000, J VIROL METHODS, V87, P13, DOI 10.1016/S0166-0934(00)00150-6; ELLIS JA, 1993, AM J VET RES, V54, P1452; Enserink M, 2008, SCIENCE, V319, P710, DOI 10.1126/science.319.5864.710; Eschbaumer M, 2011, VET REC, V168, DOI 10.1136/vr.d1184; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fandos P., 1992, GLOBAL TRENDS WILDLI, P139; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Gerdes GH, 2004, VETER ITAL SER, V40, P39; Gonzalez-Candela M, 2006, J WILDLIFE DIS, V42, P325, DOI 10.7589/0090-3558-42.2.325; Granados J.E., 2001, Galemys, V13, P3; Hateley G, 2009, IN PRACTICE, V31, P202; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Howerth E. W., 2001, INFECT DIS WILD MAMM; Hund A, 2012, VET MICROBIOL, V154, P247, DOI 10.1016/j.vetmic.2011.07.019; KATZ JB, 1993, J CLIN MICROBIOL, V31, P3028, DOI 10.1128/JCM.31.11.3028-3030.1993; Leon-Vizcaino L, 1999, J WILDLIFE DIS, V35, P647, DOI 10.7589/0090-3558-35.4.647; Lorca-Oro C, 2012, VET MICROBIOL, V154, P240, DOI 10.1016/j.vetmic.2011.07.008; Lorca-Oro C, 2011, VET MICROBIOL, V149, P230, DOI 10.1016/j.vetmic.2010.10.023; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens P P C, 2004, Vet Ital, V40, P426; MURRAY J O, 1970, Journal of Wildlife Diseases, V6, P144; Perez JM, 2002, MAMMAL REV, V32, P26, DOI 10.1046/j.1365-2907.2002.00097.x; Perez JM, 2001, DISTRIBUCION GENETIC; Puentes E, 2008, EP 2008 BLUET SAT S; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; ROBINSON RM, 1967, J WILDLIFE MANAGE, V31, P165, DOI 10.2307/3798372; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; Rodriguez-Sanchez B, 2008, VET MICROBIOL, V141, P164; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Sanchez-Cordon PJ, 2010, J COMP PATHOL, V143, P20, DOI 10.1016/j.jcpa.2009.12.017; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Tessaro SV, 2001, J WILDLIFE DIS, V37, P722, DOI 10.7589/0090-3558-37.4.722; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; VOSDING RA, 1968, CAN J COMPARAT MED, V32, P382; WHETTER LE, 1989, J GEN VIROL, V70, P1663, DOI 10.1099/0022-1317-70-7-1663; World Organization for Animal Health (OIE), 2009, BLUET EP HAEM DIS	52	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36380	10.1371/journal.pone.0036380	http://dx.doi.org/10.1371/journal.pone.0036380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666321	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400008
J	Yamaguchi, S; Yamane, T; Takahashi-Niki, K; Kato, I; Niki, T; Goldberg, MS; Shen, J; Ishimoto, K; Doi, T; Iguchi-Ariga, SMM; Ariga, H				Yamaguchi, Shiori; Yamane, Takuya; Takahashi-Niki, Kazuko; Kato, Izumi; Niki, Takeshi; Goldberg, Matthew S.; Shen, Jie; Ishimoto, Kenji; Doi, Takefumi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Transcriptional Activation of Low-Density Lipoprotein Receptor Gene by DJ-1 and Effect of DJ-1 on Cholesterol Homeostasis	PLOS ONE			English	Article							STEROL REGULATORY ELEMENT; DISEASE PROTEIN DJ-1; HELIX-LOOP-HELIX; PARKINSONS-DISEASE; CELL-DEATH; MITOCHONDRIAL LOCALIZATION; SERUM-LIPOPROTEINS; ANDROGEN RECEPTOR; OXIDATIVE STRESS; ANTIOXIDATIVE STRESS	DJ-1 is a novel oncogene and also causative gene for familial Parkinson's disease park7. DJ-1 has multiple functions that include transcriptional regulation, anti-oxidative reaction and chaperone and mitochondrial regulation. For transcriptional regulation, DJ-1 acts as a coactivator that binds to various transcription factors, resulting in stimulation or repression of the expression of their target genes. In this study, we found the low-density lipoprotein receptor (LDLR) gene is a transcriptional target gene for DJ-1. Reduced expression of LDLR mRNA and protein was observed in DJ-1-knockdown cells and DJ-1-knockout mice and this occurred at the transcription level. Reporter gene assays using various deletion and point mutations of the LDLR promoter showed that DJ-1 stimulated promoter activity by binding to the sterol regulatory element (SRE) with sterol regulatory element binding protein (SREBP) and that stimulating activity of DJ-1 toward LDLR promoter activity was enhanced by oxidation of DJ-1. Chromatin immunoprecipitation, gel-mobility shift and co-immunoprecipitation assays showed that DJ-1 made a complex with SREBP on the SRE. Furthermore, it was found that serum LDL cholesterol level was increased in DJ-1-knockout male, but not female, mice and that the increased serum LDL cholesterol level in DJ-1-knockout male mice was cancelled by administration with estrogen, suggesting that estrogen compensates the increased level of serum LDL cholesterol in DJ-1-knockout female mice. This is the first report that DJ-1 participates in metabolism of fatty acid synthesis through transcriptional regulation of the LDLR gene.	[Yamaguchi, Shiori; Yamane, Takuya; Takahashi-Niki, Kazuko; Kato, Izumi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Niki, Takeshi; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Goldberg, Matthew S.; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA; [Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Hokkaido University; Hokkaido University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Osaka University	Yamaguchi, S (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Shen, Jie/GXH-9449-2022; Goldberg, Matthew/T-7827-2019; Ariga, Sanae/H-9647-2013	Ariga, Hiroyoshi/0000-0001-7384-2143; Goldberg, Matthew/0000-0002-5172-9841	Ministry of Education, Science, Culture and Sports; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 23790970, 24650191, 21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey M, 1999, MATURITAS, V33, P259, DOI 10.1016/S0378-5122(99)00054-7; Anthony MS, 1998, AM J CLIN NUTR, V68, p1390S, DOI 10.1093/ajcn/68.6.1390S; ARIGA H, 1983, J VIROL, V48, P481, DOI 10.1128/JVI.48.2.481-491.1983; ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Berthold HK, 1998, JAMA-J AM MED ASSOC, V279, P1900, DOI 10.1001/jama.279.23.1900; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bruning JC, 2003, J STEROID BIOCHEM, V86, P113, DOI 10.1016/S0960-0760(03)00263-2; CAMUS MC, 1983, J LIPID RES, V24, P1210; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2; Hst KH, 1981, J IMMUNOL, V126, P1909; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Ishimoto K, 2006, FEBS LETT, V580, P4929, DOI 10.1016/j.febslet.2006.08.010; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Khor HT, 2000, INT J FOOD SCI NUTR, V51, pS3, DOI 10.1080/096374800750049521; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; MILLS GL, 1971, COMP BIOCHEM PHYSIOL, V40, P489, DOI 10.1016/0305-0491(71)90234-3; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Nishinaga H, 2005, NEUROSCI LETT, V390, P54, DOI 10.1016/j.neulet.2005.07.053; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; Rustembegovic Avdo, 2006, Med Arh, V60, P211; SATO R, 1994, J BIOL CHEM, V269, P17267; Sekito A, 2006, FREE RADICAL RES, V40, P155, DOI 10.1080/10715760500456847; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valk-de Roo GW, 1999, ARTERIOSCLER THROMB, V19, P2993; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	66	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38144	10.1371/journal.pone.0038144	http://dx.doi.org/10.1371/journal.pone.0038144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666465	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400090
J	Hutson, JR; Stade, B; Lehotay, DC; Collier, CP; Kapur, BM				Hutson, Janine R.; Stade, Brenda; Lehotay, Denis C.; Collier, Christine P.; Kapur, Bhushan M.			Folic Acid Transport to the Human Fetus Is Decreased in Pregnancies with Chronic Alcohol Exposure	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BLOOD-CELL FOLATE; VITAMIN-B-12 CONCENTRATIONS; S-ADENOSYLMETHIONINE; ETHANOL EXPOSURE; OXIDATIVE STRESS; MATERNAL PLASMA; BIRTH-WEIGHT; FORMIC-ACID; B-VITAMINS	Background: During pregnancy, the demand for folic acid increases since the fetus requires this nutrient for its rapid growth and cell proliferation. The placenta concentrates folic acid into the fetal circulation; as a result the fetal levels are 2 to 4 times higher than the maternal level. Animal and in vitro studies have suggested that alcohol may impair transport of folic acid across the placenta by decreasing expression of transport proteins. We aim to determine if folate transfer to the fetus is altered in human pregnancies with chronic alcohol consumption. Methodology/Principal Findings: Serum folate was measured in maternal blood and umbilical cord blood at the time of delivery in pregnancies with chronic and heavy alcohol exposure (n = 23) and in non-drinking controls (n = 24). In the alcohol-exposed pairs, the fetal: maternal serum folate ratio was <= 1.0 in over half (n = 14), whereas all but one of the controls were >1.0. Mean folate in cord samples was lower in the alcohol-exposed group than in the controls (33.15 +/- 19.89 vs 45.91 +/- 20.73, p = 0.04). Conclusions/Significance: Our results demonstrate that chronic and heavy alcohol use in pregnancy impairs folate transport to the fetus. Altered folate concentrations within the placenta and in the fetus may in part contribute to the deficits observed in the fetal alcohol spectrum disorders.	[Hutson, Janine R.; Kapur, Bhushan M.] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Hutson, Janine R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Stade, Brenda] St Michaels Hosp, Keenan Res Ctr, Dept Paediat, Toronto, ON M5B 1W8, Canada; [Lehotay, Denis C.] Univ Saskatchewan, Coll Med, Regina, SK, Canada; [Collier, Christine P.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Collier, Christine P.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Kapur, Bhushan M.] Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON, Canada; [Kapur, Bhushan M.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Saskatchewan; McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Hutson, JR (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	b.kapur@utoronto.ca			Canadian Institute of Health Research, CIHR NET [ELA-80227]; CIHR Vanier Canada Graduate Scholarship	Canadian Institute of Health Research, CIHR NET(Canadian Institutes of Health Research (CIHR)); CIHR Vanier Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	The study was funded by a grant from the Canadian Institute of Health Research, CIHR NET grant # ELA-80227. JRH is supported by a CIHR Vanier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Bisseling TM, 2004, PLACENTA, V25, P588, DOI 10.1016/j.placenta.2003.11.010; Cano MJ, 2001, FREE RADICAL RES, V34, P1, DOI 10.1080/10715760100300011; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; ECONOMIDES DL, 1992, BRIT J OBSTET GYNAEC, V99, P23, DOI 10.1111/j.1471-0528.1992.tb14386.x; FISHER SE, 1985, J PEDIATR GASTR NUTR, V4, P645, DOI 10.1097/00005176-198508000-00026; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garcia-Rodriguez S, 2003, FREE RADICAL BIO MED, V35, P428, DOI 10.1016/S0891-5849(03)00321-6; GIUGLIANI ERJ, 1985, J PERINAT MED, V13, P55, DOI 10.1515/jpme.1985.13.2.55; Goh YI, 2008, J OBSTET GYNAECOL, V28, P3, DOI 10.1080/01443610701814195; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; Gundogan F, 2010, ALCOHOL CLIN EXP RES, V34, P415, DOI 10.1111/j.1530-0277.2009.01106.x; Gutierrez CM, 2007, PATHOLOGY, V39, P495, DOI 10.1080/00313020701449290; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; HENDERSON GI, 1995, J LAB CLIN MED, V126, P184; Jones KL., 2006, SMITHS RECOGNIZABLE, V6th ed., P268; Kapur BM, 2009, ALCOHOL CLIN EXP RES, V33, p134A; Kapur BM, 2007, ALCOHOL CLIN EXP RES, V31, P2114, DOI 10.1111/j.1530-0277.2007.00541.x; Keating E, 2008, J NUTR BIOCHEM, V19, P91, DOI 10.1016/j.jnutbio.2007.01.007; Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; LARROQUE B, 1992, EUR J OBSTET GYN R B, V43, P19, DOI 10.1016/0028-2243(92)90238-T; LIN GWJ, 1988, NUTR RES, V8, P1151, DOI 10.1016/S0271-5317(88)80116-7; LIN GWJ, 1991, ALCOHOL, V8, P169, DOI 10.1016/0741-8329(91)90726-D; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; NAVARRO J, 1984, J PEDIATR GASTR NUTR, V3, P744, DOI 10.1097/00005176-198411000-00019; Obeid R, 2005, AM J CLIN NUTR, V82, P133, DOI 10.1093/ajcn/82.1.133; PRASAD PD, 1995, BIOCHEM BIOPH RES CO, V206, P681, DOI 10.1006/bbrc.1995.1096; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Sokoro AAH, 2008, METABOLISM, V57, P920, DOI 10.1016/j.metabol.2008.02.006; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Stark KD, 2005, AM J CLIN NUTR, V81, P669; Stark KD, 2007, AM J CLIN NUTR, V85, P796, DOI 10.1093/ajcn/85.3.796; Thorand B, 1996, Z GEBURTSH NEONATOL, V200, P176; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Wallace JMW, 2008, AM J CLIN NUTR, V87, P391, DOI 10.1093/ajcn/87.2.391; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Wentzel P, 2008, ALCOHOL CLIN EXP RES, V32, p48A; Xu YJ, 2008, BRIT J NUTR, V99, P455, DOI 10.1017/S0007114507812074; Yanaguita MY, 2008, CHILD NERV SYST, V24, P99, DOI 10.1007/s00381-007-0427-1; Yasuda S, 2008, BIOSCI BIOTECH BIOCH, V72, P329, DOI 10.1271/bbb.70347	43	47	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38057	10.1371/journal.pone.0038057	http://dx.doi.org/10.1371/journal.pone.0038057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666445	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600060
J	Koltsova, SV; Trushina, Y; Haloui, M; Akimova, OA; Tremblay, J; Hamet, P; Orlov, SN				Koltsova, Svetlana V.; Trushina, Yulia; Haloui, Mounsif; Akimova, Olga A.; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.			Ubiquitous [Na+](i)/[K+](i)-Sensitive Transcriptome in Mammalian Cells: Evidence for Ca-i(2+)-Independent Excitation-Transcription Coupling	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; SITE UPSTREAM; SODIUM-PUMP; CALCIUM; PROTEIN; NA+; ACTIVATION; NEURONS; INTERLEUKIN-6	Stimulus-dependent elevation of intracellular Ca2+([Ca2+](i)) affects the expression of numerous genes - a phenomenon known as excitation-transcription coupling. Recently, we found that increases in [Na+](i) trigger c-Fos expression via a novel Ca-i(2+)-independent pathway. In the present study, we identified ubiquitous and tissue-specific [Na+](i)/[K+](i)-sensitive transcriptomes by comparative analysis of differentially expressed genes in vascular smooth muscle cells from rat aorta (RVSMC), the human adenocarcinoma cell line HeLa, and human umbilical vein endothelial cells (HUVEC). To augment [Na+](i) and reduce [K+](i), cells were treated for 3 hrs with the Na+, K+-ATPase inhibitor ouabain or placed for the same time in the K+-free medium. Employing Affymetrix-based technology, we detected changes in expression levels of 684, 737 and 1839 transcripts in HeLa, HUVEC and RVSMC, respectively, that were highly correlated between two treatments (p<0.0001; R-2>0.62). Among these Na-i(+)/K-i(+)-sensitive genes, 80 transcripts were common for all three types of cells. To establish if changes in gene expression are dependent on increases in [Ca2+](i), we performed identical experiments in Ca2+-free media supplemented with extracellular and intracellular Ca2+ chelators. Surprisingly, this procedure elevated rather than decreased the number of ubiquitous and cell-type specific Na-i(+)/ K-i(+)-sensitive genes. Among the ubiquitous Na-i(+)/ K-i(+)-sensitive genes whose expression was regulated independently of the presence of Ca2+ chelators by more than 3-fold, we discovered several transcription factors (Fos, Jun, Hes1, Nfkbia), interleukin-6, protein phosphatase 1 regulatory subunit, dual specificity phosphatase (Dusp8), prostaglandin-endoperoxide synthase 2, cyclin L1, whereas expression of metallopeptidase Adamts1, adrenomedulin, Dups1, Dusp10 and Dusp16 was detected exclusively in Ca2+-depleted cells. Overall, our findings indicate that Ca-i(2+)-independent mechanisms of excitation-transcription coupling are involved in transcriptomic alterations triggered by elevation of the [Na+](i)/[K+](i) ratio. There results likely have profound implications for normal and pathological regulation of mammalian cells, including sustained excitation of neuronal cells, intensive exercise and ischemia-triggered disorders.	[Koltsova, Svetlana V.; Haloui, Mounsif; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Univ Montre CRCHUM Technopole Angus, Ctr hosp, Ctr Rech, Montreal, PQ, Canada; [Koltsova, Svetlana V.; Akimova, Olga A.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Trushina, Yulia; Akimova, Olga A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Lomonosov Moscow State University; Universite de Montreal	Koltsova, SV (corresponding author), Univ Montre CRCHUM Technopole Angus, Ctr hosp, Ctr Rech, Montreal, PQ, Canada.	sergei.n.orlov@umontreal.ca	ORLOV, SERGEI/I-4071-2013; Cossette, Suzanne/I-8008-2016; Akimova, Olga/I-2669-2014; Tremblay, Johanne/E-2154-2013		Canadian Institutes of Health Research [MOP-62696, 81392]; Kidney Foundation of Canada; Russian Foundation for Fundamental Research [09-04-00646A]; Russian Federation [MK-4641-2011.4]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	Canadian Institutes of Health Research - http://www.cihr-irsc.gc.ca (MOP-62696 and 81392); Kidney Foundation of Canada - http://www.kidney.ca; Russian Foundation for Fundamental Research - http://www.rfbr.ru/ (09-04-00646A); the grant of the President of the Russian Federation for young investigators http://grants.extech.ru (MK-4641-2011.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI M, 1990, J CLIN INVEST, V85, P121, DOI 10.1172/JCI114401; Akimova OA, 2005, J BIOL CHEM, V280, P832, DOI 10.1074/jbc.M411011200; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Haloui M, 2007, FEBS J, V274, P3557, DOI 10.1111/j.1742-4658.2007.05885.x; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lamy CM, 2012, ACS NANO, V6, P1176, DOI 10.1021/nn203822t; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ma H, 2011, NEUROSCI RES, V70, P2, DOI 10.1016/j.neures.2011.02.004; Matt T, 2004, BIOCHEM J, V381, P685, DOI 10.1042/BJ20040564; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Murphy KT, 2008, EXP PHYSIOL, V93, P1249, DOI 10.1113/expphysiol.2008.042457; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Orlov SN, 2006, J MEMBRANE BIOL, V210, P161, DOI 10.1007/s00232-006-0857-9; Orlov SN, 2005, CELL CALCIUM, V38, P53, DOI 10.1016/j.ceca.2005.03.006; Orlov SN, 1999, J BIOL CHEM, V274, P16545, DOI 10.1074/jbc.274.23.16545; Orlov SN, 2003, CELL CALCIUM, V34, P511, DOI 10.1016/S0143-4160(03)00125-8; Orlov SN, 1999, CELL DEATH DIFFER, V6, P661, DOI 10.1038/sj.cdd.4400539; Pchejetski D, 2003, BIOCHEM BIOPH RES CO, V301, P735, DOI 10.1016/S0006-291X(02)03002-4; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Suzuki S, 1999, J CEREBR BLOOD F MET, V19, P1256, DOI 10.1097/00004647-199911000-00010; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Taurin S, 2003, MOL BIOL+, V37, P315, DOI 10.1023/A:1024266722564; Taurin S, 2002, CIRC RES, V91, P915, DOI 10.1161/01.RES.0000043020.45534.3E; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Xiao L, 2008, CIRC RES, V103, P733, DOI 10.1161/CIRCRESAHA.108.171157; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005	57	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38032	10.1371/journal.pone.0038032	http://dx.doi.org/10.1371/journal.pone.0038032			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666440	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600056
J	Gao, YL; Reitz, SR; Wei, QB; Yu, WY; Lei, ZR				Gao, Yulin; Reitz, Stuart R.; Wei, Qingbo; Yu, Wenyan; Lei, Zhongren			Insecticide-Mediated Apparent Displacement between Two Invasive Species of Leafminer Fly	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; SPIREA APHID HOMOPTERA; BEMISIA-TABACI; APPLE APHID; COMPETITIVE DISPLACEMENT; PEST-MANAGEMENT; L-BRYONIAE; L-TRIFOLII; BIOTYPE-B; AGROMYZIDAE	Background: Closely related invasive species may often displace one another, but it is often difficult to determine mechanisms because of the historical nature of these events. The leafmining flies Liriomyza sativae and Liriomyza trifolii have become serious invasive agricultural pests throughout the world. Where both species have invaded the same region, one predominates over the other. Although L. sativae invaded Hainan Island of China first, it recently has been displaced by the newly invasive L. trifolii. We hypothesized that differential susceptibilities to insecticides could be causing this demographic shift. Methodology/Principal Findings: Avermectin and cyromazine are the most commonly used insecticides to manage leafminers, with laboratory bioassays demonstrating that L. trifolii is significantly less susceptible to these key insecticides than is L. sativae. In trials where similar numbers of larvae of both species infested plants, which subsequently were treated with the insecticides, the eclosing adults were predominately L. trifolii, yet similar numbers of adults of both species eclosed from control plants. The species composition was then surveyed in two regions where L. trifolii has just begun to invade and both species are still common. In field trials, both species occurred in similar proportions before insecticide treatments began. Following applications of avermectin and cyromazine, almost all eclosing adults were L. trifolii in those treatment plots. In control plots, similar numbers of adults of the two species eclosed, lending further credence to the hypothesis that differential insecticide susceptibilities could be driving the ongoing displacement of L. sativae by L. trifolii. Conclusions/Significance: Our results show that differential insecticide susceptibility can lead to rapid shifts in the demographics of pest complexes. Thus, successful pest management requires the identification of pest species to understand the outcome of insecticide applications. These results further demonstrate the importance of considering anthropogenic factors in the outcome of interspecific interactions.	[Gao, Yulin; Wei, Qingbo; Yu, Wenyan; Lei, Zhongren] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Reitz, Stuart R.] ARS, Ctr Med Agr & Vet Entomol, USDA, Tallahassee, FL USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Gao, YL (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Reitz, Stuart/AAC-4467-2019; Gao, Yu/HGE-1937-2022		National Key Basic Research Program (973 Projects) [2009CB119004]; China Agriculture Research System [CARS-25-B-07]	National Key Basic Research Program (973 Projects); China Agriculture Research System	This work was supported in part by the National Key Basic Research Program (973 Projects Grant 2009CB119004) and the China Agriculture Research System (CARS-25-B-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abe Y, 2001, APPL ENTOMOL ZOOL, V36, P277, DOI 10.1303/aez.2001.277; Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Bel Y, 2000, ARCH INSECT BIOCHEM, V45, P69, DOI 10.1002/1520-6327(200010)45:2&lt;69::AID-ARCH3&gt;3.0.CO;2-3; Brown MW, 1995, ENVIRON ENTOMOL, V24, P1581, DOI 10.1093/ee/24.6.1581; Chen XX, 2003, BIOCONTROL, V48, P515, DOI 10.1023/A:1025726813462; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Ferguson JS, 2004, J ECON ENTOMOL, V97, P112, DOI 10.1603/0022-0493-97.1.112; Gao YL, 2011, J ECON ENTOMOL, V104, P1771, DOI 10.1603/EC11206; HOGMIRE HW, 1992, J ENTOMOL SCI, V27, P113, DOI 10.18474/0749-8004-27.2.113; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; JOHNSON MW, 1983, J ECON ENTOMOL, V76, P1061, DOI 10.1093/jee/76.5.1061; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; Lei ZR, 1997, ANN AGR SCI CHINA YO, P495; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; Lowery DT, 2006, J ECON ENTOMOL, V99, P1369, DOI 10.1603/0022-0493-99.4.1369; OATMAN E R, 1976, Journal of Economic Entomology, V69, P667, DOI 10.1093/jee/69.5.667; PALUMBO JC, 1994, J ECON ENTOMOL, V87, P1070, DOI 10.1093/jee/87.4.1070; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; Reitz SR, 1999, AGR ECOSYST ENVIRON, V73, P185, DOI 10.1016/S0167-8809(99)00016-X; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; SAS Institute, 2010, SAS STAT US GUID VER; Tokumaru S, 2005, JPN J APPL ENTOMOL Z, V49, P1, DOI 10.1303/jjaez.2005.1; TRUMBLE JT, 1985, AGR ECOSYST ENVIRON, V12, P181, DOI 10.1016/0167-8809(85)90109-4; TRUMBLE JT, 1983, ENVIRON ENTOMOL, V12, P810, DOI 10.1093/ee/12.3.810; Weintraub PG, 2001, CROP PROT, V20, P207, DOI 10.1016/S0261-2194(00)00128-9	27	32	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36622	10.1371/journal.pone.0036622	http://dx.doi.org/10.1371/journal.pone.0036622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662122	Green Published, gold			2022-12-25	WOS:000305342300013
J	Linehan, C; Gupta, S; Samali, A; O'Connor, L				Linehan, Chris; Gupta, Sanjeev; Samali, Afshin; O'Connor, Lynn			Bisphenol A-Mediated Suppression of LPL Gene Expression Inhibits Triglyceride Accumulation during Adipogenic Differentiation of Human Adult Stem Cells	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; C/EBP-ALPHA; INSULIN; TRANSCRIPTION; ADIPOCYTES; SECRETION; OBESITY; CLONING	The endocrine disrupting chemical, bisphenol A (BPA), has been shown to accelerate the rate of adipogenesis and increase the amount of triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. The objective of this study was to investigate if that observation is mirrored in human primary cells. Here we investigated the effect of BPA on adipogenesis in cultured human primary adult stem cells. Continuous exposure to BPA throughout the 14 days of differentiation dramatically reduced triglyceride accumulation and suppressed gene transcription of the lipogenic enzyme, lipoprotein lipase (LPL). Results presented in the present study show for the first time that BPA can reduce triglyceride accumulation during adipogenesis by attenuating the expression of LPL gene transcription. Also, by employing image cytometric analysis rather than conventional Oil red O staining techniques we show that BPA regulates triglyceride accumulation in a manner which does not appear to effect adipogenesis per se.	[Linehan, Chris; Samali, Afshin] Natl Univ Ireland Galway, Dept Biochem, Fac Life Sci, Galway, Ireland; [Gupta, Sanjeev] Natl Univ Ireland Galway, Dept Pathol, Sch Med, Inst Clin Sci, Galway, Ireland; [O'Connor, Lynn] Natl Univ Ireland Galway, Dept Pharmacol, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Linehan, C (corresponding author), Natl Univ Ireland Galway, Dept Biochem, Fac Life Sci, Galway, Ireland.	c.linehan1@gmail.com; Lynn.oconnor@nuigalway.ie	Gupta, Sanjeev/AAG-9749-2020; Samali, Afshin/A-9571-2008; gupta, sanjeev/B-2824-2008	Gupta, Sanjeev/0000-0002-4691-6853; Samali, Afshin/0000-0002-8610-8375; gupta, sanjeev/0000-0002-4691-6853	National University of Ireland Galway	National University of Ireland Galway	This work was supported by a Ph.D. fellowship from National University of Ireland Galway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; AUWERX J, 1992, CRIT REV CL LAB SCI, V29, P243, DOI 10.3109/10408369209114602; Brede C, 2003, FOOD ADDIT CONTAM, V20, P684, DOI [10.1080/0265203031000119061, 10.1080/02652030210134236]; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; De Ferranti Sarah D, 2007, Diab Vasc Dis Res, V4, P285, DOI 10.3132/dvdr.2007.055; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; GUPTA S, 2010, INT J CELL BIOL; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lazar MA, 2002, GENE DEV, V16, P1, DOI 10.1101/gad.964002; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Masuno H, 2002, J LIPID RES, V43, P676; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Olofsson LE, 2008, J CLIN ENDOCR METAB, V93, P4880, DOI 10.1210/jc.2008-0574; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wei E, 2005, BIOCHEM J, V388, P959, DOI 10.1042/BJ20041442; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36109	10.1371/journal.pone.0036109	http://dx.doi.org/10.1371/journal.pone.0036109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662114	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300008
J	Pilarski, R; Patel, DA; Weitzel, J; McVeigh, T; Dorairaj, JJ; Heneghan, HM; Miller, N; Weidhaas, JB; Kerin, MJ; McKenna, M; Wu, XF; Hildebrandt, M; Zelterman, D; Sand, S; Shulman, LP				Pilarski, Robert; Patel, Divya A.; Weitzel, Jeffrey; McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola; Weidhaas, Joanne B.; Kerin, Michael J.; McKenna, Megan; Wu, Xifeng; Hildebrandt, Michelle; Zelterman, Daniel; Sand, Sharon; Shulman, Lee P.			The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer	PLOS ONE			English	Article							FAMILY-HISTORY; BRCA2; MUTATIONS; CHEK2; SITE	Purpose: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), and with the risk of premenopausal triple negative breast cancer, we evaluated the association of the KRAS-variant with women with personal histories of both breast and ovarian cancer, referred to as double primary patients. Experimental Design: Germline DNA from double primary patients was tested for the KRAS-variant (n = 232). Confirmation of pathologic diagnoses, age of diagnoses, interval between ovarian cancer diagnosis and sample collection, additional cancer diagnoses, and family history were obtained when available. All patients were tested for deleterious BRCA mutations. Results: The KRAS-variant was significantly enriched in uninformative (BRCA negative) double primary patients, being found in 39% of patients accrued within two years of their ovarian cancer diagnosis. Furthermore, the KRAS-variant was found in 35% of uninformative double primary patients diagnosed with ovarian cancer post-menopausally, and was significantly associated with uninformative double primary patients with a positive family history. The KRAS-variant was also significantly enriched in uninformative patients who developed more then two primary cancers, being found in 48% of women with two breast primaries plus ovarian cancer or with triple primary cancers. Conclusions: These findings further validate the importance of the KRAS-variant in breast and ovarian cancer risk, and support the association of this variant as a genetic marker for HBOC families previously considered uninformative.	[Pilarski, Robert] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Pilarski, Robert] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Patel, Divya A.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weitzel, Jeffrey; Sand, Sharon] City Hope Natl Med Ctr, Div Clin Canc Genet, Duarte, CA USA; [McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola; Kerin, Michael J.] Natl Univ Ireland, Discipline Surg, Galway, Ireland; [Weidhaas, Joanne B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT USA; [McKenna, Megan] Canc Ctr Santa Barbara, Santa Barbara, CA USA; [Wu, Xifeng; Hildebrandt, Michelle] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zelterman, Daniel] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Shulman, Lee P.] Northwestern Univ, Div Clin Genet, Feinberg Sch Med, Chicago, IL 60611 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yale University; City of Hope; Ollscoil na Gaillimhe-University of Galway; Yale University; University of Texas System; UTMD Anderson Cancer Center; Yale University; Northwestern University; Feinberg School of Medicine	Pilarski, R (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	Robert.Pilarski@osumc.edu	McVeigh, Terri/AAX-8075-2021; Pilarski, Robert/X-3256-2019; Kerin, Michael J/D-6748-2013; Miller, Nicola/F-4009-2018; Pilarski, Robert/E-3871-2011	McVeigh, Terri/0000-0001-9201-9216; Miller, Nicola/0000-0002-5416-7047; Weidhaas, Joanne/0000-0002-5096-3281; Heneghan, Helen/0000-0002-2009-3406; Sand, Sharon/0000-0002-9390-5583; Zelterman, Daniel/0000-0003-0711-8688; Kerin, Michael/0000-0003-4164-5561	United States National Cancer Institute [1RC4CA153828]; National Breast Cancer Research Institute; Galway Biobank; NATIONAL CANCER INSTITUTE [RC4CA153828] Funding Source: NIH RePORTER	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Research Institute; Galway Biobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The collection of cases from City of Hope was supported in part by award #1RC4CA153828 from the United States National Cancer Institute (PI: Weitzel). Cases from The Ohio State University were obtained in part from the Stefanie Spielman Breast Cancer Tissue Bank. The authors thank the National Breast Cancer Research Institute that funds the Galway Biobank and researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and Dr. Weidhaas has the following conflicts: She has patented the KRAS-variant through Yale University. This patent covers the discovery of the KRAS-variant and testing the KRAS-variant that is discussed in this application. This marker has been licensed to a company that she has co-founded. Dr. Weidhaas is not employed by this company, but is a consultant. The company has developed the KRAS-variant as a test. The Irish cohort was supported partially from a commercial source, the Galway Biobank. These things do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The rest of the authors have no conflicts.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Armstrong K, 2000, CANCER EPIDEM BIOMAR, V9, P1251; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Cvelbar M, 2011, NEOPLASMA, V58, P198, DOI 10.4149/neo_2011_03_198; Evans DG, 2010, J MED GENET, V47, P561, DOI 10.1136/jmg.2009.075770; Fishman A, 2000, GYNECOL ONCOL, V79, P74, DOI 10.1006/gyno.2000.5895; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Paranjape T, 2011, LANCET ONCOLOGY; Pharoah P, 2011, CLIN CANC RES; Ratner E, 2011, ONCOGENE        1205; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Stadler ZK, 2010, J CLIN ONCOL, V28, P189, DOI 10.1200/JCO.2009.25.6875; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379	17	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37891	10.1371/journal.pone.0037891	http://dx.doi.org/10.1371/journal.pone.0037891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662244	Green Published, gold			2022-12-25	WOS:000305342300135
J	Chang, MW; Lo, JM; Juan, HF; Chang, HY; Chuang, CY				Chang, Ming-Wei; Lo, Jem-Mau; Juan, Hsueh-Fen; Chang, Hsin-Yi; Chuang, Chun-Yu			Combination of RGD Compound and Low-Dose Paclitaxel Induces Apoptosis in Human Glioblastoma Cells	PLOS ONE			English	Article							ASPARTIC ACID PEPTIDE; THERAPEUTIC TARGETS; ALPHA(V)BETA(3) INTEGRIN; ALPHA-V-BETA-3 INTEGRIN; CANCER; ACTIVATION; EXPRESSION; MULTIFORME; DEATH; CILENGITIDE	Background: Integrins are a family of transmembrane adhesion proteins that mediate cell adhesion and intracellular signaling. Integrin-alpha v beta 3 is expressed on the surface of human glioblastoma cells, and can be further induced by chemical stress. The Arg-Gly-Asp (RGD) motif-containing peptides are specifically bound to integrin-alpha v beta 3, and to inhibit neovasculature underlying competition to normal extracellular matrix proteins. This study employed two types of RGD peptides, cyclic RGD (c(RGDyK)) and bi-cyclic RGD (E[c(RGDyK)] 2) peptide, to human glioblastoma U87MG cells with combination of low dose Paclitaxel (PTX) pre-treatment to augment therapeutic activity for RGD peptide-induced apoptosis. Principal Findings: Human glioblastoma U87MG cells were treated with RGD peptides in the absence or presence of initial exposure to low-dose 10 nM PTX. Results showed that integrin-alpha v beta 3 expressing on the surface of U87MG cells was induced by 10 nM PTX pre-treatment for 12 hrs. Additionally, the U87MG cells pre-treated with PTX and followed by RGD peptides exhibited greater expression of caspases-3, -8 and -9 than those merely treated with single agent of PTX or RGD peptide. Furthermore, the caspase-3, -8 and -9 inhibitor presented significant protection against E[c(RGDyK)] 2 peptide induced U87MG programmed cell death. The increased expression of PTX-induced integrin-alpha v beta 3 was correlated with the enhanced apoptosis in U87MG cells. Conclusions: This study provides a novel concept of targeting integrin-alpha v beta 3 with RGD peptides in combination with low-dose PTX pre-treatment to improve efficiency in human glioblastoma treatment.	[Chang, Ming-Wei; Lo, Jem-Mau; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Juan, Hsueh-Fen; Chang, Hsin-Yi] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University	Chang, MW (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cychuang@mx.nthu.edu.tw		Chang, Hsin-Yi/0000-0002-2742-0676; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Tsing Hua University [95N2115E1]	National Tsing Hua University	This study was financially funded by National Tsing Hua University (95N2115E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Andre N, 2000, CANCER RES, V60, P5349; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Buckner JC, 2006, J CLIN ONCOL, V24, P3871, DOI 10.1200/JCO.2005.04.6979; Chatterjee S, 2000, J NEURO-ONCOL, V46, P135, DOI 10.1023/A:1006444300504; Chen XY, 2004, J NUCL MED, V45, P1776; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Haas MJ, 2009, SCIBX, V12, P1; HEIMANS JJ, 1994, ANN ONCOL, V5, P951, DOI 10.1093/oxfordjournals.annonc.a058736; Huang TC, 2007, FEBS LETT, V581, P3517, DOI 10.1016/j.febslet.2007.06.067; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; Kim R, 2005, ONCOL REP, V14, P595; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1296, DOI 10.1007/s00259-009-1112-2; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; Lu YJ, 2006, AAPS J, V8, pE466, DOI 10.1208/aapsj080355; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; Ng SSM, 2007, CANCER GENE THER, V14, P561, DOI 10.1038/sj.cgt.7701038; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tseng S H, 1999, Neuro Oncol, V1, P101, DOI 10.1093/neuonc/1.2.101; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhou XM, 2001, J BIOL CHEM, V276, P44762, DOI 10.1074/jbc.M104029200	44	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37935	10.1371/journal.pone.0037935	http://dx.doi.org/10.1371/journal.pone.0037935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655084	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900061
J	Hu, WY; Zhao, G; Wang, CY; Zhang, JG; Fu, L				Hu, Wenyan; Zhao, Gang; Wang, Chunyou; Zhang, Jungang; Fu, Ling			Nonlinear Optical Microscopy for Histology of Fresh Normal and Cancerous Pancreatic Tissues	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; MULTIPHOTON MICROSCOPY; MOUSE MODEL; IN-VIVO; FLUORESCENCE; SPECTROSCOPY; FLAVOPROTEIN; CARCINOMA; NADH	Background: Pancreatic cancer is a lethal disease with a 5-year survival rate of only 1-5%. The acceleration of intraoperative histological examination would be beneficial for better management of pancreatic cancer, suggesting an improved survival. Nonlinear optical methods based on two-photon excited fluorescence (TPEF) and second harmonic generation (SHG) of intrinsic optical biomarkers show the ability to visualize the morphology of fresh tissues associated with histology, which is promising for real-time intraoperative evaluation of pancreatic cancer. Methodology/Principal Findings: In order to investigate whether the nonlinear optical imaging methods have the ability to characterize pancreatic histology at cellular resolution, we studied different types of pancreatic tissues by using label-free TPEF and SHG. Compared with other routine methods for the preparation of specimens, fresh tissues without processing were found to be most suitable for nonlinear optical imaging of pancreatic tissues. The detailed morphology of the normal rat pancreas was observed and related with the standard histological images. Comparatively speaking, the preliminary images of a small number of chemical-induced pancreatic cancer tissues showed visible neoplastic differences in the morphology of cells and extracellular matrix. The subcutaneous pancreatic tumor xenografts were further observed using the nonlinear optical microscopy, showing that most cells are leucocytes at 5 days after implantation, the tumor cells begin to proliferate at 10 days after implantation, and the extracellular collagen fibers become disordered as the xenografts grow. Conclusions/Significance: In this study, nonlinear optical imaging was used to characterize the morphological details of fresh pancreatic tissues for the first time. We demonstrate that it is possible to provide real-time histological evaluation of pancreatic cancer by the nonlinear optical methods, which present an opportunity for the characterization of the progress of spontaneous pancreatic cancer and further application in a non-invasive manner.	[Hu, Wenyan; Fu, Ling] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Hu, Wenyan; Fu, Ling] Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China; [Zhao, Gang; Wang, Chunyou; Zhang, Jungang] Huazhong Univ Sci & Technol, Pancreat Surg Ctr, Union Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Fu, L (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	lfu@mail.hust.edu.cn	Liu, Rebecca/F-3466-2014		National Major Scientific Research Program of China [2011CB910401]; National Natural Science Foundation of China [61178077]; Program for New Century Excellent Talents in University [NCET-08-0216]; Fundamental Research Funds for the Central Universities [HUST: 2011JC046]	National Major Scientific Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Major Scientific Research Program of China (No. 2011CB910401), National Natural Science Foundation of China (No. 61178077), Program for New Century Excellent Talents in University (No. NCET-08-0216), and the Fundamental Research Funds for the Central Universities (HUST: 2011JC046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chandra M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3314900; Chandra M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818029; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cicchi R, 2010, OPT EXPRESS, V18, P3840, DOI 10.1364/OE.18.003840; Grosberg LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019925; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hu W, 2012, J BIOMED OPT, V17, DOI DOI 10.1117/1.JBO.17.2.0262007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Islam MS, 2010, ISLETS LANGERHANS AD; Jiang XS, 2011, J INNOV OPT HEAL SCI, V4, P159, DOI 10.1142/S179354581100137X; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Neoptolemos JP, PANCREATIC CANC; Pandya AK, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815a3f1c; Ranchod M., 2010, INTRAOPERATIVE CONSU; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Rivera JA, 1997, SURGERY, V122, P82, DOI 10.1016/S0039-6060(97)90268-3; Sauer BG, 2010, GASTROINTEST ENDOSC, V72, P84, DOI 10.1016/j.gie.2010.02.049; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wilson RH, 2010, OPT EXPRESS, V18, P21612, DOI 10.1364/OE.18.021612; Wilson RH, 2009, OPT EXPRESS, V17, P17502, DOI 10.1364/OE.17.017502; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	31	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37962	10.1371/journal.pone.0037962	http://dx.doi.org/10.1371/journal.pone.0037962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655087	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900064
J	Ma, TZ; Su, ZJ; Chen, L; Liu, SY; Zhu, NX; Wen, LF; Yuan, Y; Lv, LL; Chen, XC; Huang, JM; Chen, HB				Ma, Tianzhong; Su, Zhongjing; Chen, Ling; Liu, Shuyan; Zhu, Ningxia; Wen, Lifeng; Yuan, Yan; Lv, Leili; Chen, Xiancai; Huang, Jianmin; Chen, Haibin			Human Papillomavirus Type 18 E6 and E7 Genes Integrate into Human Hepatoma Derived Cell Line Hep G2	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CERVICAL-CANCER; LIVER; TRANSFORMATION; INFECTION; APOPTOSIS; BIOLOGY; PROTEIN; HPV-18; HBV	Background and Objectives: Human papillomaviruses have been linked causally to some human cancers such as cervical carcinoma, but there is very little research addressing the effect of HPV infection on human liver cells. We chose the human hepatoma derived cell line Hep G2 to investigate whether HPV gene integration took place in liver cells as well. Methods: We applied PCR to detect the possible integration of HPV genes in Hep G2 cells. We also investigated the expression of the integrated E6 and E7 genes by using RT-PCR and Western blotting. Then, we silenced E6 and E7 expression and checked the cell proliferation and apoptosis in Hep G2 cells. Furthermore, we analyzed the potential genes involved in cell cycle and apoptosis regulatory pathways. Finally, we used in situ hybridization to detect HPV 16/18 in hepatocellular carcinoma samples. Results: Hep G2 cell line contains integrated HPV 18 DNA, leading to the expression of the E6 and E7 oncogenic proteins. Knockdown of the E7 and E6 genes expression reduced cell proliferation, caused the cell cycle arrest at the S phase, and increased apoptosis. The human cell cycle and apoptosis real-time PCR arrays analysis demonstrated E6 and E7-mediated regulation of some genes such as Cyclin H, UBA1, E2F4, p53, p107, FASLG, NOL3 and CASP14. HPV16/18 was found in only 9% (9/100) of patients with hepatocellular carcinoma. Conclusion: Our investigations showed that HPV 18 E6 and E7 genes can be integrated into the Hep G2, and we observed a low prevalence of HPV 16/18 in hepatocellular carcinoma samples. However, the precise risk of HPV as causative agent of hepatocellular carcinoma needs further study.	[Ma, Tianzhong; Su, Zhongjing; Liu, Shuyan; Zhu, Ningxia; Wen, Lifeng; Yuan, Yan; Lv, Leili; Chen, Xiancai; Chen, Haibin] Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China; [Chen, Ling] Shantou Univ, Dept Biochem & Mol Biol, Coll Med, Shantou, Guangdong, Peoples R China; [Huang, Jianmin] Harvard Univ, Sch Med, Boston, MA USA; [Huang, Jianmin] Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA	Shantou University; Shantou University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ma, TZ (corresponding author), Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China.	chenhb@stu.edu.cn			Natural Science Foundation of Guangdong Province, China [10151503102000034]; Research Foundation of Shantou University Medical College [LC0401]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Research Foundation of Shantou University Medical College	This study was supported by Natural Science Foundation of Guangdong Province, China (Grant No. 10151503102000034) and Research Foundation of Shantou University Medical College (Grant No. LC0401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BARBOSA MS, 1989, ONCOGENE, V4, P1529; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; Fink SA, 2011, NAT REV GASTRO HEPAT, V8, P285, DOI 10.1038/nrgastro.2011.57; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Korzeniewski N, 2011, CANCER LETT, V305, P113, DOI 10.1016/j.canlet.2010.10.013; Lee DH, 1999, BIOCHEM BIOPH RES CO, V265, P62, DOI 10.1006/bbrc.1999.1636; Liu XS, 2007, PLANTA MED, V73, P1192, DOI 10.1055/s-2007-981597; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Qi ZL, 2010, BIOCHEM CELL BIOL, V88, P697, DOI 10.1139/O10-005; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SCINICARIELLO F, 1992, ANTICANCER RES, V12, P763; Su ZJ, 2012, GENE, V494, P161, DOI 10.1016/j.gene.2011.12.033	18	3	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37964	10.1371/journal.pone.0037964	http://dx.doi.org/10.1371/journal.pone.0037964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655088	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900065
J	Moutier, E; Ye, T; Choukrallah, MA; Urban, S; Osz, J; Chatagnon, A; Delacroix, L; Langer, D; Rochel, N; Moras, D; Benoit, G; Davidson, I				Moutier, Emmanuel; Ye, Tao; Choukrallah, Mohamed-Amin; Urban, Sylvia; Osz, Judit; Chatagnon, Amandine; Delacroix, Laurence; Langer, Diana; Rochel, Natacha; Moras, Dino; Benoit, Gerard; Davidson, Irwin			Retinoic Acid Receptors Recognize the Mouse Genome through Binding Elements with Diverse Spacing and Topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNION-OF-PHARMACOLOGY; EMBRYONIC STEM-CELLS; RESPONSE ELEMENT; CHIP-SEQ; NUCLEAR RECEPTORS; GENE-EXPRESSION; WIDE ANALYSIS; RNA-SEQ; TRANSCRIPTION; DNA	Retinoic acid receptors (RARs) heterodimerize with retinoid X receptors(RXRs) and bind to RA response elements(RAREs) in the regulatory regions of their target genes. Although previous studies on limited sets of RA-regulated genes have defined canonical RAREs as direct repeats of the consensus RGKTCA separated by 1, 2, or 5 nucleotides (DR1, DR2, DR5), we show that in mouse embryoid bodies or F9 embryonal carcinoma cells, RARs occupy a large repertoire of sites with DR0, DR8, and IR0 (inverted repeat 0) elements. Recombinant RAR-RXR binds these non-canonical spacings in vitro with comparable affinities to DR2 and DR5. Most DR8 elements comprise three half-sites with DR2 and DR0 spacings. This specific half-site organization constitutes a previously unrecognized but frequent signature of RAR binding elements. In functional assays, DR8 and IR0 elements act as independent RAREs, whereas DR0 does not. Our results reveal an unexpected diversity in the spacing and topology of binding elements for the RAR-RXR heterodimer. The differential ability of RAR-RXR bound to DR0 compared to DR2, DR5, and DR8 to mediate RA-dependent transcriptional activation indicates that half-site spacing allosterically regulates RAR function.	[Moutier, Emmanuel; Ye, Tao; Urban, Sylvia; Osz, Judit; Langer, Diana; Rochel, Natacha; Moras, Dino; Davidson, Irwin] CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Choukrallah, Mohamed-Amin] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Chatagnon, Amandine; Benoit, Gerard] Univ Lyon 1, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Delacroix, Laurence] CHU, GIGA Neurosci, B-4000 Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Liege	Davidson, I (corresponding author), CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	irwin@titus.u-strasbg.fr	Rochel, Natacha/A-5718-2016	Rochel, Natacha/0000-0002-3573-5889; Delacroix, Laurence/0000-0003-3440-5359; BENOIT, Gerard/0000-0001-9462-6570; Davidson, Irwin/0000-0001-5533-1171	CNRS; INSERM; Universite de Strasbourg; Association pour la Recherche contre le Cancer; Ligue Nationale contre le Cancer, Institut National du Cancer [2008-037]; EuTRACC program of the European union; French Agence Nationale de la Recherche project Rapssodi	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer, Institut National du Cancer(Institut National du Cancer (INCA) France); EuTRACC program of the European union; French Agence Nationale de la Recherche project Rapssodi(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the INSERM, the Universite de Strasbourg, the Association pour la Recherche contre le Cancer, the Ligue Nationale contre le Cancer, Institut National du Cancer Grant 2008-037, the EuTRACC program of the European union, and the French Agence Nationale de la Recherche project Rapssodi.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BOUTERFA HL, 1995, DNA CELL BIOL, V14, P909, DOI 10.1089/dna.1995.14.909; Cao X, 1996, J BIOL CHEM, V271, P20650, DOI 10.1074/jbc.271.34.20650; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang YS, 2006, CANCER BIOL THER, V5, P586, DOI 10.4161/cbt.5.6.2658; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; HEERY DM, 1994, NUCLEIC ACIDS RES, V22, P726, DOI 10.1093/nar/22.5.726; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Krebs A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-533; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lee CH, 1999, BIOCHEMISTRY-US, V38, P8820, DOI 10.1021/bi9903547; LEE MO, 1995, MOL CELL BIOL, V15, P4194; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mangelsdorf David J., 1994, P319; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Simandi Z, 2010, FEBS LETT, V584, P3123, DOI 10.1016/j.febslet.2010.05.052; STEPHANOU A, 1995, ENDOCRINOLOGY, V136, P933, DOI 10.1210/en.136.3.933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Whitington T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr341; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zechel C, 2005, MOL REPROD DEV, V72, P550, DOI 10.1002/mrd.20377; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	95	95	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26328	26341		10.1074/jbc.M112.361790	http://dx.doi.org/10.1074/jbc.M112.361790			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661711	Green Published, hybrid			2022-12-25	WOS:000306916300059
J	Choi, KH; Licht, S				Choi, Kee-Hyun; Licht, Stuart			ATP-Sensitive Potassium Channels Exhibit Variance in the Number of Open Channels below the Limit Predicted for Identical and Independent Gating	PLOS ONE			English	Article							ION CHANNELS; MEDIATED PHOSPHORYLATION; SUPERPOSITION PROPERTIES; ACETYLCHOLINE-RECEPTORS; NEGATIVE COOPERATIVITY; QUANTAL VARIABILITY; CELLS; MEMBRANE; CONDUCTANCE; PROTEINS	In small cells containing small numbers of ion channels, noise due to stochastic channel opening and closing can introduce a substantial level of variability into the cell's membrane potential. Negatively cooperative interactions that couple a channel's gating conformational change to the conformation of its neighbor(s) provide a potential mechanism for mitigating this variability, but such interactions have not previously been directly observed. Here we show that heterologously expressed ATP-sensitive potassium channels generate noise (i.e., variance in the number of open channels) below the level possible for identical and independent channels. Kinetic analysis with single-molecule resolution supports the interpretation that interchannel negative cooperativity (specifically, the presence of an open channel making a closed channel less likely to open) contributes to the decrease in noise. Functional coupling between channels may be important in modulating stochastic fluctuations in cellular signaling pathways.	[Choi, Kee-Hyun; Licht, Stuart] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Choi, KH (corresponding author), Korea Inst Sci & Technol, Seoul, South Korea.	stuart.licht@sanofi.com			Massachusetts Institute of Technology Department of Chemistry; Beckman Foundation through the Beckman Young Investigators program	Massachusetts Institute of Technology Department of Chemistry; Beckman Foundation through the Beckman Young Investigators program	This work was funded by the Massachusetts Institute of Technology Department of Chemistry (web.mit.edu/chemistry/www/index.html) and the Beckman Foundation (www.beckman-foundation.com) through the Beckman Young Investigators program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; BROWN GC, 1990, FEBS LETT, V260, P1, DOI 10.1016/0014-5793(90)80051-J; Colquhoun David, 1995, P397; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Franks KM, 2003, J NEUROSCI, V23, P3186; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEHL S, 1993, EUR BIOPHYS J BIOPHY, V22, P1, DOI 10.1007/BF00205806; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; IWASA K, 1986, BIOPHYS J, V50, P531, DOI 10.1016/S0006-3495(86)83491-9; KELESHIAN AM, 1994, BIOPHYS J, V67, P634, DOI 10.1016/S0006-3495(94)80523-5; Keleshian AM, 2000, BIOPHYS J, V78, P1, DOI 10.1016/S0006-3495(00)76568-4; Kenyon JL, 2000, J NEUROSCI METH, V96, P105, DOI 10.1016/S0165-0270(99)00189-2; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; LIU Y, 1993, BIOPHYS J, V64, P26, DOI 10.1016/S0006-3495(93)81337-7; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; NEDELMAN J, 1986, AM STAT, V40, P286, DOI 10.2307/2684605; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NEUMCKE B, 1983, BIOCHIM BIOPHYS ACTA, V727, P177, DOI 10.1016/0005-2736(83)90382-6; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ribalet B, 2000, J GEN PHYSIOL, V116, P391, DOI 10.1085/jgp.116.3.391; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; YEO GF, 1989, PROC R SOC SER B-BIO, V238, P155, DOI 10.1098/rspb.1989.0073; YERAMIAN E, 1986, BIOPHYS J, V50, P253, DOI 10.1016/S0006-3495(86)83459-2	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37399	10.1371/journal.pone.0037399	http://dx.doi.org/10.1371/journal.pone.0037399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666353	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400026
J	Costa, T; Boccignone, G; Ferraro, M				Costa, Tommaso; Boccignone, Giuseppe; Ferraro, Mario			Gaussian Mixture Model of Heart Rate Variability	PLOS ONE			English	Article							SERIES	Heart rate variability (HRV) is an important measure of sympathetic and parasympathetic functions of the autonomic nervous system and a key indicator of cardiovascular condition. This paper proposes a novel method to investigate HRV, namely by modelling it as a linear combination of Gaussians. Results show that three Gaussians are enough to describe the stationary statistics of heart variability and to provide a straightforward interpretation of the HRV power spectrum. Comparisons have been made also with synthetic data generated from different physiologically based models showing the plausibility of the Gaussian mixture parameters.	[Costa, Tommaso] Univ Turin, Dipartimento Psicol, Turin, Italy; [Boccignone, Giuseppe] Univ Milan, Dipartimento Sci Informaz, Milan, Italy; [Ferraro, Mario] Univ Turin, Dipartimento Fis, Turin, Italy	University of Turin; University of Milan; University of Turin	Costa, T (corresponding author), Univ Turin, Dipartimento Psicol, Turin, Italy.	tommaso.costa@unito.it	Boccignone, Giuseppe/G-7542-2012; Boccignone, Giuseppe/AAH-4459-2020	Boccignone, Giuseppe/0000-0002-5572-0924; Boccignone, Giuseppe/0000-0002-5572-0924; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X				Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Amaral LAN, 1999, COMPUT PHYS COMMUN, V121, P126, DOI 10.1016/S0010-4655(99)00295-7; ANTONIAK CE, 1974, ANN STAT, V2, P1152, DOI 10.1214/aos/1176342871; Aubert AE, 1999, ACTA CARDIOL, V54, P107; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P599, DOI 10.1111/j.1469-8986.1994.tb02352.x; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Camm AJ, 1996, EUR HEART J, V17, P354; Chatfield C, 2004, ANAL TIME SERIES INT, V59; Corduneanu A., 2001, ARTIF INTELL, P27, DOI DOI 10.1016/J.CSDA.2006.07.020; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Garg G., 2011, INT J BIOELECTROMAGN, V13, P255; Glasbey CA, 2001, J ROY STAT SOC C-APP, V50, P143, DOI 10.1111/1467-9876.00225; Hamilton J.D., 2020, TIME SERIES ANAL, DOI 10.2307/j.ctv14jx6sm; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Kantz H., 2004, NONLINEAR TIME SERIE, V7; MANNEVILLE P, 1980, J PHYS-PARIS, V41, P1235, DOI 10.1051/jphys:0198000410110123500; Martis R, 2009, PATTERN RECOGN; McSharry PE, 2003, IEEE T BIO-MED ENG, V50, P289, DOI 10.1109/TBME.2003.808805; Muller P, 2004, STAT SCI, V19, P95, DOI 10.1214/088342304000000017; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Smith KW, 2007, NONLINEAR PROC GEOPH, V14, P73, DOI 10.5194/npg-14-73-2007; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Thong T, 2004, P ANN INT IEEE EMBS, V26, P271; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Verbeek JJ, 2003, NEURAL COMPUT, V15, P469, DOI 10.1162/089976603762553004; Vlassis N, 1999, IEEE T SYST MAN CY A, V29, P393, DOI 10.1109/3468.769758; Vlassis N, 2002, NEURAL PROCESS LETT, V15, P77, DOI 10.1023/A:1013844811137; Yule GU, 1927, PHILOS T R SOC LOND, V226, P267, DOI 10.1098/rsta.1927.0007	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37731	10.1371/journal.pone.0037731	http://dx.doi.org/10.1371/journal.pone.0037731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666386	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400045
J	Rodriguez-Frias, F; Tabernero, D; Quer, J; Esteban, JI; Ortega, I; Domingo, E; Cubero, M; Camos, S; Ferrer-Costa, C; Sanchez, A; Jardi, R; Schaper, M; Homs, M; Garcia-Cehic, D; Guardia, J; Esteban, R; Buti, M				Rodriguez-Frias, Francisco; Tabernero, David; Quer, Josep; Esteban, Juan I.; Ortega, Israel; Domingo, Esteban; Cubero, Maria; Camos, Silvia; Ferrer-Costa, Carles; Sanchez, Alex; Jardi, Rosendo; Schaper, Melanie; Homs, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria			Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome	PLOS ONE			English	Article							LAMIVUDINE THERAPY; VIRAL POLYMERASE; NATURAL-HISTORY; SURFACE PROTEIN; ENTECAVIR; MUTATIONS; REPLICATION; CONSEQUENCE; MUTANT; GENE	Background: Selection of amino acid substitutions associated with resistance to nucleos(t)ide-analog (NA) therapy in the hepatitis B virus (HBV) reverse transcriptase (RT) and their combination in a single viral genome complicates treatment of chronic HBV infection and may affect the overlapping surface coding region. In this study, the variability of an overlapping polymerase-surface region, critical for NA resistance, is investigated before treatment and under antiviral therapy, with assessment of NA-resistant amino acid changes simultaneously occurring in the same genome (linkage analysis) and their influence on the surface coding region. Methodology/Principal Findings: Serum samples obtained from chronic HBV-infected patients at pre-treatment and during sequential NA treatment with lamivudine, adefovir, and entecavir were analyzed by ultra-deep pyrosequencing (UDPS) using the GS-FLX platform (454 Life Sciences-Roche). The pre-treatment HBV quasispecies was not enriched with NA-resistant substitutions. The frequencies of this type of substitutions at pre-treatment did not predict the frequencies observed during lamivudine treatment. On linkage analysis of the RT region studied, NA-resistant HBV variants (except for rtA181T) were present in combinations of amino acid substitutions that increased in complexity after viral breakthrough to entecavir, at which time the combined variant rtL180M-S202G-M204V-V207I predominated. In the overlapping surface region, NA-resistant substitutions caused selection of stop codons in a significant percentage of sequences both at pretreatment and during sequential treatment; the rtA181T substitution, related to sW172stop, predominated during treatment with lamivudine and adefovir. A highly conserved RT residue (rtL155), even more conserved than the essential residues in the RT catalytic motif YMDD, was identified in all samples. Conclusions: UDPS methodology enabled quantification of HBV quasispecies variants, even those harboring complex combinations of amino acid changes. The high percentage of potentially defective genomes, especially in the surface region, suggests effective trans-complementation of these variants.	[Rodriguez-Frias, Francisco; Tabernero, David; Camos, Silvia; Jardi, Rosendo; Schaper, Melanie; Homs, Maria] Univ Autonoma Barcelona, HUVH, VHIR, Dept Biochem, E-08193 Barcelona, Spain; [Rodriguez-Frias, Francisco; Tabernero, David; Quer, Josep; Esteban, Juan I.; Domingo, Esteban; Cubero, Maria; Jardi, Rosendo; Schaper, Melanie; Homs, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Quer, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, VHIR, HUVH, Liver Unit, E-08193 Barcelona, Spain; [Ortega, Israel; Sanchez, Alex] Univ Autonoma Barcelona, VHIR, HUVH, UEB, E-08193 Barcelona, Spain; [Domingo, Esteban] Univ Autonoma Madrid, CSIC, CBMSO, Madrid, Spain; [Ferrer-Costa, Carles] IRB, Mol Modelling & Bioinformat Unit, Barcelona, Spain; [Sanchez, Alex] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Rodriguez-Frias, F (corresponding author), Univ Autonoma Barcelona, HUVH, VHIR, Dept Biochem, E-08193 Barcelona, Spain.	frarodri@vhebron.net	Tabernero, David/AAB-3848-2019; Rodriguez-Frias, Francisco/AAC-3507-2020; Sánchez-Pla, Alex/H-8310-2015; Quer, Josep/A-6741-2012; Domingo, Esteban/K-3937-2014	Tabernero, David/0000-0002-1146-4084; Sánchez-Pla, Alex/0000-0002-8673-7737; Quer, Josep/0000-0003-0014-084X; Homs, Maria/0000-0002-8370-8375; Garcia-Cehic, Damir/0000-0002-0009-038X; Domingo, Esteban/0000-0002-0573-1676; Buti Ferret, Maria/0000-0002-0732-3078; rodriguez-frias, francisco/0000-0002-9128-7013; esteban, rafael/0000-0001-5280-392X	CDTI (Centro para el Desarrollo Tecnologico Industrial) [IDI-20110115]; Spanish Ministry of Economy and Competitiveness [SAF2009-10403, PS09/0899, PI10/01505, PI11/01973]	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the CDTI (Centro para el Desarrollo Tecnologico Industrial, http://www.cdti.es/) (IDI-20110115) and the grants SAF2009-10403, PS09/0899, PI10/01505 and PI11/01973 from the Spanish Ministry of Economy and Competitiveness (http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude G, 2007, J VIROL, V81, P13057, DOI 10.1128/JVI.01495-07; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Honorati MC, 1997, GASTROENTEROLOGY, V112, P2017, DOI 10.1053/gast.1997.v112.pm9178695; Huang LM, 2011, CURR OPIN IMMUNOL, V23, P237, DOI 10.1016/j.coi.2010.12.013; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jardi R, 2007, J VIRAL HEPATITIS, V14, P835, DOI 10.1111/j.1365-2893.2007.00877.x; Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lanford RE, 1997, J VIROL, V71, P2996, DOI 10.1128/JVI.71.4.2996-3004.1997; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Locarnini S, 2008, HEPATOL INT, V2, P147, DOI 10.1007/s12072-008-9048-3; Lok ASF, 2002, J CLIN MICROBIOL, V40, P3729, DOI 10.1128/JCM.40.10.3729-3734.2002; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; Rhee SY, 2010, ANTIVIR RES, V88, P269, DOI 10.1016/j.antiviral.2010.09.012; Rodriguez-Frias F, 2008, ANTIVIR THER, V13, P991; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Urban M, 1998, J GEN VIROL, V79, P1121, DOI 10.1099/0022-1317-79-5-1121; van Hemert FJ, 2008, VIROLOGY, V370, P362, DOI 10.1016/j.virol.2007.08.036; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Villet S, 2007, J HEPATOL, V46, P531, DOI 10.1016/j.jhep.2006.11.016; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, ANTIVIR THER, V11, P909; Xiong XF, 2000, HEPATOLOGY, V31, P219, DOI 10.1002/hep.510310132; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	50	46	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37874	10.1371/journal.pone.0037874	http://dx.doi.org/10.1371/journal.pone.0037874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666402	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400054
J	Abian-Vicen, J; Del Coso, J; Gonzalez-Millan, C; Salinero, JJ; Abian, P				Abian-Vicen, Javier; Del Coso, Juan; Gonzalez-Millan, Cristina; Salinero, Juan Jose; Abian, Pablo			Analysis of Dehydration and Strength in Elite Badminton Players	PLOS ONE			English	Article							EXERCISE INTENSITY; HANDGRIP STRENGTH; VERTICAL JUMP; FLUID; POWER; HYDRATION; TENNIS; PERFORMANCE; FATIGUE; SPORTS	Background: The negative effects of dehydration on aerobic activities are well established. However, it is unknown how dehydration affects intermittent sports performance. The purpose of this study was to identify the level of dehydration in elite badminton players and its relation to muscle strength and power production. Methodology: Seventy matches from the National Spanish badminton championship were analyzed (46 men's singles and 24 women's singles). Before and after each match, jump height and power production were determined during a countermovement jump on a force platform. Participants' body weight and a urine sample were also obtained before and after each match. The amount of liquid that the players drank during the match was also calculated by weighing their individual drinking bottles. Results and Discussion: Sweat rate during the game was 1.14 +/- 0.46 l/h in men and 1.02 +/- 0.64 l/h in women. The players rehydrated at a rate of 1.10 +/- 0.55 l/h and 1.01 +/- 0.44 l/h in the male and female groups respectively. Thus, the dehydration attained during the game was only 0.37 +/- 0.50% in men and 0.32 +/- 0.83% in women. No differences were found in any of the parameters analyzed during the vertical jump (men: from 31.82 +/- 5.29 to 32.90 +/- 4.49 W/kg; p>0.05, women: from 26.36 +/- 4.73 to 27.25 +/- 4.44 W/kg; p>0.05). Post-exercise urine samples revealed proteinuria (60.9% of cases in men and 66.7% in women), leukocyturia (men = 43.5% and women = 50.0%) and erythrocyturia (men = 50.0% and women = 21.7%). Conclusions: Despite a moderate sweat rate, badminton players adequately hydrated during a game and thus the dehydration attained was low. The badminton match did not cause muscle fatigue but it significantly increased the prevalence of proteinuria, leukocyturia and erythrocyturia.	[Abian-Vicen, Javier; Del Coso, Juan; Gonzalez-Millan, Cristina; Salinero, Juan Jose; Abian, Pablo] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Abian-Vicen, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jabian@ucjc.edu	Del Coso, Juan/AAC-7117-2020; Salinero, Juan J./GLT-1243-2022; ABIAN, PABLO/AAZ-8278-2021; Abián-Vicén, Javier/I-8509-2012; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Del Coso, Juan/0000-0002-5785-984X; Salinero, Juan J./0000-0003-4153-5100; ABIAN, PABLO/0000-0002-6976-0740; Abián-Vicén, Javier/0000-0001-9635-3289; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Abian J, 2008, J SPORT MED PHYS FIT, V48, P305; Alkurdi ZD, 2010, J APPL BIOMECH, V26, P123, DOI 10.1123/jab.26.2.123; Apostolidis N, 2004, J SPORT MED PHYS FIT, V44, P157; Armstrong LE, 2010, INT J SPORT NUTR EXE, V20, P145, DOI 10.1123/ijsnem.20.2.145; Baker LB, 2007, MED SCI SPORT EXER, V39, P1114, DOI 10.1249/mss.0b013e3180574b02; BOILEAU M, 1980, UROLOGY, V15, P471, DOI 10.1016/0090-4295(80)90007-2; Broad EM, 1996, INT J SPORT NUTR, V6, P307, DOI 10.1123/ijsn.6.3.307; Buono MJ, 2010, J PHYSIOL SCI, V60, P103, DOI 10.1007/s12576-009-0073-3; Cabello Manrique D, 2003, BRIT J SPORT MED, V37, P62; Carr AJ, 2011, INT J SPORT NUTR EXE, V21, P357, DOI 10.1123/ijsnem.21.5.357; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Chen HL, 2008, J EXERC SCI FIT, V6, P34; Del Coso J, 2008, APPL PHYSIOL NUTR ME, V33, P290, DOI 10.1139/H07-188; Dougherty KA, 2006, MED SCI SPORT EXER, V38, P1650, DOI 10.1249/01.mss.0000227640.60736.8e; Ducher G, 2005, CAN J APPL PHYSIOL, V30, P3, DOI 10.1139/h05-101; Espana-Romero V, 2010, J STRENGTH COND RES, V24, P272, DOI 10.1519/JSC.0b013e3181b296a5; Finn JP, 2004, J HUM NUTR DIET, V61, P221; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GUR H, 1994, BRIT J SPORT MED, V28, P61, DOI 10.1136/bjsm.28.1.61; Gutierrez A, 2003, INT J SPORTS MED, V24, P518; Hamouti N, 2010, EUR J SPORT SCI, V10, P329, DOI 10.1080/17461391003632022; Hamouti N, 2010, EUR J APPL PHYSIOL, V109, P213, DOI 10.1007/s00421-009-1333-x; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; HOFFMAN JR, 1995, INT J SPORTS MED, V16, P214, DOI 10.1055/s-2007-972994; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kane SF, 2009, CURR SPORT MED REP, V8, P77, DOI 10.1249/JSR.0b013e31819e0b8d; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; KRAMER AM, 1992, PERCEPT MOTOR SKILL, V75, P363, DOI 10.2466/PMS.75.5.363-366; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Mahoney CA, 1995, SCI RACKET SPORTS; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P59, DOI 10.1111/j.1600-0838.2010.01191.x; Maughan RJ, 2005, J SPORT SCI, V23, P73, DOI 10.1080/02640410410001730115; McInnis MD, 1998, EUR J APPL PHYSIOL O, V79, P99; NOAKES TD, 1988, EUR J APPL PHYSIOL O, V57, P210, DOI 10.1007/BF00640665; Passe D, 2007, INT J SPORT NUTR EXE, V17, P284, DOI 10.1123/ijsnem.17.3.284; Penders J, 2002, CLIN CHEM, V48, P2236; Poortmans J R, 1977, Exerc Sport Sci Rev, V5, P255; POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003; Popowski LA, 2001, MED SCI SPORT EXER, V33, P747; Riggs MP, 2009, J HUM SPORT EXERC, V4, P221, DOI 10.4100/jhse.2009.43.04; Enriquez OR, 2010, NUTR HOSP, V25, P768, DOI 10.3305/nh.2010.25.5.4542; Sawka M.N., 2006, ACSMS ADV EXERCISE P, V26, P535; Segura-Orti E, 2011, PHYS THER, V91, P1244, DOI 10.2522/ptj.20100141; Sharp NC, 1998, SCI RACKET SPORTS, P52; Shi XC, 1998, SPORTS MED, V25, P157, DOI 10.2165/00007256-199825030-00003; Silva RP, 2010, J SPORT SCI MED, V9, P464; Tippet ML, 2011, J ATHL TRAINING, V46, P55, DOI 10.4085/1062-6050-46.1.55; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076; Watson G, 2005, MED SCI SPORT EXER, V37, P1168, DOI 10.1249/01.mss.0000170100.93279.be; Wilson DW, 1925, J BIOL CHEM, V65, P755; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zemkova E, 2009, KINESIOLOGY, V41, P195	54	33	33	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37821	10.1371/journal.pone.0037821	http://dx.doi.org/10.1371/journal.pone.0037821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666396	Green Accepted, Green Published, gold			2022-12-25	WOS:000305349600032
J	Prows, DR; Gibbons, WJ; Burzynski, BB				Prows, Daniel R.; Gibbons, William J., Jr.; Burzynski, Benjamin B.			Synchronizing Allelic Effects of Opposing Quantitative Trait Loci Confirmed a Major Epistatic Interaction Affecting Acute Lung Injury Survival in Mice	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QTL; SUSCEPTIBILITY; INTERCROSS; DISSECTION; OUTCOMES; GROWTH; DAMAGE; CELLS	Increased oxygen (O-2) levels help manage severely injured patients, but too much for too long can cause acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and even death. In fact, continuous hyperoxia has become a prototype in rodents to mimic salient clinical and pathological characteristics of ALI/ARDS. To identify genes affecting hyperoxia-induced ALI (HALI), we previously established a mouse model of differential susceptibility. Genetic analysis of backcross and F-2 populations derived from sensitive (C57BL/6J; B) and resistant (129X1/SvJ; X1) inbred strains identified five quantitative trait loci (QTLs; Shali1-5) linked to HALI survival time. Interestingly, analysis of these recombinant populations supported opposite within-strain effects on survival for the two major-effect QTLs. Whereas Shali1 alleles imparted the expected survival time effects (i.e., X1 alleles increased HALI resistance and B alleles increased sensitivity), the allelic effects of Shali2 were reversed (i.e., X1 alleles increased HALI sensitivity and B alleles increased resistance). For in vivo validation of these inverse allelic effects, we constructed reciprocal congenic lines to synchronize the sensitivity or resistance alleles of Shali1 and Shali2 within the same strain. Specifically, B-derived Shali1 or Shali2 QTL regions were transferred to X1 mice and X1-derived QTL segments were transferred to B mice. Our previous QTL results predicted that substituting Shali1 B alleles onto the resistant X1 background would add sensitivity. Surprisingly, not only were these mice more sensitive than the resistant X1 strain, they were more sensitive than the sensitive B strain. In stark contrast, substituting the Shali2 interval from the sensitive B strain onto the X1 background markedly increased the survival time. Reciprocal congenic lines confirmed the opposing allelic effects of Shali1 and Shali2 on HALI survival time and provide unique models to identify their respective quantitative trait genes and to critically assess the apparent bidirectional epistatic interactions between these major-effect loci.	[Prows, Daniel R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Prows, Daniel R.; Gibbons, William J., Jr.; Burzynski, Benjamin B.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA	University of Cincinnati; Cincinnati Children's Hospital Medical Center	Prows, DR (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	daniel.prows@cchmc.org			National Institutes of Health, Heart, Lung and Blood Institute [HL75562]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL075562, R01HL075562] Funding Source: NIH RePORTER	National Institutes of Health, Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was financially supported by the National Institutes of Health, Heart, Lung and Blood Institute, grant HL75562 (DRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MN, 2011, EXP LUNG RES, V37, P10, DOI 10.3109/01902148.2010.497893; Ariyarajah A, 2004, J HYPERTENS, V22, P1495, DOI 10.1097/01.hjh.0000133720.94075.6f; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Butterfield RJ, 2003, GENETICS, V163, P1041; CHEVERUD JM, 1995, GENETICS, V139, P1455; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Curley MAQ, 2005, JAMA-J AM MED ASSOC, V294, P229, DOI 10.1001/jama.294.2.229; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Donahoe Michael, 2011, Pulm Circ, V1, P192, DOI 10.4103/2045-8932.83454; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Fawcett GL, 2010, OBESITY, V18, P1383, DOI 10.1038/oby.2009.411; Ferraro TN, 2010, PHYSIOL GENOMICS, V42A, P1, DOI 10.1152/physiolgenomics.00096.2010; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; KISTLER GS, 1967, J CELL BIOL, V32, P605, DOI 10.1083/jcb.32.3.605; Knaapi J, 2011, EXP LUNG RES, V37, P408, DOI 10.3109/01902148.2011.581738; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Legare ME, 2000, GENOME RES, V10, P42; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Norgard EA, 2008, J BONE MINER RES, V23, P887, DOI 10.1359/JBMR.080210; Palijan A, 2003, PHYSIOL GENOMICS, V15, P1, DOI 10.1152/physiolgenomics.00084.2003; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Prows DR, 2007, PHYSIOL GENOMICS, V30, P262, DOI 10.1152/physiolgenomics.00232.2006; Prows DR, 2009, PHYSIOL GENOMICS, V38, P158, DOI 10.1152/physiolgenomics.90392.2008; Reddy NM, 2011, AM J RESP CELL MOL, V45, P1161, DOI 10.1165/rcmb.2011-0144OC; Roper RJ, 2003, J IMMUNOL, V170, P5886, DOI 10.4049/jimmunol.170.12.5886; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; Spragg RG, 2011, AM J RESP CRIT CARE, V183, P1055, DOI 10.1164/rccm.201009-1424OC; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WISPE JR, 1992, J BIOL CHEM, V267, P23937; Yen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026870	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38177	10.1371/journal.pone.0038177	http://dx.doi.org/10.1371/journal.pone.0038177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666475	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600068
J	Seminoff, JA; Benson, SR; Arthur, KE; Eguchi, T; Dutton, PH; Tapilatu, RF; Popp, BN				Seminoff, Jeffrey A.; Benson, Scott R.; Arthur, Karen E.; Eguchi, Tomoharu; Dutton, Peter H.; Tapilatu, Ricardo F.; Popp, Brian N.			Stable Isotope Tracking of Endangered Sea Turtles: Validation with Satellite Telemetry and delta N-15 Analysis of Amino Acids	PLOS ONE			English	Article							DERMOCHELYS-CORIACEA; LEATHERBACK TURTLES; TROPHIC POSITION; FORAGING AREAS; CARBON; DICHOTOMY; BUTTERFLIES; CALIFORNIA; PREDATORS; MOVEMENTS	Effective conservation strategies for highly migratory species must incorporate information about long-distance movements and locations of high-use foraging areas. However, the inherent challenges of directly monitoring these factors call for creative research approaches and innovative application of existing tools. Highly migratory marine species, such as marine turtles, regularly travel hundreds or thousands of kilometers between breeding and feeding areas, but identification of migratory routes and habitat use patterns remains elusive. Here we use satellite telemetry in combination with compound-specific isotope analysis of amino acids to confirm that insights from bulk tissue stable isotope analysis can reveal divergent migratory strategies and within-population segregation of foraging groups of critically endangered leatherback sea turtles (Dermochelys coriacea) across the Pacific Ocean. Among the 78 turtles studied, we found a distinct dichotomy in delta N-15 values of bulk skin, with distinct "low delta N-15" and "high delta N-15" groups. delta N-15 analysis of amino acids confirmed that this disparity resulted from isotopic differences at the base of the food chain and not from differences in trophic position between the two groups. Satellite tracking of 13 individuals indicated that their bulk skin delta N-15 value was linked to the particular foraging region of each turtle. These findings confirm that prevailing marine isoscapes of foraging areas can be reflected in the isotopic compositions of marine turtle body tissues sampled at nesting beaches. We use a Bayesian mixture model to show that between 82 and 100% of the 78 skin-sampled turtles could be assigned with confidence to either the eastern Pacific or western Pacific, with 33 to 66% of all turtles foraging in the eastern Pacific. Our forensic approach validates the use of stable isotopes to depict leatherback turtle movements over broad spatial ranges and is timely for establishing wise conservation efforts in light of this species' imminent risk of extinction in the Pacific.	[Seminoff, Jeffrey A.; Benson, Scott R.; Eguchi, Tomoharu; Dutton, Peter H.] NOAA, Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA USA; [Arthur, Karen E.; Popp, Brian N.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Tapilatu, Ricardo F.] State Univ Papua, Marine Lab, Manokwari, Papua Barat Pro, Indonesia; [Tapilatu, Ricardo F.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; University of Papua; University of Alabama System; University of Alabama Birmingham	Seminoff, JA (corresponding author), NOAA, Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA USA.	jeffrey.seminoff@noaa.gov	Tapilatu, Ricardo F./ABA-6112-2020	Tapilatu, Ricardo F./0000-0001-5216-104X; Popp, Brian/0000-0001-7021-5478	U.S. National Marine Fisheries Service; University of Hawai'i; Directorate For Geosciences [1041329] Funding Source: National Science Foundation; Division Of Ocean Sciences [1040810] Funding Source: National Science Foundation	U.S. National Marine Fisheries Service; University of Hawai'i; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by the U.S. National Marine Fisheries Service and the University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, FED REGISTER, V75, P316; Balazs G.H., 1991, BRIT HERPETOLOGICAL, V37, P33; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bolten Alan B., 1999, P110; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Congdon P., 2001, BAYESIAN STAT MODELI; Crowder L, 2000, NATURE, V405, P881, DOI 10.1038/35016247; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deutsch C. A., 2011, GLOBAL BIOGEOCHEM CY, V15, P483; Dodge KL, 2011, MAR BIOL, V158, P2813, DOI 10.1007/s00227-011-1780-x; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Evershed RP, 2007, ECOL METHOD CONCEPT, P480, DOI 10.1002/9780470691854.ch14; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Garrison Tom, 2009, ESSENTIALS OCEANOGRA, V5th; Gelman A., 2004, BAYESIAN DATA ANAL; Gemperline PJ, 2002, CHEMOMETR INTELL LAB, V60, P135, DOI 10.1016/S0169-7439(01)00191-5; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Graham BS, MOVEMENT UNDERSTANDI, P299; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Hobson KA, 2008, TERR ECOL SER, V2, P1; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie KM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00021; Macko SA, 1997, ANAL CHEM, V69, P926, DOI 10.1021/ac960956l; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; Minami H, 1997, MAR ECOL PROG SER, V158, P249, DOI 10.3354/meps158249; MINAMI H, 1995, CONDOR, V97, P565, DOI 10.2307/1369042; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Musick J.A., 1997, BIOL SEA TURTLES; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Pajuelo M, 2010, MAR ECOL PROG SER, V417, P277, DOI 10.3354/meps08804; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Reich KJ, 2008, OECOLOGIA, V155, P651, DOI 10.1007/s00442-007-0949-y; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Seminoff JA, 2009, J EXP MAR BIOL ECOL, V381, P33, DOI 10.1016/j.jembe.2009.08.018; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Tagliabue A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003037; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	71	106	109	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37403	10.1371/journal.pone.0037403	http://dx.doi.org/10.1371/journal.pone.0037403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666354	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600014
J	Cserep, C; Szabadits, E; Szonyi, A; Watanabe, M; Freund, TF; Nyiri, G				Cserep, Csaba; Szabadits, Eszter; Szonyi, Andras; Watanabe, Masahiko; Freund, Tamas F.; Nyiri, Gabor			NMDA Receptors in GABAergic Synapses during Postnatal Development	PLOS ONE			English	Article							SYNAPTIC-SCAFFOLDING-MOLECULE; D-ASPARTATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL CELLS; DEVELOPING CEREBRAL-CORTEX; SUBUNIT MESSENGER-RNAS; PDZ-DOMAIN PROTEIN; GLUTAMATERGIC SYNAPSES; SILENT SYNAPSES; GROWTH CONES; RAT HIPPOCAMPUS	GABA (gamma-aminobutyric-acid), the main inhibitory neurotransmitter in the adult brain, exerts depolarizing (excitatory) actions during development and this GABAergic depolarization cooperates with NMDARs (N-methyl-D-aspartate receptors) to drive spontaneous synchronous activity (SSA) that is fundamentally important for developing neuronal networks. Although GABAergic depolarization is known to assist in the activation of NMDARs during development, the subcellular localization of NMDARs relative to GABAergic synapses is still unknown. Here, we investigated the subcellular distribution of NMDARs in association with GABAergic synapses at the developmental stage when SSA is most prominent in mice. Using multiple immunofluorescent labeling and confocal laser-scanning microscopy in the developing mouse hippocampus, we found that NMDARs were associated with both glutamatergic and GABAergic synapses at postnatal day 6-7 and we observed a direct colocalization of GABA(A)- and NMDA-receptor labeling in GABAergic synapses. Electron microscopy of preembedding immunogold-immunoperoxidase reactions confirmed that GluN1, GluN2A and GluN2B NMDAR subunits were all expressed in glutamatergic and GABAergic synapses postsynaptically. Finally, quantitative post-embedding immunogold labeling revealed that the density of NMDARs was 3 times higher in glutamatergic than in GABAergic synapses. Since GABAergic synapses were larger, there was little difference in the total number of NMDA receptors in the two types of synapses. In addition, receptor density in synapses was substantially higher than extrasynaptically. These data can provide the neuroanatomical basis of a new interpretation of previous physiological data regarding the GABA(A)R-NMDAR cooperation during early development. We suggest that during SSA, synaptic GABA(A)R-mediated depolarization assists NMDAR activation right inside GABAergic synapses and this effective spatial cooperation of receptors and local change of membrane potential will reach developing glutamatergic synapses with a higher probability and efficiency even further away on the dendrites. This additional level of cooperation that operates within the depolarizing GABAergic synapse, may also allow its own modification triggered by Ca2+-influx through the NMDA receptors.	[Cserep, Csaba; Szabadits, Eszter; Szonyi, Andras; Freund, Tamas F.; Nyiri, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University	Cserep, C (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary.	nyiri@koki.hu	WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Szonyi, Andras/0000-0002-6818-4550	National Institutes of Health [DA09158, MH54671, NS030549]; Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok [CNK77793]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health (DA09158, MH54671, NS030549, www.nih.gov) and Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok (CNK77793, www.nih.gov.hu, www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; Aguado F, 2002, J NEUROSCI, V22, P9430; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Allene C, 2008, J NEUROSCI, V28, P12851, DOI 10.1523/JNEUROSCI.3733-08.2008; Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bergersen LH, 2009, NEUROSCIENCE, V158, P260, DOI 10.1016/j.neuroscience.2008.03.074; Bergersen LH, 2011, IMMUNOGOLD DETECTION; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Cherubini E, 2011, MOL NEUROBIOL, V43, P97, DOI 10.1007/s12035-010-8147-z; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; Cserep C, 2011, CEREB CORTEX, V21, P2065, DOI 10.1093/cercor/bhq281; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dingledine R, 1999, PHARMACOL REV, V51, P7; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Elhardt M, 2010, NEUROSCI LETT, V468, P166, DOI 10.1016/j.neulet.2009.10.091; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Gundersen V, 2004, MOL CELL NEUROSCI, V26, P156, DOI 10.1016/j.mcn.2004.01.017; Harris LW, 2003, EUR J NEUROSCI, V18, P1706, DOI 10.1046/j.1460-9568.2003.02902.x; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Jay TM, 1999, J NEUROPHYSIOL, V81, P1741, DOI 10.1152/jn.1999.81.4.1741; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaindl AM, 2008, MOL CELL PROTEOMICS, V7, P2293, DOI 10.1074/mcp.M800030-MCP200; Kaminski RM, 2011, NEUROCHEM RES, V36, P146, DOI 10.1007/s11064-010-0284-2; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kittler JT, 2004, BIOCHEM PHARMACOL, V68, P1649, DOI 10.1016/j.bcp.2004.07.028; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MARTIN DL, 1991, J NEUROSCI, V11, P2725; McCabe AK, 2007, DEV NEUROBIOL, V67, P1574, DOI 10.1002/dneu.20533; Melone M, 2005, J COMP NEUROL, V492, P495, DOI 10.1002/cne.20743; Mohajerani Majid H., 2006, Critical Reviews in Neurobiology, V18, P13; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; OERTEL WH, 1981, J HISTOCHEM CYTOCHEM, V29, P977, DOI 10.1177/29.8.7024401; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Soeda H, 2002, NEUROSCI LETT, V325, P5, DOI 10.1016/S0304-3940(02)00215-X; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Takai H, 2003, EXP MOL PATHOL, V75, P89, DOI 10.1016/S0014-4800(03)00030-3; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; TROMMER BL, 1995, EXP NEUROL, V131, P83, DOI 10.1016/0014-4886(95)90010-1; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Voigt T, 2005, J NEUROSCI, V25, P4605, DOI 10.1523/JNEUROSCI.3803-04.2005; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wenzel A, 1997, J NEUROCHEM, V68, P469; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yao WD, 2000, J NEUROSCI, V20, P2626; Yu GY, 2001, DEV BRAIN RES, V130, P217, DOI 10.1016/S0165-3806(01)00239-5; Yu W, 2008, J NEUROCHEM, V105, P2300, DOI 10.1111/j.1471-4159.2008.05311.x	91	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37753	10.1371/journal.pone.0037753	http://dx.doi.org/10.1371/journal.pone.0037753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662211	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305342300101
J	Rockx-Brouwer, D; Chong, A; Wehrly, TD; Child, R; Crane, DD; Celli, J; Bosio, CM				Rockx-Brouwer, Dedeke; Chong, Audrey; Wehrly, Tara D.; Child, Robert; Crane, Deborah D.; Celli, Jean; Bosio, Catharine M.			Low Dose Vaccination with Attenuated Francisella tularensis Strain SchuS4 Mutants Protects against Tularemia Independent of the Route of Vaccination	PLOS ONE			English	Article							AEROSOL CHALLENGE; INFECTION; LIVE; VIRULENCE; MICE; PULMONARY; S4; IDENTIFICATION; PROLIFERATION; IMMUNIZATION	Tularemia, caused by the Gram-negative bacterium Francisella tularensis, is a severe, sometimes fatal disease. Interest in tularemia has increased over the last decade due to its history as a biological weapon. In particular, development of novel vaccines directed at protecting against pneumonic tularemia has been an important goal. Previous work has demonstrated that, when delivered at very high inoculums, administration of live, highly attenuated strains of virulent F. tularensis can protect against tularemia. However, lower vaccinating inoculums did not offer similar immunity. One concern of using live vaccines is that the host may develop mild tularemia in response to infection and use of high inoculums may contribute to this issue. Thus, generation of a live vaccine that can efficiently protect against tularemia when delivered in low numbers, e.g. < 100 organisms, may address this concern. Herein we describe the ability of three defined, attenuated mutants of F. tularensis SchuS4, deleted for FTT0369c, FTT1676, or FTT0369c and FTT1676, respectively, to engender protective immunity against tularemia when delivered at concentrations of approximately 50 or fewer bacteria. Attenuated strains for use as vaccines were selected by their inability to efficiently replicate in macrophages in vitro and impaired replication and dissemination in vivo. Although all strains were defective for replication in vitro within macrophages, protective efficacy of each attenuated mutant was correlated with their ability to modestly replicate and disseminate in the host. Finally, we demonstrate the parenteral vaccination with these strains offered superior protection against pneumonic tularemia than intranasal vaccination. Together our data provides proof of principle that low dose attenuated vaccines may be a viable goal in development of novel vaccines directed against tularemia.	[Rockx-Brouwer, Dedeke; Chong, Audrey; Wehrly, Tara D.; Child, Robert; Celli, Jean] NIAID, Tularemia Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA; [Crane, Deborah D.; Bosio, Catharine M.] NIAID, Immun Pulm Pathogens Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rockx-Brouwer, D (corresponding author), NIAID, Tularemia Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.	jcelli@niaid.nih.gov; bosioc@niaid.nih.gov	Bosio, Catharine/D-7456-2015	Celli, Jean/0000-0002-6793-1788	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001013, ZIAAI000953] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anderson RV, 2010, VACCINE, V28, P6562, DOI 10.1016/j.vaccine.2010.07.072; BAKER JA, 1970, J AM VET MED ASSOC, V156, P1743; Bauler TJ, 2011, J IMMUNOL, V187, P1845, DOI 10.4049/jimmunol.1100377; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; EIGELSBACH H, 1961, P SOC EXP BIOL MED, V108, P732, DOI 10.3181/00379727-108-27049; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; HARRIS S, 1992, ANN NY ACAD SCI, V666, P21, DOI 10.1111/j.1749-6632.1992.tb38021.x; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2008, INFECT IMMUN, V76, P3086, DOI 10.1128/IAI.00363-08; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Snyder MJ, 1957, T ASSOC AM PHYSICIAN, V70, P74; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; WENGER JD, 1989, ANN INTERN MED, V110, P888, DOI 10.7326/0003-4819-110-11-888; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	42	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37752	10.1371/journal.pone.0037752	http://dx.doi.org/10.1371/journal.pone.0037752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662210	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300100
J	Yang, CL; Liu, YY; Ma, YG; Xue, YX; Liu, DG; Ren, Y; Liu, XB; Li, Y; Li, Z				Yang, Cheng-Liang; Liu, Yong-Yu; Ma, Ye-Gang; Xue, Yi-Xue; Liu, De-Gui; Ren, Yi; Liu, Xiao-Bai; Li, Yao; Li, Zhen			Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ACTIVATION; STAT3; TRANSDUCER; EXPRESSION; INTERLEUKIN-6; INHIBITOR; SURVIVAL; SUPPRESSION; CARCINOMA	Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development. However, little is known about its anti-tumor mechanism in small cell lung cancer (SCLC). In this study, we found that curcumin can inhibit SCLC cell proliferation, cell cycle, migration, invasion and angiogenesis through suppression of the STAT3. SCLC cells were treated with curcumin (15 mu mol/L) and the results showed that curcumin was effective in inhibiting STAT3 phosphorylation to downregulate of an array of STAT3 downstream targets, which contributed to suppression of cell proliferation, loss of colony formation, depression of cell migration and invasion. Curcumin also suppressed the expression of proliferative proteins (Survivin, Bcl-X-L and Cyclin B1), and invasive proteins (VEGF, MMP-2, MMP-7 and ICAM-1). Knockdown of STAT3 expression by siRNA was able to induce anti-invasive effects in vitro. In contrast, activation of STAT3 upstream of interleukin 6 (IL-6) leads to the increased cell proliferation, cell survival, angiogenesis, invasion, migration and tumor growth. Our findings illustrate the biologic significance of IL-6/JAK/STAT3 signaling in SCLC progression and providenovel evidence that the pathway may be a new potential target for therapy of SCLC. It was concluded that curcumin is a potent agent in the inhibition of STAT3 with favorable pharmacological activity, and curcumin may have translational potential as an effective cancer therapeutic or preventive agent for SCLC.	[Yang, Cheng-Liang; Liu, Yong-Yu; Ma, Ye-Gang; Liu, De-Gui; Ren, Yi] Liaoning Canc Hosp & Inst, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China; [Xue, Yi-Xue; Li, Yao] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning, Peoples R China; [Liu, Xiao-Bai] China Med Univ, Year Program 7, Shenyang, Liaoning, Peoples R China; [Li, Zhen] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Yang, CL (corresponding author), Liaoning Canc Hosp & Inst, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China.	liuyongyu_china@126.com	Liu, Yongyu/AAL-5429-2021	Liu, Yongyu/0000-0002-4094-8555; Liu, Yong-Yu/0000-0002-7968-0162; Yang, Chengliang/0000-0002-5182-4494	Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China [[2011] 20]; Liaoning Department of Health, People's Republic of China [2010-079]; Liaoning Department of Human Resources and Social Security, People's Republic of China [2009-390]	Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China; Liaoning Department of Health, People's Republic of China; Liaoning Department of Human Resources and Social Security, People's Republic of China	This work was supported by Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China (No. [2011] 20), Liaoning Department of Health, People's Republic of China (No. 2010-079), Liaoning Department of Human Resources and Social Security, People's Republic of China (No. 2009-390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kim DK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-155; Klausen P, 2000, ONCOGENE, V19, P3675, DOI 10.1038/sj.onc.1203707; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Manju V, 2005, CLIN CHIM ACTA, V358, P60, DOI 10.1016/j.cccn.2005.02.018; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Missale C, 1998, P NATL ACAD SCI USA, V95, P5366, DOI 10.1073/pnas.95.9.5366; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Shiraga M, 2002, CANCER RES, V62, P5967; Sinha R, 2003, J Postgrad Med, V49, P222; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857; Yang C, 2009, MOL CANCER THER, V8, P2597, DOI 10.1158/1535-7163.MCT-09-0504; Yang CL, 2012, DNA CELL BIOL, V31, P139, DOI 10.1089/dna.2011.1300	34	220	225	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37960	10.1371/journal.pone.0037960	http://dx.doi.org/10.1371/journal.pone.0037960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662257	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300148
J	Cuevas, JM; Delaunay, A; Visser, JC; Bellstedt, DU; Jacquot, E; Elena, SF				Cuevas, Jose M.; Delaunay, Agnes; Visser, Johan C.; Bellstedt, Dirk U.; Jacquot, Emmanuel; Elena, Santiago F.			Phylogeography and Molecular Evolution of Potato virus Y	PLOS ONE			English	Article							COAT PROTEIN; MOSAIC-VIRUS; GENETIC-STRUCTURE; AMINO-ACID; MUTATIONAL ANALYSIS; RECOMBINANT STRAIN; VENOUS NECROSIS; POTYVIRUS; IDENTIFICATION; RESISTANCE	Potato virus Y (PVY) is an important plant pathogen, whose host range includes economically important crops such as potato, tobacco, tomato, and pepper. PVY presents three main strains (PVYO, PVYN and PVYC) and several recombinant forms. PVY has a worldwide distribution, yet the mechanisms that promote and maintain its population structure and genetic diversity are still unclear. In this study, we used a pool of 77 complete PVY genomes from isolates collected worldwide. After removing the effect of recombination in our data set, we used Bayesian techniques to study the influence of geography and host species in both PVY population structure and dynamics. We have also performed selection and covariation analyses to identify evolutionarily relevant amino acid residues. Our results show that both geographic and host-driven adaptations explain PVY diversification. Furthermore, purifying selection is the main force driving PVY evolution, although some indications of positive selection accounted for the diversification of the different strains. Interestingly, the analysis of P3N-PIPO, a recently described gene in potyviruses, seems to show a variable length among the isolates analyzed, and this variability is explained, in part, by host-driven adaptation.	[Cuevas, Jose M.; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Delaunay, Agnes; Jacquot, Emmanuel] Univ Rennes 1, INRA, BiO3P Biol Organisms & Populat Appl Plant Protect, Le Rheu, France; [Visser, Johan C.; Bellstedt, Dirk U.] Univ Stellenbosch, Dept Biochem, Matieland, South Africa; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); INRAE; Universite de Rennes; Stellenbosch University; The Santa Fe Institute	Cuevas, JM (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	jmcuevas@uv.es	Cuevas, Jose M/C-6271-2016; Jacquot, Emmanuel/AAH-4367-2021; Elena, Santiago F./A-4191-2011	Cuevas, Jose M/0000-0003-2049-3554; Elena, Santiago F./0000-0001-8249-5593; Bellstedt, Dirk/0000-0002-6376-4855	Spanish Ministry of Science and Innovation grant [BFU2009-06993]; JAE program from CSIC	Spanish Ministry of Science and Innovation grant(Spanish Government); JAE program from CSIC	This research was supported by the Spanish Ministry of Science and Innovation grant BFU2009-06993 to SFE. JMC was supported by the JAE program from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ali MC, 2010, PLANT PATHOL, V59, P31, DOI 10.1111/j.1365-3059.2009.02174.x; Andersen K, 1998, VIROLOGY, V241, P304, DOI 10.1006/viro.1997.8967; Ayme V, 2006, MOL PLANT MICROBE IN, V19, P557, DOI 10.1094/MPMI-19-0557; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Delatte H, 2007, J MOL EVOL, V65, P112, DOI 10.1007/s00239-007-0005-x; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dullemans AM, 2011, ARCH VIROL, V156, P473, DOI 10.1007/s00705-010-0853-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2011, MOL PLANT MICROBE IN, V24, P287, DOI 10.1094/MPMI-09-10-0214; Fanigliulo A, 2005, ARCH VIROL, V150, P709, DOI 10.1007/s00705-004-0449-x; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Feki S, 2005, EUR J PLANT PATHOL, V112, P221, DOI 10.1007/s10658-004-6807-4; Fellers JP, 2002, MOL PLANT PATHOL, V3, P145, DOI 10.1046/j.1364-3703.2002.00106.x; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Glais L, 2002, ARCH VIROL, V147, P363, DOI 10.1007/s705-002-8325-0; Hall JS, 1998, MOL PHYLOGENET EVOL, V10, P323, DOI 10.1006/mpev.1998.0535; Hu XX, 2009, ARCH VIROL, V154, P1303, DOI 10.1007/s00705-009-0448-z; Jimenez I, 2006, MOL PLANT MICROBE IN, V19, P350, DOI 10.1094/MPMI-19-0350; Jin YS, 2007, MOL PLANT MICROBE IN, V20, P1505, DOI 10.1094/MPMI-20-12-1505; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin L, 2011, VIRUS GENES, V43, P90, DOI 10.1007/s11262-011-0596-6; Lopez-Moya JJ, 1998, J GEN VIROL, V79, P161; Lorenzen J, 2008, ARCH VIROL, V153, P517, DOI 10.1007/s00705-007-0030-5; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mascia T, 2010, J PLANT PATHOL, V92, P131; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Moury B, 2011, MOL BIOL EVOL, V28, P2707, DOI 10.1093/molbev/msr105; Moury B, 2010, MOL PLANT PATHOL, V11, P161, DOI [10.1111/j.1364-3703.2009.00573.x, 10.1111/j.1364-3703.2009.00573.X]; Ogawa T, 2008, VIRUS RES, V131, P199, DOI 10.1016/j.virusres.2007.09.010; Pagan I, 2006, PHYTOPATHOLOGY, V96, P274, DOI 10.1094/PHYTO-96-0274; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peng YH, 1998, J GEN VIROL, V79, P897, DOI 10.1099/0022-1317-79-4-897; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Schubert J, 2007, J VIROL METHODS, V140, P66, DOI 10.1016/j.jviromet.2006.10.017; Shi Y, 2007, MOL PLANT PATHOL, V8, P785, DOI [10.1111/j.1364-3703.2007.00426.x, 10.1111/J.1364-3703.2007.00426.X]; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; SLATKIN M, 1989, GENETICS, V123, P603; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Torres-Puente M, 2008, INFECT GENET EVOL, V8, P74, DOI 10.1016/j.meegid.2007.10.005; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; VERCHOT J, 1992, VIROLOGY, V190, P298, DOI 10.1016/0042-6822(92)91216-H; Visser JC, 2009, ARCH VIROL, V154, P1891, DOI 10.1007/s00705-009-0525-3; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Wen RH, 2010, VIROLOGY, V400, P1, DOI 10.1016/j.virol.2010.01.022; Wen RH, 2011, MOL PLANT PATHOL, P10; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	64	41	46	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37853	10.1371/journal.pone.0037853	http://dx.doi.org/10.1371/journal.pone.0037853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655074	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900051
J	Eberhardt, MK; Chang, WLW; Logsdon, NJ; Yue, YJ; Walter, MR; Barry, PA				Eberhardt, Meghan K.; Chang, W. L. William; Logsdon, Naomi J.; Yue, Yujuan; Walter, Mark R.; Barry, Peter A.			Host Immune Responses to a Viral Immune Modulating Protein: Immunogenicity of Viral Interleukin-10 in Rhesus Cytomegalovirus-Infected Rhesus Macaques	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; INTRAUTERINE TRANSMISSION; ANTIBODY-RESPONSES; GLYCOPROTEIN-B; VIRUS; IL-10; POPULATION; VACCINES; HOMOLOG	Background: Considerable evidence has accumulated that multiple viruses, bacteria, and protozoa manipulate interleukin-10 (IL-10)-mediated signaling through the IL-10 receptor (IL-10R) in ways that could enable establishment of a persistent microbial infection. This suggests that inhibition of pathogen targeting of IL-10/IL-10R signaling could prevent microbial persistence. Human cytomegalovirus (HCMV) and rhesus cytomegalovirus (RhCMV) express a viral interleukin-10 (cmvIL-10 and rhcmvIL-10, respectively) with comparable immune modulating properties in vitro to that of their host's cellular IL-10 (cIL-10). A prior study noted that rhcmvIL-10 alters innate and adaptive immunity to RhCMV in vivo, consistent with a central role for rhcmvIL-10 during acute virus-host interactions. Since cmvIL-10 and rhcmvIL-10 are extremely divergent from the cIL-10 of their respective hosts, vaccine-mediated neutralization of their function could inhibit establishment of viral persistence without inhibition of cIL-10. Methods and Findings: As a prelude to evaluating cmvIL-10-based vaccines in humans, the rhesus macaque model of HCMV was used to interrogate peripheral and mucosal immune responses to rhcmvIL-10 in RhCMV-infected animals. ELISA were used to detect rhcmvIL-10-binding antibodies in plasma and saliva, and an IL-12-based bioassay was used to quantify plasma antibodies that neutralized rhcmvIL-10 function. rhcmvIL-10 is highly immunogenic during RhCMV infection, stimulating high avidity rhcmvIL-10-binding antibodies in the plasma of all infected animals. Most infected animals also exhibited plasma antibodies that partially neutralized rhcmvIL-10 function but did not cross-neutralize the function of rhesus cIL-10. Notably, minimally detectable rhcmvIL-10-binding antibodies were detected in saliva. Conclusion: This study demonstrates that rhcmvIL-10, as a surrogate for cmvIL-10, is a viable vaccine candidate because (1) it is highly immunogenic during natural RhCMV infection, and (2) neutralizing antibodies to rhcmvIL-10 do not cross-react with rhesus cIL-10. Exceedingly low rhcmvIL-10 antibodies in saliva further suggest that the oral mucosa, which is critical in RhCMV natural history, is associated with suboptimal anti-rhcmvIL-10 antibody responses.	[Eberhardt, Meghan K.; Chang, W. L. William; Yue, Yujuan; Barry, Peter A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Logsdon, Naomi J.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Barry, Peter A.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Barry, Peter A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; University of California System; University of California Davis	Eberhardt, MK (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	pabarry@ucdavis.edu	Chang, W. L. William/AAX-1773-2021		National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01 AI49342, RO1 AI047300, AI047300-S1]; National Center for Research Resources [P51 RR00169]; Office of Research Infrastructure Programs/OD [P51 OD011107]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300, R01AI049342] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants R01 AI49342 (to PAB) and RO1 AI047300 and AI047300-S1 (to MRW) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health (NIH). This project was also funded by the National Center for Research Resources (P51 RR00169) and is currently supported by the Office of Research Infrastructure Programs/OD (P51 OD011107) to the California National Primate Research Center (www.cnprc.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2010, J INFECT DIS, V202, P1800, DOI 10.1086/657412; Bahjat KS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000568; Barboza L, 2009, CELL IMMUNOL, V257, P61, DOI 10.1016/j.cellimm.2009.02.008; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; BOPPANA SB, 1995, J INFECT DIS, V171, P1115, DOI 10.1093/infdis/171.5.1115; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Britt WJ, 1996, TRENDS MICROBIOL, V4, P34, DOI 10.1016/0966-842X(96)81503-4; BRITT WJ, 1984, VIROLOGY, V135, P369, DOI 10.1016/0042-6822(84)90193-4; Brodeur ND, 2010, VIRUS RES, V153, P265, DOI 10.1016/j.virusres.2010.08.012; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Chang KM, 2007, HEPATOL RES, V37, pS327, DOI 10.1111/j.1872-034X.2007.00220.x; Chang WLW, 2007, J IMMUNOL, V178, P7794, DOI 10.4049/jimmunol.178.12.7794; Chang WLW, 2010, P NATL ACAD SCI USA, V107, P22647, DOI 10.1073/pnas.1013794108; Chang WLW, 2009, VIROLOGY, V390, P330, DOI 10.1016/j.virol.2009.05.013; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Cui XH, 2008, VACCINE, V26, P5760, DOI 10.1016/j.vaccine.2008.07.092; Dar L, 2008, PEDIATR INFECT DIS J, V27, P841, DOI 10.1097/INF.0b013e3181723d55; ELEK SD, 1974, LANCET, V1, P1; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Estevez PT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-104; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gandhoke Inderjeet, 2006, Indian Journal of Pediatrics, V73, P1095, DOI 10.1007/BF02763052; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jenkins C, 2008, J VIROL, V82, P3736, DOI 10.1128/JVI.02173-07; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Langhans B, 2010, CLIN SCI, V119, P97, DOI 10.1042/CS20090661; Li J, 2010, IMMUNOL CELL BIOL, V88, P834, DOI 10.1038/icb.2010.63; Lockridge KM, 1999, J VIROL, V73, P9576, DOI 10.1128/JVI.73.11.9576-9583.1999; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Logsdon NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028127; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Oxford KL, 2011, J VIROL, V85, P5105, DOI 10.1128/JVI.02631-10; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; PLOTKIN SA, 1994, SCIENCE, V265, P1383, DOI 10.1126/science.8073277; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Raux M, 2000, AIDS RES HUM RETROV, V16, P583, DOI 10.1089/088922200309007; Revello MG, 2010, REV MED VIROL, V20, P136, DOI 10.1002/rmv.645; RIDDELL SR, 1992, SCIENCE, V257, P238; Rieper CD, 2011, J GEN VIROL, V92, P1508, DOI 10.1099/vir.0.028738-0; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Saccoccio FM, 2011, CLIN VACCINE IMMUNOL, V18, P1536, DOI 10.1128/CVI.05128-11; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; SOHN Y M, 1992, Journal of Korean Medical Science, V7, P47; Spencer JV, 2008, VIROLOGY, V374, P164, DOI 10.1016/j.virol.2007.11.031; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Stratton KR, 2000, VACCINES 21 CENTURY, DOI [10.17226/5501, DOI 10.17226/5501]; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; VOGEL P, 1994, LAB ANIM SCI, V44, P25; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang JB, 1996, J INFECT DIS, V174, P387, DOI 10.1093/infdis/174.2.387; Wu XL, 2000, AIDS RES HUM RETROV, V16, P1423, DOI 10.1089/08892220050140973; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018; YOW MD, 1989, J INFECT DIS, V159, P163, DOI 10.1093/infdis/159.2.163; Yue YJ, 2003, J GEN VIROL, V84, P3371, DOI 10.1099/vir.0.19508-0	73	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37931	10.1371/journal.pone.0037931	http://dx.doi.org/10.1371/journal.pone.0037931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655082	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900059
J	Sack, BK; Merchant, S; Markusic, DM; Nathwani, AC; Davidoff, AM; Byrne, BJ; Herzog, RW				Sack, Brandon K.; Merchant, Sherin; Markusic, David M.; Nathwani, Amit C.; Davidoff, Andrew M.; Byrne, Barry J.; Herzog, Roland W.			Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; HEMOPHILIA-A MICE; IMMUNE TOLERANCE; FACTOR-IX; RITUXIMAB; INDUCTION; VECTOR; MANAGEMENT; INHIBITORS; MECHANISM	The major complication in the treatment of hemophilia A is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). The current method for eradicating inhibitors, termed immune tolerance induction (ITI), is costly and protracted. Clinical protocols that prevent rather than treat inhibitors are not yet established. Liver-directed gene therapy hopes to achieve long-term correction of the disease while also inducing immune tolerance. We sought to investigate the use of adeno-associated viral (serotype 8) gene transfer to induce tolerance to human B domain deleted FVIII in hemophilia A mice. We administered an AAV8 vector with either human B domain deleted FVIII or a codon-optimized transgene, both under a liver-specific promoter to two strains of hemophilia A mice. Protein therapy or gene therapy was given either alone or in conjunction with anti-CD20 antibody-mediated B cell depletion. Gene therapy with a low-expressing vector resulted in sustained near-therapeutic expression. However, supplementary protein therapy revealed that gene transfer had sensitized mice to hFVIII in a high-responder strain but not in mice of a low-responding strain. This heightened response was ameliorated when gene therapy was delivered with anti-murine CD20 treatment. Transient B cell depletion prevented inhibitor formation in protein therapy, but failed to achieve a sustained hypo-responsiveness. Importantly, use of a codon-optimized hFVIII transgene resulted in sustained therapeutic expression and tolerance without a need for B cell depletion. Therefore, anti-CD20 may be beneficial in preventing vector-induced immune priming to FVIII, but higher levels of liver-restricted expression are preferred for tolerance.	[Sack, Brandon K.; Merchant, Sherin; Markusic, David M.; Byrne, Barry J.; Herzog, Roland W.] Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32611 USA; [Byrne, Barry J.; Herzog, Roland W.] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL USA; [Nathwani, Amit C.] UCL Canc Inst, Dept Haematol, London, England; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of London; University College London; St Jude Children's Research Hospital	Sack, BK (corresponding author), Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32611 USA.	rherzog@ufl.edu		Byrne, Barry J./0000-0002-7302-1756; Markusic, David/0000-0002-3774-0825	NIH [R01 HL51390, P01 HD078810, R01 HL073838, P01 HL59412, P01 DK58327]; University of Florida College of Medicine; Howard Hughes Medical Institute's Science for Life Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073838, P01HL078810, P01HL059412, R01HL109442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida College of Medicine(University of Florida); Howard Hughes Medical Institute's Science for Life Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants R01 HL51390 and P01 HD078810 (to RWH), R01 HL073838 (to AMD), and P01 HL59412 and P01 DK58327 (to BJB). BKS was supported by a Dean's Fellowship from the University of Florida College of Medicine. SM was supported by the Howard Hughes Medical Institute's Science for Life Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem A, 2009, HAEMOPHILIA, V15, P210, DOI 10.1111/j.1365-2516.2008.01865.x; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Cao O, 2009, MOL THER, V17, P1733, DOI 10.1038/mt.2009.159; Collins PW, 2009, J THROMB HAEMOST, V7, P787, DOI 10.1111/j.1538-7836.2009.03332.x; Cooper M, 2009, HUM GENE THER, V20, P767, DOI 10.1089/hum.2008.161; Di Michele DM, 2011, J THROMB HAEMOST, V9, P216, DOI 10.1111/j.1538-7836.2011.04349.x; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Foster H, 2008, MOL THER, V16, P1825, DOI 10.1038/mt.2008.186; Gangadharan B, 2006, BLOOD, V107, P3859, DOI 10.1182/blood-2005-12-4961; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Ishiwata A, 2009, J GENE MED, V11, P1020, DOI 10.1002/jgm.1391; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Li CW, 2011, P NATL ACAD SCI USA, V108, P14258, DOI 10.1073/pnas.1109522108; Lu H, 2008, HUM GENE THER, V19, P648, DOI 10.1089/hum.2007.0182; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Moghimi B, 2011, J THROMB HAEMOST, V9, P1524, DOI 10.1111/j.1538-7836.2011.04351.x; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Odeyemi IAO, 2009, CURR MED RES OPIN, V25, P239, DOI 10.1185/03007990802633863 ; Padegimas L, 2012, MOL THER, V20, P63, DOI 10.1038/mt.2011.196; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Qadura M, 2011, HAEMOPHILIA, V17, P288, DOI 10.1111/j.1365-2516.2010.02397.x; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; Sarkar R, 2003, J THROMB HAEMOST, V1, P220, DOI 10.1046/j.1538-7836.2003.00096.x; Singh AG, 2011, THROMB HAEMOSTASIS, V106, P172, DOI 10.1160/TH11-02-0097; Streif Werner, 2009, Hamostaseologie, V29, P151; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Verweij CL, 2011, DISCOV MED, V12, P229; Wang LL, 2012, MOL GENET METAB, V105, P203, DOI 10.1016/j.ymgme.2011.10.020; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Xiang Y, 2012, J IMMUNOL IN PRESS; Zhang AH, 2011, BLOOD, V117, P2223, DOI 10.1182/blood-2010-06-293324	35	67	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37671	10.1371/journal.pone.0037671	http://dx.doi.org/10.1371/journal.pone.0037671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655063	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900039
J	Cook, ZC; Gray, MA; Cann, MJ				Cook, Zara C.; Gray, Michael A.; Cann, Martin J.			Elevated Carbon Dioxide Blunts Mammalian cAMP Signaling Dependent on Inositol 1,4,5-Triphosphate Receptor-mediated Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLYL CYCLASE-D; ADENYLYL-CYCLASE; CAENORHABDITIS-ELEGANS; CO2 LEVELS; OK CELLS; ACUTE HYPERCAPNIA; IP3 RECEPTORS; BICARBONATE; INHIBITION; STIMULATION	ElevatedCO(2) is generally detrimental to animal cells, suggesting an interaction with core processes in cell biology. We demonstrate that elevated CO2 blunts G protein-activated cAMP signaling. The effect of CO2 is independent of changes in intracellular and extracellular pH, independent of the mechanism used to activate the cAMP signaling pathway, and is independent of cell context. A combination of pharmacological and genetic tools demonstrated that the effect of elevated CO2 on cAMPlevels required the activity of the IP3 receptor. Consistent with these findings, CO2 caused an increase in steady state cytoplasmic Ca2+ concentrations not observed in the absence of the IP3 receptor or under nonspecific acidotic conditions. We examined the well characterized cAMP-dependent inhibition of the isoform 3 Na+/H+ antiporter (NHE3) to demonstrate a functional relevance for CO2-mediated reductions in cellular cAMP. Consistent with the cellular biochemistry, elevated CO2 abrogated the inhibitory effect of cAMP on NHE3 function via an IP3 receptor-dependent mechanism.	[Cook, Zara C.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Biophys Sci Inst, Durham DH1 3LE, England; [Gray, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Newcastle University - UK	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Biophys Sci Inst, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Cann, Martin/G-2864-2012	Cann, Martin/0000-0001-6305-8769; GRAY, MICHAEL/0000-0002-6774-6283	Leverhulme Trust [F/00 128/AU]; Biotechnology and Biological Sciences Research Council [BB/I011994/1]; Wellcome Trust [GR083381MA]; BBSRC [BB/I011994/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Leverhulme Trust Grant F/00 128/AU, Biotechnology and Biological Sciences Research Council Grant BB/I011994/1, and Wellcome Trust Grant GR083381MA (to M. J. C.).	Adrogue H E, 2001, Respir Care, V46, P328; Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; Bouyer P, 2003, AM J PHYSIOL-RENAL, V285, pF674, DOI 10.1152/ajprenal.00107.2003; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chao YC, 2010, BIOCHEM J, V432, P267, DOI 10.1042/BJ20100617; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Cundari TR, 2009, J CHEM INF MODEL, V49, P2111, DOI 10.1021/ci9002377; Gopalakrishnan P, 2011, CARDIOL REV, V19, P279, DOI 10.1097/CRD.0b013e318223bd08; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; GUNTUPALLI J, 1987, AM J PHYSIOL, V253, pF34, DOI 10.1152/ajprenal.1987.253.1.F34; GUNTUPALLI J, 1985, KIDNEY INT, V27, P116; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jehle AW, 1999, AM J PHYSIOL-RENAL, V276, pF46, DOI 10.1152/ajprenal.1999.276.1.F46; Johnson MS, 2010, ECOHYDROLOGY, V3, P68, DOI 10.1002/eco.95; JOHNSON ME, 1994, J NEUROSCI, V14, P4040; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kaplan A, 2001, P NATL ACAD SCI USA, V98, P4817, DOI 10.1073/pnas.101119898; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; KOYAMA H, 1978, IN VITRO CELL DEV B, V14, P239; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Leclerc P, 1999, J ANDROL, V20, P126; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; MARTIN TJ, 1976, NATURE, V260, P436, DOI 10.1038/260436a0; Mou TC, 2009, BIOCHEMISTRY-US, V48, P3387, DOI 10.1021/bi802122k; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Rossi A, 2011, BIOCH BIOPHYS ACTA; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Short AD, 2000, J BIOL CHEM, V275, P1807, DOI 10.1074/jbc.275.3.1807; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Townsend PD, 2009, J BIOL CHEM, V284, P784, DOI 10.1074/jbc.M807239200; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhou YH, 2006, AM J PHYSIOL-RENAL, V291, pF358, DOI 10.1152/ajprenal.00520.2005	61	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26291	26301		10.1074/jbc.M112.349191	http://dx.doi.org/10.1074/jbc.M112.349191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654111	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000306916300055
J	Saraiva, IH; Newman, DK; Louro, RO				Saraiva, Ivo H.; Newman, Dianne K.; Louro, Ricardo O.			Functional Characterization of the FoxE Iron Oxidoreductase from the Photoferrotroph Rhodobacter ferrooxidans SW2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-ONEIDENSIS MR-1; FERROUS IRON; FE(II)-OXIDIZING BACTERIA; OXIDIZING BACTERIA; EARLY EVOLUTION; OXIDATION; CYTOCHROME; PROTEINS; NMR; PHOTOSYNTHESIS	Photoferrotrophy is presumed to be an ancient type of photosynthetic metabolism in which bacteria use the reducing power of ferrous iron to drive carbon fixation. In this work the putative iron oxidoreductase of the photoferrotroph Rhodobacter ferrooxidans SW2 was cloned, purified, and characterized for the first time. This protein, FoxE, was characterized using spectroscopic, thermodynamic, and kinetic techniques. It is a c-type cytochrome that forms a trimer or tetramer in solution; the two hemes of each monomer are hexacoordinated by histidine and methionine. The hemes have positive reduction potentials that allow downhill electron transfer from many geochemically relevant ferrous iron forms to the photosynthetic reaction center. The reduction potentials of the hemes are different and are cross- assigned to fast and slow kinetic phases of ferrous iron oxidation in vitro. Lower reactivity was observed at high pH and may contribute to prevent ferric iron precipitation inside or at the surface of the cell. These results help fill in the molecular details of a metabolic process that likely contributed to the deposition of precambrian banded iron formations, globally important sedimentary rocks that are found on every continent today.	[Saraiva, Ivo H.; Louro, Ricardo O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Universidade Nova de Lisboa; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Howard Hughes Medical Institute	Louro, RO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780157 Oeiras, Portugal.	louro@itqb.unl.pt	Louro, Ricardo O./AAB-4601-2020; Saraiva, Ivo/M-6213-2013; Guo, aitong/G-5439-2012	Louro, Ricardo O./0000-0002-2392-6450; Saraiva, Ivo/0000-0002-5833-7699; 	MIT-Portugal Program [MIT-Pt/BS-BB/0014/2008]; Fundacao para a Ciencia e a Tecnologia [REEQ/336/BIO/2005, PEst-OE/EQB/LA0004/2011]; Fundacao para a Ciencia e a Tecnologia Grant [SFRH/BD/36582/2007]	MIT-Portugal Program; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia Grant	This research was supported by the MIT-Portugal Program (MIT-Pt/BS-BB/0014/2008) and Fundacao para a Ciencia e a Tecnologia (REEQ/336/BIO/2005, PEst-OE/EQB/LA0004/2011).; Recipient of Fundacao para a Ciencia e a Tecnologia Grant SFRH/BD/36582/2007.	Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bird LJ, 2011, TRENDS MICROBIOL, V19, P330, DOI 10.1016/j.tim.2011.05.001; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Catarino T, 2001, CHEMBIOCHEM, V2, P416, DOI 10.1002/1439-7633(20010601)2:6<416::AID-CBIC416>3.3.CO;2-Q; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Dantas JM, 2011, DALTON T, V40, P12713, DOI 10.1039/c1dt10975h; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; Fonseca BM, 2009, J BIOL INORG CHEM, V14, P375, DOI 10.1007/s00775-008-0455-7; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Hegler F, 2008, FEMS MICROBIOL ECOL, V66, P250, DOI 10.1111/j.1574-6941.2008.00592.x; Hegler F, 2010, FEMS MICROBIOL ECOL, V74, P592, DOI 10.1111/j.1574-6941.2010.00975.x; Heising S, 1998, MICROBIOL-SGM, V144, P2263, DOI 10.1099/00221287-144-8-2263; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Jeffrey V., 1991, GENE, V100, P189; Kappler A, 2005, GEOLOGY, V33, P865, DOI 10.1130/G21658.1; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Louro RO, 2004, FEBS LETT, V576, P77, DOI 10.1016/j.febslet.2004.08.066; Miot J, 2009, APPL ENVIRON MICROB, V75, P5586, DOI 10.1128/AEM.00490-09; MOSER CC, 1992, BIOCHIM BIOPHYS ACTA, V1101, P171, DOI 10.1016/S0005-2728(05)80012-X; Parkhurst D.L., 1999, USERS GUIDE PHREEQC; Pessanha M, 2009, BBA-BIOENERGETICS, V1787, P113, DOI 10.1016/j.bbabio.2008.11.007; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Press W, 1989, NUMERICAL RECIPES AR; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Schadler S, 2009, GEOMICROBIOL J, V26, P93, DOI 10.1080/01490450802660573; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; XAVIER AV, 1978, NATURE, V275, P245, DOI 10.1038/275245a0; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	32	25	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25541	25548		10.1074/jbc.M112.360636	http://dx.doi.org/10.1074/jbc.M112.360636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661703	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000306651700060
J	Nande, R; Di Benedetto, A; Aimola, P; De Carlo, F; Carper, M; Claudio, CD; Denvir, J; Valluri, J; Duncan, GC; Claudio, PP				Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Valluri, Jagan; Duncan, Gary C.; Claudio, Pier Paolo			Targeting a Newly Established Spontaneous Feline Fibrosarcoma Cell Line by Gene Transfer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; APOPTOSIS INDUCING CYTOKINE; CANCER TERMINATOR VIRUS; INJECTION-SITE SARCOMAS; PHASE-I; GROWTH; CATS; P53; MDA-7/IL-24; MUTATIONS	Fibrosarcoma is a deadly disease in cats and is significantly more often located at classical vaccine injections sites. More rare forms of spontaneous non-vaccination site (NSV) fibrosarcomas have been described and have been found associated to genetic alterations. Purpose of this study was to compare the efficacy of adenoviral gene transfer in NVS fibrosarcoma. We isolated and characterized a NVS fibrosarcoma cell line (Cocca-6A) from a spontaneous fibrosarcoma that occurred in a domestic calico cat. The feline cells were karyotyped and their chromosome number was counted using a Giemsa staining. Adenoviral gene transfer was verified by western blot analysis. Flow cytometry assay and Annexin-V were used to study cell-cycle changes and cell death of transduced cells. Cocca-6A fibrosarcoma cells were morphologically and cytogenetically characterized. Giemsa block staining of metaphase spreads of the Cocca-6A cells showed deletion of one of the E1 chromosomes, where feline p53 maps. Semi-quantitative PCR demonstrated reduction of p53 genomic DNA in the Cocca-6A cells. Adenoviral gene transfer determined a remarkable effect on the viability and growth of the Cocca-6A cells following single transduction with adenoviruses carrying Mda-7/IL-24 or IFN-gamma or various combination of RB/p105, Ras-DN, IFN-gamma, and Mda-7 gene transfer. Therapy for feline fibrosarcomas is often insufficient for long lasting tumor eradication. More gene transfer studies should be conducted in order to understand if these viral vectors could be applicable regardless the origin (spontaneous vs. vaccine induced) of feline fibrosarcomas.	[Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Claudio, Pier Paolo] Marshall Univ, Joan C Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA; [Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Claudio, Pier Paolo] Edwards Comprehens Canc Ctr, McKown Translat Res Inst, Huntington, WV USA; [Di Benedetto, Altomare; Aimola, Pierpaolo] Univ Aquila, Fac Sci, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Valluri, Jagan] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Duncan, Gary C.] Martin Vet Clin, Ashland, KY USA; [Claudio, Pier Paolo] Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV USA	Marshall University; University of L'Aquila; Marshall University; Marshall University	Nande, R (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	National Cancer Institute [CA131395, CA140024]; National Institutes of Health - Center of Biological Research Excellence [5P20RR020180, WV-INBRE 5P20RR016477]; Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE [R03CA140024, R21CA131395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health - Center of Biological Research Excellence; Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The present studies were supported in part by the awards number CA131395 and CA140024 from the National Cancer Institute (to PPC), and in part by National Institutes of Health - Center of Biological Research Excellence 5P20RR020180, WV-INBRE 5P20RR016477 (West Virginia-IDeA Networks of Biomedical Research Excellence.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Marshall University Biochemistry and Microbiology & Surgery Departments for their support.	Arber N, 1999, APOPTOSIS, V4, P383, DOI 10.1023/A:1009651406017; Barber LG, 2000, J AM ANIM HOSP ASSOC, V36, P416, DOI 10.5326/15473317-36-5-416; Bergman PJ, 1998, J AM VET MED ASSOC, V213, P1424; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Claudio PP, 2000, CANCER RES, V60, P372; Doddy FD, 1996, J COMP PATHOL, V114, P165, DOI 10.1016/S0021-9975(96)80005-3; ESPLIN DG, 1993, J AM VET MED ASSOC, V202, P1245; Fisher PB, 2003, CANCER BIOL THER, V2, pS23; Gemmill LT, 1998, J AM VET MED ASSOC, V213, P955; Gemmill LT, 1997, J AM VET MED ASSOC, V210, P889; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Greco A, 2010, MOL THER, V18, P295, DOI 10.1038/mt.2009.252; GRUFFYDDJONES TJ, 1994, VET REC, V134, P310, DOI 10.1136/vr.134.12.310-a; Hampel V, 2007, J VET INTERN MED, V21, P1340, DOI 10.1892/06-201.1; HARASEN GLG, 1984, CAN VET J, V25, P207; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jahnke A, 2007, J VET MED A, V54, P599, DOI 10.1111/j.1439-0442.2007.01002.x; Jourdier TM, 2003, GENE THER, V10, P2126, DOI 10.1038/sj.gt.3302124; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Martin M, 2003, CAN VET J, V44, P660; Mayr B, 1998, VET RES COMMUN, V22, P21, DOI 10.1023/A:1005931127067; MAYR B, 1995, BRIT VET J, V151, P707, DOI 10.1016/S0007-1935(95)80151-0; Mayr B, 2000, RES VET SCI, V68, P63, DOI 10.1053/rvsc.1999.0339; Nambiar PR, 2001, VET PATHOL, V38, P236, DOI 10.1354/vp.38-2-236; OKUDA M, 1993, J VET MED SCI, V55, P801, DOI 10.1292/jvms.55.801; Poirier VJ, 2002, J VET INTERN MED, V16, P726, DOI 10.1111/j.1939-1676.2002.tb02415.x; QuintinColonna F, 1996, GENE THER, V3, P1104; Santos S, 2006, J HERED, V97, P114, DOI 10.1093/jhered/esj016; Sarkar D, 2008, CANCER GENE THER, V15, P293, DOI 10.1038/cgt.2008.14; Sarkar D, 2002, BIOTECHNIQUES, P30; Sarkar D, 2007, CANCER RES, V67, P5434, DOI 10.1158/0008-5472.CAN-07-0195; Sarkar D, 2006, CELL CYCLE, V5, P1531, DOI 10.4161/cc.5.14.3095; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sironi Giuseppe, 1999, Vet Ophthalmol, V2, P227, DOI 10.1046/j.1463-5224.1999.00086.x; Spugnini EP, 2008, IN VIVO, V22, P751; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Vattemi E, 2007, DRUG NEWS PERSPECT, V20, P511, DOI 10.1358/dnp.2007.20.8.1157613; von Erichsen J, 2011, VET PATHOLOGY	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37743	10.1371/journal.pone.0037743	http://dx.doi.org/10.1371/journal.pone.0037743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666387	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400046
J	Oreza, LAN; Alvarez, AF; Arias-Olguin, II; Larios, AT; Georgellis, D				Nunez Oreza, Luis Alberto; Alvarez, Adrian F.; Arias-Olguin, Imilla I.; Torres Larios, Alfredo; Georgellis, Dimitris			The ArcB Leucine Zipper Domain Is Required for Proper ArcB Signaling	PLOS ONE			English	Article							ESCHERICHIA-COLI; SENSOR KINASE; 2-COMPONENT SYSTEM; IN-VITRO; TRANSDUCTION SYSTEM; PHOSPHATE REGULON; REGULATOR PROTEIN; ACETYL PHOSPHATE; ACETATE KINASE; REDOX SIGNAL	The Arc two-component system modulates the expression of numerous genes in response to respiratory growth conditions. This system comprises ArcA as the response regulator and ArcB as the sensor kinase. ArcB is a tripartite histidine kinase whose activity is regulated by the oxidation of two cytosol-located redox-active cysteine residues that participate in intermolecular disulfide bond formation. Here, we report that the ArcB protein segment covering residues 70-121, fulfills the molecular characteristics of a leucine zipper containing coiled coil structure. Also, mutational analyses of this segment reveal three different phenotypical effects to be distributed along the coiled coil structure of ArcB, demonstrating that this motif is essential for proper ArcB signaling.	[Nunez Oreza, Luis Alberto; Alvarez, Adrian F.; Georgellis, Dimitris] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico; [Arias-Olguin, Imilla I.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fis, Mexico City 04510, DF, Mexico; [Torres Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biolo Estruct, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Oreza, LAN (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.	dimitris@ifc.unam.mx	Georgellis, Dimitris/U-2517-2017; Alvarez, Adrian F./L-4656-2019; Alvarez, Adrian F./L-7575-2013	Georgellis, Dimitris/0000-0002-6114-795X; Alvarez, Adrian F./0000-0003-4381-5691; Alvarez, Adrian F./0000-0003-4381-5691; Torres-Larios, Alfredo/0000-0002-0702-350X; Nunez Oreza, Luis Alberto/0000-0002-4583-8080	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [80684]; DGAPA-PAPIIT, UNAM [IN219709]; International Centre for Genetic Engineering and Biothecnology (ICGEB) [CRPMEX008-02]; DGAPA-UNAM	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); International Centre for Genetic Engineering and Biothecnology (ICGEB); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Grants 80684 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT), IN219709 from DGAPA-PAPIIT, UNAM, and CRPMEX008-02 from the International Centre for Genetic Engineering and Biothecnology (ICGEB). A. F. Alvarez is indebted to DGAPA-UNAM for the award of a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AF, 2010, METHOD ENZYMOL, V471, P205, DOI 10.1016/S0076-6879(10)71012-0; Alvarez AF, 2010, J BACTERIOL, V192, P391, DOI 10.1128/JB.00881-09; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BUCKLAND R, 1989, NATURE, V338, P547, DOI 10.1038/338547a0; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Croasdale R, 2011, J BIOL CHEM, V286, P27537, DOI 10.1074/jbc.M110.196972; DAILEY FE, 1993, J BACTERIOL, V175, P3236, DOI 10.1128/JB.175.10.3236-3239.1993; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, J BACTERIOL, V183, P7206, DOI 10.1128/JB.183.24.7206-7212.2001; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; LEE TY, 1990, J BACTERIOL, V172, P2245, DOI 10.1128/jb.172.5.2245-2249.1990; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsushika A, 2000, J BIOCHEM, V127, P855, DOI 10.1093/oxfordjournals.jbchem.a022679; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Miller JH., 1972, EXPT MOL GENETICS; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Swain KE, 2009, BIOCHEMISTRY-US, V48, P9266, DOI 10.1021/bi901020d; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Yaku H, 1997, FEBS LETT, V417, P409, DOI 10.1016/S0014-5793(97)01329-X; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	50	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38187	10.1371/journal.pone.0038187	http://dx.doi.org/10.1371/journal.pone.0038187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666479	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400097
J	Power, EF; Kelly, DL; Stout, JC				Power, Eileen F.; Kelly, Daniel L.; Stout, Jane C.			Organic Farming and Landscape Structure: Effects on Insect-Pollinated Plant Diversity in Intensively Managed Grasslands	PLOS ONE			English	Article							SPECIES COMPOSITION; FIELD BOUNDARIES; BIODIVERSITY; BUMBLEBEES; DIPTERA; COMMUNITIES; SYRPHIDAE; HEDGEROWS; ABUNDANCE; BRITAIN	Parallel declines in insect-pollinated plants and their pollinators have been reported as a result of agricultural intensification. Intensive arable plant communities have previously been shown to contain higher proportions of self-pollinated plants compared to natural or semi-natural plant communities. Though intensive grasslands are widespread, it is not known whether they show similar patterns to arable systems nor whether local and/or landscape factors are influential. We investigated plant community composition in 10 pairs of organic and conventional dairy farms across Ireland in relation to the local and landscape context. Relationships between plant groups and local factors (farming system, position in field and soil parameters) and landscape factors (e. g. landscape complexity) were investigated. The percentage cover of unimproved grassland was used as an inverse predictor of landscape complexity, as it was negatively correlated with habitat-type diversity. Intensive grasslands (organic and conventional) contained more insect-pollinated forbs than non-insect pollinated forbs. Organic field centres contained more insect-pollinated forbs than conventional field centres. Insect-pollinated forb richness in field edges (but not field centres) increased with increasing landscape complexity (% unimproved grassland) within 1, 3, 4 and 5 km radii around sites, whereas non-insect pollinated forb richness was unrelated to landscape complexity. Pollination systems within intensive grassland communities may be different from those in arable systems. Our results indicate that organic management increases plant richness in field centres, but that landscape complexity exerts strong influences in both organic and conventional field edges. Insect-pollinated forb richness, unlike that for non-insect pollinated forbs, showed positive relationships to landscape complexity reflecting what has been documented for bees and other pollinators. The insect-pollinated forbs, their pollinators and landscape context are clearly linked. This needs to be taken into account when managing and conserving insect-pollinated plant and pollinator communities.	[Power, Eileen F.; Kelly, Daniel L.; Stout, Jane C.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland; [Kelly, Daniel L.; Stout, Jane C.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Power, EF (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland.	eileen.power@newcastle.ac.uk	Stout, Jane C/B-1631-2010; Stout, Jane/AAS-8867-2020	Stout, Jane C/0000-0002-2027-0863; Stout, Jane/0000-0002-2027-0863; Power, Eileen/0000-0002-5941-4676	Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF) under the National Development Plan	Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF) under the National Development Plan	This project is part of a collaborative project led by Michael O'Donovan, Teagasc, and was funded by the Irish Department of Agriculture, Fisheries and Food (http://www.agriculture.gov.ie) Research Stimulus Fund (RSF), funded under the National Development Plan (2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2008, MAJOR MICRONUTIENT A; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bossard M, 2000, CORINE LAND COVER TE; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CONN DLT, 1976, J APPL ECOL, V13, P429, DOI 10.2307/2401792; Cope T, 2009, GRASSES BRIT ISLES B, V13; Cranmer L, 2012, OIKOS, V121, P562, DOI 10.1111/j.1600-0706.2011.19704.x; Dauber J, 2005, GLOBAL ECOL BIOGEOGR, V14, P213, DOI 10.1111/j.1466-822x.2005.00150.x; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Deckers B, 2004, ACTA OECOL, V26, P23, DOI 10.1016/j.actao.2004.03.002; Department of Agriculture, 2009, FACT SHEET IR AGR; Dziock F, 2006, INT REV HYDROBIOL, V91, P341, DOI 10.1002/iroh.200510889; Ekroos J, 2008, AGR ECOSYST ENVIRON, V124, P155, DOI 10.1016/j.agee.2007.09.003; European Environment Agency, 2007, CLC2006 TECHN GUID; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Gabbett M, 2007, SEMINATURAL GRASSLAN; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Haenke S, 2009, J APPL ECOL, V46, P1106, DOI 10.1111/j.1365-2664.2009.01685.x; Irish Organic Farmers and Growers Association, 2006, IOFGA STAND ORG FOOD; IVIMEYCO.RB, 1966, P ROY IRISH ACAD B, V64, P211; Jacobs JH, 2009, ANN BOT-LONDON, V104, P1397, DOI 10.1093/aob/mcp236; James L. F., 1992, POISONOUS PLANTS; Kleijn D, 2000, J APPL ECOL, V37, P256, DOI 10.1046/j.1365-2664.2000.00486.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Le Coeur D, 2002, AGR ECOSYST ENVIRON, V89, P23, DOI 10.1016/S0167-8809(01)00316-4; McMahon BJ, 2010, AGR ECOSYST ENVIRON, V139, P232, DOI 10.1016/j.agee.2010.08.008; Michener C.D., 2007, BEES WORLD, Vsecond; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Ouin A, 2002, AGR ECOSYST ENVIRON, V93, P45, DOI 10.1016/S0167-8809(02)00004-X; Parton K, 2002, NEW ZEAL VET J, V50, P22, DOI 10.1080/00480169.2002.36262; Petersen S, 2006, AGR ECOSYST ENVIRON, V113, P302, DOI 10.1016/j.agee.2005.09.016; PINHEIRO J., 2009, NLME LINEAR NONLINEA; PLANTUREUX S, 2005, AGRONOMY RES, V3, P152; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; R Development Core Team, 2007, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Romero A, 2008, AGR ECOSYST ENVIRON, V124, P97, DOI 10.1016/j.agee.2007.08.002; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2010, ECOGRAPHY, V33, P514, DOI 10.1111/j.1600-0587.2009.05938.x; Santorum Veronica, 2005, Tearmann, V4, P79; Schippers P, 2002, AGR ECOSYST ENVIRON, V93, P351, DOI 10.1016/S0167-8809(01)00339-5; Speight M.C., 2008, DATABASE IRISH SYRPH; Stace C.A., 2010, STACE, V3rd Edn; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Sullivan CA, 2010, BIOL CONSERV, V143, P1529, DOI 10.1016/j.biocon.2010.03.035; Van Geert A, 2010, J ECOL, V98, P178, DOI 10.1111/j.1365-2745.2009.01600.x; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Wratten SD, 2003, OECOLOGIA, V134, P605, DOI 10.1007/s00442-002-1128-9; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	61	35	36	0	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38073	10.1371/journal.pone.0038073	http://dx.doi.org/10.1371/journal.pone.0038073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666450	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400077
J	Noulas, A; Scellato, S; Lambiotte, R; Pontil, M; Mascolo, C				Noulas, Anastasios; Scellato, Salvatore; Lambiotte, Renaud; Pontil, Massimiliano; Mascolo, Cecilia			A Tale of Many Cities: Universal Patterns in Human Urban Mobility	PLOS ONE			English	Article							INTERVENING OPPORTUNITIES; SPATIAL-DISTRIBUTION; MIGRATION; DISTANCE; MODEL	The advent of geographic online social networks such as Foursquare, where users voluntarily signal their current location, opens the door to powerful studies on human movement. In particular the fine granularity of the location data, with GPS accuracy down to 10 meters, and the worldwide scale of Foursquare adoption are unprecedented. In this paper we study urban mobility patterns of people in several metropolitan cities around the globe by analyzing a large set of Foursquare users. Surprisingly, while there are variations in human movement in different cities, our analysis shows that those are predominantly due to different distributions of places across different urban environments. Moreover, a universal law for human mobility is identified, which isolates as a key component the rank-distance, factoring in the number of places between origin and destination, rather than pure physical distance, as considered in some previous works. Building on our findings, we also show how a rank-based movement model accurately captures real human movements in different cities.	[Noulas, Anastasios; Scellato, Salvatore; Mascolo, Cecilia] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Lambiotte, Renaud] Univ Namur, Dept Math, Namur, Belgium; [Pontil, Massimiliano] UCL, Dept Comp Sci, London, England	University of Cambridge; University of Namur; University of London; University College London	Noulas, A (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	anastasios.noulas@cl.cam.ac.uk	Lambiotte, Renaud/HDO-4530-2022	Lambiotte, Renaud/0000-0002-0583-4595; Mascolo, Cecilia/0000-0001-9614-4380	National Science Foundation [NSF PHY05-51164]; Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/G065802/1, EP/G069557/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G069557/1, EP/G065802/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported in part by the National Science Foundation under Grant No. NSF PHY05-51164 and the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CARROTHERS GAP, 1956, J AM I PLANNERS, V22, P94, DOI 10.1080/01944365608979229; Cheung C, 2005, J E ASIA SOC TRANSP, V6, P3773; Cho E, 2011, P KDD 11; Clauset A, 2009, ARXIVPHYSICS07061062; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; EASA SM, 1993, J TRANSP ENG-ASCE, V119, P793, DOI 10.1061/(ASCE)0733-947X(1993)119:6(793); Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; FREYMEYER RH, 1985, SOCIOL PERSPECT, V28, P419, DOI 10.2307/1389227; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; HAYNES KE, 1973, ECON GEOGR, V49, P68, DOI 10.2307/142746; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Isaacman S, 2010, 11 WORKSH MOB COMP S; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Levy M, 2010, PHYSICA A, V389, P4913, DOI 10.1016/j.physa.2010.07.008; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; MILLER E, 1972, J REGIONAL SCI, V12, P475, DOI 10.1111/j.1467-9787.1972.tb00369.x; Nicholson KG, 1998, TXB INFLUENZA, P219; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Quercia D, 2010, P IEEE ICDM 10; Ravenstein EG, 1885, LAWS MIGRATION, V48, P167; Scellato S, 2011, P ICWSM 11; Scellato S, 2011, P WWW 11; Simini F, 2012, NATURE; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; WADYCKI WJ, 1975, DEMOGRAPHY, V12, P121, DOI 10.2307/2060737; WILSON AG, 1967, TRANSPORT RES, V1, P253, DOI 10.1016/0041-1647(67)90035-4; Zheng VW, 2010, P WWW 10; Zheng Y, 2009, P WWW 09	35	382	392	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37027	10.1371/journal.pone.0037027	http://dx.doi.org/10.1371/journal.pone.0037027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666339	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600008
J	Cao, ZL; Meng, JZ; Li, XX; Wu, RP; Huang, YX; He, YX				Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; Wu, Ruiping; Huang, Yanxin; He, Yuxian			The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; A VIRUS; HEMAGGLUTININ MOLECULE; ANTIGENIC STRUCTURE; CONSERVED EPITOPE; FUSION-INHIBITION; RECEPTOR-BINDING; CELL EPITOPES; INFECTION; PREDICTION	The continued spread of highly pathogenic avian influenza (HPAI) H5N1 virus underscores the importance of effective antiviral approaches. AVFluIgG01 is a potent and broad-reactive H5N1-neutralizing human monoclonal antibody (mAb) showing great potential for use either for therapeutic purposes or as a basis of vaccine development, but its antigenic epitope and neutralization mechanism have not been finely characterized. In this study, we first demonstrated that AVFluIgG01 targets a novel conformation-dependent epitope in the globular head region of H5N1 hemagglutinin (HA). By selecting mimotopes from a random peptide library in combination with computational algorithms and site-directed mutagenesis, the epitope was mapped to three conserved discontinuous sites (I-III) that are located closely at the three-dimensional structure of HA. Further, we found that this HA1-specific human mAb can efficiently block both virus-receptor binding and post-attachment steps, while its Fab fragment exerts the post-attachment inhibition only. Consistently, AVFluIgG01 could inhibit HA-mediated cell-cell membrane fusion at a dose-dependent manner and block the acquisition of pH-induced protease sensitivity. These results suggest a neutralization mechanism of AVFluIgG01 by simultaneously blocking viral attachment to the receptors on host cells and interfering with HA conformational rearrangements associated with membrane fusion. The presented data provide critical information for developing novel antiviral therapeutics and vaccines against HPAI H5N1 virus.	[Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; He, Yuxian] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China; [Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; He, Yuxian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Ruiping] Wenzhou Med Coll, Wenzhou, Peoples R China; [Huang, Yanxin] No Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wenzhou Medical University	Cao, ZL (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China.	yhe@ipb.pumc.edu.cn			NSFC [81025009]; National 973 program of China [2010CB530100]; National Science and Technology Major Project [2012ZX10001-008]	NSFC(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by grants from the National Outstanding Youth Award of NSFC (81025009), and the National 973 program of China (2010CB530100), and the National Science and Technology Major Project (2012ZX10001-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Edwards MJ, 2001, J VIROL, V75, P10208, DOI 10.1128/JVI.75.21.10208-10218.2001; Edwards MJ, 2000, VIROLOGY, V278, P423, DOI 10.1006/viro.2000.0631; Edwards MJ, 2001, J GEN VIROL, V82, P1387, DOI 10.1099/0022-1317-82-6-1387; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Geeraedts F, 2011, ADV EXP MED BIOL, V780, P161, DOI 10.1007/978-1-4419-5632-3_13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Irving MB, 2010, MOL IMMUNOL, V47, P1137, DOI 10.1016/j.molimm.2009.10.015; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Li OTW, 2009, EXPERT REV ANTI-INFE, V7, P687, DOI [10.1586/eri.09.48, 10.1586/ERI.09.48]; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Morris Glenn E, 2005, Methods Mol Biol, V295, P255; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Yen HL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000064; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	39	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38126	10.1371/journal.pone.0038126	http://dx.doi.org/10.1371/journal.pone.0038126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662275	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300167
J	Chaurasia, SS; Champakalakshmi, R; Li, A; Poh, R; Tan, XW; Lakshminarayanan, R; Lim, CT; Tan, DT; Mehta, JS				Chaurasia, Shyam S.; Champakalakshmi, Ravi; Li, Ang; Poh, Rebekah; Tan, Xiao Wei; Lakshminarayanan, Rajamani; Lim, Chwee T.; Tan, Donald T.; Mehta, Jodhbir S.			Effect of Fibrin Glue on the Biomechanical Properties of Human Descemet's Membrane	PLOS ONE			English	Article							AUTOMATED ENDOTHELIAL KERATOPLASTY; POSTERIOR LAMELLAR KERATOPLASTY; ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; NORMAL CORNEAS; TRANSPLANTATION; CELLS; DMEK; ELASTICITY; MODULUS	Background: Corneal transplantation has rapidly evolved from full-thickness penetrating keratoplasty (PK) to selective tissue corneal transplantation, where only the diseased portions of the patient's corneal tissue are replaced with healthy donor tissue. Descemet's membrane endothelial keratoplasty (DMEK) performed in patients with corneal endothelial dysfunction is one such example where only a single layer of endothelial cells with its basement membrane (10-15 mu m in thickness), Descemet's membrane (DM) is replaced. It is challenging to replace this membrane due to its intrinsic property to roll in an aqueous environment. The main objective of this study was to determine the effects of fibrin glue (FG) on the biomechanical properties of DM using atomic force microscopy (AFM) and relates these properties to membrane folding propensity. Methodology/Principal Findings: Fibrin glue was sprayed using the EasySpray applicator system, and the biomechanical properties of human DM were determined by AFM. We studied the changes in the "rolling up'' tendency of DM by examining the changes in the elasticity and flexural rigidity after the application of FG. Surface topography was assessed using scanning electron microscopy (SEM) and AFM imaging. Treatment with FG not only stabilized and stiffened DM but also led to a significant increase in hysteresis of the glue-treated membrane. In addition, flexural or bending rigidity values also increased in FG-treated membranes. Conclusions/Significance: Our results suggest that fibrin glue provides rigidity to the DM/endothelial cell complex that may aid in subsequent manipulation by maintaining tissue integrity.	[Chaurasia, Shyam S.; Champakalakshmi, Ravi; Poh, Rebekah; Tan, Xiao Wei; Lakshminarayanan, Rajamani; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Li, Ang; Lim, Chwee T.] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Li, Ang; Lim, Chwee T.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee T.] Mechanobiol Inst, Singapore, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Mehta, Jodhbir S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Chaurasia, SS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	jodmehta@gmail.com	Mehta, Jodhbir/O-6192-2015; Chaurasia, Shyam/AAB-4709-2019; Lim, chwee Teck/B-3307-2011; Rajamani, Lakshminarayanan/AAG-5541-2019	Chaurasia, Shyam/0000-0001-8725-676X; Lim, chwee Teck/0000-0003-4019-9782; Rajamani, Lakshminarayanan/0000-0001-8214-5315	National Medical Research Council (NMRC) [NIGSERI/2009-R711/61/2009]; National Research Foundation [NMRC/TCR/002-SERI/2008-TCR621/41/2008]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); National Research Foundation	This work was supported by National Medical Research Council (NMRC) New Investigator Grant [NIGSERI/2009-R711/61/2009] and National Research Foundation-Funded Translational & Clinical Research (TCR) Programme Grant [NMRC/TCR/002-SERI/2008-TCR621/41/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Albala DM, 2006, J AM COLL SURGEONS, V202, P685, DOI 10.1016/j.jamcollsurg.2005.11.027; Bahar I, 2009, BRIT J OPHTHALMOL, V93, P186, DOI 10.1136/bjo.2007.136630; Bourne WM, 2010, EYE CONTACT LENS, V36, P310, DOI 10.1097/ICL.0b013e3181ee1450; Busin M, 2010, OPHTHALMOLOGY, V117, P2273, DOI 10.1016/j.ophtha.2010.03.038; Champalakshmi R, 2011, OPTIMIZATION COMPARI; Chen ES, 2008, CORNEA, V27, P514, DOI 10.1097/ICO.0b013e3181611c50; Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/jbm.a.31186; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Fischbarg J, 2004, EXP EYE RES, V78, P537, DOI 10.1016/j.exer.2003.09.010; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Hall RC, 2009, CLIN EXP OPHTHALMOL, V37, P584, DOI 10.1111/j.1442-9071.2009.02105.x; Hjortdal JO, 1996, J BIOMECH, V29, P931, DOI 10.1016/0021-9290(95)00152-2; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; JOHNSON DH, 1982, ARCH OPHTHALMOL-CHIC, V100, P1942, DOI 10.1001/archopht.1982.01030040922011; Kaufman HE, 2003, OPHTHALMOLOGY, V110, P2168, DOI 10.1016/S0161-6420(03)00832-7; KENNEY MC, 1979, INVEST OPHTH VIS SCI, V18, P527; LAGOUTTE FM, 1989, BRIT J OPHTHALMOL, V73, P757, DOI 10.1136/bjo.73.9.757; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Lie JT, 2008, J CATARACT REFR SURG, V34, P1578, DOI 10.1016/j.jcrs.2008.05.036; McCauley MB, 2009, J CATARACT REFR SURG, V35, P1659, DOI 10.1016/j.jcrs.2009.05.034; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mehta JS, 2008, J CATARACT REFR SURG, V34, P889, DOI 10.1016/j.jcrs.2008.01.037; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Muftuoglu O, 2010, OPHTHALMOLOGY, V117, P878, DOI 10.1016/j.ophtha.2010.02.001; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P1402; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Ozcan AA, 2008, ANN OPHTHALMOL, V40, P107; Park HC, 2011, EXPERT REV OPHTHALMO, V6, P631, DOI 10.1586/EOP.11.64; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Ramos-Esteban JC, 2006, TECH OPHTHALMOL, V4, P30; Rasband WS, 2011, IMAGEJ; REID TW, 1994, PROG RETIN EYE RES, V13, P507, DOI 10.1016/1350-9462(94)90021-3; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Sidelmann JJ, 2000, SEMIN THROMB HEMOST, V26, P605, DOI 10.1055/s-2000-13216; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; Timoshenko SP, 1959, THEORY PLATES SHELLS, P68; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P393; WARING GO, 1987, SURV OPHTHALMOL, V31, P262, DOI 10.1016/0039-6257(87)90025-7; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Yeh DL, 2006, AM J OPHTHALMOL, V141, P960, DOI 10.1016/j.ajo.2005.12.001; Yeh Patrick C., 2004, International Ophthalmology Clinics, V44, P51, DOI 10.1097/00004397-200404410-00007	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37456	10.1371/journal.pone.0037456	http://dx.doi.org/10.1371/journal.pone.0037456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662156	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300046
J	Lindell, K; Fahlgren, A; Hjerde, E; Willassen, NP; Fallman, M; Milton, DL				Lindell, Kristoffer; Fahlgren, Anna; Hjerde, Erik; Willassen, Nils-Peder; Fallman, Maria; Milton, Debra L.			Lipopolysaccharide O-Antigen Prevents Phagocytosis of Vibrio anguillarum by Rainbow Trout (Oncorhynchus mykiss) Skin Epithelial Cells	PLOS ONE			English	Article							EPIDERMAL MALPIGHIAN CELLS; TELEOST FISH EPIDERMIS; ESCHERICHIA-COLI; CORE LIPOPOLYSACCHARIDE; VARYING TEMPERATURES; TISSUE LOCALIZATION; MITOTIC-ACTIVITY; VIRULENCE; BINDING; RESISTANCE	Colonization of host tissues is a first step taken by many pathogens during the initial stages of infection. Despite the impact of bacterial disease on wild and farmed fish, only a few direct studies have characterized bacterial factors required for colonization of fish tissues. In this study, using live-cell and confocal microscopy, rainbow trout skin epithelial cells, the main structural component of the skin epidermis, were demonstrated to phagocytize bacteria. Mutant analyses showed that the fish pathogen Vibrio anguillarum required the lipopolysaccharide O-antigen to evade phagocytosis and that O-antigen transport required the putative wzm-wzt-wbhA operon, which encodes two ABC polysaccharide transporter proteins and a methyltransferase. Pretreatment of the epithelial cells with mannose prevented phagocytosis of V. anguillarum suggesting that a mannose receptor is involved in the uptake process. In addition, the O-antigen transport mutants could not colonize the skin but they did colonize the intestines of rainbow trout. The O-antigen polysaccharides were also shown to aid resistance to the antimicrobial factors, lysozyme and polymyxin B. In summary, rainbow trout skin epithelial cells play a role in the fish innate immunity by clearing bacteria from the skin epidermis. In defense, V. anguillarum utilizes O-antigen polysaccharides to evade phagocytosis by the epithelial cells allowing it to colonize rapidly fish skin tissues.	[Lindell, Kristoffer; Fahlgren, Anna; Fallman, Maria; Milton, Debra L.] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden; [Milton, Debra L.] So Res Inst, Birmingham, AL 35255 USA; [Hjerde, Erik; Willassen, Nils-Peder] Univ Tromso, Dept Chem, Fac Sci & Technol, Tromso, Norway	Umea University; UiT The Arctic University of Tromso	Lindell, K (corresponding author), Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden.	miltond@southernresearch.org	Willassen, Nils Peder/AAE-1843-2019	Willassen, Nils Peder/0000-0002-4397-8020; Lindell, Kristoffer/0000-0001-5609-6097; Hjerde, Erik/0000-0002-6014-1249	Swedish Council for Environment, Agricultural Sciences and Spatial Planning [221-2O10-577]; Carl Tryggers Foundation, Sweden [CTS: 10-261]; Swedish Research Council; Natural Science Faculty of Umea University	Swedish Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Carl Tryggers Foundation, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Science Faculty of Umea University	This work was performed within the Umea Centre for Microbial Research and was supported by funding from the Swedish Council for Environment, Agricultural Sciences and Spatial Planning (221-2O10-577), from the Carl Tryggers Foundation, Sweden (CTS: 10-261), from the Swedish Research Council, and from the Natural Science Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis LA, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P570, DOI 10.1079/9781845935542.0570; AOKI T, 1985, B JPN SOC SCI FISH, V51, P1249; Asbakk K, 1998, J MAR BIOTECHNOL, V6, P30; Asbakk K, 2001, J FISH BIOL, V58, P953, DOI 10.1111/j.1095-8649.2001.tb00547.x; AUSTIN B, 1999, BACTERIAL FISH PATHO, P272; Bereiter-Hahn J., 1986, BIOL INTEGUMENT, P443; Boesen HT, 1999, INFECT IMMUN, V67, P294, DOI 10.1128/IAI.67.1.294-301.1999; BULLOCK AM, 1978, J ZOOL, V185, P197; BULLOCK AM, 1978, J ZOOL, V184, P423; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hansen GH, 1999, MICROB ECOL, V38, P1, DOI 10.1007/s002489900158; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Irie T, 2004, J VET MED SCI, V66, P205, DOI 10.1292/jvms.66.205; Kania PW, 2010, FISH SHELLFISH IMMUN, V29, P910, DOI 10.1016/j.fsi.2010.07.020; Kanno T., 1989, Journal of Aquatic Animal Health, V1, P2, DOI 10.1577/1548-8667(1989)001&lt;0002:MOTOVA&gt;2.3.CO;2; Karlsen C, 2012, VET MICROBIOL, V154, P353, DOI 10.1016/j.vetmic.2011.07.024; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; McGee K, 1996, J BACTERIOL, V178, P5188, DOI 10.1128/jb.178.17.5188-5198.1996; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; MUROGA K, 1987, FISH PATHOL, V22, P99, DOI 10.3147/jsfp.22.99; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Naka H, 2011, INFECT IMMUN, V79, P2889, DOI 10.1128/IAI.05138-11; Naka H, 2011, FISH PATHOL, V46, P1, DOI 10.3147/jsfp.46.1; NORQVIST A, 1993, INFECT IMMUN, V61, P2434, DOI 10.1128/IAI.61.6.2434-2444.1993; PHROMSUTHIRAK P, 1977, J FISH BIOL, V11, P193, DOI 10.1111/j.1095-8649.1977.tb04113.x; Plante CJ, 2000, AQUAT MICROB ECOL, V21, P211, DOI 10.3354/ame021211; PRESTON MA, 1987, INFECT IMMUN, V55, P1806, DOI 10.1128/IAI.55.8.1806-1812.1987; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Russell S, 2008, FISH SHELLFISH IMMUN, V25, P91, DOI 10.1016/j.fsi.2008.02.018; Russell S, 2008, FISH SHELLFISH IMMUN, V24, P669, DOI 10.1016/j.fsi.2007.11.002; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Spanggaard B, 2000, J FISH DIS, V23, P423, DOI 10.1046/j.1365-2761.2000.00257.x; Stroeher UH, 1998, GENE, V223, P269, DOI 10.1016/S0378-1119(98)00407-7; Suzuki Y, 2003, COMP BIOCHEM PHYS B, V136, P723, DOI 10.1016/S1096-4959(03)00178-7; TRUST TJ, 1981, INFECT IMMUN, V34, P702, DOI 10.1128/IAI.34.3.702-707.1981; Tsutsui S, 2005, DEV COMP IMMUNOL, V29, P243, DOI 10.1016/j.dci.2004.06.005; Weber B, 2010, ENV MICROBIOL REP, V2, P133, DOI 10.1111/j.1758-2229.2009.00120.x; Welch TJ, 2005, INFECT IMMUN, V73, P5864, DOI 10.1128/IAI.73.9.5864-5872.2005; Zelensky AN, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-51; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002	56	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37678	10.1371/journal.pone.0037678	http://dx.doi.org/10.1371/journal.pone.0037678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662189	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300079
J	Ruisanchez, E; Cselenyak, A; Papp, RS; Nemeth, T; Kaldi, K; Sandor, P; Benyo, Z				Ruisanchez, Eva; Cselenyak, Attila; Papp, Rege Sugarka; Nemeth, Tamas; Kaldi, Krisztina; Sandor, Peter; Benyo, Zoltan			Perivascular Expression and Potent Vasoconstrictor Effect of Dynorphin A in Cerebral Arteries	PLOS ONE			English	Article							RAT SPINAL-CORD; SENSITIVE K+ CHANNELS; SMOOTH-MUSCLE-CELLS; NEWBORN PIGS; BRAIN-INJURY; TRAUMATIC INJURY; OPIOID RECEPTORS; CEREBROVASCULAR RESPONSES; NEUROPEPTIDE-Y; NERVE-FIBERS	Background: Numerous literary data indicate that dynorphin A (DYN-A) has a significant impact on cerebral circulation, especially under pathophysiological conditions, but its potential direct influence on the tone of cerebral vessels is obscure. The aim of the present study was threefold: 1) to clarify if DYN-A is present in cerebral vessels, 2) to determine if it exerts any direct effect on cerebrovascular tone, and if so, 3) to analyze the role of kappa-opiate receptors in mediating the effect. Methodology/Principal Findings: Immunohistochemical analysis revealed the expression of DYN-A in perivascular nerves of rat pial arteries as well as in both rat and human intraparenchymal vessels of the cerebral cortex. In isolated rat basilar and middle cerebral arteries (BAs and MCAs) DYN-A (1-13) and DYN-A (1-17) but not DYN-A (1-8) or dynorphin B (DYN-B) induced strong vasoconstriction in micromolar concentrations. The maximal effects, compared to a reference contraction induced by 124 mM K+, were 115 +/- 6% and 104 +/- 10% in BAs and 113 +/- 3% and 125 +/- 9% in MCAs for 10 mM of DYN-A (1-13) and DYN-A (1-17), respectively. The vasoconstrictor effects of DYN-A (1-13) could be inhibited but not abolished by both the kappa-opiate receptor antagonist nor-Binaltorphimine dihydrochloride (NORBI) and blockade of G(i/o)-protein mediated signaling by pertussis toxin. Finally, des-Tyr(1) DYN-A (2-13), which reportedly fails to activate kappa-opiate receptors, induced vasoconstriction of 45 +/- 11% in BAs and 50 +/- 5% in MCAs at 10 mu M, which effects were resistant to NORBI. Conclusion/Significance: DYN-A is present in rat and human cerebral perivascular nerves and induces sustained contraction of rat cerebral arteries. This vasoconstrictor effect is only partly mediated by kappa-opiate receptors and heterotrimeric G(i/o)-proteins. To our knowledge our present findings are the first to indicate that DYN-A has a direct cerebral vasoconstrictor effect and that a dynorphin-induced vascular action may be, at least in part, independent of kappa-opiate receptors.	[Ruisanchez, Eva; Cselenyak, Attila; Nemeth, Tamas; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary; [Papp, Rege Sugarka] Hungarian Acad Sci, Budapest, Hungary; [Papp, Rege Sugarka] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University	Ruisanchez, E (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary.	ruisanchez.eva@med.semmelweis-univ.hu	Káldi, Krisztina/X-4080-2019	Kaldi, Krisztina/0000-0002-5724-0182; Benyo, Zoltan/0000-0001-6015-0359	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research Fund [OTKA K-68960, K-101775]; Health Science Council [ETT 427/2009, 477/2009]; Hungarian Science and Technology Foundation (TET-SIN-CELLTHER); National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EMBO/HHMI Startup Grant	Hungarian National Innovation Office; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Health Science Council; Hungarian Science and Technology Foundation (TET-SIN-CELLTHER); National Development Agency; EMBO/HHMI Startup Grant	This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), Hungarian Scientific Research Fund (OTKA K-68960 and K-101775), Health Science Council (ETT 427/2009 and 477/2009), Hungarian Science and Technology Foundation (TET-SIN-CELLTHER), National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001) and by an EMBO/HHMI Startup Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTURA BT, 1984, BRIT J PHARMACOL, V82, P459, DOI 10.1111/j.1476-5381.1984.tb10781.x; ALTURA BT, 1983, P NATL ACAD SCI-BIOL, V80, P865, DOI 10.1073/pnas.80.3.865; ARENDT RM, 1995, J PHARMACOL EXP THER, V272, P1; ARMSTEAD WM, 1995, BRAIN RES, V689, P183, DOI 10.1016/0006-8993(95)00533-V; ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; Armstead WM, 1997, BRAIN RES, V747, P252, DOI 10.1016/S0006-8993(96)01284-X; ARMSTEAD WM, 1992, BRAIN RES, V571, P97, DOI 10.1016/0006-8993(92)90513-9; ARMSTEAD WM, 1992, J PHARMACOL EXP THER, V260, P1107; ARMSTEAD WM, 1992, AM J PHYSIOL, V262, pH862, DOI 10.1152/ajpheart.1992.262.3.H862; Benyo Z, 1996, CEREBROVAS BRAIN MET, V8, P326; Benyo Z, 2000, BRAIN RES, V877, P79, DOI 10.1016/S0006-8993(00)02611-1; Brugos B, 2004, PHARMAZIE, V59, P339; CAUDLE RM, 1988, BRAIN RES, V443, P329, DOI 10.1016/0006-8993(88)91628-9; CAUDLE RM, 1987, BRAIN RES, V435, P1, DOI 10.1016/0006-8993(87)91579-4; Deli M, 1992, NEUROCHEM INT, V21, pC3; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; Evans SJ, 2000, ENDOCRINOLOGY, V141, P2294, DOI 10.1210/en.141.7.2294; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1983, EUR J PHARMACOL, V91, P321, DOI 10.1016/0014-2999(83)90487-9; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1985, NEUROLOGY, V35, P1311, DOI 10.1212/WNL.35.9.1311; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; GRIDER JR, 1991, AM J PHYSIOL, V260, pG103, DOI 10.1152/ajpgi.1991.260.1.G103; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HARDEBO JE, 1994, J AUTONOM NERV SYST, V47, P171, DOI 10.1016/0165-1838(94)90178-3; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; Horvath B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014477; HU J, 1993, PHARMACOLOGY, V47, P351, DOI 10.1159/000139118; KAPADIA SE, 1984, BRAIN RES, V292, P33, DOI 10.1016/0006-8993(84)90887-4; KLEIN RL, 1990, J AUTONOM NERV SYST, V30, P37, DOI 10.1016/0165-1838(90)90162-C; KONG JY, 1990, PEPTIDES, V11, P565, DOI 10.1016/0196-9781(90)90060-I; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; MASSARDIER D, 1989, EUR J PHARMACOL, V170, P125, DOI 10.1016/0014-2999(89)90149-0; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; MIURA M, 1994, AM J PHYSIOL-ENDOC M, V267, pE702, DOI 10.1152/ajpendo.1994.267.5.E702; MOSKOWITZ MA, 1987, NEUROSCIENCE, V23, P731, DOI 10.1016/0306-4522(87)90090-X; MOSKOWITZ MA, 1986, CEPHALALGIA, V6, P81, DOI 10.1046/j.1468-2982.1986.0602081.x; MULLER S, 1995, PHARMACEUT RES, V12, P1165, DOI 10.1023/A:1016211910107; Muller S, 1996, NEUROCHEM RES, V21, P1213, DOI 10.1007/BF02532398; OUYANG A, 1988, AM J PHYSIOL, V254, pG224, DOI 10.1152/ajpgi.1988.254.2.G224; PICKEL VM, 1994, J NEUROSCI RES, V37, P735, DOI 10.1002/jnr.490370608; Quillan JM, 1997, PHARMACEUT RES, V14, P713, DOI 10.1023/A:1012185919153; Roy C S, 1890, J Physiol, V11, P85; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; SEVERI C, 1988, LIFE SCI, V42, P2373, DOI 10.1016/0024-3205(88)90191-9; SHANKAR V, 1995, AM J PHYSIOL-HEART C, V269, pH997, DOI 10.1152/ajpheart.1995.269.3.H997; Tada H, 2002, EUR J PHARMACOL, V454, P53, DOI 10.1016/S0014-2999(02)02474-3; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776, DOI 10.1152/ajpheart.1995.269.5.H1776; THURESONKLEIN A, 1989, BLOOD VESSELS, V26, P177; TONG JF, 1994, ACTA PHARM SINIC, V15, P488; UDDMAN R, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P230; Venteicher A, 1998, AM J PHYSIOL-HEART C, V275, pH2072, DOI 10.1152/ajpheart.1998.275.6.H2072; Willis Thomas, 1664, CEREBRI ANATOME CUI; YOUNG EA, 1987, PEPTIDES, V8, P701, DOI 10.1016/0196-9781(87)90046-5; ZHANG L, 1992, AM J PHYSIOL, V262, pG461, DOI 10.1152/ajpgi.1992.262.3.G461; ZHANG SW, 1995, J BIOL CHEM, V270, P22772, DOI 10.1074/jbc.270.39.22772	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37798	10.1371/journal.pone.0037798	http://dx.doi.org/10.1371/journal.pone.0037798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662226	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300116
J	Shapiro-Reznik, M; Jilg, A; Lerner, H; Earnest, DJ; Zisapel, N				Shapiro-Reznik, Mika; Jilg, Anje; Lerner, Hadas; Earnest, David J.; Zisapel, Nava			Diurnal Rhythms in Neurexins Transcripts and Inhibitory/Excitatory Synapse Scaffold Proteins in the Biological Clock	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; LONG-TERM POTENTIATION; CIRCADIAN-RHYTHMS; RECEPTOR; GABA; PLASTICITY; GLUTAMATE; CELLS; NEUROTRANSMITTER; DIFFERENTIATION	The neurexin genes (NRXN1/2/3) encode two families (alpha and beta) of highly polymorphic presynaptic proteins that are involved in excitatory/inhibitory synaptic balance. Recent studies indicate that neuronal activation and memory formation affect NRXN1/2/3 alpha expression and alternative splicing at splice sites 3 and 4 (SS#3/SS#4). Neurons in the biological clock residing in the suprachiasmatic nuclei of the hypothalamus (SCN) act as self-sustained oscillators, generating rhythms in gene expression and electrical activity, to entrain circadian bodily rhythms to the 24 hours day/night cycles. Cell autonomous oscillations in NRXN1/2/3 alpha expression and SS#3/SS#4 exons splicing and their links to rhythms in excitatory/inhibitory synaptic balance in the circadian clock were explored. NRXN1/2/3 alpha expression and SS#3/SS#4 splicing, levels of neurexin-2 alpha and the synaptic scaffolding proteins PSD-95 and gephyrin (representing excitatory and inhibitory synapses, respectively) were studied in mRNA and protein extracts obtained from SCN of C3H/J mice at different times of the 24 hours day/night cycle. Further studies explored the circadian oscillations in these components and causality relationships in immortalized rat SCN2.2 cells. Diurnal rhythms in mNRXN1 alpha and mNRXN2 alpha transcription, SS#3/SS#4 exon-inclusion and PSD-95 gephyrin and neurexin-2 alpha levels were found in the SCN in vivo. No such rhythms were found with mNRXN3 alpha. SCN2.2 cells also exhibited autonomous circadian rhythms in rNRXN1/2 expression SS#3/SS#4 exon inclusion and PSD-95, gephyrin and neurexin-2 alpha levels. rNRXN3 alpha and rNRXN1/2 beta were not expressed. Causal relationships were demonstrated, by use of specific siRNAs, between rNRXN2 alpha SS#3 exon included transcripts and gephyrin levels in the SCN2.2 cells. These results show for the first time dynamic, cell autonomous, diurnal rhythms in expression and splicing of NRXN1/2 and subsequent effects on the expression of neurexin-2 alpha and postsynaptic scaffolding proteins in SCN across the 24-h cycle. NRXNs gene transcripts may have a role in coupling the circadian clock to diurnal rhythms in excitatory/inhibitory synaptic balance.	[Shapiro-Reznik, Mika; Lerner, Hadas; Zisapel, Nava] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Jilg, Anje] Goethe Univ Frankfurt, Inst Cellular & Mol Anat, Frankfurt, Germany; [Earnest, David J.] Texas A&M Univ, Dept Neurosci & Expt Therapeut, Hlth Sci Ctr, College Stn, TX USA	Tel Aviv University; Goethe University Frankfurt; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Shapiro-Reznik, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	navazis@post.tau.ac.il	Zisapel, Nava/GRO-1677-2022	Earnest, David/0000-0003-4433-6481	AMN foundation; Chief Scientist Office of the Ministry of Health [3-3781]; Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel	AMN foundation; Chief Scientist Office of the Ministry of Health; Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel	This study was supported by a research grant from the AMN foundation and research grant no. 3-3781 from the Chief Scientist Office of the Ministry of Health, and the Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet D, 2008, GLIA, V56, P294, DOI 10.1002/glia.20613; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Earnest DJ, 1999, J NEUROBIOL, V39, P1, DOI 10.1002/(SICI)1097-4695(199904)39:1<1::AID-NEU1>3.0.CO;2-F; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Girardet C, 2010, EUR J NEUROSCI, V31, P359, DOI 10.1111/j.1460-9568.2009.07071.x; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gompf HS, 2004, EUR J NEUROSCI, V19, P2791, DOI 10.1111/j.1460-9568.2004.03382.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GULDNER FH, 1979, NEUROSCI LETT, V14, P235, DOI 10.1016/0304-3940(79)96154-8; Hastings M H, 1999, J Neurosci, V19, pRC11; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kretschmannova K, 2005, ANN NY ACAD SCI, V1048, P103, DOI 10.1196/annals.1342.010; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meijer JH, 2010, EUR J NEUROSCI, V32, P2143, DOI 10.1111/j.1460-9568.2010.07522.x; MINORS DS, 1988, PSYCHONEUROENDOCRINO, V13, P443, DOI 10.1016/0306-4530(88)90030-3; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moldavan MG, 2010, J NEUROPHYSIOL, V103, P2390, DOI 10.1152/jn.00695.2009; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; NISHIKAWA Y, 1995, BRAIN RES, V695, P158, DOI 10.1016/0006-8993(95)00717-5; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Petrillo Ezequiel, 2011, Commun Integr Biol, V4, P284, DOI 10.4161/cib.4.3.14777; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; River-Bermudez MA, 2004, BRAIN RES, V1002, P21, DOI 10.1016/j.brainres.2003.12.008; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	54	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37894	10.1371/journal.pone.0037894	http://dx.doi.org/10.1371/journal.pone.0037894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662246	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300137
J	Xie, CG; Wei, SM; Chen, JM; Xu, XF; Cai, JT; Chen, QY; Jia, LT				Xie, Chuan-Gao; Wei, Shu-Mei; Chen, Jia-Min; Xu, Xuan-Fu; Cai, Jian-Ting; Chen, Qin-Yu; Jia, Li-Tao			Down-Regulation of GEP100 Causes Increase in E-Cadherin Levels and Inhibits Pancreatic Cancer Cell Invasion	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; MESENCHYMAL TRANSITION; BREAST-CANCER; MONOCYTIC PHAGOCYTES; EXPRESSION; ARF6; SNAIL; SLUG; METASTASIS; ACTIVATION	Aims: Invasion and metastasis are major reasons for pancreatic cancer death and identifying signaling molecules that are specifically used in tumor invasion is of great significance. The purpose of this study was to elucidate the role of GEP100 in pancreatic cancer cell invasion and metastasis and the corresponding molecular mechanism. Methods: Stable cell lines with GEP100 knocked-down were established by transfecting GEP100 shRNA vector into PaTu8988 cells and selected by puromycin. qRT-PCR and Western blot were performed to detect gene expression. Matrigel-invasion assay was used to detect cancer cell invasion in vitro. Liver metastasis in vivo was determined by splenic injection of indicated cell lines followed by spleen resection. Immunofluorescence study was used to detect the intracellular localization of E-cadherin. Results: We found that the expression level of GEP100 protein was closely related to the invasive ability of a panel of 6 different human pancreatic cancer cell lines. Down-regulation of GEP100 in PaTu8988 cells significantly decreased invasive activity by Matrigel invasion assay, without affecting migration, invasion and viability. The inhibited invasive activity was rescued by over-expression of GEP100 cDNA. In vivo study showed that liver metastasis was significantly decreased in the PaTu8988 cells with GEP100 stably knocked-down. In addition, an epithelial-like morphological change, mimicking a mesenchymal to epithelial transition (MET) was induced by GEP100 down-regulation. The expression of E-cadherin protein was increased 2-3 folds accompanied by its redistribution to the cell-cell contacts, while no obvious changes were observed for E-cadherin mRNA. Unexpectedly, the mRNA of Slug was increased by GEP100 knock-down. Conclusion: These findings provided important evidence that GEP100 plays a significant role in pancreatic cancer invasion through regulating the expression of E-cadherin and the process of MET, indicating the possibility of it becoming a potential therapeutic target against pancreatic cancer.	[Xie, Chuan-Gao; Chen, Jia-Min; Cai, Jian-Ting; Chen, Qin-Yu; Jia, Li-Tao] Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 2, Hangzhou 310027, Zhejiang, Peoples R China; [Wei, Shu-Mei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310027, Zhejiang, Peoples R China; [Xu, Xuan-Fu] Tongji Univ, Hosp 10, Shanghai 200092, Peoples R China	Zhejiang University; Zhejiang University; Tongji University	Xie, CG (corresponding author), Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 2, Hangzhou 310027, Zhejiang, Peoples R China.	autumn200327@yahoo.com.cn; jtcai@yahoo.cn	li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022		Zhejiang Provincial Natural Science Foundation of China [Y2080372]; National Natural Science Foundation of China [81101839]; Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province [2009R10057]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province	Zhejiang Provincial Natural Science Foundation of China (No. Y2080372; URL: http://www.zjnsf.gov.cn/1/xm/lx.aspx) National Natural Science Foundation of China (No. 81101839; URL: http://159.226.244.22/portal/proj_search.asp) and Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province (No. 2009R10057; URL: http://www.zjsts.cn/index/index.jspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Dunphy JL, 2007, TRAFFIC, V8, P661, DOI 10.1111/j.1600-0854.2007.00561.x; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hiroi T, 2009, FRONT BIOSCI-LANDMRK, V14, P717, DOI 10.2741/3275; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jimenez RE, 2000, ANN SURG, V231, P644, DOI 10.1097/00000658-200005000-00004; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karayiannakis AJ, 1998, ANTICANCER RES, V18, P4177; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Shishido T, 1998, JPN J CANCER RES, V89, P963, DOI 10.1111/j.1349-7006.1998.tb00655.x; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2010, J BIOL CHEM, V285, P30698, DOI 10.1074/jbc.M110.107458; Someya A, 2006, J LEUKOCYTE BIOL, V80, P915, DOI 10.1189/jlb.0106059; Takao S, 2000, Hum Cell, V13, P15; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	39	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37854	10.1371/journal.pone.0037854	http://dx.doi.org/10.1371/journal.pone.0037854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662237	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300127
J	Ma, YG; Liu, WC; Dong, S; Du, C; Wang, XJ; Li, JS; Xie, XP; Wu, L; Ma, DC; Yu, ZB; Xie, MJ				Ma, Yu-Guang; Liu, Wen-Chao; Dong, Shuo; Du, Cheng; Wang, Xiao-Jun; Li, Jin-Sheng; Xie, Xiao-Ping; Wu, Li; Ma, Da-Chang; Yu, Zhi-Bin; Xie, Man-Jiang			Activation of BKCa Channels in Zoledronic Acid-Induced Apoptosis of MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; POTASSIUM CHANNELS; SMOOTH-MUSCLE; OSTEOSARCOMA CELLS; ION CHANNELS; KCNMA1 GENE; PROLIFERATION; BISPHOSPHONATES; K+; EXPRESSION	Background: Zoledronic acid, one of the most potent nitrogen-containing biphosphonates, has been demonstrated to have direct anti-tumor and anti-metastatic properties in breast cancer in vitro and in vivo. In particular, tumor-cell apoptosis has been recognized to play an important role in the treatment of metastatic breast cancer with zoledronic acid. However, the precise mechanisms remain less clear. In the present study, we investigated the specific role of large conductance Ca2+-activated potassium (BKCa) channel in zoledronic acid-induced apoptosis of estrogen receptor (ER)-negative MDA-MB-231 breast cancer cells. Methodology/Principal Findings: The action of zoledronic acid on BKCa channel was investigated by whole-cell and cell-attached patch clamp techniques. Cell apoptosis was assessed with immunocytochemistry, analysis of fragmented DNA by agarose gel electrophoresis, and flow cytometry assays. Cell proliferation was investigated by MTT test and immunocytochemistry. In addition, such findings were further confirmed with human embryonic kidney 293 (HEK293) cells which were transfected with functional BKCa alpha-subunit (hSlo alpha). Our results clearly indicated that zoledronic acid directly increased the activities of BKCa channels, and then activation of BKCa channel by zoledronic acid contributed to induce apoptosis in MDA-MB-231 cells. The possible mechanisms were associated with the elevated level of intracellular Ca2+ and a concomitant depolarization of mitochondrial membrane potential (Delta psi m) in MDA-MB-231 cells. Conclusions: Activation of BKCa channel was here shown to be a novel molecular pathway involved in zoledronic acid-induced apoptosis of MDA-MB-231 cells in vitro.	[Ma, Yu-Guang; Liu, Wen-Chao; Du, Cheng] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Peoples R China; [Ma, Yu-Guang; Wu, Li; Ma, Da-Chang] Lanzhou Univ, Dept Breast Dis, Hosp 1, Lanzhou 730000, Peoples R China; [Dong, Shuo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wang, Xiao-Jun; Li, Jin-Sheng; Xie, Xiao-Ping; Yu, Zhi-Bin; Xie, Man-Jiang] Fourth Mil Med Univ, Minist China, Dept Aerosp Physiol, Key Lab Aerosp Med, Xian 710032, Peoples R China	Air Force Military Medical University; Lanzhou University; Baylor College of Medicine; Air Force Military Medical University	Ma, YG (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Peoples R China.	liuch@fmmu.edu.cn; manjiangxie@hotmail.com			National Science Foundation of China [81071894, 81000336, 31070768]; Key Project from Science and Technology Committee of Gansu Province [1104FKCA125]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project from Science and Technology Committee of Gansu Province	This work was supported by National Science Foundation of China (No. 81071894, 81000336, and 31070768) and Key Project from Science and Technology Committee of Gansu Province (1104FKCA125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Almubarak Hussain, 2011, J Carcinog, V10, P2, DOI 10.4103/1477-3163.75723; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bosch-Barrera J, 2011, CLIN TRANSL ONCOL, V13, P148, DOI 10.1007/s12094-011-0634-9; Brevet M, 2008, HISTOL HISTOPATHOL, V23, P965, DOI 10.14670/HH-23.965; Burg ED, 2008, BRIT J PHARMACOL, V153, pS99, DOI 10.1038/sj.bjp.0707635; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Debska-Vielhaber G, 2009, J PHYSIOL PHARMACOL, V60, P27; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Green J, 2010, CANCER INVEST, V28, P944, DOI 10.3109/07357907.2010.512598; Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li J, 2009, MOL CELL BIOCHEM, V331, P117, DOI 10.1007/s11010-009-0149-7; Ma YG, 2010, APOPTOSIS, V15, P426, DOI 10.1007/s10495-009-0423-x; Mitrofan LM, 2009, BONE, V45, P1153, DOI 10.1016/j.bone.2009.08.010; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Neville-Webbe HL, 2010, EUR J CANCER, V46, P1211, DOI 10.1016/j.ejca.2010.02.041; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Roger S, 2004, BBA-BIOMEMBRANES, V1667, P190, DOI 10.1016/j.bbamem.2004.10.002; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Senaratne SG, 2002, BREAST CANCER RES, V4, P18, DOI 10.1186/bcr412; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Tenta R, 2008, HORM METAB RES, V40, P737, DOI 10.1055/s-2008-1078753; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162	37	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37451	10.1371/journal.pone.0037451	http://dx.doi.org/10.1371/journal.pone.0037451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655048	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900023
J	Hong, SW; Lee, SH; Moon, JH; Hwang, JJ; Kim, DE; Ko, E; Kim, HS; Cho, IJ; Kang, JS; Kim, DJ; Kim, JE; Shin, JS; Jung, DJ; Jeong, YJ; Cho, BJ; Kim, TW; Lee, JS; Kang, JS; Hwang, YI; Noh, DY; Jin, DH; Lee, WJ				Hong, S-W; Lee, S-H; Moon, J-H; Hwang, J. J.; Kim, D. E.; Ko, E.; Kim, H-S; Cho, I. J.; Kang, J. S.; Kim, D. J.; Kim, J-E; Shin, J-S; Jung, D-J; Jeong, Y-J; Cho, B-J; Kim, T-W; Lee, J. S.; Kang, J-S; Hwang, Y-I; Noh, D-Y; Jin, D-H; Lee, W. J.			SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment	ONCOGENE			English	Article						L-ascorbate; autophagy; SVCT-2; ROS; Beclin-1; LC3	VITAMIN-C TRANSPORTER; TERMINAL HUMAN CANCER; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE; SURVIVAL TIMES; ACID; CELLS; AUTOPHAGY; GROWTH	L-ascorbate (L-ascorbic acid, vitamin C) clearly has an inhibitory effect on cancer cells. However, the mechanism underlying differential sensitivity of cancer cells from same tissue to L-ascorbate is yet to be clarified. Here, we demonstrate that L-ascorbate has a selective killing effect, which is influenced by sodium-dependent vitamin C transporter 2 (SVCT-2) in human breast cancer cells. Treatment of human breast cancer cells with L-ascorbate differentially induced cell death, dependent on the SVCT-2 protein level. Moreover, knockdown of endogenous SVCT-2 via RNA interference in breast cancer cells expressing high levels of the protein induced resistance to L-ascorbate treatment, whereas transfection with SVCT-2 expression plasmids led to enhanced L-ascorbate chemosensitivity. Surprisingly, tumor regression by L-ascorbate administration in mice bearing tumor cell xenograft also corresponded to the SVCT-2 protein level. Interestingly, SVCT-2 expression was absent or weak in normal tissues, but strongly detected in tumor samples obtained from breast cancer patients. In addition, enhanced chemosensitivity to L-ascorbate occurred as a result of caspase-independent autophagy, which was mediated by beclin-1 and LC3 II. In addition, treatment with N-acetyl-L-cysteine, a reactive oxygen species (ROS) scavenger, suppressed the induction of beclin-1 and LC3 II, implying that the differential SVCT-2 protein-dependent L-ascorbate uptake was attributable to intracellular ROS induced by L-ascorbate, subsequently leading to autophagy. These results suggest that functional SVCT-2 sensitizes breast cancer cells to autophagic damage by increasing the L-ascorbate concentration and intracellular ROS production and furthermore, SVCT-2 in breast cancer may act as an indicator for commencing L-ascorbate treatment. Oncogene (2013) 32, 1508-1517; doi:10.1038/onc.2012.176; published online 4 June 2012	[Hong, S-W; Lee, S-H; Kim, J-E; Shin, J-S; Jung, D-J; Jeong, Y-J; Kang, J-S; Hwang, Y-I; Jin, D-H; Lee, W. J.] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Hong, S-W; Lee, S-H; Kim, J-E; Shin, J-S; Jung, D-J; Jeong, Y-J; Kang, J-S; Hwang, Y-I; Jin, D-H; Lee, W. J.] Seoul Natl Univ, Coll Med, Tumor Immun Res Ctr, Seoul, South Korea; [Hong, S-W; Moon, J-H; Hwang, J. J.; Kim, D. E.; Shin, J-S; Kim, T-W; Lee, J. S.; Jin, D-H] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res, Seoul 138736, South Korea; [Lee, S-H] Inje Univ, Paik Hosp, Dept Plast & Reconstruct Surg, Gyeonggi Do, South Korea; [Ko, E.; Kim, H-S; Noh, D-Y] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Ko, E.; Kim, H-S; Noh, D-Y] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Cho, I. J.; Kang, J. S.] Korea Res Insit Biosci & Biotechnol, Bioevaluat Ctr, Chungbuk, South Korea; [Kim, D. J.] Chung Ang Univ, Coll Med, Dept Anat, Seoul 156756, South Korea; [Cho, B-J] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul, South Korea; [Cho, B-J; Kim, T-W; Lee, J. S.] Asan Med Ctr, Dept Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center; Inje University; Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Konkuk University; Konkuk University Medical Center; University of Ulsan; Asan Medical Center	Jin, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res, Seoul 138736, South Korea.	inno183@amc.seoul.kr; kinglee@snu.ac.kr	Kang, Jae Seung/J-5363-2012; Hwang, Jung Jin/F-3424-2014; Noh, Dong-Young/G-5531-2011	Kang, Jong Soon/0000-0001-7698-0162	Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine [R13-2002-025-02001-0]; Ministry of Health and Welfare and Family Affairs, Republic of Korea [A062254]	Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine(Korea Science and Engineering Foundation); Ministry of Health and Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine (R13-2002-025-02001-0) and by grants from the Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea (A062254). We would like to thank Dr Norio Itoh, Osaka University, for providing SVCT-2 antibody; and Dr Tobias P Dick, German Cancer Research Center, for providing redox-probe cDNAs.	Baader SL, 1996, FEBS LETT, V381, P131, DOI 10.1016/0014-5793(96)00098-1; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMERON E, 1974, CHEM-BIOL INTERACT, V9, P285, DOI 10.1016/0009-2797(74)90019-2; Chen AA, 2009, CARCINOGENESIS, V30, P977, DOI 10.1093/carcin/bgp076; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9; Halliwell B, 1996, FREE RADICAL RES, V25, P439, DOI 10.3109/10715769609149066; Head K A, 1998, Altern Med Rev, V3, P174; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JS, 2005, J CELL PHYSIOL, V204, P192, DOI 10.1002/jcp.20286; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuo SM, 2004, J NUTR, V134, P2216; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maramag C, 1997, PROSTATE, V32, P188, DOI 10.1002/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H; Martin A, 2002, J NEUROCHEM, V82, P538, DOI 10.1046/j.1471-4159.2002.00978.x; MENNITI FS, 1986, J BIOL CHEM, V261, P6901; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; MURAD S, 1981, P NATL ACAD SCI-BIOL, V78, P2879, DOI 10.1073/pnas.78.5.2879; Ohtani S, 2007, CANCER RES, V67, P6293, DOI 10.1158/0008-5472.CAN-06-3884; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; Patak P, 2004, ENDOCR RES, V30, P871, DOI 10.1081/ERC-200044126; PETERKOFSKY B, 1977, J CELL PHYSIOL, V90, P61, DOI 10.1002/jcp.1040900109; Reidling JC, 2008, AM J PHYSIOL-GASTR L, V295, pG1217, DOI 10.1152/ajpgi.90399.2008; SCHAUS EE, 1986, BIOCHEM MED METAB B, V36, P369, DOI 10.1016/0885-4505(86)90149-0; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang HP, 1999, BBA-BIOMEMBRANES, V1461, P1, DOI 10.1016/S0005-2736(99)00182-0	32	54	56	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 21	2013	32	12					1508	1517		10.1038/onc.2012.176	http://dx.doi.org/10.1038/onc.2012.176			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22665050				2022-12-25	WOS:000316456000004
J	Dharmarajan, V; Lee, JH; Patel, A; Skalnik, DG; Cosgrove, MS				Dharmarajan, Venkatasubramanian; Lee, Jeong-Heon; Patel, Anamika; Skalnik, David G.; Cosgrove, Michael S.			Structural Basis for WDR5 Interaction (Win) Motif Recognition in Human SET1 Family Histone Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE LEUKEMIA; PARTIAL TANDEM DUPLICATION; ACUTE MYELOID-LEUKEMIA; H3 LYSINE-4; SACCHAROMYCES-CEREVISIAE; MOLECULAR RECOGNITION; STRUCTURE VALIDATION; TRITHORAX FAMILY; METHYLATION; PROTEIN	Translocations and amplifications of the mixed lineage leukemia-1 (MLL1) gene are associated with aggressive myeloid and lymphocytic leukemias in humans. MLL1 is a member of the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases, which are required for transcription of genes involved in hema-topoiesis and development. MLL1 associates with a subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD), which together form the MLL1 core complex that is required for sequential mono- and dimethylation of H3K4. We previously demonstrated that WDR5 binds the conserved WDR5 interaction (Win) motif of MLL1 in vitro, an interaction that is required for the H3K4 dimethylation activity of the MLL1 core complex. In this investigation, we demonstrate that arginine 3765 of the MLL1 Win motif is required to co-immunoprecipitate WRAD from mammalian cells, suggesting that the WDR5-Win motif interaction is important for the assembly of the MLL1 core complex in vivo. We also demonstrate that peptides that mimic SET1 family Win motif sequences inhibit H3K4 dimethylation by the MLL1 core complex with varying degrees of efficiency. To understand the structural basis for these differences, we determined structures of WDR5 bound to six different naturally occurring Win motif sequences at resolutions ranging from 1.9 to 1.2 angstrom. Our results reveal that binding energy differences result from interactions between non-conserved residues C-terminal to the Win motif and to a lesser extent from subtle variation of residues within the Win motif. These results highlight a new class of methylation inhibitors that may be useful for the treatment of MLL1-related malignancies.	[Dharmarajan, Venkatasubramanian; Patel, Anamika; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Dharmarajan, Venkatasubramanian] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Lee, Jeong-Heon] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Skalnik, David G.] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu			National Institutes of Health [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 (to M. S. C.). We have recently been awarded a patent for use of Win motif inhibitors for inhibition of SET1 family complexes. We currently have no financial arrangements with any company.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALIGIURI MA, 1994, CANCER RES, V54, P370; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2006, STRUCTURE, V14, P1096, DOI 10.1016/j.str.2006.06.004; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dharmarajan V., 2011, ACUTE LEUKEMIA SCI P, P157; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorrance AM, 2008, BLOOD, V112, P2508, DOI 10.1182/blood-2008-01-134338; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Quentmeier H, 2003, LEUKEMIA, V17, P980, DOI 10.1038/sj.leu.2402911; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; SCHICHMAN SA, 1994, P NATL ACAD SCI USA, V91, P6236, DOI 10.1073/pnas.91.13.6236; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Whitman SP, 2005, BLOOD, V106, P345, DOI 10.1182/blood-2005-01-0204; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235	66	73	73	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27275	27289		10.1074/jbc.M112.364125	http://dx.doi.org/10.1074/jbc.M112.364125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22665483	Green Published, hybrid			2022-12-25	WOS:000307840700001
J	Zhou, X; Ma, Y; Kato, T; Kuno, T				Zhou, Xin; Ma, Yan; Kato, Toshiaki; Kuno, Takayoshi			A Measurable Activation of the bZIP Transcription Factor Atf1 in a Fission Yeast Strain Devoid of Stress-activated and Cell Integrity Mitogen-activated Protein Kinase (MAPK) Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; OXIDATIVE STRESS; PATHWAY; PHOSPHORYLATION; ENCODES; LOCALIZATION; ATP	In Schizosaccharomyces pombe, the stress-activated Sty1 MAPK pathway is essential for cell survival under stress conditions. The Sty1 MAPK regulates Atf1 transcription factor to elicit stress responses in extreme conditions of osmolarity and reactive oxygen species-generating agents such as hydrogen peroxide, heat, low glucose, and heavy metal. Herein, using a newly developed Renilla luciferase reporter assay with enhanced detection sensitivity and accuracy, we show that distinct signaling pathways respond to cadmium and other reactive oxygen species-generating agents for the activation of Atf1. Also, surprisingly, a measurable activation of Atf1 transcription factor was still observed devoid of Sty1 MAPK activity. Further genetic and biological analyses revealed that the residual activation is caused by the activation of the cell wall integrity Pmk1 MAPK pathway and a redox-mediated activation of Atf1.	[Zhou, Xin; Ma, Yan; Kato, Toshiaki; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Jinzhou 121001, Liaoning, Peoples R China	Kobe University; Jinzhou Medical University	Zhou, X (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	zhouxin@med.kobe-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from the Japan Society for the Promotion of Science.	Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; HOLMSEN H, 1977, J BIOL CHEM, V252, P1752; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NICHOLLS DG, 1992, NATURE, V360, P106, DOI 10.1038/360106a0; Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309; Osorio H, 2003, EUR J BIOCHEM, V270, P1578, DOI 10.1046/j.1432-1033.2003.03529.x; OTTILIE S, 1992, MOL CELL BIOL, V12, P5571, DOI 10.1128/MCB.12.12.5571; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Samejima I, 1998, MOL BIOL CELL, V9, P2325, DOI 10.1091/mbc.9.8.2325; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	33	13	15	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23434	23439		10.1074/jbc.C111.338715	http://dx.doi.org/10.1074/jbc.C111.338715			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22661707	Green Published, hybrid			2022-12-25	WOS:000306511300016
J	Taylor, DL; Bina, XWR; Bina, JE				Taylor, Dawn L.; Bina, Xiaowen R.; Bina, James E.			Vibrio cholerae vexH Encodes a Multiple Drug Efflux Pump That Contributes to the Production of Cholera Toxin and the Toxin Co-Regulated Pilus	PLOS ONE			English	Article							MANNOSE-SENSITIVE HEMAGGLUTININ; VIRULENCE FACTOR EXPRESSION; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; BILE RESISTANCE; FATTY-ACIDS; MEMBRANE; SYSTEM; GENES; TOLC	The resistance-nodulation-division (RND) efflux systems are ubiquitous transporters that function in antimicrobial resistance. Recent studies showed that RND systems were required for virulence factor production in Vibrio cholerae. The V. cholerae genome encodes six RND efflux systems. Three of the RND systems (VexB, VexD, and VexK) were previously shown to be redundant for in vitro resistance to bile acids and detergents. A mutant lacking the VexB, VexD, and VexK RND pumps produced wild-type levels of cholera toxin (CT) and the toxin co-regulated pilus (TCP) and was moderately attenuated for intestinal colonization. In contrast, a RND negative mutant produced significantly reduced amounts of CT and TCP and displayed a severe colonization defect. This suggested that one or more of the three uncharacterized RND efflux systems (i.e. VexF, VexH, and VexM) were required for pathogenesis. In this study, a genetic approach was used to generate a panel of V. cholerae RND efflux pump mutants in order to determine the function of VexH in antimicrobial resistance, virulence factor production, and intestinal colonization. VexH contributed to in vitro antimicrobial resistance and exhibited a broad substrate specificity that was redundant with the VexB, VexD, and VexK RND efflux pumps. These four efflux pumps were responsible for in vitro antimicrobial resistance and were required for virulence factor production and intestinal colonization. Mutation of the VexF and/or VexM efflux pumps did not affect in vitro antimicrobial resistance, but did negatively affect CT and TCP production. Collectively, our results demonstrate that the V. cholerae RND efflux pumps have redundant functions in antimicrobial resistance and virulence factor production. This suggests that the RND efflux systems contribute to V. cholerae pathogenesis by providing the bacterium with protection against antimicrobial compounds that are present in the host and by contributing to the regulated expression of virulence factors.	[Taylor, Dawn L.; Bina, Xiaowen R.; Bina, James E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Taylor, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	JBina@pitt.edu	Bina, Xiaowen/AAE-9100-2022		National Institute of Allergy and Infectious Diseases [R01AI091845, R21AI092007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091845, R21AI092007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers R01AI091845 and R21AI092007 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BETLEY MJ, 1986, ANNU REV MICROBIOL, V40, P577, DOI 10.1146/annurev.mi.40.100186.003045; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Bina XR, 2008, FEMS MICROBIOL LETT, V279, P226, DOI 10.1111/j.1574-6968.2007.01033.x; Bina XWR, 2010, J BACTERIOL, V192, P3829, DOI 10.1128/JB.00191-10; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chatterjee A, 2004, J BACTERIOL, V186, P6809, DOI 10.1128/JB.186.20.6809-6814.2004; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chiang SL, 1998, MOL MICROBIOL, V27, P797, DOI 10.1046/j.1365-2958.1998.00726.x; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Giles DK, 2011, MOL MICROBIOL, V79, P716, DOI 10.1111/j.1365-2958.2010.07476.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HIGGINS DE, 1992, J BACTERIOL, V174, P6974, DOI 10.1128/JB.174.21.6974-6980.1992; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; IREDELL JR, 1994, FEMS MICROBIOL LETT, V121, P47, DOI 10.1016/0378-1097(94)90144-9; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; KAUFMAN MR, 1993, GENE, V126, P43, DOI 10.1016/0378-1119(93)90588-T; Klose KE, 2000, TRENDS MICROBIOL, V8, P189, DOI 10.1016/S0966-842X(00)01721-2; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Lamarche MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024310; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mey AR, 2012, INFECT IMMUN, V80, P518, DOI 10.1128/IAI.05851-11; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Ogierman MA, 1996, GENE, V170, P9, DOI 10.1016/0378-1119(95)00744-X; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rahman MM, 2007, MICROBIOL IMMUNOL, V51, P1061, DOI 10.1111/j.1348-0421.2007.tb04001.x; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yu RR, 1999, J BACTERIOL, V181, P2584, DOI 10.1128/JB.181.8.2584-2592.1999; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	63	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38208	10.1371/journal.pone.0038208	http://dx.doi.org/10.1371/journal.pone.0038208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666485	Green Published, gold, Green Accepted			2022-12-25	WOS:000305353400101
J	Tikoo, A; Roh, V; Montgomery, KG; Ivetac, I; Waring, P; Pelzer, R; Hare, L; Shackleton, M; Humbert, P; Phillips, WA				Tikoo, Anjali; Roh, Vincent; Montgomery, Karen G.; Ivetac, Ivan; Waring, Paul; Pelzer, Rebecca; Hare, Lauren; Shackleton, Mark; Humbert, Patrick; Phillips, Wayne A.			Physiological Levels of Pik3ca(H1047R) Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ER alpha-Positive Tumors	PLOS ONE			English	Article							PIK3CA MUTATIONS; BREAST-CANCER; EPITHELIAL-CELLS; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; BRANCHING MORPHOGENESIS; PROGENITOR CELLS; GENE; ACTIVATION; PATHWAY	PIK3CA, the gene coding for the p110 alpha subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional knock-in of the common activating mutation, Pik3ca(H1047R), into one allele of the endogenous gene in the mammary gland. These mice developed a ductal anaplasia and hyperplasia by 6 weeks of age characterized by multi-layering of the epithelial lining of the mammary ducts and expansion of the luminal progenitor (Lin(-); CD29(lo); CD24(+); CD6(+)) cell population. The Pik3ca(H1047R) expressing mice eventually develop mammary tumors with 100% penetrance but with a long latency (> 12 months). This is significantly longer than has been reported for transgenic models where expression of the mutant Pik3ca is driven by an exogenous promoter. Histological analysis of the tumors formed revealed predominantly ER alpha-positive fibroadenomas, carcinosarcomas and sarcomas. In vitro induction of Pik3ca(H1047R) in immortalized mammary epithelial cells also resulted in tumor formation when injected into the mammary fat pad of immunodeficient recipient mice. This novel model, which reproduces the scenario of a heterozygous somatic mutation occurring in the endogenous PIK3CA gene, will thus be a valuable tool for investigating the role of Pik3ca(H1047R) mutation in mammary tumorigenesis both in vivo and in vitro.	[Tikoo, Anjali; Roh, Vincent; Montgomery, Karen G.; Ivetac, Ivan; Pelzer, Rebecca; Hare, Lauren; Phillips, Wayne A.] Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Melbourne, Vic, Australia; [Shackleton, Mark; Humbert, Patrick; Phillips, Wayne A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Tikoo, Anjali; Phillips, Wayne A.] Univ Melbourne, St Vincents Hosp, Dept Surg, Parkville, Vic 3052, Australia; [Waring, Paul; Shackleton, Mark; Humbert, Patrick] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Humbert, Patrick] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Humbert, Patrick] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Hare, Lauren; Phillips, Wayne A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Peter Maccallum Cancer Center	Tikoo, A (corresponding author), Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Melbourne, Vic, Australia.	wayne.phillips@petermac.org	Phillips, Wayne A/H-8070-2013; Humbert, Patrick O/L-4264-2016; Ivetac, Ivan/AAE-9859-2020	Phillips, Wayne A/0000-0002-7961-638X; Humbert, Patrick O/0000-0002-1366-6691; Ivetac, Ivan/0000-0003-1263-8346	National Health and Medical Research Council (NHMRC) of Australia [628620]; Association of International Cancer Research [10-0052]; NHMRC; Swiss National Science Foundation; Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Research Award; Pfizer Australia; VESKI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association of International Cancer Research; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Research Award; Pfizer Australia(PfizerPfizer Australia); VESKI	This work was funded by grants from the National Health and Medical Research Council (NHMRC) of Australia (project grant No. 628620) and the Association of International Cancer Research (grant No 10-0052) to WAP. POH was supported by an NHMRC Career Development Award. VR was supported by the Swiss National Science Foundation. II was supported, in part, by the Cure Cancer Australia Foundation and Cancer Australia and LH is the recipient of an Australian Postgraduate Research Award. MS was supported by fellowships from Pfizer Australia and VESKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Bozhanov SS, 2010, J CANCER RES CLIN, V136, P1657, DOI 10.1007/s00432-010-0824-9; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Dunlap J, 2010, BREAST CANCER RES TR, V120, P409, DOI 10.1007/s10549-009-0406-1; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Kim D, 2007, DEV BIOL, V307, P290, DOI 10.1016/j.ydbio.2007.04.051; Kinross KM, 2012, J CLIN INVEST; Lai YL, 2008, ANN SURG ONCOL, V15, P1064, DOI 10.1245/s10434-007-9751-7; Li H, 2010, EXP MOL PATHOL, V88, P150, DOI 10.1016/j.yexmp.2009.09.016; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang LP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-248; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	50	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36924	10.1371/journal.pone.0036924	http://dx.doi.org/10.1371/journal.pone.0036924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666336	Green Published, gold			2022-12-25	WOS:000305353400018
J	Zhang, HL; Hassan, MY; Zheng, XY; Azimullah, S; Quezada, HC; Amir, N; Elwasila, M; Mix, E; Adem, A; Zhu, J				Zhang, Hong-Liang; Hassan, Mohammed Y.; Zheng, Xiang-Yu; Azimullah, Sheikh; Quezada, Hernan Concha; Amir, Naheed; Elwasila, Mohamed; Mix, Eilhard; Adem, Abdu; Zhu, Jie			Attenuated EAN in TNF-alpha Deficient Mice Is Associated with an Altered Balance of M1/M2 Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE NEURITIS; PERIPHERAL NERVOUS-SYSTEM; GUILLAIN-BARRE-SYNDROME; FACTOR (TNF)-ALPHA; FACTOR RECEPTORS; CELL RESPONSES; LEWIS RATS; T-CELLS; DEMYELINATION	The role of tumor necrosis factor (TNF)-alpha and its receptors in neuroautoimmune and neuroinflammatory diseases has been controversial. On the basis of our previous studies, we hereby aimed to further clarify TNF-alpha's mechanism of action and to explore the potential role of TNF-alpha receptor (TNFR) 1 as a therapeutic target in experimental autoimmune neuritis (EAN). EAN was induced by immunization with P0 peptide 180-199 in TNF-alpha knockout (KO) mice and anti-TNFR1 antibodies were used to treat EAN. Particularly, the effects of TNF-alpha deficiency and TNFR1 blockade on macrophage functions were investigated. The onset of EAN in TNF-alpha KO mice was markedly later than that in wild type (WT) mice. From day 14 post immunization, the clinical signs of TNF-alpha KO mice were significantly milder than those of their WT counterparts. Further, we showed that the clinical severity of WT mice treated with anti-TNFR1 antibodies was less severe than that of the control WT mice receiving PBS. Nevertheless, no difference with regard to the clinical signs of EAN or inflammatory infiltration in cauda equina was seen between TNF-alpha KO and WT mice with EAN after blockade of TNFR1. Although TNF-alpha deficiency did not alter the proliferation of lymphocytes in response to either antigenic or mitogenic stimuli, it down-regulated the production of interleukin (IL)-12 and nitric oxide (NO), and enhanced the production of IL-10 in macrophages. Increased ratio of regulatory T cells (Tregs) and reduced production of interferon (IFN)-gamma in cauda equina infiltrating cells, and elevated levels of IgG2b antibodies against P0 peptide 180-199 in sera were found in TNF-alpha KO mice with EAN. In conclusion, TNF-alpha deficiency attenuates EAN via altering the M1/M2 balance of macrophages.	[Zhang, Hong-Liang; Zheng, Xiang-Yu; Zhu, Jie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Hassan, Mohammed Y.; Azimullah, Sheikh; Amir, Naheed; Elwasila, Mohamed; Adem, Abdu] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Quezada, Hernan Concha] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden; [Mix, Eilhard] Univ Rostock, Dept Neurol, Rostock, Germany; [Zhu, Jie] Jilin Univ, First Hosp, Dept Neurol, Changchun 130023, Peoples R China	Karolinska Institutet; United Arab Emirates University; Karolinska Institutet; Karolinska University Hospital; University of Rostock; Jilin University	Zhang, HL (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	Jie.Zhu@ki.se	Zhang, Hongliang/AAN-3077-2020; Adem, Abdu/AAN-8271-2021; amir, naheed/AAP-5152-2020	Zhang, Hongliang/0000-0001-9205-5559; Adem, Abdu/0000-0002-9289-5301; 	Swedish Medical Association; Swedish National Board of Health and Welfare; China Scholarship Council; Faculty of Medicine & Health Science, United Arab Emirates University; Karolinska Institute	Swedish Medical Association; Swedish National Board of Health and Welfare; China Scholarship Council(China Scholarship Council); Faculty of Medicine & Health Science, United Arab Emirates University; Karolinska Institute(Karolinska Institutet)	This study was supported by Swedish Medical Association, Swedish National Board of Health and Welfare, and China Scholarship Council, as well as grants from Faculty of Medicine & Health Science, United Arab Emirates University and from Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2003, NEUROBIOL DIS, V12, P73, DOI 10.1016/S0969-9961(02)00007-4; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chan WC, 2000, FMOC SOLID PHASE PEP; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Creange A, 1996, J NEUROIMMUNOL, V68, P95, DOI 10.1016/0165-5728(96)00075-6; Deng H, 2008, EUR J NEUROL, V15, P1100, DOI 10.1111/j.1468-1331.2008.02261.x; Duan RS, 2004, NEUROBIOL DIS, V16, P630, DOI 10.1016/j.nbd.2004.04.007; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Korn T, 2001, BRAIN, V124, P1791, DOI 10.1093/brain/124.9.1791; Lu MO, 2007, J NEUROIMMUNOL, V186, P19, DOI 10.1016/j.jneuroim.2007.02.004; Mao XJ, 2010, NEUROSCI LETT, V470, P19, DOI 10.1016/j.neulet.2009.12.045; Mao XJ, 2010, NEURAL REGEN RES, V5, P70, DOI 10.3969/j.issn.1673-5374.2010.01.012; Masli S, 2009, IMMUNOLOGY, V127, P62, DOI 10.1111/j.1365-2567.2008.02933.x; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Oka N, 1998, ACTA NEUROPATHOL, V95, P57, DOI 10.1007/s004010050765; Prasad KN, 2010, HUM IMMUNOL, V71, P905, DOI 10.1016/j.humimm.2010.06.013; Radhakrishnan VV, 2004, ACTA NEUROL SCAND, V109, P71, DOI 10.1034/j.1600-0404.2003.00179.x; REDFORD EJ, 1995, BRAIN, V118, P869, DOI 10.1093/brain/118.4.869; SAID G, 1992, RES IMMUNOL, V143, P589, DOI 10.1016/0923-2494(92)80040-R; SHARIEF MK, 1993, ANN NEUROL, V33, P591, DOI 10.1002/ana.410330606; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STOLL G, 1993, J NEUROIMMUNOL, V45, P175, DOI 10.1016/0165-5728(93)90178-2; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Zhang HL, 2012, J NEUROIMMUNOL, V246, P18, DOI 10.1016/j.jneuroim.2012.02.011; Zhang HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357412; Zhang HL, 2011, EXP NEUROL, V230, P197, DOI 10.1016/j.expneurol.2011.04.016; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhu J, 1999, CLIN EXP IMMUNOL, V115, P56; Zhu J, 1997, CLIN IMMUNOL IMMUNOP, V84, P85, DOI 10.1006/clin.1997.4356; Zou LP, 2000, NEUROPHARMACOLOGY, V39, P324, DOI 10.1016/S0028-3908(99)00144-6	36	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38157	10.1371/journal.pone.0038157	http://dx.doi.org/10.1371/journal.pone.0038157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666471	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400092
J	Kim, BH; Ramanan, R; Cho, DH; Choi, GG; La, HJ; Ahn, CY; Oh, HM; Kim, HS				Kim, Byung-Hyuk; Ramanan, Rishiram; Cho, Dae-Hyun; Choi, Gang-Guk; La, Hyun-Joon; Ahn, Chi-Yong; Oh, Hee-Mock; Kim, Hee-Sik			Simple, Rapid and Cost-Effective Method for High Quality Nucleic Acids Extraction from Different Strains of Botryococcus braunii	PLOS ONE			English	Article							HYDROCARBONS; BIODIESEL; RNA	This study deals with an effective nucleic acids extraction method from various strains of Botryococcus braunii which possesses an extensive extracellular matrix. A method combining freeze/thaw and bead-beating with heterogeneous diameter of silica/zirconia beads was optimized to isolate DNA and RNA from microalgae, especially from B. braunii. Eukaryotic Microalgal Nucleic Acids Extraction (EMNE) method developed in this study showed at least 300 times higher DNA yield in all strains of B. braunii with high integrity and 50 times reduced working volume compared to commercially available DNA extraction kits. High quality RNA was also extracted using this method and more than two times the yield compared to existing methods. Real-time experiments confirmed the quality and quantity of the input DNA and RNA extracted using EMNE method. The method was also applied to other eukaryotic microalgae, such as diatoms, Chlamydomonas sp., Chlorella sp., and Scenedesmus sp. resulting in higher efficiencies. Cost-effectiveness analysis of DNA extraction by various methods revealed that EMNE method was superior to commercial kits and other reported methods by >15%. This method would immensely contribute to area of microalgal genomics.	[Kim, Byung-Hyuk; Ramanan, Rishiram; Cho, Dae-Hyun; Choi, Gang-Guk; La, Hyun-Joon; Ahn, Chi-Yong; Oh, Hee-Mock; Kim, Hee-Sik] KRIBB, Environm Biotechnol Res Ctr, Taejon, South Korea; [Oh, Hee-Mock; Kim, Hee-Sik] Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, BH (corresponding author), KRIBB, Environm Biotechnol Res Ctr, Taejon, South Korea.	hkim@kribb.re.kr	Ahn, Chi-Yong/AAI-8370-2020; Ramanan, Rishiram/ABC-9528-2021; Ramanan, Rishiram/AAW-7916-2020; Ramanan, Rishiram/GOE-4622-2022	Ramanan, Rishiram/0000-0002-4641-9603; Dae-Hyun, Cho/0000-0001-8975-2468; Ahn, Chi-Yong/0000-0002-9626-2755; Oh, Hee-Mock/0000-0002-2151-3687	Korea Ministry of Education, Science and Technology as a "Global Frontier project"; KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program	Korea Ministry of Education, Science and Technology as a "Global Frontier project"; KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program	This research was supported by grants from the Korea Ministry of Education, Science and Technology as a "Global Frontier project" (www.biomass.re.kr) and grant from the KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program (www.kribb.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; BASHYAM MD, 1994, BIOTECHNIQUES, V17, P834; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Kim BH, 2006, J PHYCOL, V42, P1137, DOI 10.1111/j.1529-8817.2006.00263.x; Kim H. S., 2011, PRIMER SETS DETECTIN; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; Preiss M. R., 2010, J COMMERCIAL BIOTECH, V16, P293, DOI DOI 10.1057/jcb.2010.15; Qu CB, 2008, BIOTECHNOL LETT, V30, P1735, DOI 10.1007/s10529-008-9758-6; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; SANTOS AR, 1993, J MED MICROBIOL, V39, P298, DOI 10.1099/00222615-39-4-298; Slininger PJ, 2007, BIOCONTROL SCI TECHN, V17, P647, DOI 10.1080/09583150701408881; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; Yoo C, 2010, BIORESOURCE TECHNOL, V101, pS71, DOI 10.1016/j.biortech.2009.03.030; Zhang JinFa, 2000, Journal of Cotton Science, V4, P193; Zurzolo C, 2001, PLANT PHYSIOL, V127, P1339, DOI 10.1104/pp.010709	18	22	27	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37770	10.1371/journal.pone.0037770	http://dx.doi.org/10.1371/journal.pone.0037770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662217	gold, Green Published			2022-12-25	WOS:000305342300107
J	Morrison, SS; Williams, T; Cain, A; Froelich, B; Taylor, C; Baker-Austin, C; Verner-Jeffreys, D; Hartnell, R; Oliver, JD; Gibas, CJ				Morrison, Shatavia S.; Williams, Tiffany; Cain, Aurora; Froelich, Brett; Taylor, Casey; Baker-Austin, Craig; Verner-Jeffreys, David; Hartnell, Rachel; Oliver, James D.; Gibas, Cynthia J.			Pyrosequencing-Based Comparative Genome Analysis of Vibrio vulnificus Environmental Isolates	PLOS ONE			English	Article							IV SECRETION; GENE ONTOLOGY; SIALIC ACIDS; RNA GENES; IDENTIFICATION; VERSATILE; SYSTEM; PATHOGENESIS; EVOLUTION; DATABASE	Between 1996 and 2006, the US Centers for Disease Control reported that the only category of food-borne infections increasing in frequency were those caused by members of the genus Vibrio. The Gram-negative bacterium Vibrio vulnificus is a ubiquitous inhabitant of estuarine waters, and is the number one cause of seafood-related deaths in the US. Many V. vulnificus isolates have been studied, and it has been shown that two genetically distinct subtypes, distinguished by 16S rDNA and other gene polymorphisms, are associated predominantly with either environmental or clinical isolation. While local genetic differences between the subtypes have been probed, only the genomes of clinical isolates have so far been completely sequenced. In order to better understand V. vulnificus as an agent of disease and to identify the molecular components of its virulence mechanisms, we have completed whole genome shotgun sequencing of three diverse environmental genotypes using a pyrosequencing approach. V. vulnificus strain JY1305 was sequenced to a depth of 336, and strains E64MW and JY1701 were sequenced to lesser depth, covering approximately 99.9% of each genome. We have performed a comparative analysis of these sequences against the previously published sequences of three V. vulnificus clinical isolates. We find that the genome of V. vulnificus is dynamic, with 1.27% of genes in the C-genotype genomes not found in the E-genotype genomes. We identified key genes that differentiate between the genomes of the clinical and environmental genotypes. 167 genes were found to be specifically associated with environmental genotypes and 278 genes with clinical genotypes. Genes specific to the clinical strains include components of sialic acid catabolism, mannitol fermentation, and a component of a Type IV secretory pathway VirB4, as well as several other genes with potential significance for human virulence. Genes specific to environmental strains included several that may have implications for the balance between self-preservation under stress and nutritional competence.	[Morrison, Shatavia S.; Cain, Aurora; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Williams, Tiffany; Froelich, Brett; Taylor, Casey; Oliver, James D.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Baker-Austin, Craig; Verner-Jeffreys, David; Hartnell, Rachel] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Centre for Environment Fisheries & Aquaculture Science	Morrison, SS (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu	Froelich, Brett/AAD-9486-2020; Froelich, Brett/W-9325-2019	Froelich, Brett/0000-0003-0402-2357; Morrison, Shatavia S/0000-0002-4658-5951; Gibas, Cynthia/0000-0002-1288-9543	United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project [AS0111]; United Kingdom's Department for Environment Food and Rural Affairs through Cefas project [DP254]; United States Department of Education Graduate Assistance in Areas of National Need award [P200A090351-10]; United States Department of Agriculture [2007-35201-1838, 2009-03571]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Office of Advanced Cyberinfrastructure (OAC) [1047896] Funding Source: National Science Foundation	United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project; United Kingdom's Department for Environment Food and Rural Affairs through Cefas project; United States Department of Education Graduate Assistance in Areas of National Need award; United States Department of Agriculture(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was partly funded by the United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project AS0111 and Cefas project DP254. No additional external funding was received for this study. SSM and AC were supported by United States Department of Education Graduate Assistance in Areas of National Need award #P200A090351-10. BF and TW were supported by United States Department of Agriculture awards #2007-35201-1838 and #2009-03571 to JDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P76, DOI 10.1111/j.1758-2229.2009.00092.x; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Been M, 2011, MICROBIOLOGY, V157, P3; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Cain AA, 2012, GENOSETS VISUAL ANAL; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Darling AE, PLOS ONE, V5; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Froelich B., 2011, ADV STUD BIOL, V3, P151; Froelich BA, 2008, 108 GEN M AM SOC MIC; Grimes DJ, 2009, MICROB ECOL, V58, P447, DOI 10.1007/s00248-009-9578-9; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kim DE, 2005, PROTEIN EXPRES PURIF, V39, P107, DOI 10.1016/j.pep.2004.09.007; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li J, 2012, GENE, V494, P57, DOI 10.1016/j.gene.2011.11.051; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lubin JB, 2010, P VIBR 2010 C; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Murray JW, 2005, PNAS, V48, P17320; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Okura M, 2004, MICROBIOL IMMUNOL, V48, P787, DOI 10.1111/j.1348-0421.2004.tb03596.x; Oliver JD, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P253; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rambaut A., FIGTREE; Rosche TM, 2010, ENV MICROBIOL REP, V2, P128, DOI 10.1111/j.1758-2229.2009.00119.x; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Senoh M, 2005, MICROBIOL IMMUNOL, V49, P513, DOI 10.1111/j.1348-0421.2005.tb03756.x; Smith AJ, 1997, J PERIODONTAL RES, V32, P1, DOI 10.1111/j.1600-0765.1997.tb01376.x; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Starks AM, 2000, INFECT IMMUN, V68, P5785, DOI 10.1128/IAI.68.10.5785-5793.2000; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Suzuki H, 2011, GENOME BIOL EVOL, V3, P168, DOI 10.1093/gbe/evr006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Warner JM, 1998, APPL ENVIRON MICROB, V64, P3025; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Yatsunami R., 2004, ENZYMATIC SYNTHESES; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	79	53	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37553	10.1371/journal.pone.0037553	http://dx.doi.org/10.1371/journal.pone.0037553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662170	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305342300060
J	Suarez, J; Romero-Zerbo, Y; Marquez, L; Rivera, P; Iglesias, M; Bermudez-Silva, FJ; Andreu, M; de Fonseca, FR				Suarez, Juan; Romero-Zerbo, Yanina; Marquez, Lucia; Rivera, Patricia; Iglesias, Mar; Bermudez-Silva, Francisco J.; Andreu, Montserrat; Rodriguez de Fonseca, Fernando			Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; ENDOGENOUS CANNABINOID SYSTEM; AMIDE HYDROLASE FAAH; PPAR-ALPHA; NITRIC-OXIDE; MOLECULAR CHARACTERIZATION; DIFFERENTIAL EXPRESSION; COLON INFLAMMATION; FOOD-INTAKE	Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPAR alpha) system in inflammatory bowel diseases. However, the presence and function of NAE-PPAR alpha signaling system in the ulcerative colitis (UC) of humans remain unknown as well as its response to active anti-inflammatory therapies such as 5-aminosalicylic acid (5-ASA) and glucocorticoids. Expression of PPAR alpha receptor and PPAR alpha ligands-biosynthetic (NAPE-PLD) and -degrading (FAAH and NAAA) enzymes were analyzed in untreated active and 5-ASA/glucocorticoids/immunomodulators-treated quiescent UC patients compared to healthy human colonic tissue by RTPCR and immunohistochemical analyses. PPAR alpha, NAAA, NAPE-PLD and FAAH showed differential distributions in the colonic epithelium, lamina propria, smooth muscle and enteric plexus. Gene expression analysis indicated a decrease of PPAR alpha, PPAR gamma and NAAA, and an increase of FAAH and iNOS in the active colitis mucosa. Immunohistochemical expression in active colitis epithelium confirmed a PPAR alpha decrease, but showed a sharp NAAA increase and a NAPE-PLD decrease, which were partially restored to control levels after treatment. We also characterized the immune cells of the UC mucosa infiltrate. We detected a decreased number of NAAA-positive and an increased number of FAAH-positive immune cells in active UC, which were partially restored to control levels after treatment. NAE-PPAR alpha signaling system is impaired during active UC and 5-ASA/glucocorticoids treatment restored its normal expression. Since 5-ASA actions may work through PPAR alpha and glucocorticoids through NAE-producing/degrading enzymes, the use of PPAR alpha agonists or FAAH/NAAA blockers that increases endogenous PPAR alpha ligands may yield similar therapeutics advantages.	[Suarez, Juan; Romero-Zerbo, Yanina; Rivera, Patricia; Bermudez-Silva, Francisco J.; Rodriguez de Fonseca, Fernando] Hosp Carlos Haya, Lab Med Regenerativa, Mediterranean Inst Adv Biotechnol & Hlth Res Fdn, Malaga, Spain; [Marquez, Lucia; Andreu, Montserrat] Univ Autonoma Barcelona, Dept Gastroenterol, E-08193 Barcelona, Spain; [Suarez, Juan; Bermudez-Silva, Francisco J.; Rodriguez de Fonseca, Fernando] Minist Ciencia & Innnovac, Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, Dept Pathol, E-08193 Barcelona, Spain	Hospital Carlos Haya; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Autonomous University of Barcelona	Suarez, J (corresponding author), Hosp Carlos Haya, Lab Med Regenerativa, Mediterranean Inst Adv Biotechnol & Hlth Res Fdn, Malaga, Spain.	MAndreu@parcdesalutmar.cat; fernando.rodriguez@fundacionimabis.org	Marquez, Lucia/AAI-8215-2021; Andreu, Montserrat/D-9911-2015; Bermudez-Silva, Francisco-Javier/Q-6920-2016; Suarez, Juan/I-5188-2015	Andreu, Montserrat/0000-0003-4286-1098; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; Suarez, Juan/0000-0001-5254-9802; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; MARQUEZ MOSQUERA, LUCIA/0000-0002-3182-9570; Rivera, Patricia/0000-0002-0478-6667	European Union [Health-F2-2008-223713, REPROBESITY]; Spanish Ministry of Science and Innovation [SAF2010-20521]; National Institute of Health "Carlos III" [PI07/1226, PI07/0880, PI 07/0953]; Red de Trastornos Adictivos-UE-ERDF [RD06/0001/0000]; El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF [CTS-433, PI45403]; Consejeria de Salud de la Junta de Andalucia, Spain [PI0232/2008]; National Institute of Health "Carlos III", Madrid, Spain [CD08/00203, CD07/00283]	European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Health "Carlos III"; Red de Trastornos Adictivos-UE-ERDF; El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF; Consejeria de Salud de la Junta de Andalucia, Spain(Junta de Andalucia); National Institute of Health "Carlos III", Madrid, Spain	This study was supported by grants to FRdF from the European Union's 7th Framework Programme (Health-F2-2008-223713, REPROBESITY); the following grants from the Spanish Ministry of Science and Innovation (SAF2010-20521); National Institute of Health "Carlos III" (PI07/1226, PI07/0880 and PI 07/0953), Red de Trastornos Adictivos-UE-ERDF (RD06/0001/0000) and El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; grants from the Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF (CTS-433 and PI45403); and a grant from the Consejeria de Salud de la Junta de Andalucia (PI0232/2008), Spain. FJBS holds a Miguel Servet research contracts CD07/00283, and JS holds a Sara Borrell postdoctoral contract CD08/00203, both from the National Institute of Health "Carlos III", Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista N, 2007, NEUROBIOL DIS, V27, P108, DOI 10.1016/j.nbd.2007.04.012; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brattsand R, 1996, ALIMENT PHARM THERAP, V10, P81, DOI 10.1046/j.1365-2036.1996.22164025.x; Brown WA, 2000, DIGEST DIS SCI, V45, P1578, DOI 10.1023/A:1005517112039; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; Clapper ML, 2008, INFLAMM BOWEL DIS, V14, P1341, DOI 10.1002/ibd.20489; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Cuzzocrea S, 2008, MOL PHARMACOL, V73, P323, DOI 10.1124/mol.107.041475; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dworzanski T, 2010, J PHYSIOL PHARMACOL, V61, P683; Esposito E, 2010, PPAR RES, V2010, DOI 10.1155/2010/917312; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Huin C, 2000, J HISTOCHEM CYTOCHEM, V48, P603, DOI 10.1177/002215540004800504; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kho YH, 2001, PHARM WORLD SCI, V23, P17, DOI 10.1023/A:1011268302386; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; LennardJones JE, 1997, EUR J GASTROEN HEPAT, V9, P353, DOI 10.1097/00042737-199704000-00007; Linard C, 2008, J PHARMACOL EXP THER, V324, P911, DOI 10.1124/jpet.107.129122; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mazzon E, 2007, SHOCK, V28, P192, DOI 10.1097/shk.0b013e318033eb29; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Paukkeri EL, 2007, BRIT J PHARMACOL, V152, P1081, DOI 10.1038/sj.bjp.0707477; Reinacher-Schick A, 2003, CARCINOGENESIS, V24, P443, DOI 10.1093/carcin/24.3.443; Riccardi L, 2009, SHOCK, V31, P308, DOI 10.1097/SHK.0b013e31818339e7; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; TRAVIS SPL, 1994, PHARMACOL THERAPEUT, V63, P135, DOI 10.1016/0163-7258(94)90042-6; Tromm A, 1999, HEPATO-GASTROENTEROL, V46, P3124; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Ueda N, 2000, CHEM PHYS LIPIDS, V108, P107, DOI 10.1016/S0009-3084(00)00190-0; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	63	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37729	10.1371/journal.pone.0037729	http://dx.doi.org/10.1371/journal.pone.0037729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662201	Green Published, gold			2022-12-25	WOS:000305342300091
J	Northrup, E; Zschemisch, NH; Eisenblatter, R; Glage, S; Wedekind, D; Cuppen, E; Dorsch, M; Hedrich, HJ				Northrup, Emily; Zschemisch, Nils-Holger; Eisenblaetter, Regina; Glage, Silke; Wedekind, Dirk; Cuppen, Edwin; Dorsch, Martina; Hedrich, Hans-Juergen			The ter Mutation in the Rat Dnd1 Gene Initiates Gonadal Teratomas and Infertility in Both Genders	PLOS ONE			English	Article							GERM-CELL TUMORS; TESTICULAR DYSGENESIS SYNDROME; GENOME-WIDE ASSOCIATION; RNA-BINDING PROTEIN; DEAD-END DND1; EMBRYONAL CARCINOMA; 129/SV-TER MICE; MESSENGER-RNA; STRAIN; SUSCEPTIBILITY	A spontaneous mutation leading to the formation of congenital ovarian and testicular tumors was detected in the WKY/Ztm rat strain. The histological evaluation revealed derivatives from all three germ layers, thereby identifying these tumors as teratomas. Teratocarcinogenesis was accompanied by infertility and the underlying mutation was termed ter. Linkage analysis of 58 (WKY-ter6SPRD-Cu3) F2 rats associated the ter mutation with RNO18 (LOD = 3.25). Sequencing of candidate genes detected a point mutation in exon 4 of the dead-end homolog 1 gene (Dnd1), which introduces a premature stop codon assumed to cause a truncation of the Dnd1 protein. Genotyping of the recessive ter mutation revealed a complete penetrance of teratocarcinogenesis and infertility in homozygous ter rats of both genders. Morphologically non-tumorous testes of homozygous ter males were reduced in both size and weight. This testicular malformation was linked to a lack of spermatogenesis using immunohistochemical and histological staining. Our WKY-Dnd1(ter)/Ztm rat is a novel animal model to investigate gonadal teratocarcinogenesis and the molecular mechanisms involved in germ cell development of both genders.	[Northrup, Emily; Zschemisch, Nils-Holger; Eisenblaetter, Regina; Glage, Silke; Wedekind, Dirk; Dorsch, Martina; Hedrich, Hans-Juergen] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Hannover Medical School; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Northrup, E (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany.	Northrup.Emily@mh-hannover.de	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542	German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies) [EXC 62/1]	German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies)	This study was supported in part by the German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies; EXC 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Bahrami A, 2007, ARCH PATHOL LAB MED, V131, P1267; Bhattacharya C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002315; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chieffi P, 2009, INT REV CEL MOL BIO, V278, P277, DOI 10.1016/S1937-6448(09)78006-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; COOK MS, 2011, DEVELOPMENT; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; Faulkner SW, 2000, GYNECOL ONCOL, V77, P283, DOI 10.1006/gyno.2000.5762; Giambartolomei C, 2009, CANCER EPIDEMIOL, V33, P31, DOI 10.1016/j.canep.2009.04.015; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Hotaling JM, 2009, NAT REV UROL, V6, P550, DOI 10.1038/nrurol.2009.179; ITOH T, 1985, EXP ANIM TOKYO, V34, P207, DOI 10.1538/expanim1978.34.2_207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Lam MYJ, 2007, HUM MOL GENET, V16, P2233, DOI 10.1093/hmg/ddm175; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Langer B, 2004, LAB ANIM-UK, V38, P425, DOI 10.1258/0023677041958873; Liu WY, 2010, FASEB J, V24, P2641, DOI 10.1096/fj.09-148403; Looijenga LHJ, 1999, REV REPROD, V4, P90, DOI 10.1530/ror.0.0040090; MIWA M, 1987, EXP ANIM TOKYO, V36, P205, DOI 10.1538/expanim1978.36.2_205; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; NINOMIYA H, 1983, EXP ANIM TOKYO, V32, P145, DOI 10.1538/expanim1978.32.3_145; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Northrup E, 2011, EXP CELL RES, V317, P1885, DOI 10.1016/j.yexcr.2011.04.013; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; RIVERS EN, 1986, AM J PATHOL, V124, P263; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Sawaki M, 2000, TOXICOL PATHOL, V28, P832, DOI 10.1177/019262330002800611; SCHARDEIN JL, 1977, LAB ANIM SCI, V27, P114; Sheikine Y, 2012, AM J CANCER RES, V2, P153; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1959, J NATL CANCER I, V23, P1249; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; van de Geijn GJM, 2009, BIRTH DEFECTS RES C, V87, P96, DOI 10.1002/bdrc.20140; Vilar E, 2006, Clin Transl Oncol, V8, P846, DOI 10.1007/s12094-006-0147-0; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Xu SZ, 1996, GENETICS, V143, P1417; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zechel JL, 2011, INT J ANDROL, V34, pE278, DOI 10.1111/j.1365-2605.2011.01160.x; Zhu R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-37	52	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38001	10.1371/journal.pone.0038001	http://dx.doi.org/10.1371/journal.pone.0038001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655094	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900071
J	Taylor, SS; Jenkins, DA; Arcese, P				Taylor, Sabrina S.; Jenkins, Deborah A.; Arcese, Peter			Loss of Mhc and Neutral Variation in Peary Caribou: Genetic Drift Is Not Mitigated by Balancing Selection or Exacerbated by Mhc Allele Distributions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; QUEEN ELIZABETH ISLANDS; RANGIFER-TARANDUS; NATURAL-SELECTION; CONSERVATION GENETICS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; LINKAGE MAP; DIVERSITY	Theory and empirical results suggest that the rate of loss of variation at Mhc and neutral microsatellite loci may differ because selection influences Mhc genes, and because a high proportion of rare alleles at Mhc loci may result in high rates of loss via drift. Most published studies compare Mhc and microsatellite variation in various contemporary populations to infer the effects of population size on genetic variation, even though different populations are likely to have different demographic histories that may also affect contemporary genetic variation. We directly compared loss of variation at Mhc and microsatellite loci in Peary caribou by comparing historical and contemporary samples. We observed that similar proportions of genetic variation were lost over time at each type of marker despite strong evidence for selection at Mhc genes. These results suggest that microsatellites can be used to estimate genome-wide levels of variation, but also that adaptive potential is likely to be lost following population bottlenecks. However, gene conversion and recombination at Mhc loci may act to increase variation following bottlenecks.	[Taylor, Sabrina S.] Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Arcese, Peter] Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada	Louisiana State University System; Louisiana State University; University of British Columbia	Taylor, SS (corresponding author), Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	staylor@lsu.edu		Taylor, Sabrina/0000-0002-0118-9883	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; NSERC post-doctoral fellowship; LSU AgCenter (start-up funding)	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC post-doctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); LSU AgCenter (start-up funding)	PA received funding from a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant. SST received funding from an NSERC post-doctoral fellowship and the LSU AgCenter (start-up funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-47; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Allen JA, 1902, B AM MUS NAT HIST, V16, P409; Allen JA, 1908, B AM MUS NAT HIST, V24, P487; Allendorf F., 2007, CONSERVATION GENETIC; Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; Belkhir K., 1999, GENETIX LOGICIEL WIN; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BISHOP MD, 1994, GENETICS, V136, P619; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Carmichael LE, 2008, CONSERV GENET, V9, P879, DOI 10.1007/s10592-007-9413-0; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; CRAWFORD AM, 1995, GENETICS, V140, P703; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Ellegren H, 1996, MOL ECOL, V5, P3, DOI 10.1111/j.1365-294X.1996.tb00286.x; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Frankham R., 2002, INTRO CONSERVATION G; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gravlund P, 1998, MOL PHYLOGENET EVOL, V10, P151, DOI 10.1006/mpev.1998.0525; Gunn A, 2006, ARCTIC, V59, P1; Hambuch TM, 2002, EVOLUTION, V56, P841; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 1998, EVOLUTION, V52, P194, DOI 10.1111/j.1558-5646.1998.tb05152.x; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Jarvi SI, 2004, MOL ECOL, V13, P2157, DOI 10.1111/j.1365-294X.2004.02228.x; Jenkins D.A., 2011, RECENT TRENDS ABUNDA; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kennedy LJ, 2011, INT J IMMUNOGENET, V38, P109, DOI 10.1111/j.1744-313X.2010.00973.x; Lawler RR, 2003, MOL ECOL, V12, P2307, DOI 10.1046/j.1365-294X.2003.01909.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucas ZL, 2009, CAN J ZOOL, V87, P310, DOI 10.1139/Z09-019; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; MacPhee RDE, 2005, BMC EVOLUTIONARY BIO, V5; Madsen T, 2000, BIOL CONSERV, V94, P257, DOI 10.1016/S0006-3207(99)00127-5; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; MIKKO S, 1995, P NATL ACAD SCI USA, V92, P4259, DOI 10.1073/pnas.92.10.4259; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Miller FL, 2003, ARCTIC, V56, P381; MILLER FL, 1977, CAN J ZOOL, V55, P1029, DOI 10.1139/z77-131; Miller FL, 2007, ARCTIC, V60, P23; Miller Frank L., 2003, Rangifer, P267; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller HC, 2004, IMMUNOGENETICS, V56, P178, DOI 10.1007/s00251-004-0666-1; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Perez-Gonzalez J, 2009, MOL ECOL, V18, P1591, DOI 10.1111/j.1365-294X.2009.04150.x; Petersen SD, 2010, J MAMMAL, V91, P698, DOI 10.1644/09-MAMM-A-231.1; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Roed KH, 1998, MOL ECOL, V7, P1773, DOI 10.1046/j.1365-294x.1998.00514.x; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sawyer S, 1999, GENECONV COMPUTER PA; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; SIGURDARDOTTIR S, 1991, ANIM GENET, V22, P199, DOI 10.1111/j.1365-2052.1991.tb00670.x; STONE RT, 1995, MAMM GENOME, V6, P714, DOI 10.1007/BF00354294; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMAS DC, 1982, CAN J ZOOL, V60, P597, DOI 10.1139/z82-089; Van der Walt JM, 2001, MOL ECOL, V10, P1679, DOI 10.1046/j.0962-1083.2001.01321.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Wilson GA, 1997, MOL ECOL, V6, P697, DOI 10.1046/j.1365-294X.1997.00237.x; Wilson PJ, 2003, CAN J ZOOL, V81, P670, DOI 10.1139/Z03-030; Zittlau KA, 2004, THESIS U ALBERTA CAN	79	22	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36748	10.1371/journal.pone.0036748	http://dx.doi.org/10.1371/journal.pone.0036748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655029	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900003
J	Bevacqua, D; Capoccioni, F; Melia, P; Vincenzi, S; Pujolar, JM; De Leo, GA; Ciccotti, E				Bevacqua, Daniele; Capoccioni, Fabrizio; Melia, Paco; Vincenzi, Simone; Pujolar, Jose M.; De Leo, Giulio A.; Ciccotti, Eleonora			Fishery-Induced Selection for Slow Somatic Growth in European Eel	PLOS ONE			English	Article							ANGUILLA-ANGUILLA; SEX-DIFFERENTIATION; MORTALITY; MATURATION; JUVENILE; BRACKISH; LAGOONS; TRAITS; LESINA	Both theoretical and experimental studies have shown that fishing mortality can induce adaptive responses in body growth rates of fishes in the opposite direction of natural selection. We compared body growth rates in European eel (Anguilla anguilla) from three Mediterranean stocks subject to different fishing pressure. Results are consistent with the hypotheses that i) fast-growing individuals are more likely to survive until sexual maturity than slow-growing ones under natural conditions (no fishing) and ii) fishing can select for slow-growing individuals by removing fast-growing ones. Although the possibility of human-induced evolution seems remote for a panmictic species like such as the European eel, further research is desirable to assess the implications of the intensive exploitation on this critically endangered fish.	[Bevacqua, Daniele; De Leo, Giulio A.] Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy; [Bevacqua, Daniele] INRA, PSH UR1115, Avignon, France; [Capoccioni, Fabrizio; Ciccotti, Eleonora] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Melia, Paco] Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; [Vincenzi, Simone] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Santa Cruz, CA 95064 USA; [Pujolar, Jose M.] Univ Padua, Dipartimento Biol, Padua, Italy; [De Leo, Giulio A.] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA	University of Parma; INRAE; University of Rome Tor Vergata; Polytechnic University of Milan; University of California System; University of California Santa Cruz; University of Padua; Stanford University	Bevacqua, D (corresponding author), Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy.	fabrizio.capoccioni@uniroma2.it	Capoccioni, Fabrizio/AFE-2116-2022; De Leo, Giulio/AAC-5098-2019; Melià, Paco/E-8844-2012; Bevacqua, Daniele/ABA-7173-2021; Bevacqua, Daniele/D-9421-2012; Vincenzi, Simone/D-9547-2012	Capoccioni, Fabrizio/0000-0002-4752-6881; De Leo, Giulio/0000-0002-4186-3369; Melià, Paco/0000-0002-7763-9836; Bevacqua, Daniele/0000-0002-3341-1696; Vincenzi, Simone/0000-0002-8436-8608; CICCOTTI, ELEONORA/0000-0001-6687-7102; pujolar, marti/0000-0002-5037-8840	Italian Ministry of Research (PRIN project 153) [2006054928]	Italian Ministry of Research (PRIN project 153)	This work was supported by the Italian Ministry of Research (PRIN project 153 #2006054928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bevacqua D, 2006, J FISH BIOL, V69, P200, DOI 10.1111/j.1095-8649.2006.01265.x; Bevacqua D, 2011, HYDROBIOLOGIA, V671, P259, DOI 10.1007/s10750-011-0725-1; Bevacqua D, 2011, OECOLOGIA, V165, P333, DOI 10.1007/s00442-010-1727-9; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Cairns DK, 2009, J FISH BIOL, V74, P2094, DOI 10.1111/j.1095-8649.2009.02290.x; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Ciccotti E, 2011, 48 ICES EIFAC WORK G; Colombo G, 1996, J FISH BIOL, V48, P493, DOI 10.1111/j.1095-8649.1996.tb01443.x; Dekker W, 2003, CAN J FISH AQUAT SCI, V60, P787, DOI 10.1139/F03-066; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; GRAVINA MF, 1989, MAR ECOL-P S Z N I, V10, P141, DOI 10.1111/j.1439-0485.1989.tb00071.x; ICES, 2011, 48 ICES EIFAC WORK G; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lorenzen K, 1996, J FISH BIOL, V49, P627, DOI 10.1111/j.1095-8649.1996.tb00060.x; Marzano CN, 2003, OCEANOL ACTA, V26, P57, DOI 10.1016/S0399-1784(02)01229-X; Melia P, 2006, J FISH BIOL, V69, P1228, DOI 10.1111/j.1095-8649.2006.01170.x; Melia P, 2006, J FISH BIOL, V68, P876, DOI 10.1111/j.0022-1112.2006.00975.x; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; PETTINE M, 1982, MAR POLLUT BULL, V13, P327, DOI 10.1016/0025-326X(82)90398-8; Poole WR, 1998, BIOL ENVIRON, V98B, P141; Regione Lazio-Centro Funzionale Regionale, 2011, UFF IDR MAR AR D2 2S; Roselli L, 2009, ESTUAR COAST SHELF S, V84, P539, DOI 10.1016/j.ecss.2009.07.023; ROSSI R, 1980, J FISH BIOL, V16, P413, DOI 10.1111/j.1095-8649.1980.tb03719.x; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Signorini A, 2008, AQUAT CONSERV, V18, pS27, DOI 10.1002/aqc.953; Sogard SM, 1997, B MAR SCI, V60, P1129; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; Tesch F-W., 2003, EEL; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x	30	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37622	10.1371/journal.pone.0037622	http://dx.doi.org/10.1371/journal.pone.0037622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666373	Green Published, gold			2022-12-25	WOS:000305345300062
J	Santana-Farre, R; Mirecki-Garrido, M; Bocos, C; Henriquez-Hernandez, LA; Kahlon, N; Herrera, E; Norstedt, G; Parini, P; Flores-Morales, A; Fernandez-Perez, L				Santana-Farre, Ruyman; Mirecki-Garrido, Mercedes; Bocos, Carlos; Henriquez-Hernandez, Luis A.; Kahlon, Nusrat; Herrera, Emilio; Norstedt, Gunnar; Parini, Paolo; Flores-Morales, Amilcar; Fernandez-Perez, Leandro			Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood	PLOS ONE			English	Article							CATCH-UP GROWTH; MALIC ENZYME GENE; DENSITY-LIPOPROTEIN RECEPTOR; THYROID-HORMONE; INSULIN-RESISTANCE; BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; RESPONSE ELEMENT; MICROARRAY DATA	Thyroid hormones are required for normal growth and development in mammals. Congenital-neonatal hypothyroidism (CH) has a profound impact on physiology, but its specific influence in liver is less understood. Here, we studied how CH influences the liver gene expression program in adulthood. Pregnant rats were given the antithyroid drug methimazole (MMI) from GD12 until PND30 to induce CH in male offspring. Growth defects due to CH were evident as reductions in body weight and tail length from the second week of life. Once the MMI treatment was discontinued, the feed efficiency increased in CH, and this was accompanied by significant catch-up growth. On PND80, significant reductions in body mass, tail length, and circulating IGF-I levels remained in CH rats. Conversely, the mRNA levels of known GH target genes were significantly upregulated. The serum levels of thyroid hormones, cholesterol, and triglycerides showed no significant differences. In contrast, CH rats showed significant changes in the expression of hepatic genes involved in lipid metabolism, including an increased transcription of PPAR alpha and a reduced expression of genes involved in fatty acid and cholesterol uptake, cellular sterol efflux, triglyceride assembly, bile acid synthesis, and lipogenesis. These changes were associated with a decrease of intrahepatic lipids. Finally, CH rats responded to the onset of hypothyroidism in adulthood with a reduction of serum fatty acids and hepatic cholesteryl esters and to T3 replacement with an enhanced activation of malic enzyme. In summary, we provide in vivo evidence that neonatal hypothyroidism influences the hepatic transcriptional program and tissue sensitivity to hormone treatment in adulthood. This highlights the critical role that a euthyroid state during development plays on normal liver physiology in adulthood.	[Santana-Farre, Ruyman; Mirecki-Garrido, Mercedes; Henriquez-Hernandez, Luis A.; Fernandez-Perez, Leandro] Univ Las Palmas, GC Canc Res Inst Canary Isl ICIC, Dept Clin Sci, Mol & Translat Endocrinol Grp, Las Palmas Gran Canaria, Spain; [Bocos, Carlos; Herrera, Emilio] Univ San Pablo CEU, Fac Pharm & Med, Dept Biol, Madrid, Spain; [Kahlon, Nusrat; Norstedt, Gunnar; Flores-Morales, Amilcar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Parini, Paolo] Karolinska Inst, Div Clin Chem, Dept Lab Med, Ctr Nutr & Toxicol, Stockholm, Sweden; [Parini, Paolo] Karolinska Inst, Ctr Nutr & Toxicol, Mol Nutr Unit, Stockholm, Sweden; [Flores-Morales, Amilcar] Univ Copenhagen, Novo Nordisk Ctr Prot Res, Copenhagen, Denmark	Universidad de Las Palmas de Gran Canaria; San Pablo CEU University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Copenhagen	Santana-Farre, R (corresponding author), Univ Las Palmas, GC Canc Res Inst Canary Isl ICIC, Dept Clin Sci, Mol & Translat Endocrinol Grp, Las Palmas Gran Canaria, Spain.	lfernandez@dcc.ulpgc.es	Mirecki-Garrido, Mercedes/H-6075-2015; Fernandez-Perez, Leandro/H-1493-2015; Henriquez-Hernandez, Luis Alberto/H-8981-2019; Bocos, Carlos/B-8460-2015; Herrera-Castillon, Emilio/D-9143-2012	Mirecki-Garrido, Mercedes/0000-0003-0488-6307; Fernandez-Perez, Leandro/0000-0001-7802-465X; Henriquez-Hernandez, Luis Alberto/0000-0003-3237-0316; Bocos, Carlos/0000-0003-0364-5958; Herrera-Castillon, Emilio/0000-0002-8152-787X; Norstedt, Gunnar/0000-0002-7759-3241	Spanish Ministry of Science and Innovation; European Regional Development Fund-European Social Fund [SAF2003-02117, SAF2006-07824]; Canary Islands Government (ACIISI) [PI2007/033]; Novo Nordisk Foundation; MCYT [SAF2003-02117]; ACIISI-FSE [SE-10/13]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund-European Social Fund; Canary Islands Government (ACIISI); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACIISI-FSE	This work was supported by grants-in-aid to LF-P from the Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund (SAF2003-02117 and SAF2006-07824) and Canary Islands Government (ACIISI; PI2007/033). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: AF-M is supported by the Novo Nordisk Foundation. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.; The excellent technical assistance of M. Morante and C. J. Mateos-Diaz is greatly appreciated. R.S-F was recipient of pre-doctoral fellowships from the MCYT (SAF2003-02117) and ACIISI-FSE (SE-10/13) and M.M-G and L.H-H were recipients from University of Las Palmas de GC and MEC (AP2001-3499), respectively.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Angelin B, 2010, CURR OPIN LIPIDOL, V21, P499, DOI 10.1097/MOL.0b013e3283402e9c; Boersma B, 1997, ENDOCR REV, V18, P646, DOI 10.1210/er.18.5.646; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; CALVO R, 1990, J CLIN INVEST, V86, P889, DOI 10.1172/JCI114790; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chen LL, 2011, METABOLISM, V60, P569, DOI 10.1016/j.metabol.2010.05.014; Chen Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1856, DOI 10.1152/ajpendo.00581.2006; COOKE PS, 1991, ENDOCRINOLOGY, V129, P244, DOI 10.1210/endo-129-1-244; COOPER DS, 1984, ENDOCRINOLOGY, V114, P786, DOI 10.1210/endo-114-3-786; DAVENPORT JW, 1976, DEV PSYCHOBIOL, V9, P67, DOI 10.1002/dev.420090110; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; de GROOT C. A., 1963, ACTA ENDOCRINOL, V42, P423; DEESCOBAR GM, 1988, ENDOCRINOLOGY, V122, P1521, DOI 10.1210/endo-122-4-1521; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Fang XX, 1998, ARCH BIOCHEM BIOPHYS, V349, P138, DOI 10.1006/abbi.1997.0406; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser A, 2008, AM J EPIDEMIOL, V168, P179, DOI 10.1093/aje/kwn106; GonzalezManchon C, 1997, DNA CELL BIOL, V16, P533, DOI 10.1089/dna.1997.16.533; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209; Ho KKY, 2006, FRONT HORM RES, V35, P115, DOI 10.1159/000094314; Holness MJ, 2006, CURR OPIN CLIN NUTR, V9, P482, DOI 10.1097/01.mco.0000232912.69236.e0; Hoogerbrugge N, 1996, METABOLISM, V45, P680, DOI 10.1016/S0026-0495(96)90131-6; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YF, 2010, HORM RES PAEDIAT, V74, P106, DOI 10.1159/000313374; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; Kirby JD, 1997, ENDOCRINOLOGY, V138, P2713, DOI 10.1210/en.138.7.2713; Klieverik LP, 2009, P NATL ACAD SCI USA, V106, P5966, DOI 10.1073/pnas.0805355106; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Larsen PR, 2009, NAT CLIN PRACT ENDOC, V5, P1, DOI 10.1038/ncpendmet1025; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; LEE MMC, 1969, AM J ANAT, V124, P239, DOI 10.1002/aja.1001240207; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; Marino R, 2008, ENDOCRINOLOGY, V149, P1820, DOI 10.1210/en.2007-0993; MEYER JH, 1963, J NUTR, V80, P343, DOI 10.1093/jn/80.4.343; Moreno B, 1997, ENDOCRINOLOGY, V138, P1194, DOI 10.1210/en.138.3.1194; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Mullis PE, 1999, MOL CELL ENDOCRINOL, V147, P17, DOI 10.1016/S0303-7207(98)00232-9; NANTOSALONEN K, 1991, ENDOCRINOLOGY, V129, P2563; NANTOSALONEN K, 1993, ENDOCRINOLOGY, V132, P781, DOI 10.1210/en.132.2.781; NESS GC, 1995, ARCH BIOCHEM BIOPHYS, V323, P404, DOI 10.1006/abbi.1995.0061; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; PEAKE GT, 1973, ENDOCRINOLOGY, V92, P487, DOI 10.1210/endo-92-2-487; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; RASMUSSEN MH, 1994, METABOLISM, V43, P315, DOI 10.1016/0026-0495(94)90099-X; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz JI, 1997, J LIPID RES, V38, P1482; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; SAMUELS MH, 1989, ENDOCRINOLOGY, V124, P2277, DOI 10.1210/endo-124-5-2277; Schaefer F, 2001, J CLIN INVEST, V108, P467, DOI 10.1172/JCI200111895; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; VLAHCEVIC ZR, 1991, HEPATOLOGY, V13, P590, DOI 10.1002/hep.1840130331; Vujovic M, 2009, ENDOCRINOLOGY, V150, P2940, DOI 10.1210/en.2008-1085; Wang YT, 2002, BIOCHEM J, V361, P391, DOI 10.1042/bj3610391; Wang YT, 2001, J BIOL CHEM, V276, P23838, DOI 10.1074/jbc.M102166200; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Xiong SB, 1998, P NATL ACAD SCI USA, V95, P12260, DOI 10.1073/pnas.95.21.12260; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002	82	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37386	10.1371/journal.pone.0037386	http://dx.doi.org/10.1371/journal.pone.0037386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22666351	Green Published, gold			2022-12-25	WOS:000305341300108
J	He, GA; Sun, DX; Ou, ZY; Ding, AH				He, Guoan; Sun, Dongxu; Ou, Zhiying; Ding, Aihao			The Protein Zfand5 Binds and Stabilizes mRNAs with AU-rich Elements in Their 3 '-Untranslated Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSFERRIN RECEPTOR; GENE-REGULATION; CANCER CELLS; C-FOS; TRISTETRAPROLIN; ACTIVATION; ALPHA; DEADENYLATION; TURNOVER	AU-rich elements (AREs) in the 3'-UTR of unstable transcripts play a vital role in the regulation of many inflammatory mediators. To identify novel ARE-dependent gene regulators, we screened a human leukocyte cDNA library for candidates that enhanced the activity of a luciferase reporter bearing the ARE sequence from TNF (ARE(TNF)). Among 171 hits, we focused on Zfand5 (zinc finger, AN1-type domain 5), a 23-kDa protein containing two zinc finger domains. Zfand5 expression was induced in macrophages in response to IFN gamma and Toll-like receptor ligands. Knockdown of Zfand5 in macrophages decreased expression of ARE class II transcripts TNF and COX2, whereas overexpression stabilized TNF mRNA by suppressing deadenylation. Zfand5 specifically bound to ARE(TNF) mRNA and competed with tristetraprolin, a protein known to bind and destabilize class II ARE-containing RNAs. Truncation studies indicated that both zinc fingers of Zfand5 contributed to its mRNA-stabilizing function. These findings add Zfand5 to the growing list of RNA-binding proteins and suggest that Zfand5 can enhance ARE-containing mRNA stability by competing with tristetraprolin for mRNA binding.	[He, Guoan; Ding, Aihao] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10065 USA; [Ding, Aihao] Cornell Univ, Grad Program Immunol & Microbial Pathogenesis, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Sun, Dongxu] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Ou, Zhiying] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Cornell University; Cornell University; Cleveland Clinic Foundation	Ding, AH (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10065 USA.	ahding@med.cornell.edu			National Institutes of Health [AI030165]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030165, R29AI030165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI030165 (to A. D.). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixit AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020921; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Gingerich Timothy J., 2004, Animal Health Research Reviews, V5, P49, DOI [10.1079/AHR200460, 10.1079/AHRR200460]; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HAN JH, 1991, BIOCHIM BIOPHYS ACTA, V1090, P22, DOI 10.1016/0167-4781(91)90032-H; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Hishiya A, 2005, J RECEPT SIG TRANSD, V25, P199, DOI 10.1080/10799890500240781; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; LUDWIG LB, 1995, NUCLEIC ACIDS RES, V23, P3792, DOI 10.1093/nar/23.18.3792; MICHAEL WM, 1995, CELL, V83, P415; Milone J, 2004, RNA, V10, P448, DOI 10.1261/rna.5180304; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Scott DA, 1998, GENE, V215, P461, DOI 10.1016/S0378-1119(98)00316-3; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	53	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24967	24977		10.1074/jbc.M112.362020	http://dx.doi.org/10.1074/jbc.M112.362020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665488	Green Published, hybrid			2022-12-25	WOS:000306651700010
J	Karacosta, LG; Foster, BA; Azabdaftari, G; Feliciano, DM; Edelman, AM				Karacosta, Loukia G.; Foster, Barbara A.; Azabdaftari, Gissou; Feliciano, David M.; Edelman, Arthur M.			A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MOLECULAR-CLONING; EXTRACELLULAR CALCIUM; IN-VIVO; ACTIVATION; CELLS; CALMODULIN; BETA; CASCADE; PHOSPHORYLATION	The androgen receptor (AR) plays a critical role in prostate cancer (PCa) progression, however, the molecular mechanisms by which the AR regulates cell proliferation in androgen-dependent and castration-resistant PCa are incompletely understood. We report that Ca2+/calmodulin-dependent kinase kinase 2 (CaMKK2) expression increases and becomes nuclear or perinuclear in advanced PCa. In the TRAMP (transgenic adenocarcinoma of mouse prostate) model of PCa, CaMKK2 expression increases with PCa progression with many cells exhibiting nuclear staining. CaMKK2 expression is higher in human castration-resistant tumor xenografts compared with androgen-responsive xenografts and is markedly higher in the AR-expressing, tumorigenic cell line LNCaP compared with cell lines that are AR-nonexpressing and/or nontumorigenic. In LNCaP cells, dihydrotestosterone induced CaMKK2 mRNA and protein expression and translocation of CaMKK2 to the nucleus. Conversely, androgen withdrawal suppressed CaMKK2 expression. Knockdown of CaMKK2 expression by RNAi reduced LNCaP cell proliferation and increased percentages of cells in G1 phase, whereas correspondingly reducing percentages in S phase, of the cell cycle. CaMKK2 knockdown reduced expression of the AR target gene prostate-specific antigen at both mRNA and protein levels, AR transcriptional activity driven by androgen responsive elements from the prostate-specific probasin gene promoter and levels of the AR-regulated cell cycle proteins, cyclin D1 and hyperphosphorylated Rb. Our results suggest that in PCa progression, CaMKK2 and the AR are in a feedback loop in which CaMKK2 is induced by the AR to maintain AR activity, AR-dependent cell cycle control, and continued cell proliferation.	[Karacosta, Loukia G.; Feliciano, David M.; Edelman, Arthur M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Azabdaftari, Gissou] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Edelman, AM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	aedelman@buffalo.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	National Institutes of Health [NS50385, CA095367]; University at Buffalo Foundation; RPCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [R01CA095367, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University at Buffalo Foundation; RPCI Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS50385 (to A. M. E.) and CA095367 (to B. A. F.) and University at Buffalo Foundation and RPCI Cancer Center Support Grant CA016056.	Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Bluemn EG, 2012, CURR OPIN ONCOL, V24, P251, DOI 10.1097/CCO.0b013e32835105b3; BOYNTON AL, 1977, CANCER RES, V37, P2657; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Colomer J., 2007, V45, P169; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Feliciano DM, 2009, J BIOL CHEM, V284, P26466, DOI 10.1074/jbc.M109.027680; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Gregory CW, 2001, CANCER RES, V61, P2892; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahl CR, 2004, J BIOL CHEM, V279, P15411, DOI 10.1074/jbc.M312543200; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lozano JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-109; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Nagabhushan M, 1996, CANCER RES, V56, P3042; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schiewer MJ, 2012, MOL CELL ENDOCRINOL, V352, P34, DOI 10.1016/j.mce.2011.06.033; Schmitt JM, 2010, MOL CELL BIOCHEM, V335, P155, DOI 10.1007/s11010-009-0252-9; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; STEINSAPIR J, 1991, BIOCHEM BIOPH RES CO, V179, P90, DOI 10.1016/0006-291X(91)91338-D; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; TILLEY WD, 1990, CANCER RES, V50, P5382; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Tomlins Scott A., 2007, P247, DOI 10.1007/978-1-59745-224-3_14; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Welsh JB, 2001, CANCER RES, V61, P5974; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yang CS, 2007, MOL CELL BIOL, V27, P3390, DOI 10.1128/MCB.02411-06; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	57	54	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24832	24843		10.1074/jbc.M112.370783	http://dx.doi.org/10.1074/jbc.M112.370783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654108	Green Published, hybrid			2022-12-25	WOS:000306651100076
J	Nguyen, TA; Sarkar, P; Veetil, JV; Koushik, SV; Vogel, SS				Nguyen, Tuan A.; Sarkar, Pabak; Veetil, Jithesh V.; Koushik, Srinagesh V.; Vogel, Steven S.			Fluorescence Polarization and Fluctuation Analysis Monitors Subunit Proximity, Stoichiometry, and Protein Complex Hydrodynamics	PLOS ONE			English	Article							ENERGY-TRANSFER-FRET; KINASE-II; CORRELATION SPECTROSCOPY; LIVING CELLS; CAM KINASE; CALMODULIN; IDENTIFICATION; MICROSCOPY; EFFICIENCY; VARIANT	Forster resonance energy transfer (FRET) microscopy is frequently used to study protein interactions and conformational changes in living cells. The utility of FRET is limited by false positive and negative signals. To overcome these limitations we have developed Fluorescence Polarization and Fluctuation Analysis (FPFA), a hybrid single-molecule based method combining time-resolved fluorescence anisotropy (homo-FRET) and fluorescence correlation spectroscopy. Using FPFA, homo-FRET (a 1-10 nm proximity gauge), brightness (a measure of the number of fluorescent subunits in a complex), and correlation time (an attribute sensitive to the mass and shape of a protein complex) can be simultaneously measured. These measurements together rigorously constrain the interpretation of FRET signals. Venus based control-constructs were used to validate FPFA. The utility of FPFA was demonstrated by measuring in living cells the number of subunits in the alpha-isoform of Venus-tagged calcium-calmodulin dependent protein kinase-II (CaMKII alpha) holoenzyme. Brightness analysis revealed that the holoenzyme has, on average, 11.9+/-1.2 subunit, but values ranged from 10-14 in individual cells. Homo-FRET analysis simultaneously detected that catalytic domains were arranged as dimers in the dodecameric holoenzyme, and this paired organization was confirmed by quantitative hetero-FRET analysis. In freshly prepared cell homogenates FPFA detected only 10.2+/-1.3 subunits in the holoenzyme with values ranging from 9-12. Despite the reduction in subunit number, catalytic domains were still arranged as pairs in homogenates. Thus, FPFA suggests that while the absolute number of subunits in an auto-inhibited holoenzyme might vary from cell to cell, the organization of catalytic domains into pairs is preserved.	[Nguyen, Tuan A.; Sarkar, Pabak; Veetil, Jithesh V.; Koushik, Srinagesh V.; Vogel, Steven S.] NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, Natl Inst Hlth, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Nguyen, TA (corresponding author), NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, Natl Inst Hlth, Rockville, MD 20852 USA.	stevevog@mail.nih.gov	Veetil, Jithesh/G-5185-2012	Vogel, Steven/0000-0002-3005-2667	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program of the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Becker W, 2005, ADV TIME CORRELATED; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bevington PR, 1969, DATA REDUCTION ERROR; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chen Y, 2010, METHOD ENZYMOL, V472, P345, DOI 10.1016/S0076-6879(10)72026-7; Clegg RM, 2009, LAB TECH BIOCHEM MOL, V33, P1, DOI 10.1016/S0075-7535(08)00001-6; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; ELSON EL, 1975, ANNU REV BIOPHYS BIO, V4, P311, DOI 10.1146/annurev.bb.04.060175.001523; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2009, LAB TECH BIOCHEM MOL, V33, P171, DOI 10.1016/S0075-7535(08)00005-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Muller JD, 2003, METHOD ENZYMOL, V361, P69; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sahoo H, 2011, CHEMPHYSCHEM, V12, P532, DOI 10.1002/cphc.201000776; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; Sarkar P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3156842; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Vogel SS, 2010, FLIM MICROSCOPY BIOL, P245; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wang P, 2000, FEBS LETT, V475, P107, DOI 10.1016/S0014-5793(00)01634-3; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Williams DJ, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00181; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	54	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38209	10.1371/journal.pone.0038209	http://dx.doi.org/10.1371/journal.pone.0038209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666486	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400102
J	Page, AL; Alberti, KP; Mondonge, V; Rauzier, J; Quilici, ML; Guerin, PJ				Page, Anne-Laure; Alberti, Kathryn P.; Mondonge, Vital; Rauzier, Jean; Quilici, Marie-Laure; Guerin, Philippe J.			Evaluation of a Rapid Test for the Diagnosis of Cholera in the Absence of a Gold Standard	PLOS ONE			English	Article							O1; SPECIFICITY; SENSITIVITY	Background: Early detection and confirmation of cholera outbreaks are crucial for rapid implementation of control measures. Because cholera frequently affects regions with limited laboratory resources, rapid diagnostic tests (RDT) designed for field conditions are important to enhance rapid response. Stool culture remains the "gold standard'' for cholera diagnosis; however, its lack of sensitivity may lead to underestimation of test specificity. We evaluated the Crystal VC (R) immunochromatographic test (Span Diagnostics, India) for cholera diagnosis using a modified reference standard that combines culture-dependent and independent assays, or a Bayesian latent class model (LCM) analysis. Methodology/Principal Findings: The study was conducted during a cholera epidemic in 2008, in Lubumbashi, Democratic Republic of Congo. Stools collected from 296 patients were used to perform the RDT on site and sent to Institut Pasteur, Paris, for bacterial culture. In comparison with culture as the gold standard, the RDT showed good sensitivity (92.2%; 95% CI: 86.8%-95.9%) but poor specificity when used by a trained laboratory technician (70.6%; 95% CI: 60.7%-79.2%) or by clinicians with no specific test training (60.4%, 95% CI: 50.2%-70.0%). The specificity of the test performed by the laboratory technician increased to 88.6% (95% CI: 78.7-94.9) when PCR was combined with culture results as the reference standard, and to 85.0% (95% CI: 70.4-99.2), when the Bayesian LCM analysis was used for performance evaluation. In both cases, the sensitivity remained high. Conclusion: Using an improved reference standard or appropriate statistical methods for diagnostic test evaluations in the absence of a gold standard, we report better performance of the Crystal VC (R) RDT than previously published. Our results confirm that this test can be used for early outbreak detection or epidemiological surveillance, key components of efficient global cholera control. Our analysis also highlights the importance of improving evaluations of RDT when no reliable gold standard is available.	[Page, Anne-Laure; Alberti, Kathryn P.; Guerin, Philippe J.] Epictr, Paris, France; [Mondonge, Vital] Minist Hlth, Kinshasa, DEM REP CONGO; [Rauzier, Jean; Quilici, Marie-Laure] Ctr Natl Reference Vibr & Cholera, Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Guerin, Philippe J.] Univ Oxford, CCVTM, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Page, AL (corresponding author), Epictr, Paris, France.	anne-laure.page@epicentre.msf.org	Guerin, Philippe/AAH-8873-2021; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres	Medecins Sans Frontieres	This research was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P325; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Cavallaro EC, 2009, TROP MED INT HLTH; Dendukuri N, 2010, STAT MED, V29, P2688, DOI 10.1002/sim.4037; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Fournier J. M., 1992, LAB METHODS DIAGNOSI, P59; Garrett ES, 2002, STAT MED, V21, P1289, DOI 10.1002/sim.1105; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Page AL, 2011, J CLIN MICROBIOL, V49, P3021, DOI 10.1128/JCM.00514-11; Spiegelhalter DJ, 1996, BUGS BAYESIAN INFERE; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17; World Health Organization, 2005, TREATM DIARRH MAN PH	20	38	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37360	10.1371/journal.pone.0037360	http://dx.doi.org/10.1371/journal.pone.0037360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666350	gold, Green Published			2022-12-25	WOS:000305353400025
J	Agundez, JA; Garcia-Martin, E; Maestro, ML; Cuenca, F; Martinez, C; Ortega, L; Carballo, M; Vidaurreta, M; Agreda, M; Diaz-Zelaya, G; Suarez, A; Diaz-Rubio, M; Ladero, JM				Agundez, Jose A.; Garcia-Martin, Elena; Maestro, Maria L.; Cuenca, Francisca; Martinez, Carmen; Ortega, Luis; Carballo, Miguel; Vidaurreta, Marta; Agreda, Marta; Diaz-Zelaya, Gabriela; Suarez, Avelina; Diaz-Rubio, Manuel; Ladero, Jose M.			Relation of IL28B Gene Polymorphism with Biochemical and Histological Features in Hepatitis C Virus-Induced Liver Disease	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOME-WIDE-ASSOCIATION; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GENOTYPE; FIBROSIS; THERAPY; CLEARANCE; INFLAMMATION; PROGRESSION	Background/Aims: Polymorphism at the IL28B gene may modify the course of hepatitis C virus (HCV) chronic infection. Our aim was to study the influence of IL28B rs12979860 gene polymorphism on the biochemistry and pathology of HCV-induced disease in the clinical course from mild chronic hepatitis C to hepatocellular carcinoma. Methods: We have determined the rs12979860 single nucleotide polymorphism (SNP) upstream IL28B gene in two groups of patients with HCV-induced chronic liver disease: 1) 268 patients (159 men) with biopsy-proven chronic hepatitis C, to analyse its relation with biochemical, virological and histological features; and 2) 134 patients (97 men) with HCV-related hepatocellular carcinoma. The distribution of the analysed SNP in hepatocellular carcinoma patients was compared with that found in untreated chronic hepatitis C patients. All patients were white and most were Spaniards. Results: In multivariate analysis ALT values were higher (P = 0.001) and GGT values were lower (P, 0.001) in chronic hepatitis C patients homozygotes for the major rs12979860C allele as compared with carriers of the mutated rs12979860T allele. Steatosis was more frequent (Odds ratio = 1.764, 95% C.I. 1.053-2.955) and severe (P = 0.026) in carriers of the rs12979860T allele. No relation was found between the analysed SNP and METAVIR scores for necroinflammation and fibrosis, and there were no differences in the distribution of the analysed SNP between hepatocellular carcinoma and untreated chronic hepatitis C patients. Conclusion: The IL28B rs12979860 polymorphism correlates with the biochemical activity and the presence and severity of liver steatosis in chronic hepatitis C.	[Agundez, Jose A.; Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Maestro, Maria L.; Vidaurreta, Marta] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Clin Biochem, Genom Unit, Madrid, Spain; [Cuenca, Francisca; Agreda, Marta] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Gastroenterol, Liver Unit, Madrid, Spain; [Ortega, Luis; Diaz-Zelaya, Gabriela] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Pathol, Madrid, Spain; [Carballo, Miguel] Hosp Terrassa, Mol Genet Lab, Terrassa, Barcelona, Spain; [Suarez, Avelina] Hosp Clin San Carlos IdISCC, Serv Clin Microbiol, Madrid, Spain; [Diaz-Rubio, Manuel] Univ Complutense, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Hosp Clin San Carlos, Dept Med,Sch Med,Liver Unit,Serv Gastreoenterol, E-28040 Madrid, Spain	Universidad de Extremadura; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Agundez, JA (corresponding author), Univ Extremadura, Dept Pharmacol, Caceres, Spain.	jladero.hcsc@salud.madrid.org	García-Martin, Elena/H-9828-2016; Agúndez, José A. G./A-5503-2008	García-Martin, Elena/0000-0002-8094-046X; Agúndez, José A. G./0000-0001-6895-9160; Vidaurreta, Marta/0000-0002-7790-6252; Ortega, Luis/0000-0002-7987-8531	FIS [PS09/00943, PS09/00469]; RETICS [RD07/0064]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain; Junta de Extremadura, Spain [GR10068]; FEDER funds; European Union	FIS(Instituto de Salud Carlos III); RETICS; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; FEDER funds(European Commission); European Union(European Commission)	Financial support: FIS PS09/00943, PS09/00469, and RETICS RD07/0064 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Ahlenstiel G, 2010, J GASTROENTEROL, V45, P903, DOI 10.1007/s00535-010-0287-4; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Asahina Y, 2011, J HEPATOL, V54, pS37, DOI 10.1016/S0168-8278(11)60084-6; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cuenca F, 2010, REV ESP ENFERM DIG, V102, P234, DOI 10.4321/s1130-01082010000400003; Di Marco V, 2011, HAEMATOLOGICA; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Kanzler S, 2001, J VIRAL HEPATITIS, V8, P430, DOI 10.1046/j.1365-2893.2001.00314.x; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; Lencioni R, 2011, J HEPATOL, V54, P184, DOI 10.1016/j.jhep.2010.07.050; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; Martinez C, 2007, J INFECT DIS, V195, P1320, DOI 10.1086/513569; Maruoka D, 2012, J GASTROEN HEPATOL, V27, P291, DOI 10.1111/j.1440-1746.2011.06871.x; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Minton EJ, 1998, J INFECT DIS, V178, P39, DOI 10.1086/514258; Miura M, 2011, HEPATOL INT; Ohnishi M, 2012, J GASTROENTEROL; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ren S, 2012, CANC IMMUNOL IMMUNOT; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thompson AJ, 2010, HEPATOLOGY, V52, p1220A; Thompson AJ, 2010, HEPATOLOGY, V52, p437A; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Trapero-Marugan M, 2011, WORLD J GASTROENTERO, V17, P493, DOI 10.3748/wjg.v17.i4.493; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang H, 2005, WORLD J GASTROENTERO, V11, P1929, DOI 10.3748/wjg.v11.i13.1929; Williams MJ, 2011, J VIRAL HEPATITIS, V18, P17, DOI 10.1111/j.1365-2893.2009.01262.x; Witthoft T, 2007, J VIRAL HEPATITIS, V14, P788, DOI 10.1111/j.1365-2893.2007.00871.x	51	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37998	10.1371/journal.pone.0037998	http://dx.doi.org/10.1371/journal.pone.0037998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666430	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600049
J	Bertucci, F; Lagarde, A; Ferrari, A; Finetti, P; Charafe-Jauffret, E; Van Laere, S; Adelaide, J; Viens, P; Thomas, G; Birnbaum, D; Olschwang, S				Bertucci, Francois; Lagarde, Arnaud; Ferrari, Anthony; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Van Laere, Steven; Adelaide, Jose; Viens, Patrice; Thomas, Gilles; Birnbaum, Daniel; Olschwang, Sylviane			8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer	PLOS ONE			English	Article							LONG-RANGE INTERACTION; COLORECTAL-CANCER; PROSTATE-CANCER; MYC; EXPRESSION; RS6983267; VARIANT; LOCI	Background: Association studies have identified low penetrance alleles that participate to the risk of cancer development. The 8q24 chromosomal region contains several such loci involved in various cancers that have been recently studied for their propensity to influence the clinical outcome of prostate cancer. We investigated here two 8q24 breast and colon cancer risk alleles in the close vicinity of the MYC gene for their role in the occurrence of distant metastases. Methodology/Principal findings: A retrospective series of 449 patients affected with breast or colon adenocarcinoma was genotyped for the rs13281615 and/or rs6983267 SNPs. Statistical analyses were done using the survival package v2.30 in the R software v2.9.1. The two SNPs did not influence the development of distant metastases of colon cancer; rs6983267 showed a mild effect on breast cancer. However, this effect was greatly emphasized when considering inflammatory breast cancer (IBC) solely. Replicated on a larger and independent series of IBC the contribution of the genotype to the metastatic risk of IBC was found an independent predictor of outcome (p = 2e-4; OR 8.3, CI95: 2.6-33). Conclusions/Significance: Our study shows first that the monitoring of this specific germline variation may add a substantial tool for IBC prognostication, an aggressive disease that evolves towards distant metastases much more frequently than non-IBC and for which no reliable prognostic factor is available in medical practice. Second, it more generally suggests that risk alleles, while associated with low susceptibility, could correlate with a high risk of metastasis.	[Bertucci, Francois; Lagarde, Arnaud; Ferrari, Anthony; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Adelaide, Jose; Viens, Patrice; Birnbaum, Daniel; Olschwang, Sylviane] Inst J Paoli I Calmettes, Dept Mol Oncol, Ctr Rech Cancerol Marseille, F-13009 Marseille, France; [Bertucci, Francois; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Adelaide, Jose; Birnbaum, Daniel; Olschwang, Sylviane] INSERM, UMR 1068, Marseille, France; [Bertucci, Francois; Charafe-Jauffret, Emmanuelle; Viens, Patrice] Aix Marseille Univ, Marseille, France; [Ferrari, Anthony; Thomas, Gilles] Ctr Leon Berard, Fdn Synergie Lyon Canc, F-69373 Lyon, France; [Van Laere, Steven] Univ Hosp, Translat Canc Res Grp, Antwerp, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Centre Leon Berard	Bertucci, F (corresponding author), Inst J Paoli I Calmettes, Dept Mol Oncol, Ctr Rech Cancerol Marseille, F-13009 Marseille, France.	sylviane.olschwang@inserm.fr	Lagarde, Arnaud/Z-1811-2019; Viens, Patrice/Q-8499-2018; ADELAIDE, José JA/O-4390-2017; lagarde, arnaud/M-3364-2016; lagarde, arnaud/AAC-8382-2020; Olschwang, Sylviane/G-2716-2013; Van Laere, Steven/GQA-8872-2022; Finetti, Pascal/O-8669-2017; Charafe-Jauffret, emmanuelle/P-6009-2017	Viens, Patrice/0000-0003-1511-1048; ADELAIDE, José JA/0000-0003-4364-9857; lagarde, arnaud/0000-0003-1619-3452; lagarde, arnaud/0000-0003-1619-3452; Olschwang, Sylviane/0000-0001-7078-3029; Van Laere, Steven/0000-0002-2640-0040; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299	French National Cancer Institute INCa	French National Cancer Institute INCa(Institut National du Cancer (INCA) France)	Funding provided by French National Cancer Institute INCa: this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Ahn J, 2011, CLIN CANCER RES, V17, P1075, DOI 10.1158/1078-0432.CCR-10-0881; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Bertucci F, 2010, CANCER-AM CANCER SOC, V116, P2783, DOI 10.1002/cncr.25165; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Glinskii AB, 2011, CELL CYCLE, V10, P3571, DOI 10.4161/cc.10.20.17842; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schlange T, 2007, BREAST CANC RES GENE, V41, P885; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09	17	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37943	10.1371/journal.pone.0037943	http://dx.doi.org/10.1371/journal.pone.0037943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666420	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600047
J	Hustedt, JW; Christie, C; Hustedt, MM; Esposito, D; Vazquez, M				Hustedt, Joshua W.; Christie, Celia; Hustedt, Madison M.; Esposito, Daina; Vazquez, Marietta			Seroepidemiology of Human Bocavirus Infection in Jamaica	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS; YOUNG-CHILDREN; IDENTIFICATION; CORONAVIRUS; PARVOVIRUS; PNEUMONIA; ETIOLOGY	Background: Human bocavirus (HBoV) is a newly identified human parvovirus. HBoV is associated with upper and lower respiratory tract infections and gastroenteritis in children. Little is known about the seroepidemiology of HBoV in populations in the Caribbean. Methods: In a cross-sectional study conducted at the University Hospital of the West Indies in Kingston, Jamaica, 287 blood samples were collected from pediatric patients and tested for the presence of HBoV-specific antibody using a virus-like-particle based enzyme-linked immunosorbent assay (ELISA). Results: HBoV-specific antibodies were found to be present in 220/287 (76.7%) of samples collected from the pediatric population. Seroprevalence of HBoV was highest in those >= 2 years old. The seroepidemiological profile suggests that most children are exposed to HBoV during the first two years of life in Jamaica. Conclusion: HBoV infection is common in children in Jamaica. HBoV seroprevalence rates in the Caribbean are similar to those previously reported in other areas of the world.	[Hustedt, Joshua W.; Hustedt, Madison M.; Esposito, Daina; Vazquez, Marietta] Yale Univ, Sch Med, Dept Pediat, Div Infect Dis, New Haven, CT 06510 USA; [Christie, Celia] Univ W Indies, Dept Pediat, Kingston 7, Jamaica	Yale University; University West Indies Mona Jamaica	Hustedt, JW (corresponding author), Yale Univ, Sch Med, Dept Pediat, Div Infect Dis, New Haven, CT 06510 USA.	joshua.hustedt@yale.edu		Hustedt, Joshua/0000-0002-9110-7115; Christie, Celia DC/0000-0002-8981-3934	Yale University; Infectious Disease Society of America	Yale University; Infectious Disease Society of America	JWH received a Wilbur Downs International Student Travel Fellowship from Yale University and a Medical Scholars award from the Infectious Disease Society of America to complete this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Hustedt Joshua W., 2010, Yale Journal of Biology and Medicine, V83, P193; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Kaplan NM, 2006, EMERG INFECT DIS, V12, P1418, DOI 10.3201/eid1209.060417; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Mathers C, 2008, GLOBAL DURDEN DIS 20; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Smuts H, 2006, EMERG INFECT DIS, V12, P1457, DOI 10.3201/eid1209.051616; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van Woensel JBM, 2003, BMJ-BRIT MED J, V327, P36, DOI 10.1136/bmj.327.7405.36; VEJTORP M, 1981, ACTA PATH MICRO IM B, V89, P369; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	33	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38206	10.1371/journal.pone.0038206	http://dx.doi.org/10.1371/journal.pone.0038206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666484	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349600071
J	Wilson, CE; Palermo, R; Brock, J				Wilson, C. Ellie; Palermo, Romina; Brock, Jon			Visual Scan Paths and Recognition of Facial Identity in Autism Spectrum Disorder and Typical Development	PLOS ONE			English	Article							FACE RECOGNITION; EYE-MOVEMENTS; WILLIAMS-SYNDROME; GAZE DIRECTION; CHILDREN; INDIVIDUALS; PERCEPTION; DISCRIMINATION; PROSOPAGNOSIA; FIXATION	Background: Previous research suggests that many individuals with autism spectrum disorder (ASD) have impaired facial identity recognition, and also exhibit abnormal visual scanning of faces. Here, two hypotheses accounting for an association between these observations were tested: i) better facial identity recognition is associated with increased gaze time on the Eye region; ii) better facial identity recognition is associated with increased eye-movements around the face. Methodology and Principal Findings: Eye-movements of 11 children with ASD and 11 age-matched typically developing (TD) controls were recorded whilst they viewed a series of faces, and then completed a two alternative forced-choice recognition memory test for the faces. Scores on the memory task were standardized according to age. In both groups, there was no evidence of an association between the proportion of time spent looking at the Eye region of faces and age-standardized recognition performance, thus the first hypothesis was rejected. However, the `Dynamic Scanning Index' which was incremented each time the participant saccaded into and out of one of the core-feature interest areas - was strongly associated with age-standardized face recognition scores in both groups, even after controlling for various other potential predictors of performance. Conclusions and Significance: In support of the second hypothesis, results suggested that increased saccading between core-features was associated with more accurate face recognition ability, both in typical development and ASD. Causal directions of this relationship remain undetermined.	[Wilson, C. Ellie; Brock, Jon] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; [Wilson, C. Ellie] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London WC2R 2LS, England; [Palermo, Romina] Univ Western Australia, Sch Psychol, Nedlands, WA 6009, Australia; [Palermo, Romina; Brock, Jon] Australian Res Council, Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia	Macquarie University; University of London; King's College London; University of Western Australia	Wilson, CE (corresponding author), Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia.	ellie.wilson@kcl.ac.uk	Palermo, Romina/G-2533-2014	Palermo, Romina/0000-0002-8678-4592; Brock, Jon/0000-0002-9655-3667	Macquarie University Research Excellence Scholarship; ARC Australian Research Fellowship [DP098466]	Macquarie University Research Excellence Scholarship; ARC Australian Research Fellowship(Australian Research Council)	Ellie Wilson was supported by a Macquarie University Research Excellence Scholarship. Jon Brock was supported by an ARC Australian Research Fellowship (DP098466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Bishop D. V. M, 2003, TEST RECEPTION GRAMM; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Brock J, 2007, CLIN LINGUIST PHONET, V21, P673, DOI 10.1080/02699200701541433; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Faja S, 2008, DEV NEUROPSYCHOL, V33, P1, DOI 10.1080/87565640701729573; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hauck M, 1998, CHILD NEUROPSYCHOL, V4, P187, DOI 10.1076/chin.4.3.187.3174; Hedley D, 2011, AUTISM RES, V4, P449, DOI 10.1002/aur.214; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hills PJ, 2011, Q J EXP PSYCHOL, V64, P17, DOI 10.1080/17470218.2010.537926; Hood BM, 2003, DEVELOPMENTAL SCI, V6, P67, DOI 10.1111/1467-7687.00256; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jeffrey L, 2004, AUST J PSYCHOL, V56, P119; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 1999, J AUTISM DEV DISORD, V29, P499, DOI 10.1023/A:1022299920240; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2001, AUTISM DIAGNOSTIC OB; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; McKone E, 2010, P NATL ACAD SCI USA, V107, P4795, DOI 10.1073/pnas.1000567107; McKone E, 2009, VISION RES, V49, P268, DOI 10.1016/j.visres.2008.10.020; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Rotshtein P, 2007, J COGNITIVE NEUROSCI, V19, P1435, DOI 10.1162/jocn.2007.19.9.1435; Rutherford MD, 2007, VISION RES, V47, P2099, DOI 10.1016/j.visres.2007.01.029; Rutter M., 2003, SCQ SOCIAL COMMUNICA; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Serra M, 2003, J AUTISM DEV DISORD, V33, P303, DOI 10.1023/A:1024458618172; Smith AD, 2006, DEVELOPMENTAL SCI, V9, P465, DOI 10.1111/j.1467-7687.2006.00513.x; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Stephan BCM, 2009, BRAIN COGNITION, V69, P262, DOI 10.1016/j.bandc.2008.07.015; Sterling L, 2008, J AUTISM DEV DISORD, V38, P1011, DOI 10.1007/s10803-007-0477-y; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; Van Belle G, 2010, NEUROPSYCHOLOGIA, V48, P2620, DOI 10.1016/j.neuropsychologia.2010.04.034; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Weschler D., 1999, WESCHLER ABBREVIATED; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Wilson CE, 2010, J INTELL DISABIL RES, V54, P1104, DOI 10.1111/j.1365-2788.2010.01340.x; Wilson CE, 2011, Q J EXP PSYCHOL, V64, P1939, DOI 10.1080/17470218.2011.603052; Wilson CE, 2010, COGN NEUROPSYCHOL, V27, P30, DOI 10.1080/02643294.2010.490207; Yarbus A.L., 1967, EYE MOVEMENT VISION	69	24	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37681	10.1371/journal.pone.0037681	http://dx.doi.org/10.1371/journal.pone.0037681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666378	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349600027
J	Chai, LC; Kong, BH; Elemfareji, OI; Thong, KL				Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin			Variable Carbon Catabolism among Salmonella enterica Serovar Typhi Isolates	PLOS ONE			English	Article							ESCHERICHIA-COLI; FATTY-ACIDS; TYPHIMURIUM; VIRULENCE; STRAINS; IDENTIFICATION; MACROPHAGES; METABOLISM; SEQUENCE; NITROGEN	Background: Salmonella enterica serovar Typhi (S. Typhi) is strictly a human intracellular pathogen. It causes acute systemic (typhoid fever) and chronic infections that result in long-term asymptomatic human carriage. S. Typhi displays diverse disease manifestations in human infection and exhibits high clonality. The principal factors underlying the unique lifestyle of S. Typhi in its human host during acute and chronic infections remain largely unknown and are therefore the main objective of this study. Methodology/Principal Findings: To obtain insight into the intracellular lifestyle of S. Typhi, a high-throughput phenotypic microarray was employed to characterise the catabolic capacity of 190 carbon sources in S. Typhi strains. The success of this study lies in the carefully selected library of S. Typhi strains, including strains from two geographically distinct areas oftyphoid endemicity, an asymptomatic human carrier, clinical stools and blood samples and sewage-contaminated rivers. An extremely low carbon catabolic capacity (27% of 190 carbon substrates) was observed among the strains. The carbon catabolic profiles appeared to suggest that S. Typhi strains survived well on carbon subtrates that are found abundantly in the human body but not in others. The strains could not utilise plant-associated carbon substrates. In addition, alpha-glycerolphosphate, glycerol, L-serine, pyruvate and lactate served as better carbon sources to monosaccharides in the S. Typhi strains tested. Conclusion: The carbon catabolic profiles suggest that S. Typhi could survive and persist well in the nutrient depleted metabolic niches in the human host but not in the environment outside of the host. These findings serve as caveats for future studies to understand how carbon catabolism relates to the pathogenesis and transmission of this pathogen.	[Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin] Univ Malaya, Lab Biomed Sci & Mol Microbiol, Inst Grad Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chai, LC (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	thongkl@um.edu.my	Chai, Lay Ching/A-7761-2011; Kong, Boon Hong/C-2568-2012; Thong, Kwai Lin/B-3946-2009; Kong, Boon Hong/AAU-3157-2021; Thong, Kwai-Lin/Q-2458-2019	Chai, Lay Ching/0000-0001-8280-3226; Kong, Boon Hong/0000-0003-3255-9960; Thong, Kwai-Lin/0000-0001-8557-5185	University of Malaya [UMC/HIR/MOHE/02 [A000002-50001]]	University of Malaya(Universiti Malaya)	The work was supported by grant from University of Malaya UMC/HIR/MOHE/02 [A000002-50001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; Baumler AJ, 1997, J BACTERIOL, V179, P317; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hammer-Jespersen K., 1983, METABOLISM NUCLEOTID, P203; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hughes LA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-4; Ismail A, 2011, MALAYSIAN J PUB HLTH, V11, P4; JENSEN KF, 1975, EUR J BIOCHEM, V51, P253, DOI 10.1111/j.1432-1033.1975.tb03925.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; SIMMONDS RJ, 1981, J CHROMATOGR, V226, P369, DOI 10.1016/S0378-4347(00)86071-5; Skyberg JA, 2006, AVIAN DIS, V50, P77, DOI 10.1637/7417.1; Soto SM, 2006, J MED MICROBIOL, V55, P365, DOI 10.1099/jmm.0.46257-0; Sternfeld L, 1937, J AM CHEM SOC, V59, P2653, DOI 10.1021/ja01291a051; Sternfeld L, 1938, J BACTERIOL, V36, P53, DOI 10.1128/JB.36.1.53-56.1938; Thong KL, 1996, APPL ENVIRON MICROB, V62, P271, DOI 10.1128/AEM.62.1.271-274.1996; THONG KL, 1994, J CLIN MICROBIOL, V32, P1135, DOI 10.1128/JCM.32.5.1135-1141.1994; Utley M, 1998, FEMS MICROBIOL LETT, V163, P129, DOI 10.1016/S0378-1097(98)00162-1; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36201	10.1371/journal.pone.0036201	http://dx.doi.org/10.1371/journal.pone.0036201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662115	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300009
J	Chen, Z; Zeng, MJ; Song, BA; Hou, CR; Hu, DY; Li, XY; Wang, ZC; Fan, HT; Bi, L; Liu, JJ; Yu, DD; Jin, LH; Yang, S				Chen, Zhuo; Zeng, Mengjiao; Song, Baoan; Hou, Chengrui; Hu, Deyu; Li, Xiangyang; Wang, Zhenchao; Fan, Huitao; Bi, Liang; Liu, Jiaju; Yu, Dandan; Jin, Linhong; Yang, Song			Dufulin Activates HrBP1 to Produce Antiviral Responses in Tobacco	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; VISUALIZATION; ARABIDOPSIS; PROTEINS; ETHYLENE; STRESS; HARPIN; ANNOTATION; BLAST2GO	Background: Dufulin is a new antiviral agent that is highly effective against plant viruses and acts by activating systemic acquired resistance (SAR) in plants. In recent years, it has been used widely to prevent and control tobacco and rice viral diseases in China. However, its targets and mechanism of action are still poorly understood. Methodology/Principal Findings: Here, differential in-gel electrophoresis (DIGE) and classical two-dimensional electrophoresis (2-DE) techniques were combined with mass spectrometry (MS) to identify the target of Dufulin. More than 40 proteins were found to be differentially expressed (>= 1.5 fold or <= 1.5 fold) upon Dufulin treatment in Nicotiana tabacum K-326. Based on annotations in the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, these proteins were found to be related to disease resistance. Directed acyclic graph (DAG) analysis of the various pathways demonstrated harpin binding protein-1 (HrBP1) as the target of action of Dufulin. Additionally, western blotting, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR), and real time PCR analyses were also conducted to identify the specific mechanism of action of Dufulin. Our results show that activation of HrBP1 triggers the salicylic acid (SA) signaling pathway and thereby produces antiviral responses in the plant host. A protective assay based on lesion counting further confirmed the antiviral activity of Dufulin. Conclusion: This study identified HrBP1 as a target protein of Dufulin and that Dufulin can activate the SA signaling pathway to induce host plants to generate antiviral responses.	[Chen, Zhuo; Song, Baoan; Hu, Deyu; Li, Xiangyang; Wang, Zhenchao; Fan, Huitao; Bi, Liang; Liu, Jiaju; Yu, Dandan; Jin, Linhong; Yang, Song] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China; [Zeng, Mengjiao] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou, Guangdong, Peoples R China; [Hou, Chengrui] Shanghai Appl Prot Technol Co Ltd, Shanghai, Peoples R China	Guizhou University; South China University of Technology	Chen, Z (corresponding author), Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China.	basong@gzu.edu.cn; fcc.syang@gzu.edu.cn	Chen, Zhuo/AFX-0411-2022; Yang, Song/H-2765-2013	Yang, Song/0000-0003-1301-3030	National Basic Research Program of China [2010CB126105]; National Basic Research Preliminary Program of China [2010CB134504]; National Natural Science Foundation of China [21132003, 20872021]	National Basic Research Program of China(National Basic Research Program of China); National Basic Research Preliminary Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the following funding sources: The National Basic Research Program of China (Nos. 2010CB126105) URL: http://www.973.gov.cn, the National Basic Research Preliminary Program of China (Grant No. 2010CB134504) URL: http://www.973.gov.cn and the National Natural Science Foundation of China (Nos. 21132003, 20872021) URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chen Z, 2008, BIOORGAN MED CHEM, V16, P3076, DOI 10.1016/j.bmc.2007.12.035; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GILLESPIE PG, 1991, P NATL ACAD SCI USA, V88, P2563, DOI 10.1073/pnas.88.6.2563; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; Gopalan S, 2008, BMC RES NOTES, V1, P1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hull Roger, 2002, MATTHEWS PLANT VIROL, p[56, 736]; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li YM, 2008, PLANT BIOTECHNOL J, V6, P301, DOI 10.1111/j.1467-7652.2008.00322.x; Liu FQ, 2006, PHYTOPATHOLOGY, V96, P1052, DOI 10.1094/PHYTO-96-1052; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Midoh N, 1997, J PESTIC SCI, V22, P45; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; SCHNEPPENHEIM R, 1991, ELECTROPHORESIS, V12, P367, DOI 10.1002/elps.1150120508; Song B.A., 2009, ENV FRIENDLY ANTIPLA, P234; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853	34	42	53	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37944	10.1371/journal.pone.0037944	http://dx.doi.org/10.1371/journal.pone.0037944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662252	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300143
J	Johansson, S; Irgens, H; Chudasama, KK; Molnes, J; Aerts, J; Roque, FS; Jonassen, I; Levy, S; Lima, K; Knappskog, PM; Bell, GI; Molven, A; Njolstad, PR				Johansson, Stefan; Irgens, Henrik; Chudasama, Kishan K.; Molnes, Janne; Aerts, Jan; Roque, Francisco S.; Jonassen, Inge; Levy, Shawn; Lima, Kari; Knappskog, Per M.; Bell, Graeme I.; Molven, Anders; Njolstad, Pal R.			Exome Sequencing and Genetic Testing for MODY	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; BETA-CELL; PHYSIOLOGICAL CHARACTERIZATION; SUSCEPTIBILITY LOCI; MOLECULAR-GENETICS; INSULIN-RESISTANCE; COMMON VARIANTS; ALPHA-GENE; MUTATIONS; ABCC8	Context: Genetic testing for monogenic diabetes is important for patient care. Given the extensive genetic and clinical heterogeneity of diabetes, exome sequencing might provide additional diagnostic potential when standard Sanger sequencing-based diagnostics is inconclusive. Objective: The aim of the study was to examine the performance of exome sequencing for a molecular diagnosis of MODY in patients who have undergone conventional diagnostic sequencing of candidate genes with negative results. Research Design and Methods: We performed exome enrichment followed by high-throughput sequencing in nine patients with suspected MODY. They were Sanger sequencing-negative for mutations in the HNF1A, HNF4A, GCK, HNF1B and INS genes. We excluded common, non-coding and synonymous gene variants, and performed in-depth analysis on filtered sequence variants in a pre-defined set of 111 genes implicated in glucose metabolism. Results: On average, we obtained 45 X median coverage of the entire targeted exome and found 199 rare coding variants per individual. We identified 0-4 rare non-synonymous and nonsense variants per individual in our a priori list of 111 candidate genes. Three of the variants were considered pathogenic (in ABCC8, HNF4A and PPARG, respectively), thus exome sequencing led to a genetic diagnosis in at least three of the nine patients. Approximately 91% of known heterozygous SNPs in the target exomes were detected, but we also found low coverage in some key diabetes genes using our current exome sequencing approach. Novel variants in the genes ARAP1, GLIS3, MADD, NOTCH2 and WFS1 need further investigation to reveal their possible role in diabetes. Conclusion: Our results demonstrate that exome sequencing can improve molecular diagnostics of MODY when used as a complement to Sanger sequencing. However, improvements will be needed, especially concerning coverage, before the full potential of exome sequencing can be realized.	[Johansson, Stefan; Irgens, Henrik; Chudasama, Kishan K.; Molnes, Janne; Knappskog, Per M.; Njolstad, Pal R.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Johansson, Stefan; Chudasama, Kishan K.; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Irgens, Henrik; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Aerts, Jan] Leuven Univ, Fac Engn ESAT SCD, Louvain, Belgium; [Aerts, Jan] Wellcome Trust Sanger Inst, Cambridge, England; [Roque, Francisco S.; Jonassen, Inge] Uni Res, Uni Comp, Computat Biol Unit, Bergen, Norway; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Lima, Kari] Akershus Univ Hosp, Div Med, Dept Endocrinol, Dept Med, Lorenskog, Norway; [Lima, Kari] Akershus Univ Hosp, Div Med, Dept Endocrinol, Dept Human Genet, Lorenskog, Norway; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Molven, Anders] Univ Bergen, Gade Inst, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; KU Leuven; Wellcome Trust Sanger Institute; University of Bergen; HudsonAlpha Institute for Biotechnology; University of Oslo; University of Oslo; University of Chicago; University of Chicago; University of Bergen; University of Bergen; Haukeland University Hospital	Johansson, S (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	pal.njolstad@uib.no	Johansson, Stefan/C-4394-2011; Irgens, Henrik/CAF-0204-2022; Jonassen, Inge/AAC-7035-2020; Aerts, Jan/AAQ-6949-2020	Johansson, Stefan/0000-0002-2298-7008; Aerts, Jan/0000-0002-6416-2717; Levy, Shawn/0000-0002-1369-5740; Jonassen, Inge/0000-0003-4110-0748	Research Council of Norway; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; United States Public Health Service	Research Council of Norway(Research Council of Norway); University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	The study was supported in part by funds from the Research Council of Norway, the University of Bergen, Haukeland University Hospital, Helse Vest, Innovest, and the United States Public Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Cheurfa N, 2010, DIABETOLOGIA, P1; Dimitri P, 2010, EUR J ENDOCRINOL; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edghill EL, 2010, J PANCREAS, V11, P14; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Gurnell M, 2007, PPAR RES, V2007, DOI 10.1155/2007/83593; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Porksen S, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-16; Riveline JP, 2012, DIABETES CARE, V35, P248, DOI 10.2337/dc11-1469; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sovik O, 1998, DIABETOLOGIA, V41, P607, DOI 10.1007/s001250050956; Steele AM, 2010, DIABETIC MED, V27, P157, DOI 10.1111/j.1464-5491.2009.02913.x; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	49	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38050	10.1371/journal.pone.0038050	http://dx.doi.org/10.1371/journal.pone.0038050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662265	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300157
J	Makino, CL; Wen, XH; Michaud, NA; Covington, HI; DiBenedetto, E; Hamm, HE; Lem, J; Caruso, G				Makino, Clint L.; Wen, Xiao-Hong; Michaud, Norman A.; Covington, Henry I.; DiBenedetto, Emmanuele; Hamm, Heidi E.; Lem, Janis; Caruso, Giovanni			Rhodopsin Expression Level Affects Rod Outer Segment Morphology and Photoresponse Kinetics	PLOS ONE			English	Article							PHOTORECEPTOR MEMBRANE; LATERAL DIFFUSION; TRANSGENIC MICE; DISK MEMBRANES; FINE STRUCTURE; KNOCKOUT MICE; MOUSE RETINA; PHOTOTRANSDUCTION; ORGANIZATION; TRANSPORT	Background: The retinal rod outer segment is a sensory cilium that is specialized for the conversion of light into an electrical signal. Within the cilium, up to several thousand membranous disks contain as many as a billion copies of rhodopsin for efficient photon capture. Disks are continually turned over, requiring the daily synthesis of a prodigious amount of rhodopsin. To promote axial diffusion in the aqueous cytoplasm, the disks have one or more incisures. Across vertebrates, the range of disk diameters spans an order of magnitude, and the number and length of the incisures vary considerably, but the mechanisms controlling disk architecture are not well understood. The finding that transgenic mice overexpressing rhodopsin have enlarged disks lacking an incisure prompted us to test whether lowered rhodopsin levels constrain disk assembly. Methodology/Principal Findings: The structure and function of rods from hemizygous rhodopsin knockout (R+/-) mice with decreased rhodopsin expression were analyzed by transmission electron microscopy and single cell recording. R+/- rods were structurally altered in three ways: disk shape changed from circular to elliptical, disk surface area decreased, and the single incisure lengthened to divide the disk into two sections. Photocurrent responses to flashes recovered more rapidly than normal. A spatially resolved model of phototransduction indicated that changes in the packing densities of rhodopsin and other transduction proteins were responsible. The decrease in aqueous outer segment volume and the lengthened incisure had only minor effects on photon response amplitude and kinetics. Conclusions/Significance: Rhodopsin availability limits disk assembly and outer segment girth in normal rods. The incisure may buffer the supply of structural proteins needed to form larger disks. Decreased rhodopsin level accelerated photoresponse kinetics by increasing the rates of molecular collisions on the membrane. Faster responses, together with fewer rhodopsins, combine to lower overall sensitivity of R+/- rods to light.	[Makino, Clint L.; Wen, Xiao-Hong; Michaud, Norman A.; Covington, Henry I.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [DiBenedetto, Emmanuele] Vanderbilt Univ, Dept Math, Nashville, TN USA; [Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Lem, Janis] Tufts Univ, Sch Med, Dept Ophthalmol, Program Genet,Program Neurosci,Program Cell Mol &, Boston, MA 02111 USA; [Caruso, Giovanni] CNR, Construct Technol Inst, Rome, Italy	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Vanderbilt University; Vanderbilt University; Tufts University; Consiglio Nazionale delle Ricerche (CNR)	Makino, CL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069	National Eye Institute [EY006062, EY011358, EY014104, EY12008]; National Institute of General Medical Sciences [GM068953]; National Science Foundation [DMS 0652385, DMS 0970008]; Lions of Massachusetts; NATIONAL EYE INSTITUTE [P30EY014104, R29EY011358, R01EY011358, R01EY006062, R01EY012008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068953] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Lions of Massachusetts; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Eye Institute (EY006062, EY011358, EY014104, EY12008), National Institute of General Medical Sciences (GM068953), National Science Foundation (DMS 0652385, DMS 0970008), and Lions of Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Bailes HJ, 2006, J COMP NEUROL, V494, P381, DOI 10.1002/cne.20809; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Caruso G, 2006, BIOPHYS J, V91, P1192, DOI 10.1529/biophysj.106.083618; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; COHEN AI, 1963, EXP EYE RES, V2, P88, DOI 10.1016/S0014-4835(63)80028-7; COHEN AI, 1960, AM J ANAT, V107, P23, DOI 10.1002/aja.1001070103; COHEN AI, 1965, ANAT REC, V152, P63, DOI 10.1002/ar.1091520108; COHEN AI, 1972, HDB SENSORY PHYSIOLO, V7, P63; CORLESS JM, 1987, EXP EYE RES, V45, P883, DOI 10.1016/S0014-4835(87)80104-5; CORLESS JM, 1987, J COMP NEUROL, V257, P9, DOI 10.1002/cne.902570103; DEROBERTIS E, 1956, J BIOPHYS BIOCHEM CY, V2, P319, DOI 10.1083/jcb.2.3.319; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farrar GJ, 2012, GENE THER, V19, P137, DOI 10.1038/gt.2011.172; Fishelson L, 2004, ANAT REC PART A, V277A, P249, DOI 10.1002/ar.a.20005; Govardovskii VI, 2009, MOL VIS, V15, P1717; Gross A. K., 2011, ADLERS PHYSL EYE, P394; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; KATZ ML, 1991, INVEST OPHTH VIS SCI, V32, P1968; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; LOCKET NA, 1971, PROC R SOC SER B-BIO, V178, P161, DOI 10.1098/rspb.1971.0059; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; PEDLER CMH, 1967, VISION RES, V7, P829, DOI 10.1016/0042-6989(67)90003-X; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; ROOF D, 1991, J COMP NEUROL, V305, P289, DOI 10.1002/cne.903050210; ROOF DJ, 1982, J CELL BIOL, V95, P487, DOI 10.1083/jcb.95.2.487; SAXTON MJ, 1989, BIOCHIM BIOPHYS ACTA, V979, P27, DOI 10.1016/0005-2736(89)90519-1; SIDMAN RL, 1957, J BIOPHYS BIOCHEM CY, V3, P15, DOI 10.1083/jcb.3.1.15; SJOSTRAND FS, 1953, J CELL COMPAR PHYSL, V42, P45, DOI 10.1002/jcp.1030420104; STEINBERG RH, 1975, J ULTRA MOL STRUCT R, V51, P397, DOI 10.1016/S0022-5320(75)80102-X; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; USUKURA J, 1981, BIOMED RES-TOKYO, V2, P177, DOI 10.2220/biomedres.2.177; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; WEN GY, 1982, ANAT EMBRYOL, V165, P315, DOI 10.1007/BF00305570; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016	50	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37832	10.1371/journal.pone.0037832	http://dx.doi.org/10.1371/journal.pone.0037832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662234	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300124
J	Neal, A; Boldrin, L; Morgan, JE				Neal, Alice; Boldrin, Luisa; Morgan, Jennifer Elizabeth			The Satellite Cell in Male and Female, Developing and Adult Mouse Muscle: Distinct Stem Cells for Growth and Regeneration	PLOS ONE			English	Article							MYONUCLEAR DOMAIN SIZE; SKELETAL-MUSCLE; FIBER GROWTH; SELF-RENEWAL; RAT; TESTOSTERONE; PROLIFERATION; HYPERTROPHY; NUMBER; AGE	Satellite cells are myogenic cells found between the basal lamina and the sarcolemma of the muscle fibre. Satellite cells are the source of new myofibres; as such, satellite cell transplantation holds promise as a treatment for muscular dystrophies. We have investigated age and sex differences between mouse satellite cells in vitro and assessed the importance of these factors as mediators of donor cell engraftment in an in vivo model of satellite cell transplantation. We found that satellite cell numbers are increased in growing compared to adult and in male compared to female adult mice. We saw no difference in the expression of the myogenic regulatory factors between male and female mice, but distinct profiles were observed according to developmental stage. We show that, in contrast to adult mice, the majority of satellite cells from two week old mice are proliferating to facilitate myofibre growth; however a small proportion of these cells are quiescent and not contributing to this growth programme. Despite observed changes in satellite cell populations, there is no difference in engraftment efficiency either between satellite cells derived from adult or pre-weaned donor mice, male or female donor cells, or between male and female host muscle environments. We suggest there exist two distinct satellite cell populations: one for muscle growth and maintenance and one for muscle regeneration.	[Neal, Alice; Boldrin, Luisa; Morgan, Jennifer Elizabeth] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Neal, Alice] UCL, Inst Neurol, MRC Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; University College London	Neal, A (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	a.neal@ion.ucl.ac.uk; jennifer.morgan@ucl.ac.uk		Neal, Alice/0000-0002-4623-6102	Wellcome Trust University Award; Muscular Dystrophy Campaign; Medical Research Council; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Wellcome Trust University Award(Wellcome Trust); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Jennifer E. Morgan was funded by a Wellcome Trust University Award. Luisa Boldrin was funded by the Muscular Dystrophy Campaign. Alice Neal was funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravamudan B, 2006, J APPL PHYSIOL, V100, P1617, DOI 10.1152/japplphysiol.01277.2005; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; Boldrin L, 2009, STEM CELLS, V27, P2478, DOI 10.1002/stem.162; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; CHEEK DB, 1965, B JOHNS HOPKINS HOSP, V116, P378; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Ishido M, 2009, ACTA PHYSIOL, V195, P459, DOI 10.1111/j.1748-1716.2008.01905.x; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; JOUBERT Y, 1989, DEV BIOL, V131, P550, DOI 10.1016/S0012-1606(89)80025-9; JOUBERT Y, 1995, DEV BIOL, V169, P286, DOI 10.1006/dbio.1995.1144; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; MacLennan MB, 2011, NUTRIENTS, V3, P929, DOI 10.3390/nu3110929; Manzano R, 2011, J CELL BIOCHEM, V112, P2825, DOI 10.1002/jcb.23197; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Morgan JE, 2002, J CELL BIOL, V157, P693, DOI 10.1083/jcb.200108047; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; MULVANEY DR, 1988, P SOC EXP BIOL MED, V188, P40; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; NELSON JF, 1975, ACTA ENDOCRINOL-COP, V80, P744, DOI 10.1530/acta.0.0800744; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Rehfeldt C, 1997, BRIT POULTRY SCI, V38, P366, DOI 10.1080/00071669708418004; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; ROWE RWD, 1969, J ANAT, V104, P519; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SCHULTZ E, 1976, AM J ANAT, V147, P49, DOI 10.1002/aja.1001470105; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Verheul AJ, 2004, J APPL PHYSIOL, V97, P1715, DOI 10.1152/japplphysiol.00625.2003; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	59	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37950	10.1371/journal.pone.0037950	http://dx.doi.org/10.1371/journal.pone.0037950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662253	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300144
J	Tambussi, CP; de Mendoza, R; Degrange, FJ; Picasso, MB				Tambussi, Claudia P.; de Mendoza, Ricardo; Degrange, Federico J.; Picasso, Mariana B.			Flexibility along the Neck of the Neogene Terror Bird Andalgalornis steulleti (Aves Phorusrhacidae)	PLOS ONE			English	Article							DINOSAURS; SYSTEM	Background: Andalgalornis steulleti from the upper Miocene-lower Pliocene (approximate to 6 million years ago) of Argentina is a medium-sized patagornithine phorusrhacid. It was a member of the predominantly South American radiation of 'terror birds' (Phorusrhacidae) that were apex predators throughout much of the Cenozoic. A previous biomechanical study suggests that the skull would be prepared to make sudden movements in the sagittal plane to subdue prey. Methodology/Principal Findings: We analyze the flexion patterns of the neck of Andalgalornis based on the neck vertebrae morphology and biometrics. The transitional cervical vertebrae 5th and 9th clearly separate regions 1-2 and 2-3 respectively. Bifurcate neural spines are developed in the cervical vertebrae 7th to 12th suggesting the presence of a very intricate ligamentary system and of a very well developed epaxial musculature. The presence of the lig. elasticum interespinale is inferred. High neural spines of R3 suggest that this region concentrates the major stresses during downstrokes. Conclusions/Significance: The musculoskeletal system of Andalgalornis seems to be prepared (1) to support a particularly big head during normal stance, and (2) to help the neck (and the head) rising after the maximum ventroflexion during a strike. The study herein is the first interpretation of the potential performance of the neck of Andalgalornis in its entirety and we considered this an important starting point to understand and reconstruct the flexion pattern of other phorusrhacids from which the neck is unknown.	[Tambussi, Claudia P.; de Mendoza, Ricardo; Picasso, Mariana B.] Museo La Plata, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Tambussi, Claudia P.; Degrange, Federico J.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Degrange, Federico J.] Ctr Invest Ciencias Tierra CICTERRA, Cordoba, Argentina	National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Tambussi, CP (corresponding author), Museo La Plata, Div Paleontol Vertebrados, Paseo del Bosque S-N, La Plata, Buenos Aires, Argentina.	tambussi.claudia@conicet.gov.ar	De Mendoza, Ricardo/GRX-2324-2022		CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); Agencia Nacional de Promociones Cientificas y Tecnicas	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promociones Cientificas y Tecnicas	The study was funded in part by a grant from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) and Agencia Nacional de Promociones Cientificas y Tecnicas to CPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Andrews C., 1896, IBIS, V7, P1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Boas J., 1929, D KGL DANSKE VIDENSK, V9, P105; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Christian A., 2007, FOSS REC, V10, P37; De Mendoza RS, 2009, AMEGHINIANA, V46, p73R; De Mendoza RS, 2009, AMEGHINIANA, V46, p19R; Degrange FJ, 2011, J VERTEBR PALEONTOL, V31, P1080, DOI 10.1080/02724634.2011.595466; Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; Degrange FJ, 2012, THESIS U NACL LA PLA; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Guinard G, 2010, POLAR BIOL, V33, P807, DOI 10.1007/s00300-009-0759-2; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Patterson B., 1960, Publ Mus Cienc nat Mar del Plata, V1, P1; SINCLAIR WILLIAM J., 1932, REPT PRINCETON UNIV EXPED PATAGONIA 1896 1899, V7, P157; Tambussi Claudia, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P245; TAMBUSSI CP, 1997, AMEGHINIANA, V34, P541; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Dozo MT, 2010, PALAEOGEOGR PALAEOCL, V297, P100, DOI 10.1016/j.palaeo.2010.07.018; Tsuihiji T, 2004, J VERTEBR PALEONTOL, V24, P165, DOI 10.1671/A1129-12; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; VANDERLEEUW AHJ, 1992, NETH J ZOOL, V42, P23, DOI 10.1163/156854292X00026; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Vogel S., 2000, ANCAS PALANCAS MECAN; Wedel MJ, 1999, J VERTEBRATE PALEONT, V19, P83; Zusi RL., 1962, STRUCTURAL ADAPTATIO; Zweers G., 1994, P201	30	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37701	10.1371/journal.pone.0037701	http://dx.doi.org/10.1371/journal.pone.0037701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662194	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300084
J	Uebi, T; Itoh, Y; Hatano, O; Kumagai, A; Sanosaka, M; Sasaki, T; Sasagawa, S; Doi, J; Tatsumi, K; Mitamura, K; Morii, E; Aozasa, K; Kawamura, T; Okumura, M; Nakae, J; Takikawa, H; Fukusato, T; Koura, M; Nish, M; Hamsten, A; Silveira, A; Bertorello, AM; Kitagawa, K; Nagaoka, Y; Kawahara, H; Tomonaga, T; Naka, T; Ikegawa, S; Tsumaki, N; Matsuda, J; Takemori, H				Uebi, Tatsuya; Itoh, Yumi; Hatano, Osamu; Kumagai, Ayako; Sanosaka, Masato; Sasaki, Tsutomu; Sasagawa, Satoru; Doi, Junko; Tatsumi, Keita; Mitamura, Kuniko; Morii, Eiichi; Aozasa, Katsuyuki; Kawamura, Tomohiro; Okumura, Meinoshin; Nakae, Jun; Takikawa, Hajime; Fukusato, Toshio; Koura, Minako; Nish, Mayumi; Hamsten, Anders; Silveira, Angela; Bertorello, Alejandro M.; Kitagawa, Kazuo; Nagaoka, Yasuo; Kawahara, Hidehisa; Tomonaga, Takeshi; Naka, Tetsuji; Ikegawa, Shigeo; Tsumaki, Noriyuki; Matsuda, Junichiro; Takemori, Hiroshi			Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice	PLOS ONE			English	Article							SALT-INDUCIBLE KINASE; ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR TORC2; RETINOID-X-RECEPTOR; BILE-ACID; NUCLEAR RECEPTOR; ENERGY-EXPENDITURE; GENE-EXPRESSION; 9-CIS-RETINOIC ACID; HEPATIC STEATOSIS	Salt-inducible kinase 3 (SIK3), an AMP-activated protein kinase-related kinase, is induced in the murine liver after the consumption of a diet rich in fat, sucrose, and cholesterol. To examine whether SIK3 can modulate glucose and lipid metabolism in the liver, we analyzed phenotypes of SIK3-deficent mice. Sik3(-/-) mice have a malnourished the phenotype (i.e., lipodystrophy, hypolipidemia, hypoglycemia, and hyper-insulin sensitivity) accompanied by cholestasis and cholelithiasis. The hypoglycemic and hyper-insulin-sensitive phenotypes may be due to reduced energy storage, which is represented by the low expression levels of mRNA for components of the fatty acid synthesis pathways in the liver. The biliary disorders in Sik3(-/-) mice are associated with the dysregulation of gene expression programs that respond to nutritional stresses and are probably regulated by nuclear receptors. Retinoic acid plays a role in cholesterol and bile acid homeostasis, wheras ALDH1a which produces retinoic acid, is expressed at low levels in Sik3(-/-) mice. Lipid metabolism disorders in Sik3(-/-) mice are ameliorated by the treatment with 9-cis-retinoic acid. In conclusion, SIK3 is a novel energy regulator that modulates cholesterol and bile acid metabolism by coupling with retinoid metabolism, and may alter the size of energy storage in mice.	[Uebi, Tatsuya; Itoh, Yumi; Kumagai, Ayako; Sanosaka, Masato; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan; [Hatano, Osamu; Nish, Mayumi] Nara Med Univ, Dept Anat, Nara, Japan; [Kumagai, Ayako; Nagaoka, Yasuo; Kawahara, Hidehisa] Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka, Japan; [Sasaki, Tsutomu; Kitagawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Sasagawa, Satoru; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, Osaka, Japan; [Doi, Junko] Senri Kinran Univ, Osaka, Japan; [Tatsumi, Keita] Osaka Univ, Grad Sch Med, Dept Lab Med, Osaka, Japan; [Mitamura, Kuniko; Ikegawa, Shigeo] Kinki Univ, Fac Pharmaceut Sci, Osaka 577, Japan; [Morii, Eiichi; Aozasa, Katsuyuki] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka, Japan; [Kawamura, Tomohiro; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Nakae, Jun] Keio Univ, Sch Med, Tokyo, Japan; [Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Tokyo 173, Japan; [Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan; [Hamsten, Anders; Silveira, Angela] Karolinska Inst, Karolinska Univ Hosp Solna, Cardiovasc Genet & Genom Atherosclerosis Res Unit, CMM, Stockholm, Sweden; [Bertorello, Alejandro M.] Karolinska Inst, Membrane Signaling Networks, Atherosclerosis Res Unit, CMM,Karolinska Univ Hosp Solna, Stockholm, Sweden; [Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka, Japan; [Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan; [Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan	National Institute of Health Sciences - Japan; Nara Medical University; Kansai University; Osaka University; Osaka University; Osaka University; Kindai University (Kinki University); Osaka University; Osaka University; Keio University; Teikyo University; Teikyo University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kyoto University	Uebi, T (corresponding author), Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan.	takemori@nibio.go.jp	邦子, 三田村/W-7184-2019	sasaki, tsutomu/0000-0001-8726-978X; Silveira, Angela/0000-0003-2063-4935; Tsumaki, Noriyuki/0000-0002-0520-3654; Naka, Tetsuji/0000-0002-1269-3997; Sasagawa, Satoru/0000-0001-5769-8700	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22591101] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Natural Scientists and the Strategic Project; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project to Support the Formation of Research Bases at Private Universities; and a grant from the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Erickson JM, 2000, J THEOR BIOL, V206, P47, DOI 10.1006/jtbi.2000.2102; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hoeke MO, 2009, HEPATOLOGY, V49, P151, DOI 10.1002/hep.22661; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kok T, 2003, BIOCHEM J, V369, P539, DOI 10.1042/BJ20020981; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; Lennerz JK, 2010, MOL CELL BIOL, V30, P5043, DOI 10.1128/MCB.01472-09; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Moschetta A, 2001, J HEPATOL, V34, P492, DOI 10.1016/S0168-8278(00)00046-5; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shikhman AR, 2001, J IMMUNOL, V167, P7001, DOI 10.4049/jimmunol.167.12.7001; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Weiss B, 2010, ISR MED ASSOC J, V12, P82; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Wu SF, 2011, ENDOCRINOLOGY, V152, P468, DOI 10.1210/en.2010-0803; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	61	47	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37803	10.1371/journal.pone.0037803	http://dx.doi.org/10.1371/journal.pone.0037803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662228	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300118
J	Wang, L; Guo, H; Yu, X; Wang, SY; Xu, CH; Fu, F; Jing, XR; Zhang, H; Dong, XZ				Wang, Lei; Guo, Heng; Yu, Xiao; Wang, Shouyan; Xu, Canhua; Fu, Feng; Jing, Xiaorong; Zhang, Hua; Dong, Xiuzhen			Responsive Electrical Stimulation Suppresses Epileptic Seizures in Rats	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; INDUCED FOCAL EPILEPSY; CORTICAL STIMULATION; BRAIN-STIMULATION; TEMPORAL-LOBE; IN-VITRO; MODEL; PARAMETERS; EEG	Background: A responsive electrical stimulation pattern based on our recently developed novel seizure prediction method was designed to suppress the penicillin-induced epileptic seizures. Methodology: Seizures were induced by Penicillin injection at rat cortex. A responsive electrical stimulation system was triggered prior to seizures predicted with phase synchronisation. Rats with induced seizures were stimulated by the electrical pulses at a responsive or 1 Hz periodic pattern of an open system. The effectiveness of stimulation on seizures suppression was assessed by measuring the average number and duration of seizures per hour. Results: The prediction algorithm reliably identified seizures in real time and triggered the responsive stimulation. This type of electrical stimulation dramatically suppressed seizure activity and the performance was better than the open stimulation system with fewer and shorter seizures. Conclusions: A responsive electrical stimulation system triggered by the phase synchronisation prediction is able to significantly suppress seizures. Significance: Responsive electrical stimulation could achieve superior treatment performance and reduce power consumption and side effects.	[Wang, Lei; Yu, Xiao; Xu, Canhua; Fu, Feng; Dong, Xiuzhen] Fourth Mil Med Univ, Fac Biomed Engn, Xian 710032, Peoples R China; [Wang, Lei] 323rd Hosp PLA, Xian, Peoples R China; [Guo, Heng; Jing, Xiaorong; Zhang, Hua] Fourth Mil Med Univ, Dept Neurosurg, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Shouyan] Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton, Hants, England; [Wang, Shouyan] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; University of Southampton; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Wang, L (corresponding author), Fourth Mil Med Univ, Fac Biomed Engn, Xian 710032, Peoples R China.	zhanghuadoc@gmail.com; dongxiuzhen@fmmu.edu.cn			National Natural Science Foundation of China [30772221, 50937005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [30772221]; and the Key Program of National Natural Science Foundation of China [50937005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canan S, 2008, EPILEPSY RES, V82, P7, DOI 10.1016/j.eplepsyres.2008.06.005; Carrington CA, 2007, EPILEPSIA, V48, P1604, DOI 10.1111/j.1528-1167.2007.01077.x; Colpan ME, 2007, EPILEPSIA, V48, P1594, DOI 10.1111/j.1528-1167.2007.01073.x; Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Fountas KN, 2007, ACTA NEUROCHIR SUPPL, V97, P357; GAITO J, 1981, CAN J NEUROL SCI, V8, P249, DOI 10.1017/S0317167100043286; GAITO J, 1980, EPILEPSIA, V21, P73, DOI 10.1111/j.1528-1157.1980.tb04046.x; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Goodman JH, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.0013-9580.2005.03804.x; Kinoshita M, 2005, CLIN NEUROPHYSIOL, V116, P1291, DOI 10.1016/j.clinph.2005.02.010; Kinoshita M, 2004, EPILEPSIA, V45, P787, DOI 10.1111/j.0013-9580.2004.60203.x; Kortelainen J, 2010, IEEE ENG MED BIO, P6674, DOI 10.1109/IEMBS.2010.5627154; Kossoff EH, 2004, EPILEPSIA, V45, P1560, DOI 10.1111/j.0013-9580.2004.26104.x; Lasemidis LD, 2003, IEEE T BIO-MED ENG, V50, P549, DOI 10.1109/TBME.2003.810705; Lesser RP, 1999, NEUROLOGY, V53, P2073, DOI 10.1212/WNL.53.9.2073; Lian J, 2003, J PHYSIOL-LONDON, V547, P427, DOI 10.1113/jphysiol.2002.033209; Liang SF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045001; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Lopez-Meraz ML, 2004, EPILEPSY RES, V59, P95, DOI 10.1016/j.eplepsyres.2004.02.005; Makiranta M, 2005, NEUROIMAGE, V27, P715, DOI 10.1016/j.neuroimage.2005.05.025; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Mirski MA, 1997, EPILEPSY RES, V28, P89, DOI 10.1016/S0920-1211(97)00034-X; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Morrell MJ, 2002, SEMIN NEUROL, V22, P247, DOI 10.1055/s-2002-36645; Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2; Osorio I, 2001, J CLIN NEUROPHYSIOL, V18, P533, DOI 10.1097/00004691-200111000-00003; Raghunathan S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056005; Rajdev P, 2011, INT J NEURAL SYST, V21, P151, DOI 10.1142/S0129065711002730; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Schiller Y, 2007, J NEUROPHYSIOL, V97, P1887, DOI 10.1152/jn.00514.2006; Silfverhuth MJ, 2011, SEIZURE-EUR J EPILEP, V20, P513, DOI 10.1016/j.seizure.2011.03.006; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Sunderam S, 2010, EPILEPSY BEHAV, V17, P6, DOI 10.1016/j.yebeh.2009.10.017; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Velasco F, 2001, STEREOT FUNCT NEUROS, V77, P228, DOI 10.1159/000064611; Wang L, 2011, CLIN NEUROPHYSIOL, V122, P656, DOI 10.1016/j.clinph.2010.09.018; Yao QH, 2008, NEUROSCI LETT, V430, P187, DOI 10.1016/j.neulet.2007.10.024; YUEN TGH, 1981, NEUROSURGERY, V9, P292, DOI 10.1227/00006123-198109000-00013	38	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38141	10.1371/journal.pone.0038141	http://dx.doi.org/10.1371/journal.pone.0038141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662277	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300169
J	Hassan, F; Ren, DB; Zhang, WH; Gu, XX				Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing			Role of c-Jun N-Terminal Protein Kinase 1/2 (JNK1/2) in Macrophage-Mediated MMP-9 Production in Response to Moraxella catarrhalis Lipooligosaccharide (LOS)	PLOS ONE			English	Article							OTITIS-MEDIA; MATRIX-METALLOPROTEINASES; TYMPANIC MEMBRANE; EXPRESSION; LIPOPOLYSACCHARIDE; INHIBITION; ACTIVATION; MONOCYTES; APOPTOSIS; INJURY	Moraxella catarrhalis is a Gram negative bacterium and a leading causative agent of otitis media (OM) in children. Recent reports have provided strong evidence for the presence of high levels of matrix metalloproteinase (MMPs) in effusion fluids from children suffering with OM, however, the precise mechanisms by which MMPs are generated are currently unknown. We hypothesized that MMPs are secreted from macrophages in the presence of M. catarrhalis lipooligosaccharide (LOS). In this report, we demonstrate that in vitro stimulation of murine macrophage RAW 264.7 cells with LOS leads to secretion of MMP-9 as determined by ELISA and zymogram assays. We have also shown that inhibition of ERK1/2 and p38 kinase completely blocked LOS induced MMP-9 production. In contrast, inhibition of JNK1/2 by the specific inhibitor SP600125 actually increased the level of expression and production of MMP-9 at both mRNA and protein levels, respectively by almost five fold. This latter result was confirmed by knocking down JNK1/2 using siRNA. Similar results have been observed in murine bone marrow derived macrophages in vitro. In contrast to and in parallel with the LOS-induced increased levels of MMP-9 in the presence of SP600125, we found a corresponding dose-dependent inhibition of TIMP-1 (tissue inhibitor of matrix metalloproteinase-1) secretion. Results of subsequent in vitro studies provided evidence that when JNK1/2 was inhibited prior to stimulation with LOS, it significantly increased both the extent of macrophage cell migration and invasion compared to control cells or cells treated with LOS alone. The results of these studies contribute to an increased understanding of the underlying pathophysiology of OM with effusion in children.	[Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing] Natl Inst Deafness & Other Commun Disorders, Vaccine Res Sect, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hassan, F (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	guxx@mail.nih.gov	Ren, Dabin/H-6263-2013		Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]	Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli PJ, 2003, LARYNGOSCOPE, V113, P1347, DOI 10.1097/00005537-200308000-00015; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; EDEBRINK P, 1995, CARBOHYD RES, V266, P237, DOI 10.1016/0008-6215(94)00276-L; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; FOMSGAARD JS, 1991, INFECT IMMUN, V59, P3346, DOI 10.1128/IAI.59.9.3346-3349.1991; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Granstrom G, 2009, PERIODONTOL 2000, V49, P179, DOI 10.1111/j.1600-0757.2008.00281.x; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Jang CH, 2006, INT J PEDIATR OTORHI, V70, P1155, DOI 10.1016/j.ijporl.2005.11.013; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee KH, 2006, EXP MOL MED, V38, P408, DOI 10.1038/emm.2006.48; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Magnuson K, 1996, ANN OTO RHINOL LARYN, V105, P397, DOI 10.1177/000348949610500513; MAGNUSON K, 1994, EUR ARCH OTO-RHINO-L, V251, P393; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; MASOUD H, 1994, CAN J CHEM, V72, P1466, DOI 10.1139/v94-182; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Moon SK, 2008, ACTA OTO-LARYNGOL, V128, P144, DOI 10.1080/00016480701477610; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; RUUSKANEN O, 1994, PEDIATR INFECT DIS J, V13, pS23, DOI 10.1097/00006454-199401001-00006; Schonermark M, 1996, ACTA OTO-LARYNGOL, V116, P451, DOI 10.3109/00016489609137872; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wilmoth JG, 2003, OTOLARYNG HEAD NECK, V129, P647, DOI 10.1016/S0194-5998(03)01388-3; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37912	10.1371/journal.pone.0037912	http://dx.doi.org/10.1371/journal.pone.0037912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655080	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900057
J	Takiyama, K; Okada, M				Takiyama, Ken; Okada, Masato			Recovery in Stroke Rehabilitation through the Rotation of Preferred Directions Induced by Bimanual Movements: A Computational Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ARM MOVEMENTS; CORTICAL REPRESENTATION; SUPPLEMENTARY MOTOR; MODEL; INFORMATION; POPULATIONS; NETWORKS; MONKEYS	Stroke patients recover more effectively when they are rehabilitated with bimanual movement rather than with unimanual movement; however, it remains unclear why bimanual movement is more effective for stroke recovery. Using a computational model of stroke recovery, this study suggests that bimanual movement facilitates the reorganization of a damaged motor cortex because this movement induces rotations in the preferred directions (PDs) of motor cortex neurons. Although the tuning curves of these neurons differ during unimanual and bimanual movement, changes in PD, but not changes in modulation depth, facilitate such reorganization. In addition, this reorganization was facilitated only when encoding PDs are rotated, but decoding PDs are not rotated. Bimanual movement facilitates reorganization because this movement changes neural activities through inter-hemispheric inhibition without changing cortical-spinal-muscle connections. Furthermore, stronger inter-hemispheric inhibition between motor cortices results in more effective reorganization. Thus, this study suggests that bimanual movement is effective for stroke rehabilitation because this movement rotates the encoding PDs of motor cortex neurons.	[Takiyama, Ken; Okada, Masato] Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Chiba, Tokyo, Japan; [Okada, Masato] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; RIKEN	Takiyama, K (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Chiba, Tokyo, Japan.	okada@k.u-tokyo.ac.jp	Takiyama, Ken/M-4526-2015	Takiyama, Ken/0000-0003-2252-7826	Japan Society for the Promotion of Science Fellows [10J04910]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20240020]	Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (grant no. 10J04910) and a Grant-in-Aid for Scientific Research (A) (grant no. 20240020) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodall S, 1997, STROKE, V28, P101, DOI 10.1161/01.STR.28.1.101; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Grefkes C, 2011, BRAIN, P1; Guigon E, 2007, EUR J NEUROSCI, V26, P250, DOI 10.1111/j.1460-9568.2007.05634.x; Han CE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000133; Latimer CP, 2010, DISABIL REHABIL, V32, P1221, DOI 10.3109/09638280903483877; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; LUKASHIN AV, 1994, NEURAL COMPUT, V6, P19, DOI 10.1162/neco.1994.6.1.19; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Reinkensmeyer DJ, 2003, NEURAL COMPUT, V15, P2619, DOI 10.1162/089976603322385090; Rokni U, 2003, J NEUROSCI, V23, P11577; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Rose Dorian K, 2004, Top Stroke Rehabil, V11, P20, DOI 10.1310/XAUM-LPBM-0RXD-RLDK; Rouille EM, 1994, EXP BRAIN RES, P227; SALINAS E, 1995, J NEUROSCI, V15, P6461; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Schweighofer N, 2009, PHYS THER, V89, P1327, DOI 10.2522/ptj.20080402; Steinberg O, 2002, EUR J NEUROSCI, V15, P1371, DOI 10.1046/j.1460-9568.2002.01968.x; Stevenson IH, 2011, J NEUROPHYSIOL; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Verstynen T, 2011, J NEUROSCI, V31, P10050, DOI 10.1523/JNEUROSCI.6525-10.2011	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37594	10.1371/journal.pone.0037594	http://dx.doi.org/10.1371/journal.pone.0037594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655060	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900036
J	Cai, Q; Lin, T; Kamarajugadda, S; Lu, J				Cai, Q.; Lin, T.; Kamarajugadda, S.; Lu, J.			Regulation of glycolysis and the Warburg effect by estrogen-related receptors	ONCOGENE			English	Article						aerobic glycolysis; Warburg effect; nuclear receptor; Randle cycle	PYRUVATE-DEHYDROGENASE KINASE; CANCER-CELL METABOLISM; PDK4 GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; ERR-ALPHA; HYPOXIA; MYC; SWITCH; PGC-1-ALPHA; ADAPTATION	Cancer cells typically display altered glucose metabolism characterized by a preference of aerobic glycolysis, known as the Warburg effect, which facilitates cell proliferation. Hypoxia-inducible factor (HIF) and oncoprotein Myc are two prominent transcription factors that drive glycolysis. Previously, we reported that the estrogen-related receptors (ERRs) act as cofactors of HIF and enhance HIF-dependent transcription of glycolytic genes under hypoxia. ERRs are orphan nuclear receptors and key regulators of energy metabolism by orchestrating mitochondrial biogenesis, fatty acid oxidation (FAO) and oxidative phosphorylation. Here, we show that ERRs also stimulate glycolysis under normoxia. ERRs directly bind to and activate promoters of many genes encoding glycolytic enzymes, and the ERR-binding sites in such promoters are essential for ERR-mediated transcriptional activation. ERRs interact with Myc, and the two factors synergistically activate transcription of glycolytic genes. Furthermore, overexpression of ERRs increases glycolytic gene expression and lactate production. Conversely, depletion of ERRs in cancer cells reduces expression of glycolytic genes and glucose uptake, resulting in decreased aerobic glycolysis and cell growth. Taken together, these results suggest that ERRs are important transcriptional activators of the glycolytic pathway and contribute to the Warburg effect in cancer cells. Oncogene (2013) 32, 2079-2086; doi:10.1038/onc.2012.221; published online 4 June 2012	[Cai, Q.; Lin, T.; Kamarajugadda, S.; Lu, J.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lu, J (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, POB 103633, Gainesville, FL 32610 USA.	jrlu@ufl.edu	Cai, Qingsong/J-6428-2012; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	National Cancer Institute [R01CA137021]; Florida Bankhead-Coley Cancer Research Program [09BN-12-23092, 2BT01]; NATIONAL CANCER INSTITUTE [R01CA137021] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (R01CA137021) and Florida Bankhead-Coley Cancer Research Program (09BN-12-23092 and 2BT01).	Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Araki M, 2006, FEBS J, V273, P1669, DOI 10.1111/j.1742-4658.2006.05183.x; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	34	65	66	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2079	2086		10.1038/onc.2012.221	http://dx.doi.org/10.1038/onc.2012.221			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22665055	Green Accepted			2022-12-25	WOS:000317919900009
J	Guttenberg, G; Hornei, S; Jank, T; Schwan, C; Lu, W; Einsle, O; Papatheodorou, P; Aktories, K				Guttenberg, Gregor; Hornei, Sven; Jank, Thomas; Schwan, Carsten; Lu, Wei; Einsle, Oliver; Papatheodorou, Panagiotis; Aktories, Klaus			Molecular Characteristics of Clostridium perfringens TpeL Toxin and Consequences of Mono-O-GlcNAcylation of Ras in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFICILE TOXIN; LETHAL TOXIN; CATALYZED GLUCOSYLATION; RHO-PROTEINS; GLYCOSYLTRANSFERASES; TRANSLOCATION; CYTOTOXINS; CLEAVAGE; DISEASE	TpeL is a member of the family of clostridial glucosylating toxins produced by Clostridium perfringens type A, B, and C strains. In contrast to other members of this toxin family, it lacks a C-terminal polypeptide repeat domain, which is suggested to be involved in target cell binding. It was shown that the glucosyltransferase domain of TpeL modifies Ras in vitro by mono-O-glucosylation or mono-O-GlcNAcylation (Nagahama, M., Ohkubo, A., Oda, M., Kobayashi, K., Amimoto, K., Miyamoto, K., and Sakurai, J. (2011) Infect. Immun. 79, 905-910). Here we show that TpeL preferably utilizes UDP-N-acetylglucosamine (UDP-GlcNAc) as a sugar donor. Change of alanine 383 of TpeL to isoleucine turns the sugar donor preference from UDP-GlcNAc to UDP-glucose. In contrast to previous studies, we show that Rac is a poor substrate in vitro and in vivo and requires 1-2 magnitudes higher toxin concentrations for modification by TpeL. The toxin is autoproteolytically processed in the presence of inositol hexakisphosphate (InsP(6)) by an intrinsic cysteine protease domain, located next to the glucosyltransferase domain. A C-terminally extended TpeL full-length variant (TpeL1-1779) induces apoptosis in HeLa cells (most likely by mono-O-GlcNAcylation of Ras), and inhibits Ras signaling including Ras-Raf interaction and ERK activation. In addition, TpeL blocks Ras signaling in rat pheochromocytoma PC12 cells. TpeL is a glucosylating toxin, which modifies Ras and induces apoptosis in target cells without having a typical C-terminal polypeptide repeat domain.	[Guttenberg, Gregor; Hornei, Sven; Jank, Thomas; Schwan, Carsten; Papatheodorou, Panagiotis; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lu, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25,Otto Krayer Haus, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015; Jank, Thomas/R-9627-2017	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739; Papatheodorou, Panagiotis/0000-0003-3571-695X; Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [AK6/16-3]; Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany)	This work was supported by the Deutsche Forschungsgemeinschaft (AK6/16-3) and the Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany).	Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; Borriello S.P., 2005, TOPLEY WILSONS MICRO; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Dreger SC, 2009, BIOCHEMISTRY-US, V48, P1785, DOI 10.1021/bi800708b; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Genth H, 2011, EUR J CELL BIOL, V90, P959, DOI 10.1016/j.ejcb.2010.10.009; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Guttenberg G, 2011, J BIOL CHEM, V286, P14779, DOI 10.1074/jbc.M110.200691; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck SC, 2009, FEBS LETT, V583, P3133, DOI 10.1016/j.febslet.2009.09.006; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Stevens D. L., 1997, NECROTIZING CLOSTRID; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	37	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24929	24940		10.1074/jbc.M112.347773	http://dx.doi.org/10.1074/jbc.M112.347773			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665487	hybrid, Green Published			2022-12-25	WOS:000306651700007
J	Zhong, DL; Lefebre, M; Kaur, K; McDowell, MA; Gdowski, C; Jo, S; Wang, Y; Benedict, SH; Lea, SM; Galan, JE; De Guzman, RN				Zhong, Dalian; Lefebre, Matthew; Kaur, Kawaljit; McDowell, Melanie A.; Gdowski, Courtney; Jo, Sunhwan; Wang, Yu; Benedict, Stephen H.; Lea, Susan M.; Galan, Jorge E.; De Guzman, Roberto N.			The Salmonella Type III Secretion System Inner Rod Protein PrgJ Is Partially Folded	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEDLE COMPLEX; SUBSTRATE-SPECIFICITY; NLRC4 INFLAMMASOME; SHIGELLA-FLEXNERI; NMR; SPECTROSCOPY; SENSITIVITY; INJECTISOME; ACTIVATION; COMPONENTS	The type III secretion system (T3SS) is essential in the pathogenesis of many bacteria. The inner rod is important in the assembly of the T3SS needle complex. However, the atomic structure of the inner rod protein is currently unknown. Based on computational methods, others have suggested that the Salmonella inner rod protein PrgJ is highly helical, forming a folded 3 helix structure. Here we show by CD and NMR spectroscopy that the monomeric form of PrgJ lacks a tertiary structure, and the only well-structured part of PrgJ is a short alpha-helix at the C-terminal region from residues 65-82. Disruption of this helix by glycine or proline mutation resulted in defective assembly of the needle complex, rendering bacteria incapable of secreting effector proteins. Likewise, CD and NMR data for the Shigella inner rod protein MxiI indicate this protein lacks a tertiary structure as well. Our results reveal that the monomeric forms of the T3SS inner rod proteins are partially folded.	[Zhong, Dalian; Kaur, Kawaljit; Gdowski, Courtney; Jo, Sunhwan; Wang, Yu; Benedict, Stephen H.; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Lefebre, Matthew; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [McDowell, Melanie A.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Kansas; Yale University; University of Oxford	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	wang, yu/A-3473-2011; Lea, Susan M/B-7678-2009	Lea, Susan M/0000-0001-9287-8053; Jo, Sunhwan/0000-0002-4104-6473; McDowell, Melanie/0000-0002-5231-8809	National Institutes of Health Grant [AI074856, AI030492]; KU Diabetes Institute; Wellcome Trust Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030492, R29AI030492, R01AI030492, R01AI074856] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Diabetes Institute; Wellcome Trust Studentship(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074856 (to R. N. D.), National Institutes of Health Grant AI030492 (to J. G.), KU Diabetes Institute (to S. B.), and Wellcome Trust Studentship (to M. A. M).	Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Davies John Q, 2005, Methods Mol Biol, V290, P91; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GODDARD T, 2000, SPARKY NMR ANAL SOFT; Gong H, 2010, MICROBIOL-SGM, V156, P116, DOI 10.1099/mic.0.032318-0; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Huth JR, 1997, PROTEIN SCI, V6, P2359; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Klein JR, 2000, INFECT IMMUN, V68, P3368, DOI 10.1128/IAI.68.6.3368-3376.2000; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; MELTZER MS, 1981, J IMMUNOL, V127, P179; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren SE, 2011, EUR J IMMUNOL, V41, P1934, DOI 10.1002/eji.201041214; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Zughaier SM, 1999, INFECT IMMUN, V67, P1505, DOI 10.1128/IAI.67.3.1505-1507.1999	47	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25303	25311		10.1074/jbc.M112.381574	http://dx.doi.org/10.1074/jbc.M112.381574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654099	hybrid, Green Published			2022-12-25	WOS:000306651700038
J	Karlberg, T; Thorsell, AG; Kallas, A; Schuler, H				Karlberg, Tobias; Thorsell, Ann-Gerd; Kallas, Asa; Schuler, Herwig			Crystal Structure of Human ADP-ribose Transferase ARTD15/PARP16 Reveals a Novel Putative Regulatory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE MUTATIONS; POLY(ADP-RIBOSE) POLYMERASE; PROTEIN-STRUCTURE; CATALYTIC FRAGMENT; DIPHTHERIA-TOXIN; FAMILY; PARP; INHIBITOR; SEQUENCE; BINDING	ADP-ribosylation is involved in the regulation of DNA repair, transcription, and other processes. The 18 human ADP-ribose transferases with diphtheria toxin homology include ARTD1/PARP1, a cancer drug target. Knowledge of other family members may guide therapeutics development and help evaluate potential drug side effects. Here, we present the crystal structure of human ARTD15/PARP16, a previously uncharacterized enzyme. ARTD15 features an alpha-helical domain that packs against its transferase domain without making direct contact with the NAD(+)-binding crevice or the donor loop. Thus, this novel domain does not resemble the regulatory domain of ARTD1. ARTD15 displays auto-mono(ADP-ribosylation) activity and is affected by canonical poly(ADP-ribose) polymerase inhibitors. These results add to a framework that will facilitate research on a medically important family of enzymes.	[Karlberg, Tobias; Thorsell, Ann-Gerd; Kallas, Asa; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Karlberg, Tobias; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	Structural Genomics Consortium; Canadian Institutes of Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Swedish Foundation for Strategic Research [RBc08-0014]	Structural Genomics Consortium(University of Toronto); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Structural Genomics Consortium, a registered charity (1097737) that received funds from the Canadian Institutes of Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was also supported by Swedish Foundation for Strategic Research Grant RBc08-0014.	Blanc E., 2011, BUSTER VERSION 2 11; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Di Paola S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037352; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; WILSON BA, 1994, J BIOL CHEM, V269, P23296	31	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24077	24081		10.1074/jbc.M112.379289	http://dx.doi.org/10.1074/jbc.M112.379289			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661712	Green Published, hybrid			2022-12-25	WOS:000306651100002
J	Kaneoke, Y; Donishi, T; Iwatani, J; Ukai, S; Shinosaki, K; Terada, M				Kaneoke, Yoshiki; Donishi, Tomohiro; Iwatani, Jun; Ukai, Satoshi; Shinosaki, Kazuhiro; Terada, Masaki			Variance and Autocorrelation of the Spontaneous Slow Brain Activity	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; NETWORK; VARIABILITY; PRECUNEUS; ANATOMY; CORTEX; SIGNAL; BOLD	Slow (<0.1 Hz) oscillatory activity in the human brain, as measured by functional magnetic imaging, has been used to identify neural networks and their dysfunction in specific brain diseases. Its intrinsic properties may also be useful to investigate brain functions. We investigated the two functional maps: variance and first order autocorrelation coefficient (r(1)). These two maps had distinct spatial distributions and the values were significantly different among the subdivisions of the precuneus and posterior cingulate cortex that were identified in functional connectivity (FC) studies. The results reinforce the functional segregation of these subdivisions and indicate that the intrinsic properties of the slow brain activity have physiological relevance. Further, we propose a sample size (degree of freedom) correction when assessing the statistical significance of FC strength with r(1) values, which enables a better understanding of the network changes related to various brain diseases.	[Kaneoke, Yoshiki; Donishi, Tomohiro] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Iwatani, Jun; Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Kaneoke, Y (corresponding author), Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan.	kaneoke@wakayama-med.ac.jp		Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24591303] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 1964, HDB APPL HYROLOGY 3, P868; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bartzokis G, 2007, ALZHEIMERS DEMENT, V3, P122, DOI 10.1016/j.jalz.2007.01.019; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Hughett P., 2007, CODE SNIPPETS, V23, P1; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Vos BP, 1999, J NEUROSCI, V19; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	36	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38131	10.1371/journal.pone.0038131	http://dx.doi.org/10.1371/journal.pone.0038131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666461	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400086
J	Rey-Cuille, MA; Seck, A; Njouom, R; Chartier, L; Sow, HD; MamadouBa; Ka, AS; Njankouo, M; Rousset, D; Giles-Vernick, T; Unal, G; Sire, JM; Garin, B; Simon, F; Vray, M				Rey-Cuille, Marie-Anne; Seck, Abdoulaye; Njouom, Richard; Chartier, Loic; Sow, Housseyn Dembel; MamadouBa; Ka, Amadou Sidy; Njankouo, Mohamadou; Rousset, Dominique; Giles-Vernick, Tamara; Unal, Guillemette; Sire, Jean-Marie; Garin, Benoit; Simon, Francois; Vray, Muriel			Low Immune Response to Hepatitis B Vaccine among Children in Dakar, Senegal	PLOS ONE			English	Article							EXPANDED PROGRAM; EPIDEMIOLOGY; IMMUNOGENICITY; INFECTION; VIRUS	HBV vaccine was introduced into the Expanded Programme on Immunization (EPI) in Senegal and Cameroon in 2005. We conducted a cross-sectional study in both countries to assess the HBV immune protection among children. All consecutive children under 4 years old, hospitalized for any reason between May 2009 and May 2010, with an immunisation card and a complete HBV vaccination, were tested for anti-HBs and anti-HBc. A total of 242 anti-HBc-negative children (128 in Cameroon and 114 in Senegal) were considered in the analysis. The prevalence of children with anti-HBs >= 10 IU/L was higher in Cameroon with 92% (95% CI: 87%-97%) compared to Senegal with 58% (95% CI: 49%-67%), (p<0.001). The response to vaccination in Senegal was lower in 2006-2007 (43%) than in 2008-2009 (65%), (p = 0.028). Our results, although not based on a representative sample of Senegalese or Cameroonian child populations, reveal a significant problem in vaccine response in Senegal. This response problem extends well beyond hepatitis B: the same children who have not developed an immune response to the HBV vaccine are also at risk for diphtheria, tetanus, pertussis (DTwP) and Haemophilus influenzae type b (Hib). Field biological monitoring should be carried out regularly in resource-poor countries to check quality of the vaccine administered.	[Rey-Cuille, Marie-Anne; Chartier, Loic; Giles-Vernick, Tamara; Unal, Guillemette; Vray, Muriel] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Rey-Cuille, Marie-Anne] CNRS, Inst Biol Sci, Paris, France; [Seck, Abdoulaye; Sire, Jean-Marie; Garin, Benoit] Inst Pasteur, Med Biol Lab, Dakar, Senegal; [Njouom, Richard; Njankouo, Mohamadou; Rousset, Dominique] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Sow, Housseyn Dembel; MamadouBa] Hop Enfants Albert Royer, Dakar, Senegal; [Ka, Amadou Sidy] Hop Principal, Serv Pediat, Dakar, Senegal; [Sire, Jean-Marie; Simon, Francois] Hop St Louis, Dept Virol, Paris, France; [Vray, Muriel] INSERM, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre Pasteur du Cameroun; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rey-Cuille, MA (corresponding author), Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France.	muriel.vray@pasteur.fr	Rey-Cuille, Marie-Anne/J-7486-2012; Rousset, Dominique/S-5400-2019; Vray, Muriel/M-7947-2018	Rousset, Dominique/0000-0002-1473-3147; 	"Actions concertees du Reseau International des Instituts Pasteur", France	"Actions concertees du Reseau International des Instituts Pasteur", France	The study was funded by the "Actions concertees du Reseau International des Instituts Pasteur", France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2000, VACCINE, V18, pS20, DOI 10.1016/S0264-410X(99)00456-9; Aspinall S, 1998, S AFR MED J, V88, P36; CHIARAMONTE M, 1991, J MED VIROL, V33, P95, DOI 10.1002/jmv.1890330206; Coursaget P, 1984, IARC Sci Publ, P319; DAO H, 1992, J TROP PEDIATRICS, V38, P179, DOI 10.1093/tropej/38.4.179; ElGamal Y, 1996, J TROP PEDIATRICS, V42, P144, DOI 10.1093/tropej/42.3.144; Foupouapouognigni Y, 2011, J CLIN MICROBIOL, V49, P737, DOI 10.1128/JCM.01475-10; GARRIGUE G, 1985, B SOC PATHOL EXOT, V78, P883; Gatchalian S, 2005, HUM VACCINES, V1, P198, DOI 10.4161/hv.1.5.2163; Kanra G, SAFETY IMMUNOGENICIT; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Lakshmi G, 2000, VACCINE, V18, P2009, DOI 10.1016/S0264-410X(99)00529-0; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Plotkin SA, 2013, VACCINES; Roingeard Philippe, 1993, Viral Immunology, V6, P65, DOI 10.1089/vim.1993.6.65; Sall Diallo A, 2004, Dakar Med, V49, P136; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Vray M, 2006, J MED VIROL, V78, P329, DOI 10.1002/jmv.20544; Wamukonya N., 2005, EC POLITICAL WKLY, V40, P5302; WHO, 2010, IMM STAND VACC QUAL; WHO, 2010, IMM SURV ASS MON; WHO, 1991, WHOEPIGEN9291	23	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38153	10.1371/journal.pone.0038153	http://dx.doi.org/10.1371/journal.pone.0038153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666468	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400091
J	Santos, JR; Molto, J; Llibre, JM; Negredo, E; Bravo, I; Ornelas, A; Clotet, B; Paredes, R				Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia; Bravo, Isabel; Ornelas, Arelly; Clotet, Bonaventura; Paredes, Roger			Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile	PLOS ONE			English	Article							MONET TRIAL; NUCLEOSIDE ANALOGS; HIV RNA; EFFICACY	Background: Simplification of antiretroviral treatment (ART) with darunavir/ritonavir (DRV/r) monotherapy has achieved sustained suppression of plasma viral load (pVL) in clinical trials; however, its effectiveness and safety profile has not been evaluated in routine clinical practice. Methodology/Principal Findings: We performed a retrospective cohort analysis of HIV-1-infected patients who initiated DRV/r monotherapy once daily with a pVL <50 copies/mL under ART and at least 1 subsequent follow-up visit in our clinic. The primary study endpoints were the percentage of patients with virological failure (VF, defined as 2 consecutive pVL>50 copies/mL) at week 48, and time to VF. Other causes of treatment discontinuation and changes in lipid profile were evaluated up to week 48. Ninety-two patients were followed for a median (IQR) of 73 (57-92) weeks. The median baseline and nadir CD4+ T-cell counts were 604 (433-837) and 238 (150-376) cells/mm3, respectively. Patients had previously received a median of 5 (3-9) ART lines and maintained a pVL<50 copies/mL for a median of 76 (32-176) weeks before initiating DRV/r monotherapy. Nine (9.8%) patients developed VF at week 48; time to VF was 47.1 (IQR: 36.1-47.8) weeks among patients with VF. Other reasons for changing ART were gastrointestinal disturbances (n = 3), rash (n = 1), and impaired CD4 recovery (n = 2). Median low-density lipoprotein cholesterol levels increased from 116.1 mg/dL at baseline to 137.3 mg/dL at 48 weeks (p = 0.001). Conclusions/Significance: Treatment simplification with DRV/r monotherapy seems safe and effective in routine clinical practice. Further research is needed to elucidate the effect of DRV/r monotherapy on cholesterol levels.	[Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia; Bravo, Isabel; Ornelas, Arelly; Clotet, Bonaventura; Paredes, Roger] Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Barcelona, Spain; [Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Ornelas, Arelly] Univ Barcelona, Dept Econometr Stat & Spanish Econ, Barcelona, Spain; [Clotet, Bonaventura; Paredes, Roger] IrsiCaixa Fdn, Barcelona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa	Santos, JR (corresponding author), Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Barcelona, Spain.	jrsantos@flsida.org		Negredo, Eugenia/0000-0001-5298-1734; Molto, Jose/0000-0003-4564-1963	Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA" [RIS,RD06/0006]; NEAT (European AIDS Treatment Network); Lluita contra la SIDA Foundation; Abbott; Boehringer Ingelheim; Gilead Sciences; Glaxo Smith-Kline; Janssen-Cilag; Bristol-Myers Squibb; ViiV Healthcare; Pfizer; Merck Sharp Dohme; Roche; Panacos; Tibotec; Roche Diagnostics; Siemens	Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA"; NEAT (European AIDS Treatment Network); Lluita contra la SIDA Foundation; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences); Glaxo Smith-Kline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare; Pfizer(Pfizer); Merck Sharp Dohme(Merck & Company); Roche(Roche Holding); Panacos; Tibotec; Roche Diagnostics; Siemens(Siemens AG)	This study was funded in part by grants from the Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA" (RIS,RD06/0006), NEAT (European AIDS Treatment Network) and Lluita contra la SIDA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jose R Santos has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. Jose Molto has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. Josep M Llibre has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, and Roche. Eugenia Negredo has received research honoraria for speaking and serving on advisory boards from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Roche, Janssen-Cilag, and Merck Sharp & Dohme. Bonaventura Clotet has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Panacos, Pfizer, Roche, and Tibotec. Arelly Ornelas and Isabel Bravo declare no competing interests. Roger Paredes has received consulting fees from Pfizer, Merck Sharp and Dohme, Roche Diagnostics. The IrsiCaixa AIDS Research Institute and the Lluita contra la SIDA Foundation have received grant support from Pfizer, ViiV Healthcare, Siemens, Merck Sharp and Dohme, and Boehringer Ingelheim for studies in which Dr. Paredes serves as principal investigator. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 3 REP NAT CHOL ED PR; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Bedimo R, 2006, HIV MED, V7, P530, DOI 10.1111/j.1468-1293.2006.00416.x; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Boffito M, 2008, HIV CLIN TRIALS, V9, P418, DOI 10.1310/hct0906-418; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Campo R, 2011, 51 INT C ANT AG CHEM; Chen JY, 2010, J GASTROEN HEPATOL, V25, P1763, DOI 10.1111/j.1440-1746.2010.06300.x; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; EUROPEAN AIDS CLINICAL SOCIETY GUIDELINES (EACS), 2011, GUID CLIN MAN TREATM; Gazzard B, 2011, APPL HEALTH ECON HEA, V9, P217, DOI 10.2165/11592220-000000000-00000; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Kolta S, 2011, CURR HIV RES, V9, P31, DOI 10.2174/157016211794582687; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tungsiripat M, 2010, AIDS, V24, P1781, DOI 10.1097/QAD.0b013e32833ad8b4; Valantin MA, 2010, J ANTIMICROB CHEMOTH, V65, P556, DOI 10.1093/jac/dkp462; Valantin MA, 2010, 17 C RETR OPP INF FE	19	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37442	10.1371/journal.pone.0037442	http://dx.doi.org/10.1371/journal.pone.0037442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666357	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600016
J	Sergeant, MJ; Constantinidou, C; Cogan, T; Penn, CW; Pallen, MJ				Sergeant, Martin J.; Constantinidou, Chrystala; Cogan, Tristan; Penn, Charles W.; Pallen, Mark J.			High-Throughput Sequencing of 16S rRNA Gene Amplicons: Effects of Extraction Procedure, Primer Length and Annealing Temperature	PLOS ONE			English	Article							PCR; BACTERIAL; MICROBIOTA; DIVERSITY; MISMATCH	The analysis of 16S-rDNA sequences to assess the bacterial community composition of a sample is a widely used technique that has increased with the advent of high throughput sequencing. Although considerable effort has been devoted to identifying the most informative region of the 16S gene and the optimal informatics procedures to process the data, little attention has been paid to the PCR step, in particular annealing temperature and primer length. To address this, amplicons derived from 16S-rDNA were generated from chicken caecal content DNA using different annealing temperatures, primers and different DNA extraction procedures. The amplicons were pyrosequenced to determine the optimal protocols for capture of maximum bacterial diversity from a chicken caecal sample. Even at very low annealing temperatures there was little effect on the community structure, although the abundance of some OTUs such as Bifidobacterium increased. Using shorter primers did not reveal any novel OTUs but did change the community profile obtained. Mechanical disruption of the sample by bead beating had a significant effect on the results obtained, as did repeated freezing and thawing. In conclusion, existing primers and standard annealing temperatures captured as much diversity as lower annealing temperatures and shorter primers.	[Sergeant, Martin J.; Constantinidou, Chrystala; Penn, Charles W.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England; [Cogan, Tristan] Univ Bristol, Sch Vet Sci, Bristol, Avon, England	University of Birmingham; University of Bristol	Sergeant, MJ (corresponding author), Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England.	m.pallen@bham.ac.uk		Sergeant, Martin/0000-0001-7264-2668; Pallen, Mark/0000-0003-1807-3657	Biotechnology and Biological Sciences Research Council [BB/H019340/1]; BBSRC [BB/H019340/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant Number: BB/H019340/1 (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Hajati H., 2010, INT J POULT SCI, V9, P298, DOI [10.3923/ijps.2010.298.304, DOI 10.3923/IJPS.2010.298.304]; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x; Scupham AJ, 2010, APPL ENVIRON MICROB, V76, P8026, DOI 10.1128/AEM.00678-10; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	22	55	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38094	10.1371/journal.pone.0038094	http://dx.doi.org/10.1371/journal.pone.0038094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666455	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600062
J	Geloen, A; Helin, L; Geeraert, B; Malaud, E; Holvoet, P; Marguerie, G				Geloen, Alain; Helin, Lionel; Geeraert, Benjamine; Malaud, Eric; Holvoet, Paul; Marguerie, Gerard			CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SCAVENGER RECEPTOR CD36; LOW-DENSITY-LIPOPROTEIN; ADIPOCYTE MEMBRANE-PROTEIN; INSULIN SENSITIVITY; OXIDIZED LDL; CHOLESTEROL UPTAKE; MACROPHAGE; MICE; DEFICIENCY	CD36 is recognized as a lipid and fatty acid receptor and plays an important role in the metabolic syndrome and associated cardiac events. The pleiotropic activity and the multiple molecular associations of this scavenger receptor with membrane associated molecules in different cells and tissues have however questioned its potential as a therapeutic target. The present study shows that it is possible to identify low molecular weight chemicals that can block the CD36 binding and uptake functions. These inhibitors were able to reduce arterial lipid deposition, fatty acid intestinal transit, plasma concentration of triglycerides and glucose, to improve insulin sensitivity, glucose tolerance and to reduce the plasma concentration of HbAc1 in different and independent rodent models. Correlation between the anti-CD36 activity of these inhibitors and the known pathophysiological activity of this scavenger receptor in the development of atherosclerosis and diabetes were observed at pharmacological doses. Thus, CD36 might represent an attractive therapeutic target.	[Geloen, Alain] Lyon Univ, INSA Lyon, IMBL Villeurbanne, INSERM U1060,CarMeN Lab, Lyon, France; [Geeraert, Benjamine; Holvoet, Paul] Katholieke Univ Leuven, Atherosclerosis & Metab Unit, Dept Cardiovasc Sci, Louvain, Belgium; [Helin, Lionel; Malaud, Eric; Marguerie, Gerard] Arteria, Caissargues, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; KU Leuven	Geloen, A (corresponding author), Lyon Univ, INSA Lyon, IMBL Villeurbanne, INSERM U1060,CarMeN Lab, Lyon, France.	g.marguerie@arteria-lab.com	HOLVOET, PAUL/T-8434-2017	HOLVOET, PAUL/0000-0001-9201-0772; GELOEN, Alain/0000-0001-7921-1254	Arteria	Arteria	This research project was supported in whole by a grant from Arteria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haffner SM, 2002, AM J CARDIOL, V90, p55I, DOI 10.1016/S0002-9149(02)02634-6; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; Howard B V, 2000, Curr Atheroscler Rep, V2, P476, DOI 10.1007/s11883-000-0046-8; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Huang WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029092; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Masson CJ, 2009, PLOS ONE, V5; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Plutzky J, 2002, J DIABETES COMPLICAT, V16, P401, DOI 10.1016/S1056-8727(02)00202-7; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Sukhanov S, 2006, CIRC RES, V99, P191, DOI 10.1161/01.RES.0000232319.02303.8c; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6	47	40	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37633	10.1371/journal.pone.0037633	http://dx.doi.org/10.1371/journal.pone.0037633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662181	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300071
J	Labrousse, VF; Nadjar, A; Joffre, C; Costes, L; Aubert, A; Gregoire, S; Bretillon, L; Laye, S				Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Gregoire, Stephane; Bretillon, Lionel; Laye, Sophie			Short-Term Long Chain Omega3 Diet Protects from Neuroinflammatory Processes and Memory Impairment in Aged Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GAMMA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ARACHIDONIC-ACID; LEARNING-ABILITY; MICROGLIAL CELLS; FOS EXPRESSION; WORKING-MEMORY; GRANULE CELLS	Regular consumption of food enriched in omega3 polyunsaturated fatty acids (omega 3 PUFAs) has been shown to reduce risk of cognitive decline in elderly, and possibly development of Alzheimer's disease. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the most likely active components of omega 3-rich PUFAs diets in the brain. We therefore hypothesized that exposing mice to a DHA and EPA enriched diet may reduce neuroinflammation and protect against memory impairment in aged mice. For this purpose, mice were exposed to a control diet throughout life and were further submitted to a diet enriched in EPA and DHA during 2 additional months. Cytokine expression together with a thorough analysis of astrocytes morphology assessed by a 3D reconstruction was measured in the hippocampus of young (3-month-old) and aged (22-month-old) mice. In addition, the effects of EPA and DHA on spatial memory and associated Fos activation in the hippocampus were assessed. We showed that a 2-month EPA/DHA treatment increased these long-chain omega 3 PUFAs in the brain, prevented cytokines expression and astrocytes morphology changes in the hippocampus and restored spatial memory deficits and Fos-associated activation in the hippocampus of aged mice. Collectively, these data indicated that diet-induced accumulation of EPA and DHA in the brain protects against neuroinflammation and cognitive impairment linked to aging, further reinforcing the idea that increased EPA and DHA intake may provide protection to the brain of aged subjects.	[Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Laye, Sophie] INRA 1286, Bordeaux, France; [Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Laye, Sophie] Univ Bordeaux, Bordeaux, France; [Gregoire, Stephane; Bretillon, Lionel] Univ Bourgogne, Eye & Nutr Res Grp, CGA, INRA, Dijon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Labrousse, VF (corresponding author), INRA 1286, Bordeaux, France.	sophie.laye@bordeaux.inra.fr	Laye, Sophie/AAX-2501-2020	Laye, Sophie/0000-0002-3843-1012; JOFFRE, Corinne/0000-0001-8327-3554; Bretillon, Lionel/0000-0002-6957-100X; NADJAR, Agnes/0000-0002-3969-6530; Labrousse, Francois/0000-0002-3185-4856	Region Aquitaine; Institut National de la Recherche Agronomique; Agence Nationale de Recherche (ANR); INRA	Region Aquitaine(Region Nouvelle-Aquitaine); Institut National de la Recherche Agronomique; Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); INRA	This work was supported by the Region Aquitaine, the Institut National de la Recherche Agronomique and the Agence Nationale de Recherche (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; V.F.L. receives a fellowship from the INRA and the Region Aquitaine. Quantitative PCR analyses were performed at the Bordeaux Genotyping and Sequencing facility. We thank F. Levet, P. Legros and C. Poujol of the Bordeaux Imaging Center at Bordeaux for their unceasing help. We thank P. Birac and C. Tridon for their help with the care of the mice. We thank Helen Bayer for editing the Ms.	Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Barham JB, 2000, J NUTR, V130, P1925, DOI 10.1093/jn/130.8.1925; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Boudrault C, 2009, J NUTR BIOCHEM, V20, P1, DOI 10.1016/j.jnutbio.2008.05.016; Bourre JM, 2005, J NUTR HEALTH AGING, V9, P31; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Campbell IL, 1997, MOL PSYCHIATR, V2, P125, DOI 10.1038/sj.mp.4000225; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Carrie I, 2002, NUTR NEUROSCI, V5, P43, DOI 10.1080/10284150290007074; Champeil-Potokar G, 2006, EUR J NEUROSCI, V24, P3084, DOI 10.1111/j.1460-9568.2006.05185.x; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; DAS GD, 1976, BRAIN RES, V110, P199, DOI 10.1016/0006-8993(76)90397-8; Das UN, 2006, PROSTAG LEUKOTR ESS, V74, P165, DOI 10.1016/j.plefa.2006.01.002; De Smedt-Peyrusse V, 2008, J NEUROCHEM, V105, P296, DOI 10.1111/j.1471-4159.2007.05129.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gautron L, 2002, NEUROSCIENCE, V112, P717, DOI 10.1016/S0306-4522(02)00115-X; Gemma C, 2007, EUR J NEUROSCI, V26, P2795, DOI 10.1111/j.1460-9568.2007.05875.x; Gemma C, 2007, REV NEUROSCIENCE, V18, P137; GIBERTINI M, 1995, BRAIN BEHAV IMMUN, V9, P113, DOI 10.1006/brbi.1995.1012; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Joardar A, 2007, CELL MOL NEUROBIOL, V27, P973, DOI 10.1007/s10571-007-9204-7; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kavanagh T, 2004, PROSTAG LEUKOTR ESS, V70, P391, DOI 10.1016/j.plefa.2003.12.014; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; LANDFIELD PW, 1977, J GERONTOL, V32, P3, DOI 10.1093/geronj/32.1.3; LAPING NJ, 1994, J NEUROSCI RES, V39, P710, DOI 10.1002/jnr.490390612; Laye S, 2010, PROSTAG LEUKOTR ESS, V82, P295, DOI 10.1016/j.plefa.2010.02.006; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; LINDSEY JD, 1979, J GERONTOL, V34, P661, DOI 10.1093/geronj/34.5.661; LIPP HP, 1984, SCIENCE, V225, P80, DOI 10.1126/science.6729469; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Lu DY, 2010, NEUROPSYCHOPHARMACOL, V35, P2238, DOI 10.1038/npp.2010.98; Luchtman DW, 2012, BEHAV BRAIN RES, V226, P386, DOI 10.1016/j.bbr.2011.09.033; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Mesches MH, 2004, NEUROBIOL AGING, V25, P315, DOI 10.1016/S0197-4580(03)00116-7; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Minogue AM, 2007, J NEUROCHEM, V103, P914, DOI 10.1111/j.1471-4159.2007.04848.x; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P222, DOI 10.1016/j.intimp.2006.10.001; Moranis A, 2011, BRAIN BEHAV IMMUN; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Murray CA, 1998, J NEUROSCI, V18, P2974; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Petursdottir AL, 2008, J GERONTOL A-BIOL, V63, P1153, DOI 10.1093/gerona/63.11.1153; Porte Y, 2008, NEUROBIOL AGING, V29, P1533, DOI 10.1016/j.neurobiolaging.2007.03.023; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Schnebelen C, 2008, OPHTHALMIC IN PRESS; Schnebelen C, 2009, LIPIDS, V44, P465, DOI 10.1007/s11745-009-3289-3; Schuster G, 1997, NEUROBIOL LEARN MEM, V68, P86, DOI 10.1006/nlme.1997.3775; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shires KL, 2008, EUR J NEUROSCI, V28, P982, DOI 10.1111/j.1460-9568.2008.06402.x; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Spulber S, 2008, EUR J NEUROSCI, V27, P549, DOI 10.1111/j.1460-9568.2008.06050.x; Sykova E, 1998, EXP GERONTOL, V33, P837, DOI 10.1016/S0531-5565(98)00038-2; Tanabe Y, 2004, CLIN EXP PHARMACOL P, V31, P700, DOI 10.1111/j.1440-1681.2004.04068.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Touzani K, 2003, EUR J NEUROSCI, V17, P628, DOI 10.1046/j.1460-9568.2003.02464.x; Viau S, 2009, GRAEF ARCH CLIN EXP, V247, P1039, DOI 10.1007/s00417-009-1080-z; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	97	136	142	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36861	10.1371/journal.pone.0036861	http://dx.doi.org/10.1371/journal.pone.0036861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662127	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300018
J	Soares, CP; Midlej, V; de Oliveira, MEW; Benchimol, M; Costa, ML; Mermelstein, C				Soares, Carolina Pontes; Midlej, Victor; Weschollek de Oliveira, Maria Eduarda; Benchimol, Marlene; Costa, Manoel Luis; Mermelstein, Claudia			2D and 3D-Organized Cardiac Cells Shows Differences in Cellular Morphology, Adhesion Junctions, Presence of Myofibrils and Protein Expression	PLOS ONE			English	Article							SHAPE	Cardiac cells are organized in vivo in a complex tridimensional structural organization that is crucial for heart function. While in vitro studies can reveal details about cardiac cell biology, usually cells are grown on simplified two-dimensional (2D) environments. To address these differences, we established a cardiac cell culture composed of both 2D and three-dimensional (3D)-organized cells. Our results shows significant differences between the two culture contexts in relation to the overall morphology of the cells, contraction ability, proliferation rate, presence of intercellular adhesion structures, organization of myofibrils, mitochondria morphology, endoplasmic reticulum contents, cytoskeletal filaments and extracellular matrix distribution, and expression of markers of cardiac differentiation. Cardiac cells grown in 2D-context displayed a flattened and well spread shape, were mostly isolated and their cytoplasm was filled with a large network of microfilaments and microtubules. In contrast, 3D-cells were smaller in size, were always in close contact with each other with several cellular junctions, and displayed a less conspicuous cytoskeletal network. 3D-cells had more mitochondria and myofibrils and these cells contract spontaneously more often than 2D-cells. On the other hand, endoplasmic reticulum membranes were present in higher amounts in 2D-cells when compared to 3D-cells. The expression of desmin, cadherin and alpha-actinin was higher in 3D-aggregates compared to 2D-spread cells. These findings indicate that the tridimensional environment in which the cardiac cells are grown influence several aspects of cardiac differentiation, including cell adhesion, cell shape, myofibril assembly, mitochondria contents and protein expression. We suggest that the use of this cardiac culture model, with 2D and 3D-context cells, could be useful for studies on the effects of different drugs, or growth factors, giving valuable information on the biological response of cells grown in different spatial organizations.	[Soares, Carolina Pontes; Weschollek de Oliveira, Maria Eduarda; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Midlej, Victor; Benchimol, Marlene] Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Soares, CP (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	mermelstein, Claudia S/C-1464-2010; Costa, Manoel/B-5009-2010; Midlej, Victor/AFU-1569-2022	mermelstein, Claudia S/0000-0002-8897-8526; Costa, Manoel/0000-0002-9037-0085; do Valle Pereira Midlej, Victor/0000-0001-9294-6597	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RE, 2010, TISSUE ENG PT A, V16, P629, DOI 10.1089/ten.tea.2009.0458; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Byers H.R., 1984, Cell and Muscle Motility, V5, P83; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; CLAYCOMB WC, 1992, TRENDS CARDIOVAS MED, V2, P231, DOI 10.1016/1050-1738(92)90030-V; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; DECKER ML, 1991, J MOL CELL CARDIOL, V23, P817, DOI 10.1016/0022-2828(91)90215-8; Ehler E, 2000, Heart Fail Rev, V5, P259, DOI 10.1023/A:1009861504264; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173; Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722; RENAUD JF, 1976, J MOL CELL CARDIOL, V8, P889, DOI 10.1016/0022-2828(76)90071-7; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Soares CP, 2010, CELLS TISSUES ORGANS, V192, P187, DOI 10.1159/000316005; SPERELAKIS N, 1978, ENVIRON HEALTH PERSP, V26, P243, DOI 10.2307/3428847; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	26	95	96	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38147	10.1371/journal.pone.0038147	http://dx.doi.org/10.1371/journal.pone.0038147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662278	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300170
J	Sokolove, J; Bromberg, R; Deane, KD; Lahey, LJ; Derber, LA; Chandra, PE; Edison, JD; Gilliland, WR; Tibshirani, RJ; Norris, JM; Holers, VM; Robinson, WH				Sokolove, Jeremy; Bromberg, Reuven; Deane, Kevin D.; Lahey, Lauren J.; Derber, Lezlie A.; Chandra, Piyanka E.; Edison, Jess D.; Gilliland, William R.; Tibshirani, Robert J.; Norris, Jill M.; Holers, V. Michael; Robinson, William H.			Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; CHRONIC INFLAMMATORY DISEASE; TOLL-LIKE RECEPTORS; C-REACTIVE PROTEIN; DOUBLE-BLIND; UP-REGULATION; BLOOD-DONORS; UNDIFFERENTIATED ARTHRITIS; AUTOIMMUNE ARTHRITIS; IMMUNE-COMPLEXES	Rheumatoid arthritis (RA) is a prototypical autoimmune arthritis affecting nearly 1% of the world population and is a significant cause of worldwide disability. Though prior studies have demonstrated the appearance of RA-related autoantibodies years before the onset of clinical RA, the pattern of immunologic events preceding the development of RA remains unclear. To characterize the evolution of the autoantibody response in the preclinical phase of RA, we used a novel multiplex autoantigen array to evaluate development of the anti-citrullinated protein antibodies (ACPA) and to determine if epitope spread correlates with rise in serum cytokines and imminent onset of clinical RA. To do so, we utilized a cohort of 81 patients with clinical RA for whom stored serum was available from 1-12 years prior to disease onset. We evaluated the accumulation of ACPA subtypes over time and correlated this accumulation with elevations in serum cytokines. We then used logistic regression to identify a profile of biomarkers which predicts the imminent onset of clinical RA (defined as within 2 years of testing). We observed a time-dependent expansion of ACPA specificity with the number of ACPA subtypes. At the earliest timepoints, we found autoantibodies targeting several innate immune ligands including citrullinated histones, fibrinogen, and biglycan, thus providing insights into the earliest autoantigen targets and potential mechanisms underlying the onset and development of autoimmunity in RA. Additionally, expansion of the ACPA response strongly predicted elevations in many inflammatory cytokines including TNF-alpha, IL-6, IL-12p70, and IFN-gamma. Thus, we observe that the preclinical phase of RA is characterized by an accumulation of multiple autoantibody specificities reflecting the process of epitope spread. Epitope expansion is closely correlated with the appearance of preclinical inflammation, and we identify a biomarker profile including autoantibodies and cytokines which predicts the imminent onset of clinical arthritis.	[Sokolove, Jeremy; Bromberg, Reuven; Lahey, Lauren J.; Chandra, Piyanka E.; Robinson, William H.] Stanford Univ, Dept Med, Div Rheumatol, Sch Med, Stanford, CA 94305 USA; [Lahey, Lauren J.; Chandra, Piyanka E.; Tibshirani, Robert J.] Stanford Univ, Dept Stat, Sch Med, Stanford, CA 94305 USA; [Tibshirani, Robert J.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Sokolove, Jeremy; Bromberg, Reuven; Robinson, William H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Deane, Kevin D.; Derber, Lezlie A.; Holers, V. Michael] Univ Colorado, Div Rheumatol, Dept Med, Sch Med, Aurora, CO USA; [Edison, Jess D.; Gilliland, William R.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Norris, Jill M.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Sokolove, J (corresponding author), Stanford Univ, Dept Med, Div Rheumatol, Sch Med, Stanford, CA 94305 USA.	sokolove@stanford.edu; wrobins@stanford.edu		Robinson, William/0000-0003-4385-704X	United States National Institutes of Health; American College of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology(General Electric); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by grants from the United States National Institutes of Health and the American College of Rheumatology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1993, J RHEUMATOL, V20, P1278; Aho K, 2000, J RHEUMATOL, V27, P1136; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Deane KD, 2010, ARTHRITIS RHEUM; DOEGLAS D, 1995, ANN RHEUM DIS, V54, P455, DOI 10.1136/ard.54.6.455; El-Gabalawy HS, 2009, J RHEUMATOL, V36, P1130, DOI 10.3899/jrheum.080855; FAARVANG KL, 1993, ANN RHEUM DIS, V52, P711, DOI 10.1136/ard.52.10.711; Firestein GS, 1997, NEW ENGL J MED, V337, P195, DOI 10.1056/NEJM199707173370310; HAAR D, 1993, SCAND J RHEUMATOL, V22, P113, DOI 10.3109/03009749309099254; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Hueber W, 2007, ANN RHEUM DIS, V66, P712, DOI 10.1136/ard.2006.054924; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kolfenbach JR, 2010, ARTHRITIS RHEUM-US, V62, P2633, DOI 10.1002/art.27570; KREMER JM, 1989, ARTHRITIS RHEUM, V32, P121, DOI 10.1002/anr.1780320202; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Majka DS, 2008, ANN RHEUM DIS, V67, P801, DOI 10.1136/ard.2007.076679; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Monach PA, 2009, P NATL ACAD SCI USA, V106, P15867, DOI 10.1073/pnas.0908032106; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; O'Dell JR, 2001, ARTHRITIS RHEUM-US, V44, P2235, DOI 10.1002/1529-0131(200110)44:10&lt;2235::AID-ART385&gt;3.0.CO;2-A; Pelayo R, 2007, NEW ENGL J MED, V356, P426, DOI 10.1056/NEJMc062467; Quinn MA, 2003, ARTHRITIS RHEUM, V48, P3039, DOI 10.1002/art.11269; Rantapaa-Dahlqvist S, 2007, ANN RHEUM DIS, V66, P121, DOI 10.1136/ard.2006.057331; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Sokolove J, 2010, ARTHRITIS RHEUM; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; 1997, JAMA, V277, P925	53	343	349	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35296	10.1371/journal.pone.0035296	http://dx.doi.org/10.1371/journal.pone.0035296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662108	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300003
J	Wu, YZ; Yu, T; Gilbertson, TA; Zhou, AH; Xu, H; Nguyen, KT				Wu, Yangzhe; Yu, Tian; Gilbertson, Timothy A.; Zhou, Anhong; Xu, Hao; Kytai Truong Nguyen			Biophysical Assessment of Single Cell Cytotoxicity: Diesel Exhaust Particle-Treated Human Aortic Endothelial Cells	PLOS ONE			English	Article							ADHESION MOLECULES; OXIDATIVE STRESS; PLASMA-MEMBRANE; IN-VIVO; BIOMECHANICS; ELASTICITY; EXPRESSION; REVEALS	Exposure to diesel exhaust particles (DEPs), a major source of traffic-related air pollution, has become a serious health concern due to its adverse influences on human health including cardiovascular and respiratory disorders. To elucidate the relationship between biophysical properties (cell topography, cytoskeleton organizations, and cell mechanics) and functions of endothelial cells exposed to DEPs, atomic force microscope (AFM) was applied to analyze the toxic effects of DEPs on a model cell line from human aortic endothelial cells (HAECs). Fluorescence microscopy and flow cytometry were also applied to further explore DEP-induced cytotoxicity in HAECs. Results revealed that DEPs could negatively impair cell viability and alter membrane nanostructures and cytoskeleton components in a dosage-and a time-dependent manner; and analyses suggested that DEPs-induced hyperpolarization in HAECs appeared in a time-dependent manner, implying DEP treatment would lead to vasodilation, which could be supported by down-regulation of cell biophysical properties (e.g., cell elasticity). These findings are consistent with the conclusion that DEP exposure triggers important biochemical and biophysical changes that would negatively impact the pathological development of cardiovascular diseases. For example, DEP intervention would be one cause of vasodilation, which will expand understanding of biophysical aspects associated with DEP cytotoxicity in HAECs.	[Wu, Yangzhe; Zhou, Anhong] Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA; [Yu, Tian; Gilbertson, Timothy A.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Xu, Hao; Kytai Truong Nguyen] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Texas System; University of Texas Arlington	Wu, YZ (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	Anhong.Zhou@usu.edu	Yu, Tian/A-2854-2013; Wu, Yangzhe/C-4435-2012; Gilbertson, Timothy/G-7147-2011	Gilbertson, Timothy/0000-0003-2569-3096	Huntsman Environmental Research Center; Utah Water Research Laboratory, Logan, UT; National Institutes of Health [HL091232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091232] Funding Source: NIH RePORTER	Huntsman Environmental Research Center; Utah Water Research Laboratory, Logan, UT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is partially supported by Huntsman Environmental Research Center and Utah Water Research Laboratory, Logan, UT (to AZ). The authors also acknowledge the partial financial support from the National Institutes of Health grant HL091232 (to KTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Brauer M., 2003, DIESEL EXHAUST PARTI, P1; Callies C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175104; Chtcheglova LA, 2007, BIOPHYS J, V93, pL11, DOI 10.1529/biophysj.107.109751; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Doornaert B, 2003, AM J PHYSIOL-LUNG C, V284, pL119, DOI 10.1152/ajplung.00039.2002; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; Forchhammer L, 2012, TOXICOL LETT, V209, P121, DOI 10.1016/j.toxlet.2011.12.003; Hillebrand U, 2008, PFLUG ARCH EUR J PHY, V456, P51, DOI 10.1007/s00424-007-0411-3; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kidoaki S, 2007, J BIOMED MATER RES A, V81A, P728, DOI 10.1002/jbm.a.31112; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lee S, 2007, P NATL ACAD SCI USA, V104, P9609, DOI 10.1073/pnas.0702668104; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li TS, 2008, J MOL NEUROSCI, V35, P289, DOI 10.1007/s12031-008-9065-7; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Mann CL, 2001, ENDOCRINOLOGY, V142, P421, DOI 10.1210/en.142.1.421; Moller W, 2002, TOXICOL APPL PHARM, V182, P197, DOI 10.1006/taap.2002.9430; Montiel-Davalos A, 2007, INHAL TOXICOL, V19, P91, DOI 10.1080/08958370701495212; Nemmar A, 2007, AM J PHYSIOL-LUNG C, V292, pL664, DOI 10.1152/ajplung.00240.2006; Okayama Y, 2006, J TOXICOL ENV HEAL A, V69, P1699, DOI 10.1080/15287390600631078; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Reichlin T, 2005, J STRUCT BIOL, V152, P52, DOI 10.1016/j.jsb.2005.07.009; Ris C, 2007, INHAL TOXICOL, V19, P229, DOI 10.1080/08958370701497960; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Shah AM, 2004, HEART, V90, P486, DOI 10.1136/hrt.2003.029389; Shaw CA, 2010, AM J RESP CELL MOL B; Shaw CA, 2011, AM J RESP CELL MOL, V44, P840, DOI 10.1165/rcmb.2010-0011OC; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki AK, 2008, TOXICOL LETT, V180, pS226, DOI 10.1016/j.toxlet.2008.06.110; Wildling L, 2009, PFLUG ARCH EUR J PHY, V458, P223, DOI 10.1007/s00424-008-0615-1; Wold LE, 2006, CARDIOVASC TOXICOL, V6, P69, DOI 10.1385/CT:6:1:69; Wu YZ, 2010, CANCER LETT, V293, P82, DOI 10.1016/j.canlet.2009.12.016; Wu YZ, 2009, CHEM COMMUN, P7021, DOI 10.1039/b914605a; Xu XH, 2009, TOXICOL LETT, V191, P57, DOI 10.1016/j.toxlet.2009.08.006	39	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36885	10.1371/journal.pone.0036885	http://dx.doi.org/10.1371/journal.pone.0036885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662129	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300020
J	Castoldi, A; Braga, TT; Correa-Costa, M; Aguiar, CF; Bassi, EJ; Correa-Silva, R; Elias, RM; Salvador, F; Moraes-Vieira, PM; Cenedeze, MA; Reis, MA; Hiyane, MI; Pacheco-Silva, A; Goncalves, GM; Camara, NOS				Castoldi, Angela; Braga, Tarcio Teodoro; Correa-Costa, Matheus; Aguiar, Cristhiane Favero; Bassi, Enio Jose; Correa-Silva, Reinaldo; Elias, Rosa Maria; Salvador, Fabia; Moraes-Vieira, Pedro Manoel; Cenedeze, Marcos Antonio; Reis, Marlene Antonia; Hiyane, Meire Ioshie; Pacheco-Silva, Alvaro; Goncalves, Giselle Martins; Saraiva Camara, Niels Olsen			TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by Sepsis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; TOLL-LIKE RECEPTOR-2; NITRIC-OXIDE; ORGAN FAILURE; CELL-DEATH; LIPOPOLYSACCHARIDE; INHIBITION; EXPRESSION; APOPTOSIS; CYTOKINE	The aim of this study was to investigate the role of TLR2, TLR4 and MyD88 in sepsis-induced AKI. C57BL/6 TLR2(-/-), TLR4(-/-) and MyD88(-/-) male mice were subjected to sepsis by cecal ligation and puncture (CLP). Twenty four hours later, kidney tissue and blood samples were collected for analysis. The TLR2(-/-), TLR4(-/-) and MyD88(-/-) mice that were subjected to CLP had preserved renal morphology, and fewer areas of hypoxia and apoptosis compared with the wild-type C57BL/6 mice (WT). MyD88(-/-) mice were completely protected compared with the WT mice. We also observed reduced expression of proinflammatory cytokines in the kidneys of the knockout mice compared with those of the WT mice and subsequent inhibition of increased vascular permeability in the kidneys of the knockout mice. The WT mice had increased GR1(+low) cells migration compared with the knockout mice and decreased in GR1(+high) cells migration into the peritoneal cavity. The TLR2(-/-), TLR4(-/-), and MyD88(-/-) mice had lower neutrophil infiltration in the kidneys. Depletion of neutrophils in the WT mice led to protection of renal function and less inflammation in the kidneys of these mice. Innate immunity participates in polymicrobial sepsis-induced AKI, mainly through the MyD88 pathway, by leading to an increased migration of neutrophils to the kidney, increased production of proinflammatory cytokines, vascular permeability, hypoxia and apoptosis of tubular cells.	[Castoldi, Angela; Aguiar, Cristhiane Favero; Correa-Silva, Reinaldo; Elias, Rosa Maria; Salvador, Fabia; Cenedeze, Marcos Antonio; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil; [Castoldi, Angela; Braga, Tarcio Teodoro; Correa-Costa, Matheus; Bassi, Enio Jose; Moraes-Vieira, Pedro Manoel; Hiyane, Meire Ioshie; Goncalves, Giselle Martins; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Imunol, Lab Imunobiol Transplantes, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Hosp Israelita Albert Einstein, IIEP, Sao Paulo, Brazil; [Reis, Marlene Antonia] Univ Fed Triangulo Mineiro, Uberaba, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade Federal do Triangulo Mineiro	Castoldi, A (corresponding author), Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil.	niels@icb.usp.br	Braga, Tarcio T/E-4827-2014; Braga, Tarcio/AAG-4475-2020; Bassi, Ênio José/P-9937-2019; Aguiar, Cristhiane/C-2678-2012; Complexos, INCT Fluidos/H-9172-2013; camara, niels olsen saraiva/AAX-3269-2020; Bassi, Ênio José/I-3616-2016; Moraes-Vieira, Pedro/C-8701-2014; Silva, Reinaldo/C-6285-2013; Castoldi, Angela/K-1889-2015; Camara, Niels OS/G-8336-2011; Correa-Costa, Matheus/B-2006-2014; Pacheco-Silva, Alvaro/K-3583-2013	Braga, Tarcio T/0000-0002-2989-1076; Bassi, Ênio José/0000-0002-7956-5746; camara, niels olsen saraiva/0000-0001-5436-1248; Bassi, Ênio José/0000-0002-7956-5746; Moraes-Vieira, Pedro/0000-0002-8263-786X; Camara, Niels OS/0000-0001-5436-1248; Castoldi, Angela/0000-0002-8434-7989	Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [07/07139-3]; International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development); National Institute of Science and Technology (INCT)	Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development); National Institute of Science and Technology (INCT)	This work was supported by the Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP), Grants Number: 07/07139-3), International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development), and National Institute of Science and Technology (INCT) Complex Fluids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Filho J. C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P151; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellomo R, 2008, NEPHRON EXP NEPHROL, V109, pE95, DOI 10.1159/000142933; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; CAVERZASIO J, 1987, AM J PHYSIOL, V252, pF943, DOI 10.1152/ajprenal.1987.252.5.F943; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Gosemann JH, 2010, INJURY, V41, P1060, DOI 10.1016/j.injury.2010.05.021; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; KLINGEBIEL T, 1983, CLIN NEPHROL, V20, P1; Komura H, 2009, J IMMUNOL, V182, P581, DOI 10.4049/jimmunol.182.1.581; MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007; Messaris E, 2008, SURG INFECT, V9, P377, DOI 10.1089/sur.2006.018; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Miyazaki S, 2004, CLIN DIAGN LAB IMMUN, V11, P452, DOI 10.1128/CDLI.11.3.452-457.2004; Oberholzer C, 2001, FASEB J, V15, P879, DOI 10.1096/fj.00-058rev; Ortiz A, 2003, BIOCHEM PHARMACOL, V66, P1589, DOI 10.1016/S0006-2952(03)00515-X; SATO T, 1993, J LEUKOCYTE BIOL, V53, P144, DOI 10.1002/jlb.53.2.144; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Traylor LA, 1997, ARCH BIOCHEM BIOPHYS, V338, P129, DOI 10.1006/abbi.1996.9840; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Yamano M, 1998, N-S ARCH PHARMACOL, V358, P253, DOI 10.1007/PL00005250; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Zhang CJ, 2000, BIOCHEM PHARMACOL, V59, P203, DOI 10.1016/S0006-2952(99)00324-X	39	105	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37584	10.1371/journal.pone.0037584	http://dx.doi.org/10.1371/journal.pone.0037584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655058	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900034
J	Krecek, RC; Mohammed, H; Michael, LM; Schantz, PM; Ntanjana, L; Morey, L; Werre, SR; Willingham, AL				Krecek, Rosina Claudia; Mohammed, Hamish; Michael, Lynne Margaret; Schantz, Peter Mullineaux; Ntanjana, Lulama; Morey, Liesl; Werre, Stephen Rakem; Willingham, Arve Lee, III			Risk Factors of Porcine Cysticercosis in the Eastern Cape Province, South Africa	PLOS ONE			English	Article							TAENIA-SOLIUM CYSTICERCOSIS; NORTH-WEST PROVINCE; RURAL-COMMUNITY; MORETELE 1; NEUROCYSTICERCOSIS; PREVALENCE; HEALTH; DISTRICT; EPILEPSY	There is a high prevalence of Taenia solium taeniosis/cysticercosis in humans and pigs in the Eastern Cape Province (ECP) of South Africa. The objective of this study was to identify risk factors of porcine cysticercosis in select districts of the ECP. Data were collected in 2003 by interviewing 217 pig producers from the area. Blood samples were collected from 261 of their pigs, which were tested using two enzyme-linked immunosorbent assays (ELISA) for the presence of antibodies to cysticercosis. Frequencies of both owner- and pig-level characteristics were determined. For pig-level analysis, all bivariable and multivariable associations were determined using the surveylogistic procedure of the SAS/STAT((R)) software to accommodate for the intraclass correlation that exists for clusters of pigs within one owner and for clusters of owners within a district. All tests for significance were performed at the alpha = 0.05 level, and adjusted odds ratios (aOR) and 95% confidence intervals (CI) were determined. Among the respondents, 48% of their households lacked a latrine, 98% slaughtered pigs at home, and 99% indicated that meat inspection services were not available. On bivariable analysis, there was a significant association between porcine infection and district (p = 0.003), breed (p = 0.041) and the absence of a latrine (p = 0.006). On multivariable analysis, the absence of a latrine was the only variable significantly associated with porcine infection (aOR = 1.89; 95% CI = 1.07, 3.35) (p = 0.028). The increased odds of porcine infection with households lacking a latrine contributes to our understanding of the transmission of this parasite in the ECP. Determining and addressing the risk factors for T. solium infection can potentially lower the very high prevalence in humans and pigs in this endemic area.	[Krecek, Rosina Claudia] RUSVM, Dept Res, Basseterre, St Kitts, St Kitts & Nevi; [Krecek, Rosina Claudia] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa; [Mohammed, Hamish] Univ Trinidad & Tobago, Arima, Trinidad Tobago; [Michael, Lynne Margaret] Bayer Pty Ltd, Div Anim Hlth, Isando, South Africa; [Schantz, Peter Mullineaux] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Ntanjana, Lulama] Vet Serv Eastern Cape Prov, Dept Agr, Bhisho, Eastern Cape, South Africa; [Morey, Liesl] Agr Res Council, Biometry Unit, Pretoria, South Africa; [Werre, Stephen Rakem] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Lab Study Design & Stat Anal, Blacksburg, VA USA; [Willingham, Arve Lee, III] UNICEF UNDP World Bank WHO Special Programme Res, Stewardship Res Infect Dis Poverty STE, Geneva, Switzerland	University of Johannesburg; Bayer AG; Emory University; Rollins School Public Health; Agricultural Research Council of South Africa; Virginia Polytechnic Institute & State University; The World Bank; World Health Organization	Krecek, RC (corresponding author), RUSVM, Dept Res, Basseterre, St Kitts, St Kitts & Nevi.	tkrecek@rossvet.edu.kn	Krecek, Rosina/AAI-6962-2020	Mohammed, Hamish/0000-0002-2060-7286	United States Agency for International Development (South Africa); RUSVM	United States Agency for International Development (South Africa)(United States Agency for International Development (USAID)); RUSVM	Mr. D Stockdale and Dr. K Lucas of the United States Agency for International Development (USAID) Mission in South Africa, and RUSVM are thanked for support; Dr. L Mrwebi, Dr. R Hyde, Mr. M Lephallo and other staff of the Veterinary Services Eastern Cape Province; the Cysticercosis Working Group of Eastern and Southern Africa for technical inputs to field collections; Mr. TE Krecek of Krecek and Krecek CC, and Mr. B Weaver, Mr. B Ho-Thanh, Mr. M McMillan, Mr. D JohnKing, J Heller, J Moore and A Hefter of RUSVM for technical assistance; Dr. LJS Harrison, Dr. P Dorny and Dr. N Praet for inputs with the diagnostic test analysis; Ms. MF Smith of the Agricultural Research Council for statistical support; the emerging pig producers who cooperated so willingly throughout this study; and several anonymous reviewers for valuable comments that helped improve previous versions of this manuscript.r The source of funding for this work was the United States Agency for International Development (South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICR WIND PROF 2002; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; International Livestock Research Institute (ILRI), 2000, LIV STRAT 2010 MAK L; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Krecek RC, 2011, VET PARASITOL, V183, P198, DOI 10.1016/j.vetpar.2011.09.033; Krecek R.C., 2004, SE ASIAN J TROPICAL, V35, P271; Krecek RC, 2005, J S AFR VET ASSOC, V76, P2; Krecek RC, 2004, J S AFR VET ASSOC, V75, P24; Letsoalo SS, 2000, J S AFR VET ASSOC, V71, P92; LJS Harrison, 1991, PARASITIC HELMINTHS; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; Minnaar WN, 1999, J S AFR VET ASSOC, V70, P92; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; O'Neal SE, 2012, EMERG INFECT DIS MAR; Phiri IK, 2003, ACTA TROP, V87, P13, DOI 10.1016/S0001-706X(03)00051-2; Pondja A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000594; Sarti E, 1997, AM J TROP MED HYG, V56, P127, DOI 10.4269/ajtmh.1997.56.127; SAS Institute Inc, CAR; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Statistics South Africa, 2001, CENS 2007 COMM SURV; Vazquez-Flores S, 2001, SALUD PUBLICA MEXICO, V43, P574, DOI 10.1590/S0036-36342001000600009; Wells D, 2001, J S AFR VET ASSOC, V72, P37; Wohlgemut J, 2010, AM J TROP MED HYG, V82, P634, DOI 10.4269/ajtmh.2010.09-0404; World Health Organization, 2003, 56 WORLD HLTH ASS CO	27	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37718	10.1371/journal.pone.0037718	http://dx.doi.org/10.1371/journal.pone.0037718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655065	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900041
J	Zhu, YC; Tian, YH; Du, J; Hu, ZZ; Yang, L; Liu, JJ; Gu, L				Zhu, Yichao; Tian, Yinhui; Du, Jun; Hu, Zhenzhen; Yang, Ling; Liu, Jiaojing; Gu, Luo			Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; FRIZZLED-RELATED PROTEINS; CANONICAL WNT PATHWAY; TYROSINE KINASE ROR2; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; DISHEVELLED PHOSPHORYLATION; VERTEBRATE GASTRULATION; UP-REGULATION; BETA-CATENIN	Background: The Dishevelled (Dvl) and Dishevelled-associated activator of morphogenesis 1 (Daam1) pathway triggered by Wnt5a regulates cellular polarity during development and tissue homoeostasis. However, Wnt5a signaling in breast cancer progression remains poorly defined. Methodology/Principal Findings: We showed here that Wnt5a activated Dvl2, Daam1 and RhoA, and promoted migration of breast cancer cells, which was, however, abolished by Secreted Frizzled-related protein 2 (sFRP2) pretreatment. Dominant negative Dvl2 mutants or Dvl2 siRNA significantly decreased Wnt5a-induced Daam1/RhoA activation and cell migration. Ectopic expression of N-Daam1, a dominant negative mutant, or Daam1 siRNA remarkably inhibited Wnt5a-induced RhoA activation, stress fiber formation and cell migration. Ectopic expression of dominant negative RhoA (N19) or C3 exoenzyme transferase, a Rho inhibitor, decreased Wnt5a-induced stress fiber formation and cell migration. Conclusions/Significance: Taken together, we demonstrated for the first time that Wnt5a promotes breast cancer cell migration via Dvl2/Daam1/RhoA.	[Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Tian, Yinhui; Hu, Zhenzhen; Liu, Jiaojing] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Yang, Ling] Suzhou Univ, Affiliated Hosp 3, Dept Cardiol, Changzhou, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	lgu@njmu.edu.cn			Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; Jiangsu Planned Projects for Postdoctoral Research Funds [0902023C]; National Natural Science Foundation of China [30872926, 81172002, 81101999]	Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; Jiangsu Planned Projects for Postdoctoral Research Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30872926 and 81172002) and a research grant from Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University to Luo Gu, the National Natural Science Foundation of China (81101999), and the Jiangsu Planned Projects for Postdoctoral Research Funds (0902023C) to Yichao Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fernandez-Cobo M, 2007, ONCOL REP, V17, P903; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; HUGUET EL, 1994, CANCER RES, V54, P2615; Jonsson M, 2002, CANCER RES, V62, P409; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno-Aspitia A, 2010, FUTURE ONCOL, V6, P655, DOI 10.2217/FON.10.41; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tada M, 2000, DEVELOPMENT, V127, P2227; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Tsuji T, 2010, MOL BIOL CELL, V21, P3590, DOI 10.1091/mbc.E10-02-0095; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644	64	77	83	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37823	10.1371/journal.pone.0037823	http://dx.doi.org/10.1371/journal.pone.0037823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655072	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900049
J	Borgal, L; Habbig, S; Hatzold, J; Liebau, MC; Dafinger, C; Sacarea, I; Hammerschmidt, M; Benzing, T; Schermer, B				Borgal, Lori; Habbig, Sandra; Hatzold, Julia; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Hammerschmidt, Matthias; Benzing, Thomas; Schermer, Bernhard			The Ciliary Protein Nephrocystin-4 Translocates the Canonical Wnt Regulator Jade-1 to the Nucleus to Negatively Regulate beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; PRIMARY CILIUM; NEPHRONOPHTHISIS; PHOSPHORYLATION; MECHANISMS; DEFECTS; PATHWAY; MORPHOGENESIS; INACTIVATION; HOMEOSTASIS	Nephronophthisis (NPH) is an autosomal-recessive cystic kidney disease and represents the most common genetic cause for end-stage renal disease in children and adolescents. It can be caused by the mutation of genes encoding for the nephrocystin proteins (NPHPs). All NPHPs localize to primary cilia, classifying this disease as a "ciliopathy." The primary cilium is a critical regulator of several cell signaling pathways. Cystogenesis in the kidney is thought to involve overactivation of canonical Wnt signaling, which is negatively regulated by the primary cilium and several NPH proteins, although the mechanism remains unclear. Jade-1 has recently been identified as a novel ubiquitin ligase targeting the canonical Wnt downstream effector beta-catenin for proteasomal degradation. Here, we identify Jade-1 as a novel component of the NPHP protein complex. Jade-1 colocalizes with NPHP1 at the transition zone of primary cilia and interacts with NPHP4. Furthermore, NPHP4 stabilizes protein levels of Jade-1 and promotes the translocation of Jade-1 to the nucleus. Finally, NPHP4 and Jade-1 additively inhibit canonical Wnt signaling, and this genetic interaction is conserved in zebrafish. The stabilization and nuclear translocation of Jade-1 by NPHP4 enhances the ability of Jade-1 to negatively regulate canonical Wnt signaling. Loss of this repressor function in nephronophthisis might be an important factor promoting Wnt activation and contributing to cyst formation.	[Borgal, Lori; Habbig, Sandra; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Borgal, Lori; Habbig, Sandra; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Habbig, Sandra; Liebau, Max C.] Univ Cologne, Dept Pediat, D-50937 Cologne, Germany; [Hatzold, Julia; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Hammerschmidt, Matthias; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Benzing, Thomas/X-5476-2019; Borgal, Lori/ABB-9343-2021; Schermer, Bernhard/E-9972-2014; Liebau, Max Christoph/K-3470-2019; Habbig, Sandra/AHC-1168-2022; Hatzold, Julia/AAN-2996-2021	Schermer, Bernhard/0000-0002-5194-9000; Liebau, Max Christoph/0000-0003-0494-9080; Hatzold, Julia/0000-0002-5491-1921	Deutsche Forschungsgemeinschaft Grants [SCHE1562, SFB832, BE2212, SFB829, SFB 572]; Center for Molecular Medicine Cologne	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Center for Molecular Medicine Cologne	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHE1562 and SFB832 (to B. S.), BE2212 and SFB829 (to T. B.), and SFB 572 (to T. B. and M. H.) and by the Center for Molecular Medicine Cologne (to T. B. and B. S.).	Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bellavia S, 2010, NEPHROL DIAL TRANSPL, V25, P4097, DOI 10.1093/ndt/gfq519; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Burckle C, 2011, HUM MOL GENET, V20, P2611, DOI 10.1093/hmg/ddr164; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dale T, 2006, NAT STRUCT MOL BIOL, V13, P9, DOI 10.1038/nsmb0106-9; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Krishnan R, 2008, KIDNEY BLOOD PRESS R, V31, P152, DOI 10.1159/000129648; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Liebau MC, 2011, J BIOL CHEM, V286, P14237, DOI 10.1074/jbc.M110.165464; Lienkamp S, 2012, DIFFERENTIATION, V83, pS49, DOI 10.1016/j.diff.2011.11.012; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; van Reeuwijk J, 2011, HUM MOL GENET, V20, pR149, DOI 10.1093/hmg/ddr354; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wiens CJ, 2010, J BIOL CHEM, V285, P16218, DOI 10.1074/jbc.M109.070953; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	58	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25370	25380		10.1074/jbc.M112.385658	http://dx.doi.org/10.1074/jbc.M112.385658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654112	hybrid, Green Published			2022-12-25	WOS:000306651700045
J	George, AA; Lucero, LM; Damaj, MI; Lukas, RJ; Chen, XN; Whiteaker, P				George, Andrew A.; Lucero, Linda M.; Damaj, M. Imad; Lukas, Ronald J.; Chen, Xiangning; Whiteaker, Paul			Function of Human alpha 3 beta 4 alpha 5 Nicotinic Acetylcholine Receptors Is Reduced by the alpha 5(D398N) Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; ALTERNATE STOICHIOMETRIES; SUBUNIT INTERFACES; UP-REGULATION; DEPENDENCE; RISK; BINDING; SENSITIVITY; ACTIVATION; INHIBITION	Genome-wide studies have strongly associated a non-synonymous polymorphism (rs16969968) that changes the 398th amino acid in the nAChR alpha 5 subunit from aspartic acid to asparagine (D398N), with greater risk for increased nicotine consumption. We have used a pentameric concatemer approach to express defined and consistent populations of alpha 3 beta 4 alpha 5 nAChR in Xenopus oocytes. alpha 5(Asn-398; risk) variant incorporation reduces ACh-evoked function compared with inclusion of the common alpha 5(Asp-398) variant without altering agonist or antagonist potencies. Unlinked alpha 3, beta 4, and alpha 5 subunits assemble to form a uniform nAChR population with pharmacological properties matching those of concatemeric alpha 3 beta 4* nAChRs. alpha 5 subunit incorporation reduces alpha 3 beta 4* nAChR function after coinjection with unlinked alpha 3 and beta 4 subunits but increases that of alpha 3 beta 4 alpha 5 versus alpha 3 beta 4-only concatemers. alpha 5 subunit incorporation into alpha 3 beta 4* nAChR also alters the relative efficacies of competitive agonists and changes the potency of the non-competitive antagonist mecamylamine. Additional observations indicated that in the absence of alpha 5 subunits, free alpha 3 and beta 4 subunits form at least two further subtypes. The pharmacological profiles of these free subunit alpha 3 beta 4-only subtypes are dissimilar both to each other and to those of alpha 3 beta 4 alpha 5 nAChR. The alpha 5 variant-induced change in alpha 3 beta 4 alpha 5 nAChR function may underlie some of the phenotypic changes associated with this polymorphism.	[George, Andrew A.; Lucero, Linda M.; Lukas, Ronald J.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Damaj, M. Imad] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA 23298 USA; [Chen, Xiangning] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA	Barrow Neurological Institute; Virginia Commonwealth University; Virginia Commonwealth University	Whiteaker, P (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	paul.whiteaker@dignityhealth.org			National Institutes of Health [R21 DA027070-02S1, R21 DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026627, R21DA027070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DA027070-02S1 (to P. W., X. C., M. I. D., and R. J. L.) and R21 DA026627 (to P. W.). This work was also supported by an endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P. W.). Portions of this work were presented as a Society for Neuroscience abstract (46).	Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Chang YC, 2002, J NEUROSCI, V22, P7982; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; David R, 2010, EUR J NEUROSCI, V31, P978, DOI 10.1111/j.1460-9568.2010.07133.x; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gahring LC, 2010, J BIOL CHEM, V285, P26049, DOI 10.1074/jbc.M110.105346; George A. A., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stokes C., 2012, NEUROPHARMA IN PRESS; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Zhou Y, 2003, J NEUROSCI, V23, P9004; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	46	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25151	25162		10.1074/jbc.M112.379339	http://dx.doi.org/10.1074/jbc.M112.379339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665477	Green Published, hybrid			2022-12-25	WOS:000306651700026
J	Guo, HB; Nairn, A; dela Rosa, M; Nagy, T; Zhao, SY; Moremen, K; Pierce, M				Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Nagy, Tamas; Zhao, Shaying; Moremen, Kelley; Pierce, Michael			Transcriptional Regulation of the Protocadherin beta Cluster during Her-2 Protein-induced Mammary Tumorigenesis Results from Altered N-Glycan Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; BETA-1,6-BRANCHED OLIGOSACCHARIDES; TUMOR-SUPPRESSOR; DNA METHYLATION; MESSENGER-RNA; CELL-ADHESION; NEU ONCOGENE; EXPRESSION; CARCINOMA; GLYCOSYLATION	Changes in the levels of N-acetylglucosaminyltransferase V (GnT-V) can alter the function of several types of cell surface receptors and adhesion molecules by causing altered N-linked glycan branching. Using a her-2 mammary tumor mouse model, her-2 receptor signaling was down-regulated by GnT-V knockout, resulting in a significant delay in the onset of her-2-induced mammary tumors. To identify the genes that contributed to this GnT-V regulation of early events in tumorigenesis, microarray analysis was performed using her-2 induced mammary tumors from wild-type and GnT-V-null mice. We found that 142 genes were aberrantly expressed (>2.0-fold) with 64 genes up-regulated and 78 genes down-regulated after deletion of GnT-V. Among differentially expressed genes, the expression of a subgroup of the cadherin superfamily, the protocadherin beta (Pcdh beta) cluster, was up-regulated in GnT-V-null tumors. Altered expression of the Pcdh beta cluster in GnT-V-null tumors was not due to changes in promoter methylation; instead, impaired her-2-mediated signaling pathways were implicated at least in part resulting from reduced microRNA-21 expression. Overexpression of Pcdh beta genes inhibited tumor cell growth, decreased the proportion of tumor-initiating cells, and decreased tumor formation in vivo, demonstrating that expression of the Pcdh beta gene cluster can serve as an inhibitor of the transformed phenotype. Our results suggest the up-regulation of the Pcdh beta gene cluster as a mechanism for reduced her-2-mediated tumorigenesis resulting from GnT-V deletion.	[Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Zhao, Shaying; Moremen, Kelley; Pierce, Michael] Univ Georgia, Dept Biochem & Mol Biol, Coll Vet Med, Athens, GA 30602 USA; [Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Moremen, Kelley; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Coll Vet Med, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, Coll Vet Med, Athens, GA 30602 USA; [Pierce, Michael] Univ Georgia, Ctr Canc, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Pierce, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Coll Vet Med, 315 Riverbend Rd, Athens, GA 30602 USA.	hawkeye@uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593	National Institutes of Health [U01CA128454, P41RR018502]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01CA128454 (to M. P.) and P41RR018502 (to M. P. and K. M.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Granovsky M, 2000, NAT MED, V6, P306; Gurlevik E, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp374; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Hoque MO, 2009, CANCER EPIDEM BIOMAR, V18, P2694, DOI 10.1158/1055-9965.EPI-08-0821; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Moreira F, 2011, AM J PATHOL, V179, P462, DOI 10.1016/j.ajpath.2011.03.044; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; OBATA S, 1995, J CELL SCI, V108, P3765; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pierce JM, 2009, HANDBOOK OF GLYCOMICS, P399; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Seelentag WKF, 1998, CANCER RES, V58, P5559; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Terada K, 2009, CARCINOGENESIS, V30, P466, DOI 10.1093/carcin/bgp021; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yamamoto H, 2000, CANCER RES, V60, P134; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	59	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24941	24954		10.1074/jbc.M112.369355	http://dx.doi.org/10.1074/jbc.M112.369355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665489	hybrid, Green Published			2022-12-25	WOS:000306651700008
J	Desantis, A; Weiss, C; Schutz-Bosbach, S; Waszak, F				Desantis, Andrea; Weiss, Carmen; Schuetz-Bosbach, Simone; Waszak, Florian			Believing and Perceiving: Authorship Belief Modulates Sensory Attenuation	PLOS ONE			English	Article							SELF; PERCEPTION; AGENCY; CONSEQUENCES; SCHIZOPHRENIA; SUPPRESSION; EXPERIENCE; CAUSATION; INFERENCE; AWARENESS	Sensory attenuation refers to the observation that self-generated stimuli are attenuated, both in terms of their phenomenology and their cortical response compared to the same stimuli when generated externally. Accordingly, it has been assumed that sensory attenuation might help individuals to determine whether a sensory event was caused by themselves or not. In the present study, we investigated whether this dependency is reciprocal, namely whether sensory attenuation is modulated by prior beliefs of authorship. Participants had to judge the loudness of auditory effects that they believed were either self-generated or triggered by another person. However, in reality, the sounds were always triggered by the participants' actions. Participants perceived the tones' loudness attenuated when they believed that the sounds were self-generated compared to when they believed that they were generated by another person. Sensory attenuation is considered to contribute to the emergence of people's belief of authorship. Our results suggest that sensory attenuation is also a consequence of prior belief about the causal link between an action and a sensory change in the environment.	[Desantis, Andrea; Waszak, Florian] Univ Paris 05, Paris, France; [Desantis, Andrea; Waszak, Florian] CNRS, UMR 8158, Lab Psychol Percept, Paris, France; [Weiss, Carmen; Schuetz-Bosbach, Simone] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Desantis, Andrea] Ecole Hautes Etud Sci Sociales, Paris, France; [Desantis, Andrea] CNRS, Inst Jean Nicod, UMR 8129, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Desantis, A (corresponding author), Univ Paris 05, Paris, France.	aerdna.desantis@gmail.com		Schutz-Bosbach, Simone/0000-0002-0937-9454	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC Grant [263067]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement n<SUP>o</SUP>263067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Anton-Erxleben K, 2010, J VISION, V10, DOI 10.1167/10.11.6; Baess P, 2009, EUR J NEUROSCI, V29, P1514, DOI 10.1111/j.1460-9568.2009.06683.x; Bass P, 2008, INT J PSYCHOPHYSIOL, V70, P137, DOI 10.1016/j.ijpsycho.2008.06.005; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Cardoso-Leite P, 2010, PSYCHOL SCI, V21, P1740, DOI 10.1177/0956797610389187; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Desantis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029557; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Dogge M, 2012, CONSCIOUS COGN, V21, P501, DOI 10.1016/j.concog.2011.10.014; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Gentsch A, 2011, J COGNITIVE NEUROSCI, V23, P3817, DOI 10.1162/jocn_a_00012; Green DM, 1966, SIGNAL DETECTION THE; HAERING C, ACTA PSYCHOL, V152, P109, DOI DOI INTENTIONALBINDINGISINDEPENDENTOFTHEVALIDITYOFTHEACTIONEFFECTSIDENTITY   BY:HAERING,CAROLA;KIESEL,ANDREA   ACTAPSYCHOLOGICAVOLUME:?152PAGES:?109-119PUBLISHED:?OCT2014; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hughes G, 2012, PSYCHOL B IN PRESS; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Wegner DM, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1201; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Weiss C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022723; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; YOUNG ME, 1995, PSYCHON B REV, V2, P83, DOI 10.3758/BF03214413	45	69	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37959	10.1371/journal.pone.0037959	http://dx.doi.org/10.1371/journal.pone.0037959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666424	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600048
J	Tostar, U; Finta, C; Rahman, MFU; Shimokawa, T; Zaphiropoulos, PG				Tostar, Ulrica; Finta, Csaba; Rahman, Mohammed Ferdous-Ur; Shimokawa, Takashi; Zaphiropoulos, Peter G.			Novel Mechanism of Action on Hedgehog Signaling by a Suppressor of Fused Carboxy Terminal Variant	PLOS ONE			English	Article							NEGATIVE REGULATOR; GLI PROTEINS; 1ST EXON; SUFU; PATHWAY; GENE; DEGRADATION; PATCHED1	The Suppressor of Fused (SUFU) protein plays an essential role in the Hedgehog (HH) signaling pathway, by regulation of the GLI transcription factors. Two major isoforms of human SUFU are known, a full-length (SUFU-FL) and a carboxy-terminal truncated (SUFU-Delta C) variant. Even though SUFU-Delta C is expressed at an equivalent level as SUFU-FL in certain tissues, the function of SUFU-Delta C and its impact on HH signal transduction is still unclear. In two cell lines from rhabdomyosarcoma, a tumor type associated with deregulated HH signaling, SUFU-Delta C mRNA was expressed at comparable levels as SUFU-FL mRNA, but at the protein level only low amounts of SUFU-Delta C were detectable. Heterologous expression provided support to the notion that the SUFU-Delta C protein is less stable compared to SUFU-FL. Despite this, biochemical analysis revealed that SUFU-Delta C could repress GLI2 and GLI1 Delta N, but not GLI1FL, transcriptional activity to the same extent as SUFU-FL. Moreover, under conditions of activated HH signaling SUFU-Delta C was more effective than SUFU-FL in inhibiting GLI1 Delta N. Importantly, co-expression with GLI1FL indicated that SUFU-Delta C but not SUFU-FL reduced the protein levels of GLI1FL. Additionally, confocal microscopy revealed a co-localization of GLI1FL with SUFU-Delta C but not SUFU-FL in aggregate structures. Moreover, specific siRNA mediated knock-down of SUFU-Delta C resulted in up-regulation of the protein levels of GLI1FL and the HH signaling target genes PTCH1 and HHIP. Our results are therefore suggesting the presence of novel regulatory controls in the HH signaling pathway, which are elicited by the distinct mechanism of action of the two alternative spliced SUFU proteins.	[Tostar, Ulrica; Finta, Csaba; Rahman, Mohammed Ferdous-Ur; Shimokawa, Takashi; Zaphiropoulos, Peter G.] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Tostar, U (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	peter.zaphiropoulos@ki.se	Shimokawa, Takashi/AAA-5870-2020; RAHMAN, MOHAMMED FERDOUS UR/AAO-5991-2020	Shimokawa, Takashi/0000-0001-6549-9277; RAHMAN, MOHAMMED FERDOUS UR/0000-0002-0239-7414; Zaphiropoulos, Peter/0000-0003-4298-3861	Swedish Research Council [K2008-67X-20778-01-3]; Swedish Cancer Fund [09 0788]; Swedish Childhood Cancer Foundation [PROJ10/011]; Magnus Bergvall foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Fund; Swedish Childhood Cancer Foundation(European Commission); Magnus Bergvall foundation	The work was supported by the following sources of funding: Swedish Research Council, Grant number K2008-67X-20778-01-3, www.vr.se; Swedish Cancer Fund, Grant number 09 0788, www.cancerfonden.se; Swedish Childhood Cancer Foundation, Grant number PROJ10/011, www.barncancerfonden.se; and Magnus Bergvall foundation, www.magnbergvallsstiftelse.nu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Grimm T, 2001, FEBS LETT, V505, P13, DOI 10.1016/S0014-5793(01)02682-5; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shimokawa T, 2007, ONCOGENE, V26, P4889, DOI 10.1038/sj.onc.1210301; Shimokawa T, 2004, FEBS LETT, V578, P157, DOI 10.1016/j.febslet.2004.11.006; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tostar Ulrica, 2010, Genes Cancer, V1, P941, DOI 10.1177/1947601910385449; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403	24	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37761	10.1371/journal.pone.0037761	http://dx.doi.org/10.1371/journal.pone.0037761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666390	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600029
J	Abraham, F; Sacerdoti, F; De Leon, R; Gentile, T; Canellada, A				Abraham, Florencia; Sacerdoti, Flavia; De Leon, Romina; Gentile, Teresa; Canellada, Andrea			Angiotensin II Activates the Calcineurin/NFAT Signaling Pathway and Induces Cyclooxygenase-2 Expression in Rat Endometrial Stromal Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; NUCLEAR-FACTOR; T-CELLS; TRANSCRIPTIONAL REGULATION; CYCLOSPORINE-A; TNF-ALPHA; COX-2; BLASTOCYST; INDUCTION; GENE	Cyclooxygenase (COX)-2, the inducible isoform of cyclooxygenase, plays a role in the process of uterine decidualization and blastocyst attachment. On the other hand, overexpression of COX-2 is involved in the proliferation of the endometrial tissue during endometriosis. Deregulation of the renin-angiotensin-system plays a role in the pathophysiology of endometriosis and pre-eclampsia. Angiotensin II increases intracellular Ca2+ concentration by targeting phospholypase C-gamma in endometrial stromal cells (ESC). A key element of the cellular response to Ca2+ signals is the activity of the Ca2+ - and calmodulin-dependent phosphatase calcineurin. Our first aim was to study whether angiotensin II stimulated Cox-2 gene expression in rat ESC and to analyze whether calcineurin activity was involved. In cells isolated from non-pregnant uteri, COX-2 expression -both mRNA and protein-was induced by co-stimulation with phorbol ester and calcium ionophore (PIo), as well as by angiotensin II. Pretreatment with the calcineurin inhibitor cyclosporin A inhibited this induction. We further analyzed the role of the calcineurin/NFAT signaling pathway in the induction of Cox-2 gene expression in non-pregnant rat ESC. Cyclosporin A abolished NFATc1 dephosphorylation and translocation to the nucleus. Cyclosporin A also inhibited the transcriptional activity driven by the Cox-2 promoter. Exogenous expression of the peptide VIVIT-specific inhibitor of calcineurin/NFAT binding-blocked the activation of Cox-2 promoter and the up-regulation of COX-2 protein in these cells. Finally we analyzed Cox-2 gene expression in ESC of early-pregnant rats. COX-2 expression -both mRNA and protein-was induced by stimulation with PIo as well as by angiotensin II. This induction appears to be calcineurin independent, since it was not abrogated by cyclosporin A. In conclusion, angiotensin II induced Cox-2 gene expression by activating the calcineurin/NFAT signaling pathway in endometrial stromal cells of non-pregnant but not of early-pregnant rats. These results might be related to differential roles that COX-2 plays in the endometrium.	[Abraham, Florencia; Sacerdoti, Flavia; De Leon, Romina; Gentile, Teresa; Canellada, Andrea] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral Prof Ricardo A Ma, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Abraham, F (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral Prof Ricardo A Ma, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina.	acanell@ffyb.uba.ar		Sacerdoti, Flavia/0000-0002-8480-756X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 20092011]; Universidad de Buenos Aires [UBACyT-B406, UBACyT-B118]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; www.conicet.gov.ar) (PIP 20092011) and Universidad de Buenos Aires (UBACyT-B406) and (UBACyT-B118; www.uba.ar). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braileanu GT, 2002, REPROD FERT DEVELOP, V14, P199, DOI 10.1071/RD02003; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chen CC, 2000, J IMMUNOL, V165, P2719, DOI 10.4049/jimmunol.165.5.2719; Cong J, 2006, REPRODUCTION, V131, P139, DOI 10.1530/rep.1.00861; Cook IH, 2010, MOL HUM REPROD, V16, P158, DOI 10.1093/molehr/gap084; Corral RS, 2007, ONCOGENE, V26, P958, DOI 10.1038/sj.onc.1209856; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Derecka K, 2008, MOL CELL ENDOCRINOL, V287, P65, DOI 10.1016/j.mce.2008.02.015; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ebert AD, 2005, EUR J OBSTET GYN R B, V122, P144, DOI 10.1016/j.ejogrb.2005.04.017; Erol AYG, 2012, J MATERN-FETAL NEO M, V25, P826, DOI 10.3109/14767058.2011.595853; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Garavito RM, 1999, BBA-MOL CELL BIOL L, V1441, P278, DOI 10.1016/S1388-1981(99)00147-X; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; GRIENDLING KK, 1988, CLIN EXP PHARMACOL P, V15, P105, DOI 10.1111/j.1440-1681.1988.tb01051.x; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; Harris RC, 2003, ACTA PHYSIOL SCAND, V177, P423, DOI 10.1046/j.1365-201X.2003.01101.x; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hernandez J, 2002, AM J PHYSIOL-RENAL, V282, pF592, DOI 10.1152/ajprenal.00194.2001; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Hsieh YY, 2005, MOL HUM REPROD, V11, P11, DOI 10.1093/molehr/gah131; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143, DOI 10.1006/bbrc.1998.8222; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Kelly RW, 2001, REPRODUCTION, V121, P3, DOI 10.1530/rep.0.1210003; KENNEDY TG, 1993, PROSTAG OTH LIPID M, V46, P243, DOI 10.1016/0090-6980(93)90007-T; KENNEDY TG, 1980, BIOL REPROD, V23, P955, DOI 10.1095/biolreprod23.5.955; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu ZT, 2004, EXP CELL RES, V296, P317, DOI 10.1016/j.yexcr.2004.02.006; Maldonado-Perez D, 2009, BBA-MOL CELL RES, V1793, P1315, DOI 10.1016/j.bbamcr.2009.03.008; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Matsumoto Y, 2001, INT J MOL MED, V8, P31; McGiff JC, 2002, J PHYSIOL PHARMACOL, V53, P525; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Page M, 2002, J REPROD IMMUNOL, V54, P1, DOI 10.1016/S0165-0378(01)00122-X; Pham H, 2008, J CELL PHYSIOL, V214, P96, DOI 10.1002/jcp.21167; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; Schroer K, 2002, CIRCULATION, V105, P2760, DOI 10.1161/01.CIR.0000018127.10968.34; Shah DM, 2006, CURR HYPERTENS REP, V8, P144, DOI 10.1007/s11906-006-0011-1; Shah TJ, 2007, AM J OBSTET GYNECOL, V196, P48, DOI 10.1016/j.ajog.2006.08.038; SIROIS J, 1993, J BIOL CHEM, V268, P21931; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; SQUIRES PM, 1992, J REPROD FERTIL, V95, P791, DOI 10.1530/jrf.0.0950791; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Sugimoto T, 2001, J AM SOC NEPHROL, V12, P1359, DOI 10.1681/ASN.V1271359; Tabata C, 2009, AM J REPROD IMMUNOL, V62, P44, DOI 10.1111/j.1600-0897.2009.00710.x; Wang J, 2007, DEV BIOL, V302, P143, DOI 10.1016/j.ydbio.2006.09.015; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xia Y, 2003, J SOC GYNECOL INVEST, V10, P82, DOI 10.1016/S1071-5576(02)00259-9; Xia Y, 2002, J BIOL CHEM, V277, P24601, DOI 10.1074/jbc.M201369200; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Young JL, 2008, GYNECOL ONCOL, V109, P140, DOI 10.1016/j.ygyno.2008.01.008	68	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37750	10.1371/journal.pone.0037750	http://dx.doi.org/10.1371/journal.pone.0037750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662209	Green Published, gold			2022-12-25	WOS:000305342300099
J	Essig, S; von der Weid, NX; Strippoli, MPF; Rebholz, CE; Michel, G; Rueegg, CS; Niggli, FK; Kuehni, CE				Essig, Stefan; von der Weid, Nicolas X.; Strippoli, Marie-Pierre F.; Rebholz, Cornelia E.; Michel, Gisela; Rueegg, Corina S.; Niggli, Felix K.; Kuehni, Claudia E.		Swiss Pediat Oncology Grp SPOG	Health-Related Quality of Life in Long-Term Survivors of Relapsed Childhood Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ADULT SURVIVORS; CANCER SURVIVOR; FOLLOW-UP; ADOLESCENT; TRANSLATION; US	Background: Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. Methodology/Principal Findings: As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age <16 years, survived >= 5 years, and were currently aged >= 16 years. HRQOL was assessed with the Short Form-36 (SF-36), which measures four aspects of physical health and four aspects of mental health. A score of 50 corresponded to the mean of a healthy reference population. We analyzed data from 457 ALL survivors (response: 79%). Sixty-one survivors had suffered a relapse. Compared to the general population, ALL survivors reported similar or higher HRQOL scores on all scales. Survivors with a relapse scored lower in general health perceptions (51.6) compared to those without (55.8; p = 0.005), but after adjusting for self-reported late effects, this difference disappeared. Conclusion/Significance: Compared to population norms, ALL survivors reported good HRQOL, even after a relapse. However, relapsed ALL survivors reported poorer general health than non-relapsed. Therefore, we encourage specialists to screen for poor general health in survivors after a relapse and, when appropriate, specifically seek and treat underlying late effects. This will help to improve patients' HRQOL.	[Essig, Stefan; Strippoli, Marie-Pierre F.; Rebholz, Cornelia E.; Michel, Gisela; Rueegg, Corina S.; Kuehni, Claudia E.] Univ Bern, Swiss Childhood Canc Registry, Inst Social & Prevent Med, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Paediat Hematol Oncol Unit, CH-1011 Lausanne, Switzerland; [Niggli, Felix K.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University Children's Hospital Zurich	Essig, S (corresponding author), Univ Bern, Swiss Childhood Canc Registry, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Strippoli, Marie-Pierre F/K-8164-2013; Rueegg, Corina Silvia/H-7128-2019; Michel, Gisela/G-1081-2018; Niggli, Felix/L-6547-2017	Strippoli, Marie-Pierre F/0000-0003-3053-484X; Rueegg, Corina Silvia/0000-0003-3720-4659; Michel, Gisela/0000-0002-9589-0928; Niggli, Felix/0000-0002-7553-3712; Essig, Stefan/0000-0003-3228-7010; Kuehni, Claudia E./0000-0001-8957-2002; Leibundgut, Kurt/0000-0003-2514-6041	Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008, KLS 02631-08-2010]; Wyeth Foundation; Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung fur Krebsbekampfung; Cancer Research Switzerland [KFS-02606-06-2010]; Swiss National Science Foundation [PA001-117433/1, PZ00P3-121682/1, 323630-133897]; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Swiss Conference of the Cantonal Ministers of Public Health	Swiss Cancer League; Wyeth Foundation(Wyeth); Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung fur Krebsbekampfung; Cancer Research Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Swiss Conference of the Cantonal Ministers of Public Health	Swiss Cancer League (Grant No KLS-01605-10-2004, KLS-2215-02-2008 and KLS 02631-08-2010) http://www.krebsliga.ch/. Wyeth Foundation http://www.fondation-ch.org/. Bernese Cancer League http://www.bernischekrebsliga.ch/. Cancer League Zurich http://www.krebsliga-zh.ch/. Swiss Bridge http://www.swissbridge.ch/. Stiftung fur Krebsbekampfung http://www.krebsbekaempfung.ch/. Cancer Research Switzerland (Grant No KFS-02606-06-2010) http://www.krebsforschung.ch/. Swiss National Science Foundation (Grant No PA001-117433/1, PZ00P3-121682/1, 323630-133897) http://www.snf.ch/. Swiss Pediatric Oncology Group http://www.spog.ch/. Kinderkrebshilfe Schweiz http://www.kinderkrebshilfe.ch/. Stiftung fur krebskranke Kinder Regio Basiliensis http://www.krebskrankekinder.ch/. Swiss Conference of the Cantonal Ministers of Public Health http://www.gdk-cds.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Asner S, 2008, PEDIATR BLOOD CANCER, V51, P118, DOI 10.1002/pbc.21496; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Bellach B M, 1999, Gesundheitswesen, V61 Spec No, pS55; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Filipp S-H, 1991, PRAXIS KLIN VERHALTE, V4, P274; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Germann U, 2005, EIDGENOSSISCHE VOLKS; Goldsby RE, 2010, J CLIN ONCOL, V28, P324, DOI 10.1200/JCO.2009.22.5060; Harila MJ, 2010, PEDIATR BLOOD CANCER, V55, P331, DOI 10.1002/pbc.22531; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Kuehni CE, 2011, INT J EPIDE IN PRESS; Kuehni CE, 2011, CANCER IN PRESS; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Linabery AM, 2008, CANCER-AM CANCER SOC, V113, P2575, DOI 10.1002/cncr.23866; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Maunsell E, 2006, J CLIN ONCOL, V24, P2527, DOI 10.1200/JCO.2005.03.9297; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Moe PJ, 1997, PEDIATR HEMAT ONCOL, V14, P513, DOI 10.3109/08880019709030908; Morfeld M, 2005, SOZ PRAVENTIV MED, V50, P292, DOI 10.1007/s00038-005-4090-6; O'Leary TE, 2007, QUAL LIFE RES, V16, P1211, DOI 10.1007/s11136-007-9231-3; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Parry C, 2005, QUAL HEALTH RES, V15, P1055, DOI 10.1177/1049732305277860; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Reulen RC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-77; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Sprangers MAG, 1999, ANN ONCOL, V10, P747, DOI 10.1023/A:1008305523548; Stam H, 2006, PSYCHO-ONCOLOGY, V15, P31, DOI 10.1002/pon.920; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Ware JE, 2000, SCORE VERSION 2 SF 3; Zebrack BJ, 2002, PSYCHO-ONCOLOGY, V11, P132, DOI 10.1002/pon.569; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	40	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38015	10.1371/journal.pone.0038015	http://dx.doi.org/10.1371/journal.pone.0038015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662262	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305342300154
J	Gandhi, S; Vaarmann, A; Yao, Z; Duchen, MR; Wood, NW; Abramov, AY				Gandhi, Sonia; Vaarmann, Annika; Yao, Zhi; Duchen, Michael R.; Wood, Nicholas W.; Abramov, Andrey Y.			Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; MONOAMINE-OXIDASE; CYCLOSPORINE-A; CALCIUM; NEURONS; VULNERABILITY; METABOLISM; MUTATIONS	Background: Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function causes mitochondrial dysfunction, increased reactive oxygen species production and calcium dysregulation, which increases susceptibility to neuronal death in Parkinson's disease. The basis of neuronal vulnerability to dopamine in Parkinson's disease is not well understood. Methodology: We investigated the mechanism of dopamine induced cell death in transgenic PINK1 knockout mouse neurons. We show that dopamine results in mitochondrial depolarisation caused by mitochondrial permeability transition pore (mPTP) opening. Dopamine-induced mPTP opening is dependent on a complex of reactive oxygen species production and calcium signalling. Dopamine-induced mPTP opening, and dopamine-induced cell death, could be prevented by inhibition of reactive oxygen species production, by provision of respiratory chain substrates, and by alteration in calcium signalling. Conclusions: These data demonstrate the mechanism of dopamine toxicity in PINK1 deficient neurons, and suggest potential therapeutic strategies for neuroprotection in Parkinson's disease.	[Gandhi, Sonia; Vaarmann, Annika; Yao, Zhi; Wood, Nicholas W.; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London; University of London; University College London	Gandhi, S (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London, England.	a.abramov@ucl.ac.uk	Abramov, Andrey/AAC-6712-2019; Wood, Nicholas W/C-2505-2009; YAO, Zhi/C-6096-2009; duchen, michael/A-2116-2009; Abramov, Andrey Y/H-9053-2012; Vaarmann, Annika/AAH-7289-2021; Yao, Zhi/B-9047-2013	Abramov, Andrey/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; duchen, michael/0000-0003-2548-4294; Abramov, Andrey Y/0000-0002-7646-7235; Vaarmann, Annika/0000-0003-0296-8325; Yao, Zhi/0000-0001-6432-5734	The Wellcome Trust/MRC strategic award; Academy of Medical Sciences (AMS) [AMS-SGCL5-Gandhi] Funding Source: researchfish; Medical Research Council [MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [G-0612, F-0806, G-1101] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	The Wellcome Trust/MRC strategic award; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AYA is a Parkinson's UK Senior Research Fellow. SG was a Wellcome Trust Clinical Research Fellow. NWW, AYA and MD are supported by The Wellcome Trust/MRC strategic award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Burchell VS, 2010, EXPERT OPIN THER TAR, V14, P369, DOI 10.1517/14728221003652489; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chu CT, 2010, BBA-MOL BASIS DIS, V1802, P20, DOI 10.1016/j.bbadis.2009.06.012; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Das UN, 2006, NUTRITION, V22, P965, DOI 10.1016/j.nut.2006.05.009; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Szabadkai G, 2007, CHAPERONES PARTS ORG, P64; Vaarmann A, 2010, CELL CALCIUM, V48, P176, DOI 10.1016/j.ceca.2010.08.008; Vaarmann A, 2010, J BIOL CHEM, V285, P25018, DOI 10.1074/jbc.M110.111450; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464	22	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37564	10.1371/journal.pone.0037564	http://dx.doi.org/10.1371/journal.pone.0037564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662171	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300061
J	Kostopoulou, F; Gkretsi, V; Malizos, KN; Iliopoulos, D; Oikonomou, P; Poultsides, L; Tsezou, A				Kostopoulou, Fotini; Gkretsi, Vasiliki; Malizos, Konstantinos N.; Iliopoulos, Dimitrios; Oikonomou, Pagona; Poultsides, Lazaros; Tsezou, Aspasia			Central Role of SREBP-2 in the Pathogenesis of Osteoarthritis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; LEUCINE ZIPPER PROTEIN; EXPRESSION; GENE; TRANSCRIPTION; CHOLESTEROL; IDENTIFICATION; (SREBP)-2; COMPLEX; OBESITY	Background: Recent studies have implied that osteoarthritis (OA) is a metabolic disease linked to deregulation of genes involved in lipid metabolism and cholesterol efflux. Sterol Regulatory Element Binding Proteins (SREBPs) are transcription factors regulating lipid metabolism with so far no association with OA. Our aim was to test the hypothesis that SREBP-2, a gene that plays a key role in cholesterol homeostasis, is crucially involved in OA pathogenesis and to identify possible mechanisms of action. Methodology/Principal Findings: We performed a genetic association analysis using a cohort of 1,410 Greek OA patients and healthy controls and found significant association between single nucleotide polymorphism (SNP) 1784G>C in SREBP-2 gene and OA development. Moreover, the above SNP was functionally active, as normal chondrocytes' transfection with SREBP-2-G/C plasmid resulted in interleukin-1 beta and metalloproteinase-13 (MMP-13) upregulation. We also evaluated SREBP-2, its target gene 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR), phospho-phosphoinositide3-kinase (PI3K), phospho-Akt, integrin-alphaV (ITGAV) and transforming growth factor-beta (TGF-beta) mRNA and protein expression levels in osteoarthritic and normal chondrocytes and found that they were all significantly elevated in OA chondrocytes. To test whether TGF-beta alone can induce SREBP-2, we treated normal chondrocytes with TGF-beta and found significant upregulation of SREBP-2, HMGCR, phospho-PI3K and MMP-13. We also showed that TGF-beta activated aggrecan (ACAN) in chondrocytes only through Smad3, which interacts with SREBP-2. Finally, we examined the effect of an integrin inhibitor, cyclo-RGDFV peptide, on osteoarthritic chondrocytes, and found that it resulted in significant upregulation of ACAN and downregulation of SREBP-2, HMGCR, phospho-PI3K and MMP-13 expression levels. Conclusions/Significance: We demonstrated, for the first time, the association of SREBP-2 with OA pathogenesis and provided evidence on the molecular mechanism involved. We suggest that TGF-beta induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.	[Kostopoulou, Fotini; Tsezou, Aspasia] Univ Thessaly, Dept Cytogenet & Mol Genet, Sch Med, Larisa, Greece; [Kostopoulou, Fotini; Gkretsi, Vasiliki; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia] Ctr Res & Technol Thessaly, Inst Biomed Res & Technol, Larisa, Greece; [Malizos, Konstantinos N.; Poultsides, Lazaros] Univ Thessaly, Dept Orthopaed, Sch Med, Larisa, Greece; [Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Tsezou, Aspasia] Univ Thessaly, Dept Biol, Sch Med, Larisa, Greece	University of Thessaly; University of Thessaly; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Thessaly	Kostopoulou, F (corresponding author), Univ Thessaly, Dept Cytogenet & Mol Genet, Sch Med, Larisa, Greece.	atsezou@med.uth.gr	Iliopoulos, Dimitrios/AAE-9106-2019; Gkretsi, Vasiliki/Q-2158-2019	Gkretsi, Vasiliki/0000-0002-3671-4078	Hellenic Society of Orthopaedic Surgery and Traumatology	Hellenic Society of Orthopaedic Surgery and Traumatology	The present study was financed by the Hellenic Society of Orthopaedic Surgery and Traumatology. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aspden RM, 2001, LANCET, V357, P1118, DOI 10.1016/S0140-6736(00)04264-1; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; Davidson ENB, 2010, ARTHRITIS RES THER, V12, P1; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; Grimsby S, 2004, FEBS LETT, V577, P93, DOI 10.1016/j.febslet.2004.09.069; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Gylling Helena, 2005, Curr Atheroscler Rep, V7, P466, DOI 10.1007/s11883-005-0064-7; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Laaksonen R, 2006, ATHEROSCLEROSIS, V185, P206, DOI 10.1016/j.atherosclerosis.2005.06.007; Liu XL, 2010, ATHEROSCLEROSIS, V208, P421, DOI 10.1016/j.atherosclerosis.2009.08.011; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Miserez AR, 2001, AIDS, V15, P2045, DOI 10.1097/00002030-200110190-00020; Muller PY, 2002, J MED GENET, V39, P271, DOI 10.1136/jmg.39.4.271; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Robinet P, 2003, ATHEROSCLEROSIS, V168, P381, DOI 10.1016/S0021-9150(03)00144-8; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakao K, 2009, J ORTHOP SCI, V14, P738, DOI 10.1007/s00776-009-1401-4; Schiphof D, 2008, ANN RHEUM DIS, V67, P1034, DOI 10.1136/ard.2007.079020; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Simopoulou T, 2007, CLIN EXP RHEUMATOL, V25, P605; Simopoulou T, 2010, J ORTHOP RES, V28, P110, DOI 10.1002/jor.20953; Sowers M, 2001, CURR OPIN RHEUMATOL, V13, P447, DOI 10.1097/00002281-200109000-00018; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; VANSAASE JLCM, 1988, J RHEUMATOL, V15, P1152; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	38	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35753	10.1371/journal.pone.0035753	http://dx.doi.org/10.1371/journal.pone.0035753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662110	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300005
J	Lopez-Lopez, P; Sara, M; Di Vittorio, M				Lopez-Lopez, Pascual; Sara, Maurizio; Di Vittorio, Massimiliano			Living on the Edge: Assessing the Extinction Risk of Critically Endangered Bonelli's Eagle in Italy	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; HIERAAETUS-FASCIATUS; TOP PREDATORS; CONSERVATION; MANAGEMENT; DEMOGRAPHY; SURVIVAL; DENSITY; BIOLOGY; MODELS	Background: The population of Bonelli's eagle (Aquila fasciata) has declined drastically throughout its European range due to habitat degradation and unnatural elevated mortality. There are less than 1500 breeding pairs accounted for in Europe, and the species is currently catalogued as Critically Endangered in Italy, where the 22 territories of Sicily, represent nearly 95% of the entire Italian population. However, despite national and European conservation concerns, the species currently lacks a specific conservation plan, and no previous attempts to estimate the risk of extinction have been made. Methodology/Principal Findings: We incorporated the most updated demographic information available to assess the extinction risk of endangered Bonelli's eagle in Italy through a Population Viability Analysis. Using perturbation analyses (sensitivity and elasticity), and a combination of demographic data obtained from an assortment of independent methods, we evaluated which demographic parameters have more influence on the population's fate. We also simulated different scenarios to explore the effects of possible management actions. Our results showed that under the current conditions, Bonelli's eagle is expected to become extinct in Italy in less than 50 years. Stand-alone juvenile mortality was the most critical demographic parameter with the strongest influence on population persistence with respect to other demographic parameters. Measures aimed at either decreasing juvenile mortality, adult mortality or decreasing both juvenile and adult mortality resulted in equivalent net positive effects on population persistence (population growth rate lambda>1). In contrast, changes aimed at increasing breeding success had limited positive effects on demographic trends. Conclusions/Significance: Our PVA provides essential information to direct the decision-making process and exposes gaps in our previous knowledge. To ensure the long-term persistence of the species in Italy, measures are urgently needed to decrease both adult mortality due to poaching and juvenile mortality due to nest plundering, the top ranking mortality causes.	[Lopez-Lopez, Pascual] Univ Alicante, Vertebrates Zool Res Grp, E-03080 Alicante, Spain; [Sara, Maurizio; Di Vittorio, Massimiliano] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy	Universitat d'Alacant; University of Palermo	Lopez-Lopez, P (corresponding author), Univ Alicante, Vertebrates Zool Res Grp, E-03080 Alicante, Spain.	Pascual.Lopez@uv.es	Sarà, Maurizio/H-2662-2012; López-López, Pascual/C-1039-2011	Sarà, Maurizio/0000-0003-4274-422X; López-López, Pascual/0000-0001-5269-652X	"Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]	"Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness	PLL is supported by a "Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Arrigoni degliOddi E., 1929, ORNITOLOGIA ITALIANA; Arroyo B, 1997, EUROPEAN UNION ACTIO; Barov B., 2011, REV IMPLEMENTATION S; Beissinger S. R., 2002, POPULATION VIABILITY; BirdLife International, 2011, IUCN RED LIST BIRDS; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Cadahia L, 2010, EUR J WILDLIFE RES, V56, P923, DOI 10.1007/s10344-010-0391-z; Calvario E., 1999, NEW RED LISTS BREEDI; Carrascal LM, 2009, ECOL RES, V24, P565, DOI 10.1007/s11284-008-0527-8; Carrete M, 2005, OIKOS, V108, P125, DOI 10.1111/j.0030-1299.2005.12942.x; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Christie D ., 2001, RAPTORS BIRDS PREY W; Cortone P., 1987, Supplemento alle Ricerche di Biologia della Selvaggina, V12, P57; Di Vittorio M, 2007, THESIS U STUDI PALER; Di Vittorio M, 2012, BIRD STUDY, V59, P207, DOI 10.1080/00063657.2012.656577; DisVittorio M., 2000, ALULA, V7, P57; Doderlein P, 1869, AVIFAUNA MODENESE SI; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FERRER M, 1991, WILDLIFE SOC B, V19, P436; FERRER M, 1990, BIOL CONSERV, V51, P151, DOI 10.1016/0006-3207(90)90109-3; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2009, CONSERV BIOL, V23, P1017, DOI 10.1111/j.1523-1739.2009.01215.x; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fujiwara M, 2007, ECOLOGY, V88, P2345, DOI 10.1890/06-1405.1; Garcia-Ripolles C, 2011, J ORNITHOL, V152, P879, DOI 10.1007/s10336-011-0671-8; HARRIS R B, 1987, Conservation Biology, V1, P72, DOI 10.1111/j.1523-1739.1987.tb00011.x; Heppell S, 2000, ECOLOGY, V81, P605, DOI 10.1890/0012-9658(2000)081[0605:EAIPBM]2.0.CO;2; Hernandez-Matias A, 2011, P INT C MONTP FRANC, P23; Hernandez-Matias A, 2011, IBIS, V153, P846, DOI 10.1111/j.1474-919X.2011.01158.x; Hernandez-Matias A, 2011, J WILDLIFE MANAGE, V75, P856, DOI 10.1002/jwmg.102; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Lo Valvo M., 1992, FAUNA ITALIA, P616; Lopez-Lopez P, 2006, J ORNITHOL, V147, P97, DOI 10.1007/s10336-005-0019-3; Lopez-Lopez P, 2010, ITAL J ZOOL, V77, P289, DOI 10.1080/11250000902950637; Lopez-Lopez P, 2007, BIODIVERS CONSERV, V16, P3755, DOI 10.1007/s10531-007-9179-1; Lopez-Lopez P, 2007, BIRD STUDY, V54, P335, DOI 10.1080/00063650709461493; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Lubben J, 2008, BIOL CONSERV, V141, P517, DOI 10.1016/j.biocon.2007.11.003; Massa B., 1983, LAVORI SOC ITALIANA, V8, P757; Massa B, 1985, NATURALISTA SICIL, P9; McDonald-Madden E, 2010, ECOL APPL, V20, P1476, DOI 10.1890/09-0647.1; McGowan CP, 2011, BIOL CONSERV, V144, P1400, DOI 10.1016/j.biocon.2011.01.005; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Miller PS., 2005, VORTEX STOCHASTIC SI; Moleon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022851; Morris W. F., 2002, QUANTITATIVE CONSERV; Naujokaitis-Lewis IR, 2009, CONSERV BIOL, V23, P225, DOI 10.1111/j.1523-1739.2008.01066.x; NORTON TW, 1995, BIOL CONSERV, V73, P91, DOI 10.1016/0006-3207(95)90027-6; Ontiveros D, 2005, BIOL CONSERV, V123, P19, DOI 10.1016/j.biocon.2004.10.004; Ontiveros D, 2004, ARDEOLA, V51, P461; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Ponchon C., 2011, CONSERVATION AIGLE B, P14; Primack RB, 2010, ESSENTIALS OF CONSERVATION BIOLOGY, FIFTH EDITION, P1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Real J, 1997, BIOL CONSERV, V79, P59, DOI 10.1016/S0006-3207(96)00100-0; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Scher O, 2011, P INT C MONTP INT C; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; Steenhof K., 2007, RAPTOR RES MANAGEMEN, P181; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Wintle BA, 2010, ECOL LETT, V13, P1325, DOI 10.1111/j.1461-0248.2010.01514.x	73	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37862	10.1371/journal.pone.0037862	http://dx.doi.org/10.1371/journal.pone.0037862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662239	Green Published, gold			2022-12-25	WOS:000305342300129
J	Tran, VG; Court, F; Duputie, A; Antoine, E; Aptel, N; Milligan, L; Carbonell, F; Lelay-Taha, MN; Piette, J; Weber, M; Montarras, D; Pinset, C; Dandolo, L; Forne, T; Cathala, G				Van Giang Tran; Court, Franck; Duputie, Anne; Antoine, Etienne; Aptel, Nathalie; Milligan, Laura; Carbonell, Francoise; Lelay-Taha, Marie-Noelle; Piette, Jacques; Weber, Michael; Montarras, Didier; Pinset, Christian; Dandolo, Luisa; Forne, Thierry; Cathala, Guy			H19 Antisense RNA Can Up-Regulate Igf2 Transcription by Activation of a Novel Promoter in Mouse Myoblasts	PLOS ONE			English	Article							LONG NONCODING RNA; TUMOR-SUPPRESSOR; IMPRINTED GENES; METHYLATED REGION; WILMS-TUMOR; IN-VIVO; EXPRESSION; LOCUS; CANCER; CELLS	It was recently shown that a long non-coding RNA (lncRNA), that we named the 91H RNA (i.e. antisense H19 transcript), is overexpressed in human breast tumours and contributes in trans to the expression of the Insulin-like Growth Factor 2 (IGF2) gene on the paternal chromosome. Our preliminary experiments suggested that an H19 antisense transcript having a similar function may also be conserved in the mouse. In the present work, we further characterise the mouse 91H RNA and, using a genetic complementation approach in H19 KO myoblast cells, we show that ectopic expression of the mouse 91H RNA can up-regulate Igf2 expression in trans despite almost complete unmethylation of the Imprinting-Control Region (ICR). We then demonstrate that this activation occurs at the transcriptional level by activation of a previously unknown Igf2 promoter which displays, in mouse tissues, a preferential mesodermic expression (Pm promoter). Finally, our experiments indicate that a large excess of the H19 transcript can counteract 91H-mediated Igf2 activation. Our work contributes, in conjunction with other recent findings, to open new horizons to our understanding of Igf2 gene regulation and functions of the 91H/H19 RNAs in normal and pathological conditions.	[Van Giang Tran; Court, Franck; Duputie, Anne; Antoine, Etienne; Aptel, Nathalie; Milligan, Laura; Carbonell, Francoise; Lelay-Taha, Marie-Noelle; Piette, Jacques; Weber, Michael; Forne, Thierry; Cathala, Guy] Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France; [Montarras, Didier] Inst Pasteur, Mol Genet Dev Unit, Dept Dev Biol, CNRS,URA 2578, Paris, France; [Pinset, Christian] CECS, ISTEM, Evry, France; [Dandolo, Luisa] Univ Paris 05, Inst Cochin, UMR 8104, Genet & Dev Dept,CNRS,INSERM,U567, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tran, VG (corresponding author), Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France.	forne@igmm.cnrs.fr; cathala@igmm.cnrs.fr	Forne, Thierry/D-3718-2013; Weber, Michael/P-1914-2016	Forne, Thierry/0000-0002-9179-1551; Weber, Michael/0000-0003-3484-5821; court, franck/0000-0003-0327-9708; Duputie, Anne/0000-0003-2213-7940; Milligan, Laura/0000-0001-6985-3034	Association pour la Recherche contre le Cancer [ARC] [SFI20101201555]; Agence Nationale de la Recherche [ANR-07-BLAN-0052-02, NT09_669034]; CEFIC-Long-range Research Initiative [LRI-EMSG49-CNRS-08]; Ligue Nationale contre le Cancer (comite de l'Herault); "Centre National de la Recherche Scientifique" (CNRS); fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche); governmental fellowship from the socialist republic of Vietnam	Association pour la Recherche contre le Cancer [ARC](Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); CEFIC-Long-range Research Initiative; Ligue Nationale contre le Cancer (comite de l'Herault); "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche); governmental fellowship from the socialist republic of Vietnam	This work was supported by grants from the Association pour la Recherche contre le Cancer [ARC contract n SFI20101201555 to T. F.]; the Agence Nationale de la Recherche [ANR-07-BLAN-0052-02 to T. F. and L. D., NT09_669034 to M. W.]; the CEFIC-Long-range Research Initiative [LRI-EMSG49-CNRS-08 to M. W.]; the Ligue Nationale contre le Cancer (comite de l'Herault) and the "Centre National de la Recherche Scientifique" (CNRS). F. C. was supported by a fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche). T. V. G. was supported by a governmental fellowship from the socialist republic of Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 1998, AM J PATHOL, V153, P1597, DOI 10.1016/S0002-9440(10)65748-3; Ariel I, 1997, J CLIN PATHOL-MOL PA, V50, P34, DOI 10.1136/mp.50.1.34; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; BIRAN H, 1994, TUMOR BIOL, V15, P123, DOI 10.1159/000217882; Braem C, 2008, J BIOL CHEM, V283, P18612, DOI 10.1074/jbc.M801883200; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Cooper MJ, 1996, J UROLOGY, V155, P2120, DOI 10.1016/S0022-5347(01)66120-2; Court F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r42; Court F, 2011, NUCLEIC ACIDS RES, V39, P5893, DOI 10.1093/nar/gkr209; Davies K, 2002, DEVELOPMENT, V129, P1657; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Latos PA, 2009, RNA BIOL, V6, P100, DOI 10.4161/rna.6.2.7854; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; LustigYariv O, 1997, ONCOGENE, V15, P169, DOI 10.1038/sj.onc.1201175; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Milligan L, 2000, ONCOGENE, V19, P5810, DOI 10.1038/sj.onc.1203965; Milligan L, 2002, EMBO REP, V3, P774, DOI 10.1093/embo-reports/kvf142; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Onyango P, 2011, P NATL ACAD SCI USA, V108, P16759, DOI 10.1073/pnas.1110904108; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Schoenfelder S, 2007, EMBO REP, V8, P1068, DOI 10.1038/sj.embor.7401094; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Watanabe Y, 2010, GENOMICS, V96, P333, DOI 10.1016/j.ygeno.2010.08.007; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weber ML, 2003, ANAL BIOCHEM, V320, P252, DOI 10.1016/S0003-2697(03)00396-8; Wilkin F, 2000, EUR J BIOCHEM, V267, P4020, DOI 10.1046/j.1432-1327.2000.01438.x; Wilusz J, 2011, GENE DEV, V23, P1494; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105	58	34	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37923	10.1371/journal.pone.0037923	http://dx.doi.org/10.1371/journal.pone.0037923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662250	gold, Green Published			2022-12-25	WOS:000305342300141
J	Wang, X; Ke, ZJ; Chen, G; Xu, M; Bower, KA; Frank, JA; Zhang, Z; Shi, XL; Luo, J				Wang, Xin; Ke, Zunji; Chen, Gang; Xu, Mei; Bower, Kimberly A.; Frank, Jacqueline A.; Zhang, Zhuo; Shi, Xianglin; Luo, Jia			Cdc42-Dependent Activation of NADPH Oxidase Is Involved in Ethanol-Induced Neuronal Oxidative Stress	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; FREE-RADICAL DAMAGE; FETAL ALCOHOL; MOUSE; BRAIN; RAT; MITOCHONDRIA; ASTROCYTES; EXPRESSION; MECHANISM	It has been suggested that excessive reactive oxygen species (ROS) and oxidative stress play an important role in ethanol-induced damage to both the developing and mature central nervous system (CNS). The mechanisms underlying ethanol-induced neuronal ROS, however, remain unclear. In this study, we investigated the role of NADPH oxidase (NOX) in ethanol-induced ROS generation. We demonstrated that ethanol activated NOX and inhibition of NOX reduced ethanol-promoted ROS generation. Ethanol significantly increased the expression of p47(phox) and p67(phox), the essential subunits for NOX activation in cultured neuronal cells and the cerebral cortex of infant mice. Ethanol caused serine phosphorylation and membrane translocation of p47(phox) and p67(phox), which were prerequisites for NOX assembly and activation. Knocking down p47(phox) with the small interfering RNA was sufficient to attenuate ethanol-induced ROS production and ameliorate ethanol-mediated oxidative damage, which is indicated by a decrease in protein oxidation and lipid peroxidation. Ethanol activated cell division cycle 42 (Cdc42) and overexpression of a dominant negative (DN) Cdc42 abrogate ethanol-induced NOX activation and ROS generation. These results suggest that Cdc42-dependent NOX activation mediates ethanol-induced oxidative damages to neurons.	[Wang, Xin; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA; [Ke, Zunji; Chen, Gang; Xu, Mei; Bower, Kimberly A.; Frank, Jacqueline A.; Luo, Jia] Univ Kentucky, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Wang, X (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA.	xshi5@uky.edu; jialuo888@uky.edu	Zhang, Zhuo/B-8601-2012; Ke, Zunji/E-4822-2010; Ke, Zun-Ji/N-5689-2014; Luo, Jia/E-4674-2012	Ke, Zunji/0000-0003-4038-2456; Ke, Zun-Ji/0000-0003-4038-2456; Luo, Jia/0000-0002-6968-3618	NIH [AA015407, AA019693]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA019693, R01AA015407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by NIH grants AA015407 and AA019693. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Antonio AM, 2008, BRAIN RES, V1204, P16, DOI 10.1016/j.brainres.2008.02.018; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen SY, 2000, J PHARMACOL EXP THER, V294, P134; CHEN WJA, 1995, ALCOHOL, V12, P351, DOI 10.1016/0741-8329(95)00017-L; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Hasegawa T, 2002, LIVER, V22, P321, DOI 10.1034/j.1600-0676.2002.01493.x; Heaton MB, 2006, J NEUROBIOL, V66, P95, DOI 10.1002/neu.20208; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Ke ZJ, 2011, J NEUROSCI RES, V89, P1676, DOI 10.1002/jnr.22689; Luo J, 2001, J NEUROCHEM, V76, P1354, DOI 10.1046/j.1471-4159.2001.00129.x; Luo J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00041; Miyano K, 2012, METHODS MOL BIOL, V827, P195, DOI 10.1007/978-1-61779-442-1_14; Naseer MI, 2011, SYNAPSE, V65, P562, DOI 10.1002/syn.20875; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Olney JW, 2002, NEUROBIOL DIS, V9, P205, DOI 10.1006/nbdi.2001.0475; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Polikandriotis JA, 2006, AM J RESP CELL MOL, V34, P314, DOI 10.1165/rcmb.2005-0320OC; Qian Y, 2005, J BIOL CHEM, V280, P3875, DOI 10.1074/jbc.M403788200; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; Sigal N, 2003, J BIOL CHEM, V278, P4854, DOI 10.1074/jbc.M211011200; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Thomson A D, 2000, Alcohol Alcohol Suppl, V35, P2; Wang X, 2011, TOXICOL SCI, V123, P399, DOI 10.1093/toxsci/kfr180; Wentzel P, 2006, ALCOHOL CLIN EXP RES, V30, P1752, DOI 10.1111/j.1530-0277.2006.00208.x; Wentzel P, 2006, TOXICOL SCI, V92, P416, DOI 10.1093/toxsci/kfl024	38	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38075	10.1371/journal.pone.0038075	http://dx.doi.org/10.1371/journal.pone.0038075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662267	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300159
J	Zhu, FC; Liang, ZL; Meng, FY; Zeng, Y; Mao, QY; Chu, K; Song, XF; Yao, X; Li, JX; Ji, H; Zhang, YJ; Li, L; Pan, HX; Xu, K; Dai, WM; Zhang, WW; Deng, F; Wang, H; Wang, JZ				Zhu, Feng-Cai; Liang, Zheng-Lun; Meng, Fan-Yue; Zeng, Ying; Mao, Qun-Ying; Chu, Kai; Song, Xue-Fang; Yao, Xin; Li, Jing-Xin; Ji, Hong; Zhang, Yi-Ju; Li, Liang; Pan, Hong-Xing; Xu, Ke; Dai, Wei-Ming; Zhang, Wei-Wei; Deng, Fei; Wang, Hua; Wang, Jun-Zhi			Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants	PLOS ONE			English	Article							1998 ENTEROVIRUS-71 OUTBREAK; MOUTH-DISEASE; COXSACKIEVIRUS A16; 71 INFECTION; TAIWAN; FOOT; HAND; EPIDEMIOLOGY; CHINA; ANTIGENICITY	Background: Hand, foot, and mouth disease (HFMD) has been emerging as an important public problem over the past few decades, especially in Asian and Pacific regions. A national program on EV71 vaccine development against HFMD was initiated in China, in 2008, which called for a need for seroepidemiological study for the target population. Methodology/Principal Findings: This was a retrospective study conducted in Jiangsu Province, in October, 2010. We measured the neutralizing antibodies against EV71 and CoxA16 in a cohort of infants aged of 2, 7, 12, and 27-38 months and their mothers just before delivery. Series sera samples from 975 infants and 555 mothers were collected and analyzed. Questionnaires on the history of HFMD were completed in the survey. A total of 143 HFMD cases were collected, but only 11.2% were reported to the National Infectious Disease Information Management System. The level of maternal antibody titers decreased dramatically during the first 7 month and remained at a relatively low level thereafter. But it increased significantly from month 12 to months 27-38. The accumulate incidence density of HFMD demonstrated a significant increase after 14 months of age, resulting in a accumulate incidence density of 50.8/1000 person-years in survey period. Seropositivity of EV71 antibody in infants at the age of 2 months seems to demonstrate a protective effect against HFMD. Conclusions and Significance: High seropositive rate of EV71 and CoxA16 antibody was found in prenatal women in mainland China, and there is a need to enhance the HFMD case management and the current surveillance system. We suggest that infants aged between 6 to 14 months should have the first priority to receive EV71 vaccine.	[Zhu, Feng-Cai; Meng, Fan-Yue; Chu, Kai; Li, Jing-Xin; Ji, Hong; Zhang, Yi-Ju; Li, Liang; Pan, Hong-Xing; Xu, Ke; Dai, Wei-Ming; Deng, Fei; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zeng, Ying; Song, Xue-Fang] Shenzhen Kangtai Biol Prod Co Ltd, Guangzhou, Guangdong, Peoples R China; [Liang, Zheng-Lun; Mao, Qun-Ying; Yao, Xin; Wang, Jun-Zhi] Natl Inst Food & Drug Control, Lab 2, Beijing, Peoples R China; [Zhang, Wei-Wei] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Southeast University - China	Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jszfc@vip.sina.com; lzlun@yahoo.com; wangjz@nicpbp.org.cn			Chinese governmental grants [2008BAI69B01, 2009ZX10004-806]	Chinese governmental grants	The study was funded by Chinese governmental grants (2008BAI69B01 and 2009ZX10004-806). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jia Lei, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P635; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Teng Zheng, 2010, Chinese Journal of Virology, V26, P437; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wang SM, 2010, CLIN VACCINE IMMUNOL, V17, P1517, DOI 10.1128/CVI.00108-10; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	25	86	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37206	10.1371/journal.pone.0037206	http://dx.doi.org/10.1371/journal.pone.0037206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662137	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300028
J	Dichosa, AEK; Fitzsimons, MS; Lo, CC; Weston, LL; Preteska, LG; Snook, JP; Zhang, XJ; Gu, W; McMurry, K; Green, LD; Chain, PS; Detter, JC; Han, CS				Dichosa, Armand E. K.; Fitzsimons, Michael S.; Lo, Chien-Chi; Weston, Lea L.; Preteska, Lara G.; Snook, Jeremy P.; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.			Artificial Polyploidy Improves Bacterial Single Cell Genome Recovery	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; TARGETING FTSZ; SMALL-MOLECULE; AMPLIFICATION; CYTOKINESIS; METABOLISM; POLYMERASE; DISCOVERY	Background: Single cell genomics (SCG) is a combination of methods whose goal is to decipher the complete genomic sequence from a single cell and has been applied mostly to organisms with smaller genomes, such as bacteria and archaea. Prior single cell studies showed that a significant portion of a genome could be obtained. However, breakages of genomic DNA and amplification bias have made it very challenging to acquire a complete genome with single cells. We investigated an artificial method to induce polyploidy in Bacillus subtilis ATCC 6633 by blocking cell division and have shown that we can significantly improve the performance of genomic sequencing from a single cell. Methodology/Principal Findings: We inhibited the bacterial cytoskeleton protein FtsZ in B. subtilis with an FtsZ-inhibiting compound, PC190723, resulting in larger undivided single cells with multiple copies of its genome. qPCR assays of these larger, sorted cells showed higher DNA content, have less amplification bias, and greater genomic recovery than untreated cells. Significance: The method presented here shows the potential to obtain a nearly complete genome sequence from a single bacterial cell. With millions of uncultured bacterial species in nature, this method holds tremendous promise to provide insight into the genomic novelty of yet-to-be discovered species, and given the temporary effects of artificial polyploidy coupled with the ability to sort and distinguish differences in cell size and genomic DNA content, may allow recovery of specific organisms in addition to their genomes.	[Dichosa, Armand E. K.; Fitzsimons, Michael S.; Lo, Chien-Chi; Weston, Lea L.; Preteska, Lara G.; Snook, Jeremy P.; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.] Los Alamos Natl Lab, Dept Energy DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [Lo, Chien-Chi; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Dichosa, AEK (corresponding author), Los Alamos Natl Lab, Dept Energy DOE Joint Genome Inst, Los Alamos, NM 87545 USA.	han_cliff@lanl.gov	t, lf/AAJ-4924-2020; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013	Chain, Patrick/0000-0003-3949-3634; Dichosa, Armand/0000-0003-0640-6629; Han, Cliff/0000-0003-1972-0692; Lo, Chien-Chi/0000-0003-3470-1078	Los Alamos National Laboratory: Laboratory Directed Research and Development Fund [20100034DR]; Department of Defense: Defense Threat Reduction Agency [R-3708-09]	Los Alamos National Laboratory: Laboratory Directed Research and Development Fund(United States Department of Energy (DOE)Los Alamos National Laboratory); Department of Defense: Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Los Alamos National Laboratory: Laboratory Directed Research and Development Fund, Grant# 20100034DR, and by the Department of Defense: Defense Threat Reduction Agency, Contract# R-3708-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMARAL L, 1986, DRUG EXP CLIN RES, V12, P653; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Erickson HP, 2000, J CELL BIOL, V148, P1103, DOI 10.1083/jcb.148.6.1103; Fox J., 2014, R COMPANION APPL REG; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rozen S, 2000, Methods Mol Biol, V132, P365; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Sokal RR, 1995, BIOMETRY PRINCIPLES, P521; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urgaonkar S, 2005, ORG LETT, V7, P5609, DOI 10.1021/ol052269z; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	42	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37387	10.1371/journal.pone.0037387	http://dx.doi.org/10.1371/journal.pone.0037387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666352	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300037
J	Kuck, P; Mayer, C; Wagele, JW; Misof, B				Kueck, Patrick; Mayer, Christoph; Waegele, Johann-Wolfgang; Misof, Bernhard			Long Branch Effects Distort Maximum Likelihood Phylogenies in Simulations Despite Selection of the Correct Model	PLOS ONE			English	Article							SITE RATE VARIATION; EVOLUTIONARY TREES; DNA-SEQUENCES; SUBSTITUTION RATES; PARSIMONY; PERFORMANCE; ATTRACTION; HETEROGENEITY; ALGORITHMS; SUCCESS	The aim of our study was to test the robustness and efficiency of maximum likelihood with respect to different long branch effects on multiple-taxon trees. We simulated data of different alignment lengths under two different 11-taxon trees and a broad range of different branch length conditions. The data were analyzed with the true model parameters as well as with estimated and incorrect assumptions about among-site rate variation. If length differences between connected branches strongly increase, tree inference with the correct likelihood model assumptions can fail. We found that incorporating invariant sites together with Gamma distributed site rates in the tree reconstruction (Gamma+I) increases the robustness of maximum likelihood in comparison with models using only Gamma. The results show that for some topologies and branch lengths the reconstruction success of maximum likelihood under the correct model is still low for alignments with a length of 100,000 base positions. Altogether, the high confidence that is put in maximum likelihood trees is not always justified under certain tree shapes even if alignment lengths reach 100,000 base positions.	[Kueck, Patrick; Mayer, Christoph; Waegele, Johann-Wolfgang; Misof, Bernhard] Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	patrick_kueck@web.de		Mayer, Christoph/0000-0001-5104-6621	Deutsche Forschungsgemeinschaft [MI649/6-2, SPP 1174 (WA530/33)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (MI649/6-2 to BM and SPP 1174 (WA530/33) to WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Bruno WJ, 1999, MOL BIOL EVOL, V16, P564, DOI 10.1093/oxfordjournals.molbev.a026137; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fischer M, 2009, J THEOR BIOL, V256, P247, DOI 10.1016/j.jtbi.2008.09.031; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; FUKAMIKOBAYASHI K, 1991, J MOL EVOL, V32, P79, DOI 10.1007/BF02099932; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; Mayrose I, 2005, BIOINFORMATICS, V21, P151, DOI 10.1093/bioinformatics/bti1125; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Philippe H, 2000, MOL BIOL EVOL, V17, P830, DOI 10.1093/oxfordjournals.molbev.a026362; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Regier JC, 2010, NATURE, V319, P473; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Rogers JS, 1997, SYST BIOL, V46, P354, DOI 10.2307/2413629; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Siddall ME, 1998, CLADISTICS, V14, P209, DOI 10.1111/j.1096-0031.1998.tb00334.x; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; Sullivan J, 1996, J MOL EVOL, V42, P308, DOI 10.1007/BF02198857; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Tourasse NJ, 1997, MOL BIOL EVOL, V14, P287, DOI 10.1093/oxfordjournals.molbev.a025764; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; YANG Z, 1995, SYST BIOL, V44, P384, DOI 10.2307/2413599; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 1997, MOL BIOL EVOL, V14, P105, DOI 10.1093/oxfordjournals.molbev.a025695	46	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36593	10.1371/journal.pone.0036593	http://dx.doi.org/10.1371/journal.pone.0036593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22662120	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336100044
J	Kastberger, G; Weihmann, F; Hoetzl, T; Weiss, SE; Maurer, M; Kranner, I				Kastberger, Gerald; Weihmann, Frank; Hoetzl, Thomas; Weiss, Sara E.; Maurer, Michael; Kranner, Ilse			How to Join a Wave: Decision-Making Processes in Shimmering Behavior of Giant Honeybees (Apis dorsata)	PLOS ONE			English	Article							COLONY DEFENSE; MOTION	Shimmering is a collective defence behaviour in Giant honeybees (Apis dorsata) whereby individual bees flip their abdomen upwards, producing Mexican wave-like patterns on the nest surface. Bucket bridging has been used to explain the spread of information in a chain of members including three testable concepts: first, linearity assumes that individual "agent bees'' addresses the coincidence of the individual property of trigger direction with the collective property of wave direction. Second, continuity describes the transfer of information without being stopped, delayed or re-routed. The active-neighbours hypothesis assumes coincidence between the direction of the majority of shimmering-active neighbours and the trigger direction of the agents. Third, the graduality hypothesis refers to the interaction between an agent and her active neighbours, assuming a proportional relationship in the strength of abdomen flipping of the agent and her previously active neighbours. Shimmering waves provoked by dummy wasps were recorded with high-resolution video cameras. Individual bees were identified by 3D-image analysis, and their strength of abdominal flipping was assessed by pixel-based luminance changes in sequential frames. For each agent, the directedness of wave propagation was based on wave direction, trigger direction, and the direction of the majority of shimmering-active neighbours. The data supported the bucket bridging hypothesis, but only for a small proportion of agents: linearity was confirmed for 2.5%, continuity for 11.3% and graduality for 0.4% of surface bees (but in 2.6% of those agents with high wave-strength levels). The complimentary part of 90% of surface bees did not conform to bucket bridging. This fuzziness is discussed in terms of self-organisation and evolutionary adaptedness in Giant honeybee colonies to respond to rapidly changing threats such as predatory wasps scanning in front of the nest.	[Kastberger, Gerald; Weihmann, Frank; Hoetzl, Thomas; Weiss, Sara E.] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Maurer, Michael] Graz Univ Technol, Inst Comp Graph & Vis, A-8010 Graz, Austria; [Kranner, Ilse] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Graz; Graz University of Technology; University of Innsbruck	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	FWF (Soziale Wellen bei Riesenhonigbienen) [P 20515-B16]	FWF (Soziale Wellen bei Riesenhonigbienen)	The paper had been granted by the Austrian Science Fund (FWF Project P 20515-B16)(Soziale Wellen bei Riesenhonigbienen), http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, BEHAV ECOLOGY; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Born M, 1999, PRINCIPLES OPTICS, V461; Bradbury J.W., 1983, P109; BUCK J, 1976, SCI AM, V234, P74; Butani DK, 1950, INDIAN BEE J, V12, P115; BUTLER CG, 1962, WORLD HONEYBEE; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Camazine S., 2003, SELF ORG BIOL SYSTEM; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; Freixenet J, 2002, LECT NOTES COMPUT SC, V2352, P408, DOI 10.1007/3-540-47977-5_27; Gibson R.M., 1986, P379; Hartley R., 2003, MULTIPLE VIEW GEOMET, V2nd second; Hepburn HR, 2007, APIDOLOGIE, V38, P219, DOI 10.1051/apido:2007010; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA, DOI DOI 10.1017/CBO9780511618536; Kastberger G, 1996, APIDOLOGIE, V27, P381, DOI 10.1051/apido:19960506; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 2010, COMMUNICATIVE INTEGR, V3, P1; Kastberger G, 2012, TRANSIENT MECH UNPUB; Kastberger G, 2011, TRANSMITTANCE UNPUB; KASTBERGER G, 1999, MAGIC TREES ASSAM DO; Kastberger G, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-3; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Klabunde RE, 2005, CARDIOVASCULAR PHYSL; KOENIGER N, 1975, Zeitschrift fuer Tierpsychologie, V37, P99; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; Lloyd J.E., 1979, P293; Morse RA, 1969, APIS DORSALA PHILLIP; OTTE D, 1977, BIOL BEHAV, V2, P143; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; Phillips O.M., 1977, DYNAMICS UPPER OCEAN, V2nd ed.; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Procaccini A, 2011, ANIM BEHAV, V82, P759, DOI 10.1016/j.anbehav.2011.07.006; Roepke W, 1930, BEOBACHTUNGEN INDISC; Sakagami S. F., 1960, Acta Hymenopterologica, V1, P171; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Schmelzer E, 2009, NATURWISSENSCHAFTEN, V96, P1431, DOI 10.1007/s00114-009-0605-y; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Weihmann F, 2011, DGAAE ANN M S; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Woyke J, 2008, J INSECT BEHAV, V21, P481, DOI 10.1007/s10905-008-9144-1; Zureiki A, 2007, IEEE IMAGE PROC, P237	46	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36736	10.1371/journal.pone.0036736	http://dx.doi.org/10.1371/journal.pone.0036736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22662123	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335500027
J	Homer, CR; Kabi, A; Marina-Garcia, N; Sreekumar, A; Nesvizhskii, AI; Nickerson, KP; Chinnaiyan, AM; Nunez, G; McDonald, C				Homer, Craig R.; Kabi, Amrita; Marina-Garcia, Noemi; Sreekumar, Arun; Nesvizhskii, Alexey I.; Nickerson, Kourtney P.; Chinnaiyan, Arul M.; Nunez, Gabriel; McDonald, Christine			A Dual Role for Receptor-interacting Protein Kinase 2 (RIP2) Kinase Activity in Nucleotide-binding Oligomerization Domain 2 (NOD2)-dependent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; PHOSPHATASE 2A; CROHNS-DISEASE; COORDINATED REGULATION; SUSCEPTIBILITY LOCI; SIGNALING PATHWAYS; P38 MAPK; NOD2; ACTIVATION	Autophagy is triggered by the intracellular bacterial sensor NOD2 (nucleotide-binding, oligomerization domain 2) as an anti-bacterial response. Defects in autophagy have been implicated in Crohn's disease susceptibility. The molecular mechanisms of activation and regulation of this process by NOD2 are not well understood, with recent studies reporting conflicting requirements for RIP2 (receptor-interacting protein kinase 2) in autophagy induction. We examined the requirement of NOD2 signaling mediated by RIP2 for anti-bacterial autophagy induction and clearance of Salmonella typhimurium in the intestinal epithelial cell line HCT116. Our data demonstrate that NOD2 stimulates autophagy in a process dependent on RIP2 tyrosine kinase activity. Autophagy induction requires the activity of the mitogen-activated protein kinases MEKK4 and p38 but is independent of NF kappa B signaling. Activation of autophagy was inhibited by a PP2A phosphatase complex, which interacts with both NOD2 and RIP2. PP2A phosphatase activity inhibited NOD2-dependent autophagy but not activation of NF kappa B or p38. Upon stimulation of NOD2, the phosphatase activity of the PP2A complex is inhibited through tyrosine phosphorylation of the catalytic subunit in a process dependent on RIP2 activity. These findings demonstrate that RIP2 tyrosine kinase activity is not only required for NOD2-dependent autophagy but plays a dual role in this process. RIP2 both sends a positive autophagy signal through activation of p38 MAPK and relieves repression of autophagy mediated by the phosphatase PP2A.	[Homer, Craig R.; Kabi, Amrita; Nickerson, Kourtney P.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Marina-Garcia, Noemi; Nesvizhskii, Alexey I.; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun] Baylor Coll Med, Dept Mol & Cell Biol, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Nickerson, Kourtney P.; McDonald, Christine] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44105 USA	Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Baylor College of Medicine; Case Western Reserve University; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst NC22, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcdonac2@ccf.org	Nesvizhskii, Alexey/A-5410-2012; Nuñez, Gabriel/A-7160-2014	Nesvizhskii, Alexey/0000-0002-2806-7819; McDonald, Christine/0000-0002-6745-9487; Marina, Noemi/0000-0003-0019-8072	National Institutes of Health [R01DK082437, R01DK61707]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Institutes of Health [UL1 RR024989]; NCRR; Crohn's & Colitis Foundation of America; Gerald and Nancy Goldberg; NATIONAL CANCER INSTITUTE [R01CA133458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, R01DK061707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Institutes of Health; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crohn's & Colitis Foundation of America; Gerald and Nancy Goldberg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK082437 (to C. M.) and R01DK61707 (to G. N.) and Case Western Reserve University/Cleveland Clinic CTSA Grant UL1 RR024989 from the National Institutes of Health, NCRR. This work was also supported by a research grant from the Crohn's & Colitis Foundation of America (to C. M.). These studies were also supported in part by the generosity of Gerald and Nancy Goldberg.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inohara N, 2000, J BIOL CHEM, V275, P27823; Islam Z, 2006, TOXICOL APPL PHARM, V213, P235, DOI 10.1016/j.taap.2005.11.001; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kabi A, 2012, INFLAMM BOWEL DIS, V18, P782, DOI 10.1002/ibd.21868; LEE J, 1993, J BIOL CHEM, V268, P19192; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Park IH, 2008, IMMUNOPHARM IMMUNOT, V30, P837, DOI [10.1080/08923970802135732, 10.1080/08923970802135732 ]; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; Qi ZF, 2011, NEUROCHEM INT, V59, P572, DOI 10.1016/j.neuint.2011.03.023; Richmond AL, 2012, GASTROENTEROLOGY, V142, P1483, DOI 10.1053/j.gastro.2012.02.040; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008	46	61	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25565	25576		10.1074/jbc.M111.326835	http://dx.doi.org/10.1074/jbc.M111.326835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665475	Green Published, hybrid			2022-12-25	WOS:000306651700064
J	Mahawar, M; Atianand, MK; Dotson, RJ; Mora, V; Rabadi, SM; Metzger, DW; Huntley, JF; Harton, JA; Malik, M; Bakshi, CS				Mahawar, Manish; Atianand, Maninjay K.; Dotson, Rachel J.; Mora, Vanessa; Rabadi, Seham M.; Metzger, Dennis W.; Huntley, Jason F.; Harton, Jonathan A.; Malik, Meenakshi; Bakshi, Chandra Shekhar			Identification of a Novel Francisella tularensis Factor Required for Intramacrophage Survival and Subversion of Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN-A; ESCHERICHIA-COLI K1; NF-KAPPA-B; MICROVASCULAR ENDOTHELIAL-CELLS; SCHU S4; SALMONELLA-ENTERICA; VACCINE STRAIN; LIVE VACCINE; HOST-CELLS; IV PILI	Francisella tularensis, the causative agent of tularemia, is one of the deadliest agents of biological warfare and bioterrorism. Extremely high virulence of this bacterium is associated with its ability to dampen or subvert host innate immune response. The objectives of this study were to identify factors and understand the mechanisms of host innate immune evasion by F. tularensis. We identified and explored the pathogenic role of a mutant interrupted at gene locus FTL_0325, which encodes an OmpA-like protein. Our results establish a pathogenic role of FTL_0325 and its ortholog FTT0831c in the virulent F. tularensis SchuS4 strain in intramacrophage survival and suppression of proinflammatory cytokine responses. This study provides mechanistic evidence that the suppressive effects on innate immune responses are due specifically to these proteins and that FTL_0325 and FTT0831c mediate immune subversion by interfering with NF-kappa B signaling. Furthermore, FTT0831c inhibits NF-kappa B activity primarily by preventing the nuclear translocation of p65 subunit. Collectively, this study reports a novel F. tularensis factor that is required for innate immune subversion caused by this deadly bacterium.	[Dotson, Rachel J.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Sch Arts & Sci, Albany, NY 12208 USA; [Mahawar, Manish; Atianand, Maninjay K.; Metzger, Dennis W.; Harton, Jonathan A.; Malik, Meenakshi; Bakshi, Chandra Shekhar] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Huntley, Jason F.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH USA; [Mora, Vanessa; Rabadi, Seham M.; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	Albany College of Pharmacy & Health Sciences; Albany Medical College; University of Toledo; New York Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Sch Arts & Sci, 106 New Scotland Ave, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015; Huntley, Jason F/N-3848-2015; Metzger, Dennis W/I-2771-2019; Atianand, Maninjay/AAF-7823-2019; Harton, Jonathan A/AAW-5283-2021; Harton, Jonathan/F-2848-2010	Malik, Meenakshi/0000-0003-0051-4485; Huntley, Jason F/0000-0002-0501-6103; Metzger, Dennis W/0000-0002-8000-9907; Atianand, Maninjay/0000-0003-4135-2515; Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877	National Institutes of Health Grants [2P01AI056320, 1R21AI075250-01A2, 7R56AI090072-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090072, P01AI056320, R21AI075250] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P01AI056320, 1R21AI075250-01A2 (to M. Malik), and 7R56AI090072-02 (to C.S.B.).	Alvarez JI, 2005, FRONT BIOSCI, V10, P582, DOI 10.2741/1554; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Dabo SM, 2003, MICROB PATHOGENESIS, V35, P147, DOI 10.1016/S0882-4010(03)00098-6; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Gallagher-Smith Melissa, 2004, Clin Lab Sci, V17, P35; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Mahawar M, 2009, J BACTERIOL, V191, P4798, DOI 10.1128/JB.00212-09; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marsh D, 2000, J MOL BIOL, V297, P803, DOI 10.1006/jmbi.2000.3557; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mittal R, 2008, J IMMUNOL, V181, P2672, DOI 10.4049/jimmunol.181.4.2672; Mortensen BL, 2010, INFECT IMMUN, V78, P5022, DOI 10.1128/IAI.00544-10; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Nair MKM, 2009, FOODBORNE PATHOG DIS, V6, P495, DOI 10.1089/fpd.2008.0228; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pavlova B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-16; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Platz GJ, 2010, INFECT IMMUN, V78, P1022, DOI 10.1128/IAI.00992-09; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Regueiro V, 2011, CELL MICROBIOL, V13, P135, DOI 10.1111/j.1462-5822.2010.01526.x; Reiterer V, 2011, CELL SIGNAL, V23, P1188, DOI 10.1016/j.cellsig.2011.03.006; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sanapala S, 2012, INFECT IMMUN, V80, P2177, DOI 10.1128/IAI.00036-12; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Selvaraj SK, 2005, J LEUKOCYTE BIOL, V78, P544, DOI 10.1189/jlb.0904516; Serino L, 2007, MOL MICROBIOL, V64, P1391, DOI 10.1111/j.1365-2958.2007.05745.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; Starnino S, 2010, NEW MICROBIOL, V33, P167; Sukumaran SK, 2004, INFECT IMMUN, V72, P6012, DOI 10.1128/IAI.72.10.6012-6022.2004; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Tarnvik A, 2004, SCAND J INFECT DIS, V36, P350, DOI 10.1080/00365540410020442; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120	69	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25216	25229		10.1074/jbc.M112.367672	http://dx.doi.org/10.1074/jbc.M112.367672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654100	Green Published, hybrid			2022-12-25	WOS:000306651700031
J	Sato-Nishiuchi, R; Nakano, I; Ozawa, A; Sato, Y; Takeichi, M; Kiyozumi, D; Yamazaki, K; Yasunaga, T; Futaki, S; Sekiguchi, K				Sato-Nishiuchi, Ryoko; Nakano, Itsuko; Ozawa, Akio; Sato, Yuya; Takeichi, Makiko; Kiyozumi, Daiji; Yamazaki, Kiyoshi; Yasunaga, Teruo; Futaki, Sugiko; Sekiguchi, Kiyotoshi			Polydom/SVEP1 Is a Ligand for Integrin alpha 9 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; STRUCTURAL REQUIREMENTS; ALPHA-4-BETA-1 INTEGRIN; BINDING SPECIFICITIES; RECOGNITION SEQUENCE; GROWTH-FACTOR; EDA SEGMENT; III REPEAT; A-DOMAINS; FIBRONECTIN	A variety of proteins, including tenascin-C and osteopontin, have been identified as ligands for integrin alpha 9 beta 1. However, their affinities for integrin alpha 9 beta 1 are apparently much lower than those of other integrins (e.g. alpha 3 beta 1, alpha 5 beta 1, and alpha 8 beta 1) for their specific ligands, leaving the possibility that physiological ligands for integrin alpha 9 beta 1 still remain unidentified. In this study, we found that polydom (also named SVEP1) mediates cell adhesion in an integrin alpha 9 beta 1-dependent manner and binds directly to recombinant integrin alpha 9 beta 1 with an affinity that far exceeds those of the known ligands. Using a series of recombinant polydom proteins with N-terminal deletions, we mapped the integrin-binding site to the 21st complement control protein domain. Alanine-scanning mutagenesis revealed that the EDDMMEVPY sequence (amino acids 2636-2644) in the 21st complement control protein domain was involved in the binding to integrin alpha 9 beta 1 and that Glu(2641) was the critical acidic residue for the integrin binding. The importance of this sequence was further confirmed by integrin binding inhibition assays using synthetic peptides. Immunohistochemical analyses of mouse embryonic tissues showed that polydom colocalized with integrin alpha 9 in the stomach, intestine, and other organs. Furthermore, in situ integrin alpha 9 beta 1 binding assays using frozen mouse tissues showed that polydom accounts for most, but not all, of the integrin alpha 9 beta 1 ligands in tissues. Taken together, the present findings indicate that polydom is a hitherto unknown ligand for integrin alpha 9 beta 1 that functions as a physiological ligand in vivo.	[Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Yamazaki, Kiyoshi; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp	Kiyozumi, Daiji/A-2112-2015	Kiyozumi, Daiji/0000-0003-3289-227X	New Energy and Industrial Technology Development Organization of Japan;  [22122006];  [06001294-0];  [10001843-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); ; ; 	This study was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas 22122006 and Research Contracts 06001294-0 and 10001843-0 with the New Energy and Industrial Technology Development Organization of Japan.	Bazan-Socha S, 2004, BIOCHEMISTRY-US, V43, P1639, DOI 10.1021/bi035853t; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; EDMAN KAP, 1950, ACTA PHYSIOL SCAND, V21, P230, DOI 10.1111/j.1748-1716.1950.tb00731.x; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Katayama M, 2003, CANCER RES, V63, P222; Kikkawa Y, 2000, J CELL SCI, V113, P869; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Kozaki T, 2003, J BIOL CHEM, V278, P50546, DOI 10.1074/jbc.M307432200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Saini A, 1997, INT J CANCER, V73, P264, DOI 10.1002/(SICI)1097-0215(19971009)73:2<264::AID-IJC17>3.3.CO;2-V; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; Schwarz RS, 2008, DEV COMP IMMUNOL, V32, P1192, DOI 10.1016/j.dci.2008.03.007; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Shur I, 2006, J CELL PHYSIOL, V206, P420, DOI 10.1002/jcp.20497; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; WANG A, 1995, DEV DYNAM, V204, P421, DOI 10.1002/aja.1002040408; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	59	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25615	25630		10.1074/jbc.M112.355016	http://dx.doi.org/10.1074/jbc.M112.355016			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654117	hybrid, Green Published			2022-12-25	WOS:000306651700069
J	Thomas, RM; Sai, H; Wells, AD				Thomas, Rajan M.; Sai, Hong; Wells, Andrew D.			Conserved Intergenic Elements and DNA Methylation Cooperate to Regulate Transcription at the il17 Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROR-GAMMA-T; CELL-DIFFERENTIATION; GENE-EXPRESSION; CYTOKINE; LINEAGE; IL-23; STAT3; INFLAMMATION; PLASTICITY; RESPONSES	Naive CD4(+) T cells can differentiate into distinct lineages with unique immune functions. The cytokines TGF beta and IL-6 promote the development of Th17 cells that produce IL-17, an inflammatory cytokine not expressed by other T helper lineages. To further understand how IL-17 production is controlled, we studied an similar to 120-kb genomic region containing the murine il17a and il17f genes and seven evolutionarily conserved, intergenic noncoding sequences. We show that the +28-kb noncoding sequence cooperates with STAT3, ROR gamma t, and Runx1 to enhance transcription from both il17a and il17f promoters. This enhancer and both promoters exhibited Th17 lineage-specific DNA demethylation, accompanied by demethylation of lysine 27 of histone H3 (H3K27) and increased H3K4 methylation. Loss of DNA methylation tended to occur at STAT3 consensus elements, and we show that methylation of one of these elements in the il17a promoter directly inhibits STAT3 binding and transcriptional activity. These results demonstrate that TGF beta and IL-6 synergize to epigenetically poise the il17 loci for expression in Th17 cells, and suggest a general mechanism by which active STAT3 may be epigenetically excluded from STAT3-responsive genes in non-Th17 lineages.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Wells, AD (corresponding author), Abramson Res Ctr, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021		National Institutes of Health [AI054643, AI070807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054643, R01AI054643, R01AI070807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054643 and AI070807 (to A. D. W.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	28	54	55	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25049	25059		10.1074/jbc.M112.351916	http://dx.doi.org/10.1074/jbc.M112.351916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665476	Green Published, hybrid			2022-12-25	WOS:000306651700018
J	Burton, AC; Sam, MK; Balangtaa, C; Brashares, JS				Burton, A. Cole; Sam, Moses K.; Balangtaa, Cletus; Brashares, Justin S.			Hierarchical Multi-Species Modeling of Carnivore Responses to Hunting, Habitat and Prey in a West African Protected Area	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; COMMUNITY STRUCTURE; SPATIAL AUTOCORRELATION; SPECIES DISTRIBUTION; PANTHERA-PARDUS; SPOTTED HYENAS; NATIONAL-PARK; CONSERVATION; EXTINCTION; BIODIVERSITY	Protected areas (PAs) are a cornerstone of global efforts to shield wildlife from anthropogenic impacts, yet their effectiveness at protecting wide-ranging species prone to human conflict - notably mammalian carnivores - is increasingly in question. An understanding of carnivore responses to human-induced and natural changes in and around PAs is critical not only to the conservation of threatened carnivore populations, but also to the effective protection of ecosystems in which they play key functional roles. However, an important challenge to assessing carnivore communities is the often infrequent and imperfect nature of survey detections. We applied a novel hierarchical multi-species occupancy model that accounted for detectability and spatial autocorrelation to data from 224 camera trap stations (sampled between October 2006 and January 2009) in order to test hypotheses about extrinsic influences on carnivore community dynamics in a West African protected area (Mole National Park, Ghana). We developed spatially explicit indices of illegal hunting activity, law enforcement patrol effort, prey biomass, and habitat productivity across the park, and used a Bayesian model selection framework to identify predictors of site occurrence for individual species and the entire carnivore community. Contrary to our expectation, hunting pressure and edge proximity did not have consistent, negative effects on occurrence across the nine carnivore species detected. Occurrence patterns for most species were positively associated with small prey biomass, and several species had either positive or negative associations with riverine forest (but not with other habitat descriptors). Influences of sampling design on carnivore detectability were also identified and addressed within our modeling framework (e. g., road and observer effects), and the multi-species approach facilitated inference on even the rarest carnivore species in the park. Our study provides insight for the conservation of these regionally significant carnivore populations, and our approach is broadly applicable to the robust assessment of communities of rare and elusive species subject to environmental change.	[Burton, A. Cole; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Burton, A. Cole] Univ Alberta, Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada; [Sam, Moses K.; Balangtaa, Cletus] Forestry Commiss Ghana, Wildlife Div, Accra, Ghana	University of California System; University of California Berkeley; University of Alberta	Burton, AC (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	acburton@ualberta.ca	Burton, Cole/J-3184-2012; Burton, Cole/AAF-9234-2019	Burton, Cole/0000-0002-8799-3847; Burton, Cole/0000-0002-8799-3847	Panthera/Wildlife Conservation Society Kaplan Awards Program; Safari Club International; Hellman Family Fund; College of Natural Resources of the University of California, Berkeley; U.S. National Science Foundation; Natural Sciences and Engineering Research Council of Canada	Panthera/Wildlife Conservation Society Kaplan Awards Program; Safari Club International; Hellman Family Fund; College of Natural Resources of the University of California, Berkeley; U.S. National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was received from the Panthera/Wildlife Conservation Society Kaplan Awards Program, Safari Club International, Hellman Family Fund, and College of Natural Resources of the University of California, Berkeley. ACB was supported by fellowships from the U.S. National Science Foundation and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; [Anonymous], 2010, R LANG ENV STAT COMP; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; Burton AC, 2010, THESIS U CALIFORNIA; Caro T, 2007, AFR J ECOL, V45, P233, DOI 10.1111/j.1365-2028.2007.00814.x; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carroll C, 2004, CONSERV BIOL, V18, P1110, DOI 10.1111/j.1523-1739.2004.00083.x; Carroll C, 2010, CONSERV BIOL, V24, P1538, DOI 10.1111/j.1523-1739.2010.01528.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Colyn Marc, 2004, Small Carnivore Conservation, V31, P15; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fensholt R, 2005, INT J REMOTE SENS, V26, P2561, DOI 10.1080/01431160500033724; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gelman A., 2004, BAYESIAN DATA ANAL; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Henschel P, 2003, LEOPARDS AFRICAN RAI; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hines, 2017, OCCUPANCY ESTIMATION; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2009, ENVIRON ECOL STAT SE, V3, P639, DOI 10.1007/978-0-387-78151-8_28; Klop E, 2008, J TROP ECOL, V24, P39, DOI 10.1017/S0266467407004609; Kolowski JM, 2009, J ZOOL, V277, P23, DOI 10.1111/j.1469-7998.2008.00505.x; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Linkie M, 2003, ORYX, V37, P41, DOI 10.1017/S0030605303000103; Linnell JDC, 2005, CONSERV BIOL SER, V9, P162; Long RA, 2008, NONINVASIVE SURVEY M; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Marker LL, 2005, S AFR J WILDL RES, V35, P105; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Moruzzi TL, 2002, WILDLIFE SOC B, V30, P380; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; NEWMARK WD, 1987, NATURE, V325, P430, DOI 10.1038/325430a0; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Pangle WM, 2010, J MAMMAL, V91, P154, DOI [10.1644/08-MAMM-A-359R.1, 10.1644/08-MAMM-A-359R.1.]; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ray J.C., 2005, 24 WILDL CONS SOC; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, BIOMETRICS, V64, P364, DOI 10.1111/j.1541-0420.2007.00891.x; Royle J. Andrew, 2008, P293; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sberze M, 2010, ANIM CONSERV, V13, P3, DOI 10.1111/j.1469-1795.2009.00312.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thompson WL, 2004, SAMPLING RARE ELUSIV; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wildlife Division of Ghana, 2005, 54 WDSP GOV GHAN WIL, P141; Wintle BA, 2006, ECOL APPL, V16, P1945, DOI 10.1890/1051-0761(2006)016[1945:MSRWSA]2.0.CO;2; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x; Zuur Alain F., 2009, P1	112	102	104	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38007	10.1371/journal.pone.0038007	http://dx.doi.org/10.1371/journal.pone.0038007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666433	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400068
J	Calzolari, M; Gaibani, P; Bellini, R; Defilippo, F; Pierro, A; Albieri, A; Maioli, G; Luppi, A; Rossini, G; Balzani, A; Tamba, M; Galletti, G; Gelati, A; Carrieri, M; Poglayen, G; Cavrini, F; Natalini, S; Dottori, M; Sambri, V; Angelini, P; Bonilauri, P				Calzolari, Mattia; Gaibani, Paolo; Bellini, Romeo; Defilippo, Francesco; Pierro, Anna; Albieri, Alessandro; Maioli, Giulia; Luppi, Andrea; Rossini, Giada; Balzani, Agnese; Tamba, Marco; Galletti, Giorgio; Gelati, Antonio; Carrieri, Marco; Poglayen, Giovanni; Cavrini, Francesca; Natalini, Silvano; Dottori, Michele; Sambri, Vittorio; Angelini, Paola; Bonilauri, Paolo			Mosquito, Bird and Human Surveillance of West Nile and Usutu Viruses in Emilia-Romagna Region (Italy) in 2010	PLOS ONE			English	Article							SEROLOGICAL EVIDENCE; PCR ASSAY; EMERGENCE; INFECTION; TRANSMISSION; TEMPERATURE; FLAVIVIRUS; AUSTRIA; AMPLIFICATION; ESTABLISHMENT	Background: In 2008, after the first West Nile virus (WNV) detection in the Emilia-Romagna region, a surveillance system, including mosquito-and bird-based surveillance, was established to evaluate the virus presence. Surveillance was improved in following years by extending the monitoring to larger areas and increasing the numbers of mosquitoes and birds tested. Methodology/Principal Findings: A network of mosquito traps, evenly distributed and regularly activated, was set up within the surveyed area. A total of 438,558 mosquitoes, grouped in 3,111 pools and 1,276 birds (1,130 actively sampled and 146 from passive surveillance), were tested by biomolecular analysis. The survey detected WNV in 3 Culex pipiens pools while Usutu virus (USUV) was found in 89 Cx. pipiens pools and in 2 Aedes albopictus pools. Two birds were WNV-positive and 12 were USUV-positive. Furthermore, 30 human cases of acute meningoencephalitis, possibly caused by WNV or USUV, were evaluated for both viruses and 1,053 blood bags were tested for WNV, without any positive result. Conclusions/Significance: Despite not finding symptomatic human WNV infections during 2010, the persistence of the virus, probably due to overwintering, was confirmed through viral circulation in mosquitoes and birds, as well as for USUV. In 2010, circulation of the two viruses was lower and more delayed than in 2009, but this decrease was not explained by the relative abundance of Cx. pipiens mosquito, which was greater in 2010. The USUV detection in mosquito species confirms the role of Cx. pipiens as the main vector and the possible involvement of Ae. albopictus in the virus cycle. The effects of meteorological conditions on the presence of USUV-positive mosquito pools were considered finding an association with drought conditions and a wide temperature range. The output produced by the surveillance system demonstrated its usefulness and reliability in terms of planning public health policies.	[Calzolari, Mattia; Defilippo, Francesco; Maioli, Giulia; Luppi, Andrea; Balzani, Agnese; Tamba, Marco; Galletti, Giorgio; Dottori, Michele; Bonilauri, Paolo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Gaibani, Paolo; Pierro, Anna; Rossini, Giada; Cavrini, Francesca; Sambri, Vittorio] S Orsola Malpighi Univ Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Bologna, Italy; [Bellini, Romeo; Albieri, Alessandro; Carrieri, Marco] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Gelati, Antonio] Serv Vet Azienda USL Modena, Mirandola, Italy; [Poglayen, Giovanni] Alma Mater Studiorum Univ Bologna, Bologna, Italy; [Natalini, Silvano; Angelini, Paola] Reg Emilia Romagna, DG Sanita & Polit Sociali, Bologna, Italy	IZS Lombardia e Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	mattia.calzolari@izsler.it	Tamba, Marco/J-5495-2016; balzani, agnese/X-6719-2019; gaibani, paolo/K-7690-2016; Maioli, Giulia/AAB-7559-2019; Sambri, Vittorio/H-5372-2019; dottori, michele/AAB-3815-2019; Pierro, Anna/AAC-7407-2022; Rossini, Giada/K-8815-2016; Calzolari, Mattia/AAB-9487-2019	Tamba, Marco/0000-0002-5878-4595; balzani, agnese/0000-0002-4535-0026; gaibani, paolo/0000-0003-3791-8635; Maioli, Giulia/0000-0002-7076-9005; Sambri, Vittorio/0000-0002-5012-7355; Pierro, Anna/0000-0001-9873-0367; Rossini, Giada/0000-0002-8917-6680; Calzolari, Mattia/0000-0001-7489-2556; Galletti, Giorgio/0000-0003-4522-8976; Dottori, Michele/0000-0002-9975-0367; Bonilauri, Paolo/0000-0002-2625-7993; defilippo, francesco/0000-0002-1898-0997; Carrieri, Marco/0000-0001-6444-0636	Regione Emilia-Romagna [COMM07001]; Italian Ministry of Health on West Nile virus overwintering mechanisms in Emilia-Romagna region [PRC2009004]	Regione Emilia-Romagna(Regione Emilia Romagna); Italian Ministry of Health on West Nile virus overwintering mechanisms in Emilia-Romagna region	The Regione Emilia-Romagna (www.regione.emilia-romagna.it/) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). Also funds obtained by the IZSLER project, financed by the Italian Ministry of Health (http://www.salute.gov.it/), on West Nile virus overwintering mechanisms in Emilia-Romagna region (PRC2009004) were utilized. No other external funding was utilized for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini P, 2010, EUROSURVEILLANCE, V15, P11; [Anonymous], 2010, CAA B ZANZ AUT; Antolini G, 2006, ATT CONV AIAM TOR IT; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bellini R., 2002, 68 ANN M AM MOSQ CON; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; Calzolari M, 2012, J GEN VIROL IN PRESS; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008; Chisenhall DM, 2008, J AM MOSQUITO CONTR, V24, P311, DOI 10.2987/5671.1; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Deubel V, 2001, ENCY ARTHROPOD TRANS, P563; Erdelyi K, 2007, VECTOR-BORNE ZOONOT, V7, P181, DOI 10.1089/vbz.2006.0586; Gaibani P, 2011, VECTOR BORN IN PRESS; Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09; Glavits R, 2005, AVIAN PATHOL, V34, P408, DOI 10.1080/03079450500268039; Gould EA, 2003, EPIDEMIOL INFECT, V131, P583, DOI 10.1017/S0950268803008707; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Hubalek Z, 2008, VECTOR-BORNE ZOONOT, V8, P659, DOI 10.1089/vbz.2007.0283; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Macini P., 2008, Eurosurveillance, V13, P18990; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Mannelli A, 2012, EN234 EFSA; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Pierro A, 2011, VECTOR-BORNE ZOONOT, V11, P1605, DOI 10.1089/vbz.2011.0616; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Savini G, 2011, VET MICROBIOL, V151, P264, DOI 10.1016/j.vetmic.2011.03.036; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smartt CT, 2010, ENVIRON ENTOMOL, V39, P190, DOI 10.1603/EN09172; Sotelo E, 2011, J GEN VIROL, V92, P2512, DOI 10.1099/vir.0.033829-0; Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2007, ECOL CONT VECTOR-BOR, V1, P153	68	78	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38058	10.1371/journal.pone.0038058	http://dx.doi.org/10.1371/journal.pone.0038058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666446	Green Published, gold			2022-12-25	WOS:000305353400073
J	Close, RA; Rayfield, EJ				Close, Roger A.; Rayfield, Emily J.			Functional Morphometric Analysis of the Furcula in Mesozoic Birds	PLOS ONE			English	Article							ENANTIORNITHINE BIRD; AVIAN FLIGHT; EVOLUTIONARY RADIATION; PHYLOGENETIC SIGNAL; WINGBEAT FREQUENCY; SOUTHERN FRANCE; CRETACEOUS BIRD; PRIMITIVE BIRD; FLYING BIRDS; CHINA	The furcula displays enormous morphological and structural diversity. Acting as an important origin for flight muscles involved in the downstroke, the form of this element has been shown to vary with flight mode. This study seeks to clarify the strength of this form-function relationship through the use of eigenshape morphometric analysis coupled with recently developed phylogenetic comparative methods (PCMs), including phylogenetic Flexible Discriminant Analysis (pFDA). Additionally, the morphospace derived from the furculae of extant birds is used to shed light on possible flight adaptations of Mesozoic fossil taxa. While broad conclusions of earlier work are supported (U-shaped furculae are associated with soaring, strong anteroposterior curvature with wing-propelled diving), correlations between form and function do not appear to be so clear-cut, likely due to the significantly larger dataset and wider spectrum of flight modes sampled here. Interclavicular angle is an even more powerful discriminator of flight mode than curvature, and is positively correlated with body size. With the exception of the close relatives of modern birds, the ornithuromorphs, Mesozoic taxa tend to occupy unique regions of morphospace, and thus may have either evolved unfamiliar flight styles or have arrived at similar styles through divergent musculoskeletal configurations.	[Close, Roger A.] Monash Univ, Sch Geosci, Clayton, Vic, Australia; [Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	Monash University; University of Bristol	Close, RA (corresponding author), Monash Univ, Sch Geosci, Clayton, Vic, Australia.	roger.close@monash.edu	Close, Roger/V-3052-2019; Rayfield, Emily/F-5038-2010	Close, Roger/0000-0003-3302-9902; Rayfield, Emily/0000-0002-2618-750X	Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University	Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University	This study was funded via Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; BAILEY JP, 1991, CAN J ZOOL, V69, P2751, DOI 10.1139/z91-387; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Baumel JJ, 1993, NOMINA ANATOMICA AVI, P45; Bell A, 2011, J SYST PALAEONTOL, V9, P119, DOI 10.1080/14772019.2010.525536; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Buffetaut E, 1998, J GEOL SOC LONDON, V155, P1, DOI 10.1144/gsjgs.155.1.0001; Buffetaut E, 2000, CR ACAD SCI II A, V331, P557, DOI 10.1016/S1251-8050(00)01451-8; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM, 2002, MESOZOIC BIRDS HEADS, P1; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dyke GJ, 2009, LETHAIA, V42, P248, DOI 10.1111/j.1502-3931.2008.00135.x; Dyke GJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P275; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gardiner E., 2011, LIVING DINOSAURS, P146; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; GOSLOW GE, 1990, BIOSCIENCE, V40, P108, DOI 10.2307/1311343; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Habib M, 2010, BIOL J LINN SOC, V99, P687, DOI 10.1111/j.1095-8312.2010.01372.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; Hinic-Frlog S, 2008, THESIS U CALIFORNIA; Hornik K., 2011, R FAQ; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hui CA, 2002, J MORPHOL, V251, P284, DOI 10.1002/jmor.1089; Hui CA, 1999, ENVIRON TOXICOL CHEM, V18, P970, DOI [10.1897/1551-5028(1999)018&lt;0970:EOHACO&gt;2.3.CO;2, 10.1002/etc.5620180523]; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; Maddison WP, 2011, MESQUITE MODULAR SYS; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; Naish D, 2012, BIOL LETTERS, V8, P97, DOI 10.1098/rsbl.2011.0683; Nesbitt SJ, 2009, J MORPHOL, V270, P856, DOI 10.1002/jmor.10724; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Nudds RL, 2004, P ROY SOC B-BIOL SCI, V271, pS324, DOI 10.1098/rsbl.2004.0167; O'Connor JMK, 2011, ACTA PALAEONTOL POL, V56, P463, DOI 10.4202/app.2010.0047; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; OLSON SL, 1979, NATURE, V278, P247, DOI 10.1038/278247a0; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Ostrom JH, 1999, SM C PALEOB, P301; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ, 2001, J EXP BIOL, V204, P3283; PENNYCUICK CJ, 1990, J EXP BIOL, V150, P171; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; Rayner JMV, 2003, EXPTL BIOL REV, P297; Rayner JMV, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P363; Revell L. J., 2011, PHYTOOLS PHYLOGENETI; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; SANZ JL, 1988, NATURE, V331, P433, DOI 10.1038/331433a0; SANZ JL, 1992, PALAEONTOLOGY, V35, P829; Schmaljohann H, 2009, J EXP BIOL, V212, P3633, DOI 10.1242/jeb.031435; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Simons ELR, 2011, J MORPHOL, V272, P958, DOI 10.1002/jmor.10963; Simons ELR, 2010, ZOOLOGY, V113, P39, DOI 10.1016/j.zool.2009.05.002; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Tobalske BW, 2009, EXP FLUIDS, V46, P963, DOI 10.1007/s00348-009-0614-9; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; VISCOR G, 1987, COMP BIOCHEM PHYS A, V87, P231, DOI 10.1016/0300-9629(87)90118-6; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang FC, 2004, CAN J EARTH SCI, V41, P1097, DOI 10.1139/E04-055; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; ZHOU Z, 1995, COUR FORSCHUNGSINST, V181, P9; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zhou Z, 2010, P ROY SOC B-BIOL SCI, V277, P219, DOI 10.1098/rspb.2009.0885	95	30	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36664	10.1371/journal.pone.0036664	http://dx.doi.org/10.1371/journal.pone.0036664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666324	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400010
J	Kaul, D; Habbel, P; Derkow, K; Kruger, C; Franzoni, E; Wulczyn, FG; Bereswill, S; Nitsch, R; Schott, E; Veh, R; Naumann, T; Lehnardt, S				Kaul, David; Habbel, Piet; Derkow, Katja; Krueger, Christina; Franzoni, Eleonora; Wulczyn, F. Gregory; Bereswill, Stefan; Nitsch, Robert; Schott, Eckart; Veh, Ruediger; Naumann, Thomas; Lehnardt, Seija			Expression of Toll-Like Receptors in the Developing Brain	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEGATIVE REGULATOR; NEUROFILAMENT SUBUNITS; MONOCLONAL-ANTIBODIES; SIGNALING PATHWAY; IMMUNE CELLS; ACTIVATION; DROSOPHILA; NEURONS; DISEASE	Toll-like receptors (TLR) are key players of the innate and adaptive immune response in vertebrates. The original protein Toll in Drosophila melanogaster regulates both host defense and morphogenesis during development. Making use of real-time PCR, in situ hybridization, and immunohistochemistry we systematically examined the expression of TLR1-9 and the intracellular adaptor molecules MyD88 and TRIF during development of the mouse brain. Expression of TLR7 and TLR9 in the brain was strongly regulated during different embryonic, postnatal, and adult stages. In contrast, expression of TLR1-6, TLR8, MyD88, and TRIF mRNA displayed no significant changes in the different phases of brain development. Neurons of various brain regions including the neocortex and the hippocampus were identified as the main cell type expressing both TLR7 and TLR9 in the developing brain. Taken together, our data reveal specific expression patterns of distinct TLRs in the developing mouse brain and lay the foundation for further investigation of the pathophysiological significance of these receptors for developmental processes in the central nervous system of vertebrates.	[Kaul, David; Habbel, Piet; Derkow, Katja; Krueger, Christina; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Franzoni, Eleonora; Wulczyn, F. Gregory; Veh, Ruediger; Naumann, Thomas; Lehnardt, Seija] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany; [Schott, Eckart] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kaul, D (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	seija.lehnardt@charite.de	Lehnardt, Seija/AAA-4113-2022; Nitsch, Robert/AAI-9129-2021	Veh, Rudiger/0000-0002-6253-9808	Deutsche Forschungsgemeinschaft [SFB-TRR43/A1]; NeuroCure [Exc 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) SFB-TRR43/A1 and NeuroCure Exc 257 (to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Larsen Peter H, 2007, Sci STKE, V2007, ppe47, DOI 10.1126/stke.4022007pe47; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rose D, 1997, DEVELOPMENT, V124, P1561; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TROJANOWSKI JQ, 1985, J HISTOCHEM CYTOCHEM, V33, P557, DOI 10.1177/33.6.3889140; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Visser L, 2006, AM J PATHOL, V169, P1671, DOI 10.2353/ajpath.2006.060143; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	31	83	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37767	10.1371/journal.pone.0037767	http://dx.doi.org/10.1371/journal.pone.0037767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666391	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400048
J	Young, JC; Dill, BD; Pan, CL; Hettich, RL; Banfield, JF; Shah, M; Fremaux, C; Horvath, P; Barrangou, R; VerBerkmoes, NC				Young, Jacque C.; Dill, Brian D.; Pan, Chongle; Hettich, Robert L.; Banfield, Jillian F.; Shah, Manesh; Fremaux, Christophe; Horvath, Philippe; Barrangou, Rodolphe; VerBerkmoes, Nathan C.			Phage-Induced Expression of CRISPR-Associated Proteins Is Revealed by Shotgun Proteomics in Streptococcus thermophilus	PLOS ONE			English	Article							IMMUNE-SYSTEM; COMMUNITY PROTEOMICS; ACQUIRED-RESISTANCE; RNA; IDENTIFICATION; BACTERIA; TRANSCRIPTION; SEQUENCE; RECOGNITION; EVOLUTION	The CRISPR/Cas system, comprised of clustered regularly interspaced short palindromic repeats along with their associated (Cas) proteins, protects bacteria and archaea from viral predation and invading nucleic acids. While the mechanism of action for this acquired immunity is currently under investigation, the response of Cas protein expression to phage infection has yet to be elucidated. In this study, we employed shotgun proteomics to measure the global proteome expression in a model system for studying the CRISPR/Cas response in S. thermophilus DGCC7710 infected with phage 2972. Host and viral proteins were simultaneously measured following inoculation at two different multiplicities of infection and across various time points using two-dimensional liquid chromatography tandem mass spectrometry. Thirty-seven out of forty predicted viral proteins were detected, including all proteins of the structural virome and viral effector proteins. In total, 1,013 of 2,079 predicted S. thermophilus proteins were detected, facilitating the monitoring of host protein synthesis changes in response to virus infection. Importantly, Cas proteins from all four CRISPR loci in the S. thermophilus DGCC7710 genome were detected, including loci previously thought to be inactive. Many Cas proteins were found to be constitutively expressed, but several demonstrated increased abundance following infection, including the signature Cas9 proteins from the CRISPR1 and CRISPR3 loci, which are key players in the interference phase of the CRISPR/Cas response. Altogether, these results provide novel insights into the proteomic response of S. thermophilus, specifically CRISPR-associated proteins, upon phage 2972 infection.	[Young, Jacque C.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37920 USA; [Young, Jacque C.; Dill, Brian D.; Pan, Chongle; Hettich, Robert L.; Shah, Manesh; VerBerkmoes, Nathan C.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Fremaux, Christophe; Horvath, Philippe] DuPont Nutr & Hlth, Dange St Romain, France; [Barrangou, Rodolphe] DuPont Nutr & Hlth, Madison, WI USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; DuPont	Young, JC (corresponding author), Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37920 USA.	verberkmoesn@ornl.gov	HORVATH, Philippe/K-5266-2015; Pan, Chongle/C-6960-2008; Hettich, Robert L/N-1458-2016; Barrangou, Rodolphe/I-2878-2014	HORVATH, Philippe/0000-0003-2015-8123; Pan, Chongle/0000-0003-2860-0334; Hettich, Robert L/0000-0001-7708-786X; Barrangou, Rodolphe/0000-0002-0648-3504; Dill, Brian/0000-0002-4532-3044; Banfield, Jill/0000-0001-8203-8771	US Department of Energy's Office of Science, Biological and Environmental Research Program [DE-FG02-07ER64505]; Danisco	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); Danisco	This work was funded by the US Department of Energy's Office of Science, Biological and Environmental Research Program; grant number DE-FG02-07ER64505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors have read the journal's policy and have the following conflicts: authors Rodolphe Barrangou, Christophe Fremaux, and Philippe Horvath are supported and employed by Danisco and are co-inventors on patents and patent applications relating to various uses of CRISPR technologies (patent number 7,919,277: Detection and Typing of Bacterial Strains, and patent applications 20110300538: Bifidobacteria CRISPR Sequences, 20110002889: Cultures with Improved Phage Resistance, 20100104690: Tagged Microorganisms and Methods of Tagging, 20100093617: Use, 20080124725: Tagged Microorganisms and Methods of Tagging). They do not, however, have financial interests such as stock, equity nor consultancies. Further, their affiliation and inventorships do not impact their scientific objectivity. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Azcarate-Peril MA, 2005, APPL ENVIRON MICROB, V71, P5794, DOI 10.1128/AEM.71.10.5794-5804.2005; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANN REV GENETICS, V45; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gagnaire V, 2009, J DAIRY SCI, V92, P811, DOI 10.3168/jds.2008-1476; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Li M, 2010, J PROTEOME RES; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Sambrook J, 2001, MOL CLONING LAB MANU; Sapranauskas R, 2011, NUCL ACIDS RES; Semenova E, 2011, P NATL ACAD SCI US; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thompson DK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-311; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCL ACIDS RES	52	52	53	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38077	10.1371/journal.pone.0038077	http://dx.doi.org/10.1371/journal.pone.0038077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666452	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400078
J	Bhowmik, D; Das, S; Hossain, M; Haq, L; Kumar, GS				Bhowmik, Debipreeta; Das, Suman; Hossain, Maidul; Haq, Lucy; Kumar, Gopinatha Suresh			Biophysical Characterization of the Strong Stabilization of the RNA Triplex poly(U).poly(A)(*)poly(U) by 9-O-(omega-amino) Alkyl Ether Berberine Analogs	PLOS ONE			English	Article							SEQUENCE-SPECIFIC RECOGNITION; PHENYLALANINE TRANSFER-RNA; PLANT ALKALOID BERBERINE; SELF-STRUCTURE INDUCTION; DOUBLE-HELICAL DNA; SMALL MOLECULES; TAR RNA; ISOQUINOLINE ALKALOIDS; STRANDED POLY(A); BINDING ASPECTS	Background: Binding of two 9-O-(omega-amino) alkyl ether berberine analogs BC1 and BC2 to the RNA triplex poly(U).poly(A)(*)poly(U) was studied by various biophysical techniques. Methodology/Principal Findings: Berberine analogs bind to the RNA triplex non-cooperatively. The affinity of binding was remarkably high by about 5 and 15 times, respectively, for BC1 and BC2 compared to berberine. The site size for the binding was around 4.3 for all. Based on ferrocyanide quenching, fluorescence polarization, quantum yield values and viscosity results a strong intercalative binding of BC1 and BC2 to the RNA triplex has been demonstrated. BC1 and BC2 stabilized the Hoogsteen base paired third strand by about 18.1 and 20.5 degrees C compared to a 17.5 degrees C stabilization by berberine. The binding was entropy driven compared to the enthalpy driven binding of berbeine, most likely due to additional contacts within the grooves of the triplex and disruption of the water structure by the alkyl side chain. Conclusions/Significance: Remarkably higher binding affinity and stabilization effect of the RNA triplex by the amino alkyl berberine analogs was achieved compared to berberine. The length of the alkyl side chain influence in the triplex stabilization phenomena.	[Bhowmik, Debipreeta; Hossain, Maidul; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Div Chem, Kolkata, India; [Das, Suman; Haq, Lucy] Jadavpur Univ, Dept Chem, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Bhowmik, D (corresponding author), CSIR Indian Inst Chem Biol, Biophys Chem Lab, Div Chem, Kolkata, India.	gskumar@csiriicb.in	Kumar, Gopinatha Suresh/W-1461-2019; Hossain, Maidul/AAW-7669-2021; Kumar, Dr Suresh/HHZ-2615-2022; Bhowmik, Debipreeta/AAX-6860-2021	Kumar, Dr Suresh/0000-0002-2539-6553; Bhowmik, Debipreeta/0000-0003-4726-5922; Hossain, Maidul/0000-0003-1408-2273	Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India; University Grants Commission, Government of India fellowship; CSIR Research Associateship	Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India; University Grants Commission, Government of India fellowship; CSIR Research Associateship	This work was supported by the grants from Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India, University Grants Commission, Government of India fellowship (to DB) and CSIR Research Associateship (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Auyeung KKW, 2009, INT J MOL MED, V24, P571, DOI 10.3892/ijmm_00000267; Basu A, 2012, BIOORGAN MED CHEM, V20, P2498, DOI 10.1016/j.bmc.2012.03.006; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Bhadra K, 2011, MED RES REV, V31, P821, DOI 10.1002/med.20202; Bhowmik D, 2012, J PHYS CHEM B, V116, P2314, DOI 10.1021/jp210072a; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; CHASTAIN M, 1992, BIOCHEMISTRY-US, V31, P12733, DOI 10.1021/bi00166a004; Choi MS, 2008, ANTICANCER RES, V28, P3777; Das S, 2003, J BIOMOL STRUCT DYN, V20, P703, DOI 10.1080/07391102.2003.10506887; Dinman JD, 2002, P NATL ACAD SCI USA, V99, P5331, DOI 10.1073/pnas.082102199; DOAN TL, 1987, NUCLEIC ACIDS RES, V15, P7749; ESCUDE C, 1993, NUCLEIC ACIDS RES, V21, P5547, DOI 10.1093/nar/21.24.5547; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Ferraroni M, 2011, CHEM COMMUN, V47, P4917, DOI 10.1039/c1cc10971e; Fox KR, 2004, 3 HELIX SPECIFIC LIG, P360; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2010, MINI-REV MED CHEM, V10, P568, DOI 10.2174/138955710791384009; GREEN R, 1994, J MOL BIOL, V235, P140, DOI 10.1016/S0022-2836(05)80022-1; Halimani M, 2009, LANGMUIR, V25, P2339, DOI 10.1021/la802761b; HAN HY, 1993, P NATL ACAD SCI USA, V90, P3806, DOI 10.1073/pnas.90.9.3806; Ho YT, 2009, ANTICANCER RES, V29, P4063; Holland JA, 1996, NUCLEIC ACIDS RES, V24, P2841, DOI 10.1093/nar/24.14.2841; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Huang L, 2010, BIOORGAN MED CHEM, V18, P4475, DOI 10.1016/j.bmc.2010.04.063; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2011, DNA CELL BIOL, V30, P123, DOI 10.1089/dna.2010.1109; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; James MA, 2011, MOL CARCINOGEN, V50, P1, DOI 10.1002/mc.20690; Job P, 1928, ANN CHIM FRANCE, V9, P113; Kanak M, 2010, APPL IMMUNOHISTO M M, V18, P532, DOI 10.1097/PAI.0b013e3181e1ef6a; Keppler MD, 1999, EUR J BIOCHEM, V263, P817, DOI 10.1046/j.1432-1327.1999.00566.x; Kim DW, 2007, J KOREAN NEUROSURG S, V42, P392, DOI 10.3340/jkns.2007.42.5.392; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; KINNIBURGH AJ, 1994, GENE, V149, P93, DOI 10.1016/0378-1119(94)90416-2; KLINCK R, 1994, FEBS LETT, V355, P297, DOI 10.1016/0014-5793(94)01228-8; Krishnan P, 2000, ANTI-CANCER DRUG DES, V15, P255; KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; LIQUIER J, 1995, NUCLEIC ACIDS RES, V23, P1722, DOI 10.1093/nar/23.10.1722; Long YH, 2006, BIOORGAN MED CHEM, V14, P4670, DOI 10.1016/j.bmc.2006.03.004; Ma Y, 2008, BIOORGAN MED CHEM, V16, P7582, DOI 10.1016/j.bmc.2008.07.029; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; Pang JY, 2005, BIOORGAN MED CHEM, V13, P5835, DOI 10.1016/j.bmc.2005.05.048; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; PUGLISI JD, 1993, P NATL ACAD SCI USA, V90, P3680, DOI 10.1073/pnas.90.8.3680; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Ray A, 1999, BIOCHEMISTRY-US, V38, P6239, DOI 10.1021/bi982128n; REINHARDT CG, 1982, BIOCHEM BIOPH RES CO, V104, P1376, DOI 10.1016/0006-291X(82)91402-4; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; SARI MA, 1990, BIOCHEMISTRY-US, V29, P4205, DOI 10.1021/bi00469a025; SCARIA PV, 1991, J BIOL CHEM, V266, P5417; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Shan WJ, 2011, EUR J MED CHEM, V46, P5885, DOI 10.1016/j.ejmech.2011.09.051; Sharma N.K., 2011, AM J BIOCH BIOTECHNO, V7, P130, DOI [10.3844/ajbbsp.2011.132.137, DOI 10.3844/AJBBSP.2011.132.137]; Shi AD, 2011, BIOORGAN MED CHEM, V19, P2298, DOI 10.1016/j.bmc.2011.02.025; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Song YJ, 2011, NUCLEIC ACIDS RES, V39, P6835, DOI 10.1093/nar/gkr322; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Yu FS, 2007, IN VIVO, V21, P407; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zheng RP, 2010, J CELL SCI, V123, P3734, DOI 10.1242/jcs.070466	80	54	59	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37939	10.1371/journal.pone.0037939	http://dx.doi.org/10.1371/journal.pone.0037939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666416	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600044
J	Ribeiro, GS; Tartof, SY; Oliveira, DWS; Guedes, ACS; Reis, MG; Riley, LW; Ko, AI				Ribeiro, Guilherme S.; Tartof, Sara Y.; Oliveira, Dalton W. S.; Guedes, Aldalice C. S.; Reis, Mitermayer G.; Riley, Lee W.; Ko, Albert I.			Surgery for Valvular Heart Disease: A Population-Based Study in a Brazilian Urban Center	PLOS ONE			English	Article							VALVE-REPLACEMENT; MITRAL-VALVE; EPIDEMIOLOGY; PREDICTION; MORTALITY	Background: In middle income countries, the burden of rheumatic heart disease (RHD) remains high, but the prevalence of other heart valve diseases may rise as the population life expectancy increases. Here, we compared population-based data on surgical procedures to assess the relative importance of causes of heart valve disease in Salvador, Brazil. Methodology/Principal Findings: Medical charts of patients who underwent surgery for valvular heart disease from January 2002-December 2005 were reviewed. Incidence of surgery for valvular heart disease was calculated. Logistic regression was used to identify factors associated with in-hospital death following surgery. The most common etiologies for valvular dysfunction in 491 valvular heart surgery patients were RHD (60.3%), degenerative valve disease (15.3%), and endocarditis (4.5%). Mean annual incidence for surgeries due to any valvular heart diseases, RHD, and degenerative valvular disease were 5.02, 3.03, and 0.77 per 100,000 population, respectively. Incidence of surgery due to RHD was highest in young adults; procedures were predominantly paid by the public health sector. In contrast, the incidence of surgery due to degenerative valvular disease was highest among those older than 60 years of age; procedures were mostly paid by the private sector. The overall in-hospital case-fatality ratio was 11.9%. Independent factors associated with death included increase in age (odds ratio: 1.04 per year of age; 95% confidence interval: 1.02-1.06), endocarditis (6.35; 1.92-21.04), multiple valve operative procedures (4.35; 2.12-8.95), and prior heart valve surgery (2.49; 1.05-5.87). Conclusions/Significance: RHD remains the main cause for valvular heart surgery in Salvador, which primarily affects young adults without private health insurance. In contrast, surgery due to degenerative valvular disease primarily impacts the elderly with private health insurance. Strategies to reduce the burden of valvular heart disease will need to address the disparate factors that contribute to RHD as well as degenerative valve disease.	[Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Ribeiro, Guilherme S.; Oliveira, Dalton W. S.; Guedes, Aldalice C. S.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Tartof, Sara Y.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; University of California System; University of California Berkeley; Yale University	Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.	gsribeiro@ufba.br	Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; Ko, Albert/P-2343-2015	Ribeiro, Guilherme/0000-0002-6798-2059; Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert/0000-0001-9023-2339; Tartof, Sara/0000-0003-2336-8476	Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health [TW006563]; Centers for Disease Control and Prevention Grants for Public Health Research Dissertation [R36]; FOGARTY INTERNATIONAL CENTER [D43TW006563, R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052473] Funding Source: NIH RePORTER	Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health; Centers for Disease Control and Prevention Grants for Public Health Research Dissertation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health (TW006563), and Centers for Disease Control and Prevention Grants for Public Health Research Dissertation (R36). The funding sources had no involvement in study design, data collection, analysis, interpretation, report writing, or publication. The authors had full access to all data and accept full responsibility for the content of this report.	Boudoulas H, 1994, J Heart Valve Dis, V3, P516; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Datasus Departamento de Informatica do SUS Secretaria Executiva Ministerio da Saude, 2012, POP RES AN 2 FAIX ET, P2002; Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; Instituto Brasileiro de Geografia e Estatistica, 2008, PROJ POP BRAS SEX ID; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Jamieson WRE, 1999, ANN THORAC SURG, V67, P943, DOI 10.1016/S0003-4975(99)00175-7; Kleinert S, 2011, LANCET, V377, P1721, DOI 10.1016/S0140-6736(11)60433-9; Lisboa LAF, 2010, ARQ BRAS CARDIOL, V94, P174, DOI 10.1590/S0066-782X2010000200006; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Monin JL, 2005, J AM COLL CARDIOL, V46, P302, DOI 10.1016/j.jacc.2005.03.064; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Nowicki ER, 2004, ANN THORAC SURG, V77, P1966, DOI 10.1016/j.athoracsur.2003.12.035; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; Ray S, 2010, CLIN MED, V10, P168; Rose AG, 1996, CURR OPIN CARDIOL, V11, P98, DOI 10.1097/00001573-199603000-00002; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2004, RHEUM FEV RHEUM HEAR	20	27	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37855	10.1371/journal.pone.0037855	http://dx.doi.org/10.1371/journal.pone.0037855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666401	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600034
J	Kerns, SL; Schultz, KM; Barry, KA; Thorne, TM; McGarry, TJ				Kerns, Sarah L.; Schultz, Kathryn M.; Barry, Kelly A.; Thorne, Tina M.; McGarry, Thomas J.			Geminin Is Required for Zygotic Gene Expression at the Xenopus Mid-Blastula Transition	PLOS ONE			English	Article							DROSOPHILA MIDBLASTULA TRANSITION; MAJOR DEVELOPMENTAL TRANSITION; CHK2 PROTEIN-KINASE; CELL-CYCLE; DNA-REPLICATION; PREVENTS REREPLICATION; CHECKPOINT CONTROL; EMBRYOS; PHOSPHORYLATION; TRANSCRIPTION	In many organisms early development is under control of the maternal genome and zygotic gene expression is delayed until the mid-blastula transition (MBT). As zygotic transcription initiates, cell cycle checkpoints become activated and the tempo of cell division slows. The mechanisms that activate zygotic transcription at the MBT are incompletely understood, but they are of interest because they may resemble mechanisms that cause stem cells to stop dividing and terminally differentiate. The unstable regulatory protein Geminin is thought to coordinate cell division with cell differentiation. Geminin is a bi-functional protein. It prevents a second round of DNA replication during S and G2 phase by binding and inhibiting the essential replication factor Cdt1. Geminin also binds and inhibits a number of transcription factors and chromatin remodeling proteins and is thought to keep dividing cells in an undifferentiated state. We previously found that the cells of Geminin-deficient Xenopus embryos arrest in G2 phase just after the MBT then disintegrate at the onset of gastrulation. Here we report that they also fail to express most zygotic genes. The gene expression defect is cell-autonomous and is reproduced by over-expressing Cdt1 or by incubating the embryos in hydroxyurea. Geminin deficient and hydroxyurea-treated blastomeres accumulate DNA damage in the form of double stranded breaks. Bypassing the Chk1 pathway overcomes the cell cycle arrest caused by Geminin depletion but does not restore zygotic gene expression. In fact, bypassing the Chk1 pathway by itself induces double stranded breaks and abolishes zygotic transcription. We did not find evidence that Geminin has a replication-independent effect on transcription. We conclude that Geminin is required to maintain genome integrity during the rapid cleavage divisions, and that DNA damage disrupts zygotic gene transcription at the MBT, probably through activation of DNA damage checkpoint pathways.	[Kerns, Sarah L.; Schultz, Kathryn M.; Barry, Kelly A.; Thorne, Tina M.; McGarry, Thomas J.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Kerns, Sarah L.; Barry, Kelly A.; McGarry, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [McGarry, Thomas J.] Northwestern Univ, Robert H Lurie Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kerns, SL (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA.	t-mcgarry@northwestern.edu			National Heart Lung and Blood Institute; American Heart Association; Schweppe Foundation; Illinois Division of the American Cancer Society	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Schweppe Foundation; Illinois Division of the American Cancer Society(American Cancer Society)	This work was supported by grants to TJM from the National Heart Lung and Blood Institute, the American Heart Association, the Schweppe Foundation, and the Illinois Division of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; FOE VE, 1993, DEV DROSOPHILA MELAN; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; KANE DA, 1993, DEVELOPMENT, V119, P447; Karamitros D, 2010, J IMMUNOL, V184, P2432, DOI 10.4049/jimmunol.0901983; Keren A, 2010, METHODS MOL BIOL, V661, P409, DOI 10.1007/978-1-60761-795-2_25; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nakajo N, 1999, DEV BIOL, V207, P432, DOI 10.1006/dbio.1998.9178; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017736; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Skirkanich J, 2011, DEV BIOL; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Spella M, 2011, STEM CELLS, V29, P1269, DOI 10.1002/stem.678; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILSON R, 1995, MECH DEVELOP, V49, P211, DOI 10.1016/0925-4773(94)00319-I; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wroble BN, 2005, DEV DYNAM, V233, P1359, DOI 10.1002/dvdy.20449; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	68	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38009	10.1371/journal.pone.0038009	http://dx.doi.org/10.1371/journal.pone.0038009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662261	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300153
J	Nghia, HDT; Tu, LTP; Wolbers, M; Hoang, NVM; Thanh, VN; Van, MP; Nga, TVT; Van, TL; Song, DT; Thi, PL; Thao, NTP; Van, CB; Tang, V; Tuan, HNA; Nguyen, D; Trung, TP; Lien, NTN; Kiem, HT; Tam, NTT; Campbell, J; Caws, M; Day, J; de Jong, MD; Chau, NVV; Van Doorn, HR; Tinh, HT; Farrar, J; Schultsz, C				Nghia Ho Dang Trung; Tu Le Thi Phuong; Wolbers, Marcel; Hoang Nguyen Van Minh; Vinh Nguyen Thanh; Minh Pham Van; Nga Tran Vu Thieu; Tan Le Van; Diep To Song; Phuong Le Thi; Thao Nguyen Thi Phuong; Cong Bui Van; Vu Tang; Tuan Hoang Ngoc Anh; Dong Nguyen; Tien Phan Trung; Lien Nguyen Thi Nam; Hao Tran Kiem; Tam Nguyen Thi Thanh; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Chau Nguyen Van Vinh; Van Doorn, H. Rogier; Hien Tran Tinh; Farrar, Jeremy; Schultsz, Constance		VIZIONS CNS Infection Network	Aetiologies of Central Nervous System Infection in Viet Nam: A Prospective Provincial Hospital-Based Descriptive Surveillance Study	PLOS ONE			English	Article							ACQUIRED BACTERIAL-MENINGITIS; STREPTOCOCCUS-SUIS INFECTION; HERPES-SIMPLEX-VIRUS; TUBERCULOUS MENINGITIS; CEREBROSPINAL-FLUID; CRYPTOCOCCAL MENINGITIS; HAEMOPHILUS-INFLUENZAE; CLINICAL SPECIMENS; BCG VACCINATION; HIV-INFECTION	Background: Infectious diseases of the central nervous system (CNS) remain common and life-threatening, especially in developing countries. Knowledge of the aetiological agents responsible for these infections is essential to guide empiric therapy and develop a rational public health policy. To date most data has come from patients admitted to tertiary referral hospitals in Asia and there is limited aetiological data at the provincial hospital level where most patients are seen. Methods: We conducted a prospective Provincial Hospital-based descriptive surveillance study in adults and children at thirteen hospitals in central and southern Viet Nam between August 2007-April 2010. The pathogens of CNS infection were confirmed in CSF and blood samples by using classical microbiology, molecular diagnostics and serology. Results: We recruited 1241 patients with clinically suspected infection of the CNS. An aetiological agent was identified in 640/1241 (52%) of the patients. The most common pathogens were Streptococcus suis serotype 2 in patients older than 14 years of age (147/617, 24%) and Japanese encephalitis virus in patients less than 14 years old (142/624, 23%). Mycobacterium tuberculosis was confirmed in 34/617 (6%) adult patients and 11/624 (2%) paediatric patients. The acute case fatality rate (CFR) during hospital admission was 73/617 (12%) in adults and to 42/624 (7%) in children. Conclusions: Zoonotic bacterial and viral pathogens are the most common causes of CNS infection in adults and children in Viet Nam.	[Nghia Ho Dang Trung] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Nghia Ho Dang Trung; Tu Le Thi Phuong; Wolbers, Marcel; Hoang Nguyen Van Minh; Vinh Nguyen Thanh; Minh Pham Van; Nga Tran Vu Thieu; Tan Le Van; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Van Doorn, H. Rogier; Hien Tran Tinh; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Ctr Trop Med, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nghia Ho Dang Trung; Diep To Song; Chau Nguyen Van Vinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Phuong Le Thi] Dong Thap Prov Hosp, Ho Chi Minh City, Dong Thap Provi, Vietnam; [Cong Bui Van] Kien Giang Prov Hosp, Ho Chi Minh City, Kien Giang Prov, Vietnam; [Tien Phan Trung; Lien Nguyen Thi Nam; Hao Tran Kiem] Hue Cent Hosp, Ho Chi Minh City, Thua Thien Hue, Vietnam; [Tam Nguyen Thi Thanh] Can Tho Cent Hosp, Can Tho City, Vietnam; [Wolbers, Marcel; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Van Doorn, H. Rogier; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Nghia, HDT (corresponding author), Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam.	nghiahdt@oucru.org	Farrar, Jeremy J./HGA-7610-2022; van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821; Le Van, Tan/0000-0002-1791-3901; Kiem Hao, Tran/0000-0002-5218-3529; Caws, Maxine/0000-0002-9109-350X; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust Major Overseas Programme; MRC [G1100684] Funding Source: UKRI; Medical Research Council [G1100684] Funding Source: researchfish	Wellcome Trust Major Overseas Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2009, MED SCI MONITOR, V15, pPI10; Barnett, 2010, ANAL SEASONAL HLTH D; Beld M, 2004, J CLIN MICROBIOL, V42, P3059, DOI 10.1128/JCM.42.7.3059-3064.2004; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Casas I, 1996, J MED VIROL, V50, P82, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;82::AID-JMV14&gt;3.0.CO;2-#; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Cho HK, 2010, J KOREAN MED SCI, V25, P895, DOI 10.3346/jkms.2010.25.6.895; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Ganiem AR, 2009, AIDS, V23, P2309, DOI 10.1097/QAD.0b013e3283320de8; Gjini AB, 2006, EPIDEMIOL INFECT, V134, P567, DOI 10.1017/S0950268805005595; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Ha D, 1994, TROP MED, P202; HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350; HO DTN, 2011, PLOS ONE, V0006; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; Ihekwaba UK, 2008, CLIN INFECT DIS, V47, P783, DOI 10.1086/591129; Jackson ST, 2008, W INDIAN MED J, V57, P373; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; KAY R, 1995, QJM-INT J MED, V88, P39; Koskiniemi M, 1996, J NEUROL NEUROSUR PS, V60, P174, DOI 10.1136/jnnp.60.2.174; Kumar P, 2005, NATL MED J INDIA, V18, P7; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lee BE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-68; Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Molyneux E, 2006, ANN TROP PAEDIATR, V26, P29, DOI 10.1179/146532806X90583; Muangchana C, 2009, SE ASIAN J TROP MED, V40, P553; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nguyen TY, 2010, AM J TROP MED HYG, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Soares CN, 2011, J NEUROL SCI; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Tang YW, 1997, J CLIN MICROBIOL, V35, P2869, DOI 10.1128/JCM.35.11.2869-2872.1997; Tansuphasawadikul S, 1999, J ACQ IMMUN DEF SYND, V21, P326, DOI 10.1097/00126334-199908010-00011; Thuy L, 2010, CLIN INFECT DIS, V51, pE65, DOI 10.1086/656685; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Tram TT, 1998, PEDIATR INFECT DIS J, V17, pS192, DOI 10.1097/00006454-199809001-00023; Tran VTN, 2011, DIAGN MICR INFEC DIS, V70, P461, DOI 10.1016/j.diagmicrobio.2010.12.015; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Varatharaj A, 2010, NEUROL INDIA, V58, P585, DOI 10.4103/0028-3886.68655; Vianello F, 2008, INFECTION, V36, P174, DOI 10.1007/s15010-007-6249-y; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Weinberg A, 2005, J INFECT DIS, V191, P234, DOI 10.1086/426402; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2003, WHO REC STAND SURV S; Yamamoto T, 2000, J NEUROVIROL, V6, P410, DOI 10.3109/13550280009018305; Yong YK, 2008, NEUROL ASIA, V13, P65; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	63	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37825	10.1371/journal.pone.0037825	http://dx.doi.org/10.1371/journal.pone.0037825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662232	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300122
J	Munoz, JP; Gonzalez, C; Parra, B; Corvalan, AH; Tornesello, ML; Eizuru, Y; Aguayo, F				Pablo Munoz, Juan; Gonzalez, Carolina; Parra, Barbara; Corvalan, Alejandro H.; Tornesello, Maria Lina; Eizuru, Yoshito; Aguayo, Francisco			Functional Interaction between Human Papillomavirus Type 16 E6 and E7 Oncoproteins and Cigarette Smoke Components in Lung Epithelial Cells	PLOS ONE			English	Article							CERVICAL-CANCER; ORAL CARCINOGENESIS; CARCINOMAS; INFECTION; HPV; MECHANISMS; NICOTINE; PROLIFERATION; INVOLVEMENT; PROTEINS	The smoking habit is the most important, but not a sufficient cause for lung cancer development. Several studies have reported the human papillomavirus type 16 (HPV16) presence and E6 and E7 transcripts expression in lung carcinoma cases from different geographical regions. The possible interaction between HPV infection and smoke carcinogens, however, remains unclear. In this study we address a potential cooperation between tobacco smoke and HPV16 E6 and E7 oncoproteins for alterations in proliferative and tumorigenic properties of lung epithelial cells. A549 (alveolar, tumoral) and BEAS-2B (bronchial, non-tumoral) cell lines were stably transfected with recombinant pLXSN vectors expressing HPV16 E6 and E7 oncoproteins and exposed to cigarette smoke condensate (CSC) at different concentrations. HPV16 E6 and E7 expression was associated with loss of p53 stability, telomerase (hTERT) and p16(INK4A) overexpression in BEAS-2B cells as demonstrated by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (WB). In A549 cells we observed downregulation of p53 but not a significant increase of hTERT transcripts. In addition, the HPV16 E6/E7 transfected cell lines showed an increased proliferation rate and anchorage-independent growth in a HPV16 E6 and E7 expression-dependent manner. Moreover, both HPV16 E6/E7 and mock transfected cells showed an increased proliferation rate and anchorage-independent growth in the presence of 0.1 and 10 mu g/mL CSC. However, this increase was significantly greater in HPV16 E6/E7 transfected cells (p<0.001). Data were confirmed by FCSE proliferation assay. The results obtained in this study are suggestive of a functional interaction between tobacco smoke and HPV16 E6/E7 oncoproteins for malignant transformation and tumorigenesis of lung epithelial cells. More studies are warranted in order to dissect the molecular mechanisms involved in this cooperation.	[Pablo Munoz, Juan; Gonzalez, Carolina; Parra, Barbara; Aguayo, Francisco] Univ Chile, Fac Med, Virol Program, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Dept Hematol Oncol, Sch Med, Santiago, Chile; [Tornesello, Maria Lina] Natl Canc Inst Fond Pascale, Mol Biol & Viral Oncol & AIDS Reference Ctr, Naples, Italy; [Eizuru, Yoshito] Kagoshima Univ, Div Oncogen & Persistent Viruses, Ctr Chron Viral Dis, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Universidad de Chile; Pontificia Universidad Catolica de Chile; Kagoshima University	Munoz, JP (corresponding author), Univ Chile, Fac Med, Virol Program, Inst Ciencias Biomed ICBM, Santiago 7, Chile.	faguayo@med.uchile.cl	Tornesello, Maria Lina/A-1964-2008; Muñoz, Juan P/GSJ-1484-2022	Tornesello, Maria Lina/0000-0002-3523-3264; Corvalan, Alejandro/0000-0001-5492-3853	Fondecyt from the government of Chile [11080198]	Fondecyt from the government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondecyt Grant 11080198 to FA from the government of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2007, BRIT J CANCER, V97, P85, DOI 10.1038/sj.bjc.6603848; Aguayo Francisco, 2010, Infect Agent Cancer, V5, P20, DOI 10.1186/1750-9378-5-20; Alam S, 2010, J VIROL, V84, P4630, DOI 10.1128/JVI.02431-09; Andl T, 1998, CANCER RES, V58, P5; ARMITAGE AK, 1975, BRIT MED J, V4, P313, DOI 10.1136/bmj.4.5992.313; Baroldi P, 2012, J CHILD ADOLESCENT P; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Buonomo T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-2; Castillo A, 2006, ONCOL REP, V15, P883; Center CoAcoKTRD, 1974, REF CIG PROGR; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Cheng YW, 2008, CLIN CANCER RES, V14, P7173, DOI 10.1158/1078-0432.CCR-08-0850; Cheng YW, 2004, LUNG CANCER-J IASLC, V46, P165, DOI 10.1016/j.lungcan.2004.03.023; Cheng YW, 2001, CANCER RES, V61, P2799; Ciotti M, 2009, RESPIRATION, V77, P427, DOI 10.1159/000176209; Coelho WS, 2012, INT J BIOCHEM CELL B, V44, P150, DOI 10.1016/j.biocel.2011.10.010; Dennis Phillip A, 2005, Cancer Epidemiol Biomarkers Prev, V14, P764, DOI 10.1158/1055-9965.EPI-04-0652; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Goto A, 2011, J MED VIROL, V83, P1383, DOI 10.1002/jmv.22150; Gunnell AS, 2006, CANCER EPIDEM BIOMAR, V15, P2141, DOI 10.1158/1055-9965.EPI-06-0399; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Itakura M, 2000, INT J ONCOL, V16, P591; KIM MS, 1993, CANCER RES, V53, P4811; Klein F, 2009, LUNG CANCER, V65, P13, DOI 10.1016/j.lungcan.2008.10.003; Kometani T, 2009, CANCER LETT, V278, P27, DOI 10.1016/j.canlet.2008.12.017; Krikelis D, 2010, J CLIN VIROL, V49, P169, DOI 10.1016/j.jcv.2010.07.020; LI SL, 1992, CARCINOGENESIS, V13, P1981, DOI 10.1093/carcin/13.11.1981; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Motoyama Satoru, 2004, Kobe Journal of Medical Sciences, V50, P9; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; PARK NH, 1995, ONCOGENE, V10, P2145; Petersen I, 2008, PATHOLOGE S, V29, P118; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Rohrer J, 2010, LARYNGOSCOPE, V120, P1609, DOI 10.1002/lary.20972; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Silva DCM, 2012, J PERIODONT IN PRESS, V47; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P885, DOI 10.1136/jcp.55.12.885; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; zur Hausen H, 2009, INDIAN J MED RES, V130, P209; zur Hausen H, 2009, ANGEW CHEM INT EDIT, V48, P5798, DOI 10.1002/anie.200901917	47	35	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38178	10.1371/journal.pone.0038178	http://dx.doi.org/10.1371/journal.pone.0038178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662279	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300171
J	Pendyala, G; Buescher, JL; Fox, HS				Pendyala, Gurudutt; Buescher, James L.; Fox, Howard S.			Methamphetamine and Inflammatory Cytokines Increase Neuronal Na+/K+-ATPase Isoform 3: Relevance for HIV Associated Neurocognitive Disorders	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; INFECTED MICROGLIA; BRAIN; AMPHETAMINE; ACTIVATION; EXPRESSION; PLASMA; NEURODEGENERATION; COMMUNICATION	Methamphetamine (METH) abuse in conjunction with human immunodeficiency virus (HIV) exacerbates neuropathogenesis and accelerates neurocognitive impairments in the central nervous system (CNS), collectively termed HIV Associated Neurocognitive Disorders (HAND). Since both HIV and METH have been implicated in altering the synaptic architecture, this study focused on investigating alterations in synaptic proteins. Employing a quantitative proteomics approach on synaptosomes isolated from the caudate nucleus from two groups of rhesus monkeys chronically infected with simian immunodeficiency virus (SIV) differing by one regimen, METH treatment, we identified the neuron specific Na+/K+-ATPase alpha 1 isoform 3 (ATP1A3) to be up regulated after METH treatment, and validated its up regulation by METH in vitro. Further studies on signaling mechanisms revealed that the activation of ATP1A3 involves the extracellular regulated kinase (ERK) pathway. Given its function in maintaining ionic gradients and emerging role as a signaling molecule, changes in ATP1A3 yields insights into the mechanisms associated with HAND and interactions with drugs of abuse.	[Pendyala, Gurudutt; Buescher, James L.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Pendyala, G (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	gpendyala@unmc.edu		Fox, Howard/0000-0003-2032-374X	National Institutes of Health [P30 MH062261, R01 DA032513, P01 DA026146]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146, R01DA032513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P30 MH062261, R01 DA032513 and P01 DA026146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Burdo TH, 2005, AIDS, V19, P1704, DOI 10.1097/01.aids.0000186823.76230.33; Burudi EME, 2002, J VIROL, V76, P12233, DOI 10.1128/JVI.76.23.12233-12241.2002; Cadet JL, 2007, NEUROTOX RES, V12, P181, DOI 10.1007/BF03033915; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Chang L, 2005, AM J PSYCHIAT, V162, P361, DOI 10.1176/appi.ajp.162.2.361; Cheng WS, 2010, J PSYCHOACTIVE DRUGS, V42, P11, DOI 10.1080/02791072.2010.10399781; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gelman BB, 2009, J NEUROIMMUNE PHARM; GJERDE H, 1993, J ANAL TOXICOL, V17, P65, DOI 10.1093/jat/17.2.65; Kalasinsky KS, 2001, FORENSIC SCI INT, V116, P163, DOI 10.1016/S0379-0738(00)00368-6; Klette KL, 2006, J ANAL TOXICOL, V30, P319, DOI 10.1093/jat/30.5.319; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Mahajan SD, 2006, MOL DIAGN THER, V10, P257, DOI 10.1007/BF03256465; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marquez C, 2009, AIDS CARE, V21, P575, DOI 10.1080/09540120802385579; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Muneer PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019258; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Orandle MS, 2002, J VIROL, V76, P5797, DOI 10.1128/JVI.76.11.5797-5802.2002; Pendyala G, 2011, AIDS RES HUM RETROV, V27, P179, DOI 10.1089/aid.2010.0090; Pendyala G, 2010, J PROTEOME RES, V9, P352, DOI 10.1021/pr900685u; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Runden E, 1998, J NEUROSCI, V18, P7296; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Schepers RJF, 2003, CLIN CHEM, V49, P121, DOI 10.1373/49.1.121; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; SHARER LR, 1992, J NEUROPATH EXP NEUR, V51, P3, DOI 10.1097/00005072-199201000-00002; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Takayasu T, 1995, J Clin Forensic Med, V2, P25, DOI 10.1016/1353-1131(95)90036-5; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; WATRY D, 1995, AM J PATHOL, V146, P914; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	52	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37604	10.1371/journal.pone.0037604	http://dx.doi.org/10.1371/journal.pone.0037604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662178	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300068
J	Truong, HT; Ramos, AM; Yalcin, F; de Ruiter, M; van der Poel, HJA; Huvenaars, KHJ; Hogers, RCJ; van Enckevort, LJG; Janssen, A; van Orsouw, NJ; van Eijk, MJT				Truong, Hoa T.; Ramos, A. Marcos; Yalcin, Feyruz; de Ruiter, Marjo; van der Poel, Hein J. A.; Huvenaars, Koen H. J.; Hogers, Rene C. J.; van Enckevort, Leonora J. G.; Janssen, Antoine; van Orsouw, Nathalie J.; van Eijk, Michiel J. T.			Sequence-Based Genotyping for Marker Discovery and Co-Dominant Scoring in Germplasm and Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE MAP; ARABIDOPSIS-THALIANA; SNP DISCOVERY; AFLP; CONSTRUCTION; TECHNOLOGIES; TRAITS; BARLEY; L.	Conventional marker-based genotyping platforms are widely available, but not without their limitations. In this context, we developed Sequence-Based Genotyping (SBG), a technology for simultaneous marker discovery and co-dominant scoring, using next-generation sequencing. SBG offers users several advantages including a generic sample preparation method, a highly robust genome complexity reduction strategy to facilitate de novo marker discovery across entire genomes, and a uniform bioinformatics workflow strategy to achieve genotyping goals tailored to individual species, regardless of the availability of a reference sequence. The most distinguishing features of this technology are the ability to genotype any population structure, regardless whether parental data is included, and the ability to co-dominantly score SNP markers segregating in populations. To demonstrate the capabilities of SBG, we performed marker discovery and genotyping in Arabidopsis thaliana and lettuce, two plant species of diverse genetic complexity and backgrounds. Initially we obtained 1,409 SNPs for arabidopsis, and 5,583 SNPs for lettuce. Further filtering of the SNP dataset produced over 1,000 high quality SNP markers for each species. We obtained a genotyping rate of 201.2 genotypes/SNP and 58.3 genotypes/SNP for arabidopsis (n = 222 samples) and lettuce (n = 87 samples), respectively. Linkage mapping using these SNPs resulted in stable map configurations. We have therefore shown that the SBG approach presented provides users with the utmost flexibility in garnering high quality markers that can be directly used for genotyping and downstream applications. Until advances and costs will allow for routine whole-genome sequencing of populations, we expect that sequence-based genotyping technologies such as SBG will be essential for genotyping of model and non-model genomes alike.	[Truong, Hoa T.; Ramos, A. Marcos; Yalcin, Feyruz; de Ruiter, Marjo; van der Poel, Hein J. A.; Huvenaars, Koen H. J.; Hogers, Rene C. J.; van Enckevort, Leonora J. G.; Janssen, Antoine; van Orsouw, Nathalie J.; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	Truong, HT (corresponding author), Keygene NV, Wageningen, Netherlands.	michiel.van-eijk@keygene.com		Ramos, Marcos/0000-0003-3450-0970				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bao E, 2011, BIOINFORMATICS, V27, P2502, DOI 10.1093/bioinformatics/btr447; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Buntjer J, 2002, PLANT AN MICR GEN 10; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Edenberg HJ, 2009, LAB METHODS HIGH THR; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Hayes RJ, 2011, THEOR APPL GENET, V123, P509, DOI 10.1007/s00122-011-1603-y; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; NAM HG, 1989, PLANT CELL, V1, P699, DOI 10.1105/tpc.1.7.699; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Shinozuka H, 2010, PLANT MOL BIOL, V72, P343, DOI 10.1007/s11103-009-9574-y; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Poecke R, 2012, PLANT AN GEN 20 C SA; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399	37	97	105	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37565	10.1371/journal.pone.0037565	http://dx.doi.org/10.1371/journal.pone.0037565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662172	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300062
J	Wu, PH; Coultrap, S; Pinnix, C; Davies, KD; Tailor, R; Ang, KK; Browning, MD; Grosshans, DR				Wu, Peter H.; Coultrap, Steven; Pinnix, Chelsea; Davies, Kurtis D.; Tailor, Ramesh; Ang, Kian K.; Browning, Michael D.; Grosshans, David R.			Radiation Induces Acute Alterations in Neuronal Function	PLOS ONE			English	Article							NMDA RECEPTOR TRAFFICKING; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; AMPA RECEPTOR; DENTATE GYRUS; ADULT-RAT; BRAIN; HIPPOCAMPAL	Every year, nearly 200,000 patients undergo radiation for brain tumors. For both patients and caregivers the most distressing adverse effect is impaired cognition. Efforts to protect against this debilitating effect have suffered from inadequate understanding of the cellular mechanisms of radiation damage. In the past it was accepted that radiation-induced normal tissue injury resulted from a progressive reduction in the survival of clonogenic cells. Moreover, because radiation-induced brain dysfunction is believed to evolve over months to years, most studies have focused on late changes in brain parenchyma. However, clinically, acute changes in cognition are also observed. Because neurons are fully differentiated post-mitotic cells, little information exists on the acute effects of radiation on synaptic function. The purpose of our study was to assess the potential acute effects of radiation on neuronal function utilizing ex vivo hippocampal brain slices. The cellular localization and functional status of excitatory and inhibitory neurotransmitter receptors was identified by immunoblotting. Electrophysiological recordings were obtained both for populations of neuronal cells and individual neurons. In the dentate gyrus region of isolated ex vivo slices, radiation led to early decreases in tyrosine phosphorylation and removal of excitatory N-methyl-D-aspartate receptors (NMDARs) from the cell surface while simultaneously increasing the surface expression of inhibitory gamma-aminobutyric acid receptors (GABA(A)Rs). These alterations in cellular localization corresponded with altered synaptic responses and inhibition of long-term potentiation. The non-competitive NMDAR antagonist memantine blocked these radiation-induced alterations in cellular distribution. These findings demonstrate acute effects of radiation on neuronal cells within isolated brain slices and open new avenues for study.	[Wu, Peter H.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Coultrap, Steven; Davies, Kurtis D.; Browning, Michael D.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Pinnix, Chelsea; Tailor, Ramesh; Ang, Kian K.; Grosshans, David R.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; UTMD Anderson Cancer Center	Wu, PH (corresponding author), Univ Colorado Denver, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA.	dgrossha@mdanderson.org		Pinnix, Chelsea/0000-0003-3982-3664	DRG by the American Society for Radiation Oncology; American Cancer Society [IRG-08-061-01]	DRG by the American Society for Radiation Oncology; American Cancer Society(American Cancer Society)	This work was supported by awards provided to DRG by the American Society for Radiation Oncology and Grant # IRG-08-061-01 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coultrap SJ, 2005, MOL BRAIN RES, V135, P104, DOI 10.1016/j.molbrainres.2004.12.005; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; GROSSHANS DR, 2002, SCI STKE, pPL8; Hellier JL, 2007, J NEUROPHYSIOL, V98, P2818, DOI 10.1152/jn.00346.2007; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nakaya K, 2005, INT J RADIAT BIOL, V81, P545, DOI 10.1080/09553000500280492; PELLMAR TC, 1990, RADIAT RES, V122, P209, DOI 10.2307/3577608; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun A, 2011, J CLIN ONCOL, V29, P279, DOI 10.1200/JCO.2010.29.6053; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Warrington JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030444; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7	40	62	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37677	10.1371/journal.pone.0037677	http://dx.doi.org/10.1371/journal.pone.0037677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662188	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300078
J	Zarringhalam, K; Zhang, L; Kiebish, MA; Yang, K; Han, XL; Gross, RW; Chuang, J				Zarringhalam, Kourosh; Zhang, Lu; Kiebish, Michael A.; Yang, Kui; Han, Xianlin; Gross, Richard W.; Chuang, Jeffrey			Statistical Analysis of the Processes Controlling Choline and Ethanolamine Glycerophospholipid Molecular Species Composition	PLOS ONE			English	Article							SHOTGUN LIPIDOMICS; MASS-SPECTROMETRY; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; BIOSYNTHESIS; DECARBOXYLATION; BIOINFORMATICS; SPECIFICITY; METABOLISM; MEDIATORS	The regulation and maintenance of the cellular lipidome through biosynthetic, remodeling, and catabolic mechanisms are critical for biological homeostasis during development, health and disease. These complex mechanisms control the architectures of lipid molecular species, which have diverse yet highly regulated fatty acid chains at both the sn1 and sn2 positions. Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) serve as the predominant biophysical scaffolds in membranes, acting as reservoirs for potent lipid signals and regulating numerous enzymatic processes. Here we report the first rigorous computational dissection of the mechanisms influencing PC and PE molecular architectures from high-throughput shotgun lipidomic data. Using novel statistical approaches, we have analyzed multidimensional mass spectrometry-based shotgun lipidomic data from developmental mouse heart and mature mouse heart, lung, brain, and liver tissues. We show that in PC and PE, sn1 and sn2 positions are largely independent, though for low abundance species regulatory processes may interact with both the sn1 and sn2 chain simultaneously, leading to cooperative effects. Chains with similar biochemical properties appear to be remodeled similarly. We also see that sn2 positions are more regulated than sn1, and that PC exhibits stronger cooperative effects than PE. A key aspect of our work is a novel statistically rigorous approach to determine cooperativity based on a modified Fisher's exact test using Markov Chain Monte Carlo sampling. This computational approach provides a novel tool for developing mechanistic insight into lipidomic regulation.	[Zarringhalam, Kourosh; Zhang, Lu; Chuang, Jeffrey] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Kiebish, Michael A.; Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL USA	Boston College; Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Zarringhalam, K (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	chuangj@bc.edu		Chuang, Jeffrey/0000-0002-3298-2358	Boston College Biology Department	Boston College Biology Department	This work was supported by startup funds from the Boston College Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; ARTHUR G, 1984, BIOCHIM BIOPHYS ACTA, V795, P221, DOI 10.1016/0005-2760(84)90069-9; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BORKENHAGEN L, 1961, J BIOL CHEM, V236, pPC28; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Forrester JS, 2004, MOL PHARMACOL, V65, P813, DOI 10.1124/mol.65.4.813; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Han X, 2011, MASS SPECTROMETRY RE; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Jung HR, 2011, BIOCH BIOPHYSICA ACT; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kazachkov M, 2008, LIPIDS, V43, P895, DOI 10.1007/s11745-008-3233-y; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Niemela PS, 2009, J CHROMATOGR B, V877, P2855, DOI 10.1016/j.jchromb.2009.01.025; Oresic M, 2011, BIOCH BIOPHYSICA ACT; Proschogo N, 2009, CURR OPIN LIPIDOL, V20, P522, DOI 10.1097/MOL.0b013e32833301cb; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Seppanen-Laakso T, 2009, J MOL ENDOCRINOL, V42, P185, DOI 10.1677/JME-08-0150; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Torkhovskaya TI, 2007, B EXP BIOL MED+, V144, P408, DOI 10.1007/s10517-007-0342-1; Tsalouhidou S, 2006, J ANIM SCI, V84, P2818, DOI 10.2527/jas.2006-031; Vance DE, 2008, N COMP BIOC, P1; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; West LJ, 2008, J STAT SOFTW, V28, P1; Wheelock CE, 2009, METHODS MOL BIOL, V580, P339, DOI 10.1007/978-1-60761-325-1_19; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; ZELINSKI TA, 1980, J BIOL CHEM, V255, P1423; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]	40	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37293	10.1371/journal.pone.0037293	http://dx.doi.org/10.1371/journal.pone.0037293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662143	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300033
J	Siboni, N; Abrego, D; Seneca, F; Motti, CA; Andreakis, N; Tebben, J; Blackall, LL; Harder, T				Siboni, Nachshon; Abrego, David; Seneca, Francois; Motti, Cherie A.; Andreakis, Nikos; Tebben, Jan; Blackall, Linda L.; Harder, Tilmann			Using Bacterial Extract along with Differential Gene Expression in Acropora millepora Larvae to Decouple the Processes of Attachment and Metamorphosis	PLOS ONE			English	Article							URCHIN HELIOCIDARIS-ERYTHROGRAMMA; SCLERACTINIAN CORAL; SEA-URCHIN; CYCLIC-AMP; SETTLEMENT; PROTEIN; INDUCTION; BIOFILMS; GENOME; STRESS	Biofilms of the bacterium Pseudoalteromonas induce metamorphosis of acroporid coral larvae. The bacterial metabolite tetrabromopyrrole (TBP), isolated from an extract of Pseudoalteromonas sp. associated with the crustose coralline alga (CCA) Neogoniolithon fosliei, induced coral larval metamorphosis (100%) with little or no attachment (0-2%). To better understand the molecular events and mechanisms underpinning the induction of Acropora millepora larval metamorphosis, including cell proliferation, apoptosis, differentiation, migration, adhesion and biomineralisation, two novel coral gene expression assays were implemented. These involved the use of reverse-transcriptase quantitative PCR (RT-qPCR) and employed 47 genes of interest (GOI), selected based on putative roles in the processes of settlement and metamorphosis. Substantial differences in transcriptomic responses of GOI were detected following incubation of A. millepora larvae with a threshold concentration and 10-fold elevated concentration of TBP-containing extracts of Pseudoalteromonas sp. The notable and relatively abrupt changes of the larval body structure during metamorphosis correlated, at the molecular level, with significant differences (p < 0.05) in gene expression profiles of 24 GOI, 12 hours post exposure. Fourteen of those GOI also presented differences in expression (p < 0.05) following exposure to the threshold concentration of bacterial TBP-containing extract. The specificity of the bacterial TBP-containing extract to induce the metamorphic stage in A. millepora larvae without attachment, using a robust, low cost, accurate, ecologically relevant and highly reproducible RT-qPCR assay, allowed partially decoupling of the transcriptomic processes of attachment and metamorphosis. The bacterial TBP-containing extract provided a unique opportunity to monitor the regulation of genes exclusively involved in the process of metamorphosis, contrasting previous gene expression studies that utilized cues, such as crustose coralline algae, biofilms or with GLW-amide neuropeptides that stimulate the entire onset of larval metamorphosis and attachment.	[Siboni, Nachshon; Abrego, David; Seneca, Francois; Motti, Cherie A.; Andreakis, Nikos; Blackall, Linda L.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	Australian Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney	Siboni, N (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	N.Siboni@aims.gov.au	Seneca, Francois/F-9040-2010; Harder, Tilmann/B-6861-2008; Motti, Cherie/A-2588-2012; Abrego, David/AAT-8120-2020; Blackall, Linda Louise/AAC-4312-2020; Blackall, Linda L/H-1947-2013; Andreakis, Nikos/A-4010-2010; Tebben, Jan/ABD-2247-2020; Siboni, Nachshon/K-4202-2012	Seneca, Francois/0000-0002-8908-1227; Harder, Tilmann/0000-0003-3173-6806; Abrego, David/0000-0003-3311-2730; Blackall, Linda Louise/0000-0002-8848-7698; Blackall, Linda L/0000-0002-8848-7698; Andreakis, Nikos/0000-0001-7120-4279; Tebben, Jan/0000-0002-2780-2236; Siboni, Nachshon/0000-0001-6082-0949; Motti, Cherie/0000-0002-3292-2785	Australian Institute of Marine Science [2233]	Australian Institute of Marine Science	Funding was provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER G, 1987, P NATL ACAD SCI USA, V84, P1867, DOI 10.1073/pnas.84.7.1867; Beltran-Ramirez V, 2010, THESIS J COOK U TOWN; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Tran C, 2011, MAR ECOL PROG SER, V433, P85, DOI 10.3354/meps09192; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chia CY, 2010, IUBMB LIFE, V62, P200, DOI 10.1002/iub.295; CLARE AS, 1995, J EXP BIOL, V198, P655; Davidson B, 2002, DEVELOPMENT, V129, P4739; Degnan SM, 2010, PHILOS T R SOC B, V365, P641, DOI 10.1098/rstb.2009.0248; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Haag ES, 1998, DEV GENES EVOL, V208, P188, DOI 10.1007/s004270050173; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hewes RS, 2000, GENETICS, V155, P1711; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Jimbo M, 2010, FISHERIES SCI, V76, P355, DOI 10.1007/s12562-009-0204-z; Kenkel CD, 2011, P BIOL SCI, V26, P26; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Knack BA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-136; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li HL, 2007, THESIS HONG KONG U S; Li HL, 2008, J EXP ZOOL PART B, V310B, P417, DOI 10.1002/jez.b.21214; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; MORSE DE, 1990, B MAR SCI, V46, P465; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Qian PY, 2010, PROTEOMICS, V10, P3435, DOI 10.1002/pmic.201000199; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; RUMRILL SS, 1983, MAR BIOL, V72, P243, DOI 10.1007/BF00396829; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v	64	27	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37774	10.1371/journal.pone.0037774	http://dx.doi.org/10.1371/journal.pone.0037774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655067	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900043
J	Chen, J; Abi-Daoud, M; Wang, A; Yang, X; Zhang, X; Feilotter, HE; Tron, VA				Chen, J.; Abi-Daoud, M.; Wang, A.; Yang, X.; Zhang, X.; Feilotter, H. E.; Tron, V. A.			Stathmin 1 is a potential novel oncogene in melanoma	ONCOGENE			English	Article						STMN1; miR-193b; melanoma; oncogene	HUMAN BREAST-CANCER; PROSTATE-CANCER; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; MALIGNANT-MELANOMA; MICRORNA TARGETS; LUNG-CANCER; EXPRESSION; OVEREXPRESSION; PROGRESSION	In previous studies, we demonstrated that miR-193b expression is reduced in melanoma relative to benign nevi, and also that miR193b represses cyclin D1 and Mcl-1 expression. We suggested that stathmin 1 (STMN1) might be a target of miR-193b. STMN1 normally regulates microtubule dynamics either by sequestering free tubulin heterodimers or by promoting microtubule catastrophe. Increased expression of STMN1 has been observed in a variety of human malignancies, but its association with melanoma is unknown. We now report that STMN1 is upregulated during the progression of melanoma relative to benign nevi, and that STMN1 is directly regulated by miR-193b. Using an experimental cell culture approach, overexpression of miR-193b using synthetic microRNAs repressed STMN1 expression, whereas inhibition of miR-193b with anti-miR oligos increased STMN1 expression in melanoma cells. The use of a luciferase reporter assay confirmed that miR-193b directly regulates STMN1 by targeting the 3'-untranslated region of STMN1 mRNA. We further demonstrated that STMN1 is overexpressed in malignant melanoma compared with nevi in two independent melanoma cohorts, and that its level is inversely correlated with miR-193b expression. However, STMN1 expression was not significantly associated with patient survival, Breslow depth, mitotic count or patient age. STMN1 knockdown by small-interfering RNA in melanoma cells drastically repressed cell proliferation and migration potential, whereas ectopic expression of STMN1 using lentivirus increased cell proliferation and migration rates. Subsequent gene expression analysis indicated that interconnected cytoskeletal networks are directly affected following STMN1 knockdown. In addition, we identified deregulated genes associated with proliferation and migration, and revealed that p21(Cip1/Waf1) and p27(Kip) could be downstream effectors of STMN1 signaling. Taken together, our study suggests that downregulation of miR-193b may contribute to increased STMN1 expression in melanoma, which consequently promotes migration and proliferation of tumor cells. Oncogene (2013) 32, 1330-1337; doi:10.1038/onc.2012.141; published online 4 June 2012	[Chen, J.; Abi-Daoud, M.; Wang, A.; Yang, X.; Zhang, X.; Feilotter, H. E.; Tron, V. A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Tron, VA (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Lab, 88 Stuart St,Room 202, Kingston, ON K7L 3N6, Canada.	tronv@queensu.ca			Canadian Institutes of Health Research (CIHR) Grant; Queen's University Terry Fox Foundation Training Program in Transdisciplinary Cancer Research; CIHR	Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); Queen's University Terry Fox Foundation Training Program in Transdisciplinary Cancer Research; CIHR(Canadian Institutes of Health Research (CIHR))	This work is supported by the Canadian Institutes of Health Research (CIHR) Grant (VAT; HEF). JC is funded in part by the Queen's University Terry Fox Foundation Training Program in Transdisciplinary Cancer Research in partnership with CIHR.	Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Bieche I, 1998, BRIT J CANCER, V78, P701, DOI 10.1038/bjc.1998.565; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen G, 2003, MOL CELL PROTEOMICS, V2, P107, DOI 10.1074/mcp.M200055-MCP200; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghosh R, 2007, PROSTATE, V67, P1038, DOI 10.1002/pros.20601; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kumar PS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-42; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li Z, 2011, J BIOL CHEM, V286, P21164, DOI 10.1074/jbc.M110.207571; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Rothhammer T, 2007, PIGM CELL RES, V20, P92, DOI 10.1111/j.1600-0749.2007.00367.x; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; Wang CH, 2000, BIOCHEM BIOPH RES CO, V270, P303, DOI 10.1006/bbrc.2000.2422; Wellen J, 2009, NEUROPHARMACOLOGY, V56, P386, DOI 10.1016/j.neuropharm.2008.09.011; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Zheng P, 2010, J PROTEOME RES, V9, P4897, DOI 10.1021/pr100712t	51	35	36	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 7	2013	32	10					1330	1337		10.1038/onc.2012.141	http://dx.doi.org/10.1038/onc.2012.141			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22665054				2022-12-25	WOS:000316454500013
J	Schramm, A; Lee, B; Higgs, PI				Schramm, Andreas; Lee, Bongsoo; Higgs, Penelope I.			Intra- and Interprotein Phosphorylation between Two-hybrid Histidine Kinases Controls Myxococcus xanthus Developmental Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; 2-COMPONENT SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; PROTEIN-KINASE; CELL-DIFFERENTIATION; PHOSPHATASE-ACTIVITY; PERIPHERAL RODS; DOMAINS; SYSTEMS; AGGREGATION	Histidine-aspartate phosphorelay signaling systems are used to couple stimuli to cellular responses. A hallmark feature is the highly modular signal transmission modules that can form both simple "two-component" systems and sophisticated multicomponent systems that integrate stimuli over time and space to generate coordinated and fine-tuned responses. The deltaproteobacterium Myxococcus xanthus contains a large repertoire of signaling proteins, many of which regulate its multicellular developmental program. Here, we assign an orphan hybrid histidine protein kinase, EspC, to the Esp signaling system that negatively regulates progression through the M. xanthus developmental program. The Esp signal system consists of the hybrid histidine protein kinase, EspA, two serine/threonine protein kinases, and a putative transport protein. We demonstrate that EspC is an essential component of this system because Delta espA, Delta espC, and Delta espA Delta espC double mutants share an identical developmental phenotype. Neither substitution of the phosphoaccepting histidine residue nor deletion of the entire catalytic ATPase domain in EspC produces an in vivo mutant developmental phenotype. In contrast, substitution of the receiver phosphoaccepting residue yields the null phenotype. Although the EspC histidine kinase can efficiently autophosphorylate in vitro, it does not act as a phosphodonor to its own receiver domain. Our in vitro and in vivo analyses suggest the phosphodonor is instead the EspA histidine kinase. We propose EspA and EspC participate in a novel hybrid histidine protein kinase signaling mechanism involving both inter- and intraprotein phosphotransfer. The output of this signaling system appears to be the combined phosphorylated state of the EspA and EspC receiver modules. This system regulates the proteolytic turnover of MrpC, an important regulator of the developmental program.	[Schramm, Andreas; Lee, Bongsoo; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	Max Planck Society	Higgs, PI (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	higgs@mpi-marburg.mpg.de	Lee, BongSoo/AAP-3262-2020; Higgs, Penelope/Y-8862-2019	Higgs, Penelope/0000-0003-4726-3329	Max Planck Society; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology	Max Planck Society(Max Planck Society); International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology	This work was supported in part by the Max Planck Society.; Supported by the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARIAS IM, 1969, J BIOL CHEM, V244, P3303; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; Cho KY, 2000, J BACTERIOL, V182, P6614, DOI 10.1128/JB.182.23.6614-6621.2000; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Huntley S, 2012, J BACTERIOL, V194, P3012, DOI 10.1128/JB.00397-12; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Inclan YF, 2008, MOL MICROBIOL, V68, P1328, DOI 10.1111/j.1365-2958.2008.06238.x; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Ivanova N, 2010, STAND GENOMIC SCI, V2, P96, DOI 10.4056/sigs.69.1277; Jagadeesan S, 2009, J BIOL CHEM, V284, P21435, DOI 10.1074/jbc.M109.033415; JANSSEN GR, 1985, DEV BIOL, V112, P194, DOI 10.1016/0012-1606(85)90133-2; Jiang P, 2000, BIOCHEMISTRY-US, V39, P13433, DOI 10.1021/bi000794u; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Lee B, 2005, J BACTERIOL, V187, P5029, DOI 10.1128/JB.187.14.5029-5031.2005; Lee B, 2010, METHOD ENZYMOL, V471, P253, DOI 10.1016/S0076-6879(10)71014-4; Li ZF, 2011, J BACTERIOL, V193, P5015, DOI 10.1128/JB.05516-11; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Maniatis T., 1982, MOL CLONING LAB MANU; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; NATH K, 1970, J BIOL CHEM, V245, P2889; Nikolskaya AN, 2003, J MOL MICROB BIOTECH, V5, P11, DOI 10.1159/000068720; OCONNOR KA, 1991, J BACTERIOL, V173, P3342, DOI 10.1128/jb.173.11.3342-3355.1991; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rasmussen AA, 2003, J BACTERIOL, V185, P5452, DOI 10.1128/JB.185.18.5452-5464.2003; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SEGAL HL, 1963, P NATL ACAD SCI USA, V50, P912, DOI 10.1073/pnas.50.5.912; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Stein EA, 2006, MOL MICROBIOL, V60, P1414, DOI 10.1111/j.1365-2958.2006.05195.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun H, 2001, J BACTERIOL, V183, P6733, DOI 10.1128/JB.183.23.6733-6739.2001; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; TuAnh NH, 2010, P NATL ACAD SCI USA, V107, P21140, DOI 10.1073/pnas.1013081107; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; Wegener-Feldbrugge S, 2009, J BACTERIOL, V191, P1765, DOI 10.1128/JB.01405-08; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P169; Whitworth DE, 2008, MICROBIOL-SGM, V154, P360, DOI 10.1099/mic.0.2007/013672-0; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	67	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25060	25072		10.1074/jbc.M112.387241	http://dx.doi.org/10.1074/jbc.M112.387241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661709	Green Published, hybrid			2022-12-25	WOS:000306651700019
J	Goodwin, R; Takahashi, M; Sun, SJ; Gaines, SO				Goodwin, Robin; Takahashi, Masahito; Sun, Shaojing; Gaines, Stanley O., Jr.			Modelling Psychological Responses to the Great East Japan Earthquake and Nuclear Incident	PLOS ONE			English	Article							NIIGATA-CHUETSU EARTHQUAKE; MENTAL-HEALTH-CARE; RISK PERCEPTIONS; COMMUNITY; DISTRESS; DISASTER; VALUES; ATTRIBUTIONS; INFORMATION; EXPOSURE	The Great East Japan (Tohoku/Kanto) earthquake of March 2011 was followed by a major tsunami and nuclear incident. Several previous studies have suggested a number of psychological responses to such disasters. However, few previous studies have modelled individual differences in the risk perceptions of major events, or the implications of these perceptions for relevant behaviours. We conducted a survey specifically examining responses to the Great Japan earthquake and nuclear incident, with data collected 11-13 weeks following these events. 844 young respondents completed a questionnaire in three regions of Japan; Miyagi (close to the earthquake and leaking nuclear plants), Tokyo/Chiba (approximately 220 km from the nuclear plants), and Western Japan (Yamaguchi and Nagasaki, some 1000 km from the plants). Results indicated significant regional differences in risk perception, with greater concern over earthquake risks in Tokyo than in Miyagi or Western Japan. Structural equation analyses showed that shared normative concerns about earthquake and nuclear risks, conservation values, lack of trust in governmental advice about the nuclear hazard, and poor personal control over the nuclear incident were positively correlated with perceived earthquake and nuclear risks. These risk perceptions further predicted specific outcomes (e. g. modifying homes, avoiding going outside, contemplating leaving Japan). The strength and significance of these pathways varied by region. Mental health and practical implications of these findings are discussed in the light of the continuing uncertainties in Japan following the March 2011 events.	[Goodwin, Robin; Gaines, Stanley O., Jr.] Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Takahashi, Masahito] Yamaguchi Univ, Fac Humanities, Yamaguchi, Japan; [Sun, Shaojing] Fudan Univ, Sch Journalism, Shanghai 200433, Peoples R China	Brunel University; Yamaguchi University; Fudan University	Goodwin, R (corresponding author), Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England.	robin.goodwin@brunel.ac.uk						[Anonymous], 2011, REUTERS; [Anonymous], 2011, NEW SCI; [Anonymous], 2011, WASHINGTON POST 0324; Bardi A, 2011, J CROSS CULT PSYCHOL, V42, P271, DOI 10.1177/0022022110396916; Brown T. A., 2015, CONFIRMATORY FACTOR, VSecond; Chang EC, 2001, J PERS SOC PSYCHOL, V81, P476, DOI 10.1037/0022-3514.81.3.476; Cowan J, 2002, ASIAN J SOC PSYCHOL, V5, P169, DOI 10.1111/1467-839X.00102; Dumont M, 2003, PERS SOC PSYCHOL B, V29, P1509, DOI 10.1177/0146167203256923; Frink DD, 2004, J APPL SOC PSYCHOL, V34, P85, DOI 10.1111/j.1559-1816.2004.tb02538.x; Furukawa K, 2011, J NEUROL, DOI [10.1007/s00415-0110-6329-x, DOI 10.1007/S00415-0110-6329-X]; Gierlach E, 2010, RISK ANAL, V30, P1539, DOI 10.1111/j.1539-6924.2010.01451.x; Goodwin R, 2011, INT J BEHAV MED, V18, P88, DOI 10.1007/s12529-010-9083-z; Goto Toyomi, 2003, Trauma Violence Abuse, V4, P195, DOI 10.1177/1524838003004003001; Hatfield E., 1994, REV PERSONALITY SOCI; Hine DW, 1997, RISK ANAL, V17, P293, DOI 10.1111/j.1539-6924.1997.tb00867.x; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Jonas E, 2003, PERS SOC PSYCHOL B, V29, P1181, DOI 10.1177/0146167203254599; Kaniasty K., 2004, BIOTERRORISM PSYCHOL, P200, DOI DOI 10.1056/NEJM200506163522421; Kasperson J.X., 2003, SOC CONTOURS RISK, p217.; Kim J, 2008, J APPL SOC PSYCHOL, V38, P2821, DOI 10.1111/j.1559-1816.2008.00415.x; Kim Y, 2011, GUIDELINE LOCAL MENT; Kim Y, 2011, PSYCHIAT CLIN NEUROS, V65, P539, DOI 10.1111/j.1440-1819.2011.02270.x; Kim Y, 2011, LANCET, V378, P317, DOI 10.1016/S0140-6736(11)61169-0; Kline RB, 2005, PRINCIPLES PRACTICE; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Kwon Y S, 2001, Environ Health Prev Med, V6, P97, DOI 10.1007/BF02897953; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lindeman M, 2005, J PERS ASSESS, V85, P170, DOI 10.1207/s15327752jpa8502_09; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; McClure J, 1999, APPL PSYCHOL-INT REV, V48, P239, DOI 10.1080/026999499377637; McClure J, 2007, ASIAN J SOC PSYCHOL, V10, P233, DOI 10.1111/j.1467-839X.2007.00232.x; McClure J, 2007, J APPL SOC PSYCHOL, V37, P1956, DOI 10.1111/j.1559-1816.2007.00245.x; Meguro K, 2011, NEUROLOGY, V77, pE12, DOI 10.1212/WNL.0b013e31822511a5; Miyadai S, 2011, ESCAPE SOC BASED NUC; National Police Agency of Japan, 2012, DAM SIT POL COUNT AS; Nishio A, 2009, PSYCHIAT CLIN NEUROS, V63, P247, DOI 10.1111/j.1440-1819.2009.01942.x; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Piotrkowski CS, 2002, AM J ORTHOPSYCHIAT, V72, P476, DOI 10.1037//0002-9432.72.4.476; Rencher AC, 2002, METHODS MULTIVARIATE; Satomi S, 2011, SURG TODAY, V41, P1171, DOI 10.1007/s00595-011-4587-y; Schwartz SH, 2000, J PERS, V68, P309, DOI 10.1111/1467-6494.00099; Seo M, 2011, COMMUN RES, DOI 10.11.1177/0093650210388407; Silove D, 2010, J TRAUMA STRESS, V23, P151, DOI 10.1002/jts.20499; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sullivan H. S., 1953, INTERPERSONAL THEORY; Suzuki Y, 2011, LANCET, V378, P317, DOI 10.1016/S0140-6736(11)61168-9; Suzuki Y, 2011, J EPIDEMIOL, V21, P144, DOI 10.2188/jea.JE20100093; Takahashi M, 2012, MEDIA EFFECTS RISK B; Toyabe S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-230; Triandis H.C., 2018, INDIVIDUALISM COLLEC, DOI [10.4324/9780429499845, DOI 10.4324/9780429499845]; US Geological Survey, 2011, GREAT TOH EARTHQ NE; Valeo T, 2011, NEUROL TODAY, V21, P10; VAUGHAN E, 1993, HEALTH PSYCHOL, V12, P74, DOI 10.1037/0278-6133.12.1.74; Wilson JP, 1989, TRAUMA TRANSFORMATIO; Yamamoto T, 2011, LANCET, V378, P318, DOI 10.1016/S0140-6736(11)61170-7	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37690	10.1371/journal.pone.0037690	http://dx.doi.org/10.1371/journal.pone.0037690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666380	Green Published, gold			2022-12-25	WOS:000305353400039
J	Honda, T; Hirashima, M; Nozaki, D				Honda, Takuya; Hirashima, Masaya; Nozaki, Daichi			Adaptation to Visual Feedback Delay Influences Visuomotor Learning	PLOS ONE			English	Article							CEREBELLAR CONTRIBUTIONS; SENSORIMOTOR CONTROL; RHYTHMIC MOVEMENTS; SENSORY PREDICTION; REACHING MOVEMENTS; PRISM ADAPTATION; MOTOR ADAPTATION; ERROR-CORRECTION; VOLUNTARY ACTION; SMITH PREDICTOR	Computational theory of motor control suggests that the brain continuously monitors motor commands, to predict their sensory consequences before actual sensory feedback becomes available. Such prediction error is a driving force of motor learning, and therefore appropriate associations between motor commands and delayed sensory feedback signals are crucial. Indeed, artificially introduced delays in visual feedback have been reported to degrade motor learning. However, considering our perceptual ability to causally bind our own actions with sensory feedback, demonstrated by the decrease in the perceived time delay following repeated exposure to an artificial delay, we hypothesized that such perceptual binding might alleviate deficits of motor learning associated with delayed visual feedback. Here, we evaluated this hypothesis by investigating the ability of human participants to adapt their reaching movements in response to a novel visuomotor environment with 3 visual feedback conditions-no-delay, sudden-delay, and adapted-delay. To introduce novelty into the trials, the cursor position, which originally indicated the hand position in baseline trials, was rotated around the starting position. In contrast to the no-delay condition, a 200-ms delay was artificially introduced between the cursor and hand positions during the presence of visual rotation (sudden-delay condition), or before the application of visual rotation (adapted-delay condition). We compared the learning rate (representing how the movement error modifies the movement direction in the subsequent trial) between the 3 conditions. In comparison with the no-delay condition, the learning rate was significantly degraded for the sudden-delay condition. However, this degradation was significantly alleviated by prior exposure to the delay (adapted-delay condition). Our data indicate the importance of appropriate temporal associations between motor commands and sensory feedback in visuomotor learning. Moreover, they suggest that the brain is able to account for such temporal associations in a flexible manner.	[Honda, Takuya; Hirashima, Masaya; Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan; [Honda, Takuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Honda, T (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan.	nozaki@p.u-tokyo.ac.jp		Nozaki, Daichi/0000-0002-1338-8337	Japan Society for the Promotion of Science [22-9430]; Funding Program for Next Generation World-Leading Researchers [LS034];  [20670008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was supported by Grants-in-Aid for Research Fellow of the Japan Society for the Promotion of Science (#22-9430) to TH and by Grants-in-Aid for Young Scientists (#20670008) and the Funding Program for Next Generation World-Leading Researchers (#LS034) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; COOKE JD, 1984, J MOTOR BEHAV, V16, P348; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kasuga S, 2011, J NEUROPHYSIOL, V106, P1218, DOI 10.1152/jn.00278.2011; Kawato M, 2002, HDB BRAIN THEORY NEU; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Ljung L., SYSTEM IDENTIFICATIO; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Saijo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009399; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Tanaka H, 2011, EXP BRAIN RES, V208, P257, DOI 10.1007/s00221-010-2476-z; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wei YJ, 2005, IEEE INT CONF ROBOT, P4406; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009	51	47	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37900	10.1371/journal.pone.0037900	http://dx.doi.org/10.1371/journal.pone.0037900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666408	Green Submitted, gold, Green Published			2022-12-25	WOS:000305353400056
J	Padgham, M				Padgham, Mark			Human Movement Is Both Diffusive and Directed	PLOS ONE			English	Article							TRAVEL BEHAVIOR; MOBILITY; MODEL; LAWS	Understanding the influence of the built environment on human movement requires quantifying spatial structure in a general sense. Because of the difficulty of this task, studies of movement dynamics often ignore spatial heterogeneity and treat movement through journey lengths or distances alone. This study analyses public bicycle data from central London to reveal that, although journey distances, directions, and frequencies of occurrence are spatially variable, their relative spatial patterns remain largely constant, suggesting the influence of a fixed spatial template. A method is presented to describe this underlying space in terms of the relative orientation of movements toward, away from, and around locations of geographical or cultural significance. This produces two fields: one of convergence and one of divergence, which are able to accurately reconstruct the observed spatial variations in movement. These two fields also reveal categorical distinctions between shorter journeys merely serving diffusion away from significant locations, and longer journeys intentionally serving transport between spatially distinct centres of collective importance. Collective patterns of human movement are thus revealed to arise from a combination of both diffusive and directed movement, with aggregate statistics such as mean travel distances primarily determined by relative numbers of these two kinds of journeys.	Univ New England, Dept Geog & Planning, Armidale, NSW 2351, Australia	University of New England	Padgham, M (corresponding author), Univ New England, Dept Geog & Planning, Armidale, NSW 2351, Australia.	mark.padgham@email.com						[Anonymous], 2011, GUARDIAN NEWSPAPER; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bazzani A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/05/P05001; Belik V., 2009, P INT C COMP SCI ENG, P932, DOI DOI 10.1109/CSE.2009.432; Benhamou S, 1997, BEHAV PROCESS, V40, P149, DOI 10.1016/S0376-6357(97)00775-4; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; Borgnat P, 2011, ADV COMPLEX SYST, V14, P415, DOI 10.1142/S0219525911002950; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434015; Boyer D, 2011, J ROYAL SOC INTERFAC; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Ewing R, 2001, TRANSPORT RES REC, P87, DOI 10.3141/1780-10; Froehlich J, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1420; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Green N, 2007, URBAN STUD, V44, P2077, DOI 10.1080/00420980701518941; Handy S, 2005, TRANSPORT RES D-TR E, V10, P427, DOI 10.1016/j.trd.2005.05.002; HANKIN BD, 1958, OPER RES QUART, V9, P81, DOI 10.2307/3006732; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Miller HJ, 2010, J REGIONAL SCI, V50, P181, DOI 10.1111/j.1467-9787.2009.00641.x; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Sauer Carl O., 1925, GEOGRAPHY, V2, P19; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Sun JB, 2011, PHYSICA A, V390, P929, DOI 10.1016/j.physa.2010.10.033; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Transport for London (TfL), PASS DAT YEAR 2010; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017	43	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37754	10.1371/journal.pone.0037754	http://dx.doi.org/10.1371/journal.pone.0037754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666388	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400047
J	Sandhu, G; Battaglia, F; Ely, BK; Athanasakis, D; Montoya, R; Valencia, T; Gilman, RH; Evans, CA; Friedland, JS; Fernandez-Reyes, D; Agranoff, DD				Sandhu, Gurjinder; Battaglia, Francesca; Ely, Barry K.; Athanasakis, Dimitrios; Montoya, Rosario; Valencia, Teresa; Gilman, Robert H.; Evans, Carlton A.; Friedland, Jon S.; Fernandez-Reyes, Delmiro; Agranoff, Daniel D.			Discriminating Active from Latent Tuberculosis in Patients Presenting to Community Clinics	PLOS ONE			English	Article							SELDI-TOF-MS; POTENTIAL BIOMARKERS; DIAGNOSTIC-TEST; SKIN-TEST; GAMMA; TB; STRATEGIES; INFARCTION; PROTEOMICS; DISCOVERY	Background: Because of the high global prevalence of latent TB infection (LTBI), a key challenge in endemic settings is distinguishing patients with active TB from patients with overlapping clinical symptoms without active TB but with coexisting LTBI. Current methods are insufficiently accurate. Plasma proteomic fingerprinting can resolve this difficulty by providing a molecular snapshot defining disease state that can be used to develop point-of-care diagnostics. Methods: Plasma and clinical data were obtained prospectively from patients attending community TB clinics in Peru and from household contacts. Plasma was subjected to high-throughput proteomic profiling by mass spectrometry. Statistical pattern recognition methods were used to define mass spectral patterns that distinguished patients with active TB from symptomatic controls with or without LTBI. Results: 156 patients with active TB and 110 symptomatic controls (patients with respiratory symptoms without active TB) were investigated. Active TB patients were distinguishable from undifferentiated symptomatic controls with accuracy of 87% (sensitivity 84%, specificity 90%), from symptomatic controls with LTBI (accuracy of 87%, sensitivity 89%, specificity 82%) and from symptomatic controls without LTBI (accuracy 90%, sensitivity 90%, specificity 92%). Conclusions: We show that active TB can be distinguished accurately from LTBI in symptomatic clinic attenders using a plasma proteomic fingerprint. Translation of biomarkers derived from this study into a robust and affordable point-of-care format will have significant implications for recognition and control of active TB in high prevalence settings.	[Sandhu, Gurjinder; Evans, Carlton A.; Friedland, Jon S.; Agranoff, Daniel D.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Sandhu, Gurjinder; Evans, Carlton A.; Friedland, Jon S.; Agranoff, Daniel D.] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, London, England; [Battaglia, Francesca; Ely, Barry K.; Athanasakis, Dimitrios; Fernandez-Reyes, Delmiro] Natl Inst Med Res, Div Parasitol, Med Res Council, London NW7 1AA, England; [Gilman, Robert H.; Evans, Carlton A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Montoya, Rosario; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Assoc Benef PRISMA, San Miguel Lab Invest Enfermedades Infecciosas, Lima, Peru; [Valencia, Teresa; Gilman, Robert H.; Evans, Carlton A.] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Lima, Peru	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Sandhu, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England.	dfernan@nimr.mrc.ac.uk; d.agranoff@imperial.ac.uk	Evans, Carlton/AAI-1653-2020	Evans, Carlton/0000-0002-6873-5447; Friedland, Jonathan S/0000-0001-7789-9649; Montoya Villanueva, Maria del Rosario/0000-0001-8692-9475; Fernandez-Reyes, Delmiro/0000-0001-5070-9198	Wellcome Trust; DFID Civil Society Challenge Fund; Innovation For Health And Development (IFHAD); Foundation for Innovative New Diagnostics (FIND); UK Medical Research Council; National Institute of Health Biomedical Research Centre at Imperial College; Medical Research Council [MC_U117585869, MR/K007467/1] Funding Source: researchfish; MRC [MC_U117585869, MR/K007467/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); DFID Civil Society Challenge Fund; Innovation For Health And Development (IFHAD); Foundation for Innovative New Diagnostics (FIND); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Biomedical Research Centre at Imperial College; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research and members of the project team were supported by the Wellcome Trust, the DFID Civil Society Challenge Fund, the Innovation For Health And Development (IFHAD), the Foundation for Innovative New Diagnostics (FIND) and UK Medical Research Council. G. S. was a Wellcome Trust Clinical Tropical Research Training Fellow (0783404/Z4/05/Z). J.S.F. and C. E. were in part supported by the Wellcome Trust. J.S.F. and D. A. are grateful for support from the National Institute of Health Biomedical Research Centre at Imperial College. D.F.-R. is supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USDaF, 2009, FDA CLEARS TEST OV C; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Bamford ARJ, 2010, ARCH DIS CHILD, V95, P180, DOI 10.1136/adc.2009.169805; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Engwegen JYMN, 2006, TRENDS PHARMACOL SCI, V27, P251, DOI 10.1016/j.tips.2006.03.003; Fung ET, 2010, CLIN CHEM, V56, P327, DOI 10.1373/clinchem.2009.140855; Fung ET, 2000, CURR OPIN MOL THER, V2, P643; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hodgetts A, 2007, FUTURE MICROBIOL, V2, P35, DOI 10.2217/17460913.2.1.35; Hong M, 2009, THROMB RES, V123, P556, DOI 10.1016/j.thromres.2008.05.019; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pang RTK, 2006, CLIN CHEM, V52, P421, DOI 10.1373/clinchem.2005.061689; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; Sanghavi DM, 1998, AM J EPIDEMIOL, V148, P384, DOI 10.1093/oxfordjournals.aje.a009657; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu C, 2009, J GASTROEN HEPATOL, V24, P55, DOI 10.1111/j.1440-1746.2008.05580.x; Wu FX, 2009, CANCER LETT, V279, P163, DOI 10.1016/j.canlet.2009.01.034; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zhang XP, 2008, AM J CLIN PATHOL, V130, P299, DOI 10.1309/CA242R5VY14HUGE8	31	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38080	10.1371/journal.pone.0038080	http://dx.doi.org/10.1371/journal.pone.0038080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666453	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305353400079
J	Fujimura, Y; Sumida, M; Sugihara, K; Tsukamoto, S; Yamada, K; Tachibana, H				Fujimura, Yoshinori; Sumida, Mami; Sugihara, Kaori; Tsukamoto, Shuntaro; Yamada, Koji; Tachibana, Hirofumi			Green Tea Polyphenol EGCG Sensing Motif on the 67-kDa Laminin Receptor	PLOS ONE			English	Article							EPSILON-RI EXPRESSION; (-)-EPIGALLOCATECHIN GALLATE; BINDING PROTEIN; PRION PROTEIN; CELLS; CANCER; PRECURSOR; VIRUS; EPIGALLOCATECHIN-3-O-GALLATE; PATHWAY	Background: We previously identified the 67-kDa laminin receptor (67LR) as the cell-surface receptor conferring the major green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) responsiveness to cancer cells. However, the underlying mechanism for interaction between EGCG and 67LR remains unclear. In this study, we investigated the possible role of EGCG-67LR interaction responsible for its bioactivities. Methodology/Principal Findings: We synthesized various peptides deduced from the extracellular domain corresponding to the 102-295 region of human 67LR encoding a 295-amino acid. The neutralizing activity of these peptides toward EGCG cell-surface binding and inhibition of cancer cell growth were assayed. Both activities were inhibited by a peptide containing the 10-amino acid residues, IPCNNKGAHS, corresponding to residues 161-170. Furthermore, mass spectrometric analysis revealed the formation of a EGCG-LR161-170 peptide complex. A study of the amino acid deletion/replacement of the peptide LR161-170 indicated that the 10-amino acid length and two basic amino acids, K-166 and H-169, have a critical role in neutralizing EGCG's activities. Moreover, neutralizing activity against the anti-proliferation action of EGCG was observed in a recombinant protein of the extracellular domain of 67LR, and this effect was abrogated by a deletion of residues 161-170. These findings support that the 10 amino-acid sequence, IPCNNKGAHS, might be the functional domain responsible for the anti-cancer activity of EGCG. Conclusions/Significance: Overall, our results highlight the nature of the EGCG-67LR interaction and provide novel structural insights into the understanding of 67LR-mediated functions of EGCG, and could aid in the development of potential anti-cancer compounds for chemopreventive or therapeutic uses that can mimic EGCG-67LR interactions.	[Fujimura, Yoshinori; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Sumida, Mami; Sugihara, Kaori; Tsukamoto, Shuntaro; Yamada, Koji; Tachibana, Hirofumi] Fac Agr, Dept Biosci & Biotechnol, Fukuoka, Japan; [Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Fujimura, Y (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	tatibana@agr.kyushu-u.ac.jp	Fujimura, Yoshinori/AAG-4403-2019	Fujimura, Yoshinori/0000-0003-0798-0649	Scientific Research (S) [22228002]	Scientific Research (S)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (S) (Grant 22228002) (to HT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Cao D, 2009, RAPID COMMUN MASS SP, V23, P1147, DOI 10.1002/rcm.3985; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Dorchies OM, 2009, BIOFACTORS, V35, P279, DOI 10.1002/biof.34; Fujimura Y, 2005, BIOCHEM BIOPH RES CO, V336, P674, DOI 10.1016/j.bbrc.2005.08.146; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Fujimura Y, 2008, ARCH BIOCHEM BIOPHYS, V476, P133, DOI 10.1016/j.abb.2008.03.002; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011051; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Osanai K, 2007, BIOORGAN MED CHEM, V15, P5076, DOI 10.1016/j.bmc.2007.05.041; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tachibana H, 2009, FORUM NUTR, V61, P156, DOI 10.1159/000212748; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Umeda D, 2008, BIOCHEM BIOPH RES CO, V371, P172, DOI 10.1016/j.bbrc.2008.04.041; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; Wan SB, 2005, BIOORGAN MED CHEM, V13, P2177, DOI 10.1016/j.bmc.2004.12.056; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	45	61	64	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37942	10.1371/journal.pone.0037942	http://dx.doi.org/10.1371/journal.pone.0037942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666419	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600046
J	Korkalainen, M; Huumonen, K; Naarala, J; Viluksela, M; Juutilainen, J				Korkalainen, Merja; Huumonen, Katriina; Naarala, Jonne; Viluksela, Matti; Juutilainen, Jukka			Dioxin Induces Genomic Instability in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; IONIZING-RADIATION; IN-VITRO; DNA-DAMAGE; CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MECHANISMS; ASSAY; ANIMALS; AGENTS	Ionizing radiation and certain other exposures have been shown to induce genomic instability (GI), i.e., delayed genetic damage observed many cell generations later in the progeny of the exposed cells. The aim of this study was to investigate induction of GI by a nongenotoxic carcinogen, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Mouse embryonic fibroblasts (C3H10T1/2) were exposed to 1, 10 or 100 nM TCDD for 2 days. Micronuclei (MN) and expression of selected cancer-related genes were assayed both immediately and at a delayed point in time (8 days). For comparison, similar experiments were done with cadmium, a known genotoxic agent. TCDD treatment induced an elevated frequency of MN at 8 days, but not directly after the exposure. TCDD-induced alterations in gene expression were also mostly delayed, with more changes observed at 8 days than at 2 days. Exposure to cadmium produced an opposite pattern of responses, with pronounced effects immediately after exposure but no increase in MN and few gene expression changes at 8 days. Although all responses to TCDD alone were delayed, menadione-induced DNA damage (measured by the Comet assay), was found to be increased directly after a 2-day TCDD exposure, indicating that the stability of the genome was compromised already at this time point. The results suggested a flat dose-response relationship consistent with dose-response data reported for radiation-induced GI. These findings indicate that TCDD, although not directly genotoxic, induces GI, which is associated with impaired DNA damage response.	[Korkalainen, Merja; Viluksela, Matti] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Huumonen, Katriina; Naarala, Jonne; Juutilainen, Jukka] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland	Finland National Institute for Health & Welfare; University of Eastern Finland	Korkalainen, M (corresponding author), Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland.	merja.korkalainen@thl.fi		Korkalainen, Merja/0000-0002-1221-0617	Academy of Finland [123439]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland [grant number 123439] (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Baverstock K, 2011, MUTAT RES-GEN TOX EN, V718, P1, DOI 10.1016/j.mrgentox.2010.11.003; Birnbaum LS, 2000, FOOD ADDIT CONTAM A, V17, P275, DOI 10.1080/026520300283351; Brennan RJ, 2001, RADIAT RES, V155, P768, DOI 10.1667/0033-7587(2001)155[0768:PGIITY]2.0.CO;2; Bryce SM, 2007, MUTAT RES-GEN TOX EN, V630, P78, DOI 10.1016/j.mrgentox.2007.03.002; Coen N, 2001, J PATHOL, V195, P293; Dubrova YE, 2003, ONCOGENE, V22, P7087, DOI 10.1038/sj.onc.1206993; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang L, 2007, CANCER RES, V67, P1099, DOI 10.1158/0008-5472.CAN-06-3697; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; International Agency for Research on Cancer (IARC), 1997, IARC MON EV CARC RIS, V69; Katic J, 2010, FOOD CHEM TOXICOL, V48, P2612, DOI 10.1016/j.fct.2010.06.030; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Markkanen A, 2008, INT J RADIAT BIOL, V84, P742, DOI 10.1080/09553000802360836; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Parfett CL, 2006, MUTAT RES-GEN TOX EN, V604, P42, DOI 10.1016/j.mrgentox.2005.12.008; Phillipson RP, 2002, FREE RADICAL BIO MED, V32, P474, DOI 10.1016/S0891-5849(01)00829-2; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Puga A, 2000, BIOCHEM PHARMACOL, V60, P1129, DOI 10.1016/S0006-2952(00)00403-2; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Valic E, 2004, INT ARCH OCC ENV HEA, V77, P301, DOI 10.1007/s00420-004-0508-3; Viluksela M, 2000, CANCER RES, V60, P6911; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047	30	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37895	10.1371/journal.pone.0037895	http://dx.doi.org/10.1371/journal.pone.0037895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666406	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349600037
J	Rousseau, L; Etienne, O; Roque, T; Desmaze, C; Haton, C; Mouthon, MA; Bernardino-Sgherri, J; Essers, J; Kanaar, R; Boussin, FD				Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Essers, Jeroen; Kanaar, Roland; Boussin, Francois D.			In vivo Importance of Homologous Recombination DNA Repair for Mouse Neural Stem and Progenitor Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; INTERKINETIC NUCLEAR MIGRATION; NERVOUS-SYSTEM; MAMMALIAN-CELLS; NEURONAL DEVELOPMENT; VENTRICULAR ZONE; PATHWAY CHOICE; DAMAGE REPAIR; S-PHASE; RAD54	We characterized the in vivo importance of the homologous recombination factor RAD54 for the developing mouse brain cortex in normal conditions or after ionizing radiation exposure. Contrary to numerous homologous recombination genes, Rad54 disruption did not impact the cortical development without exogenous stress, but it dramatically enhanced the radiation sensitivity of neural stem and progenitor cells. This resulted in the death of all cells irradiated during S or G2, whereas the viability of cells irradiated in G1 or G0 was not affected by Rad54 disruption. Apoptosis occurred after long arrests at intra-S and G2/M checkpoints. This concerned every type of neural stem and progenitor cells, showing that the importance of Rad54 for radiation response was linked to the cell cycle phase at the time of irradiation and not to the differentiation state. In the developing brain, RAD54-dependent homologous recombination appeared absolutely required for the repair of damages induced by ionizing radiation during S and G2 phases, but not for the repair of endogenous damages in normal conditions. Altogether our data support the existence of RAD54-dependent and -independent homologous recombination pathways.	[Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Boussin, Francois D.] CEA, Lab Radiopathol, SCSR, iRCM,DSV, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] INSERM, U967, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] Univ Paris Diderot, UMR 967, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] Univ Paris Sud, UMR 967, Fontenay Aux Roses, France; [Bernardino-Sgherri, Jacqueline] CEA, Lab Gametogenese Apoptose & Genotoxicite, SCSR, iRCM,DSV, Fontenay Aux Roses, France; [Essers, Jeroen; Kanaar, Roland] Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, Rotterdam, Netherlands; [Essers, Jeroen; Kanaar, Roland] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rousseau, L (corresponding author), CEA, Lab Radiopathol, SCSR, iRCM,DSV, Fontenay Aux Roses, France.	boussin@cea.fr		Bernardino-Sgherri, Jacqueline/0000-0003-3980-4041; Desmaze, Chantal/0000-0003-0777-8854; Mouthon, Marc-Andre/0000-0003-2633-9179; Boussin, francois/0000-0003-3778-4403	l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad); Electricite de France; Association pour la Recherche sur le Cancer [ARC3900]; European Community [HEALTH-F2-2010-259893]; Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Netherlands Genomics Initiative/NWO	l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad)(French National Research Agency (ANR)); Electricite de France; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); European Community(European Commission); Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad), Electricite de France and Association pour la Recherche sur le Cancer (ARC3900). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) under grant agreement [HEALTH-F2-2010-259893] and from grants from the Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) and Netherlands Genomics Initiative/NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; D'Sa-Eipper C, 2001, DEVELOPMENT, V128, P137; Daboussi F, 2008, J CELL SCI, V121, P162, DOI 10.1242/jcs.010330; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Eppink B, 2011, DNA REPAIR, V10, P1095, DOI 10.1016/j.dnarep.2011.08.006; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; HEYER WD, 1994, EXPERIENTIA, V50, P189, DOI 10.1007/BF01924001; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; SHIBATA K, 1993, J BIOL CHEM, V268, P18431; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Sii-Felice K, 2008, CELL CYCLE, V7, P1911, DOI 10.4161/cc.7.13.6235; Sii-Felice K, 2008, EMBO J, V27, P770, DOI 10.1038/emboj.2008.14; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Stephan AK, 2011, MOL CELL BIOL, V31, P1369, DOI 10.1128/MCB.00786-10; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tanori M, 2011, ONCOGENE; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37194	10.1371/journal.pone.0037194	http://dx.doi.org/10.1371/journal.pone.0037194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666344	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600012
J	Traister, A; Aafaqi, S; Masse, S; Dai, XJ; Li, M; Hinek, A; Nanthakumar, K; Hannigan, G; Coles, JG				Traister, Alexandra; Aafaqi, Shabana; Masse, Stephane; Dai, Xiaojing; Li, Mark; Hinek, Aleksander; Nanthakumar, Kumaraswamy; Hannigan, Gregory; Coles, John G.			ILK Induces Cardiomyogenesis in the Human Heart	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; CARDIOVASCULAR PROGENITORS; SELF-RENEWAL; CANCER-CELLS; EXPRESSION; DIFFERENTIATION; CARDIOMYOCYTES; MOUSE; CONTRACTILITY; PATHWAYS	Background: Integrin-linked kinase (ILK) is a widely conserved serine/threonine kinase that regulates diverse signal transduction pathways implicated in cardiac hypertrophy and contractility. In this study we explored whether experimental overexpression of ILK would up-regulate morphogenesis in the human fetal heart. Methodology/Principal Findings: Primary cultures of human fetal myocardial cells (19-22 weeks gestation) yielded scattered aggregates of cardioblasts positive for the early cardiac lineage marker nkx2.5 and containing nascent sarcomeres. Cardiac cells in colonies uniformly expressed the gap junction protein connexin 43 (Cx43) and displayed a spectrum of differentiation with only a subset of cells exhibiting the late cardiomyogenic marker troponin T (cTnT) and evidence of electrical excitability. Adenovirus-mediated overexpression of ILK potently increased the number of new aggregates of primitive cardioblasts (p<0.001). The number of cardioblast colonies was significantly decreased (p<0.05) when ILK expression was knocked down with ILK targeted siRNA. Interestingly, overexpression of the activation resistant ILK mutant (ILKR211A) resulted in much greater increase in the number of new cell aggregates as compared to overexpression of wild-type ILK (ILKWT). The cardiomyogenic effects of ILKR211A and ILKWT were accompanied by concurrent activation of beta-catenin (p<0.001) and increase expression of progenitor cell marker islet-1, which was also observed in lysates of transgenic mice with cardiac-specific over-expression of ILKR211A and ILKWT. Finally, endogenous ILK expression was shown to increase in concert with those of cardiomyogenic markers during directed cardiomyogenic differentiation in human embryonic stem cells (hESCs). Conclusions/Significance: In the human fetal heart ILK activation is instructive to the specification of mesodermal precursor cells towards a cardiomyogenic lineage. Induction of cardiomyogenesis by ILK overexpression bypasses the requirement of proximal PI3K activation for transduction of growth factor-and beta 1-integrin-mediated differentiation signals. Altogether, our data indicate that ILK represents a novel regulatory checkpoint during human cardiomyogenesis.	[Traister, Alexandra; Aafaqi, Shabana; Dai, Xiaojing; Li, Mark; Hinek, Aleksander; Coles, John G.] Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; [Masse, Stephane; Nanthakumar, Kumaraswamy] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Hannigan, Gregory] Monash Univ, Monash Inst Med Res, Cell Adhes Signaling Lab, Melbourne, Vic 3004, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Monash University	Traister, A (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.coles@sickkids.ca	Hinek, Aleksander/V-8790-2019; , Nanthakumar/AAA-9943-2020		Canadian Institute of Health Research [MOP-86625]; Australian National Health and Medical Research Council; Victorian Operational Infrastructure Program; GL2 grant: Cardiovascular Biomarker Discovery and Validation	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure Program; GL2 grant: Cardiovascular Biomarker Discovery and Validation	This work was supported by Canadian Institute of Health Research grant #MOP-86625. Grant support to Gregory Hannigan by Australian National Health and Medical Research Council, funds from the Victorian Operational Infrastructure Program, and the GL2 grant: Cardiovascular Biomarker Discovery and Validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud ER, 2007, INT J ONCOL, V30, P113; Anton R, 2007, BIOESSAYS, V29, P422, DOI 10.1002/bies.20562; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; CARY RB, 1994, J CELL BIOL, V126, P445, DOI 10.1083/jcb.126.2.445; de Boer TP, 2010, J MOL CELL CARDIOL, V48, P254, DOI 10.1016/j.yjmcc.2009.05.004; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Durbin AD, 2010, CELL CYCLE, V9, P1951, DOI 10.4161/cc.9.10.11554; Easley CAB-YA, 2009, 7 ANN M INT SOC STEM; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Fudim MBJ, 2009, P ISSCR C; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kirby M. L., 2007, CARDIAC DEV; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lee SP, 2006, CIRCULATION, V114, P150, DOI 10.1161/CIRCULATIONAHA.105.595918; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Pan WJ, 2006, J CELL SCI, V119, P4850, DOI 10.1242/jcs.03257; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Xie J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024115; Yamabi H, 2006, J THORAC CARDIOV SUR, V132, P1272, DOI 10.1016/j.jtcvs.2006.08.028; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37802	10.1371/journal.pone.0037802	http://dx.doi.org/10.1371/journal.pone.0037802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666394	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600030
J	Ban, Y; Tozaki, T; Taniyama, M; Skrabanek, L; Nakano, Y; Ban, Y; Hirano, T				Ban, Yoshiyuki; Tozaki, Teruaki; Taniyama, Matsuo; Skrabanek, Luce; Nakano, Yasuko; Ban, Yoshio; Hirano, Tsutomu			Multiple SNPs in Intron 41 of Thyroglobulin Gene Are Associated with Autoimmune Thyroid Disease in the Japanese Population	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY LOCI; C/T POLYMORPHISM; UNITED-STATES; CD40 GENE; REGION; VARIANTS; EXON-33; COMMON	Background: The etiology of the autoimmune thyroid diseases (AITDs), Graves' disease (GD) and Hashimoto's thyroiditis (HT), is largely unknown. However, genetic susceptibility is believed to play a major role. Two whole genome scans from Japan and from the US identified a locus on chromosome 8q24 that showed evidence for linkage with AITD and HT. Recent studies have demonstrated an association between thyroglobulin (Tg) polymorphisms and AITD in Caucasians, suggesting that Tg is a susceptibility gene on 8q24. Objectives: The objective of the study was to refine Tg association with AITD, by analyzing a panel of 25 SNPs across an extended 260 kb region of the Tg. Methods: We studied 458 Japanese AITD patients (287 GD and 171 HT patients) and 221 matched Japanese control subjects in association studies. Case-control association studies were performed using 25 Tg single nucleotide polymorphisms (SNPs) chosen from a database of the Single Nucleotide Polymorphism Database (dbSNP). Haplotype analysis was undertaken using the computer program SNPAlyze version 7.0. Principal Findings and Conclusions: In total, 5 SNPs revealed association with GD (P<0.05), with the strongest SNP associations at rs2256366 (P = 0.002) and rs2687836 (P = 0.0077), both located in intron 41 of the Tg gene. Because of the strong LD between these two strongest associated variants, we performed the haplotype analysis, and identified a major protective haplotype for GD (P = 0.001). These results suggested that the Tg gene is involved in susceptibility for GD and AITD in the Japanese.	[Ban, Yoshiyuki; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan; [Tozaki, Teruaki; Nakano, Yasuko] Showa Univ, Sch Pharm, Dept Pharmacogen, Shinagawa Ku, Tokyo, Japan; [Taniyama, Matsuo] Showa Univ, Fujigaoka Hosp, Div Endocrinol & Metab, Yokohama, Kanagawa 227, Japan; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Ban, Yoshio] Ban Thyroid Clin, Meguro Ku, Tokyo, Japan	Showa University; Showa University; Showa University; Cornell University; Cornell University	Ban, Y (corresponding author), Showa Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan.	yshyban@yahoo.co.jp; yshyban@yahoo.co.jp	Tozaki, Teruaki/ABD-9286-2021	Tozaki, Teruaki/0000-0001-8797-6644	Showa University; Showa University School of Medicine Alumni Association; Yamaguchi Endocrine Research Association; Grants-in-Aid for Scientific Research [23590474] Funding Source: KAKEN	Showa University; Showa University School of Medicine Alumni Association; Yamaguchi Endocrine Research Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Showa University Grant-in-aid for Innovative Collaborative Research Projects (to Yoshiyuki Ban), a grant from the Showa University School of Medicine Alumni Association (to Yoshiyuki Ban), and a grant from the Yamaguchi Endocrine Research Association (to Yoshiyuki Ban). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ban Y, 2004, CLIN ENDOCRINOL, V61, P263, DOI 10.1111/j.1365-2265.2004.02096.x; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Ban YY, 2003, AUTOIMMUNITY, V36, P367, DOI 10.1080/08916930310001603037; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Collins JE, 2004, J CLIN ENDOCR METAB, V89, P6336, DOI 10.1210/jc.2004-1336; Collins JE, 2003, J CLIN ENDOCR METAB, V88, P5039, DOI 10.1210/jc.2003-030093; Davies T.F., 2000, WERNER INGBARS THYRO, P518; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hsiao JY, 2007, J CLIN ENDOCR METAB, V92, P3197, DOI 10.1210/jc.2007-0675; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Kim TY, 2003, THYROID, V13, P919, DOI 10.1089/105072503322511319; MANGKLABRUKS A, 1991, J CLIN ENDOCR METAB, V73, P236, DOI 10.1210/jcem-73-2-236; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Stefan M, 2011, J BIOL CHEM, V286, P31168, DOI 10.1074/jbc.M111.247510; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 1997, CLIN IMMUNOL IMMUNOP, V82, P3, DOI 10.1006/clin.1996.4243; Weetman Anthony P., 1996, P738; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yanagawa T, 1997, THYROID, V7, P843, DOI 10.1089/thy.1997.7.843; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	31	37	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37501	10.1371/journal.pone.0037501	http://dx.doi.org/10.1371/journal.pone.0037501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662162	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300052
J	Cardone, L; Bardelli, A; Avvedimento, VE				Cardone, Luca; Bardelli, Alberto; Avvedimento, Vittorio Enrico			Activation of beta-Catenin by Oncogenic PIK3CA and EGFR Promotes Resistance to Glucose Deprivation by Inducing a Strong Antioxidant Response	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TUMOR-CELL GROWTH; OXIDATIVE STRESS; PROTEIN-KINASE; BREAST-CANCER; HIGH-FREQUENCY; LUNG-CANCER; METABOLISM; MUTATIONS; GENE	Glucose is an essential fuel for cell survival and its availability limits aberrant cellular proliferation. We have hypothesized that specific cancer mutations regulate metabolic response(s) to glucose deprivation (GD). By means of somatic knock-in cellular models, we have analyzed the response to glucose deprivation in cells carrying the frequent (delE746-A750)EGFR, (G13D)KRAS or (E545K)PIK3CA cancer alleles. We demonstrate that, in mammary epithelial cells, glucose has an essential antioxidant function and that these cells are very sensitive to GD. Conversely, isogenic cells carrying the (delE746-A750)EGFR or the (E545K)PIK3CA, but not the (G13D)KRAS allele, display high tolerance to GD by stimulating the expression of anti-oxidant genes (MnSOD and catalase). This adaptive transcriptional response is mediated by the activation of WNT/beta-catenin and FOXO4 signalling. Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/beta-catenin conferring high tolerance to oxidative stress generated by nutrient deprivation.	[Cardone, Luca; Avvedimento, Vittorio Enrico] Univ Naples Federico II, Sch Med, Dept Biol & Cellular & Mol Pathol, Naples, Italy; [Bardelli, Alberto] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, Milan, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; IFOM - FIRC Institute of Molecular Oncology	Cardone, L (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.	lcardone@tigem.it; avvedim@unina.it	; BARDELLI, Alberto/J-9721-2018	Cardone, Luca/0000-0001-8184-2856; BARDELLI, Alberto/0000-0003-1647-5070	Associazione Italiana Ricerca sul Cancro (AIRC) [IG11364]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from the Associazione Italiana Ricerca sul Cancro (AIRC), IG11364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Blancher C, 2001, CANCER RES, V61, P7349; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dansen TB, 2011, ANTIOXID REDOX SIGN, V14, P559, DOI 10.1089/ars.2010.3778; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ennen M, 2011, FREE RADICAL BIO MED, V50, P1771, DOI 10.1016/j.freeradbiomed.2011.03.013; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Nelson KK, 2003, CLIN CANCER RES, V9, P424; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	47	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37526	10.1371/journal.pone.0037526	http://dx.doi.org/10.1371/journal.pone.0037526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662165	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300055
J	Hardy, C; Fara, E; Laffont, R; Dommergues, JL; Meister, C; Neige, P				Hardy, Clotilde; Fara, Emmanuel; Laffont, Remi; Dommergues, Jean-Louis; Meister, Christian; Neige, Pascal			Deep-Time Phylogenetic Clustering of Extinctions in an Evolutionarily Dynamic Clade (Early Jurassic Ammonites)	PLOS ONE			English	Article							TAXONOMIC SELECTIVITY; RISK; HISTORY; AUTOCORRELATION; DIVERSITY; PATTERNS; TETHYS; FUTURE; THREAT; SIGNAL	Conservation biologists and palaeontologists are increasingly investigating the phylogenetic distribution of extinctions and its evolutionary consequences. However, the dearth of palaeontological studies on that subject and the lack of methodological consensus hamper our understanding of that major evolutionary phenomenon. Here we address this issue by (i) reviewing the approaches used to quantify the phylogenetic selectivity of extinctions and extinction risks; (ii) investigating with a high-resolution dataset whether extinctions and survivals were phylogenetically clustered among early Pliensbachian (Early Jurassic) ammonites; (iii) exploring the phylogenetic and temporal maintenance of this signal. We found that ammonite extinctions were significantly clumped phylogenetically, a pattern that prevailed throughout the 6.6 Myr-long early Pliensbachian interval. Such a phylogenetic conservatism did not alter - or may even have promoted - the evolutionary success of this major cephalopod clade. However, the comparison of phylogenetic autocorrelation among studies remains problematic because the notion of phylogenetic conservatism is scale-dependent and the intensity of the signal is sensitive to temporal resolution. We recommend a combined use of Moran's I, Pearson's phi and Fritz and Purvis' D statistics because they highlight different facets of the phylogenetic pattern of extinctions and/or survivals.	[Hardy, Clotilde; Fara, Emmanuel; Laffont, Remi; Dommergues, Jean-Louis; Neige, Pascal] Univ Bourgogne, Lab Biogeosci, CNRS, UMR 6282, Dijon, France; [Meister, Christian] Museum Hist Nat Geneve, Dept Geol & Paleontol, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Geneva	Hardy, C (corresponding author), Univ Bourgogne, Lab Biogeosci, CNRS, UMR 6282, Dijon, France.	clotilde.hardy@u-bourgogne.fr	FARA, Emmanuel/B-8840-2013; Neige, Pascal/A-3346-2012; Neige, Pascal/ABC-8451-2021	FARA, Emmanuel/0000-0002-7991-4467; Neige, Pascal/0000-0002-6543-3611	Fondation pour la Recherche sur la Biodiversite (FRB)	Fondation pour la Recherche sur la Biodiversite (FRB)	This work is part of the project "PhyloDiv" kindly funded by the Fondation pour la Recherche sur la Biodiversite (FRB, http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2004, EVOL ECOL, V18, P273, DOI 10.1023/B:EVEC.0000035072.54176.5a; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1991, EXTINCTION BAD GENES; [Anonymous], [No title captured]; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Bilotta M, 2010, GEOBIOS-LYON, V43, P581, DOI 10.1016/j.geobios.2010.05.002; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Corey SJ, 2008, DIVERS DISTRIB, V14, P614, DOI 10.1111/j.1472-4642.2007.00448.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Davis Richard Arnold, 1996, Topics in Geobiology, V13, P463; Dera G, 2010, J GEOL SOC LONDON, V167, P21, DOI 10.1144/0016-76492009-068; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Dommergues J-L, 1997, B CTR RECHERCHE ELF, P347; Dommergues J-L, 2012, ACTA PALAEO IN PRESS, DOI 10.4202/app.2011.0148; Dommergues Jean-Louis, 2011, Revue de Paleobiologie, V30, P193; Dommergues Jean-Louis, 1999, Revue de Paleobiologie, V18, P273; Dommergues JL, 2009, PALAEOGEOGR PALAEOCL, V280, P64, DOI 10.1016/j.palaeo.2009.06.005; Dommergues JL, 2002, PALAEOGEOGR PALAEOCL, V184, P407, DOI 10.1016/S0031-0182(02)00276-6; Dommergues JL, 2001, PALAEOGEOGR PALAEOCL, V165, P195, DOI 10.1016/S0031-0182(00)00160-7; Doyle Peter, 1994, Palaeopelagos Special Publication, V1, P109; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; Escarguel G, 2011, CR BIOL, V334, P351, DOI 10.1016/j.crvi.2011.02.006; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Gittleman JL, 1998, BIODIVERSITY DYNAMICS, P51; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Green WA, 2011, PALEOBIOLOGY, V37, P72, DOI 10.1666/09078.1; Guilford J., 1936, PSYCHOMETRIC METHODS; Harnik PG, 2011, P NATL ACAD SCI USA, V108, P13594, DOI 10.1073/pnas.1100572108; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Hoffmann Rene, 2010, Revue de Paleobiologie, V29, P1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lockwood JL, 2002, CONSERV BIOL, V16, P1137, DOI 10.1046/j.1523-1739.2002.01152.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Meister Christian, 2000, Revue de Paleobiologie, V19, P227; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Orme D., 2008, CAIC COMP ANAL USING; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Ricotta C, 2004, DIVERS DISTRIB, V10, P143, DOI 10.1111/j.1366-9516.2004.00069.x; Rosales I, 2004, PALAEOGEOGR PALAEOCL, V203, P253, DOI 10.1016/S0031-0182(03)00686-2; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sjostrom A, 2006, J BIOGEOGR, V33, P271, DOI 10.1111/j.1365-2699.2005.01393.x; Upton G.J.G., 1985, SPATIAL DATA ANAL EX; VENTURI F., 2010, AMMONITI VIAGGIO GEO	56	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37977	10.1371/journal.pone.0037977	http://dx.doi.org/10.1371/journal.pone.0037977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662258	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300150
J	Hassan, F; Ren, DB; Zhang, WH; Merkel, TJ; Gu, XX				Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Merkel, Tod J.; Gu, Xin-Xing			Moraxella catarrhalis Activates Murine Macrophages through Multiple Toll Like Receptors and Has Reduced Clearance in Lungs from TLR4 Mutant Mice	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; MOUSE MODEL; SEROTYPE-A; RECOGNITION; EXPRESSION; LIPOPOLYSACCHARIDE; TOLL-LIKE-RECEPTOR-4; PATHOGEN; CHILDREN	Moraxella catarrhalis is a Gram negative bacterium and a leading causative agent of otitis media (OM) in children. Several recent reports have provided strong evidence for an association between toll like receptors and OM. It has been found that both Streptococcus pneumoniae and nontypeable Haemophilus influenzae activate host protective immune responses through toll like receptors (TLRs), however, the precise mechanism by which Moraxella catarrhalis initiates the host immune response is currently unknown. In this report, using murine macrophages generated from a series of knock-out mice, we have demonstrated that M. catarrhalis lipooligosaccharide (LOS) and either heat killed or live bacteria are recognized by one or more TLRs. LOS activates the host immune response through a membrane bound CD14-TLR4 complex, while both heat killed and live M. cat require recognition by multiple toll like receptors such as TLR2, TLR4 and TLR9 without the requirement of CD14. We have also shown that M. cat stimuli are capable of triggering the host innate immune response by both MyD88- and TRIF- dependent signaling pathways. We further showed that M. cat induced activation of mitogen activated protein kinase (MAPK) is essential in order to achieve optimal secretion of pro-inflammatory cytokine TNF-alpha. We finally showed that TLR4 mutant C3H/HeJ mice produce significantly lower levels of pro-inflammatory cytokines TNF-alpha and IL-6 in vivo, An increased bacterial loads at 12 and 24 hours (P<0.001) in their lungs upon challenge with live M. cat in an aerosol chamber compared to wild-type (WT) control mice. These data suggest that TLRs are crucial for an effective innate immune response induced by M. cat. The results of these studies contribute to an increased understanding of molecular mechanism and possible novel treatment strategies for diseases caused by M. cat by specifically targeting TLRs and their signaling pathways.	[Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing] Natl Inst Deafness & Other Commun Disorders, Vaccine Res Sect, Rockville, MD USA; [Merkel, Tod J.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); US Food & Drug Administration (FDA)	Hassan, F (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	hassanmf@umkc.edu; guxx@mail.nih.gov	Ren, Dabin/H-6263-2013		Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]	Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Granath A, 2011, J INFECTION, V63, P174, DOI 10.1016/j.jinf.2011.06.006; Granath A, 2010, ACTA OTO-LARYNGOL, V130, P57, DOI 10.3109/00016480902963061; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hirano T, 2007, FEMS IMMUNOL MED MIC, V49, P75, DOI 10.1111/j.1574-695X.2006.00186.x; Hirano T, 2009, INT J PEDIATR OTORHI, V73, P1657, DOI 10.1016/j.ijporl.2009.08.015; Hu WG, 2001, INFECT IMMUN, V69, P1358, DOI 10.1128/IAI.69.3.1358-1363.2001; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim MG, 2010, INT J PEDIATR OTORHI, V74, P1425, DOI 10.1016/j.ijporl.2010.09.026; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee YC, 2008, CLIN EXP OTORHINOLAR, V1, P189, DOI 10.3342/ceo.2008.1.4.189; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Leichtle A, 2012, INNATE IMMUN-LONDON, V18, P3, DOI 10.1177/1753425910393539; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Slevogt H, 2007, CELL MICROBIOL, V9, P694, DOI 10.1111/j.1462-5822.2006.00821.x; Szczepanski M, 2006, EUR ARCH OTO-RHINO-L, V263, P603, DOI 10.1007/s00405-006-0030-1; VANEECHOUTTE M, 1990, J CLIN MICROBIOL, V28, P182, DOI 10.1128/JCM.28.2.182-187.1990; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37610	10.1371/journal.pone.0037610	http://dx.doi.org/10.1371/journal.pone.0037610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662179	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300069
J	Shah, SB; Sahinidis, NV				Shah, Shweta B.; Sahinidis, Nikolaos V.			SAS-Pro: Simultaneous Residue Assignment and Structure Superposition for Protein Structure Alignment	PLOS ONE			English	Article							DATABASE; CLASSIFICATION; SEQUENCE; SEARCH; SIMILARITIES	Protein structure alignment is the problem of determining an assignment between the amino-acid residues of two given proteins in a way that maximizes a measure of similarity between the two superimposed protein structures. By identifying geometric similarities, structure alignment algorithms provide critical insights into protein functional similarities. Existing structure alignment tools adopt a two-stage approach to structure alignment by decoupling and iterating between the assignment evaluation and structure superposition problems. We introduce a novel approach, SAS-Pro, which addresses the assignment evaluation and structure superposition simultaneously by formulating the alignment problem as a single bilevel optimization problem. The new formulation does not require the sequentiality constraints, thus generalizing the scope of the alignment methodology to include non-sequential protein alignments. We employ derivative-free optimization methodologies for searching for the global optimum of the highly nonlinear and non-differentiable RMSD function encountered in the proposed model. Alignments obtained with SAS-Pro have better RMSD values and larger lengths than those obtained from other alignment tools. For non-sequential alignment problems, SAS-Pro leads to alignments with high degree of similarity with known reference alignments. The source code of SAS-Pro is available for download at http://eudoxus.cheme.cmu.edu/saspro/SAS-Pro.html.	[Shah, Shweta B.; Sahinidis, Nikolaos V.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Sahinidis, Nikolaos V.] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Shah, SB (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	sahinidis@cmu.edu	Sahinidis, Nikolaos V/L-7951-2016	Sahinidis, Nikolaos V/0000-0003-2087-9131				ALEXANDROV NN, 1992, J MOL BIOL, V225, P5, DOI 10.1016/0022-2836(92)91021-G; Alexandrov NN, 1996, ANAL TOPOLOGICAL NON; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreani R, 2008, IMA J NUMER ANAL, V28, P690, DOI 10.1093/imanum/drn012; Andreani R, 2008, MATH PROGRAM, V112, P93, DOI 10.1007/s10107-006-0091-3; Caprara A, 2004, J COMPUT BIOL, V11, P27, DOI 10.1089/106652704773416876; Carr RD, 2000, SAND20002171 SAND NA; Dell'Amico M, 2001, DISCRETE APPL MATH, V110, P25, DOI 10.1016/S0166-218X(00)00301-2; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Gerstein M, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P59; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 1996, NUCLEIC ACIDS RES, V24, P206, DOI 10.1093/nar/24.1.206; HUBER R, 1971, EUR J BIOCHEM, V19, P42, DOI 10.1111/j.1432-1033.1971.tb01285.x; Huyer W, 2008, ACM T MATH SOFTWARE, V35, DOI 10.1145/1377612.1377613; Kleywegt GJ, 1994, NEWSLETTER PROTEIN C, V31, P9; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Kolodny R, 2004, P NATL ACAD SCI USA, V101, P12201, DOI 10.1073/pnas.0404383101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Lancia G, 2004, MATH METHODS PROTEIN, V2666/2004, P1; Lancia G, 2001, P 5 ANN INT C COMP B, P193, DOI [10.1145/369133.369199, DOI 10.1145/369133.369199]; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Rios L., 2009, THESIS U ILLINOIS UR; Rios LM, 2011, DERIVATIVE FREE OPTI; Rocha J, 2009, BIOINFORMATICS, V25, P1625, DOI 10.1093/bioinformatics/btp296; Salem Saeed, 2009, Journal of Bioinformatics and Computational Biology, V7, P571, DOI 10.1142/S0219720009004205; Salem S, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-12; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Singh AP, 2001, NATURE STRUCTURAL BI; SIPPL MJ, 1982, J MOL BIOL, V156, P359, DOI 10.1016/0022-2836(82)90334-5; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Wohlers I, 2010, BIOINFORMATICS, V26, P2273, DOI 10.1093/bioinformatics/btq420; Wu T D, 1998, Pac Symp Biocomput, P509; Xie W, 2007, J COMPUT BIOL, V14, P637, DOI 10.1089/cmb.2007.R007; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37493	10.1371/journal.pone.0037493	http://dx.doi.org/10.1371/journal.pone.0037493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662161	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300051
J	van Well, GTJ; Sanders, MS; Ouburg, S; van Furth, AM; Morre, SA				van Well, Gijs Th J.; Sanders, Marieke S.; Ouburg, Sander; van Furth, A. Marceline; Morre, Servaas A.			Polymorphisms in Toll-Like Receptors 2, 4, and 9 Are Highly Associated with Hearing Loss in Survivors of Bacterial Meningitis	PLOS ONE			English	Article							EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; INVASIVE MENINGOCOCCAL DISEASE; MANNOSE-BINDING LECTIN; STREPTOCOCCUS-PNEUMONIAE; INNATE IMMUNITY; FUNCTIONAL CONSEQUENCES; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; SCHOOL-AGE; CHILDREN	Genetic variation in innate immune response genes contributes to inter-individual differences in disease manifestation and degree of complications upon infection. We recently described an association of single nucleotide polymorphisms (SNPs) in TLR9 with susceptibility to meningococcal meningitis (MM). In this study, we investigate the association of SNPs in multiple pathogen recognition and immune response genes with clinical features that determine severity and outcome (especially hearing loss) of childhood MM and pneumococcal meningitis (PM). Eleven SNPs in seven genes (TLR2, TLR4, TLR9, NOD1, NOD2, CASP1, and TRAIL) were genotyped in 393 survivors of childhood bacterial meningitis (BM) (327 MM patients and 66 PM patients). Genotype distributions of single SNPs and combination of SNPs were compared between thirteen clinical characteristics associated with severity of BM. After correction for multiple testing, TLR4+896 mutant alleles were highly associated with post-meningitis hearing loss, especially MM (p = 0.001, OR 4.0 for BM, p = 0.0004, OR 6.2 for MM). In a multigene analysis, combined carriership of the TLR2+2477 wild type (WT) with TLR4+896 mutant alleles increases the risk of hearing loss (p < 0.0001, OR 5.7 in BM and rho = 0.0001, OR 7.6 in MM). Carriage of one or both mutant alleles in TLR4+896 and TLR9-1237 increases the risk for hearing loss (p = 0.0006, OR 4.1 in BM). SNPs in immune response genes contribute to differences in clinical severity and outcome of BM. The TLR system seems to play an important role in the immune response to BM and subsequent neuronal damage as well as in cochlear inflammation. Genetic markers may be used for identification of high-risk patients by creating prediction rules for post-meningitis hearing loss and other sequelae, and provide more insight in the complex immune response in the CNS possibly resulting in new therapeutic interventions.	[van Well, Gijs Th J.; Sanders, Marieke S.; van Furth, A. Marceline] Vrije Univ Amsterdam, Dept Pediat Infect Dis Immunol & Rheumatol, Med Ctr, Amsterdam, Netherlands; [Sanders, Marieke S.; Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam, Immunogenet Lab, Dept Med Microbiol, Med Ctr, Amsterdam, Netherlands; [van Well, Gijs Th J.] Maastricht Univ, Dept Pediat, Med Ctr, Maastricht, Netherlands; [Sanders, Marieke S.] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands; [Morre, Servaas A.] Univ Maastricht, Inst Publ Hlth Genom, Dept Genet & Cell Biol, Res Inst CAPHRI,Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, GROW Sch Oncol & Dev Biol, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; St. Antonius Hospital Utrecht; Maastricht University; Maastricht University	van Well, GTJ (corresponding author), Vrije Univ Amsterdam, Dept Pediat Infect Dis Immunol & Rheumatol, Med Ctr, Amsterdam, Netherlands.	samorretravel@yahoo.co.uk	van Well, Gijs/L-3904-2013; Ouburg, Sander/H-5775-2019	Ouburg, Sander/0000-0002-2092-0002; Van Furth, Marceline/0000-0003-1666-8956				Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Blankenberg S, 2006, CIRC RES, V99, P102, DOI 10.1161/01.RES.0000232324.87983.4b; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Chavez-Bueno S, 2005, PEDIATR CLIN N AM, V52, P795, DOI 10.1016/j.pcl.2005.02.011; CHAVEZBUENO S, 2005, PEDIATR CLIN N AM, V52, pR7; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; de Jonge RCJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-232; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Faber J, 2007, PEDIATR INFECT DIS J, V26, P243, DOI 10.1097/01.inf.0000256751.76218.7c; Faber J, 2009, ACTA PAEDIATR, V98, P548, DOI 10.1111/j.1651-2227.2008.01163.x; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; HARRIS JP, 1995, OTOLARYNG HEAD NECK, V112, P639, DOI 10.1016/S0194-5998(95)70170-2; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2007, J INFECT DIS, V195, P1189, DOI 10.1086/512859; Koedel U, 2002, ANN NEUROL, V51, P319, DOI 10.1002/ana.10103; Koedel U, 2009, CURR TOP MICROBIOL, V336, P15, DOI 10.1007/978-3-642-00549-7_2; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koomen I, 2003, PEDIATRICS, V112, P1049, DOI 10.1542/peds.112.5.1049; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lu WG, 2010, WORLD J GASTROENTERO, V16, P4348, DOI 10.3748/wjg.v16.i34.4348; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sanders MS, 2011, GENES IMMUN, V12, P321, DOI 10.1038/gene.2011.20; Sanders MS, 2011, CLIN INFECT DIS, V52, P475, DOI 10.1093/cid/ciq155; Sanders MS, 2012, PEDIATRICS IN PRESS; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; Theiner G, 2008, MOL IMMUNOL, V45, P244, DOI 10.1016/j.molimm.2007.02.021; Weber A, 2004, J NEUROIMMUNOL, V149, P195, DOI 10.1016/j.jneuroim.2003.12.014; Winter AJ, 1997, INFECT IMMUN, V65, P4411, DOI 10.1128/IAI.65.11.4411-4418.1997; Yoshimura A, 1999, J IMMUNOL, V163, P1; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155	49	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35837	10.1371/journal.pone.0035837	http://dx.doi.org/10.1371/journal.pone.0035837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662111	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300006
J	Gonoi, W; Akai, H; Hagiwara, K; Akahane, M; Hayashi, N; Maeda, E; Yoshikawa, T; Kiryu, S; Tada, M; Uno, K; Ohtsu, H; Okura, N; Koike, K; Ohtomo, K				Gonoi, Wataru; Akai, Hiroyuki; Hagiwara, Kazuchika; Akahane, Masaaki; Hayashi, Naoto; Maeda, Eriko; Yoshikawa, Takeharu; Kiryu, Shigeru; Tada, Minoru; Uno, Kansei; Ohtsu, Hiroshi; Okura, Naoki; Koike, Kazuhiko; Ohtomo, Kuni			Meandering Main Pancreatic Duct as a Relevant Factor to the Onset of Idiopathic Recurrent Acute Pancreatitis	PLOS ONE			English	Article							MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; DIAGNOSTIC-CRITERIA; MR CHOLANGIOPANCREATOGRAPHY; PROGNOSTIC FACTORS; ODDI MANOMETRY; SPINK1 GENE; CFTR GENE; DIVISUM; SYSTEM; ASSOCIATION	Background: Meandering main pancreatic duct (MMPD), which comprises loop type and reverse-Z type main pancreatic duct (MPD), has long been discussed its relation to pancreatitis. However, no previous study has investigated its clinical significance. We aimed to determine the non-biased prevalence and the effect of MMPD on idiopathic pancreatitis using non-invasive magnetic resonance (MR) technique. Methods and Findings: A cross-sectional study performed in a tertiary referral center. The study enrolled 504 subjects from the community and 30 patients with idiopathic pancreatitis (7 acute, 13 chronic, and 10 recurrent acute). All subjects underwent MR scanning and medical examination. MMPD was diagnosed when the MPD in the head of pancreas formed two or more extrema in the horizontal direction on coronal images of MR cholangiopancreatography, making a loop or a reverse-Z shaped hairpin curves and not accompanied by other pancreatic ductal anomaly. Statistical comparison was made among groups on the rate of MMPD including loop and reverse-Z subtypes, MR findings, and clinical features. The rate of MMPD was significantly higher for all idiopathic pancreatitis/idiopathic recurrent acute pancreatitis (RAP) (20%/40%; P<0.001/0.0001; odds ratio (OR), 11.1/29.0) than in the community (2.2%) but was not higher for acute/chronic pancreatitis (14%/8%; P = 0.154/0.266). Multiple logistic regression analysis revealed MMPD to be a significant factor that induces pancreatitis/RAP (P<0.0001/0.0001; OR, 4.01/26.2). Loop/reverse-Z subtypes were found more frequently in idiopathic RAP subgroup (20%/20%; P = 0.009/0.007; OR, 20.2/24.2) than in the community (1.2%/1.0%). The other clinical and radiographic features were shown not associated with the onset of pancreatitis. Conclusions: MMPD is a common anatomical variant and might be a relevant factor to the onset of idiopathic RAP.	[Gonoi, Wataru; Akai, Hiroyuki; Hagiwara, Kazuchika; Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan; [Hayashi, Naoto; Maeda, Eriko; Yoshikawa, Takeharu; Uno, Kansei] Tokyo Univ Hosp, Dept Computat Diagnost Radiol & Prevent Med, Bunkyo Ku, Tokyo 113, Japan; [Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan; [Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Ohtsu, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Clin Bioinformat, Bunkyo Ku, Tokyo, Japan; [Okura, Naoki] Kanto Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Radiol, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Gonoi, W (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan.	watapi-tky@umin.net	Gonoi, Wataru/AAB-2160-2019; Kiryu, Shigeru/B-6867-2019; Akai, Hiroyuki/G-8962-2018; Ohtsu, Hiroshi/ABF-2536-2021	Gonoi, Wataru/0000-0002-5018-4683; Kiryu, Shigeru/0000-0003-1440-9483; Akai, Hiroyuki/0000-0002-6494-1091; Ohtsu, Hiroshi/0000-0003-3261-8828				Bang S, 2006, YONSEI MED J, V47, P243, DOI 10.3349/ymj.2006.47.2.243; BLAMEY SL, 1984, GUT, V25, P1340, DOI 10.1136/gut.25.12.1340; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Bret PM, 1996, RADIOLOGY, V199, P99, DOI 10.1148/radiology.199.1.8633179; Carnes ML, 2008, PANCREAS, V37, P151, DOI 10.1097/MPA.0b013e318164cbaf; COTTON PB, 1980, GUT, V21, P105, DOI 10.1136/gut.21.2.105; Coyle WJ, 2002, ENDOSCOPY, V34, P617, DOI 10.1055/s-2002-33245; Crisan LS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.003; Delhaye M, 2008, WORLD J GASTROENTERO, V14, P1027, DOI 10.3748/wjg.14.1027; Dray X, 2007, PANCREAS, V35, P90, DOI 10.1097/MPA.0b013e318054771f; Garg PK, 2009, J CLIN GASTROENTEROL, V43, P848, DOI 10.1097/MCG.0b013e3181a4e772; Gonoi W, 2011, CLIN IMAG, V35, P442, DOI 10.1016/j.clinimag.2011.01.002; Gonoi W, 2011, GUT, V60, P1103, DOI 10.1136/gut.2010.230011; Ishii H, 1998, J Hepatobiliary Pancreat Surg, V5, P327, DOI 10.1007/s005340050054; Kamisawa T, 2007, SURG RADIOL ANAT, V29, P405, DOI 10.1007/s00276-007-0220-6; Kamisawa T, 2004, DIGESTION, V70, P146, DOI 10.1159/000081293; Kamisawa T, 1999, DIGESTION, V60, P161, DOI 10.1159/000007642; Kamisawa T, 2007, PANCREAS, V34, P96; Kaw M, 2002, GASTROINTEST ENDOSC, V55, P157, DOI 10.1067/mge.2002.118944; Koizumi M, 2006, J HEPATO-BILIARY-PAN, V13, P25, DOI 10.1007/s00534-005-1048-2; Kume K, 2005, PANCREATOLOGY, V5, P354, DOI 10.1159/000086535; Li ZS, 1998, WORLD J GASTROENTERO, V4, P178; Liao Z, 2009, ENDOSCOPY, V41, P439, DOI 10.1055/s-0029-1214505; Matos C, 2001, GASTROINTEST ENDOSC, V53, P728, DOI 10.1067/mge.2001.114784; Matsuno S, 1996, COMMITTEE INTRACTABL, P27; Milosavljevic T, 2010, DIGEST DIS, V28, P330, DOI 10.1159/000319409; Ogawa M, 2002, PANCREAS, V25, P325, DOI 10.1097/00006676-200211000-00001; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; Quest L, 2000, GUT, V47, P317, DOI 10.1136/gut.47.3.317; RANSON JHC, 1982, AM J GASTROENTEROL, V77, P633; RESHEF R, 1988, AM J GASTROENTEROL, V83, P86; Sajith KG, 2010, DIGEST DIS SCI, V55, P3610, DOI 10.1007/s10620-010-1175-8; Shanbhogue AKP, 2009, RADIOGRAPHICS, V29, P1003, DOI 10.1148/rg.294085748; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Soto JA, 2005, RADIOLOGY, V235, P503, DOI 10.1148/radiol.2352040342; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; TANAKA T, 1992, AM J GASTROENTEROL, V87, P806; Vitellas KM, 2000, RADIOGRAPHICS, V20, P939, DOI 10.1148/radiographics.20.4.g00jl23939; Weiss FU, 2005, GUT, V54, P1456, DOI 10.1136/gut.2005.064808	39	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37652	10.1371/journal.pone.0037652	http://dx.doi.org/10.1371/journal.pone.0037652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655061	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900037
J	Rodriguez, AM; Pascutti, MF; Maeto, C; Falivene, J; Holgado, MP; Turk, G; Gherardi, MM				Maria Rodriguez, Ana; Fernanda Pascutti, Maria; Maeto, Cynthia; Falivene, Juliana; Pia Holgado, Maria; Turk, Gabriela; Magdalena Gherardi, Maria			IL-12 and GM-CSF in DNA/MVA Immunizations against HIV-1 CRF12_BF Nef Induced T-Cell Responses With an Enhanced Magnitude, Breadth and Quality	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COLONY-STIMULATING FACTOR; BOOST VACCINE REGIMEN; IMMUNE-RESPONSE; DNA VACCINE; PRIMARY INFECTION; RISK-FACTORS; TYPE-1; IMMUNOGENICITY; SUBTYPE	In Argentina, the HIV epidemic is characterized by the co-circulation of subtype B and BF recombinant viral variants. Nef is an HIV protein highly variable among subtypes, making it a good tool to study the impact of HIV variability in the vaccine design setting. We have previously reported a specific cellular response against NefBF with low cross-reactivity to NefB in mice. The aim of this work was to analyze whether the co-administration of IL-12 and GM-CSF, using DNA and MVA vaccine vectors, could improve the final cellular response induced. Mice received three DNA priming doses of a plasmid that express NefBF plus DNAs expressing IL-12 and/or GM-CSF. Afterwards, all the groups were boosted with a MVAnefBF dose. The highest increase in the magnitude of the NefBF response, compared to that induced in the control was found in the IL-12 group. Importantly, a response with higher breadth was detected in groups which received IL-12 or GM-CSF, evidenced as an increased frequency of recognition of homologous (BF) and heterologous (B) Nef peptides, as well as a higher number of other Nef peptide pools representing different viral subtypes. However, these improvements were lost when both DNA cytokines were simultaneously administered, as the response was focused against the immunodominant peptide with a detrimental response towards subdominant epitopes. The pattern of cytokines secreted and the specific-T-cell proliferative capacity were improved in IL-12 and IL-12+GM-CSF groups. Importantly IL-12 generated a significant higher T-cell avidity against a B heterologous peptide. This study indicates that the incorporation of DNA expressing IL-12 in DNA/MVA schemes produced the best results in terms of improvements of T-cell-response key properties such as breadth, cross-reactivity and quality (avidity and pattern of cytokines secreted). These relevant results contribute to the design of strategies aimed to induce T-cell responses against HIV antigens with higher quality.	[Maria Rodriguez, Ana; Fernanda Pascutti, Maria; Maeto, Cynthia; Falivene, Juliana; Pia Holgado, Maria; Turk, Gabriela; Magdalena Gherardi, Maria] Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina	University of Buenos Aires	Rodriguez, AM (corresponding author), Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar		Pascutti, Maria Fernanda/0000-0003-3212-780X; Falivene, Juliana/0000-0003-3437-4863	Argentinean National Research Council (CONICET); ANPCYT [0459]; Spain Agency for International Cooperation for Development [A/031560/10]; Argentinean Agency for the Promotion of Science and Technology (ANPCyT)	Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCYT(ANPCyT); Spain Agency for International Cooperation for Development; Argentinean Agency for the Promotion of Science and Technology (ANPCyT)(ANPCyT)	AMR was supported by the Argentinean Agency for the Promotion of Science and Technology (ANPCyT) and the Argentinean National Research Council (CONICET). This study has been funded by ANPCYT grant 0459 and Spain Agency for International Cooperation for Development grant A/031560/10 to MMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Ahlers JD, 1997, J IMMUNOL, V158, P3947; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; [Anonymous], UNAIDS GLOB HIV AIDS; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Battig P, 2005, MICROBES INFECT, V7, P729, DOI 10.1016/j.micinf.2005.01.014; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brave Andreas, 2007, Infect Agent Cancer, V2, P14, DOI 10.1186/1750-9378-2-14; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Currier JR, 2002, J VIROL, V76, P4971, DOI 10.1128/JVI.76.10.4971-4986.2002; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; DALLO S, 1987, VIROLOGY, V159, P408, DOI 10.1016/0042-6822(87)90480-6; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; De Rose R, 2005, VACCINE, V23, P1949, DOI 10.1016/j.vaccine.2004.10.012; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Erfle V, 2005, MICROBES INFECT, V7, P1400, DOI 10.1016/j.micinf.2005.07.015; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Gherardi MM, 2003, J VIROL, V77, P7048, DOI 10.1128/JVI.77.12.7048-7057.2003; Gherardi MM, 2000, J VIROL, V74, P6278, DOI 10.1128/JVI.74.14.6278-6286.2000; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez-Carrillo M, 2006, AIDS RES HUM RETROV, V22, P1186, DOI 10.1089/aid.2006.22.1186; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; Hinkula J, 1997, J VIROL, V71, P5528, DOI 10.1128/JVI.71.7.5528-5539.1997; Hoffmann Christian, 2007, HIV MED; Institute of Laboratory Animal Resources CoLSNRC, 1996, GUID CAR US LAB AN; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Majumder B, 2003, IMMUNOL LETT, V89, P207, DOI 10.1016/S0165-2478(03)00141-X; Rodriguez AM, 2010, MEDICINA-BUENOS AIRE, V70, P543; Markiewicz MA, 2009, J IMMUNOL, V182, P1351, DOI 10.4049/jimmunol.182.3.1351; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Ministerio de Salud PdlN, 2008, B VIH SIDA ARG; Monaco DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017185; Morrow MP, 2008, AIDS, V22, P333, DOI 10.1097/QAD.0b013e3282f42461; Okada E, 1997, J IMMUNOL, V159, P3638; Pando MA, 2008, J MED MICROBIOL, V57, P190, DOI 10.1099/jmm.0.47492-0; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Van der Ryst E, 1998, RES VIROLOGY, V149, P5, DOI 10.1016/S0923-2516(97)86896-3; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; Zimra R, 2002, CLIN APPL IMMUNOLOGY, V2, P32	63	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37801	10.1371/journal.pone.0037801	http://dx.doi.org/10.1371/journal.pone.0037801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655069	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900045
J	Yamamoto, DJ; Zahniser, NR				Yamamoto, Dorothy J.; Zahniser, Nancy R.			Differences in Rat Dorsal Striatal NMDA and AMPA Receptors following Acute and Repeated Cocaine-Induced Locomotor Activation	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; SELF-ADMINISTER COCAINE; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; INDIVIDUAL-DIFFERENCES; PSYCHOMOTOR STIMULANTS; DOPAMINE TRANSPORTER; IMPULSIVITY PREDICTS; DRUG-ADDICTION; PHOSPHORYLATION	Sprague-Dawley rats can be classified as low or high cocaine responders (LCRs or HCRs, respectively) based on their locomotor activity induced by an acute low dose of cocaine. Upon repeated cocaine exposure, LCRs display greater locomotor sensitization, reward, and reinforcement than HCRs. Altered glutamate receptor expression in the brain reward pathway has been linked to locomotor sensitization and addiction. To determine if such changes contribute to the differential development of locomotor sensitization, we examined protein levels of total, phosphorylated, and cell surface glutamate N-methyl D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors (Rs) following acute or repeated cocaine (10 mg/kg, i.p.) in LCRs, HCRs and saline controls. Three areas involved in the development and expression of locomotor sensitization were investigated: the ventral tegmental area (VTA), nucleus accumbens (NAc) and dorsal striatum (dSTR). Our results revealed differences only in the dSTR, where we found that after acute cocaine, GluN2B(Tyr-1472) phosphorylation was significantly greater in LCRs, compared to HCRs and controls. Additionally in dSTR, after repeated cocaine, we observed significant increases in total GluA1, phosphorylated GluA1(Ser-845), and cell surface GluA1 in all cocaine-treated animals vs. controls. The acute cocaine-induced increases in NMDARs in dSTR of LCRs may help to explain the more ready development of locomotor sensitization and susceptibility to addiction-like behaviors in rats that initially exhibit little or no cocaine-induced activation, whereas the AMPAR increases after repeated cocaine may relate to recruitment of more dorsal striatal circuits and maintenance of the marked cocaine-induced locomotor activation observed in all of the rats.	[Yamamoto, Dorothy J.; Zahniser, Nancy R.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Pharmacol, Aurora, CO USA; [Zahniser, Nancy R.] Univ Colorado Anschutz Med Campus, Sch Med, Neurosci Program, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Yamamoto, DJ (corresponding author), Univ Colorado Anschutz Med Campus, Sch Med, Dept Pharmacol, Aurora, CO USA.	dorothy.yamamoto@ucdenver.edu			NIH [DA027277, DA015050, DA004216]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA027277, R37DA004216, K05DA015050, R01DA004216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by NIH grants DA027277 (DJY), DA015050 and DA004216 (NRZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2007, PHARMACOL BIOCHEM BE, V86, P37, DOI 10.1016/j.pbb.2006.12.005; Amen SL, 2011, NEUROPSYCHOPHARMACOL, V36, P871, DOI 10.1038/npp.2010.226; Anker JJ, 2009, PHARMACOL BIOCHEM BE, V93, P343, DOI 10.1016/j.pbb.2009.05.013; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Boudreau AC, 2009, J NEUROCHEM, V110, P363, DOI 10.1111/j.1471-4159.2009.06140.x; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ferrario CR, 2011, SYNAPSE, V65, P54, DOI 10.1002/syn.20823; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Gulley JM, 2003, NEUROPSYCHOPHARMACOL, V28, P2089, DOI 10.1038/sj.npp.1300279; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim M, 2009, BIOCHEM BIOPH RES CO, V379, P65, DOI 10.1016/j.bbrc.2008.12.003; Kim SM, 2009, NEUROSCIENCE, V163, P618, DOI 10.1016/j.neuroscience.2009.06.054; Klein DA, 2009, BEHAV PHARMACOL, V20, P67, DOI 10.1097/FBP.0b013e3283242fdd; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mandt B, 2008, PSYCHOPHARMACOLOGY, V201, P195, DOI 10.1007/s00213-008-1265-x; Mandt BH, 2010, NEUROPHARMACOLOGY, V58, P605, DOI 10.1016/j.neuropharm.2009.11.015; Nelson AM, 2009, J PHARMACOL EXP THER, V331, P985, DOI 10.1124/jpet.109.159897; Pascoli V, 2011, BIOL PSYCHIAT, V69, P218, DOI 10.1016/j.biopsych.2010.08.031; Philibin SD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00060; Pierce RC, 1996, J NEUROSCI, V16, P1550; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Sabeti J, 2002, J PHARMACOL EXP THER, V302, P1201, DOI 10.1124/jpet.102.035816; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Schumann J, 2009, J NEUROSCI, V29, P6955, DOI 10.1523/JNEUROSCI.1329-09.2009; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Walker QD, 2009, PHARMACOL BIOCHEM BE, V91, P398, DOI 10.1016/j.pbb.2008.08.019; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006	46	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37673	10.1371/journal.pone.0037673	http://dx.doi.org/10.1371/journal.pone.0037673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655064	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900040
J	Hamilton, JJ; Reed, JL				Hamilton, Joshua J.; Reed, Jennifer L.			Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models	PLOS ONE			English	Article							PROTEIN SYNTHASE-III; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; SCALE RECONSTRUCTION; KNOCKOUT STRATEGIES; ACID; BIOSYNTHESIS; FRAMEWORK	Genome-scale network reconstructions are useful tools for understanding cellular metabolism, and comparisons of such reconstructions can provide insight into metabolic differences between organisms. Recent efforts toward comparing genome-scale models have focused primarily on aligning metabolic networks at the reaction level and then looking at differences and similarities in reaction and gene content. However, these reaction comparison approaches are time-consuming and do not identify the effect network differences have on the functional states of the network. We have developed a bilevel mixed-integer programming approach, CONGA, to identify functional differences between metabolic networks by comparing network reconstructions aligned at the gene level. We first identify orthologous genes across two reconstructions and then use CONGA to identify conditions under which differences in gene content give rise to differences in metabolic capabilities. By seeking genes whose deletion in one or both models disproportionately changes flux through a selected reaction (e. g., growth or by-product secretion) in one model over another, we are able to identify structural metabolic network differences enabling unique metabolic capabilities. Using CONGA, we explore functional differences between two metabolic reconstructions of Escherichia coli and identify a set of reactions responsible for chemical production differences between the two models. We also use this approach to aid in the development of a genome-scale model of Synechococcus sp. PCC 7002. Finally, we propose potential antimicrobial targets in Mycobacterium tuberculosis and Staphylococcus aureus based on differences in their metabolic capabilities. Through these examples, we demonstrate that a gene-centric approach to comparing metabolic networks allows for a rapid comparison of metabolic models at a functional level. Using CONGA, we can identify differences in reaction and gene content which give rise to different functional predictions. Because CONGA provides a general framework, it can be applied to find functional differences across models and biological systems beyond those presented here.	[Hamilton, Joshua J.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Hamilton, JJ (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	reed@engr.wisc.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220; Hamilton, Joshua/0000-0001-9790-3609	Genomic Science Program (GSP); Office of Biological and Environmental Research (OBER); United States Department of Energy; Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0718123]	Genomic Science Program (GSP); Office of Biological and Environmental Research (OBER)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	The research was supported in part by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), United States Department of Energy, and is a contribution of the PNNL Biofuels Scientific Focus Area. JJH also received support from the Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship, and through a National Science Foundation Graduate Research Fellowship under grant no. DGE-0718123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blanchard JS, 1996, ANNU REV BIOCHEM, V65, P215, DOI 10.1146/annurev.bi.65.070196.001243; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Ferris MC, 2008, LINEAR PROGRAMMING M; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Fu PC, 2009, J CHEM TECHNOL BIOT, V84, P473, DOI 10.1002/jctb.2065; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; He X, 2002, ANTIMICROB AGENTS CH, V46, P1310, DOI 10.1128/AAC.46.5.1310-1318.2002; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024162; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kumar VS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-28; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156; MURATA N, 1995, BIOCHEM J, V308, P1; Neres J, 2008, J MED CHEM, V51, P5349, DOI 10.1021/jm800567v; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nie Z, 2005, J MED CHEM, V48, P1596, DOI 10.1021/jm049141s; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sakamoto T, 1998, ARCH MICROBIOL, V169, P20; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Sun J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-174; Sun J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-15; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Vu T, PLOS COMPUT IN PRESS; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Williams H.P., 1999, MODEL BUILDING MATH, V4th; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Yang L, 2011, METAB ENG, V13, P272, DOI 10.1016/j.ymben.2011.03.002; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	77	30	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34670	10.1371/journal.pone.0034670	http://dx.doi.org/10.1371/journal.pone.0034670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22666308	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000024
J	Illeghems, K; De Vuyst, L; Papalexandratou, Z; Weckx, S				Illeghems, Koen; De Vuyst, Luc; Papalexandratou, Zoi; Weckx, Stefan			Phylogenetic Analysis of a Spontaneous Cocoa Bean Fermentation Metagenome Reveals New Insights into Its Bacterial and Fungal Community Diversity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; RIBOSOMAL-RNA; STARTER CULTURE; TAXONOMIC CLASSIFICATION; HEAP FERMENTATION; SPECIES-DIVERSITY; GHANAIAN; POPULATIONS; SEQUENCES; CHOCOLATE	This is the first report on the phylogenetic analysis of the community diversity of a single spontaneous cocoa bean box fermentation sample through a metagenomic approach involving 454 pyrosequencing. Several sequence-based and composition-based taxonomic profiling tools were used and evaluated to avoid software-dependent results and their outcome was validated by comparison with previously obtained culture-dependent and culture-independent data. Overall, this approach revealed a wider bacterial (mainly gamma-Proteobacteria) and fungal diversity than previously found. Further, the use of a combination of different classification methods, in a software-independent way, helped to understand the actual composition of the microbial ecosystem under study. In addition, bacteriophage-related sequences were found. The bacterial diversity depended partially on the methods used, as composition-based methods predicted a wider diversity than sequence-based methods, and as classification methods based solely on phylogenetic marker genes predicted a more restricted diversity compared with methods that took all reads into account. The metagenomic sequencing analysis identified Hanseniaspora uvarum, Hanseniaspora opuntiae, Saccharomyces cerevisiae, Lactobacillus fermentum, and Acetobacter pasteurianus as the prevailing species. Also, the presence of occasional members of the cocoa bean fermentation process was revealed (such as Erwinia tasmaniensis, Lactobacillus brevis, Lactobacillus casei, Lactobacillus rhamnosus, Lactococcus lactis, Leuconostoc mesenteroides, and Oenococcus oeni). Furthermore, the sequence reads associated with viral communities were of a restricted diversity, dominated by Myoviridae and Siphoviridae, and reflecting Lactobacillus as the dominant host. To conclude, an accurate overview of all members of a cocoa bean fermentation process sample was revealed, indicating the superiority of metagenomic sequencing over previously used techniques.	[Illeghems, Koen; De Vuyst, Luc; Papalexandratou, Zoi; Weckx, Stefan] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol IMDO, Brussels, Belgium	Vrije Universiteit Brussel	Illeghems, K (corresponding author), Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol IMDO, Brussels, Belgium.	Stefan.Weckx@vub.ac.be	Weckx, Stefan/AAF-8996-2019; Weckx, Stefan/J-4254-2014; Weckx, Stefan/ABB-5390-2021	Weckx, Stefan/0000-0002-1380-8610; De Vuyst, Luc/0000-0002-7534-7186	Research Council of the Vrije Universiteit Brussel; Research Foundation Flanders (FWO) [1.5.108.09N]; Titanium FLX-award of the Flanders Institute for Biotechnology (VIB); Roche Diagnostics Belgium; Agency for Innovation by Science and Technology (IWT)	Research Council of the Vrije Universiteit Brussel; Research Foundation Flanders (FWO)(FWO); Titanium FLX-award of the Flanders Institute for Biotechnology (VIB); Roche Diagnostics Belgium; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was financed by the Research Council of the Vrije Universiteit Brussel, the Research Foundation Flanders (FWO; project number 1.5.108.09N) and a Titanium FLX-award of the Flanders Institute for Biotechnology (VIB) and Roche Diagnostics Belgium. KI is the receiver of a post-graduate Grant of the Agency for Innovation by Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Afoakwa E.O., 2010, CHOCOLATE SCI TECHNO; Afoakwa EO, 2008, CRIT REV FOOD SCI, V48, P840, DOI 10.1080/10408390701719272; Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Ardhana MM, 2003, INT J FOOD MICROBIOL, V86, P87, DOI 10.1016/S0168-1605(03)00081-3; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Becket ST, 2009, IND CHOCOLATE MANUFA; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Camu N, 2008, APPL ENVIRON MICROB, V74, P86, DOI 10.1128/AEM.01512-07; Camu N, 2007, APPL ENVIRON MICROB, V73, P1809, DOI 10.1128/AEM.02189-06; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Carr J. G., 1979, 7 INT COC RES C DOUA, V4, P573; Daniel HM, 2009, FEMS YEAST RES, V9, P774, DOI 10.1111/j.1567-1364.2009.00520.x; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Vuyst L., 2010, BIOTECHNOLOGY LACTIC, P301, DOI DOI 10.1002/9780813820866.CH17; De Vuyst L., 2010, P 16 INT COC RES C N, P1325; Devriese LA, 2002, J APPL MICROBIOL, V92, P821, DOI 10.1046/j.1365-2672.2002.01586.x; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Dobson A, 2011, FEMS MICROBIOL LETT, V320, P56, DOI 10.1111/j.1574-6968.2011.02290.x; Emond Eric, 2007, P93; Finn R. D., 2008, NUCLEIC ACIDS RES, V38, pD211; Galvez SL, 2007, INT J FOOD MICROBIOL, V114, P124, DOI 10.1016/j.ijfoodmicro.2006.10.041; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Giraffa G, 2001, INT J FOOD MICROBIOL, V67, P19, DOI 10.1016/S0168-1605(01)00445-7; Hansen CE, 1998, J SCI FOOD AGR, V77, P273, DOI [10.1002/(SICI)1097-0010(199806)77:2&lt;273::AID-JSFA40&gt;3.0.CO;2-M, 10.1002/(SICI)1097-0010(199806)77:2<273::AID-JSFA40>3.3.CO;2-D]; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunt J, 2004, MICROB ECOL, V47, P385, DOI 10.1007/s00248-003-2018-3; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jespersen L, 2005, FEMS YEAST RES, V5, P441, DOI 10.1016/j.femsyr.2004.11.002; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Kobayashi M, 1998, J FERMENT BIOENG, V85, P642, DOI 10.1016/S0922-338X(98)80021-4; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kostinek M, 2008, CURR MICROBIOL, V56, P306, DOI 10.1007/s00284-008-9097-9; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lefeber T, 2012, FOOD MICROBIOL, V30, P379, DOI 10.1016/j.fm.2011.12.021; Lefeber T, 2011, APPL ENVIRON MICROB, V77, P6694, DOI 10.1128/AEM.00594-11; Lefeber T, 2011, FOOD MICROBIOL, V28, P457, DOI 10.1016/j.fm.2010.10.010; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima LJR, 2011, CRIT REV FOOD SCI, V51, P731, DOI 10.1080/10408391003799913; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Nielsen DS, 2007, INT J FOOD MICROBIOL, V114, P168, DOI 10.1016/j.ijfoodmicro.2006.09.010; Nielsen DS, 2007, INT J SYST EVOL MICR, V57, P1468, DOI 10.1099/ijs.0.64811-0; Nielsen DS, 2005, YEAST, V22, P271, DOI 10.1002/yea.1207; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Papalexandratou Z, 2011, APPL ENVIRON MICROB, V77, P7698, DOI 10.1128/AEM.05523-11; Papalexandratou Z, 2011, FEMS YEAST RES, V11, P564, DOI 10.1111/j.1567-1364.2011.00747.x; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P1326, DOI 10.1016/j.fm.2011.06.003; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P964, DOI 10.1016/j.fm.2011.01.010; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; PASSOS FML, 1984, J FOOD SCI, V49, P205, DOI 10.1111/j.1365-2621.1984.tb13708.x; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Schwan RF, 1998, APPL ENVIRON MICROB, V64, P1477; Schwan RF, 2004, CRIT REV FOOD SCI, V44, P205, DOI 10.1080/10408690490464104; Shapiro OH, 2010, ISME J, V4, P327, DOI 10.1038/ismej.2009.118; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Thompson SS, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P837; Villion M, 2009, FRONT BIOSCI-LANDMRK, V14, P1661, DOI 10.2741/3332; WOOD G. A. R., 2001, COCOA	77	81	87	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38040	10.1371/journal.pone.0038040	http://dx.doi.org/10.1371/journal.pone.0038040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666442	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349600058
J	Janic, B; Jafari-Khouzani, K; Babajani-Feremi, A; Iskander, ASM; Varma, NRS; Ali, MM; Knight, RA; Arbab, AS				Janic, Branislava; Jafari-Khouzani, Kourosh; Babajani-Feremi, Abbas; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Ali, Meser M.; Knight, Robert A.; Arbab, Ali S.			MRI Tracking of FePro Labeled Fresh and Cryopreserved Long Term In Vitro Expanded Human Cord Blood AC133+Endothelial Progenitor Cells in Rat Glioma	PLOS ONE			English	Article							CIRCULATING ENDOTHELIAL-CELLS; STEM-CELL; HEMATOPOIETIC STEM; AC133+PROGENITOR CELLS; GROWTH-FACTOR; VIVO; ANGIOGENESIS; TRAFFICKING; DIFFERENTIATION; NEOVASCULARIZATION	Background: Endothelial progenitors cells (EPCs) are important for the development of cell therapies for various diseases. However, the major obstacles in developing such therapies are low quantities of EPCs that can be generated from the patient and the lack of adequate non-invasive imaging approach for in vivo monitoring of transplanted cells. The objective of this project was to determine the ability of cord blood (CB) AC133+ EPCs to differentiate, in vitro and in vivo, toward mature endothelial cells (ECs) after long term in vitro expansion and cryopreservation and to use magnetic resonance imaging (MRI) to assess the in vivo migratory potential of ex vivo expanded and cryopreserved CB AC133+ EPCs in an orthotopic glioma rat model. Materials, Methods and Results: The primary CB AC133+ EPC culture contained mainly EPCs and long term in vitro conditions facilitated the maintenance of these cells in a state of commitment toward endothelial lineage. At days 15-20 and 25-30 of the primary culture, the cells were labeled with FePro and cryopreserved for a few weeks. Cryopreserved cells were thawed and in vitro differentiated or IV administered to glioma bearing rats. Different groups of rats also received long-term cultured, magnetically labeled fresh EPCs and both groups of animals underwent MRI 7 days after IV administration of EPCs. Fluorescent microscopy showed that in vitro differentiation of EPCs was not affected by FePro labeling and cryopreservation. MRI analysis demonstrated that in vivo accumulation of previously cryopreserved transplanted cells resulted in significantly higher R2 and R2* values indicating a higher rate of migration and incorporation into tumor neovascularization of previously cryopreserved CB AC133+ EPCs to glioma sites, compared to non-cryopreserved cells. Conclusion: Magnetically labeled CB EPCs can be in vitro expanded and cryopreserved for future use as MRI probes for monitoring the migration and incorporation to the sites of neovascularization.	[Janic, Branislava; Jafari-Khouzani, Kourosh; Babajani-Feremi, Abbas; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Ali, Meser M.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Jafari-Khouzani, Kourosh] Harvard Univ, Sch Med, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Massachus, Boston, MA 02115 USA; [Knight, Robert A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Harvard University; Harvard Medical School; Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		AHA [09SDG2230011];  [R01 CA 122031];  [K25 CA 129173-01A2];  [R21 NS 055143-01]; NATIONAL CANCER INSTITUTE [R01CA122031, K25CA129173, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066143, R01NS055143] Funding Source: NIH RePORTER	AHA(American Heart Association); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: R01 CA 122031, K25 CA 129173-01A2, http://www.cancer.gov/; R21 NS 055143-01, http://www.ninds.nih.gov/; and AHA 09SDG2230011, http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar S, 2010, TRANSFUSION, V50, P2402, DOI 10.1111/j.1537-2995.2010.02743.x; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; Bhattacharya V, 2000, BLOOD, V95, P581, DOI 10.1182/blood.V95.2.581; Bonanno G, 2007, TRANSFUSION, V47, P280, DOI 10.1111/j.1537-2995.2007.01104.x; Broxmeyer H.E., 2008, CORD BLOOD HEMATOPOI; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; Dong Chunming, 2007, J Interv Cardiol, V20, P93, DOI 10.1111/j.1540-8183.2007.00251.x; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Fibbe WE, 2001, ANN NY ACAD SCI, V938, P9; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Gammaitoni L, 2004, BLOOD, V103, P4440, DOI 10.1182/blood-2003-09-3079; Gehling UM, 2000, BLOOD, V95, P3106; Goldberg JL, 2007, J MOL CELL CARDIOL, V42, P912, DOI 10.1016/j.yjmcc.2007.02.005; Gross P, 2004, Rocz Akad Med Bialymst, V49, P174; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HLADOVEC J, 1978, KLIN WOCHENSCHR, V56, P1033, DOI 10.1007/BF01476669; HLADOVEC J, 1978, PHYSIOL BOHEMOSLOV, V27, P140; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Hur J, 2007, STEM CELLS, V25, P1769, DOI 10.1634/stemcells.2006-0385; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Katayama Y, 1997, BONE MARROW TRANSPL, V19, P283, DOI 10.1038/sj.bmt.1700644; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kuci S, 2008, CELL PROLIFERAT, V41, P12, DOI 10.1111/j.1365-2184.2007.00502.x; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Ma Gang, 2008, Zhonghua Zheng Xing Wai Ke Za Zhi, V24, P144; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Navarro-Sobrino M, 2010, MICROVASCUL IN PRESS; Rad AM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-28; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Richardson MR, 2010, J MOL CELL CARDIOL; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025; SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3; Senegaglia AC, 2008, REV BRAS CIR CARDIOV, V23, P467, DOI 10.1590/S0102-76382008000400003; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; SOWEMIMOCOKER SO, 1989, AM J HEMATOL, V31, P263, DOI 10.1002/ajh.2830310409; Sputtek A, 2001, ANASTH INTENSIV NOTF, V36, pS162; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; TIMMERMANS F, 2008, J CELL MOL MED; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Varma NRS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030310; Watt SM, 2005, SEMIN FETAL NEONAT M, V10, P209, DOI 10.1016/j.siny.2005.02.001; Watt SM, 2010, J R SOC INTERFACE, V7, pS731, DOI [10.1098/rsif.2010.0377.focus, 10.1098/rsif.2010.0377.focas]; Werner C, 2008, BIOCHEM BIOPH RES CO, V377, P331, DOI 10.1016/j.bbrc.2008.09.081; Woods EJ, 2007, TRANSFUS MED HEMOTH, V34, P276, DOI 10.1159/000104183; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Yokomuro H, 2010, ANN THORAC CARDIOVAS, V16, P105; Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004; Zeisberger SM, 2010, CELL TRANSPLANT	72	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37577	10.1371/journal.pone.0037577	http://dx.doi.org/10.1371/journal.pone.0037577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662174	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300064
J	Kautz, S; Ballhorn, DJ; Kroiss, J; Pauls, SU; Moreau, CS; Eilmus, S; Strohm, E; Heil, M				Kautz, Stefanie; Ballhorn, Daniel J.; Kroiss, Johannes; Pauls, Steffen U.; Moreau, Corrie S.; Eilmus, Sascha; Strohm, Erhard; Heil, Martin			Host Plant Use by Competing Acacia-Ants: Mutualists Monopolize While Parasites Share Hosts	PLOS ONE			English	Article							INTRASPECIFIC AGGRESSION; MICROSATELLITE LOCI; SOFTWARE; SPECIALIZATION; COEXISTENCE; PATTERNS; NECTAR	Protective ant-plant mutualisms that are exploited by non-defending parasitic ants represent prominent model systems for ecology and evolutionary biology. The mutualist Pseudomyrmex ferrugineus is an obligate plant-ant and fully depends on acacias for nesting space and food. The parasite Pseudomyrmex gracilis facultatively nests on acacias and uses host-derived food rewards but also external food sources. Integrative analyses of genetic microsatellite data, cuticular hydrocarbons and behavioral assays showed that an individual acacia might be inhabited by the workers of several P. gracilis queens, whereas one P. ferrugineus colony monopolizes one or more host trees. Despite these differences in social organization, neither of the species exhibited aggressive behavior among conspecific workers sharing a tree regardless of their relatedness. This lack of aggression corresponds to the high similarity of cuticular hydrocarbon profiles among ants living on the same tree. Host sharing by unrelated colonies, or the presence of several queens in a single colony are discussed as strategies by which parasite colonies could achieve the observed social organization. We argue that in ecological terms, the non-aggressive behavior of non-sibling P. gracilis workers - regardless of the route to achieve this social structure - enables this species to efficiently occupy and exploit a host plant. By contrast, single large and long-lived colonies of the mutualist P. ferrugineus monopolize individual host plants and defend them aggressively against invaders from other trees. Our findings highlight the necessity for using several methods in combination to fully understand how differing life history strategies affect social organization in ants.	[Kautz, Stefanie; Ballhorn, Daniel J.; Eilmus, Sascha; Heil, Martin] Univ Duisburg Essen, Dept Gen Bot, FB BioGeo, Essen, Germany; [Kautz, Stefanie; Moreau, Corrie S.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Ballhorn, Daniel J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Kroiss, Johannes; Strohm, Erhard] Univ Regensburg, Dept Zool, Regensburg, Germany; [Kroiss, Johannes] Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany; [Pauls, Steffen U.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Pauls, Steffen U.] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Heil, Martin] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico	University of Duisburg Essen; Field Museum of Natural History (Chicago); Portland State University; University of Regensburg; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Kautz, S (corresponding author), Univ Duisburg Essen, Dept Gen Bot, FB BioGeo, Essen, Germany.	skautz@fieldmuseum.org	Pauls, Steffen U/C-2192-2011; Heil, Martin/AAC-2730-2022; Heil, Martin/I-1797-2012; Heil, Martin/T-3960-2019	Heil, Martin/0000-0001-8036-8697; Moreau, Corrie/0000-0003-1139-5792; Pauls, Steffen/0000-0002-6451-3425	Deutsche Forschungsgemeinschaft (DFG) [He 3169/4-2, Ba 3966/1-1]; Universitat Duisburg-Essen; DAAD; German Academy of Sciences Leopoldina [LPDS 2009-29, BMBF-LPD 9901/8-169]; Portland State University; 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Universitat Duisburg-Essen; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Academy of Sciences Leopoldina; Portland State University; 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG) (grant He 3169/4-2) and the Universitat Duisburg-Essen. The molecular work of this study was conducted in the Pritzker Laboratory of Molecular Systematics and Evolution at the Field Museum of Natural History in Chicago. Dr. Kautz gratefully acknowledges financial support from the DAAD and the German Academy of Sciences Leopoldina (grant LPDS 2009-29), Dr. Ballhorn from the DFG (grant Ba 3966/1-1) and start-up funds from Portland State University, Dr. Pauls from the German Academy of Sciences Leopoldina (grant BMBF-LPD 9901/8-169) and the research funding program 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Buckley R.C., 1982, Geobotany, V4, P111; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Clement Lars W, 2008, Behav Ecol Sociobiol, V62, P953; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; Dalecky A, 2007, EVOLUTION, V61, P579, DOI 10.1111/j.1558-5646.2007.00044.x; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Debout GDG, 2009, OIKOS, V118, P873, DOI 10.1111/j.1600-0706.2009.16317.x; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feldhaar H, 2005, INSECT SOC, V52, P222, DOI 10.1007/s00040-004-0797-2; Fiala B, 1996, DIPTEROCARP FOREST E, P102; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gonzalez-Teuber M, 2009, PLANT J, V58, P464, DOI 10.1111/j.1365-313X.2009.03790.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2010, CHEMOECOLOGY, V20, P63, DOI 10.1007/s00049-009-0036-4; Heil M, 2009, P NATL ACAD SCI USA, V106, P18091, DOI 10.1073/pnas.0904304106; Heinze Juergen, 2008, Myrmecological News, V11, P9; Holldobler B., 1990, pi; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Izzo TJ, 2009, INSECT SOC, V56, P341, DOI 10.1007/s00040-009-0029-x; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; JANZEN DH, 1973, J ANIM ECOL, V42, P727, DOI 10.2307/3134; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Janzen DH, 1974, SWOLLEN THORN ACACIA; Kautz S, 2009, MOL ECOL, V18, P5180, DOI 10.1111/j.1365-294X.2009.04395.x; Kautz S, 2009, MOL ECOL RESOUR, V9, P1016, DOI 10.1111/j.1755-0998.2009.02569.x; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Longino JT, 2006, ZOOTAXA, P1; Peng RK, 1998, AUST J ENTOMOL, V37, P249, DOI 10.1111/j.1440-6055.1998.tb01579.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; PROVOST E, 1991, BEHAV GENET, V21, P151, DOI 10.1007/BF01066333; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Schmid VS, 2009, MOL ECOL RESOUR, V9, P1150, DOI 10.1111/j.1755-0998.2009.02590.x; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; TALBOT CC, 1995, HUM MOL GENET, V4, P1193, DOI 10.1093/hmg/4.7.1193; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; Vander Meer Robert K., 1998, P79; VASCONCELOS HL, 1993, OECOLOGIA, V95, P439, DOI 10.1007/BF00321000; Vasquez GM, 2008, ANIM BEHAV, V75, P583, DOI 10.1016/j.anbehav.2007.06.019; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Ward Philip S., 1993, Journal of Hymenoptera Research, V2, P117; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]	51	11	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37691	10.1371/journal.pone.0037691	http://dx.doi.org/10.1371/journal.pone.0037691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662191	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300081
J	Qiu, J; Yang, R; Rao, YH; Du, YK; Kalembo, FW				Qiu, Jun; Yang, Rong; Rao, Yanhua; Du, Yukai; Kalembo, Fatch W.			Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HEALTH; WEIGHT; NURSES; CELLS; GAIN; GENE	Purpose: The purpose of this study was to explore the risk factors for breast cancer and establish the expression rate of IGF-2 in female patients. Methods: A case control study with 500 people in case group and 500 people in control group. A self-administered questionnaire was used to investigate risk factors for breast cancer. All cases were interviewed during a household survey. Immune-histochemical method was used to inspect the expression of IGF-2 in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue). Results: Multivariate adjusted odds ratios and 95% confidence intervals were calculated using unconditional logistic regression. High body mass index (OR = 1.012,95% CI = 1.008-1.016), working attributes (OR = 1.004, 95% CI = 1.002 = 1.006), long menstrual period (OR = 1.007, 95% CI = 1.005-1.009), high parity OR = 1.003, 95% CI = 1.001-1.005), frequent artificial abortion (OR = 1.004, 95% CI = 1.001-1.005), family history of cancer (OR = 1.003, 95% CI = 1.000-1.005), period of night shift (OR = 1.003, 95% CI = 1.001-1.006), live in high risk environment (OR = 1.005, 95% CI = 1.002-1.008), and family problems (OR = 1.010, 95% CI = 1.005-1.014) were associated with increased risk for breast cancer. In this study, good sleeping status, positive coping strategies, subjective support, and utility degree of social support were associated with reduced risk for breast cancer (OR = 0.998, 0.997, 0.985, 0.998 respectively; 95% CI = 0.996-1.000, 0.994-1.000, 0.980-0.989, 0.996-1.000, respectively). In benign breast lesions, breast cancer and tumor-adjacent tissue, IGF-2 was mainly expressed in the cytoplasm, but its expression rate was different (p < 0.05). Conclusions: The incidence of breast cancer is a common result of multiple factors. IGF-2 is involved in the development of breast cancer, and its expression varies in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue).	[Qiu, Jun; Du, Yukai; Kalembo, Fatch W.] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Rong] Ctr Wuhan City Maternal & Child Hlth Care, Qiaokou, Peoples R China	Huazhong University of Science & Technology	Qiu, J (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	duyukai100@yahoo.com.cn		Kalembo, Fatch W./0000-0003-3032-3495	Huazhong University of Science and Technology	Huazhong University of Science and Technology	Huazhong University of Science and Technology funded the research study (http://english.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer: Breast, 1980, HDB STAG CANC; De Myets P, 1994, DIABETOLOG, V37, pS135; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giani C, 2002, INT J BIOL MARKER, V17, P90, DOI 10.1177/172460080201700203; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hankinson Susan E, 2003, Breast Dis, V17, P27; Harvie M, 2005, CANCER EPIDEM BIOMAR, V14, P656, DOI 10.1158/1055-9965.EPI-04-0001; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kaaks R, 2001, Gynecol Obstet Fertil, V29, P185; Kang HJ, 2002, CANCER LETT, V178, P175, DOI 10.1016/S0304-3835(01)00861-8; Kotsopoulos J, 2005, CANCER CAUSE CONTROL, V16, P667, DOI 10.1007/s10552-005-1724-1; Kristensen VN, 2000, MUTAT RES-REV MUTAT, V462, P323, DOI 10.1016/S1383-5742(00)00018-1; LeRioth D, 2003, CANC LETT, V195, P127; Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2; Molloy CA, 2000, J BIOL CHEM, V275, P12565, DOI 10.1074/jbc.275.17.12565; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Muller S, 2000, EUR J CANCER, V36, P651, DOI 10.1016/S0959-8049(99)00328-7; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Richardson AE, 2011, GROWTH FACTORS, V29, P82, DOI 10.3109/08977194.2011.565003; ROSEN N, 1991, BREAST CANCER RES TR, V18, pS55, DOI 10.1007/BF02633529; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Shetty PJ, 2011, J CANCER RES CLIN, V137, P339, DOI 10.1007/s00432-010-0890-z; Soares MR, 2010, GROWTH HORM IGF RES, V20, P295, DOI 10.1016/j.ghir.2010.03.006; Turner-Cobb JM, 2000, PSYCHOSOM MED, V62, P337, DOI 10.1097/00006842-200005000-00007; Visual D, 2004, BREAST CANC RES TREA, V84, P225; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664	34	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36497	10.1371/journal.pone.0036497	http://dx.doi.org/10.1371/journal.pone.0036497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662119	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300012
J	Moreau, KL; King, JA				Moreau, Kate L.; King, Jonathan A.			Cataract-Causing Defect of a Mutant gamma-Crystallin Proceeds through an Aggregation Pathway Which Bypasses Recognition by the alpha-Crystallin Chaperone	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; B-CRYSTALLIN; IN-VITRO; DEAMIDATION DESTABILIZES; DIMER INTERFACE; A-CRYSTALLIN; STABILITY; SOLUBILITY	Background: The transparency of the eye lens depends upon maintenance of the native state of the gamma- and beta-crystallins, which is aided by the abundant chaperones alpha A-and alpha B-crystallin. Mature onset cataract, the leading cause of blindness worldwide, involves the polymerization of covalently damaged or partially unfolded crystallins into light-scattering aggregates. A number of single amino acid substitutions and truncations of gamma-crystallins result in congenital cataract in both humans and mice, though in many cases the coupling between the protein alterations and the accumulation of aggregates is poorly defined. Methodology/Principal Findings: We have studied the aggregation properties and chaperone interactions of human gamma D-crystallin carrying substitutions of two buried core mutants, I90F and V75D, which cause congenital cataract in mice. The in vitro aggregation pathway competing with productive refolding was not altered by either substitution. Furthermore, this aggregation pathway for both mutant proteins-originating from a partially folded intermediate-was efficiently suppressed by alpha B-crystallin. Thus the cataract pathology was unlikely to be associated with a direct folding defect. The native state of wild-type human gamma D-crystallin exhibited no tendency to aggregate under physiological conditions. However both I90F and V75D native-like proteins exhibited slow (days) aggregation to high molecular weight aggregates under physiological conditions. The perturbed conformation of I90F was recognized and bound by both alpha A and alpha B chaperones. In contrast, the aggregation derived from the perturbed state of V75D was not suppressed by either chaperone, and the aggregating species were not bound by the chaperone. Conclusions/Significance: The cataract phenotype of I90F in mice may be due to premature saturation of the finite alpha-crystallin pool. The V75D aggregation pathway and its escape from chaperone surveillance and aggregation suppression can account for the congenital cataract pathology of this mutant. Failure of chaperone recognition may be an important source of pathology for many other protein folding defects.	[Moreau, Kate L.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moreau, KL (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	jaking@mit.edu			National Eye Institute [EY015834]; National Institutes of Health [GM17980]; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Eye Institute grant EY015834 and a National Institutes of Health grant GM17980 to JAK. The funding websites are www.nih.gov and www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Banerjee PR, 2011, J MOL BIOL, V412, P647, DOI 10.1016/j.jmb.2011.07.058; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; CARTER JM, 1995, EXP EYE RES, V60, P181, DOI 10.1016/S0014-4835(95)80009-3; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Flaugh SL, 2006, FOLDING STABILITY AG; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; GOPALAKRISHNAN S, 1994, INVEST OPHTH VIS SCI, V35, P382; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Heys KR, 2007, AGING CELL, V6, P807, DOI 10.1111/j.1474-9726.2007.00342.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Kim YH, 2002, BIOCHEMISTRY-US, V41, P14076, DOI 10.1021/bi026288h; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2002, MOL VIS, V8, P359; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Mills-Henry I, 2007, STABILITY UNFOLDING; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Moran S. D., 2012, P NATL ACAD SCI US; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Rajaraman K, 2001, FEBS LETT, V497, P118, DOI 10.1016/S0014-5793(01)02451-6; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wang YZ, 2010, ECS TRANSACTIONS, V33, P487, DOI 10.1149/1.3481638; Wang YT, 2010, INVEST OPHTH VIS SCI, V51, P672, DOI 10.1167/iovs.09-3987; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020564	68	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37256	10.1371/journal.pone.0037256	http://dx.doi.org/10.1371/journal.pone.0037256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655036	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900011
J	Remot, A; Roux, X; Dubuquoy, C; Fix, J; Bouet, S; Moudjou, M; Eleouet, JF; Riffault, S; Petit-Camurdan, A				Remot, Aude; Roux, Xavier; Dubuquoy, Catherine; Fix, Jenna; Bouet, Stephan; Moudjou, Mohammed; Eleouet, Jean-Francois; Riffault, Sabine; Petit-Camurdan, Agnes			Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; T-CELL RESPONSES; DNA IMMUNIZATION; YOUNG-CHILDREN; INFECTION; MICE; IMMUNOPATHOLOGY; EOSINOPHILS; TH2; DISEASE	Background: The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide. The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when the immune system is prone to Th2 responses that may turn deleterious upon exposure to the virus. So far, the high risk to prime for immunopathological responses in infants has hampered the development of vaccine. In the present study we investigated the safety and efficacy of ring-nanostructures formed by the recombinant nucleoprotein N of hRSV (N-SRS) as a mucosal vaccine candidate against RSV in BALB/c neonates, which are highly sensitive to immunopathological Th2 imprinting. Methodology and Principal Findings: A single intranasal administration of N-SRS with detoxified E.coli enterotoxin LT(R192G) to 5-7 day old neonates provided a significant reduction of the viral load after an RSV challenge at five weeks of age. However, neonatal vaccination also generated an enhanced lung infiltration by neutrophils and eosinophils following the RSV challenge. Analysis of antibody subclasses and cytokines produced after an RSV challenge or a boost administration of the vaccine suggested that neonatal vaccination induced a Th2 biased local immune memory. This Th2 bias and the eosinophilic reaction could be prevented by adding CpG to the vaccine formulation, which, however did not prevent pulmonary inflammation and neutrophil infiltration upon viral challenge. Conclusions/Significance: In conclusion, protective vaccination against RSV can be achieved in neonates but requires an appropriate combination of adjuvants to prevent harmful Th2 imprinting.	[Remot, Aude; Roux, Xavier; Dubuquoy, Catherine; Fix, Jenna; Moudjou, Mohammed; Eleouet, Jean-Francois; Riffault, Sabine; Petit-Camurdan, Agnes] French Natl Inst Agr Res, Mol Virol & Immunol UR892, Jouy En Josas, France; [Bouet, Stephan] French Natl Inst Agr Res, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Remot, A (corresponding author), French Natl Inst Agr Res, Mol Virol & Immunol UR892, Jouy En Josas, France.	sabine.riffault@jouy.inra.fr	Eléouët, Jean-François/AAD-1994-2019	ELeouet, Jean-Francois/0000-0002-7361-4885; Remot, Aude/0000-0001-9896-3216; Tripp, Ralph/0000-0002-2924-9956	National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA)	National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA)	During her thesis Aude Remot was the recipient of a grant for young investigators by the National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios C, 1996, EUR J IMMUNOL, V26, P2666, DOI 10.1002/eji.1830261118; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Boxus M, 2007, J VIROL, V81, P6879, DOI 10.1128/JVI.00502-07; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; Cho JY, 2001, J ALLERGY CLIN IMMUN, V108, P697, DOI 10.1067/mai.2001.119918; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Cormier SA, 2010, EXPERT REV ANTI-INFE, V8, P1371, DOI [10.1586/eri.10.125, 10.1586/ERI.10.125]; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Dakhama A, 2005, J IMMUNOL, V175, P1876, DOI 10.4049/jimmunol.175.3.1876; Dakhama A, 2009, J ALLERGY CLIN IMMUN, V123, P138, DOI 10.1016/j.jaci.2008.10.012; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kovarik J, 1999, J IMMUNOL, V162, P1611; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Martinez X, 1999, EUR J IMMUNOL, V29, P3390, DOI 10.1002/(SICI)1521-4141(199910)29:10<3390::AID-IMMU3390>3.0.CO;2-A; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Pala P, 2002, EUR RESPIR J, V20, P376, DOI 10.1183/09031936.02.00249902; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Plotnicky H, 2003, VACCINE, V21, P2651, DOI 10.1016/S0264-410X(03)00055-0; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Riffault S, 2010, VACCINE, V28, P3722, DOI 10.1016/j.vaccine.2010.03.008; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Rosenberg HF, 2009, ANTIVIR RES, V83, P1, DOI 10.1016/j.antiviral.2009.04.005; Roux X, 2011, EUR J IMMUNOL, V41, P2852, DOI 10.1002/eji.201041224; Roux X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001766; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Simmons CP, 2001, J IMMUNOL, V166, P1106, DOI 10.4049/jimmunol.166.2.1106; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Tasker L, 2008, CLIN EXP IMMUNOL, V153, P277, DOI 10.1111/j.1365-2249.2008.03591.x; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tregoning JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009381; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; VanCott JL, 2006, J VIROL, V80, P4949, DOI 10.1128/JVI.80.10.4949-4961.2006; Vaughan K, 2005, VACCINE, V23, P2928, DOI 10.1016/j.vaccine.2004.10.046; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	55	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37722	10.1371/journal.pone.0037722	http://dx.doi.org/10.1371/journal.pone.0037722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655066	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900042
J	Cartelli, D; Goldwurm, S; Casagrande, F; Pezzoli, G; Cappelletti, G				Cartelli, Daniele; Goldwurm, Stefano; Casagrande, Francesca; Pezzoli, Gianni; Cappelletti, Graziella			Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson's Disease Patient Fibroblasts	PLOS ONE			English	Article							CELL-DEATH; DOPAMINERGIC-NEURONS; CLINICAL-DIAGNOSIS; FEATURES IMPROVE; G2019S MUTATION; ALPHA-SYNUCLEIN; TUBULIN; PROTEIN; LRRK2; NEURODEGENERATION	Data from both toxin-based and gene-based models suggest that dysfunction of the microtubule system contributes to the pathogenesis of Parkinson's disease, even if, at present, no evidence of alterations of microtubules in vivo or in patients is available. Here we analyze cytoskeleton organization in primary fibroblasts deriving from patients with idiopathic or genetic Parkinson's disease, focusing on mutations in parkin and leucine-rich repeat kinase 2. Our analyses reveal that genetic and likely idiopathic pathology affects cytoskeletal organization and stability, without any activation of autophagy or apoptosis. All parkinsonian fibroblasts have a reduced microtubule mass, represented by a higher fraction of unpolymerized tubulin in respect to control cells, and display significant changes in microtubule stability-related signaling pathways. Furthermore, we show that the reduction of microtubule mass is so closely related to the alteration of cell morphology and behavior that both pharmacological treatment with microtubule-targeted drugs, and genetic approaches, by transfecting the wild type parkin or leucine-rich repeat kinase 2, restore the proper microtubule stability and are able to rescue cell architecture. Taken together, our results suggest that microtubule destabilization is a point of convergence of genetic and idiopathic forms of parkinsonism and highlight, for the first time, that microtubule dysfunction occurs in patients and not only in experimental models of Parkinson's disease. Therefore, these data contribute to the knowledge on molecular and cellular events underlying Parkinson's disease and, revealing that correction of microtubule defects restores control phenotype, may offer a new therapeutic target for the management of the disease.	[Cartelli, Daniele; Casagrande, Francesca; Cappelletti, Graziella] Univ Milan, Dept Biol, Milan, Italy; [Goldwurm, Stefano; Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy	University of Milan	Cartelli, D (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	graziella.cappelletti@unimi.it	Cappelletti, Graziella/AAS-7780-2021; Cartelli, Daniele/K-5110-2018; Goldwurm, Stefano/Q-8978-2016; CASAGRANDE, FRANCESCA/AAC-1296-2019; Cartelli, Daniele/AAI-3424-2021	Cartelli, Daniele/0000-0002-7069-420X; Goldwurm, Stefano/0000-0002-1651-567X; CASAGRANDE, FRANCESCA/0000-0002-2093-1393; Cartelli, Daniele/0000-0002-7069-420X; Pezzoli, Gianni/0000-0003-4665-6710; Cappelletti, Graziella/0000-0003-0903-5392	Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy; "Dote ricerca", FSE, Regione Lombardia, Italy; Telethon Genetic Biobank Network [GTB07001]	Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy; "Dote ricerca", FSE, Regione Lombardia, Italy; Telethon Genetic Biobank Network(Fondazione Telethon)	This work was supported by Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy (to G.C.) and "Dote ricerca", FSE, Regione Lombardia, Italy (to D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jennifer S. Hartwig for reading and editing the manuscript, Dr Jenny Sassone (IRCCS Istituto Auxologico Italiano, Milano, Italy) and Dr Elisa Greggio (Department of Biology, University of Padova, Padova, Italy) for providing constructs. The samples were obtained from the "Cell Line and DNA Biobank from Patients affected by Genetic Diseases" (G. Gaslini Institute) and "Parkinson Institute Biobank" (Milan, http://www.parkinson.it/dnabank.html) of the Telethon Genetic Biobank Network (http://www.biobanknetwork.org) (project n. GTB07001).	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Auburger G, 2012, MOL NEUROBIOL; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cappelletti G, 2005, FEBS LETT, V579, P4781, DOI 10.1016/j.febslet.2005.07.058; Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hughes AJ, 2001, NEUROLOGY, V57, pS34; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liang YJ, 2008, J NEUROCHEM, V106, P1815, DOI 10.1111/j.1471-4159.2008.05526.x; MACEJAK DG, 1991, VIRUS RES, V19, P31, DOI 10.1016/0168-1702(91)90092-A; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitra G, 2007, PROTEINS, V67, P112, DOI 10.1002/prot.21286; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Reed MJ, 2001, MECH AGEING DEV, V122, P1203, DOI 10.1016/S0047-6374(01)00260-3; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ren Y, 2003, J NEUROSCI, V23, P3316; Ren Y, 2009, J BIOL CHEM, V284, P4009, DOI 10.1074/jbc.M806245200; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Schulze C, 2010, BIOPHYS J, V99, P2434, DOI 10.1016/j.bpj.2010.08.026; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sironi F, 2008, PARKINSONISM RELAT D, V14, P326, DOI 10.1016/j.parkreldis.2007.10.003; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Xiao DH, 2003, CANCER RES, V63, P6825; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200	52	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37467	10.1371/journal.pone.0037467	http://dx.doi.org/10.1371/journal.pone.0037467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666358	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300044
J	Maidment, SCR; Linton, DH; Upchurch, P; Barrett, PM				Maidment, Susannah C. R.; Linton, Deborah H.; Upchurch, Paul; Barrett, Paul M.			Limb-Bone Scaling Indicates Diverse Stance and Gait in Quadrupedal Ornithischian Dinosaurs	PLOS ONE			English	Article							LONG BONES; MAMMALS; LOCOMOTION; ALLOMETRY; EVOLUTION; POSTURE; MASS; HADROSAURIDAE; ORNITHOPODA; PERSPECTIVE	Background: The most primitive ornithischian dinosaurs were small bipeds, but quadrupedality evolved three times independently in the clade. The transition to quadrupedality from bipedal ancestors is rare in the history of terrestrial vertebrate evolution, and extant analogues do not exist. Constraints imposed on quadrupedal ornithischians by their ancestral bipedal bauplan remain unexplored, and consequently, debate continues about their stance and gait. For example, it has been proposed that some ornithischians could run, while others consider that none were cursorial. Methodology/Principal Findings: Drawing on biomechanical concepts of limb bone scaling and locomotor theory developed for extant taxa, we use the largest dataset of ornithischian postcranial measurements so far compiled to examine stance and gait in quadrupedal ornithischians. Differences in femoral midshaft eccentricity in hadrosaurs and ceratopsids may indicate that hadrosaurs placed their feet on the midline during locomotion, while ceratopsids placed their feet more laterally, under the hips. More robust humeri in the largest ceratopsids relative to smaller taxa may be due to positive allometry in skull size with body mass in ceratopsids, while slender humeri in the largest stegosaurs may be the result of differences in dermal armor distribution within the clade. Hadrosaurs are found to display the most cursorial morphologies of the quadrupedal ornithischian cades, indicating higher locomotor performance than in ceratopsids and thyreophorans. Conclusions/Significance: Limb bone scaling indicates that a previously unrealised diversity of stances and gaits were employed by quadrupedal ornithischians despite apparent convergence in limb morphology. Grouping quadrupedal ornithischians together as a single functional group hides this disparity. Differences in limb proportions and scaling are likely due to the possession of display structures such as horns, frills and dermal armor that may have affected the center of mass of the animal, and differences in locomotor behaviour such as migration, predator escape or home range size.	[Maidment, Susannah C. R.; Linton, Deborah H.; Barrett, Paul M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Linton, Deborah H.; Upchurch, Paul] UCL, Dept Earth Sci, London, England	Natural History Museum London; University of London; University College London	Maidment, SCR (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	s.maidment@nhm.ac.uk	Barrett, Paul M/A-2648-2010; Maidment, Susannah C. R./A-5100-2010; Upchurch, Paul/C-1654-2008	Barrett, Paul M/0000-0003-0412-3000; Maidment, Susannah C. R./0000-0002-7741-2500; 	Natural Environment Research Council [NE/G001898/1]; NERC [NE/G001898/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DHL was funded by a Natural Environment Research Council studentship during the course of this work. SCRM is funded by Natural Environment Research Council grant number NE/G001898/1 awarded to PMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; Alexander R. M. N., 1985, FUNCTIONAL VERTEBRAT, P26; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1979, J ZOOL, V189, P305; Apesteguia S, 2005, LIFE O PAST, P321; BAKKER R T, 1968, Discovery (New Haven), V3, P11; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Bates KT, 2012, J ANAT, V220, P212, DOI 10.1111/j.1469-7580.2011.01469.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Brett-Surman Michael K., 2007, P135; Brown CM, 2011, ZOOL J LINN SOC-LOND, V163, P1157, DOI 10.1111/j.1096-3642.2011.00735.x; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christiansen P, 1999, J ZOOL, V247, P333, DOI 10.1017/S0952836999003052; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Coombs WP., 1971, THESIS COLUMBIA U; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eaton TH, 1944, J MORPHOL, V75, P167, DOI 10.1002/jmor.1050750108; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; FARLOW JO, 1981, NATURE, V294, P746; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galton P.M., 1985, Journal of Vertebrate Paleontology, V5, P211; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gatton P. M., 1970, J. Paleont., V44, P464; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARWELL MR, 1988, PSYCHOL BULL, V104, P268, DOI 10.1037/0033-2909.104.2.268; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hildebrand M., 1985, P38; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Lanyon L.E., 1985, P1; Lockley Martin G., 2001, P428; Lockley MG, 1995, J VERTEBR PALEONTOL, V15, P592, DOI 10.1080/02724634.1995.10011251; Maidment SCR, 2010, SWISS J GEOSCI, V103, P199, DOI 10.1007/s00015-010-0023-3; Marsh O.C., 1881, AM J SCI, V21, P167, DOI DOI 10.2475/AJS.S3-21.122.167; MARYANSKA T, 1984, Palaeontologia Polonica, P119; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2010, ROYAL TYRRELL MUSEUM, P156; NORMAN D B, 1980, Institut Royal des Sciences Naturelles de Belgique Memoires, P1; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Olejnik SF., 1984, J ED STAT, V9, P129, DOI [DOI 10.3102/10769986009002129, 10.3102/10769986009002129]; OSTROM JH, 1964, AM J SCI, V262, P975, DOI 10.2475/ajs.262.8.975; Paul Gregory S., 1997, P129; Prieto-Marquez Albert, 2007, P91; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; PROTHERO DR, 1982, PALEOBIOLOGY, V8, P16, DOI 10.1017/S0094837300004322; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sellers WI, 2009, PALAEONTOL ELECTRON, V12; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P168; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Sereno Paul C., 2010, P21; STERNBERG CHARLES M., 1927, CANADIAN FIELD NAT, V41, P67; Tereshchenko V. S., 1996, PALEONTOL J, V30, P232; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Thompson S, 2007, PALAEONTOL ELECTRON, V10; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Yates AM, 2007, SPEC PAP PALAEONTOL, P9	90	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36904	10.1371/journal.pone.0036904	http://dx.doi.org/10.1371/journal.pone.0036904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666333	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300014
J	Liu, XY; Zhao, GX; Yan, Y; Bao, L; Chen, BD; Qi, RM				Liu, Xiyun; Zhao, Gexin; Yan, Yan; Bao, Li; Chen, Beidong; Qi, Ruomei			Ginkgolide B Reduces Atherogenesis and Vascular Inflammation in ApoE(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; P-SELECTIN; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-E; DEFICIENT MICE; ATHEROSCLEROSIS; ACTIVATION; PLATELETS; ADHESION; KINASE	Aims: To investigate whether ginkgolide B (a platelet-activating factor inhibitor) affects vascular inflammation in atherosclerosis-prone apolipoprotein E-deficient (ApoE(-/-)) mice. Methods and Results: Human platelets were used to evaluate the effects of ginkgolide B on platelet aggregation and signal transduction. Ginkgolide B attenuated platelet aggregation and inhibited phosphatidylinositol 3 kinase (PI3K) activation and Akt phosphorylation in thrombin-and collagen-activated platelets. ApoE(-/-) mice were administered a high-cholesterol diet for 8 weeks. Plasma platelet factor 4 (PF4) and RANTES (regulated upon activation, normal T-cell expressed, and secreted protein) were then measured using an enzyme-linked immunosorbent assay. Scanning electron microscopy and immunohistochemistry were used to determine atherosclerotic lesions. Ginkgolide B decreased plasma PF4 and RANTES levels in ApoE(-/-) mice. Scanning electron microscopic examination showed that ginkgolide B reduced aortic plaque in ApoE(-/-) mice. Immunohistochemistry analysis demonstrated that ginkgolide B diminished P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE(-/-) mice. Moreover, ginkgolide B suppressed macrophage and vascular cell adhesion protein 1 (VCAM-1) expression in aorta lesions in ApoE(-/-) mice. Similar effects were observed in aspirin-treated ApoE(-/-) mice. Conclusion: Ginkgolide B significantly reduced atherosclerotic lesions and P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE(-/-) mice. The efficacy of ginkgolide B was similar to aspirin. These results provide direct evidence that ginkgolide B inhibits atherosclerosis, which may be associated with inhibition of the PI3K/Akt pathway in activated platelets.	[Liu, Xiyun] Minist Hlth, Beijing Inst Geriatr, Beijing Hosp, Beijing, Peoples R China; Minist Hlth, Key Lab Geriatr, Beijing, Peoples R China	Beijing Hospital	Liu, XY (corresponding author), Minist Hlth, Beijing Inst Geriatr, Beijing Hosp, Beijing, Peoples R China.	ruomeiqi@yahoo.com.cn	Zhao, Gexin/O-8269-2019; Stefanadis, Christodoulos/ABH-2232-2020	Zhao, Gexin/0000-0003-2278-3432; Stefanadis, Christodoulos/0000-0001-5974-6454	National Natural Science Foundation of China [81070231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81070231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Braquet P, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P179; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Christodoulakos GE, 2007, ATHEROSCLEROSIS, V193, P142, DOI 10.1016/j.atherosclerosis.2006.05.045; Coppinger JA, 2007, CURR PHARM DESIGN, V13, P2640, DOI 10.2174/138161207781662885; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Kasper B, 2004, BLOOD, V103, P1602, DOI 10.1182/blood-2003-08-2802; King SM, 2009, CIRCULATION, V120, P785, DOI 10.1161/CIRCULATIONAHA.108.845461; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; LAMANT V, 1987, BIOCHEM PHARMACOL, V36, P2749, DOI 10.1016/0006-2952(87)90259-0; Li R, 2009, J PHARMACOL SCI, V110, P362, DOI 10.1254/jphs.08275FP; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McClelland S, 2009, ATHEROSCLEROSIS, V202, P84, DOI 10.1016/j.atherosclerosis.2008.04.016; Nassar T, 2003, J BIOL CHEM, V278, P6187, DOI 10.1074/jbc.M208894200; Penna C, 2005, AM J PHYSIOL-HEART C, V288, pH2512, DOI 10.1152/ajpheart.00599.2004; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rex S, 2009, THROMB HAEMOSTASIS, V102, P97, DOI 10.1160/TH08-08-0513; Santilli F, 2007, INTERN EMERG MED, V2, P256, DOI 10.1007/s11739-007-0076-0; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Westmuckett AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020406; Zhang S, 2011, J CARDIOVASC PHARM, V57, P721, DOI 10.1097/FJC.0b013e31821a50a8; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201; ZUCKER MB, 1991, P SOC EXP BIOL MED, V198, P693	28	30	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36237	10.1371/journal.pone.0036237	http://dx.doi.org/10.1371/journal.pone.0036237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22662117	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200018
J	Hozumi, K; Ishikawa, M; Hayashi, T; Yamada, Y; Katagiri, F; Kikkawa, Y; Nomizu, M				Hozumi, Kentaro; Ishikawa, Masaya; Hayashi, Takemitsu; Yamada, Yuji; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi			Identification of Cell Adhesive Sequences in the N-terminal Region of the Laminin alpha 2 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-DOMAIN; BINDING-SITES; SYNTHETIC PEPTIDES; GLOBULAR DOMAIN; HEPARIN-BINDING; MUSCULAR-DYSTROPHY; CHITOSAN MEMBRANES; NEURITE OUTGROWTH; SHORT ARM; INTEGRIN	The laminin alpha 2 chain is specifically expressed in the basement membrane surrounding muscle and nerve. We screened biologically active sequences in the mouse laminin N-terminal region of alpha 2 chain using 216 soluble peptides and three recombinant proteins (rec-a2LN, rec-a2LN+, and rec-a2N) by both the peptide-or protein-coated plate and the peptide-conjugated Sepharose bead assays. Ten peptides showed cell attachment activity in the plate assay, and 8 peptides were active in the bead assay. Seven peptides were active in the both assays. Five peptides promoted neurite outgrowth with PC12 cells. To clarify the cellular receptors, we examined the effects of heparin and EDTA on cell attachment to 11 active peptides. Heparin inhibited cell attachment to 10 peptides, and EDTA significantly affected only A2-8 peptide (YHYVTITLDLQQ, mouse laminin alpha 2 chain, 117-128)-mediated cell attachment. Cell attachment to A2-8 was also specifically inhibited by anti-integrin beta 1 and anti-integrin alpha 2 beta 1 antibodies. These results suggest that A2-8 promotes an integrin alpha 2 beta 1-mediated cell attachment. The rec-a2LN protein, containing the A2-8 sequence, bound to integrin alpha 2 beta 1 and cell attachment to rec-a2LN was inhibited by A2-8 peptide. Further, alanine substitution analysis of both the A2-8 peptide and the rec-a2LN+ protein revealed that the amino acids Ile-122, Leu-124, and Asp-125 were involved in integrin alpha 2 beta 1-mediated cell attachment, suggesting that the A2-8 site plays a functional role as an integrin alpha 2 beta 1 binding site in the LN module. These active peptides may provide new insights on the molecular mechanism of laminin-receptor interactions.	[Hozumi, Kentaro; Ishikawa, Masaya; Hayashi, Takemitsu; Yamada, Yuji; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Nomizu, M (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	nomizu@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010	Hozumi, Kentaro/0000-0002-6671-4386; Yamada, Yuji/0000-0003-2338-6906	Ministry of Education, Cultures, Sports, Science and Technology of Japan [MN 22390017]	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research MN 22390017 from the Ministry of Education, Cultures, Sports, Science and Technology of Japan.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BERNIER SM, 1995, MATRIX BIOL, V14, P447, DOI 10.1016/0945-053X(95)90002-0; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Helbling-Leclerc A, 2002, EUR J HUM GENET, V10, P157, DOI 10.1038/sj.ejhg.5200744; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012; Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2001, BIOCHEMISTRY-US, V40, P15310, DOI 10.1021/bi011552c; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Song SY, 1997, INT J CANCER, V71, P436, DOI 10.1002/(SICI)1097-0215(19970502)71:3<436::AID-IJC22>3.0.CO;2-C; Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006; Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8	45	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25111	25122		10.1074/jbc.M112.348151	http://dx.doi.org/10.1074/jbc.M112.348151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654118	Green Published, hybrid			2022-12-25	WOS:000306651700023
J	Mukherjee, A; Wu, JH; Barbour, S; Fang, XJ				Mukherjee, Abir; Wu, Jinhua; Barbour, Suzanne; Fang, Xianjun			Lysophosphatidic Acid Activates Lipogenic Pathways and de Novo Lipid Synthesis in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; PROTEIN-COUPLED RECEPTOR; BREAST-CANCER; GROWTH-FACTOR; SYNTHASE INHIBITION; OVER-EXPRESSION; LPA RECEPTORS; SREBP PATHWAY; KINASE; IDENTIFICATION	One of the most common molecular changes in cancer is the increased endogenous lipid synthesis, mediated primarily by overexpression and/or hyperactivity of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC). The changes in these key lipogenic enzymes are critical for the development and maintenance of the malignant phenotype. Previous efforts to control oncogenic lipogenesis have been focused on pharmacological inhibitors of FAS and ACC. Although they show anti-tumor effects in culture and in mouse models, these inhibitors are nonselective blockers of lipid synthesis in both normal and cancer cells. To target lipid anabolism in tumor cells specifically, it is important to identify the mechanism governing hyperactive lipogenesis in malignant cells. In this study, we demonstrate that lysophosphatidic acid (LPA), a growth factor-like mediator present at high levels in ascites of ovarian cancer patients, regulates the sterol regulatory element binding protein-FAS and AMP-activated protein kinase-ACC pathways in ovarian cancer cells but not in normal or immortalized ovarian epithelial cells. Activation of these lipogenic pathways is linked to increased de novo lipid synthesis. The pro-lipogenic action of LPA is mediated through LPA(2), an LPA receptor subtype overexpressed in ovarian cancer and other malignancies. Downstream of LPA(2), the G(12/13) and G(q) signaling cascades mediate LPA-dependent sterol regulatory element-binding protein activation and AMP-activated protein kinase inhibition, respectively. Moreover, inhibition of de novo lipid synthesis dramatically attenuated LPA-induced cell proliferation. These results demonstrate that LPA signaling is causally linked to the hyperactive lipogenesis in ovarian cancer cells, which can be exploited for development of new anti-cancer therapies.	[Mukherjee, Abir; Wu, Jinhua; Barbour, Suzanne; Fang, Xianjun] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Fang, XJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	xfang@vcu.edu			National Institutes of Health from NCI [2R01CA102196, R21CA161478]; Department of Defense [W81XWH-11-1-0541]; Jeffress Memorial Fund award; National Institutes of Health [P30 CA16059]; NATIONAL CANCER INSTITUTE [R21CA161478, R01CA102196, P30CA016059] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Jeffress Memorial Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA102196 and R21CA161478 from NCI (to X. F.). This work was also supported by Department of Defense Ovarian Cancer Research Program Grant W81XWH-11-1-0541 (to X. F.) and The Jeffress Memorial Fund award (to X. F.).; Massey Cancer Center of Virginia Commonwealth University School of Medicine was recipient of National Institutes of Health Grant P30 CA16059.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Baker DL, 2002, JAMA-J AM MED ASSOC, V287, P3081, DOI 10.1001/jama.287.23.3081; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dent P, 2005, BIOCHEM PHARMACOL, V70, P1685, DOI 10.1016/j.bcp.2005.08.020; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fang XJ, 1998, ONCOGENE, V16, P1, DOI 10.1038/sj.onc.1201525; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Goetzl EJ, 1999, CANCER RES, V59, P5370; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; HA J, 1994, J BIOL CHEM, V269, P22162; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Huang MC, 2004, ONCOGENE, V23, P122, DOI 10.1038/sj.onc.1206986; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Kitayama J, 2004, BREAST CANCER RES, V6, pR640, DOI 10.1186/bcr935; KUHAJDA FP, 1989, NEW ENGL J MED, V321, P636, DOI 10.1056/NEJM198909073211003; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Li JN, 2001, CANCER RES, V61, P1493; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Menendez JA, 2005, INT J ONCOL, V26, P1507; Menendez JA, 2004, ONCOL REP, V12, P411; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; OOKHTENS M, 1984, AM J PHYSIOL, V247, pR146, DOI 10.1152/ajpregu.1984.247.1.R146; Oyesanya RA, 2008, FASEB J, V22, P2639, DOI 10.1096/fj.07-101428; Pizer ES, 2000, CANCER RES, V60, P213; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Rashid A, 1997, AM J PATHOL, V150, P201; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schulte KM, 2001, INT J CANCER, V92, P249, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Soede RDM, 2000, BLOOD, V96, P691; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Swinnen JV, 1997, CANCER RES, V57, P1086; Van de Sande T, 2002, CANCER RES, V62, P642; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zhou WB, 2003, CANCER RES, V63, P7330	71	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24990	25000		10.1074/jbc.M112.340083	http://dx.doi.org/10.1074/jbc.M112.340083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665482	Green Published, hybrid			2022-12-25	WOS:000306651700012
J	Zhao, P; Nairn, AV; Hester, S; Moremen, KW; O'Regan, RM; Oprea, G; Wells, L; Pierce, M; Abbott, KL				Zhao, Peng; Nairn, Alison V.; Hester, Shanterian; Moremen, Kelley W.; O'Regan, Ruth M.; Oprea, Gabriella; Wells, Lance; Pierce, Michael; Abbott, Karen L.			Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; SEPTICUM ALPHA-TOXIN; GPI TRANSAMIDASE; PROSTATE-CANCER; DIFFERENTIATION; ATTACHMENT; EXPRESSION; SEQUENCES; CLEAVAGE; INVASION	The glycosylphosphatidylinositol (GPI) anchor is a lipid and glycan modification added to the C terminus of certain proteins in the endoplasmic reticulum by the activity of a multiple subunit enzyme complex known as the GPI transamidase (GPIT). Several subunits of GPIT have increased expression levels in breast carcinoma. In an effort to identify GPI-anchored proteins and understand the possible role of these proteins in breast cancer progression, we employed a combination of strategies. First, alpha toxin from Clostridium septicum was used to capture GPI-anchored proteins from human breast cancer tissues, cells, and serum for proteomic analysis. We also expressed short interfering RNAs targeting the expression of the GPAA1 and PIGT subunits of GPIT in breast cancer cell lines to identify proteins in which membrane localization is dependent on GPI anchor addition. Comparative membrane proteomics using nano-ESI-RPLC-MS/MS led to the discovery of several new potential diagnostic and therapeutic targets for breast cancer. Furthermore, we provide evidence that increased levels of GPI anchor addition in malignant breast epithelial cells promotes the dedifferentiation of malignant breast epithelial cells in part by increasing the levels of cell surface markers associated with mesenchymal stem cells.	[Zhao, Peng; Wells, Lance] Univ Georgia, Dept Chem, Athens, GA 30605 USA; [Nairn, Alison V.; Hester, Shanterian; Moremen, Kelley W.; Pierce, Michael; Abbott, Karen L.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30605 USA; [O'Regan, Ruth M.; Oprea, Gabriella] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University	Abbott, KL (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	kabbott@uga.edu	Wells, Lance/H-3118-2013; Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293	National Institutes of Health Grants [UO1CA128454, P41RR018502]; Department of Defense Breast Cancer Concept Award [BC075534]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Concept Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1CA128454 and P41RR018502. This work was also supported by Department of Defense Breast Cancer Concept Award BC075534 (to K.L.A.).	Al-Nbaheen M, 2012, STEM CELL R IN PRESS; Argani P, 2001, CLIN CANCER RES, V7, P3862; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Doering T. L., 2001, CURR PROTOC PROTEIN; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Eisenhaber B, 2001, PROTEIN ENG, V14, P17, DOI 10.1093/protein/14.1.17; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Han KR, 2004, J UROLOGY, V171, P1117, DOI 10.1097/01.ju.0000109982.60619.93; IKEZAWA H, 1991, CELL BIOL INT REP, V15, P1115; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; McCabe NP, 2000, ONCOL REP, V7, P879; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P7939, DOI 10.1073/pnas.87.20.7939; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shin DJ, 2005, J MICROBIOL, V43, P266; Steinert AF, 2011, TISSUE ENG PT A, V17, P1375, DOI [10.1089/ten.tea.2010.0413, 10.1089/ten.TEA.2010.0413]; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; Weise F, 2000, J CELL SCI, V113, P4587; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Yamamoto Y, 2005, BIOCHEM BIOPH RES CO, V333, P223, DOI 10.1016/j.bbrc.2005.05.084	36	37	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25230	25240		10.1074/jbc.M112.339465	http://dx.doi.org/10.1074/jbc.M112.339465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654114	hybrid, Green Published			2022-12-25	WOS:000306651700032
J	Daners, MS; Knobloch, V; Soellinger, M; Boesiger, P; Seifert, B; Guzzella, L; Kurtcuoglu, V				Daners, Marianne Schmid; Knobloch, Verena; Soellinger, Michaela; Boesiger, Peter; Seifert, Burkhardt; Guzzella, Lino; Kurtcuoglu, Vartan			Age-Specific Characteristics and Coupling of Cerebral Arterial Inflow and Cerebrospinal Fluid Dynamics	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; PHASE-CONTRAST MRI; RATE WAVE-FORMS; BRAIN STRUCTURE; RISK-FACTORS; FLOW; BLOOD; AQUEDUCT; ATROPHY; GENDER	The objective of this work is to quantify age-related differences in the characteristics and coupling of cerebral arterial inflow and cerebrospinal fluid (CSF) dynamics. To this end, 3T phase-contrast magnetic resonance imaging blood and CSF flow data of eleven young (24+/-3 years) and eleven elderly subjects (70+/-5 years) with a comparable sex-ratio were acquired. Flow waveforms and their frequency composition, transfer functions from blood to CSF flows and cross-correlations were analyzed. The magnitudes of the frequency components of CSF flow in the aqueduct differ significantly between the two age groups, as do the frequency components of the cervical spinal CSF and the arterial flows. The males' aqueductal CSF stroke volumes and average flow rates are significantly higher than those of the females. Transfer functions and cross-correlations between arterial blood and CSF flow reveal significant age-dependence of phase-shift between these, as do the waveforms of arterial blood, as well as cervical-spinal and aqueductal CSF flows. These findings accentuate the need for age- and sex-matched control groups for the evaluation of cerebral pathologies such as hydrocephalus.	[Daners, Marianne Schmid; Guzzella, Lino] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Inst Dynam Syst & Control, Zurich, Switzerland; [Knobloch, Verena; Soellinger, Michaela; Boesiger, Peter] Univ & ETH Zurich, Inst Biomed Engn, Zurich, Switzerland; [Soellinger, Michaela] Med Univ Graz, Dept Neurol, Neuroimaging Res Unit, Graz, Austria; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Kurtcuoglu, Vartan] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University of Graz; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Daners, MS (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Inst Dynam Syst & Control, Zurich, Switzerland.	vartan.kurtcuoglu@ethz.ch	Kurtcuoglu, Vartan/A-8940-2008; Schmid Daners, Marianne/E-1800-2013	Kurtcuoglu, Vartan/0000-0003-2665-0995; Schmid Daners, Marianne/0000-0002-6411-8871; Seifert, Burkhardt/0000-0002-5829-2478	Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project [K-32K1-120531]	Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project	This work was funded by the Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project, Grant No. K-32K1-120531. The SNSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 1996, MAGNET RESON MED, V35, P741, DOI 10.1002/mrm.1910350516; Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; BARKHOF E, 1994, ACTA RADIOL, V35, P123, DOI 10.1177/028418519403500204; Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; Bombardini T, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-15; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; de Marco G, 2004, J COMPUT ASSIST TOMO, V28, P247, DOI 10.1097/00004728-200403000-00015; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; DOLAN RJ, 1985, PSYCHOL MED, V15, P873, DOI 10.1017/S0033291700005110; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Ford MD, 2005, PHYSIOL MEAS, V26, P477, DOI 10.1088/0967-3334/26/4/013; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; GIDEON P, 1994, ACTA NEUROL SCAND, V89, P362; GIDEON P, 1994, NEURORADIOLOGY, V36, P210, DOI 10.1007/BF00588133; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Grichisch Y, 2012, HUM BRAIN MAPP, V33, P280, DOI 10.1002/hbm.21216; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110; Hirata K, 2006, STROKE, V37, P2552, DOI 10.1161/01.STR.0000242289.20381.f4; Hoi Y, 2010, PHYSIOL MEAS, V31, P291, DOI 10.1088/0967-3334/31/3/002; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; Miyati T, 2003, EUR RADIOL, V13, P1019, DOI 10.1007/s00330-002-1697-3; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Orfanidis SJ, 1996, INTRO SIGNAL PROCESS, V1st; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Ropele S, 2010, AM J NEURORADIOL, V31, P1297, DOI 10.3174/ajnr.A2042; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schibli M, 2009, BIOMED TECH, V54, P161, DOI 10.1515/BMT.2009.021; Stoquart-ElSankari S, 2007, J CEREBR BLOOD F MET, V27, P1563, DOI 10.1038/sj.jcbfm.9600462; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/jcbfm.2009.29, 10.1038/sj.jcbfm.jcbfm200929]; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; THOMSEN C, 1990, RADIOLOGY, V177, P659, DOI 10.1148/radiology.177.3.2243965; Uftring SJ, 2000, MAGN RESON IMAGING, V18, P991, DOI 10.1016/S0730-725X(00)00195-8; Xu J, 2000, AM J NEURORADIOL, V21, P112	42	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37502	10.1371/journal.pone.0037502	http://dx.doi.org/10.1371/journal.pone.0037502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666360	gold, Green Submitted, Green Published			2022-12-25	WOS:000305353400029
J	Fan, ZX; Liu, SY; Liu, Y; Liao, LH; Zhang, XY; Yue, BS				Fan, Zhenxin; Liu, Shaoying; Liu, Yang; Liao, Lihuan; Zhang, Xiuyue; Yue, Bisong			Phylogeography of the South China Field Mouse (Apodemus draco) on the Southeastern Tibetan Plateau Reveals High Genetic Diversity and Glacial Refugia	PLOS ONE			English	Article							VOLE MICROTUS-OECONOMUS; POPULATION-GROWTH; MITOCHONDRIAL PHYLOGEOGRAPHY; PLEISTOCENE GLACIATIONS; MOLECULAR PHYLOGENY; SOFTWARE PACKAGE; NEUTRALITY TESTS; SNOW FINCH; QUATERNARY; EVOLUTION	The southeastern margin of the Tibetan Plateau (SEMTP) is a particularly interesting region due to its topographic complexity and unique geologic history, but phylogeographic studies that focus on this region are rare. In this study, we investigated the phylogeography of the South China field mouse, Apodemus draco, in order to assess the role of geologic and climatic events on the Tibetan Plateau in shaping its genetic structure. We sequenced mitochondrial cytochrome b (cyt b) sequences in 103 individuals from 47 sampling sites. In addition, 23 cyt b sequences were collected from GenBank for analyses. Phylogenetic, demographic and landscape genetic methods were conducted. Seventy-six cyt b haplotypes were found and the genetic diversity was extremely high (pi = 0.0368; h = 0.989). Five major evolutionary clades, based on geographic locations, were identified. Demographic analyses implied subclade 1A and subclade 1B experienced population expansions at about 0.052-0.013 Mya and 0.014-0.004 Mya, respectively. The divergence time analysis showed that the split between clade 1 and clade 2 occurred 0.26 Mya, which fell into the extensive glacial period (EGP, 0.5-0.17 Mya). The divergence times of other main clades (2.20-0.55 Mya) were congruent with the periods of the Qingzang Movement (3.6-1.7 Mya) and the Kun-Huang Movement (1.2-0.6 Mya), which were known as the most intense uplift events in the Tibetan Plateau. Our study supported the hypothesis that the SEMTP was a large late Pleistocene refugium, and further inferred that the Gongga Mountain Region and Hongya County were glacial refugia for A. draco in clade 1. We hypothesize that the evolutionary history of A. draco in the SEMTP primarily occurred in two stages. First, an initial divergence would have been shaped by uplift events of the Tibetan Plateau. Then, major glaciations in the Pleistocene added complexity to its demographic history and genetic structure.	[Fan, Zhenxin; Zhang, Xiuyue] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China; [Liu, Shaoying; Liu, Yang] Sichuan Acad Forestry, Chengdu, Peoples R China; [Liao, Lihuan; Yue, Bisong] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Fan, ZX (corresponding author), Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China.	bsyue@scu.edu.cn		Yue, Bisong/0000-0001-6731-538X	National Key Technology RD Program [2012BAC01B06]	National Key Technology RD Program(National Key Technology R&D Program)	This research was funded by the National Key Technology R&D Program (2012BAC01B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Ci HX, 2009, J ZOOL, V279, P396, DOI 10.1111/j.1469-7998.2009.00635.x; Drummond AJ, 2008, BEAST WEBSITE BEAST; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan ZX, 2011, GENETICA, V139, P339, DOI 10.1007/s10709-011-9553-5; Fan ZX, 2009, MOL PHYLOGENET EVOL, V51, P447, DOI 10.1016/j.ympev.2009.03.005; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2004, MOL ECOL, V13, P135, DOI 10.1046/j.1365-294X.2004.02026.x; Hafner JC, 2008, J BIOGEOGR, V35, P2102, DOI 10.1111/j.1365-2699.2008.01942.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hu J.C., 1984, SICHUAN FAUNA EC, V2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; Krystufek B, 2009, HEREDITY, V103, P129, DOI 10.1038/hdy.2009.41; Kuhle M., 1988, GeoJournal, V17, P581; Lehmkuhl F, 2005, BOREAS, V34, P87, DOI 10.1080/03009480510012908; Li JJ, 1981, PROCESS UPLIFT QINGH; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu GQ, 2006, J W CHINA FORESTRY S, V35, P147; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Luo ZX, 2000, FAUNA SINICA MAMMALI; MANTEL N, 1967, CANCER RES, V27, P209; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander J. A. A., 2004, MRMODELTEST V2; Oshida T, 2005, MOL ECOL, V14, P1191, DOI 10.1111/j.1365-294X.2005.02475.x; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2009, MOL PHYLOGENET EVOL, V51, P312, DOI 10.1016/j.ympev.2009.01.013; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A., 2008, MOL EVOLUTION PHYLOG; Rambaut A., 2007, FIGTREE V1; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y, 1990, J GLACIOLOGY GEOCRYO, V12, P1; Shi YF, 1998, UPLIFT ENV CHANGES Q; SLATKIN M, 1991, GENETICS, V129, P555; Song MK, 1987, EXPLORATION NATURE, V6, P145; [苏珍 Su Zhen], 2002, [地球科学进展, Advance in Earth Sciences], V17, P639; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; Wang YZ, 1999, SICHUAN MAMMAL PRIMI; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; XIA W, 1984, Acta Theriologica Sinica, V4, P93; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang SJ, 2006, MOL PHYLOGENET EVOL, V41, P257, DOI 10.1016/j.ympev.2006.06.003; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Zeng Zongyong, 1994, Sichuan Daxue Xuebao (Ziran Kexueban), V31, P540; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2	74	30	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38184	10.1371/journal.pone.0038184	http://dx.doi.org/10.1371/journal.pone.0038184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666478	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400096
J	Maruzzo, D; Aldred, N; Clare, AS; Hoeg, JT				Maruzzo, Diego; Aldred, Nick; Clare, Anthony S.; Hoeg, Jens T.			Metamorphosis in the Cirripede Crustacean Balanus amphitrite	PLOS ONE			English	Article							AMPHIBALANUS AMPHITRITE; BARNACLE NOMENCLATURE; LARVAL METAMORPHOSIS; SETTLEMENT BEHAVIOR; METHYL FARNESOATE; CYPRIS; ULTRASTRUCTURE; RHIZOCEPHALA; THORACICA	Stalked and acorn barnacles (Cirripedia Thoracica) have a complex life cycle that includes a free-swimming nauplius larva, a cypris larva and a permanently attached sessile juvenile and adult barnacle. The barnacle cyprid is among the most highly specialized of marine invertebrate larvae and its settlement biology has been intensively studied. By contrast, surprisingly few papers have dealt with the critical series of metamorphic events from cementation of the cyprid to the substratum until the appearance of a suspension feeding juvenile. This metamorphosis is both ontogenetically complex and critical to the survival of the barnacle. Here we use video microscopy to present a timeline and description of morphological events from settled cyprid to juvenile barnacle in the model species Balanus amphitrite, representing an important step towards both a broader understanding of the settlement ecology of this species and a platform for studying the factors that control its metamorphosis. Metamorphosis in B. amphitrite involves a complex sequence of events: cementation, epidermis separation from the cypris cuticle, degeneration of cypris musculature, rotation of the thorax inside the mantle cavity, building of the juvenile musculature, contraction of antennular muscles, raising of the body, shedding of the cypris cuticle, shell plate and basis formation and, possibly, a further moult to become a suspension feeding barnacle. We compare these events with developmental information from other barnacle species and discuss them in the framework of barnacle settlement ecology.	[Maruzzo, Diego] Univ Padua, Dept Biol, Padua, Italy; [Aldred, Nick; Clare, Anthony S.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hoeg, Jens T.] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark	University of Padua; Newcastle University - UK; University of Copenhagen	Maruzzo, D (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	maruzzo@bio.unipd.it	Aldred, Nick/H-7896-2012; Hoeg, Jens Thorvald/D-5784-2015	Aldred, Nick/0000-0003-2285-5133; Hoeg, Jens Thorvald/0000-0002-3596-1691; Clare, Anthony S./0000-0002-7692-9583	European Union Synthesys-2 program [DK-TAF-1091]; Carlsberg Foundation [2007_01_0095]; Danish Council for Independent Research [09-063868-FNU]; Office of Naval Research [N00014-08-1-1240]; Synthesys [DK-TAF-355]	European Union Synthesys-2 program; Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Office of Naval Research(Office of Naval Research); Synthesys	DM was financed the European Union Synthesys-2 program (DK-TAF-1091). JTH was financed by the Carlsberg Foundation (2007_01_0095) and by The Danish Council for Independent Research (09-063868-FNU). NA was supported by Office of Naval Research Grant N00014-08-1-1240 to ASC and Synthesys (DK-TAF-355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred N, 2008, BIOFOULING, V24, P351, DOI 10.1080/08927010802256117; Anderson D.T., 1994, BARNACLES STRUCTURE; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; Blomsterberg M, 2004, J MORPHOL, V260, P141, DOI 10.1002/jmor.10131; Bourget E, 1975, J MAR BIOL ASSOC UK, V554, P39; Brickner I, 2010, J EXP MAR BIOL ECOL, V392, P115, DOI 10.1016/j.jembe.2010.04.015; Carlton J, 2009, BIOFOULING, V25, P77, DOI 10.1080/08927010802535247; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Clare AS, 2009, WOODHEAD PUBL MATER, P46, DOI 10.1533/9781845696313.1.46; Clare AS, 2008, BIOFOULING, V24, P55, DOI 10.1080/08927010701830194; CLARE AS, 1994, J CRUSTACEAN BIOL, V14, P27, DOI 10.2307/1549052; Clare AS, 1987, NEW FRONTIERS BARNAC, P49; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; COSTLOW JOHN D., 1956, J MORPH, V99, P359, DOI 10.1002/jmor.1050990206; Crisp D.J., 1988, P409; CRISP DJ, 1985, B MAR SCI, V37, P478; CRISP DJ, 1953, J ANIM ECOL, V22, P331, DOI 10.2307/1821; DANIEL A., 1958, JOUR MADRAS UNIV, V28B, P23; De Gregoris TB, 2011, BIOFOULING, V27, P367, DOI 10.1080/08927014.2011.577211; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DOOCHIN HERMAN D., 1951, BULL MARINE SCI GULF AND CARIBBEAN, V1, P15; GLENNER H, 1993, MAR BIOL, V117, P431; Glenner H, 2001, J MORPHOL, V249, P43, DOI 10.1002/jmor.1040.abs; Glenner H, 1998, J CRUSTACEAN BIOL, V18, P463, DOI 10.2307/1549411; Hoeg JT, 2006, INVERTEBR REPROD DEV, V49, P125, DOI 10.1080/07924259.2006.9652204; HOEG JT, 1985, ACTA ZOOL-STOCKHOLM, V66, P1, DOI 10.1111/j.1463-6395.1985.tb00645.x; HOEG JT, 1987, ZOOMORPHOLOGY, V107, P299, DOI 10.1007/BF00312176; Hoeg JT, 2012, INTEGR COMP IN PRESS; Hoeg JT, 1995, NEW FRONTIERS BARNAC, P195; Hoeg JT., 2005, MARINE PARASITES, P154; Kuhl H., 1950, ZOOL ANZ, V145, P461; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; LEFURGEY A, 1995, FASEB J, V9, pA639; Maruzzo D, 2011, BIOFOULING, V27, P225, DOI 10.1080/08927014.2011.555534; Pearse V., 1987, LIVING INVERTEBRATES; Petrone L, 2011, BIOFOULING, V27, P1043, DOI 10.1080/08927014.2011.625474; PFEIFFER CJ, 1989, ACTA ZOOL-STOCKHOLM, V70, P243, DOI 10.1111/j.1463-6395.1989.tb00937.x; RITCHIE L E, 1981, Journal of Crustacean Biology, V1, P334, DOI 10.2307/1547966; Smith PA, 2000, INSECT BIOCHEM MOLEC, V30, P885, DOI 10.1016/S0965-1748(00)00062-X; TAKENAKA M, 1993, DEV GROWTH DIFFER, V35, P245; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; WALKER G, 1992, MICROSCOPIC ANATOMY, V9, P249; Walker G, 1995, NEW FRONTIERS BARNAC, V10, P69; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Yamamoto H, 1997, J EXP ZOOL, V278, P349, DOI 10.1002/(SICI)1097-010X(19970815)278:6<349::AID-JEZ2>3.0.CO;2-O; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887	46	45	47	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37408	10.1371/journal.pone.0037408	http://dx.doi.org/10.1371/journal.pone.0037408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666355	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400027
J	Tsigkari, KK; Acevedo, SF; Skoulakis, EMC				Tsigkari, K. Kirki; Acevedo, Summer F.; Skoulakis, Efthimios M. C.			14-3-3 epsilon Is Required for Germ Cell Migration in Drosophila	PLOS ONE			English	Article							14-3-3 PROTEINS; 14-3-3-PROTEINS; EXPRESSION; LEONARDO; BINDING; FAMILY; RAF	Although 14-3-3 proteins participate in multiple biological processes, isoform-specific specialized functions, as well as functional redundancy are emerging with tissue and developmental stage-specificity. Accordingly, the two 14-3-3 epsilon proteins in Drosophila exhibit functional specificity and redundancy. Homozygotes for loss of function alleles of D14-3-3 epsilon contain significantly fewer germ line cells (pole cells) in their gonads, a phenotype not shared by mutants in the other 14-3-3 gene leo. We show that although D14-3-3 epsilon is enriched within pole cells it is required in mesodermal somatic gonad precursor cells which guide pole cells in their migration through the mesoderm and coalesce with them to form the embryonic gonad. Loss of D14-3-3 epsilon results in defective pole cell migration, reduced pole cell number. We present evidence that D14-3-3 epsilon loss results in reduction or loss of the transcription factor Zfh-1, one of the main regulatory molecules of the pole cell migration, from the somatic gonad precursor cells.	[Tsigkari, K. Kirki; Acevedo, Summer F.; Skoulakis, Efthimios M. C.] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Tsigkari, KK (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Vari, Greece.	skoulakis@fleming.gr		Acevedo, Summer/0000-0002-3206-6819	National Science Foundation [IBN-0080687]; PENED grant from the Greek Secretariat for Research and Technology (GSRT) [01EDelta207]	National Science Foundation(National Science Foundation (NSF)); PENED grant from the Greek Secretariat for Research and Technology (GSRT)	Initial phases of this work were supported by National Science Foundation IBN-0080687 and by a PENED grant (01E Delta 207) from the Greek Secretariat for Research and Technology (GSRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Boyle M, 1997, DEVELOPMENT, V124, P971; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Broihier HT, 1998, DEVELOPMENT, V125, P655; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CALLAINI G, 1995, DEV BIOL, V170, P365, DOI 10.1006/dbio.1995.1222; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Dalal SN, 2004, CELL CYCLE, V3, P672; Ferl RJ, 2002, GENOME BIOL, V3; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140; Li W, 1997, DEVELOPMENT, V124, P4163; Mershin A, 2004, LEARN MEMORY, V11, P277, DOI 10.1101/lm.70804; Messaritou G, 2009, FEBS LETT, V583, P2934, DOI 10.1016/j.febslet.2009.08.003; Mils V, 2000, ONCOGENE, V19, P1257, DOI 10.1038/sj.onc.1203419; Moore LA, 1998, DEVELOPMENT, V125, P667; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; REUTER R, 1994, DEVELOPMENT, V120, P1123; Rudolph T, 1999, DROSOPHILA INF SERV, V82, P99; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sokal R. R., 1981, BIOMETRY; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; Su TT, 2001, J CELL SCI, V114, P3445; Tsichritzis T, 2007, DEVELOPMENT, V177, P89; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang WF, 1996, J MOL EVOL, V43, P384; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36702	10.1371/journal.pone.0036702	http://dx.doi.org/10.1371/journal.pone.0036702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666326	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400012
J	Carnini, A; Scott, LOM; Ahrendt, E; Proft, J; Winkfein, RJ; Kim, SW; Colicos, MA; Braun, JEA				Carnini, Anna; Scott, Lucas O. M.; Ahrendt, Eva; Proft, Juliane; Winkfein, Robert J.; Kim, Sung-Woo; Colicos, Michael A.; Braun, Janice E. A.			Cell Line Specific Modulation of Extracellular A beta(42) by Hsp40	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMYLOID-BETA OLIGOMERS; ALPHA-B-CRYSTALLIN; PRION PROTEIN; ALZHEIMERS-DISEASE; MOLECULAR CHAPERONES; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; CORTICAL-NEURONS; STRESS-RESPONSE	Heat shock proteins (Hsps) are a set of molecular chaperones involved in cellular repair. They provide protective mechanisms that allow cells to survive potentially lethal insults, In response to a conditioning stress their expression is increased. Here we examined the connection between Hsps and A beta(42), the amyloid peptide involved in the pathological sequence of Alzheimer's disease (AD). Extracellular A beta(42) associates with neuronal cells and is a major constituent of senile plaques, one of the hallmarks of AD. Although Hsps are generally thought to prevent accumulation of misfolded proteins, there is a lack of mechanistic evidence that heat shock chaperones directly modulate A beta(42) toxicity. In this study we show that neither extracellular A beta(42) nor A beta(42)/PrPC trigger the heat shock response in neurons. To address the influence of the neuroprotective heat shock response on cellular A beta(42), Western analysis of A beta(42) was performed following external A beta(42) application. Five hours after a conditioning heat shock, A beta(42) association with CAD cells was increased compared to control neurons. However, at forty-eight hours following heat shock A beta(42) levels were reduced compared to that found for control cells. Moreover, transient transfection of the stress induced Hsp40, decreased CAD levels of A beta(42). In contrast to CAD cells, hippocampal neurons transfected with Hsp40 retained A beta(42) indicating that Hsp40 modulation of A beta(42) proteostasis is cell specific. Mutation of the conserved HPD motif within Hsp40 significantly reduced the Hsp40-mediated A beta(42) increase in hippocampal cultures indicating the importance of this motif in regulating cellular A beta(42). Our data reveal a biochemical link between Hsp40 expression and A beta(42) proteostasis that is cell specific. Therefore, increasing Hsp40 therapeutically with the intention of interfering with the pathogenic cascade leading to neurodegeneration in AD should be pursued with caution.	[Carnini, Anna; Scott, Lucas O. M.; Ahrendt, Eva; Proft, Juliane; Winkfein, Robert J.; Colicos, Michael A.; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kim, Sung-Woo] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary	Carnini, A (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014	Proft, Juliane/0000-0003-0980-8930	Canadian Institute of Health Research [74713, 7944]; Alberta Prion Research Institute	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute	This work was supported by funding from the Canadian Institute of Health Research MOP#74713 (Dr. Braun) and MOP#7944 (Dr. Colicos) and the Alberta Prion Research Institute. Dr. Braun is a Senior Scholar of the Alberta Heritage Foundation for Medical Research. Dr. Colicos is a Scholar of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman DA, 2011, INT J ALZHEIMERS DIS, V2011; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Bateman DA, 2009, BIOPHYS J, V96, P4260, DOI 10.1016/j.bpj.2009.01.056; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Eiden M, 2006, J VET MED B, V53, P251, DOI 10.1111/j.1439-0450.2006.00966.x; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gutierrez RC, 2009, NEUROSCIENCE, V162, P208, DOI 10.1016/j.neuroscience.2009.04.062; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; King M, 2009, J NEUROSCI RES, V87, P3161, DOI 10.1002/jnr.22145; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Magrane Jordi, 2008, V3, P25, DOI 10.1007/978-1-4020-8231-3_2; Mohamed A, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/127984; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Suzuki T, 1999, BRAIN RES, V816, P99, DOI 10.1016/S0006-8993(98)01083-X; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Tampellini D, 2011, J NEUROSCI, V31, P15384, DOI 10.1523/JNEUROSCI.2986-11.2011; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z	63	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37755	10.1371/journal.pone.0037755	http://dx.doi.org/10.1371/journal.pone.0037755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666389	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600028
J	Feyler, S; Scott, GB; Parrish, C; Jarmin, S; Evans, P; Short, M; McKinley, K; Selby, PJ; Cook, G				Feyler, Sylvia; Scott, Gina B.; Parrish, Christopher; Jarmin, Sarah; Evans, Paul; Short, Mike; McKinley, Katherine; Selby, Peter J.; Cook, Gordon			Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent	PLOS ONE			English	Article							IMMUNE SUPPRESSION; TGF-BETA; DENDRITIC CELLS; THERAPEUTIC REVERSAL; MOLECULAR-MECHANISMS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; CANCER PATIENTS; FOXP3(+) TREGS; INDUCTION	Regulatory T-cells (T-Reg cells) are increased in patients with multiple myeloma (MM). We investigated whether MM cells could generate and/or expand T-Reg cells as a method of immuno-surveillance avoidance. In an in vitro model, CD4(+)CD25(-)FoxP3(-) T-cells co-cultured with malignant plasma cells (primary MM cells and cell lines) induced a significant generation of CD4(+)CD25(+)FoxP3(+) inducible T-Reg cells (tT(Reg) cells; p<0.0001), in a contact-dependent manner. tT(Reg) cells were polyclonal, demonstrated a suppressive phenotype and phenotypically, demonstrated increased FoxP3 (p = 0.0001), increased GITR (p<0.0001), increased PD1 (p = 0.003) and decreased CD62L (p = 0.007) expression compared with naturally occurring T-Reg cells. FACS-sorted tT(Reg) cells differentiated into FoxP(+)IL-17(+) and FoxP3(-)IL-17(+) CD4(+) cells upon TCR-mediated stimulation. Blocking experiments with anti-ICOS-L MoAb resulted in a significant inhibition of tT(Reg) cell generation whereas both IL-10 & TGF beta blockade did not. MM tumour cells can directly generate functional T-Reg cells in a contact-dependent manner, mediated by ICOS/ICOS-L. These features suggest that tumour generation of T-Reg cells may contribute to evasion of immune surveillance by the host.	[Feyler, Sylvia; Scott, Gina B.; Parrish, Christopher; Jarmin, Sarah; Cook, Gordon] Univ Leeds, Acad Dept Haematol & Oncol, Transplant Immunol Grp, Leeds, W Yorkshire, England; [Feyler, Sylvia] Calderdale & Huddersfield NHS Trust, Dept Haematol, Huddersfield, W Yorkshire, England; [Evans, Paul; Short, Mike] Leeds Teaching Hosp NHS Trust, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [McKinley, Katherine] Leeds Teaching Hosp Trust, Dept Clin Immunol, Leeds, W Yorkshire, England; [Cook, Gordon] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Saint James's University Hospital; University of Leeds	Feyler, S (corresponding author), Univ Leeds, Acad Dept Haematol & Oncol, Transplant Immunol Grp, Leeds, W Yorkshire, England.	Gordon.Cook@leedsth.nhs.uk			Tunstall Fellowship; British Society of Haematology; Leukaemia Lymphoma Research Fellowship; Leukemia Lymphoma Research; British Journal of Haematology Fellowship	Tunstall Fellowship; British Society of Haematology; Leukaemia Lymphoma Research Fellowship; Leukemia Lymphoma Research; British Journal of Haematology Fellowship	SF was supported by the Tunstall Fellowship, a British Society of Haematology research grant and Leukaemia Lymphoma Research Fellowship. GS is currently supported by Leukemia Lymphoma Research and SJ was supported by a British Journal of Haematology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; BERIOU G, 2009, BLOOD; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Campbell JDM, 2001, J IMMUNOL, V167, P553, DOI 10.4049/jimmunol.167.1.553; Chatenoud L, 2006, J CLIN INVEST, V116, P2325, DOI 10.1172/JCI29748; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2003, TRANSPL INT, V16, P66, DOI 10.1111/j.1432-2277.2003.tb00266.x; Cook G, 1999, J LEUKOCYTE BIOL, V66, P981, DOI 10.1002/jlb.66.6.981; Coquerelle C, 2009, GUT, V58, P1363, DOI 10.1136/gut.2008.162842; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; de Jong YP, 2004, INT IMMUNOL, V16, P205, DOI 10.1093/intimm/dxh019; Feng T, 2011, GASTROENTEROLOGY, V140, P2031, DOI 10.1053/j.gastro.2011.03.009; Feyler S, 2009, BRIT J HAEMATOL, V144, P686, DOI 10.1111/j.1365-2141.2008.07530.x; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Fiore F, 2005, EUR J IMMUNOL, V35, P1155, DOI 10.1002/eji.200425093; Gabrilovich DI, 2007, CURR CANCER DRUG TAR, V7, P1, DOI 10.2174/156800907780006850; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; GJERDRUM LM, 2007, LEUKEMIA; Hadjur S, 2009, IMMUNOL LETT, V122, P37, DOI 10.1016/j.imlet.2008.11.001; HAMILTON MS, 1991, LEUKEMIA, V5, P768; Harrison SJ, 2005, BRIT J HAEMATOL, V130, P344, DOI 10.1111/j.1365-2141.2005.05534.x; Hauben E, 2005, MICROBES INFECT, V7, P1023, DOI 10.1016/j.micinf.2005.03.027; Herber DL, 2007, CANCER RES, V67, P5067, DOI 10.1158/0008-5472.CAN-07-0897; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Kitani A, 2008, MUCOSAL IMMUNOL, V1, pS43, DOI 10.1038/mi.2008.51; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lizee G, 2006, CLIN CANCER RES, V12, P4794, DOI 10.1158/1078-0432.CCR-06-0944; Lutsiak MEC, 2008, J IMMUNOL, V180, P5871, DOI 10.4049/jimmunol.180.9.5871; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Mercer F, 2009, ADV EXP MED BIOL, V665, P47; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Ohtsuki T, 1989, Hum Cell, V2, P297; Pan F, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001709; PELLATDECEUNYNK C, 1995, BLOOD, V86, P4001, DOI 10.1182/blood.V86.10.4001.bloodjournal86104001; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Prabhala RH, 2006, BLOOD, V107, P301, DOI 10.1182/blood-2005-08-3101; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VANRIET I, 1994, BRIT J HAEMATOL, V87, P258; Wang RF, 2006, SEMIN CANCER BIOL, V16, P73, DOI 10.1016/j.semcancer.2005.07.009; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321	56	56	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e35981	10.1371/journal.pone.0035981	http://dx.doi.org/10.1371/journal.pone.0035981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666318	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600004
J	Gibson, CM; Kao, RH; Blevins, KK; Travers, PD				Gibson, Cara M.; Kao, Rebecca H.; Blevins, Kali K.; Travers, Patrick D.			Integrative Taxonomy for Continental-Scale Terrestrial Insect Observations	PLOS ONE			English	Article							GROUND BEETLES COLEOPTERA; SPECIES IDENTIFICATION; MITOCHONDRIAL-DNA; CARABIDAE; POPULATION; ECOLOGY; SYSTEMATICS; BARCODES; MTDNA; LIFE	Although 21st century ecology uses unprecedented technology at the largest spatio-temporal scales in history, the data remain reliant on sound taxonomic practices that derive from 18th century science. The importance of accurate species identifications has been assessed repeatedly and in instances where inappropriate assignments have been made there have been costly consequences. The National Ecological Observatory Network (NEON) will use a standardized system based upon an integrative taxonomic foundation to conduct observations of the focal terrestrial insect taxa, ground beetles and mosquitoes, at the continental scale for a 30 year monitoring program. The use of molecular data for continental-scale, multi-decadal research conducted by a geographically widely distributed set of researchers has not been evaluated until this point. The current paper addresses the development of a reference library for verifying species identifications at NEON and the key ways in which this resource will enhance a variety of user communities.	[Gibson, Cara M.; Kao, Rebecca H.; Blevins, Kali K.; Travers, Patrick D.] Natl Ecol Observ Network, Boulder, CO USA		Gibson, CM (corresponding author), Natl Ecol Observ Network, Boulder, CO USA.	cara.m.gibson@gmail.com	Gibson, Cara/B-4138-2017		National Science Foundation (NSF) [DBI-0752017]; Direct For Biological Sciences [0752017] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation (NSF) grant DBI-0752017 to NEON, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBSnews, 2007, BIOSCIENCE, V57, P198; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Butovsky RO, 2011, ZOOKEYS, P215, DOI 10.3897/zookeys.100.1529; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frank JH, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.14.188; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Koivula MJ, 2011, ZOOKEYS, P287, DOI 10.3897/zookeys.100.1533; Kotze DJ, 2011, ZOOKEYS, P55, DOI 10.3897/zookeys.100.1523; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Lis JA, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2932.1.5; Locke J.M., 2008, P 11 INT COR REEF S, P1348; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maddison DR, 2008, ANN CARNEGIE MUS, V77, P147, DOI 10.2992/0097-4463-77.1.147; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rodriguez-Fernandez JI, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2933.1.3; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wallace SK, 2004, THESIS U MONTANA BOZ; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Woodcock RM, 2009, ENTOMOL NEWS, V120, P341, DOI 10.3157/021.120.0401	35	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37528	10.1371/journal.pone.0037528	http://dx.doi.org/10.1371/journal.pone.0037528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666362	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600018
J	Medan, D; Luanpitpong, S; Azad, N; Wang, LY; Jiang, BH; Davis, ME; Barnett, JB; Guo, L; Rojanasakul, Y				Medan, Djordje; Luanpitpong, Sudjit; Azad, Neelam; Wang, Liying; Jiang, Bing-Hua; Davis, Mary E.; Barnett, John B.; Guo, Lan; Rojanasakul, Yon			Multifunctional Role of Bcl-2 in Malignant Transformation and Tumorigenesis of Cr(VI)-Transformed Lung Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; CANCER; P53; EXPRESSION; ABNORMALITIES; INDUCTION; CHROMIUM	B-cell lymphoma-2 (Bcl-2) is an antiapoptotic protein known to be important in the regulation of apoptosis in various cell types. However, its role in malignant transformation and tumorigenesis of human lung cells is not well understood. We previously reported that chronic exposure of human lung epithelial cells to the carcinogenic hexavalent chromium Cr(VI) caused malignant transformation and Bcl-2 upregulation; however, the role of Bcl-2 in the transformation is unclear. Using a gene silencing approach, we showed that Bcl-2 plays an important role in the malignant properties of Cr(VI)-transformed cells. Downregulation of Bcl-2 inhibited the invasive and proliferative properties of the cells as well as their colony forming and angiogenic activities, which are upregulated in the transformed cells as compared to control cells. Furthermore, animal studies showed the inhibitory effect of Bcl-2 knockdown on the tumorigenesis of Cr(VI)-transformed cells. The role of Bcl-2 in malignant transformation and tumorigenesis was confirmed by gene silencing experiments using human lung carcinoma NCI-H460 cells. These cells exhibited aggressive malignant phenotypes similar to those of Cr(VI)-transformed cells. Knockdown of Bcl-2 in the H460 cells inhibited malignant and tumorigenic properties of the cells, indicating the general role of Bcl-2 in human lung tumorigenesis. Ingenuity Pathways Analysis (IPA) revealed potential effectors of Bcl-2 in tumorigenesis regulation. Additionally, using IPA together with ectopic expression of p53, we show p53 as an upstream regulator of Bcl-2 in Cr(VI)-transformed cells. Together, our results indicate the novel and multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of human lung epithelial cells chronically exposed to Cr(VI).	[Medan, Djordje; Luanpitpong, Sudjit; Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Azad, Neelam] Hampton Univ, Dept Pharmaceut Sci, Hampton, VA 23668 USA; [Wang, Liying] NIOSH, Pathol & Physiol Res Branch, Morgantown, WV USA; [Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Davis, Mary E.] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Barnett, John B.] W Virginia Univ, Dept Immunol Microbiol & Cell Biol, Morgantown, WV 26506 USA; [Guo, Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; Hampton University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Jefferson University; West Virginia University; West Virginia University; West Virginia University	Medan, D (corresponding author), W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA.	yrojan@hsc.wvu.edu	Barnett, John/AAW-6642-2020; Luanpitpong, Sudjit/ABF-1962-2021	Luanpitpong, Sudjit/0000-0002-1639-4935; Jiang, Bing-Hua/0000-0003-4526-2031; Rojanasakul, Yon/0000-0002-8839-6462	National Institutes of Health [HL095579, HL076340-04S1, P20-RR016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340, R01HL095579] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health [grant numbers HL095579, HL076340-04S1, and P20-RR016477]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; [Anonymous], 1990, IARC MON EV CARC RIS, V49; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Azad N, 2010, AM J RESP CELL MOL, V42, P578, DOI 10.1165/rcmb.2009-0094OC; BAETJER A M, 1959, AMA Arch Ind Health, V20, P124; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; CARNEY DN, 1980, CANCER RES, V40, P1820; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cohen AJ, 1995, ENVIRON HEALTH PERSP, V103, P219, DOI 10.2307/3432314; Costa AN, 2010, MOL CARCINOGEN, V49, P582, DOI 10.1002/mc.20624; De Flora S, 2000, CARCINOGENESIS, V21, P533, DOI 10.1093/carcin/21.4.533; Fahy BN, 2005, CANCER CHEMOTH PHARM, V56, P46, DOI 10.1007/s00280-004-0944-5; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HALDAR S, 1994, CANCER RES, V54, P2095; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; HUEPER W C, 1959, Am Ind Hyg Assoc J, V20, P274, DOI 10.1080/00028895909343716; Hussain SP, 2003, CANCER RES, V113, P238; JIANG SX, 1995, J PATHOL, V177, P135, DOI 10.1002/path.1711770206; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Laudanski J, 2001, EUR RESPIR J, V17, P660, DOI 10.1183/09031936.01.17406600; LEHMAN TA, 1991, ENVIRON HEALTH PERSP, V93, P133, DOI 10.2307/3431181; Liao WT, 2007, TOXICOL APPL PHARM, V225, P162, DOI 10.1016/j.taap.2007.07.017; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; MACHLE W, 1948, PUBLIC HEALTH REP, V63, P1114, DOI 10.2307/4586677; MACKENZIE R D, 1958, AMA Arch Ind Health, V18, P232; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; Ohmura Y, 2000, CLIN CANCER RES, V6, P2980; Oxford SME, 2004, CURR MED CHEM, V11, P1031, DOI 10.2174/0929867043455486; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529; SIMONATO L, 1991, BRIT J IND MED, V48, P145; Sutton R., 2010, CHROMIUM 6 US TAP WA; USEPA, 2000, CHROM COMP FACTSH; Van Vleet TR, 2006, TOXICOL SCI, V89, P399, DOI 10.1093/toxsci/kfj039; Wang LY, 2011, NANO LETT, V11, P2796, DOI 10.1021/nl2011214; Woodruff TJ, 1998, ENVIRON HEALTH PERSP, V106, P245, DOI 10.2307/3434011	42	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37045	10.1371/journal.pone.0037045	http://dx.doi.org/10.1371/journal.pone.0037045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666341	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600009
J	Hrdinka, M; Otahal, P; Horejsi, V				Hrdinka, Matous; Otahal, Pavel; Horejsi, Vaclav			The Transmembrane Region Is Responsible for Targeting of Adaptor Protein LAX into "Heavy Rafts''	PLOS ONE			English	Article							T-CELL-ACTIVATION; LIPID RAFTS; SIGNAL-TRANSDUCTION; MEMBRANE RAFTS; PALMITOYLATION; RECEPTOR; LOCALIZATION; MICRODOMAINS; IDENTIFICATION; TRANSPORT	Background: The importance of membrane compartmentalization into specific membrane microdomains has been shown in many biological processes such as immunoreceptor signaling, membrane trafficking, pathogen infection, and tumor progression. Microdomains like lipid rafts, caveolae and tetraspanin enriched microdomains are relatively resistant to solubilization by some detergents. Large detergent-resistant membrane fragments (DRMs) resulting from such membrane solubilization can be conveniently isolated by density gradient ultracentrifugation or gel filtration. Recently, we described a novel type of raft-like membrane microdomains producing, upon detergent Brij98 solubilization, "heavy DRMs'' and containing a number of functionally relevant proteins. Transmembrane adaptor protein LAX is a typical "heavy raft'' protein. The present study was designed to identify the molecular determinants targeting LAX-derived constructs to heavy rafts. Methodology/Principal Findings: We prepared several constructs encoding chimeric proteins containing various informative segments of the LAX sequence and evaluated their effects on targeting to heavy rafts. Replacement of the polybasic membrane-proximal part of LAX by CD3e-derived membrane-proximal part had no effect on LAX solubilization. Similarly, the membrane-proximal part of LAX, when introduced into non-raft protein CD25 did not change CD25 detergent solubility. These results indicated that membrane-proximal part of LAX is not important for LAX targeting to heavy rafts. On the other hand, the replacement of transmembrane part of CD25 by the transmembrane part of LAX resulted in targeting into heavy rafts. We also show that LAX is not S-acylated, thus palmitoylation is not involved in LAX targeting to heavy rafts. Also, covalent dimerization was excluded as a cause of targeting into heavy rafts. Conclusions/Significance: We identified the transmembrane domain of LAX as a first motif targeting transmembrane protein constructs to detergent-resistant heavy rafts, a novel type of membrane microdomains containing a number of physiologically important proteins.	[Hrdinka, Matous; Otahal, Pavel; Horejsi, Vaclav] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hrdinka, M (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	vaclav.horejsi@img.cas.cz	Hrdinka, Matous/B-9187-2011; Otahal, Pavel/G-3153-2014; Horejsi, Vaclav/G-3113-2014	Hrdinka, Matous/0000-0002-2981-2825; Horejsi, Vaclav/0000-0003-4925-0142; Otahal, Pavel/0000-0002-5513-4159	Academy of Sciences of the Czech Republic, GACR [AV0Z50520514, MEM/09/E011]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic) [1M0506]; Faculty of Science, Charles University, Prague, Czech Republic	Academy of Sciences of the Czech Republic, GACR; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government)	This work was supported by project no. AV0Z50520514, awarded by the Academy of Sciences of the Czech Republic, GACR (project MEM/09/E011), and by the Center of Molecular and Cellular Immunology (project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic). MH was a Ph.D. student supported in part by the Faculty of Science, Charles University, Prague, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hrdinka M, 2011, J BIOL CHEM, V286, P19617, DOI 10.1074/jbc.M110.175117; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Ludford-Menting MJ, 2011, J LIPIDS, V2011, DOI 10.1155/2011/521863; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Otahal P, 2011, BBA-MOL CELL RES, V1813, P367, DOI 10.1016/j.bbamcr.2010.12.003; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; PERSCHL A, 1995, J CELL SCI, V108, P1033; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36330	10.1371/journal.pone.0036330	http://dx.doi.org/10.1371/journal.pone.0036330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662118	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300011
J	Lee, KH; Kim, SH; Kim, DY; Kim, S; Kim, KT				Lee, Kyung-Ha; Kim, Sung-Hoon; Kim, Do-Yeon; Kim, Seunghwan; Kim, Kyong-Tai			Internal Ribosomal Entry Site-Mediated Translation Is Important for Rhythmic PERIOD1 Expression	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; MESSENGER-RNA; HNRNP-Q; CIRCADIAN CLOCK; INITIATING TRANSLATION; MOUSE PERIOD; CKI-EPSILON; CELL-TYPE; PROTEIN; DEGRADATION	The mouse PERIOD1 (mPER1) plays an important role in the maintenance of circadian rhythm. Translation of mPer1 is directed by both a cap-dependent process and cap-independent translation mediated by an internal ribosomal entry site (IRES) in the 5' untranslated region (UTR). Here, we compared mPer1 IRES activity with other cellular IRESs. We also found critical region in mPer1 5'UTR for heterogeneous nuclear ribonucleoprotein Q (HNRNPQ) binding. Deletion of HNRNPQ binding region markedly decreased IRES activity and disrupted rhythmicity. A mathematical model also suggests that rhythmic IRES-dependent translation is a key process in mPER1 oscillation. The IRES-mediated translation of mPer1 will help define the post-transcriptional regulation of the core clock genes.	[Lee, Kyung-Ha; Kim, Do-Yeon; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Gyeongbuk, South Korea; [Kim, Sung-Hoon] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, KH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Gyeongbuk, South Korea.	ktk@postech.ac.kr	Lee, Kyung-Ha/GRY-2640-2022	Lee, Kyung-Ha/0000-0003-0515-7392; KIM, Seunghwan/0000-0002-0563-3902; kim, sunghoon/0000-0002-1570-3230; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea (NRF) [20100030089, 20100002146, 20100019706, 20110031517]; Brain Korea 21 program; World Class University program [R31-10105]; Korean Ministry of Education, Science, and Technology (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); World Class University program; Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF) (nos. 20100030089, 20100002146, 20100019706, 20110031517), the Brain Korea 21 program, the World Class University program (R31-10105) funded by the Korean Ministry of Education, Science, and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; [Anonymous], 2005, J BIOL CHEM, DOI DOI 10.1074/jbc.M502716200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghalayini AJ, 2002, J BIOL CHEM, V277, P1469, DOI 10.1074/jbc.M011432200; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hamada J, 2004, FEBS LETT, V557, P204, DOI 10.1016/S0014-5793(03)01493-5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hresko RC, 2002, J BIOL CHEM, V277, P25233, DOI 10.1074/jbc.M202556200; INGRAHAM CA, 1992, ONCOGENE, V7, P95; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kozak M, 2001, MOL CELL BIOL, V21, P1899, DOI 10.1128/MCB.21.6.1899-1907.2001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Omri B, 1998, ONCOGENE, V16, P2351, DOI 10.1038/sj.onc.1201761; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Quaresma AJC, 2009, EXP CELL RES, V315, P968, DOI 10.1016/j.yexcr.2009.01.012; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schmutz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021325; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shima T, 2000, BRAIN RES, V870, P36, DOI 10.1016/S0006-8993(00)02399-4; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; ZHAO YH, 1991, ONCOGENE, V6, P1725	57	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37936	10.1371/journal.pone.0037936	http://dx.doi.org/10.1371/journal.pone.0037936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662251	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300142
J	Shoji, K; Oda, K; Kashiyama, T; Ikeda, Y; Nakagawa, S; Sone, K; Miyamoto, Y; Hiraike, H; Tanikawa, M; Miyasaka, A; Koso, T; Matsumoto, Y; Wada-Hiraike, O; Kawana, K; Kuramoto, H; McCormick, F; Aburatani, H; Yano, T; Kozuma, S; Taketani, Y				Shoji, Keiko; Oda, Katsutoshi; Kashiyama, Tomoko; Ikeda, Yuji; Nakagawa, Shunsuke; Sone, Kenbun; Miyamoto, Yuichiro; Hiraike, Haruko; Tanikawa, Michihiro; Miyasaka, Aki; Koso, Takahiro; Matsumoto, Yoko; Wada-Hiraike, Osamu; Kawana, Kei; Kuramoto, Hiroyuki; McCormick, Frank; Aburatani, Hiroyuki; Yano, Tetsu; Kozuma, Shiro; Taketani, Yuji			Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; HIGH-FREQUENCY; ANTITUMOR-ACTIVITY; CANCER-CELLS; MUTATIONS; PI3K; EVEROLIMUS; PIK3CA	The PI3K (phosphatidylinositol-3-kinase)/mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various PI3K/AKT-activating genetic alterations. We examined the antitumor effect of NVP-BEZ235-a dual PI3K/mTOR inhibitor-and RAD001-an mTOR inhibitor-in 13 endometrial cancer cell lines, all of which possess one or more alterations in PTEN, PIK3CA, and K-Ras. We also combined these compounds with a MAPK pathway inhibitor (PD98059 or UO126) in cell lines with K-Ras alterations (mutations or amplification). PTEN mutant cell lines without K-Ras alterations (n = 9) were more sensitive to both RAD001 and NVP-BEZ235 than were cell lines with K-Ras alterations (n = 4). Dose-dependent growth suppression was more drastically induced by NVP-BEZ235 than by RAD001 in the sensitive cell lines. G1 arrest was induced by NVP-BEZ235 in a dose-dependent manner. We observed in vivo antitumor activity of both RAD001 and NVP-BEZ235 in nude mice. The presence of a MEK inhibitor, PD98059 or UO126, sensitized the K-Ras mutant cells to NVP-BEZ235. Robust growth suppression by NVP-BEZ235 suggests that a dual PI3K/mTOR inhibitor is a promising therapeutic for endometrial carcinomas. Our data suggest that mutational statuses of PTEN and K-Ras might be useful predictors of sensitivity to NVP-BEZ235 in certain endometrial carcinomas.	[Shoji, Keiko; Oda, Katsutoshi; Kashiyama, Tomoko; Ikeda, Yuji; Nakagawa, Shunsuke; Sone, Kenbun; Miyamoto, Yuichiro; Hiraike, Haruko; Tanikawa, Michihiro; Miyasaka, Aki; Koso, Takahiro; Matsumoto, Yoko; Wada-Hiraike, Osamu; Kawana, Kei; Yano, Tetsu; Kozuma, Shiro; Taketani, Yuji] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Kuramoto, Hiroyuki] Kitasato Univ, Grad Sch Med Sci, Dept Clin Cytol, Kanagawa, Japan; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo; Kitasato University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Tokyo	Shoji, K (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan.	katsutoshi-tky@umin.ac.jp		Wada-Hiraike, Osamu/0000-0002-3458-6711	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19599005, 23592437, 21791544, 20221009, 117100001060]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (C), 19599005 and 23592437, a Grant-in-Aid for Young Scientists (B), grant number 21791544 (to KO), grant number: Scientific Research (S) 20221009 (to HA), and Next-Generation Cancer Research Project, grant number: 117100001060 to TY) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bernstam F-M, 2009, J CLIN ONCOL, V27, P2278; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; ENOMOTO T, 1991, CANCER RES, V51, P5308; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Minaguchi T, 2001, CLIN CANCER RES, V7, P2636; Mordant P, 2010, MOL CANCER THER, V9, P358, DOI 10.1158/1535-7163.MCT-09-1014; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Murayama Hosokawa S, 2010, ONCOGENE, V29, P1897; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang JL, 2010, J CANCER RES CLIN, V136, P1303, DOI 10.1007/s00432-010-0781-3; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	46	65	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37431	10.1371/journal.pone.0037431	http://dx.doi.org/10.1371/journal.pone.0037431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662154	Green Published, gold			2022-12-25	WOS:000305342300044
J	Weber, H; Scholz, CJ; Domschke, K; Baumann, C; Klauke, B; Jacob, CP; Maier, W; Fritze, J; Bandelow, B; Zwanzger, PM; Lang, T; Fehm, L; Strohle, A; Hamm, A; Gerlach, AL; Alpers, GW; Kircher, T; Wittchen, HU; Arolt, V; Pauli, P; Deckert, J; Reif, A				Weber, Heike; Scholz, Claus Juergen; Domschke, Katharina; Baumann, Christian; Klauke, Benedikt; Jacob, Christian P.; Maier, Wolfgang; Fritze, Juergen; Bandelow, Borwin; Zwanzger, Peter Michael; Lang, Thomas; Fehm, Lydia; Stroehle, Andreas; Hamm, Alfons; Gerlach, Alexander L.; Alpers, Georg W.; Kircher, Tilo; Wittchen, Hans-Ulrich; Arolt, Volker; Pauli, Paul; Deckert, Juergen; Reif, Andreas			Gender Differences in Associations of Glutamate Decarboxylase 1 Gene (GAD1) Variants with Panic Disorder	PLOS ONE			English	Article							POPULATION-BASED ASSOCIATION; ANXIETY DISORDERS; GABA LEVELS; RESONANCE SPECTROSCOPY; ANTERIOR CINGULATE; MAJOR DEPRESSION; CANDIDATE GENES; DECARBOXYLASE 1; SCHIZOPHRENIA; ACID	Background: Panic disorder is common (5% prevalence) and females are twice as likely to be affected as males. The heritable component of panic disorder is estimated at 48%. Glutamic acid dehydrogenase GAD1, the key enzyme for the synthesis of the inhibitory and anxiolytic neurotransmitter GABA, is supposed to influence various mental disorders, including mood and anxiety disorders. In a recent association study in depression, which is highly comorbid with panic disorder, GAD1 risk allele associations were restricted to females. Methodology/Principal Findings: Nineteen single nucleotide polymorphisms (SNPs) tagging the common variation in GAD1 were genotyped in two independent gender and age matched case-control samples (discovery sample n = 478; replication sample n = 584). Thirteen SNPs passed quality control and were examined for gender-specific enrichment of risk alleles associated with panic disorder by using logistic regression including a genotypexgender interaction term. The latter was found to be nominally significant for four SNPs (rs1978340, rs3762555, rs3749034, rs2241165) in the discovery sample; of note, the respective minor/risk alleles were associated with panic disorder only in females. These findings were not confirmed in the replication sample; however, the genotypexgender interaction of rs3749034 remained significant in the combined sample. Furthermore, this polymorphism showed a nominally significant association with the Agoraphobic Cognitions Questionnaire sum score. Conclusions/Significance: The present study represents the first systematic evaluation of gender-specific enrichment of risk alleles of the common SNP variation in the panic disorder candidate gene GAD1. Our tentative results provide a possible explanation for the higher susceptibility of females to panic disorder.	[Weber, Heike; Domschke, Katharina; Baumann, Christian; Jacob, Christian P.; Arolt, Volker; Deckert, Juergen; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Scholz, Claus Juergen] Univ Wurzburg, Interdisciplinary Ctr Clin Res IZKF, Wurzburg, Germany; [Domschke, Katharina; Klauke, Benedikt; Zwanzger, Peter Michael] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Fritze, Juergen] Goethe Univ Frankfurt, Dept Psychiat, Frankfurt, Germany; [Bandelow, Borwin] Univ Gottingen, Dept Psychiat, Gottingen, Germany; [Lang, Thomas] Christoph Dornier Fdn Clin Psychol, Bremen, Germany; [Lang, Thomas] Univ Bremen, Zentrum Klin Psychol & Rehabil, D-28359 Bremen, Germany; [Fehm, Lydia] Univ Berlin, Inst Psychol, Berlin, Germany; [Stroehle, Andreas] Charite, Dept Psychiat, Berlin, Germany; [Hamm, Alfons] Ernst Moritz Arndt Univ Greifswald, Inst Psychol, Greifswald, Germany; [Gerlach, Alexander L.] Univ Cologne, Inst Clin Psychol & Psychotherapy, D-50931 Cologne, Germany; [Alpers, Georg W.; Pauli, Paul] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Alpers, Georg W.] Univ Mannheim, Sch Social Sci, Mannheim, Germany; [Kircher, Tilo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany	University of Wurzburg; University of Wurzburg; University of Munster; University of Bonn; Goethe University Frankfurt; University of Gottingen; University of Bremen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald; University of Cologne; University of Wurzburg; University of Mannheim; Philipps University Marburg; Technische Universitat Dresden	Weber, H (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.	Weber_H2@klinik.uni-wuerzburg.de	Kircher, Tilo/AAT-6480-2020; Scholz, Claus Jürgen/H-3202-2019; Bandelow, Borwin/E-7295-2011; Ströhle, Andreas/E-4286-2012; Wittchen, Hans-Ulrich/A-8507-2014; Domschke, Katharina/I-7921-2013; Wittchen, Hans-Ulrich/ABA-8901-2020; Gerlach, Alexander L./L-5045-2019; Gerlach, Alexander L. L/C-2990-2011	Kircher, Tilo/0000-0002-2514-2625; Scholz, Claus Jürgen/0000-0002-6406-7859; Bandelow, Borwin/0000-0003-2511-3768; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Gerlach, Alexander L./0000-0001-6794-5349; Gerlach, Alexander L. L/0000-0001-6794-5349; Pauli, Paul/0000-0003-0692-6720; Fehm, Lydia/0000-0002-0825-8466; Alpers, Georg W./0000-0001-9896-5158; Weber, Heike/0000-0002-9421-1292	Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization) [SFB TRR 58 Z02, C01, C02, RE1632/1-5, KFO 125, RTG 1252]; Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF); Bundesministerium fur Bildung und Forschung (Panic-Net)	Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (Panic-Net)(Federal Ministry of Education & Research (BMBF))	This study was supported by the Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization; Grant SFB TRR 58 Z02 to AR, PP and JD, C01 to PZ and C02 to KD; RE1632/1-5 to AR, KFO 125 to AR, PP and CPJ; RTG 1252, to AR, PP and JD; for details see website http://www.dfg.de) and the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF; Panic-Net, to ALG, TK, AS, HUW, VA, AH and JD; for details see web pages http://www.bmbf.de/ and http://www.paniknetz.de/netzwerk.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; [Anonymous], 2010, R LANG ENV STAT COMP; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Buttenschon HN, 2009, J NEURAL TRANSM, V116, P381, DOI 10.1007/s00702-008-0142-4; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Donner J, 2012, AM J MED GENET B, V159B, P316, DOI 10.1002/ajmg.b.32029; Du J, 2008, J NEURAL TRANSM, V115, P513, DOI 10.1007/s00702-007-0844-z; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fyer AJ, 2006, BIOL PSYCHIAT, V60, P388, DOI 10.1016/j.biopsych.2006.04.018; Geis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016775; Geller B, 2008, J CHILD ADOL PSYCHOP, V18, P25, DOI 10.1089/cap.2007.0056; Gloster AT, 2009, EUR ARCH PSY CLIN N, V259, P155, DOI 10.1007/s00406-009-0065-6; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Ikeda M, 2007, SCHIZOPHR RES, V91, P22, DOI 10.1016/j.schres.2006.12.020; Jarius S, 2010, J NEUROIMMUNOL; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klauke B, 2010, DEPRESS ANXIETY, V27, P716, DOI 10.1002/da.20667; Koerner C, 2004, NEUROLOGY, V62, P1357, DOI 10.1212/01.WNL.0000120543.65812.33; Lappalainen J, 2004, AM J MED GENET B, V124B, P81, DOI 10.1002/ajmg.b.20055; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lundorf MD, 2005, AM J MED GENET B, V135B, P94, DOI 10.1002/ajmg.b.30137; MANNUZZA S, 1986, J PSYCHIAT RES, V20, P317, DOI 10.1016/0022-3956(86)90034-8; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; MCCARTHY MM, 1995, J COMP NEUROL, V360, P685, DOI 10.1002/cne.903600412; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Noriega NC, 2010, BRAIN RES, V1307, P28, DOI 10.1016/j.brainres.2009.10.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabionet R, 2004, NEUROSCI LETT, V372, P209, DOI 10.1016/j.neulet.2004.09.037; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Utge S, 2010, AM J MED GENET B, V153B, P468, DOI 10.1002/ajmg.b.31002; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010; Zhao X, 2007, SCHIZOPHR RES, V93, P374, DOI 10.1016/j.schres.2007.02.023; Zwanzger P, 2005, J PSYCHIATR NEUROSCI, V30, P167	49	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37651	10.1371/journal.pone.0037651	http://dx.doi.org/10.1371/journal.pone.0037651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662185	Green Published, gold			2022-12-25	WOS:000305342300075
J	Cronier, S; Carimalo, J; Schaeffer, B; Jaumain, E; Beringue, V; Miquel, MC; Laude, H; Peyrin, JM				Cronier, Sabrina; Carimalo, Julie; Schaeffer, Brigitte; Jaumain, Emilie; Beringue, Vincent; Miquel, Marie-Christine; Laude, Hubert; Peyrin, Jean-Michel			Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death	FASEB JOURNAL			English	Article						neurodegeneration; primary culture; astrocyte; scrapie	PRP KNOCKOUT MICE; IN-VIVO; SCRAPIE; INFECTION; NEURODEGENERATION; OLIGOMERS; TOXICITY; DISEASE; MECHANISMS; ASTROCYTES	Prions cause fatal neurodegenerative conditions and result from the conversion of host-encoded cellular prion protein (PrPC) into abnormally folded scrapie PrP (PrPSc). Prions can propagate both in neurons and astrocytes, yet neurotoxicity mechanisms remain unclear. Recently, PrPC was proposed to mediate neurotoxic signaling of beta-sheet-rich PrP and non-PrP conformers independently of conversion. To investigate the role of astrocytes and neuronal PrPC in prion-induced neurodegeneration, we set up neuron and astrocyte primary cocultures derived from PrP transgenic mice. In this system, prion-infected astrocytes delivered ovine PrPSc to neurons lacking PrPC (prion-resistant), or expressing a PrPC convertible (sheep) or not (mouse, human). We show that interaction between neuronal PrPC and exogenous PrPSc was not sufficient to induce neuronal death but that efficient PrPC conversion was required for prion-associated neurotoxicity. Prion-infected astrocytes markedly accelerated neurodegeneration in homologous cocultures compared to infected single neuronal cultures, despite no detectable neurotoxin release. Finally, PrPSc accumulation in neurons led to neuritic damages and cell death, both potentiated by glutamate and reactive oxygen species. Thus, conversion of neuronal PrPC rather than PrPC-mediated neurotoxic signaling appears as the main culprit in prion-induced neurodegeneration. We suggest that active prion replication in neurons sensitizes them to environmental stress regulated by neighboring cells, including astrocytes.-Cronier, S., Carimalo, J., Schaeffer, B., Jaumain, E., Beringue, V., Miquel, M.-C., Laude, H., Peyrin, J.-M. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J. 26, 3854-3861 (2012). www.fasebj.org	[Cronier, Sabrina; Jaumain, Emilie; Beringue, Vincent; Laude, Hubert; Peyrin, Jean-Michel] INRA, Virol & Immunol Mol UR892, F-78352 Jouy En Josas, France; [Schaeffer, Brigitte] INRA, Math & Informat Appl UR0341, F-78352 Jouy En Josas, France; [Carimalo, Julie; Miquel, Marie-Christine; Peyrin, Jean-Michel] Univ Paris 06, CNRS, UMR 7102, Paris, France; [Carimalo, Julie] Univ Gottingen, Natl Reference Ctr Transmissible Spongiform Encep, Dept Neurol, Gottingen, Germany	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Gottingen	Cronier, S (corresponding author), INRA, Virol & Immunol Mol UR892, F-78352 Jouy En Josas, France.	sabrina.cronier@jouy.inra.fr; jean-michel.peyrin@snv.jussieu.fr		Miquel, Marie-Christine/0000-0002-9332-2572; Peyrin, Jean-Michel/0000-0002-0108-1266; Peyrin, Jean-Michel/0000-0002-8705-8672	French government (GIS-Infections a Prion); European Union [Neurodegeneration-QLG3CT2001]; French Ministry of Research and Education (MRE); MRE; French Foundation France Alzheimer	French government (GIS-Infections a Prion); European Union(European Commission); French Ministry of Research and Education (MRE); MRE; French Foundation France Alzheimer	This project was supported by grants from the French government (GIS-Infections a Prion) and from the European Union (Neurodegeneration-QLG3CT2001). S. C. was a recipient of a French Ministry of Research and Education (MRE) fellowship. J.C. was funded by an MRE fellowship and the French Foundation France Alzheimer. The authors thank S. Hawke (Imperial College, London, UK; now at University of Sydney, Sydney, NSW, Australia) and G. S. Jackson (Medical Research Council Prion Unit, London, UK) for kindly providing the antibodies ICSM18 and ICSM35, and ICSM33, respectively; J. Grassi and S. Simon (Commissariat a l'energie Atomique et aux energies Alternatives, Saclay, France) for Sha31 antibody; C. Weissmann (Scripps Research Institute, Jupiter, FL, USA) for authorizing the inclusion of tga20 and PrP<SUP>0/0</SUP> mice in this study. The authors thank T. Szeto for careful reading of the manuscript and R. Young for preparation of the figures.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 2002, J NEUROCHEM, V82, P209, DOI 10.1046/j.1471-4159.2002.01004.x; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gavin R, 2005, FEBS LETT, V579, P4099, DOI 10.1016/j.febslet.2005.06.037; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kunz B, 1999, FEBS LETT, V458, P65, DOI 10.1016/S0014-5793(99)01123-0; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Laude H, 2002, CR BIOL, V325, P49, DOI 10.1016/S1631-0691(02)01393-8; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lefebvre-Roque M, 2007, PRION, V1, P198, DOI 10.4161/pri.1.3.4870; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sakudo A, 2009, CURR MED CHEM, V16, P380, DOI 10.2174/092986709787002673; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Schengrund CL, 2010, BRAIN RES BULL, V82, P7, DOI 10.1016/j.brainresbull.2010.02.013; Schneider B, 2011, FRONT BIOSCI-LANDMRK, V16, P169, DOI 10.2741/3682; Silveira JR, 2004, CURR TOP MICROBIOL, V284, P1; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011	48	19	19	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3854	3861		10.1096/fj.11-201772	http://dx.doi.org/10.1096/fj.11-201772			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22661006				2022-12-25	WOS:000308391600025
J	Butler, MW; McGraw, KJ				Butler, Michael W.; McGraw, Kevin J.			Differential Effects of Early- and Late-Life Access to Carotenoids on Adult Immune Function and Ornamentation in Mallard Ducks (Anas platyrhynchos)	PLOS ONE			English	Article							MULTIPLE MALE ORNAMENTS; DIETARY CAROTENOIDS; MATING PREFERENCES; NEONATAL NUTRITION; THRIFTY PHENOTYPE; LOCAL RECRUITMENT; SEXUAL ORNAMENTS; NITRIC-OXIDE; COLORATION; IMMUNOCOMPETENCE	Environmental conditions early in life can affect an organism's phenotype at adulthood, which may be tuned to perform optimally in conditions that mimic those experienced during development (Environmental Matching hypothesis), or may be generally superior when conditions during development were of higher quality (Silver Spoon hypothesis). Here, we tested these hypotheses by examining how diet during development interacted with diet during adulthood to affect adult sexually selected ornamentation and immune function in male mallard ducks (Anas platyrhynchos). Mallards have yellow, carotenoid-pigmented beaks that are used in mate choice, and the degree of beak coloration has been linked to adult immune function. Using a 2x2 factorial experimental design, we reared mallards on diets containing either low or high levels of carotenoids (nutrients that cannot be synthesized de novo) throughout the period of growth, and then provided adults with one of these two diets while simultaneously quantifying beak coloration and response to a variety of immune challenges. We found that both developmental and adult carotenoid supplementation increased circulating carotenoid levels during dietary treatment, but that birds that received low-carotenoid diets during development maintained relatively higher circulating carotenoid levels during an adult immune challenge. Individuals that received low levels of carotenoids during development had larger phytohemagglutinin (PHA)-induced cutaneous immune responses at adulthood; however, dietary treatment during development and adulthood did not affect antibody response to a novel antigen, nitric oxide production, natural antibody levels, hemolytic capacity of the plasma, or beak coloration. However, beak coloration prior to immune challenges positively predicted PHA response, and strong PHA responses were correlated with losses in carotenoid-pigmented coloration. In sum, we did not find consistent support for either the Environmental Matching or Silver Spoon hypotheses. We then describe a new hypothesis that should be tested in future studies examining developmental plasticity.	[Butler, Michael W.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Butler, MW (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	Mike.Butler@asu.edu		Butler, Michael/0000-0002-8390-2960	Sigma-Xi; Frank M. Chapman Research Grant; Graduate and Professional Student Association; Animal Behavior Society; National Science Foundation [0746364]; Arizona State University Graduate College; Faculty Emeriti Association	Sigma-Xi; Frank M. Chapman Research Grant; Graduate and Professional Student Association; Animal Behavior Society; National Science Foundation(National Science Foundation (NSF)); Arizona State University Graduate College; Faculty Emeriti Association	The ASU Chapter of Sigma-Xi Grants-in-Aid of Research, the Frank M. Chapman Research Grant, the Graduate and Professional Student Association JumpStart Research Grant, the Sigma-Xi Grants-in-Aid of Research, and the Animal Behavior Society Student Research Grant provided financial support to MWB, and the National Science Foundation (#0746364) provided support to KJM. MWB was partially supported by the Arizona State University Graduate College Dissertation Fellowship and the Faculty Emeriti Association Fellowship during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; ALLEN PC, 1987, COMP BIOCHEM PHYS B, V87, P313, DOI 10.1016/0305-0491(87)90145-3; Auer SK, 2010, AM NAT, V176, P818, DOI 10.1086/657061; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2009, ENTOMOL EXP APPL, V130, P229, DOI 10.1111/j.1570-7458.2008.00814.x; Biard C, 2009, J EXP BIOL, V212, P1336, DOI 10.1242/jeb.028449; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Bischoff LL, 2009, BEHAV ECOL, V20, P265, DOI 10.1093/beheco/arp012; Bland ST, 2010, BRAIN BEHAV IMMUN, V24, P329, DOI 10.1016/j.bbi.2009.09.012; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; Blount JD, 2006, IBIS, V148, P509, DOI 10.1111/j.1474-919X.2006.00554.x; Bourgeon S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P793, DOI 10.1086/504609; Butler MW, 2012, FUNCT ECOL, V26, P406, DOI 10.1111/j.1365-2435.2011.01942.x; Butler MW, 2012, P ROY SOC B-BIOL SCI, V279, P326, DOI 10.1098/rspb.2011.0842; Butler MW, 2011, J COMP PHYSIOL B, V181, P551, DOI 10.1007/s00360-010-0529-z; Butler MW, 2011, BEHAV ECOL SOCIOBIOL, V65, P401, DOI 10.1007/s00265-010-1074-1; Butler MW, 2010, ARCH BIOCHEM BIOPHYS, V504, P154, DOI 10.1016/j.abb.2010.07.003; Butler MW, 2009, AVIAN BIOL RES, V2, P203, DOI 10.3184/175815509X12570082777157; Butler MW, 2009, AUK, V126, P536, DOI 10.1525/auk.2009.08179; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Connor WE, 2007, INVEST OPHTH VIS SCI, V48, P4226, DOI 10.1167/iovs.06-1275; Cote J, 2010, J EXP BIOL, V213, P2116, DOI 10.1242/jeb.040220; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Drilling N., 2002, MALLARD ANAS PLATYRH; Fenoglio S, 2002, ETHOL ECOL EVOL, V14, P149; Giraudeau M, 2011, P ROY SOC B-BIOL SCI, V278, P781, DOI 10.1098/rspb.2010.1115; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Gray DA, 2008, AM J PHYSIOL-REG I, V294, pR1666, DOI 10.1152/ajpregu.00865.2007; Grether GF, 2008, FUNCT ECOL, V22, P294, DOI 10.1111/j.1365-2435.2007.01365.x; Hill G. E., 2006, BIRD COLORATION, VI; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Huggins KA, 2010, NATURWISSENSCHAFTEN, V97, P637, DOI 10.1007/s00114-010-0679-6; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2; Koutsos EA, 2003, J NUTR, V133, P1132, DOI 10.1093/jn/133.4.1132; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin SM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P333, DOI 10.1086/649965; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Macedo RC, 2010, EUR J NUTR, V49, P447, DOI 10.1007/s00394-010-0103-1; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; McGraw KJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1991, DOI 10.1007/s00265-008-0622-4; McGraw KJ, 2011, J COMP PHYSIOL A, V197, P683, DOI 10.1007/s00359-011-0631-z; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Monaghan P, 2012, P ROY SOC B-BIOL SCI, V279, P709, DOI 10.1098/rspb.2011.1291; Montgomerie R., 2008, CLR COLOUR ANAL PROG; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Ohlsson T, 2003, ETHOL ECOL EVOL, V15, P31; Okai Y, 1996, INT J IMMUNOPHARMACO, V18, P753, DOI 10.1016/S0192-0561(97)85558-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P361, DOI 10.1007/s002650050301; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P353, DOI 10.1007/s002650050300; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Ruiz M, 2010, HORM BEHAV, V57, P134, DOI 10.1016/j.yhbeh.2009.09.019; Saastamoinen M, 2010, AM NAT, V176, P686, DOI 10.1086/657038; Salvante KG, 2006, AUK, V123, P575, DOI 10.1642/0004-8038(2006)123[575:TFSIIF]2.0.CO;2; Sanchez MM, 2006, HORM BEHAV, V50, P623, DOI 10.1016/j.yhbeh.2006.06.012; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHRANK CS, 1990, J WILDLIFE DIS, V26, P307, DOI 10.7589/0090-3558-26.3.307; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; Sild E, 2009, BEHAV ECOL SOCIOBIOL, V63, P959, DOI 10.1007/s00265-009-0710-0; Smith HG, 2007, J EVOLUTION BIOL, V20, P310, DOI 10.1111/j.1420-9101.2006.01203.x; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; SULLIVAN KA, 1989, J ANIM ECOL, V58, P275, DOI 10.2307/5000; Vinkler M, 2012, ANIM BEHAV, V83, P17, DOI 10.1016/j.anbehav.2011.10.001; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P575, DOI 10.1016/S0304-4165(97)00007-X; Zheng CL, 2003, INFLAMMATION, V27, P247, DOI 10.1023/A:1025092615584	79	10	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38043	10.1371/journal.pone.0038043	http://dx.doi.org/10.1371/journal.pone.0038043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666443	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400072
J	Chesters, D; Wang, Y; Yu, F; Bai, M; Zhang, TX; Hu, HY; Zhu, CD; Li, CD; Zhang, YZ				Chesters, Douglas; Wang, Ying; Yu, Fang; Bai, Ming; Zhang, Tong-Xin; Hu, Hao-Yuan; Zhu, Chao-Dong; Li, Cheng-De; Zhang, Yan-Zhou			The Integrative Taxonomic Approach Reveals Host Specific Species in an Encyrtid Parasitoid Species Complex	PLOS ONE			English	Article							DNA BARCODES; BIOLOGICAL IDENTIFICATIONS; DIVERGENCE TIMES; NATURAL-HISTORY; FLIES DIPTERA; HONEY-BEES; HYMENOPTERA; BRACONIDAE; POPULATIONS; DIVERSITY	Integrated taxonomy uses evidence from a number of different character types to delimit species and other natural groupings. While this approach has been advocated recently, and should be of particular utility in the case of diminutive insect parasitoids, there are relatively few examples of its application in these taxa. Here, we use an integrated framework to delimit independent lineages in Encyrtus sasakii (Hymenoptera: Chalcidoidea: Encyrtidae), a parasitoid morphospecies previously considered a host generalist. Sequence variation at the DNA barcode (cytochrome c oxidase I, COI) and nuclear 28S rDNA loci were compared to morphometric recordings and mating compatibility tests, among samples of this species complex collected from its four scale insect hosts, covering a broad geographic range of northern and central China. Our results reveal that Encyrtus sasakii comprises three lineages that, while sharing a similar morphology, are highly divergent at the molecular level. At the barcode locus, the median K2P molecular distance between individuals from three primary populations was found to be 11.3%, well outside the divergence usually observed between Chalcidoidea conspecifics (0.5%). Corroborative evidence that the genetic lineages represent independent species was found from mating tests, where compatibility was observed only within populations, and morphometric analysis, which found that despite apparent morphological homogeneity, populations clustered according to forewing shape. The independent lineages defined by the integrated analysis correspond to the three scale insect hosts, suggesting the presence of host specific cryptic species. The finding of hidden host specificity in this species complex demonstrates the critical role that DNA barcoding will increasingly play in revealing hidden biodiversity in taxa that present difficulties for traditional taxonomic approaches.	[Chesters, Douglas; Wang, Ying; Yu, Fang; Bai, Ming; Zhu, Chao-Dong; Zhang, Yan-Zhou] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Ying; Li, Cheng-De] NE Forestry Univ, Sch Forestry, Div Forest Protect, Harbin, Peoples R China; [Zhang, Tong-Xin] Ningbo Technol Extens Ctr Forestry & Specialty Fo, Ningbo, Peoples R China; [Hu, Hao-Yuan] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Forestry University - China; Ningbo University of Technology; Anhui Normal University	Chesters, D (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhangyz@ioz.ac.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011	ZHU, Chao-Dong/0000-0002-9347-3178	National Natural Science Foundation of China (NSFC) [30870321, 31071950]; Public Welfare Project from the Ministry of Agriculture, China [201103022, 201103024]; Program of Ministry of Science and Technology of the People's Republic of China [2011FY120200]; Programs of Chinese Academy of Sciences [KSCX2-YW-NF-02, KSCX2-EW-G-4]; Ningbo Science and Technology Bureau [2009C10004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Welfare Project from the Ministry of Agriculture, China; Program of Ministry of Science and Technology of the People's Republic of China; Programs of Chinese Academy of Sciences; Ningbo Science and Technology Bureau	This research was supported by the National Natural Science Foundation of China (NSFC grant no. 30870321, 31071950), Public Welfare Project from the Ministry of Agriculture, China (Grant No. 201103022, 201103024); the Program of Ministry of Science and Technology of the People's Republic of China (2011FY120200), the Programs of Chinese Academy of Sciences (KSCX2-YW-NF-02, KSCX2-EW-G-4), and partially by Ningbo Science and Technology Bureau (2009C10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021600; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Billah MK, 2008, B ENTOMOL RES, V98, P63, DOI 10.1017/S000748530700541X; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell B., 2000, P59; Campbell B. C., 1993, Insect Molecular Biology, V2, P225, DOI 10.1111/j.1365-2583.1994.tb00142.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Daane KM, 2000, BIOCONTROL, V45, P269, DOI 10.1023/A:1009960223681; May-Itza WD, 2010, CONSERV GENET, V11, P2079, DOI 10.1007/s10592-010-0087-7; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emery VJ, 2009, MOL ECOL RESOUR, V9, P217, DOI 10.1111/j.1755-0998.2009.02647.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Guerrieri E, 2001, J NAT HIST, V35, P41, DOI 10.1080/002229301447880; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hassell, 2000, SPATIAL TEMPORAL DYN; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; Herre EA, 2006, P NATL ACAD SCI USA, V103, P3949, DOI 10.1073/pnas.0600550103; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Jones OR, 2009, INSECT CONSERV DIVER, V2, P204, DOI 10.1111/j.1752-4598.2009.00057.x; Kandemir I, 2009, J APICULT RES, V48, P238, DOI 10.3896/IBRA.1.48.4.03; Leo SST, 2010, J MED ENTOMOL, V47, P565, DOI 10.1603/ME10006; Liao DX, 1987, EC INSECT FAUNA CHIN, V34, P1; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; Lou JX, 2011, CHALCIDOIDEA CHRYSID; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Lu XP, 2006, FOREST SCI TECHNOLOG, V31, P34; Lysyk TJ, 2008, J MED ENTOMOL, V45, P1064, DOI 10.1603/0022-2585(2008)45[1064:RCOPAM]2.0.CO;2; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Mendes Marcelo Fidelis Marques, 2007, Bioscience Journal, V23, P147; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Nylander J, 2005, MRAIC 1 4 COMPUTER S; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Phillips CB, 2008, MOL PHYLOGENET EVOL, V49, P467, DOI 10.1016/j.ympev.2008.08.005; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Prinsloo G.L., 1991, South Africa Department of Agricultural Development Entomology Memoir, P1; Quicke D. L. J., 1997, PARASITIC WASPS; R Core Team, 2021, R LANG ENV STAT COMP; Ratnasingham S, MOL ECOLOGY NOTES, V7, P355; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf FJ, 2006, TPS RELW RELATIVE WA; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Sha ZL, 2006, BIOL CONTROL, V38, P380, DOI 10.1016/j.biocontrol.2006.04.008; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; SPSS, 2007, SPSS VERS 16 0 WIND; Sugonjaev ES, 1981, ENTOMOL REV, V60, P124; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Van valen L, 1976, EVOL THEORY, V1, P179; Villemant C, 2007, SYST ENTOMOL, V32, P625, DOI 10.1111/j.1365-3113.2007.00389.x; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Whiteman NK, 2006, J PARASITOL, V92, P1218, DOI 10.1645/GE-918R.1; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Xie Ying-ping, 2007, Entomotaxonomia, V29, P145; Xie YP, 1998, SCALE INSECTS FOREST, P46; Xu ZH, 2004, CHINESE FAUNA PARASI; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Zhang YZ, 2011, BIOL CONTROL, V58, P182, DOI 10.1016/j.biocontrol.2011.05.006	90	32	38	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37655	10.1371/journal.pone.0037655	http://dx.doi.org/10.1371/journal.pone.0037655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666375	Green Published, gold			2022-12-25	WOS:000305353400037
J	Labar, AS; Millman, JS; Ruebush, E; Opintan, JA; Bishar, RA; Aboderin, O; Newman, MJ; Lamikanra, A; Okeke, IN				Labar, Amy S.; Millman, Jennifer S.; Ruebush, Ellen; Opintan, Japheth A.; Bishar, Rima A.; Aboderin, Oladipo; Newman, Mercy J.; Lamikanra, Adebayo; Okeke, Iruka N.			Regional Dissemination of a Trimethoprim-Resistance Gene Cassette via a Successful Transposable Element	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; VIBRIO-CHOLERAE O1; DIHYDROFOLATE-REDUCTASE GENES; ENTERICA SEROVAR TYPHIMURIUM; COMPLETE GENOME SEQUENCE; ADHERENCE FACTOR PLASMID; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; COTRIMOXAZOLE PROPHYLAXIS	Background: Antimicrobial resistance is a growing international problem. We observed a 50% increase in the prevalence of trimethoprim resistance among fecal Escherichia coli from healthy Nigerian students between 1998 and 2005, a trend to increase that continued in 2009. Methods and Findings: A PCR-based screen revealed that 131 (43.1%) of isolates obtained in Nigeria in 2005 and 2009 carried integron-borne dfrA cassettes. In the case of 67 (51.1%) of these isolates, the cassette was a class 1-integron-borne dfrA7 gene, which has been reported at high prevalence from E. coli isolates from other parts of Africa. Complete sequencing of a 27 Kb dfrA7-bearing plasmid from one isolate located the dfrA7 gene within a Tn21-type transposon. The transposon also contained an IS26-derived bla/sul/str element, encoding resistance to beta-lactams, sulphonamides and streptomycin, and mercury resistance genes. Although the plasmid backbone was only found in 12 (5.8%) of trimethoprim-resistant isolates, dfrA7 and other transposon-borne genes were detected in 14 (16.3%) and 32 (26.3%) of trimethoprim resistant isolates collected in Nigeria in 2005 and 2009, respectively. Additionally, 37 (19.3%) of trimethoprim-resistant E. coli isolates collected between 2006 and 2008 from Ghana were positive for the dfrA7 and a transposon marker, but only 4 (2.1%) harbored the plasmid backbone. Conclusions: Our data point to transposition as a principal mechanism for disseminating dfrA7 among E. coli from Nigeria and Ghana. On-going intensive use of the affordable broad-spectrum antibacterials is likely to promote selective success of a highly prevalent transposable element in West Africa.	[Labar, Amy S.; Millman, Jennifer S.; Ruebush, Ellen; Bishar, Rima A.; Okeke, Iruka N.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Opintan, Japheth A.; Newman, Mercy J.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Aboderin, Oladipo] Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Nigeria; [Lamikanra, Adebayo] Obafemi Awolowo Univ, Dept Pharmaceut, Ife, Nigeria	Haverford College; University of Ghana; Obafemi Awolowo University; Obafemi Awolowo University	Labar, AS (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Aboderin, Aaron/V-8025-2019	Okeke, Iruka N/0000-0002-1694-7587; Aboderin, Aaron/0000-0002-4280-2218	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College	This work was supported by a Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO. AL and RAB were supported by undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN PV, 1995, J ANTIMICROB CHEMOTH, V35, P497, DOI 10.1093/jac/35.4.497; Ahmed AM, 2006, J MED MICROBIOL, V55, P643, DOI 10.1099/jmm.0.46378-0; Ajiboye RM, 2009, CLIN INFECT DIS, V49, P365, DOI 10.1086/600301; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Brolund A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009233; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Ceccarelli D, 2006, J ANTIMICROB CHEMOTH, V58, P1095, DOI 10.1093/jac/dkl352; Ceccarelli D, 2006, ANTIMICROB AGENTS CH, V50, P2493, DOI 10.1128/AAC.01310-05; Chah KF, 2010, J BASIC MICROB, V50, pS18, DOI 10.1002/jobm.200900325; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Crespo O, 2005, INT J ANTIMICROB AG, V25, P341, DOI 10.1016/j.ijantimicag.2005.01.016; Dahmen S, 2010, MICROB DRUG RESIST, V16, P43, DOI 10.1089/mdr.2009.0091; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Djie-Maletz A, 2008, J ANTIMICROB CHEMOTH, V61, P1315, DOI 10.1093/jac/dkn108; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; El-Najjar NG, 2010, LETT APPL MICROBIOL, V51, P456, DOI 10.1111/j.1472-765X.2010.02926.x; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Ford N, 2009, NEW ENGL J MED, V360, P1808, DOI 10.1056/NEJMp0902820; France AM, 2005, CLIN INFECT DIS, V40, P1101, DOI 10.1086/428727; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Gangoue-Pieboji Joseph, 2006, Afr Health Sci, V6, P232; Gassama A, 2004, MICROB DRUG RESIST, V10, P27, DOI 10.1089/107662904323047763; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; HEIKKILA E, 1990, J ANTIMICROB CHEMOTH, V25, P275, DOI 10.1093/jac/25.2.275; HEIKKILA E, 1990, J INFECT DIS, V161, P1242, DOI 10.1093/infdis/161.6.1242; HEIKKILA E, 1991, ANTIMICROB AGENTS CH, V35, P1562, DOI 10.1128/AAC.35.8.1562; HEIKKILA E, 1990, ANTIMICROB AGENTS CH, V34, P2013, DOI 10.1128/AAC.34.10.2013; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; JANSSON C, 1991, ANTIMICROB AGENTS CH, V35, P1891, DOI 10.1128/AAC.35.9.1891; JANSSON C, 1992, ANTIMICROB AGENTS CH, V36, P2704, DOI 10.1128/AAC.36.12.2704; Johnson JR, 2011, EMERG INFECT DIS, V17, P2001, DOI 10.3201/eid1711.110488; Johnson JR, 2002, LANCET, V359, P2249, DOI 10.1016/S0140-6736(02)09264-4; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; KRAFT CA, 1986, J MED MICROBIOL, V22, P125, DOI 10.1099/00222615-22-2-125; Lamikanra A, 1996, INT J ANTIMICROB AG, V7, P59, DOI 10.1016/0924-8579(96)00011-8; LAMIKANRA A, 1989, FEMS MICROBIOL LETT, V59, P275; Lamikanra A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-312; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Morpeth SC, 2008, JAIDS-J ACQ IMM DEF, V47, P585, DOI 10.1097/QAI.0b013e31816856db; Namboodiri SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-44; NCCLS, 2003, M2A8 NCCLS, P130; Newman Mercy J, 2002, West Afr J Med, V21, P48; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; Ojo KK, 2002, J ANTIMICROB CHEMOTH, V49, P573, DOI 10.1093/jac/49.3.573; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2000, EMERG INFECT DIS, V6, P393; Okeke IN, 2002, J CLIN MICROBIOL, V40, P301, DOI 10.1128/JCM.40.1.301-305.2002; Okeke IN, 2001, CLIN INFECT DIS, V33, P364, DOI 10.1086/321877; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P1179, DOI 10.1128/AAC.01101-06; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Ploy MC, 2003, ANTIMICROB AGENTS CH, V47, P1427, DOI 10.1128/AAC.47.4.1427-1429.2003; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J, 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik D, 2009, MICROB DRUG RESIST, V15, P173, DOI 10.1089/mdr.2009.0918; Solberg OD, 2006, J CLIN MICROBIOL, V44, P1347, DOI 10.1128/JCM.44.4.1347-1351.2006; STEEN R, 1985, ANTIMICROB AGENTS CH, V27, P933, DOI 10.1128/AAC.27.6.933; SUNDSTROM L, 1993, J BACTERIOL, V175, P1796; TAIT S, 1994, EPIDEMIOL INFECT, V113, P247, DOI 10.1017/S0950268800051670; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; TOWNER KJ, 1994, J ANTIMICROB CHEMOTH, V33, P25, DOI 10.1093/jac/33.1.25; Vasilakopoulou A, 2009, FOODBORNE PATHOG DIS, V6, P1211, DOI 10.1089/fpd.2009.0281; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; WOMBLE DD, 1988, MICROBIOL REV, V52, P433, DOI 10.1128/MMBR.52.4.433-451.1988; World Health Organization, 2001, Afr Health Sci, V1, P30; Yang CM, 2009, JPN J INFECT DIS, V62, P177; Yau S, 2010, MICROB DRUG RESIST, V16, P249, DOI 10.1089/mdr.2010.0033	93	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38142	10.1371/journal.pone.0038142	http://dx.doi.org/10.1371/journal.pone.0038142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666464	Green Submitted, gold, Green Published			2022-12-25	WOS:000305353400089
J	Lorat, Y; Schanz, S; Schuler, N; Wennemuth, G; Rube, C; Rube, CE				Lorat, Yvonne; Schanz, Stefanie; Schuler, Nadine; Wennemuth, Gunther; Ruebe, Christian; Ruebe, Claudia E.			Beyond Repair Foci: DNA Double-Strand Break Repair in Euchromatic and Heterochromatic Compartments Analyzed by Transmission Electron Microscopy	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NORMAL-TISSUES; CHROMATIN; KU; PHOSPHORYLATION; GAMMA-H2AX; ORGANIZATION; HETERODIMER; CHROMOSOMES; COMPLEX	Purpose: DNA double-strand breaks (DSBs) generated by ionizing radiation pose a serious threat to the preservation of genetic and epigenetic information. The known importance of local chromatin configuration in DSB repair raises the question of whether breaks in different chromatin environments are recognized and repaired by the same repair machinery and with similar efficiency. An essential step in DSB processing by non-homologous end joining is the high-affinity binding of Ku70-Ku80 and DNA-PKcs to double-stranded DNA ends that holds the ends in physical proximity for subsequent repair. Methods and Materials: Using transmission electron microscopy to localize gold-labeled pKu70 and pDNA-PKcs within nuclear ultrastructure, we monitored the formation and repair of actual DSBs within euchromatin (electron-lucent) and heterochromatin (electron-dense) in cortical neurons of irradiated mouse brain. Results: While DNA lesions in euchromatin (characterized by two pKu70-gold beads, reflecting the Ku70-Ku80 heterodimer) are promptly sensed and rejoined, DNA packaging in heterochromatin appears to retard DSB processing, due to the time needed to unravel higher-order chromatin structures. Complex pKu70-clusters formed in heterochromatin (consisting of 4 or >= 6 gold beads) may represent multiple breaks in close proximity caused by ionizing radiation of highly-compacted DNA. All pKu70-clusters disappeared within 72 hours post-irradiation, indicating efficient DSB rejoining. However, persistent 53BP1 clusters in heterochromatin (comprising >= 10 gold beads), occasionally co-localizing with gamma H2AX, but not pKu70 or pDNA-PKcs, may reflect incomplete or incorrect restoration of chromatin structure rather than persistently unrepaired DNA damage. Discussion: Higher-order organization of chromatin determines the accessibility of DNA lesions to repair complexes, defining how readily DSBs are detected and processed. DNA lesions in heterochromatin appear to be more complex, with multiple breaks in spatial vicinity inducing severe chromatin disruptions. Imperfect restoration of chromatin configurations may leave DSB-induced epigenetic memory of damage with potentially pathological repercussions.	[Lorat, Yvonne; Schanz, Stefanie; Schuler, Nadine; Ruebe, Christian; Ruebe, Claudia E.] Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany; [Wennemuth, Gunther] Univ Saarland, Dept Cell Biol & Anat, D-6650 Homburg, Germany	Saarland University; Saarland University	Lorat, Y (corresponding author), Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany.	claudia.ruebe@uks.eu		Wennemuth, Gunther/0000-0003-3313-2475	Deutsche Forschungsgemeinschaft [Ru821/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (Ru821/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Dellaire G, 2009, CELL CYCLE, V8, P3750, DOI 10.4161/cc.8.22.10065; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Orlowski C, 2011, CHROMOSOMA, V120, P129, DOI 10.1007/s00412-010-0305-6; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Rube CE, 2010, INT J RADIAT ONCOL, V78, P359, DOI 10.1016/j.ijrobp.2009.08.052; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Takahashi A, 2010, J RADIAT RES, V51, P91, DOI [10.1269/jrr.09111, 10.1269/jrr.0911]; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	29	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38165	10.1371/journal.pone.0038165	http://dx.doi.org/10.1371/journal.pone.0038165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666473	Green Submitted, Green Published, gold			2022-12-25	WOS:000305353400094
J	Mir, O; Coriat, R; Blanchet, B; Durand, JP; Boudou-Rouquette, P; Michels, J; Ropert, S; Vidal, M; Pol, S; Chaussade, S; Goldwasser, F				Mir, Olivier; Coriat, Romain; Blanchet, Benoit; Durand, Jean-Philippe; Boudou-Rouquette, Pascaline; Michels, Judith; Ropert, Stanislas; Vidal, Michel; Pol, Stanislas; Chaussade, Stanislas; Goldwasser, Francois			Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER-PATIENTS; BODY-COMPOSITION; SKELETAL-MUSCLE; PHASE-I; VALIDATION; INHIBITOR	Background: Sorafenib induces frequent dose limiting toxicities (DLT) in patients with advanced hepatocellular carcinoma (HCC). Sarcopenia has been associated with poor performance status and shortened survival in cancer patients. Patients and Methods: The characteristics of Child Pugh A cirrhotic patients with HCC receiving sorafenib in our institution were retrospectively analyzed. Sorafenib plasma concentrations were determined at each visit. Toxicities were recorded during the first month of treatment, and sarcopenia was determined from baseline CT-scans. Results: Forty patients (30 males) were included. Eleven (27.5%) were sarcopenic. Eighteen patients (45%) experienced a DLT during the first month of treatment. Sarcopenic patients experienced significantly more DLTs than non-sarcopenic patients did (82% versus 31%, p = 0.005). Grade 3 diarrhea was significantly more frequent in sarcopenic patients than in non-sarcopenic patients (45.5% versus 6.9%, p = 0.01), but not grade 3 hand foot syndrome reaction (9% versus 17.2%, p = 1). On day 28, median sorafenib AUC (n = 17) was significantly higher in sarcopenic patients (102.4 mg/l. h versus 53.7 mg/l. h, p = 0.013). Conclusions: Among cirrhotic Child Pugh A patients with advanced HCC, sarcopenia predicts sorafenib exposure and the occurrence of DLT within the first month of treatment.	[Mir, Olivier; Coriat, Romain; Blanchet, Benoit; Durand, Jean-Philippe; Boudou-Rouquette, Pascaline; Michels, Judith; Ropert, Stanislas; Goldwasser, Francois] Univ Paris 05, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, Cochin Teaching Hosp,Dept Med Oncol, Paris, France; [Mir, Olivier] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Clin Pharmacol, Paris, France; [Coriat, Romain; Chaussade, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Gastroenterol, Paris, France; [Blanchet, Benoit; Vidal, Michel] Univ Paris 05, AP HP, Cochin Teaching Hosp, Lab Pharmacol & Toxicol, Paris, France; [Pol, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Hepatol, Paris, France; [Pol, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, INSERM U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mir, O (corresponding author), Univ Paris 05, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, Cochin Teaching Hosp,Dept Med Oncol, Paris, France.	olivier.mir@cch.aphp.fr	/AFP-4402-2022; Vidal, Michel/ABA-3396-2020; /ABG-4006-2020; Mir, Olivier/GNP-7828-2022; Goldwasser, François/P-4861-2017; Michels, Judith/Q-5693-2018; Coriat, Romain/O-7902-2017	/0000-0002-4860-305X; /0000-0002-4860-305X; Mir, Olivier/0000-0002-6761-4002; Michels, Judith/0000-0002-9640-0222; Vidal, Michel/0000-0002-4858-1591				Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Blanchet B, 2009, J PHARMACEUT BIOMED, V49, P1109, DOI 10.1016/j.jpba.2009.02.008; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Hornecker M, 2011, INVEST NEW DRUGS, DOI [10.1007/s10637-10011-19760-z, DOI 10.1007/S10637-10011-19760-Z]; Izzedine H, 2009, ANN ONCOL, V20, P807, DOI 10.1093/annonc/mdn713; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kacevska M, 2008, EXPERT OPIN DRUG MET, V4, P137, DOI 10.1517/17425255.4.2.137; Kim JE, 2012, ONCOLOGY-BASEL, V82, P119, DOI 10.1159/000336082; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Meza-Junco J, 2011, J CLIN ONCOL, V29; Miller AA, 2009, J CLIN ONCOL, V27, P1800, DOI 10.1200/JCO.2008.20.0931; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130	23	210	214	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37563	10.1371/journal.pone.0037563	http://dx.doi.org/10.1371/journal.pone.0037563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666367	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400034
J	Piazza, BP; La Peyre, MK				Piazza, Bryan P.; La Peyre, Megan K.			Measuring Changes in Consumer Resource Availability to Riverine Pulsing in Breton Sound, Louisiana, USA	PLOS ONE			English	Article							FRESH-WATER FLOW; TERRESTRIAL INVERTEBRATES; PERIODICAL CICADAS; ESTUARINE HABITATS; GAMBUSIA-AFFINIS; DELTAIC ESTUARY; ENERGY DENSITY; SALMON; NUTRIENTS; DYNAMICS	Resource pulses are thought to structure communities and food webs through the assembly of consumers. Aggregated consumers represent a high quality resource subsidy that becomes available for trophic transfer during and after the pulse. In estuarine systems, riverine flood pulses deliver large quantities of basal resources and make high quality habitat available for exploitation by consumers. These consumers represent a change in resources that may be available for trophic transfer. We quantified this increased consumer resource availability (nekton density, biomass, energy density) provided by riverine flood pulsing in Breton Sound, Louisiana, USA. We used water level differences between an area subject to two experimental riverine flood pulses (inflow) and a reference area not receiving inflow to identify the percentage of nekton standing stock and energy density that may be attributable solely to riverine pulsing and may represent a consumer resource subsidy. Riverine pulsing accounted for more than 60% of resident nekton density (ind m(-2)), biomass (g m(-2)), and energy density (cal m(-2)) on the flooded marsh surface during two experimental pulse events in 2005. Our results document the potential subsidy of resident nekton standing stock from a riverine flood pulse available for export to subtidal habitats. Given predicted large scale changes in river discharge globally, this approach could provide a useful tool for quantifying the effects of changes in riverine discharge on consumer resource availability.	[Piazza, Bryan P.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA USA; [La Peyre, Megan K.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Louisiana Fish & Wildlife Cooperat Res Unit, US Geol Survey, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey	Piazza, BP (corresponding author), Nature Conservancy, Baton Rouge, LA 70821 USA.	bpiazza@tnc.org			Louisiana Governor's Applied Coastal Research and Development Program (LACRDP); Coastal Restoration and Enhancement through Science and Technology (CREST) Program; Louisiana Department of Wildlife and Fisheries	Louisiana Governor's Applied Coastal Research and Development Program (LACRDP); Coastal Restoration and Enhancement through Science and Technology (CREST) Program; Louisiana Department of Wildlife and Fisheries	This work was funded by grants from the Louisiana Governor's Applied Coastal Research and Development Program (LACRDP), the Coastal Restoration and Enhancement through Science and Technology (CREST; www.gulfcrest.org) Program and by the Louisiana Department of Wildlife and Fisheries. The use of trade, product, industry or firm names, or products is for informative purposes only and does not constitute an endorsement by the U.S. Government or the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2002, ESTUARIES, V25, P1246, DOI 10.1007/BF02692222; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; Banasek-Richter C, 2009, ECOLOGY, V90, P1470, DOI 10.1890/08-2207.1; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Brock CS, 2007, LIMNOL OCEANOGR, V52, P1588, DOI 10.4319/lo.2007.52.4.1588; Ciancio Javier, 2006, Ecol. austral, V16, P91; Claeson SM, 2006, CAN J FISH AQUAT SCI, V63, P1230, DOI 10.1139/F06-029; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; Connolly RM, 2009, MAR BIOL RES, V5, P164, DOI 10.1080/17451000802266625; de Mutsert K, 2010, THESIS LOUISIANA STA; DURBIN AG, 1979, ECOLOGY, V60, P8, DOI 10.2307/1936461; Eberle LC, 2010, RIVER RES APPL, V26, P682, DOI 10.1002/rra.1270; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Howe ER, 2007, MAR ECOL PROG SER, V351, P65, DOI 10.3354/meps07120; Jonsson B, 2005, ECOL FRESHW FISH, V14, P296, DOI 10.1111/j.1600-0633.2005.00098.x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Kimmerer WJ, 2002, ESTUARIES, V25, P1275, DOI 10.1007/BF02692224; Kitchell JF, 1999, LIMNOL OCEANOGR, V44, P828, DOI 10.4319/lo.1999.44.3_part_2.0828; Kneib Ronald T., 1997, Oceanography and Marine Biology an Annual Review, V35, P163; Kneib RT, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P267; Lane RR, 2004, ESTUAR COAST SHELF S, V60, P1, DOI 10.1016/j.ecss.2003.11.015; Livingston RJ, 1997, ECOL APPL, V7, P277, DOI 10.1890/1051-0761(1997)007[0277:FITAGE]2.0.CO;2; Loneragan NR, 1999, AUST J ECOL, V24, P431, DOI 10.1046/j.1442-9993.1999.00975.x; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; Nowlin WH, 2007, ECOLOGY, V88, P2174, DOI 10.1890/06-0570.1; Odum EP, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P3; ODUM WE, 1995, ESTUARIES, V18, P547, DOI 10.2307/1352375; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Pangle KL, 2005, J FISH BIOL, V66, P1060, DOI 10.1111/j.0022-1112.2005.00660.x; Pedersen J, 2001, J FISH BIOL, V59, P380, DOI 10.1006/jfbi.2001.1649; Perez M.A., 1994, NMFSAFSC32 NOAA; Piazza BP, 2007, AQUAT BIOL, V1, P109, DOI 10.3354/ab00013; Piazza BP, 2011, ESTUAR COAST SHELF S, V91, P379, DOI 10.1016/j.ecss.2010.11.001; Piazza BP, 2010, MAR ECOL PROG SER, V412, P231, DOI 10.3354/meps08686; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rozas LP, 2005, ESTUAR COAST SHELF S, V65, P319, DOI 10.1016/j.ecss.2005.05.019; Rozas LP, 1997, ESTUARIES, V20, P199, DOI 10.2307/1352731; Rutherford DA, 2001, T AM FISH SOC, V130, P276, DOI 10.1577/1548-8659(2001)130&lt;0276:PEOTFP&gt;2.0.CO;2; Schlacher TA, 2009, AQUAT ECOL, V43, P383, DOI 10.1007/s10452-008-9196-5; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Sklar FH, 1998, ENVIRON MANAGE, V22, P547, DOI 10.1007/s002679900127; Snedden GA, 2007, ESTUAR COAST, V30, P802, DOI 10.1007/BF02841335; Snedden GA, 2007, ESTUAR COAST SHELF S, V71, P181, DOI 10.1016/j.ecss.2006.06.035; Stevens PW, 2006, MAR ECOL PROG SER, V327, P267, DOI 10.3354/meps327267; STRANGE RJ, 1987, T AM FISH SOC, V116, P60, DOI 10.1577/1548-8659(1987)116<60:NCOCFF>2.0.CO;2; Vinagre C, 2011, ESTUAR COAST, V34, P663, DOI 10.1007/s12237-010-9315-0; VONDRACEK B, 1988, ENVIRON BIOL FISH, V21, P45, DOI 10.1007/BF02984442; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Williams AJ, 2006, HYDROBIOLOGIA, V569, P493, DOI 10.1007/s10750-006-0151-y; Winemiller K. O, 2004, P 2 INT S MAN LARG R, V2, P285, DOI DOI 10.1017/CBO9781107415324.004; Winemiller Kirk O., 2005, P10; WINEMILLER KO, 1993, OECOLOGIA, V95, P266, DOI 10.1007/BF00323499; Wissel B, 2005, OECOLOGIA, V144, P659, DOI 10.1007/s00442-005-0119-z; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293	61	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37536	10.1371/journal.pone.0037536	http://dx.doi.org/10.1371/journal.pone.0037536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666363	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400030
J	Tobi, EW; Slagboom, PE; van Dongen, J; Kremer, D; Stein, AD; Putter, H; Heijmans, BT; Lumey, LH				Tobi, Elmar W.; Slagboom, P. Eline; van Dongen, Jenny; Kremer, Dennis; Stein, Aryeh D.; Putter, Hein; Heijmans, Bastiaan T.; Lumey, L. H.			Prenatal Famine and Genetic Variation Are Independently and Additively Associated with DNA Methylation at Regulatory Loci within IGF2/H19	PLOS ONE			English	Article							FOLIC-ACID USE; INSULIN GENE; TANDEM REPEAT; BIRTH-WEIGHT; COMMON; MASS; EXPRESSION; EXPOSURE; REGION; H19	Both the early environment and genetic variation may affect DNA methylation, which is one of the major molecular marks of the epigenome. The combined effect of these factors on a well-defined locus has not been studied to date. We evaluated the association of periconceptional exposure to the Dutch Famine of 1944-45, as an example of an early environmental exposure, and single nucleotide polymorphisms covering the genetic variation (tagging SNPs) with DNA methylation at the imprinted IGF2/H19 region, a model for an epigenetically regulated genomic region. DNA methylation was measured at five differentially methylated regions (DMRs) that regulate the imprinted status of the IGF2/H19 region. Small but consistent differences in DNA methylation were observed comparing 60 individuals with periconceptional famine exposure with unexposed same-sex siblings at all IGF2 DMRs (P-BH<0.05 after adjustment for multiple testing), but not at the H19 DMR. IGF2 DMR0 methylation was associated with IGF2 SNP rs2239681 (P-BH=0.027) and INS promoter methylation with INS SNPs, including rs689, which tags the INS VNTR, suggesting a mechanism for the reported effect of the VNTR on INS expression (P-BH=3.4x10(-3)). Prenatal famine and genetic variation showed similar associations with IGF2/H19 methylation and their contributions were additive. They were small in absolute terms (<3%), but on average 0.5 standard deviations relative to the variation in the population. Our analyses suggest that environmental and genetic factors could have independent and additive similarly sized effects on DNA methylation at the same regulatory site.	[Tobi, Elmar W.; Slagboom, P. Eline; Heijmans, Bastiaan T.] Leiden Univ, Med Ctr, Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [van Dongen, Jenny] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Lumey, L. H.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Emory University; Rollins School Public Health; Columbia University	Tobi, EW (corresponding author), Leiden Univ, Med Ctr, Netherlands Consortium Healthy Ageing, Leiden, Netherlands.	B.T.Heijmans@lumc.nl	Slagboom, P. Eline/R-4790-2016; Putter, Hein/C-2244-2018; Tobi, Elmar W/C-1834-2014	Slagboom, P. Eline/0000-0002-2875-4723; Putter, Hein/0000-0001-5395-1422; Tobi, Elmar W/0000-0002-1378-3687; van Dongen, Jenny/0000-0003-2063-8741; Stein, Aryeh/0000-0003-1138-6458	European Union [FP6 036894]; European Union's Seventh Framework Program IDEAL [259679]; Netherlands Consortium for Healthy Ageing [05060810]; United States National Institutes of Health [R01-HL067914]	European Union(European Commission); European Union's Seventh Framework Program IDEAL; Netherlands Consortium for Healthy Ageing; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the European Union-funded Network of Excellence LifeSpan [FP6 036894], the European Union's Seventh Framework Program IDEAL [FP7/2007-2011] under grant agreement no 259679, the Netherlands Consortium for Healthy Ageing [Grant 05060810] in the framework of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research and the United States National Institutes of Health ([R01-HL067914 to LHL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2008, INT J OBESITY, V32, P372, DOI 10.1038/sj.ijo.0803700; Adkins RM, 2007, PEDIATR RES, V62, P451, DOI 10.1203/PDR.0b013e3181425841; Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bennett A, 2005, DIABETOLOGIA, V48, P886, DOI 10.1007/s00125-005-1737-z; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Burger G., 1948, MALNUTRITION STARVAT; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; D'Aleo V, 2011, NUTR METAB CARDIOVAS, V21, pE9, DOI 10.1016/j.numecd.2010.10.005; Davey Smith G, 2009, ADV EXP MED BIOL, V646, P1, DOI 10.1007/978-1-4020-9173-5_1; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Du MJ, 2003, HUM MOL GENET, V12, P1927, DOI 10.1093/hmg/ddg194; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ferguson LA, 2009, FEBS LETT, V583, P3181, DOI 10.1016/j.febslet.2009.08.041; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Heude B, 2007, J CLIN ENDOCR METAB, V92, P2734, DOI 10.1210/jc.2006-1948; Heude B, 2006, J CLIN ENDOCR METAB, V91, P2770, DOI 10.1210/jc.2005-2055; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Lumey LH, 2012, INT J EPIDEMIOL, V41, P116, DOI 10.1093/ije/dyr137; Maas JAJBM, 2010, HORM RES PAEDIAT, V73, P120, DOI 10.1159/000277631; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nagaya K, 2009, PEDIATR RES, V66, P135, DOI 10.1203/PDR.0b013e3181a9e818; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; O'Dell SD, 1999, EUR J HUM GENET, V7, P821, DOI 10.1038/sj.ejhg.5200381; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Otte K, 1998, NUCLEIC ACIDS RES, V26, P1605, DOI 10.1093/nar/26.7.1605; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; Petry CJ, 2009, HUM GENET, V126, P375, DOI 10.1007/s00439-009-0681-2; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Stoger R, 2008, BIOESSAYS, V30, P156, DOI 10.1002/bies.20700; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Talens RP, 2012, INT J EPIDEMIOL, V41, P106, DOI 10.1093/ije/dyr153; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Trienekens G., 2000, FOOD SCI POLICY REGU, P117; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	78	102	104	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37933	10.1371/journal.pone.0037933	http://dx.doi.org/10.1371/journal.pone.0037933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666415	gold, Green Submitted, Green Published			2022-12-25	WOS:000305353400058
J	Lee, S; Jung, KJ; Jung, HS; Chang, S				Lee, Suho; Jung, Kyung Jin; Jung, Hyun Suk; Chang, Sunghoe			Dynamics of Multiple Trafficking Behaviors of Individual Synaptic Vesicles Revealed by Quantum-Dot Based Presynaptic Probe	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FROG NEUROMUSCULAR JUNCTION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; LATERAL DIFFUSION; LIVING CELLS; RECEPTORS; TRACKING; PLASTICITY; MEMBRANE	Although quantum dots (QDs) have provided invaluable information regarding the diffusive behaviors of postsynaptic receptors, their application in presynaptic terminals has been rather limited. In addition, the diffraction-limited nature of the presynaptic bouton has hampered detailed analyses of the behaviors of synaptic vesicles (SVs) at synapses. Here, we created a quantum-dot based presynaptic probe and characterized the dynamic behaviors of individual SVs. As previously reported, the SVs exhibited multiple exchanges between neighboring boutons. Actin disruption induced a dramatic decrease in the diffusive behaviors of SVs at synapses while microtubule disruption only reduced extrasynaptic mobility. Glycine-induced synaptic potentiation produced significant increases in synaptic and inter-boutonal trafficking of SVs, which were NMDA receptor-and actin-dependent while NMDA-induced synaptic depression decreased the mobility of the SVs at synapses. Together, our results show that sPH-AP-QD revealed previously unobserved trafficking properties of SVs around synapses, and the dynamic modulation of SV mobility could regulate presynaptic efficacy during synaptic activity.	[Lee, Suho; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul, South Korea; [Lee, Suho; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomax Inst, Seoul, South Korea; [Lee, Suho] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Jung, Kyung Jin; Jung, Hyun Suk] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Korea Basic Science Institute (KBSI)	Lee, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul, South Korea.	sunghoe@snu.ac.kr	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	Korea Science and Engineering Foundation [R01-2006-000-10818-0]; National Research Foundation of Korea [SRC. 20100029395]; BRC of the 21st Century Frontier Research Program [M103KV010009-06K2201-00910]; MEST, Republic of Korea	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); BRC of the 21st Century Frontier Research Program; MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Korea Science and Engineering Foundation (R01-2006-000-10818-0), from the National Research Foundation of Korea (SRC. 20100029395), the BRC of the 21st Century Frontier Research Program (M103KV010009-06K2201-00910) to S.C. funded by the MEST, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bayazitov IT, 2007, J NEUROSCI, V27, P11510, DOI 10.1523/JNEUROSCI.3077-07.2007; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]; Johnstone VPA, 2011, LEARN MEMORY, V18, P625, DOI 10.1101/lm.2245911; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Ratnayaka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1534; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Yeung C, 2007, BIOPHYS J, V92, P2271, DOI 10.1529/biophysj.106.081794; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	35	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38045	10.1371/journal.pone.0038045	http://dx.doi.org/10.1371/journal.pone.0038045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666444	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349600059
J	Barringer, LE; Tomback, DF; Wunder, MB; McKinney, ST				Barringer, Lauren E.; Tomback, Diana F.; Wunder, Michael B.; McKinney, Shawn T.			Whitebark Pine Stand Condition, Tree Abundance, and Cone Production as Predictors of Visitation by Clark's Nutcracker	PLOS ONE			English	Article							BLISTER RUST; BRITISH-COLUMBIA; SEED DISPERSAL; CANADA; ECOSYSTEM; BEETLE	Background: Accurately quantifying key interactions between species is important for developing effective recovery strategies for threatened and endangered species. Whitebark pine (Pinus albicaulis), a candidate species for listing under the Endangered Species Act, depends on Clark's nutcracker (Nucifraga columbiana) for seed dispersal. As whitebark pine succumbs to exotic disease and mountain pine beetles (Dendroctonus ponderosae), cone production declines, and nutcrackers visit stands less frequently, reducing the probability of seed dispersal. Methodology/Principal Findings: We quantified whitebark pine forest structure, health metrics, and the frequency of nutcracker occurrence in national parks within the Northern and Central Rocky Mountains in 2008 and 2009. Forest health characteristics varied between the two regions, with the northern region in overall poorer health. Using these data, we show that a previously published model consistently under-predicts the proportion of survey hours resulting in nutcracker observations at all cone density levels. We present a new statistical model of the relationship between whitebark pine cone production and the probability of Clark's nutcracker occurrence based on combining data from this study and the previous study. Conclusions/Significance: Our model clarified earlier findings and suggested a lower cone production threshold value for predicting likely visitation by nutcrackers: Although nutcrackers do visit whitebark pine stands with few cones, the probability of visitation increases with increased cone production. We use information theoretics to show that beta regression is a more appropriate statistical framework for modeling the relationship between cone density and proportion of survey time resulting in nutcracker observations. We illustrate how resource managers may apply this model in the process of prioritizing areas for whitebark pine restoration.	[Barringer, Lauren E.; Tomback, Diana F.; Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [McKinney, Shawn T.] Natl Pk Serv, Inventory & Monitoring Program, Sierra Nevada Network, El Portal, CA USA	University of Colorado System; University of Colorado Denver; United States Department of the Interior	Barringer, LE (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	Michael.Wunder@ucdenver.edu			Whitebark Pine Restoration Fund; USDA Forest Service; Forest Health Protection; Jerry O'Neal fellowship; National Park Service; Rocky Mountains Cooperative Ecosystem Studies Unit; Technical Assistance Grant; Global Forest Science [GF-18-2008-216]	Whitebark Pine Restoration Fund; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Forest Health Protection; Jerry O'Neal fellowship; National Park Service; Rocky Mountains Cooperative Ecosystem Studies Unit; Technical Assistance Grant; Global Forest Science	Funding for this project is gratefully acknowledged as follows: Whitebark Pine Restoration Fund, USDA Forest Service, Forest Health Protection, to DFT; Jerry O'Neal fellowship, National Park Service, Rocky Mountains Cooperative Ecosystem Studies Unit to LEB; Technical Assistance Grant, National Park Service, Rocky Mountains Cooperative Ecosystem Studies Unit to DFT; Global Forest Science grant (# GF-18-2008-216) to DFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell EM, 2000, CAN J FOREST RES, V30, P1051, DOI 10.1139/cjfr-30-7-1051; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; Kendall K.C., WHITEBARK PINE COMMU, P221; LANNER RM, 1982, CAN J FOREST RES, V12, P391, DOI 10.1139/x82-056; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Mahalovich MF, 2006, P RMRS P 43 FORT COL; McKinney ST, 2007, CAN J FOREST RES, V37, P1044, DOI 10.1139/X06-305; McKinney ST, 2010, OECOLOGIA, V162, P697, DOI 10.1007/s00442-009-1496-5; McKinney ST, 2009, ECOL APPL, V19, P597, DOI 10.1890/08-0151.1; McKinney ST, 2011, MOUNTAIN ECOSYSTEMS, P45; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Schwartz CC, 2010, ANN REPORT INTERAGEN, P63; Smith CM, 2008, CAN J FOREST RES, V38, P982, DOI 10.1139/X07-182; Tomback D., 2001, WHITEBARK PINE COMMU, P3; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2005, METHODS SURVEYING MO; Tomback D.F., 2001, WHITEBARK PINE COMMU, P243; Tomback DF, 2001, ECOLOGY, V82, P2587, DOI 10.1890/0012-9658(2001)082[2587:DSGIWP]2.0.CO;2; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; Tomback DF, 1998, BIRDS N AM; USFWS, 2011, FED REGISTER, V76, P42631; VANDERWALL SB, 1988, CONDOR, V90, P621, DOI 10.2307/1368351; Zeglen S, 2002, CAN J FOREST RES, V32, P1265, DOI 10.1139/X02-049	27	38	41	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37663	10.1371/journal.pone.0037663	http://dx.doi.org/10.1371/journal.pone.0037663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662186	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300076
J	Clark, SCA; Sharp, NP; Rowe, L; Agrawal, AF				Clark, Sean C. A.; Sharp, Nathaniel P.; Rowe, Locke; Agrawal, Aneil F.			Relative Effectiveness of Mating Success and Sperm Competition at Eliminating Deleterious Mutations in Drosophila melanogaster	PLOS ONE			English	Article							SEXUAL SELECTION; ADAPTATION; ENVIRONMENT; ALLELES; CAPTURE; LOAD	Condition-dependence theory predicts that sexual selection will facilitate adaptation by selecting against deleterious mutations that affect the expression of sexually selected traits indirectly via condition. Recent empirical studies have provided support for this prediction; however, their results do not elucidate the relative effects of pre- and postcopulatory sexual selection on deleterious mutations. We used the Drosophila melanogaster model system to discern the relative contributions of pre- and postcopulatory processes to selection against deleterious mutations. To assess second-male ejaculate competition success (P2; measured as the proportion of offspring attributable to the experimental male) and mating success, mutant and wild-type male D. melanogaster were given the opportunity to mate with females that were previously mated to a standard competitor male. This process was repeated for males subjected to a diet quality manipulation to test for effects of environmentally-manipulated condition on P2 and mating success. While none of the tested mutations affected P2, there was a clear effect of condition. Conversely, several of the mutations affected mating success, while condition showed no effect. Our results suggest that precopulatory selection may be more effective than postcopulatory selection at removing deleterious mutations. The opposite result obtained for our diet manipulation points to an interesting discrepancy between environmental and genetic manipulations of condition, which may be explained by the multidimensionality of condition. Establishing whether the various stages of sexual selection affect deleterious mutations differently, and to what extent, remains an important issue to resolve.	[Clark, Sean C. A.; Sharp, Nathaniel P.; Rowe, Locke; Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Clark, SCA (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	s.clark@utoronto.ca		Sharp, Nathaniel/0000-0001-6016-083X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) provided graduate fellowships to SCAC and NPS, and Discovery Grants to LR and AFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Amitin EG, 2007, J EVOLUTION BIOL, V20, P381, DOI 10.1111/j.1420-9101.2006.01184.x; Clark AG, 1998, GENETICS, V149, P1487; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gromko MH, 1984, SPERM COMPETITION EV; Holland B, 2002, EVOLUTION, V56, P721, DOI 10.1554/0014-3820(2002)056[0721:SSFTPA]2.0.CO;2; Hollis B, 2009, EVOLUTION, V63, P324, DOI 10.1111/j.1558-5646.2008.00551.x; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Mallet MA, 2011, HEREDITY, V106, P994, DOI 10.1038/hdy.2010.148; Mallet MA, 2012, BIOL LETTERS, V8, P426, DOI 10.1098/rsbl.2011.0977; Mallet MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-156; McGraw LA, 2007, BIOL LETTERS, V3, P607, DOI 10.1098/rsbl.2007.0334; R Development Core Team, 2009, R FDN STAT COMP; Radwan J, 2004, ECOL LETT, V7, P1149, DOI 10.1111/j.1461-0248.2004.00681.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rundle HD, 2006, EVOLUTION, V60, P2218, DOI 10.1111/j.0014-3820.2006.tb01859.x; Sharp NP, 2008, EVOLUTION, V62, P857, DOI 10.1111/j.1558-5646.2008.00333.x; Sharp NP, 2009, AM NAT, V174, P613, DOI 10.1086/605960; Simmons L. W., 2001, MG BEH ECOL; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wang AD, 2009, AM NAT, V174, P863, DOI 10.1086/645088; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7	24	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37351	10.1371/journal.pone.0037351	http://dx.doi.org/10.1371/journal.pone.0037351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662148	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300037
J	Moen, EL; Wen, SC; Anwar, T; Cross-Knorr, S; Brilliant, K; Birnbaum, F; Rahaman, S; Sedivy, JM; Moss, SF; Chatterjee, D				Moen, Erika L.; Wen, Sicheng; Anwar, Talha; Cross-Knorr, Sam; Brilliant, Kate; Birnbaum, Faith; Rahaman, Sherida; Sedivy, John M.; Moss, Steven F.; Chatterjee, Devasis			Regulation of RKIP Function by Helicobacter pylori in Gastric Cancer	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; NF-KAPPA-B; INDUCED APOPTOSIS; GASTROINTESTINAL-TRACT; EXPRESSION; CELLS; ACTIVATION; PROSTATE	Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that infects more than half of the world's population and is a major cause of gastric adenocarcinoma. The mechanisms that link H. pylori infection to gastric carcinogenesis are not well understood. In the present study, we report that the Raf-kinase inhibitor protein (RKIP) has a role in the induction of apoptosis by H. pylori in gastric epithelial cells. Western blot and luciferase transcription reporter assays demonstrate that the pathogenicity island of H. pylori rapidly phosphorylates RKIP, which then localizes to the nucleus where it activates its own transcription and induces apoptosis. Forced overexpression of RKIP enhances apoptosis in H. pylori-infected cells, whereas RKIP RNA inhibition suppresses the induction of apoptosis by H. pylori infection. While inducing the phosphorylation of RKIP, H. pylori simultaneously targets non-phosphorylated RKIP for proteasome-mediated degradation. The increase in RKIP transcription and phosphorylation is abrogated by mutating RKIP serine 153 to valine, demonstrating that regulation of RKIP activity by H. pylori is dependent upon RKIP's S153 residue. In addition, H. pylori infection increases the expression of Snail, a transcriptional repressor of RKIP. Our results suggest that H. pylori utilizes a tumor suppressor protein, RKIP, to promote apoptosis in gastric cancer cells.	[Moen, Erika L.; Wen, Sicheng; Anwar, Talha; Cross-Knorr, Sam; Brilliant, Kate; Birnbaum, Faith; Moss, Steven F.; Chatterjee, Devasis] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Moen, Erika L.; Cross-Knorr, Sam; Brilliant, Kate; Chatterjee, Devasis] Rhode Isl Hosp, Ctr Biomed Res Excellence COBRE, Providence, RI USA; [Rahaman, Sherida] Brown Univ, Dept Pathobiol, Grad Program, Providence, RI 02912 USA; [Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Brown University; Brown University	Moen, EL (corresponding author), Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.	dchatter@lifespan.org		Moen, Erika/0000-0002-9800-8742	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103421]; National Center for Research Resources (NCRR) [P20 RR 017695, R01 CA111533, R21 CA133601]; NATIONAL CANCER INSTITUTE [R21CA133601, R01CA111533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103421 (DC); the previous segment of this project was supported by the National Center for Research Resources (NCRR) under P20 RR 017695 (DC), R01 CA111533 (SFM) and R21 CA133601 (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; BRENES F, 1993, AM J GASTROENTEROL, V88, P1870; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Chen G, 1997, BIOCHEM BIOPH RES CO, V239, P626, DOI 10.1006/bbrc.1997.7485; Chu SH, 2003, ANN NY ACAD SCI, V1010, P568, DOI 10.1196/annals.1299.106; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Garcia M, 2007, GLOBAL CANC FACTS FI, P1; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Ishihara S, 2001, HELICOBACTER, V6, P283, DOI 10.1046/j.1523-5378.2001.00043.x; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Matsumoto A, 2011, DIGEST DIS SCI, V56, P999, DOI 10.1007/s10620-010-1420-1; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Minohara Y, 2007, HELICOBACTER, V12, P583, DOI 10.1111/j.1523-5378.2007.00537.x; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Odenbreit S, 2006, HELICOBACTER, V11, P196, DOI 10.1111/j.1523-5378.2006.00400.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Pignatelli B, 2001, AM J GASTROENTEROL, V96, P1758, DOI 10.1111/j.1572-0241.2001.03869.x; Schuierer MM, 2006, ONCOL REP, V16, P451; Shibayama K, 2001, INFECT IMMUN, V69, P3181, DOI 10.1128/IAI.69.5.3181-3189.2001; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Sugimoto M, 2010, WORLD J GASTROENTERO, V16, P1188, DOI 10.3748/wjg.v16.i10.1188; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Wang TC, 1998, GASTROENTEROLOGY, V114, P675, DOI 10.1016/S0016-5085(98)70581-5; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Wen S, 2011, ONCOGENE; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	50	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37819	10.1371/journal.pone.0037819	http://dx.doi.org/10.1371/journal.pone.0037819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662230	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300120
J	Pilsner, JR; Hall, MN; Liu, XH; Ilievski, V; Slavkovich, V; Levy, D; Factor-Litvak, P; Yunus, M; Rahman, M; Graziano, JH; Gamble, MV				Pilsner, J. Richard; Hall, Megan N.; Liu, Xinhua; Ilievski, Vesna; Slavkovich, Vesna; Levy, Diane; Factor-Litvak, Pam; Yunus, Mahammad; Rahman, Mahfuzar; Graziano, Joseph H.; Gamble, Mary V.			Influence of Prenatal Arsenic Exposure and Newborn Sex on Global Methylation of Cord Blood DNA	PLOS ONE			English	Article							URINARY CREATININE; DRINKING-WATER; FOLATE-DEFICIENCY; LEUKOCYTE DNA; LUNG-CANCER; HYPOMETHYLATION; METABOLISM; HOMOCYSTEINE; EXPRESSION; MORTALITY	Background: An emerging body of evidence indicates that early-life arsenic (As) exposure may influence the trajectory of health outcomes later in life. However, the mechanisms underlying these observations are unknown. Objective: The objective of this study was to investigate the influence of prenatal As exposure on global methylation of cord blood DNA in a study of mother/newborn pairs in Matlab, Bangladesh. Design: Maternal and cord blood DNA were available from a convenience sample of 101 mother/newborn pairs. Measures of As exposure included maternal urinary As (uAs), maternal blood As (mbAs) and cord blood As (cbAs). Several measures of global DNA methylation were assessed, including the [3H]-methyl-incorporation assay and three Pyrosequencing assays: Alu, LINE-1 and LUMA. Results: In the total sample, increasing quartiles of maternal uAs were associated with an increase in covariate-adjusted means of newborn global DNA methylation as measured by the [3H]-methyl-incorporation assay (quartile 1 (Q1) and Q2 vs. Q4; p = 0.06 and 0.04, respectively). Sex-specific linear regression analyses, while not reaching significance level of 0.05, indicated that the associations between As exposures and Alu, LINE-1 and LUMA were positive among male newborns (N = 58) but negative among female newborns (N = 43); tests for sex differences were borderline significant for the association of cbAs and mbAs with Alu (p = 0.05 and 0.09, respectively) and for the association between maternal uAs and LINE-1 (p = 0.07). Sex-specific correlations between maternal urinary creatinine and newborn methyl-incorporation, Alu and LINE-1 were also evident (p < 0.05). Conclusions: These results suggest that prenatal As exposure is associated with global DNA methylation in cord blood DNA, possibly in a sex-specific manner. Arsenic-induced epigenetic modifications in utero may potentially influence disease outcomes later in life. Additional studies are needed to confirm these findings and to examine the persistence of DNA methylation marks over time.	[Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Hall, Megan N.; Factor-Litvak, Pam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Liu, Xinhua; Levy, Diane] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA; [Ilievski, Vesna; Slavkovich, Vesna; Graziano, Joseph H.; Gamble, Mary V.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Yunus, Mahammad] ICDDR B, Dhaka, Bangladesh; [Rahman, Mahfuzar] Columbia Univ Arsen Project Bangladesh, Dhaka, Bangladesh	University of Massachusetts System; University of Massachusetts Amherst; Columbia University; Columbia University; Columbia University; International Centre for Diarrhoeal Disease Research (ICDDR)	Pilsner, JR (corresponding author), Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.	mvg7@columbia.edu		Yunus, Mohammed/0000-0003-1116-4978	National Institute of Environmental Health Sciences [P42 ES10349, P30 ES09089]; Mailman School of Public Health, Lamont-Dougherty Earth Observatory; Earth Institute at Columbia University; International Centre for Diarrheal Disease Research, Bangladesh; Mailman School of Public Health; The International Center for Diarrheal Disease, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES018890, P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mailman School of Public Health, Lamont-Dougherty Earth Observatory; Earth Institute at Columbia University; International Centre for Diarrheal Disease Research, Bangladesh; Mailman School of Public Health; The International Center for Diarrheal Disease, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences grants P42 ES10349 and P30 ES09089, the Mailman School of Public Health, Lamont-Dougherty Earth Observatory, the Earth Institute at Columbia University, and International Centre for Diarrheal Disease Research, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was a collaboration between the Mailman School of Public Health and The International Center for Diarrheal Disease, Bangladesh (ICDDR,B). We acknowledge with gratitude the support of these organizations for this research.	Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basu A, 2001, MUTAT RES-REV MUTAT, V488, P171, DOI 10.1016/S1383-5742(01)00056-4; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gamble MV, 2006, AM J CLIN NUTR, V84, P1093, DOI 10.1093/ajcn/84.5.1093; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, P1683, DOI 10.1289/ehp.8084; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hall MN, 2010, ENV HLTH PERSPECT; IARC W, SOM DRINK WAT DIS CO; Ireland Z, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-39; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Karimi M, 2006, EPIGENETICS-US, V1, P45; Kinniburgh D.G., 2003, ARSENIC GROUND WATER, P211, DOI [DOI 10.1007/0-306-47956-7_8, 10.1007/0, DOI 10.1007/0]; Majumdar S, 2010, ENVIRON TOXICOL, V25, P315, DOI 10.1002/tox.20497; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; NIXON DE, 1991, CLIN CHEM, V37, P1575; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; Okoji RS, 2002, CARCINOGENESIS, V23, P777, DOI 10.1093/carcin/23.5.777; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P254, DOI 10.1289/ehp.11872; POOLE JR, 1975, J CLIN INVEST, V55, P1033, DOI 10.1172/JCI108004; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sciandrello G, 2004, CARCINOGENESIS, V25, P413, DOI 10.1093/carcin/bgh029; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P452; Vahter M, 2000, TOXICOL LETT, V112, P209, DOI 10.1016/S0378-4274(99)00271-4; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	63	105	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37147	10.1371/journal.pone.0037147	http://dx.doi.org/10.1371/journal.pone.0037147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662134	Green Published, gold			2022-12-25	WOS:000305342300025
J	Gogliettino, M; Balestrieri, M; Cocca, E; Mucerino, S; Rossi, M; Petrillo, M; Mazzella, E; Palmieri, G				Gogliettino, Marta; Balestrieri, Marco; Cocca, Ennio; Mucerino, Sabrina; Rossi, Mose; Petrillo, Mauro; Mazzella, Emanuela; Palmieri, Gianna			Identification and Characterisation of a Novel Acylpeptide Hydrolase from Sulfolobus Solfataricus: Structural and Functional Insights	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; MULTIPLE SEQUENCE ALIGNMENT; ACYL-PEPTIDE-HYDROLASE; AEROPYRUM-PERNIX K1; ACYLAMINOACYL PEPTIDASE; PROLYL OLIGOPEPTIDASE; ENZYME; SITE; PURIFICATION; PHYLOGENIES	A novel acylpeptide hydrolase, named APEH-3(Ss), was isolated from the hypertermophilic archaeon Sulfolobus solfataricus. APEH is a member of the prolyl oligopeptidase family which catalyzes the removal of acetylated amino acid residues from the N terminus of oligopeptides. The purified enzyme shows a homotrimeric structure, unique among the associate partners of the APEH cluster and, in contrast to the archaeal APEHs which show both exo/endo peptidase activities, it appears to be a "true" aminopeptidase as exemplified by its mammalian counterparts, with which it shares a similar substrate specificity. Furthermore, a comparative study on the regulation of apeh gene expression, revealed a significant but divergent alteration in the expression pattern of apeh-3(Ss) and apeh(Ss) (the gene encoding the previously identified APEH(Ss) from S. solfataricus), which is induced in response to various stressful growth conditions. Hence, both APEH enzymes can be defined as stress-regulated proteins which play a complementary role in enabling the survival of S. solfataricus cells under different conditions. These results provide new structural and functional insights into S. solfataricus APEH, offering a possible explanation for the multiplicity of this enzyme in Archaea.	[Gogliettino, Marta; Balestrieri, Marco; Cocca, Ennio; Mucerino, Sabrina; Rossi, Mose; Mazzella, Emanuela; Palmieri, Gianna] Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy; [Petrillo, Mauro] CEINGE Biotecnol Avanzate, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); CEINGE Biotecnologie Avanzate	Gogliettino, M (corresponding author), Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy.	g.palmieri@ibp.cnr.it	Cocca, Ennio/AAY-3817-2020; Palmieri, Gianna/S-4872-2017; BALESTRIERI, MARCO/AAA-1869-2021; Palmieri, Gianna/AAW-6176-2020; Balestrieri, Marco/G-1847-2011; Petrillo, Mauro/AAL-6533-2021	Cocca, Ennio/0000-0003-2432-9663; BALESTRIERI, MARCO/0000-0003-4343-2148; Palmieri, Gianna/0000-0002-9007-4075; Petrillo, Mauro/0000-0002-6782-4704	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	FIRB-MERIT 1 GAE: P0000407 MoMa n. 1/014/06/0 of the Agenzia Spaziale Italiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; DIAZLAZCOZ Y, 1995, J MOL BIOL, V250, P123, DOI 10.1006/jmbi.1995.0363; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujino T, 2000, BBA-PROTEIN STRUCT M, V1478, P102, DOI 10.1016/S0167-4838(00)00004-2; Fujino T, 1998, BBA-BIOMEMBRANES, V1374, P47, DOI 10.1016/S0005-2736(98)00131-X; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; GADE W, 1978, J BIOL CHEM, V253, P5012; Gogliettino M, 2010, J BACTERIOL, V192, P3123, DOI 10.1128/JB.01414-09; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; Ishikawa K, 1998, J BIOL CHEM, V273, P17726, DOI 10.1074/jbc.273.28.17726; JONES WM, 1994, METHOD ENZYMOL, V244, P227; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; KOBAYASHI K, 1987, J BIOL CHEM, V262, P11435; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Palmieri G, 2010, MOL BIOSYST, V6, P2498, DOI 10.1039/c005293k; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Raphel V, 1999, BBA-PROTEIN STRUCT M, V1432, P371, DOI 10.1016/S0167-4838(99)00087-4; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; SCALONI A, 1992, J BIOL CHEM, V267, P3811; Senthilkumar R, 2002, J PROTEIN CHEM, V21, P323, DOI 10.1023/A:1019938217294; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; Yamin R, 2007, J NEUROCHEM, V100, P458, DOI 10.1111/j.1471-4159.2006.04251.x	47	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37921	10.1371/journal.pone.0037921	http://dx.doi.org/10.1371/journal.pone.0037921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655081	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900058
J	Sussillo, D; Abbott, LF				Sussillo, David; Abbott, L. F.			Transferring Learning from External to Internal Weights in Echo-State Networks with Sparse Connectivity	PLOS ONE			English	Article								Modifying weights within a recurrent network to improve performance on a task has proven to be difficult. Echo-state networks in which modification is restricted to the weights of connections onto network outputs provide an easier alternative, but at the expense of modifying the typically sparse architecture of the network by including feedback from the output back into the network. We derive methods for using the values of the output weights from a trained echo-state network to set recurrent weights within the network. The result of this "transfer of learning'' is a recurrent network that performs the task without requiring the output feedback present in the original network. We also discuss a hybrid version in which online learning is applied to both output and recurrent weights. Both approaches provide efficient ways of training recurrent networks to perform complex tasks. Through an analysis of the conditions required to make transfer of learning work, we define the concept of a "self-sensing'' network state, and we compare and contrast this with compressed sensing.	[Sussillo, David] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Abbott, L. F.] Columbia Univ, Dept Neurosci, New York, NY USA	Stanford University; Columbia University	Sussillo, D (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	sussillo@stanford.edu		Sussillo, David/0000-0003-1620-1264	Gatsby Foundation; Swartz Foundation; Kavli Institute for Brain Science at Columbia University; National Institutes of Health [MH093338]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338] Funding Source: NIH RePORTER	Gatsby Foundation; Swartz Foundation; Kavli Institute for Brain Science at Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Gatsby Foundation, the Swartz Foundation, the Kavli Institute for Brain Science at Columbia University, and by National Institutes of Health grant MH093338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2011, DYNAMIC BRAIN EXPLOR, P65; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2011, IEEE T INFORM THEORY, V57, P7235, DOI 10.1109/TIT.2011.2161794; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Haykin S., 2001, ADAPTIVE FILTER THEO; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H, 2003, ADV NEURAL INFORM PR, V15; Jaeger H, 2010, 23 JAC U; Li J, 2011, 26 JAC U; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Mayer NM, 2004, LECT NOTES COMPUT SC, V3141, P40; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Reinhart R. F., 2011, EUR S ANNS D FACT, P59; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018	19	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37372	10.1371/journal.pone.0037372	http://dx.doi.org/10.1371/journal.pone.0037372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655041	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900016
J	Xia, SS; Ma, YL; Zhang, W; Yang, YW; Wu, SW; Zhu, MZ; Deng, LF; Li, B; Liu, ZL; Qi, C				Xia, Sisi; Ma, Yanlin; Zhang, Wei; Yang, Yi; Wu, Shaowen; Zhu, Minzhe; Deng, Lingfu; Li, Bing; Liu, Zhonglai; Qi, Chao			Identification of Sare0718 As an Alanine-Activating Adenylation Domain in Marine Actinomycete Salinispora arenicola CNS-205	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; BIOSYNTHETIC GENE-CLUSTER; NATURAL-PRODUCTS; METABOLITES; POLYKETIDE; PREDICTION; DISCOVERY; RESOURCE; SEQUENCE; ASSAY	Background: Amino acid adenylation domains (A domains) are critical enzymes that dictate the identity of the amino acid building blocks to be incorporated during nonribosomal peptide (NRP) biosynthesis. NRPs represent a large group of valuable natural products that are widely applied in medicine, agriculture, and biochemical research. Salinispora arenicola CNS-205 is a representative strain of the first discovered obligate marine actinomycete genus, whose genome harbors a large number of cryptic secondary metabolite gene clusters. Methodology/Principal Findings: In order to investigate cryptic NRP-related metabolites in S. arenicola CNS-205, we cloned and identified the putative gene sare0718 annotated "amino acid adenylation domain''. Firstly, the general features and possible functions of sare0718 were predicted by bioinformatics analysis, which suggested that Sare0718 is a soluble protein with an AMP-binding domain contained in the sequence and its cognate substrate is L-Val. Then, a GST-tagged fusion protein was expressed and purified to further explore the exact adenylation activity of Sare0718 in vitro. By a newly mentioned nonradioactive malachite green colorimetric assay, we found that L-Ala but not L-Val is the actual activated amino acid substrate and the basic kinetic parameters of Sare0718 for it are K-m = 0.1164 +/- 0.0159 (mM), V-max = 3.1484 +/- 0.1278 (mu M/min), k(cat) = 12.5936 +/- 0.5112 (min(-1)). Conclusions/Significance: By revealing the biochemical role of sare0718 gene, we identified an alanine-activating adenylation domain in marine actinomycete Salinispora arenicola CNS-205, which would provide useful information for next isolation and function elucidation of the whole cryptic nonribosomal peptide synthetase (NRPS)-related gene cluster covering Sare0718. And meanwhile, this work also enriched the biochemical data of A domain substrate specificity in newly discovered marine actinomycete NRPS system, which bioinformatics prediction will largely depend on.	[Xia, Sisi; Ma, Yanlin; Zhang, Wei; Wu, Shaowen; Zhu, Minzhe; Deng, Lingfu; Li, Bing; Liu, Zhonglai; Qi, Chao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Yang, Yi] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Central China Normal University; Hebei Medical University	Xia, SS (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	hslzl2007@163.com; qichao@mail.ccnu.edu.cn		Xia, Sisi/0000-0003-3409-1302	National Science Foundation of China [20772040]; Central China Normal University (CCNU); MOE [CCNU11A02013]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central China Normal University (CCNU); MOE(Ministry of Higher Education & Scientific Research (MHESR))	This research was supported by the National Science Foundation of China (No. 20772040.) and financially supported by self-determined research funds of Central China Normal University (CCNU) from the colleges' basic research and operation of MOE (No. CCNU11A02013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lam KS, 2006, CURR OPIN MICROBIOL, V9, P245, DOI 10.1016/j.mib.2006.03.004; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; Lombo F, 2006, CHEMBIOCHEM, V7, P366, DOI 10.1002/cbic.200500325; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Mok MTS, 2005, J BIOL CHEM, V280, P39363, DOI 10.1074/jbc.M509209200; Mok MTS, 2005, ANAL BIOCHEM, V343, P341, DOI 10.1016/j.ab.2005.05.023; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Santi D V, 1974, Methods Enzymol, V29, P620; Schultz AW, 2008, J AM CHEM SOC, V130, P4507, DOI 10.1021/ja711188x; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wilkins MR, 1999, METH MOL B, V112, P531	42	5	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37487	10.1371/journal.pone.0037487	http://dx.doi.org/10.1371/journal.pone.0037487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655051	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900027
J	Zhang, K; Wang, Z; Liu, XL; Yin, CC; Basit, ZS; Xia, B; Liu, WJ				Zhang, Ke; Wang, Zhao; Liu, Xiaoling; Yin, Changcheng; Basit, Zeshan; Xia, Bin; Liu, Wenjun			Dissection of Influenza A Virus M1 Protein: pH-Dependent Oligomerization of N-Terminal Domain and Dimerization of C-Terminal Domain	PLOS ONE			English	Article							RNA-BINDING-PROTEIN; MATRIX PROTEIN; MEMBRANE ASSOCIATION; M2 PROTEIN; PARTICLES; REPLICATION; MORPHOGENESIS; GLYCOPROTEINS; TRANSPORT; RIBONUCLEOPROTEINS	Background: The matrix 1 (M1) protein of Influenza A virus plays many critical roles throughout the virus life cycle. The oligomerization of M1 is essential for the formation of the viral matrix layer during the assembly and budding process. Methodology/Principal Findings: In the present study, we report that M1 can oligomerize in vitro, and that the oligomerization is pH-dependent. The N-terminal domain of M1 alone exists as multiple-order oligomers at pH 7.4, and the C-terminal domain alone forms an exclusively stable dimer. As a result, intact M1 can display different forms of oligomers and dimer is the smallest oligomerization state, at neutral pH. At pH 5.0, oligomers of the N-terminal domain completely dissociate into monomers, while the C-terminal domain remains in dimeric form. As a result, oligomers of intact M1 dissociate into a stable dimer at acidic pH. Conclusions/Significance: Oligomerization of M1 involves both the N- and C-terminal domains. The N-terminal domain determines the pH-dependent oligomerization characteristic, and C-terminal domain forms a stable dimer, which contributes to the dimerization of M1. The present study will help to unveil the mechanisms of influenza A virus assembly and uncoating process.	[Zhang, Ke; Liu, Xiaoling; Basit, Zeshan; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Zhang, Ke; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Zhao; Yin, Changcheng] Peking Univ, Hlth Sci Ctr, Dept Biophys, Beijing 100871, Peoples R China; [Xia, Bin] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Zhang, K (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	binxia@pku.edu.cn; liuwj@im.ac.cn	wang, zhao/E-1996-2016; Liu, Xiaoling/HGD-3566-2022; wang, zhao/E-7013-2015	Yin, Chang-Cheng/0000-0001-7748-3205; Wang, Zhao/0000-0003-4897-9986	National Basic Research Program (973) of China [2011CB504705]; Chinese Academy of Sciences Innovation [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Natural Science Foundation of China [30972185, 30901073]	National Basic Research Program (973) of China(National Basic Research Program of China); Chinese Academy of Sciences Innovation(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2011CB504705), Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-158), and National Natural Science Foundation of China (30972185, 30901073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; ELSTER C, 1994, J GEN VIROL, V75, P37, DOI 10.1099/0022-1317-75-1-37; ENAMI M, 1985, VIROLOGY, V142, P68, DOI 10.1016/0042-6822(85)90423-4; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; FUJIYOSHI Y, 1994, EMBO J, V13, P318, DOI 10.1002/j.1460-2075.1994.tb06264.x; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; HEGGENESS MH, 1982, VIROLOGY, V118, P466, DOI 10.1016/0042-6822(82)90367-1; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Hui EKW, 2002, J GEN VIROL, V83, P3055, DOI 10.1099/0022-1317-83-12-3055; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Kraus I, 2005, FEBS LETT, V579, P2686, DOI 10.1016/j.febslet.2005.04.002; Ksenofontov AL, 2011, MOL BIOL+, V45, P634, DOI 10.1134/S0026893311030071; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Laue TM, 2001, CURR PROTOC PROTEIN; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Pohl C, 2007, J GEN VIROL, V88, P1243, DOI 10.1099/vir.0.82578-0; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Ruigrok R, 2001, INT CONGR SER, V1219, P397, DOI 10.1016/S0531-5131(01)00637-9; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHULZE IT, 1972, VIROLOGY, V47, P181, DOI 10.1016/0042-6822(72)90251-6; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shishkov A, 2011, FEBS J IN PRESS; Shishkov AV, 2009, PROTEIN PEPTIDE LETT, V16, P1407, DOI 10.2174/092986609789353682; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; WAKEFIELD L, 1989, NUCLEIC ACIDS RES, V17, P8569, DOI 10.1093/nar/17.21.8569; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Wang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022625; Wu CY, 2011, J VIROL, V85, P6618, DOI 10.1128/JVI.02401-10; Zhao HX, 1998, J GEN VIROL, V79, P2435, DOI 10.1099/0022-1317-79-10-2435; ZHIRNOV OP, 1992, VIROLOGY, V186, P324, DOI 10.1016/0042-6822(92)90090-C	61	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37786	10.1371/journal.pone.0037786	http://dx.doi.org/10.1371/journal.pone.0037786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655068	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338900044
J	Radulescu, S; Ridgway, RA; Cordero, J; Athineos, D; Salgueiro, P; Poulsom, R; Neumann, J; Jung, A; Patel, S; Woodgett, J; Barker, N; Pritchard, DM; Oien, K; Sansom, OJ				Radulescu, S.; Ridgway, R. A.; Cordero, J.; Athineos, D.; Salgueiro, P.; Poulsom, R.; Neumann, J.; Jung, A.; Patel, S.; Woodgett, J.; Barker, N.; Pritchard, D. M.; Oien, K.; Sansom, O. J.			Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation	ONCOGENE			English	Article						beta-catenin; gastric cancer; APC; GSK3	FAMILIAL ADENOMATOUS POLYPOSIS; FUNDIC GLAND POLYPS; WNT/BETA-CATENIN PATHWAY; E-CADHERIN GENE; BETA-CATENIN; STEM-CELLS; SOMATIC MUTATIONS; GASTRIC-CARCINOMA; APC GENE; FLUORESCENT PROTEIN	A role for WNT signalling in gastric carcinogenesis has been suggested due to two major observations. First, patients with germline mutations in adenomatous polyposis coli (APC) are susceptible to stomach polyps and second, in gastric cancer, WNT activation confers a poor prognosis. However, the functional significance of deregulated WNT signalling in gastric homoeostasis and cancer is still unclear. In this study we have addressed this by investigating the immediate effects of WNT signalling activation within the stomach epithelium. We have specifically activated the WNT signalling pathway within the mouse adult gastric epithelium via deletion of either glycogen synthase kinase 3 (GSK3) or APC or via expression of a constitutively active beta-catenin protein. WNT pathway deregulation dramatically affects stomach homoeostasis at very short latencies. In the corpus, there is rapid loss of parietal cells with fundic gland polyp (FGP) formation and adenomatous change, which are similar to those observed in familial adenomatous polyposis. In the antrum, adenomas occur from 4 days post-WNT activation. Taken together, these data show a pivotal role for WNT signalling in gastric homoeostasis, FGP formation and adenomagenesis. Loss of the parietal cell population and corresponding FGP formation, an early event in gastric carcinogenesis, as well as antral adenoma formation are immediate effects of nuclear beta-catenin translocation and WNT target gene expression. Furthermore, our inducible murine model will permit a better understanding of the molecular changes required to drive tumourigenesis in the stomach. Oncogene (2013) 32, 2048-2057; doi:10.1038/onc.2012.224; published online 4 June 2012	[Radulescu, S.; Ridgway, R. A.; Cordero, J.; Athineos, D.; Salgueiro, P.; Sansom, O. J.] CR UK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Salgueiro, P.; Barker, N.] ASTAR, Inst Med Biol, Singapore, Singapore; [Poulsom, R.] CR UK London Res Inst, Histopathol Lab, London, England; [Neumann, J.; Jung, A.] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Patel, S.; Woodgett, J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pritchard, D. M.] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Oien, K.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Munich; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Liverpool; University of Glasgow	Sansom, OJ (corresponding author), CR UK Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Woodgett, Jim/F-1087-2010; Barker, Nick/AAE-9833-2021; Oien, Karin/AAH-3849-2019	Woodgett, Jim/0000-0003-3731-5797; Barker, Nick/0000-0003-3566-4475; Sansom, Owen J./0000-0001-9540-3010; Athineos, Dimitris/0000-0001-5298-7941; Pritchard, David Mark/0000-0001-7971-3561	CR-UK; AICR [06-0614]; CRUK; Cancer Research UK [12481] Funding Source: researchfish	CR-UK(Cancer Research UK); AICR; CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by the CR-UK project and programme grants and AICR grant 06-0614 to Owen Sansom. Help from Colin Nixon with histology and from Derek Miller and Tom Hamilton with transgenic work was much appreciated. This work was funded by AICR and CRUK grants.	Abraham SC, 2000, AM J PATHOL, V157, P747, DOI 10.1016/S0002-9440(10)64588-9; Abraham SC, 2001, AM J PATHOL, V158, P1005, DOI 10.1016/S0002-9440(10)64047-3; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; BECKER KF, 1995, JNCI-J NATL CANCER I, V87, P1082, DOI 10.1093/jnci/87.14.1082; Bianchi LK, 2008, CLIN GASTROENTEROL H, V6, P180, DOI 10.1016/j.cgh.2007.11.018; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Clements WM, 2002, CANCER RES, V62, P3503; CORREA P, 1994, CANCER RES, V54, pS1941; CORREA P, 1992, CANCER RES, V52, P6735; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; Ebert MPA, 2002, CARCINOGENESIS, V23, P87, DOI 10.1093/carcin/23.1.87; FORTE JG, 1983, J CLIN GASTROENTEROL, V5, P17, DOI 10.1097/00004836-198312001-00003; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1318, DOI 10.3748/wjg.14.1318; Garrean S, 2008, AM SURGEON, V74, P79; Gatta G, 2006, LANCET ONCOL, V7, P132, DOI 10.1016/S1470-2045(05)70471-X; Gnad T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-31; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; HORII A, 1992, CANCER RES, V52, P3231; IIDA M, 1985, GASTROENTEROLOGY, V89, P1021, DOI 10.1016/0016-5085(85)90203-3; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kim B, 2010, PATHOLOGY, V42, P58, DOI 10.3109/00313020903356392; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Miyazawa K, 2000, VIRCHOWS ARCH, V437, P508, DOI 10.1007/s004280000283; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; NAKATSURU S, 1993, HUM MOL GENET, V2, P1463, DOI 10.1093/hmg/2.9.1463; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Park DY, 2008, ARCH PATHOL LAB MED, V132, P633, DOI 10.1043/1543-2165(2008)132[633:GPCAM]2.0.CO;2; Park WS, 1999, CANCER RES, V59, P4257; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Przemeck SMC, 2007, AM J PHYSIOL-GASTR L, V292, pG620, DOI 10.1152/ajpgi.00391.2006; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sekine S, 2002, VIRCHOWS ARCH, V440, P381, DOI 10.1007/s004280100527; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Sokolova O, 2008, J BIOL CHEM, V283, P29367, DOI 10.1074/jbc.M801818200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; TAHARA E, 1995, WORLD J SURG, V19, P484, DOI 10.1007/BF00294705; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torbenson M, 2002, MODERN PATHOL, V15, P718, DOI 10.1097/01.MP.0000018976.15044.9B; Tycko B, 2007, CURR MOL MED, V7, P479; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; WATANABE H, 1978, HUM PATHOL, V9, P269, DOI 10.1016/S0046-8177(78)80085-9; Zhang HF, 2008, HEPATO-GASTROENTEROL, V55, P1126; Zhao ZM, 2010, J GENET GENOMICS, V37, P647, DOI 10.1016/S1673-8527(09)60083-7; Zheng HC, 2010, HUM PATHOL, V41, P1255, DOI 10.1016/j.humpath.2010.02.003	75	42	42	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2048	2057		10.1038/onc.2012.224	http://dx.doi.org/10.1038/onc.2012.224			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22665058	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000317919900006
J	Tomkiewicz, C; Herry, L; Bui, LC; Metayer, C; Bourdeloux, M; Barouki, R; Coumoul, X				Tomkiewicz, C.; Herry, L.; Bui, L-C; Metayer, C.; Bourdeloux, M.; Barouki, R.; Coumoul, X.			The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway	ONCOGENE			English	Article						AhR; cell plasticity; FAK; integrin; Src	PROTEIN-TYROSINE KINASES; AH DIOXIN RECEPTOR; CANCER CELL-LINE; C-SRC; SIGNAL-TRANSDUCTION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; ENVIRONMENTAL-POLLUTANTS; GENE-EXPRESSION; HUMAN ENHANCER; KNOCKOUT MICE	The aryl hydrocarbon receptor (AhR) is commonly described as a transcription factor, which regulates xenobiotic-metabolizing enzymes. Recent studies have suggested that the binding of ligands to the AhR also activates the Src kinase. In this manuscript, we show that the AhR, through the activation of Src, activates focal adhesion kinase (FAK) and promotes integrin clustering. These effects contribute to cell migration. Further, we show that the activation of the AhR increases the interaction of FAK with the metastatic marker, HEF1/NEDD9/CAS-L, and the expression of several integrins. Xenobiotic exposure, thus, may contribute to novel cell-migratory programs. Oncogene (2013) 32, 1811-1820; doi: 10.1038/onc.2012.197; published online 4 June 2012	[Tomkiewicz, C.; Herry, L.; Bui, L-C; Metayer, C.; Bourdeloux, M.; Barouki, R.; Coumoul, X.] INSERM, UMR S Toxicol Pharmacol & Signalisat Cellulaire 7, Paris, France; [Tomkiewicz, C.; Herry, L.; Bui, L-C; Metayer, C.; Bourdeloux, M.; Barouki, R.; Coumoul, X.] Univ Paris 05, Sorbonne Paris Cite, Ctr Univ St Peres, F-75006 Paris, France; [Herry, L.; Barouki, R.] Hop Necker Enfants Malad, AP HP, Serv Biochim Metab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Coumoul, X (corresponding author), Univ Paris 05, Sorbonne Paris Cite, 45 Rue St Peres, F-75006 Paris, France.	xavier.coumoul@parisdescartes.fr	COUMOUL, Xavier/AAR-3649-2020	COUMOUL, Xavier/0000-0003-2928-9648	ANSES (Agence Nationale de SEcurite Sanitaire de l'alimentation, de l'environnement et du travail); ANR (Agence Nationale de la Recherche) [06SEST26]; ARC (Association pour la Recherche sur le Cancer) [3927, SFI20101201842]; CNRS (Center Nationale de la recherche scientifique); Fondation pour la Recherche Medicale; Ecole Doctorale du Medicament; Hospitals Europeen Georges Pompidou and Necker Enfants Malade; INSERM (Institut National de la Sante et de la Recherche Medicale); Ligue contre le Cancer; Ministere de l'enseignement superieur et de la recherche; Region Ile de France; Universite Paris Descartes, Paris Sorbonne Cite	ANSES (Agence Nationale de SEcurite Sanitaire de l'alimentation, de l'environnement et du travail)(French National Research Agency (ANR)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); CNRS (Center Nationale de la recherche scientifique); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ecole Doctorale du Medicament; Hospitals Europeen Georges Pompidou and Necker Enfants Malade; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue contre le Cancer(Ligue nationale contre le cancer); Ministere de l'enseignement superieur et de la recherche; Region Ile de France(Region Ile-de-France); Universite Paris Descartes, Paris Sorbonne Cite	This work was supported by the ANSES (Agence Nationale de SEcurite Sanitaire de l'alimentation, de l'environnement et du travail; all authors), ANR (Agence Nationale de la Recherche, 06SEST26, Oncopop; all authors), ARC (Association pour la Recherche sur le Cancer, 3927 and SFI20101201842; all authors), CNRS (Center Nationale de la recherche scientifique), Fondation pour la Recherche Medicale, 'Ecole Doctorale du Medicament', Hospitals Europeen Georges Pompidou and Necker Enfants Malade, INSERM (Institut National de la Sante et de la Recherche Medicale; all authors), Ligue contre le Cancer (post-doctoral fellowship), Ministere de l'enseignement superieur et de la recherche, Region Ile de France (doctoral fellowship) and Universite Paris Descartes, Paris Sorbonne Cite. The FRNK-expressing vector is a generous gift of Dr Kenneth M Yamada (NIDCR, NIH, USA) and Dr Bernard Rothhut (CNRS UMR 6237, Reims). We warmly thank Dr Lawrence Aggerbeck for his critical reading of this manuscript.	Ahmed S, 2005, FEBS J, V272, P903, DOI 10.1111/j.1742-4658.2004.04519.x; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Garcia MA, 2010, TOXICOL LETT, V192, P195, DOI 10.1016/j.toxlet.2009.10.026; Ambolet-Camoit A, 2010, TOXICOL SCI, V115, P501, DOI 10.1093/toxsci/kfq082; Ashida H, 2008, EXPERT OPIN DRUG MET, V4, P1429, DOI [10.1517/17425255.4.11.1429, 10.1517/17425255.4.11.1429 ]; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Blankenship A, 1997, MOL PHARMACOL, V52, P667, DOI 10.1124/mol.52.4.667; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Diry M, 2006, ONCOGENE, V25, P5570, DOI 10.1038/sj.onc.1209553; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Enan E, 1998, J BIOCHEM MOL TOXIC, V12, P263, DOI 10.1002/(SICI)1099-0461(1998)12:5<263::AID-JBT2>3.0.CO;2-J; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Frueh FW, 2001, TOXICOL LETT, V122, P189, DOI 10.1016/S0378-4274(01)00364-2; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Hamadi A, 2010, J ONCOL, V2010, DOI 10.1155/2010/932803; Hivert V, 2009, BIOCHEM PHARMACOL, V78, P1017, DOI 10.1016/j.bcp.2009.06.005; Hoelper P, 2005, ARCH TOXICOL, V79, P201, DOI 10.1007/s00204-004-0624-6; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kohle C, 1999, ARCH TOXICOL, V73, P152, DOI 10.1007/s002040050600; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lemaire G, 2004, LIFE SCI, V74, P2265, DOI 10.1016/j.lfs.2003.09.056; Marchand A, 2005, MOL PHARMACOL, V67, P444, DOI 10.1124/mol.104.004010; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Mayati A, 2012, J BIOL CHEM, V287, P4041, DOI 10.1074/jbc.M111.319970; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Provenzano PP, 2009, CELL ADHES MIGR, V3, P347, DOI 10.4161/cam.3.4.9458; Puga A, 2000, BIOCHEM PHARMACOL, V60, P1129, DOI 10.1016/S0006-2952(00)00403-2; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Randi AS, 2008, TOXICOL LETT, V177, P116, DOI 10.1016/j.toxlet.2008.01.003; Ratushny V, 2012, ONCOGENE, V31, P1217, DOI 10.1038/onc.2011.314; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Sciullo EM, 2009, CHEMOSPHERE, V74, P1531, DOI 10.1016/j.chemosphere.2008.11.010; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tompkins LM, 2007, J BIOCHEM MOL TOXIC, V21, P176, DOI 10.1002/jbt.20180; Vogel CFA, 2003, J BIOCHEM MOL TOXIC, V17, P305, DOI 10.1002/jbt.10096; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413	64	57	62	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1811	1820		10.1038/onc.2012.197	http://dx.doi.org/10.1038/onc.2012.197			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22665056				2022-12-25	WOS:000317043900007
J	Azibani, F; Devaux, Y; Coutance, G; Schlossarek, S; Polidano, E; Fazal, L; Merval, R; Carrier, L; Solal, AC; Chatziantoniou, C; Launay, JM; Samuel, JL; Delcayre, C				Azibani, Feriel; Devaux, Yvan; Coutance, Guillaume; Schlossarek, Saskia; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Carrier, Lucie; Solal, Alain Cohen; Chatziantoniou, Christos; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude			Aldosterone Inhibits the Fetal Program and Increases Hypertrophy in the Heart of Hypertensive Mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ENZYME GENE-EXPRESSION; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; CORONARY DYSFUNCTION; SPIRONOLACTONE; FIBROSIS; FAILURE; ACTIVATION; MICRORNAS	Background: Arterial hypertension (AH) induces cardiac hypertrophy and reactivation of "fetal" gene expression. In rodent heart, alpha-Myosin Heavy Chain (MyHC) and its micro-RNA miR-208a regulate the expression of beta-MyHC and of its intronic miR-208b. However, the role of aldosterone in these processes remains unclear. Methodology/Principal Findings: RT-PCR and western-blot were used to investigate the genes modulated by arterial hypertension and cardiac hyperaldosteronism. We developed a model of double-transgenic mice (AS-Ren) with cardiac hyperaldosteronism (AS mice) and systemic hypertension (Ren). AS-Ren mice had increased (x2) angiotensin II in plasma and increased (x2) aldosterone in heart. Ren and AS-Ren mice had a robust and similar hypertension (+70%) versus their controls. Anatomical data and echocardiography showed a worsening of cardiac hypertrophy (+41%) in AS-Ren mice (P<0.05 vs Ren). The increase of ANP (x 2.5; P<0.01) mRNA observed in Ren mice was blunted in AS-Ren mice. This non-induction of antitrophic natriuretic peptides may be involved in the higher trophic cardiac response in AS-Ren mice, as indicated by the markedly reduced cardiac hypertrophy in ANP-infused AS-Ren mice for one month. Besides, the AH-induced increase of ssMyHC and its intronic miRNA-208b was prevented in AS-Ren. The inhibition of miR 208a (-75%, p<0.001) in AS-Ren mice compared to AS was associated with increased Sox 6 mRNA (x 1.34; p<0.05), an inhibitor of ssMyHC transcription. Eplerenone prevented all aldosterone-dependent effects. Conclusions/Significance: Our results indicate that increased aldosterone in heart inhibits the induction of atrial natriuretic peptide expression, via the mineralocorticoid receptor. This worsens cardiac hypertrophy without changing blood pressure. Moreover, this work reveals an original aldosterone-dependent inhibition of miR-208a in hypertension, resulting in the inhibition of beta-myosin heavy chain expression through the induction of its transcriptional repressor Sox6. Thus, aldosterone inhibits the fetal program and increases cardiac hypertrophy in hypertensive mice.	[Azibani, Feriel; Coutance, Guillaume; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude] INSERM, Unit 942, Paris, France; [Azibani, Feriel; Coutance, Guillaume; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude] Univ Paris Diderot, Paris, France; [Devaux, Yvan] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Schlossarek, Saskia; Carrier, Lucie] Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Schlossarek, Saskia; Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Carrier, Lucie] Inst Myol, UPMC, INSERM,UMR7215, UMR S974,CNRS, Paris, France; [Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise] Lariboisiere Hosp, AP HP, Paris, France; [Chatziantoniou, Christos] INSERM, Unit 702, Paris, France; [Chatziantoniou, Christos] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Luxembourg Institute of Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Azibani, F (corresponding author), INSERM, Unit 942, Paris, France.	Claude.Delcayre@inserm.fr	Coutance, Guillaume/ABE-9491-2020; Chatziantoniou, Christos/L-2501-2016; DEVAUX, Yvan/AAK-3463-2020	Coutance, Guillaume/0000-0003-4939-2175; Samuel, Jane-Lise/0000-0002-7346-2404; Devaux, Yvan/0000-0002-5321-8543	Universite Pierre et Marie Curie; INSERM; CNRS; ANR; GRRC; Fondation de France; Societe Francaise d'Hypertension	Universite Pierre et Marie Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); GRRC; Fondation de France(Fondation de France); Societe Francaise d'Hypertension	This work was supported by Universite Pierre et Marie Curie (LF), INSERM, CNRS, ANR, GRRC and Fondation de France. FA is the recipient of a PhD grant from the Societe Francaise d'Hypertension. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; BAUWENS FR, 1991, AM J CARDIOL, V68, P925, DOI 10.1016/0002-9149(91)90410-M; BRILLA CG, 1992, J LAB CLIN MED, V120, P893; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Dartsch T, 2011, INT J CARDI IN PRESS; El Jamali A, 2004, FASEB J, V18, P1096, DOI 10.1096/fj.03-1054fje; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Garnier A, 2004, CIRCULATION, V110, P1819, DOI 10.1161/01.CIR.0000142858.44680.27; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Harada E, 2001, CIRCULATION, V104, P137, DOI 10.1161/01.CIR.104.2.137; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Levy BI, 2001, AM J HYPERTENS, V14, P7, DOI 10.1016/S0895-7061(00)01212-7; Lopez-Andres N, 2011, AM J PHYSIOL-HEART C, V301, pH2372, DOI 10.1152/ajpheart.00283.2011; Matsumura K, 2006, AM J HYPERTENS, V19, P13, DOI 10.1016/j.amjhyper.2005.05.013; Messaoudi S, 2009, FASEB J, V23, P2176, DOI 10.1096/fj.08-125302; Milliez P, 2005, EUR HEART J, V26, P2193, DOI 10.1093/eurheartj/ehi478; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Okoshi MP, 2004, J CARD FAIL, V10, P511, DOI 10.1016/j.cardfail.2004.03.002; Pitt B, 2003, CIRCULATION, V108, P1831, DOI 10.1161/01.CIR.0000091405.00772.6E; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; ROBERT V, 1994, HYPERTENSION, V24, P30, DOI 10.1161/01.HYP.24.1.30; Robert V, 1999, HYPERTENSION, V33, P981, DOI 10.1161/01.HYP.33.4.981; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sugiyama T, 2005, ENDOCRINOLOGY, V146, P3900, DOI 10.1210/en.2004-1674; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tanabe A, 1997, Hypertens Res, V20, P85, DOI 10.1291/hypres.20.85; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Yoshida C, 2011, J HYPERTENS, V29, P357, DOI 10.1097/HJH.0b013e32834103d4; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	37	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38197	10.1371/journal.pone.0038197	http://dx.doi.org/10.1371/journal.pone.0038197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666483	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400100
J	Gualda, GAR; Pamukcu, AS; Ghiorso, MS; Anderson, AT; Sutton, SR; Rivers, ML				Gualda, Guilherme A. R.; Pamukcu, Ayla S.; Ghiorso, Mark S.; Anderson, Alfred T., Jr.; Sutton, Stephen R.; Rivers, Mark L.			Timescales of Quartz Crystallization and the Longevity of the Bishop Giant Magma Body	PLOS ONE			English	Article							CRYSTAL SIZE DISTRIBUTIONS; TUFF RHYOLITIC MAGMA; X-RAY TOMOGRAPHY; LONG-VALLEY; U-TH; ZONED PHENOCRYSTS; PHASE-EQUILIBRIA; MELT INCLUSIONS; PUMICE CLASTS; EXSOLVED GAS	Supereruptions violently transfer huge amounts (100 s-1000 s km(3)) of magma to the surface in a matter of days and testify to the existence of giant pools of magma at depth. The longevity of these giant magma bodies is of significant scientific and societal interest. Radiometric data on whole rocks, glasses, feldspar and zircon crystals have been used to suggest that the Bishop Tuff giant magma body, which erupted similar to 760,000 years ago and created the Long Valley caldera (California), was long-lived (>100,000 years) and evolved rather slowly. In this work, we present four lines of evidence to constrain the timescales of crystallization of the Bishop magma body: (1) quartz residence times based on diffusional relaxation of Ti profiles, (2) quartz residence times based on the kinetics of faceting of melt inclusions, (3) quartz and feldspar crystallization times derived using quartz+feldspar crystal size distributions, and (4) timescales of cooling and crystallization based on thermodynamic and heat flow modeling. All of our estimates suggest quartz crystallization on timescales of <10,000 years, more typically within 500-3,000 years before eruption. We conclude that large-volume, crystal-poor magma bodies are ephemeral features that, once established, evolve on millennial timescales. We also suggest that zircon crystals, rather than recording the timescales of crystallization of a large pool of crystal-poor magma, record the extended periods of time necessary for maturation of the crust and establishment of these giant magma bodies.	[Gualda, Guilherme A. R.; Pamukcu, Ayla S.] Vanderbilt Univ, Nashville, TN 37240 USA; [Ghiorso, Mark S.] OFM Res W, Seattle, WA USA; [Anderson, Alfred T., Jr.; Sutton, Stephen R.] Univ Chicago, Chicago, IL 60637 USA; [Sutton, Stephen R.; Rivers, Mark L.] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL USA	Vanderbilt University; University of Chicago; University of Chicago	Gualda, GAR (corresponding author), Vanderbilt Univ, Nashville, TN 37240 USA.	g.gualda@vanderbilt.edu	; Gualda, Guilherme/A-2467-2009	Ghiorso, Mark/0000-0002-0489-0018; Gualda, Guilherme/0000-0003-0720-2679	NSF [EAR-0408707, EAR-0948528, EAR-0948734, EAR-0622171]; Department of Energy-Geosciences [DE-FG02-94ER14466]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Directorate For Geosciences [0948532] Funding Source: National Science Foundation; Division Of Earth Sciences [0948734] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Energy-Geosciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided by NSF to ATA (EAR-0408707), GARG (EAR-0948528) and MSG (EAR-0948734). Portions of this work were performed at GeoSoilEnviroCARS (Sector 13), Advanced Photon Source (APS), Argonne National Laboratory; GeoSoilEnviroCARS is supported by NSF (EAR-0622171) and Department of Energy-Geosciences (DE-FG02-94ER14466); use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (Contract No. DE-AC02-06CH11357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AT, 2000, J PETROL, V41, P449, DOI 10.1093/petrology/41.3.449; Annen C, 2011, TECTONOPHYSICS, V500, P3, DOI 10.1016/j.tecto.2009.04.010; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; BAILEY RA, 1976, J GEOPHYS RES, V81, P725, DOI 10.1029/JB081i005p00725; BAKER DR, 1991, CONTRIB MINERAL PETR, V106, P462, DOI 10.1007/BF00321988; BEDDOESTEPHENS B, 1983, CONTRIB MINERAL PETR, V83, P278, DOI 10.1007/BF00371196; BERMAN RG, 1988, J PETROL, V29, P445, DOI 10.1093/petrology/29.2.445; Bindeman IN, 2008, J PETROL, V49, P163, DOI 10.1093/petrology/egm075; Bindeman IN, 2002, CONTRIB MINERAL PETR, V144, P185, DOI 10.1007/s00410-002-0371-8; Carslaw HS, 1984, CONDUCTION HEAT SOLI; Chaigneau M., 1980, B VOLCANOL, V43, P233; Chakraborty S, 2008, ANNU REV EARTH PL SC, V36, P153, DOI 10.1146/annurev.earth.36.031207.124125; Charlier BLA, 2005, J PETROL, V46, P3, DOI 10.1093/petrology/egh060; Cherniak DJ, 2007, CHEM GEOL, V236, P65, DOI 10.1016/j.chemgeo.2006.09.001; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Crank J, 1979, MATH DIFFUSION, P13; Crowley JL, 2007, GEOLOGY, V35, P1123, DOI 10.1130/G24017A.1; Dowty E., 1980, PHYS MAGMATIC PROCES; Fowler SJ, 2010, J PETROL, V51, P1783, DOI 10.1093/petrology/egq039; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Gualda GAR, 2006, J PETROL, V47, P1245, DOI 10.1093/petrology/egl010; Gualda GAR, 2004, T ROY SOC EDIN-EARTH, V95, P375; Gualda GAR, 2007, THESIS U CHICAGO; Gualda GAR, 2006, J VOLCANOL GEOTH RES, V154, P48, DOI 10.1016/j.jvolgeores.2005.09.019; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Gualda GAR, 2011, J PETROL, V52, P431, DOI 10.1093/petrology/egq097; HERVIG RL, 1992, EARTH PLANET SC LETT, V111, P97, DOI 10.1016/0012-821X(92)90172-R; Hildreth W, 1979, GEOLOGICAL SOC AM SP; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; Holtz F, 2001, CONTRIB MINERAL PETR, V141, P347, DOI 10.1007/s004100100245; Johannes W., 1996, PETROGENESIS EXPT PE, DOI 10.1007/978-3-642-61049-3_2; Lipman PW, 2008, GEOL SOC AM BULL, V120, P771, DOI 10.1130/B26330.1; Lovering TS, 1936, BULL GEOL SOC AM, V47, P87; Lowenstern JB, 2006, PHILOS T R SOC A, V364, P2055, DOI 10.1098/rsta.2006.1813; MAHOOD GA, 1990, EARTH PLANET SC LETT, V99, P395, DOI 10.1016/0012-821X(90)90145-N; Manley CR, 1996, AM MINERAL, V81, P158; MARSH BD, 1988, CONTRIB MINERAL PETR, V99, P277, DOI 10.1007/BF00375362; Marsh BD, 1998, J PETROL, V39, P553, DOI 10.1093/petrology/39.4.553; McCanta MC, 2007, J VOLCANOL GEOTH RES, V160, P263, DOI 10.1016/j.jvolgeores.2006.10.004; MICHAEL PJ, 1983, GEOLOGY, V11, P31, DOI 10.1130/0091-7613(1983)11<31:CDOTBT>2.0.CO;2; MILLER CF, 1984, EARTH PLANET SC LETT, V68, P151, DOI 10.1016/0012-821X(84)90147-X; Miller JS, 2007, J VOLCANOL GEOTH RES, V167, P282, DOI 10.1016/j.jvolgeores.2007.04.019; Morgan DJ, 2006, GEOLOGY, V34, P845, DOI 10.1130/G22604.1; Morgan DJ, 2006, CONTRIB MINERAL PETR, V151, P58, DOI 10.1007/s00410-005-0045-4; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; Pabst S, 2008, B VOLCANOL, V70, P961, DOI 10.1007/s00445-007-0180-z; Pamukcu AS, 2012, J PETROL, V53, P589, DOI 10.1093/petrology/egr072; Pamukcu AS, 2010, GEOSPHERE, V6, P775, DOI 10.1130/GES00565.1; Papale P, 2006, CHEM GEOL, V229, P78, DOI 10.1016/j.chemgeo.2006.01.013; Paul A., 1982, CHEM GLASSES; Peppard BT, 2001, AM MINERAL, V86, P1034; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Roedder E, 1984, REV MINERAL, V12, P59; Schmitt AK, 2010, EARTH PLANET SC LETT, V295, P91, DOI 10.1016/j.epsl.2010.03.028; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Shewmon PG, 1969, TRANSFORMATIONS META; Simon JI, 2007, GEOCHIM COSMOCHIM AC, V71, P2014, DOI 10.1016/j.gca.2007.01.023; Simon JI, 2005, EARTH PLANET SC LETT, V235, P123, DOI 10.1016/j.epsl.2005.03.013; Storm S, 2011, EARTH PLANET SC LETT, V301, P511, DOI 10.1016/j.epsl.2010.11.034; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Tamic N, 2001, CHEM GEOL, V174, P333, DOI 10.1016/S0009-2541(00)00324-7; Thomas JB, 2010, CONTRIB MINERAL PETR, V160, P743, DOI 10.1007/s00410-010-0505-3; Vazquez JA, 2004, SCIENCE, V305, P991, DOI 10.1126/science.1096994; Walker BA, 2007, J VOLCANOL GEOTH RES, V167, P239, DOI 10.1016/j.jvolgeores.2006.12.008; Wallace PJ, 1999, J GEOPHYS RES-SOL EA, V104, P20097, DOI 10.1029/1999JB900207; WALLACE PJ, 1995, NATURE, V377, P612, DOI 10.1038/377612a0; Wark DA, 2007, GEOLOGY, V35, P235, DOI 10.1130/G23316A.1; Wark DA, 2006, CONTRIB MINERAL PETR, V152, P743, DOI 10.1007/s00410-006-0132-1; Watson EB, 1996, T ROY SOC EDIN-EARTH, V87, P43, DOI 10.1017/S0263593300006465; Whittington AG, 2009, NATURE, V458, P319, DOI 10.1038/nature07818; Wilson CJN, 2009, J PETROL, V50, P875, DOI 10.1093/petrology/egp023; Wilson CJN, 1997, J GEOL, V105, P407, DOI 10.1086/515937; Wortis M, 1988, CHEM PHYS SOLID SURF, VVII; Zandt G, 2003, PURE APPL GEOPHYS, V160, P789, DOI 10.1007/PL00012557	74	90	91	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37492	10.1371/journal.pone.0037492	http://dx.doi.org/10.1371/journal.pone.0037492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666359	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400028
J	Kong, R; Jia, G; Cheng, ZX; Wang, YW; Mu, M; Wang, SJ; Pan, SH; Gao, Y; Jiang, HC; Dong, DL; Sun, B				Kong, Rui; Jia, Guang; Cheng, Zhuo-xin; Wang, Yong-wei; Mu, Ming; Wang, Shuang-jia; Pan, Shang-ha; Gao, Yue; Jiang, Hong-chi; Dong, De-li; Sun, Bei			Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LIGAND-INDUCED APOPTOSIS; HUMAN PROSTATE-CANCER; IN-VITRO; DOWN-REGULATION; ARTEMISININ; CASPASE-8; THERAPY; GROWTH; VIVO	Background: Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor activity in various cancer cells. Apo2 ligand or tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) is regarded as a promising anticancer agent, but chemoresistance affects its efficacy as a treatment strategy. Apoptosis induced by the combination of DHA and Apo2L/TRAIL has not been well documented, and the mechanisms involved remain unclear. Methodology/Principal Findings: Here, we report that DHA enhances the efficacy of Apo2L/TRAIL for the treatment of pancreatic cancer. We found that combined therapy using DHA and Apo2L/TRAIL significantly enhanced apoptosis in BxPC-3 and PANC-1 cells compared with single-agent treatment in vitro. The effect of DHA was mediated through the generation of reactive oxygen species, the induction of death receptor 5 (DR5) and the modulation of apoptosis-related proteins. However, N-acetyl cysteine significantly reduced the enhanced apoptosis observed with the combination of DHA and Apo2L/TRAIL. In addition, knockdown of DR5 by small interfering RNA also significantly reduced the amount of apoptosis induced by DHA and Apo2L/TRAIL. Conclusions/Significance: These results suggest that DHA enhances Apo2L/TRAIL-mediated apoptosis in human pancreatic cancer cells through reactive oxygen species-mediated up-regulation of DR5.	[Kong, Rui; Jia, Guang; Cheng, Zhuo-xin; Wang, Yong-wei; Wang, Shuang-jia; Pan, Shang-ha; Gao, Yue; Jiang, Hong-chi; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China; [Mu, Ming] Univ Wisconsin Madison, Sch Agr & Life Sci, Dept Biol, Madison, WI USA; [Dong, De-li] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China	Harbin Medical University; University of Wisconsin System; University of Wisconsin Madison; Harbin Medical University	Kong, R (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	shuangjia, wang/AFX-8272-2022; Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984	Foundation of the First Affiliated Hospital of Harbin Medical University [2011BS007]; National Science Foundation for Post-doctoral Scientists of China [20110491109]; Research Foundation of Education Bureau of Heilongjiang Province, China [12511246]	Foundation of the First Affiliated Hospital of Harbin Medical University; National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Research Foundation of Education Bureau of Heilongjiang Province, China	This work was supported in part by grants from the Foundation of the First Affiliated Hospital of Harbin Medical University (2011BS007), the National Science Foundation for Post-doctoral Scientists of China (20110491109), and the Research Foundation of Education Bureau of Heilongjiang Province, China (12511246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger HG, 2003, WORLD J SURG, V27, P1075, DOI 10.1007/s00268-003-7165-7; Cabello CM, 2011, INVEST NEW DRUGS; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; He Q, 2010, CANCER BIOL THER, V9, P819, DOI 10.4161/cbt.9.10.11552; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HIEN TT, 1993, LANCET, V341, P603; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim SJ, 2006, J CANCER RES CLIN, V132, P129, DOI 10.1007/s00432-005-0052-x; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Lu YY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-16; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mizutani Y, 2001, J UROLOGY, V165, P263, DOI 10.1097/00005392-200101000-00076; Mu DG, 2008, CANCER CHEMOTH PHARM, V61, P639, DOI 10.1007/s00280-007-0517-5; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Posner GH, 2004, ACCOUNTS CHEM RES, V37, P397, DOI 10.1021/ar020227u; Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113; Raraty MGT, 2002, ACTA ONCOL, V41, P582, DOI 10.1080/028418602321028184; Schuler S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-80; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Singh NP, 2004, ANTICANCER RES, V24, P2277; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; van Agtmael MA, 1999, TRENDS PHARMACOL SCI, V20, P199, DOI 10.1016/S0165-6147(99)01302-4; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; White SJ, 2007, FREE RADICAL BIO MED, V43, P1313, DOI 10.1016/j.freeradbiomed.2007.06.015; White-Gilbertson SJ, 2009, J UROLOGY, V182, P1178, DOI 10.1016/j.juro.2009.05.005; WOERDENBAG HJ, 1994, PHARM WORLD SCI, V16, P169, DOI 10.1007/BF01872865; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Yang XZ, 2003, CANCER RES, V63, P1122; Yasuda T, 2008, MOL CANCER RES, V6, P1852, DOI 10.1158/1541-7786.MCR-08-0012; Yasui H, 2005, INT J ONCOL, V26, P537; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161	54	54	58	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37222	10.1371/journal.pone.0037222	http://dx.doi.org/10.1371/journal.pone.0037222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666346	gold, Green Submitted, Green Published			2022-12-25	WOS:000305353400022
J	Mitro, S; Gordon, AR; Olsson, MJ; Lundstrom, JN				Mitro, Susanna; Gordon, Amy R.; Olsson, Mats J.; Lundstrom, Johan N.			The Smell of Age: Perception and Discrimination of Body Odors of Different Ages	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PERCEIVED INTENSITY; KIN RECOGNITION; OLFACTORY CUES; MOUSE URINE; IDENTIFICATION; COMMUNICATION; HUMANS; SEX; GENDER	Our natural body odor goes through several stages of age-dependent changes in chemical composition as we grow older. Similar changes have been reported for several animal species and are thought to facilitate age discrimination of an individual based on body odors, alone. We sought to determine whether humans are able to discriminate between body odor of humans of different ages. Body odors were sampled from three distinct age groups: Young (20-30 years old), Middle-age (45-55), and Old-age (75-95) individuals. Perceptual ratings and age discrimination performance were assessed in 41 young participants. There were significant differences in ratings of both intensity and pleasantness, where body odors from the Old-age group were rated as less intense and less unpleasant than body odors originating from Young and Middle-age donors. Participants were able to discriminate between age categories, with body odor from Old-age donors mediating the effect also after removing variance explained by intensity differences. Similarly, participants were able to correctly assign age labels to body odors originating from Old-age donors but not to body odors originating from other age groups. This experiment suggests that, akin to other animals, humans are able to discriminate age based on body odor alone and that this effect is mediated mainly by body odors emitted by individuals of old age.	[Mitro, Susanna; Gordon, Amy R.; Lundstrom, Johan N.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Mitro, Susanna] Swarthmore Coll, Swarthmore, PA 19081 USA; [Gordon, Amy R.; Olsson, Mats J.; Lundstrom, Johan N.] Karolinska Inst, Dept Clin Neurosci, Psychol Sect, Stockholm, Sweden; [Lundstrom, Johan N.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Swarthmore College; Karolinska Institutet; University of Pennsylvania	Mitro, S (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	jlundstrom@monell.org	Lundström, Johan N./AAK-5002-2020; Lundström, Johan N/E-9482-2014	Lundström, Johan N./0000-0002-3529-8981; Lundström, Johan N/0000-0002-3529-8981; Mitro, Susanna/0000-0003-3202-1941; Olsson, Mats/0000-0001-5592-3759	National Institute on Deafness and other Communication Disorders - NIDCD [R03DC009869]; Swedish Research Council - VR [2008-20712]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009869] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders - NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Research Council - VR(Swedish Research Council); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by the National Institute on Deafness and other Communication Disorders - NIDCD (R03DC009869) [http://www.nidcd.nih.gov] and the Swedish Research Council - VR (2008-20712)[http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; BAUM MJ, 1990, BEHAV NEUROSCI, V104, P183, DOI 10.1037/0735-7044.104.1.183; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Bonadonna F, 2007, J CHEM ECOL, V33, P1819, DOI 10.1007/s10886-007-9345-7; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Djordjevic J, 2008, J NEUROPHYSIOL, V99, P386, DOI 10.1152/jn.00896.2007; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; Eggert F, 1998, GENETICA, V104, P191, DOI 10.1023/A:1026402531196; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GOODRICH BS, 1972, J MAMMAL, V53, P540, DOI 10.2307/1379043; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Hepper PG, 2010, CHEM SENSES, V35, P263, DOI 10.1093/chemse/bjq015; HOLD B, 1977, Z TIERPSYCHOL, V43, P225; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Kean EF, 2011, CHEM SENSES, V36, P555, DOI 10.1093/chemse/bjr025; Labows JN, 1999, COSMET SCI TECHNOL S, V20, P59; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Lundstrom JN, 2009, HORM BEHAV, V55, P280, DOI 10.1016/j.yhbeh.2008.11.009; Lundstrom JN, 2006, BIOL PSYCHOL, V71, P244, DOI 10.1016/j.biopsycho.2005.07.001; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Macdonald EA, 2008, AM J PRIMATOL, V70, P12, DOI 10.1002/ajp.20450; Martins Y, 2005, PSYCHOL SCI, V16, P694, DOI 10.1111/j.1467-9280.2005.01598.x; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; MULLERSCHWARZE D, 1971, ANIM BEHAV, V19, P141, DOI 10.1016/S0003-3472(71)80149-5; NAZZAROPORRO M, 1979, J INVEST DERMATOL, V73, P112, DOI 10.1111/1523-1747.ep12532793; Nieberding CM, 2012, ECOL LETT; OLSEN RL, 1983, BIOCHEM J, V209, P781, DOI 10.1042/bj2090781; Olsson SB, 2006, J CHEM ECOL, V32, P1635, DOI 10.1007/s10886-006-9098-8; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Osada K, 2008, CHEM SENSES, V33, P815, DOI 10.1093/chemse/bjn045; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Pierman S, 2006, HORM BEHAV, V49, P96, DOI 10.1016/j.yhbeh.2005.05.007; POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; ROBINSON AB, 1976, EXP GERONTOL, V11, P11, DOI 10.1016/0531-5565(76)90005-X; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; Sergeant MJT, 2007, ARCH SEX BEHAV, V36, P395, DOI 10.1007/s10508-006-9126-3; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WYSOCKI CJ, 2000, JPN J SMELL TASTE RE, V7, P19; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Yamazaki K, 2007, ADV GENET, V59, P129, DOI 10.1016/S0065-2660(07)59005-X	52	85	87	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38110	10.1371/journal.pone.0038110	http://dx.doi.org/10.1371/journal.pone.0038110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666457	Green Submitted, gold, Green Published			2022-12-25	WOS:000305353400082
J	Kadir, R; Bakhrat, A; Tokarsky, R; Abdu, U				Kadir, Rotem; Bakhrat, Anna; Tokarsky, Ronit; Abdu, Uri			Localization of the Drosophila Rad9 Protein to the Nuclear Membrane Is Regulated by the C-Terminal Region and Is Affected in the Meiotic Checkpoint	PLOS ONE			English	Article							RECOMBINATION PARTNER CHOICE; DNA-DAMAGE CHECKPOINTS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; REPAIR; COMPLEX; CLAMP; ACTIVATION; OOGENESIS; MEIOSIS	Rad9, Rad1, and Hus1 (9-1-1) are part of the DNA integrity checkpoint control system. It was shown previously that the C-terminal end of the human Rad9 protein, which contains a nuclear localization sequence (NLS) nearby, is critical for the nuclear transport of Rad1 and Hus1. In this study, we show that in Drosophila, Hus1 is found in the cytoplasm, Rad1 is found throughout the entire cell and that Rad9 (DmRad9) is a nuclear protein. More specifically, DmRad9 exists in two alternatively spliced forms, DmRad9A and DmRad9B, where DmRad9B is localized at the cell nucleus, and DmRad9A is found on the nuclear membrane both in Drosophila tissues and also when expressed in mammalian cells. Whereas both alternatively spliced forms of DmRad9 contain a common NLS near the C terminus, the 32 C-terminal residues of DmRad9A, specific to this alternative splice form, are required for targeting the protein to the nuclear membrane. We further show that activation of a meiotic checkpoint by a DNA repair gene defect but not defects in the anchoring of meiotic chromosomes to the oocyte nuclear envelope upon ectopic expression of non-phosphorylatable Barrier to Autointegration Factor (BAF) dramatically affects DmRad9A localization. Thus, by studying the localization pattern of DmRad9, our study reveals that the DmRad9A C-terminal region targets the protein to the nuclear membrane, where it might play a role in response to the activation of the meiotic checkpoint.	[Kadir, Rotem; Bakhrat, Anna; Tokarsky, Ronit; Abdu, Uri] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Kadir, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	abdu@bgu.ac.il						Abdu U, 2003, GENETICS, V165, P197; Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Abdu U, 2007, J CELL SCI, V120, P1042, DOI 10.1242/jcs.03414; Aylon Y, 2003, MOL CELL BIOL, V23, P6585, DOI 10.1128/MCB.23.18.6585-6596.2003; Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Ghabrial A, 1998, GENE DEV, V12, P2711, DOI 10.1101/gad.12.17.2711; Grushcow JM, 1999, GENETICS, V153, P607; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCaffrey R, 2006, GENETICS, V174, P1273, DOI 10.1534/genetics.106.058289; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peretz G, 2009, MECH DEVELOP, V126, P677, DOI 10.1016/j.mod.2009.05.004; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564; Van Doren M, 1998, CURR BIOL, V8, P243; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002	36	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38010	10.1371/journal.pone.0038010	http://dx.doi.org/10.1371/journal.pone.0038010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666434	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600052
J	Amselem, G; Theves, M; Bae, A; Bodenschatz, E; Beta, C				Amselem, Gabriel; Theves, Matthias; Bae, Albert; Bodenschatz, Eberhard; Beta, Carsten			A Stochastic Description of Dictyostelium Chemotaxis	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; CELL-MIGRATION; MOTION; DISCOIDEUM; GRADIENTS; MOVEMENT; MODEL; MOTILITY; SYSTEMS; REPAIR	Chemotaxis, the directed motion of a cell toward a chemical source, plays a key role in many essential biological processes. Here, we derive a statistical model that quantitatively describes the chemotactic motion of eukaryotic cells in a chemical gradient. Our model is based on observations of the chemotactic motion of the social ameba Dictyostelium discoideum, a model organism for eukaryotic chemotaxis. A large number of cell trajectories in stationary, linear chemoattractant gradients is measured, using microfluidic tools in combination with automated cell tracking. We describe the directional motion as the interplay between deterministic and stochastic contributions based on a Langevin equation. The functional form of this equation is directly extracted from experimental data by angle-resolved conditional averages. It contains quadratic deterministic damping and multiplicative noise. In the presence of an external gradient, the deterministic part shows a clear angular dependence that takes the form of a force pointing in gradient direction. With increasing gradient steepness, this force passes through a maximum that coincides with maxima in both speed and directionality of the cells. The stochastic part, on the other hand, does not depend on the orientation of the directional cue and remains independent of the gradient magnitude. Numerical simulations of our probabilistic model yield quantitative agreement with the experimental distribution functions. Thus our model captures well the dynamics of chemotactic cells and can serve to quantify differences and similarities of different chemotactic eukaryotes. Finally, on the basis of our model, we can characterize the heterogeneity within a population of chemotactic cells.	[Amselem, Gabriel; Theves, Matthias; Bae, Albert; Bodenschatz, Eberhard; Beta, Carsten] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Amselem, Gabriel] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Theves, Matthias; Beta, Carsten] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Bae, Albert; Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY USA; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany	Max Planck Society; Harvard University; University of Potsdam; Cornell University; University of Gottingen	Amselem, G (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	beta@uni-potsdam.de		Amselem, Gabriel/0000-0003-4563-2899; Bodenschatz, Eberhard/0000-0002-2901-0144	Deutsche Forschungsgemeinschaft (DFG) [BE 3978/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	CB acknowledges financial support by the Deutsche Forschungsgemeinschaft (DFG BE 3978/3-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amselem G, 2010, THESIS U GOTTINGEN; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Beta C, 2008, LAB CHIP, V8, P1087, DOI 10.1039/b801331d; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Friedrich R, 2000, PHYS LETT A; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gamba A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02019; Gruver JS, 2008, BIOPHYS J, V95, P4057, DOI 10.1529/biophysj.108.130179; Hu B, 2010, PHYS REV E, P81; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Kam Z, 1998, BIOIMAGING, V6, P166, DOI 10.1002/1361-6374(199812)6:4<166::AID-BIO2>3.0.CO;2-Y; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kloeden P.E., 1992, APPL MATH NEW YORK, V23, pxxxvi+632; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Przibram K, 1913, PFLUG ARCH GES PHYS, V153, P401, DOI 10.1007/BF01686480; Risken H., 1989, FOKKER PLANCK EQUATI, DOI 10.1007/978-3-642-61544-3; Romanczuk P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230601; Schenzle A, 1979, PHYS REV A, P20; SCHIENBEIN M, 1993, B MATH BIOL, V55, P585, DOI 10.1016/S0092-8240(05)80241-1; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Shenderov AD, 1997, BIOPHYS J, V72, P2382, DOI 10.1016/S0006-3495(97)78883-0; Siegert S, 1998, PHYS LETT A, V243, P275, DOI 10.1016/S0375-9601(98)00283-7; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; STOKES CL, 1991, J CELL SCI, V99, P419; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Weber C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011132; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107	44	44	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37213	10.1371/journal.pone.0037213	http://dx.doi.org/10.1371/journal.pone.0037213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662138	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300029
J	Benz, V; Bloch, M; Wardat, S; Bohm, C; Maurer, L; Mahmoodzadeh, S; Wiedmer, P; Spranger, J; Foryst-Ludwig, A; Kintscher, U				Benz, Verena; Bloch, Mandy; Wardat, Sami; Boehm, Christian; Maurer, Lukas; Mahmoodzadeh, Shokoufeh; Wiedmer, Petra; Spranger, Joachim; Foryst-Ludwig, Anna; Kintscher, Ulrich			Sexual Dimorphic Regulation of Body Weight Dynamics and Adipose Tissue Lipolysis	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIPOPROTEIN-LIPASE; ENERGY-EXPENDITURE; FAT; LEPTIN; EXERCISE; NEURONS; WOMEN; GENE; MEN	Background: Successful reduction of body weight (BW) is often followed by recidivism to obesity. BW-changes including BW-loss and -regain is associated with marked alterations in energy expenditure (EE) and adipose tissue (AT) metabolism. Since these processes are sex-specifically controlled, we investigated sexual dimorphisms in metabolic processes during BW-dynamics (gain-loss-regain). Research Design: Obesity was induced in C57BL/6J male (m) and female (f) mice by 15 weeks high-fat diet (HFD) feeding. Subsequently BW was reduced (-20%) by caloric restriction (CR) followed by adaptive feeding, and a regain-phase. Measurement of EE, body composition, blood/organ sampling were performed after each feeding period. Lipolysis was analyzed ex-vivo in gonadal AT. Results: Male mice exhibited accelerated BW-gain compared to females (relative BW-gain m:140.5 +/- 3.2%; f:103.7 +/- 6.5%; p<0.001). In consonance, lean mass-specific EE was significantly higher in females compared to males during BW-gain. Under CR female mice reached their target-BW significantly faster than male mice (m:12.2 days; f:7.6 days; p<0.001) accompanied by a sustained sex-difference in EE. In addition, female mice predominantly downsized gonadal AT whereas the relation between gonadal and total body fat was not altered in males. Accordingly, only females exhibited an increased rate of forskolin-stimulated lipolysis in AT associated with significantly higher glycerol concentrations, lower RER-values, and increased AT expression of adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). Analysis of AT lipolysis in estrogen receptor alpha (ER alpha)-deficient mice revealed a reduced lipolytic rate in the absence of ER alpha exclusively in females. Finally, re-feeding caused BW-regain faster in males than in females. Conclusion: The present study shows sex-specific dynamics during BW-gain-loss-regain. Female mice responded to CR with an increase in lipolytic activity, and augmented lipid-oxidation leading to more efficient weight loss. These processes likely involve ER alpha-dependent signaling in AT and sexual dimorphic regulation of genes involved in lipid metabolism.	[Benz, Verena; Bloch, Mandy; Wardat, Sami; Boehm, Christian; Foryst-Ludwig, Anna; Kintscher, Ulrich] Charite, Cardiovasc Res Ctr, Inst Pharmacol, D-13353 Berlin, Germany; [Maurer, Lukas; Spranger, Joachim] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Mahmoodzadeh, Shokoufeh] Charite, Cardiovasc Res Ctr, Inst Gender Med, D-13353 Berlin, Germany; [Wiedmer, Petra] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Benz, V (corresponding author), Charite, Cardiovasc Res Ctr, Inst Pharmacol, D-13353 Berlin, Germany.	ulrich.kintscher@charite.de	Biguzzi, Felipe A/E-4724-2015; Böhm, Christian/HDN-5925-2022	Wiedmer, Petra/0000-0001-7284-7823; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kintscher, Ulrich/0000-0001-7386-0990; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Benz, Verena/0000-0003-2710-3803	Deusche Forschungsgemeinschaft [DFG-KFO 218/1]	Deusche Forschungsgemeinschaft	This study was supported by the Deusche Forschungsgemeinschaft (DFG-KFO 218/1) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2001, DIABETES OBES METAB, V3, P338, DOI 10.1046/j.1463-1326.2001.00145.x; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Geldszus R, 1996, EUR J ENDOCRINOL, V135, P659, DOI 10.1530/eje.0.1350659; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Homma H, 2000, J BIOL CHEM, V275, P11404, DOI 10.1074/jbc.275.15.11404; Horton TJ, 2009, J APPL PHYSIOL, V107, P200, DOI 10.1152/japplphysiol.90812.2008; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEIBEL RL, 1984, METABOLISM, V33, P164, DOI 10.1016/0026-0495(84)90130-6; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Maher AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012025; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Shi HF, 2007, AM J PHYSIOL-ENDOC M, V293, pE316, DOI 10.1152/ajpendo.00710.2006; Shi HF, 2009, OBESITY, V17, P1702, DOI 10.1038/oby.2009.106; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Toth MJ, 2000, ANN NY ACAD SCI, V904, P502; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	35	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37794	10.1371/journal.pone.0037794	http://dx.doi.org/10.1371/journal.pone.0037794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662224	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300114
J	Cai, YC; Lu, SN; Li, CY				Cai, Yong-Chun; Lu, Shena; Li, Chao-Yi			Interactions between Surround Suppression and Interocular Suppression in Human Vision	PLOS ONE			English	Article							CROSS-ORIENTATION SUPPRESSION; CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; 2 DISTINCT MECHANISMS; SPATIAL INTERACTIONS; PERCEIVED CONTRAST; INHIBITION; ATTENTION; FREQUENCIES; INTEGRATION	Several types of suppression phenomena have been observed in the visual system. For example, the ability to detect a target stimulus is often impaired when the target is embedded in a high-contrast surround. This contextual modulation, known as surround suppression, was formerly thought to occur only in the periphery. Another type of suppression phenomena is interocular suppression, in which the sensitivity to a monocular target is reduced by a superimposed mask in the opposite eye. Here, we explored how the two types of suppression operating across different spatial regions interact with one another when they simultaneously exert suppressive influences on a common target presented at the fovea. In our experiments, a circular target grating presented to the fovea of one eye was suppressed interocularly by a noise pattern of the same size in the other eye. The foveal stimuli were either shown alone or surrounded by a monocular annular grating. The orientation and eye-of-origin of the surround grating were varied. We found that the detection of the foveal target subjected to interocular suppression was severely impaired by the addition of the surround grating, indicating strong surround suppression in the fovea. In contrast, when the interocular suppression was released by superimposing a binocular fusion ring onto both the target and the dichoptic mask, the surround suppression effect was found to be dramatically decreased. In addition, the surround suppression was found to depend on the contrast of the dichoptic noise with the greatest surround suppression effect being obtained only when the noise contrast was at an intermediate level. These findings indicate that surround suppression and interocular suppression are not independent of each other, but there are strong interactions between them. Moreover, our results suggest that strong surround suppression may also occur at the fovea and not just the periphery.	[Cai, Yong-Chun; Lu, Shena] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Yong-Chun; Li, Chao-Yi] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Ctr Life Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Zhejiang University; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, YC (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yccai@zju.edu.cn			Natural Science Foundations of China [31100731, 60972108, 30900390, 90820301, 60835005]; Zhejiang Provincial Natural Science Foundation of China [Y2090524]; Zhejiang Province Education Department [Y201122208]	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Province Education Department	This research was supported by the Natural Science Foundations of China (31100731 and 60972108 to YC, 30900390 to SL, 90820301 and 60835005 to CL, website: http://www.nsfc.gov.cn), Zhejiang Provincial Natural Science Foundation of China (Y2090524 to SL, website: http://www.zjnsf.gov.cn), and Zhejiang Province Education Department (Y201122208 to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht D.C., 2003, VISUAL NEUROSCIENCES, P747; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Baker DH, 2007, NEUROSCIENCE, V146, P435, DOI 10.1016/j.neuroscience.2007.01.030; Baker DH, 2008, J VISION, V8, DOI 10.1167/8.4.26; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cai YC, 2008, J VISION, V8, DOI 10.1167/8.9.9; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEWEERT CMM, 1988, VISION RES, V28, P1031, DOI 10.1016/0042-6989(88)90080-6; Durand S, 2007, VISUAL NEUROSCI, V24, P679, DOI 10.1017/S0952523807070563; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; FUKUDA H, 1992, J EXP PSYCHOL HUMAN, V18, P362, DOI 10.1037/0096-1523.18.2.362; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; KOOI FL, 1993, DISPLAYS, V14, P11, DOI 10.1016/0141-9382(93)90004-O; LEGGE GE, 1979, J OPT SOC AM, V69, P838, DOI 10.1364/JOSA.69.000838; Li BW, 2005, J NEUROPHYSIOL, V94, P1645, DOI 10.1152/jn.00203.2005; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Meese TS, 2009, VISION RES, V49, P2927, DOI 10.1016/j.visres.2009.09.006; Meese TS, 2005, VISION RES, V45, P9, DOI 10.1016/j.visres.2004.08.004; Meese TS, 2004, J VISION, V4, P843, DOI 10.1167/4.10.2; Meier Lorenz, 2002, J Vis, V2, P293, DOI 10.1167/2.4.2; Murakami I, 1996, VISION RES, V36, P3629, DOI 10.1016/0042-6989(96)00094-6; Paffen CLE, 2006, VISION RES, V46, P599, DOI 10.1016/j.visres.2005.05.013; Paffen CLE, 2005, VISION RES, V45, P2642, DOI 10.1016/j.visres.2005.04.018; Paffen CLE, 2005, J VISION, V5, P571, DOI 10.1167/5.6.8; Paffen CLE, 2004, VISION RES, V44, P1635, DOI 10.1016/j.visres.2004.02.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Petrov Y, 2006, J VISION, V6, P224, DOI 10.1167/6.3.4; Petrov Y, 2009, J VISION, V9, DOI 10.1167/9.1.21; Roberts MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3742, DOI 10.2741/2963; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Sengpiel F, 2005, J NEUROSCI, V25, P6394, DOI 10.1523/JNEUROSCI.0862-05.2005; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Takeuchi T, 2000, VISION RES, V40, P2697, DOI 10.1016/S0042-6989(00)00129-2; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Zenger B, 2000, VISION RES, V40, P3717, DOI 10.1016/S0042-6989(00)00218-2	49	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38093	10.1371/journal.pone.0038093	http://dx.doi.org/10.1371/journal.pone.0038093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662270	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300162
J	Egeblad, L; Welin, M; Flodin, S; Graslund, S; Wang, LY; Balzarini, J; Eriksson, S; Nordlund, P				Egeblad, Louise; Welin, Martin; Flodin, Susanne; Graslund, Susanne; Wang, Liya; Balzarini, Jan; Eriksson, Staffan; Nordlund, Par			Pan-Pathway Based Interaction Profiling of FDA-Approved Nucleoside and Nucleobase Analogs with Enzymes of the Human Nucleotide Metabolism	PLOS ONE			English	Article							URIDINE PHOSPHORYLASE; GUANINE; BENZYLACYCLOURIDINE; PURIFICATION; SPECIFICITY; STABILITY; DEAMINASE; EVOLUTION; DISCOVERY; PROTEINS	To identify interactions a nucleoside analog library (NAL) consisting of 45 FDA-approved nucleoside analogs was screened against 23 enzymes of the human nucleotide metabolism using a thermal shift assay. The method was validated with deoxycytidine kinase; eight interactions known from the literature were detected and five additional interactions were revealed after the addition of ATP, the second substrate. The NAL screening gave relatively few significant hits, supporting a low rate of "off target effects." However, unexpected ligands were identified for two catabolic enzymes guanine deaminase (GDA) and uridine phosphorylase 1 (UPP1). An acyclic guanosine prodrug analog, valaciclovir, was shown to stabilize GDA to the same degree as the natural substrate, guanine, with a Delta T-agg around 7 degrees C. Aciclovir, penciclovir, ganciclovir, thioguanine and mercaptopurine were also identified as ligands for GDA. The crystal structure of GDA with valaciclovir bound in the active site was determined, revealing the binding of the long unbranched chain of valaciclovir in the active site of the enzyme. Several ligands were identified for UPP1: vidarabine, an antiviral nucleoside analog, as well as trifluridine, idoxuridine, floxuridine, zidovudine, telbivudine, fluorouracil and thioguanine caused concentration-dependent stabilization of UPP1. A kinetic study of UPP1 with vidarabine revealed that vidarabine was a mixed-type competitive inhibitor with the natural substrate uridine. The unexpected ligands identified for UPP1 and GDA imply further metabolic consequences for these nucleoside analogs, which could also serve as a starting point for future drug design.	[Egeblad, Louise; Wang, Liya; Eriksson, Staffan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Welin, Martin; Flodin, Susanne; Graslund, Susanne; Nordlund, Par] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, Stockholm, Sweden; [Balzarini, Jan] Catholic Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium; [Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Nordlund, Par] Nanyang Technol Univ, Ctr Biomed Struct Biol, Sch Biol Sci, Singapore, Singapore	Swedish University of Agricultural Sciences; Karolinska Institutet; KU Leuven; Universite Catholique Louvain; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Egeblad, L (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	Staffan.Eriksson@slu.se	Gräslund, Susanne/ABB-6339-2020	Graslund, Susanne/0000-0003-0077-8333	Swedish Research Council; Swedish Cancer Society; KU Leuven [GOA 10/14]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KU Leuven(KU Leuven); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Society and the KU Leuven (GOA 10/14). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beausejour CM, 2002, BIOCHEM BIOPH RES CO, V293, P1478, DOI 10.1016/S0006-291X(02)00413-8; BERGSTROM JD, 1979, ARCH BIOCHEM BIOPHYS, V194, P107, DOI 10.1016/0003-9861(79)90600-3; CALABRESI P, 1990, BLOOD, V76, P2210; Cao DL, 2002, CANCER RES, V62, P2313; De Clercq E, 2006, BRIT J PHARMACOL, V147, P1, DOI 10.1038/sj.bjp.0706446; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez JR, 2010, BIOORGAN MED CHEM, V18, P6748, DOI 10.1016/j.bmc.2010.07.054; Fernandez JR, 2009, J MOL EVOL, V68, P227, DOI 10.1007/s00239-009-9205-x; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; FRIEDMAN MA, 1978, CANCER CHEMOTH PHARM, V1, P77; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kubo K, 2006, J MED INVESTIG, V53, P264, DOI 10.2152/jmi.53.264; Matsunaga Hiroko, 2003, Journal of Medical Investigation, V50, P64; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Peters Godefridus J., 2006, P1; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; ROSSI CA, 1978, BIOCHIM BIOPHYS ACTA, V526, P235, DOI 10.1016/0005-2744(78)90308-X; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Usova EV, 1997, EUR J BIOCHEM, V248, P762, DOI 10.1111/j.1432-1033.1997.t01-2-00762.x; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Welin M, 2010, BIOCHEM BIOPH RES CO, V396, P157, DOI 10.1016/j.bbrc.2010.04.054; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	41	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37724	10.1371/journal.pone.0037724	http://dx.doi.org/10.1371/journal.pone.0037724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662200	Green Published, gold			2022-12-25	WOS:000305342300090
J	Gidlof, O; Smith, JG; Melander, O; Lovkvist, H; Hedblad, B; Engstrom, G; Nilsson, P; Carlson, J; Berglund, G; Olsson, S; Jood, K; Jern, C; Norrving, B; Lindgren, A; Erlinge, D				Gidlof, Olof; Smith, J. Gustav; Melander, Olle; Lovkvist, Hakan; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Carlson, Joyce; Berglund, Goran; Olsson, Sandra; Jood, Katarina; Jern, Christina; Norrving, Bo; Lindgren, Arne; Erlinge, David			A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events	PLOS ONE			English	Article							GAIN-OF-FUNCTION; HUMAN P2X(7) RECEPTOR; GENETIC ASSOCIATION; ISCHEMIC-STROKE; BLOOD-PRESSURE; POLYMORPHISM; DISEASE; LYMPHOCYTES; ATHEROSCLEROSIS; SUSCEPTIBILITY	Background and Purpose: Extracellular adenosine triphosphate (ATP) regulates inflammatory cells by activation of the P2X(7) receptor. We hypothesized that polymorphisms in P2RX7 influence the risk of ischemic heart disease (IHD), ischemic stroke (IS) and cardiovascular risk factors and tested this hypothesis using genetic association studies. Methods: Two loss-of-function SNPs in P2RX7 were genotyped in 1244 IHD cases and 2488 controls as well as 5969 individuals with cardiovascular risk factors. Eleven SNPs in a 250 kb region on chromosome 12 spanning P2RX7 as well as neighboring genes OASL, P2RX4 and CAMKK2 were genotyped in 4138 individuals with IS and 2528 controls. Association was examined using linear and logistic regression models with an additive genetic model. Results: The common loss-of-function variant rs3751143 was significantly associated with a decreased risk of IHD in smokers (P = 0.03) as well as decreased risk of IS (OR 0.89; 95% CI = 0.81-0.97; P = 0.012). In addition, an intronic SNP in CAMKK2, rs2686342, were associated with a decreased risk of IS (OR 0.89; 95% CI = 0.82-0.97; P = 0.011). In subgroup analyses, both SNPs were associated with decreased risk of IS in individuals with hypertension (P = 0.045 and 0.015, respectively). Conclusions: A common loss-of-function missense variant in the gene encoding the P2X7 receptor is associated with reduced risk of IS and with IHD in smokers. These findings might implicate a role of purinergic signaling in atherogenesis or atherothrombosis.	[Gidlof, Olof; Smith, J. Gustav; Lovkvist, Hakan; Norrving, Bo; Lindgren, Arne; Erlinge, David] Lund Univ, Dept Clin Sci, Lund, Sweden; [Carlson, Joyce] Lund Univ, Dept Lab Sci, Lund, Sweden; [Smith, J. Gustav; Melander, Olle; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Berglund, Goran] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Norrving, Bo; Lindgren, Arne] Skane Univ Hosp Lund, Dept Neurol, Lund, Sweden; [Olsson, Sandra; Jood, Katarina; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; University of Gothenburg	Gidlof, O (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	olof.gidlof@med.lu.se	Olsson, Sandra/L-5964-2013	Gidlof, Olof/0000-0002-7402-3139; Norrving, Bo/0000-0002-8024-5096; Melander, Olle/0000-0002-2581-484X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engstrom, Gunnar/0000-0002-8618-9152	Swedish Heart and Lung Foundation; Swedish Research Council; Vascular Wall Program; Swedish Stroke Association; Craaford Foundation; Lund University; Swedish state (ALF); Freemasons Lodge of Instruction EOS in Lund; Yngve Land foundation for Neurological Research; Gothenburg Foundation for Neurological Research	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vascular Wall Program; Swedish Stroke Association; Craaford Foundation; Lund University; Swedish state (ALF); Freemasons Lodge of Instruction EOS in Lund; Yngve Land foundation for Neurological Research; Gothenburg Foundation for Neurological Research	The study was supported by the Swedish Heart and Lung Foundation, the Swedish Research Council, the Vascular Wall Program, the Swedish Stroke Association, the Craaford Foundation, Lund University, the Swedish state (ALF), Freemasons Lodge of Instruction EOS in Lund, the Yngve Land foundation for Neurological Research and the Gothenburg Foundation for Neurological Research. DE holds the Lars Werko Distinguished Research Fellowship from the Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; BOTHIG S, 1989, INT J EPIDEMIOL, V18, pS29; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Dichgans M, 2005, STROKE, V36, P2027, DOI 10.1161/01.STR.0000177498.21594.9e; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hakim TS, 1997, J APPL PHYSIOL, V82, P852, DOI 10.1152/jappl.1997.82.3.852; Hallstrom B, 2007, ACTA NEUROL SCAND, V115, P49, DOI 10.1111/j.1600-0404.2006.00738.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Oyanguren-Desez O, 2011, CELL CALCIUM, V50, P468, DOI 10.1016/j.ceca.2011.08.002; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Smith JG, 2009, CIRC-CARDIOVASC GENE, V2, P159, DOI 10.1161/CIRCGENETICS.108.835173; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37491	10.1371/journal.pone.0037491	http://dx.doi.org/10.1371/journal.pone.0037491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662160	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300050
J	Krasnoslobodtsev, AV; Peng, J; Asiago, JM; Hindupur, J; Rochet, JC; Lyubchenko, YL				Krasnoslobodtsev, Alexey V.; Peng, Jie; Asiago, Josephat M.; Hindupur, Jagadish; Rochet, Jean-Christophe; Lyubchenko, Yuri L.			Effect of Spermidine on Misfolding and Interactions of Alpha-Synuclein	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VITRO; TERMINAL REGION; AGGREGATION; PROTEIN; CONFORMATION; SPECTROSCOPY	Alpha-synuclein (alpha-Syn) is a 140 aa presynaptic protein which belongs to a group of natively unfolded proteins that are unstructured in aqueous solutions. The aggregation rate of alpha-Syn is accelerated in the presence of physiological levels of cellular polyamines. Here we applied single molecule AFM force spectroscopy to characterize the effect of spermidine on the very first stages of alpha-Syn aggregation - misfolding and assembly into dimers. Two alpha-Syn variants, the wild-type (WT) protein and A30P, were studied. The two protein molecules were covalently immobilized at the C-terminus, one at the AFM tip and the other on the substrate, and intermolecular interactions between the two molecules were measured by multiple approach-retraction cycles. At conditions close to physiological ones at which alpha-Syn misfolding is a rare event, the addition of spermidine leads to a dramatic increase in the propensity of the WT and mutant proteins to misfold. Importantly, misfolding is characterized by a set of conformations, and A30P changes the misfolding pattern as well as the strength of the intermolecular interactions. Together with the fact that spermidine facilitates late stages of alpha-Syn aggregation, our data demonstrate that spermidine promotes the very early stages of protein aggregation including alpha-Syn misfolding and dimerization. This finding suggests that increased levels of spermidine and potentially other polyamines can initiate the disease-related process of alpha-Syn.	[Krasnoslobodtsev, Alexey V.; Peng, Jie; Lyubchenko, Yuri L.] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68182 USA; [Peng, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Asiago, Josephat M.; Hindupur, Jagadish; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	University of Nebraska System; University of Nebraska Medical Center; Shanghai Jiao Tong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Krasnoslobodtsev, AV (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68182 USA.	ylyubchenko@unmc.edu	Krasnoslobodtsev, Alexey/AAC-8536-2020	Peng, Jie/0000-0002-4748-3682; Rochet, Jean-Christophe/0000-0002-6484-1541	National Institutes of Health [1P01GM091743-01A1, 1 R01 GM096039-01A1]; U.S. Department of Energy [DE-FG02-08ER64579]; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096039, P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by grants from National Institutes of Health Grants (1P01GM091743-01A1 and 1 R01 GM096039-01A1), U.S. Department of Energy Grant DE-FG02-08ER64579, and the Nebraska Research Initiative grant to YLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Grabenauer M, 2008, J PHYS CHEM B, V112, P11147, DOI 10.1021/jp801175w; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kransnoslobodtsev AV, 2005, NANOMED-NANOTECHNOL, V1, P300, DOI 10.1016/j.nano.2005.10.005; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Losasso V, 2011, BIOCHEMISTRY-US, V50, P6994, DOI 10.1021/bi2007564; Lu Y, 2011, ACS CHEM NEUROSCI, V2, P667, DOI 10.1021/cn200074d; Lyubchenko YL, 2010, WIRES NANOMED NANOBI, V2, P526, DOI 10.1002/wnan.102; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yu JP, 2011, NANOMED-NANOTECHNOL, V7, P146, DOI 10.1016/j.nano.2010.08.001; Yu JP, 2009, J NEUROIMMUNE PHARM, V4, P10, DOI 10.1007/s11481-008-9115-5; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	47	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38099	10.1371/journal.pone.0038099	http://dx.doi.org/10.1371/journal.pone.0038099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662273	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300165
J	Posnien, N; Hopfen, C; Hilbrant, M; Ramos-Womack, M; Murat, S; Schoenauer, A; Herbert, SL; Nunes, MDS; Arif, S; Breuker, CJ; Schlotterer, C; Mitteroecker, P; McGregor, AP				Posnien, Nico; Hopfen, Corinna; Hilbrant, Maarten; Ramos-Womack, Margarita; Murat, Sophie; Schoenauer, Anna; Herbert, Samantha L.; Nunes, Maria D. S.; Arif, Saad; Breuker, Casper J.; Schloetterer, Christian; Mitteroecker, Philipp; McGregor, Alistair P.			Evolution of Eye Morphology and Rhodopsin Expression in the Drosophila melanogaster Species Subgroup	PLOS ONE			English	Article							R8 PHOTORECEPTOR CELLS; COMPOUND EYES; OPSIN GENE; QUANTITATIVE GENETICS; MARGINAL OMMATIDIA; VISUAL-ACUITY; BODY PARTS; HEAD SHAPE; INSECTS; FLY	A striking diversity of compound eye size and shape has evolved among insects. The number of ommatidia and their size are major determinants of the visual sensitivity and acuity of the compound eye. Each ommatidium is composed of eight photoreceptor cells that facilitate the discrimination of different colours via the expression of various light sensitive Rhodopsin proteins. It follows that variation in eye size, shape, and opsin composition is likely to directly influence vision. We analyzed variation in these three traits in D. melanogaster, D. simulans and D. mauritiana. We show that D. mauritiana generally has larger eyes than its sibling species, which is due to a combination of larger ommatidia and more ommatidia. In addition, intra- and inter-specific differences in eye size among D. simulans and D. melanogaster strains are mainly caused by variation in ommatidia number. By applying a geometric morphometrics approach to assess whether the formation of larger eyes influences other parts of the head capsule, we found that an increase in eye size is associated with a reduction in the adjacent face cuticle. Our shape analysis also demonstrates that D. mauritiana eyes are specifically enlarged in the dorsal region. Intriguingly, this dorsal enlargement is associated with enhanced expression of rhodopsin 3 in D. mauritiana. In summary, our data suggests that the morphology and functional properties of the compound eyes vary considerably within and among these closely related Drosophila species and may be part of coordinated morphological changes affecting the head capsule.	[Posnien, Nico; Hilbrant, Maarten; Murat, Sophie; Nunes, Maria D. S.; Arif, Saad; Breuker, Casper J.; McGregor, Alistair P.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Posnien, Nico; Hopfen, Corinna; Murat, Sophie; Schoenauer, Anna; Nunes, Maria D. S.; Arif, Saad; Schloetterer, Christian; McGregor, Alistair P.] Vet Med Univ Wien, Inst Populat Genet, Vienna, Austria; [Ramos-Womack, Margarita] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Ramos-Womack, Margarita] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Herbert, Samantha L.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria	Oxford Brookes University; University of Veterinary Medicine Vienna; Howard Hughes Medical Institute; Princeton University; Princeton University; Fundacao Champalimaud; University of Vienna	Posnien, N (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	philipp.mitteroecker@univie.ac.at; amcgregor@brookes.ac.uk	Breuker, Casper/N-6582-2013; Schlötterer, Christian/Q-5264-2019; Santos Nunes, Maria Daniela/A-4480-2013; Breuker, Casper/P-8270-2019; Schlötterer, Christian/G-6326-2010; Posnien, Nico/D-1639-2012; Mitteroecker, Philipp/A-1591-2012	Breuker, Casper/0000-0001-7909-1950; Schlötterer, Christian/0000-0003-4710-6526; Santos Nunes, Maria Daniela/0000-0003-2178-4628; Breuker, Casper/0000-0001-7909-1950; Schlötterer, Christian/0000-0003-4710-6526; Posnien, Nico/0000-0003-0700-5595; Mitteroecker, Philipp/0000-0002-5308-3837; McGregor, Alistair/0000-0002-2908-2420; , Samantha/0000-0002-1024-467X	ERC Starting Independent Investigator grant; Volkswagenstiftung fellowship	ERC Starting Independent Investigator grant; Volkswagenstiftung fellowship	This work was funded by an ERC Starting Independent Investigator grant to APM, and by a Volkswagenstiftung fellowship to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; BARLOW HB, 1952, J EXP BIOL, V29, P667; Bonduriansky R, 2003, EVOLUTION, V57, P2046, DOI 10.1111/j.0014-3820.2003.tb00384.x; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Carleton KL, 2011, METHODS MOL BIOL, V772, P279, DOI 10.1007/978-1-61779-228-1_17; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; CAVICCHI S, 1989, J EVOLUTION BIOL, V2, P235, DOI 10.1046/j.1420-9101.1989.2040235.x; Chapman R.F., 2012, INSECTS STRUCTURE FU; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2001, SEMIN CELL DEV BIOL, V12, P509, DOI 10.1006/scdb.2001.0275; COWLEY DE, 1988, GENETICS, V119, P421; COWLEY DE, 1990, AM NAT, V135, P242, DOI 10.1086/285041; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Elzinga R. J., 2003, FUNDAMENTALS ENTOMOL; Emery Patrick, 2007, Methods Mol Biol, V362, P375; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Evans JM, 2008, J EXP BIOL, V211, P890, DOI 10.1242/jeb.014837; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gonzalez-Bellido PT, 2011, P NATL ACAD SCI USA, V108, P4224, DOI 10.1073/pnas.1014438108; Good P, 2000, PERMUTATION TESTS PR; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Hammerle B, 2003, EVOL DEV, V5, P221, DOI 10.1046/j.1525-142X.2003.03030.x; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Hofmann CM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000266; HORRIDGE GA, 1978, PHILOS T R SOC B, V285, P1, DOI 10.1098/rstb.1978.0093; HORRIDGE GA, 1978, PROC R SOC SER B-BIO, V200, P137, DOI 10.1098/rspb.1978.0011; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; JANDER U, 1994, INT J INSECT MORPHOL, V23, P329, DOI 10.1016/0020-7322(94)90029-9; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; Kacmarczyk Thadeous, 2000, Drosophila Information Service, V83, P144; Kirschfeld K., 1976, P354; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1976, Z NATURFORSCH C, V31, P764, DOI 10.1515/znc-1976-11-1231; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Mallock A., 1894, Proceedings of the Royal Society London, Vlv, P85; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MONTELL C, 1987, J NEUROSCI, V7, P1558; MORATA G, 1979, DEV BIOL, V70, P355, DOI 10.1016/0012-1606(79)90033-2; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; Nilsson EE, 2000, J NEUROGENET, V13, P213, DOI 10.3109/01677060009084495; Norry FM, 2000, HEREDITY, V85, P177, DOI 10.1046/j.1365-2540.2000.00735.x; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; R Core Team, 2022, R LANG ENV STAT COMP; Rohlf F.J., 2006, TPSDIG2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rutowski RL, 2009, ARTHROPOD STRUCT DEV, V38, P91, DOI 10.1016/j.asd.2008.08.003; Schmitt A, 2005, J EXP BIOL, V208, P1247, DOI 10.1242/jeb.01527; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Snodgrass RE, 1935, PRINCIPLES INSECT MO; SNYDER AW, 1977, J COMP PHYSIOL, V116, P161, DOI 10.1007/BF00605401; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Stern DL, 1999, DEVELOPMENT, V126, P1091; Sukontason KL, 2008, PARASITOL RES, V103, P123, DOI 10.1007/s00436-008-0939-y; Tan SJ, 2005, CURR BIOL, V15, pR540, DOI 10.1016/j.cub.2005.07.019; Vasiliauskas D, 2011, NATURE; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2004, TRENDS CELL BIOL, V14, P576, DOI 10.1016/j.tcb.2004.09.007; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wolff Tanya, 1993, P1277; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	85	36	36	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37346	10.1371/journal.pone.0037346	http://dx.doi.org/10.1371/journal.pone.0037346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662147	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300036
J	Sau, A; Misra, AK				Sau, Abhijit; Misra, Anup Kumar			Synthesis of the Tetrasaccharide Motif and Its Structural Analog Corresponding to the Lipopolysaccharide of Escherichia coli O75	PLOS ONE			English	Article							PROMOTED REACTIONS; O-POLYSACCHARIDE; REPEATING UNIT; GLYCOSIDES; OLIGOSACCHARIDE; TRISACCHARIDE; RESISTANT; ANTIGEN	Background: Extraintestinal pathogenic E. coli are mostly responsible for a diverse spectrum of invasive human and animal infections leading to the urinary tract infections. Bacterial lipopolysaccharides are responsible for their pathogenicity and their interactions with host immune responses. In spite of several breakthroughs in the development of therapeutics to combat urinary tract infections and related diseases, the emergence of multidrug-resistant bacterial strains is a serious concern. Lipopolysaccharides are attractive targets for the development of long-term therapeutic agents to eradicate the infections. Since the natural sources cannot provide the required amount of oligosaccharides, development of chemical synthetic strategies for their synthesis is relevant to gain access to a reservoir of oligosaccharides and their close analogs. Methodology: Two tetrasaccharide derivatives were synthesized from a single disaccharide intermediate. beta-D-mannoside moiety was prepared from beta-D-glucoside moiety following oxidation-reduction methodology. A [2+2] stereoselective block glycosylation strategy has been adopted for the preparation of tetrasaccharide derivative. alpha-D-Glucosamine moiety was prepared from alpha-D-mannosidic moiety following triflate formation at C-2 and S-N(2) substitution. A one-pot iterative glycosylation exploiting the orthogonal property of thioglycoside was carried out during the synthesis of tetrasaccharide analog. Results: Synthesis of the tetrasaccharide motif (1) and its structural analog (2) corresponding to the lipopolysaccharide of Escherichia coli O75 was successfully achieved in excellent yield. Most of the reactions are clean and high yielding. Both compounds 1 and 2 were synthesized as their 4-methoxyphenyl glycoside, which can act as a temporary anomeric protecting group for further use of these tetrasaccharides in the preparation of glycoconjugates.	[Sau, Abhijit; Misra, Anup Kumar] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sau, A (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	akmisra69@gmail.com		Sau, Abhijit/0000-0002-9870-7420	Department of Science and Technology (DST), New Delhi [SR/S1/OC-83/2010]; Bose Institute, Kolkata; CSIR, New Delhi	Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); Bose Institute, Kolkata(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology (DST), New Delhi (Project No. SR/S1/OC-83/2010) and the Bose Institute, Kolkata. AS thanks CSIR, New Delhi, for providing a Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergonzi MC, 1998, CARBOHYD RES, V311, P231, DOI 10.1016/S0008-6215(98)00211-0; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/nchem.399, 10.1038/NCHEM.399]; Caracciolo A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-3; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; CHARETTE AB, 1994, J CARBOHYD CHEM, V13, P421, DOI 10.1080/07328309408009203; Crich D, 2002, J ORG CHEM, V67, P4640, DOI 10.1021/jo0108818; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; EIS MJ, 1988, CARBOHYD RES, V176, P316, DOI 10.1016/0008-6215(88)80144-7; Eom JS, 2002, MICROB DRUG RESIST, V8, P227, DOI 10.1089/107662902760326959; ERBING C, 1978, CARBOHYD RES, V60, P400, DOI 10.1016/S0008-6215(78)80049-4; Gotze S, 2009, SYNLETT, P3346, DOI 10.1055/s-0029-1218356; Goluszko P, 1997, J CLIN INVEST, V99, P1662, DOI 10.1172/JCI119329; Hellerstein S, 2006, CURR OPIN PEDIATR, V18, P134, DOI 10.1097/01.mop.0000193271.09001.a3; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; Kebira A. N., 2009, Journal of Applied Biosciences, V22, P1320; KONRADSSON P, 1990, TETRAHEDRON LETT, V31, P4313, DOI 10.1016/S0040-4039(00)97609-3; Madhusudan SK, 2005, CARBOHYD RES, V340, P1373, DOI 10.1016/j.carres.2005.03.007; MISRA AK, 1995, CARBOHYD RES, V278, P103; Misra AK, 1997, INDIAN J CHEM B, V36, P308; MOOTOO DR, 1989, TETRAHEDRON LETT, V30, P2363, DOI 10.1016/S0040-4039(01)80399-3; MOOTOO DR, 1988, J AM CHEM SOC, V110, P5583, DOI 10.1021/ja00224a060; Nimmich W, 1997, J CLIN MICROBIOL, V35, P1112, DOI 10.1128/JCM.35.5.1112-1117.1997; NOWICKI B, 1988, AM J PATHOL, V133, P1; Nowicki Bogdan J., 1996, P341; OGAWA T, 1981, CARBOHYD RES, V93, pC1, DOI 10.1016/S0008-6215(00)80764-8; Pandey S, 2009, SYNTHESIS-STUTTGART, P2584, DOI 10.1055/s-0029-1217401; PEARLMAN WM, 1967, TETRAHEDRON LETT, P1663; Pozsgay V, 2008, CURR TOP MED CHEM, V8, P126, DOI 10.2174/156802608783378864; RAY AK, 1990, CARBOHYD RES, V197, P93, DOI 10.1016/0008-6215(90)84132-E; Roy Rene, 2004, Drug Discov Today Technol, V1, P327, DOI 10.1016/j.ddtec.2004.10.005; Sau A, 2012, CARBOHYD RES, V352, P18, DOI 10.1016/j.carres.2012.01.026; Schmidt RR, 1982, ANGEW CHEM, V94, P790; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; VEENEMAN GH, 1990, TETRAHEDRON LETT, V31, P1331, DOI 10.1016/S0040-4039(00)88799-7; Warren John W., 1996, P3	37	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37291	10.1371/journal.pone.0037291	http://dx.doi.org/10.1371/journal.pone.0037291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662142	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300032
J	Verbeek, E; Oliver, MH; Waas, JR; McLeay, LM; Blache, D; Matthews, LR				Verbeek, Else; Oliver, Mark Hope; Waas, Joseph Rupert; McLeay, Lance Maxwell; Blache, Dominique; Matthews, Lindsay Ross			Reduced Cortisol and Metabolic Responses of Thin Ewes to an Acute Cold Challenge in Mid-Pregnancy: Implications for Animal Physiology and Welfare	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; BODY CONDITION SCORE; FEED RESTRICTION; PLASMA LEPTIN; FETAL-GROWTH; PERICONCEPTIONAL UNDERNUTRITION; CIRCULATING LEPTIN; NUTRITIONAL-STATUS; HORMONAL PROFILES; BLOOD METABOLITES	Background: Low food availability leading to reductions in Body Condition Score (BCS; 0 indicates emaciation and 5 obesity) in sheep often coincides with low temperatures associated with the onset of winter in New Zealand. The ability to adapt to reductions in environmental temperature may be impaired in animals with low BCS, in particular during pregnancy when metabolic demand is higher. Here we assess whether BCS affects a pregnant animal's ability to cope with cold challenges. Methods: Eighteen pregnant ewes with a BCS of 2.7 +/- 0.1 were fed to attain low (LBC: BCS2.3 +/- 0.1), medium (MBC: BCS3.2 +/- 0.2) or high BCS (HBC: BCS3.6 +/- 0.2). Shorn ewes were exposed to a 6-h acute cold challenge in a climate-controlled room (wet and windy conditions, 4.4 +/- 0.1 degrees C) in mid-pregnancy. Blood samples were collected during the BCS change phase, acute cold challenge and recovery phase. Results: During the BCS change phase, plasma glucose and leptin concentrations declined while free fatty acids (FFA) increased in LBC compared to MBC (P<0.01, P<0.01 and P<0.05, respectively) and HBC ewes (P<0.05, P<0.01 and P<0.01, respectively). During the cold challenge, plasma cortisol concentrations were lower in LBC than MBC (P<0.05) and HBC ewes (P<0.05), and FFA and insulin concentrations were lower in LBC than HBC ewes (P<0.05 and P<0.001, respectively). Leptin concentrations declined in MBC and HBC ewes while remaining unchanged in LBC ewes (P<0.01). Glucose concentrations and internal body temperature (T-core) increased in all treatments, although peak T-core tended to be higher in HBC ewes (P<0.1). During the recovery phase, T4 concentrations were lower in LBC ewes (P<0.05). Conclusion: Even though all ewes were able to increase T-core and mobilize glucose, low BCS animals had considerably reduced cortisol and metabolic responses to a cold challenge in mid-pregnancy, suggesting that their ability to adapt to cold challenges through some of the expected pathways was reduced.	[Verbeek, Else; Waas, Joseph Rupert; McLeay, Lance Maxwell] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Verbeek, Else; Matthews, Lindsay Ross] AgResearch Ltd, Anim Behav & Welf, Hamilton, New Zealand; [Oliver, Mark Hope] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Blache, Dominique] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Waikato; AgResearch - New Zealand; University of Auckland; University of Western Australia	Verbeek, E (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	else.verbeek@csiro.au	Blache, Dominique/H-4991-2014; Verbeek, Else/H-2814-2013	Blache, Dominique/0000-0003-3476-3068; Verbeek, Else/0000-0002-6769-8314; Verbeek, Else/0000-0002-1223-3480; Oliver, Mark/0000-0002-0359-2297	Beef+Lamb NZ [06AR/CS01]; Meat and Livestock Australia [06AR/CS01]; Foundation for Research, Science and Technology [C10X0312]	Beef+Lamb NZ; Meat and Livestock Australia(Meat and Livestock Australia); Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The study received combined funding from Beef+Lamb NZ (http://www.beeflambnz.co.nz) and Meat and Livestock Australia (http://www.mla.com.au/Home; grant number: 06AR/CS01). Additional funding was received from the Foundation for Research, Science and Technology (grant number: C10X0312; http://www.frst.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana A, 2005, CAN J ANIM SCI, V85, P101, DOI 10.4141/A04-020; Asakuma S, 2003, COMP BIOCHEM PHYS A, V134, P329, DOI 10.1016/S1095-6433(02)00269-6; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Blache D, 2000, J ENDOCRINOL, V165, P625, DOI 10.1677/joe.0.1650625; Blache D, 2008, ANIM FEED SCI TECH, V147, P140, DOI 10.1016/j.anifeedsci.2007.09.014; Blum W F, 1994, Growth Regul, V4 Suppl 1, P11; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Caldeira RM, 2007, SMALL RUMINANT RES, V68, P233, DOI 10.1016/j.smallrumres.2005.08.027; Caldeira RM, 2007, SMALL RUMINANT RES, V68, P242, DOI 10.1016/j.smallrumres.2005.08.026; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; Daniel JA, 2002, J ANIM SCI, V80, P1083; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; DELFA R, 1989, ANIM PROD, V49, P327, DOI 10.1017/S0003356100032487; Ekpe ED, 2000, CAN J ANIM SCI, V80, P87, DOI 10.4141/A99-028; Faulconnier Y, 2001, BRIT J NUTR, V85, P299, DOI 10.1079/BJN2000275; Fernandez C, 1997, SMALL RUMINANT RES, V26, P277, DOI 10.1016/S0921-4488(97)00007-2; Fernandez C, 1998, SMALL RUMINANT RES, V27, P159, DOI 10.1016/S0921-4488(97)00034-5; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Goldstein DS, 2007, STRESS, V10, P109, DOI 10.1080/10253890701288935; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; Jaquiery AL, 2006, J PHYSIOL-LONDON, V572, P109, DOI 10.1113/jphysiol.2006.105734; Jessop NS, 2000, FARM ANIMAL METABOLISM AND NUTRITION, P149, DOI 10.1079/9780851993782.0149; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Kenyon PR, 2003, NEW ZEAL VET J, V51, P200, DOI 10.1080/00480169.2003.36368; Korhonen T, 2005, COMP BIOCHEM PHYS A, V140, P217, DOI 10.1016/j.cbpb.2005.01.006; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Korte SM, 2009, VET J, V182, P378, DOI 10.1016/j.tvjl.2009.08.023; Li BT, 2000, CAN J ANIM SCI, V80, P97, DOI 10.4141/A99-041; Luther J, 2007, BIOL REPROD, V77, P343, DOI 10.1095/biolreprod.107.061440; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McMullen S, 2005, PLACENTA, V26, P25, DOI 10.1016/j.placenta.2004.04.010; Meza-Herrera CA, 2007, REPROD DOMEST ANIM, V42, P461, DOI 10.1111/j.1439-0531.2006.00807.x; Miller DR, 2009, J ANIM SCI, V87, P3167, DOI 10.2527/jas.2009-1825; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; NIWA, 2008, NAT CLIM SUMM; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OLIVER MH, 1993, PEDIATR RES, V34, P62, DOI 10.1203/00006450-199307000-00015; Pijlman FTA, 2003, EUR NEUROPSYCHOPHARM, V13, P369, DOI 10.1016/S0924-977X(03)00040-3; Pijlman FTA, 2002, BEHAV BRAIN RES, V136, P365, DOI 10.1016/S0166-4328(02)00128-6; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sano H, 1999, J ANIM SCI, V77, P2564; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SASAKI Y, 1980, J PHYSIOL-LONDON, V306, P323, DOI 10.1113/jphysiol.1980.sp013399; SLEE J, 1972, J PHYSIOL-LONDON, V227, P51, DOI 10.1113/jphysiol.1972.sp010019; Thomas L, 2001, J ENDOCRINOL, V169, P465, DOI 10.1677/joe.0.1690465; Tilbrook AJ, 2006, FRONT NEUROENDOCRIN, V27, P285, DOI 10.1016/j.yfrne.2006.06.002; Turner AI, 2011, SEX STEROIDS, P115; Vickers MH, 1999, GROWTH HORM IGF RES, V9, P236, DOI 10.1054/ghir.1999.0114; VOLLENWEIDER P, 1993, J CLIN INVEST, V92, P147, DOI 10.1172/JCI116542; Wallace JM, 2000, PLACENTA, V21, P100, DOI 10.1053/plac.1999.0440; Wallace JM, 1999, BIOL REPROD, V61, P101, DOI 10.1095/biolreprod61.1.101; WHEATON JE, 1993, ANIM REPROD SCI, V33, P127, DOI 10.1016/0378-4320(93)90111-4	60	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37315	10.1371/journal.pone.0037315	http://dx.doi.org/10.1371/journal.pone.0037315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662144	gold, Green Submitted, Green Published			2022-12-25	WOS:000305342300034
J	Yuan, SG; Le Roy, K; Venken, T; Lammens, W; Van den Ende, W; De Maeyer, M				Yuan, Shuguang; Le Roy, Katrien; Venken, Tom; Lammens, Willem; Van den Ende, Wim; De Maeyer, Marc			pKa Modulation of the Acid/Base Catalyst within GH32 and GH68: A Role in Substrate/Inhibitor Specificity?	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; PH-DEPENDENT PROPERTIES; CELL-WALL INVERTASE; CRYSTAL-STRUCTURES; BETA-FRUCTOSIDASE; PK(A) VALUES; GLYCOSYL HYDROLASES; THERMOTOGA-MARITIMA; ASPERGILLUS-AWAMORI; CICHORIUM-INTYBUS	Glycoside hydrolases of families 32 (GH32) and 68 (GH68) belong to clan GH-J, containing hydrolytic enzymes (sucrose/fructans as donor substrates) and fructosyltransferases (sucrose/fructans as donor and acceptor substrates). In GH32 members, some of the sugar substrates can also function as inhibitors, this regulatory aspect further adding to the complexity in enzyme functionalities within this family. Although 3D structural information becomes increasingly available within this clan and huge progress has been made on structure-function relationships, it is not clear why some sugars bind as inhibitors without being catalyzed. Conserved aspartate and glutamate residues are well known to act as nucleophile and acid/bases within this clan. Based on the available 3D structures of enzymes and enzyme-ligand complexes as well as docking simulations, we calculated the pKa of the acid-base before and after substrate binding. The obtained results strongly suggest that most GH-J members show an acid-base catalyst that is not sufficiently protonated before ligand entrance, while the acid-base can be fully protonated when a substrate, but not an inhibitor, enters the catalytic pocket. This provides a new mechanistic insight aiming at understanding the complex substrate and inhibitor specificities observed within the GH-J clan. Moreover, besides the effect of substrate entrance on its own, we strongly suggest that a highly conserved arginine residue (in the RDP motif) rather than the previously proposed Tyr motif (not conserved) provides the proton to increase the pKa of the acid-base catalyst.	[Yuan, Shuguang; Le Roy, Katrien; Lammens, Willem; Van den Ende, Wim] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Mol Plant Physiol, Heverlee, Belgium; [Yuan, Shuguang; Venken, Tom; De Maeyer, Marc] Katholieke Univ Leuven, Div Biochem Mol & Struct Biol, Dept Chem, Lab Biomol Modelling, Louvain, Belgium	KU Leuven; KU Leuven	Yuan, SG (corresponding author), Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Mol Plant Physiol, Heverlee, Belgium.	wim.vandenende@bio.kuleuven.be; marc.demaeyer@fys.kuleuven.be	Yuan, Shuguang/C-3615-2013; YUAN, SHUGUANG/S-9686-2019; Van Den Ende, Wim/I-6899-2013	YUAN, SHUGUANG/0000-0001-9858-4742; Van Den Ende, Wim/0000-0003-1137-3614; Venken, Tom/0000-0003-0773-1810	FWO Vlaanderen [G.0379.09, PDO-08-00246];  [DBOF/08/31];  [PDMK/09/104]	FWO Vlaanderen(FWO); ; 	SY was supported by DBOF/08/31. WVdE and MDM are supported by G.0379.09 (FWO Vlaanderen). KLR is supported by PDO-08-00246 (FWO Vlaanderen). WL was supported by PDMK/09/104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alexov E, 2003, PROTEINS, V50, P94, DOI 10.1002/prot.10265; Altenbach D, 2005, FEBS LETT, V579, P4647, DOI 10.1016/j.febslet.2005.07.034; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; [Anonymous], PYM MOL GRAPH SYST V; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bjarnadottir U, 2010, PROTEIN SCI, V19, P2485, DOI 10.1002/pro.530; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Coutinho PM, CARBOHYDRATE ACTIVE, P3; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies Matthew N., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-18; De Roover J, 1999, PHYSIOL PLANTARUM, V106, P28, DOI 10.1034/j.1399-3054.1999.106104.x; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; Esawy MA, 2008, BRAZ J CHEM ENG, V25, P237, DOI 10.1590/S0104-66322008000200003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fukamizo T, 2000, J BIOL CHEM, V275, P25633, DOI 10.1074/jbc.M002574200; Grigoriev IV, 1999, P NATL ACAD SCI USA, V96, P14318, DOI 10.1073/pnas.96.25.14318; Gunner MR, 2006, BBA-BIOENERGETICS, V1757, P942, DOI 10.1016/j.bbabio.2006.06.005; Hajjar E, 2009, J PHYS CHEM A, V113, P11783, DOI 10.1021/jp902930u; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOJ PB, 1995, PLANT J, V7, P367, DOI 10.1046/j.1365-313X.1995.7030367.x; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; Kongsted J, 2007, BIOCHEMISTRY-US, V46, P13581, DOI 10.1021/bi7016365; KOSHLAND DE, 1954, J BIOL CHEM, V208, P139; Kukic P, 2010, PROTEINS, V78, P971, DOI 10.1002/prot.22621; Kulminskaya AA, 2003, BBA-PROTEINS PROTEOM, V1650, P22, DOI 10.1016/S1570-9639(03)00187-0; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Lawson SL, 1997, BIOCHEMISTRY-US, V36, P2257, DOI 10.1021/bi9620215; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liebl W, 1998, APPL MICROBIOL BIOT, V50, P55, DOI 10.1007/s002530051256; Mason AC, 2008, PROTEINS, V71, P81, DOI 10.1002/prot.21657; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Onufriev A, 2001, BIOCHEMISTRY-US, V40, P3413, DOI 10.1021/bi002740q; Polgar T, 2007, J CHEM INF MODEL, V47, P2366, DOI 10.1021/ci700223p; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; SCOTTI PA, 1995, FEBS LETT, V360, P307, DOI 10.1016/0014-5793(95)00099-U; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; Trujillo LE, 2001, ENZYME MICROB TECH, V28, P139, DOI 10.1016/S0141-0229(00)00290-8; Tynan-Connolly BM, 2007, PROTEIN SCI, V16, P239, DOI 10.1110/ps.062538707; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	55	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37453	10.1371/journal.pone.0037453	http://dx.doi.org/10.1371/journal.pone.0037453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662155	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300045
J	Franklin, MT; Ritland, CE; Myers, JH; Cory, JS				Franklin, Michelle T.; Ritland, Carol E.; Myers, Judith H.; Cory, Jenny S.			Multiple Mating and Family Structure of the Western Tent Caterpillar, Malacosoma californicum pluviale: Impact on Disease Resistance	PLOS ONE			English	Article							GENETIC DIVERSITY; HOST RACES; FITNESS; HETEROZYGOSITY; LEPIDOPTERA; INFECTION; OUTBREAKS; BEHAVIOR; POPULATIONS; POLYANDRY	Background: Levels of genetic diversity can strongly influence the dynamics and evolutionary changes of natural populations. Survival and disease resistance have been linked to levels of genetic diversity in eusocial insects, yet these relationships remain untested in gregarious insects where disease transmission can be high and selection for resistance is likely to be strong. Methodology/Principal Findings: Here we use 8 microsatellite loci to examine genetic variation in 12 families of western tent caterpillars, Malacosoma californicum pluviale from four different island populations to determine the relationship of genetic variability to survival and disease resistance. In addition these genetic markers were used to elucidate the population structure of western tent caterpillars. Multiple paternity was revealed by microsatellite markers, with the number of sires estimated to range from one to three per family (mean +/- SE = 1.92 +/- 0.23). Observed heterozygosity (H-O) of families was not associated to the resistance of families to a nucleopolyhedrovirus (NPV) (r = 0.161, F-1,F-12 = 0.271, P = 0.614), a major cause of mortality in high-density populations, but was positively associated with larval survival (r = 0.635, F-1,F-10 = 5.412, P = 0.048). Genetic differentiation among the families was high (F-ST = 0.269, P<0.0001), and families from the same island were as differentiated as were families from other islands. Conclusion/Significance: We have been able to describe and characterize 8 microsatellite loci, which demonstrate patterns of variation within and between families of western tent caterpillars. We have discovered an association between larval survival and family-level heterozygosity that may be relevant to the population dynamics of this cyclic forest lepidopteran, and this will be the topic of future work.	[Franklin, Michelle T.; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Ritland, Carol E.] Univ British Columbia, Dept Forest Sci, Genet Data Ctr, Vancouver, BC V6T 1W5, Canada; [Myers, Judith H.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia	Franklin, MT (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jsc21@sfu.ca	Cory, Jenny S/M-9991-2013	Cory, Jenny S/0000-0002-4637-6439	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to JSC and JHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Cooke BJ, 2006, FOREST ECOL MANAG, V226, P110, DOI 10.1016/j.foreco.2006.01.034; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; Costa JT, 2003, P ROY SOC B-BIOL SCI, V270, P1697, DOI 10.1098/rspb.2003.2422; COSTA JT, 1993, BEHAV ECOL SOCIOBIOL, V32, P47, DOI 10.1007/BF00172222; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Ebert D, 2008, CURR OPIN MICROBIOL, V11, P290, DOI 10.1016/j.mib.2008.05.012; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Emelianov I, 2004, P ROY SOC B-BIOL SCI, V271, P97, DOI 10.1098/rspb.2003.2574; EMELIANOV I, 1995, HEREDITY, V75, P416, DOI 10.1038/hdy.1995.154; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fitzgerald T, 1995, TENT CATERPILLAR; Frid L, 2002, ECOL ENTOMOL, V27, P665, DOI 10.1046/j.1365-2311.2002.00460.x; Ganz HH, 2010, ECOLOGY, V91, P1263, DOI 10.1890/09-1243.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedrick PW, 2000, GENETICS POPULATIONS, P408; HOCHBERG ME, 1991, OIKOS, V61, P291, DOI 10.2307/3545236; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; King KC, 2011, EVOLUTION, V65, P1474, DOI 10.1111/j.1558-5646.2010.01215.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Myers JH, 1998, ECOLOGY, V79, P1111, DOI 10.1890/0012-9658(1998)079[1111:SIOOFL]2.0.CO;2; Myers JH, 2000, POPUL ECOL, V42, P231, DOI 10.1007/PL00012002; Nei M., 1987, MOL EVOLUTIONARY GEN; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Parker BJ, 2010, J ANIM ECOL, V79, P863, DOI 10.1111/j.1365-2656.2010.01690.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SCHMIDHEMPEL P, 1994, PHILOS T R SOC B, V346, P313, DOI 10.1098/rstb.1994.0148; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Torres-Vila LM, 2004, BEHAV ECOL SOCIOBIOL, V55, P315, DOI 10.1007/s00265-003-0712-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WELLINGTON WG, 1962, J INSECT PATHOL, V4, P285; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wilson K., 2008, PHENOTYPIC PLASTICIT, V44, P137; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	52	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37472	10.1371/journal.pone.0037472	http://dx.doi.org/10.1371/journal.pone.0037472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655050	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338900025
J	Huang, BT; Chang, PY; Su, CH; Chao, CCK; Sue, LC				Huang, Bo-Tsang; Chang, Pu-Yuan; Su, Ching-Hua; Chao, Chuck C-K; Sue Lin-Chao			Gas7-Deficient Mouse Reveals Roles in Motor Function and Muscle Fiber Composition during Aging	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; TERMINAL SCHWANN-CELLS; RAT SOLEUS MUSCLE; MULTIJOINT MOVEMENTS; GAS7; PROTEIN; GROWTH; ISOFORMS; MODEL; LEADS	Background: Growth arrest-specific gene 7 (Gas7) has previously been shown to be involved in neurite outgrowth in vitro; however, its actual role has yet to be determined. To investigate the physiological function of Gas7 in vivo, here we generated a Gas7-deficient mouse strain with a labile Gas7 mutant protein whose functions are similar to wild-type Gas7. Methodology/Principal Findings: Our data show that aged Gas7-deficient mice have motor activity defects due to decreases in the number of spinal motor neurons and in muscle strength, of which the latter may be caused by changes in muscle fiber composition as shown in the soleus. In cross sections of the soleus of Gas7-deficient mice, gross morphological features and levels of myosin heavy chain I (MHC I) and MHC II markers revealed significantly fewer fast fibers. In addition, we found that nerve terminal sprouting, which may be associated with slow and fast muscle fiber composition, was considerably reduced at neuromuscular junctions (NMJ) during aging. Conclusions/Significance: These findings indicate that Gas7 is involved in motor neuron function associated with muscle strength maintenance.	[Huang, Bo-Tsang; Sue Lin-Chao] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Bo-Tsang; Su, Ching-Hua] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Pu-Yuan; Chao, Chuck C-K] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Chang Gung University	Huang, BT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Institute of Molecular Biology, Academia Sinica; National Science Council [NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011]; Academia Sinica [2323]	Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by an intramural fund from the Institute of Molecular Biology, Academia Sinica, and by a grant from the National Science Council (NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011), http://web1.nsc.gov.tw/mp.aspx?mp=7 and theme project of Academia Sinica (2323), http://www.sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2009, J BIOL CHEM, V284, P32695, DOI 10.1074/jbc.M109.035998; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Bear MF, 1996, NEUROSCIENCE EXPLORI; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Boron WF, 2003, MEDICAL PHYSL; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Campana ALM, 2003, EUR J NEUROSCI, V17, P2135, DOI 10.1046/j.1460-9568.2003.02631.x; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Durieux AC, 2009, J PHYSIOL-LONDON, V587, P3703, DOI 10.1113/jphysiol.2009.171355; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Garwicz M, 2002, BRAIN RES REV, V40, P152, DOI 10.1016/S0165-0173(02)00198-4; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; GUTMANN E, 1972, Ceskoslovenska Fysiologie, V21, P9; Hayworth CR, 2006, J NEUROSCI, V26, P6873, DOI 10.1523/JNEUROSCI.1086-06.2006; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; KUGELBERG E, 1976, J NEUROL SCI, V27, P269, DOI 10.1016/0022-510X(76)90001-0; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; LARSSON L, 1995, PROG NEUROBIOL, V45, P397, DOI 10.1016/0301-0082(95)98601-Z; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lazakovitch EM, 1999, GENOMICS, V61, P298, DOI 10.1006/geno.1999.5964; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.2007; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Prochazka A, 2002, PROG BRAIN RES, V137, P109; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; REISER PJ, 1985, J BIOL CHEM, V260, P9077; RondiReig L, 1997, NEUROSCIENCE, V77, P955, DOI 10.1016/S0306-4522(96)00518-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; SCHENAU GJV, 1995, HUM MOVEMENT SCI, V14, P511, DOI 10.1016/0167-9457(95)00026-1; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stigger F, 2011, EXP NEUROL, V228, P183, DOI 10.1016/j.expneurol.2011.01.001; SUGIURA T, 1992, ACTA PHYSIOL SCAND, V144, P419, DOI 10.1111/j.1748-1716.1992.tb09315.x; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081; VANSOEST AJ, 1995, HUM MOVEMENT SCI, V14, P391, DOI 10.1016/0167-9457(95)00022-4; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094	64	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37702	10.1371/journal.pone.0037702	http://dx.doi.org/10.1371/journal.pone.0037702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	23166618	Green Published, Green Submitted, gold			2022-12-25	WOS:000305342300085
J	Lee, CL; Lin, YT; Chang, FR; Chen, GY; Backlund, A; Yang, JC; Chen, SL; Wu, YC				Lee, Chia-Lin; Lin, Ying-Ting; Chang, Fang-Rong; Chen, Guan-Yu; Backlund, Anders; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang			Synthesis and Biological Evaluation of Phenanthrenes as Cytotoxic Agents with Pharmacophore Modeling and ChemGPS-NP Prediction as Topo II Inhibitors	PLOS ONE			English	Article							DENBINOBIN INDUCES APOPTOSIS; CANCER; CELLS	In a structure-activity relationship (SAR) study, 3-methoxy-1,4-phenanthrenequinones, calanquinone A (6a), denbinobin (6b), 5-OAc-calanquinone A (7a) and 5-OAc-denbinobin (7b), have significantly promising cytotoxicity against various human cancer cell lines (IC50 0.08-1.66 mu g/mL). Moreover, we also established a superior pharmacophore model for cytotoxicity (r = 0.931) containing three hydrogen bond acceptors (HBA1, HBA2 and HBA3) and one hydrophobic feature (HYD) against MCF-7 breast cancer cell line. The pharmacophore model indicates that HBA3 is an essential feature for the oxygen atom of 5-OH in 6a-b and for the carbonyl group of 5-OCOCH3 in 7a-b, important for their cytotoxic properties. The SAR for moderately active 5a-b (5-OCH3), and highly active 6a-b and 7a-b, are also elaborated in a spatial aspect model. Further rational design and synthesis of new cytotoxic phenanthrene analogs can be implemented via this model. Additionally, employing a ChemGPS-NP based model for cytotoxicity mode of action (MOA) provides support for a preliminary classification of compounds 6a-b as topoisomerase II inhibitors.	[Lee, Chia-Lin; Wu, Yang-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lee, Chia-Lin; Chen, Guan-Yu; Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Lin, Ying-Ting] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Backlund, Anders] Uppsala Univ, BMC, Dept Med Chem, Div Pharmacognosy, Uppsala, Sweden; [Wu, Yang-Chang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Uppsala University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, CL (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	aaronfrc@kmu.edu.tw; yachwu@mail.cmu.edu.tw	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	National Science Council, Taiwan [NSC99-2113-M-039-003]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-C-111-002]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from National Science Council, Taiwan awarded to YW (NSC99-2113-M-039-003) and the Department of Health, Executive Yuan, Taiwan awarded to KMU (DOH99-TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P155, DOI 10.1016/j.jtice.2008.07.010; Chen TH, 2008, N-S ARCH PHARMACOL, V378, P447, DOI 10.1007/s00210-008-0324-5; FARINA F, 1986, SYNTHETIC COMMUN, V16, P1015, DOI 10.1080/00397918608056343; Huang YC, 2005, J BIOMED SCI, V12, P113, DOI 10.1007/s11373-004-8171-y; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; Kraus GA, 2002, TETRAHEDRON LETT, V43, P9597, DOI 10.1016/S0040-4039(02)02411-5; Kraus GA, 2002, TETRAHEDRON LETT, V43, P5319, DOI 10.1016/S0040-4039(02)01026-2; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Kuo CT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-43; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee CL, 2008, BIOORG MED CHEM LETT, V18, P4275, DOI 10.1016/j.bmcl.2008.06.099; Lee CL, 2009, J NAT PROD, V72, P210, DOI 10.1021/np800622a; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Magwere T, 2009, BRIT J PHARMACOL, V157, P1172, DOI 10.1111/j.1476-5381.2009.00286.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rosen J, 2009, QSAR COMB SCI, V28, P436, DOI 10.1002/qsar.200810162; Sadiq AA, 2010, INVEST NEW DRUG, V28, P20, DOI 10.1007/s10637-008-9209-1; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Schmalle HW, 2001, ARKIVOC, V1, P88; Yang CR, 2009, BRIT J PHARMACOL, V157, P1175, DOI 10.1111/j.1476-5381.2009.00237.x; Yang KC, 2005, WORLD J GASTROENTERO, V11, P3040, DOI 10.3748/wjg.v11.i20.3040	21	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37897	10.1371/journal.pone.0037897	http://dx.doi.org/10.1371/journal.pone.0037897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22253887	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600038
J	Huang, BL; Lv, CQ; Zhao, YL; Huang, R				Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong			A Novel Strain D5 Isolated from Acacia confusa	PLOS ONE			English	Article							NITROGEN-FIXATION; SP NOV.; SYM PLASMID; NODULATION; RHIZOBIA; NODULES; LEGUMES; MIMOSA; ROOTS	We isolated a novel strain D5 from nodules of Acacia confusa. Under strict sterile conditions the strain could successfully nodulate Acacia confusa, A. crassicarpa and A. mangium, with nitrogenase activity ranging from 18.90 to 19.86 nmol.g(-1).min(-1). In the phylogenetic tree based on a complete 16S rRNA gene sequence, the sequence of strain D5 shared 99% homology with that of four species of genus Pseudomonas. The 685 bp nodA fragment amplified from strain D5 shared 95% homology with the nodA sequence of 9 species of genus Bradyrhizobium, with a genetic distance of 0.01682. The 740 bp nifH gene fragment was amplified from strain D5. This strain D5 nifH gene and Bradyrhizobium spp. formed a branch, showing 98% homology and a genetic distance of 0. The homology between this branch and the Bradyrhizobium spp. DG in another branch was 99%, with a genetic distance of 0.007906. These results indicate that this strain D5 is a new type of nitrogen-fixing bacterium.	[Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China	Guangxi University	Huang, BL (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China.	hnboln@126.com	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Department of Education, Guangxi Zhuang Autonomous Region [201012MS002]	Department of Education, Guangxi Zhuang Autonomous Region	This research was supported by the Scientific Research Project (201012MS002) of the Department of Education, Guangxi Zhuang Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WenXin, 2004, Scientia Agricultura Sinica, V37, P81; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; Desnoues N, 2003, MICROBIOL-SGM, V149, P2251, DOI 10.1099/mic.0.26270-0; [樊利勤 FAN Liqin], 2007, [生态科学, Ecologic Science], V26, P107; He S, 2008, ARCH MICROBIOL, V190, P1, DOI 10.1007/s00203-008-0354-x; HOOYKAAS PJJ, 1981, NATURE, V291, P351, DOI 10.1038/291351a0; Huang BL, 2007, SCI CHINA SER C, V50, P228, DOI 10.1007/s11427-007-0034-0; Huang BaoLing, 2006, Journal of Beijing Forestry University, V28, P102; Huang BaoLing, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P29; Lu Cheng-Qun, 2006, Journal of Tropical and Subtropical Botany, V14, P19; [吕成群 Lu Chengqun], 2003, [微生物学通报, Microbiology], V30, P1; [吕成群 LV ChengQun], 2008, [微生物学通报, Microbiology], V35, P215; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; [缪礼鸿 MIAO Lihong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P428; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; PLAZINSKI J, 1985, J BACTERIOL, V162, P1261, DOI 10.1128/JB.162.3.1261-1269.1985; Shang JH, 2005, BIOTECHNOLOGY, V15, P72; Shang Jun-hong, 2005, Forest Research, V18, P177; TRINICK M. J., 1965, Australian Journal of Science, V27, P263; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; TRINICK MJ, 1968, EXP AGR, V4, P243, DOI 10.1017/S0014479700004257; Trujillo ME, 2005, APPL ENVIRON MICROB, V71, P1318, DOI 10.1128/AEM.71.3.1318-1327.2005; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Wang Fengqin, 2008, Weishengwu Xuebao, V48, P1; Wang Su-ying, 2006, Weishengwu Xuebao, V46, P132; Wang XD, 2006, BIOTECHNOLOGY, V16, P24; [韦原莲 WEI Yuanlian], 2006, [西北林学院学报, Journal of Northwest Forestry College], V21, P120; Xie ZH, 2006, MICROBIOL-SGM, V152, P3535, DOI 10.1099/mic.0.29171-0; Yan YL, 2008, J AGR SCI TECHNOLOGY, V10, P45; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yi YouJin, 2007, Acta Phytopathologica Sinica, V37, P301; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0	33	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49236	10.1371/journal.pone.0049236	http://dx.doi.org/10.1371/journal.pone.0049236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166618	Green Submitted, Green Published, gold			2022-12-25	WOS:000311272300034
J	Zhang, LD; Yu, SW; Zuo, KJ; Luo, LJ; Tang, KX				Zhang, Lida; Yu, Shunwu; Zuo, Kaijing; Luo, Lijun; Tang, Kexuan			Identification of Gene Modules Associated with Drought Response in Rice by Network-Based Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COEXPRESSION NETWORKS; EXPRESSION DATA; TOOL; TOLERANCE; DATABASE; TRAITS; FAMILY; DNA	Understanding the molecular mechanisms that underlie plant responses to drought stress is challenging due to the complex interplay of numerous different genes. Here, we used network-based gene clustering to uncover the relationships between drought-responsive genes from large microarray datasets. We identified 2,607 rice genes that showed significant changes in gene expression under drought stress; 1,392 genes were highly intercorrelated to form 15 gene modules. These drought-responsive gene modules are biologically plausible, with enrichments for genes in common functional categories, stress response changes, tissue-specific expression and transcription factor binding sites. We observed that a gene module (referred to as module 4) consisting of 134 genes was significantly associated with drought response in both drought-tolerant and drought-sensitive rice varieties. This module is enriched for genes involved in controlling the response of the plant to water and embryonic development, including a heat shock transcription factor as the key regulator in the expression of ABRE-containing genes. These results suggest that module 4 is highly conserved in the ABA-mediated drought response pathway in different rice varieties. Moreover, our study showed that many hub genes clustered in rice chromosomes had significant associations with QTLs for drought stress tolerance. The relationship between hub gene clusters and drought tolerance QTLs may provide a key to understand the genetic basis of drought tolerance in rice.	[Zhang, Lida; Zuo, Kaijing; Tang, Kexuan] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yu, Shunwu; Luo, Lijun] Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences	Zhang, LD (corresponding author), Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	Shanghai Science and Technology Commission [09DJ1400504]; Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Key Project of Shanghai Science and Technology Commission (Grant No. 09DJ1400504), Genetically Modified Organisms Breeding Major Projects of China, and Chen Xing Young Scholar Award Program of Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Harrak H, 1999, PLANT PHYSIOL, V121, P557, DOI 10.1104/pp.121.2.557; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Yue B, 2005, THEOR APPL GENET, V111, P1127, DOI 10.1007/s00122-005-0040-1; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	44	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e33748	10.1371/journal.pone.0033748	http://dx.doi.org/10.1371/journal.pone.0033748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662107	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300001
J	Zhang, L; Ding, XB; Lu, RR; Feng, LG; Li, XF; Xiao, Y; Ruan, YH; Vermund, SH; Shao, YM; Qian, HZ				Zhang, Lan; Ding, Xianbin; Lu, Rongrong; Feng, Liangui; Li, Xuefeng; Xiao, Yan; Ruan, Yuhua; Vermund, Sten H.; Shao, Yiming; Qian, Han-Zhu			Predictors of HIV and Syphilis among Men Who Have Sex with Men in a Chinese Metropolitan City: Comparison of Risks among Students and Non-Students	PLOS ONE			English	Article							HIDDEN POPULATIONS; DRUG-USERS; PREVALENCE; INFECTIONS; BEHAVIOR; PROVINCE; MUNICIPALITY; ATTITUDES; HIV/AIDS; WORKERS	Background: Men who have sex with men (MSM) are at a substantial risk of HIV, given rising HIV prevalence in urban China. Adolescent and adult students often take HIV-related risk as part of sexual exploration. We compared the risks of HIV and syphilis infections and risky sexual behaviors between student and non-student among urban MSM. Methods: Respondent driven sampling approach was used to recruit men who were self-identified as MSM in Chongqing Metropolitan City in southwestern China in 2009. Each participant completed a computer-assisted self-interview which collected demographic and behavioral data, and provided blood specimens for HIV and syphilis testing. Multivariable logistic regression analyses identified predictors for HIV and syphilis infections while comparing student and non-student MSM. Results: Among 503 MSM participants, 36.4% were students, of whom 84.2% were in college. The adjusted prevalence of HIV infection was 5.5% (95% confidence interval [CI]: 2.1%-10.2%) in students and 20.9% (95% CI: 13.7%-27.5%) in non-students; the adjusted prevalence of syphilis was 4.4% (95% CI: 0.7%-9.0%) in students and 7.9% (95% CI: 3.6%-12.9%) in non-students (P = 0.12). Two groups had similar risky sexual behaviors such as number of sexual partners and exchanging sex for money. Multivariate analysis showed that students had lower HIV prevalence than non-students (adjusted odds ratio [AOR]: 0.3; 95% CI: 0.1-0.8) adjusting for age, ethnicity and other variables. Conclusion: Student MSM have lower HIV and similar syphilis prevalence compared with non-student MSM. However, due to a shorter duration of sexual experience and high prevalence of at-risk sexual behaviors among student MSM, HIV risk might be quite high in students as in non-students.	[Zhang, Lan; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Zhang, Lan; Li, Xuefeng; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ding, Xianbin; Lu, Rongrong; Feng, Liangui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Xiao, Yan] Joint United Nations Program HIV AIDS, China Off, Beijing, Peoples R China	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, L (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	xiaoy1800@163.com; ruanyuhua92@gmail.com; han-zhu.qian@vanderbilt.edu	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	United States National Institutes of Health [R01AI078933, D43TW001035, R01AI094562]; Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory for Infectious Disease Development Grant [2011SKLID102]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Development Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	United States National Institutes of Health (R01AI078933, D43TW001035, and R01AI094562), the Ministry of Science and Technology of China (2012ZX10001-002), and a Chinese State Key Laboratory for Infectious Disease Development Grant (2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; Chongqing Municipal Goverment, 2007, ADV; Chow EP, 2011, AIDS BEHAV      0403; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2001, J DRUG ISSUES, V31, P543, DOI 10.1177/002204260103100209; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Kong TSK, 2009, CHINESE MALE HOMOSEX; Leiber E, 2009, AIDS EDUC PREV, V21, P415, DOI 10.1521/aeap.2009.21.5.415; Li Chun-mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P882; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Liu L, 2009, CURR HIV RES, V7, P390, DOI 10.2174/157016209788680642; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mahfoud Z, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000386733.02425.98; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Reisner SL, 2010, AIDS CARE, V22, P577, DOI 10.1080/09540120903311482; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Tao XR, 2010, SE ASIAN J TROP MED, V41, P358; Volz E, 2008, J OFF STAT, V24, P79; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang HS, 2004, AIDS BEHAV, V8, P105, DOI 10.1023/B:AIBE.0000030242.46843.71; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhang LL, 2010, SUBST USE MISUSE, V45, P2503, DOI 10.3109/10826084.2010.487234; Zheng Jian-Dong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P337; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x	50	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37211	10.1371/journal.pone.0037211	http://dx.doi.org/10.1371/journal.pone.0037211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22662107	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500074
J	Zhang, L; Li, YG; Li, YH; Qi, L; Liu, XG; Yuan, CZ; Hus, NW; Ma, DX; Li, ZF; Yang, Q; Li, W; Li, JM				Zhang, Lei; Li, Yong-gang; Li, Yu-hua; Qi, Lei; Liu, Xin-guang; Yuan, Cun-zhong; Hus, Nai-wen; Ma, Dao-xin; Li, Zhen-feng; Yang, Qiang; Li, Wei; Li, Jian-min			Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; MEMORY T-CELLS; DISEASE-ACTIVITY; PROINFLAMMATORY CYTOKINE; AUTOIMMUNE INFLAMMATION; INFLAMED JOINTS; CROHNS-DISEASE; INTERLEUKIN 22; DISTINCT	Background: T-helper (Th) 22 is involved in the pathogenesis of inflammatory diseases. The roles of Th22 cells in the pathophysiological of ankylosing spondylitis (AS) and rheumatoid arthritis (RA) remain unsettled. So we examined the frequencies of Th22 cells, Th17 cells and Th1 cells in peripheral blood (PB) from patients with AS and patients with RA compared with both healthy controls as well as patients with osteoarthritis. Design and Methods: We studied 32 AS patients, 20 RA patients, 10 OA patients and 20 healthy controls. The expression of IL-22, IL-17 and IFN-gamma were examined in AS, RA, OA patients and healthy controls by flow cytometry. Plasma IL-22 and IL-17 levels were examined by enzyme-linked immunosorbent assay. Results: Th22 cells, Th17 cells and interleukin-22 were significantly elevated in AS and RA patients compared with OA patients and healthy controls. Moreover, Th22 cells showed positive correlation with Th17 cells as well as interleukin-22 in AS and RA patients. However, positive correlation between IL-22 and Th17 cells was only found in AS patients not in RA patients. In addition, the percentages of both Th22 cells and Th17 cells correlated positively with disease activity only in RA patients not in AS patients. Conclusions:The frequencies of both Th22 cells and Th17 cells were elevated in PB from patients with AS and patients with RA. These findings suggest that Th22 cells and Th17 cells may be implicated in the pathogenesis of AS and RA, and Th22 cells and Th17 cells may be reasonable cellular targets for therapeutic intervention.	[Zhang, Lei; Li, Yong-gang; Qi, Lei; Li, Zhen-feng; Yang, Qiang; Li, Jian-min] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Yu-hua] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Peoples R China; [Liu, Xin-guang; Ma, Dao-xin] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Cun-zhong] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Peoples R China; [Hus, Nai-wen] Shandong Univ, Prov Hosp, Dept Rheumatol, Jinan 250100, Peoples R China; [Li, Wei] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, L (corresponding author), Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China.	daoxinma@hotmail.com; jianminli123456@163.com	Li, yu/HHZ-5236-2022	Zhang, Lurong/0000-0002-0829-4942; Liang, Guoqiang/0000-0002-2355-444X; Liu, Haiyan/0000-0002-4652-469X; Liu, Xin Guang/0000-0001-9033-9099; Yao, Fei/0000-0002-6936-4553; Li, Yonggang/0000-0001-8280-4827	National Natural Science Foundation [30600680, 81070407, 30973018]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [yzc21300071613082, yzc10147]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407 and 30973018), the Shandong Technological Development Project (2005BS03022, Q2008C07, and BS2009SW014), and Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (yzc21300071613082, yzc10147). (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.art.sdu.edu.cn/2011/0321/931.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	187	202	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31000	10.1371/journal.pone.0031000	http://dx.doi.org/10.1371/journal.pone.0031000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485125	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500001
J	Lee, CT; Zhong, LW; Mace, TA; Repasky, EA				Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.			Elevation in Body Temperature to Fever Range Enhances and Prolongs Subsequent Responsiveness of Macrophages to Endotoxin Challenge	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK PROTEINS; NF-KAPPA-B; LIPOPOLYSACCHARIDE TOLERANCE; THERMOREGULATORY RESPONSES; SYSTEMIC INFLAMMATION; HOST-DEFENSE; CYTOKINE; HYPERTHERMIA; ACTIVATION	Macrophages are often considered the sentries in innate immunity, sounding early immunological alarms, a function which speeds the response to infection. Compared to the large volume of studies on regulation of macrophage function by pathogens or cytokines, relatively little attention has been devoted to the role of physical parameters such as temperature. Given that temperature is elevated during fever, a long-recognized cardinal feature of inflammation, it is possible that macrophage function is responsive to thermal signals. To explore this idea, we used LPS to model an aseptic endotoxin induced inflammatory response in BALB/c mice and found that raising mouse body temperature by mild external heat treatment significantly enhances subsequent LPS-induced release of TNF-alpha into the peritoneal fluid. It also reprograms macrophages, resulting in sustained subsequent responsiveness to LPS, i.e., this treatment reduces "endotoxin tolerance" in vitro and in vivo. At the molecular level, elevating body temperature of mice results in a increase in LPS-induced downstream signaling including enhanced phosphorylation of IKK and I kappa B, NF kappa B nuclear translocation and binding to the TNF-alpha promoter in macrophages upon secondary stimulation. Mild heat treatment also induces expression of HSP70 and use of HSP70 inhibitors (KNK437 or Pifithrin-mu) largely abrogates the ability of the thermal treatment to enhance TNF-alpha, suggesting that the induction of HSP70 is important for mediation of thermal effects on macrophage function. Collectively, these results support the idea that there has been integration between the evolution of body temperature regulation and macrophage function that could help to explain the known survival benefits of fever in organisms following infection.	[Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Lee, CT (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	elizabeth.repasky@roswellpark.org	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	NIH [P01 CA094045, R01 CA135368, R01 CA071599]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants NIH P01 CA094045, R01 CA135368 and R01 CA071599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINS C, 1991, PHYSIOL BEHAV, V50, P461, DOI 10.1016/0031-9384(91)90095-6; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; ASTIZ ME, 1995, CRIT CARE MED, V23, P9, DOI 10.1097/00003246-199501000-00006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BLATTEIS CM, 1980, EXPERIENTIA, V36, P1086, DOI 10.1007/BF01965985; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Dai WJ, 1997, J IMMUNOL, V158, P5297; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Depraetere V, 2000, NAT CELL BIOL, V2, pE104, DOI 10.1038/35014098; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FREUDENBERG MA, 1988, INFECT IMMUN, V56, P1352, DOI 10.1128/IAI.56.5.1352-1357.1988; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; Gordon CJ, 1993, FEVER TEMPERATURE RE, P45; Guptill V, 2011, ANESTHESIOLOGY, V114, P1190, DOI 10.1097/ALN.0b013e318212515b; HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Hasday JD, 1996, INFLUENCE TEMPERATUR; Horan P K, 1990, Methods Cell Biol, V33, P469; Ivanov AI, 2000, AUTON NEUROSCI-BASIC, V85, P111, DOI 10.1016/S1566-0702(00)00229-0; Jiang QQ, 1999, INFECT IMMUN, V67, P1539; Jiang QQ, 2000, INFECT IMMUN, V68, P1265, DOI 10.1128/IAI.68.3.1265-1270.2000; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Kluger M J, 1979, Int Rev Physiol, V20, P209; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Kluger MJ., 1979, FEVER ITS BIOL EVOLU; Kluger MJ, 1991, ADAPTIVE VALUE FEVER, P105; Kox M, 2011, CRIT CARE MED, V39, P1866, DOI 10.1097/CCM.0b013e3182190d5d; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Lenz AM, 2011, CYTOKINE, V53, P84, DOI 10.1016/j.cyto.2010.08.012; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; MACKOWIAK PA, 1981, REV INFECT DIS, V3, P508; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V43, P387, DOI 10.1002/jlb.43.5.387; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Paul WE, 1989, INFLAMMATION FUNDAME, P721; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Robert R, 2009, CRIT CARE MED, V37, P2860, DOI 10.1097/CCM.0b013e3181b3a0e1; Romanovsky AA, 1998, MED HYPOTHESES, V50, P219, DOI 10.1016/S0306-9877(98)90022-6; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2006, CELL CYCLE, V5, P2195, DOI 10.4161/cc.5.19.3321; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Steiner AA, 2008, J APPL PHYSIOL, V105, P1028, DOI 10.1152/japplphysiol.90619.2008; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; TITE JP, 1991, J IMMUNOL, V147, P3161; Torigoe T, 2009, INT J HYPERTHER, V25, P610, DOI 10.3109/02656730903315831; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Xaus J, 2001, IMMUNOBIOLOGY, V204, P543, DOI 10.1078/0171-2985-00091; Yokota S, 2000, CANCER RES, V60, P2942	76	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					393	405	e30077	10.1371/journal.pone.0030077	http://dx.doi.org/10.1371/journal.pone.0030077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253887	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900040
J	Song, YX; Zhou, X; Wang, ZN; Gao, P; Li, AL; Liang, JW; Zhu, JL; Xu, YY; Xu, HM				Song, Yong-Xi; Zhou, Xin; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian			The Association between Individual SNPs or Haplotypes of Matrix Metalloproteinase 1 and Gastric Cancer Susceptibility, Progression and Prognosis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MALDI-TOF MS; PROMOTER POLYMORPHISM; NO ASSOCIATION; RISK; MMP-1; MATRIX-METALLOPROTEINASE-1; GENES; EPIDEMIOLOGY; GENOTYPES	Background: The single nucleotide polymorphisms (SNPs) in matrix metalloproteinase 1(MMP-1) play important roles in some cancers. This study examined the associations between individual SNPs or haplotypes in MMP-1 and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methods: In this case-controlled study, there were 404 patients with gastric cancer and 404 healthy controls. Seven SNPs were genotyped using the MALDI-TOF MS system. Then, SPSS software, Haploview 4.2 software, Haplo. states software and THEsias software were used to estimate the association between individual SNPs or haplotypes of MMP-1 and gastric cancer susceptibility, progression and prognosis. Results: Among seven SNPs, there were no individual SNPs correlated to gastric cancer risk. Moreover, only the rs470206 genotype had a correlation with histologic grades, and the patients with GA/AA had well cell differentiation compared to the patients with genotype GG (OR = 0.573; 95% CI: 0.353-0.929; P = 0.023). Then, we constructed a four-marker haplotype block that contained 4 common haplotypes: TCCG, GCCG, TTCG and TTTA. However, all four common haplotypes had no correlation with gastric cancer risk and we did not find any relationship between these haplotypes and clinicopathological parameters in gastric cancer. Furthermore, neither individual SNPs nor haplotypes had an association with the survival of patients with gastric cancer. Conclusions: This study evaluated polymorphisms of the MMP-1 gene in gastric cancer with a MALDI-TOF MS method in a large northern Chinese case-controlled cohort. Our results indicated that these seven SNPs of MMP-1 might not be useful as significant markers to predict gastric cancer susceptibility, progression or prognosis, at least in the Han population in northern China.	[Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China; [Zhou, Xin] China Med Univ, Dept Gynecol & Obstet, ShengJing Hosp, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; Yu, Jiguo/0000-0001-7607-475X; Stal, Per/0000-0002-9340-5298	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), the Program of Scientific and Technological Department of Liaoning Province (No. 2010225032) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1324, DOI 10.1158/1055-9965.EPI-09-0046; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Camp NJ, 2012, CANCER EPIDEM BIOMAR, V21, P176, DOI 10.1158/1055-9965.EPI-11-0845; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang WL, 2010, ASS MATRIX METALLOPR; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hettiaratchi A, 2007, BRIT J CANCER, V96, P783, DOI 10.1038/sj.bjc.6603630; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030277; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; Nam SI, 2011, LARYNGOSCOPE, V121, P171, DOI 10.1002/lary.21334; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Xu EP, 2005, J BIOCHEM BIOPH METH, V63, P222, DOI 10.1016/j.jbbm.2005.03.007; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zinzindohoue F, 2005, CLIN CANCER RES, V11, P594	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38002	10.1371/journal.pone.0038002	http://dx.doi.org/10.1371/journal.pone.0038002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	23284946	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900072
